FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Alston, CL
   Howard, C
   Oláhová, M
   Hardy, SA
   He, LP
   Murray, PG
   O'Sullivan, S
   Doherty, G
   Shield, JPH
   Hargreaves, IP
   Monavari, AA
   Knerr, I
   McCarthy, P
   Morris, AAM
   Thorburn, DR
   Prokisch, H
   Clayton, PE
   McFarland, R
   Hughes, J
   Crushell, E
   Taylor, RW
AF Alston, Charlotte L.
   Howard, Caoimhe
   Olahova, Monika
   Hardy, Steven A.
   He, Langping
   Murray, Philip G.
   O'Sullivan, Siobhan
   Doherty, Gary
   Shield, Julian P. H.
   Hargreaves, Iain P.
   Monavari, Ardeshir A.
   Knerr, Ina
   McCarthy, Peter
   Morris, Andrew A. M.
   Thorburn, David R.
   Prokisch, Holger
   Clayton, Peter E.
   McFarland, Robert
   Hughes, Joanne
   Crushell, Ellen
   Taylor, Robert W.
TI A recurrent mitochondrial p.Trp22Arg <i>NDUFB3</i> variant causes a
   distinctive facial appearance, short stature and a mild biochemical and
   clinical phenotype
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE mitochondrial disease; complex I deficiency; prognosis; dysmorphic
   features
ID COMPLEX-I DEFICIENCY; DNA MUTATIONS; DISEASE; NUCLEAR; PREVALENCE;
   DIAGNOSIS; SPECTRUM
AB Background Isolated Complex I deficiency is the most common paediatric mitochondrial disease presentation, associated with poor prognosis and high mortality. Complex I comprises 44 structural subunits with at least 10 ancillary proteins; mutations in 29 of these have so far been associated with mitochondrial disease but there are limited genotype-phenotype correlations to guide clinicians to the correct genetic diagnosis.
   Methods Patients were analysed by whole-exome sequencing, targeted capture or candidate gene sequencing. Clinical phenotyping of affected individuals was performed.
   Results We identified a cohort of 10 patients from 8 families (7 families are of unrelated Irish ancestry) all of whom have short stature (<9th centile) and similar facial features including a prominent forehead, smooth philtrum and deep-set eyes associated with a recurrent homozygous c.64T>C, p.Trp22Arg NDUFB3 variant. Two sibs presented with primary short stature without obvious metabolic dysfunction. Analysis of skeletal muscle from three patients confirmed a defect in Complex I assembly.
   Conclusions Our report highlights that the long-term prognosis related to the p.Trp22Arg NDUFB3 mutation can be good, even for some patients presenting in acute metabolic crisis with evidence of an isolated Complex I deficiency in muscle. Recognition of the distinctive facial featuresparticularly when associated with markers of mitochondrial dysfunction and/or Irish ancestryshould suggest screening for the p.Trp22Arg NDUFB3 mutation to establish a genetic diagnosis, circumventing the requirement of muscle biopsy to direct genetic investigations.
C1 [Alston, Charlotte L.; Olahova, Monika; Hardy, Steven A.; He, Langping; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Howard, Caoimhe; Monavari, Ardeshir A.; Knerr, Ina; McCarthy, Peter; Hughes, Joanne; Crushell, Ellen] Temple St Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin, Ireland.
   [Murray, Philip G.; Clayton, Peter E.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Ctr Paediat & Child Hlth, Manchester, Lancs, England.
   [Murray, Philip G.; Clayton, Peter E.] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.
   [O'Sullivan, Siobhan; Doherty, Gary] Royal Hosp Sick Children, Dept Metab Paediat, Belfast, Antrim, North Ireland.
   [Shield, Julian P. H.] Univ Bristol, Bristol, Avon, England.
   [Shield, Julian P. H.] Bristol Royal Hosp Children, Bristol, Avon, England.
   [Hargreaves, Iain P.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, England.
   [Morris, Andrew A. M.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Ctr Genom Med, Manchester, Lancs, England.
   [Thorburn, David R.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Dept Paediat, Parkville, Vic, Australia.
   [Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Munich, Germany.
C3 Newcastle University - UK; Childrens University Hospital - Temple
   Street; University of Manchester; University of Manchester; University
   of Bristol; Bristol Royal Hospital For Children; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of Manchester; Royal
   Children's Hospital Melbourne; University of Melbourne; Murdoch
   Children's Research Institute; Helmholtz Association; Helmholtz-Center
   Munich - German Research Center for Environmental Health
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI Thorburn, David/G-6266-2013; Prokisch, Holger/N-8964-2013; Maier,
   Andrea/Q-5548-2019; Hargreaves, Iain/AAJ-6757-2020; Alston,
   Charlotte/ABG-9602-2020; Hamilton-Shield, Julian/D-6297-2014; Knerr,
   Ina/S-5784-2019
OI thorburn, david/0000-0002-7725-9470; Murray, Philip/0000-0002-1480-1576;
   Hamilton-Shield, Julian/0000-0003-2601-7575; Crushell,
   Ellen/0000-0003-3768-8569; Knerr, Ina/0000-0002-4015-0658; McCarthy,
   Peter/0000-0003-0383-8688; Clayton, Peter/0000-0003-1225-4537; Alston,
   Charlotte/0000-0003-2095-5464; Prokisch, Holger/0000-0003-2379-6286;
   McFarland, Robert/0000-0002-8833-2688
FU Wellcome Trust Centre for Mitochondrial Research [096919Z/11/Z]; Medical
   Research Council (UK) Centre for Translational Muscle Disease Research
   [G0601943]; Lily Foundation; UK NHS Highly Specialised Commissioners;
   German Bundesministerium fur Bildung und Forschung (BMBF) through the
   German Network for mitochondrial disorders (mitoNET) [01GM1113C]; E-Rare
   project GENOMIT [01GM1207]; Early Career Grant from the Society for
   Endocrinology; National Institute for Health Research (NIHR) doctoral
   fellowship [NIHRHCS-D12-03-04]; MRC [G0601943] Funding Source: UKRI
FX This work was supported by grants (to RWT and RM) from The Wellcome
   Trust Centre for Mitochondrial Research (096919Z/11/Z), the Medical
   Research Council (UK) Centre for Translational Muscle Disease Research
   (G0601943), The Lily Foundation and the UK NHS Highly Specialised
   Commissioners which funds the "Rare Mitochondrial Disorders of Adults
   and Children" Diagnostic Service in Newcastle upon Tyne
   (http://www.newcastle-mitochondria.com). HP was supported by the German
   Bundesministerium fur Bildung und Forschung (BMBF) through the German
   Network for mitochondrial disorders (mitoNET, 01GM1113C) and the E-Rare
   project GENOMIT (01GM1207). This work was supported by an Early Career
   Grant from the Society for Endocrinology to PGM. CLA is the recipient of
   a National Institute for Health Research (NIHR) doctoral fellowship
   (NIHRHCS-D12-03-04).
CR [Anonymous], NHLBI GO EX SEQ PROJ
   Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Cain N, 2013, AM J CARDIOL, V112, P961, DOI 10.1016/j.amjcard.2013.05.035
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   Nishio SY, 2015, GENET TEST MOL BIOMA, V19, P209, DOI 10.1089/gtmb.2014.0252
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Pagniez-Mammeri H, 2012, MOL GENET METAB, V105, P163, DOI 10.1016/j.ymgme.2011.11.188
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
NR 24
TC 30
Z9 35
U1 0
U2 4
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD SEP
PY 2016
VL 53
IS 9
BP 634
EP 641
DI 10.1136/jmedgenet-2015-103576
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DV9TE
UT WOS:000383284200007
PM 27091925
OA Green Published, Green Accepted, hybrid
DA 2024-11-01
ER

PT J
AU Lam, FC
AF Lam, Fred C.
TI The DNA damage response - from cell biology to human disease
SO JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS
LA English
DT Review
DE DNA damage response; DNA damage repair; mutagenesis; cancer;
   neurodegeneration; neuropsychiatric disorders; premature aging; clinical
   outcomes
ID FANCONI-ANEMIA PATHWAY; MISMATCH REPAIR DEFICIENCY; STRAND BREAK REPAIR;
   TRANSCRIPTION-COUPLED REPAIR; XERODERMA-PIGMENTOSUM;
   ATAXIA-TELANGIECTASIA; TARGETED DISRUPTION; COCKAYNE-SYNDROME; MOUSE
   MODEL; GENOMIC INSTABILITY
AB Maintenance of DNA integrity is crucial for faithful transmission of the genetic code from generation to generation. Our genetic code is constantly under attack from both endogenous and exogenous sources of DNA damage. To ensure genome stability, cells have developed elegant DNA damage repair mechanisms. Defects in DNA damage repair have been linked to several human diseases including promoting oncogenesis, heritable neurodegenerative and neuromuscular diseases caused by unstable DNA repeats, neuropathies and myopathies caused by mutations and rearrangements in mitochondrial DNA, neuropsychiatric disorders, and heritable premature aging syndromes. This review will discuss our current understanding of how these underlying errors in DNA repair contribute to the clinical outcomes of patients who present with these diseases.
C1 [Lam, Fred C.] McMaster Univ, Hamilton Gen Hosp, Fac Hlth Sci, Div Neurosurg, Hamilton, ON L8L 2X2, Canada.
C3 McMaster University
RP Lam, FC (corresponding author), McMaster Univ, Hamilton Gen Hosp, Fac Hlth Sci, Div Neurosurg, Hamilton, ON L8L 2X2, Canada.
EM lamf9@mcmaster.ca
CR Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828
   Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335
   Altmann T, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0520-1
   Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004
   Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211
   Assaf Y, 2008, EXP NEUROL, V209, P181, DOI 10.1016/j.expneurol.2007.09.021
   Baranes K, 2009, EXP NEUROL, V218, P24, DOI 10.1016/j.expneurol.2009.03.026
   Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001
   Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006
   Bohgaki M, 2013, P NATL ACAD SCI USA, V110, P20982, DOI 10.1073/pnas.1320302111
   Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016
   Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7
   Carpenter DO, 2013, J ADOLESCENT HEALTH, V52, pS21, DOI 10.1016/j.jadohealth.2013.01.027
   Carreau M, 1998, BLOOD, V91, P2737, DOI 10.1182/blood.V91.8.2737.2737_2737_2744
   Casellas R, 2016, NAT REV IMMUNOL, V16, P164, DOI 10.1038/nri.2016.2
   Ceccaldi R, 2016, NAT REV MOL CELL BIO, V17, P337, DOI 10.1038/nrm.2016.48
   Chan SH, 2021, JNCI CANCER SPECT, V5, DOI 10.1093/jncics/pkaa117
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087
   Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962
   Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011
   Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066
   Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805
   Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382
   Chistiakov DA, 2010, ADV EXP MED BIOL, V685, P175
   Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Croteau DL, 2012, TRENDS GENET, V28, P624, DOI 10.1016/j.tig.2012.08.003
   Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9
   D'Errico M, 2006, EMBO J, V25, P4305, DOI 10.1038/sj.emboj.7601277
   de Andrade KC, 2019, HUM MUTAT, V40, P97, DOI 10.1002/humu.23673
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   de Villartay JP, 2015, BRIT MED BULL, V114, P157, DOI 10.1093/bmb/ldv020
   de Villartay JP, 2003, NAT REV IMMUNOL, V3, P962, DOI 10.1038/nri1247
   de Villartay JP, 2003, CURR OPIN IMMUNOL, V15, P592, DOI 10.1016/S0952-7915(03)00101-8
   de Wind N, 1998, CANCER RES, V58, P248
   DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4
   di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504
   Divine KK, 2001, MUTAT RES-DNA REPAIR, V461, P273, DOI 10.1016/S0921-8777(00)00059-8
   Drost R, 2011, CANCER CELL, V20, P797, DOI 10.1016/j.ccr.2011.11.014
   Dumitrache LC, 2017, MECH AGEING DEV, V161, P121, DOI 10.1016/j.mad.2016.04.009
   Durandy Anne, 2007, Adv Immunol, V94, P275, DOI 10.1016/S0065-2776(06)94009-7
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084
   Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629
   Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054
   Felgentreff K, 2015, J ALLERGY CLIN IMMUN, V136, P140, DOI 10.1016/j.jaci.2015.03.005
   FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3
   Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142
   Frappart PO, 2005, NAT MED, V11, P538, DOI 10.1038/nm1228
   FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630
   Galron R, 2011, J MOL NEUROSCI, V45, P202, DOI 10.1007/s12031-011-9494-6
   Garfinkel David J., 2002, Journal of Biomedicine & Biotechnology, V2, P55, DOI 10.1155/S1110724302201023
   Gatti RA, 2003, Ataxia Telangiectasia, P600
   Gennery AR, 2000, CLIN EXP IMMUNOL, V121, P1, DOI 10.1046/j.1365-2249.2000.01257.x
   Gool AJ, 1997, EMBO J, V16, P5955
   Grover S, 2012, JAMA-J AM MED ASSOC, V308, P485, DOI 10.1001/jama.2012.8780
   Guirouilh-Barbat J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00175
   Guo CW, 2015, J ALLERGY CLIN IMMUN, V136, P1007, DOI 10.1016/j.jaci.2015.06.007
   Haber JE, 2015, CELL, V162, P1183, DOI 10.1016/j.cell.2015.08.034
   Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1
   Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harhouri K, 2018, NUCLEUS-PHILA, V9, P246, DOI 10.1080/19491034.2018.1460045
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346
   HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4
   Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089
   Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232
   Ibrahim M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4098-y
   Inlora J, APTX, V3
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Jiricny J, 2000, CURR OPIN GENET DEV, V10, P157, DOI 10.1016/S0959-437X(00)00066-6
   Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447
   Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002
   Katsuki Y, 2016, ENDOCR-RELAT CANCER, V23, pT19, DOI 10.1530/ERC-16-0221
   Katyal S, 2008, MECH AGEING DEV, V129, P483, DOI 10.1016/j.mad.2008.03.008
   Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0
   Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kerzendorfer C, 2009, DNA REPAIR, V8, P1139, DOI 10.1016/j.dnarep.2009.04.018
   Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372
   Kote-Jarai Z, 2011, BRIT J CANCER, V105, P1230, DOI 10.1038/bjc.2011.383
   Kracker S, 2010, ADV EXP MED BIOL, V685, P166
   Kraemer KH, 2015, PHOTOCHEM PHOTOBIOL, V91, P452, DOI 10.1111/php.12345
   KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511
   KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241
   Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161
   Lanz MC, 2019, EMBO J, V38, DOI 10.15252/embj.2019101801
   Laugel V, 2008, J MED GENET, V45, P564, DOI 10.1136/jmg.2007.057141
   Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006
   Lavin MF, 2013, DNA REPAIR, V12, P612, DOI 10.1016/j.dnarep.2013.04.014
   Quyen PL, 2020, AM J MED GENET A, V182, P1236, DOI 10.1002/ajmg.a.61520
   Lehmann J, 2018, ANTICANCER RES, V38, P1159, DOI 10.21873/anticanres.12335
   Levy-Lahad E, 2010, NAT GENET, V42, P368, DOI 10.1038/ng0510-368
   Li JW, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24232-3
   Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131
   Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266
   Liu FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011152
   Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104
   Livingston JH, 2016, NEUROPEDIATRICS, V47, P355, DOI 10.1055/s-0036-1592307
   Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007
   Longhese MP, 2008, GENE DEV, V22, P125, DOI 10.1101/gad.1626908
   Luong TT, 2021, GENES-BASEL, V12, DOI 10.3390/genes12121919
   Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034
   Martin LJ, 2018, J NEUROPATH EXP NEUR, V77, P636, DOI 10.1093/jnen/nly040
   Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549
   MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6
   Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101
   Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Moreira MC, 1993, Ataxia with oculomotor apraxia type 2
   Morimoto M, 1993, Schimke Immunoosseous Dysplasia
   Morio T, 2017, INT J HEMATOL, V106, P357, DOI 10.1007/s12185-017-2263-8
   Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9
   Murai M, 2001, P NATL ACAD SCI USA, V98, P13379, DOI 10.1073/pnas.231329598
   Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420
   Nalepa G, 2018, NAT REV CANCER, V18, P168, DOI 10.1038/nrc.2017.116
   Natale V, 2011, AM J MED GENET A, V155A, P1081, DOI 10.1002/ajmg.a.33933
   Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885
   Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858
   Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422
   O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129
   O'Driscoll M, 2008, DNA REPAIR, V7, P1039, DOI 10.1016/j.dnarep.2008.03.018
   Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002
   Otake M, 1998, INT J RADIAT BIOL, V74, P159, DOI 10.1080/095530098141555
   Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350
   PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J
   Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2
   Perez H, 2021, ELIFE, V10, DOI [10.7554/eLife.64695, 10.7554/eLife.64695.sa0, 10.7554/eLife.64695.sa1, 10.7554/eLife.64695.sa2]
   Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2
   Pilié PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z
   Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678
   Prakash R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016600
   Qamar N, 2014, CLIN REV ALLERG IMMU, V46, P120, DOI 10.1007/s12016-013-8378-7
   Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043
   Reynolds JJ, 2013, BRAIN, V136, P14, DOI 10.1093/brain/aws310
   Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318
   Richardson C, 2004, DNA REPAIR, V3, P1149, DOI 10.1016/j.dnarep.2004.05.007
   Root H, 2016, HUM MOL GENET, V25, P3255, DOI 10.1093/hmg/ddw175
   RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013
   Ryan E, 2017, CRIT REV ONCOL HEMAT, V116, P38, DOI 10.1016/j.critrevonc.2017.05.006
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Savage SA, 2009, HEMATOL ONCOL CLIN N, V23, P215, DOI 10.1016/j.hoc.2009.01.003
   Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Seidle HF, 2005, J BIOL CHEM, V280, P20927, DOI 10.1074/jbc.M502889200
   Sharma R, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.570084
   Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526
   Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609
   Sidorova JM, 2014, Adv Genomics Genet, V5, P19
   Specks Julia, 2015, Methods Mol Biol, V1267, P413, DOI 10.1007/978-1-4939-2297-0_21
   Spring K, 2001, CANCER RES, V61, P4561
   Spry M, 2007, FRONT BIOSCI-LANDMRK, V12, P4191, DOI 10.2741/2380
   Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042
   Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0
   Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X
   Tai YC, 2007, J NATL CANCER I, V99, P1811, DOI 10.1093/jnci/djm203
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tal E, 2018, DNA REPAIR, V72, P10, DOI 10.1016/j.dnarep.2018.10.001
   Tilgner K, 2013, STEM CELLS, V31, P2015, DOI 10.1002/stem.1456
   Tiwari V, 2019, AM J HUM GENET, V105, P237, DOI 10.1016/j.ajhg.2019.06.005
   Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9
   van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002
   van Wietmarschen N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02760-1
   vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8
   Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976
   Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864
   Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010
   Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010
   Welty S, 2018, J BIOL CHEM, V293, P1353, DOI 10.1074/jbc.M117.808402
   Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287
   Whitney MA, 1996, BLOOD, V88, P49
   Wiesmueller Lisa, 2002, Journal of Biomedicine & Biotechnology, V2, P45, DOI 10.1155/S1110724302001985
   Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002
   Wilson BT, 2016, GENET MED, V18, P483, DOI 10.1038/gim.2015.110
   Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284
   Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743
   Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401
   Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004
   Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7
NR 189
TC 11
Z9 11
U1 4
U2 4
PU OAE PUBLISHING INC
PI ALHAMBRA
PA 245 E MAIN ST, ST122, ALHAMBRA, CA 91801 USA
EI 2578-5281
J9 J TRANSL GENET GENOM
JI J. Transl. Genet. Genom.
PY 2022
VL 6
IS 2
BP 204
EP 222
DI 10.20517/jtgg.2021.61
PG 19
WC Genetics & Heredity
WE Emerging Sources Citation Index (ESCI)
SC Genetics & Heredity
GA OO1I0
UT WOS:001208119200006
OA gold
DA 2024-11-01
ER

PT J
AU Tang, C
   Liang, XC
   Liu, HM
   Guo, LP
   Pi, RX
   Yang, JT
AF Tang, Chun
   Liang, Xianchun
   Liu, Hongming
   Guo, Liping
   Pi, Ruxian
   Yang, Juntao
TI Changes in mitochondrial DNA and its encoded products in alcoholic
   cirrhosis
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article
DE Alcoholic cirrhosis; mitochondria; mitochondrial DNA; cytochrome c
   oxidase 2
ID OXIDATIVE STRESS; LIVER-DISEASE; DELETION; ACETALDEHYDE; STEATOSIS;
   ADDUCTS; ETHANOL; NUMBER; MUSCLE
AB The purpose of this study was to investigate hepatic mitochondrial DNA (mtDNA) damage and changes in its encoded products in patients with alcoholic cirrhosis (AC) in order to understand disease pathogenesis. We enrolled 23 patients with AC, 26 alcoholics without cirrhosis, and 25 normal subjects in this study. Hepatic mtDNA deletions were positioned using a combination of long and accurate polymerase chain reaction (LA PCR) and gene sequencing. The mtDNA copy number was measured using real-time quantitative PCR. The expression of the mtDNA-encoded cytochrome c oxidase 2 (cox2) was detected by western blotting. A large deletion of bases located at positions 749-15486 was identified in hepatic mtDNA from AC patients. Moreover, the mtDNA copy number was significantly reduced (P<0.05), and its encoded product, cox2, was significantly downregulated (P<0.05). Collectively, our results suggest that specific deletions and reduced copy numbers of hepatic mtDNA in patients with AC is an important pathogenetic factor.
C1 [Tang, Chun; Liang, Xianchun; Liu, Hongming; Guo, Liping; Pi, Ruxian; Yang, Juntao] Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing 400042, Peoples R China.
C3 Army Medical University
RP Yang, JT (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing 400042, Peoples R China.
EM juntaoyang6@gmail.com
RI Hongming, Liu/F-9840-2018
FU National Natural Science Fund of China [30801114]
FX This study was supported by the National Natural Science Fund of China
   (project number: 30801114).
CR Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   CHEDID A, 1991, AM J GASTROENTEROL, V86, P210
   Devi SL, 2010, AMINO ACIDS, V38, P869, DOI 10.1007/s00726-009-0293-0
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008
   Elli L, 2009, DIGEST LIVER DIS, V41, P541, DOI 10.1016/j.dld.2008.12.095
   ERNST BP, 1994, MOL CELL PROBE, V8, P45, DOI 10.1006/mcpr.1994.1006
   Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7
   FERNANDEZCHECA JC, 1993, ALCOHOL, V10, P469, DOI 10.1016/0741-8329(93)90067-X
   FROMENTY B, 1995, GASTROENTEROLOGY, V108, P193, DOI 10.1016/0016-5085(95)90024-1
   Graeber MB, 1998, J NEUROSCI RES, V52, P1
   GRIVELL LA, 1989, NATURE, V341, P569, DOI 10.1038/341569a0
   Henderson NC, 2008, TOXICOLOGY, V254, P130, DOI 10.1016/j.tox.2008.08.017
   Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0
   Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007
   Mariani E, 1999, CLIN EXP IMMUNOL, V116, P19
   Mello T, 2008, MOL ASPECTS MED, V29, P17, DOI 10.1016/j.mam.2007.10.001
   Miñana JB, 2002, HEPATOLOGY, V35, P1205, DOI 10.1053/jhep.2002.32969
   Niemela Onni, 1999, Frontiers in Bioscience, V4, pD506, DOI 10.2741/Niemela
   Nieto N, 2007, HEPATOLOGY, V45, P1433, DOI 10.1002/hep.21659
   Porteous WK, 1998, EUR J BIOCHEM, V257, P192, DOI 10.1046/j.1432-1327.1998.2570192.x
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373
   Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047
   Spahr L, 2003, MED SCI MONITOR, V9, pCR6
   Stickel F, 2006, ALCOHOL ALCOHOLISM, V41, P209, DOI 10.1093/alcalc/agl011
   Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007
   Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev
   Tuma DJ, 2003, ALCOHOL RES HEALTH, V27, P285
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P376
NR 31
TC 7
Z9 7
U1 0
U2 7
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2012
VL 5
IS 3
BP 245
EP 250
PG 6
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 138RF
UT WOS:000318525400005
PM 22837799
DA 2024-11-01
ER

PT J
AU Zorov, DB
   Zorova, LD
   Andrianova, NV
   Babenko, VA
   Zorov, SD
   Pevzner, IB
   Sukhikh, GT
   Silachev, DN
AF Zorov, Dmitry B.
   Zorova, Ljubava D.
   Andrianova, Nadezda V.
   Babenko, Valentina A.
   Zorov, Savva D.
   Pevzner, Irina B.
   Sukhikh, Gennady T.
   Silachev, Denis N.
TI Isn't It Time for Establishing Mitochondrial Nomenclature Breaking
   Mitochondrial Paradigm?
SO BIOCHEMISTRY-MOSCOW
LA English
DT Review
DE mitochondria; bacteria; structure; heterogeneity; mitochondrial DNA;
   heteroplasmy; diseases; phenotype; taxonomy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; LINKED MECHANICAL-ACTIVITY;
   MULTIPOTENT STROMAL CELLS; RED-BLOOD-CELLS; ULTRASTRUCTURAL BASES;
   CARDIAC MYOCYTES; DNA DELETIONS; IN-VIVO; ORIGIN; GENOME
AB In this work, we decided to initiate a discussion concerning heterogeneity of mitochondria, suggesting that it is time to build classification of mitochondria, like the one that exists for their progenitors, alpha-proteobacteria, proposing possible separation of mitochondrial strains and maybe species. We continue to adhere to the general line that mitochondria are friends and foes: on the one hand, they provide the cell and organism with the necessary energy and signaling molecules, and, on the other hand, participate in destruction of the cell and the organism. Current understanding that the activity of mitochondria is not only limited to energy production, but also that these alternative non-energetic functions are unique and irreplaceable in the cell, allowed us to speak about the strong subordination of the entire cellular metabolism to characteristic functional manifestations of mitochondria. Mitochondria are capable of producing not only ATP, but also iron-sulfur clusters, steroid hormones, heme, reactive oxygen and nitrogen species, participate in thermogenesis, regulate cell death, proliferation and differentiation, participate in detoxification, etc. They are a mandatory attribute of eukaryotic cells, and, so far, no eukaryotic cells performing a non-parasitic or non-symbiotic life style have been found that lack mitochondria. We believe that the structural-functional intracellular, intercellular, inter-organ, and interspecific diversity of mitochondria is large enough to provide grounds for creating a mitochondrial nomenclature. The arguments for this are given in this analytical work.
C1 [Zorov, Dmitry B.; Zorova, Ljubava D.; Andrianova, Nadezda V.; Babenko, Valentina A.; Zorov, Savva D.; Pevzner, Irina B.; Silachev, Denis N.] Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119991, Russia.
   [Zorov, Dmitry B.; Zorova, Ljubava D.; Babenko, Valentina A.; Pevzner, Irina B.; Sukhikh, Gennady T.; Silachev, Denis N.] Kulakov Natl Med Res Ctr Obstet Gynecol & Perinato, Moscow 117997, Russia.
   [Zorov, Savva D.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia.
C3 Lomonosov Moscow State University; Lomonosov Moscow State University
RP Zorov, DB (corresponding author), Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow 119991, Russia.; Zorov, DB (corresponding author), Kulakov Natl Med Res Ctr Obstet Gynecol & Perinato, Moscow 117997, Russia.
EM zorov@belozersky.msu.ru
RI Andrianova, Nadezda/T-1824-2017; Zorov, Dmitry/AAB-1738-2019; Zorov,
   Savva/ABD-4306-2021; Silachev, Denis/ABE-8515-2020; Pevzner,
   Irina/S-6178-2018; Babenko, Valentina/O-4218-2015; Zorova,
   Ljubava/AAC-7286-2022
OI Zorova, Ljubava/0000-0001-9046-712X; Silachev, Denis/0000-0003-0581-9755
FU Russian Science Foundation [19-14-00173-P]
FX The work was financially supported by the Russian Science Foundation
   (grant no. 19-14-00173-P).
CR Abele D, 2002, NATURE, V420, P27, DOI 10.1038/420027a
   AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995
   AMCHENKOVA AA, 1988, J CELL BIOL, V107, P481, DOI 10.1083/jcb.107.2.481
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Anusha-Kiran Y, 2022, FREE RADICAL BIO MED, V193, P34, DOI 10.1016/j.freeradbiomed.2022.09.027
   Aryaman J, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00718
   Babenko VA, 2018, MOLECULES, V23, DOI 10.3390/molecules23030687
   Babenko VA, 2015, STEM CELL TRANSL MED, V4, P1011, DOI 10.5966/sctm.2015-0010
   BAKEEVA LE, 1981, EUR J CELL BIOL, V25, P175
   BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4
   BAKEEVA LE, 1970, BIOCHIM BIOPHYS ACTA, V216, P13, DOI 10.1016/0005-2728(70)90154-4
   Beck EA, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.925786
   Burki F, 2016, CURR BIOL, V26, pR410, DOI 10.1016/j.cub.2016.04.032
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   DEMPSEY ME, 1974, ANNU REV BIOCHEM, V43, P967, DOI 10.1146/annurev.bi.43.070174.004535
   DILISA F, 1995, J PHYSIOL-LONDON, V486, P1
   DRACHEV VA, 1986, DOKL AKAD NAUK SSSR+, V287, P1237
   Driscoll TP, 2017, MBIO, V8, DOI [10.1128/mBio.00859-17, 10.1128/mbio.00859-17]
   DUBIEL W, 1989, RBC-CELL BIOL REV, V21, P505
   Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601
   Eldarov CM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030712
   Emelyanov VV, 2003, EUR J BIOCHEM, V270, P1599, DOI 10.1046/j.1432-1033.2003.03499.x
   Emelyanov VV, 2001, FEBS LETT, V501, P11, DOI 10.1016/S0014-5793(01)02618-7
   Famintzin A.S., 1907, ZAP IMP AKAD NAUK F, V20, P1
   Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009
   Frankenberg G., 2022, AM J RESP CELL MOL, V67, P471, DOI [10.1165/rcmb.2022-0041OC, DOI 10.1165/RCMB.2022-0041OC]
   GAEHTGENS P, 1981, PFLUG ARCH EUR J PHY, V390, P278, DOI 10.1007/BF00658276
   Géminard C, 2002, BIOCELL, V26, P205
   Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359
   GRAY MW, 1983, BIOSCIENCE, V33, P693, DOI 10.2307/1309349
   Gureev AP, 2022, FEBS J, V289, P5697, DOI 10.1111/febs.16451
   HACKENBR.CR, 1968, P NATL ACAD SCI USA, V61, P598, DOI 10.1073/pnas.61.2.598
   HACKENBROCK CR, 1968, J CELL BIOL, V37, P345, DOI 10.1083/jcb.37.2.345
   HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269
   HACKENBROCK CR, 1972, ANN NY ACAD SCI, V195, P492, DOI 10.1111/j.1749-6632.1972.tb54831.x
   He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Jazwinski SM, 2002, ANNU REV MICROBIOL, V56, P769, DOI 10.1146/annurev.micro.56.012302.160830
   John U, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1110
   JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105
   Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053
   Kayal E, 2021, MOL BIOL EVOL, V38, P2493, DOI 10.1093/molbev/msab041
   Khryapenkova TG, 2008, B EXP BIOL MED+, V146, P506, DOI 10.1007/s10517-009-0327-3
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kopinski PK, 2021, NAT REV CANCER, V21, P431, DOI 10.1038/s41568-021-00358-w
   Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038
   Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   MARGULIS L, 1985, Symbiosis, V1, P101
   Margulis L., 1981, P1
   Martin W., 2010, NAT ED, V3
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012
   McLean JS, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107939
   Mereschkowsky C, 1905, Biol. Cent., V25, P593, DOI DOI 10.1017/S0967026299002231
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Ngo J, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10090927
   Pallen MJ, 2011, TRENDS MICROBIOL, V19, P58, DOI 10.1016/j.tim.2010.11.001
   Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x
   Plotnikov EY, 2008, FEBS LETT, V582, P3117, DOI 10.1016/j.febslet.2008.08.002
   Plotnikov EY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P542, DOI 10.1134/S0006297915050041
   Plotnikov EY, 2017, HEART LUNG CIRC, V26, P648, DOI 10.1016/j.hlc.2016.12.002
   Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009
   Popkov VA, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1549, DOI 10.1134/S0006297917120148
   Popkov VA, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1480, DOI 10.1134/S0006297916120099
   Popkov VA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P532, DOI 10.1134/S000629791505003X
   Portier P. J, 1918, LES SYMBIOTES, P1
   POULTON J, 1989, LANCET, V1, P236
   Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sakai C, 2012, BBA-GEN SUBJECTS, V1820, P643, DOI 10.1016/j.bbagen.2011.12.013
   Salinas G, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148278
   Santamaria M, 2007, BIOL CHEM, V388, P943, DOI 10.1515/BC.2007.121
   Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163
   Sinha P, 2016, CURR OPIN GENET DEV, V38, P97, DOI 10.1016/j.gde.2016.05.002
   Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   SMITH RA, 1983, INT REV CYTOL, V83, P63, DOI 10.1016/S0074-7696(08)61686-1
   Snyder GK, 1999, AM ZOOL, V39, P189
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Torroni A, 1996, GENETICS, V144, P1835
   Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
   Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x
   VIALE AM, 1994, FEBS LETT, V341, P146, DOI 10.1016/0014-5793(94)80446-X
   VOROBJEV IA, 1983, FEBS LETT, V163, P311, DOI 10.1016/0014-5793(83)80842-4
   Wallace DC, 2018, NAT GENET, V50, P1642, DOI 10.1038/s41588-018-0264-z
   Wallin IE, 1925, AM J ANAT, V36, P131, DOI 10.1002/aja.1000360106
   Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757
   Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006
   Willingham TB, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.757305
   Winkler HH, 1999, TRENDS BIOCHEM SCI, V24, P64, DOI 10.1016/S0968-0004(98)01334-6
   Yang C, 2021, BRIT J HAEMATOL, V193, P1260, DOI 10.1111/bjh.17531
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Zaidi AA, 2019, P NATL ACAD SCI USA, V116, P25172, DOI 10.1073/pnas.1906331116
   Zorov DB, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1115, DOI 10.1134/S0006297907100094
   Zorov DB, 2014, BIOCHEMISTRY-MOSCOW+, V79, P1017, DOI 10.1134/S0006297914100046
   Zorov DB, 2013, BIOCHEMISTRY-MOSCOW+, V78, P979, DOI 10.1134/S0006297913090034
   Zorov DB, 2012, BIOCHEMISTRY-MOSCOW+, V77, P742, DOI 10.1134/S0006297912070073
   Zorov DB, 1997, BIOSCIENCE REP, V17, P507, DOI 10.1023/A:1027304122259
   Zorov DB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020175
   Zorov DB, 2017, J GERONTOL A-BIOL, V72, P1171, DOI 10.1093/gerona/glw184
   Zorova LD, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010482
   Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009
NR 108
TC 0
Z9 0
U1 0
U2 1
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD DEC
PY 2022
VL 87
IS 12-13
SI SI
BP 1487
EP 1497
DI 10.1134/S0006297922120069
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 7Z9BQ
UT WOS:000915846700006
PM 36717442
DA 2024-11-01
ER

PT J
AU Elfawy, HA
   Das, B
AF Elfawy, Hasnaa A.
   Das, Biswadeep
TI Crosstalk between mitochondrial dysfunction, oxidative stress, and age
   related neurodegenerative disease: Etiologies and therapeutic strategies
SO LIFE SCIENCES
LA English
DT Review
DE Mitochondrial dysfunction; Oxidative stress; Neurodegenerative disease;
   Mitochondrial heteroplasmy; Therapeutic strategies
ID ACTIVATED-RECEPTOR-GAMMA; DYNAMIN-RELATED GTPASE; LIFE-SPAN; TARGETED
   ANTIOXIDANT; CALORIC RESTRICTION; PARKINSONS-DISEASE; SKELETAL-MUSCLE;
   AMYLOID-BETA; PPAR-GAMMA; ALZHEIMERS-DISEASE
AB Mitochondrial function is vital for normal cellular processes. Mitochondrial damage and oxidative stress have been greatly implicated in the progression of aging, along with the pathogenesis of age-related neurodegenerative diseases (NDs), such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis. Although antioxidant therapy has been proposed for the prevention and treatment of age-related NDs, unraveling the molecular mechanisms of mitochondrial dysfunction can lead to significant progress in the development of effective treatments against such diseases. Aging is associated with the generation and accumulation of reactive oxygen species (ROS) that are the major contributors to oxidative stress. Oxidative stress is caused because of the imbalance between the production of ROS and their oxidation, which can affect the mitochondrial respiratory chain function, thereby altering the membrane permeability and calcium homeostasis, along with increasing the heteroplasmic mtDNA and weakening the mitochondrial defense systems. Mitochondrial dysfunction mainly affects mitochondrial biogenesis and dynamics that are prominent in several age-related NDs. Mitochondrial dysfunction has a crucial role in the pathophysiology of age-related NDs. Several mitochondria targeted strategies, such as enhancing the antioxidant bioavailability via novel delivery systems, identifying unique mitochondrial proteins as specific drug targets, investigating the signaling pathways of mitochondrial biogenesis and dynamics, and identifying effective natural products are potentially effective to counteract mitochondrial dysfunction-related NDs.
C1 [Elfawy, Hasnaa A.; Das, Biswadeep] KIIT, Sch Biotechnol, Campus 11, Bhubaneswar 751024, Odisha, India.
C3 Kalinga Institute of Industrial Technology (KIIT)
RP Das, B (corresponding author), KIIT Univ, Sch Biotechnol, Campus 11, Bhubaneswar 751024, India.
EM biswadeep.das@kiitbiotech.ac.in
RI Das, Biswadeep/AAX-5120-2020
OI A. Elfawy, Hasnaa/0000-0003-0258-3783; Das,
   Biswadeep/0000-0001-8214-3600
CR Ahola-Erkkilä S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076
   Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168
   Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Barbieri E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/917085
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138
   Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x
   Benedusi V, 2012, J BIOL CHEM, V287, P35899, DOI 10.1074/jbc.M112.366419
   Berg J.M., 2002, Biochemistry, V5th ed.
   Blesa J, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00091
   Brazier MW, 2014, ANTIOXIDANTS-BASEL, V3, P288, DOI 10.3390/antiox3020288
   Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029
   Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474
   Calabrese V, 2007, NEUROCHEM RES, V32, P757, DOI 10.1007/s11064-006-9203-y
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cardinali DP, 2013, HORM BEHAV, V63, P322, DOI 10.1016/j.yhbeh.2012.02.020
   Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Corona JC, 2015, NEUROCHEM RES, V40, P308, DOI 10.1007/s11064-014-1377-0
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269
   Danta CC, 2014, EXPERT OPIN DRUG DIS, V9, P1205, DOI 10.1517/17460441.2014.942218
   de Oliveira MR, 2016, BIOTECHNOL ADV, V34, P532, DOI 10.1016/j.biotechadv.2015.12.014
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Dhingra R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.310
   Elbaz A, 2016, REV NEUROL-FRANCE, V172, P14, DOI 10.1016/j.neurol.2015.09.012
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   FAHN S, 1992, ANN NEUROL, V32, pS128, DOI 10.1002/ana.410320722
   Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5
   Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001
   Flis VV, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013235
   Forbes JM, 2018, NAT REV NEPHROL, V14, P291, DOI 10.1038/nrneph.2018.9
   Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985
   Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/nchembio.2287, 10.1038/NCHEMBIO.2287]
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Gomes CM, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/487534
   Gott JM, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120128
   Gottlieb RA, 2016, CELL CALCIUM, V60, P88, DOI 10.1016/j.ceca.2016.04.006
   Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586
   Herskovits AZ, 2014, NEURON, V81, P471, DOI 10.1016/j.neuron.2014.01.028
   Horvath TL, 2003, ENDOCRINOLOGY, V144, P2757, DOI 10.1210/en.2003-0163
   Hsieh Tze-chen, 2006, Med Chem, V2, P275, DOI 10.2174/157340606776930709
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008
   Johnson ME, 2015, NEUROTOXICOLOGY, V46, P101, DOI 10.1016/j.neuro.2014.12.002
   Kandimalla R, 2018, HUM MOL GENET, V27, P30, DOI 10.1093/hmg/ddx381
   Karaaslan C, 2015, CURR TOP MED CHEM, V15, P894, DOI 10.2174/1568026615666150220120946
   Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Kiaei M, 2008, PPAR RES, V2008, DOI 10.1155/2008/418765
   Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477
   Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758
   Klopstock T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0380-2
   Kobayashi I, 1998, TRENDS GENET, V14, P368, DOI 10.1016/S0168-9525(98)01532-7
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Kowaltowski AJ, 2011, REDOX REP, V16, P237, DOI 10.1179/1351000211Y.0000000014
   Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252
   Kwon HJ, 2016, ACS NANO, V10, P2860, DOI 10.1021/acsnano.5b08045
   Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010
   Lane N, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-35
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee M, 2007, J DRUG TARGET, V15, P115, DOI 10.1080/10611860600953555
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Levites Y, 2001, J NEUROCHEM, V78, P1073, DOI 10.1046/j.1471-4159.2001.00490.x
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lightowlers RN, 2014, EMBO MOL MED, V6, P705, DOI 10.15252/emmm.201404179
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lowes DA, 2008, FREE RADICAL BIO MED, V45, P1559, DOI 10.1016/j.freeradbiomed.2008.09.003
   Campo ML, 2017, J BIOENERG BIOMEMBR, V49, P75, DOI 10.1007/s10863-016-9662-z
   Luo Y, 2015, INT J MOL SCI, V16, P20704, DOI 10.3390/ijms160920704
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Madamanchi NR, 2001, ARTERIOSCL THROM VAS, V21, P321, DOI 10.1161/01.ATV.21.3.321
   Magrané J, 2009, ANTIOXID REDOX SIGN, V11, P1615, DOI [10.1089/ars.2009.2604, 10.1089/ARS.2009.2604]
   Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754
   Manczak M, 2019, HUM MOL GENET, V28, P177, DOI 10.1093/hmg/ddy335
   Manczak M, 2015, HUM MOL GENET, V24, P7308, DOI 10.1093/hmg/ddv429
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Masino SA, 2008, TRENDS NEUROSCI, V31, P273, DOI 10.1016/j.tins.2008.02.009
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049
   McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023
   McLachlan J, 2014, J HYPERTENS, V32, P555, DOI 10.1097/HJH.0000000000000054
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mercer JR, 2012, FREE RADICAL BIO MED, V52, P841, DOI 10.1016/j.freeradbiomed.2011.11.026
   Mhyre Timothy R, 2012, Subcell Biochem, V65, P389, DOI 10.1007/978-94-007-5416-4_16
   Miwa S, 2004, ANN NY ACAD SCI, V1019, P388, DOI 10.1196/annals.1297.069
   Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3
   Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Moussaoui S, 2000, EXP NEUROL, V166, P235, DOI 10.1006/exnr.2000.7516
   Muller M, 2014, J NEUROCHEM, V130, P328, DOI 10.1111/jnc.12739
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9
   Multhaup G, 1997, BIOCHEM PHARMACOL, V54, P533, DOI 10.1016/S0006-2952(97)00062-2
   Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110
   NAKASHIMA RA, 1989, J BIOENERG BIOMEMBR, V21, P461, DOI 10.1007/BF00762518
   Nieman DC, 2010, MED SCI SPORT EXER, V42, P338, DOI 10.1249/MSS.0b013e3181b18fa3
   Niforou K, 2014, REDOX BIOL, V2, P323, DOI 10.1016/j.redox.2014.01.017
   Onyango IG, 2010, BBA-MOL BASIS DIS, V1802, P228, DOI 10.1016/j.bbadis.2009.07.014
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Ozden O, 2011, AGING-US, V3, P102, DOI 10.18632/aging.100291
   Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018
   Perera ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090449
   Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Pollari E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00131
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439
   Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629
   Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200
   Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45
   Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108
   Ramis MR, 2015, CURR MED CHEM, V22, P2690, DOI 10.2174/0929867322666150619104143
   Rappold PM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6244
   Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882
   Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007
   Rawlins MD, 2016, NEUROEPIDEMIOLOGY, V46, P144, DOI 10.1159/000443738
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2018, HUM MOL GENET, V27, P2502, DOI 10.1093/hmg/ddy154
   Reddy PH, 2017, HUM MOL GENET, V26, P1597, DOI 10.1093/hmg/ddx129
   Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510
   REMACLE J, 1995, MUTAT RES-DNAGING G, V316, P103, DOI 10.1016/0921-8734(95)90004-7
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014
   Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173
   Róna-Vörös K, 2010, CURR DRUG TARGETS, V11, P1262, DOI 10.2174/1389450111007011262
   Rosas HD, 2012, ARCH NEUROL-CHICAGO, V69, P887, DOI 10.1001/archneurol.2011.2945
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741
   Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027
   Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974
   Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Smilansky A, 2015, J BIOL CHEM, V290, P30670, DOI 10.1074/jbc.M115.691493
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200
   Suzuki Y, 2012, SENSORS-BASEL, V12, P549, DOI 10.3390/s120100549
   Sweeney G, 2016, ANAT CELL BIOL, V49, P1, DOI 10.5115/acb.2016.49.1.1
   Szeto HH, 2014, CLIN PHARMACOL THER, V96, P672, DOI 10.1038/clpt.2014.174
   Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461
   Talbott EO, 2016, HAND CLINIC, V138, P225, DOI 10.1016/B978-0-12-802973-2.00013-6
   Tan WZ, 2014, BBA-MOL BASIS DIS, V1842, P1295, DOI 10.1016/j.bbadis.2014.02.009
   Tanaka AJ, 2013, NAT MED, V19, P1578, DOI 10.1038/nm.3422
   Taylor R W, 2000, Hum Reprod, V15 Suppl 2, P79
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Thomas RR, 2012, AGING-US, V4, P620, DOI 10.18632/aging.100488
   Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Ungvari Z, 2008, CIRC RES, V102, P519, DOI 10.1161/CIRCRESAHA.107.168369
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072
   Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015
   Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13
   Ward MS, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-10209-0, 10.1038/s41598-017-15589-x]
   Weissig V, 2001, J CONTROL RELEASE, V75, P401, DOI 10.1016/S0168-3659(01)00392-3
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008
   Wesselink E, 2019, CLIN NUTR, V38, P982, DOI 10.1016/j.clnu.2018.08.032
   Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200
   Wolf DP, 2015, TRENDS MOL MED, V21, P68, DOI 10.1016/j.molmed.2014.12.001
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Woods LC, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00019
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu SZ, 2009, FREE RADICAL BIO MED, V47, P167, DOI 10.1016/j.freeradbiomed.2009.04.021
   Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x
   Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070
   Yin XL, 2016, HUM MOL GENET, V25, P1739, DOI 10.1093/hmg/ddw045
   Yun JS, 2005, TOXICOLOGY, V216, P140, DOI 10.1016/j.tox.2005.08.017
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhang SM, 2002, NEUROLOGY, V59, P1161, DOI 10.1212/01.WNL.0000028688.75881.12
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 210
TC 227
Z9 237
U1 11
U2 172
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD FEB 1
PY 2019
VL 218
BP 165
EP 184
DI 10.1016/j.lfs.2018.12.029
PG 20
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HH4WO
UT WOS:000455727100018
PM 30578866
HC Y
HP N
DA 2024-11-01
ER

PT J
AU González-Quintana, A
   Trujillo-Tiebas, MJ
   Fernández-Perrone, AL
   Blázquez, A
   Lucia, A
   Morán, M
   Ugalde, C
   Arenas, J
   Ayuso, C
   Martín, MA
AF Gonzalez-Quintana, Adrian
   Trujillo-Tiebas, Maria J.
   Fernandez-Perrone, Ana L.
   Blazquez, Alberto
   Lucia, Alejandro
   Moran, Maria
   Ugalde, Cristina
   Arenas, Joaquin
   Ayuso, Carmen
   Martin, Miguel A.
TI Uniparental isodisomy as a cause of mitochondrial complex I respiratory
   chain disorder due to a novel splicing NDUFS4 mutation
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Mitochondrial diseases; Mitochondrial complex I deficiency; NDUFS4;
   mitochondrial Supercomplexes; Uniparental Disomy; RNA splicing; Genetic
   counselling
ID LEIGH-SYNDROME; PATERNAL ISODISOMY; DISOMY; PATIENT; DNA; CHROMOSOME-5;
   DEFICIENCY
AB Uniparental disomy (UPD) is an underestimated cause of autosomal recessive disorders. In this study, we aim to raise awareness about the possibility of UPD in mitochondrial disorders where it is a hardly described event-, by functionally characterizing a novel variant in a structural subunit of complex I (CI) of the mitochondrial oxidative phosphorylation system.
   Using next-generation sequencing, we identified a new intronic homozygous c.350 + 5G > A variant in the NDUFS4 gene in a one-year-old girl (being alive at the age of 7) belonging to a non-consanguineous family presenting with encephalopathy, psychomotor delay, lactic acidosis and a single CI deficiency, a less severe phenotype than those previously reported in most NDUFS4 patients. One parent lacked the variant, and microsatellite genotyping showed complete paternal uniparental isodisomy of the non-imprinted chromosome 5.
   We demonstrated in patient's skeletal muscle and fibroblasts splicing abnormalities, low expression of NDUFS4, undetectable NDUFS4 protein, defects in cellular respiration (decreased oxygen consumption and ATP production), and impaired assembly or stability of mitochondrial supercomplexes containing CI.
   Our findings support that c.350 + 5G > A variant is pathogenic, and reinforce that UPD, although rare, should be considered as a possible cause of mitochondrial diseases in order to provide accurate genetic counselling.
C1 [Gonzalez-Quintana, Adrian; Blazquez, Alberto; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Mitochondrial Dis Lab, Madrid, Spain.
   [Gonzalez-Quintana, Adrian; Trujillo-Tiebas, Maria J.; Blazquez, Alberto; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Ayuso, Carmen; Martin, Miguel A.] Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.
   [Trujillo-Tiebas, Maria J.] UAM, Dept Genet, IIS Fdn Jimenez Diaz Univ Hosp, IIS FJD, Madrid, Spain.
   [Fernandez-Perrone, Ana L.] Hosp Quironsalud, Pediat Neurol Dept, Madrid, Spain.
   [Blazquez, Alberto; Lucia, Alejandro; Moran, Maria; Ugalde, Cristina; Arenas, Joaquin; Ayuso, Carmen; Martin, Miguel A.] Inst Invest Sanitaria Hosp 12 Octubre Imas12, Madrid, Spain.
   [Lucia, Alejandro] Univ Europea Madrid, Fac Sport Sci, Madrid, Spain.
   [Lucia, Alejandro] Ctr Biomed Res Network Frailty & Hlth Aging CIBER, Madrid, Spain.
C3 Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion
   Biomedica en Red; CIBERER; Autonomous University of Madrid; Fundacion
   Jimenez Diaz; quironsalud Group; European University of Madrid
RP Martín, MA (corresponding author), Hosp Univ 12 Octubre, Dept Clin Biochem, Mitochondrial Dis Lab, Madrid, Spain.
EM mamcasanueva.imas12@h12o.es
RI Martin, Miguel/S-2758-2018; Morán, María/HHS-1798-2022;
   González-Quintana, Adrián/S-3724-2018; Encinar, Alberto/S-4425-2018;
   Ayuso, Carmen/A-4843-2019; Ugalde, Cristina/P-7533-2016
OI Ayuso, Carmen/0000-0002-9242-7065; Ugalde, Cristina/0000-0002-9742-1877;
   Gonzalez-Quintana, Adrian/0000-0002-4011-362X; Moran,
   Maria/0000-0001-5408-7189
FU Spanish Instituto de Salud Carlos III (ISCIII)-ERDF grants [PI18/01374,
   PI18/00139]; RAREGENOMICS - Education Council, Comunidad de Madrid,
   Spain [B2017/BMD-3721]; AEPMI/FACDM Spanish mitochondrial patient's
   associations
FX This work was funded by Spanish Instituto de Salud Carlos III
   (ISCIII)-ERDF grants PI18/01374, and PI18/00139; RAREGENOMICS funded by
   the Education Council, Comunidad de Madrid, Spain (B2017/BMD-3721), and
   AEPMI/FACDM Spanish mitochondrial patient's associations.
CR Bravo-Alonso I, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111811
   Bris C, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000205
   BRZUSTOWICZ LM, 1994, AM J HUM GENET, V54, P482
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Daniels EG, 2019, CSH MOL CASE STUD, V5, DOI 10.1101/mcs.a004457
   Ortigoza-Escobar JD, 2016, MITOCHONDRION, V28, P73, DOI 10.1016/j.mito.2016.04.001
   del Gaudio D, 2020, GENET MED, V22, P1133, DOI 10.1038/s41436-020-0782-9
   Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094
   Douglas GV, 2011, J HUM GENET, V56, P834, DOI 10.1038/jhg.2011.112
   Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619
   Erger F, 2018, EUR J HUM GENET, V26, P1392, DOI 10.1038/s41431-018-0195-2
   Fujita A, 2013, AM J MED GENET A, V161, P1904, DOI 10.1002/ajmg.a.36026
   Haudry C, 2012, MOL GENET METAB, V107, P700, DOI 10.1016/j.ymgme.2012.10.008
   Hoppman N, 2018, GENET MED, V20, P1522, DOI 10.1038/gim.2018.24
   Lamont RE, 2017, AM J MED GENET A, V173, P596, DOI 10.1002/ajmg.a.37983
   Lin SP, 2007, ARCH DERMATOL RES, V299, P145, DOI 10.1007/s00403-007-0751-z
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   García MM, 2014, AM J MED GENET A, V164, P1075, DOI 10.1002/ajmg.a.36378
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Morán M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nogueira C, 2013, MOL GENET METAB, V110, P493, DOI 10.1016/j.ymgme.2013.09.010
   Numata S, 2014, J INVEST DERMATOL, V134, P849, DOI 10.1038/jid.2013.398
   Reittinger AM, 2017, AM J MED GENET A, V173, P2528, DOI 10.1002/ajmg.a.38344
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Robinson WP, 2000, BIOESSAYS, V22, P452
   Seal JL, 2006, J MED GENET, V43, P887, DOI 10.1136/jmg.2006.043380
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tiranti V, 1999, J MED GENET, V36, P927
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   van Riesen AKJ, 2006, NEUROPEDIATRICS, V37, P88, DOI 10.1055/s-2006-924227
   Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233
NR 32
TC 9
Z9 9
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD NOV
PY 2020
VL 131
IS 3
BP 341
EP 348
DI 10.1016/j.ymgme.2020.10.008
PG 8
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA PG4PA
UT WOS:000599717700007
PM 33093004
DA 2024-11-01
ER

PT J
AU Kim, JT
   Lee, YJ
   Lee, YM
   Kang, HC
   Lee, JS
   Kim, HD
AF Kim, Jeong Tae
   Lee, Yun Jin
   Lee, Young Mock
   Kang, Hoon Chul
   Lee, Joon Soo
   Kim, Heung Dong
TI Clinical characteristics of patients with non-specific and
   non-categorized mitochondrial diseases
SO ACTA PAEDIATRICA
LA English
DT Article
DE Magnetic resonance imaging; Mitochondria; Neuromuscular system;
   Respiratory chain complex
ID PEDIATRIC-PATIENTS; DISORDERS; CHILDREN; DNA; MANIFESTATIONS; DIAGNOSIS;
   DELETIONS; SPECTRUM
AB Aim:
   Mitochondrial disease is a heterogeneous disorder entity induced by defects in mitochondrial respiratory chain complex (MRC). A significant portion of patients with MRC defect will not conform to a specific, known syndrome. We have analysed the clinical features of 108 Korean paediatric patients with non-specific and non-categorized mitochondrial disease.
   Methods:
   We retrospectively reviewed the clinical and laboratory features of 108 paediatrics patients with non-specific and non-categorized mitochondrial diseases who showed defects in MRC activity, confirmed by spectrophotometric biochemical enzyme assay of their muscles.
   Results:
   Neuromuscular involvement was noted in all patients, with developmental delay and seizure accounting for 92.6% and 77.8% of total patients respectively. Various extraneurological symptoms were observed. Most patients exhibited MRC I defect, accounting for 100 (92.6%) patients. The most common brain magnetic resonance imaging (MRI) finding was diffuse cerebral atrophy. However, in 23.1% of patients, no notable changes were visible on MRI.
   Conclusions:
   Mitochondrial respiratory chain complex I defect was the most common finding in this study. Though neuromuscular symptoms predominated, with presence of numerous extraneurological findings, we could not find any novel symptoms that might be unique to this category of mitochondrial disease. But, comparatively, more patients presented with unremarkable birth histories and normal brain MRI findings.
C1 [Kim, Jeong Tae; Lee, Yun Jin; Lee, Young Mock; Kang, Hoon Chul; Lee, Joon Soo; Kim, Heung Dong] Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, Seoul 135720, South Korea.
C3 Yonsei University; Yonsei University Health System
RP Lee, YM (corresponding author), Yonsei Univ, Severance Childrens Hosp, Gangnam Severance Hosp, Dept Pediat,Coll Med, POB 1217,712 Eonjuro,146-92 Dogok Dong, Seoul 135720, South Korea.
EM ymleemd@yuhs.ac
RI LEE, SOOYEON/KAM-6204-2024; Lee, Jun Young/CAI-2335-2022; Cho,
   Hye-Min/D-9097-2019
OI Lee, Joon Soo/0000-0001-9036-9343; Kim, Heung Dong/0000-0002-8031-7336;
   LEE, YOUNG-MOCK/0000-0002-5838-249X; Kang, Hoon-Chul/0000-0002-3659-8847
FU Korean Government (MEST) [KRF-2008-331-E00154]
FX This work was supported by the Korea Research Foundation Grant funded by
   the Korean Government (MEST) (No. KRF-2008-331-E00154). The authors have
   no conflicts of interest to declare.
CR Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Gillis L, 2002, PEDIATR CLIN N AM, V49, P203, DOI 10.1016/S0031-3955(03)00115-9
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Kang HC, 2007, CHILD NERV SYST, V23, P1301, DOI 10.1007/s00381-007-0369-7
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   McFarland R, 2007, CURR TOP DEV BIOL, V77, P113, DOI 10.1016/S0070-2153(06)77005-3
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Sperl W, 1997, WIEN KLIN WOCHENSCHR, V109, P93
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
NR 23
TC 14
Z9 15
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0803-5253
EI 1651-2227
J9 ACTA PAEDIATR
JI Acta Paediatr.
PD NOV
PY 2009
VL 98
IS 11
BP 1825
EP 1829
DI 10.1111/j.1651-2227.2009.01428.x
PG 5
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 503PI
UT WOS:000270549700025
PM 19659453
DA 2024-11-01
ER

PT J
AU Yang, H
   Hur, G
   Lee, TK
   Kim, JE
   Kim, JH
   Kim, JR
   Kim, J
   Park, JHY
   Lee, KW
AF Yang, Hee
   Hur, Gihyun
   Lee, Tae Kyung
   Kim, Jong-Eun
   Kim, Jong Hun
   Kim, Jong Rhan
   Kim, Jiyoung
   Park, Jung Han Yoon
   Lee, Ki Won
TI Sulforaphane Mitigates High-Fat Diet-Induced Obesity by Enhancing
   Mitochondrial Biogenesis in Skeletal Muscle via the HDAC8-PGC1α Axis
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE histone deacetylase 8; mitochondrial biogenesis; obesity; PGC1 alpha;
   sulforaphane
ID HISTONE DEACETYLASE INHIBITORS; INSULIN-RESISTANCE; HDAC8; PGC-1-ALPHA;
   METABOLISM; MECHANISMS; EXPRESSION; NRF2
AB Scope: Histone deacetylases (HDACs) play a crucial role in the transcriptional regulation of various genes which can contribute to metabolic disorders. Although sulforaphane (SFN), a natural HDAC inhibitor, has been reported to alleviate obesity in humans and mice, the specific mechanisms and how HDACs contribute to SFN's anti-obesity effects remain unclear.Methods and results: Oral administration of SFN in mice fed high-fat diet increases peroxisome proliferator activating receptor gamma coactivator (PGC1 alpha)-induced mitochondrial biogenesis in skeletal muscle. Among HDACs, SFN specifically inhibits HDAC8 activity. SFN enhances mitochondrial DNA and adenosine triphosphate (ATP) production in C2C12 myotubes, similar to the action of PCI34051, a synthetic HDAC8-specific inhibitor. These effects are mediated by increased expression of PGC1 alpha via upregulation of cAMP response element binding (CREB, Ser(133)) phosphorylation and p53 (Lys(379)) acetylation. These SFN-induced effects are not observed in cells with a genetic deletion of HDAC8, suggesting the existence of a regulatory loop between HDAC8 and PGC1 alpha in SFN's action.Conclusion: SFN prevents obesity-related metabolic dysregulation by enhancing mitochondrial biogenesis and function via targeting the HDAC8-PGC alpha axis. These results suggest SFN as a beneficial anti-obesity agent providing new insight into the role of HDAC8 in the PGC1 alpha-mediated mitochondrial biogenesis, which may be a novel and promising drug target for metabolic diseases.
C1 [Yang, Hee] Kookmin Univ, Dept Food & Nutr, 77 Jeongneung Ro, Seoul 02707, South Korea.
   [Hur, Gihyun; Lee, Tae Kyung; Lee, Ki Won] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.
   [Kim, Jong-Eun] Korea Natl Univ Transportat, Dept Food Sci & Technol, Jeungpyeong, South Korea.
   [Kim, Jong Hun] Sungshin Womens Univ, Dept Food Sci & Biotechnol, Seoul 01133, South Korea.
   [Kim, Jong Rhan] Sungshin Univ, Basic Sci Res Inst, Seoul 01133, South Korea.
   [Kim, Jong Rhan] Korea Inst Sci & Technol Evaluat & Planning, R&D Evaluat Ctr, Eumseong 1339, Chungcheongbug, South Korea.
   [Kim, Jiyoung] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
   [Park, Jung Han Yoon; Lee, Ki Won] Seoul Natl Univ, BioMAX Inst, Seoul 08826, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 16229, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.
   [Lee, Ki Won] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
C3 Kookmin University; Seoul National University (SNU); Korea National
   University of Transportation; Sungshin Women's University; Seoul
   National University (SNU); Seoul National University (SNU); Seoul
   National University (SNU); Seoul National University (SNU); Seoul
   National University (SNU); Seoul National University (SNU)
RP Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, BioMAX Inst, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 16229, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang 25354, South Korea.; Lee, KW (corresponding author), Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 08826, South Korea.
EM kiwon@snu.ac.kr
RI kim, jong-eun/B-3550-2017
FU This project was supported by a National Research Foundation of Korea
   (NRF) grant (2018R1A2A1A05078707), the K-BIO KIURI Center Program
   through the Ministry of Science and ICT (2020M3H1A1073304), Korea
   Institute of Planning and Evaluation for Technology in
   [2018R1A2A1A05078707, 2020M3H1A1073304]; National Research Foundation of
   Korea (NRF) [821027]; Korea Institute of Planning and Evaluation for
   Technology in Food, Agriculture and Forestry (IPET) through Technology
   Commercialization Support Program - Ministry of Agriculture, Food and
   Rural Affairs (MAFRA); Brain Korea 21 Plus Program of the Department of
   Agricultural Biotechnology from Seoul National University, Republic of
   Korea
FX This project was supported by a National Research Foundation of Korea
   (NRF) grant (2018R1A2A1A05078707), the K-BIO KIURI Center Program
   through the Ministry of Science and ICT (2020M3H1A1073304), Korea
   Institute of Planning and Evaluation for Technology in Food, Agriculture
   and Forestry (IPET) through Technology Commercialization Support
   Program, funded by Ministry of Agriculture, Food and Rural Affairs
   (MAFRA) (No. 821027), and the Brain Korea 21 Plus Program of the
   Department of Agricultural Biotechnology from Seoul National University,
   Republic of Korea. Proposed mechanisms in Figures 4a and 5a were created
   with BioRender.com.
CR Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9
   Banerjee S, 2019, EUR J MED CHEM, V164, P214, DOI 10.1016/j.ejmech.2018.12.039
   Çakir I, 2022, ELIFE, V11, DOI 10.7554/eLife.67368
   Chakrabarti A, 2015, TRENDS PHARMACOL SCI, V36, P481, DOI 10.1016/j.tips.2015.04.013
   Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   Dashwood RH, 2007, SEMIN CANCER BIOL, V17, P363, DOI 10.1016/j.semcancer.2007.04.001
   Dinkova-Kostova AT, 2017, TRENDS FOOD SCI TECH, V69, P257, DOI 10.1016/j.tifs.2017.02.002
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135
   Gough N. R., 2016, SCI SIGNAL, V9
   Greco T, 2011, FREE RADICAL BIO MED, V51, P2164, DOI 10.1016/j.freeradbiomed.2011.09.017
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Harakalova M, 2012, J MED GENET, V49, P539, DOI 10.1136/jmedgenet-2012-100921
   Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hua WK, 2017, BLOOD, V130, P2619, DOI 10.1182/blood-2017-03-771386
   Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003
   Juengel E, 2018, CANCER LETT, V435, P121, DOI 10.1016/j.canlet.2018.07.017
   Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   King J, 2021, METABOLITES, V11, DOI 10.3390/metabo11110792
   Kobayashi M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072054
   Lee S, 2014, PHARMACOL RES, V85, P23, DOI 10.1016/j.phrs.2014.05.003
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Liu YL, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.665894
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marek M, 2018, J MED CHEM, V61, P10000, DOI 10.1021/acs.jmedchem.8b01087
   McIntyre RL, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809854
   Moore MS, 2000, P NUTR SOC, V59, P193, DOI 10.1017/S0029665100000215
   Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje
   Nagata N, 2017, DIABETES, V66, P1222, DOI 10.2337/db16-0662
   Park JY, 2009, CIRC RES, V105, P705, DOI 10.1161/CIRCRESAHA.109.205310
   Ricquier Daniel, 2011, Front Endocrinol (Lausanne), V2, P85, DOI 10.3389/fendo.2011.00085
   Schell JC, 2017, NAT CELL BIOL, V19, P589, DOI 10.1038/ncb3540
   Sharma BK, 2014, J CELL PHYSIOL, V229, P1901, DOI 10.1002/jcp.24664
   Tian Y, 2015, CANCER RES, V75, P4803, DOI 10.1158/0008-5472.CAN-14-3786
   Vaughan RA, 2014, J PHYSIOL BIOCHEM, V70, P271, DOI 10.1007/s13105-013-0301-4
   Venegas V., 2011, CURR PROTOC HUM GENE, P19
   Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620
   Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426
   Zhang HQ, 2016, MOL NUTR FOOD RES, V60, P2185, DOI 10.1002/mnfr.201500915
NR 44
TC 1
Z9 2
U1 2
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD DEC
PY 2023
VL 67
IS 23
AR 2300149
DI 10.1002/mnfr.202300149
EA SEP 2023
PG 11
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA LV3D4
UT WOS:001075108500001
PM 37775334
DA 2024-11-01
ER

PT J
AU Yang, X
   Fu, LJ
AF Yang, Xiao
   Fu, Le-Jun
TI Familial mitochondrial encephalomyopathy, lactic acidosis, and
   stroke-like episode syndrome: Three case reports
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE Mitochondrial encephalomyopathy; Magnetic resonance imaging; Genetic
   testing; Pathological results; Case report
AB BACKGROUND Mitochondrial encephalomyopathy (ME) is a multisystem metabolic disease that primarily affects the central nervous system and skeletal muscle. It is caused by mutations in mitochondrial or nuclear DNA, resulting in abnormal mitochondrial structure and function and insufficient ATP synthesis. The most common subtype is mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode (MELAS) syndrome. In recent years, reports of MELAS syndrome have increased but familial cases are rare.
   CASE SUMMARY We report a case of familial MELAS syndrome. Cases 2 and 3 are sisters and case 1 is their nephew. All are short in stature and showed stroke-like episodes with rapid onset and no obvious symptoms such as paroxysmal headache, aphasia, or blurred vision. After admission, blood lactate levels were significantly higher than normal. The patients underwent magnetic resonance imaging of the head. Cases 1 and 2 were considered to have ME, whereas case 3 was considered to have a space-occupying lesion in the left temporal lobe. Pathological evaluation showed no obvious tumor cells in the brain lesions of case 3. Muscle biopsy or genetic test results were consistent with ME. The patients were diagnosed with MELAS syndrome and their symptoms improved with intravenous infusions of coenzyme Q10, coenzyme A, vitamin B, and vitamin C. At the 6 mo follow-up, there was no recurrence or progression.
   CONCLUSION When a patient has MELAS syndrome, familial MELAS syndrome should be considered if related family members have similar symptoms.
C1 [Yang, Xiao; Fu, Le-Jun] Tianjin Huanhu Hosp, Dept Med Imaging, Tianjin 300350, Peoples R China.
RP Fu, LJ (corresponding author), Tianjin Huanhu Hosp, Dept Med Imaging, 6 Jizhao Rd, Tianjin 300350, Peoples R China.
EM doctorfu20220505@163.com
CR Chen H, 2020, SOMATOSENS MOT RES, V37, P45, DOI 10.1080/08990220.2020.1720636
   Cheng WQ, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.843386
   Dawod PGA, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11111969
   Dias SP, 2018, J NEUROL SCI, V385, P144, DOI 10.1016/j.jns.2017.12.036
   Gagliardi D, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00038
   Gramegna LL, 2021, ANN CLIN TRANSL NEUR, V8, P1200, DOI 10.1002/acn3.51329
   Hou Y, 2020, Beijing Da Xue Xue Bao Yi Xue Ban, V52, P851
   Lahiri D, 2019, J MED CASE REP, V13, DOI 10.1186/s13256-018-1936-0
   Licchetta L, 2021, ANN CLIN TRANSL NEUR, V8, P704, DOI 10.1002/acn3.51259
   Liu KM, 2021, CNS NEUROSCI THER, V27, P733, DOI 10.1111/cns.13618
   Tragni V, 2022, MOLECULES, V27, DOI 10.3390/molecules27113494
   Wang R, 2021, MITOCHONDRION, V59, P276, DOI 10.1016/j.mito.2021.06.012
   Wang S, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020310
   Zhang Q, 2019, Zhonghua Bing Li Xue Za Zhi, V48, P298, DOI 10.3760/cma.j.issn.0529-5807.2019.04.007
NR 14
TC 0
Z9 0
U1 0
U2 1
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD SEP 26
PY 2022
VL 10
IS 27
BP 9945
EP 9953
DI 10.12998/wjcc.v10.i27.9945
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 6R2JS
UT WOS:000892134800045
PM 36186180
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Dupuis, L
   Oudart, H
   René, F
   de Aguilar, JLG
   Loeffler, JP
AF Dupuis, L
   Oudart, H
   René, F
   de Aguilar, JLG
   Loeffler, JP
TI Evidence for defective energy homeostasis in amyotrophic lateral
   sclerosis:: benefit of a high-energy diet in a transgenic mouse
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CU/ZN SUPEROXIDE-DISMUTASE; NUTRITIONAL-STATUS; MITOCHONDRIAL-DNA;
   SKELETAL-MUSCLE; ANIMAL-MODEL; ALS PATIENTS; MICE; DEGENERATION; SOD1;
   DISEASE
AB Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by selective loss of motor neurons and progressive muscle wasting. Growing evidence indicates that mitochondrial dysfunction, not only occurring in motor neurons but also in skeletal muscle, may play a crucial role in the pathogenesis. In this regard, the life expectancy of the ALS G93A mouse line is extended by creatine, an intracellular energy shuttle that ameliorates muscle function. Moreover, a population of patients with sporadic ALS exhibits a generalized hypermetabolic state of as yet unknown origin. Altogether, these findings led us to explore whether alterations in energy homeostasis may contribute to the disease process. Here, we show important variations in a number of metabolic indicators in transgenic ALS mice, which in all shows a metabolic deficit. These alterations were accompanied early in the asymptomatic phase of the disease by reduced adipose tissue accumulation, increased energy expenditure, and concomitant skeletal muscle hypermetabolism. Compensating this energetic imbalance with a highly energetic diet extended mean survival by 20%. In conclusion, we suggest that hypermetabolism, mainly of muscular origin, may represent by itself an additional driven force involved in increasing motor neuron vulnerability.
C1 Univ Strasbourg 1, EA3433, Fac Med, Lab Signalisat Mol & Neurodegenerescence, F-67085 Strasbourg, France.
   CNRS, Unite Propre Rech 9010, Ctr Ecol & Physiol Energet, F-67087 Strasbourg, France.
C3 Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Centre National de la Recherche Scientifique (CNRS);
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg
RP Univ Strasbourg 1, EA3433, Fac Med, Lab Signalisat Mol & Neurodegenerescence, 11 Rue Humann, F-67085 Strasbourg, France.
EM loeffler@neurochem.u-strasbg.fr
RI LOEFFLER, Jean-Philippe/AAS-4401-2020; Dupuis, Luc/A-6981-2012
OI Gonzalez de Aguilar, Jose Luis/0009-0009-0288-7294
CR AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118
   Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8
   Brooks BR, 2000, AMYOTROPHIC LATERAL, P31
   Cameron A, 2002, CURR OPIN CLIN NUTR, V5, P631, DOI 10.1097/00075197-200211000-00005
   Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060
   Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059
   Desport JC, 2001, AM J CLIN NUTR, V74, P328
   Dugan LL, 1997, P NATL ACAD SCI USA, V94, P9434, DOI 10.1073/pnas.94.17.9434
   Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje
   Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522
   Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000
   Groeneveld GJ, 2003, ANN NEUROL, V53, P437, DOI 10.1002/ana.10554
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203
   Hottinger AF, 1997, EUR J NEUROSCI, V9, P1548, DOI 10.1111/j.1460-9568.1997.tb01511.x
   Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130
   Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568
   Kong JM, 1998, J NEUROSCI, V18, P3241
   Leclerc N, 2001, NEUROMUSCULAR DISORD, V11, P722, DOI 10.1016/S0960-8966(01)00240-1
   Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002
   Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527
   Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200
   Menzies FM, 2002, NEUROCHEM INT, V40, P543, DOI 10.1016/S0197-0186(01)00125-5
   Morrison BM, 1998, J COMP NEUROL, V391, P64, DOI 10.1002/(SICI)1096-9861(19980202)391:1<64::AID-CNE6>3.0.CO;2-P
   NAKANO Y, 1987, ARCH NEUROL-CHICAGO, V44, P103, DOI 10.1001/archneur.1987.00520130079022
   Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8
   Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001
   RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Vielhaber S, 2000, BRAIN, V123, P1339, DOI 10.1093/brain/123.7.1339
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a
NR 38
TC 409
Z9 449
U1 0
U2 27
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 27
PY 2004
VL 101
IS 30
BP 11159
EP 11164
DI 10.1073/pnas.0402026101
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 842JM
UT WOS:000223000200057
PM 15263088
OA Green Published
DA 2024-11-01
ER

PT J
AU de Wit, HM
   Westeneng, HJ
   van Engelen, BGM
   Mudde, AH
AF de Wit, H. M.
   Westeneng, H. J.
   van Engelen, B. G. M.
   Mudde, A. H.
TI MIDD or MELAS: that's not the question MIDD evolving into MELAS: a
   severe phenotype of the m.3243A&gt;G mutation due to paternal
   co-inheritance of type 2 diabetes and a high heteroplasmy level
SO NETHERLANDS JOURNAL OF MEDICINE
LA English
DT Article
DE Insulin resistance; m.3243A > G mutation; MELAS; MIDD; heteroplasmy
ID CLINICAL PHENOTYPE; INSULIN-RESISTANCE; MITOCHONDRIAL; MELLITUS;
   DEAFNESS; GENE; MUSCLE; DNA
AB Maternally inherited diabetes and deafness (MIDD) and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) are different syndromes, but are caused by the same m.3243A>G mutation in mitochondrial DNA. Why some patients develop MIDD while others MELAS is unknown, but may be related to heteroplasmy level. Progression from MIDD to MELAS has not been described. Here we report a patient with MIDD who over time developed severe insulin resistance and symptoms and signs consistent with MELAS. The most likely explanation here was paternal co-inheritance of type 2 diabetes in combination with a high heteroplasmy level. The present case showing evolution of MIDD to MELAS supports the concept that both syndromes can be regarded as two phenotypes of the same disease.
C1 [de Wit, H. M.; Mudde, A. H.] Slingeland Hosp, Dept Internal Med, Doetinchem, Netherlands.
   [de Wit, H. M.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
   [van Engelen, B. G. M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
   [Westeneng, H. J.] St Antonius Hosp, Dept Neurol, Nieuwegein, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; St. Antonius
   Hospital Utrecht
RP Mudde, AH (corresponding author), Slingeland Hosp, Dept Internal Med, Doetinchem, Netherlands.
EM a.mudde@slingeland.nl
RI de Wit, Helena/E-1690-2016; van Engelen, Baziel/H-8027-2014
OI van Engelen, Baziel/0000-0001-9867-9047
CR De Laat P, 2012, J INHERIT METAB DIS, P9
   Fromont I, 2009, J NEUROL, V256, P1696, DOI 10.1007/s00415-009-5185-4
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hendrickx JJ, 2006, OTOL NEUROTOL, V27, P802, DOI 10.1097/01.mao.0000224091.02506.a0
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Jeppesen TD, 2006, ARCH NEUROL-CHICAGO, V63, P1701, DOI 10.1001/archneur.63.12.1701
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Tack CJJ, 2000, DIABETES CARE, V23, P424, DOI 10.2337/diacare.23.3.424
   tHart LM, 1996, HUM MUTAT, V7, P193
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
NR 16
TC 17
Z9 20
U1 0
U2 2
PU VAN ZUIDEN COMMUNICATIONS
PI ALPHEN AAN DE RIJN
PA HENRY DUNANTWEG 40A, 2402 NR ALPHEN AAN DE RIJN, NETHERLANDS
SN 0300-2977
J9 NETH J MED
JI Neth. J. Med.
PD DEC
PY 2012
VL 70
IS 10
BP 460
EP 462
PG 3
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 082PZ
UT WOS:000314405700006
PM 23230016
DA 2024-11-01
ER

PT J
AU Pérez-Hernández, M
   van Opbergen, CJM
   Bagwan, N
   Vissing, CR
   Marrón-Liñares, GM
   Zhang, ML
   Vega, ET
   Sorrentino, A
   Drici, L
   Sulek, K
   Zhai, RX
   Hansen, FB
   Christensen, AH
   Boesgaard, S
   Gustafsson, F
   Rossing, K
   Small, EM
   Davies, MJ
   Rothenberg, E
   Sato, PY
   Cerrone, M
   Jensen, THL
   Qvortrup, K
   Bundgaard, H
   Delmar, M
   Lundby, A
AF Perez-Hernandez, Marta
   van Opbergen, Chantal J. M.
   Bagwan, Navratan
   Vissing, Christoffer Rasmus
   Marron-Linares, Grecia M.
   Zhang, Mingliang
   Vega, Estefania Torres
   Sorrentino, Andrea
   Drici, Lylia
   Sulek, Karolina
   Zhai, Ruxu
   Hansen, Finn B.
   Christensen, Alex Horby
   Boesgaard, Soren
   Gustafsson, Finn
   Rossing, Kasper
   Small, Eric M.
   Davies, Michael J.
   Rothenberg, Eli
   Sato, Priscila Y.
   Cerrone, Marina
   Jensen, Thomas Hartvig Lindkaer
   Qvortrup, Klaus
   Bundgaard, Henning
   Delmar, Mario
   Lundby, Alicia
TI Loss of Nuclear Envelope Integrity and Increased Oxidant Production
   Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular
   Substrate of ARVC
SO CIRCULATION
LA English
DT Article
DE arrhythmogenic right ventricular dysplasia; DNA damage; nuclear
   envelope; oxidative stress; plakophilins; sirtuin 3
ID ARRHYTHMOGENIC CARDIOMYOPATHIES; INTERMEDIATE-FILAMENTS; GENE;
   MUTATIONS; REPAIR
AB Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by high propensity to life-threatening arrhythmias and progressive loss of heart muscle. More than 40% of reported genetic variants linked to ARVC reside in the PKP2 gene, which encodes the PKP2 protein (plakophilin-2). Methods: We describe a comprehensive characterization of the ARVC molecular landscape as determined by high-resolution mass spectrometry, RNA sequencing, and transmission electron microscopy of right ventricular biopsy samples obtained from patients with ARVC with PKP2 mutations and left ventricular ejection fraction >45%. Samples from healthy relatives served as controls. The observations led to experimental work using multiple imaging and biochemical techniques in mice with a cardiac-specific deletion of Pkp2 studied at a time of preserved left ventricular ejection fraction and in human induced pluripotent stem cell-derived PKP2-deficient myocytes. Results: Samples from patients with ARVC present a loss of nuclear envelope integrity, molecular signatures indicative of increased DNA damage, and a deficit in transcripts coding for proteins in the electron transport chain. Mice with a cardiac-specific deletion of Pkp2 also present a loss of nuclear envelope integrity, which leads to DNA damage and subsequent excess oxidant production (O-2(.-) and H2O2), the latter increased further under mechanical stress (isoproterenol or exercise). Increased oxidant production and DNA damage is recapitulated in human induced pluripotent stem cell-derived PKP2-deficient myocytes. Furthermore, PKP2-deficient cells release H2O2 into the extracellular environment, causing DNA damage and increased oxidant production in neighboring myocytes in a paracrine manner. Treatment with honokiol increases SIRT3 (mitochondrial nicotinamide adenine dinucleotide-dependent protein deacetylase sirtuin-3) activity, reduces oxidant levels and DNA damage in vitro and in vivo, reduces collagen abundance in the right ventricular free wall, and has a protective effect on right ventricular function. Conclusions: Loss of nuclear envelope integrity and subsequent DNA damage is a key substrate in the molecular pathology of ARVC. We show transcriptional downregulation of proteins of the electron transcript chain as an early event in the molecular pathophysiology of the disease (before loss of left ventricular ejection fraction <45%), which associates with increased oxidant production (O-2(.-) and H2O2). We propose therapies that limit oxidant formation as a possible intervention to restrict DNA damage in ARVC.
C1 [Perez-Hernandez, Marta; van Opbergen, Chantal J. M.; Marron-Linares, Grecia M.; Zhang, Mingliang; Cerrone, Marina; Delmar, Mario] NYU, Leon H Charney Div Cardiol, Grossman Sch Med, New York, NY USA.
   [Bagwan, Navratan; Vega, Estefania Torres; Sorrentino, Andrea; Hansen, Finn B.; Davies, Michael J.; Qvortrup, Klaus; Lundby, Alicia] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.
   [Drici, Lylia; Sulek, Karolina] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark.
   [Vissing, Christoffer Rasmus; Christensen, Alex Horby; Gustafsson, Finn; Rossing, Kasper; Jensen, Thomas Hartvig Lindkaer; Bundgaard, Henning] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.
   [Vissing, Christoffer Rasmus; Christensen, Alex Horby; Boesgaard, Soren; Gustafsson, Finn; Rossing, Kasper; Jensen, Thomas Hartvig Lindkaer; Bundgaard, Henning] Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark.
   [Zhai, Ruxu; Sato, Priscila Y.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
   [Christensen, Alex Horby] Copenhagen Univ Hosp, Dept Cardiol, Herlev Gentofte Hosp, Copenhagen, Denmark.
   [Small, Eric M.] Univ Rochester, Sch Med & Dent, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.
   [Rothenberg, Eli] NYU, Div Pharmacol, Sch Med, New York, NY USA.
C3 New York University; University of Copenhagen; University of Copenhagen;
   University of Copenhagen; University of Copenhagen; Rigshospitalet;
   Drexel University; University of Copenhagen; University of Rochester;
   New York University
RP Delmar, M (corresponding author), NYU, Leon H Chamey Div Cardiol, Sch Med, 435 East 30th St,NSB 707, New York, NY 10016 USA.; Lundby, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Norregade 10, DK-1165 Copenhagen, Denmark.
EM mario.delmar@nyulangone.org; alicia.lundby@sund.ku.dk
RI Zhai, Ruxu/JOZ-4188-2023; Bundgaard, Henning/AAA-4381-2020; Lundby,
   Alicia/H-3322-2013; Christensen, Alex/GVU-3505-2022; Jensen,
   Thomas/ABA-5751-2020; Vissing, Christoffer/AAX-2530-2020; Sulek,
   Karolina/GLN-8212-2022; Rothenberg, Eli/A-6879-2009; Davies,
   Michael/H-4939-2011; Gustafsson, Finn/HJK-3467-2023
OI Bagwan, Navratan/0000-0002-3958-6382; Sorrentino,
   Andrea/0000-0002-3172-0284; Torres-Vega, Estefania/0000-0001-8495-9902;
   Davies, Michael/0000-0002-5196-6919; Jensen, Thomas Hartvig
   Lindkaer/0000-0001-5622-9347; Sato, Priscila/0000-0003-0512-7011;
   Rothenberg, Eli/0000-0002-1382-1380; Drici, Lylia/0000-0002-6633-1721;
   Gustafsson, Finn/0000-0003-2144-341X; Vissing,
   Christoffer/0000-0002-0834-206X; van Opbergen,
   Chantal/0000-0002-1656-4447; Perez-Hernandez, Marta/0000-0001-6119-103X;
   Bundgaard, Henning/0000-0002-0563-7049
FU Transatlantic Network of Excellence grant from the Leducq Foundation;
   Heart Rhythm Society; American Heart Association; Danish Council for
   Independent Research [DFF-0134-00054B]; Novo Nordisk Foundation
   [NNF18OC0052844, NNF20OC0059767, NNF20SA0064214, NNF14CC0001]; NIH
   [R56HL149887, R01HL163666]; Innovation Fund Denmark; NordForsk; AP
   Moller Foundation; Research Foundation at Rigshospitalet; Research
   Foundation at Capital Region of Denmark;  [R35HL160840];  [R01HL136179];
   [R01HL145911]; National Heart Lung and Blood Institute [R01HL145911]
   Funding Source: NIH RePORTER; National Institute of General Medical
   Sciences [R35GM134947] Funding Source: NIH RePORTER
FX This work was supported by a Transatlantic Network of Excellence grant
   from the Leducq Foundation to Drs Lundby and Delmar, grant R35HL160840
   to Dr Delmar, grant R01HL136179 to Drs Delmar and Small, and grant
   R01HL145911 to Dr Delmar, as well as Postdoctoral Fellowships from the
   Heart Rhythm Society to Dr van Opbergen and from the American Heart
   Association to Drs van Opbergen and Marron-Linares. The work was also
   supported by the Danish Council for Independent Research (grant
   DFF-0134-00054B) to Dr Lundby as well as by The Novo Nordisk Foundation
   (grants NNF18OC0052844 and NNF20OC0059767 to Dr Lundby and
   NNF20SA0064214 to Dr Davies). Dr Sato was supported by NIH R56HL149887
   and R01HL163666. Support was received from The Innovation Fund Denmark,
   NordForsk, The AP Moller Foundation, and The Research Foundations at
   Rigshospitalet and at The Capital Region of Denmark to Dr Bundgaard. The
   mass spectrometry measurements were performed at The Novo Nordisk
   Foundation Center for Protein Research, which is funded in part by a
   donation from the Novo Nordisk Foundation (grant NNF14CC0001).
CR Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219
   Akdis D, 2016, HEART RHYTHM, V13, P731, DOI 10.1016/j.hrthm.2015.11.010
   Austin KM, 2019, NAT REV CARDIOL, V16, P519, DOI 10.1038/s41569-019-0200-7
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Cerrone M, 2022, EUR HEART J, V43, P1251, DOI 10.1093/eurheartj/ehab772
   Cerrone M, 2019, CIRCULATION, V140, P595, DOI 10.1161/CIRCULATIONAHA.118.035954
   Cerrone M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00127-0
   Chelko SP, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf0891
   Chelko SP, 2019, CIRCULATION, V140, P1491, DOI 10.1161/CIRCULATIONAHA.119.040676
   Chen SN, 2019, CIRC RES, V124, P856, DOI 10.1161/CIRCRESAHA.118.314238
   Cheung KG, 2015, J BIOL CHEM, V290, P10981, DOI 10.1074/jbc.M114.607960
   Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195
   Corrado D, 2017, NEW ENGL J MED, V376, P61, DOI 10.1056/NEJMra1509267
   Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412
   Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297
   Earle AJ, 2020, NAT MATER, V19, P464, DOI 10.1038/s41563-019-0563-5
   Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003
   Haywood AFM, 2013, EUR HEART J, V34, P1002, DOI 10.1093/eurheartj/ehs383
   Heffler J, 2020, CIRC RES, V126, pE10, DOI 10.1161/CIRCRESAHA.119.315582
   KARTENBECK J, 1983, EMBO J, V2, P735, DOI 10.1002/j.1460-2075.1983.tb01493.x
   Kerr M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140326
   Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799
   Kim JC, 2019, CIRCULATION, V140, P1015, DOI 10.1161/CIRCULATIONAHA.119.039710
   Li N, 2016, SCI REP-UK, V6, DOI 10.1038/srep30817
   Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004
   Linscheid N, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001144
   Linscheid N, 2020, MOL CELL PROTEOMICS, V19, P1132, DOI 10.1074/mcp.RA119.001878
   Ljubojevic S, 2014, CIRCULATION, V130, P244, DOI 10.1161/CIRCULATIONAHA.114.008927
   Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6
   Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1161/CIRCULATIONAHA.108.840827, 10.1093/eurheartj/ehq025]
   Nicolás-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031
   Nishikawa T, 1999, CARDIOVASC PATHOL, V8, P185, DOI 10.1016/S1054-8807(99)00007-1
   Numaga-Tomita T, 2019, PFLUG ARCH EUR J PHY, V471, P507, DOI 10.1007/s00424-018-2211-3
   Pan J, 2017, CANCER PREV RES, V10, P133, DOI [10.1158/1940-6207.capr-16-0129, 10.1158/1940-6207.CAPR-16-0129]
   Paulo JA, 2019, ANAL CHEM, V91, P12167, DOI 10.1021/acs.analchem.9b03162
   Pérez-Hernández M, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.623190
   Pérez-Hernández M, 2021, CIRC RES, V128, P419, DOI 10.1161/CIRCRESAHA.120.318239
   Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656
   Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451
   Reid DA, 2021, SCIENCE, V372, P91, DOI 10.1126/science.abb9032
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rouhi L., 2020, CARDIOVASC RES, V117, P2377
   Sato PY, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aau0144
   Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560
   Towbin JA, 2019, HEART RHYTHM, V16, pE373, DOI 10.1016/j.hrthm.2019.09.019
   Valente M, 1998, AM J PATHOL, V152, P479
   Zecha J, 2019, MOL CELL PROTEOMICS, V18, P1468, DOI 10.1074/mcp.TIR119.001385
NR 50
TC 20
Z9 20
U1 2
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD SEP 13
PY 2022
VL 146
IS 11
BP 851
EP 867
DI 10.1161/CIRCULATIONAHA.122.060454
PG 17
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 4M2ZI
UT WOS:000853194300014
PM 35959657
OA Bronze
DA 2024-11-01
ER

PT J
AU Madreiter-Sokolowski, CT
   Sokolowski, AA
   Waldeck-Weiermair, M
   Malli, R
   Graier, WF
AF Madreiter-Sokolowski, Corina T.
   Sokolowski, Armin A.
   Waldeck-Weiermair, Markus
   Malli, Roland
   Graier, Wolfgang F.
TI Targeting Mitochondria to Counteract Age-Related Cellular Dysfunction
SO GENES
LA English
DT Review
DE mitochondria; aging; caloric restriction; exercise; caloric restriction
   mimetics; polyphenols; aspirin
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OPERATED CA2+ ENTRY; INCREASE
   LIFE-SPAN; OXIDATIVE STRESS; SKELETAL-MUSCLE; ENDOPLASMIC-RETICULUM;
   CALORIE RESTRICTION; DNA DELETIONS; DROSOPHILA-MELANOGASTER;
   CARDIOVASCULAR-DISEASE
AB Senescence is related to the loss of cellular homeostasis and functions, which leads to a progressive decline in physiological ability and to aging-associated diseases. Since mitochondria are essential to energy supply, cell differentiation, cell cycle control, intracellular signaling and Ca2+ sequestration, fine-tuning mitochondrial activity appropriately, is a tightrope walk during aging. For instance, the mitochondrial oxidative phosphorylation (OXPHOS) ensures a supply of adenosine triphosphate (ATP), but is also the main source of potentially harmful levels of reactive oxygen species (ROS). Moreover, mitochondrial function is strongly linked to mitochondrial Ca2+ homeostasis and mitochondrial shape, which undergo various alterations during aging. Since mitochondria play such a critical role in an organism's process of aging, they also offer promising targets for manipulation of senescent cellular functions. Accordingly, interventions delaying the onset of age-associated disorders involve the manipulation of mitochondrial function, including caloric restriction (CR) or exercise, as well as drugs, such as metformin, aspirin, and polyphenols. In this review, we discuss mitochondria's role in and impact on cellular aging and their potential to serve as a target for therapeutic interventions against age-related cellular dysfunction.
C1 [Madreiter-Sokolowski, Corina T.; Waldeck-Weiermair, Markus; Malli, Roland; Graier, Wolfgang F.] Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-6, A-8010 Graz, Austria.
   [Sokolowski, Armin A.] Med Univ Graz, Dept Dent & Maxillofacial Surg, Billrothgasse 4, A-8010 Graz, Austria.
   [Malli, Roland; Graier, Wolfgang F.] BioTechMed, Mozartgasse 12-2, A-8010 Graz, Austria.
C3 Medical University of Graz; Medical University of Graz
RP Madreiter-Sokolowski, CT; Graier, WF (corresponding author), Med Univ Graz, Gottfried Schatz Res Ctr, Mol Biol & Biochem, Neue Stiftingtalstr 6-6, A-8010 Graz, Austria.; Graier, WF (corresponding author), BioTechMed, Mozartgasse 12-2, A-8010 Graz, Austria.
EM corina.madreiter@medunigraz.at; armin.sokolowski@medunigraz.at;
   markus.weiermair@medunigraz.at; roland.malli@medunigraz.at;
   wolfgang.graier@medunigraz.at
RI Waldeck-Weiermair, Markus/AAV-5193-2020; Malli, Roland/B-7369-2008;
   Madreiter-Sokolowski, Corina/AAK-4722-2020; Graier, Wolfgang/B-7052-2008
OI Graier, Wolfgang/0000-0003-1871-3298; Madreiter-Sokolowski, Corina
   T./0000-0002-8631-9949; Waldeck-Weiermair, Markus/0000-0002-5792-6766;
   Malli, Roland/0000-0001-6327-8729
FU Austrian Science Fund (FWF) [P28529] Funding Source: Austrian Science
   Fund (FWF)
CR Afshordel S, 2015, PROSTAG LEUKOTR ESS, V92, P23, DOI 10.1016/j.plefa.2014.05.008
   Alvarez-Illera P, 2017, ONCOTARGET, V8, P55889, DOI 10.18632/oncotarget.18600
   Amigo I, 2017, AGING CELL, V16, P73, DOI 10.1111/acel.12527
   Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12
   [Anonymous], J APPL PHYSL
   Babayev E, 2016, MATURITAS, V93, P121, DOI 10.1016/j.maturitas.2016.06.015
   Baker DJ, 2017, TRENDS BIOCHEM SCI, V42, P702, DOI 10.1016/j.tibs.2017.06.005
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berman AY, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0038-6
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Brandt T, 2017, ELIFE, V6, DOI 10.7554/eLife.24662
   Brenmoehl J, 2013, MITOCHONDRION, V13, P755, DOI 10.1016/j.mito.2013.04.002
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Brini M, 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A004168
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Calvo-Rodríguez M, 2016, BBA-MOL CELL RES, V1863, P2637, DOI 10.1016/j.bbamcr.2016.08.001
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Cárdenas C, 2016, CELL REP, V14, P2313, DOI [10.1016/j.celrep.2016.02.030, 10.1016/j.celrep.2016.03.045]
   Cerella C, 2016, CURR DRUG TARGETS, V17, P405, DOI 10.2174/1389450116666150202155915
   Chacko BK, 2011, HEPATOLOGY, V54, P153, DOI 10.1002/hep.24377
   Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914
   Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chinnery PF, 1993, GENEREVIEWS
   Chung JH, 2012, TRENDS CELL BIOL, V22, P546, DOI 10.1016/j.tcb.2012.07.004
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Conti V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00024
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Cuyàs E, 2016, CELL CYCLE, V15, P3355, DOI 10.1080/15384101.2016.1249547
   Danilov A, 2015, ONCOTARGET, V6, P19428, DOI 10.18632/oncotarget.5118
   Daubert MA, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004389
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   de Oliveira MR, 2016, BIOTECHNOL ADV, V34, P532, DOI 10.1016/j.biotechadv.2015.12.014
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Degli Esposti M, 2014, GENOME BIOL EVOL, V6, P3238, DOI 10.1093/gbe/evu257
   Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/S0140-6736(17)32252-3, 10.1016/s0140-6736(17)32252-3]
   DENTON RM, 1978, INT J BIOCHEM, V9, P545, DOI 10.1016/0020-711X(78)90113-1
   Desjardins D, 2017, AGING CELL, V16, P104, DOI 10.1111/acel.12528
   Dong D, 2017, ONCOTARGET, V8, P16109, DOI 10.18632/oncotarget.14884
   Dong ZW, 2017, MOL CELL, V65, P1014, DOI 10.1016/j.molcel.2017.01.032
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El'darov CM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P604, DOI 10.1134/S0006297915050132
   Farfariello V, 2015, BBA-MOL CELL RES, V1853, P1974, DOI 10.1016/j.bbamcr.2015.03.005
   Fernandez-Sanz C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.526
   Ferrières J, 2004, HEART, V90, P107, DOI 10.1136/heart.90.1.107
   Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Forkink M, 2015, REDOX BIOL, V6, P607, DOI 10.1016/j.redox.2015.09.003
   Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x
   Gauba E, 2017, J ALZHEIMERS DIS, V55, P1351, DOI 10.3233/JAD-160822
   Gellerich FN, 2000, BIOCHEM SOC T, V28, P164, DOI 10.1042/bst0280164
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Görlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Guignabert C, 2016, J CLIN INVEST, V126, P3207, DOI 10.1172/JCI86249
   Halling JF, 2017, EXP GERONTOL, V96, P1, DOI 10.1016/j.exger.2017.05.020
   Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327
   Hekimi S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23793
   Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502
   Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Huang XB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184027
   Huffman DM, 2016, EXP GERONTOL, V86, P73, DOI 10.1016/j.exger.2016.05.012
   Jensen MB, 2017, ELIFE, V6, DOI [10.7554/eLife.26952, 10.7554/eLife.26952.001]
   Jiang YF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45474
   Joseph AM, 2016, J PHYSIOL-LONDON, V594, P5105, DOI 10.1113/JP270659
   Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014
   Kamer KJ, 2014, EMBO REP, V15, P299, DOI 10.1002/embr.201337946
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lalia AZ, 2017, AGING-US, V9, P1096, DOI 10.18632/aging.101210
   Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618
   LAWLIS VB, 1981, BIOCHEMISTRY-US, V20, P2512, DOI 10.1021/bi00512a023
   Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Li HZ, 2017, BBA-MOL BASIS DIS, V1863, P2266, DOI 10.1016/j.bbadis.2017.05.022
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lodgdon MD, 1999, INT J RADIAT ONCOL, V44, P19
   Lopez T, 2014, J MED FOOD, V17, P1314, DOI 10.1089/jmf.2013.0190
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003
   Lunnon K, 2017, NEUROBIOL AGING, V53, P36, DOI 10.1016/j.neurobiolaging.2016.12.029
   Madreiter-Sokolowski CT, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101117
   Maiti AK, 2017, NEUROTOX RES, V31, P358, DOI 10.1007/s12640-016-9692-7
   Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200
   Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200
   Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622
   Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564
   Manzo-Avalos S, 2010, INT J ENV RES PUB HE, V7, P4281, DOI 10.3390/ijerph7124281
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Marin TL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf7478
   Martín-Hernández E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Menezes SL, 2017, FREE RADICAL BIO MED, V110, P219, DOI 10.1016/j.freeradbiomed.2017.06.013
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Merry TL, 2016, FREE RADICAL BIO MED, V98, P123, DOI 10.1016/j.freeradbiomed.2015.11.032
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572
   Morozov YM, 2017, NEUROBIOL AGING, V51, P9, DOI 10.1016/j.neurobiolaging.2016.12.001
   Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Ocampo A, 2016, TRENDS MOL MED, V22, P725, DOI 10.1016/j.molmed.2016.06.005
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481
   Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013
   Pérez VI, 2011, J GERONTOL A-BIOL, V66, P1286, DOI 10.1093/gerona/glr125
   Pérez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x
   Pestronk A, 2017, MUSCLE NERVE, V56, P122, DOI 10.1002/mus.25442
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Pinto M, 2017, CELL DEATH DIFFER, V24, P288, DOI 10.1038/cdd.2016.123
   Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126
   Pugh TD, 2013, AGING CELL, V12, P672, DOI 10.1111/acel.12091
   Qi WB, 2017, AGING CELL, V16, P1125, DOI 10.1111/acel.12651
   Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485
   Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a
   Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003
   Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Safdar A, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0075-9
   Sakellariou GK, 2016, FASEB J, V30, P3771, DOI 10.1096/fj.201600450R
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Shabalina IG, 2017, AGING-US, V9, P315, DOI 10.18632/aging.101174
   Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525
   Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Smieszek A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040872
   Son JM, 2017, AGING CELL, V16, P1136, DOI 10.1111/acel.12649
   Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218
   Sparks LM, 2017, J CLIN ENDOCR METAB, V102, P111, DOI 10.1210/jc.2016-3211
   Stöckl P, 2007, FREE RADICAL BIO MED, V43, P947, DOI 10.1016/j.freeradbiomed.2007.06.005
   Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x
   Sylow L, 2016, ENDOCRINOLOGY, V157, P4184, DOI 10.1210/en.2016-1398
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tepp K, 2017, MOL CELL BIOCHEM, V432, P141, DOI 10.1007/s11010-017-3005-1
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tian Y, 2016, TRENDS CELL BIOL, V26, P563, DOI 10.1016/j.tcb.2016.06.006
   Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X
   Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556
   Trepanowski JF, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-107
   Trnka J, 2009, FREE RADICAL RES, V43, P4, DOI 10.1080/10715760802582183
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Uzhachenko R, 2017, AGING-US, V9, P627, DOI 10.18632/aging.101213
   Vais H, 2016, CELL REP, V14, P403, DOI 10.1016/j.celrep.2015.12.054
   Valencia WM, 2017, DIABETOLOGIA, V60, P1630, DOI 10.1007/s00125-017-4349-5
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Waldeck-Weiermair M, 2013, J BIOL CHEM, V288, P15367, DOI 10.1074/jbc.M113.462259
   Ward MS, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-10209-0, 10.1038/s41598-017-15589-x]
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Wierman MB, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00562-16
   Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x
   Wu J, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00119
   Wu LF, 2016, CELL, V167, P1705, DOI 10.1016/j.cell.2016.11.055
   Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yi JK, 2016, ONCOTARGET, V7, P21124, DOI 10.18632/oncotarget.8195
   Zampieri S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13005
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011
   ZORATTI M, 1994, J BIOENERG BIOMEMBR, V26, P543, DOI 10.1007/BF00762739
   Zwerschke W, 2003, BIOCHEM J, V376, P403, DOI 10.1042/BJ20030816
NR 181
TC 36
Z9 43
U1 1
U2 17
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD MAR
PY 2018
VL 9
IS 3
AR 165
DI 10.3390/genes9030165
PG 20
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GA7IE
UT WOS:000428508800048
PM 29547561
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Ferdinandusse, S
   Waterham, HR
   Heales, SJR
   Brown, GK
   Hargreaves, IP
   Taanman, JW
   Gunny, R
   Abulhoul, L
   Wanders, RJA
   Clayton, PT
   Leonard, JV
   Rahman, S
AF Ferdinandusse, Sacha
   Waterham, Hans R.
   Heales, Simon J. R.
   Brown, Garry K.
   Hargreaves, Iain P.
   Taanman, Jan-Willem
   Gunny, Roxana
   Abulhoul, Lara
   Wanders, Ronald J. A.
   Clayton, Peter T.
   Leonard, James V.
   Rahman, Shamima
TI HIBCH mutations can cause Leigh-like disease with combined deficiency of
   multiple mitochondrial respiratory chain enzymes and pyruvate
   dehydrogenase
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE Mitochondrial disease; Multiple respiratory chain enzyme deficiencies;
   Pyruvate dehydrogenase deficiency; 3-hydroxy-isobutyryl-CoA hydrolase;
   HIBCH; Acylcarnitines; Multiple mitochondrial dysfunctions syndrome;
   Valine catabolism; Organic aciduria
ID ACIDURIA TYPE-I; DNA DEPLETION; GLUTATHIONE DEFICIENCY; ETHYLMALONIC
   ENCEPHALOPATHY; METHYLMALONIC ACIDURIA; PROPIONIC ACIDURIA; THIOL
   STATUS; COA; NEURODEGENERATION; ABNORMALITIES
AB Background: Deficiency of 3-hydroxy-isobutyryl-CoA hydrolase (HIBCH) caused by HIBCH mutations is a rare cerebral organic aciduria caused by disturbance of valine catabolism. Multiple mitochondrial respiratory chain (RC) enzyme deficiencies can arise from a number of mechanisms, including defective maintenance or expression of mitochondrial DNA. Impaired biosynthesis of iron-sulphur clusters and lipoic acid can lead to pyruvate dehydrogenase complex (PDHc) deficiency in addition to multiple RC deficiencies, known as the multiple mitochondrial dysfunctions syndrome.
   Methods: Two brothers born to distantly related Pakistani parents presenting in early infancy with a progressive neurodegenerative disorder, associated with basal ganglia changes on brain magnetic resonance imaging, were investigated for suspected Leigh-like mitochondrial disease. The index case had deficiencies of multiple RC enzymes and PDHc in skeletal muscle and fibroblasts respectively, but these were normal in his younger brother. The observation of persistently elevated hydroxy-C4-carnitine levels in the younger brother led to suspicion of HIBCH deficiency, which was investigated by biochemical assay in cultured skin fibroblasts and molecular genetic analysis.
   Results: Specific spectrophotometric enzyme assay revealed HIBCH activity to be below detectable limits in cultured skin fibroblasts from both brothers. Direct Sanger sequence analysis demonstrated a novel homozygous pathogenic missense mutation c.950G>A; p.Gly317Glu in the HIBCH gene, which segregated with infantile-onset neurodegeneration within the family.
   Conclusions: HIBCH deficiency, a disorder of valine catabolism, is a novel cause of the multiple mitochondrial dysfunctions syndrome, and should be considered in the differential diagnosis of patients presenting with multiple RC deficiencies and/or pyruvate dehydrogenase deficiency.
C1 [Ferdinandusse, Sacha; Waterham, Hans R.; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
   [Heales, Simon J. R.; Gunny, Roxana] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
   [Abulhoul, Lara; Rahman, Shamima] Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 3JH, England.
   [Heales, Simon J. R.; Hargreaves, Iain P.] Natl Hosp Neurol, Neurometab Unit, London, England.
   [Heales, Simon J. R.; Clayton, Peter T.; Leonard, James V.; Rahman, Shamima] UCL Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Brown, Garry K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London, England.
C3 University of Amsterdam; Academic Medical Center Amsterdam; University
   of London; University College London; Great Ormond Street Hospital for
   Children NHS Foundation Trust; University of London; University College
   London; Great Ormond Street Hospital for Children NHS Foundation Trust;
   University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; University of
   London; University College London; University of Oxford; University of
   London; University College London
RP Rahman, S (corresponding author), Great Ormond St Hosp Sick Children, Metab Unit, Great Ormond St, London WC1N 3JH, England.
EM shamima.rahman@ucl.ac.uk
RI Rahman, Shamima/C-5232-2008; Hargreaves, Iain/AAJ-6757-2020; Clayton,
   Peter/C-1523-2008; Taanman, Jan-Willem/A-5379-2011
OI Ferdinandusse, Sacha/0000-0002-7738-5709; Clayton,
   Peter/0000-0001-7592-4302; Taanman, Jan-Willem/0000-0002-5476-9785
FU Great Ormond Street Hospital Children's Charity
FX SR and PTC are supported by Great Ormond Street Hospital Children's
   Charity.
CR ALI MS, 1993, J BIOL CHEM, V268, P22353
   BROWN GK, 1982, PEDIATRICS, V70, P532
   Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435
   Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011
   Chen Y, 2006, TOXICOL APPL PHARM, V216, P256, DOI 10.1016/j.taap.2006.05.006
   Chrzanowska-Lightowlers Z M A, 2011, Neuromuscul Disord, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   COOPERSTEIN SJ, 1963, J BIOL CHEM, V238, P3606
   Danielson SR, 2011, J BIOL CHEM, V286, P7601, DOI 10.1074/jbc.M110.190108
   de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Haack TB., 2012, J Inherit Metab Dis
   Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Harting I, 2008, J INHERIT METAB DIS, V31, P368, DOI 10.1007/s10545-008-0801-5
   Harting I, 2009, BRAIN, V132, P1764, DOI 10.1093/brain/awp112
   HAYASAKA K, 1989, J INHERIT METAB DIS, V12, P247, DOI 10.1007/BF01799214
   KHAILOVA LS, 1989, ANN NY ACAD SCI, V573, P36, DOI 10.1111/j.1749-6632.1989.tb14985.x
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lehnert W, 2005, MED HYPOTHESES, V65, P330, DOI 10.1016/j.mehy.2005.02.021
   Loupatty FJ, 2007, AM J HUM GENET, V80, P195, DOI 10.1086/510725
   Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005
   Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200
   PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019
   Salmi H, 2012, ACTA PAEDIATR, V101, pe505, DOI 10.1111/j.1651-2227.2012.02799.x
   Salmi H, 2012, SCAND J CLIN LAB INV, V72, P152, DOI 10.3109/00365513.2011.646299
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221
   SCHWARTZ ER, 1970, J BIOL CHEM, V245, P183
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653
   Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907
   Treacy E, 1996, J PEDIATR-US, V129, P445, DOI 10.1016/S0022-3476(96)70080-X
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   WICKING CA, 1986, BIOCHEM J, V239, P89, DOI 10.1042/bj2390089
NR 39
TC 60
Z9 66
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD DEC 4
PY 2013
VL 8
AR 188
DI 10.1186/1750-1172-8-188
PG 11
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA AB8BW
UT WOS:000332016100001
PM 24299452
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hue, THD
   Montanari, A
   Rozanska, A
   Tuppen, HA
   Almalki, AA
   Abg-Kamaludin, DP
   Frontali, L
   Francisci, S
   Lightowlers, RN
   Chrzanowska-Lightowlers, ZM
AF Hue Tran Hornig-Do
   Montanari, Arianna
   Rozanska, Agata
   Tuppen, Helen A.
   Almalki, Abdulraheem A.
   Abg-Kamaludin, Dyg P.
   Frontali, Laura
   Francisci, Silvia
   Lightowlers, Robert N.
   Chrzanowska-Lightowlers, Zofia M.
TI Human mitochondrial leucyl tRNA synthetase can suppress non cognate
   pathogenic mt-tRNA mutations
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE aminoacyl tRNA synthetase; disease; mitochondria; protein synthesis;
   therapy
ID GROUP-I INTRONS; MATURASE DEFICIENCY; TRNA(LEU(UUR)) GENE; SPLICING
   FUNCTION; CRYSTAL-STRUCTURE; EF-TU; DNA; AMINOACYLATION; DISEASE;
   PROTEIN
AB Disorders of the mitochondrial genome cause a wide spectrum of disease, these present mainly as neurological and/or muscle related pathologies. Due to the intractability of the human mitochondrial genome there are currently no effective treatments for these disorders. The majority of the pathogenic mutations lie in the genes encoding mitochondrial tRNAs. Consequently, the biochemical deficiency is due to mitochondrial protein synthesis defects, which manifest as aberrant cellular respiration and ATP synthesis. It has previously been reported that overexpression of mitochondrial aminoacyl tRNA synthetases has been effective, in cell lines, at partially suppressing the defects resulting from mutations in their cognate mt-tRNAs. We now show that leucyl tRNA synthetase is able to partially rescue defects caused by mutations in non-cognate mt-tRNAs. Further, a C terminal peptide alone can enter mitochondria and interact with the same spectrum of mt-tRNAs as the entire synthetase, in intact cells. These data support the possibility that a small peptide could correct at least the biochemical defect associated with many mt-tRNA mutations, inferring a novel therapy for these disorders.
C1 [Hue Tran Hornig-Do; Rozanska, Agata; Tuppen, Helen A.; Almalki, Abdulraheem A.; Abg-Kamaludin, Dyg P.; Chrzanowska-Lightowlers, Zofia M.] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Montanari, Arianna; Frontali, Laura; Francisci, Silvia] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, Dept Biol & Biotechnol C Darwin, I-00185 Rome, Italy.
   [Lightowlers, Robert N.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; Fondazione Cenci Bolognetti; Sapienza
   University Rome; Newcastle University - UK
RP Lightowlers, RN (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM Robert.Lightowlers@ncl.ac.uk; Zofia.Chrzanowska-Lightowlers@ncl.ac.uk
RI MONTANARI, ARIANNA/HLW-5611-2023; Almalki, Abdulraheem/KYP-1626-2024
OI Francisci, silvia/0000-0002-6756-9491; Tuppen,
   Helen/0000-0001-8762-0824; Montanari, Arianna/0000-0001-6832-7569;
   Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152
FU Deutsche Forschungsgemeinschaft (DFG); FEBS; Malaysian Government; BBSRC
   [BB/F011520/1] Funding Source: UKRI
FX We thank Satomi Miwa for help with XF24 analyzer experiments, and Conor
   Lawless for computer programming assistance for CLIP data presentation.
   RNL and ZCL would like to thank The Wellcome Trust [096919/Z/11/Z] and
   the BBSRC [BB/F011520/1] for continuing support. HTHD was supported by a
   Deutsche Forschungsgemeinschaft (DFG) postdoctoral Fellowship. AM was
   sponsored by a FEBS short term Fellowship and DAK by the Malaysian
   Government.
CR AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1
   Bullard JM, 2000, BBA-GENE STRUCT EXPR, V1490, P245, DOI 10.1016/S0167-4781(99)00240-7
   Bullard JN, 1999, J MOL BIOL, V288, P567, DOI 10.1006/jmbi.1999.2708
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Chinnery PF, 2000, MOL MED TODAY, V6, P425, DOI 10.1016/S1357-4310(00)01805-0
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   Chrzanowska-Lightowlers Z M A, 2011, Neuromuscul Disord, V21, P142, DOI 10.1016/j.nmd.2010.10.005
   Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   Dennerlein S, 2010, BIOCHEM J, V430, P551, DOI 10.1042/BJ20100757
   DUJARDIN G, 1980, MOL GEN GENET, V179, P469, DOI 10.1007/BF00271736
   Fender A, 2012, BIOCHIMIE, V94, P1090, DOI 10.1016/j.biochi.2012.02.030
   Feuermann M, 2003, EMBO REP, V4, P53, DOI 10.1038/sj.embor.embor713
   Francisci S, 2011, MITOCHONDRION, V11, P919, DOI 10.1016/j.mito.2011.08.006
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x
   Hornig-Do HT, 2012, EMBO J, V31, P1293, DOI 10.1038/emboj.2011.477
   Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040
   Houman F, 2000, P NATL ACAD SCI USA, V97, P13743, DOI 10.1073/pnas.240465597
   Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200
   Keogh MJ, 2013, CLIN NEUROL NEUROSUR, V115, P948, DOI 10.1016/j.clineuro.2012.09.030
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   KITTLE JD, 1991, GENE DEV, V5, P1009, DOI 10.1101/gad.5.6.1009
   LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x
   LABOUESSE M, 1985, CELL, V41, P133, DOI 10.1016/0092-8674(85)90068-6
   LABOUESSE M, 1990, MOL GEN GENET, V224, P209, DOI 10.1007/BF00271554
   Larkin DC, 2002, NUCLEIC ACIDS RES, V30, P2103, DOI 10.1093/nar/30.10.2103
   Li GY, 1996, MOL GEN GENET, V252, P667, DOI 10.1007/s004380050275
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   MAJUMDER AL, 1989, MOL CELL BIOL, V9, P2089, DOI 10.1128/MCB.9.5.2089
   McFarland R, 2002, NAT GENET, V30, P145, DOI 10.1038/ng819
   MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0
   Montanari A, 2010, BBA-MOL CELL RES, V1803, P1050, DOI 10.1016/j.bbamcr.2010.05.003
   Myers CA, 2002, P NATL ACAD SCI USA, V99, P2630, DOI 10.1073/pnas.052596299
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   PEGG AE, 1988, CANCER RES, V48, P759
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75
   Rho SB, 2002, EMBO J, V21, P6874, DOI 10.1093/emboj/cdf671
   Rinaldi T, 1997, CURR GENET, V31, P494, DOI 10.1007/s002940050235
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147
   Sarkar J, 2012, J BIOL CHEM, V287, P14772, DOI 10.1074/jbc.M111.322412
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shaag A, 1997, BIOCHEM BIOPH RES CO, V233, P637, DOI 10.1006/bbrc.1997.6496
   Smits P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737385
   Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031
   Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yao P, 2013, TOP CURR CHEM
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
NR 53
TC 33
Z9 34
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD FEB
PY 2014
VL 6
IS 2
BP 183
EP 193
DI 10.1002/emmm.201303202
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA AA9BU
UT WOS:000331389500004
PM 24413189
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Warda, M
   Kim, HK
   Kim, N
   Ko, KS
   Rhee, BD
   Han, J
AF Warda, Mohamad
   Kim, Hyoung Kyu
   Kim, Nari
   Ko, Kyung Soo
   Rhee, Byoung Doo
   Han, Jin
TI A matter of life, death and diseases: mitochondria from a proteomic
   perspective
SO EXPERT REVIEW OF PROTEOMICS
LA English
DT Review
DE apoptosis; mitochondria; oxidative stress; proteome
ID MYOCARDIAL ISCHEMIA-REPERFUSION; RADICAL OXIDATIVE STRESS; CYTOCHROME-C
   RELEASE; FATTY-ACID OXIDATION; K-ATP CHANNELS; ALZHEIMERS-DISEASE;
   PARKINSONS-DISEASE; ENDOPLASMIC-RETICULUM; DNA MUTATIONS;
   SKELETAL-MUSCLE
AB Mitochondria are highly ordered, integrated organelles that energize cellular activities and contribute to programmed death by initiating disciplined apoptotic cascades. This review seeks to clarify our understanding of mitochondrial structural-functional integrity beyond the resolved nuclear genome by unraveling the dynamic mitochondrial proteome and elucidating proteome/genome interplay. The roles of mechanochemical coupling between mitoskeleton and cytoskeleton and crosstalk with other organelles in orchestrating cellular outcomes are explained. The authors also review the modulation of mitochondrial-related oxidative stress on apoptosis and cancer development and the context is applied to interpret pathogenetic events in neurodegenerative disorders and cardiovascular diseases. The accumulated proteomics evidence is used to describe the integral role that mitochondria play and how they influence other intracellular organelles. Possible mitochondrial-targeted therapeutic interventions are also discussed.
C1 [Warda, Mohamad] Cairo Univ, Fac Vet Med, Biochem Mol Biol & Chem Nutr Dept, Giza, Egypt.
   [Kim, Hyoung Kyu; Kim, Nari; Ko, Kyung Soo; Rhee, Byoung Doo; Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling, Dept Physiol, Coll Med,Cardiovasc & Metab Dis Ctr, Pusan, South Korea.
C3 Egyptian Knowledge Bank (EKB); Cairo University; Inje University
RP Warda, M (corresponding author), Cairo Univ, Fac Vet Med, Biochem Mol Biol & Chem Nutr Dept, Giza, Egypt.
EM maawarda@eun.eg; phyhanj@inje.ac.kr
RI Gamal, Mahmoud/JXN-2660-2024; Kim, Hyung/J-5451-2012; Kim,
   Jung-Wook/AAI-1668-2020
OI Warda, Mohamed/0000-0001-7004-8526; Warda, Mohamad/0000-0003-0516-4023;
   Kim, Hyoung Kyu/0000-0002-1791-7865
FU Inje University; Priority Research Centers Program through the National
   Research Foundation of Korea(NRF); Ministry of Education, Science and
   Technology [2010-0020224, 2012R1A2A1A03007595]
FX This work was supported by the Inje University Research Grant (2004) and
   Priority Research Centers Program through the National Research
   Foundation of Korea(NRF) funded by the Ministry of Education, Science
   and Technology(2010-0020224 and 2012R1A2A1A03007595). The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7
   Alzualde A, 2010, J NEUROPATH EXP NEUR, V69, P789, DOI 10.1097/NEN.0b013e3181e85737
   Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Babiychuk EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023706
   Beal MF, 2000, ANN NY ACAD SCI, V924, P164
   Bennett MJ, 2000, CRIT REV CL LAB SCI, V37, P1, DOI 10.1080/10408360091174169
   Bereiter-Hahn J, 2010, INT REV CEL MOL BIO, V284, P1, DOI 10.1016/S1937-6448(10)84001-8
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   BRDICZKA D, 1994, MOL CELL BIOCHEM, V133, P69, DOI 10.1007/BF01267948
   Bresalier RS, 1997, CANCER, V80, P776
   Buchwalow IB, 2001, MOL CELL BIOCHEM, V217, P73, DOI 10.1023/A:1007286602865
   Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3
   Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015
   Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308
   Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181
   Chen XL, 2012, PROTEIN CELL, V3, P648, DOI 10.1007/s13238-012-2043-4
   Chen XL, 2010, EXPERT REV PROTEOMIC, V7, P333, DOI 10.1586/EPR.10.22
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chiang SF, 2012, INT J MOL MED, V29, P365, DOI 10.3892/ijmm.2011.849
   Chu VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028551
   Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001
   Coletta DK, 2011, AM J PHYSIOL-ENDOC M, V301, pE749, DOI 10.1152/ajpendo.00363.2011
   DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213
   Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005
   Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329
   Decuypere JP, 2011, BBA-MOL CELL RES, V1813, P1003, DOI 10.1016/j.bbamcr.2010.11.023
   Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233
   Di Lisa F, 2003, BASIC RES CARDIOL, V98, P235, DOI 10.1007/s00395-003-0415-x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duneau M, 2005, EXP CELL RES, V302, P194, DOI 10.1016/j.yexcr.2004.08.041
   Durazo SA, 2012, MITOCHONDRION, V12, P190, DOI 10.1016/j.mito.2011.11.001
   Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4
   Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Fraser F, 1998, BIOCHEM J, V329, P225, DOI 10.1042/bj3290225
   Fujimoto M, 2012, BIOCHEM BIOPH RES CO, V417, P635, DOI 10.1016/j.bbrc.2011.12.022
   Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336
   Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039
   García-Dorado D, 2004, CARDIOVASC RES, V61, P386, DOI 10.1016/j.cardiores.2003.11.039
   Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Goldstein B, 2000, DEV DYNAM, V218, P23, DOI 10.1002/(SICI)1097-0177(200005)218:1<23::AID-DVDY3>3.0.CO;2-Z
   Gonzalez CD, 2011, AUTOPHAGY, V7, P2, DOI 10.4161/auto.7.1.13044
   Gonzalez P, 2007, BIOCHEMISTRY-US, V46, P7374, DOI 10.1021/bi700213p
   Good PF, 1996, AM J PATHOL, V149, P21
   Gottlieb RA, 2003, BASIC RES CARDIOL, V98, P242, DOI 10.1007/s00395-003-0404-0
   Gottlieb RA, 2001, BIOL SIGNAL RECEPT, V10, P147
   Gottlieb Roberta A, 2007, Methods Mol Biol, V357, P127
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gray MW, 2001, GENOME BIOL, V2
   Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1
   Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903
   Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878
   Gross GJ, 2003, AM J PHYSIOL-HEART C, V285, pH921, DOI 10.1152/ajpheart.00421.2003
   Gross GJ, 2002, BRIT J PHARMACOL, V137, P939, DOI 10.1038/sj.bjp.0704965
   Hahn T, 2012, CURR PHARM BIOTECHNO
   Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128
   Hales KG, 2004, MITOCHONDRION, V4, P285, DOI 10.1016/j.mito.2004.05.007
   Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001
   Hanley PJ, 2002, J PHYSIOL-LONDON, V542, P735, DOI 10.1113/jphysiol.2002.023960
   Heath-Engel HM, 2012, BBA-MOL CELL RES, V1823, P335, DOI 10.1016/j.bbamcr.2011.11.020
   Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x
   Jakupciak JP, 2005, J MOL DIAGN, V7, P258, DOI 10.1016/S1525-1578(10)60553-3
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   Jiang WW, 2005, CLIN CANCER RES, V11, P2486, DOI 10.1158/1078-0432.CCR-04-2147
   Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200
   Jobson RW, 2010, MITOCHONDRION, V10, P540, DOI 10.1016/j.mito.2010.05.013
   Kagan J, 2005, CRIT REV CL LAB SCI, V42, P453, DOI 10.1080/10408360500295477
   Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260
   Kartha GK, 2008, ACTA DIABETOL, V45, P75, DOI 10.1007/s00592-008-0025-z
   Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6
   Khairallah RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034402
   Kim HK, 2007, AM J PHYSIOL-CELL PH, V293, pC761, DOI 10.1152/ajpcell.00043.2007
   Kim N, 2006, PROTEOMICS, V6, P1237, DOI 10.1002/pmic.200500291
   Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8
   Krügel K, 2011, EXP EYE RES, V92, P87, DOI 10.1016/j.exer.2010.11.007
   Kuerschner L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031342
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   KUROIWA T, 1994, MICROSC RES TECHNIQ, V27, P220, DOI 10.1002/jemt.1070270304
   Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592
   Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200
   Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7
   Li X, 2004, J MOL CELL CARDIOL, V36, P161, DOI 10.1016/j.yjmcc.2003.10.019
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lo MC, 2010, ANN NY ACAD SCI, V1201, P1, DOI 10.1111/j.1749-6632.2010.05630.x
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Melkikh AV, 2012, PROG BIOPHYS MOL BIO, V109, P33, DOI 10.1016/j.pbiomolbio.2012.04.008
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Miura T, 2004, AM J PHYSIOL-HEART C, V286, pH214, DOI 10.1152/ajpheart.00441.2003
   Miura T, 2010, AM J PHYSIOL-HEART C, V298, pH1115, DOI 10.1152/ajpheart.00879.2009
   Miyama A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027883
   Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495
   Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   Naitoh K, 2006, CARDIOVASC RES, V70, P374, DOI 10.1016/j.cardiores.2006.01.023
   NAKAMURA K, 1993, ONCOGENE, V8, P3133
   Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159
   Nomoto S, 2002, CLIN CANCER RES, V8, P481
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Padilla F, 2003, AM J PHYSIOL-HEART C, V285, pH1909, DOI 10.1152/ajpheart.00438.2003
   Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200
   Parrella P, 2001, CANCER RES, V61, P7623
   Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005
   Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102
   Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104
   Plotkin LI, 2005, J BIOL CHEM, V280, P7317, DOI 10.1074/jbc.M412817200
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Przyklenk K, 2005, J PHARMACOL EXP THER, V314, P1386, DOI 10.1124/jpet.105.087742
   Psarra AMG, 2009, BBA-BIOENERGETICS, V1787, P431, DOI 10.1016/j.bbabio.2008.11.011
   Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x
   Quarato G, 2012, HEPATOLOGY, V55, P1333, DOI 10.1002/hep.25514
   Quarato G, 2011, MITOCHONDRION, V11, P764, DOI 10.1016/j.mito.2011.06.014
   Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166
   Rebelato E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024507
   Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393
   Reddy PH, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/31372
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reipert S, 1999, EXP CELL RES, V252, P479, DOI 10.1006/excr.1999.4626
   Rodríguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003
   Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de
   Ruiz-Romero C, 2006, OSTEOARTHR CARTILAGE, V14, P507, DOI 10.1016/j.joca.2005.12.004
   Saks VA, 1998, MOL CELL BIOCHEM, V184, P81, DOI 10.1023/A:1006834912257
   Saks VA, 1996, MOL CELL BIOCHEM, V161, P195, DOI 10.1007/BF00240050
   Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103
   Sano R, 2012, GENE DEV, V26, P1041, DOI 10.1101/gad.184325.111
   Santos JM, 2011, INVEST OPHTH VIS SCI, V52, P8791, DOI 10.1167/iovs.11-8203
   Santos JM, 2011, FREE RADICAL BIO MED, V51, P1849, DOI 10.1016/j.freeradbiomed.2011.08.017
   Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675
   SCHOEPPNER HL, 1995, CANCER, V75, P2818, DOI 10.1002/1097-0142(19950615)75:12<2818::AID-CNCR2820751206>3.0.CO;2-#
   Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002
   Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x
   Siegelin MD, 2010, MOL CANCER THER, V9, P1638, DOI 10.1158/1535-7163.MCT-10-0097
   Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009
   Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056
   Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Smith MA, 1997, J NEUROSCI, V17, P2653
   SMITH MA, 1994, ANN NY ACAD SCI, V738, P447
   SMITH MA, 1994, AM J PATHOL, V145, P42
   Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003
   Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Souchelnytskyi S, 2005, PROTEOMICS, V5, P4123, DOI 10.1002/pmic.200500135
   Sourris KC, 2012, FREE RADICAL BIO MED, V52, P716, DOI 10.1016/j.freeradbiomed.2011.11.017
   STAAL FJT, 1994, P NATL ACAD SCI USA, V91, P3619, DOI 10.1073/pnas.91.9.3619
   STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496
   Struewing IT, 2006, J BIOL CHEM, V281, P7282, DOI 10.1074/jbc.M511182200
   Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12
   Tell G, 2001, MUTAT RES-DNA REPAIR, V485, P143, DOI 10.1016/S0921-8777(00)00068-9
   Touyz RM, 2005, CAN J PHYSIOL PHARM, V83, P91, DOI 10.1139/Y05-006
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Vallance HD, 2004, PEDIATR CARDIOL, V25, P538, DOI 10.1007/s00246-003-0446-y
   Van Cuong D, 2007, AM J PHYSIOL-HEART C, V293, pH1457, DOI 10.1152/ajpheart.01282.2006
   VANDERKLEI IJ, 1994, MICROSC RES TECHNIQ, V27, P284, DOI 10.1002/jemt.1070270404
   Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274
   Velazquez JLP, 2000, NEUROSCIENCE, V97, P363
   Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192
   Wagner I, 1997, EMBO J, V16, P7317, DOI 10.1093/emboj/16.24.7317
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200
   Warburg O., 1930, The Metabolism of Tumors
   Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436
   Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101
   Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481
   Winter L, 2008, J CELL BIOL, V181, P903, DOI 10.1083/jcb.200710151
   Wong R, 2010, AM J PHYSIOL-HEART C, V298, pH75, DOI 10.1152/ajpheart.00515.2009
   Woo DK, 2009, BBA-GENE REGUL MECH, V1789, P135, DOI 10.1016/j.bbagrm.2008.09.008
   Wu CC, 2012, ANTIOXID REDOX SIGNA
   Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022
   Yang SH, 2009, J BIOL CHEM, V284, P9540, DOI 10.1074/jbc.M808246200
   Ye L, 2011, BRAIN RES, V1411, P57, DOI 10.1016/j.brainres.2011.07.011
   Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200
   Yuan HP, 2010, FEBS J, V277, P5061, DOI 10.1111/j.1742-4658.2010.07911.x
   Zamorano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037782
   Zelenaya-Troitskaya O, 1998, GENETICS, V148, P1763
   Zhang HN, 2011, J PROTEOME RES, V10, P4757, DOI 10.1021/pr200553c
   Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011
   Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084
NR 193
TC 17
Z9 17
U1 0
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-9450
EI 1744-8387
J9 EXPERT REV PROTEOMIC
JI Expert Rev. Proteomics
PD FEB
PY 2013
VL 10
IS 1
BP 97
EP 111
DI 10.1586/EPR.12.69
PG 15
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 093AB
UT WOS:000315163000017
PM 23414362
DA 2024-11-01
ER

PT J
AU Wolfe, R
   Heiman, P
   D'Annibale, O
   Karunanidhi, A
   Powers, A
   Mcguire, M
   Seminotti, B
   Dobrowolski, SF
   Reyes-Múgica, M
   Torok, KS
   Mohsen, AW
   Vockley, J
   Ghaloul-Gonzalez, L
AF Wolfe, Rachel
   Heiman, Paige
   D'Annibale, Olivia
   Karunanidhi, Anuradha
   Powers, Alyssa
   Mcguire, Marianne
   Seminotti, Bianca
   Dobrowolski, Steven F.
   Reyes-Mugica, Miguel
   Torok, Kathryn S.
   Mohsen, Al-Walid
   Vockley, Jerry
   Ghaloul-Gonzalez, Lina
TI ITCH deficiency clinical phenotype expansion and mitochondrial
   dysfunction
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE ITCH; Autoimmune disease; Ubiquitination; Apoptosis; E3 ligase;
   Mitochondrial dysfunction
ID UBIQUITIN-PROTEASOME SYSTEM; PROTEIN-DEGRADATION; FBXL4; UBIQUITYLATION;
   THIOREDOXIN; MUTATIONS
AB Autoimmune Disease, Multisystem, with Facial Dysmorphism (ADMFD) is an autosomal recessive disorder due to pathogenic variants in the ITCH gene. It is characterized by failure to thrive, dysmorphic facial features, developmental delay, and systemic autoimmunity that can manifest variably with autoimmune hepatitis, thyroiditis, and enteropathy, among other organ manifestations. It was originally described in 10 consanguineous Old Order Amish patients, and more recently in two patients of White British and Black German ethnicities. While the role of ITCH protein in apoptosis and inflammation has previously been characterized, a defect in cellular bioenergetics has not yet been reported in ITCH deficiency. Here we present a Caucasian female originally evaluated for possible mitochondrial respiratory chain deficiency, who ultimately was found to have two novel variants in ITCH with absence of ITCH protein in patient derived fibroblasts. Clinical studies of patient muscle showed mitochondrial DNA copy number of 57% compared to controls. Functional studies in skin fibroblasts revealed decreased activity of mitochondrial fatty acid oxidation and oxidative phosphorylation, and decreased overall ATP production. Our findings confirm mitochondrial energy dysfunction in a patient with ITCH deficiency offering the opportunity to assess alternative therapeutic options.
C1 [Wolfe, Rachel; Heiman, Paige; D'Annibale, Olivia; Karunanidhi, Anuradha; Powers, Alyssa; Seminotti, Bianca; Mohsen, Al-Walid; Vockley, Jerry; Ghaloul-Gonzalez, Lina] Univ Pittsburgh, Dept Pediat, Div Genet & Genom Med, Pittsburgh, PA 15224 USA.
   [Wolfe, Rachel] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA.
   [D'Annibale, Olivia; Powers, Alyssa; Mohsen, Al-Walid; Vockley, Jerry; Ghaloul-Gonzalez, Lina] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15224 USA.
   [Mcguire, Marianne] UPMC Magee Womens Hosp, UPMC Clin Genom Lab, Pittsburgh, PA USA.
   [Dobrowolski, Steven F.; Reyes-Mugica, Miguel] Univ Pittsburgh, Dept Pathol, Div Clin Chem, Pittsburgh, PA 15224 USA.
   [Torok, Kathryn S.] Univ Pittsburgh, Dept Pediat, Div Rheumatol, Pittsburgh, PA 15224 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Ghaloul-Gonzalez, L (corresponding author), UPMC Childrens Hosp Pittsburgh, Dept Pediat, Div Genet & Genom Med, Rangos Res Bldg, Pittsburgh, PA 15224 USA.
EM lina.gonzalez@chp.edu
RI Vockley, Jerry/AAF-8523-2020; Reyes-Mugica, Miguel/C-2483-2008; Torok,
   Kathryn/AAI-5810-2020; Ghaloul-Gonzalez, Lina/JSK-3435-2023; Mohsen,
   Al-Walid/D-6577-2018
OI Ghaloul-Gonzalez, Lina/0000-0001-7697-2672; Mohsen,
   Al-Walid/0000-0002-0096-5959; D'Annibale, Olivia/0000-0002-6498-2889
FU National Human Genome Research Institute (NHGRI) [K08 HG010490];
   National Institutes of Health (NIH)
FX LGG is funded in part by the National Human Genome Research Institute
   (NHGRI) grant #K08 HG010490, a component of the National Institutes of
   Health (NIH). The contents of this manuscript are solely the
   responsibility of the authors and do not necessarily represent the
   official view of NHGRI/NIH.
CR Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Brittain HK, 2019, AM J MED GENET A, V179, P1346, DOI 10.1002/ajmg.a.61169
   Choi YB, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00422-16
   Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692
   de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028
   Gai XW, 2013, AM J HUM GENET, V93, P482, DOI 10.1016/j.ajhg.2013.07.016
   Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007
   Goetzman ES, 2014, J BIOL CHEM, V289, P10668, DOI 10.1074/jbc.M113.540260
   Gold VAM, 2017, EMBO REP, V18, P1786, DOI 10.15252/embr.201744261
   Heiman P, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-07076-9
   Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702
   Huemer M, 2015, J INHERIT METAB DIS, V38, P905, DOI 10.1007/s10545-015-9836-6
   HUSTAD CM, 1995, GENETICS, V140, P255
   Jiang LF, 2020, MOL MED REP, V22, P4307, DOI 10.3892/mmr.2020.11499
   Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032
   Kleine-Eggebrecht N, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-1554
   Lavie J, 2018, CELL REP, V23, P2852, DOI 10.1016/j.celrep.2018.05.013
   Lehmann G, 2016, BIOCHEM BIOPH RES CO, V473, P80, DOI 10.1016/j.bbrc.2016.03.055
   Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028
   Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185
   Mentrup HL, 2018, DIFFERENTIATION, V99, P51, DOI 10.1016/j.diff.2017.12.003
   Otaki Y, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002485
   Parravicini V, 2008, BLOOD, V111, P4273, DOI 10.1182/blood-2007-10-115667
   Patel T, 2021, J ALLER CL IMM-PRACT, V9, P2885, DOI 10.1016/j.jaip.2021.04.010
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Roberts JZ, 2022, CELL DEATH DIFFER, V29, P272, DOI 10.1038/s41418-021-00922-9
   Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103
   Schiff M, 2013, MOL GENET METAB, V109, P21, DOI 10.1016/j.ymgme.2013.02.002
   Seminotti B, 2019, HUM MOL GENET, V28, P928, DOI 10.1093/hmg/ddy403
   Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094
   Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905
   Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284
   Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249
   Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321
   Ziviani E, 2010, AUTOPHAGY, V6, P660, DOI 10.4161/auto.6.5.12242
NR 36
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD DEC
PY 2022
VL 33
AR 100932
DI 10.1016/j.ymgmr.2022.100932
EA OCT 2022
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 7H4OE
UT WOS:000903182600013
PM 36338154
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Galber, C
   Carissimi, S
   Baracca, A
   Giorgio, V
AF Galber, Chiara
   Carissimi, Stefania
   Baracca, Alessandra
   Giorgio, Valentina
TI The ATP Synthase Deficiency in Human Diseases
SO LIFE-BASEL
LA English
DT Review
DE ATP synthase; human disease; mitochondria
ID COMPLEX-V DEFICIENCY; HUMAN MITOCHONDRIAL-DNA;
   AMYOTROPHIC-LATERAL-SCLEROSIS; BOVINE HEART-MITOCHONDRIA;
   ALZHEIMERS-DISEASE; OXIDATIVE-PHOSPHORYLATION; T8993G MUTATION;
   LEIGH-SYNDROME; INFANTILE CARDIOMYOPATHY; PATHOGENIC MECHANISM
AB Human diseases range from gene-associated to gene-non-associated disorders, including age-related diseases, neurodegenerative, neuromuscular, cardiovascular, diabetic diseases, neurocognitive disorders and cancer. Mitochondria participate to the cascades of pathogenic events leading to the onset and progression of these diseases independently of their association to mutations of genes encoding mitochondrial protein. Under physiological conditions, the mitochondrial ATP synthase provides the most energy of the cell via the oxidative phosphorylation. Alterations of oxidative phosphorylation mainly affect the tissues characterized by a high-energy metabolism, such as nervous, cardiac and skeletal muscle tissues. In this review, we focus on human diseases caused by altered expressions of ATP synthase genes of both mitochondrial and nuclear origin. Moreover, we describe the contribution of ATP synthase to the pathophysiological mechanisms of other human diseases such as cardiovascular, neurodegenerative diseases or neurocognitive disorders.
C1 [Galber, Chiara; Carissimi, Stefania; Giorgio, Valentina] CNR, Inst Neurosci, I-35121 Padua, Italy.
   [Galber, Chiara; Baracca, Alessandra; Giorgio, Valentina] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); University of Bologna
RP Giorgio, V (corresponding author), CNR, Inst Neurosci, I-35121 Padua, Italy.; Giorgio, V (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
EM chiara.galber@phd.unipd.it; stefania.carissimi@unipd.it;
   alessandra.baracca@unibo.it; valentina.giorgio4@unibo.it
RI Giorgio, Valentina/I-6110-2016; Giorgio, Valentina/O-1969-2015
OI BARACCA, ALESSANDRA/0000-0002-0490-1776; Giorgio,
   Valentina/0000-0002-4229-3054
FU AIRC [MFAG 2017-ID, 20316, PRIN 2017-ID]
FX The research in the authors' laboarory received funding from AIRC under
   the MFAG 2017-ID. 20316 and PRIN 2017-ID. 201789LFKB projects, P.I.
   Giorgio Valentina.
CR ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986
   Adav SS, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0430-y
   Ala-Rämi A, 2003, BASIC RES CARDIOL, V98, P250, DOI 10.1007/s00395-003-0413-z
   Alexeyev MF, 2008, GENE THER, V15, P516, DOI 10.1038/sj.gt.2008.11
   Arrell DK, 2006, CIRC RES, V99, P706, DOI 10.1161/01.RES.0000243995.74395.f8
   Bahri H., 2020, CELL BIOL, DOI [10.1101/2020.04.03.023861, DOI 10.1101/2020.04.03.023861]
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Beck SJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11483
   Boada M, 2014, MOL PSYCHIATR, V19, P682, DOI 10.1038/mp.2013.86
   Boillée S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Bosetti F, 2004, FEBS LETT, V563, P161, DOI 10.1016/S0014-5793(04)00294-7
   Bosetti F, 2002, NEUROBIOL AGING, V23, P371, DOI 10.1016/S0197-4580(01)00314-1
   Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717
   Braczynski AK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/462592
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   Carelli V, 2002, ARCH NEUROL-CHICAGO, V59, P264, DOI 10.1001/archneur.59.2.264
   Carrette O, 2006, J CHROMATOGR B, V840, P1, DOI 10.1016/j.jchromb.2006.05.019
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Cha MY, 2015, HUM MOL GENET, V24, P6492, DOI 10.1093/hmg/ddv358
   Chandrasekaran K, 1997, MOL BRAIN RES, V44, P99, DOI 10.1016/S0169-328X(96)00191-X
   Chen RM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1679-x
   Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079
   Chinnery PF, 2015, EMBO MOL MED, V7, P1503, DOI 10.15252/emmm.201505079
   Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475
   Choi SY, 2019, NAT NEUROSCI, V22, P851, DOI 10.1038/s41593-019-0397-0
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Collinson IR, 1996, BIOCHEMISTRY-US, V35, P12640, DOI 10.1021/bi960969t
   COLLINSON IR, 1994, J MOL BIOL, V242, P408
   Comelli M, 2007, AM J PHYSIOL-HEART C, V292, pH820, DOI 10.1152/ajpheart.00366.2006
   Contessi S, 2004, BIOCHEM PHARMACOL, V67, P1843, DOI 10.1016/j.bcp.2004.02.001
   Cross HR, 2002, J MOL CELL CARDIOL, V34, P361, DOI 10.1006/jmcc.2001.1518
   D'Antoni S, 2020, BIOL CHEM, V401, P497, DOI 10.1515/hsz-2019-0221
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329
   Davies KM, 2011, P NATL ACAD SCI USA, V108, P14121, DOI 10.1073/pnas.1103621108
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Deng JW, 2018, P NATL ACAD SCI USA, V115, pE9678, DOI 10.1073/pnas.1806655115
   Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031
   Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177
   DILISA F, 1995, J PHYSIOL-LONDON, V486, P1
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Ding BQ, 2014, AM J ALZHEIMERS DIS, V29, P526, DOI 10.1177/1533317514523487
   Diodato D, 2014, JIMD REP, V4, P71, DOI [10.1007/8904, DOI 10.1007/8904]
   Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868
   Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107
   Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003
   FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751
   Fragaki K, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100543
   FRALIX TA, 1993, AM J PHYSIOL, V264, pC986, DOI 10.1152/ajpcell.1993.264.4.C986
   Franco LVR, 2020, LIFE-BASEL, V10, DOI 10.3390/life10110304
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Gather C, 2020, BIOL CHEM, V401, P1199, DOI 10.1515/hsz-2020-0157
   Gauba E, 2019, NEUROBIOL DIS, V121, P138, DOI 10.1016/j.nbd.2018.09.020
   Gauba E, 2017, J ALZHEIMERS DIS, V55, P1351, DOI 10.3233/JAD-160822
   Ghezzi D, 2018, ESSAYS BIOCHEM, V62, P271, DOI 10.1042/EBC20170099
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115
   Green DW, 1998, AM J PHYSIOL-HEART C, V274, pH90, DOI 10.1152/ajpheart.1998.274.1.H90
   Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002
   Guo H, 2017, SCIENCE, V358, P936, DOI 10.1126/science.aao4815
   Havlícková V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009
   He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115
   Hejzlarová K, 2014, PHYSIOL RES, V63, pS57, DOI 10.33549/physiolres.932643
   HIGUCHI MD, 1987, CLIN CARDIOL, V10, P665
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c
   Imai A, 2016, INT J CARDIOL, V207, P203, DOI 10.1016/j.ijcard.2016.01.026
   Jackson CB, 2017, EUR J MED GENET, V60, P345, DOI 10.1016/j.ejmg.2017.04.006
   Jolly RD, 2002, NEUROCHEM INT, V40, P565, DOI 10.1016/S0197-0186(01)00128-0
   Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kaludercic N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3869610
   Kane LA, 2010, CIRC RES, V106, P504, DOI 10.1161/CIRCRESAHA.109.214155
   Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003
   Kovalcíková J, 2019, FASEB J, V33, P14103, DOI 10.1096/fj.201900685RR
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Kühlbrandt W, 2016, TRENDS BIOCHEM SCI, V41, P106, DOI 10.1016/j.tibs.2015.10.006
   Kytövuori L, 2016, J NEUROL, V263, P2188, DOI 10.1007/s00415-016-8249-2
   Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669
   Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105
   Licznerski P, 2020, CELL, V182, P1170, DOI 10.1016/j.cell.2020.07.008
   Lieber DS, 2013, NEUROLOGY, V80, P1762, DOI 10.1212/WNL.0b013e3182918c40
   Ludtmann MHR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04422-2
   Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Manczak M, 2004, NEUROMOL MED, V5, P147, DOI 10.1385/NMM:5:2:147
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   Martín-Maestro P, 2019, MOL NEUROBIOL, V56, P8220, DOI 10.1007/s12035-019-01665-y
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Meulemans A, 2010, J BIOL CHEM, V285, P4099, DOI 10.1074/jbc.M109.046920
   Moslemi AR, 2005, NEUROPEDIATRICS, V36, P314, DOI 10.1055/s-2005-872845
   MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124
   MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913
   Ng YS, 2019, ANN NEUROL, V86, P310, DOI 10.1002/ana.25525
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Nobile V, 2020, HUM GENET, V139, P227, DOI 10.1007/s00439-019-02104-7
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Orr AL, 2019, J ALZHEIMERS DIS, V68, P991, DOI 10.3233/JAD-181184
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007
   Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027
   Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109
   Robinson RAS, 2011, NEUROSCIENCE, V177, P207, DOI 10.1016/j.neuroscience.2011.01.005
   Rouslin W, 1996, J BIOL CHEM, V271, P23638, DOI 10.1074/jbc.271.39.23638
   ROUSLIN W, 1983, J BIOL CHEM, V258, P9657
   ROUSLIN W, 1986, AM J PHYSIOL, V250, pH503, DOI 10.1152/ajpheart.1986.250.3.H503
   ROUSLIN W, 1987, AM J PHYSIOL, V252, pH622, DOI 10.1152/ajpheart.1987.252.3.H622
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   SCHAGGER H, 1995, EUR J BIOCHEM, V227, P916, DOI 10.1111/j.1432-1033.1995.tb20219.x
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Sgarbi G, 2018, BBA-BIOENERGETICS, V1859, P99, DOI 10.1016/j.bbabio.2017.10.007
   Sgarbi G, 2009, ARCH NEUROL-CHICAGO, V66, P951, DOI 10.1001/archneurol.2009.134
   Shi X, 2011, NEUROSCI LETT, V500, P87, DOI 10.1016/j.neulet.2011.06.009
   Skoczén N, 2018, BBA-BIOENERGETICS, V1859, P602, DOI 10.1016/j.bbabio.2018.05.009
   Solaini G, 2005, BIOCHEM J, V390, P377, DOI 10.1042/BJ20042006
   Solaini G, 2008, BBA-BIOENERGETICS, V1777, P941, DOI 10.1016/j.bbabio.2008.04.034
   Solaini G, 2011, BBA-BIOENERGETICS, V1807, P534, DOI 10.1016/j.bbabio.2010.09.003
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spikes TE, 2020, P NATL ACAD SCI USA, V117, P23519, DOI 10.1073/pnas.2013998117
   STEENBERGEN C, 1993, CIRC RES, V72, P112, DOI 10.1161/01.RES.72.1.112
   Stendel C, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000393
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35
   Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004
   Teixeira PC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001205
   Terni B, 2010, BRAIN PATHOL, V20, P222, DOI 10.1111/j.1750-3639.2009.00266.x
   Tetaud E, 2014, MOL BIOL CELL, V25, P791, DOI 10.1091/mbc.E13-02-0112
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   VanderHeide RS, 1996, J MOL CELL CARDIOL, V28, P103, DOI 10.1006/jmcc.1996.0010
   Vrbacky M, 2016, HUM MOL GENET, V25, P4674, DOI 10.1093/hmg/ddw295
   Walker JE, 1998, ANGEW CHEM INT EDIT, V37, P2309, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2308::AID-ANIE2308>3.0.CO;2-W
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107
   Wen SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36313
   Xu T, 2015, MICROB CELL, V2, P105, DOI 10.15698/mic2015.04.197
   Yu HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00074
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180
NR 152
TC 30
Z9 30
U1 2
U2 36
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD APR
PY 2021
VL 11
IS 4
AR 325
DI 10.3390/life11040325
PG 19
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA RR6RL
UT WOS:000643222600001
PM 33917760
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Schreglmann, SR
   Riederer, F
   Galovic, M
   Ganos, C
   Kägi, G
   Waldvogel, D
   Jaunmuktane, Z
   Schaller, A
   Hidding, U
   Krasemann, E
   Michels, L
   Baumann, CR
   Bhatia, K
   Jung, HH
AF Schreglmann, Sebastian R.
   Riederer, Franz
   Galovic, Marian
   Ganos, Christos
   Kagi, Georg
   Waldvogel, Daniel
   Jaunmuktane, Zane
   Schaller, Andre
   Hidding, Ute
   Krasemann, Ernst
   Michels, Lars
   Baumann, Christian R.
   Bhatia, Kailash
   Jung, Hans H.
TI Movement Disorders in Genetically Confirmed Mitochondrial Disease and
   the Putative Role of the Cerebellum
SO MOVEMENT DISORDERS
LA English
DT Article
DE Mitochondrial disorders; volumetric MRI; dystonia; cerebellum; basal
   ganglia
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; HUNTINGTONS-DISEASE; BASAL
   GANGLIA; PARKINSONS-DISEASE; LEIGH-SYNDROME; DNA MUTATION; A8344G MERRF;
   DYSTONIA; CHILDREN; ADULTS
AB Background: Mitochondrial disease can present as a movement disorder. Data on this entity's epidemiology, genetics, and underlying pathophysiology, however, is scarce.
   Objective: The objective of this study was to describe the clinical, genetic, and volumetric imaging data from patients with mitochondrial disease who presented with movement disorders.
   Methods: In this retrospective analysis of all genetically confirmed mitochondrial disease cases from three centers (n=50), the prevalence and clinical presentation of video-documented movement disorders was assessed. Voxel-based morphometry from high-resolution MRI was employed to compare cerebral and cerebellar gray matter volume between mitochondrial disease patients with and without movement disorders and healthy controls.
   Results: Of the 50 (30%) patients with genetically confirmed mitochondrial disease, 15 presented with hypokinesia (parkinsonism 3/15), hyperkinesia (dystonia 5/15, myoclonus 3/15, chorea 2/15), and ataxia (3/15). In 3 patients, mitochondrial disease presented as adult-onset isolated dystonia. In comparison to healthy controls and mitochondrial disease patients without movement disorders, patients with hypo- and hyperkinetic movement disorders had significantly more cerebellar atrophy and an atrophy pattern predominantly involving cerebellar lobules VI and VII.
   Conclusion: This series provides clinical, genetic, volumetric imaging, and histologic data that indicate major involvement of the cerebellum in mitochondrial disease when it presents with hyper- and hypokinetic movement disorders. As a working hypothesis addressing the particular vulnerability of the cerebellum to energy deficiency, this adds substantially to the pathophysiological understanding of movement disorders in mitochondrial disease. Furthermore, it provides evidence that mitochondrial disease can present as adult-onset isolated dystonia. (c) 2017 International Parkinson and Movement Disorder Society
C1 [Schreglmann, Sebastian R.; Ganos, Christos; Bhatia, Kailash] UCL, Sobell Dept Motor Neurosci & Movement Disorders, Inst Neurol, Queen Sq, London, England.
   [Schreglmann, Sebastian R.; Riederer, Franz; Waldvogel, Daniel; Baumann, Christian R.; Jung, Hans H.] Univ Hosp Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.
   [Schreglmann, Sebastian R.; Galovic, Marian; Kagi, Georg] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.
   [Riederer, Franz] Neurol Ctr Rosenhuegel, Vienna, Austria.
   [Riederer, Franz] Karl Landsteiner Inst Epilepsy Res & Cognit Neuro, Vienna, Austria.
   [Galovic, Marian] Univ Coll London Hosp Biomed Res Ctr, UK Natl Inst Hlth Res, London, England.
   [Galovic, Marian] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, London, England.
   [Galovic, Marian] Epilepsy Soc, Gerrards Cross, England.
   [Ganos, Christos; Hidding, Ute] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.
   [Jaunmuktane, Zane] UCL, Inst Neurol, Dept Mol Neurosci, London, England.
   [Jaunmuktane, Zane] Natl Hosp Neurol & Neurosurg, Div Neuropathol, London, England.
   [Schaller, Andre] Inselspital Bern, Dept Genet, Bern, Switzerland.
   [Krasemann, Ernst] Labor Fenner GmbH, Med Versorgungszentrum MVZ, Dept Human Genet, Hamburg, Germany.
   [Michels, Lars] Univ Hosp Zurich, Clin Neuroradiol, Zurich, Switzerland.
C3 University of London; University College London; University of Zurich;
   University Zurich Hospital; Kantonsspital St. Gallen; University College
   London Hospitals NHS Foundation Trust; University of London; University
   College London; University of Hamburg; University Medical Center
   Hamburg-Eppendorf; University of London; University College London;
   University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; University of
   Bern; University Hospital of Bern; University of Zurich; University
   Zurich Hospital
RP Jung, HH (corresponding author), Univ Hosp Zurich, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.
EM hans.jung@usz.ch
RI Jaunmuktane, Zane/ABC-9039-2020; Michels, Lars/X-6939-2018; Waldvoge,
   Daniel/HOH-8373-2023; Schaller, Andre/L-4174-2018
OI Baumann, Christian/0000-0003-3417-1978; Michels,
   Lars/0000-0003-3750-1100; Schreglmann, Sebastian/0000-0002-4129-5808;
   Galovic, Marian/0000-0002-2307-071X; Jaunmuktane,
   Zane/0000-0001-7738-8881; Waldvogel, Daniel/0000-0003-0137-7187; Ganos,
   Christos/0000-0001-8077-8530; Schaller, Andre/0000-0001-5174-5764;
   Riederer, Franz/0000-0002-9722-9754
CR Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Bargiela David, 2015, Cerebellum Ataxias, V2, P16, DOI 10.1186/s40673-015-0035-x
   Barragán-Campos HM, 2005, ARCH NEUROL-CHICAGO, V62, P737, DOI 10.1001/archneur.62.5.737
   Bauer E, 2015, BRAIN RES, V1622, P137, DOI 10.1016/j.brainres.2015.06.026
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   Caer M, 2005, MOVEMENT DISORD, V20, P490, DOI 10.1002/mds.20363
   Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802
   Debray FG, 2007, AM J MED GENET A, V143A, P2046, DOI 10.1002/ajmg.a.31880
   DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126
   Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034
   Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217
   Filip P, 2017, MOVEMENT DISORD, V32, P757, DOI 10.1002/mds.26930
   Filip P, 2013, CLIN NEUROPHYSIOL, V124, P1269, DOI 10.1016/j.clinph.2013.01.003
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Ganos C, 2014, MOVEMENT DISORD, V29, P437, DOI 10.1002/mds.25867
   Hanna MG, 1997, CURR OPIN NEUROL, V10, P351, DOI 10.1097/00019052-199708000-00012
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Husárová I, 2014, J NEUROIMAGING, V24, P45, DOI [10.1111/j.1552-6569.2011.00663.x, 10.1111/jon.12030]
   JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339
   Jia X, 2015, AM J NEURORADIOL, V36, P2219, DOI 10.3174/ajnr.A4447
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   MACAYA A, 1993, NEUROPEDIATRICS, V24, P60, DOI 10.1055/s-2008-1071515
   Mancuso M, 2008, PARKINSONISM RELAT D, V14, P381, DOI 10.1016/j.parkreldis.2007.10.001
   Martikainen MH, 2016, JAMA NEUROL
   Mottolese C, 2013, BRAIN, V136, P330, DOI 10.1093/brain/aws186
   Mukai M, 2013, PARKINSONISM RELAT D, V19, P821, DOI 10.1016/j.parkreldis.2013.04.011
   Nakagaki Hideaki, 2005, Rinsho Shinkeigaku, V45, P502
   NELSON I, 1995, ANN NEUROL, V37, P400, DOI 10.1002/ana.410370317
   Planetta PJ, 2015, HUM BRAIN MAPP, V36, P1165, DOI 10.1002/hbm.22694
   Rees EM, 2014, MOVEMENT DISORD, V29, P1648, DOI 10.1002/mds.25984
   Reetz K, 2009, MOVEMENT DISORD, V24, P99, DOI 10.1002/mds.22333
   Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027
   Scaglia F, 2005, AM J NEURORADIOL, V26, P1675
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Shakkottai VG, 2016, CEREBELLUM, V73, P668
   Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039
   Sudarsky L, 1999, MOVEMENT DISORD, V14, P488, DOI 10.1002/1531-8257(199905)14:3<488::AID-MDS1017>3.0.CO;2-4
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tranchant C, 2016, REV NEUROL-FRANCE, V172, P524, DOI 10.1016/j.neurol.2016.07.003
   TRUONG DD, 1990, MOVEMENT DISORD, V5, P109, DOI 10.1002/mds.870050204
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Wolf RC, 2015, J NEUROL, V262, P859, DOI 10.1007/s00415-015-7642-6
   Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360
   Zeviani Massimo, 2012, Handb Clin Neurol, V103, P359, DOI 10.1016/B978-0-444-51892-7.00022-X
NR 47
TC 22
Z9 22
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD JAN
PY 2018
VL 33
IS 1
BP 146
EP 155
DI 10.1002/mds.27174
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FS7FO
UT WOS:000419963500022
PM 28901595
DA 2024-11-01
ER

PT J
AU Ma, YY
   Zhang, XL
   Wu, TF
   Liu, YP
   Wang, Q
   Zhang, Y
   Song, JQ
   Wang, YJ
   Yang, YL
AF Ma, Yan-Yan
   Zhang, Xue-Lin
   Wu, Tong-Fei
   Liu, Yu-Peng
   Wang, Qiao
   Zhang, Yao
   Song, Jin-Qing
   Wang, Yu-Jie
   Yang, Yan-Ling
TI Analysis of the Mitochondrial Complex I-V Enzyme Activities of
   Peripheral Leukocytes in Oxidative Phosphorylation Disorders
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE oxidative phosphorylation; mitochondrial disease; Leigh syndrome;
   respiratory chain complex deficiency; leukocytes
ID CHINESE PATIENTS; LEIGH-SYNDROME; DEFICIENCIES; FIBROBLASTS; CHILDREN;
   TISSUES; DISEASE
AB Mitochondrial oxidative phosphorylation defects are a common cause of mitochondrial diseases, which are characterized by multiorgan involvement and clinically heterogeneous manifestations. Diagnosis is difficult because of the lack of clinically feasible methods. In this study, mitochondrial complex I-V enzyme activity was measured in 64 patients with suspected mitochondrial disease and 200 healthy controls. Spectrophotometric assay was used for the analysis of mitochondrial complex I-V enzyme activity in peripheral leukocytes. Diagnosis was based on clinical presentation, magnetic resonance imaging (MRI), muscle pathology, and point mutation screening in mitochondrial DNA. The differential diagnosis of aminoacidopathies, organic acidurias, and fatty acid beta-oxidation defects was made. Thirty-five patients (54.7%) were diagnosed with Leigh syndrome based on characteristic brain MRI. Complex enzyme activity in controls was found to be stable. A deficiency in the oxidative phosphorylation was found in 29 patients (45.3%). Twenty (31.2%) patients had isolated complex defects, complex I deficiency (n = 2, 3.1%), complex II deficiency (n = 3, 4.7%), complex III deficiency (n = 5, 7.8%), complex IV deficiency (n = 5, 7.8%), and complex V deficiency (n 5, 7.8%). Nine patients were found to have combined deficiencies, 3 (4.7%) had combined deficiencies of complex I and IV, 2 (3.1%) had combined deficiencies of complex III and V, and 2 (3.1%) had a combined deficiency of complex I and V. In conclusion, the peripheral leukocyte oxidative phosphorylation enzyme activity assay was found to be a reliable method for the diagnosis of mitochondrial diseases.
C1 [Ma, Yan-Yan; Wu, Tong-Fei; Liu, Yu-Peng; Wang, Qiao; Zhang, Yao; Song, Jin-Qing; Wang, Yu-Jie; Yang, Yan-Ling] Peking Univ, Dept Pediat, Hosp 1, Beijing 100034, Peoples R China.
   [Zhang, Xue-Lin] Capital Inst Phys Educ, Beijing, Peoples R China.
C3 Peking University
RP Yang, YL (corresponding author), Peking Univ, Dept Pediat, Hosp 1, 1 Xi An Men Rd, Beijing 100034, Peoples R China.
EM amino_acid3003@126.com
RI Yang, Yanling/F-5954-2014; wu, tong/ITV-6896-2023
FU National Nature Science Foundation of China [30872794]; National Key
   Technology R and D Programme [2006BAI05A07]
FX The authors disclosed receipt of the following financial support for the
   research and/or authorship of this article: If no conflict declared,
   this work was supported by the National Nature Science Foundation of
   China (# 30872794) and the National Key Technology R and D Programme (#
   2006BAI05A07).
CR Acín-Pérez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001
   Cameron JM, 2004, MITOCHONDRION, V4, P387, DOI 10.1016/j.mito.2004.07.039
   CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6
   GERARD B, 1993, EUR J PEDIATR, V152, P270
   Gu Xue-fan, 2004, Zhonghua Er Ke Za Zhi, V42, P401
   Kimura H, 1999, TOHOKU J EXP MED, V188, P317, DOI 10.1620/tjem.188.317
   Luo C, 2008, CLIN CHIM ACTA, V395, P38, DOI 10.1016/j.cca.2008.04.025
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Munnich A, 1996, J INHERIT METAB DIS, V19, P521, DOI 10.1007/BF01799112
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   SKLADAL D, 1995, PADIATR PRAX, V50, P79
   Song J, 2006, Zhongguo Yikan, V41, P38, DOI [10.3969/j.issn.10081070.2006.02.015, DOI 10.3969/J.ISSN.10081070.2006.02.015]
   SUN F, 2005, CHIN J NEUROL, V38, P560
   SUN F, 2005, CHIN J CONT PEDIAT, V7, P25
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6
   Wei Xiao-Qiong, 2009, Zhongguo Dang Dai Er Ke Za Zhi, V11, P333
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
   Zhang Y, 2007, J INHERIT METAB DIS, V30, P265, DOI 10.1007/s10545-006-0481-y
   Zhang Yao, 2007, Zhongguo Dang Dai Er Ke Za Zhi, V9, P216
NR 29
TC 27
Z9 36
U1 0
U2 18
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD AUG
PY 2011
VL 26
IS 8
BP 974
EP 979
DI 10.1177/0883073811399905
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 796WY
UT WOS:000293085400007
PM 21540367
DA 2024-11-01
ER

PT J
AU Du, ZD
   Hu, YJ
   Yang, Y
   Sun, Y
   Zhang, SL
   Zhou, T
   Zeng, LL
   Zhang, WJ
   Huang, X
   Kong, WJ
   Zhang, HL
AF Du, Zhengde
   Hu, Yujuan
   Yang, Yang
   Sun, Yu
   Zhang, Sulin
   Zhou, Tao
   Zeng, Lingling
   Zhang, Wenjuan
   Huang, Xiang
   Kong, Weijia
   Zhang, Honglian
TI NADPH oxidase-dependent oxidative stress and mitochondrial damage in
   hippocampus of D-galactose-induced aging rats
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE D-galactose; common deletion; oxidative stress; NADPH oxidase;
   uncoupling protein 2
ID DNA DELETIONS; ENERGY-METABOLISM; BP DELETION; MEMORY LOSS; NEURO
   DEGENERATION; COMMON DELETION; SKELETAL-MUSCLE; INNER-EAR; MICE; BRAIN
AB Mitochondrial DNA (mtDNA) common deletion (CD) plays a significant role in aging and age-related diseases. In this study, we used D-galactose (D-gal) to generate an animal model of aging and the involvement and causative mechanisms of mitochondrial damage in such a model were investigated. Twenty 5-week-old male Sprague-Dawley rats were randomly divided into two groups: D-gal group (n=10) and control group (n=10). The quantity of the mtDNA CD in the hippocampus was determined using a TaqMan real-time PCR assay. Transmission electron microscopy was used to observe the mitochondrial ultrastructure in the hippocampus. Western blot was used to detect the protein levels of NADPH oxidase (NOX) and uncoupling protein 2 (UCP2). We found that the level of mtDNA CD was significantly higher in the hippocampus of D-gal-induced aging rats than in control rats. In comparison with the control group, the mitochondrial ultrastructure in the hippocampus of D-gal-treated rats was damaged, and the protein levels of NOX and UCP2 were significantly increased in the hippocampus of D-gal-induced aging rats. This study demonstrated that the levels of mtDNA CD and NOX protein expression were significantly increased in the hippocampus of D-gal-induced aging rats. These findings indicate that NOX-dependent reactive oxygen species generation may contribute to D-gal-induced mitochondrial damage.
C1 [Du, Zhengde; Hu, Yujuan; Yang, Yang; Sun, Yu; Zhang, Sulin; Zhou, Tao; Zeng, Lingling; Zhang, Wenjuan; Huang, Xiang; Kong, Weijia] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Tongji Med Coll, Union Hosp, Wuhan 430022, Peoples R China.
   [Zhang, Honglian] Huazhong Univ Sci & Technol, Dept Publ Hlth, Tongji Med Coll, Union Hosp, Wuhan 430022, Peoples R China.
   [Du, Zhengde] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Shenzhen Peoples Hosp 6, Nanshan Hosp, Shenzhen 518052, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Huazhong University of Science & Technology
RP Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Tongji Med Coll, Union Hosp, Wuhan 430022, Peoples R China.
EM duzhengde@gmail.com; safiner@gmail.com; entwjkong@yahoo.com.cn;
   zhl_bjk@whuh.com
RI Zhang, Sulin/X-3617-2019; Sun, Yu/AAX-9942-2021
OI Sun, Yu/0000-0002-1771-3715; Kong, Wei-Jia/0000-0001-5410-2297
FU Natural Science Foundation of Hubei province [2010CDB08005]; National
   Natural Science Foundation of China [30730094, 81000409]; Special Funds
   for State Key Development Program for Basic Research of China (973
   Program) [2011CB504504]
FX This project was supported by grants from the Natural Science Foundation
   of Hubei province (No. 2010CDB08005), the National Natural Science
   Foundation of China (No. 30730094 and 81000409) and Special Funds for
   State Key Development Program for Basic Research of China (973 Program)
   (No. 2011CB504504).
CR Amaral S, 2008, FEBS LETT, V582, P4191, DOI 10.1016/j.febslet.2008.11.020
   Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2
   Barazzoni R, 2001, AM J PHYSIOL-ENDOC M, V280, pE413, DOI 10.1152/ajpendo.2001.280.3.E413
   Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034
   Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002
   Bruce-Keller AJ, 2011, NEUROBIOL DIS, V44, P317, DOI 10.1016/j.nbd.2011.07.012
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576
   Chen TF, 2011, BRIT J NUTR, V105, P1294, DOI 10.1017/S0007114510005052
   Choi Jung Hoon, 2011, Lab Anim Res, V27, P181, DOI 10.5625/lar.2011.27.3.181
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Deng SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030714
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   Frisard M, 2006, ENDOCRINE, V29, P27, DOI 10.1385/ENDO:29:1:27
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030
   Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479
   Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008
   Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kumar A, 2010, FOOD CHEM TOXICOL, V48, P626, DOI 10.1016/j.fct.2009.11.043
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lu J, 2010, BRAIN PATHOL, V20, P598, DOI 10.1111/j.1750-3639.2009.00339.x
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859
   Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014
   Nair D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019847
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8
   Pamenter ME, 2012, BRAIN RES, V1452, P165, DOI 10.1016/j.brainres.2012.03.004
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606
   Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2
   SOONG NW, 1992, NAT GENET, V2, P318
   Tian Y, 2011, FOOD CHEM TOXICOL, V49, P1728, DOI 10.1016/j.fct.2011.04.018
   Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6
   Zhang D, 2006, J ETHNOPHARMACOL, V104, P250, DOI 10.1016/j.jep.2005.09.010
   Zhang XL, 2008, FOOD CHEM TOXICOL, V46, P2888, DOI 10.1016/j.fct.2008.05.032
   Zhong Y, 2011, FEBS J, V278, P2500, DOI 10.1111/j.1742-4658.2011.08176.x
   Zhong Y, 2011, MUTAT RES-FUND MOL M, V712, P11, DOI 10.1016/j.mrfmmm.2011.03.013
NR 56
TC 15
Z9 18
U1 1
U2 22
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1672-0733
EI 1993-1352
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD AUG
PY 2012
VL 32
IS 4
BP 466
EP 472
DI 10.1007/s11596-012-0081-z
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 988SW
UT WOS:000307512000002
PM 22886955
DA 2024-11-01
ER

PT J
AU Zheng, M
   Xiao, RP
AF Zheng, Ming
   Xiao, Rui-Ping
TI Role of mitofusin 2 in cardiovascular oxidative injury
SO JOURNAL OF MOLECULAR MEDICINE-JMM
LA English
DT Review
DE Mitochondria; Mitofusin; Cardiovascular disease; Oxidative stress
ID MUSCLE-CELL APOPTOSIS; MITOCHONDRIAL FUSION; SKELETAL-MUSCLE; MFN2;
   MUTATIONS; NEUROPATHY; DYNAMICS; FISSION; COMPLEMENTATION; DYSFUNCTION
AB Mitochondria are highly dynamic organelles with constant shape changes regulated by fusion and fission events. In addition to regulating mitochondrial morphology, mitochondrial fusion/fission is involved in fundamental mitochondrial biological processes, including mitochondrial metabolism, energization, respiration, mitochondrial membrane potential, and mtDNA stability. Dysfunction of mitochondrial dynamics has been implicated in various human diseases, especially in neurodegenerative diseases. Emerging evidence indicates that impaired expression of mitochondrial fusion proteins or their malfunction participates in oxidative stress-induced cardiovascular injury. This review will focus on recent advances of mitochondrial fusion in regulating various cellular processes in cardiovascular system.
C1 [Zheng, Ming; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
   [Xiao, Rui-Ping] Peking Univ, Sch Chem Biol & Biotechnol, Ctr Drug Discovery, Shenzhen Grad Sch, Shenzhen, Peoples R China.
C3 Peking University; Peking University
RP Xiao, RP (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.
EM Xiaor@grc.nia.nih.gov
RI Xiao, Rui-Ping/AAE-2629-2019
FU Major State Basic Research Development Program of China [2007CB512100];
   National Natural Science Foundation of China [30770870, 30500182,
   30971062]
FX This work was supported by Major State Basic Research Development
   Program of China (2007CB512100) and National Natural Science Foundation
   of China (30770870, 30500182 & 30971062).
CR Bach D, 2005, DIABETES, V54, P2685, DOI 10.2337/diabetes.54.9.2685
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161
   Chien KR, 2004, NAT CELL BIOL, V6, P807, DOI 10.1038/ncb0904-807
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534
   de Brito OM, 2009, MITOCHONDRION, V9, P222, DOI 10.1016/j.mito.2009.02.005
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Guo XM, 2007, CIRC RES, V101, P1113, DOI 10.1161/CIRCRESAHA.107.157644
   Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565
   Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316
   Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200
   Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029
   Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149
   Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479
   Santel A, 2001, J CELL SCI, V114, P867
   Shen T, 2007, J BIOL CHEM, V282, P23354, DOI 10.1074/jbc.M702657200
   Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 35
TC 12
Z9 14
U1 0
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0946-2716
J9 J MOL MED
JI J. Mol. Med.
PD OCT
PY 2010
VL 88
IS 10
BP 987
EP 991
DI 10.1007/s00109-010-0675-5
PG 5
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA 652ZT
UT WOS:000282052100005
PM 20824264
DA 2024-11-01
ER

PT J
AU Mhlanga-Mutangadura, T
   Bullock, G
   Cerda-Gonzalez, S
   Katz, ML
AF Mhlanga-Mutangadura, Tendai
   Bullock, Garrett
   Cerda-Gonzalez, Sofia
   Katz, Martin L.
TI Neuronal Ceroid Lipofuscinosis in a Mixed-Breed Dog with a Splice Site
   Variant in <i>CLN6</i>
SO GENES
LA English
DT Article
DE neurodegeneration; lysosomal storage; mitochondrial subunit c protein;
   lipofuscin; fluorescence; whole genome sequencing; electron microscopy
ID LYSOSOMAL STORAGE DISEASE; SYNTHASE SUBUNIT C; NONSENSE MUTATION;
   BATTEN-DISEASE; GENE; SPECTRUM; NCL; EXPRESSION; SEQUENCE; DELETION
AB A 23-month-old neutered male dog of unknown ancestry presented with a history of progressive neurological signs that included anxiety, cognitive impairment, tremors, seizure activity, ataxia, and pronounced visual impairment. The clinical signs were accompanied by global brain atrophy. Due to progression in the severity of disease signs, the dog was euthanized at 26 months of age. An examination of the tissues collected at necropsy revealed dramatic intracellular accumulations of autofluorescent inclusions in the brain, retina, and cardiac muscle. The inclusions were immunopositive for subunit c of mitochondrial ATP synthase, and their ultrastructural appearances were similar to those of lysosomal storage bodies that accumulate in some neuronal ceroid lipofuscinosis (NCL) diseases. The dog also exhibited widespread neuroinflammation. Based on these findings, the dog was deemed likely to have suffered from a form of NCL. A whole genome sequence analysis of the proband's DNA revealed a homozygous C to T substitution that altered the intron 3-exon 4 splice site of CLN6. Other mutations in CLN6 cause NCL diseases in humans and animals, including dogs. The CLN6 protein was undetectable with immunolabeling in the tissues of the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the disorder in this dog was classified as an NCL resulting from the absence of the CLN6 protein. Screening the dog's genome for a panel of breed-specific polymorphisms indicated that its ancestry included numerous breeds, with no single breed predominating. This suggests that the CLN6 disease variant is likely to be present in other mixed-breed dogs and at least some ancestral breeds, although it is likely to be rare since other cases have not been reported to date.
C1 [Mhlanga-Mutangadura, Tendai; Bullock, Garrett; Katz, Martin L.] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Canine Genet Lab, Columbia, MO 65211 USA.
   [Cerda-Gonzalez, Sofia] MedVet Chicago, Chicago, IL 60618 USA.
   [Katz, Martin L.] Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
C3 University of Missouri System; University of Missouri Columbia;
   University of Missouri System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Canine Genet Lab, Columbia, MO 65211 USA.; Katz, ML (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
EM tendai@missouri.edu; gebkd2@missouri.edu;
   sofia.cerda-gonzalez@medvet.com; katzm@health.missouri.edu
OI Bullock, Garrett/0000-0002-9231-8758
FU American Kennel Club Canine Health Foundation [02604]; U.S. National
   Institutes of Health [S10 OD032246, EY031674]; Orthopedic Foundation for
   Animals; National Science Foundation [2138259, 2138286, 2138307,
   2137603, 2138296]
FX This research was supported by American Kennel Club Canine Health
   Foundation Grant No. 02604, by the U.S. National Institutes of Health
   grants S10 OD032246 and EY031674, and by the Orthopedic Foundation for
   Animals. The bioinformatic analyses used Bridges-2 at the Pittsburgh
   Supercomputing Center through allocation mcb160068p from the Advanced
   Cyberinfrastructure Coordination Ecosystem: Services & Support (ACCESS)
   program, which is supported by National Science Foundation grants
   #2138259, #2138286, #2138307, #2137603, and #2138296, and the computing
   resources of the University of Missouri Bioinformatics and Analytics
   Core Facility.
CR Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107
   Ashwini A, 2016, MOL GENET METAB, V118, P326, DOI 10.1016/j.ymgme.2016.05.008
   Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005
   Awano T, 2006, MOL GENET METAB, V89, P254, DOI 10.1016/j.ymgme.2006.02.016
   Bajaj L, 2020, J CLIN INVEST, V130, P4118, DOI [10.1172/JCl130955, 10.1172/JCI130955]
   Bathke J, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04317-y
   Beck-Wödl S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0646-6
   Best HL, 2021, J NEUROCHEM, V157, P764, DOI 10.1111/jnc.15285
   Bouhouche A, 2013, INDIAN J PEDIATR, V80, P694, DOI 10.1007/s12098-012-0889-3
   Bullock G, 2023, GENES-BASEL, V14, DOI 10.3390/genes14091746
   Bullock G, 2022, GENE, V830, DOI 10.1016/j.gene.2022.146513
   Butz ES, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165571
   Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118
   Chin JJ, 2019, MOL GENET METAB, V126, P188, DOI 10.1016/j.ymgme.2018.12.001
   Das AM, 1999, MOL GENET METAB, V66, P349, DOI 10.1006/mgme.1999.2811
   Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009
   FEARNLEY IM, 1990, BIOCHEM J, V268, P751, DOI 10.1042/bj2680751
   Gilliam D, 2015, MOL GENET METAB, V115, P101, DOI 10.1016/j.ymgme.2015.04.001
   Guo JY, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100521
   Guo JY, 2015, BMC VET RES, V10, DOI 10.1186/s12917-014-0181-z
   Guo J, 2014, MOL GENET METAB, V112, P302, DOI 10.1016/j.ymgme.2014.05.014
   Hansen FM, 2023, LIFE SCI ALLIANCE, V7, DOI 10.26508/lsa.202302147
   Heine C, 2003, BIOCHEM J, V376, P369, DOI 10.1042/BJ20030598
   Heine C, 2007, MOL MEMBR BIOL, V24, P74, DOI 10.1080/09687860600967317
   Hirz M, 2017, MOL GENET METAB, V120, P269, DOI 10.1016/j.ymgme.2016.12.007
   Hughes SM, 2001, ELECTROPHORESIS, V22, P1785, DOI 10.1002/1522-2683(200105)22:9<1785::AID-ELPS1785>3.0.CO;2-L
   Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z
   Kaminiów K, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23105729
   Katz ML, 2017, NEUROBIOL DIS, V108, P277, DOI 10.1016/j.nbd.2017.08.017
   Katz ML, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/198042
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   Keller SH, 2024, GENES-BASEL, V15, DOI 10.3390/genes15020246
   Kolicheski A, 2017, J VET INTERN MED, V31, P149, DOI 10.1111/jvim.14632
   Kolicheski A, 2016, J VET INTERN MED, V30, P1149, DOI 10.1111/jvim.13971
   Kominami E, 1995, NEUROCHEM RES, V20, P1305, DOI 10.1007/BF00992505
   Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624
   Lingaas F, 2018, ANIM GENET, V49, P52, DOI 10.1111/age.12629
   MARTINUS RD, 1991, VET RES COMMUN, V15, P85, DOI 10.1007/BF00405140
   Matsumoto A, 2019, BRAIN DEV-JPN, V41, P726, DOI 10.1016/j.braindev.2019.04.009
   Melville SA, 2005, GENOMICS, V86, P287, DOI 10.1016/j.ygeno.2005.06.005
   Mole S.E., 2011, The Neuronal Ceroid Lipofuscinoses (Batten Disease), V2nd
   Mole SE, 2004, EXP CELL RES, V298, P399, DOI 10.1016/j.yexcr.2004.04.042
   Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332
   Naseri N, 2021, CLIN GENET, V99, P111, DOI 10.1111/cge.13829
   Nathanson J, 2013, AM J MED GENET A, V161A, P473, DOI 10.1002/ajmg.a.35736
   Onodera M, 2021, CLIN CHIM ACTA, V523, P191, DOI 10.1016/j.cca.2021.09.021
   Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014
   PALMER DN, 1989, ADV EXP MED BIOL, V266, P211
   PALMER DN, 1992, AM J MED GENET, V42, P561, DOI 10.1002/ajmg.1320420428
   Panjeshahi S, 2023, HUM GENET, V142, P1001, DOI 10.1007/s00439-023-02556-y
   Pezzini F, 2011, BIOCHEM BIOPH RES CO, V416, P159, DOI 10.1016/j.bbrc.2011.11.016
   Rus CM, 2023, SCI REP-UK, V13, DOI 10.1038/s41598-023-45789-7
   Rus CM, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02288-8
   Sadeesh EM, 2023, MOL BIOL REP, V50, P5255, DOI 10.1007/s11033-023-08416-2
   Sanders DN, 2010, MOL GENET METAB, V100, P349, DOI 10.1016/j.ymgme.2010.04.009
   Sato R, 2016, BRAIN DEV-JPN, V38, P852, DOI 10.1016/j.braindev.2016.04.007
   Schmutz I, 2019, MOL GENET METAB, V127, P95, DOI 10.1016/j.ymgme.2018.11.015
   Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227
   Shiro Y, 2021, BIOMED RES-TOKYO, V42, P129, DOI 10.2220/biomedres.42.129
   Sun GL, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0690-x
   Tanner AJ, 1996, BIOCHEM MOL MED, V57, P1, DOI 10.1006/bmme.1996.0001
   Teixeira CAF, 2006, BBA-MOL BASIS DIS, V1762, P637, DOI 10.1016/j.bbadis.2006.06.002
   Teixeira CA, 2003, HUM MUTAT, V21, P502, DOI 10.1002/humu.10207
   Tuermer A, 2021, PROTEOMICS, V21, DOI 10.1002/pmic.202100043
   Villani NA, 2019, MOL GENET METAB, V127, P107, DOI 10.1016/j.ymgme.2019.04.003
   Wheeler RB, 2002, AM J HUM GENET, V70, P537, DOI 10.1086/338708
   Yamashita A, 2020, BIOCHEM BIOPH RES CO, V525, P883, DOI 10.1016/j.bbrc.2020.03.019
   Yamashita A, 2017, BIOCHEM BIOPH RES CO, V487, P917, DOI 10.1016/j.bbrc.2017.05.002
NR 68
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD JUN
PY 2024
VL 15
IS 6
AR 661
DI 10.3390/genes15060661
PG 21
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA WW2S8
UT WOS:001257849400001
PM 38927597
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Nimmo, GAM
   Venkatesh, S
   Pandey, AK
   Marshall, CR
   Hazrati, LN
   Blaser, S
   Ahmed, S
   Cameron, J
   Singh, K
   Ray, PN
   Suzuki, CK
   Yoon, G
AF Nimmo, Graeme A. M.
   Venkatesh, Sundararajan
   Pandey, Ashutosh K.
   Marshall, Christian R.
   Hazrati, Lili-Naz
   Blaser, Susan
   Ahmed, Sohnee
   Cameron, Jessie
   Singh, Kamalendra
   Ray, Peter N.
   Suzuki, Carolyn K.
   Yoon, Grace
TI Bi-allelic mutations of <i>LONP1</i> encoding the mitochondrial LonP1
   protease cause pyruvate dehydrogenase deficiency and profound
   neurodegeneration with progressive cerebellar atrophy
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID CODAS SYNDROME; SKELETAL ANOMALIES; OXIDASE SUBUNITS; DNA-BINDING;
   PHOSPHORYLATION; ACCUMULATION; DEGRADATION; EXPRESSION; PROTEINS;
   DEFECTS
AB LonP1 is crucial for maintaining mitochondrial proteostasis and mitigating cell stress. We identified a novel homozygous missense LONP1 variant, c.2282 C > T, (p.Pro761Leu), by whole-exome and Sanger sequencing in two siblings born to healthy consanguineous parents. Both siblings presented with stepwise regression during infancy, profound hypotonia and muscle weakness, severe intellectual disability and progressive cerebellar atrophy on brain imaging. Muscle biopsy revealed the absence of ragged-red fibers, however, scattered cytochrome c oxidase-negative staining and electron dense mitochondrial inclusions were observed. Primary cultured fibroblasts from the siblings showed normal levels of mtDNA and mitochondrial transcripts, and normal activities of oxidative phosphorylation complexes I through V. Interestingly, fibroblasts of both siblings showed glucose-repressed oxygen consumption compared to their mother, whereas galactose and palmitic acid utilization were similar. Notably, the siblings' fibroblasts had reduced pyruvate dehydrogenase (PDH) activity and elevated intracellular lactate: pyruvate ratios, whereas plasma ratios were normal. We demonstrated that in the siblings' fibroblasts, PDH dysfunction was caused by increased levels of the phosphorylated E1 alpha subunit of PDH, which inhibits enzyme activity. Blocking E1 alpha phosphorylation activated PDH and reduced intracellular lactate concentrations. In addition, overexpressing wild-type LonP1 in the siblings' fibroblasts down-regulated phosphoE1 alpha. Furthermore, in vitro studies demonstrated that purified LonP1-P761L failed to degrade phosphorylated E1 alpha, in contrast to wild-type LonP1. We propose a novel mechanism whereby homozygous expression of the LonP1-P761L variant leads to PDH deficiency and energy metabolism dysfunction, which promotes severe neurologic impairment and neurodegeneration.
C1 [Nimmo, Graeme A. M.; Ahmed, Sohnee; Yoon, Grace] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON M5G 1X8, Canada.
   [Venkatesh, Sundararajan; Pandey, Ashutosh K.; Suzuki, Carolyn K.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.
   [Marshall, Christian R.; Cameron, Jessie; Ray, Peter N.] Univ Toronto, Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada.
   [Marshall, Christian R.; Ray, Peter N.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada.
   [Hazrati, Lili-Naz] Univ Toronto, Hosp Sick Children, Div Neuropathol, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan] Univ Toronto, Hosp Sick Children, Div Paediat Neuroradiol, Toronto, ON M5G 1X8, Canada.
   [Singh, Kamalendra] Univ Missouri, Christopher Bond Life Sci Ctr, Mol Microbiol & Immunol, Sch Med, Columbia, MO 65211 USA.
   [Singh, Kamalendra] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, SE-17176 Stockholm, Sweden.
   [Ray, Peter N.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada.
   [Yoon, Grace] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); Rutgers
   University System; Rutgers University Newark; Rutgers University New
   Brunswick; Rutgers University Biomedical & Health Sciences; University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); University of Toronto;
   Hospital for Sick Children (SickKids); University of Toronto; Hospital
   for Sick Children (SickKids); University of Missouri System; University
   of Missouri Columbia; Karolinska Institutet; University of Toronto;
   University of Toronto; Hospital for Sick Children (SickKids)
RP Yoon, G (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Suzuki, CK (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, 225 Warren St,E450S, Newark, NJ 07103 USA.
EM carolyn.suzuki@njms.rutgers.edu; grace.yoon@utoronto.ca
RI Ahmed, Sohnee/KRP-7308-2024; Pandey, Ashutosh/X-9389-2018; hazrati,
   lili-naz/AAE-7785-2020; Sundararajan, Venkatesh/H-3837-2014
OI Ahmed, Sohnee/0000-0002-3938-2304; Sundararajan,
   Venkatesh/0000-0003-4195-7776
FU University of Toronto McLaughlin Centre: Next Generation Diagnostics:
   Advancing the Clinical Application of Genomic Analysis [MC-2012-13A];
   National Institutes of Health [1R21HD008391601]
FX This work was supported by the University of Toronto McLaughlin Centre:
   Next Generation Diagnostics: Advancing the Clinical Application of
   Genomic Analysis (grant ID MC-2012-13A to G.Y.) and funded in part by
   National Institutes of Health (1R21HD008391601) and a generous gift from
   M. Maholtra to C.K.S.
CR Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   BROWN GK, 1988, EUR J PEDIATR, V147, P10, DOI 10.1007/BF00442603
   Cameron JM, 2009, HUM GENET, V125, P319, DOI 10.1007/s00439-009-0629-6
   Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127
   DEALMEIDA JCC, 1995, AM J MED GENET, V55, P19, DOI 10.1002/ajmg.1320550107
   Dikoglu E, 2015, AM J MED GENET A, V167, P1501, DOI 10.1002/ajmg.a.37029
   Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047
   Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458
   Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103
   Innes AM, 2001, AM J MED GENET, V102, P44, DOI 10.1002/1096-8628(20010722)102:1<44::AID-AJMG1410>3.0.CO;2-7
   Inui T, 2017, J HUM GENET, V62, P653, DOI 10.1038/jhg.2017.11
   Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Khan AO, 2018, J AAPOS, V22, P229, DOI 10.1016/j.jaapos.2017.10.012
   Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200
   Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7
   Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023
   Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123
   Marlin S, 2010, AM J MED GENET A, V152A, P1510, DOI 10.1002/ajmg.a.33242
   Ngo JK, 2011, J GERONTOL A-BIOL, V66, P1178, DOI 10.1093/gerona/glr145
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Peter B, 2018, HUM MOL GENET, V27, P1743, DOI 10.1093/hmg/ddy080
   Quirós PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018
   Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Sepuri NBV, 2017, BBA-BIOENERGETICS, V1858, P519, DOI 10.1016/j.bbabio.2017.04.003
   SHEBIB SM, 1991, AM J MED GENET, V40, P88, DOI 10.1002/ajmg.1320400118
   SHEU KFR, 1981, J CLIN INVEST, V67, P1463, DOI 10.1172/JCI110176
   Strauss KA, 2015, AM J HUM GENET, V96, P121, DOI 10.1016/j.ajhg.2014.12.003
   SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144
   Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772
   UTTER MF, 1963, J BIOL CHEM, V238, P2603
   van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515
   Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003
NR 36
TC 26
Z9 26
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JAN 15
PY 2019
VL 28
IS 2
BP 290
EP 306
DI 10.1093/hmg/ddy351
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA HP8MW
UT WOS:000461947100010
PM 30304514
OA Green Published
DA 2024-11-01
ER

PT J
AU Lee, JS
   Kim, H
   Lim, BC
   Hwang, H
   Choi, J
   Kim, KJ
   Hwang, YS
   Chae, JH
AF Lee, Jin Sook
   Kim, Hunmin
   Lim, Byung Chan
   Hwang, Hee
   Choi, Jieun
   Kim, Ki Joong
   Hwang, Yong Seung
   Chae, Jong-Hee
TI Leigh Syndrome in Childhood: Neurologic Progression and Functional
   Outcome
SO JOURNAL OF CLINICAL NEUROLOGY
LA English
DT Article
DE Leigh syndrome; mitochondrial DNA mutation; functional outcome;
   prognostic indicators
ID CHINESE CHILDREN; GREATER-THAN; FOLLOW-UP; MUTATION; DEFICIENCY;
   DIAGNOSIS
AB Background and Purpose Few studies have analyzed the clinical course and functional outcome in Leigh syndrome (LS). The aim of this study was to determine the clinical, radiological, biochemical, and genetic features of patients with LS, and identify prognostic indicators of the disease progression and neurological outcome.
   Methods Thirty-nine patients who had been diagnosed with LS at the Seoul National University Children's Hospital were included. Their medical records, neuroimaging findings, and histological/biochemical findings of skeletal muscle specimens were reviewed. Targeted sequencing of mitochondrial DNA was performed based on mitochondrial respiratory chain (MRC) enzyme defects.
   Results Isolated complex I deficiency was the most frequently observed MRC defect (in 42% of 38 investigated patients). Mitochondrial DNA mutations were identified in 11 patients, of which 81.8% were MT-ND genes. The clinical outcome varied widely, from independent daily activity to severe disability. Poor functional outcomes and neurological deterioration were significantly associated with early onset (before an age of 1 year) and the presence of other lesions additional to basal ganglia involvement in the initial neuroimaging.
   Conclusions The neurological severity and outcome of LS may vary widely and be better than those predicted based on previous studies. We suggest that age at onset and initial neuroimaging findings are prognostic indicators in LS.
C1 [Lee, Jin Sook] Gachon Univ, Gil Med Ctr, Dept Pediat, Inchon, South Korea.
   [Kim, Hunmin; Hwang, Hee] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea.
   [Lim, Byung Chan; Kim, Ki Joong; Hwang, Yong Seung; Chae, Jong-Hee] Seoul Natl Univ, Coll Med, Seoul Natl Univ Childrens Hosp, Dept Pediat,Pediat Clin Neurosci Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
   [Choi, Jieun] SMG SNU Boramae Hosp, Dept Pediat, Seoul, South Korea.
C3 Gachon University; Seoul National University (SNU); Seoul National
   University (SNU); Seoul National University Hospital; Seoul National
   University (SNU); Seoul National University Hospital
RP Chae, JH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Childrens Hosp, Dept Pediat,Pediat Clin Neurosci Ctr, 101 Daehak Ro, Seoul 03080, South Korea.
EM chaeped1@snu.ac.kr
RI Hwang, Yong/J-5730-2012; Chae, Jong/J-5683-2012; Cheon, Jae/B-4523-2015;
   Kim, Sae/AAR-3907-2020
OI Lim, Byung Chan/0000-0002-8509-4135; CHOI, JI EUN/0000-0001-6845-8745
FU Korea Health Industry Development Institute (KHIDI) - Ministry for
   Health & Welfare, Republic of Korea [HI12C0066]
FX This study was supported by a grant of the Korea Healthcare Technology
   R&D project through the Korea Health Industry Development Institute
   (KHIDI), funded by the Ministry for Health & Welfare, Republic of Korea
   (Grant No. HI12C0066).
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Chae JH, 2008, BRAIN DEV-JPN, V30, P387, DOI 10.1016/j.braindev.2007.11.001
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Jin TR, 2014, J CHILD NEUROL, V29, pNP143, DOI 10.1177/0883073813512524
   Koenig MK, 2008, PEDIATR NEUROL, V38, P305, DOI 10.1016/j.pediatrneurol.2007.12.001
   Lee HF, 2009, PEDIATR NEUROL, V40, P88, DOI 10.1016/j.pediatrneurol.2008.09.020
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Leng YL, 2015, MITOCHONDR DNA, V26, P208, DOI 10.3109/19401736.2014.905860
   Ma YY, 2015, CLIN GENET, V87, P179, DOI 10.1111/cge.12356
   Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034
   Mak SC, 1998, J CHILD NEUROL, V13, P349, DOI 10.1177/088307389801300709
   Naess K, 2009, BBA-BIOENERGETICS, V1787, P484, DOI 10.1016/j.bbabio.2008.11.014
   Sobreira C, 2009, J NEUROL SCI, V278, P132, DOI 10.1016/j.jns.2008.11.023
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Wang ZX, 2010, NEUROPATHOLOGY, V30, P606, DOI 10.1111/j.1440-1789.2010.01115.x
   Yang YL, 2006, CHINESE MED J-PEKING, V119, P373, DOI 10.1097/00029330-200603010-00004
NR 19
TC 21
Z9 25
U1 0
U2 14
PU KOREAN NEUROLOGICAL ASSOC
PI SEOUL
PA 1111 DAEIL BLD, 43 INSA-DONG, JONGNO-GU, SEOUL, 110-741, SOUTH KOREA
SN 1738-6586
EI 2005-5013
J9 J CLIN NEUROL
JI J. Clin. Neurol.
PD APR
PY 2016
VL 12
IS 2
BP 181
EP 187
DI 10.3988/jcn.2016.12.2.181
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DI5EU
UT WOS:000373522500008
PM 27074294
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Braganza, A
   Annarapu, GK
   Shiva, S
AF Braganza, Andrea
   Annarapu, Gowtham K.
   Shiva, Sruti
TI Blood-based bioenergetics: An emerging translational and clinical tool
SO MOLECULAR ASPECTS OF MEDICINE
LA English
DT Review
DE Mitochondria; Bioenergetics; Platelets; Blood cell; Biomarker; Precision
   medicine
ID MITOCHONDRIAL-DNA MUTATIONS; RIGHT-VENTRICULAR HYPERTROPHY; NEUTROPHIL
   LIFE-SPAN; COMPLEX-I ACTIVITY; SKELETAL-MUSCLE; PULMONARY-HYPERTENSION;
   PLATELET-AGGREGATION; METABOLIC-REGULATION; BIPOLAR DISORDER; HEALTH
   INDEX
AB Accumulating studies demonstrate that mitochondrial genetics and function are central to determining the susceptibility to, and prognosis of numerous diseases across all organ systems. Despite this recognition, mitochondrial function remains poorly characterized in humans primarily due to the invasiveness of obtaining viable tissue for mitochondrial studies. Recent studies have begun to test the hypothesis that circulating blood cells, which can be obtained by minimally invasive methodology, can be utilized as a biomarker of systemic bioenergetic function in human populations. Here we present the available methodologies for assessing blood cell bioenergetics and review studies that have applied these techniques to healthy and disease populations. We focus on the validation of this methodology in healthy subjects, as well as studies testing whether blood cell bioenergetics are altered in disease, correlate with clinical parameters, and compare with other methodology for assessing human mitochondrial function. Finally, we present the challenges and goals for the development of this emerging approach into a tool for translational research and personalized medicine.
C1 [Braganza, Andrea; Annarapu, Gowtham K.; Shiva, Sruti] Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA USA.
   [Shiva, Sruti] Dept Pharmacol & Chem Biol, Pittsburgh, PA USA.
   [Shiva, Sruti] Univ Pittsburgh, Sch Med, Ctr Metab & Mitochondrial Med C3M, Pittsburgh, PA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh
RP Shiva, S (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh Heart Lung Vasc Med Inst, 200 Lothrop St 1240E BST, Pittsburgh, PA 15261 USA.
EM Sss43@pitt.edu
RI Annarapu, Gowtham Kumar/N-5829-2017
OI Annarapu, Gowtham Kumar/0000-0002-6761-0976; Braganza Jardini,
   Andrea/0000-0002-7391-3658
FU NIH [R01 HL133003-01A1]; Hemophilia Center of Western Pennsylvania; AHA
   [19POST34380956]; Vitalant; American Heart Association (AHA)
   [19POST34380956] Funding Source: American Heart Association (AHA)
FX Dr. Shiva receives funding support from NIH R01 HL133003-01A1 and
   Vitalant and The Hemophilia Center of Western Pennsylvania. Dr. Braganza
   receives support from AHA 19POST34380956.
CR Akki A, 2013, AM J PHYSIOL-HEART C, V304, pH633, DOI 10.1152/ajpheart.00771.2011
   Al Badarin FJ, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1146-4
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   [Anonymous], [No title captured]
   Aoyama R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188479
   Avila C, 2012, EXP CLIN ENDOCR DIAB, V120, P248, DOI 10.1055/s-0031-1285833
   Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC
   Beadnell TC, 2018, CANCER METAST REV, V37, P615, DOI 10.1007/s10555-018-9772-7
   Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649
   Ben-Shachar D, 2007, PROG NEURO-PSYCHOPH, V31, P807, DOI 10.1016/j.pnpbp.2006.12.025
   Betancourt AM, 2014, BIOCHEM J, V461, P223, DOI 10.1042/BJ20131433
   Boushel R, 2001, SCAND J MED SCI SPOR, V11, P213, DOI 10.1034/j.1600-0838.2001.110404.x
   Braganza A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128248
   Brookes PS, 2002, METHOD ENZYMOL, V359, P305
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006
   Caccese D, 2000, THROMB HAEMOSTASIS, V83, P485, DOI 10.1055/s-0037-1613841
   Cardena MMSG, 2016, J HUM HYPERTENS, V30, P120, DOI 10.1038/jhh.2015.39
   Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Cesari F, 2008, THROMB HAEMOSTASIS, V99, P930, DOI [10.1160/THOS-01-0002, 10.1160/TH08-01-0002]
   Chacko B, 2019, MOL GENET METAB REP, V19, DOI 10.1016/j.ymgmr.2019.100451
   Chacko BK, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101165
   Chacko BK, 2016, REDOX BIOL, V8, P43, DOI 10.1016/j.redox.2015.12.008
   Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101
   Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53
   Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34
   Chen EI, 2012, J BIOENERG BIOMEMBR, V44, P619, DOI 10.1007/s10863-012-9465-9
   Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338
   Chou CH, 2019, INT J CARDIOL, V274, P214, DOI 10.1016/j.ijcard.2018.07.104
   Chung J, 2011, BIOL PHARM BULL, V34, P495, DOI 10.1248/bpb.34.495
   Cochran BJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55184
   Coen PM, 2013, J GERONTOL A-BIOL, V68, P447, DOI 10.1093/gerona/gls196
   Cohen BH, 2001, CLEV CLIN J MED, V68, P625, DOI 10.3949/ccjm.68.7.625
   Cowan DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160889
   Coxhead J, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.036
   Culley MK, 2018, J CLIN INVEST, V128, P3704, DOI 10.1172/JCI120847
   De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532
   De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479
   Dezfulian C, 2017, REDOX BIOL, V12, P491, DOI 10.1016/j.redox.2017.03.010
   Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Dunham-Snary KJ, 2018, EBIOMEDICINE, V36, P316, DOI 10.1016/j.ebiom.2018.08.036
   Fetterman JL, 2013, BIOCHEM J, V455, P157, DOI 10.1042/BJ20130029
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   FUKAMI MH, 1973, BLOOD, V42, P913, DOI 10.1182/blood.V42.6.913.913
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Garcia-Souza LF, 2014, INT J BIOCHEM CELL B, V50, P156, DOI 10.1016/j.biocel.2014.02.015
   Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127
   Granatiero V, 2017, ADV EXP MED BIOL, V982, P25, DOI 10.1007/978-3-319-55330-6_2
   Grove EL, 2011, J THROMB HAEMOST, V9, P185, DOI 10.1111/j.1538-7836.2010.04115.x
   Gründler K, 2014, CRIT CARE, V18, DOI 10.1186/cc13724
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Hamaoka T, 1996, J APPL PHYSIOL, V81, P1410
   Harker LA, 2000, BLOOD, V95, P2514
   Hasegawa A, 2009, BLOOD, V114, P2917, DOI 10.1182/blood-2009-02-204263
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   Japiassú AM, 2011, CRIT CARE MED, V39, P1056, DOI 10.1097/CCM.0b013e31820eda5c
   Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006
   Kaufman BA, 2015, MOL ASPECTS MED, V42, P91, DOI 10.1016/j.mam.2015.01.004
   Kaur A, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/1286054
   Keuper M, 2019, MOL METAB, V20, P28, DOI 10.1016/j.molmet.2018.11.006
   Khare A, 2016, CELL REP, V15, P1700, DOI 10.1016/j.celrep.2016.04.060
   Klimmeck D, 2012, MOL CELL PROTEOMICS, V11, P286, DOI 10.1074/mcp.M111.016790
   Kramer PA, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150161
   Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026
   Krzywanski DM, 2011, LAB INVEST, V91, P1122, DOI 10.1038/labinvest.2011.95
   Kuznetsov Andrey V., 1998, Biofactors, V7, P221
   Lanza IR, 2010, CURR OPIN CLIN NUTR, V13, P511, DOI 10.1097/MCO.0b013e32833cc93d
   LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004
   Lin MT, 2012, ANN NEUROL, V71, P850, DOI 10.1002/ana.23568
   Lopaschuk GD, 2017, CAN J CARDIOL, V33, P838, DOI 10.1016/j.cjca.2016.12.013
   Mahapatra G, 2018, CLIN SCI, V132, P2509, DOI 10.1042/CS20180690
   Malenfant S, 2015, J MOL MED, V93, P573, DOI 10.1007/s00109-014-1244-0
   Marshall JD, 2018, AM J PHYSIOL-LUNG C, V314, pL782, DOI 10.1152/ajplung.00331.2017
   Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66
   Romero MM, 2016, CELL MICROBIOL, V18, P875, DOI 10.1111/cmi.12562
   Michalak S, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9703574
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   Mookerjee SA, 2017, J BIOL CHEM, V292, P7189, DOI 10.1074/jbc.M116.774471
   Nguyen QL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220490
   Nguyen QL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91415
   Nierenberg AA, 2013, AUST NZ J PSYCHIAT, V47, P26, DOI 10.1177/0004867412449303
   Nishigaki Y, 2010, GERIATR GERONTOL INT, V10, pS221, DOI 10.1111/j.1447-0594.2010.00599.x
   Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025
   Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585
   PARKER WD, 1990, NEUROLOGY, V40, P1231, DOI 10.1212/WNL.40.8.1231
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355
   Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Picado C, 1999, ALLERGY, V54, P569, DOI 10.1034/j.1398-9995.1999.00024.x
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Pignatelli P, 1998, BLOOD, V91, P484, DOI 10.1182/blood.V91.2.484.484_484_490
   Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028
   Prakash YS, 2017, CHEST, V152, P618, DOI 10.1016/j.chest.2017.03.020
   Qian PX, 2016, CELL STEM CELL, V18, P214, DOI 10.1016/j.stem.2015.11.001
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rezania S, 2017, THROMB RES, V155, P106, DOI 10.1016/j.thromres.2017.05.009
   Romero-Moya D, 2013, HAEMATOLOGICA, V98, P1022, DOI 10.3324/haematol.2012.079244
   Rose G, 2001, EUR J HUM GENET, V9, P701, DOI 10.1038/sj.ejhg.5200703
   Ryan J, 2015, J MOL MED, V93, P229, DOI 10.1007/s00109-015-1263-5
   Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018
   Sandoval H, 2018, MITOCHONDRION, V41, P58, DOI 10.1016/j.mito.2017.11.005
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003
   Serrano-Teruel Maria E, 2019, Asian Cardiovasc Thorac Ann, V27, P5, DOI 10.1177/0218492318813220
   Shanely RA, 2014, JOVE-J VIS EXP, DOI 10.3791/51812
   Shi C, 2008, EXP GERONTOL, V43, P589, DOI 10.1016/j.exger.2008.02.004
   Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777
   SIEGEL A, 1971, THROMB DIATH HAEMOST, V25, P252
   Silva AC, 2013, MITOCHONDRION, V13, P801, DOI 10.1016/j.mito.2013.05.006
   Silva AM, 2012, METHODS MOL BIOL, V810, P7, DOI 10.1007/978-1-61779-382-0_2
   Sjövall F, 2010, CRIT CARE, V14, DOI 10.1186/cc9337
   Stork C, 2005, MOL PSYCHIATR, V10, P900, DOI 10.1038/sj.mp.4001711
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004
   Sutendra G, 2013, J MOL MED, V91, P1315, DOI 10.1007/s00109-013-1059-4
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Tofts PS, 2011, BLOOD, V117, P6050, DOI 10.1182/blood-2010-10-310532
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494
   Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956
   Tyrrell DJ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7317251
   Tyrrell DJ, 2016, REDOX BIOL, V10, P65, DOI 10.1016/j.redox.2016.09.009
   Tyrrell DJ, 2015, J GERONTOL A-BIOL, V70, P1394, DOI 10.1093/gerona/glu096
   Tyrrell DJ, 2015, EXP GERONTOL, V70, P84, DOI 10.1016/j.exger.2015.07.015
   Umbri M, 2019, MITOCHONDRION, V44, P1, DOI 10.1016/j.mito.2017.12.004
   Valkovic L, 2017, ANAL BIOCHEM, V529, P193, DOI 10.1016/j.ab.2017.01.018
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Villagra J, 2007, BLOOD, V110, P2166, DOI 10.1182/blood-2006-12-061697
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117
   Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005
   Weiss K, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004129
   Williams J, 2016, UROLOGY, V93, DOI 10.1016/j.urology.2016.03.004
   Willig AL, 2017, REDOX BIOL, V12, P648, DOI 10.1016/j.redox.2017.04.005
   Winnica D, 2019, ANTIOXID REDOX SIGN, V31, P673, DOI 10.1089/ars.2018.7627
   Xu J, 2007, J BIOENERG BIOMEMBR, V39, P195, DOI 10.1007/s10863-007-9077-y
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925
   Xu WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132007
   Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005
   Yu QJ, 2017, ADV EXP MED BIOL, V967, P373, DOI 10.1007/978-3-319-63245-2_24
   Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022
   Zhang JY, 2015, INT J MOL SCI, V16, P4083, DOI 10.3390/ijms16024083
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zifa E, 2012, MOL BIOL REP, V39, P4697, DOI 10.1007/s11033-011-1262-8
NR 161
TC 25
Z9 28
U1 2
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0098-2997
EI 1872-9452
J9 MOL ASPECTS MED
JI Mol. Asp. Med.
PD FEB
PY 2020
VL 71
AR 100835
DI 10.1016/j.mam.2019.100835
PG 12
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA KN1YC
UT WOS:000514635900004
PM 31864667
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Piekutowska-Abramczuk, D
   Assouline, Z
   Matakovic, L
   Feichtinger, RG
   Konariková, E
   Jurkiewicz, E
   Stawinski, P
   Gusic, M
   Koller, A
   Pollak, A
   Gasperowicz, P
   Trubicka, J
   Ciara, E
   Iwanicka-Pronicka, K
   Rokicki, D
   Hanein, S
   Wortmann, SB
   Sperl, W
   Rötig, A
   Prokisch, H
   Pronicka, E
   Ploski, R
   Barcia, G
   Mayr, JA
AF Piekutowska-Abramczuk, Dorota
   Assouline, Zahra
   Matakovic, Lavinija
   Feichtinger, Rene G.
   Konarikova, Eliska
   Jurkiewicz, Elzbieta
   Stawinski, Piotr
   Gusic, Mirjana
   Koller, Andreas
   Pollak, Agnieszka
   Gasperowicz, Piotr
   Trubicka, Joanna
   Ciara, Elzbieta
   Iwanicka-Pronicka, Katarzyna
   Rokicki, Dariusz
   Hanein, Sylvain
   Wortmann, Saskia B.
   Sperl, Wolfgang
   Rotig, Agnes
   Prokisch, Holger
   Pronicka, Ewa
   Ploski, Rafa
   Barcia, Giulia
   Mayr, Johannes A.
TI <i>NDUFB8</i> Mutations Cause Mitochondrial Complex I Deficiency in
   Individuals with Leigh-like Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID RESPIRATORY-CHAIN DEFICIENCY; ACAD9 MUTATIONS; DISEASE; ARCHITECTURE;
   DIAGNOSIS; FEATURES
AB Respiratory chain complex I deficiency is the most frequently identified biochemical defect in childhood mitochondrial diseases. Clinical symptoms range from fatal infantile lactic acidosis to Leigh syndrome and other encephalomyopathies or cardiomyopathies. To date, disease-causing variants in genes coding for 27 complex I subunits, including 7 mitochondrial DNA genes, and in 11 genes encoding complex I assembly factors have been reported. Here, we describe rare biallelic variants in NDUFB8 encoding a complex I accessory subunit revealed by whole-exome sequencing in two individuals from two families. Both presented with a progressive course of disease with encephalo(cardio) myopathic features including muscular hypotonia, cardiac hypertrophy, respiratory failure, failure to thrive, and developmental delay. Blood lactate was elevated. Neuroimaging disclosed progressive changes in the basal ganglia and either brain stem or internal capsule. Biochemical analyses showed an isolated decrease in complex I enzymatic activity in muscle and fibroblasts. Complementation studies by expression of wild-type NDUFB8 in cells from affected individuals restored mitochondrial function, confirming NDUFB8 variants as the cause of complex I deficiency. Hereby we establish NDUFB8 as a relevant gene in childhood-onset mitochondrial disease.
C1 [Piekutowska-Abramczuk, Dorota; Trubicka, Joanna; Ciara, Elzbieta; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Assouline, Zahra; Barcia, Giulia] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria.
   [Matakovic, Lavinija; Feichtinger, Rene G.; Koller, Andreas; Wortmann, Saskia B.; Sperl, Wolfgang; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria.
   [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Konarikova, Eliska; Gusic, Mirjana; Wortmann, Saskia B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Jurkiewicz, Elzbieta] Childrens Mem Hlth Inst, Dept Diagnost Imaging, PL-04730 Warsaw, Poland.
   [Stawinski, Piotr; Gasperowicz, Piotr; Ploski, Rafa] Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.
   [Stawinski, Piotr; Pollak, Agnieszka] Inst Physiol & Pathol Hearing, Dept Genet, PL-05830 Warsaw, Poland.
   [Iwanicka-Pronicka, Katarzyna] Childrens Mem Hlth Inst, Dept Audiol & Phoniatr, PL-04730 Warsaw, Poland.
   [Rokicki, Dariusz; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Paediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
   [Hanein, Sylvain; Rotig, Agnes] Univ Paris 05, Sorbonne Paris Cite,Inst Imagine, INSERM, U1163, F-75015 Paris, France.
C3 Children's Memorial Health Institute; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Paracelsus Private Medical University; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Technical University of Munich; Children's
   Memorial Health Institute; Medical University of Warsaw; Institute of
   Physiology & Hearing Pathology; Children's Memorial Health Institute;
   Children's Memorial Health Institute; Universite Paris Cite; Institut
   National de la Sante et de la Recherche Medicale (Inserm)
RP Mayr, JA (corresponding author), Salzburger Landeskliniken, Dept Pediat, A-5020 Salzburg, Austria.; Mayr, JA (corresponding author), Paracelsus Med Univ Salzburg, A-5020 Salzburg, Austria.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, PL-02106 Warsaw, Poland.
EM rploski@wp.pl; h.mayr@salk.at
RI Wortmann, Saskia/E-6125-2010; Prokisch, Holger/N-8964-2013; Koňaříková,
   Eliška/AAG-4073-2021; hanein, sylvain/AAG-4933-2019; Barcia,
   Giulia/H-7907-2017; ROTIG, AGNES/G-9592-2017; Trubicka,
   Joanna/R-1215-2018
OI Gusic, Mirjana/0000-0002-9350-291X; Koller, Andreas/0000-0001-6108-8411;
   ROTIG, AGNES/0000-0003-0589-0703; Rokicki, Dariusz/0000-0002-9736-2838;
   Gasperowicz, Piotr/0000-0002-1037-7974; Pronicka,
   Ewa/0000-0002-5705-4814; Jurkiewicz, Elzbieta/0000-0003-4505-8815;
   Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Ploski,
   Rafal/0000-0001-6286-5526; Stawinski, Piotr/0000-0001-7113-4434; Pollak,
   Agnieszka/0000-0002-2847-1782; Ciara, Elzbieta/0000-0002-1065-7968;
   Trubicka, Joanna/0000-0002-9848-3674; Iwanicka-Pronicka,
   Katarzyna/0000-0003-2164-6663; Konarikova, Eliska/0000-0001-7365-5006;
   Prokisch, Holger/0000-0003-2379-6286
FU NSC [2012/05/B/NZ2/01627]; CMHI [S136/13, S145/16]; E-Rare project
   GENOMIT [01GM1603, 01GM1207, O1GML 1207]; E-Rare project GENOMIT
   (Austrian Science Fonds [FWF]) [I 2741-B26]; PMU-FFF [R-16/03/082-FEK];
   EC PEOPLE-ITN (MEET) [317433]; Austrian Science Fund (FWF) [I2741]
   Funding Source: Austrian Science Fund (FWF)
FX The study was partly supported by NSC 2012/05/B/NZ2/01627 to D.P.-A.,
   CMHI S136/13 and S145/16 to E.P., E-Rare project GENOMIT (01GM1603 and
   01GM1207 to H.P., O1GML 1207 to A.R, Austrian Science Fonds [FWF]: I
   2741-B26 to J.A.M.), PMU-FFF R-16/03/082-FEK (to R.G.F. and A.K.), and
   EC FP7-PEOPLE-ITN (GA #317433, MEET) projects.
CR Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   Collet M, 2016, EUR J HUM GENET, V24, P1112, DOI 10.1038/ejhg.2015.264
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Herzer M, 2010, NEUROPEDIATRICS, V41, P30, DOI 10.1055/s-0030-1255062
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501
   Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824
   Kremer LS, 2017, METHODS MOL BIOL, V1567, P391, DOI 10.1007/978-1-4939-6824-4_24
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Metodiev MD, 2014, J MED GENET, V51, P834, DOI 10.1136/jmedgenet-2014-102532
   Olsen RKJ, 2016, AM J HUM GENET, V98, P1130, DOI 10.1016/j.ajhg.2016.04.006
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Rodenburg RJ, 2016, BBA-BIOENERGETICS, V1857, P938, DOI 10.1016/j.bbabio.2016.02.012
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012
   Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095
   Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859
NR 24
TC 41
Z9 45
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD MAR 1
PY 2018
VL 102
IS 3
BP 460
EP 467
DI 10.1016/j.ajhg.2018.01.008
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FX9ZL
UT WOS:000426469600016
PM 29429571
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Harada, N
   Nagasaki, H
   Yamamoto, H
   Matsubara, K
   Suzuki, T
   Gomori, A
   Yokogawa, T
   Matsuo, K
   Miyadera, K
AF Harada, Naomoto
   Nagasaki, Haruka
   Yamamoto, Hiromi
   Matsubara, Kenji
   Suzuki, Takamasa
   Gomori, Akira
   Yokogawa, Tatsushi
   Matsuo, Kenichi
   Miyadera, Kazutaka
TI Depletion of plasma thymidine results in growth retardation and
   mitochondrial myopathy in mice overexpressing human thymidine
   phosphorylase
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID URIDINE PHOSPHORYLASE; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY;
   DEOXYNUCLEOTIDE POOLS; KINASE 2; EXPRESSION; DNA; GENE; NUCLEOSIDE;
   DELETION; TRIPHOSPHATE
AB Plasma thymidine levels in rodents are higher than in other mammals including humans, possibly due to a different pattern and lower level of thymidine phosphorylase expression. Here, we generated a novel knock-in (KI) mouse line with high systemic expression of human thymidine phosphorylase to investigate this difference in nucleotide metabolism in rodents. The KI mice showed growth retardation around weaning and died by 4 weeks of age with a decrease in plasma thymidine level compared with the litter-control WT mice. These phenotypes were completely or partially rescued by administration of the thymidine phosphorylase inhibitor 5-chloro-6-(2drochloride or thymidine, respectively. Interestingly, when thymidine phosphorylase inhibitor administration was discontinued in adult animals, KI mice showed deteriorated grip strength and locomotor activity, decreased bodyweight, and subsequent hind-limb paralysis. Upon histological analyses, we observed axonal degeneration in the spinal cord, muscular atrophy with morphologically abnormal mitochondria in quadriceps, retinal degeneration, and abnormality in the exocrine pancreas. Moreover, we detected mitochondrial DNA depletion in multiple tissues of KI mice. These results indicate that the KI mouse represents a new animal model for mitochondrial diseases and should be applicable for the study of differences in nucleotide metabolism between humans and mice.
C1 [Harada, Naomoto; Nagasaki, Haruka; Yamamoto, Hiromi; Matsubara, Kenji; Suzuki, Takamasa; Gomori, Akira; Yokogawa, Tatsushi; Matsuo, Kenichi; Miyadera, Kazutaka] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.
C3 Taiho Pharmaceutical
RP Harada, N (corresponding author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Tsukuba, Ibaraki, Japan.
EM nm-harada@taiho.co.jp
OI Harada, Naomoto/0000-0003-1083-7253
CR Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104
   Barboni P, 2004, GRAEF ARCH CLIN EXP, V242, P878, DOI 10.1007/s00417-004-0914-y
   Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043
   Brown NS, 1998, BIOCHEM J, V334, P1
   Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200
   Dobrovolsky VN, 2003, MOL GENET METAB, V78, P1, DOI 10.1016/S1096-7192(02)00224-X
   ELKOUNI MH, 1993, CANCER RES, V53, P3687
   Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021
   FRIEDKIN M, 1954, J BIOL CHEM, V207, P245
   Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7
   Haraguchi M, 2002, MOL CELL BIOL, V22, P5212, DOI 10.1128/MCB.22.14.5212-5221.2002
   Hurwitz Selwyn J., 2005, Antiviral Chemistry & Chemotherapy, V16, P117
   ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0
   JACKMAN AL, 1984, BIOCHEM PHARMACOL, V33, P3269, DOI 10.1016/0006-2952(84)90089-3
   Koszalka G. W., 1993, Antiviral Research, V20, P143
   KRENITSKY TA, 1964, J BIOL CHEM, V239, P805
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Mazat JP, 2001, BBA-BIOENERGETICS, V1504, P20, DOI 10.1016/S0005-2728(00)00236-X
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   Mikhailopulo IA, 2010, ACTA NATURAE, V2, P36, DOI 10.32607/20758251-2010-2-2-36-58
   MIYADERA K, 1995, CANCER RES, V55, P1687
   Moraes CT, 2001, TRENDS GENET, V17, P199, DOI 10.1016/S0168-9525(01)02238-7
   Munch-Petersen B, 2010, NUCLEOS NUCLEOT NUCL, V29, P363, DOI 10.1080/15257771003729591
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pacitti D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00669
   Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100
   Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SMITH GK, 1995, CANCER RES, V55, P6117
   Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007
   Stevenson DP, 1998, AM J PATHOL, V152, P1641
   TAX WJM, 1976, BIOCHEM PHARMACOL, V25, P2025, DOI 10.1016/0006-2952(76)90425-1
   TAYLOR GA, 1984, ADV EXP MED BIOL, V165, P379
   Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042
   van der Wilt CL, 2001, CANCER RES, V61, P3675
   Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610
   Xu P, 2000, J BIOL CHEM, V275, P5918, DOI 10.1074/jbc.275.8.5918
   YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X
   Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 42
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR
PY 2023
VL 299
IS 3
AR 103002
DI 10.1016/j.jbc.2023.103002
EA MAR 2023
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA J1AV3
UT WOS:001007010500001
PM 36773803
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Oláhová, M
   Thompson, K
   Hardy, SA
   Barbosa, IA
   Besse, A
   Anagnostou, ME
   White, K
   Davey, T
   Simpson, MA
   Champion, M
   Enns, G
   Schelley, S
   Lightowlers, RN
   Chrzanowska-Lightowlers, ZMA
   McFarland, R
   Deshpande, C
   Bonnen, PE
   Taylor, RW
AF Olahova, Monika
   Thompson, Kyle
   Hardy, Steven A.
   Barbosa, Ines A.
   Besse, Arnaud
   Anagnostou, Maria-Eleni
   White, Kathryn
   Davey, Tracey
   Simpson, Michael A.
   Champion, Michael
   Enns, Greg
   Schelley, Susan
   Lightowlers, Robert N.
   Chrzanowska-Lightowlers, Zofia M. A.
   McFarland, Robert
   Deshpande, Charu
   Bonnen, Penelope E.
   Taylor, Robert W.
TI Pathogenic variants in <i>HTRA2</i> cause an early-onset mitochondrial
   syndrome associated with 3-methylglutaconic aciduria
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID SERINE-PROTEASE; PARKINSON DISEASE; ESSENTIAL TREMOR; DNA MAINTENANCE;
   BARTH-SYNDROME; CELL-DEATH; MUTATIONS; GENE; NEUTROPENIA; DEFICIENCY
AB Mitochondrial diseases collectively represent one of the most heterogeneous group of metabolic disorders. Symptoms can manifest at any age, presenting with isolated or multiple-organ involvement. Advances in next-generation sequencing strategies have greatly enhanced the diagnosis of patients with mitochondrial disease, particularly where a mitochondrial aetiology is strongly suspected yet OXPHOS activities in biopsied tissue samples appear normal. We used whole exome sequencing (WES) to identify the molecular basis of an early-onset mitochondrial syndrome-pathogenic biallelic variants in the HTRA2 gene, encoding a mitochondria-localised serine protease-in five subjects from two unrelated families characterised by seizures, neutropenia, hypotonia and cardio-respiratory problems. A unifying feature in all affected children was 3-methylglutaconic aciduria (3-MGA-uria), a common biochemical marker observed in some patients with mitochondrial dysfunction. Although functional studies of HTRA2 subjects' fibroblasts and skeletal muscle homogenates showed severely decreased levels of mutant HTRA2 protein, the structural subunits and complexes of the mitochondrial respiratory chain appeared normal. We did detect a profound defect in OPA1 processing in HTRA2-deficient fibroblasts, suggesting a role for HTRA2 in the regulation of mitochondrial dynamics and OPA1 proteolysis. In addition, investigated subject fibroblasts were more susceptible to apoptotic insults. Our data support recent studies that described important functions for HTRA2 in programmed cell death and confirm that patients with genetically-unresolved 3-MGA-uria should be screened by WES with pathogenic variants in the HTRA2 gene prioritised for further analysis.
C1 [Olahova, Monika; Thompson, Kyle; Hardy, Steven A.; Anagnostou, Maria-Eleni; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M. A.; McFarland, Robert; Taylor, Robert W.] Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Barbosa, Ines A.; Simpson, Michael A.] Kings Coll London, Sch Med, Div Genet & Mol Med, London, England.
   [Besse, Arnaud] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [White, Kathryn; Davey, Tracey] Newcastle Univ, Elect Microscopy Res Serv, Newcastle Upon Tyne, Tyne & Wear, England.
   [Champion, Michael] Evelina London Childrens Hosp, Guys & St Thomas NHS Fdn Trusts, Dept Inherited Metab Dis, London, England.
   [Enns, Greg; Schelley, Susan] Lucile Packard Childrens Hosp Stanford, Palo Alto, CA USA.
   [Enns, Greg; Schelley, Susan] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA.
   [Deshpande, Charu] Guys & St Thomas NHS Fdn Trust, Clin Genet Unit, London, England.
C3 Newcastle University - UK; University of London; King's College London;
   Baylor College of Medicine; Newcastle University - UK; Lucile Packard
   Children's Hospital (LPCH); Stanford University; Guy's & St Thomas' NHS
   Foundation Trust
RP Taylor, RW (corresponding author), Newcastle Univ, Sch Med, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM robert.taylor@ncl.ac.uk
RI ; Simpson, Michael/F-4737-2011; Davey, Tracey/JWA-4940-2024
OI McFarland, Robert/0000-0002-8833-2688; Simpson,
   Michael/0000-0002-8539-8753; Chrzanowska-Lightowlers,
   Zofia/0000-0002-0045-3152; Davey, Tracey/0000-0001-9409-7410
FU Wellcome Trust Strategic Award [096919/Z/11/Z]; MRC Centre for
   Neuromuscular Diseases [G0601943]; Lily Foundation; UK NHS Highly
   Specialised "Rare Mitochondrial Disorders of Adults and Children"
   Service in Newcastle upon Tyne; Biotechnology and Biological Sciences
   Research Council [BB/M012093/1]; Department of Health via the NIHR
   comprehensive Biomedical Research Centre; National Institute of
   Neurological Disorders and Stroke of the National Institutes of Health
   [R01NS08372]; King's College London; Wellcome Trust [096919/Z/11/Z]
   Funding Source: Wellcome Trust; BBSRC [BB/M012093/1] Funding Source:
   UKRI; MRC [G0601943] Funding Source: UKRI
FX This work was supported by a Wellcome Trust Strategic Award
   (096919/Z/11/Z), the MRC Centre for Neuromuscular Diseases (G0601943),
   the Lily Foundation, the UK NHS Highly Specialised "Rare Mitochondrial
   Disorders of Adults and Children" Service in Newcastle upon Tyne
   (http://www.newcastle-mitochondria.com), the Biotechnology and
   Biological Sciences Research Council (BB/M012093/1), the Department of
   Health via the NIHR comprehensive Biomedical Research Centre award to
   Guy's and St. Thomas' NHS Foundation Trust in partnership with the
   King's College London and the National Institute of Neurological
   Disorders and Stroke of the National Institutes of Health under award
   number R01NS08372.
CR Anikster Y, 2001, AM J HUM GENET, V69, P1218, DOI 10.1086/324651
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008
   Bonnen PE, 2013, AM J HUM GENET, V93, P471, DOI 10.1016/j.ajhg.2013.07.017
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657
   Deerinck T.J., 2010, Microscopy, V1, P6
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111
   Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jones WD, 2012, AM J HUM GENET, V91, P358, DOI 10.1016/j.ajhg.2012.06.008
   Kanabus M, 2015, J INHERIT METAB DIS, V38, P211, DOI 10.1007/s10545-015-9813-0
   Kang S, 2013, CELL DEATH DIFFER, V20, P259, DOI 10.1038/cdd.2012.117
   KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6
   Kieper N, 2010, EXP CELL RES, V316, P1213, DOI 10.1016/j.yexcr.2010.01.005
   Krüger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186
   Magner M, 2015, J INHERIT METAB DIS, V38, P583, DOI 10.1007/s10545-015-9833-9
   Magner M, 2015, J INHERIT METAB DIS, V38, P417, DOI 10.1007/s10545-014-9774-8
   Mandel H, 2016, J MED GENET, V53, P690, DOI 10.1136/jmedgenet-2016-103922
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Oláhová M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291
   Oláhová M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Pfeffer G, 2014, BRAIN, V137, P1323, DOI 10.1093/brain/awu060
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Tzoulis C, 2015, P NATL ACAD SCI USA, V112, pE2268, DOI 10.1073/pnas.1503105112
   Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291
   Wortmann SB, 2015, AM J HUM GENET, V96, P245, DOI 10.1016/j.ajhg.2014.12.013
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P913, DOI 10.1007/s10545-012-9579-6
   Wortmann SB, 2012, NAT GENET, V44, P797, DOI 10.1038/ng.2325
NR 40
TC 20
Z9 26
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN
PY 2017
VL 40
IS 1
BP 121
EP 130
DI 10.1007/s10545-016-9977-2
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA EG6CW
UT WOS:000391132500009
PM 27696117
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Hintze, S
   Baber, L
   Hofmeister, F
   Jarmusch, S
   Todorow, V
   Mehaffey, S
   Tanganelli, F
   Ferrari, U
   Neuerburg, C
   Teupser, D
   Bidlingmaier, M
   Marques, JG
   Koletzko, B
   Schoser, B
   Drey, M
   Meinke, P
AF Hintze, Stefan
   Baber, Lisa
   Hofmeister, Fabian
   Jarmusch, Stefanie
   Todorow, Vanessa
   Mehaffey, Stefan
   Tanganelli, Fabiana
   Ferrari, Uta
   Neuerburg, Carl
   Teupser, Daniel
   Bidlingmaier, Martin
   Marques, Jair Gonzalez
   Koletzko, Berthold
   Schoser, Benedikt
   Drey, Michael
   Meinke, Peter
TI Exploration of mitochondrial defects in sarcopenic hip fracture patients
SO HELIYON
LA English
DT Article
DE Sarcopenia; Tricarboxylic acid cycle; TCA; Mitochondria; Metabolism;
   Myoblast culture
ID SKELETAL-MUSCLE MASS; DNA DELETION; PREVALENCE; CONSENSUS; FALLS; RISK;
   MEN; AGE
AB Severe cases of age-related loss of muscle function and mass are clinically unique to sarcopenia. Mitochondrial dysfunction has been associated with aging and sarcopenia, but the causal connection in this context is not well eluded. Here we investigated different aspects of mitochondrial respiration in sarcopenia. Open muscle biopsies were taken from a total of 31 hip fracture patients, older than 70 years. Patients were assigned a sarcopenia Z -score based on EWGSOP2 criteria. Primary myoblast cultures were generated from the muscle tissue samples and used for real time metabolic measurement. Muscle and serum samples showed correlation of high Z-scores with reduced mitochondrial complex I activity, increased tricarboxylic acid cycle (TCA) metabolites, reduced vitamin D3 levels, and signs of an altered iron metabolism. Primary myoblast cultures gained from the same muscle bi-opsies did not show significant mitochondrial defects. We hypothesize that a sum of external consequences, including vitamin D3 deficiency and iron deficiency caused by disturbances in the iron metabolism, result in complex I deficiency, which in turn affects the TCA and contributes to muscle weakness and loss.
C1 [Hintze, Stefan; Todorow, Vanessa; Schoser, Benedikt; Meinke, Peter] Ludwig Maximilians Univ Munchen, Dept Neurol, LMU Klinikum, Munich, Germany.
   [Baber, Lisa; Hofmeister, Fabian; Jarmusch, Stefanie; Tanganelli, Fabiana; Ferrari, Uta; Drey, Michael] Ludwig Maximilians Univ Munchen, Dept Med 4, LMU Klinikum, Munich, Germany.
   [Mehaffey, Stefan; Neuerburg, Carl] Ludwig Maximilians Univ Munchen, Dept Gen Trauma and Reconstruct Surg, LMU Klinikum, Munich, Germany.
   [Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, LMU Klinikum, Munich, Germany.
   [Bidlingmaier, Martin] Ludwig Maximilians Univ Munchen, Dept Med 4, LMU Klinikum, Endocrinol, Munich, Germany.
   [Marques, Jair Gonzalez; Koletzko, Berthold] Ludwig Maximilians Univ Munchen, Dr Von Hauner Childrens Hosp, Dept Pediat, LMU Klinikum, Munich, Germany.
C3 University of Munich; University of Munich; University of Munich;
   University of Munich; University of Munich; University of Munich
RP Meinke, P (corresponding author), Ludwig Maximilians Univ Munchen, Dept Neurol, LMU Klinikum, Munich, Germany.
EM peter.meinke@med.uni-muenchen.de
RI Inerbaev, Talgat/AAB-7633-2020; Meinke, Peter/AFA-8801-2022; Neuerburg,
   Carl/AAE-7269-2020
OI Meinke, Peter/0000-0003-3359-3837; Gonzalez, Jair/0000-0002-8095-8475
FU EU project Keep Control; European Union's Horizon 2020 research and
   innovation programmed under the Marie Sklodowska-Curie [721577];
   European Commission H2020 Programme Lifecycle [733206]; European Joint
   Programming Initiative Projects NutriPRO-GRAM; German Research Council
   DFG [INST 409/224-1 FUGG]; Else Kroner-Fresenius-Foundation; LMU
   University Hospitals; Deutsche For-schungsgemeinschaft (DFG, German
   Research Foundation) - Pro-jektnummer [470092532]
FX This study was supported by the EU project Keep Control, funded under
   the European Union's Horizon 2020 research and innovation programmed
   under the Marie Sklodowska-Curie grant agreement No [721577]. The work
   of Berthold Koletzko and Jair Gonzalez Marques is supported by the
   European Commission H2020 Programme Lifecycle-733206, the European Joint
   Programming Initiative Projects NutriPRO-GRAM, and the German Research
   Council DFG (INST 409/224-1 FUGG), Berthold Koletzko is the Else Kroner
   Senior professor of Paediatrics at LMU - University of Munich,
   financially supported by the Else Kroner-Fresenius-Foundation, the LMU
   Medical Faculty and the LMU University Hospitals. Peter Meinke is funded
   by the Deutsche For-schungsgemeinschaft (DFG, German Research
   Foundation) - Pro-jektnummer [470092532].
CR Bastian TW, 2020, NEUROSCI INSIGHTS, V15, DOI 10.1177/2633105520935104
   Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548
   Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Brunetti D, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01171
   Cawthon PM, 2015, J AM GERIATR SOC, V63, P2247, DOI 10.1111/jgs.13788
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
   Ferri E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155236
   Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
   Fischer J.C., 1986, EUR J PEDIATR
   Han DS, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.630009
   Hida T, 2013, GERIATR GERONTOL INT, V13, P413, DOI 10.1111/j.1447-0594.2012.00918.x
   Hipkiss AR, 2010, ADV CLIN CHEM, V50, P123, DOI 10.1016/S0065-2423(10)50007-6
   Huo YR, 2015, J NUTR HEALTH AGING, V19, P474, DOI 10.1007/s12603-014-0543-z
   Janssen I, 2000, J APPL PHYSIOL, V89, P81
   Kemmler W, 2016, OSTEOPOROSIS INT, V27, P3261, DOI 10.1007/s00198-016-3662-z
   Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378
   Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007
   Lee CM, 1997, FREE RADICAL BIO MED, V22, P1259, DOI 10.1016/S0891-5849(96)00546-1
   LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marchioro L, 2020, CLIN NUTR, V39, P2129, DOI 10.1016/j.clnu.2019.08.030
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Migliavacca E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13694-1
   Montenegro KR, 2019, NUTR RES REV, V32, P192, DOI 10.1017/S0954422419000064
   Oliveira A, 2015, CLIN RHEUMATOL, V34, P1673, DOI 10.1007/s10067-015-2943-9
   Rezus E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020592
   Rineau E, 2018, INT J CARDIOL, V266, P206, DOI 10.1016/j.ijcard.2018.02.021
   Romanello V, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010091
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Sergi G, 2015, CLIN NUTR, V34, P667, DOI 10.1016/j.clnu.2014.07.010
   Shah VO, 2009, GENET MED, V11, P147, DOI 10.1097/GIM.0b013e31819307a2
   Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578
   Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09
   Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956
   Stangl MK, 2019, EXP CLIN ENDOCR DIAB, V127, P8, DOI 10.1055/a-0672-1007
   Tanganelli F, 2021, EXP GERONTOL, V144, DOI 10.1016/j.exger.2020.111171
   Urrutia PJ, 2017, BBA-MOL BASIS DIS, V1863, P2202, DOI 10.1016/j.bbadis.2017.05.015
   von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2
   Wu W.T., 2021, J CLIN MED, V10
   Yeung SSY, 2019, J CACHEXIA SARCOPENI, V10, P485, DOI 10.1002/jcsm.12411
NR 43
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2405-8440
J9 HELIYON
JI Heliyon
PD OCT
PY 2022
VL 8
IS 10
DI 10.1016/j.heliyon.2022.e11143
EA OCT 2022
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA C3OL9
UT WOS:000961048700018
PM 36303924
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Vasta, V
   Merritt, JL
   Saneto, RP
   Hahn, SH
AF Vasta, Valeria
   Merritt, J. Lawrence, II
   Saneto, Russell P.
   Hahn, Si Houn
TI Next-generation sequencing for mitochondrial diseases: A wide diagnostic
   spectrum
SO PEDIATRICS INTERNATIONAL
LA English
DT Article
DE mitochondrial disorders; mitochondrial respiratory chain complex enzyme
   deficiency; next-generation sequencing
ID POLYMERASE-GAMMA; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY;
   DEHYDROGENASE-DEFICIENCY; MUTATION ANALYSIS; POLG1 MUTATIONS; POINT
   MUTATIONS; DNA; IDENTIFICATION; HETEROZYGOSITY; DISORDERS
AB Background: The current diagnostic approach for mitochondrial disorders requires invasive procedures such as muscle biopsy and multiple biochemical testing but the results are often inconclusive. Clinical sequencing tests are available only for a limited number of genes. Recently, massively parallel sequencing has become a powerful tool for testing genetically heterogeneous conditions such as mitochondrial disorders. Methods: Targeted next-generation sequencing was performed on 26 patients with known or suspected mitochondrial disorders using in-solution capture for the exons of 908 known and candidate nuclear genes and an Illumina genome analyzer. Results: None of the 18 patients with various abnormal respiratory chain complex (RCC) activities had molecular defects in either subunits or assembly factors of mitochondrial RCC enzymes except a reference control sample with known mutations in SURF1. Instead, several variants in known pathogenic genes including CPT2, POLG, PDSS1, UBE3A, SDHD, and a few potentially pathogenic variants in candidate genes such as MTO1 or SCL7A13 were identified. Conclusions: Sequencing only nuclear genes for RCC subunits and assembly factors may not provide the diagnostic answers for suspected patients with mitochondrial disorders. The present findings indicate that the diagnostic spectrum of mitochondrial disorders is much broader than previously thought, which could potentially lead to misdiagnosis and/or inappropriate treatment. Overall analytic sensitivity and precision appear acceptable for clinical testing. Despite the limitations in finding mutations in all patients, the present findings underscore the considerable clinical benefits of targeted next-generation sequencing and serve as a prototype for extending the clinical evaluation in this clinically heterogeneous patient group.
C1 [Vasta, Valeria; Hahn, Si Houn] Univ Washington, Sch Med, Seattle Childrens Hosp, Seattle Childrens Hosp Res Inst, Seattle, WA 98101 USA.
   [Merritt, J. Lawrence, II; Hahn, Si Houn] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Pediat,Div Genet Med, Seattle, WA 98101 USA.
   [Saneto, Russell P.] Univ Washington, Sch Med, Seattle Childrens Hosp, Dept Neurol,Div Pediat Neurol, Seattle, WA 98101 USA.
C3 Seattle Children's Hospital; University of Washington; University of
   Washington Seattle; University of Washington; University of Washington
   Seattle; Seattle Children's Hospital; Seattle Children's Hospital;
   University of Washington; University of Washington Seattle
RP Hahn, SH (corresponding author), Univ Washington, Sch Med, Seattle Childrens Res Inst, Dept Pediat, C9S,1900 9th Ave, Seattle, WA 98101 USA.
EM sihahn@uw.edu
OI Vasta, Valeria/0000-0002-8148-1795; Merritt, II, John
   Lawrence/0000-0002-2552-7306
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110
   Amstutz U, 2011, CLIN CHEM, V57, P102, DOI 10.1373/clinchem.2010.150706
   Ashley N, 2008, HUM MOL GENET, V17, P2496, DOI 10.1093/hmg/ddn150
   Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756
   Bennett RR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-66
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Biery BJ, 1996, AM J HUM GENET, V59, P1006
   Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109
   Blish KR, 2005, MED HYPOTHESES, V64, P96, DOI 10.1016/j.mehy.2004.06.005
   Braathen GJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-48
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chen XL, 2011, GENET MED, V13, P794, DOI 10.1097/GIM.0b013e31821afca5
   Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945
   Coughlin EM, 1998, MOL GENET METAB, V63, P254, DOI 10.1006/mgme.1998.2684
   Cruz DN, 2001, KIDNEY INT, V59, P710, DOI 10.1046/j.1523-1755.2001.059002710.x
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Dursun A, 2002, J INHERIT METAB DIS, V25, P89, DOI 10.1023/A:1015668425004
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Engelfried K, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-53
   Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07
   Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gobin S, 2003, J BIOL CHEM, V278, P50428, DOI 10.1074/jbc.M310130200
   Hsiao P, 2007, J HEPATOL, V47, P303, DOI 10.1016/j.jhep.2007.04.014
   IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7
   Kay DM, 2007, ANN NEUROL, V61, P47, DOI 10.1002/ana.21039
   Kocaefe YÇ, 2003, EUR J HUM GENET, V11, P102, DOI 10.1038/sj.ejhg.5200908
   Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011
   Loudianos G, 1999, J MED GENET, V36, P833
   MATSUDA J, 1995, J INHERIT METAB DIS, V18, P534, DOI 10.1007/BF02435998
   McCorquodale DS, 2011, J NEUROL, V258, P1234, DOI 10.1007/s00415-011-5910-7
   McKinney JT, 2004, MOL GENET METAB, V82, P112, DOI 10.1016/j.ymgme.2004.04.004
   Meder B, 2011, CIRC-CARDIOVASC GENE, V4, P110, DOI 10.1161/CIRCGENETICS.110.958322
   Molinari F, 2010, J BIOENERG BIOMEMBR, V42, P467, DOI 10.1007/s10863-010-9323-6
   Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926
   Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   Ni Y, 2008, AM J HUM GENET, V83, P261, DOI 10.1016/j.ajhg.2008.07.011
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nouws J, 2012, BRAIN, V135, P12, DOI 10.1093/brain/awr261
   Oberkanins C, 2000, GENET TEST, V4, P121, DOI 10.1089/10906570050114812
   Oglesbee D, 2007, GENET MED, V9, P108, DOI 10.1097/GIM.0b013e31802f78d6
   Oglesbee D, 2006, PEDIATR NEUROL, V35, P289, DOI 10.1016/j.pediatrneurol.2006.05.007
   Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255
   Perren A, 2002, ONCOGENE, V21, P7605, DOI 10.1038/sj.onc.1205812
   PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341
   Quinzii CM, 2008, BIOFACTORS, V32, P113, DOI 10.1002/biof.5520320113
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Scharfe C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000374
   Schimmenti LA, 2007, MOL GENET METAB, V90, P441, DOI 10.1016/j.ymgme.2006.10.003
   Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507
   Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0
   Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Su HL, 2011, NEUROSCI LETT, V487, P129, DOI 10.1016/j.neulet.2009.06.079
   Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Traverso M, 2008, LAB INVEST, V88, P275, DOI 10.1038/labinvest.3700713
   Tsurusaki Y, 2011, J MED GENET, V48, P606, DOI 10.1136/jmg.2010.083535
   Tucker EJ, 2012, HUM MUTAT, V33, P411, DOI 10.1002/humu.21654
   Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100
   Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268
   Vladutiu GD, 1999, MUSCLE NERVE, V22, P949, DOI 10.1002/(SICI)1097-4598(199907)22:7<949::AID-MUS23>3.3.CO;2-9
   Vladutiu GD, 2000, MOL GENET METAB, V70, P134, DOI 10.1006/mgme.2000.3009
   Wang WY, 2011, NUCLEIC ACIDS RES, V39, P44, DOI 10.1093/nar/gkq750
   Wang XJ, 2009, MITOCHONDRION, V9, P180, DOI 10.1016/j.mito.2009.01.010
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 70
TC 56
Z9 64
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1328-8067
EI 1442-200X
J9 PEDIATR INT
JI Pediatr. Int.
PD OCT
PY 2012
VL 54
IS 5
BP 585
EP 601
DI 10.1111/j.1442-200X.2012.03644.x
PG 17
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA 012KI
UT WOS:000309234600001
PM 22494076
DA 2024-11-01
ER

PT J
AU Van Bergen, NJ
   Blake, RE
   Crowston, JG
   Trounce, IA
AF Van Bergen, Nicole J.
   Blake, Rachel E.
   Crowston, Jonathan G.
   Trounce, Ian A.
TI Oxidative phosphorylation measurement in cell lines and tissues
SO MITOCHONDRION
LA English
DT Article
DE Mitochondria; Oxidative phosphorylation; Enzymology; Respiration;
   Protocol; ATP synthesis
ID HIGH-RESOLUTION RESPIROMETRY; MITOCHONDRIAL-DNA MUTATIONS; LYMPHOBLAST
   MITOCHONDRIA; ATP SYNTHESIS; RAT-BRAIN; COMPLEX-I; MUSCLE; RESPIRATION;
   METABOLISM; DEFECTS
AB Mitochondrial oxidative phosphorylation (OXPHOS) dysfunction is implicated in a growing spectrum of diseases, from neurodegeneration to cancer. Where tissues or transformed cells are available, respirometry and enzymology allow a sophisticated analysis of OXPHOS with modest-cost equipment. The isolation of organelle fractions is also invaluable for determining association of proteins of interest. Here we revisit and consolidate methods to measure whole cell mitochondrial ATP synthesis, respiration, isolation of mitochondria from cultured cells and tissues, and OXPHOS enzymology. We also explain common pitfalls, guide optimisation of the methods for new users, and provide full laboratory protocols in Supplementary materials. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Ctr Eye Res Australia, Melbourne, Vic 3002, Australia.
   [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic 3002, Australia.
   [Van Bergen, Nicole J.; Blake, Rachel E.; Crowston, Jonathan G.; Trounce, Ian A.] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia.
   [Trounce, Ian A.] St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
C3 Centre for Eye Research Australia; University of Melbourne; Royal
   Victorian Eye & Ear Hospital; St Vincent's Health; St Vincent's Hospital
   Melbourne; NSW Health; St Vincents Hospital Sydney
RP Trounce, IA (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.
EM i.trounce@unimelb.edu.au
RI Trounce, Ian/F-8338-2010
OI Trounce, Ian/0000-0002-1070-8892
FU Victorian Government
FX The Ophthalmic Research Institute of Australia, Glaucoma Australia,
   University of Melbourne Early Career Fellowship, Henry Greenfield
   Research Fund, and Edols Trust Fund. CERA receives Operational
   Infrastructure Support from the Victorian Government.
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36
   Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480
   Anderson MF, 2000, BRAIN RES PROTOC, V5, P95, DOI 10.1016/S1385-299X(99)00060-4
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bonora E, 2006, CANCER RES, V66, P6087, DOI 10.1158/0008-5472.CAN-06-0171
   Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200
   Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018
   Chretien D., 1998, BIOCHEM J, P329
   CLARK JB, 1970, J BIOL CHEM, V245, P4724
   ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z
   Graham J.M., 1999, CURRENT PROTOCOLS CE, V33
   Holtzman E., 1989, Lysosomes
   Hussain T, 2012, INDIAN J MED RES, V135, P820
   Hütter E, 2006, EXP GERONTOL, V41, P103, DOI 10.1016/j.exger.2005.09.011
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   KANG CH, 1977, J BIOL CHEM, V252, P919
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Lai J C, 1979, Methods Enzymol, V55, P51
   Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596
   Manfredi G, 2002, METHODS, V26, P317, DOI 10.1016/S1046-2023(02)00037-3
   Mayorov Vladimir I., 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-22
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   MOREADITH RW, 1984, ANAL BIOCHEM, V137, P360, DOI 10.1016/0003-2697(84)90098-8
   Pecinová A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Scatena R, 2012, ADV EXP MED BIOL, V942, P287, DOI 10.1007/978-94-007-2869-1_13
   Schoer JK, 2000, BIOCHEMISTRY-US, V39, P7662, DOI 10.1021/bi992686h
   SHERRATT HSA, 1988, METHOD BIOCHEM ANAL, V33, P243
   SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x
   SPECK SH, 1984, P NATL ACAD SCI-BIOL, V81, P347, DOI 10.1073/pnas.81.2.347
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stadlmann S, 2002, TRANSPLANTATION, V74, P1800, DOI 10.1097/01.TP.0000039262.25355.67
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
   TAYLOR RW, 1993, BIOCHIM BIOPHYS ACTA, V1181, P261, DOI 10.1016/0925-4439(93)90030-5
   Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Van Bergen NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021347
   VANDENBOGERT C, 1992, J CELL PHYSIOL, V152, P632, DOI 10.1002/jcp.1041520323
   WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010
   Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5
   ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N
NR 51
TC 25
Z9 25
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD MAR
PY 2014
VL 15
BP 24
EP 33
DI 10.1016/j.mito.2014.03.003
PG 10
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA AH3FR
UT WOS:000336009600004
PM 24657935
DA 2024-11-01
ER

PT J
AU Sarzi, E
   Angebault, C
   Seveno, M
   Gueguen, N
   Chaix, B
   Bielicki, G
   Boddaert, N
   Mausset-Bonnefont, AL
   Cazevieille, C
   Rigau, V
   Renou, JP
   Wang, J
   Delettre, C
   Brabet, P
   Puel, JL
   Hamel, CP
   Reynier, P
   Lenaers, G
AF Sarzi, Emmanuelle
   Angebault, Claire
   Seveno, Marie
   Gueguen, Naig
   Chaix, Benjamin
   Bielicki, Guy
   Boddaert, Nathalie
   Mausset-Bonnefont, Anne-Laure
   Cazevieille, Chantal
   Rigau, Valerie
   Renou, Jean-Pierre
   Wang, Jing
   Delettre, Cecile
   Brabet, Philippe
   Puel, Jean-Luc
   Hamel, Christian P.
   Reynier, Pascal
   Lenaers, Guy
TI The human <i>OPA1<SUP>delTTAG</SUP></i> mutation induces premature
   age-related systemic neurodegeneration in mouse
SO BRAIN
LA English
DT Article
DE dominant optic atrophy; neurodegeneration; mitochondria; respiratory
   chain complexes; mouse model
ID DOMINANT OPTIC ATROPHY; MITOCHONDRIAL-DNA INSTABILITY; OPA1 MUTATIONS;
   ALZHEIMERS-DISEASE; IN-VITRO; CARDIOLIPIN; MODEL; DEFICIENCY; FUSION;
   DEFECTS
AB Dominant optic atrophy is a rare inherited optic nerve degeneration caused by mutations in the mitochondrial fusion gene OPA1. Recently, the clinical spectrum of dominant optic atrophy has been extended to frequent syndromic forms, exhibiting various degrees of neurological and muscle impairments frequently found in mitochondrial diseases. Although characterized by a specific loss of retinal ganglion cells, the pathophysiology of dominant optic atrophy is still poorly understood. We generated an Opa1 mouse model carrying the recurrent Opa1(delTTAG) mutation, which is found in 30% of all patients with dominant optic atrophy. We show that this mouse displays a multi-systemic poly-degenerative phenotype, with a presentation associating signs of visual failure, deafness, encephalomyopathy, peripheral neuropathy, ataxia and cardiomyopathy. Moreover, we found premature age-related axonal and myelin degenerations, increased autophagy and mitophagy and mitochondrial supercomplex instability preceding degeneration and cell death. Thus, these results support the concept that Opa1 protects against neuronal degeneration and opens new perspectives for the exploration and the treatment of mitochondrial diseases.
C1 [Sarzi, Emmanuelle; Seveno, Marie; Chaix, Benjamin; Wang, Jing; Delettre, Cecile; Brabet, Philippe; Puel, Jean-Luc; Hamel, Christian P.; Lenaers, Guy] Univ Montpellier I & II, Inst Neurosci Montpellier, INSERM, U1051, F-34091 Montpellier 5, France.
   [Angebault, Claire; Gueguen, Naig; Reynier, Pascal] CHU Angers, Dept Biochim & Genet, CNRS, UMR 6214,INSERM,U1083, F-49000 Angers, France.
   [Bielicki, Guy; Renou, Jean-Pierre] INRA, UR370, F-63122 St Genes Champanelle, France.
   [Boddaert, Nathalie] Hop Necker Enfants Malad, Serv Radiol Pediat, F-75743 Paris, France.
   [Mausset-Bonnefont, Anne-Laure] Univ Montpellier I & II, Inst Neurosci Montpellier, INSERM, U844, F-34091 Montpellier, France.
   [Cazevieille, Chantal] Univ Montpellier I, Ctr Ressources Imagerie Cellulaire, F-34093 Montpellier, France.
   [Rigau, Valerie] CHU Guy de Chauliac, Serv Anat & Cytol Pathol, F-34295 Montpellier, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Montpellier; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier
   Universitaire d'Angers; Centre National de la Recherche Scientifique
   (CNRS); INRAE; Assistance Publique Hopitaux Paris (APHP); Universite
   Paris Cite; Hopital Universitaire Necker-Enfants Malades - APHP;
   Universite de Montpellier; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite de Montpellier; Universite de
   Montpellier; CHU de Montpellier
RP Lenaers, G (corresponding author), Univ Montpellier I & II, CHU St Eloi, Inst Neurosci Montpellier, INSERM,U1051, 80 Rue Auguste Fliche, F-34091 Montpellier 5, France.
EM guy.lenaers@inserm.fr
RI Delettre, Cécile/HPH-2003-2023; Bonnefont, Anne-Laure/AAB-5022-2020;
   Reynier, Pascal/K-3677-2015; boddaert, nathalie/GWV-2865-2022; Lenaers,
   guy/X-4727-2019; Brabet, Philippe/AAO-8522-2020; lenaers,
   guy/K-2421-2015
OI lenaers, guy/0000-0003-2736-3349; boddaert,
   nathalie/0000-0003-0991-7774; Puel, jean-luc/0000-0002-3772-5190;
   Delettre, Cecile/0000-0003-3269-2155; Reynier,
   Pascal/0000-0003-0802-4608; Sarzi, Emmanuelle/0000-0002-7623-6699;
   Bonnefont, Anne-Laure/0000-0003-4119-1475
FU Association Francaise contre les Myopathies; Retina France; Union
   Nationale des Aveugles et Deficients Visuels; Ouvrir Les Yeux; European
   E-RARE program ERMION
FX Authors wish to acknowledge the support from the Association Francaise
   contre les Myopathies, Retina France, Union Nationale des Aveugles et
   Deficients Visuels, Ouvrir Les Yeux and from an European E-RARE program
   ERMION.
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Acin-Pérez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021
   Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x
   Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005
   Alavi MV, 2009, EXP NEUROL, V220, P404, DOI 10.1016/j.expneurol.2009.09.026
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, CLIN GENET, V67, P102, DOI 10.1111/j.1399-0004.2004.00358.x
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Baker MR, 2011, NEUROLOGY, V77, P1309, DOI 10.1212/WNL.0b013e318230a15a
   Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   Boddaert N, 2008, MOL GENET METAB, V93, P85, DOI 10.1016/j.ymgme.2007.09.003
   Bürklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936
   Chekroud K, 2011, OPHTHALMIC RES, V45, P174, DOI 10.1159/000321118
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9
   Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001
   d'Ydewalle C, 2011, NAT MED, V17, P968, DOI 10.1038/nm.2396
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Dorn GW, 2011, CIRC RES, V108, P12, DOI 10.1161/CIRCRESAHA.110.236745
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Ferdinandusse S, 2008, P NATL ACAD SCI USA, V105, P17712, DOI 10.1073/pnas.0806066105
   Forster DM, 2012, NMR BIOMED, V25, P52, DOI 10.1002/nbm.1712
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200
   Gómez LA, 2009, ARCH BIOCHEM BIOPHYS, V490, P30, DOI 10.1016/j.abb.2009.08.002
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Hoffmann MH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2950
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117
   ROBINSON DW, 1979, AUDIOLOGY, V18, P320
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002
   Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478
   Vancová O, 2010, J CELL MOL MED, V14, P2667, DOI 10.1111/j.1582-4934.2009.00879.x
   Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2
   White KE, 2009, INVEST OPHTH VIS SCI, V50, P2567, DOI 10.1167/iovs.08-2913
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2011, BRAIN, V134, DOI 10.1093/brain/awq288
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 55
TC 81
Z9 87
U1 0
U2 31
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD DEC
PY 2012
VL 135
BP 3599
EP 3613
DI 10.1093/brain/aws303
PN 12
PG 15
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 058SU
UT WOS:000312655100013
PM 23250881
DA 2024-11-01
ER

PT J
AU Ishimoto, Y
   Inagi, R
   Yoshihara, D
   Kugita, M
   Nagao, S
   Shimizu, A
   Takeda, N
   Wake, M
   Honda, K
   Zhou, J
   Nangaku, M
AF Ishimoto, Yu
   Inagi, Reiko
   Yoshihara, Daisuke
   Kugita, Masanori
   Nagao, Shizuko
   Shimizu, Akira
   Takeda, Norihiko
   Wake, Masaki
   Honda, Kenjiro
   Zhou, Jing
   Nangaku, Masaomi
TI Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal
   Dominant Polycystic Kidney Disease
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
DE mitochondrial metabolism; polycystic kidney disease
ID SIGNAL-REGULATED KINASE; DNA COPY NUMBER; OXIDATIVE STRESS;
   PROTEIN-PHOSPHORYLATION; EPITHELIAL-CELLS; MOLECULAR-BASIS; BIOGENESIS;
   METABOLISM; SKELETAL; MUSCLE
AB Autosomal dominant polycystic kidney disease (ADPKD) constitutes the most inherited kidney disease. Mutations in the PKD1 and PKD2 genes, encoding the polycystin 1 and polycystin 2 Ca2+ ion channels, respectively, result in tubular epithelial cell-derived renal cysts. Recent clinical studies demonstrate oxidative stress to be present early in ADPKD. Mitochondria comprise the primary reactive oxygen species source and also their main effector target; however, the pathophysiological role of mitochondria in ADPKD remains uncharacterized. To clarify this function, we examined the mitochondria of cyst-lining cells in ADPKD model mice (Ksp-Cre PKD1(flox/flox)) and rats (Han: SPRD Cy/+), demonstrating obvious tubular cell morphological abnormalities. Notably, the mitochondrial DNA copy number and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) expression were decreased in ADPKD model animal kidneys, with PGC-1 alpha expression inversely correlated with oxidative stress levels. Consistent with these findings, human ADPKD cyst-derived cells with heterozygous and homozygous PKD1 mutation exhibited morphological and functional abnormalities, including increased mitochondrial superoxide. Furthermore, PGC-1 alpha expression was suppressed by decreased intracellular Ca2+ levels via calcineurin, p38 mitogen-activated protein kinase (MAPK), and nitric oxide synthase deactivation. Moreover, the mitochondrion-specific antioxidant MitoQuinone (MitoQ) reduced intracellular superoxide and inhibited cyst epithelial cell proliferation through extracellular signal-related kinase/MAPK inactivation. Collectively, these results indicate that mitochondrial abnormalities facilitate cyst formation in ADPKD.
C1 [Ishimoto, Yu; Inagi, Reiko; Honda, Kenjiro; Nangaku, Masaomi] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan.
   [Ishimoto, Yu; Inagi, Reiko] Univ Tokyo, Grad Sch Med, Div CKD Pathophysiol, Tokyo, Japan.
   [Yoshihara, Daisuke; Kugita, Masanori; Nagao, Shizuko] Fujita Hlth Univ, Educ & Res Ctr Anim Models Human Dis, Toyoake, Aichi, Japan.
   [Shimizu, Akira] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo, Japan.
   [Takeda, Norihiko; Wake, Masaki] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.
   [Zhou, Jing] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Ctr Polycyst Kidney Dis,Res & Renal Div, Boston, MA USA.
C3 University of Tokyo; University of Tokyo; Fujita Health University;
   Nippon Medical School; University of Tokyo; Harvard University; Harvard
   Medical School; Brigham & Women's Hospital
RP Inagi, R; Nangaku, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan.; Inagi, R (corresponding author), Univ Tokyo, Grad Sch Med, Div CKD Pathophysiol, Tokyo, Japan.
EM inagi-npr@umin.ac.jp; mnangaku-tky@umin.ac.jp
OI Ishimoto, Yu/0000-0001-5773-8637; Nagao, Shizuko/0000-0003-2014-9411
FU Japan Society for the Promotion of Science [25461207, 15KT0088,
   16K15465, 24390213, 16K15464]; Japanese Association of Dialysis
   Physicians (JADP) [2012-05]; Kyowa Hakko Kirin Co. Ltd.; U.S. National
   Institutes of Health [RO1DK099532, R37DK51050]; U.S. Department of
   Defense [PR152162]; Grants-in-Aid for Scientific Research [26111003,
   16K15464, 15K09247, 15KT0088, 16K15465] Funding Source: KAKEN
FX This work was supported by funding from Grants-in-Aid for Scientific
   Research (25461207, 15KT0088, and 16K15465 [to R.I.] and 24390213 and
   16K15464 [to M.N.]) from the Japan Society for the Promotion of Science,
   by the Japanese Association of Dialysis Physicians (JADP grant 2012-05
   to R.I.), by Kyowa Hakko Kirin Co. Ltd. (to R.I.), by the U.S. National
   Institutes of Health (RO1DK099532 and R37DK51050), and by the U.S.
   Department of Defense (PR152162 to J.Z.).
CR Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024
   Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   Ahrabi AK, 2010, NEPHROL DIAL TRANSPL, V25, P1067, DOI 10.1093/ndt/gfp611
   Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037
   BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75
   Baumann K, 2010, NAT REV MOL CELL BIO, V11, P392, DOI 10.1038/nrm2910
   Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147
   Burbulla LF, 2012, JOVE-J VIS EXP, DOI 10.3791/4228
   Calvet JP, 2015, POLYCYSTIC KIDNEY DISEASE, P169
   Chapman AB, 2015, KIDNEY INT, V88, P17, DOI 10.1038/ki.2015.59
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   Edwards JL, 2010, DIABETOLOGIA, V53, P160, DOI 10.1007/s00125-009-1553-y
   Hajarnis S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14395
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Harris PC, 2002, CURR OPIN NEPHROL HY, V11, P309, DOI 10.1097/00041552-200205000-00007
   Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3
   HEGG O, 1966, J PATHOL BACTERIOL, V91, P311, DOI 10.1002/path.1700910204
   Hood DA, 2009, APPL PHYSIOL NUTR ME, V34, P465, DOI 10.1139/H09-045
   KASPAREITRITTINGHAUSEN J, 1989, VET PATHOL, V26, P195, DOI 10.1177/030098588902600302
   Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200
   Klawitter J, 2014, AM J PHYSIOL-RENAL, V307, pF1198, DOI 10.1152/ajprenal.00327.2014
   Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200
   Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002
   Luciano RL, 2014, NEPHROL DIAL TRANSPL, V29, P247, DOI 10.1093/ndt/gft437
   Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027
   Menon V, 2011, CLIN J AM SOC NEPHRO, V6, P7, DOI 10.2215/CJN.04140510
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nagao S, 2003, KIDNEY INT, V63, P427, DOI 10.1046/j.1523-1755.2003.00755.x
   Nagao S, 2012, EXP ANIM TOKYO, V61, P477, DOI 10.1538/expanim.61.477
   Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com
   Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597
   Park JS, 2009, HUM MOL GENET, V18, P1578, DOI 10.1093/hmg/ddp069
   Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027
   Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6
   Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   Rossman TG, 1998, MUTAT RES-FUND MOL M, V402, P103, DOI 10.1016/S0027-5107(97)00287-X
   Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803
   Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929
   Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039
   Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17
   Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511
   Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184
   Wang CH, 2013, EXP BIOL MED, V238, P450, DOI 10.1177/1535370213493069
   Wang W, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7410
   Weber KH, 2008, AM J PHYSIOL-RENAL, V294, pF1279, DOI 10.1152/ajprenal.00348.2007
   Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107
   Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x
   Yu TM, 2016, LANCET ONCOL, V17, P1419, DOI 10.1016/S1470-2045(16)30250-9
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
NR 62
TC 101
Z9 110
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD DEC
PY 2017
VL 37
IS 24
AR e00337-17
DI 10.1128/MCB.00337-17
PG 23
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA FN9SU
UT WOS:000416383100004
PM 28993480
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Fu, XL
   Zhou, XX
   Shi, Z
   Zheng, WC
AF Fu, Xiao-Li
   Zhou, Xiang-Xue
   Shi, Zhu
   Zheng, Wei-Cheng
TI Adult-onset mitochondrial encephalopathy in association with the
   <i>MT-ND3</i> T10158C mutation exhibits unique characteristics: A case
   report
SO WORLD JOURNAL OF CLINICAL CASES
LA English
DT Article
DE Mitochondrial disease; Stroke-like episode; Magnetic resonance;
   diagnosis; Case report
AB BACKGROUND
   Mitochondrial diseases are a heterogenous group of multisystemic disorders caused by genetic mutations affecting mitochondrial oxidation function. Brain involvement is commonly found in most cases but rarely as the unique clinical manifestation. Since the knowledge of its clinical manifestation combined with genetic testing is important for preventing misdiagnosis and delay in treatment, we report here how we diagnosed and managed a very unusual case of mitochondrial encephalopathy.
   CASE SUMMARY
   We report a 52-year-old woman with recurrent stroke-like episodes carrying the m.10158T>C mutation in the MT-ND3 gene, which is also responsible for fatal infant-onset Leigh syndrome. Despite the common mutation, the present case featured a distinct clinical and neuroimaging manifestation from Leigh syndrome. This patient presented with sudden onset of right-sided hemiparesis and hemilateral sensory disturbance accompanied by a left temporal duster-like headache and later developed epilepsy during hospitalization, with no other sips suggestive of myopa thy, lactate acidosis, or other systemic symptoms. Brain magnetic resonance imaging revealed variable lesions involving multiple cortical and subcortical regions. Furthermore, a negative genetic test obtained from peripheral blood delayed the diagnosis of mitochondrial disease, which was eventually established through second-generation DNA sequencing using biopsied muscle.
   CONCLUSION
   Based on this report, we suggest that clinicians pursue proper genetic testing for patients when the clinical phenotype is suggestive of mitochondrial diseases.
C1 [Fu, Xiao-Li; Shi, Zhu; Zheng, Wei-Cheng] Dongguan Peoples Hosp, Dept Neurol, 2 Wandaolu South Ave, Dongguan 523059, Guangdong, Peoples R China.
   [Zhou, Xiang-Xue] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China.
C3 Sun Yat Sen University
RP Shi, Z (corresponding author), Dongguan Peoples Hosp, Dept Neurol, 2 Wandaolu South Ave, Dongguan 523059, Guangdong, Peoples R China.
EM sound_shi@126.com
RI shi, zhu/D-9576-2015
FU Socioeconomic Development Project of Dongguan Science and Technology
   Bureau [2016108101002]
FX Supported by the Socioeconomic Development Project of Dongguan Science
   and Technology Bureau, No. 2016108101002.
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   El-Mewafy ZMH, 2018, POL J RADIOL, V83, pE215, DOI 10.5114/pjr.2018.76024
   Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Mezuki S, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-1001-4
   Mukai M, 2017, INTERNAL MED, V56, P95, DOI 10.2169/internalmedicine.56.7301
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 8
TC 5
Z9 5
U1 0
U2 5
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 2307-8960
J9 WORLD J CLIN CASES
JI World J. Clin. Cases
PD MAY 6
PY 2019
VL 7
IS 9
BP 1066
EP 1072
DI 10.12998/wjcc.v7.i9.1066
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA HW9FA
UT WOS:000466994900008
PM 31123680
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Crofts, AR
AF Crofts, AR
TI The cytochrome bc<sub>1</sub> complex:: Function in the context of
   structure
SO ANNUAL REVIEW OF PHYSIOLOGY
LA English
DT Review
DE antimycin; stigmatellin; myxothiazol; superoxide; mechanism
ID IRON-SULFUR PROTEIN; MITOCHONDRIAL ELECTRON-TRANSPORT; UBIQUINONE
   BINDING-CAPACITY; FORMING HYDROGEN-BONDS; SCALE DOMAIN MOVEMENT; FE-S
   PROTEIN; RHODOBACTER-SPHAEROIDES; Q(O) SITE; QUINOL OXIDATION; BOVINE
   HEART
AB The bc(1) complexes are intrinsic membrane proteins that catalyze the oxidation of ubihydroquinone and the reduction of cytochrome c in mitochondrial respiratory chains and bacterial photosynthetic and respiratory chains. The bc(1) complex operates through a Q-cycle mechanism that couples electron transfer to generation of the proton gradient that drives ATP synthesis.
   Genetic defects leading to mutations in proteins of the respiratory chain, including the subunits of the bc(1) complex, result in mitochondrial myopathies, many of which are a direct result of dysfunction at catalytic sites. Some myopathies, especially those in the cytochrome b subunit, exacerbate free-radical damage by enhancing superoxide production at the ubihydroquinone oxidation site. This bypass reaction appears to be an unavoidable feature of the reaction mechanism. Cellular aging is largely attributable to damage to DNA and proteins from the reactive oxygen species arising from superoxide and is a major contributing factor in many diseases of old age. An understanding of the mechanism of the bc(1) complex is therefore central to our understanding of the aging process. In addition, a wide range of inhibitors that mimic the quinone substrates are finding important applications in clinical therapy and agronomy. Recent structural studies have shown how many of these inhibitors bind, and have provided important clues to the mechanism of action and the basis of resistance through mutation.
   This paper reviews recent advances in our understanding of the mechanism of the bc(1) complex and their relation to these physiologically important issues in the context of the structural information available.
C1 Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
EM a-crofts@life.uiuc.edu
FU FIC NIH HHS [1 R03 TW01495] Funding Source: Medline; NIGMS NIH HHS [GM
   62954, GM 35438] Funding Source: Medline
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDREWS KM, 1984, PURIFICATION CHARACT
   Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520
   Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200
   BEAUTEMENT K, 1991, PESTIC SCI, V31, P499, DOI 10.1002/ps.2780310406
   BECHMANN G, 1992, EUR J BIOCHEM, V208, P315, DOI 10.1111/j.1432-1033.1992.tb17189.x
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Berry EA, 1999, BIOCHEM SOC T, V27, P565, DOI 10.1042/bst0270565
   Berry EA, 1999, J BIOENERG BIOMEMBR, V31, P177, DOI 10.1023/A:1005459426843
   Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   BOWYER JR, 1980, BIOCHIM BIOPHYS ACTA, V592, P445, DOI 10.1016/0005-2728(80)90091-2
   BOWYER JR, 1982, J BIOL CHEM, V257, P8321
   BRANDT U, 1988, EUR J BIOCHEM, V173, P499, DOI 10.1111/j.1432-1033.1988.tb14026.x
   Brandt U, 1998, BBA-BIOENERGETICS, V1365, P261, DOI 10.1016/S0005-2728(98)00078-4
   BRANDT U, 1991, J BIOL CHEM, V266, P19958
   Brandt U, 1997, BIOCHEMISTRY-US, V36, P11234, DOI 10.1021/bi970968g
   Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   CLOUGH JM, 1995, CHEM BRIT, V31, P466
   Colbert CL, 2000, STRUCTURE, V8, P1267, DOI 10.1016/S0969-2126(00)00536-0
   Covián R, 2002, J BIOL CHEM, V277, P48449, DOI 10.1074/jbc.M208060200
   Covián R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x
   Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477
   Crofts A.R., 1985, ENZYMES BIOCLOGICAL, V4, P347
   Crofts A.R., 1999, PHOTOTROPHIC PROKARY, P229
   Crofts AR, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P1481
   Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15827, DOI 10.1021/bi990963e
   Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m
   CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6
   Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15791, DOI 10.1021/bi990961u
   Crofts AR, 2003, J BIOL CHEM, V278, P36191, DOI 10.1074/jbc.M305461200
   Crofts AR, 2002, BBA-BIOENERGETICS, V1555, P48, DOI 10.1016/S0005-2728(02)00253-0
   Crofts AR, 1998, CURR OPIN STRUC BIOL, V8, P501, DOI 10.1016/S0959-440X(98)80129-2
   CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768
   CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2
   Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021
   Crofts AR, 2000, BBA-BIOENERGETICS, V1459, P456, DOI 10.1016/S0005-2728(00)00184-5
   Crofts AR, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL II, P493
   CROFTS AR, 2002, P C PHOT RES 12 BRIS
   CROFTS AR, 2003, IN PRESS BIOCH BIOPH
   CROFTS AR, 2003, IN PRESS PHOTOSYNTH
   Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337
   Darrouzet E, 2000, P NATL ACAD SCI USA, V97, P4567, DOI 10.1073/pnas.97.9.4567
   Darrouzet E, 2003, BIOCHEMISTRY-US, V42, P1499, DOI 10.1021/bi026656h
   Darrouzet E, 2002, J BIOL CHEM, V277, P3464, DOI 10.1074/jbc.M107973200
   Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7
   Davidson VL, 1996, BIOCHEMISTRY-US, V35, P14035, DOI 10.1021/bi961577p
   DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N
   DELAROSA FF, 1983, FEBS LETT, V163, P140, DOI 10.1016/0014-5793(83)81181-8
   Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085
   DEVAULT D, 1980, Q REV BIOPHYS, V13, P387, DOI 10.1017/S003358350000175X
   DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P316, DOI 10.1016/0005-2728(79)90049-5
   DEVRIES S, 1983, BIOCHIM BIOPHYS ACTA, V723, P91, DOI 10.1016/0005-2728(83)90013-0
   DEVRIES S, 1982, FUNCTION QUINONES EN, P235
   DEVRIES S, 1983, THESIS AMSTERDAM U T
   Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012
   DING HG, 1992, BIOCHEMISTRY-US, V31, P3144, DOI 10.1021/bi00127a015
   Dutton P L, 1978, Methods Enzymol, V54, P411
   DUTTON PL, 1972, EUR J BIOCHEM, V30, P495, DOI 10.1111/j.1432-1033.1972.tb02121.x
   Engstrom G, 2002, J BIOL CHEM, V277, P31072, DOI 10.1074/jbc.M202594200
   Fisher N, 2001, EUR J BIOCHEM, V268, P1155, DOI 10.1046/j.1432-1327.2001.02010.x
   Fivelman Quinton L, 2002, Malar J, V1, P1
   Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814
   Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p
   Garland PB., 1975, Electron Transfer Chains and Oxidative Phosphorylation, P351
   GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5
   GLASER EG, 1984, FEBS LETT, V178, P336, DOI 10.1016/0014-5793(84)80629-8
   Graige MS, 1999, BIOCHEMISTRY-US, V38, P11465, DOI 10.1021/bi990708u
   GRAY KA, 1994, BIOCHEMISTRY-US, V33, P723, DOI 10.1021/bi00169a014
   Guergova-Kuras M, 2000, BIOCHEMISTRY-US, V39, P7436, DOI 10.1021/bi992491+
   HACKER B, 1994, BIOCHEMISTRY-US, V33, P13022, DOI 10.1021/bi00248a011
   HACKER B, 1993, BIOCHEMISTRY-US, V32, P4403, DOI 10.1021/bi00067a033
   HACKER B, 1994, THESIS U ILLINOIS UR
   Hansen KC, 2000, BBA-BIOENERGETICS, V1456, P121, DOI 10.1016/S0005-2728(99)00107-3
   Harman D, 1992, EXS, V62, P1
   Hoek TLV, 1997, J MOL CELL CARDIOL, V29, P2441
   Hong SJ, 1999, J BIOL CHEM, V274, P33931, DOI 10.1074/jbc.274.48.33931
   Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0
   Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0
   Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9
   Hunte C, 2001, FEBS LETT, V504, P126, DOI 10.1016/S0014-5793(01)02744-2
   IWATA M, 2001, THESIS UPPSALA U SWE
   Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64
   Izrailev S, 1999, BIOPHYS J, V77, P1753, DOI 10.1016/S0006-3495(99)77022-0
   Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2<105::AID-PS879>3.0.CO;2-D
   Jünemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603
   Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200
   Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026
   King T.E., 1975, Electron Transfer Chains and Oxidative Phosphorylation, P105
   Kolling DRJ, 2003, J BIOL CHEM, V278, P39747, DOI 10.1074/jbc.M305913200
   Kresge AJ, 1999, METHODS ENZYMOL, V308, P276
   Kristal BS, 1997, FREE RADICAL BIO MED, V22, P823, DOI 10.1016/S0891-5849(96)00428-5
   Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591
   Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699
   LINK TA, 1993, J BIOENERG BIOMEMBR, V25, P221, DOI 10.1007/BF00762584
   LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001
   Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2
   Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X
   MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X
   MATSUURA K, 1983, J BIOL CHEM, V258, P1571
   Meinhardt S W., 1984, Advances in Photosynthesis Research, V1, P649
   MEINHARDT SW, 1983, BIOCHIM BIOPHYS ACTA, V723, P219, DOI 10.1016/0005-2728(83)90121-4
   MEINHARDT SW, 1982, FEBS LETT, V149, P217, DOI 10.1016/0014-5793(82)81104-6
   MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6
   MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7
   MOSER CC, 1995, J BIOENERG BIOMEMBR, V27, P263, DOI 10.1007/BF02110096
   Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e
   Muller F, 2000, J AM AGING ASSOC, V23, P227, DOI 10.1007/s11357-000-0022-9
   Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160
   Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x
   Nitschke W., 1997, Photosynthesis: a Comprehensive Treatise, P285
   OHNISHI T, 1980, J BIOL CHEM, V255, P3278
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972
   Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   Pines E, 1997, CHEM PHYS LETT, V281, P413, DOI 10.1016/S0009-2614(97)01245-1
   Raha S, 2001, AM J MED GENET, V106, P62, DOI 10.1002/ajmg.1398
   RICH PR, 1990, BIOCHIM BIOPHYS ACTA, V1018, P29, DOI 10.1016/0005-2728(90)90106-E
   RICH PR, 1980, BIOCHIM BIOPHYS ACTA, V592, P506, DOI 10.1016/0005-2728(80)90095-X
   RICH PR, 1981, BIOCHIM BIOPHYS ACTA, V637, P28, DOI 10.1016/0005-2728(81)90206-1
   RICH PR, 1991, BIOCHIM BIOPHYS ACTA, V1058, P312, DOI 10.1016/S0005-2728(05)80252-X
   Roberts JA, 1997, INORG CHIM ACTA, V263, P395, DOI 10.1016/S0020-1693(97)05668-5
   ROBERTSON DE, 1984, J BIOL CHEM, V259, P1758
   Rose MR, 1998, ARCH NEUROL-CHICAGO, V55, P17, DOI 10.1001/archneur.55.1.17
   SALERNO JC, 1990, BIOCHEMISTRY-US, V29, P6987, DOI 10.1021/bi00482a006
   SALERNO JC, 1989, J BIOL CHEM, V264, P15398
   Samoilova RI, 2002, J BIOL CHEM, V277, P4605, DOI 10.1074/jbc.C100664200
   Sauter H., 1996, Crop Protection Agents from Nature, P50
   Schröter T, 1998, EUR J BIOCHEM, V255, P100, DOI 10.1046/j.1432-1327.1998.2550100.x
   Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23
   Sharp RE, 1999, BIOCHEMISTRY-US, V38, P3440, DOI 10.1021/bi982639+
   Sharp RE, 1999, BIOCHEMISTRY-US, V38, P14973, DOI 10.1021/bi9914863
   Shinkarev VP, 2002, BIOCHEMISTRY-US, V41, P14372, DOI 10.1021/bi026198c
   Shinkarev VP, 2001, BIOCHEMISTRY-US, V40, P12584, DOI 10.1021/bi011334j
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   Slater E.C., 1981, Chemiosmotic Proton Circuits in Biological Membranes, P69
   SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5
   Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8
   Snyder CH, 1999, J BIOL CHEM, V274, P31209, DOI 10.1074/jbc.274.44.31209
   Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535
   Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x
   Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409
   Tian H, 1999, J BIOL CHEM, V274, P7146, DOI 10.1074/jbc.274.11.7146
   Tian H, 2000, J BIOL CHEM, V275, P9587, DOI 10.1074/jbc.275.13.9587
   Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953
   Trumpower BL, 2002, BBA-BIOENERGETICS, V1555, P166, DOI 10.1016/S0005-2728(02)00273-6
   TSAI AL, 1985, BIOCHIM BIOPHYS ACTA, V806, P418, DOI 10.1016/0005-2728(85)90249-X
   TSAI AL, 1983, J BIOL CHEM, V258, P2122
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   Ugulava NB, 1998, FEBS LETT, V440, P409, DOI 10.1016/S0014-5793(98)01493-8
   Ullmann GM, 2002, J BIOL INORG CHEM, V7, P632, DOI 10.1007/s00775-002-0342-6
   VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7
   VANDOREN SR, 1993, BIOCHEMISTRY-US, V32, P8083, DOI 10.1021/bi00083a005
   Vogel H, 2001, J NEUROPATH EXP NEUR, V60, P217, DOI 10.1093/jnen/60.3.217
   VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253
   WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987
   Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60
   Xiao KH, 2003, J BIOL CHEM, V278, P11419, DOI 10.1074/jbc.M211620200
   Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200
   Yu CA, 1998, BBA-BIOENERGETICS, V1365, P151, DOI 10.1016/S0005-2728(98)00055-3
   Yu CA, 2002, BBA-BIOENERGETICS, V1555, P65, DOI 10.1016/S0005-2728(02)00256-6
   Yu CA, 1996, BBA-BIOENERGETICS, V1275, P47, DOI 10.1016/0005-2728(96)00049-7
   YUN CH, 1991, BIOCHEMISTRY-US, V30, P6747, DOI 10.1021/bi00241a017
   Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100
   Zhang L, 2000, J BIOL CHEM, V275, P7656, DOI 10.1074/jbc.275.11.7656
   Zhang Z, 2000, Subcell Biochem, V35, P541
   Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612
   ZU Y, 2003, IN PRESS BIOCHEMISTR
   ZWECK A, 1989, EUR J BIOCHEM, V183, P199, DOI 10.1111/j.1432-1033.1989.tb14913.x
   [No title captured]
NR 172
TC 360
Z9 436
U1 4
U2 61
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-4278
EI 1545-1585
J9 ANNU REV PHYSIOL
JI Annu. Rev. Physiol.
PY 2004
VL 66
BP 689
EP 733
DI 10.1146/annurev.physiol.66.032102.150251
PG 49
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 812GK
UT WOS:000220827800027
PM 14977419
DA 2024-11-01
ER

PT J
AU Sparber, P
   Krylova, T
   Repina, S
   Demina, N
   Rudenskaya, G
   Sharkova, I
   Sharkov, A
   Kadyshev, V
   Kanivets, I
   Korostelev, S
   Pomerantseva, E
   Kaimonov, V
   Mikhailova, S
   Zakharova, E
   Skoblov, M
AF Sparber, Peter
   Krylova, Tatiana
   Repina, Svetlana
   Demina, Nina
   Rudenskaya, Galina
   Sharkova, Inna
   Sharkov, Artem
   Kadyshev, Vitaly
   Kanivets, Ilya
   Korostelev, Sergey
   Pomerantseva, Ekaterina
   Kaimonov, Vladimir
   Mikhailova, Svetlana
   Zakharova, Ekaterina
   Skoblov, Mikhail
TI Retrospective analysis of 17 patients with mitochondrial membrane
   protein-associated neurodegeneration diagnosed in Russia
SO PARKINSONISM & RELATED DISORDERS
LA English
DT Article
DE MPAN; NBIA; MRI; Pathogenic variants; Russian cohort
ID BRAIN IRON ACCUMULATION; VARIANTS; C19ORF12; MUTATIONS; SUBTYPE
AB Introduction: Mitochondrial membrane protein-associated neurodegeneration (MPAN) is a rare neurological syndrome caused by pathogenic variants in the C19orf12 and is characterized by iron deposition in the basal ganglia and substantia nigra. Only a limited number of cohort studies were published to date and the prevalence of MPAN remains uncertain.
   Methods: Recruited subjects with MPAN in Russia were diagnosed by whole-exome sequencing or Sanger sequencing of the C19orf12 gene. Data of over 14000 whole exome sequencing analyses was used to calculate the estimated disease frequency. RNA analysis was performed by RT-PCR. QSVanalyzer software was used to quantify the allelic disbalance.
   Results: We describe the clinical and molecular characterizations of 17 patients with MPAN. DNA analysis detected three previously undescribed pathogenic/likely pathogenic variants in the C19orf12 gene. The esti-mated disease frequency was calculated to be 1:619150. We describe unusual clinical observations in several cases. One patient showed severe neurogenic muscle weakness along with a lack of marked spasticity or optic nerve atrophy. In another mild clinical case with the NM_001031726.3:c.204_214del (p.(Gly69Argfs*10)) variant in a heterozygous state, a marked allelic disbalance was observed on the RNA level with reduced expression level of the wild-type allele. Thus, this case became the first one of a possible regulatory variant causing MPAN.
   Conclusion: We reported a detailed clinical and molecular characterization of the third-largest MPAN cohort. We expanded the mutational and clinical spectrum of MPAN. Moreover, we calculated the estimated MPAN fre-quency in the Russian population for the first time.
C1 [Sparber, Peter; Krylova, Tatiana; Repina, Svetlana; Demina, Nina; Rudenskaya, Galina; Sharkova, Inna; Kadyshev, Vitaly; Zakharova, Ekaterina; Skoblov, Mikhail] Res Ctr Med Genet, Moscow, Russia.
   [Sharkov, Artem; Kanivets, Ilya; Korostelev, Sergey] Genomed Ltd, Moscow, Russia.
   [Sharkov, Artem] Res & Clin Inst Pediat Pirogov RNRMU, Moscow, Russia.
   [Sharkov, Artem] RAS, Inst Gene Biol, Moscow, Russia.
   [Pomerantseva, Ekaterina; Kaimonov, Vladimir] Ctr Genet & Reprod Med Genet, Moscow, Russia.
   [Mikhailova, Svetlana] Russian Childrens Clin Hosp, Moscow, Russia.
C3 Research Centre for Medical Genetics; Russian Academy of Sciences;
   Institute of Gene Biology (IGB) of Russian Academy of Sciences
RP Sparber, P (corresponding author), Moscow Ctr Med Genet, Moskvorechie 1, Moscow 115522, Russia.
EM psparber93@gmail.com
RI Mikhailova, Svetlana/N-2399-2018; Inna, Sharkova/AAJ-9120-2021; Krylova,
   Tatiana/K-6396-2018; Skoblov, Mikhail/P-1387-2015; Sharkov,
   Artem/AAO-7543-2020; Sparber, Peter/HSG-0837-2023; Zakharova,
   Ekaterina/AAU-8702-2021
OI Pomerantseva, Ekaterina/0000-0002-2027-2738; Sparber,
   Peter/0000-0002-9160-0794; Sarkov, Artem/0000-0002-0980-2638
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Akçakaya NH, 2019, NEUROL NEUROCHIR POL, V53, P476, DOI 10.5603/PJNNS.a2019.0062
   Altuame FD, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01355-2
   Brezavar D, 2019, MOL GENET METAB, V128, P463, DOI 10.1016/j.ymgme.2019.09.002
   Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583
   Dastsooz H, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0439-y
   Deschauer M, 2012, J NEUROL, V259, P2434, DOI 10.1007/s00415-012-6521-7
   Di Meo I, 2018, EUR J PAEDIATR NEURO, V22, P272, DOI 10.1016/j.ejpn.2018.01.008
   Dogu O, 2013, CLIN GENET, V84, P350, DOI 10.1111/cge.12079
   Gowda VK, 2019, INDIAN J PEDIATR, V86, P746, DOI 10.1007/s12098-019-02903-w
   Gregory A, 2013, NEURODEGENERATION BR
   Gregory A, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.736
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hogarth P, 2015, J MOV DISORD, V8, P1, DOI 10.14802/jmd.14034
   Hogarth P, 2013, NEUROLOGY, V80, P268, DOI 10.1212/WNL.0b013e31827e07be
   Horvath R, 2012, MOVEMENT DISORD, V27, P789, DOI 10.1002/mds.24980
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Korvigo I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192829
   Monfrini E, 2018, PARKINSONISM RELAT D, V48, P109, DOI 10.1016/j.parkreldis.2017.12.025
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Olgiati S, 2017, PARKINSONISM RELAT D, V39, P64, DOI 10.1016/j.parkreldis.2017.03.012
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Skowronska M, 2017, PARKINSONISM RELAT D, V39, P71, DOI 10.1016/j.parkreldis.2017.03.013
   Sparber P, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01128-5
   Sparber P, 2018, NEUROGENETICS, V19, P257, DOI 10.1007/s10048-018-0558-4
   Tariq H, 2019, PARKINSONISM RELAT D, V65, P267, DOI 10.1016/j.parkreldis.2019.05.020
   Zakharova E Yu, 2014, Zh Nevrol Psikhiatr Im S S Korsakova, V114, P4
NR 27
TC 9
Z9 9
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8020
EI 1873-5126
J9 PARKINSONISM RELAT D
JI Parkinsonism Relat. Disord.
PD MAR
PY 2021
VL 84
BP 98
EP 104
DI 10.1016/j.parkreldis.2021.02.002
EA FEB 2021
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA RB3PM
UT WOS:000632026700017
PM 33607528
DA 2024-11-01
ER

PT J
AU Serrano, RJ
   Oorschot, V
   Palipana, D
   Calcinotto, V
   Sonntag, C
   Ramm, G
   Bryson-Richardson, RJ
AF Serrano, Rita J.
   Oorschot, Viola
   Palipana, Dashika
   Calcinotto, Vanessa
   Sonntag, Carmen
   Ramm, Georg
   Bryson-Richardson, Robert J.
TI Genetic model of UBA5 deficiency highlights the involvement of both
   peripheral and central nervous systems and identifies widespread
   mitochondrial abnormalities
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE UBA5; ufmylation; encephalopathy; mitochondria; zebrafish
ID BIALLELIC VARIANTS; ZEBRAFISH MODELS; UFM1; REVEAL
AB Variants in UBA5 have been reported to cause neurological disease with impaired motor function, developmental delay, intellectual disability and brain pathology as recurrent clinical manifestations. UBA5 encodes a ubiquitin-activating-like enzyme that activates ufmylation, a post-translational ubiquitin-like modification pathway, which has been implicated in neurodevelopment and neuronal survival. The reason behind the variation in severity and clinical manifestations in affected individuals and the signal transduction pathways regulated by ufmylation that compromise the nervous system remains unknown. Zebrafish have emerged as a powerful model to study neurodegenerative disease due to its amenability for in vivo analysis of muscle and neuronal tissues, high-throughput examination of motor function and rapid embryonic development allowing an examination of disease progression. Using clustered regularly interspaced short palindromic repeats-associated protein 9 genome editing, we developed and characterized zebrafish mutant models to investigate disease pathophysiology. uba5 mutant zebrafish showed a significantly impaired motor function accompanied by delayed growth and reduced lifespan, reproducing key phenotypes observed in affected individuals. Our study demonstrates the suitability of zebrafish to study the pathophysiology of UBA5-related disease and as a powerful tool to identify pathways that could reduce disease progression. Furthermore, uba5 mutants exhibited widespread mitochondrial damage in both the nervous system and the skeletal muscle, suggesting that a perturbation of mitochondrial function may contribute to disease pathology.
C1 [Oorschot, Viola] European Mol Biol Lab, Electron Microscopy Core Facil, D-69117 Heidelberg, Germany.
   [Serrano, Rita J.; Palipana, Dashika; Calcinotto, Vanessa; Sonntag, Carmen; Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, Melbourne 3800, Australia.
   [Oorschot, Viola; Ramm, Georg] Monash Univ, Monash Ramaciotti Ctr Cryoelectron Microscopy, Melbourne 3800, Australia.
   [Ramm, Georg] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne 3800, Australia.
   [Bryson-Richardson, Robert J.] Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Melbourne, Vic 3800, Australia.
C3 European Molecular Biology Laboratory (EMBL); Monash University; Monash
   University; Monash University; Monash University
RP Bryson-Richardson, RJ (corresponding author), Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Melbourne, Vic 3800, Australia.
EM robert.bryson-richardson@monash.edu
RI ; Bryson-Richardson, Robert/B-7556-2008
OI Calcinotto, Vanessa/0009-0002-9991-4824; Ramm,
   Georg/0000-0003-3596-2288; Bryson-Richardson,
   Robert/0000-0002-9501-8208; Sonntag, Carmen/0000-0003-2560-1710;
   Palipana, Dashika/0000-0002-4890-7467
FU Monash University through a Monash Graduate Scholarship (MGS); Monash
   International Postgraduate Research Scholarship (MIPRS); National Health
   and Medical Research Council [1080587]
FX This research was supported by Monash University through a Monash
   Graduate Scholarship (MGS) and Monash International Postgraduate
   Research Scholarship (MIPRS) to R.J.S. and supported by the National
   Health and Medical Research Council project grant 1080587 (investigator
   R.J.B.-R.).
CR Al-Saady ML, 2021, NEUROPEDIATRICS, V52, P489, DOI 10.1055/s-0041-1724130
   Arnadottir GA, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0466-8
   Briere LC., 2021, Cold Spring Harb Mol Case Stud, V7, pa005827
   Cabrera-Serrano M, 2020, J MED GENET, V57, P835, DOI 10.1136/jmedgenet-2019-106496
   Chitre M, 2018, J MED GENET, V55, P803, DOI 10.1136/jmedgenet-2018-105288
   Colin E, 2016, AM J HUM GENET, V99, P695, DOI 10.1016/j.ajhg.2016.06.030
   Daida A, 2018, EPILEPTIC DISORD, V20, P313, DOI 10.1684/epd.2018.0981
   Dark C, 2020, TRANSL PSYCHIAT, V10, DOI [10.1038/s41398-020-01077-w, 10.1038/s41398-020-01057-0]
   Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039
   Gannavaram S, 2012, MOL MICROBIOL, V86, P187, DOI 10.1111/j.1365-2958.2012.08183.x
   Gannavaram S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016156
   Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464
   Gupta T, 2018, METHODS, V150, P49, DOI 10.1016/j.ymeth.2018.06.008
   Hamilton EMC, 2017, NEUROLOGY, V89, P1821, DOI 10.1212/WNL.0000000000004578
   Homrich M, 2014, EXP CELL RES, V324, P192, DOI 10.1016/j.yexcr.2014.04.003
   Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205
   Lange M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070172
   Low KJ, 2019, EUR J MED GENET, V62, P97, DOI 10.1016/j.ejmg.2018.06.009
   Mignon-Ravix C, 2018, HUM MUTAT, V39, P934, DOI 10.1002/humu.23534
   Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410
   Muona M, 2016, AM J HUM GENET, V99, P683, DOI 10.1016/j.ajhg.2016.06.020
   Nahorski MS, 2018, BRAIN, V141, P1934, DOI 10.1093/brain/awy135
   Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898
   Quinn PMJ, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-01062-w
   Rangaraju V, 2019, J NEUROSCI, V39, P8200, DOI 10.1523/JNEUROSCI.1157-19.2019
   Ruparelia AA, 2012, HUM MOL GENET, V21, P4073, DOI 10.1093/hmg/dds231
   Soudah N, 2019, J MOL BIOL, V431, P463, DOI 10.1016/j.jmb.2018.10.007
   Sztal TE, 2016, JOVE-J VIS EXP, DOI 10.3791/54431
   Sztal TE, 2015, ACTA NEUROPATHOL, V130, P389, DOI 10.1007/s00401-015-1430-3
   Tatsumi K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1182
   Tumiene B, 2018, CLIN GENET, V93, P1057, DOI 10.1111/cge.13203
   Zheng M, 2008, J CELL BIOCHEM, V104, P2324, DOI 10.1002/jcb.21791
NR 32
TC 0
Z9 0
U1 1
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD NOV 1
PY 2023
VL 5
IS 6
AR fcad317
DI 10.1093/braincomms/fcad317
PG 13
WC Clinical Neurology; Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA CR2H5
UT WOS:001126899900004
PM 38046095
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Garcia-Diaz, B
   Barca, E
   Balreira, A
   Lopez, LC
   Tadesse, S
   Krishna, S
   Naini, A
   Mariotti, C
   Castellotti, B
   Quinzii, CM
AF Garcia-Diaz, Beatriz
   Barca, Emanuele
   Balreira, Andrea
   Lopez, Luis C.
   Tadesse, Saba
   Krishna, Sindhu
   Naini, Ali
   Mariotti, Caterina
   Castellotti, Barbara
   Quinzii, Catarina M.
TI Lack of aprataxin impairs mitochondrial functions via downregulation of
   the APE1/NRF1/NRF2 pathway
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID STRAND-BREAK REPAIR; OCULOMOTOR APRAXIA TYPE-1; COENZYME Q(10)
   DEFICIENCY; OCULAR MOTOR APRAXIA; EARLY-ONSET ATAXIA; CEREBELLAR-ATAXIA;
   OXIDATIVE STRESS; COQ(10) DEFICIENCY; PROTEIN APRATAXIN; MAMMALIAN-CELLS
AB Ataxia oculomotor apraxia type 1 (AOA1) is an autosomal recessive disease caused by mutations in APTX, which encodes the DNA strand-break repair protein aprataxin (APTX). CoQ10 deficiency has been identified in fibroblasts and muscle of AOA1 patients carrying the common W279X mutation, and aprataxin has been localized to mitochondria in neuroblastoma cells, where it enhances preservation of mitochondrial function. In this study, we show that aprataxin deficiency impairs mitochondrial function, independent of its role in mitochondrial DNA repair. The bioenergetics defect in AOA1-mutant fibroblasts and APTX-depleted Hela cells is caused by decreased expression of SDHA and genes encoding CoQ biosynthetic enzymes, in association with reductions of APE1, NRF1 and NRF2. The biochemical and molecular abnormalities in APTX-depleted cells are recapitulated by knockdown of APE1 in Hela cells and are rescued by overexpression of NRF1/2. Importantly, pharmacological upregulation of NRF1 alone by 5-aminoimidazone-4-carboxamide ribonucleotide does not rescue the phenotype, which, in contrast, is reversed by the upregulation of NRF2 by rosiglitazone. Accordingly, we propose that the lack of aprataxin causes reduction of the pathway APE1/NRF1/NRF2 and their target genes. Our findings demonstrate a critical role of APTX in transcription regulation of mitochondrial function and the pathogenesis of AOA1 via a novel pathomechanistic pathway, which may be relevant to other neurodegenerative diseases.
C1 [Garcia-Diaz, Beatriz; Barca, Emanuele; Balreira, Andrea; Lopez, Luis C.; Tadesse, Saba; Quinzii, Catarina M.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Krishna, Sindhu; Naini, Ali] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.
   [Barca, Emanuele] Univ Messina, Dept Neurosci, UOC Neurol & Neuromuscular Disorders, I-98100 Messina, Italy.
   [Lopez, Luis C.] Univ Granada, Hlth Sci Technol Pk PTS, Biomed Res Ctr CIBM, Inst Biotechnol, Granada 18100, Spain.
   [Mariotti, Caterina; Castellotti, Barbara] Fdn IRCCS Ist Neurol Carlo Besta, Unite Genet Malattie Neurodegenerat & Metabol, I-20126 Milan, Italy.
C3 Columbia University; Columbia University; University of Messina;
   University of Granada; Fondazione IRCCS Istituto Neurologico Carlo Besta
RP Quinzii, CM (corresponding author), Columbia Univ, Med Ctr, 630 W 168th St,P&S 4-431, New York, NY 10032 USA.
EM cmq2101@cumc.columbia.edu
RI Mariotti, Caterina/AAP-9425-2021; Garcia Diaz, Beatriz/HJZ-2823-2023;
   CASTELLOTTI, BARBARA/J-4939-2016; Lopez, Luis Carlos/L-5129-2014
OI Garcia Diaz, Beatriz/0000-0003-2655-571X; Mariotti,
   Caterina/0000-0003-2405-3564; CASTELLOTTI, BARBARA/0000-0002-9098-3041;
   BARCA, EMANUELE/0009-0007-6672-6524; Lopez, Luis
   Carlos/0000-0003-3355-0298
FU NIH [P01 HD080642-01]; 'Fundacion Alfonso Martin Escudero', Spain;
   'Ramon y Cajal' National Programme, Ministerio de Economia y
   Competitividad, Spain [RYC-2011-07643]; NICHD [5K23 HD065871]; Muscle
   Dystrophy Association (MDA)
FX This work has been supported by NIH P01 HD080642-01 (C.M.Q.). B.G.D. is
   supported by a grant from the 'Fundacion Alfonso Martin Escudero',
   Spain; L.C.L. is supported by the 'Ramon y Cajal' National Programme,
   Ministerio de Economia y Competitividad, Spain (RYC-2011-07643); and
   C.M.Q. is supported also by NICHD 5K23 HD065871 and by the Muscle
   Dystrophy Association (MDA).
CR Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164
   Becherel OJ, 2006, HUM MOL GENET, V15, P2239, DOI 10.1093/hmg/ddl149
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Castellotti B, 2011, NEUROGENETICS, V12, P193, DOI 10.1007/s10048-011-0281-x
   Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017
   D'Arrigo S, 2008, J CHILD NEUROL, V23, P895, DOI 10.1177/0883073808314959
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   El-Khamisy SF, 2009, DNA REPAIR, V8, P760, DOI 10.1016/j.dnarep.2009.02.002
   Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   García-Corzo L, 2013, HUM MOL GENET, V22, P1233, DOI 10.1093/hmg/dds530
   González-Mariscal I, 2014, IUBMB LIFE, V66, P63, DOI 10.1002/iub.1243
   Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122
   Harris JL, 2009, HUM MOL GENET, V18, P4102, DOI 10.1093/hmg/ddp359
   Hirano M, 2007, ANN NEUROL, V61, P162, DOI 10.1002/ana.21078
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Inoue N., 1971, Rinsho Shinkeigaku, V11, P855
   Kijas AW, 2006, J BIOL CHEM, V281, P13939, DOI 10.1074/jbc.M507946200
   Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024
   Le Ber I, 2007, NEUROLOGY, V68, P295, DOI 10.1212/01.wnl.0000252366.10731.43
   Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283
   Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492
   Li MX, 2012, FREE RADICAL BIO MED, V53, P237, DOI 10.1016/j.freeradbiomed.2012.04.002
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Martin J, 2013, HEPATOLOGY, V57, P2037, DOI 10.1002/hep.26060
   Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Mosesso P, 2005, CELL MOL LIFE SCI, V62, P485, DOI 10.1007/s00018-004-4441-0
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47
   Piantadosi CA, 2008, J BIOL CHEM, V283, P10967, DOI 10.1074/jbc.M709741200
   Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Quinzii CM, 2013, FASEB J, V27, P612, DOI 10.1096/fj.12-209361
   Quinzii CM, 2010, FASEB J, V24, P3733, DOI 10.1096/fj.09-152728
   Quinzii CM, 2005, NEUROLOGY, V64, P539, DOI 10.1212/01.WNL.0000150588.75281.58
   Rass U, 2007, J BIOL CHEM, V282, P9469, DOI 10.1074/jbc.M611489200
   Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08
   Sano Y, 2004, ANN NEUROL, V55, P241, DOI 10.1002/ana.10808
   Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Strosznajder RP, 2010, MOL NEUROBIOL, V41, P187, DOI 10.1007/s12035-010-8124-6
   Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108
   Tranchant C, 2003, NEUROLOGY, V60, P868, DOI 10.1212/01.WNL.0000048562.88536.A4
   Uekawa K, 1992, Rinsho Shinkeigaku, V32, P1067
   Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026
   Vascotto C, 2009, PROTEOMICS, V9, P1058, DOI 10.1002/pmic.200800638
   Yokoseki A, 2011, BRAIN, V134, P1387, DOI 10.1093/brain/awr069
NR 51
TC 19
Z9 20
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD AUG 15
PY 2015
VL 24
IS 16
BP 4516
EP 4529
DI 10.1093/hmg/ddv183
PG 14
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA CR4OU
UT WOS:000361315400004
PM 25976310
OA Green Published
DA 2024-11-01
ER

PT J
AU Prasad, M
   Narayan, B
   Prasad, AN
   Rupar, CA
   Levin, S
   Kronick, J
   Ramsay, D
   Tay, KY
   Prasad, C
AF Prasad, M.
   Narayan, B.
   Prasad, A. N.
   Rupar, C. A.
   Levin, S.
   Kronick, J.
   Ramsay, D.
   Tay, K. Y.
   Prasad, C.
TI MELAS: A Multigenerational Impact of the <i>MTTL1 A3243G</i> MELAS
   Mutation
SO CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LA English
DT Article
ID STROKE-LIKE EPISODES; L-ARGININE; LACTIC-ACIDOSIS; MITOCHONDRIAL
   MYOPATHY; MOLECULAR PATHOLOGY; CLINICAL PHENOTYPE; ENCEPHALOPATHY;
   DYSFUNCTION; PATIENT; BLOOD
AB Background: The maternally inherited MTTLI A3243G mutation in the mitochondrial genome causes MELAS (Mitochondrial Encephalopathy Lactic Acidosis with Stroke-like Episodes), a condition that is multisystemic but affects primarily the nervous system. Significant intra-familial variation in phenotype and severity of disease is well recognized. Methods: Retrospective and ongoing study of an extended family carrying the MTTLI A3243G mutation with multiple symptomatic individuals. Tissue heteroplasmy is reviewed based on the clinical presentations, imaging studies, laboratory findings in affected individuals and pathological material obtained at autopsy in two of the family members. Results: There were seven affected individuals out of thirteen members in this three generation family who each carried the MTTLI A3243G mutation. The clinical presentations were varied with symptoms ranging from hearing loss, migraines, dementia, seizures, diabetes, visual manifestations, and stroke like episodes. Three of the family members are deceased from MELAS or to complications related to MELAS. Conclusions: The results of the clinical, pathological and radiological findings in this family provide strong support to the current concepts of maternal inheritance, tissue heteroplasmy and molecular pathogenesis in MELAS. Neurologists (both adult and paediatric) are the most likely to encounter patients with MELAS in their practice. Genetic counselling is complex in view of maternal inheritance and heteroplasmy. Newer therapeutic options such as arginine are being used for acute and preventative management of stroke like episodes.
C1 [Prasad, A. N.; Rupar, C. A.; Levin, S.; Prasad, C.] Univ Western Ontario, Dept Paediat, London, ON, Canada.
   [Rupar, C. A.; Ramsay, D.] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.
   [Tay, K. Y.] Univ Western Ontario, Dept Med Imaging, London, ON, Canada.
   [Rupar, C. A.] Univ Western Ontario, Dept Biochem, London, ON, Canada.
   [Rupar, C. A.; Prasad, C.] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada.
   [Prasad, M.; Narayan, B.] London Hlth Sci Ctr, London, ON, Canada.
   [Kronick, J.] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada.
C3 Western University (University of Western Ontario); Western University
   (University of Western Ontario); Western University (University of
   Western Ontario); Western University (University of Western Ontario);
   Western University (University of Western Ontario); London Health
   Sciences Centre; University of Toronto; Hospital for Sick Children
   (SickKids)
RP Prasad, C (corresponding author), Childrens Hosp, London Hlth Sci Ctr, 800 Commissioners Rd East, London, ON N6C 2V5, Canada.
EM Chitra.Prasad@lhsc.on.ca
RI Prasad, Asuri/I-6068-2019; Levin, Simon/J-1218-2014
OI Prasad, Madhavi/0000-0001-5520-5589; Prasad, Asuri/0000-0002-6057-1038
CR Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011
   Finsterer J, 2009, J NEUROL SCI, V283, P143, DOI 10.1016/j.jns.2009.02.347
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hirata K, 2008, BRAIN DEV-JPN, V30, P238, DOI 10.1016/j.braindev.2007.08.007
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Kaido M, 1996, ACTA NEUROPATHOL, V92, P312, DOI 10.1007/s004010050524
   Kaufmann P, 2004, NEUROLOGY, V62, P1297, DOI 10.1212/01.WNL.0000120557.83907.A8
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2012, BBA-GEN SUBJECTS, V1820, P608, DOI 10.1016/j.bbagen.2011.09.005
   Lax NZ, 2012, BRAIN, V135, P1736, DOI 10.1093/brain/aws110
   Lekoubou A, 2011, REV NEUROL-FRANCE, V167, P852, DOI 10.1016/j.neurol.2011.02.038
   MIZUKAMI K, 1992, ACTA NEUROPATHOL, V83, P449, DOI 10.1007/BF00713541
   Morán M, 2012, FREE RADICAL BIO MED, V53, P595, DOI 10.1016/j.freeradbiomed.2012.05.009
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   OHAMA E, 1987, ACTA NEUROPATHOL, V74, P226, DOI 10.1007/BF00688185
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066
   Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94
   Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sarnat HB, 2005, CAN J NEUROL SCI, V32, P152, DOI 10.1017/S0317167100003929
   Sparaco M, 2003, ACTA NEUROPATHOL, V106, P202, DOI 10.1007/s00401-003-0716-z
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647
   Yokoyama T, 2010, NEUROPATHOLOGY, V30, P56, DOI 10.1111/j.1440-1789.2009.01026.x
NR 34
TC 12
Z9 14
U1 0
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0317-1671
EI 2057-0155
J9 CAN J NEUROL SCI
JI Can. J. Neurol. Sci.
PD MAR
PY 2014
VL 41
IS 2
BP 210
EP 219
DI 10.1017/S0317167100016607
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AY4WL
UT WOS:000347575800015
PM 24534033
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Son, JM
   Lee, C
AF Son, Jyung Mean
   Lee, Changhan
TI Aging: All roads lead to mitochondria
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
ID PERMEABILITY TRANSITION PORE; LIFE-SPAN; OXIDATIVE STRESS;
   METABOLIC-REGULATION; DNA MUTATIONS; INFLAMMATORY RESPONSES;
   SUPEROXIDE-PRODUCTION; IMMUNE-RESPONSES; HUMANIN PEPTIDE;
   SKELETAL-MUSCLE
AB Mitochondria were described as early as 1890 as ubiquitous intracellular structures by Ernster and Schatz (1981) [1]. Since then, the accretion of knowledge in the past century has revealed much of the molecular details of mitochondria, ranging from mitochondrial origin, structure, metabolism, genetics, and signaling, and their implications in health and disease. We now know that mitochondria are remarkably multifunctional and deeply intertwined with many vital cellular processes. They are quasi-self organelles that still possess remnants of its bacterial ancestry, including an independent genome. The mitochondrial free radical theory of aging (MFRTA), which postulated that aging is a product of oxidative damage to mitochondrial DNA, provided a conceptual framework that put mitochondria on the map of aging research. However, several studies have more recently challenged the general validity of the theory, favoring novel ideas based on emerging evidence to understand how mitochondria contribute to aging and age-related diseases. One prominent topic of investigation lies on the fact that mitochondria are not only production sites for bioenergetics and macromolecules, but also regulatory hubs that communicate and coordinate many vital physiological processes at the cellular and organismal level. The bi-directional communication and coordination between the co-evolved mitochondrial and nuclear genomes is especially interesting in terms of cellular regulation. Mitochondria are dynamic and adaptive, rendering their function sensitive to cellular context. Tissues with high energy demands, such as the brain, seem to be uniquely affected by age-dependent mitochondrial dysfunction, providing a foundation for the development of novel mitochondrial-based therapeutics and diagnostics.
C1 [Son, Jyung Mean; Lee, Changhan] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
   [Lee, Changhan] USC Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.
   [Lee, Changhan] Ajou Univ, Biomed Sci Grad Sch, Suwon 16499, South Korea.
C3 University of Southern California; University of Southern California;
   Ajou University
RP Lee, C (corresponding author), Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA.
RI Son, Jyung Mean/AAW-4712-2021
FU NIH [R01AG052258, R01GM136837]; American Federation for Aging Research
   (AFAR); Larry L. Hillblom Foundation (LLHF) fellowship
FX We are grateful to members of the Lee laboratory for discussions and
   feedback. This work was funded by NIH R01AG052258 and R01GM136837 to CL
   and the American Federation for Aging Research (AFAR) and the Larry L.
   Hillblom Foundation (LLHF) fellowship to JMS.
CR Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657
   Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028
   Anderson NS, 2020, TRENDS CELL BIOL, V30, P428, DOI 10.1016/j.tcb.2020.03.001
   Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202
   Assmann N, 2016, J CLIN INVEST, V126, P2031, DOI 10.1172/JCI83005
   Bachar AR, 2010, CARDIOVASC RES, V88, P360, DOI 10.1093/cvr/cvq191
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012
   Baumgart M, 2016, CELL SYST, V2, P122, DOI 10.1016/j.cels.2016.01.014
   Benayoun BA, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900046
   Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030
   Bock FJ, 2020, NAT REV MOL CELL BIO, V21, P85, DOI 10.1038/s41580-019-0173-8
   Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6
   Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7
   Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013
   Boyapati Ray K, 2017, F1000Res, V6, P169, DOI 10.12688/f1000research.10397.1
   Breiling A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0016-6
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037
   Carlberg C., 2018, Human Epigenomics, P75, DOI [DOI 10.1007/978-981-10-7614-5_5, 10.1007/978-981-10-7614-5_5]
   Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262
   Cheng Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00163
   Ciabattini A, 2018, SEMIN IMMUNOL, V40, P83, DOI 10.1016/j.smim.2018.10.010
   Cobb LJ, 2016, AGING-US, V8, P796, DOI 10.18632/aging.100943
   Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Conte M, 2020, SEMIN IMMUNOPATHOL, V42, P607, DOI 10.1007/s00281-020-00813-0
   Conte M, 2019, J GERONTOL A-BIOL, V74, P600, DOI 10.1093/gerona/gly153
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314
   Couso JP, 2017, NAT REV MOL CELL BIO, V18, P575, DOI 10.1038/nrm.2017.58
   da Silveira WA, 2020, CELL, V183, P1185, DOI 10.1016/j.cell.2020.11.002
   DEGUCHI T, 1971, J BIOL CHEM, V246, P3175
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053
   ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s
   Fabrizio P, 2003, GENETICS, V163, P35
   Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gambardella S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01064
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   García N, 2005, LIFE SCI, V76, P2873, DOI 10.1016/j.lfs.2004.12.012
   García N, 2007, LIFE SCI, V81, P1160, DOI 10.1016/j.lfs.2007.08.019
   Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885
   Glück S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586
   Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627
   Guo Q, 2020, DIABETOLOGIA, V63, P2675, DOI 10.1007/s00125-020-05269-3
   Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Hara Y, 2014, P NATL ACAD SCI USA, V111, P486, DOI 10.1073/pnas.1311310110
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D, 2006, ANN NY ACAD SCI, V1067, P454, DOI 10.1196/annals.1354.065
   Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498
   Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P460, DOI 10.1006/bbrc.2001.4765
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Henderson V.W., 2010, MENOPAUSE MITOCHONDR, P77
   Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009
   Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213
   Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045
   Hummel EM, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0264-x
   Hunter P, 2016, EMBO REP, V17, P136, DOI 10.15252/embr.201541835
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Jambhekar A, 2019, NAT REV MOL CELL BIO, V20, P625, DOI 10.1038/s41580-019-0151-1
   Janssen JJE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00078
   Jung SS, 2003, J NEUROCHEM, V84, P266, DOI 10.1046/j.1471-4159.2003.01524.x
   Kang GM, 2021, CELL METAB, V33, P334, DOI 10.1016/j.cmet.2021.01.003
   Kann LM, 1998, P NATL ACAD SCI USA, V95, P2372, DOI 10.1073/pnas.95.5.2372
   Kennedy SR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003794
   Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276
   Khan S, 2020, J CLIN INVEST, V130, P20, DOI 10.1172/JCI129202
   Kim J, 2019, SCIENCE, V366, P1531, DOI 10.1126/science.aav4011
   Kim KH, 2018, CELL METAB, V28, P516, DOI 10.1016/j.cmet.2018.06.008
   Knoop A, 2019, RAPID COMMUN MASS SP, V33, P371, DOI 10.1002/rcm.8337
   Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109
   Kopinski PK, 2019, P NATL ACAD SCI USA, V116, P16028, DOI 10.1073/pnas.1906896116
   Krukowski K, 2020, ELIFE, V9, DOI 10.7554/eLife.62048
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lane N, 2015, P NATL ACAD SCI USA, V112, pE4823, DOI 10.1073/pnas.1509237112
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee SR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8060949
   Lei XG, 2016, PHYSIOL REV, V96, P307, DOI 10.1152/physrev.00010.2014
   Li SC, 2015, TRENDS PHARMACOL SCI, V36, P906, DOI 10.1016/j.tips.2015.08.014
   Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lindqvist D, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.236
   Lindqvist D, 2018, NEUROPSYCHOPHARMACOL, V43, P1557, DOI 10.1038/s41386-017-0001-9
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Loftus RM, 2016, J BIOL CHEM, V291, P1, DOI 10.1074/jbc.R115.693903
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   LOPEZ JV, 1994, J MOL EVOL, V39, P174
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Lowes H, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00362-y
   Lowes H, 2019, MITOCHONDRION, V46, P307, DOI 10.1016/j.mito.2018.07.008
   Lu HY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102456
   Lyko F, 2018, NAT REV GENET, V19, P81, DOI 10.1038/nrg.2017.80
   Makarewich CA, 2017, TRENDS CELL BIOL, V27, P685, DOI 10.1016/j.tcb.2017.04.006
   Martin I, 2009, FREE RADICAL BIO MED, V47, P803, DOI 10.1016/j.freeradbiomed.2009.06.021
   Martínez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Martire S, 2020, NAT REV MOL CELL BIO, V21, P522, DOI 10.1038/s41580-020-0262-8
   Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Michalak EM, 2019, NAT REV MOL CELL BIO, V20, P573, DOI 10.1038/s41580-019-0143-1
   Miquel J, 1998, EXP GERONTOL, V33, P113, DOI 10.1016/S0531-5565(97)00060-0
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003
   MORRIS RL, 1993, J CELL SCI, V104, P917
   Mottis A, 2019, SCIENCE, V366, P827, DOI 10.1126/science.aax3768
   Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Ng LF, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00311
   Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100
   O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   Ogrodnik M, 2019, TRENDS BIOCHEM SCI, V44, P996, DOI 10.1016/j.tibs.2019.06.011
   Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18
   Parlakgul G., 2020, HIGH RESOLUTION 3D I
   Patrushev M, 2006, MITOCHONDRION, V6, P43, DOI 10.1016/j.mito.2005.12.001
   Pence BD, 2018, EXP GERONTOL, V108, P112, DOI 10.1016/j.exger.2018.04.008
   Peng Y., 2019, FRONT IMMUNOL, V10
   Pérez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00441
   Picard M, 2019, CURR OPIN BEHAV SCI, V28, P142, DOI 10.1016/j.cobeha.2019.04.015
   Picard M, 2016, MITOCHONDRION, V30, P105, DOI 10.1016/j.mito.2016.07.003
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Pike CJ, 2017, J NEUROSCI RES, V95, P671, DOI 10.1002/jnr.23827
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Podlesniy P, 2018, METHODS MOL BIOL, V1768, P111, DOI 10.1007/978-1-4939-7778-9_7
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Prevost CT, 2018, CURR GENET, V64, P199, DOI 10.1007/s00294-017-0717-4
   Qian F, 2012, AGING CELL, V11, P104, DOI 10.1111/j.1474-9726.2011.00759.x
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Quirós PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23
   Rabhi N, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00304
   Raefsky SM, 2017, FREE RADICAL BIO MED, V102, P203, DOI 10.1016/j.freeradbiomed.2016.11.045
   Rath S., 2020, NUCLEIC ACIDS RES
   Ren ZH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01030
   Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001
   Reynolds JC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20790-0
   Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273
   Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799
   Riley JS, 2018, EMBO J, V37, DOI 10.15252/embj.201899238
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140
   Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007
   Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156
   Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025
   Shi YG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017947
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Sloan DB, 2018, NAT REV GENET, V19, P635, DOI 10.1038/s41576-018-0035-9
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Sun T, 2013, CELL REP, V4, P413, DOI 10.1016/j.celrep.2013.06.040
   Sunnucks P, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00025
   Szczepanowska K., 2020, HUMAN MITOCHONDRIAL, P221
   Szczepanowska K, 2017, ESSAYS BIOCHEM, V61, P325, DOI 10.1042/EBC20160090
   Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4
   Takihara Y, 2015, P NATL ACAD SCI USA, V112, P10515, DOI 10.1073/pnas.1509879112
   Tan JX, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202002179
   Thevis M, 2016, RAPID COMMUN MASS SP, V30, P635, DOI 10.1002/rcm.7470
   Thurairajah K, 2018, EUR J TRAUMA EMERG S, V44, P325, DOI 10.1007/s00068-018-0954-3
   Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011
   Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271
   Tranah GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30255-6
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V107, P82, DOI 10.1016/j.psyneuen.2019.05.001
   Trumpff C, 2019, PSYCHONEUROENDOCRINO, V106, P268, DOI 10.1016/j.psyneuen.2019.03.026
   TSUZUKI T, 1983, BIOCHEM BIOPH RES CO, V114, P670, DOI 10.1016/0006-291X(83)90833-1
   Unlu ES, 2007, ANN NY ACAD SCI, V1100, P505, DOI 10.1196/annals.1395.055
   Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Viña J, 2019, FREE RADICAL BIO MED, V134, P690, DOI 10.1016/j.freeradbiomed.2019.01.045
   Wang CG, 2019, P NATL ACAD SCI USA, V116, P15817, DOI 10.1073/pnas.1905924116
   West AP, 2017, NAT REV IMMUNOL, V17, P363, DOI 10.1038/nri.2017.21
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Wicks S, 2009, FREE RADICAL BIO MED, V46, P176, DOI 10.1016/j.freeradbiomed.2008.09.036
   Wiese M, 2020, MOL METAB, V38, DOI 10.1016/j.molmet.2020.01.006
   Willemsen D, 2020, ELIFE, V9, DOI 10.7554/eLife.55794
   Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33
   Wu Z, 2019, NAT METAB, V1, P1209, DOI 10.1038/s42255-019-0150-8
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018
   Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114
   Yao J, 2012, ADV PHARMACOL, V64, P327, DOI 10.1016/B978-0-12-394816-8.00010-6
   Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005
   Yen K, 2020, AGING-US, V12, P11185, DOI 10.18632/aging.103534
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zarse K, 2015, CELL METAB, V21, P355, DOI 10.1016/j.cmet.2015.02.013
   Zhang JZ, 2014, INT J MOL MED, V33, P817, DOI 10.3892/ijmm.2014.1650
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang YQ, 2017, REDOX BIOL, V11, P30, DOI 10.1016/j.redox.2016.10.014
   Zhang YQ, 2016, MECH AGEING DEV, V154, P1, DOI 10.1016/j.mad.2016.01.005
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847
NR 211
TC 40
Z9 44
U1 4
U2 37
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
EI 1096-3634
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD AUG
PY 2021
VL 116
SI SI
BP 160
EP 168
DI 10.1016/j.semcdb.2021.02.006
EA JUL 2021
PG 9
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA TK8KO
UT WOS:000674402300019
PM 33741252
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Chien, KR
   Karsenty, G
AF Chien, KR
   Karsenty, G
TI Longevity and lineages: Toward the integrative biology of degenerative
   diseases in heart, muscle, and bone
SO CELL
LA English
DT Review
ID GROWTH-FACTOR-I; MITOCHONDRIAL-DNA DELETIONS; SKELETAL-MUSCLE;
   LIFE-SPAN; OXIDATIVE STRESS; MICE; OSTEOCLAST; DIFFERENTIATION;
   HYPERTROPHY; REGULATOR
AB Human aging is characterized by debilitating diseases, including heart failure, cardiac pacemaker defects, muscle wasting, and osteoporosis, in heart, skeletal muscle, and bone. Recent studies are identifying pathways for these aging-related diseases by examining how the process of aging influences tissue-specific progenitors and differentiated cell lineages in these organ systems. These advances form a foundation for new therapeutic strategies to delay the onset of aging-related disorders.
C1 Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA.
   Baylor Coll Med, Dept Genet, Houston, TX 77030 USA.
C3 University of California System; University of California San Diego;
   Baylor College of Medicine
RP Univ Calif San Diego, Sch Med, Inst Mol Med, La Jolla, CA 92093 USA.
EM kchien@partners.org; karsenty@bcm.tmc.edu
CR Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2
   Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI200214588
   Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603
   Bernecker Oliver Y, 2003, Semin Thorac Cardiovasc Surg, V15, P268, DOI 10.1016/S1043-0679(03)70006-9
   Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154
   Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0
   Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3
   Cheng G, 1999, DEVELOPMENT, V126, P5041
   Chien KR, 2002, CELL, V110, P153, DOI 10.1016/S0092-8674(02)00834-6
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Cooper Cyrus, 1996, P419
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9
   Dacquin R, 2004, J CELL BIOL, V164, P509, DOI 10.1083/jcb.200312135
   Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251
   Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101
   DUERR RL, 1995, J CLIN INVEST, V95, P619, DOI 10.1172/JCI117706
   Elefteriou F, 2003, ENDOCRINOLOGY, V144, P3842, DOI 10.1210/en.2003-0369
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482
   Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219
   Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87
   Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2
   GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18
   Harada T, 2003, PATHOL INT, V53, P382, DOI 10.1046/j.1440-1827.2003.01485.x
   Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701
   Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549
   Iwanaga Y, 2004, J CLIN INVEST, V113, P727, DOI 10.1172/JCI200418716
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200
   Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089
   Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444
   Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9
   Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1
   Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200
   Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215
   Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836
   Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450
   Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015
   MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151
   McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0
   McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457
   Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Musarò A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101
   Musarò A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2
   Perls T, 2003, ANN INTERN MED, V139, P445, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00013
   Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599
   Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355
   Ruiz-Lozano P, 2003, NAT GENET, V33, P8, DOI 10.1038/ng0103-8
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790
   Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933
   SCHWARTZ JB, 2005, BRAUNWALDS HEART DIS, P1925
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0
   TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600
   Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   Weitzmann MN, 2002, J CLIN INVEST, V110, P1643, DOI 10.1172/JCI200215687
   Winn N, 2002, COLD SPRING HARB SYM, V67, P507, DOI 10.1101/sqb.2002.67.507
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35
   YOSHIDA H, 1990, NATURE, V16, P391
   Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525
NR 83
TC 113
Z9 129
U1 2
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD FEB 25
PY 2005
VL 120
IS 4
BP 533
EP 544
DI 10.1016/j.cell.2005.02.006
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 901GR
UT WOS:000227271500010
PM 15734685
OA Bronze
DA 2024-11-01
ER

PT J
AU Yu, H
   Koilkonda, RD
   Chou, TH
   Porciatti, V
   Mehta, A
   Hentall, ID
   Chiodo, VA
   Boye, SL
   Hauswirth, WW
   Lewin, AS
   Guy, J
AF Yu, Hong
   Koilkonda, Rajeshwari D.
   Chou, Tsung-Han
   Porciatti, Vittorio
   Mehta, Arpit
   Hentall, Ian D.
   Chiodo, Vince A.
   Boye, Sanford L.
   Hauswirth, William W.
   Lewin, Alfred S.
   Guy, John
TI Consequences of zygote injection and germline transfer of mutant human
   mitochondrial DNA in mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gene therapy; adeno-associated virus; mitochondria; Leber hereditary
   optic neuropathy; blindness
ID HEREDITARY OPTIC NEUROPATHY; COMPLEX-I; GENE DELIVERY; MUTATION; MOUSE;
   MODEL; DEGENERATION; THERAPY; TRANSCRIPTION; TRANSMISSION
AB Considerable evidence supports mutations in mitochondrial genes as the cause of maternally inherited diseases affecting tissues that rely primarily on oxidative energymetabolism, usually the nervous system, the heart, and skeletal muscles. Mitochondrial diseases are diverse, and animal models currently are limited. Here we introduced a mutant human mitochondrial gene responsible for Leber hereditary optic neuropathy (LHON) into the mouse germ line using fluorescence imaging for tissue-specific enrichment in the target retinal ganglion cells. A mitochondria-targeted adeno-associated virus (MTS-AAV) containing the mutant human NADH ubiquinone oxidoreductase subunit 4 (ND4) gene followed by mitochondrial-encoded mCherry was microinjected into zygotes. Female founders with mCherry fluorescence on ophthalmoscopy were backcrossed with normal males for eight generations. Mutant human ND4 DNA was 20% of mouse ND4 and did not integrate into the host genome. Translated human ND4 protein assembled into host respiratory complexes, decreasing respiratory chain function and increasing oxidative stress. Swelling of the optic nerve head was followed by progressive demise of ganglion cells and their axons, the hallmarks of human LHON. Early visual loss that began at 3 mo and progressed to blindness 8 mo after birth was reversed by intraocular injection of MTS-AAV expressing wild-type human ND4. The technology of introducing human mitochondrial genes into the mouse germ line has never been described, to our knowledge, and has implications not only for creating animal models recapitulating the counterpart human disorder but more importantly for reversing the adverse effects of the mutant gene using gene therapy to deliver the wild-type allele.
C1 [Yu, Hong; Koilkonda, Rajeshwari D.; Chou, Tsung-Han; Porciatti, Vittorio; Guy, John] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [Mehta, Arpit] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA.
   [Hentall, Ian D.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.
   [Chiodo, Vince A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32603 USA.
   [Lewin, Alfred S.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32603 USA.
C3 University of Miami; Bascom Palmer Eye Institute; University of Miami;
   University of Miami; State University System of Florida; University of
   Florida; State University System of Florida; University of Florida
RP Guy, J (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
EM jguy@med.miami.edu
RI CHOU, TSUNG-HAN/C-9958-2011
OI Lewin, Alfred/0000-0002-4192-9727; hauswirth,
   william/0000-0002-3244-4947; Hentall, Ian/0000-0002-9937-2546; Yu,
   Hong/0000-0002-1272-4511; Porciatti, Vittorio/0000-0002-1592-3532
FU NIH [R01 EY017141, EY012355, P30-EY014801]; Research to Prevent
   Blindness, Inc.
FX We thank Mabel Wilson for editing the manuscript and Donna Bortner and
   Debra Banner (TransViragen, Inc.) for production of the transgenic mice.
   This work was supported by NIH Grants R01 EY017141, EY012355, and
   P30-EY014801 and by an unrestricted grant to Bascom Palmer Eye Institute
   from Research to Prevent Blindness, Inc.
CR Chinnery PF, 2001, AM J MED GENET, V98, P235, DOI 10.1002/1096-8628(20010122)98:3<235::AID-AJMG1086>3.0.CO;2-O
   Chou TH, 2011, INVEST OPHTH VIS SCI, V52, P3604, DOI 10.1167/iovs.10-6340
   Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110
   CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0
   Cogné B, 2014, NAT MED, V20, P577, DOI 10.1038/nm.3578
   Collombet JM, 1997, J BIOL CHEM, V272, P5342, DOI 10.1074/jbc.272.8.5342
   Committee on Care and Use of Laboratory Animals, 1996, DHHS PUBL
   Cwerman-Thibault H, 2011, J INHERIT METAB DIS, V34, P327, DOI 10.1007/s10545-010-9131-5
   Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013
   Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0
   Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028
   Guy J, 2002, ANN NEUROL, V52, P534, DOI 10.1002/ana.10354
   HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686
   Howell N, 1998, VISION RES, V38, P1495, DOI 10.1016/S0042-6989(97)00444-6
   Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8
   HOWELL N, 1994, AM J HUM GENET, V55, P203
   Ibrahim N, 2011, PHARM RES-DORDR, V28, P2871, DOI 10.1007/s11095-011-0516-4
   JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007
   Kaeppel C, 2013, NAT MED, V19, P889, DOI 10.1038/nm.3230
   Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105
   Khan SM, 2004, J BIOENERG BIOMEMBR, V36, P387, DOI 10.1023/B:JOBB.0000041773.20072.9e
   Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x
   Kogelnik AM, 1996, NUCLEIC ACIDS RES, V24, P177, DOI 10.1093/nar/24.1.177
   Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109
   MAUL GG, 1978, J VIROL, V28, P936, DOI 10.1128/JVI.28.3.936-944.1978
   Mileshina D, 2011, MECH AGEING DEV, V132, P412, DOI 10.1016/j.mad.2011.05.002
   MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9
   MORAES CT, 1992, NAT GENET, V1, P359, DOI 10.1038/ng0892-359
   NEWMAN NJ, 1991, AM J OPHTHALMOL, V111, P750, DOI 10.1016/S0002-9394(14)76784-4
   Ni TH, 1998, J VIROL, V72, P2777, DOI 10.1128/JVI.72.4.2777-2787.1998
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8
   Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789
   Qi XP, 2007, ARCH OPHTHALMOL-CHIC, V125, P268, DOI 10.1001/archopht.125.2.268
   Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200
   Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175
   Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007
   Shoffner J M, 1992, Heart Dis Stroke, V1, P235
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   SMITH KH, 1993, ARCH OPHTHALMOL-CHIC, V111, P1486, DOI 10.1001/archopht.1993.01090110052022
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Yoon YG, 2003, NUCLEIC ACIDS RES, V31, P1407, DOI 10.1093/nar/gkg228
   Yu H, 2012, MOL VIS, V18, P1668
   Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109
   Yuan H, 2014, ARVO SUPPLEMENT INVE, V55, P3311
NR 49
TC 23
Z9 24
U1 0
U2 16
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 20
PY 2015
VL 112
IS 42
BP E5689
EP E5698
DI 10.1073/pnas.1506129112
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CT9LN
UT WOS:000363138600008
PM 26438859
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Younis, S
   Hougaard, A
   Vestergaard, MB
   Larsson, HBW
   Ashina, M
AF Younis, Samaira
   Hougaard, Anders
   Vestergaard, Mark B.
   Larsson, Henrik B. W.
   Ashina, Messoud
TI Migraine and magnetic resonance spectroscopy: a systematic review
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE glutamate; magnetic resonance spectroscopy; metabolism; migraine;
   mitochondrial dysfunction
ID RANDOMIZED CONTROLLED-TRIAL; VIVO H-1-NMR SPECTROSCOPY; MUSCLE
   ENERGY-METABOLISM; GENOME-WIDE ASSOCIATION; H-1 MR SPECTROSCOPY; LOW
   BRAIN MAGNESIUM; N-ACETYL-ASPARTATE; IN-VIVO; CLINICAL-MANIFESTATIONS;
   HEMIPLEGIC MIGRAINE
AB Purpose of review
   To present an updated and streamlined overview of the metabolic and biochemical aspect of the migraine pathophysiology based on findings from phosphorous (P-31) and hydrogen (H-1) magnetic resonance spectroscopy (MRS) studies.
   Recent findings
   Despite of the variation in the methodology and quality of the MRS migraine studies over time, some results were consistent and reproducible. P-31-MRS studies suggested reduced availability of neuronal energy and implied a mitochondrial dysfunction in the migraine brain. H-1-MRS studies reported interictal abnormalities in the excitatory and inhibitory neurotransmitters, glutamate and gamma-aminobutyric acid (GABA), suggesting persistent altered excitability in migraine patients. N-Acetylaspartate levels were decreased in migraine, probably due to a mitochondrial dysfunction and abnormal energy metabolism. The reported abnormalities may increase the susceptibility of migraine patients to excitatory stimulation, such as migraine attack triggers.
   Summary
   Several biochemical aspects of the migraine pathophysiology remain to be elucidated using MRS, such as the migraine attack, correlation to disease severity, and medication efficacy. Nevertheless, to identify a biomarker in migraine, MRS may be a valuable noninvasive technique.
C1 [Younis, Samaira; Hougaard, Anders; Ashina, Messoud] Univ Copenhagen, Danish Headache Ctr, Copenhagen, Denmark.
   [Younis, Samaira; Hougaard, Anders; Ashina, Messoud] Univ Copenhagen, Dept Neurol, Copenhagen, Denmark.
   [Vestergaard, Mark B.; Larsson, Henrik B. W.] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Funct Imaging Unit,Dept Clin Physiol Nucl Med & P, Copenhagen, Denmark.
C3 University of Copenhagen; University of Copenhagen; University of
   Copenhagen
RP Ashina, M (corresponding author), Univ Copenhagen, Danish Headache Ctr, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.; Ashina, M (corresponding author), Univ Copenhagen, Rigshosp Glostrup, Fac Hlth & Med Sci, Dept Neurol, Ndr Ringvej 57, DK-2600 Glostrup, Denmark.
EM ashina@dadlnet.dk
RI Ashina, Messoud/AFU-1246-2022
OI BW Larsson, Henrik/0000-0002-1348-7749; Ashina,
   Messoud/0000-0003-0951-5804; Younis, Samaira/0000-0002-9750-690X
FU Lundbeck Foundation [R155-2014-171]
FX This study was supported by the Lundbeck Foundation, grant number
   R155-2014-171. The funding source had no role in the study.
CR Aguila MER, 2015, NMR BIOMED, V28, P890, DOI 10.1002/nbm.3321
   Anttila V, 2010, NAT GENET, V42, P869, DOI 10.1038/ng.652
   Arngrim N, 2016, BRAIN, V139, P723, DOI 10.1093/brain/awv359
   Assarzadegan F, 2016, INT CLIN PSYCHOPHARM, V31, P287, DOI 10.1097/YIC.0000000000000130
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARBIROLI B, 1992, NEUROLOGY, V42, P1209, DOI 10.1212/WNL.42.6.1209
   BARBIROLI B, 1990, CEPHALALGIA, V10, P263, DOI 10.1046/j.1468-2982.1990.1005263.x
   Becerra L, 2016, NEUROIMAGE-CLIN, V11, P588, DOI 10.1016/j.nicl.2016.03.020
   BIERMANS W, 1990, BIOCHIM BIOPHYS ACTA, V1018, P225, DOI 10.1016/0005-2728(90)90254-2
   Bigal ME, 2008, NEUROLOGY, V70, P2078, DOI 10.1212/01.wnl.0000313376.07248.28
   Boska MD, 2002, NEUROLOGY, V58, P1227, DOI 10.1212/WNL.58.8.1227
   BOTTOMLEY PA, 1989, CLIN CHEM, V35, P392
   Bridge H, 2015, CEPHALALGIA, V35, P1025, DOI 10.1177/0333102414566860
   Chasman DI, 2011, NAT GENET, V43, P695, DOI 10.1038/ng.856
   CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D
   Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321
   de Tommaso M, 2012, J HEADACHE PAIN, V13, P389, DOI 10.1007/s10194-012-0448-3
   Dichgans M, 2005, NEUROLOGY, V64, P608, DOI 10.1212/01.WNL.0000151855.98318.50
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fayed N, 2014, ACAD RADIOL, V21, P1211, DOI 10.1016/j.acra.2014.04.009
   Goadsby PJ, 2009, NEUROL CLIN, V27, P335, DOI 10.1016/j.ncl.2008.11.012
   de la Aleja JG, 2013, HEADACHE, V53, P365, DOI 10.1111/head.12030
   Grimaldi D, 2010, CEPHALALGIA, V30, P552, DOI 10.1111/j.1468-2982.2009.01979.x
   Grubbs RD, 1987, MAGNESIUM, V6, P781
   Gu M, 2013, NMR BIOMED, V26, P164, DOI 10.1002/nbm.2831
   Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473
   Guo S, 2016, EUR J NEUROL, V23, P175, DOI 10.1111/ene.12832
   HALVORSON HR, 1992, NMR BIOMED, V5, P53, DOI 10.1002/nbm.1940050202
   Hougaard A, 2013, NEUROLOGY, V80, P428, DOI 10.1212/WNL.0b013e31827f0f10
   Iotti S, 1996, NMR BIOMED, V9, P24, DOI 10.1002/(SICI)1099-1492(199602)9:1<24::AID-NBM392>3.0.CO;2-B
   Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314
   Jourdain P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21250
   Klopstock T, 1996, NEUROLOGY, V46, P1735, DOI 10.1212/WNL.46.6.1735
   Lai T, 2011, J HEADACHE PAIN, V12, P295
   Landim RCG, 2016, MAGN RESON IMAGING, V34, P239, DOI 10.1016/j.mri.2015.10.038
   LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32
   Li BSY, 2003, MAGN RESON IMAGING, V21, P923, DOI 10.1016/S0730-725X(03)00181-4
   Lirng JF, 2015, CEPHALALGIA, V35, P702, DOI 10.1177/0333102414557048
   Lodi R, 1997, PEDIATR RES, V42, P866, DOI 10.1203/00006450-199712000-00024
   Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3
   Macrì MA, 2003, MAGN RESON IMAGING, V21, P1201, DOI 10.1016/j.mri.2003.08.021
   Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J
   Mohamed RE, 2013, EGYPT J RADIOL NUC M, V44, P859, DOI 10.1016/j.ejrnm.2013.08.004
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   MONTAGNA P, 1994, NEUROLOGY, V44, P666, DOI 10.1212/WNL.44.4.666
   NIOKA S, 1987, J APPL PHYSIOL, V62, P2094, DOI 10.1152/jappl.1987.62.5.2094
   Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021
   O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520
   Olesen J, 2009, LANCET NEUROL, V8, P679, DOI 10.1016/S1474-4422(09)70090-0
   Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x
   PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781
   Pradhan S, 2015, MAGN RESON IMAGING, V33, P1013, DOI 10.1016/j.mri.2015.06.003
   Prescot A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-34
   RAMADAN NM, 1989, HEADACHE, V29, P590, DOI 10.1111/j.1526-4610.1989.hed2909590.x
   Reyngoudt H, 2012, CEPHALALGIA, V32, P845, DOI 10.1177/0333102412452048
   Reyngoudt H, 2011, CEPHALALGIA, V31, P1243, DOI 10.1177/0333102410394675
   Reyngoudt H, 2011, J HEADACHE PAIN, V12, P295, DOI 10.1007/s10194-011-0295-7
   Reyngoudt H, 2010, MAGN RESON MATER PHY, V23, P227, DOI 10.1007/s10334-010-0221-z
   RYNER LN, 1995, MAGN RESON IMAGING, V13, P853, DOI 10.1016/0730-725X(95)00031-B
   Sándor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED
   Sándor PS, 2005, CEPHALALGIA, V25, P507, DOI 10.1111/j.1468-2982.2005.00900.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584, DOI 10.1038/jcbfm.1992.82
   Sarchielli P, 2005, NEUROIMAGE, V24, P1025, DOI 10.1016/j.neuroimage.2004.11.005
   Schaller B, 2013, J NEUROSCI RES, V91, P1076, DOI 10.1002/jnr.23194
   Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466
   Schulz UG, 2007, BRAIN, V130, P3102, DOI 10.1093/brain/awm165
   Siniatchkin M, 2012, CEREB CORTEX, V22, P2207, DOI 10.1093/cercor/bhr248
   Tkác I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213
   Tkác I, 2009, MAGN RESON MED, V62, P868, DOI 10.1002/mrm.22086
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614
   Vecchia D, 2012, TRENDS NEUROSCI, V35, P507, DOI 10.1016/j.tins.2012.04.007
   VEECH RL, 1979, J BIOL CHEM, V254, P6538
   Vestergaard MB, 2016, J CEREBR BLOOD F MET, V36, P1046, DOI 10.1177/0271678X15606460
   Wang SJ, 2006, J NEUROL NEUROSUR PS, V77, P622, DOI 10.1136/jnnp.2005.081836
   Watanabe H., 1996, Neurology, V47, P1093
   WELCH KMA, 1988, CEPHALALGIA, V8, P273, DOI 10.1046/j.1468-2982.1988.0804273.x
   WELCH KMA, 1995, J NEUROL SCI, V134, P9, DOI 10.1016/0022-510X(95)00196-1
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Yang SL, 2008, MAGN RESON MED, V59, P236, DOI 10.1002/mrm.21463
   Zielman R, 2014, CEPHALALGIA, V34, P959, DOI 10.1177/0333102414527016
NR 82
TC 63
Z9 68
U1 1
U2 19
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD JUN
PY 2017
VL 30
IS 3
BP 246
EP 262
DI 10.1097/WCO.0000000000000436
PG 17
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EU5RC
UT WOS:000401089600008
PM 28240609
DA 2024-11-01
ER

PT J
AU Kumari, U
   Jun, WY
   Bay, BH
   Lyakhovich, A
AF Kumari, U.
   Jun, W. Ya
   Bay, B. Huat
   Lyakhovich, A.
TI Evidence of mitochondrial dysfunction and impaired ROS detoxifying
   machinery in Fanconi Anemia cells
SO ONCOGENE
LA English
DT Article
DE Fanconi Anemia; reactive oxygen species; mitochondria
ID INTERSTRAND CROSS-LINK; OXIDATIVE STRESS; REACTIVE OXYGEN;
   SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; DNA-REPAIR; PATHWAY; MUTATION;
   DAMAGE; FANCD2
AB Fanconi Anemia (FA) is a rare genetic disorder associated with a bone-marrow failure, cancer predisposition and hypersensitivity to DNA crosslinking agents. Majority of the 15 FA genes and encoded proteins characterized so far are integrated into DNA repair pathways, however, other important functions cannot be excluded. FA cells are sensitive to oxidants, and accumulation of oxidized proteins has been characterized for several FA subgroups. Clinical phenotypes of both FA and other closely related diseases suggest altered functions of mitochondria, organelles responsible for cellular energetic metabolism, and also serving as an important producer and the most susceptible target from reactive oxidative species (ROS). In this study, we have shown that elevated level of mitochondrial ROS in FA cells is in parallel with the decrease of mitochondrial membrane potential, the decrease of ATP production, impaired oxygen uptake and pathological changes in the morphology of mitochondria. This is accompanied by inactivation of enzymes that are essential for the energy production (F1F0ATPase and cytochrome C oxidase) and detoxification of ROS (superoxide dismutase, SOD1). In turn, overexpression of SOD1 could rescue oxygen consumption rate in FA-deficient cells. Importantly, the depletion of mitochondria improved survival rate of mitomycin C treated FA cells suggesting that hypersensitivity of FA cells to chemotherapeutic drugs could be in part due to the mitochondria-mediated oxidative stress. On the basis of our results, we propose that deficiency in FA genes lead to disabling mitochondrial ROS-scavenging machinery further affecting mitochondrial functions and suppressing cell respiration.
C1 [Kumari, U.; Lyakhovich, A.] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore.
   [Jun, W. Ya; Bay, B. Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.
C3 National University of Singapore; National University of Singapore
RP Lyakhovich, A (corresponding author), Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Coll Rd,Level 6, Singapore 169857, Singapore.
EM lyakhovich@gmail.com
RI Lyakhovich, Alex/B-4410-2008
OI Lyakhovich, Alex/0000-0002-8279-4697
CR Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432
   Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559
   AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J
   Bogliolo M, 2002, MUTAGENESIS, V17, P25, DOI 10.1093/mutage/17.1.25
   Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574
   Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005
   Cossarizza A., 2001, Curr Protoc Cytom, V9, P14
   Cuccarolo P, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-63
   DALLAPICCOLA B, 1985, HUM GENET, V69, P62, DOI 10.1007/BF00295530
   Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088
   DEGAN P, 1995, CARCINOGENESIS, V16, P735, DOI 10.1093/carcin/16.4.735
   Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Du W, 2012, BLOOD, V119, P4142, DOI 10.1182/blood-2011-09-381970
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Fridlyand LE, 2005, ANN NY ACAD SCI, V1066, P136, DOI 10.1196/annals.1363.019
   Hadjur S, 2001, BLOOD, V98, P1003, DOI 10.1182/blood.V98.4.1003
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0
   Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505
   Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750
   Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259
   Li RC, 2008, BRAIN RES, V1190, P159, DOI 10.1016/j.brainres.2007.11.022
   Lyakhovich A, 2010, MOL CANCER RES, V8, P46, DOI 10.1158/1541-7786.MCR-09-0373
   Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241
   Miller SW, 1996, J NEUROCHEM, V67, P1897
   Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006
   Mukhopadhyay SS, 2006, J CELL BIOL, V175, P225, DOI 10.1083/jcb.200607061
   NORDENSON I, 1977, HEREDITAS, V86, P147
   O'Neill HC, 2011, AM J RESP CELL MOL, V45, P323, DOI 10.1165/rcmb.2010-0214OC
   Pagano G, 2004, CARCINOGENESIS, V25, P1899, DOI 10.1093/carcin/bgh194
   Pagano G, 1997, BLOOD, V89, P1111, DOI 10.1182/blood.V89.3.1111
   Pagano G, 2012, BIOL CHEM, V393, P11, DOI 10.1515/BC-2011-227
   Pallardó FV, 2010, BIOGERONTOLOGY, V11, P401, DOI 10.1007/s10522-010-9269-4
   Petrovic S, 2011, BIOL CHEM, V392, P625, DOI 10.1515/BC.2011.064
   Ponte F, 2011, TOXICOLOGY, V289, P52, DOI 10.1016/j.tox.2011.07.009
   Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998
   Rani R, 2008, CANCER RES, V68, P9693, DOI 10.1158/0008-5472.CAN-08-1790
   RICHTER C, 1991, CHEM-BIOL INTERACT, V77, P1, DOI 10.1016/0009-2797(91)90002-O
   Rousset S, 2002, PHOTOCHEM PHOTOBIOL, V75, P159, DOI 10.1562/0031-8655(2002)075<0159:MAIFAF>2.0.CO;2
   ROUSSET S, 1990, CANCER RES, V50, P2443
   Ruppitsch W, 1997, HUM GENET, V99, P710, DOI 10.1007/s004390050437
   Saadatzadeh MR, 2004, J BIOL CHEM, V279, P16805, DOI 10.1074/jbc.M313721200
   SCHINDLER D, 1988, AM J HUM GENET, V43, P429
   TAKEUCHI T, 1993, CARCINOGENESIS, V14, P1115, DOI 10.1093/carcin/14.6.1115
   Talbot DA, 2004, FEBS LETT, V556, P111, DOI 10.1016/S0014-5793(03)01386-3
   Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92
   Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6
   Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8
   Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570
   Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016
   Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
NR 53
TC 86
Z9 91
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD JAN 9
PY 2014
VL 33
IS 2
BP 165
EP 172
DI 10.1038/onc.2012.583
PG 8
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 286BY
UT WOS:000329440700004
PM 23318445
OA Bronze
DA 2024-11-01
ER

PT J
AU Bérat, CM
   Montealegre, S
   Wiedemann, A
   Nuzum, ML
   Blondel, A
   Debruge, H
   Cano, A
   Chabrol, B
   Hoebeke, C
   Polak, M
   Stoupa, A
   Feillet, F
   Torre, S
   Boddaert, N
   Bruel, H
   Barth, M
   Damaj, L
   Abi-Wardé, MT
   Afenjar, A
   Benoist, JF
   Madrange, M
   Caccavelli, L
   Renard, P
   Hubas, A
   Nusbaum, P
   Pontoizeau, C
   Gobin, S
   van Endert, P
   Ottolenghi, C
   Maltret, A
   de Lonlay, P
AF Berat, Claire-Marine
   Montealegre, Sebastian
   Wiedemann, Arnaud
   Nuzum, Malou Le Corronc
   Blondel, Amelie
   Debruge, Hugo
   Cano, Aline
   Chabrol, Brigitte
   Hoebeke, Celia
   Polak, Michel
   Stoupa, Athanasia
   Feillet, Francois
   Torre, Stephanie
   Boddaert, Nathalie
   Bruel, Henri
   Barth, Magalie
   Damaj, Lena
   Abi-Warde, Marie-Therese
   Afenjar, Alexandra
   Benoist, Jean-Francois
   Madrange, Marine
   Caccavelli, Laure
   Renard, Perrine
   Hubas, Arnaud
   Nusbaum, Patrick
   Pontoizeau, Clement
   Gobin, Stephanie
   van Endert, Peter
   Ottolenghi, Chris
   Maltret, Alice
   de Lonlay, Pascale
TI Clinical and biological characterization of 20 patients
   withTANGO2deficiency indicates novel triggers of metabolic crises and no
   primary energetic defect
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
DE Brugada pattern; glutamate oxidation; long-QT; palmitate oxidation;
   TANGO2; triggers
ID MITOCHONDRIAL; MUTATIONS
AB TANGO2 disease is a severe inherited disorder associating multiple symptoms such as metabolic crises, encephalopathy, cardiac arrhythmias, and hypothyroidism. The mechanism of action of TANGO2 is currently unknown. Here, we describe a cohort of 20 French patients bearing mutations in theTANGO2gene. We found that the main clinical presentation was the association of neurodevelopmental delay (n = 17), acute metabolic crises (n = 17) and hypothyroidism (n = 12), with a large intrafamilial clinical variability. Metabolic crises included rhabdomyolysis (15/17), neurological symptoms (14/17), and cardiac features (12/17; long QT (n = 10), Brugada pattern (n = 2), cardiac arrhythmia (n = 6)) that required intensive care. We show previously uncharacterized triggers of metabolic crises in TANGO2 patients, such as some anesthetics and possiblyl-carnitine. Unexpectedly, plasma acylcarnitines, plasma FGF-21, muscle histology, and mitochondrial spectrometry were mostly normal. Moreover, in patients' primary myoblasts, palmitate and glutamine oxidation rates, and the mitochondrial network were also normal. Finally, we found variable mitochondrial respiration and defective clearance of oxidized DNA upon cycles of starvation and refeeding. We conclude that TANGO2 disease is a life-threatening disease that needs specific cardiac management and anesthesia protocol. Mechanistically, TANGO2 disease is unlikely to originate from a primary mitochondrial defect. Rather, we suggest that mitochondrial defects are secondary to strong extrinsic triggers in TANGO2 deficient patients.
C1 [Berat, Claire-Marine; Montealegre, Sebastian; Nuzum, Malou Le Corronc; Debruge, Hugo; Madrange, Marine; Caccavelli, Laure; Renard, Perrine; van Endert, Peter; de Lonlay, Pascale] Inst Necker Enfants Malad, INSERM, U1151, Paris, France.
   [Berat, Claire-Marine; Polak, Michel; Stoupa, Athanasia; Boddaert, Nathalie; van Endert, Peter; de Lonlay, Pascale] Univ Paris, Paris, France.
   [Berat, Claire-Marine; Montealegre, Sebastian; Madrange, Marine; Caccavelli, Laure; de Lonlay, Pascale] Necker Enfants Malad Univ Hosp, APHP, Imagine Inst, Filiere G2M,Reference Ctr Inherited Metab Dis, Paris, France.
   [Wiedemann, Arnaud; Feillet, Francois] Nancy Hosp, Reference Ctr Inherited Metab Disorders, Dept Pediat Intens Care, INSERM,U1256, Nancy, France.
   [Blondel, Amelie; Benoist, Jean-Francois; Pontoizeau, Clement; Ottolenghi, Chris] Necker Enfants Malad Univ Hosp, APHP, Dept Biochem, Filiere G2M, Paris, France.
   [Cano, Aline; Chabrol, Brigitte; Hoebeke, Celia] La Timone Hosp, Reference Ctr Inherited Metab Disorders, Filiere G2M, Marseille, France.
   [Polak, Michel; Stoupa, Athanasia] Univ Hosp, APHP, Reference Ctr Rare Endocrine Dis Growth & Dev, Necker Enfants Malad,Imagine Inst,Endocrinol Unit, Paris, France.
   [Torre, Stephanie] Rouen Hosp, Competence Ctr Inherited Metab Disorders, Filiere G2M, Rouen, France.
   [Boddaert, Nathalie] Necker Enfants Malad Univ Hosp, APHP, Paediat Radiol Dept, Paris, France.
   [Boddaert, Nathalie] INSERM, U1163, Imagine Inst, Paris, France.
   [Bruel, Henri] Le Havre Hosp, Pediat Dept, Le Havre, France.
   [Barth, Magalie] Angers Hosp, Pediat Dept, Angers, France.
   [Damaj, Lena] Rennes Hosp, Pediat Dept, Rennes, France.
   [Abi-Warde, Marie-Therese] Strasbourg Hosp, Pediat Dept, Strasbourg, France.
   [Afenjar, Alexandra] Trousseau Hosp, APHP, Reference Ctr Cerebellar Malformat & Congenital D, Paris, France.
   [Hubas, Arnaud; Nusbaum, Patrick] Hop Cochin, Lab Culture Cellulaire, Genet & Mol Biol, Paris, France.
   [Gobin, Stephanie] Necker Enfants Malad Univ Hosp, APHP, Genet Dept, Paris, France.
   [Maltret, Alice] Necker Enfants Malad Univ Hosp, APHP, Cardiol Unit, Paris, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Universite Paris Cite; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Hopital Universitaire Cochin - APHP;
   Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante
   et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Cochin - APHP;
   Hopital Universitaire Hotel-Dieu - APHP; Hopital Universitaire
   Necker-Enfants Malades - APHP; Aix-Marseille Universite; Assistance
   Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance
   Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants
   Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Universite de
   Rouen Normandie; CHU de Rouen; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Hopital Universitaire Hotel-Dieu - APHP; Hopital
   Universitaire Cochin - APHP; Universite Paris Cite; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite d'Angers;
   Centre Hospitalier Universitaire d'Angers; Universite de Rennes; CHU
   Rennes; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Sorbonne
   Universite; Hopital Universitaire Armand-Trousseau - APHP; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Cochin - APHP; Hopital
   Universitaire Necker-Enfants Malades - APHP; Hopital Universitaire
   Hotel-Dieu - APHP; Assistance Publique Hopitaux Paris (APHP); Universite
   Paris Cite; Hopital Universitaire Hotel-Dieu - APHP; Hopital
   Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants
   Malades - APHP
RP de Lonlay, P (corresponding author), Hop Necker Enfants Malad, Metab Unit, 149 Rue Sevres, F-75015 Paris, France.
EM pdelonlay@neuf.fr
RI boddaert, nathalie/GWV-2865-2022; Stoupa, Athanasia/JCE-5011-2023; van
   Endert, Peter/R-4606-2017; Ottolenghi, Chris/H-3745-2017
OI benoist, jean-francois/0000-0002-5389-8585; van Endert,
   Peter/0000-0003-3782-0750; Stoupa, Athanasia/0000-0002-1164-5862;
   Ottolenghi, Chris/0000-0002-0734-344X
FU Agence Nationale de la Recherche [ANR - AAPG 2018 CE17 MetabInf];
   Association Francaise contre les Myopathies [19773]; Erreurs Innees du
   Metabolisme (SFEIM); Societe Francaise de Pediatrie (SFP); Fondation
   Jerome Lejeune; Fondation maladies rares; Nos Anges; No Myolyse; AMMI;
   OPPH; TANGO2 family associations; TANGO2 fundation; Hyperinsulinisme;
   Noa Luu
FX Agence Nationale de la Recherche, Grant/Award Number: ANR - AAPG 2018
   CE17 MetabInf; Association Francaise contre les Myopathies, Grant/Award
   Number: 19773; Erreurs Innees du Metabolisme (SFEIM) and Societe
   Francaise de Pediatrie (SFP); Fondation Jerome Lejeune, Grant/Award
   Number: grants 2014 2017; Fondation maladies rares; patient associations
   (Nos Anges, No Myolyse, AMMI, OPPH, TANGO2 family associations, TANGO2
   fundation, Hyperinsulinisme, Noa Luu)
CR Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377
   Dines JN, 2019, GENET MED, V21, P601, DOI 10.1038/s41436-018-0137-y
   DING ZF, 2013, SCI REP UK, V3
   Habarou F, 2017, AM J HUM GENET, V101, P283, DOI 10.1016/j.ajhg.2017.07.001
   Hume-Smith HV, 2008, ANESTH ANALG, V107, P806, DOI 10.1213/ane.0b013e3181815ce3
   Jennions E, 2019, J INHERIT METAB DIS, V42, P898, DOI 10.1002/jimd.12149
   Kloesel B, 2011, CAN J ANESTH, V58, P824, DOI 10.1007/s12630-011-9546-y
   Kremer LS, 2016, AM J HUM GENET, V98, P358, DOI 10.1016/j.ajhg.2015.12.009
   Lalani SR, 2016, AM J HUM GENET, V98, P347, DOI 10.1016/j.ajhg.2015.12.008
   Maynard TM, 2008, MOL CELL NEUROSCI, V39, P439, DOI 10.1016/j.mcn.2008.07.027
   Meisner JK, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/CIRCGEN.120.002928
   Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021
   Mingirulli N, 2020, J INHERIT METAB DIS, V43, P297, DOI 10.1002/jimd.12156
   Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Scuotto Frederico, 2020, HeartRhythm Case Rep, V6, P256, DOI 10.1016/j.hrcr.2020.01.007
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001
NR 18
TC 29
Z9 29
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD MAR
PY 2021
VL 44
IS 2
BP 415
EP 425
DI 10.1002/jimd.12314
EA SEP 2020
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA RF6NN
UT WOS:000574439900001
PM 32929747
DA 2024-11-01
ER

PT J
AU Bartman, S
   Coppotelli, G
   Ross, JM
AF Bartman, Sydney
   Coppotelli, Giuseppe
   Ross, Jaime M.
TI Mitochondrial Dysfunction: A Key Player in Brain Aging and Diseases
SO CURRENT ISSUES IN MOLECULAR BIOLOGY
LA English
DT Review
DE mitochondria; mitochondrial dysfunction; aging; neurodegenerative
   diseases
ID OXIDATIVE STRESS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODEL;
   CALORIC RESTRICTION; CYTOCHROME-C; HUNTINGTONS-DISEASE; TRANSGENIC
   MODEL; SKELETAL-MUSCLE; DNA MUTATIONS
AB Mitochondria are thought to have become incorporated within the eukaryotic cell approximately 2 billion years ago and play a role in a variety of cellular processes, such as energy production, calcium buffering and homeostasis, steroid synthesis, cell growth, and apoptosis, as well as inflammation and ROS production. Considering that mitochondria are involved in a multitude of cellular processes, mitochondrial dysfunction has been shown to play a role within several age-related diseases, including cancers, diabetes (type 2), and neurodegenerative diseases, although the underlying mechanisms are not entirely understood. The significant increase in lifespan and increased incidence of age-related diseases over recent decades has confirmed the necessity to understand the mechanisms by which mitochondrial dysfunction impacts the process of aging and age-related diseases. In this review, we will offer a brief overview of mitochondria, along with structure and function of this important organelle. We will then discuss the cause and consequence of mitochondrial dysfunction in the aging process, with a particular focus on its role in inflammation, cognitive decline, and neurodegenerative diseases, such as Huntington's disease, Parkinson's disease, and Alzheimer's disease. We will offer insight into therapies and interventions currently used to preserve or restore mitochondrial functioning during aging and neurodegeneration.
C1 [Bartman, Sydney; Coppotelli, Giuseppe; Ross, Jaime M.] Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA.
   [Bartman, Sydney; Coppotelli, Giuseppe; Ross, Jaime M.] Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.
C3 University of Rhode Island; University of Rhode Island
RP Coppotelli, G; Ross, JM (corresponding author), Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA.; Coppotelli, G; Ross, JM (corresponding author), Univ Rhode Isl, Coll Pharm, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA.
EM gcoppotelli@uri.edu; jaime_ross@uri.edu
RI Ross, Jaime/A-6893-2012
FU National Institute on Aging
FX Figures were created with BioRender and Figure 2A was adapted from the
   "Human mtDNA Sequence Map" available on BioRender.
CR Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004
   Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005
   Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2
   Aidt Frederik Heurlin, 2013, PLoS Curr, V5, DOI 10.1371/currents.hd.d8917b4862929772c5a2f2a34ef1c201
   Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107
   Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204
   Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018
   Amartuvshin O, 2020, AGING CELL, V19, DOI 10.1111/acel.13191
   Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS58, DOI 10.1038/sj.ejcn.1602300
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Ayyub SA, 2020, RNA BIOL, V17, P165, DOI 10.1080/15476286.2019.1690099
   Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Bang E, 2022, J NEUROSCI, V42, P1020, DOI 10.1523/JNEUROSCI.1442-21.2021
   Banoth B, 2018, TRANSL RES, V202, P52, DOI 10.1016/j.trsl.2018.07.014
   Bar-Yaacov D, 2012, BBA-GENE REGUL MECH, V1819, P1107, DOI 10.1016/j.bbagrm.2011.10.008
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819
   Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a
   Becanovic K, 2021, NPJ AGING MECH DIS, V7, DOI 10.1038/s41514-021-00079-2
   Berridge MJ, 2017, J PHYSIOL-LONDON, V595, P6825, DOI 10.1113/JP274887
   Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004
   Branch SY, 2016, J NEUROSCI, V36, P4026, DOI 10.1523/JNEUROSCI.1395-15.2016
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8
   Brown GC, 2015, EMBO REP, V16, P137, DOI 10.15252/embr.201439518
   Brown MR, 2004, J BIOENERG BIOMEMBR, V36, P401, DOI 10.1023/B:JOBB.0000041775.10388.23
   BUCANA CD, 1974, TISSUE CELL, V6, P85, DOI 10.1016/0040-8166(74)90024-X
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Burtscher J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155412
   Businaro Rita, 2012, Curr Gerontol Geriatr Res, V2012, P986823, DOI 10.1155/2012/986823
   Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040
   Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang PS, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.910289
   Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959
   Chen C, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020038
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chen KQ, 2017, J AUTOIMMUN, V85, P64, DOI 10.1016/j.jaut.2017.06.012
   Chen LZ, 2019, AGING-US, V11, P10242, DOI 10.18632/aging.102451
   Chiareli RA, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.665795
   Chmielewski PP, 2020, BIOGERONTOLOGY, V21, P125, DOI 10.1007/s10522-019-09839-w
   Cho J, 2011, EXP GERONTOL, V46, P331, DOI 10.1016/j.exger.2010.08.010
   Choe YM, 2023, ALZHEIMERS RES THER, V15, DOI 10.1186/s13195-023-01293-8
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   Colak E, 2017, J CLIN BIOCHEM NUTR, V60, P100, DOI 10.3164/jcbn.16-30
   Colizzi C, 2019, ALZH DEMENT-TRCI, V5, P184, DOI 10.1016/j.trci.2018.09.002
   Collin F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102407
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Coppotelli G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050711
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae
   Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   de Barcelos IP, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020028
   de Cabo R, 2019, NEW ENGL J MED, V381, P2541, DOI 10.1056/NEJMra1905136
   de Oliveira LG, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.624919
   Deota S, 2023, CELL METAB, V35, P150, DOI 10.1016/j.cmet.2022.12.006
   Deshwal S, 2020, ANNU REV BIOCHEM, V89, P501, DOI 10.1146/annurev-biochem-062917-012739
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Dharmalingam Mala, 2011, Indian J Endocrinol Metab, V15, P9, DOI 10.4103/2230-8210.77571
   Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961
   Dias GP, 2021, MOL PSYCHIATR, V26, P6365, DOI 10.1038/s41380-021-01102-4
   Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Ding L, 2015, INT J MOL SCI, V16, P10870, DOI 10.3390/ijms160510870
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021
   Djordjevic J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061541
   Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Dumont M, 2011, J ALZHEIMERS DIS, V27, P211, DOI 10.3233/JAD-2011-110209
   Duncan T, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0567-5
   Edgar D, 2009, AGING-US, V1, P1028, DOI 10.18632/aging.100109
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296
   elsevier, Polyphenols in Human Health and Disease, V1st
   Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546
   ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3
   Faitg J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00420
   Fakouri NB, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020035
   Femminella GD, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3259-x
   Finch CE., 2000, CHANCE DEV AGING
   Finkbeiner S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007476
   Firenzuoli F, 2007, EVID-BASED COMPL ALT, V4, P37, DOI 10.1093/ecam/nem096
   Flones IH, 2018, ACTA NEUROPATHOL, V135, P409, DOI 10.1007/s00401-017-1794-7
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Furukawa K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01479
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x
   García ML, 2013, J NEUROL SCI, V330, P18, DOI 10.1016/j.jns.2013.03.019
   Garcia S, 2018, AGING CELL, V17, DOI 10.1111/acel.12707
   Gentile F, 2017, AIMS GENET, V4, P103, DOI 10.3934/genet.2017.2.103
   Ghosh S, 2011, DIABETES, V60, P2051, DOI 10.2337/db11-0121
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655
   Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414
   GOODRICK CL, 1990, MECH AGEING DEV, V55, P69, DOI 10.1016/0047-6374(90)90107-Q
   Götz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832
   Grimolizzi F, 2018, HAEMATOLOGICA, V103, P1586, DOI 10.3324/haematol.2018.196097
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gudden J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093166
   Guo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32581
   Hall AM, 2012, BRAIN RES BULL, V88, P3, DOI 10.1016/j.brainresbull.2011.11.017
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hauser DN, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0075-14.2015
   Hawkins KE, 2019, WORLD J STEM CELLS, V11, P236, DOI 10.4252/wjsc.v11.i5.236
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Henderson ST, 2020, J ALZHEIMERS DIS, V75, P547, DOI 10.3233/JAD-191302
   Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3
   Holbrook JA, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.643254
   Holtze S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.660959
   Hsieh PC, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1281
   Huang YD, 2014, NEUROBIOL DIS, V72, P3, DOI 10.1016/j.nbd.2014.08.025
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006
   Jeppesen TD, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00349
   Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khatoon R, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134376
   Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Kriebel M, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00043
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kulic L, 2011, NEUROBIOL AGING, V32, P1827, DOI 10.1016/j.neurobiolaging.2009.10.014
   Kulkarni AS, 2018, AGING CELL, V17, DOI 10.1111/acel.12723
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000
   Laberge RM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.199
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lasserre JP, 2015, DIS MODEL MECH, V8, P509, DOI 10.1242/dmm.020438
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lei YJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe7548
   LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060
   Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008
   Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447
   Li ZX, 2023, EUR J PHARM BIOPHARM, V182, P41, DOI 10.1016/j.ejpb.2022.11.022
   Liraz O, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-16
   Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   MACAYA A, 1994, P NATL ACAD SCI USA, V91, P8117, DOI 10.1073/pnas.91.17.8117
   Madsen PM, 2017, J NEUROSCI, V37, P10185, DOI 10.1523/JNEUROSCI.1378-17.2017
   Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050
   Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x
   Marchi S, 2023, NAT REV IMMUNOL, V23, P159, DOI 10.1038/s41577-022-00760-x
   Markaki M, 2017, AUTOPHAGY: CANCER, OTHER PATHOLOGIES, INFLAMMATION, IMMUNITY, INFECTION, AND AGING, VOL 12, P123, DOI 10.1016/B978-0-12-812146-7.00002-0
   Martín M, 2000, J PINEAL RES, V28, P242, DOI 10.1034/j.1600-079X.2000.280407.x
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Masters Alina, 2014, Brain Disord Ther, V4
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   Mattar JM, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073921
   Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892
   Mattison JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14063
   Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   McClean PL, 2014, NEUROPHARMACOLOGY, V76, P57, DOI 10.1016/j.neuropharm.2013.08.005
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Mhyre Timothy R, 2012, Subcell Biochem, V65, P389, DOI 10.1007/978-94-007-5416-4_16
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032
   Mor DE, 2020, P NATL ACAD SCI USA, V117, P26438, DOI 10.1073/pnas.2009838117
   Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006
   Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020040
   Nilsson MI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210863
   Niu X, 2007, EXP CELL RES, V313, P3924, DOI 10.1016/j.yexcr.2007.05.029
   Nopoulos PC, 2016, DIALOGUES CLIN NEURO, V18, P91
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3
   Oettinghaus B, 2016, CELL DEATH DIFFER, V23, P18, DOI 10.1038/cdd.2015.39
   Oliveira JMA, 2007, J NEUROCHEM, V101, P241, DOI 10.1111/j.1471-4159.2006.04361.x
   Oliveira JMA, 2006, J NEUROSCI, V26, P11174, DOI 10.1523/JNEUROSCI.3004-06.2006
   Omodei D, 2011, FEBS LETT, V585, P1537, DOI 10.1016/j.febslet.2011.03.015
   Onyango IG, 2016, AGING DIS, V7, P201, DOI 10.14336/AD.2015.1007
   Papa S, 2012, ADV EXP MED BIOL, V942, P3, DOI 10.1007/978-94-007-2869-1_1
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Park JS, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0829-3
   Park JS, 2014, HUM MOL GENET, V23, P2802, DOI 10.1093/hmg/ddt623
   Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222
   Peng Y, 2010, J NEUROSCI, V30, P8180, DOI 10.1523/JNEUROSCI.0340-10.2010
   Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500
   Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665
   Picca A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050933
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763
   Pizzuto M, 2020, TRENDS CELL BIOL, V30, P892, DOI 10.1016/j.tcb.2020.09.004
   Pullerits R, 2005, RHEUMATOLOGY, V44, P32, DOI 10.1093/rheumatology/keh406
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X
   Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588
   Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111
   Quintana FJ, 2005, J IMMUNOL, V175, P2777, DOI 10.4049/jimmunol.175.5.2777
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rabin JS, 2019, JAMA NEUROL, V76, P1203, DOI 10.1001/jamaneurol.2019.1879
   Raoof M, 2010, J TRAUMA, V68, P1328, DOI 10.1097/TA.0b013e3181dcd28d
   Rattray I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084726
   Rebrin I, 2007, BRAIN RES, V1127, P10, DOI 10.1016/j.brainres.2006.10.040
   Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001
   Reimers C D, 2012, J Aging Res, V2012, P243958, DOI 10.1155/2012/243958
   Ricca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061672
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   Romero-Garcia S, 2019, INT J ONCOL, V54, P1155, DOI 10.3892/ijo.2019.4696
   Ross JM, 2024, BIOMOLECULES, V14, DOI 10.3390/biom14020162
   Ross JM, 2019, AGING CELL, V18, DOI 10.1111/acel.13029
   Ross JM, 2015, INT J MOL SCI, V16, P19458, DOI 10.3390/ijms160819458
   Ross JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06569
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6
   Roy J, 2022, FRONT NEUROENDOCRIN, V65, DOI 10.1016/j.yfrne.2022.100986
   Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657
   Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005
   Salim S, 2017, J PHARMACOL EXP THER, V360, P201, DOI 10.1124/jpet.116.237503
   Sams Eleanor Catherine, 2021, Neuronal Signal, V5, pNS20210008, DOI 10.1042/NS20210008
   Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Schmukler E, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02776-4
   Scott L, 2022, J NEUROSCI, V42, P9263, DOI 10.1523/JNEUROSCI.0545-22.2022
   Sebastián D, 2016, EMBO J, V35, P1677, DOI 10.15252/embj.201593084
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00694
   Sharma P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020100
   Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shin SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123030
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sikora E, 2021, FRONT AGING NEUROSCI, V13, DOI 10.3389/fnagi.2021.646924
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169
   Snezhkina AV, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6175804
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Son HG, 2019, AGING CELL, V18, DOI 10.1111/acel.12853
   SOONG NW, 1992, NAT GENET, V2, P318
   Spindler M, 2009, NEUROPSYCH DIS TREAT, V5, P597
   Srivastava S, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120398
   Stan AD, 2006, BRAIN RES, V1123, P1, DOI 10.1016/j.brainres.2006.09.025
   Stauch KL, 2014, AGING-US, V6, P320, DOI 10.18632/aging.100657
   Stefano GB, 2017, ADV EXP MED BIOL, V982, P577, DOI 10.1007/978-3-319-55330-6_30
   Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537
   Strobbe D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00068
   Stuart Jeffrey A, 2014, Longev Healthspan, V3, P4, DOI 10.1186/2046-2395-3-4
   Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Tan DX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122124
   Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986
   TELLEZNAGEL I, 1974, J NEUROPATH EXP NEUR, V33, P308, DOI 10.1097/00005072-197404000-00008
   Terock J, 2022, PSYCHIAT RES-NEUROIM, V327, DOI 10.1016/j.pscychresns.2022.111558
   Tezze C, 2017, CELL METAB, V25, P1374, DOI 10.1016/j.cmet.2017.04.021
   Tönnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088
   Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vaittinen M, 2023, DIABETES RES CLIN PR, V199, DOI 10.1016/j.diabres.2023.110635
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072
   Van Raamsdonk JM, 2007, BRAIN RES BULL, V72, P124, DOI 10.1016/j.brainresbull.2006.10.018
   VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X
   Varela-López A, 2016, MOLECULES, V21, DOI 10.3390/molecules21030373
   Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369
   Wan M, 2014, ATHEROSCLEROSIS, V235, P592, DOI 10.1016/j.atherosclerosis.2014.05.913
   Wang XL, 2014, BBA-MOL BASIS DIS, V1842, P1240, DOI 10.1016/j.bbadis.2013.10.015
   Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003
   Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105
   Wang ZT, 2023, ZOOL RES, V44, P559, DOI 10.24272/j.issn.2095-8137.2022.406
   Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003
   Waziry R, 2023, NATURE AGING, V3, P248, DOI 10.1038/s43587-022-00357-y
   Weber D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1401452
   Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   Weidling I, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020039
   Weinrich TW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48383-y
   Wenceslau CF, 2016, PULM PHARMACOL THER, V37, P49, DOI 10.1016/j.pupt.2016.02.005
   Wenceslau CF, 2015, AM J PHYSIOL-HEART C, V308, pH768, DOI 10.1152/ajpheart.00779.2014
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   Will Y, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020032
   Will Y, 2014, EXPERT OPIN DRUG MET, V10, P1061, DOI 10.1517/17425255.2014.939628
   Wimalawansa S., 2012, Sri Lanka J. Diabetes Endocrinol. Metab, V2, P73, DOI [10.4038/sjdem.v2i2.4776, DOI 10.4038/SJDEM.V2I2.4776]
   Wimalawansa SJ, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020030
   Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013
   Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860
   Wu YB, 2019, MITOCHONDRION, V49, P35, DOI 10.1016/j.mito.2019.07.003
   Xu Y, 2020, AUTOPHAGY, V16, P3, DOI 10.1080/15548627.2019.1603547
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Yuan Y, 2018, FRONT COMPUT NEUROSC, V12, DOI 10.3389/fncom.2018.00079
   Zeng XS, 2018, ASN NEURO, V10, DOI 10.1177/1759091418777438
   Zhang HJ, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.1077249
   Zhang HQ, 2017, FREE RADICAL BIO MED, V111, P219, DOI 10.1016/j.freeradbiomed.2016.11.032
   Zhang XD, 2016, ELIFE, V5, DOI 10.7754/eLife.13374
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 319
TC 5
Z9 5
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1467-3037
EI 1467-3045
J9 CURR ISSUES MOL BIOL
JI Curr. Issues Mol. Biol.
PD MAR
PY 2024
VL 46
IS 3
BP 1987
EP 2026
DI 10.3390/cimb46030130
PG 40
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA MD1W8
UT WOS:001191607700001
PM 38534746
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wen, SZ
   Niedzwiecka, K
   Zhao, WW
   Xu, ST
   Liang, SS
   Zhu, XD
   Xie, HL
   Tribouillard-Tanvier, D
   Giraud, MF
   Zeng, CH
   Dautant, A
   Kucharczyk, R
   Liu, ZH
   di Rago, JP
   Chen, HM
AF Wen, Shuzhen
   Niedzwiecka, Katarzyna
   Zhao, Weiwei
   Xu, Shutian
   Liang, Shaoshan
   Zhu, Xiaodong
   Xie, Honglang
   Tribouillard-Tanvier, Deborah
   Giraud, Marie-France
   Zeng, Caihong
   Dautant, Alain
   Kucharczyk, Roza
   Liu, Zhihong
   di Rago, Jean-Paul
   Chen, Huimei
TI Identification of G8969>A in mitochondrial <i>ATP6</i> gene that
   severely compromises ATP synthase function in a patient with IgA
   nephropathy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID YEAST MODEL; MUTATION; DNA; DISEASE; PATHOGENESIS; DISORDERS; DEFECTS;
   DEFICIENCY; MECHANISMS; PROTEINS
AB Here we elucidated the pathogenesis of a 14-year-old Chinese female who initially developed an isolated nephropathy followed by a complex clinical presentation with brain and muscle problems, which indicated that the disease process was possibly due to a mitochondrial dysfunction. Careful evaluation of renal biopsy samples revealed a decreased staining of cells induced by COX and NADH dehydrogenase activities, and a strong fragmentation of the mitochondrial network. These anomalies were due to the presence of a mutation in the mitochondrial ATP6 gene, G8969>A. This mutation leads to replacement of a highly conserved serine residue at position 148 of the a-subunit of ATP synthase. Increasing the mutation load in cybrid cell lines was paralleled by the appearance of abnormal mitochondrial morphologies, diminished respiration and enhanced production of reactive oxygen species. An equivalent of the G8969>A mutation in yeast had dramatic consequences on ATP synthase, with a block in proton translocation. The mutation was particularly abundant (89%) in the kidney compared to blood and urine, which is likely the reason why this organ was affected first. Based on these findings, we suggest that nephrologists should pay more attention to the possibility of a mitochondrial dysfunction when evaluating patients suffering from kidney problems.
C1 [Wen, Shuzhen; Zhao, Weiwei; Xu, Shutian; Liang, Shaoshan; Zhu, Xiaodong; Xie, Honglang; Zeng, Caihong; Liu, Zhihong; Chen, Huimei] Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.
   [Niedzwiecka, Katarzyna; Kucharczyk, Roza] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.
   [Tribouillard-Tanvier, Deborah; Giraud, Marie-France; Dautant, Alain; di Rago, Jean-Paul] Inst Biochimie & Genet Cellulaires, CNRS, UMR 5095, F-33077 Bordeaux, France.
   [Tribouillard-Tanvier, Deborah; Giraud, Marie-France; Dautant, Alain; di Rago, Jean-Paul] Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France.
   [Tribouillard-Tanvier, Deborah] Inst Biochimie & Genet Cellulaires, INSERM, F-33077 Bordeaux, France.
C3 Nanjing University; Polish Academy of Sciences; Institute of
   Biochemistry & Biophysics - Polish Academy of Sciences; Centre National
   de la Recherche Scientifique (CNRS); CNRS - National Institute for
   Biology (INSB); Universite de Bordeaux; Centre National de la Recherche
   Scientifique (CNRS); CNRS - National Institute for Biology (INSB);
   Universite de Bordeaux; Institut National de la Sante et de la Recherche
   Medicale (Inserm)
RP Liu, ZH; Chen, HM (corresponding author), Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, Nanjing, Jiangsu, Peoples R China.; di Rago, JP (corresponding author), Inst Biochimie & Genet Cellulaires, CNRS, UMR 5095, F-33077 Bordeaux, France.; di Rago, JP (corresponding author), Univ Bordeaux, IBGC, UMR 5095, F-33077 Bordeaux, France.
EM liuzhihong@nju.edu.cn; jp.dirago@ibgc.cnrs.fr; chenhuimei@nju.edu.cn
RI zhao, wei/IQS-1144-2023; Kucharczyk, Roza/H-8154-2012; Lin,
   Fan/JZT-1441-2024
OI Niedzwiecka, Katarzyna/0000-0002-9482-3918; Liu,
   Zhi-Hong/0000-0001-6093-0726; Chen, Huimei/0000-0001-7788-1334;
   Kucharczyk, Roza/0000-0002-8712-7535; Tribouillard-Tanvier,
   Deborah/0000-0002-2290-5375
FU National Basic Research Program of China 973 Program [2012CB517600,
   2012CB517606]; National Natural Science Foundation (NSF) Grant
   [81370788, 8151101098]; Scientific Research Foundation for the Returned
   Overseas Chinese Scholars, SEM; FRM (Fondation pour la Recherche
   Medicale); AFM (Association Francaise contre les Myopathies); Agence
   Nationale de la Recherche [ANR-12-BSV8-024]; National Science Center of
   Poland [UMO-2013/11/B/NZ1/02102]
FX This work was supported in part by National Basic Research Program of
   China 973 Program No. 2012CB517600 (No. 2012CB517606) (to Z.L.),
   National Natural Science Foundation (NSF) Grant 81370788 & 8151101098
   (to H.C.) and Scientific Research Foundation for the Returned Overseas
   Chinese Scholars, SEM (to H.C., 2012). This work was also funded by
   grants from FRM (Fondation pour la Recherche Medicale) and AFM
   (Association Francaise contre les Myopathies) to J.-P.dR, Agence
   Nationale de la Recherche to M.-F.G. and A.D. (ANR-12-BSV8-024), and by
   National Science Center of Poland (UMO-2013/11/B/NZ1/02102) to R.K. We
   thank for Professor Bin Lu (Wenzhou Medical University) for technical
   support for the rho<SUP>0</SUP> cell construct and Seahorse XF96
   Extracellular Flux Analyser. We are grateful to Jean-Paul Lasserre for a
   critical reading of the manuscript and James Tolchard for English
   revision.
CR ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952
   Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185
   Bietenhader M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002876
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3
   Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x
   Guerin B, 1979, Methods Enzymol, V55, P149
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850
   Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256
   Jin B, 2014, NEPHROL DIAL TRANSPL, V29, P2251, DOI 10.1093/ndt/gfu239
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Kucharczyk R, 2013, INT J BIOCHEM CELL B, V45, P130, DOI 10.1016/j.biocel.2012.07.001
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   Lightowlers RN, 2014, FEBS LETT, V588, P2496, DOI 10.1016/j.febslet.2014.05.054
   Magistroni R, 2015, KIDNEY INT, V88, P974, DOI 10.1038/ki.2015.252
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Morales-Rios E, 2015, P NATL ACAD SCI USA, V112, P13231, DOI 10.1073/pnas.1517542112
   Morava E, 2006, AM J MED GENET A, V140A, P863, DOI 10.1002/ajmg.a.31194
   Nijtmans LGJ, 2001, J BIOL CHEM, V276, P6755, DOI 10.1074/jbc.M008114200
   Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613
   Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200
   RIGOULET M, 1979, FEBS LETT, V102, P18, DOI 10.1016/0014-5793(79)80919-9
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rötig A, 2003, J NEPHROL, V16, P286
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006
   Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x
   Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   VIK SB, 1988, J BIOL CHEM, V263, P6599
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107
   White KE, 2012, MICRON, V43, P1001, DOI 10.1016/j.micron.2012.04.013
   Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd
   Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180
NR 51
TC 25
Z9 27
U1 0
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 4
PY 2016
VL 6
AR 36313
DI 10.1038/srep36313
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EB0FD
UT WOS:000387017900001
PM 27812026
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Nido, GS
   Dölle, C
   Flones, I
   Tuppen, HA
   Alves, G
   Tysnes, OB
   Haugarvoll, K
   Tzoulis, C
AF Nido, Gonzalo S.
   Dolle, Christian
   Flones, Irene
   Tuppen, Helen A.
   Alves, Guido
   Tysnes, Ole-Bjorn
   Haugarvoll, Kristoffer
   Tzoulis, Charalampos
TI Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's
   disease
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE Parkinson's disease; Mitochondrial DNA; Deletions; Neurodegeneration
ID DNA-SEQUENCING DATA; SUBSTANTIA-NIGRA; MUSCLE-FIBERS; REPLICATION;
   MTDNA; FRAMEWORK; CELLS
AB Mitochondrial DNA (mtDNA) deletions accumulate with age in postmitotic cells and are associated with aging and neurodegenerative disorders such as Parkinson's disease. Although the exact mechanisms by which deletions form remain elusive, the dominant theory is that they arise spontaneously at micro-homologous sites and undergo clonal expansion. We characterize mtDNA deletions at unprecedented resolution in individual substantia nigra neurons from individuals with Parkinson's disease, using ultradeep sequencing. We show that the number of deleted mtDNA species per neuron is substantially higher than previously reported. Moreover, each deleted mtDNA species shows significant differences in sequence composition compared with the remaining mtDNA population, which is highly consistent with independent segregation and clonal expansion. Deletion breakpoints occur consistently in regions of sequence homology, which may be direct or interrupted stretches of tandem repeats. While our results support a crucial role for misannealing in deletion generation, we find no overrepresentation of the 3'-repeat sequence, an observation that is difficult to reconcile with the current view of replication errors as the source of mtDNA deletions. (C) 2017 The Author(s). Published by Elsevier Inc.
C1 [Nido, Gonzalo S.; Dolle, Christian; Flones, Irene; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Tzoulis, Charalampos] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Nido, Gonzalo S.; Dolle, Christian; Flones, Irene; Tysnes, Ole-Bjorn; Haugarvoll, Kristoffer; Tzoulis, Charalampos] Univ Bergen, Dept Clin Med, Bergen, Norway.
   [Tuppen, Helen A.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Alves, Guido] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway.
   [Alves, Guido] Stavanger Univ Hosp, Dept Neurol, Stavanger, Norway.
   [Alves, Guido] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; Newcastle University - UK; Stavanger University Hospital;
   Stavanger University Hospital; Universitetet i Stavanger
RP Tzoulis, C (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM charalampos.tzoulis@nevro.uib.no
RI Alves, Guido/AAB-4015-2020; Haugarvoll, Kristoffer/AAB-5860-2019;
   Tzoulis, Charalampos/AGD-5114-2022; Haugarvoll, Kristoffer/L-1486-2015
OI Tzoulis, Charalampos/0000-0003-0341-5191; Tuppen,
   Helen/0000-0001-8762-0824; Alves, Guido/0000-0003-0630-2870; Flones,
   Irene/0000-0001-9612-0696; Haugarvoll, Kristoffer/0000-0001-9381-1109
FU Regional Health Authority of Western Norway [911903, 911988]; Research
   Council of Norway [240369/F20]
FX The authors are grateful to Professor Laurence Bindoff for the
   insightful discussions and help accessing essential material. This work
   was supported by grants from the Regional Health Authority of Western
   Norway (grant no. 911903 and 911988) and the Research Council of Norway
   (grant no. 240369/F20). We thank patients and family for contributing to
   this study.
CR Alves G, 2009, J NEUROL NEUROSUR PS, V80, P851, DOI 10.1136/jnnp.2008.168211
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   Damas J, 2014, NUCLEIC ACIDS RES, V42, pD1261, DOI 10.1093/nar/gkt982
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Guo XH, 2010, TRENDS GENET, V26, P340, DOI 10.1016/j.tig.2010.05.006
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kowald A, 2014, P NATL ACAD SCI USA, V111, P2972, DOI 10.1073/pnas.1314970111
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1
   Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591
   Martin M., 2011, EMBnet.journal, V17, P10, DOI 10.14806/ej.17.1.200
   Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810
   Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   VAZQUEZACEVEDO M, 1995, BBA-MOL BASIS DIS, V1271, P363, DOI 10.1016/0925-4439(95)00062-9
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118
NR 30
TC 39
Z9 42
U1 4
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD MAR
PY 2018
VL 63
BP 120
EP 127
DI 10.1016/j.neurobiolaging.2017.10.024
PG 8
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA FX0PW
UT WOS:000425749100012
PM 29257976
OA hybrid
DA 2024-11-01
ER

PT J
AU Pfeffer, G
   Majamaa, K
   Turnbull, DM
   Thorburn, D
   Chinnery, PF
AF Pfeffer, Gerald
   Majamaa, Kari
   Turnbull, Douglass M.
   Thorburn, David
   Chinnery, Patrick F.
TI Treatment for mitochondrial disorders
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Creatine [therapeutic use]; Dichloroacetate [therapeutic use];
   Mitochondrial Diseases [drug therapy]; Sarcosine [analogs & derivatives;
   therapeutic use]; Ubiquinone [therapeutic use]; Humans
ID COMPLEX-I DEFICIENCY; STROKE-LIKE EPISODES; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; MAGNETIC-RESONANCE-SPECTROSCOPY; HEREDITARY OPTIC
   NEUROPATHY; CONGENITAL LACTIC-ACIDOSIS; COENZYME Q(10) TREATMENT;
   KEARNS-SAYRE SYNDROME; DOUBLE-BLIND; DNA MUTATIONS
AB Background
   Mitochondrial respiratory chain disorders are the most prevalent group of inherited neurometabolic diseases. They present with central and peripheral neurological features usually in association with other organ involvement including the eye, the heart, the liver, and kidneys, diabetes mellitus and sensorineural deafness. Current treatment is largely supportive and the disorders progress relentlessly causing significant morbidity and premature death. Vitamin supplements, pharmacological agents and exercise therapy have been used in isolated cases and small clinical trials, but the efficacy of these interventions is unclear. The first review was carried out in 2003, and identified six clinical trials. This major update was carried out to identify new studies and grade the original studies for potential bias in accordance with revised Cochrane Collaboration guidelines.
   Objectives
   To determine whether there is objective evidence to support the use of current treatments for mitochondrial disease.
   Search methods
   We searched the Cochrane Neuromuscular Disease Group Specialized Register (4 July 2011), CENTRAL (2011, Issue 2, MEDLINE (1966 to July 2011), and EMBASE (January 1980 to July 2011), and contacted experts in the field.
   Selection criteria
   We included randomised controlled trials (including cross-over studies). Two of the authors independently selected abstracts for further detailed review. Further review was performed independently by all five authors to decide which trials fit the inclusion criteria and graded risk of bias. Participants included males and females of any age with a confirmed diagnosis of mitochondrial disease based upon muscle histochemistry, respiratory chain complex analysis of tissues or cell lines or DNA studies. Interventions included any pharmacological agent, dietary modification, nutritional supplement, exercise therapy or other treatment. The review authors excluded studies at high risk of bias in any category. The primary outcome measures included an change in muscle strength and/or endurance, or neurological clinical features. Secondary outcome measures included quality of life assessments, biochemical markers of disease and negative outcomes.
   Data collection and analysis
   Two of the authors (GP and PFC) independently identified studies for further evaluation from all abstracts within the search period. For those studies identified for further review, all five authors then independently assessed which studies met the entry criteria. For the included studies, we extracted details of the number of randomised participants, treatment, study design, study category, allocation concealment and other risk of bias criteria, and participant characteristics. Analysis was based on intention-to-treat data. We planned to use meta-analysis, but this did not prove necessary.
   Main results
   The authors reviewed 1335 abstracts, and from these identified 21 potentially eligible abstracts. Upon detailed review, 12 studies fulfilled the entry criteria. Of these, eight were new studies that had been published since the previous version of this review. Two studies which were included in the previous version of this review were excluded because of potential for bias. The comparability of the included studies is extremely low because of differences in the specific diseases studied, differences in the therapeutic agents used, dosage, study design, and outcomes. The methodological quality of included studies was generally high, although risk of bias was unclear in random sequence generation and allocation concealment for most studies. Otherwise, the risk of bias was low for most studies in the other categories. Serious adverse events were uncommon, except for peripheral nerve toxicity in a long-term trial of dichloroacetate (DCA) in adults.
   One trial studied high-dose coenzyme Q10 without clinically meaningful improvement (although there were multiple biochemical, physiologic, and neuroimaging outcomes, in 30 participants). Three trials used creatine monohydrate alone, with one reporting evidence of improved measures of muscle strength and post-exercise lactate, but the other two reported no benefit (total of 38 participants). One trial studied the effects of a combination of coenzyme Q10, creatine monohydrate, and lipoic acid and reported a statistically significant improvement in biochemical markers and peak ankle dorsiflexion strength, but overall no clinical improvement in 16 participants. Five trials studied the effects of DCA: three trials in children showed a statistically significant improvement in secondary outcome measures of mitochondrial metabolism (venous lactate in three trials, and magnetic resonance spectroscopy (MRS) in one trial; total of 63 participants). One trial of short-term DCA in adults demonstrated no clinically relevant improvement (improved venous lactate but no change in physiologic, imaging, or questionnaire findings, in eight participants). One longer-term DCA trial in adults was terminated prematurely due to peripheral nerve toxicity without clinical benefit (assessments included the GATE score, venous lactate and MRS, in 30 participants). One trial using dimethylglycine showed no significant effect (measurements of venous lactate and oxygen consumption (VO2) in five participants). One trial using a whey-based supplement showed statistically significant improvement in markers of free radical reducing capacity but no clinical benefit (assessments included the Short Form 36 Health Survey (SF-36) questionnaire and UK Medical Research Council (MRC) muscle strength, in 13 participants).
   Authors' conclusions
   Despite identifying eight new trials there is currently no clear evidence supporting the use of any intervention in mitochondrial disorders. Further research is needed to establish the role of a wide range of therapeutic approaches. We suggest further research should identify novel agents to be tested in homogeneous study populations with clinically relevant primary endpoints.
C1 [Pfeffer, Gerald; Chinnery, Patrick F.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Pfeffer, Gerald] Univ British Columbia, Clinician Investigator Program, Vancouver, BC V5Z 1M9, Canada.
   [Majamaa, Kari] Univ Oulu, Inst Clin Med, Dept Neurol, Oulu, Finland.
   [Turnbull, Douglass M.] Newcastle Univ, Sch Med, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
   [Thorburn, David] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
C3 Newcastle University - UK; University of British Columbia; University of
   Oulu; Newcastle University - UK; Murdoch Children's Research Institute;
   Royal Children's Hospital Melbourne
RP Chinnery, PF (corresponding author), Newcastle Univ, Inst Med Genet, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.
EM p.f.chinnery@ncl.ac.uk
RI Majamaa, Kari/A-1344-2012; Thorburn, David/G-6266-2013
OI thorburn, david/0000-0002-7725-9470; Pfeffer,
   Gerald/0000-0002-7657-7098; Chinnery, Patrick/0000-0002-7065-6617;
   Majamaa, Kari/0000-0002-9070-3791; Turnbull, Doug/0000-0002-8878-9901
FU Medical Research Council (UK); Association Francaise contre les
   Myopathies; UK NIHR Biomedical Research Centre for Ageing and
   Age-related disease; MRC Centre for Neuromuscular Diseases; Muscular
   Dystrophy Campaign; Octapharma; Lundbeck; Wellcome Trust Centre for
   Mitochondrial Research [906919]; Newcastle University Centre for Brain
   Ageing and Vitality; BBSRC; EPSRC; ESRC; MRC as part of the
   cross-council Lifelong Health and Wellbeing Initiative [G0700718];
   Wellcome Trust, UK; Muscular Dystrophy Campaign, UK; Ataxia, UK;
   Association Francaise contre les myopathies, France; Council for Health
   Research, Finland; Sigrid Juselius Foundation, Finland; Australian
   National Health and Medical Research Council, Australia; Muscular
   Dystrophy Association, USA; Parkinson's UK, UK; National Institute for
   Health Research (NIHR), UK; Newcastle NIHR Biomedical Research Centre in
   ageing and age-related disease; MRC [G0700718] Funding Source: UKRI
FX With thanks to the staff of University of British Columbia libraries.
   PFC is a Wellcome Trust Senior Fellow in Clinical Science and a UK NIHR
   Senior Investigator who also receives funding from the Medical Research
   Council (UK), the Association Francaise contre les Myopathies, and the
   UK NIHR Biomedical Research Centre for Ageing and Age-related disease
   award to the Newcastle upon Tyne Foundation Hospitals NHS Trust.The
   editorial base of the Cochrane Neuromuscular Disease Group is supported
   by the MRC Centre for Neuromuscular Diseases and the Muscular Dystrophy
   Campaign.Kari Majamaa: has received funding for travel from Octapharma
   and Lundbeck and speaker honoraria from OrionPharma.Douglass Turnbull:
   our work was supported by The Wellcome Trust Centre for Mitochondrial
   Research (906919), the Newcastle University Centre for Brain Ageing and
   Vitality supported by BBSRC, EPSRC, ESRC and MRC as part of the
   cross-council Lifelong Health and Wellbeing Initiative
   (G0700718)External sourcesWellcome Trust, UK.Funding for PFC and
   DMTMuscular Dystrophy Campaign, UK.Funding for DRTMedical Research
   Council, UK.Funding for PFC and DMTAtaxia, UK.Association Francaise
   contre les myopathies, France.Funding for PFC and DMTCouncil for Health
   Research, Finland.Sigrid Juselius Foundation, Finland.Australian
   National Health and Medical Research Council, Australia.Funding for
   DRTMuscular Dystrophy Association, USA.Funding for DRTParkinson's UK,
   UK.Funding for PFC and DMTNational Institute for Health Research (NIHR),
   UK.Funding for PFC and DMT through the Newcastle NIHR Biomedical
   Research Centre in ageing and age-related disease
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   ABE K, 1991, ACTA NEUROL SCAND, V83, P356, DOI 10.1111/j.1600-0404.1991.tb03962.x
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Barshop BA, 2004, MOL GENET METAB, V83, P138, DOI 10.1016/j.ymgme.2004.06.009
   BENDAHAN D, 1992, NEUROLOGY, V42, P1203, DOI 10.1212/WNL.42.6.1203
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368
   Chen RS, 1997, EUR NEUROL, V37, P212, DOI 10.1159/000117445
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559
   Chinnery PF, 1998, AM J HUM GENET, V63, P1908, DOI 10.1086/302157
   Cortelli P, 1997, J NEUROL SCI, V148, P25, DOI 10.1016/S0022-510X(96)00311-5
   CURLESS RG, 1986, NEUROLOGY, V36, P872, DOI 10.1212/WNL.36.6.872
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   Duncan GE, 2004, J CLIN ENDOCR METAB, V89, P1733, DOI 10.1210/jc.2003-031684
   ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529
   Gimenes AC, 2007, EUROPEAN RESP J S51, pE297
   Glover EI, 2010, MUSCLE NERVE, V42, P739, DOI 10.1002/mus.21758
   Gold R, 1996, EUR NEUROL, V36, P191, DOI 10.1159/000117246
   GUBBAY SS, 1989, MED J AUSTRALIA, V151, P100, DOI 10.5694/j.1326-5377.1989.tb101170.x
   Hassani A, 2010, CURR OPIN NEUROL, V23, P459, DOI 10.1097/WCO.0b013e32833d1096
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HSU CC, 1995, ACTA NEUROL SCAND, V92, P252
   IHARA Y, 1989, J NEUROL SCI, V90, P263, DOI 10.1016/0022-510X(89)90112-3
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Klopstock T, 2000, NEUROLOGY, V55, P1748, DOI 10.1212/WNL.55.11.1748
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Kornblum C, 2005, EUR J NEUROL, V12, P300, DOI 10.1111/j.1468-1331.2004.00970.x
   KURLEMANN G, 1995, EUR J PEDIATR, V154, P928, DOI 10.1007/BF01957508
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3
   Liet JM, 2003, J PEDIATR-US, V142, P62, DOI 10.1067/mpd.2003.mpd0333
   LOU HC, 1981, ARCH NEUROL-CHICAGO, V38, P469, DOI 10.1001/archneur.1981.00510070103027
   MACMILLAN C, 1993, NEUROLOGY, V43, P1586, DOI 10.1212/WNL.43.8.1586
   Majamaa K, 1997, MOL CELL BIOCHEM, V174, P291, DOI 10.1023/A:1006833200371
   Mancuso M, 2010, J NEUROL, V257, P774, DOI 10.1007/s00415-009-5409-7
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   MASHIMA Y, 1992, LANCET, V340, P368, DOI 10.1016/0140-6736(92)91442-B
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   Mitsui T, 2002, ACTA NEUROPATHOL, V104, P260, DOI 10.1007/s00401-002-0553-5
   Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582
   Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Mori M, 2004, BRAIN DEV-JPN, V26, P453, DOI 10.1016/j.braindev.2003.12.009
   Mowat D, 1999, J PEDIATR-US, V134, P352, DOI 10.1016/S0022-3476(99)70463-4
   Muller W, 1990, NEUROLOGICAL SCI S, V9 8, P442
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   NISHIKAWA Y, 1989, NEUROLOGY, V39, P399, DOI 10.1212/WNL.39.3.399
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   OGASAHARA S, 1986, NEUROLOGY, V36, P45, DOI 10.1212/WNL.36.1.45
   OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38
   Papadimitriou A, 1996, NEUROMUSCULAR DISORD, V6, P49, DOI 10.1016/0960-8966(95)00020-8
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   Remes AM, 2002, NEUROLOGY, V59, P1275, DOI 10.1212/WNL.59.8.1275
   Rodriguez MC, 2007, MUSCLE NERVE, V35, P235, DOI 10.1002/mus.20688
   Rötig A, 2000, LANCET, V356, P391, DOI 10.1016/S0140-6736(00)02531-9
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952
   Sobreira C, 1997, NEUROLOGY, V48, P1238, DOI 10.1212/WNL.48.5.1238
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spinazzola A, 2009, ADV EXP MED BIOL, V652, P69, DOI 10.1007/978-90-481-2813-6_6
   Stacpoole PW, 2008, PEDIATRICS, V121, pE1223, DOI 10.1542/peds.2007-2062
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tarnopolsky M, 1999, NEUROLOGY, V52, P854, DOI 10.1212/WNL.52.4.854
   Tarnopolsky MA, 1997, MUSCLE NERVE, V20, P1502, DOI 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C
   Tucker EJ, 2010, CURR NEUROL NEUROSCI, V10, P277, DOI 10.1007/s11910-010-0112-8
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Zhu XY, 2009, ACTA BIOCH BIOPH SIN, V41, P179, DOI 10.1093/abbs/gmn021
NR 93
TC 240
Z9 256
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2012
IS 4
AR CD004426
DI 10.1002/14651858.CD004426.pub3
PG 44
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 928US
UT WOS:000303012500026
PM 22513923
OA Green Published
DA 2024-11-01
ER

PT J
AU Zhang, SB
   Maguire, D
   Zhang, M
   Zhang, ZH
   Zhang, A
   Yin, LJ
   Zhang, LR
   Huang, LQ
   Vidyasagar, S
   Swarts, S
   Okunieff, P
AF Zhang, Steven B.
   Maguire, David
   Zhang, Mei
   Zhang, Zhenhuan
   Zhang, Amy
   Yin, Liangjie
   Zhang, Lurong
   Huang, Luquiang
   Vidyasagar, Sadasivan
   Swarts, Steven
   Okunieff, Paul
TI The Murine Common Deletion: Mitochondrial DNA 3,860-bp Deletion after
   Irradiation
SO RADIATION RESEARCH
LA English
DT Article
ID HUMAN SKELETAL-MUSCLE; COPY NUMBER; OXIDATIVE STRESS; BP DELETION;
   CANCER; AGE; CELLS; RADIATION; INCREASE; DISEASE
AB This study demonstrates that mice, similar to humans, have a common mitochondrial DNA deletion (3,860 bp) that encodes 5 transfer RNA genes and 5 polypeptide genes that is related to aging, tissue type and radiotoxicity. Our research indicates that the deletion ratio in the liver was significantly higher than in the brain and gut tissues of 8-month-old mice, as compared to 8-week-old mice. Our results also demonstrate that tissue type, oxidative metabolic capacity and radiosensitivity influence the 3,860-bp deletion level. Therefore, this 3,860-bp deletion content may serve as a biomarker of aging and oxidative damage in mice. (C) 2013 by Radiation Research Society
C1 [Zhang, Steven B.; Maguire, David; Zhang, Mei; Zhang, Zhenhuan; Zhang, Amy; Yin, Liangjie; Zhang, Lurong; Huang, Luquiang; Vidyasagar, Sadasivan; Swarts, Steven; Okunieff, Paul] Univ Florida, Dept Radiat Oncol, Gainesville, FL 32610 USA.
C3 State University System of Florida; University of Florida
RP Zhang, SB (corresponding author), Univ Florida, Canc & Genet Res Complex,2033 Mowry Rd,POB 103633, Gainesville, FL 32610 USA.
EM bszhang@ufl.edu
RI Swarts, Steven/S-7361-2019
CR Anderson RF, 2001, CARCINOGENESIS, V22, P1189, DOI 10.1093/carcin/22.8.1189
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bianchini F, 2001, CARCINOGENESIS, V22, P885, DOI 10.1093/carcin/22.6.885
   Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767
   BURNET NG, 1994, RADIOTHER ONCOL, V33, P228, DOI 10.1016/0167-8140(94)90358-1
   BYRNE E, 1991, AUST NZ J MED, V21, P837, DOI 10.1111/j.1445-5994.1991.tb01404.x
   Carew JS, 2004, LEUKEMIA, V18, P1934, DOI 10.1038/sj.leu.2403545
   Chen T, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-8
   CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Cree LM, 2008, DIABETOLOGIA, V51, P1440, DOI 10.1007/s00125-008-1054-4
   Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421
   FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9
   Frahm T, 2005, MECH AGEING DEV, V126, P1192, DOI 10.1016/j.mad.2005.06.008
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hartmann N, 2011, AGING CELL, V10, P824, DOI 10.1111/j.1474-9726.2011.00723.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010
   Kubota N, 1997, RADIAT RES, V148, P395, DOI 10.2307/3579525
   Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342
   Lott M.T., 2013, MITOMAP: A Human Mitochondrial Genome Database
   Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Ringborg U, 2003, ACTA ONCOL, V42, P357, DOI 10.1080/02841860310010826
   Romano Antonino D, 2010, J Nephrol, V23 Suppl 15, pS29
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   Shen LJ, 2010, ANN NY ACAD SCI, V1201, P26, DOI 10.1111/j.1749-6632.2010.05635.x
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simonnet H, 2002, CARCINOGENESIS, V23, P759, DOI 10.1093/carcin/23.5.759
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Soong N W, 1996, Methods Enzymol, V264, P421, DOI 10.1016/S0076-6879(96)64038-5
   Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F
   Suliman HB, 2002, FREE RADICAL BIO MED, V32, P246, DOI 10.1016/S0891-5849(01)00797-3
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2008, GENETICS, V179, P727, DOI 10.1534/genetics.104.91769
   Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955
   Zhang HS, 2009, ADV EXP MED BIOL, V645, P43, DOI 10.1007/978-0-387-85998-9_7
   Zhang L, 2010, BRIT J RADIOL, V83, P694, DOI 10.1259/bjr/49886569
   Zhang SB, 2012, ADV EXP MED BIOL, V737, P139, DOI 10.1007/978-1-4614-1566-4_21
NR 52
TC 9
Z9 11
U1 0
U2 3
PU RADIATION RESEARCH SOC
PI LAWRENCE
PA 810 E TENTH STREET, LAWRENCE, KS 66044 USA
SN 0033-7587
EI 1938-5404
J9 RADIAT RES
JI Radiat. Res.
PD OCT
PY 2013
VL 180
IS 4
BP 407
EP 413
DI 10.1667/RR3373.1
PG 7
WC Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology,
   Nuclear Medicine & Medical Imaging
GA AA3KS
UT WOS:000330991900009
PM 24059680
DA 2024-11-01
ER

PT J
AU Maassen, JA
   't Hart, LM
   Ouwens, DM
AF Maassen, Johannes A.
   't Hart, Leen M.
   Ouwens, D. Margriet
TI Lessons that can be learned from patients with diabetogenic mutations in
   mitochondrial DNA: Implications for common type 2 diabetes
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE fatty acids; antiretroviral therapy; highly active; mitochondria;
   diabetes mellitus; type 2
ID INSULIN-RESISTANCE; ADIPOSE-TISSUE; MOLECULAR-MECHANISMS; FATTY-ACIDS;
   OXIDATIVE-PHOSPHORYLATION; POTENTIAL LINKS; INFLAMMATION; OBESITY;
   DISEASES; INVOLVEMENT
AB These observations suggest a pathogenic model for obesity associated type 2 diabetes, in which mitochondrial activity in peripheral adipocytes is essential to keep triabylglycerol stored within these cells. Mitochondria protect the organism against fatty acid-induced insulin, resistance and lipotoxicity to the pancreas. In adipocytes,e fatty acids through uncoupled beta oxidation, whereas in muscle fatty acids, removal is largely driven by adenosine dip hate, production through physical activity.
C1 Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.
C3 Leiden University; Leiden University Medical Center (LUMC); Leiden
   University - Excl LUMC
RP Maassen, JA (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Albinusdreef 2, NL-2300 RC Leiden, Netherlands.
EM j.a.maassen@lumc.nl
RI 't Hart, Leen/ABG-3185-2021; Ouwens, Margriet/H-2442-2013
OI 't Hart, Leen/0000-0003-4401-2938; Ouwens, Margriet/0000-0001-6709-2702
CR Beck V, 2007, FASEB J, V21, P1137, DOI 10.1096/fj.06-7489com
   Blaak EE, 2007, OBESITY, V15, P653, DOI 10.1038/oby.2007.606
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   BORST P, 1962, BIOCHIM BIOPHYS ACTA, V62, P509, DOI 10.1016/0006-3002(62)90232-9
   Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360
   Capeau J, 2005, BIOCHEM SOC T, V33, P1073, DOI 10.1042/BST0331073
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Hirabara SM, 2006, BBA-BIOENERGETICS, V1757, P57, DOI 10.1016/j.bbabio.2005.11.007
   Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911
   Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73
   HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271
   Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0
   Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224
   Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008
   Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036
   Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018
   Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158
   Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002
   Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005
   Perseghin G, 2003, INT J OBESITY, V27, pS6, DOI 10.1038/sj.ijo.0802491
   Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580
   Roden M, 2005, INT J OBESITY, V29, pS111, DOI 10.1038/sj.ijo.0803102
   Rydén M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Suzuki S, 2003, DIABETES RES CLIN PR, V59, P207, DOI 10.1016/S0168-8227(02)00246-2
   Suzuki Y, 2004, DIABETES RES CLIN PR, V63, P225, DOI 10.1016/j.diabres.2003.10.024
   t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892
   TAKEDA S, 1990, ACTA NEUROPATHOL, V80, P118, DOI 10.1007/BF00308913
   Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213
   VAARTJES WJ, 1978, BIOCHIM BIOPHYS ACTA, V503, P437, DOI 10.1016/0005-2728(78)90143-3
   van der Valk M, 2004, ANTIVIR THER, V9, P385
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834
   Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zierath JR, 2007, CELL METAB, V5, P161, DOI 10.1016/j.cmet.2007.02.005
NR 46
TC 16
Z9 17
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD NOV
PY 2007
VL 10
IS 6
BP 693
EP 697
DI 10.1097/MCO.0b013e3282f0b774
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 226EA
UT WOS:000250569100006
PM 18089949
DA 2024-11-01
ER

PT J
AU Bahreini, F
   Houshmand, M
   Modarressi, MH
   Akrami, SM
AF Bahreini, Fatemeh
   Houshmand, Massoud
   Modarressi, Mohammad Hossein
   Akrami, Seyed Mohammad
TI Mitochondrial Variants in Pompe Disease: A Comparison between Classic
   and Non-Classic Forms
SO CELL JOURNAL
LA English
DT Article
DE Alpha-Glucosidase; Cytochrome-C Oxidase; Mitochondria; Pompe
ID GENOTYPE-PHENOTYPE CORRELATION; SKELETAL-MUSCLE; LATE-ONSET; MUTATIONS;
   DNA; GLYCOGENOSIS; OXIDASE; GENE; DEFICIENCY; PATHOLOGY
AB Objective: Pompe disease (PD) is a progressive neuromuscular disorder that is caused by glucosidase acid alpha (GAA) deleterious mutations. Mitochondrial involvement is an important contributor to neuromuscular diseases. In this study the sequence of MT-ATP 6/8 and Cytochrome C oxidase I/II genes along with the expression levels of the former genes were compared in classic and non-classic patients.
   Materials and Methods: In this case-control study, the sequence of MT-ATP 6/8 and Cytochrome C oxidase was analyzed by polymerase chain reaction (PCR)-Sanger sequencing and expression of MT-ATP genes were quantified by real time-PCR (RT-PCR) in 28 Pompe patients. The results were then compared with 100 controls. All sequences were compared with the revised Cambridge reference sequence as reference.
   Results: Screening of MT-ATP6/8 resulted in the identification of three novel variants, namely T9117A, A8456C and A8524C. There was a significant decrease in MT-ATP6 expression between classic (i.e. adult) and control groups (P=0.030). Additionally, the MT-ATP8 expression was significantly decreased in classic (P=0.004) and non-classic (i.e. infant) patients (P=0.013). In total, 22 variants were observed in Cytochrome C oxidase, five of which were nonsynonymous, one leading to a stop codon and another (C9227G) being a novel heteroplasmic variant. The A8302G in the lysine tRNA gene was found in two brothers in a pedigree, while a T7572C variant in the aspartate tRNA gene was observed in two brothers in another pedigree.
   Conclusion: The extent of mitochondrial involvement in the classic group was more significant than in the non-classic form. Beside GAA deleterious mutations, it seems that mtDNA variants have a secondary effect on PD. Understanding, the role of mitochondria in the pathogenesis of Pompe may potentially be helpful in developing new therapeutic strategies.
C1 [Bahreini, Fatemeh; Modarressi, Mohammad Hossein; Akrami, Seyed Mohammad] Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
   [Bahreini, Fatemeh] Hamadan Univ Med Sci, Sch Med, Dept Mol Med & Genet, Hamadan, Iran.
   [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.
C3 Tehran University of Medical Sciences; Hamadan University of Medical
   Sciences
RP Akrami, SM (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Med Genet, POB 14176-13151,Keshavarz BLV,Poursina St, Tehran, Iran.
EM akramism@tums.ac.ir
RI Modarressi, Mohammad/AAL-8377-2020; Houshmand, Massoud/AEG-9909-2022
OI Houshmand, Massoud/0000-0002-2198-223X
FU Tehran University of Medical Sciences, Tehran, Iran [23162]
FX We thank all the participants in this study. This study was funded by
   Tehran University of Medical Sciences, Tehran, Iran (Grant Number:
   23162). The authors declare no conflict of interest.
CR Ahari SE, 2007, IRAN J CHILD NEUROL, V2, P41
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3
   ENGEL AG, 1968, MAYO CLIN PROC, V43, P233
   Fernández R, 1999, NEUROMUSCULAR DISORD, V9, P136, DOI 10.1016/S0960-8966(98)00117-5
   Ghaffarpour M, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-21
   Govindaraj P, 2013, MITOCHONDRION, V13, P721, DOI 10.1016/j.mito.2013.02.003
   Gurses C, 2014, GENE, V538, P323, DOI 10.1016/j.gene.2014.01.030
   Herzog A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-35
   Hobson-Webb LD, 2012, MOL GENET METAB, V106, P462, DOI 10.1016/j.ymgme.2012.05.007
   HOUSHMAND M, 1994, BBA-MOL BASIS DIS, V1226, P49, DOI 10.1016/0925-4439(94)90058-2
   Houshmand M, 2011, ARCH MED SCI, V7, P523, DOI 10.5114/aoms.2011.23424
   Houshmand M, 2011, ARCH MED SCI, V7, P242, DOI 10.5114/aoms.2011.22074
   HUDGSON P, 1975, J PATHOL, V116, P139, DOI 10.1002/path.1711160303
   Kasraie S, 2008, CELL MOL NEUROBIOL, V28, P933, DOI 10.1007/s10571-008-9261-6
   Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kishnani PS, 2012, AM J MED GENET C, V160C, P1, DOI [10.1002/ajmg.c.31324, 10.1002/ajmc.31324]
   Kroos M, 2012, AM J MED GENET C, V160C, P59, DOI [10.1002/ajmc.31318, 10.1002/ajmg.c.31318]
   Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751
   Laforêt P, 2000, NEUROLOGY, V55, P1122, DOI 10.1212/WNL.55.8.1122
   Lewandowska E, 2008, FOLIA NEUROPATHOL, V46, P123
   Li LJ, 2017, BIOMED RES-INDIA, V28, P4908
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mkaouar-Rebai E, 2014, MITOCHONDR DNA, V25, P394, DOI 10.3109/19401736.2013.803086
   Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0
   Pecina P, 2004, PHYSIOL RES, V53, pS213, DOI 10.33549/physiolres.930000.53.S213
   Pittis M G, 2008, Hum Mutat, V29, pE27, DOI 10.1002/humu.20753
   Reddy PL, 2002, BRIT J HAEMATOL, V116, P564, DOI 10.1046/j.0007-1048.2001.03323.x
   Schüller A, 2012, AM J MED GENET C, V160C, P80, DOI [10.1002/ajmc.31322, 10.1002/ajmg.c.31322]
   Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Sisková A, 2001, PHYSIOL RES, V50, P267, DOI 10.33549/physiolres.930083
   Sternberg D, 2001, BRAIN, V124, P984, DOI 10.1093/brain/124.5.984
   Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484
   Tzen CY, 2005, ANN NY ACAD SCI, V1042, P19, DOI 10.1196/annals.1338.002
   Tzen CY, 2001, FORENSIC SCI INT, V120, P204, DOI 10.1016/S0379-0738(01)00389-9
   VANDENOUWELAND JMW, 1992, NUCLEIC ACIDS RES, V20, P679, DOI 10.1093/nar/20.4.679
   VERITY MA, 1991, MUSCLE NERVE, V14, P435, DOI 10.1002/mus.880140509
NR 40
TC 2
Z9 2
U1 0
U2 6
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD FAL
PY 2018
VL 20
IS 3
BP 333
EP 339
DI 10.22074/cellj.2018.5238
PG 7
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GI7NY
UT WOS:000434690400006
PM 29845786
DA 2024-11-01
ER

PT J
AU Sun, N
   Youle, RJ
   Finkel, T
AF Sun, Nuo
   Youle, Richard J.
   Finkel, Toren
TI The Mitochondrial Basis of Aging
SO MOLECULAR CELL
LA English
DT Review
ID EXTENDS LIFE-SPAN; SKELETAL-MUSCLE; PYRUVATE-DEHYDROGENASE; DNA
   MUTATIONS; STEM-CELLS; NLRP3 INFLAMMASOME; PHYSICAL-EXERCISE; OXIDATIVE
   STRESS; QUALITY-CONTROL; LONGEVITY
AB A decline inmitochondrial quality and activity has been associated with normal aging and correlated with the development of a wide range of age-related diseases. Here, we review the evidence that a decline in mitochondria function contributes to aging. In particular, we discuss how mitochondria contribute to specific aspects of the aging process, including cellular senescence, chronic inflammation, and the age-dependent decline in stem cell activity. Signaling pathways regulating the mitochondrial unfolded protein response and mitophagy are also reviewed, with particular emphasis placed on how these pathways might, in turn, regulate longevity. Taken together, these observations suggest that mitochondria influence or regulate a number of key aspects of aging and suggest that strategies directed at improving mitochondrial quality and function might have far-reaching beneficial effects.
C1 [Sun, Nuo; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.
   [Youle, Richard J.] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Heart Lung &
   Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH
   National Institute of Neurological Disorders & Stroke (NINDS)
RP Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.; Youle, RJ (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.
EM richard.youle@nih.guy; finkelt@nih.gov
FU NIH Intramural Funds; Leducq Foundation Transatlantic Network Award
FX We are grateful to members of the T.F. and R.J.Y. labs for helpful
   comments and to Ilsa Rovira for help with the preparation of the
   manuscript. This work was supported by NIH Intramural Funds and a Leducq
   Foundation Transatlantic Network Award.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Argilés JM, 2015, CURR OPIN PHARMACOL, V22, P100, DOI 10.1016/j.coph.2015.04.003
   Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662
   Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483
   Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397
   Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086
   Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780
   Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291
   Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211
   Hertz NT, 2013, CELL, V154, P737, DOI 10.1016/j.cell.2013.07.030
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654
   Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409
   Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122
   Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040
   Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905
   Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046
   McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008
   McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   O'Connor KG, 1998, J GERONTOL A-BIOL, V53, pM176, DOI 10.1093/gerona/53A.3.M176
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Owusu-Ansah E, 2013, CELL, V155, P699, DOI 10.1016/j.cell.2013.09.021
   PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818
   Pernas L., 2015, ANN REV PHYSL
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   Pulliam DA, 2014, BIOCHEM J, V462, P359, DOI 10.1042/BJ20140291
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Quirós PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   ROCKSTEIN M, 1963, SCIENCE, V139, P1049, DOI 10.1126/science.139.3559.1049
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowe GC, 2014, CIRCULATION, V129, P798, DOI 10.1161/CIRCULATIONAHA.113.001590
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137
   Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   SOONG NW, 1992, NAT GENET, V2, P318
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Williams SL, 2010, CELL METAB, V12, P675, DOI 10.1016/j.cmet.2010.11.012
   Willis BL, 2012, ARCH INTERN MED, V172, P1333, DOI 10.1001/archinternmed.2012.3400
   Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951
   Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Wu YB, 2014, CELL, V158, P1415, DOI 10.1016/j.cell.2014.07.039
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010
   Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
NR 137
TC 914
Z9 1009
U1 16
U2 272
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD MAR 3
PY 2016
VL 61
IS 5
BP 654
EP 666
DI 10.1016/j.molcel.2016.01.028
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DG8IJ
UT WOS:000372326800006
PM 26942670
OA hybrid, Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Udar, N
   Atilano, SR
   Memarzadeh, M
   Boyer, DS
   Chwa, M
   Lu, S
   Maguen, B
   Langberg, J
   Coskun, P
   Wallace, DC
   Nesburn, AB
   Khatibi, N
   Hertzog, D
   Le, K
   Hwang, D
   Kenney, MC
AF Udar, Nitin
   Atilano, Shari R.
   Memarzadeh, Masood
   Boyer, David S.
   Chwa, Marilyn
   Lu, Stephanie
   Maguen, Barak
   Langberg, Jonathan
   Coskun, Pinar
   Wallace, Douglas C.
   Nesburn, Anthony B.
   Khatibi, Nikan
   Hertzog, Dieter
   Le, Khoi
   Hwang, Daniel
   Kenney, M. Cristina
TI Mitochondrial DNA Haplogroups Associated with Age-Related Macular
   Degeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID FACTOR-H POLYMORPHISM; PARKINSONS-DISEASE; ALZHEIMER-DISEASE;
   SKELETAL-MUSCLE; RISK-FACTORS; COMPLEMENT; MTDNA; GENE; MACULOPATHY;
   POPULATION
AB PURPOSE. To examine the mtDNA control regions in normal and age-related macular degeneration (AMD) retinas. To identify the mtDNA variations associated with AMD.
   METHODS. Retinas from 10 normal and 11 AMD globes were isolated and analyzed for mtDNA rearrangements by long extension-polymerase chain reaction (LX-PCR) and for the nature and frequency of single-nucleotide polymorphisms (SNPs) in the mtDNA control region by direct sequencing. Blood DNA was extracted from 99 AMD and 92 age-matched control subjects. The sequence variations that define haplogroups H, I, J, K, T, V, X, and U were characterized by PCR, restriction enzyme digestion, and/or sequencing.
   RESULTS. LX-PCR of retinal mtDNAs revealed high levels of rearrangements in the patients with AMD and the control subjects, consistent with the decline in mitochondrial function with age. However, the AMD retinas had higher oxidized DNA levels and a higher number of SNPs than controls (P = 0.02). The control region SNPs T16126C and A73G, commonly found in haplogroups J and T, were more frequent in the AMD retinas than in normal retinas. The associations between AMD and haplogroups J and T were confirmed and extended by analysis of blood DNA. SNPs at position a T16126C (J; odds ratio [OR] = 3.66), T16126C+G13368A (JT; OR = 10.27), A4917G + A73G (T4; OR = 5), and T3197C + A12308G (U5; OR = infinity), were all strongly associated with AMD.
   CONCLUSIONS. AMD retinas exhibited increased mtDNA control region SNPs compared to normal retinas. This correlated with an increased frequency of mtDNA SNPs associated with haplogroups J, T and U in patients with AMD. These results implicate mitochondrial alterations in the etiology of AMD. ( Invest Ophthalmol Vis Sci. 2009; 50: 2966-2974) DOI:10.1167/iovs.08-2646
C1 [Kenney, M. Cristina] Univ Calif Irvine, Med Ctr, Dept Ophthalmol, Orange, CA 92868 USA.
   [Boyer, David S.] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Coskun, Pinar; Wallace, Douglas C.] Univ Calif Irvine, Dept Pediat, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92717 USA.
   [Nesburn, Anthony B.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA.
   [Khatibi, Nikan] Kansas City Med Sch, Kansas City, MO USA.
   [Hertzog, Dieter] Loma Linda Med Ctr, Loma Linda, CA USA.
   [Le, Khoi] Dartmouth Hitchcock Med Ctr, Hanover, NH USA.
C3 University of California System; University of California Irvine; Retina
   Vitreous Associates Medical Group; University of California System;
   University of California Irvine; University of California System;
   University of California Irvine; University of California System;
   University of California Irvine; Cedars Sinai Medical Center; Loma Linda
   University; Dartmouth College
RP Kenney, MC (corresponding author), Univ Calif Irvine, Med Ctr, Dept Ophthalmol, 101 City Dr, Orange, CA 92868 USA.
EM mkenney@uci.edu
OI Kenney, M. Cristina/0000-0003-1765-1750; Udar,
   Nitin/0000-0001-8533-9190; Atilano, Shari/0000-0002-7729-7864
FU Discovery Eye Foundation; Lincy Foundation; Henry L. Guenther
   Foundation; Iris and B. Gerald Cantor Foundation; Gilbert Foundation;
   Research to Prevent Blindness
FX Supported by the Discovery Eye Foundation, the Lincy Foundation, the
   Henry L. Guenther Foundation, the Iris and B. Gerald Cantor Foundation,
   the Gilbert Foundation, and Research to Prevent Blindness.
CR Andrews R, 2006, BRIT J OPHTHALMOL, V90, P488, DOI 10.1136/bjo.2005.084335
   Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395
   Brown MD, 1997, AM J HUM GENET, V60, P381
   Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091
   Castro MG, 2006, INT J CARDIOL, V112, P202, DOI 10.1016/j.ijcard.2005.09.008
   Chagnon P, 1999, AM J MED GENET, V85, P20, DOI 10.1002/(SICI)1096-8628(19990702)85:1<20::AID-AJMG6>3.0.CO;2-K
   Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204
   Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101
   Dewan A, 2007, CURR OPIN GENET DEV, V17, P228, DOI 10.1016/j.gde.2007.04.004
   Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001
   Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435
   Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189
   Fesahat F, 2007, CELL MOL NEUROBIOL, V27, P329, DOI 10.1007/s10571-006-9126-9
   Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359
   Hamdi HK, 2003, FRONT BIOSCI-LANDMRK, V8, pE305, DOI 10.2741/1019
   Hassani-Kumleh H, 2006, CELL MOL NEUROBIOL, V26, P119, DOI 10.1007/s10571-006-9026-z
   Hofmann S, 1997, GENOMICS, V39, P8, DOI 10.1006/geno.1996.4474
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557
   Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
   Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015
   Moshfeghi DM, 2007, RETINA-J RET VIT DIS, V27, P269, DOI 10.1097/IAE.0b013e31802e3e9b
   Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5
   Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035
   Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293
   Roquet W, 2004, BRIT J OPHTHALMOL, V88, P638, DOI 10.1136/bjo.2003.017632
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434
   Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001
   Shastry BS, 2006, OPHTHALMOLOGICA, V220, P291, DOI 10.1159/000094617
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011
   Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010
   Torroni A, 1996, GENETICS, V144, P1835
   TORRONI A, 1993, AM J HUM GENET, V53, P563
   van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang AL, 2008, MOL VIS, V14, P644
   Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811
   Yoshida T, 2007, MOL VIS, V13, P545
NR 50
TC 100
Z9 111
U1 0
U2 7
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUN
PY 2009
VL 50
IS 6
BP 2966
EP 2974
DI 10.1167/iovs.08-2646
PG 9
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 450ME
UT WOS:000266403800059
PM 19151382
DA 2024-11-01
ER

PT J
AU Dumic, KK
   Anticevic, D
   Petrinovic-Doresic, J
   Zigman, T
   Zarkovicl, K
   Rokic, F
   Vugrek, O
AF Dumic, Katja K.
   Anticevic, Darko
   Petrinovic-Doresic, Jelena
   Zigman, Tamara
   Zarkovicl, Kamelija
   Rokic, Filip
   Vugrek, Oliver
TI Lowe syndrome - Old and new evidence of secondary mitochondrial
   dysfunction
SO EUROPEAN JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE Oculocerebrorenal syndrome; Lowe syndrome; OCRL gene; Mitochondriopathy
ID OCULOCEREBRORENAL SYNDROME; OCRL1
AB The oculocerebrorenal syndrome of Lowe (LS) is a rare, progressive, multisystemic X-linked disorder caused by mutations in OCRL gene. Patients classically present with ocular abnormalities including bilateral congenital cataracts and glaucoma, intellectual delay, severe generalized hypotonia with absent tendon reflexes, and proximal renal tubular dysfunction. Congenital bilateral cataracts and hypotonia are present at birth in almost all patients, while other classical symptoms develop gradually with variable severity. Consequently, differential diagnosis in infant period in these patients can be broad including other rare metabolic and neurologic disorders.
   Herein we present a 4.5 year old boy with Lowe syndrome caused by mutation of OCRL gene, NM_000276.4: c.643C > T; p.(Gln215*), initially diagnosed as having mitochondriopathy due to alteration of mitochondria on electron microscopic examination in different tissues and decreased values of mitochondrial energy metabolism measurements in muscle. No pathogenic mutations in mitochondrial DNA were found on whole exome sequencing.
   This patient recall historical hypothesis of secondary mitochondrial dysfunction in Lowe syndrome, that may be caused/intensified by some of disease symptoms.
C1 [Dumic, Katja K.] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Pediat, Div Pediat Endocrinol & Diabet,Med Sch, Zagreb, Croatia.
   [Anticevic, Darko] Specialty Hosp St Catherine, Div Orthoped Surg, Zabok, Croatia.
   [Petrinovic-Doresic, Jelena] Univ Hosp Sveti Duh, Dept Ophthalmol, Zagreb, Croatia.
   [Zigman, Tamara] Univ Hosp Ctr Zagreb, Dept Pediat, Div Genet & Inherited Metab Dis, Zagreb, Croatia.
   [Zarkovicl, Kamelija] Univ Zagreb, Univ Hosp Ctr Zagreb, Dept Pathol, Med Sch, Zagreb, Croatia.
   [Rokic, Filip; Vugrek, Oliver] Rudjer Boskovic Inst, Lab Adv Genom, Zagreb, Croatia.
C3 University of Zagreb; University of Zagreb; University of Zagreb; Rudjer
   Boskovic Institute
RP Dumic, KK (corresponding author), Univ Hosp Ctr Zagreb, Div Pediat Endocrinol & Diabet, Dept Pediat, Kispaticeva 12, Zagreb 10000, Croatia.
EM katja.dumic@gmail.com
RI Kubat, Katja/AAW-1023-2021; Vugrek, Oliver/A-8166-2013; /AAZ-3300-2020
OI /0000-0001-6713-1273
CR Bökenkamp A, 2016, PEDIATR NEPHROL, V31, P2201, DOI 10.1007/s00467-016-3343-3
   Coon BG, 2012, HUM MOL GENET, V21, P1835, DOI 10.1093/hmg/ddr615
   Craigen WJ, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-83
   Festa BP, 2019, HUM MOL GENET, V28, P1931, DOI 10.1093/hmg/ddy449
   GOBERNADO JM, 1984, ARCH NEUROL-CHICAGO, V41, P208, DOI 10.1001/archneur.1984.04050140106037
   Hichri H, 2011, HUM MUTAT, V32, P379, DOI 10.1002/humu.21391
   Lin T, 1999, OPHTHALMOLOGY, V106, P119, DOI 10.1016/S0161-6420(99)90012-X
   Mehta ZB, 2014, TRAFFIC, V15, P471, DOI 10.1111/tra.12160
   Ramos AR, 2019, J LIPID RES, V60, P276, DOI 10.1194/jlr.R087908
   Röschinger W, 2000, MOL GENET METAB, V69, P213, DOI 10.1006/mgme.1999.2955
   SAGEL I, 1970, J PEDIATR-US, V77, P124, DOI 10.1016/S0022-3476(70)80056-7
   SCHOEN EJ, 1959, AM J MED, V27, P781, DOI 10.1016/0002-9343(59)90193-7
   SPEED CJ, 1995, EUR J BIOCHEM, V234, P216, DOI 10.1111/j.1432-1033.1995.216_c.x
NR 13
TC 4
Z9 4
U1 1
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1769-7212
EI 1878-0849
J9 EUR J MED GENET
JI Eur. J. Med. Genet.
PD OCT
PY 2020
VL 63
IS 10
AR 104022
DI 10.1016/j.ejmg.2020.104022
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA NT7CM
UT WOS:000573094100009
PM 32712215
DA 2024-11-01
ER

PT J
AU Hepple, RT
AF Hepple, Russell T.
TI Mitochondrial involvement and impact in aging skeletal muscle
SO FRONTIERS IN AGING NEUROSCIENCE
LA English
DT Review
DE sarcopenia; bioenergetics; mitochondria; skeletal muscle; reactive
   oxygen species; permeability transition; oxidative stress; muscle
   atrophy
ID PERMEABILITY TRANSITION PORE; RESPIRATORY-CHAIN FUNCTION; IN-VIVO;
   OXIDATIVE CAPACITY; VASTUS LATERALIS; SOLEUS MUSCLE; DNA-DELETION;
   DIETARY RESTRICTION; METABOLIC-RESPONSE; FIBER ATROPHY
AB Atrophy is a defining feature of aging skeletal muscle that contributes to progressive weakness and an increased risk of mobility impairment, falls, and physical frailty in very advanced age. Amongst the most frequently implicated mechanisms of aging muscle atrophy is mitochondrial dysfunction. Recent studies employing methods that are well-suited to interrogating intrinsic mitochondrial function find that mitochondrial respiration and reactive oxygen species emission changes are inconsistent between aging rat muscles undergoing atrophy and appear normal in human skeletal muscle from septuagenarian physically active subjects. On the other hand, a sensitization to permeability transition seems to be a general property of atrophying muscle with aging and this effect is even seen in atrophying muscle from physically active septuagenarian subjects. In addition to this intrinsic alteration in mitochondrial function, factors extrinsic to the mitochondria may also modulate mitochondrial function in aging muscle. In particular, recent evidence implicates oxidative stress in the aging milieu as a factor that depresses respiratory function in vivo (an effect that is not present ex vivo). Furthermore, in very advanced age, not only does muscle atrophy become more severe and clinically relevant in terms of its impact, but also there is evidence that this is driven by an accumulation of severely atrophied denervated myofibers. As denervation can itself modulate mitochondrial function and recruit mitochondrial-mediated atrophy pathways, future investigations need to address the degree to which skeletal muscle mitochondrial alterations in very advanced age are a consequence of denervation, rather than a primary organelle defect, to refine our understanding of the relevance of mitochondria as a therapeutic target at this more advanced age.
C1 [Hepple, Russell T.] McGill Univ, Ctr Hlth, Dept Kinesiol, Montreal, PQ, Canada.
C3 McGill University
RP Hepple, RT (corresponding author), Royal Victoria Hosp, Dept Crit Care Med, 675 Pine Ave West, Montreal, PQ H3A 1A1, Canada.
EM russell.hepple@mcgill.ca
OI Hepple, Russell/0000-0003-3640-486X
CR Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104
   Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005
   Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755
   Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839
   BASS A, 1975, GERONTOLOGY, V21, P31, DOI 10.1159/000212028
   Betik AC, 2009, AM J PHYSIOL-REG I, V297, pR744, DOI 10.1152/ajpregu.90959.2008
   Bhattacharya A, 2009, J BIOL CHEM, V284, P46, DOI 10.1074/jbc.M806311200
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Callahan DM, 2014, J APPL PHYSIOL, V116, P1582, DOI 10.1152/japplphysiol.01362.2013
   Capel F, 2005, MECH AGEING DEV, V126, P505, DOI 10.1016/j.mad.2004.11.001
   Carter EE, 2010, EXP GERONTOL, V45, P662, DOI 10.1016/j.exger.2010.04.001
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   CHANCE B, 1956, J BIOL CHEM, V221, P477
   Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Cruz-Jentoft AJ, 2010, CURR OPIN CLIN NUTR, V13, P1, DOI 10.1097/MCO.0b013e328333c1c1
   Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702
   Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Edström E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x
   Edström E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040
   Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147
   Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013
   Hemion C, 2014, FREE RADICAL BIO MED, V75, P121, DOI 10.1016/j.freeradbiomed.2014.07.016
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337
   Huang JH, 2010, J GERONTOL A-BIOL, V65, P138, DOI 10.1093/gerona/glp201
   Hütter E, 2007, AGING CELL, V6, P245, DOI 10.1111/j.1474-9726.2007.00282.x
   Joseph AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069327
   Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x
   Joseph AM, 2010, AM J PHYSIOL-CELL PH, V298, pC1308, DOI 10.1152/ajpcell.00644.2008
   KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011
   Konopka AR, 2014, J GERONTOL A-BIOL, V69, P371, DOI 10.1093/gerona/glt107
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza IR, 2005, J APPL PHYSIOL, V99, P1736, DOI 10.1152/japplphysiol.00566.2005
   Lawrenson L, 2003, AM J PHYSIOL-HEART C, V285, pH1023, DOI 10.1152/ajpheart.00135.2003
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   Li W, 2014, J BIOL CHEM, V289, P10691, DOI 10.1074/jbc.M113.537050
   Ljubicic V, 2009, AGING-US, V1, P818, DOI 10.18632/aging.100083
   Ljubicic V, 2009, AGING CELL, V8, P394, DOI 10.1111/j.1474-9726.2009.00483.x
   Lyons CN, 2006, J GERONTOL A-BIOL, V61, P3, DOI 10.1093/gerona/61.1.3
   Mahler M, 1985, J GEN PHYSIOL, V86, P165
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Martin KR, 2014, J AM GERIATR SOC, V62, P1263, DOI 10.1111/jgs.12893
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Marzetti E, 2010, BBA-GEN SUBJECTS, V1800, P235, DOI 10.1016/j.bbagen.2009.05.007
   Mathieu-Costello O, 2005, J APPL PHYSIOL, V99, P281, DOI 10.1152/japplphysiol.00750.2004
   MCCULLY KK, 1993, J APPL PHYSIOL, V75, P813, DOI 10.1152/jappl.1993.75.2.813
   MELOV S, 1995, NUCLEIC ACIDS RES, V23, P4122, DOI 10.1093/nar/23.20.4122
   MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006
   ODA K, 1984, J NEUROL SCI, V66, P327, DOI 10.1016/0022-510X(84)90021-2
   ORLANDER J, 1978, ACTA PHYSIOL SCAND, V104, P249, DOI 10.1111/j.1748-1716.1978.tb06277.x
   Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008
   Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011
   Picard M, 2011, AGING CELL, V10, P1047, DOI 10.1111/j.1474-9726.2011.00745.x
   Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712
   Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317
   Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x
   Poole JG, 2003, AM J PHYSIOL-HEART C, V284, pH1251, DOI 10.1152/ajpheart.00790.2002
   Prompers JJ, 2014, INT J BIOCHEM CELL B, V50, P67, DOI 10.1016/j.biocel.2014.02.014
   Rasmussen UF, 2003, PFLUG ARCH EUR J PHY, V446, P270, DOI 10.1007/s00424-003-1022-2
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   ROCKSTEIN M, 1963, SCIENCE, V139, P1049, DOI 10.1126/science.139.3559.1049
   Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60
   Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082
   Rowan SL, 2011, EXP GERONTOL, V46, P660, DOI 10.1016/j.exger.2011.03.005
   Rudolf R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00099
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778
   SCELSI R, 1980, ACTA NEUROPATHOL, V51, P99, DOI 10.1007/BF00690450
   Scheibye-Knudsen M, 2014, AUTOPHAGY, V10, P1468, DOI 10.4161/auto.29321
   Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015
   Siegel MP, 2013, AGING CELL, V12, P763, DOI 10.1111/acel.12102
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   Siu PM, 2005, AM J PHYSIOL-REG I, V289, pR1015, DOI 10.1152/ajpregu.00198.2005
   Snow LM, 2005, ANAT REC PART A, V286A, P866, DOI 10.1002/ar.a.20218
   Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x
   Stary CM, 2004, EXP PHYSIOL, V89, P617, DOI 10.1113/expphysiol.2004.027763
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   TOMONAGA M, 1977, J AM GERIATR SOC, V25, P125, DOI 10.1111/j.1532-5415.1977.tb00274.x
   Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601
   YANG JSJ, 1991, NEURON, V7, P421, DOI 10.1016/0896-6273(91)90294-A
NR 108
TC 114
Z9 126
U1 0
U2 32
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1663-4365
J9 FRONT AGING NEUROSCI
JI Front. Aging Neurosci.
PD SEP 10
PY 2014
VL 6
AR 211
DI 10.3389/fnagi.2014.00211
PG 13
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA AO9SD
UT WOS:000341696000001
PM 25309422
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Guo, J
   Chiang, WC
AF Guo, Jing
   Chiang, Wei-Chung
TI Mitophagy in aging and longevity
SO IUBMB LIFE
LA English
DT Article
DE aging; longevity; mitophagy
ID LIFE-SPAN EXTENSION; MITOCHONDRIAL-DNA MUTATIONS; AUTOPHAGIC CELL-DEATH;
   TUMOR-SUPPRESSOR GENE; PATERNAL MITOCHONDRIA; SELECTIVE AUTOPHAGY;
   OXIDATIVE STRESS; SKELETAL-MUSCLE; MOLECULAR-MECHANISMS;
   NEURODEGENERATIVE DISEASES
AB The clearance of damaged or unwanted mitochondria by autophagy (also known as mitophagy) is a mitochondrial quality control mechanism postulated to play an essential role in cellular homeostasis, metabolism, and development and confers protection against a wide range of diseases. Proper removal of damaged or unwanted mitochondria is essential for organismal health. Defects in mitophagy are associated with Parkinson's, Alzheimer's disease, cancer, and other degenerative disorders. Mitochondria regulate organismal fitness and longevity via multiple pathways, including cellular senescence, stem cell function, inflammation, mitochondrial unfolded protein response (mtUPR), and bioenergetics. Thus, mitophagy is postulated to be pivotal for maintaining organismal healthspan and lifespan and the protection against aged-related degeneration. In this review, we will summarize recent understanding of the mechanism of mitophagy and aspects of mitochondrial functions. We will focus on mitochondria-related cellular processes that are linked to aging and examine current genetic evidence that supports the hypothesis that mitophagy is a pro-longevity mechanism.
C1 [Guo, Jing; Chiang, Wei-Chung] Natl Yang Ming Chiao Tung Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.
C3 National Yang Ming Chiao Tung University
RP Chiang, WC (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.
EM wchiang@nycu.edu.tw
RI Chiang, Wei-Chung/AAZ-5494-2020
OI Guo, Jing/0000-0003-4154-1885; Chiang, Wei-Chung/0000-0003-3149-435X
FU Ministry of Science and Technology, Taiwan [MOST 110-2628-B-010-009,
   MOST 110-2628-BA49A-513]; National Health Research Institutes
   [NHRIEX110-11009SC]; Yen Tjing Ling Medical Foundation [CI110-31]
FX Ministry of Science and Technology, Taiwan, Grant/Award Numbers: MOST
   110-2628-B-010-009, MOST 110-2628-BA49A-513; National Health Research
   Institutes, Grant/Award Number: NHRIEX110-11009SC; Yen Tjing Ling
   Medical Foundation, Grant/Award Number: CI110-31
CR Agnihotri S, 2016, CANCER RES, V76, P4708, DOI 10.1158/0008-5472.CAN-15-3079
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Akada M, 2005, CLIN CANCER RES, V11, P3094, DOI 10.1158/1078-0432.CCR-04-1785
   Al Rawi S, 2011, SCIENCE, V334, P1144, DOI 10.1126/science.1211878
   Amartuvshin O, 2020, AGING CELL, V19, DOI 10.1111/acel.13191
   An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Aparicio R, 2019, CELL REP, V28, P1029, DOI 10.1016/j.celrep.2019.06.070
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466
   Bonifati V, 2002, NEUROL SCI, V23, pS59, DOI 10.1007/s100720200069
   Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457
   Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205
   Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012
   Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100
   Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Chaudhari SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00274-4
   Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034
   Chen ML, 2009, BLOOD, V114, P4045, DOI 10.1182/blood-2008-08-169474
   Chen M, 2016, AUTOPHAGY, V12, P689, DOI 10.1080/15548627.2016.1151580
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Chiu FL, 2008, FEBS LETT, V582, P2407, DOI 10.1016/j.febslet.2008.05.049
   Chourasia AH, 2015, EMBO REP, V16, P1145, DOI 10.15252/embr.201540759
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Cianfanelli V, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970059
   Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2
   Compagnoni GM, 2020, MOL NEUROBIOL, V57, P2959, DOI 10.1007/s12035-020-01926-1
   Cooper JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16637-2
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   Cummins J M, 2000, Hum Reprod, V15 Suppl 2, P92
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Daido S, 2004, CANCER RES, V64, P4286, DOI 10.1158/0008-5472.CAN-03-3084
   Dalle Pezze Piero, 2014, PLoS Comput Biol, V10, pe1003728, DOI 10.1371/journal.pcbi.1003728
   de la Cruz-Ruiz P, 2021, AGING CELL, V20, DOI 10.1111/acel.13359
   Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Di Rita A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05722-3
   Di Rita A, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00092
   Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537
   Drummond MJ, 2014, J GERONTOL A-BIOL, V69, P1040, DOI 10.1093/gerona/glu004
   Duicu OM, 2013, CAN J PHYSIOL PHARM, V91, P593, DOI 10.1139/cjpp-2012-0422
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Dutta D, 2018, MOL NEUROBIOL, V55, P804, DOI 10.1007/s12035-016-0328-y
   Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642
   Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Fang EF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46208
   Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fernandez Alvaro F, 2018, Nature, V558, P136, DOI 10.1038/s41586-018-0162-7
   Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026
   Franco-Iborra S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00342
   Fu M, 2013, MOL BIOL CELL, V24, P1153, DOI 10.1091/mbc.E12-08-0607
   Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199
   Fujiwara Y, 2012, J AGR FOOD CHEM, V60, P2472, DOI 10.1021/jf204197r
   Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gatsi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107671
   Gelino Sara, 2012, J Clin Exp Pathol, VSuppl 4
   Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529
   Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564
   Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Grumati P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217364
   Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Heeman B, 2011, J CELL SCI, V124, P1115, DOI 10.1242/jcs.078303
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Hoshino A, 2014, P NATL ACAD SCI USA, V111, P3116, DOI 10.1073/pnas.1318951111
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Humpton TJ, 2019, CANCER DISCOV, V9, P1268, DOI 10.1158/2159-8290.CD-18-1409
   Hwang S, 2010, MOL CELLS, V29, P575, DOI 10.1007/s10059-010-0068-1
   Ikeda Y, 2015, J MOL CELL CARDIOL, V78, P116, DOI 10.1016/j.yjmcc.2014.09.019
   Ishihara-Paul L, 2008, NEUROLOGY, V71, P896, DOI 10.1212/01.wnl.0000323812.40708.1f
   Ising C, 2015, EMBO MOL MED, V7, P275, DOI 10.15252/emmm.201404916
   Iwadate R, 2015, AM J PATHOL, V185, P2523, DOI 10.1016/j.ajpath.2015.05.008
   Jiang HC, 2015, P NATL ACAD SCI USA, V112, P8768, DOI 10.1073/pnas.1501831112
   Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095
   Kawajiri S, 2011, TRENDS PHARMACOL SCI, V32, P573, DOI 10.1016/j.tips.2011.06.001
   Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002
   Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015
   Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416
   Knuppertz L, 2016, MECH AGEING DEV, V153, P30, DOI 10.1016/j.mad.2016.01.003
   Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917
   Koop EA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-175
   Korwitz A, 2016, J CELL BIOL, V212, P157, DOI 10.1083/jcb.201507022
   Koushyar S, 2015, CANCER LETT, V369, P316, DOI 10.1016/j.canlet.2015.09.012
   Krüger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumsta C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13540-4
   Kwon J, 2012, EMBO REP, V13, P150, DOI 10.1038/embor.2011.246
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee TT, 2021, AGING CELL, V20, DOI 10.1111/acel.13379
   Lee Y, 2011, AM J PHYSIOL-HEART C, V301, pH1924, DOI 10.1152/ajpheart.00368.2011
   Lei C, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018791
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Levine B, 2011, SCIENCE, V334, P1069, DOI 10.1126/science.1215480
   Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112
   Li CF, 2018, DEV CELL, V46, P441, DOI 10.1016/j.devcel.2018.07.012
   Liau WS, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-8
   Lim Y, 2019, DEV BIOL, V454, P15, DOI 10.1016/j.ydbio.2019.06.016
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lionaki E, 2015, BBA-BIOENERGETICS, V1847, P1412, DOI 10.1016/j.bbabio.2015.04.010
   Lionaki E, 2013, AGEING RES REV, V12, P413, DOI 10.1016/j.arr.2012.05.001
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Liu PY, 2017, CELL CYCLE, V16, P776, DOI 10.1080/15384101.2017.1295193
   Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702
   Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lou GF, 2020, TRENDS MOL MED, V26, P8, DOI 10.1016/j.molmed.2019.07.002
   Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Manka D, 2005, CANCER RES, V65, P11689, DOI 10.1158/0008-5472.CAN-05-3091
   Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024
   Marder KS, 2010, ARCH NEUROL-CHICAGO, V67, P731, DOI 10.1001/archneurol.2010.95
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902
   Meléndez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Merkwirth C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003021
   Mizushima N, 2020, NEW ENGL J MED, V383, P1564, DOI 10.1056/NEJMra2022774
   Mookherjee D, 2021, AUTOPHAGY, V17, P1729, DOI 10.1080/15548627.2020.1783118
   Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161
   Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Moscat J, 2016, CELL, V167, P606, DOI 10.1016/j.cell.2016.09.030
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Müller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036
   Muñoz-Carvajal F, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.581849
   Murai M, 2005, BRIT J CANCER, V92, P1165, DOI 10.1038/sj.bjc.6602422
   Murai M, 2005, CLIN CANCER RES, V11, P1021
   Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Okami J, 2004, CANCER RES, V64, P5338, DOI 10.1158/0008-5472.CAN-04-0089
   Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013
   Oliveira SA, 2003, ANN NEUROL, V53, P624, DOI 10.1002/ana.10524
   Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546
   Otsu K, 2015, AUTOPHAGY, V11, P1932, DOI 10.1080/15548627.2015.1084459
   Palikaras K, 2015, CELL DEATH DIFFER, V22, P1399, DOI 10.1038/cdd.2015.86
   Palikaras K, 2018, NAT CELL BIOL, V20, P1013, DOI 10.1038/s41556-018-0176-2
   Palikaras K, 2015, AUTOPHAGY, V11, P1428, DOI 10.1080/15548627.2015.1061172
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Papa L, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/4067162
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102
   Pham AH, 2012, GENESIS, V50, P833, DOI 10.1002/dvg.22050
   Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004
   Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007
   Piper PW, 2002, MECH AGEING DEV, V123, P287, DOI 10.1016/S0047-6374(01)00326-8
   Piper PW, 2002, AGING CELL, V1, P149, DOI 10.1046/j.1474-9728.2002.00018.x
   Pircs K, 2018, CELL REP, V24, P1397, DOI 10.1016/j.celrep.2018.07.017
   Politi Y, 2014, DEV CELL, V29, P305, DOI 10.1016/j.devcel.2014.04.005
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003
   Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300
   Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746
   Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110
   Rauthan M, 2015, G3-GENES GENOM GENET, V5, P1639, DOI 10.1534/g3.115.018598
   Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901
   Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010
   Ren Y, 2009, J BIOL CHEM, V284, P4009, DOI 10.1074/jbc.M806245200
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Rivera-Torres J, 2013, J PROTEOMICS, V91, P466, DOI 10.1016/j.jprot.2013.08.008
   Rogov VV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01258-6
   Rojansky R, 2016, ELIFE, V5, DOI 10.7554/eLife.17896
   Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Rui YN, 2015, AUTOPHAGY, V11, P858, DOI 10.1080/15548627.2015.1039219
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Salminen A, 2012, PROG NEUROBIOL, V96, P87, DOI 10.1016/j.pneurobio.2011.11.005
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sato M, 2018, NAT CELL BIOL, V20, P81, DOI 10.1038/s41556-017-0008-9
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schleit J, 2013, AGING CELL, V12, P1050, DOI 10.1111/acel.12130
   Schroeder S, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108985
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Si HB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225214
   Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052
   Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399
   STOCCO DM, 1977, J CELL PHYSIOL, V90, P295, DOI 10.1002/jcp.1040900215
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   Strappazzon F, 2015, CELL DEATH DIFFER, V22, P419, DOI 10.1038/cdd.2014.139
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152
   Szargel R, 2016, HUM MOL GENET, V25, P3476, DOI 10.1093/hmg/ddw189
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011
   Vartiainen S, 2006, EXP GERONTOL, V41, P871, DOI 10.1016/j.exger.2006.05.005
   Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110
   Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12569
   Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wu YB, 2019, MITOCHONDRION, V49, P35, DOI 10.1016/j.mito.2019.07.003
   Wu ZY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0615-3
   Yaku K, 2018, AGEING RES REV, V47, P1, DOI 10.1016/j.arr.2018.05.006
   Yan XY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01196-w
   Yang CC, 2011, AGING CELL, V10, P724, DOI 10.1111/j.1474-9726.2011.00711.x
   Yang X, 2020, AGING-US, V12, P16852, DOI 10.18632/aging.103578
   Yang Y, 2014, J ALZHEIMERS DIS, V40, P929, DOI 10.3233/JAD-132270
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
   Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958
   Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108
   Zhang F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2238-1
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410
   Zhang Y, 2019, ELIFE, V8, DOI 10.7554/eLife.49158
   Zhao YH, 2018, ELIFE, V7, DOI 10.7554/eLife.34701
   Zhou QH, 2016, SCIENCE, V353, P394, DOI 10.1126/science.aaf4777
   Zhou QH, 2011, CELL RES, V21, P1662, DOI 10.1038/cr.2011.182
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
   Ziada AS, 2019, AGING CELL, V18, DOI 10.1111/acel.13018
NR 260
TC 25
Z9 26
U1 2
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD APR
PY 2022
VL 74
IS 4
SI SI
BP 296
EP 316
DI 10.1002/iub.2585
EA DEC 2021
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA ZV4BN
UT WOS:000728695400001
PM 34889504
DA 2024-11-01
ER

PT J
AU Michot, C
   Hubert, L
   Brivet, M
   De Meirleir, L
   Valayannopoulos, V
   Müller-Felber, W
   Venkateswaran, R
   Ogier, H
   Desguerre, I
   Altuzarra, C
   Thompson, E
   Smitka, M
   Huebner, A
   Husson, M
   Horvath, R
   Chinnery, P
   Vaz, FM
   Munnich, A
   Elpeleg, O
   Delahodde, A
   de Keyzer, Y
   de Lonlay, P
AF Michot, Caroline
   Hubert, Laurence
   Brivet, Michele
   De Meirleir, Linda
   Valayannopoulos, Vassili
   Mueller-Felber, Wolfgang
   Venkateswaran, Ramesh
   Ogier, Helene
   Desguerre, Isabelle
   Altuzarra, Cecilia
   Thompson, Elizabeth
   Smitka, Martin
   Huebner, Angela
   Husson, Marie
   Horvath, Rita
   Chinnery, Patrick
   Vaz, Frederic M.
   Munnich, Arnold
   Elpeleg, Orly
   Delahodde, Agnes
   de Keyzer, Yves
   de Lonlay, Pascale
TI <i>LPIN1</i> Gene Mutations: A Major Cause of Severe Rhabdomyolysis in
   Early Childhood
SO HUMAN MUTATION
LA English
DT Article
DE Rhabdomyolysis; LPIN1; intragenic deletion; founder effect
ID ADIPOSE-TISSUE; BARTH-SYNDROME; DUAL ROLES; LIPIN-1; EXPRESSION;
   MYOGLOBINURIA; BIOSYNTHESIS; DEFICIENCY; DYSTROPHY; DISEASE
AB Autosomal recessive LPIN1 mutations have been recently described as a novel cause of rhabdomyolysis in a few families. The purpose of the study was to evaluate the prevalence of LPIN1 mutations in patients exhibiting severe episodes of rhabdomyolysis in infancy. After exclusion of primary fatty acid oxidation disorders, LPIN1 coding sequence was determined in genomic DNA and cDNA. Among the 29 patients studied, 17 (59%) carried recessive nonsense or frameshift mutations, or a large scale intragenic deletion. In these 17 patients, episodes of rhabdomyolysis occurred at a mean age of 21 months. Secondary defect of mitochondrial fatty oxidation or respiratory chain was found in skeletal muscle of two patients. The intragenic deletion, c. 2295-866_2410-30del, was identified in 8/17 patients (47%), all Caucasians, and occurred on the background of a common haplotype, suggesting a founder effect. This deleted human LPIN1 form was unable to complement Delta pah1 yeast for growth on glycerol, in contrast to normal LPIN1. Since more than 50% of our series harboured LPIN1 mutations, LPIN1 should be regarded as a major cause of severe myoglobinuria in early childhood. The high frequency of the intragenic LPIN1 deletion should provide a valuable criterion for fast diagnosis, prior to muscle biopsy. (C) 2010 Wiley-Liss, Inc.
C1 [Michot, Caroline; Hubert, Laurence; Valayannopoulos, Vassili; Desguerre, Isabelle; Munnich, Arnold; de Keyzer, Yves; de Lonlay, Pascale] Hop Necker Enfants Malad, Reference Ctr Metab Dis, F-75015 Paris, France.
   [Michot, Caroline; Hubert, Laurence; Valayannopoulos, Vassili; Desguerre, Isabelle; Munnich, Arnold; de Keyzer, Yves; de Lonlay, Pascale] Paris Descartes Univ, INSERM, U781, F-75015 Paris, France.
   [Brivet, Michele] Kremlin Bicetre Hosp, Dpt Biochem, Le Kremlin Bicetre, France.
   [De Meirleir, Linda] UZ Brussel, Brussels, Belgium.
   [Mueller-Felber, Wolfgang] Univ Munich, Dpt Pediat, Munich, Germany.
   [Venkateswaran, Ramesh] Newcastle Gen Hosp, Dpt Pediat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   [Ogier, Helene] Hop Robert Debre, Ref Ctr Metab Dis, F-75019 Paris, France.
   [Altuzarra, Cecilia] Besancon CHU, Dpt Pediat, Besancon, France.
   [Thompson, Elizabeth] Womens & Childrens Hosp, SA Clin Genet, Adelaide, SA, Australia.
   [Smitka, Martin; Huebner, Angela] Tech Univ Dresden, Childrens Hosp, Dpt Neuropaediat, Dresden, Germany.
   [Husson, Marie] Bordeaux CHU, Dpt Pediat, Bordeaux, France.
   [Horvath, Rita] Univ Munich, Friedrich Baur Inst, Munich, Germany.
   [Horvath, Rita; Chinnery, Patrick] Newcastle Univ, Inst Hlth & Aging, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.
   [Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Dpt Clin Chem, NL-1105 AZ Amsterdam, Netherlands.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Dpt Genet & Metab Dis, Jerusalem, Israel.
   [Delahodde, Agnes] Univ Paris 11, CNRS, UMR8621, Inst Genet & Microbiol, F-91405 Orsay, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Necker-Enfants Malades - APHP; Institut National
   de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP);
   Hopital Universitaire Bicetre - APHP; University of Munich; Newcastle
   General Hospital; Universite Paris Cite; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Universite de
   Franche-Comte; CHU Besancon; Women's & Children's Hospital; Technische
   Universitat Dresden; CHU Bordeaux; University of Munich; Newcastle
   University - UK; University of Amsterdam; Academic Medical Center
   Amsterdam; Hebrew University of Jerusalem; Hadassah University Medical
   Center; Centre National de la Recherche Scientifique (CNRS); Universite
   Paris Saclay
RP de Lonlay, P (corresponding author), Hop Necker Enfants Malad, Reference Ctr Metab Dis, 149 Rue Sevres, F-75015 Paris, France.
EM pascale.delonlay@nck.aphp.fr
RI De Meirleir, Linda/D-6591-2016; Valayannopoulos, Vassili/AFR-8311-2022;
   Horvath, Rita/AAY-7042-2020; Vaz, Frederic/JJE-4884-2023; michot,
   caroline/H-2862-2017
OI Chinnery, Patrick/0000-0002-7065-6617; michot,
   caroline/0000-0002-8749-5899; Horvath, Rita/0000-0002-9841-170X;
   Huebner, Angela/0000-0003-1338-5192; Vaz, Frederic/0000-0002-9048-1041
FU AFM [13864, 13988]; Fondation de l'Avenir [09071]; Fondation pour la
   Recherche Medicale; Prinses Beatrix Fonds [WAR05-0126]; Barth syndrome
   foundation; MRC [G0601943] Funding Source: UKRI
FX This work was supported by AFM (grants 13864 and 13988), Fondation de
   l'Avenir (grant 09071), Fondation pour la Recherche Medicale (fellowship
   CM), the Prinses Beatrix Fonds (n<SUP>o</SUP> WAR05-0126), the Barth
   syndrome foundation. Patrick Chinnery is Wellcome Trust Senior Fellow in
   Clinical Science. No conflict of interests has to be disclosed, nor
   commercial considerations.
CR Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   de Lonlay-Debeney P, 1999, NEUROPEDIATRICS, V30, P42, DOI 10.1055/s-2007-973456
   Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535
   Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200
   DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P253, DOI 10.1016/0960-8966(95)90011-X
   Ellis KJ, 2000, ANN NY ACAD SCI, V904, P374
   Farooqui AA, 2000, CHEM PHYS LIPIDS, V106, P1, DOI 10.1016/S0009-3084(00)00128-6
   Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607
   Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200
   Higashida K, 2008, BIOCHEM BIOPH RES CO, V374, P587, DOI 10.1016/j.bbrc.2008.07.079
   Isackson PJ, 2006, MOL GENET METAB, V89, P323, DOI 10.1016/j.ymgme.2006.08.004
   KISHIMOTO C, 1994, CIRCULATION, V89, P2836, DOI 10.1161/01.CIR.89.6.2836
   Liu L, 2009, DIABETES, V58, P2516, DOI 10.2337/db08-1096
   Lu B, 2008, AM J PHYSIOL-ENDOC M, V295, pE1502, DOI 10.1152/ajpendo.90323.2008
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Ohkuma A, 2009, MUSCLE NERVE, V39, P333, DOI 10.1002/mus.21167
   Péterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685
   Phan J, 2005, DRUG NEWS PERSPECT, V18, P5, DOI 10.1358/dnp.2005.18.1.877165
   Reue K, 2000, J LIPID RES, V41, P1067
   Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200
   Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Tein I, 1999, SEMIN PERINATOL, V23, P125, DOI 10.1016/S0146-0005(99)80046-9
   TONIN P, 1990, ANN NEUROL, V27, P181, DOI 10.1002/ana.410270214
   Tsuchiya Y, 2009, BIOCHEM BIOPH RES CO, V382, P348, DOI 10.1016/j.bbrc.2009.03.021
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
NR 31
TC 97
Z9 108
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JUL
PY 2010
VL 31
IS 7
BP E1564
EP E1573
DI 10.1002/humu.21282
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 626QQ
UT WOS:000279982300004
PM 20583302
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Capaldi, RA
   Murray, J
   Byrne, L
   Janes, MS
   Marusich, MF
AF Capaldi, RA
   Murray, J
   Byrne, L
   Janes, MS
   Marusich, MF
TI Immunological approaches to the characterization and diagnosis of
   mitochondrial disease
SO MITOCHONDRION
LA English
DT Article; Proceedings Paper
CT 1st Mitochondrial Standards Workshop
CY 2002
CL Dallas, TX
SP United Mitochondrial Dis Fdn, Mitochondrial Res Soc, Natl Inst Stand & Technol
DE monoclonal antibodies; pyruvate dehydrogenase; mitochondrial DNA;
   OXPHOS; respiratory chain
ID PYRUVATE-DEHYDROGENASE COMPLEX; C-OXIDASE DEFICIENCY; RESPIRATORY-CHAIN;
   SKELETAL-MUSCLE; IMMUNOCAPTURE; DISORDERS; MUTATIONS; DEFECTS; TISSUE
AB Monoclonal antibodies (mAbs) are important tools in the diagnosis and characterization of mitochondrial diseases. They can be used in immunohistochemical and/or Western blotting approaches to identify misassembled OXPHOS complexes or pyruvate dehydrogenase deficiencies where the intact complex is not formed which is the great majority of cases. The advantage of antibody based approaches is that they can be quantitative, require very small amounts of tissue sample and are fast, simple and relatively cheap to perform. Here we provide details of the mAbs currently available and describe optimized protocols for both immunohistochemistry using patient fibroblasts as well as Western blotting using either cell culture or biopsy material. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
   Mol Probes Inc, Eugene, OR 97402 USA.
   Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.
C3 University of Oregon; Thermo Fisher Scientific; Molecular Probes, Inc.;
   University of Oregon
RP Capaldi, RA (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
EM rcapaldi@oregon.uoregon.edu
RI Marusich, Michael/AAQ-3447-2020
CR Aggeler R, 2002, J BIOL CHEM, V277, P33906, DOI 10.1074/jbc.M204538200
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004
   Davey GP, 1997, J NEUROCHEM, V69, P2564
   Hanson BJ, 2002, J HISTOCHEM CYTOCHEM, V50, P1281, DOI 10.1177/002215540205001001
   Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461
   Huang CC, 1999, ACTA NEUROL SCAND, V99, P125, DOI 10.1111/j.1600-0404.1999.tb00670.x
   JANES MS, 2003, UNPUB J HISTOCHEM CY
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   JOHNSON MA, 1988, J NEUROL SCI, V87, P75, DOI 10.1016/0022-510X(88)90056-1
   Lib M, 2003, ANAL BIOCHEM, V314, P121, DOI 10.1016/S0003-2697(02)00645-0
   Lissens W, 2000, HUM MUTAT, V15, P209, DOI 10.1002/(SICI)1098-1004(200003)15:3<209::AID-HUMU1>3.3.CO;2-B
   Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6
   MATTHEWS PM, 1994, BRAIN, V117, P435, DOI 10.1093/brain/117.3.435
   Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Scheffler I.E., 1999, MITOCHONDRIA
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schon EA, 2003, CURR MED CHEM, V10, P2523, DOI 10.2174/0929867033456503
   Szuhai K, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e13
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   Triepels RH, 2001, J BIOL CHEM, V276, P8892, DOI 10.1074/jbc.M009903200
   von Kleist-Retzow JC, 1999, BBA-MOL BASIS DIS, V1455, P35, DOI 10.1016/S0925-4439(99)00050-2
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Williams SE., 1994, J Biol Chem
   Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004
NR 26
TC 29
Z9 31
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
J9 MITOCHONDRION
JI Mitochondrion
PD SEP
PY 2004
VL 4
IS 5-6
BP 417
EP 426
DI 10.1016/j.mito.2004.07.006
PG 10
WC Cell Biology; Genetics & Heredity
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 885QS
UT WOS:000226172600008
PM 16120403
DA 2024-11-01
ER

PT J
AU Chance, B
   Im, J
   Nioka, S
   Kushmerick, M
AF Chance, Britton
   Im, Joohee
   Nioka, Shoko
   Kushmerick, Martin
TI Skeletal muscle energetics with PNMR: personal views and historic
   perspectives
SO NMR IN BIOMEDICINE
LA English
DT Review
DE phosphorylcreatine; ATP; oxidative phosphorylation; glycolysis; human
   muscle; muscle disorders
ID MAGNETIC-RESONANCE-SPECTROSCOPY; COMPARTMENTALIZED ENERGY-TRANSFER;
   NONINVASIVE TISSUE OXIMETRY; MITOCHONDRIAL-DNA MUTATIONS; P-31
   NMR-SPECTROSCOPY; HUMAN CALF MUSCLE; COUPLING IN-VIVO;
   OXIDATIVE-PHOSPHORYLATION; CREATINE-KINASE; ADENOSINE-TRIPHOSPHATE
AB This article reviews historical and current NMR approaches to describing in vivo bioenergetics of skeletal muscles in normal and diseased populations. It draws upon the first author's more than 70 years of personal experience in enzyme kinetics and the last author's physiological approaches. The development of in vivo PNMR jointly with researchers around the world is described. It is explained how non-invasive PNMR has advanced human exercise biochemistry, physiology and pathology. Further, after a brief explanation of bioenergetics with PNMR on creatine kinase, anerobic glycolysis and mitochondrial oxidative phosphorylation, some basic and controversial subjects are focused upon, and the authors' view of the subjects are offered, with questions and answers. Some of the research has been introduced in exercise physiology. Future directions of NMR on bioenergetics, as a part of system biological approaches, are indicated. Copyright (C) 2006 John Wiley & Sons, Ltd.
C1 Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.
   Temple Univ, Dept Kinesiol, Philadelphia, PA 19140 USA.
   Univ Washington, Dept Radiol, Seattle, WA 98195 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Physiol, Seattle, WA 98195 USA.
   Univ Washington, Dept Biophys, Seattle, WA 98195 USA.
C3 University of Pennsylvania; Pennsylvania Commonwealth System of Higher
   Education (PCSHE); Temple University; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; University of Washington; University of
   Washington Seattle; University of Washington; University of Washington
   Seattle
RP Chance, B (corresponding author), Univ Penn, Dept Biochem & Biophys, 250 Anat Chem Bldg, Philadelphia, PA 19104 USA.
EM chance@mail.med.upenn.edu
CR Abe K, 1999, J NEUROL SCI, V162, P65, DOI 10.1016/S0022-510X(98)00296-2
   ADAMS GR, 1990, J APPL PHYSIOL, V69, P968, DOI 10.1152/jappl.1990.69.3.968
   Aliev MK, 1997, BIOPHYS J, V73, P428, DOI 10.1016/S0006-3495(97)78082-2
   Aliev MK, 1998, MOL CELL BIOCHEM, V184, P209, DOI 10.1023/A:1006871903596
   ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615
   Arnett DC, 1999, J PHYS CHEM B, V103, P2014, DOI 10.1021/jp984464j
   Asperio RM, 2001, RADIOLOGY, V220, P413, DOI 10.1148/radiology.220.2.r01au03413
   BANK W, 1994, ANN NEUROL, V36, P830, DOI 10.1002/ana.410360606
   Barbiroli B, 1999, BIOFACTORS, V9, P253, DOI 10.1002/biof.5520090221
   Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036
   BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446
   BINZONI T, 1992, J APPL PHYSIOL, V73, P1644, DOI 10.1152/jappl.1992.73.4.1644
   BITTL JA, 1985, J BIOL CHEM, V260, P3512
   BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673
   BOTTOMLEY PA, 1985, SCIENCE, V229, P769, DOI 10.1126/science.4023711
   Bottomley PA, 2001, RADIOLOGY, V219, P411, DOI 10.1148/radiology.219.2.r01ma39411
   Bourdel-Marchasson I, 2001, AM J CLIN NUTR, V73, P832
   Brooks G., 2004, EXERCISE PHYSL HUMAN, V4th
   BURT CT, 1982, BIOCHIM BIOPHYS ACTA, V721, P492, DOI 10.1016/0167-4889(82)90107-0
   BUSBY SJW, 1978, BIOCHEM J, V170, P103, DOI 10.1042/bj1700103
   CAIN DF, 1963, BIOCHIM BIOPHYS ACTA, V74, P735, DOI 10.1016/0006-3002(63)91425-2
   CAIN DF, 1962, NATURE, V196, P214, DOI 10.1038/196214a0
   CAIN DF, 1962, BIOCHEM BIOPH RES CO, V8, P361, DOI 10.1016/0006-291X(62)90008-6
   Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163
   Chan A, 1998, J NEUROL, V245, P681, DOI 10.1007/s004150050267
   CHANCE B, 1970, P NATL ACAD SCI USA, V66, P1175, DOI 10.1073/pnas.66.4.1175
   CHANCE B, 1951, REV SCI INSTRUM, V22, P634, DOI 10.1063/1.1746021
   CHANCE B, 1978, P NATL ACAD SCI USA, V75, P4925, DOI 10.1073/pnas.75.10.4925
   CHANCE B, 1955, J BIOL CHEM, V217, P429
   CHANCE B, 1957, NATURE, V179, P1235, DOI 10.1038/1791235a0
   CHANCE B, 1982, P NATL ACAD SCI-BIOL, V79, P7714, DOI 10.1073/pnas.79.24.7714
   Chance B, 1983, Acta Radiol Suppl, V365, P73
   CHANCE B, 1986, P NATL ACAD SCI USA, V83, P9458, DOI 10.1073/pnas.83.24.9458
   CHANCE B, 1981, P NATL ACAD SCI-BIOL, V78, P6714, DOI 10.1073/pnas.78.11.6714
   CHANCE B, 1975, ANAL BIOCHEM, V67, P552, DOI 10.1016/0003-2697(75)90331-0
   Chance B., 1962, Muscle as a Tissue, P128
   Chaussain M, 1992, Eur J Med, V1, P457
   Chung YR, 1998, AM J PHYSIOL-CELL PH, V274, pC846, DOI 10.1152/ajpcell.1998.274.3.C846
   Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404
   Conley KE, 1997, AM J PHYSIOL-CELL PH, V273, pC306, DOI 10.1152/ajpcell.1997.273.1.C306
   Conley KE, 1998, J PHYSIOL-LONDON, V511, P935, DOI 10.1111/j.1469-7793.1998.935bg.x
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P211, DOI 10.1111/j.1469-7793.2000.00211.x
   CONLEY KE, 1994, ADV VET SCI COMP MED, V38, P1
   Conley KE, 2001, J EXP BIOL, V204, P3189
   COOPER C, 1955, BIOCHIM BIOPHYS ACTA, V18, P159, DOI 10.1016/0006-3002(55)90034-2
   Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE67, DOI 10.1152/ajpendo.2002.282.1.E67
   Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE74, DOI 10.1152/ajpendo.2002.282.1.E74
   Damon BM, 2003, MAGNET RESON MED, V49, P233, DOI 10.1002/mrm.10384
   DAVIES R E, 1952, Biochem J, V50, pxxiv
   DAVIES RE, 1951, BIOCHEM J, V50, P119, DOI 10.1042/bj0500119
   DAVIES RE, 1963, NATURE, V199, P1068, DOI 10.1038/1991068a0
   de Haan JH, 2003, MAGNET RESON MED, V50, P1302, DOI 10.1002/mrm.10630
   Dengler R, 1996, MUSCLE NERVE, V19, P456, DOI 10.1002/(SICI)1097-4598(199604)19:4<456::AID-MUS5>3.0.CO;2-B
   DESMEDT JE, 1977, J PHYSIOL-LONDON, V264, P673, DOI 10.1113/jphysiol.1977.sp011689
   DUBOC D, 1987, NEUROLOGY, V37, P663, DOI 10.1212/WNL.37.4.663
   Duteil S, 2004, AM J PHYSIOL-REG I, V287, pR1441, DOI 10.1152/ajpregu.00242.2004
   ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529
   ELEFF S, 1980, FED PROC, V39, P6
   ERECINSKA M, 1982, J MEMBRANE BIOL, V70, P1, DOI 10.1007/BF01871584
   FERENCZI MA, 1984, J PHYSIOL-LONDON, V352, P575, DOI 10.1113/jphysiol.1984.sp015311
   FERRIS CD, 1990, P NATL ACAD SCI USA, V87, P2147, DOI 10.1073/pnas.87.6.2147
   Fitts R H, 1996, Exerc Sport Sci Rev, V24, P427
   Gabr RE, 2006, J MAGN RESON, V179, P152, DOI 10.1016/j.jmr.2005.11.004
   GADIAN DG, 1976, P NATL ACAD SCI USA, V73, P4446, DOI 10.1073/pnas.73.12.4446
   Grassi B, 1998, J APPL PHYSIOL, V85, P1404, DOI 10.1152/jappl.1998.85.4.1404
   Greenman RL, 2005, LANCET, V366, P1711, DOI 10.1016/S0140-6736(05)67696-9
   Grehl T, 1998, NEUROMUSCULAR DISORD, V8, P480, DOI 10.1016/S0960-8966(98)00066-2
   GYULAI L, 1985, J BIOL CHEM, V260, P3947
   Han YS, 2003, J APPL PHYSIOL, V94, P2188, DOI 10.1152/japplphysiol.00618.2002
   Harkema SJ, 1997, AM J PHYSIOL-CELL PH, V272, pC491, DOI 10.1152/ajpcell.1997.272.2.C491
   HEERSCHAP A, 1993, MUSCLE NERVE, V16, P367, DOI 10.1002/mus.880160405
   Hill AV, 1920, J PHYSIOL-LONDON, V54, P84
   HILL AV, 1949, J PHYSL, V109, P8
   HOCHACHKA PW, 1985, J EXP BIOL, V115, P149
   HOGAN MC, 1992, J APPL PHYSIOL, V73, P1662, DOI 10.1152/jappl.1992.73.4.1662
   Horská A, 2000, AM J PHYSIOL-ENDOC M, V279, pE333, DOI 10.1152/ajpendo.2000.279.2.E333
   HOULT DI, 1974, NATURE, V252, P285, DOI 10.1038/252285a0
   Hsu AC, 2003, MAGNET RESON MED, V49, P626, DOI 10.1002/mrm.10412
   Hug F, 2005, MED SCI SPORT EXER, V37, P846, DOI 10.1249/01.MSS.0000162616.20085.B4
   JENESON JAL, 1992, AM J PHYSIOL, V263, pC357, DOI 10.1152/ajpcell.1992.263.2.C357
   Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813
   Jeneson JAL, 1996, J BIOL CHEM, V271, P27995, DOI 10.1074/jbc.271.45.27995
   Johansen KL, 2001, INT J ARTIF ORGANS, V24, P183, DOI 10.1177/039139880102400402
   JONG YSA, 1983, ARCH BIOCHEM BIOPHYS, V222, P179, DOI 10.1016/0003-9861(83)90515-5
   Jubrias SA, 2003, J PHYSIOL-LONDON, V553, P589, DOI 10.1113/jphysiol.2003.045872
   Keilin D, 1929, P R SOC LOND B-CONTA, V104, P206, DOI 10.1098/rspb.1929.0009
   Keilin D, 1938, NATURE, V141, P870, DOI 10.1038/141870a0
   KEMP GJ, 1994, MAGNET RESON MED, V31, P103, DOI 10.1002/mrm.1910310203
   Kemp GJ, 2001, J VASC SURG, V34, P1103, DOI 10.1067/mva.2001.117152
   Kemper WF, 2001, P NATL ACAD SCI USA, V98, P723, DOI 10.1073/pnas.011387598
   Kent-Braun JA, 2000, J APPL PHYSIOL, V89, P1072, DOI 10.1152/jappl.2000.89.3.1072
   KENYON GL, 1983, ADV ENZYMOL RAMB, V54, P367
   KEYNES RD, 1964, NATURE, V203, P261, DOI 10.1038/203261a0
   Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3
   KORZENIEWSKI B, 1992, BIOCHIM BIOPHYS ACTA, V1102, P67, DOI 10.1016/0167-4838(92)90500-D
   Korzeniewski B, 2000, BIOPHYS CHEM, V83, P19, DOI 10.1016/S0301-4622(99)00120-9
   KREBS MA, 1937, ENZYMOLOGIA, V4, P149
   KUHL CK, 1994, RADIOLOGY, V192, P223, DOI 10.1148/radiology.192.1.8208943
   KUSHMERICK MJ, 1969, PROC R SOC SER B-BIO, V174, P315, DOI 10.1098/rspb.1969.0096
   Kutsuzawa T, 2001, MED SCI SPORT EXER, V33, P901, DOI 10.1097/00005768-200106000-00008
   Lanza IR, 2004, J APPL PHYSIOL, V97, P967, DOI 10.1152/japplphysiol.01351.2003
   LARDY HA, 1969, ANNU REV BIOCHEM, V38, P991, DOI 10.1146/annurev.bi.38.070169.005015
   LEIGH JS, 1981, FED PROC, V40, P586
   Linnane AW, 2002, ANN NY ACAD SCI, V959, P396, DOI 10.1111/j.1749-6632.2002.tb02110.x
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Malucelli Emil, 2005, Dyn Med, V4, P7, DOI 10.1186/1476-5918-4-7
   Mancini L, 2005, MAGN RESON MED, V54, P1065, DOI 10.1002/mrm.20659
   Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782
   Marcinek DJ, 2004, AM J PHYSIOL-CELL PH, V286, pC457, DOI 10.1152/ajpcell.00237.2003
   Marcinek DJ, 2003, AM J PHYSIOL-HEART C, V285, pH1900, DOI 10.1152/ajpheart.00192.2003
   Mattei JP, 2002, BBA-BIOENERGETICS, V1554, P129, DOI 10.1016/S0005-2728(02)00226-8
   MATTHEWS PM, 1982, BIOCHIM BIOPHYS ACTA, V721, P312, DOI 10.1016/0167-4889(82)90084-2
   MATTHEWS PM, 1991, NEUROLOGY, V41, P114, DOI 10.1212/WNL.41.1.114
   MCCULLY KK, 1989, J APPL PHYSIOL, V67, P926, DOI 10.1152/jappl.1989.67.3.926
   MCCULLY KK, 1993, J APPL PHYSIOL, V75, P813, DOI 10.1152/jappl.1993.75.2.813
   MCFARLAND EW, 1994, BIOPHYS J, V67, P1912, DOI 10.1016/S0006-3495(94)80674-5
   MEYER RA, 1984, AM J PHYSIOL, V246, pC365, DOI 10.1152/ajpcell.1984.246.5.C365
   MEYER RA, 1988, AM J PHYSIOL, V254, pC548, DOI 10.1152/ajpcell.1988.254.4.C548
   MEYER RA, 1996, HDB PHYSL
   MEYERHOFF O, 1949, S RESP ENZYM, P3
   MINOTTI JR, 1990, J APPL PHYSIOL, V68, P289, DOI 10.1152/jappl.1990.68.1.289
   OGAWA S, 1982, BIOCHEMISTRY-US, V21, P4467, DOI 10.1021/bi00261a042
   OZAWA T, 1995, BIOCHEM BIOPH RES CO, V213, P432, DOI 10.1006/bbrc.1995.2150
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1
   PFAFF E, 1969, EUR J BIOCHEM, V10, P484, DOI 10.1111/j.1432-1033.1969.tb00715.x
   QUISTORFF B, 1993, BIOCHEM J, V291, P681, DOI 10.1042/bj2910681
   Richardson RS, 2002, BIOCHEM SOC T, V30, P232, DOI 10.1042/BST0300232
   Richardson RS, 2001, J APPL PHYSIOL, V91, P1845, DOI 10.1152/jappl.2001.91.4.1845
   Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004
   Rossiter HB, 2002, J APPL PHYSIOL, V93, P2059, DOI 10.1152/japplphysiol.00446.2002
   SAHLIN K, 1988, ACTA PHYSIOL SCAND, V134, P175, DOI 10.1111/j.1748-1716.1988.tb08477.x
   Sako T, 2001, J APPL PHYSIOL, V90, P338, DOI 10.1152/jappl.2001.90.1.338
   SAKS VA, 1977, BIOCHIM BIOPHYS ACTA, V465, P550, DOI 10.1016/0005-2736(77)90272-3
   SATRUSTEGUI J, 1988, MECH AGEING DEV, V42, P105, DOI 10.1016/0047-6374(88)90066-8
   Saupe KW, 1998, CIRC RES, V82, P898
   SCHAEFER S, 1988, J AM COLL CARDIOL, V12, P1449, DOI 10.1016/S0735-1097(88)80008-1
   Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10
   Schneider-Gold C, 2004, MUSCLE NERVE, V30, P636, DOI 10.1002/mus.20156
   Schunk K, 1998, INVEST RADIOL, V33, P329, DOI 10.1097/00004424-199806000-00003
   Short KR, 2005, J APPL PHYSIOL, V99, P95, DOI 10.1152/japplphysiol.00129.2005
   Smith NP, 2005, PROG BIOPHYS MOL BIO, V88, P1, DOI 10.1016/j.pbiomolbio.2003.11.014
   Smith SA, 2004, J APPL PHYSIOL, V96, P2288, DOI 10.1152/japplphysiol.01021.2003
   SOBOLL S, 1978, EUR J BIOCHEM, V87, P377, DOI 10.1111/j.1432-1033.1978.tb12387.x
   't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9
   Taivassalo T, 2002, ANN NEUROL, V51, P38, DOI 10.1002/ana.10027
   TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6
   TWIEG DB, 1989, MAGN RESON MED, V12, P291, DOI 10.1002/mrm.1910120302
   Van Dorsten FA, 1998, AM J PHYSIOL-HEART C, V275, pH1191, DOI 10.1152/ajpheart.1998.275.4.H1191
   VANDENBORNE K, 1995, AM J PHYSIOL-CELL PH, V268, pC869, DOI 10.1152/ajpcell.1995.268.4.C869
   VANDENBORNE K, 1993, AM J PHYSIOL, V265, pC1332, DOI 10.1152/ajpcell.1993.265.5.C1332
   VANDENBORNE K, 1991, P NATL ACAD SCI USA, V88, P5714, DOI 10.1073/pnas.88.13.5714
   Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747
   Vicini P, 2000, AM J PHYSIOL-CELL PH, V279, pC213, DOI 10.1152/ajpcell.2000.279.1.C213
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   WALLIMANN T, 1994, CURR BIOL, V4, P42, DOI 10.1016/S0960-9822(00)00008-7
   WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021
   WALLIMANN T, 1984, J BIOL CHEM, V259, P5238
   Warburg O, 1929, BIOCHEM Z, V214, P64
   Wasserman K, 1986, Adv Cardiol, V35, P1
   Wegener G, 2002, BIOCHEM SOC T, V30, P264, DOI 10.1042/bst0300264
   Whipp BJ, 2002, BIOCHEM SOC T, V30, P237, DOI 10.1042/BST0300237
   WILLIAMS RJP, 1976, TRENDS BIOCHEM SCI, V1, pN222, DOI 10.1016/0968-0004(76)90158-4
   WOLEDGE RC, 1986, ENERGETIC ASPECTS MU
   YOSHIZAKI K, 1982, BIOPHYS J, V38, P209, DOI 10.1016/S0006-3495(82)84549-9
   Yu X, 1995, BIOPHYS J, V69, P2090, DOI 10.1016/S0006-3495(95)80080-9
   Zange J, 2003, MUSCLE NERVE, V27, P728, DOI 10.1002/mus.10377
   ZATINA MA, 1986, J VASC SURG, V3, P411
NR 168
TC 80
Z9 84
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0952-3480
EI 1099-1492
J9 NMR BIOMED
JI NMR Biomed.
PD NOV
PY 2006
VL 19
IS 7
BP 904
EP 926
DI 10.1002/nbm.1109
PG 23
WC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy
GA 114DK
UT WOS:000242646700010
PM 17075955
OA Bronze
DA 2024-11-01
ER

PT J
AU Ho, J
   Pacaud, D
   Rakic, M
   Khan, A
AF Ho, Josephine
   Pacaud, Daniele
   Rakic, Maja
   Khan, Aneal
TI Diabetes in Pediatric Patients with Kearns-Sayre Syndrome: Clinical
   Presentation of 2 Cases and a Review of Pathophysiology
SO CANADIAN JOURNAL OF DIABETES
LA English
DT Article
DE children; diabetes; mitochondria
ID MITOCHONDRIAL MYOPATHIES; OPHTHALMOPLEGIA
AB Kearns-Sayre syndrome (KSS), resulting from a mitochondrial DNA deletion, is a rare cause of diabetes in children. We report 2 pediatric cases of KSS associated with diabetes that presented with hyperosmolar hyperglycemia with minimal ketosis. Both patients were treated initially with isotonic fluid resuscitation followed by intravenous insulin infusion.
   The first case was a boy of Blackfoot Aboriginal ancestry who presented with failure to thrive, developmental delay and Fanconi syndrome and was diagnosed with KSS at 3 years of age. At 4 years he presented with a cough and left upper lobe lung infiltrate as well as a hyperosmolar hyperglycemic episode. He subsequently required multiple daily insulin injections. This patient developed cardiomyopathy and died at the age of 10 years.
   The second case was a 6-year-old boy of Asian ancestry who presented with ataxia exacerbated by intercurrent illnesses, decreased exercise tolerance, gross motor and fine motor delays, anorexia and recurrent episodes of vomiting associated with dehydration, and he was subsequently diagnosed with KSS. At 11 years of age, the patient developed hyperosmolar hyperglycemia, and after treatment for it, he required multiple daily insulin injections. He died of end stage congestive heart failure secondary to cardiomyopathy at 13 years of age.
   These 2 cases are presented to describe the possible pathophysiology of mitochondrial diabetes and to emphasize the need to monitor for the development of diabetes in patients with known mitochondrial disease and also to be aware of possible mitochondrial disease in pediatric patients who present with hyperglycemia in the context of multisystem involvement. (C) 2014 Canadian Diabetes Association
C1 [Ho, Josephine; Pacaud, Daniele] Univ Calgary, Dept Pediat, Div Pediat Endocrinol, Calgary, AB T2N 1N4, Canada.
   [Rakic, Maja] Univ Calgary, Fac Med, Bachelor Hlth Sci Program, Calgary, AB, Canada.
   [Khan, Aneal] Univ Calgary, Dept Med Genet & Pediat, Metab Clin, Calgary, AB, Canada.
C3 University of Calgary; University of Calgary; University of Calgary
RP Khan, A (corresponding author), Alberta Childrens Prov Gen Hosp, Dept Med Genet & Pediat, Metab Clin, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.
EM khaa@ucalgary.ca
RI Khan, Aneal/W-2019-2018
CR Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Debray FG, 2006, AM J MED GENET A, V140A, P2330, DOI 10.1002/ajmg.a.31457
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   OKA Y, 1993, LANCET, V342, P527, DOI 10.1016/0140-6736(93)91649-7
   PICCOLO G, 1989, J NEUROL SCI, V94, P163, DOI 10.1016/0022-510X(89)90226-8
   POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
NR 9
TC 17
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1499-2671
J9 CAN J DIABETES
JI Can. J. Diabetes
PD AUG
PY 2014
VL 38
IS 4
BP 225
EP 228
DI 10.1016/j.jcjd.2014.04.003
PG 4
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AU1FD
UT WOS:000345365500006
PM 25092642
DA 2024-11-01
ER

PT J
AU Ehrlich, KC
   Deng, HW
   Ehrlich, M
AF Ehrlich, Kenneth C.
   Deng, Hong-Wen
   Ehrlich, Melanie
TI Epigenetics of Mitochondria-Associated Genes in Striated Muscle
SO EPIGENOMES
LA English
DT Article
DE skeletal muscle; heart; enhancer; epigenetics; DNA methylation;
   mitochondria; mitophagy; Parkinson's disease; PGC-1 alpha/PPARGC1A;
   PRKN/PARK2
ID SKELETAL-MUSCLE; PGC-1-ALPHA ISOFORMS; HEART-FAILURE; EXPRESSION;
   MUTATIONS; DISEASE; DEFICIENCY; METHYLATION; METABOLISM; MITOPHAGY
AB Striated muscle has especially large energy demands. We identified 97 genes preferentially expressed in skeletal muscle and heart, but not in aorta, and found significant enrichment for mitochondrial associations among them. We compared the epigenomic and transcriptomic profiles of the 27 genes associated with striated muscle and mitochondria. Many showed strong correlations between their tissue-specific transcription levels, and their tissue-specific promoter, enhancer, or open chromatin as well as their DNA hypomethylation. Their striated muscle-specific enhancer chromatin was inside, upstream, or downstream of the gene, throughout much of the gene as a super-enhancer (CKMT2, SLC25A4, and ACO2), or even overlapping a neighboring gene (COX6A2, COX7A1, and C0010A). Surprisingly, the 3' end of the 1.38 Mb PRKN (PARK2) gene (involved in mitophagy and linked to juvenile Parkinson's disease) displayed skeletal muscle/myoblast-specific enhancer chromatin, a myoblast-specific antisense RNA, as well as brain-specific enhancer chromatin. We also found novel tissue-specific RNAs in brain and embryonic stem cells within PPARGC1A (PGC-1 alpha), which encodes a master transcriptional coregulator for mitochondrial formation and metabolism. The tissue specificity of this gene's four alternative promoters, including a muscle-associated promoter, correlated with nearby enhancer chromatin and open chromatin. Our in-depth epigenetic examination of these genes revealed previously undescribed tissue-specific enhancer chromatin, intragenic promoters, regions of DNA hypomethylation, and intragenic noncoding RNAs that give new insights into transcription control for this medically important set of genes.
C1 [Ehrlich, Kenneth C.; Deng, Hong-Wen; Ehrlich, Melanie] Tulane Univ, Ctr Bioinformat & Genom, Hlth Sci Ctr, New Orleans, LA 70112 USA.
   [Ehrlich, Melanie] Tulane Univ, Tulane Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
   [Ehrlich, Melanie] Tulane Univ, Hayward Genet Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
C3 Tulane University; Tulane University; Tulane University
RP Ehrlich, M (corresponding author), Tulane Univ, Ctr Bioinformat & Genom, Hlth Sci Ctr, New Orleans, LA 70112 USA.; Ehrlich, M (corresponding author), Tulane Univ, Tulane Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.; Ehrlich, M (corresponding author), Tulane Univ, Hayward Genet Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA.
EM kehrlich@tulane.edu; hcleng2@tulane.edu; ehrlich@tulane.edu
OI Ehrlich, Melanie/0000-0002-8187-4476
FU National Institutes of Health [NS04885, U19AG05537301, R01AR069055];
   National Institutes of Health (National Center for Advancing
   Translational Sciences) [UL1TR001417]; Louisiana Cancer Center
FX This research was supported in part by grants to M.E. from the National
   Institutes of Health (NS04885), the National Institutes of Health
   (National Center for Advancing Translational Sciences, award number
   UL1TR001417), and the Louisiana Cancer Center and to H.-W.D. from the
   National Institutes of Health (U19AG05537301 and R01AR069055).
CR Allan R, 2020, EUR J APPL PHYSIOL, V120, P2487, DOI 10.1007/s00421-020-04467-6
   Ang YS, 2016, CELL, V167, P1734, DOI 10.1016/j.cell.2016.11.033
   Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110
   Banerji CRS, 2019, HUM MOL GENET, V28, P1244, DOI 10.1093/hmg/ddy405
   Benhar H, 2020, COMPUT METH PROG BIO, V195, DOI 10.1016/j.cmpb.2020.105635
   Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026
   Bhattacharya D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00480
   Boczonadi V, 2015, INT J BIOCHEM CELL B, V63, P32, DOI 10.1016/j.biocel.2015.01.025
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731
   Breckenridge RA, 2009, J MOL CELL CARDIOL, V47, P133, DOI 10.1016/j.yjmcc.2009.04.007
   Chambers JM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102234
   Cordeiro AV, 2020, J GERONTOL A-BIOL, V75, P2258, DOI 10.1093/gerona/glaa059
   Dagher R, 2021, MOL GENET METAB, V133, P1, DOI 10.1016/j.ymgme.2021.03.010
   Doblado L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083903
   Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115
   Ehrlich KC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218394
   Ehrlich KC, 2020, EPIGENOMES, V4, DOI 10.3390/epigenomes4010001
   Eryilmaz IE, 2017, NEUROL RES, V39, P965, DOI 10.1080/01616412.2017.1368141
   Garry GA, 2022, SEMIN CELL DEV BIOL, V122, P3, DOI 10.1016/j.semcdb.2021.05.019
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Gladyck S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020197
   Glancy B, 2021, PHYSIOL REV, V101, P1561, DOI 10.1152/physrev.00040.2020
   Gouspillou G, 2018, J PHYSIOL-LONDON, V596, P2565, DOI 10.1113/JP275604
   Gumeni S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03952-w
   Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095
   Ji S, 2008, MOL GENET METAB, V93, P314, DOI 10.1016/j.ymgme.2007.10.006
   Kadenbach B, 2021, MITOCHONDRION, V58, P296, DOI 10.1016/j.mito.2020.10.004
   Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002
   Krämer AI, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215449
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Kwik M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073296
   Lacey M, 2019, DATA BRIEF, V23, DOI 10.1016/j.dib.2019.103812
   Lampert MA, 2019, AUTOPHAGY, V15, P1182, DOI 10.1080/15548627.2019.1580095
   Larson C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165740
   Leach JP, 2017, NATURE, V550, P260, DOI 10.1038/nature24045
   Leduc-Gaudet JP, 2019, J PHYSIOL-LONDON, V597, P1975, DOI 10.1113/JP277157
   Léveillé M, 2020, MOL METAB, V34, P72, DOI 10.1016/j.molmet.2020.01.004
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lindskog C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1686-y
   Liu L, 2020, J CLIN INVEST, V130, P4710, DOI 10.1172/JCI136155
   Lochmann TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129647
   Mackey AL, 2017, J PHYSIOL-LONDON, V595, P5115, DOI 10.1113/JP273997
   Marshall LL, 2020, NAT NEUROSCI, V23, P1203, DOI 10.1038/s41593-020-0690-y
   Martinez-Redondo V, 2016, J BIOL CHEM, V291, P15169, DOI 10.1074/jbc.M115.705822
   Martínez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z
   Miquerol L, 2013, WIRES DEV BIOL, V2, P17, DOI 10.1002/wdev.68
   Mizuno Y, 2020, NEUROSCI RES, V159, P3, DOI 10.1016/j.neures.2020.02.002
   Moore-Morris T, 2018, PHYSIOL REV, V98, P2453, DOI 10.1152/physrev.00048.2017
   Murillo-González FE, 2021, BIOCHEM PHARMACOL, V190, DOI 10.1016/j.bcp.2021.114650
   Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046
   Napoli C, 2020, AM HEART J, V224, P113, DOI 10.1016/j.ahj.2020.03.007
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Padmanabhan A, 2020, CIRCULATION, V142, P2338, DOI 10.1161/CIRCULATIONAHA.120.047753
   Park HD, 2009, ANN CLIN LAB SCI, V39, P399
   Patel BV, 2020, J MOL BIOL, V432, P6127, DOI 10.1016/j.jmb.2020.09.022
   Popov DV, 2015, ACTA NATURAE, V7, P48, DOI 10.32607/20758251-2015-7-1-48-59
   Puig RR, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07760-6
   Rönn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8
   Roudbar MA, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkab112
   Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050
   Sartorelli V, 2020, NAT STRUCT MOL BIOL, V27, P521, DOI 10.1038/s41594-020-0446-0
   Schiaffino S, 2021, J NEUROMUSCULAR DIS, V8, P169, DOI 10.3233/JND-200568
   Schiaffino S, 2020, HISTOL HISTOPATHOL, V35, P239, DOI 10.14670/HH-18-170
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shintaku J, 2016, CELL REP, V17, P514, DOI 10.1016/j.celrep.2016.09.010
   Shouman S, 2021, ADV EXP MED BIOL, V1312, P51, DOI 10.1007/5584_2020_594
   Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172
   Sondheimer N, 2017, MOL GENET METAB REP, V12, P23, DOI 10.1016/j.ymgmr.2017.05.001
   Song HX, 2021, AUTOPHAGY, V17, P4102, DOI 10.1080/15548627.2021.1904488
   Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148
   Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6
   Soyal SM, 2020, MOL NEUROBIOL, V57, P752, DOI 10.1007/s12035-019-01731-5
   Soyal SM, 2019, NEUROBIOL DIS, V121, P34, DOI 10.1016/j.nbd.2018.09.016
   Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177
   Steimle JD, 2017, CURR TOP DEV BIOL, V122, P195, DOI 10.1016/bs.ctdb.2016.08.008
   Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5
   Swedlund B, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036731
   Sweeney HL, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a023200
   Taylor-Weiner H, 2020, P NATL ACAD SCI USA, V117, P2978, DOI 10.1073/pnas.1919600117
   Terragni J, 2014, EPIGENETICS-US, V9, P842, DOI 10.4161/epi.28597
   Terry EE, 2018, ELIFE, V7, DOI 10.7554/eLife.34613
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   Timón-Gómez A, 2018, SEMIN CELL DEV BIOL, V76, P163, DOI 10.1016/j.semcdb.2017.08.055
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wagner AE, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/835970
   Wardle FC, 2019, J MUSCLE RES CELL M, V40, P211, DOI 10.1007/s10974-019-09538-6
   Whittington HJ, 2018, CARDIOVASC RES, V114, P858, DOI 10.1093/cvr/cvy054
   Zhang RH, 2020, MECH AGEING DEV, V188, DOI 10.1016/j.mad.2020.111245
NR 89
TC 3
Z9 3
U1 2
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4655
J9 EPIGENOMES
JI Epigenomes
PD MAR
PY 2022
VL 6
IS 1
AR 1
DI 10.3390/epigenomes6010001
PG 23
WC Genetics & Heredity
WE Emerging Sources Citation Index (ESCI)
SC Genetics & Heredity
GA 0C6JY
UT WOS:000775418300001
PM 35076500
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Bennett, B
   Helbling, D
   Meng, H
   Jarzembowski, J
   Geurts, AM
   Friederich, MW
   Van Hove, JLK
   Lawlor, MW
   Dimmock, DP
AF Bennett, Brian
   Helbling, Daniel
   Meng, Hui
   Jarzembowski, Jason
   Geurts, Aron M.
   Friederich, Marisa W.
   Van Hove, Johan L. K.
   Lawlor, Michael W.
   Dimmock, David P.
TI Potentially diagnostic electron paramagnetic resonance spectra elucidate
   the underlying mechanism of mitochondrial dysfunction in the
   deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA
   depletion syndrome
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE DGUOK; Redox; Oxidative; Stress; mtDNA depletion; Pathology; EPR; ESR
ID OXIDOREDUCTASE COMPLEX-I; IRON-SULFUR CLUSTERS; CYTOCHROME-C-OXIDASE;
   COMPARATIVE GENOMIC HYBRIDIZATION; NADH-UBIQUINONE OXIDOREDUCTASE;
   RESPIRATORY-CHAIN DISORDERS; LIVER-FAILURE; QUINONE OXIDOREDUCTASE;
   ESCHERICHIA-COLI; SKELETAL-MUSCLE
AB A novel rat model for a well-characterized human mitochondrial disease, mitochondrial DNA depletion syndrome with associated deoxyguanosine kinase (DGUOK) deficiency, is described. The rat model recapitulates the pathologic and biochemical signatures of the human disease. The application of electron paramagnetic (spin) resonance (EPR) spectroscopy to the identification and characterization of respiratory chain abnormalities in the mitochondria from freshly frozen tissue of the mitochondrial disease model rat is introduced. EPR is shown to be a sensitive technique for detecting mitochondrial functional abnormalities in situ and, here, is particularly useful in characterizing the redox state changes and oxidative stress that can result from depressed expression and/or diminished specific activity of the distinct respiratory chain complexes. As EPR requires no sample preparation or non-physiological reagents, it provides information on the status of the mitochondrion as it was in the functioning state. On its own, this information is of use in identifying respiratory chain dysfunction; in conjunction with other techniques, the information from EPR shows how the respiratory chain is affected at the molecular level by the dysfunction. It is proposed that EPR has a role in mechanistic pathophysiological studies of mitochondrial disease and could be used to study the impact of new treatment modalities or as an additional diagnostic tool. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Bennett, Brian] Med Coll Wisconsin, Dept Biophys, Natl Biomed EPR Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Helbling, Daniel; Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Helbling, Daniel; Dimmock, David P.] Med Coll Wisconsin, Dept Pediat, Div Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Meng, Hui; Jarzembowski, Jason; Lawlor, Michael W.] Med Coll Wisconsin, Dept Pathol & Lab Med, Div Pediat Pathol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Geurts, Aron M.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
   [Friederich, Marisa W.; Van Hove, Johan L. K.] Univ Colorado, Clin Genet & Metab, Dept Pediat, Mailstop 8400,13121 East 17th Ave, Aurora, CO 80045 USA.
   [Bennett, Brian] Marquette Univ, Dept Phys, 540 N 15th St, Milwaukee, WI 53233 USA.
C3 Medical College of Wisconsin; Medical College of Wisconsin; Medical
   College of Wisconsin; Medical College of Wisconsin; Medical College of
   Wisconsin; University of Colorado System; University of Colorado
   Anschutz Medical Campus; Marquette University
RP Dimmock, DP (corresponding author), Med Coll Wisconsin, Dept Pediat, Human Mol Genet Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Dimmock, DP (corresponding author), Med Coll Wisconsin, Dept Pediat, Div Genet, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.
EM brian.bennett@mu.edu; dhelbling@mcw.edu; hmeng@mcw.edu;
   jjarzemb@mcw.edu; ageurts@mcw.edu; Marisa.Friederich@ucdenver.edu;
   johan.vanhove@childrenscolorado.org; mlawlor@mcw.edu; ddimmock@mcw.edu
RI Jarzembowski, Jason/L-6551-2019; Dimmock, David/I-7913-2015
OI Jarzembowski, Jason/0000-0002-9027-5686; /0000-0002-2693-5598; Dimmock,
   David/0000-0001-6690-2523
FU Children's Hospital of Wisconsin: Children's Research Institute; 
   [P41EB001980]
FX EPR work was supported in part by P41EB001980 (James S Hyde PI). Animal
   work was in part supported by Children's Hospital of Wisconsin:
   Children's Research Institute funding to David Dimmock.
CR AASA R, 1976, BIOCHIM BIOPHYS ACTA, V422, P260, DOI 10.1016/0005-2744(76)90137-6
   Abramovich CM, 2001, HUM PATHOL, V32, P649, DOI 10.1053/hupa.2001.24995
   BEINERT H, 1975, EUR J BIOCHEM, V54, P185, DOI 10.1111/j.1432-1033.1975.tb04128.x
   Beinert H, 1978, Methods Enzymol, V54, P133
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   BINDOFF LA, 1991, J NEUROL SCI, V102, P17, DOI 10.1016/0022-510X(91)90088-O
   Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002
   Borchert Astrid, 2002, Semin Pediatr Neurol, V9, P151, DOI 10.1053/spen.2002.33800
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Buchaklian AH, 2012, MOL GENET METAB, V107, P92, DOI 10.1016/j.ymgme.2012.04.019
   Carelli V, 2013, CURR OPIN NEUROL, V26, P52, DOI 10.1097/WCO.0b013e32835c5f0b
   Chandran K, 2009, BIOPHYS J, V96, P1388, DOI 10.1016/j.bpj.2008.10.042
   Chinnery PF, 1993, GENEREVIEWS
   Chitkara DK, 2003, AM J GASTROENTEROL, V98, P871, DOI 10.1016/S0002-0270(03)00049-2
   Chow C W, 2000, Hum Reprod, V15 Suppl 2, P68
   Collins J, 2009, NEUROMUSCULAR DISORD, V19, P784, DOI 10.1016/j.nmd.2009.08.002
   COOPER CE, 1991, BIOCHEM SOC T, V19, pS259, DOI 10.1042/bst019259s
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   Darras BT, 2000, PEDIATR NEUROL, V22, P87, DOI 10.1016/S0887-8994(99)00133-2
   De Camaret BM, 2007, BIOCHEM J, V402, P377, DOI 10.1042/BJ20060705
   DIMAURO S, 1990, PEDIATR RES, V28, P536, DOI 10.1203/00006450-199011000-00025
   Dimmock DP, 2008, HUM MUTAT, V29, P330, DOI 10.1002/humu.9519
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Driessen J, 2007, PEDIATR ANESTH, V17, P16, DOI 10.1111/j.1460-9592.2006.02043.x
   EDWARDS RHT, 1983, MUSCLE NERVE, V6, P676, DOI 10.1002/mus.880060910
   FECKE W, 1994, EUR J BIOCHEM, V220, P551, DOI 10.1111/j.1432-1033.1994.tb18655.x
   FIGARELLABRANGER D, 1992, J NEUROL SCI, V108, P105, DOI 10.1016/0022-510X(92)90195-Q
   FINEL M, 1994, EUR J BIOCHEM, V226, P237, DOI 10.1111/j.1432-1033.1994.tb20046.x
   Fodale V, 2008, DRUG SAFETY, V31, P293, DOI 10.2165/00002018-200831040-00003
   Footitt EJ, 2008, BRIT J ANAESTH, V100, P436, DOI 10.1093/bja/aen014
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Gellerich FN, 2004, MITOCHONDRION, V4, P427, DOI 10.1016/j.mito.2004.07.007
   Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447
   Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028
   Goh V, 2012, J PEDIATR GASTR NUTR, V54, P291, DOI 10.1097/MPG.0b013e318227e53c
   Goodfellow JA, 2012, POSTGRAD MED J, V88, P326, DOI 10.1136/postgradmedj-2011-130326
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185
   Gropman A.L., 2012, NEUROTHERAPEUTICS
   Gulati Sheffali, 2003, Indian Journal of Pediatrics, V70, P317, DOI 10.1007/BF02723588
   Gurrieri C, 2011, CAN J ANESTH, V58, P751, DOI 10.1007/s12630-011-9528-0
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Haddy A, 1999, COMP BIOCHEM PHYS B, V123, P407, DOI 10.1016/S0305-0491(99)00087-5
   Hadzsiev K, 2010, NEUROMOL MED, V12, P277, DOI 10.1007/s12017-010-8115-9
   Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003
   Hanson GR, 2003, PROG T CHEM, V10, P197
   HARDING AE, 1989, BRIT MED BULL, V45, P760, DOI 10.1093/oxfordjournals.bmb.a072356
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Jacob HJ, 2010, TRENDS GENET, V26, P510, DOI 10.1016/j.tig.2010.08.006
   Ji JQ, 2010, MITOCHONDRION, V10, P188, DOI 10.1016/j.mito.2009.11.002
   Katzberg H, 2010, J CHILD NEUROL, V25, P1382, DOI 10.1177/0883073810367683
   Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791
   Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Kyriacou K., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P201
   Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035
   Lee NC, 2009, ARCH DIS CHILD, V94, P55, DOI 10.1136/adc.2008.139584
   Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Lutz RE, 2009, J PEDIATR GASTR NUTR, V49, P126, DOI 10.1097/MPG.0b013e31817d9cad
   MAILER C, 1973, BIOCHIM BIOPHYS ACTA, V322, P195, DOI 10.1016/0005-2795(73)90293-6
   Maly T, 2009, BBA-BIOENERGETICS, V1787, P584, DOI 10.1016/j.bbabio.2009.02.003
   Mari M., 2012, BIOCH BIOPHYS ACTA
   MAZZIOTTA MRM, 1992, J PEDIATR-US, V121, P896, DOI 10.1016/S0022-3476(05)80335-X
   McCormick E, 2012, NEUROTHERAPEUTICS
   McDonald DGM, 2002, AM J MED GENET, V111, P191, DOI 10.1002/ajmg.10522
   McFarland R, 2008, ARCH DIS CHILD, V93, P151, DOI 10.1136/adc.2007.122911
   Menezes MP, 2012, DEV MED CHILD NEUROL, V54, P407, DOI 10.1111/j.1469-8749.2012.04271.x
   Micaglio G, 1987, Riv Neurol, V57, P261
   Mills DA, 2008, BIOCHEMISTRY-US, V47, P11499, DOI 10.1021/bi801156s
   Mohri I, 1998, J NEUROL SCI, V158, P106, DOI 10.1016/S0022-510X(98)00082-3
   MORAES CT, 1991, AM J HUM GENET, V48, P492
   Morris AAM, 1998, J HEPATOL, V28, P556, DOI 10.1016/S0168-8278(98)80278-X
   Morris AAM, 1999, LIVER, V19, P357, DOI 10.1111/j.1478-3231.1999.tb00063.x
   Myers CR, 2010, FREE RADICAL BIO MED, V49, P1903, DOI 10.1016/j.freeradbiomed.2010.09.020
   Nakamaru-Ogiso E, 2008, J BIOL CHEM, V283, P25979, DOI 10.1074/jbc.M804015200
   OHIRA Y, 1982, BRIT J HAEMATOL, V52, P623, DOI 10.1111/j.1365-2141.1982.tb03938.x
   Ohnishi T, 2008, BBA-BIOENERGETICS, V1777, P703, DOI 10.1016/j.bbabio.2008.04.032
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   Papaioannou V, 2008, ACTA ANAESTH BELG, V59, P79
   Parikh S, 2014, MITOCHONDRION, V14, P26, DOI 10.1016/j.mito.2013.07.116
   Pearce LL, 2009, NITRIC OXIDE-BIOL CH, V20, P135, DOI 10.1016/j.niox.2008.12.001
   Procaccio V, 2004, NEUROLOGY, V62, P1899, DOI 10.1212/01.WNL.0000125251.56131.65
   Rahman S, 2009, ARCH DIS CHILD, V94, P3, DOI 10.1136/adc.2008.147983
   RICCI E, 1992, BRAIN PATHOL, V2, P141, DOI 10.1111/j.1750-3639.1992.tb00682.x
   Rötig A, 2004, BBA-BIOENERGETICS, V1659, P129, DOI 10.1016/j.bbabio.2004.07.007
   RYLKOV VV, 1991, EUR J BIOCHEM, V197, P185, DOI 10.1111/j.1432-1033.1991.tb15897.x
   Sakushima K, 2011, NEUROLOGIST, V17, P222, DOI 10.1097/NRL.0b013e318217357a
   SALERNO JC, 1980, BIOCHEM J, V192, P769, DOI 10.1042/bj1920769
   SALERNO JC, 1984, J AM CHEM SOC, V106, P2156, DOI 10.1021/ja00319a041
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Scaglia F, 2010, DEV DISABIL RES REV, V16, P136, DOI 10.1002/ddrr.115
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schrier SA, 2011, CURR OPIN OPHTHALMOL, V22, P325, DOI 10.1097/ICU.0b013e328349419d
   Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110
   Shergill JK, 1996, BIOCHEM BIOPH RES CO, V228, P298, DOI 10.1006/bbrc.1996.1656
   SHERGILL JK, 1991, BIOCHEM SOC T, V19, pS256, DOI 10.1042/bst019256s
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Smet J, 2011, J INHERIT METAB DIS, V34, P741, DOI 10.1007/s10545-011-9315-7
   Smet J, 2009, ELECTROPHORESIS, V30, P3565, DOI 10.1002/elps.200900213
   Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006
   Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Svistunenko DA, 2006, BBA-BIOENERGETICS, V1757, P262, DOI 10.1016/j.bbabio.2006.03.007
   Tatke Medha, 2007, Indian J Pathol Microbiol, V50, P467
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   TORII K, 1970, J BIOCHEM-TOKYO, V68, P837, DOI 10.1093/oxfordjournals.jbchem.a129421
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vallance H, 2004, PEDIATR DEVEL PATHOL, V7, P633, DOI 10.1007/s10024-004-5053-2
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   VANEKEREN GJ, 1993, EUR J PEDIATR, V152, P255, DOI 10.1007/BF01956157
   Venegas V., 2011, CURR PROTOC HUM GENE, V17
   Vu TH, 2002, NEUROL CLIN, V20, P809, DOI 10.1016/S0733-8619(01)00017-2
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Weil JA., 1994, ELECT PARAMAGNETIC R, P568
   Wells GD, 2008, CAN J NEUROL SCI, V35, P31, DOI 10.1017/S0317167100007538
   Whitworth JR, 2006, J PEDIATR GASTR NUTR, V43, P536, DOI 10.1097/01.mpg.0000232332.00677.3d
   WILLIAMSSMITH DL, 1984, BRIT J CANCER, V50, P399, DOI 10.1038/bjc.1984.189
   Wojtovich A.P., 2013, BIOCH BIOPHYS ACTA
   Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721
   Wray CD, 2013, MITOCHONDRION, V13, P656, DOI 10.1016/j.mito.2013.09.004
   Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104
   YANG AS, 1987, BIOPHYS J, V51, P55, DOI 10.1016/S0006-3495(87)83311-8
NR 129
TC 13
Z9 15
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAR
PY 2016
VL 92
BP 141
EP 151
DI 10.1016/j.freeradbiomed.2016.01.001
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DE5BJ
UT WOS:000370645400012
PM 26773591
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Gamba, J
   Gamba, LT
   Rodrigues, GS
   Kiyomoto, BH
   Moraes, CT
   Tengan, CH
AF Gamba, Juliana
   Gamba, Luana T.
   Rodrigues, Gabriela S.
   Kiyomoto, Beatriz H.
   Moraes, Carlos T.
   Tengan, Celia H.
TI Nitric Oxide Synthesis Is Increased in Cybrid Cells with m.3243A&gt;G
   Mutation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE mitochondria; nitric oxide; arginine; mitochondrial disease;
   mitochondrial DNA
ID STROKE-LIKE EPISODES; L-ARGININE; IN-VIVO; SPECTROPHOTOMETRIC METHOD;
   LACTIC-ACIDOSIS; MUSCLE-FIBERS; MELAS; ENCEPHALOPATHY; MITOCHONDRIA;
   CITRULLINE
AB Nitric oxide (NO) is a free radical and a signaling molecule in several pathways, produced by nitric oxide synthase (NOS) from the conversion of L-arginine to citrulline. Supplementation of L-arginine has been used to treat MELAS (mitochondrial encephalopathy with lactic acidosis and stroke like syndrome), a mitochondrial disease caused by the m. 3243A>G mutation. Low levels of serum arginine and endothelium dysfunction have been reported in MELAS and this treatment may increase NO in endothelial cells and promote vasodilation, decreasing cerebral ischemia and strokes. Although clinical benefits have been reported, little is known about NO synthesis in MELAS. In this study we found that osteosarcoma derived cybrid cells with high levels of m. 3243A>G had increased nitrite, an NO metabolite, and increased intracellular NO, demonstrated by an NO fluorescent probe (DAF-FM). Muscle vessels from patients with the same mutation had increased staining in NADPH diaphorase, suggestive of increased NOS. These results indicate increased production of NO in cells harboring the m. 3243A>G, however no nitrated protein was detected by Western blotting. Further studies are necessary to clarify the exact mechanisms of L-arginine effect to determine the appropriate clinical use of this drug therapy.
C1 [Gamba, Juliana; Gamba, Luana T.; Rodrigues, Gabriela S.; Kiyomoto, Beatriz H.; Tengan, Celia H.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04039032 Sao Paulo, Brazil.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol & Cell Biol, Miami, FL 33101 USA.
C3 Universidade Federal de Sao Paulo (UNIFESP); University of Miami
RP Tengan, CH (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, R Pedro de Toledo 781, BR-04039032 Sao Paulo, Brazil.
EM juliana.gamba@unifesp.br; luana_biologa@hotmail.com; 1000gabi@gmail.com;
   bhkiyomoto@unifesp.br; cmoraes@med.miami.edu; chtengan@unifesp.br
RI Moraes, Carlos/AAT-3818-2021; Tengan, Celia/D-8458-2013; Rodrigues,
   Gabriela/LCD-4106-2024
FU Fundacao de Amparo a Pesquisa de Sao Paulo; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior
FX This study was supported by Fundacao de Amparo a Pesquisa de Sao Paulo
   (CHT, LTG, GSR) and Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (JG).
CR Abraham MB, 2012, J PAEDIATR CHILD H, V48, pE96, DOI 10.1111/j.1440-1754.2011.02074.x
   Arakawa K, 2010, CIRC J, V74, P2702, DOI 10.1253/circj.CJ-10-0044
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63
   Boveris A, 2000, ANN NY ACAD SCI, V899, P121
   Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001
   Coman D, 2008, CLIN NUTR, V27, P489, DOI 10.1016/j.clnu.2008.05.007
   Desquiret-Dumas V, 2012, BBA-MOL BASIS DIS, V1822, P1019, DOI 10.1016/j.bbadis.2012.01.010
   El-Hattab AW, 2012, MOL GENET METAB, V107, P247, DOI 10.1016/j.ymgme.2012.06.018
   El-Hattab AW, 2012, MOL GENET METAB, V105, P607, DOI 10.1016/j.ymgme.2012.01.016
   Elly L, 2009, METHOD ENZYMOL, V456, P169, DOI 10.1016/S0076-6879(08)04409-1
   Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472
   Gerard JM, 1997, J TOXICOL-CLIN TOXIC, V35, P621, DOI 10.3109/15563659709001243
   Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6
   Haqqani AS, 2002, J BIOL CHEM, V277, P3614, DOI 10.1074/jbc.M105730200
   James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Koga Y, 2006, NEUROLOGY, V66, P1766, DOI 10.1212/01.wnl.0000220197.36849.1e
   Koga Y, 2005, NEUROLOGY, V64, P710, DOI 10.1212/01.WNL.0000151976.60624.01
   Koga Y, 2002, NEUROLOGY, V58, P827, DOI 10.1212/WNL.58.5.827
   Koga Y, 2007, MITOCHONDRION, V7, P133, DOI 10.1016/j.mito.2006.11.006
   Koga Y, 2010, ANN NY ACAD SCI, V1201, P104, DOI 10.1111/j.1749-6632.2010.05624.x
   Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723
   Kubota M, 2004, BRAIN DEV-JPN, V26, P481, DOI 10.1016/j.braindev.2004.01.006
   McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Naini A, 2005, J NEUROL SCI, V229, P187, DOI 10.1016/j.jns.2004.11.026
   NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6
   Nisoli E, 2006, J CELL SCI, V119, P2855, DOI 10.1242/jcs.03062
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oliveira KK, 2013, ANAL BIOCHEM, V435, P57, DOI 10.1016/j.ab.2012.12.002
   Planitzer G, 2000, HISTOCHEM J, V32, P303, DOI 10.1023/A:1004041129915
   Ridnour LA, 2000, ANAL BIOCHEM, V281, P223, DOI 10.1006/abio.2000.4583
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209
   Tengan CH, 2007, BIOCHEM BIOPH RES CO, V359, P771, DOI 10.1016/j.bbrc.2007.05.184
   Vattemi G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002964
   Yoneda M, 2012, BBA-GEN SUBJECTS, V1820, P615, DOI 10.1016/j.bbagen.2011.04.018
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 42
TC 12
Z9 14
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2013
VL 14
IS 1
BP 394
EP 410
DI 10.3390/ijms14010394
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 077SS
UT WOS:000314048800024
PM 23263669
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Larosa, V
   Coosemans, N
   Motte, P
   Bonnefoy, N
   Remacle, C
AF Larosa, Veronique
   Coosemans, Nadine
   Motte, Patrick
   Bonnefoy, Nathalie
   Remacle, Claire
TI Reconstruction of a human mitochondrial complex I mutation in the
   unicellular green alga Chlamydomonas
SO PLANT JOURNAL
LA English
DT Article
DE Chlamydomonas; mutation; mitochondrial; human; heteroplasmic;
   homoplasmic
ID NADH-UBIQUINONE OXIDOREDUCTASE; STRUCTURAL ORGANIZATION; SUBUNIT
   COMPOSITION; RNA GENES; REINHARDTII; DNA; TRANSFORMATION; SEQUENCE;
   BINDING; ENZYME
AB Defects in complex I (NADH:ubiquinone oxidoreductase (EC 1.6.5.3)) are the most frequent cause of human respiratory disorders. The pathogenicity of a given human mitochondrial mutation can be difficult to demonstrate because the mitochondrial genome harbors large numbers of polymorphic base changes that have no pathogenic significance. In addition, mitochondrial mutations are usually found in the heteroplasmic state, which may hide the biochemical effect of the mutation. We propose that the unicellular green alga Chlamydomonas could be used to study such mutations because (i) respiratory complex-deficient mutants are viable and mitochondrial mutations are found in the homoplasmic state, (ii) transformation of the mitochondrial genome is feasible, and (iii) Chlamydomonas complex I is similar to that of humans. To illustrate this proposal, we introduced a Leu157Pro substitution into the Chlamydomonas ND4 subunit of complex I in two recipient strains by biolistic transformation, demonstrating that site-directed mutagenesis of the Chlamydomonas mitochondrial genome is possible. This substitution did not lead to any respiratory enzyme defects when present in the heteroplasmic state in a patient with chronic progressive external ophthalmoplegia. When present in the homoplasmic state in the alga, the mutation does not prevent assembly of whole complex I (950 kDa) and the NADH dehydrogenase activity of the peripheral arm of the complex is mildly affected. However, the NADH:duroquinone oxidoreductase activity is strongly reduced, suggesting that the substitution could affect binding of ubiquinone to the membrane domain. The in vitro defects correlate with a decrease in dark respiration and growth rate in vivo.
C1 [Larosa, Veronique; Coosemans, Nadine; Motte, Patrick; Remacle, Claire] Univ Liege, Inst Bot, Dept Life Sci, B-4000 Liege, Belgium.
   [Bonnefoy, Nathalie] CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France.
C3 University of Liege; Centre National de la Recherche Scientifique
   (CNRS); Universite Paris Saclay
RP Remacle, C (corresponding author), Univ Liege, Inst Bot, Dept Life Sci, B-4000 Liege, Belgium.
EM c.remacle@ulg.ac.be
RI Bonnefoy, Nathalie/GYD-2949-2022
OI Remacle, Claire/0000-0002-5016-9547; Bonnefoy,
   Nathalie/0000-0002-5068-8849
FU Fonds National de la Recherche Scientifique [1.5.255.08, 2.4.601.08,
   2.4567.11]; Action de la Recherche Concertee [ARC07/12-04]; FP7 [GA
   245070]; University of Liege; Formation a la Recherche dans l'Industrie
   et l'Agriculture; Agence Nationale pour la Recherche (ANR)
   [JCJC06-0163]; FNRS [2.4581.10, 2.4531.09]
FX We warmly thank M. Radoux for helpful technical assistance. C.R. was
   supported by the Fonds National de la Recherche Scientifique (grant
   numbers 1.5.255.08, 2.4.601.08 and 2.4567.11), Action de la Recherche
   Concertee ARC07/12-04, the FP7-funded Sunbiopath project (GA 245070) and
   'Fonds Speciaux du Conseil de la Recherche' from the University of
   Liege. V.L. is supported by a fellowship from the Formation a la
   Recherche dans l'Industrie et l'Agriculture. N.B. was supported by a
   grant JCJC06-0163 from the Agence Nationale pour la Recherche (ANR). P.
   M. was supported by FNRS (grants 2.4581.10 and 2.4531.09) and the 'Fonds
   Speciaux du Conseil de la Recherche' from the University of Liege.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009
   Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x
   BOER PH, 1988, CURR GENET, V14, P583, DOI 10.1007/BF00434084
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BUSCHGES R, 1994, YEAST, V10, P475, DOI 10.1002/yea.320100406
   Cardol P, 2004, BBA-BIOENERGETICS, V1658, P212, DOI 10.1016/j.bbabio.2004.06.001
   Cardol P, 2003, PLANT PHYSIOL, V133, P2010, DOI 10.1104/pp.103.028076
   Cardol P, 2002, J MOL BIOL, V319, P1211, DOI 10.1016/S0022-2836(02)00407-2
   Cardol P, 2008, BBA-BIOENERGETICS, V1777, P388, DOI 10.1016/j.bbabio.2008.01.001
   Cardol P, 2011, BBA-BIOENERGETICS, V1807, P1390, DOI 10.1016/j.bbabio.2011.06.015
   Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017
   Darrouzet E, 1998, FEBS LETT, V431, P34, DOI 10.1016/S0014-5793(98)00719-4
   Dauvillee D, 2004, PHOTOSYNTH RES, V79, P219, DOI 10.1023/B:PRES.0000015384.24958.a9
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   DiMauro S, 2007, BIOSCIENCE REP, V27, P5, DOI 10.1007/s10540-007-9032-5
   Dröse S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128
   Duby F, 1999, PLANT CELL, V11, P115
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   EHARA T, 1995, J CELL SCI, V108, P499
   Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010
   Fearnley Ian M, 2007, Methods Mol Biol, V357, P103
   Förster B, 2005, BBA-BIOENERGETICS, V1709, P45, DOI 10.1016/j.bbabio.2005.05.012
   Guénebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518
   Harris E. H., 1989, CHLAMYDOMONAS SOURCE
   Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Karpova OV, 1999, PLANT J, V17, P511, DOI 10.1046/j.1365-313X.1999.00401.x
   Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x
   Lunardi J, 1998, BBA-MOL BASIS DIS, V1407, P114, DOI 10.1016/S0925-4439(98)00036-2
   MARIENFELD JR, 1994, GENETICS, V138, P855
   Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2
   Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474
   NEWMAN SM, 1990, GENETICS, V126, P875
   Peters K, 2008, BBA-BIOENERGETICS, V1777, P84, DOI 10.1016/j.bbabio.2007.10.012
   Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128
   Pulkes T, 2003, NEUROLOGY, V61, P1144, DOI 10.1212/01.WNL.0000090465.27024.3D
   Quiles MJ, 1996, PLANT CELL PHYSIOL, V37, P1134, DOI 10.1093/oxfordjournals.pcp.a029064
   Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103
   Remacle C, 2001, GENETICS, V158, P1051
   Remacle C, 2001, BIOCHEM SOC T, V29, P442, DOI 10.1042/BST0290442
   Remacle C, 2010, PLANT MOL BIOL, V74, P223, DOI 10.1007/s11103-010-9668-6
   RUITERS MHJ, 1991, J INHERIT METAB DIS, V14, P45, DOI 10.1007/BF01804387
   Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Simpson Deborah J., 2007, Environmental Biosafety Research, V6, P55, DOI 10.1051/ebr:2007027
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   STAUB JM, 1992, PLANT CELL, V4, P39, DOI 10.1105/tpc.4.1.39
   Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200
   Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200
   Venegas V., 2011, CURR PROTOC HUM GENE, V68, P1971, DOI DOI 10.1002/0471142905.HG1907S68
   Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012
NR 53
TC 14
Z9 16
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7412
J9 PLANT J
JI Plant J.
PD JUN
PY 2012
VL 70
IS 5
BP 759
EP 768
DI 10.1111/j.1365-313X.2012.04912.x
PG 10
WC Plant Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences
GA 945ZJ
UT WOS:000304316600004
PM 22268373
OA Bronze
DA 2024-11-01
ER

PT J
AU Tyagi, SC
   Pushpakumar, S
   Sen, U
   Akinterinwa, OE
   Zheng, YT
   Mokshagundam, SPL
   Kalra, DK
   Singh, M
AF Tyagi, Suresh C.
   Pushpakumar, Sathnur
   Sen, Utpal
   Akinterinwa, Oluwaseun E.
   Zheng, Yuting
   Mokshagundam, Sri Prakash L.
   Kalra, Dinesh K.
   Singh, Mahavir
TI Role of circadian clock system in the mitochondrial trans-sulfuration
   pathway and tissue remodeling
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article; Early Access
DE circadian clock; folate 1-carbon metabolism; trans-sulfuration pathway
ID CYSTATHIONINE BETA-SYNTHASE; BLOOD-PRESSURE VARIATION; HYDROGEN-SULFIDE;
   DNA METHYLATION; HOMOCYSTEINE; RISK; DYSFUNCTION; EXPRESSION; DISEASE;
   MMP-13
AB Previous studies from our laboratory revealed that the gaseous molecule hydrogen sulfide (H2S), a metabolic product of epigenetics, involves trans-sulfuration pathway for ensuring metabolism and clearance of homocysteine (Hcy) from body, thereby mitigating the skeletal muscle's pathological remodeling. Although the master circadian clock regulator that is known as brain and muscle aryl hydrocarbon receptor nuclear translocator like protein 1 (i.e., BMAL 1) is associated with S-adenosylhomocysteine hydrolase (SAHH) and Hcy metabolism but how trans-sulfuration pathway is influenced by the circa-dian clock remains unexplored. We hypothesize that alterations in the functioning of circadian clock during sleep and wake cycle affect skeletal muscle's biology. To test this hypothesis, we measured serum matrix metalloproteinase (MMP) activities using gelatin gels for analyzing the MMP-2 and MMP-9. Further, employing casein gels, we also studied MMP-13 that is known to be influenced by the growth arrest and DNA damage-45 (GADD45) protein during sleep and wake cycle. The wild type and cys-tathionine beta synthase-deficient (CBS-/+) mice strains were treated with H2S and subjected to measurement of trans-sulfuration factors from skeletal muscle tissues. The results suggested highly robust activation of MMPs in the wake mice versus sleep mice, which appears somewhat akin to the "1-carbon metabolic dysregulation", which takes place during remodeling of extracellu-lar matrix during muscular dystrophy. Interestingly, the levels of trans-sulfuration factors such as CBS, cystathionine gamma lyase (CSE), methyl tetrahydrofolate reductase (MTHFR), phosphatidylethanolamine N-methyltransferase (PEMT), and Hcy-protein bound paraoxonase 1 (PON1) were attenuated in CBS-/+ mice. However, treatment with H2S mitigated the attenuation of the trans-sulfuration pathway. In addition, levels of mitochondrial peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC 1-alpha) and mitofusin-2 (MFN-2) were significantly improved by H2S intervention. Our findings suggest participation of the circadian clock in trans-sulfuration pathway that affects skeletal muscle remodeling and mitochondrial regeneration.
C1 [Tyagi, Suresh C.; Pushpakumar, Sathnur; Sen, Utpal; Akinterinwa, Oluwaseun E.; Zheng, Yuting; Singh, Mahavir] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.
   [Mokshagundam, Sri Prakash L.] Univ Louisville, Div Endocrinol Metab & Diabet, Sch Med, Louisville, KY 40202 USA.
   [Mokshagundam, Sri Prakash L.] Univ Louisville, Robley Rex VA Med Ctr, Sch Med, Louisville, KY 40202 USA.
   [Kalra, Dinesh K.] Univ Louisville, Sch Med, Div Cardiovasc Med, Louisville, KY 40202 USA.
C3 University of Louisville; University of Louisville; University of
   Louisville; University of Louisville
RP Singh, M (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40202 USA.
EM mahavir.singh@louisville.edu
RI Singh, Mahavir/L-2556-2018; Sen, Unal/K-4273-2012; YE,
   Chen/KFR-3858-2024
OI Singh, Mahavir/0000-0002-2415-3314; Sen, Utpal/0000-0002-0600-3443
FU NIH [HL-139047, DK116591, AR-71789]
FX Funding The study was partly supported by the following NIH grants
   (HL-139047, DK116591, and AR-71789) .
CR Adamovich Y, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2101115118
   Agrawal A, 2018, J CELL COMMUN SIGNAL, V12, P645, DOI 10.1007/s12079-018-0477-z
   Albano C, 2020, FEMS MICROBIOL LETT, V367, DOI 10.1093/femsle/fnaa059
   Amarnath K, 2003, TALANTA, V60, P1229, DOI 10.1016/S0039-9140(03)00232-7
   Anea CB, 2010, ARTERIOSCL THROM VAS, V30, P2535, DOI 10.1161/ATVBAHA.110.214379
   Bailey M, 2014, FRONT NEUROENDOCRIN, V35, P111, DOI 10.1016/j.yfrne.2013.11.003
   Baribault C, 2018, EPIGENETICS-US, V13, P275, DOI 10.1080/15592294.2018.1445900
   Bremner WF, 2000, AM J CARDIOL, V86, P1153, DOI 10.1016/S0002-9149(00)01181-4
   Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882
   Chen JL, 2017, P NATL ACAD SCI USA, V114, pE5266, DOI 10.1073/pnas.1620013114
   Covic A, 2000, AM J KIDNEY DIS, V35, P617, DOI 10.1016/S0272-6386(00)70007-2
   Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102
   Dong YF, 2018, AM J HYPERTENS, V31, pE3, DOI 10.1093/ajh/hpy015
   Dong YF, 2017, AM J HYPERTENS, V30, P1203, DOI 10.1093/ajh/hpx116
   Ellwood RA, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-04212-z
   Ellwood RA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018342118
   Gbadegesin MA, 2010, GENET MOL RES, V9, P639, DOI 10.4238/vol9-2gmr713
   Gensous N, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00996
   Greco CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5629
   Griñán R, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232012452
   Gwon D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072352
   Habibe JJ, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10102611
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Hughes JR, 2009, EPILEPSY BEHAV, V15, P92, DOI 10.1016/j.yebeh.2009.02.037
   Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200
   Jacques M, 2019, EPIGENETICS-US, V14, P633, DOI 10.1080/15592294.2019.1614416
   Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E
   King AL, 2014, P NATL ACAD SCI USA, V111, P3182, DOI 10.1073/pnas.1321871111
   Kishi T, 2001, HYPERTENSION, V38, P896, DOI 10.1161/hyp.38.4.896
   Laha A, 2019, CAN J PHYSIOL PHARM, V97, P1013, DOI 10.1139/cjpp-2019-0227
   Laker RC, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5725927
   Lei HQ, 2013, AM J PHYSIOL-CELL PH, V305, pC529, DOI 10.1152/ajpcell.00051.2013
   Majumder A, 2019, CAN J PHYSIOL PHARM, V97, P441, DOI 10.1139/cjpp-2018-0501
   Majumder A, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13858
   Majumder A, 2018, AM J PHYSIOL-CELL PH, V315, pC609, DOI 10.1152/ajpcell.00147.2018
   Majumder A, 2017, J CELL BIOCHEM, V118, P2108, DOI 10.1002/jcb.25841
   Meléndez-Fernández OH, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11060883
   Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491
   Moshal KS, 2007, CURR NEUROVASC RES, V4, P289, DOI 10.2174/156720207782446324
   Murphy B, 2019, FASEB J, V33, P13098, DOI 10.1096/fj.201901304R
   Oh G, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0946-8
   Paul BD, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101772
   Potabattula R, 2022, AGING-US, V14, P1214, DOI 10.18632/aging.203891
   Qipshidze N, 2011, J CELL PHYSIOL, V226, P2712, DOI 10.1002/jcp.22621
   Rabinovich-Nikitin I, 2023, CAN J CARDIOL, V39, P1772, DOI 10.1016/j.cjca.2023.08.022
   Rabinovich-Nikitin I, 2022, CAN J PHYSIOL PHARM, DOI 10.1139/cjpp-2022-0222
   Rabinovich-Nikitin I, 2024, TRENDS CARDIOVAS MED, V34, P1, DOI 10.1016/j.tcm.2022.09.003
   Rahman FA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134575
   Rivers JR, 2012, EXPERT OPIN THER TAR, V16, P439, DOI 10.1517/14728222.2012.673591
   Rodrigo GC, 2016, EXP PHYSIOL, V101, P1030, DOI 10.1113/EP085780
   ROSANSKY SJ, 1995, AM J KIDNEY DIS, V26, P716, DOI 10.1016/0272-6386(95)90433-6
   Sellami M, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.652497
   Sincennes MC, 2016, STEM CELL TRANSL MED, V5, P282, DOI 10.5966/sctm.2015-0266
   Singh M, 2022, PHYSIOL REP, V10, DOI 10.14814/phy2.15422
   Singh M, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.617953
   Singh M, 2021, CAN J PHYSIOL PHARM, V99, P56, DOI 10.1139/cjpp-2020-0093
   Smith Lucas R, 2020, Cell Physiol Biochem, V54, P333, DOI 10.33594/000000223
   Soni CV, 2016, CELL BIOCHEM BIOPHYS, V74, P59, DOI 10.1007/s12013-015-0711-8
   Theilen NT, 2019, ARCH BIOCHEM BIOPHYS, V666, P138, DOI 10.1016/j.abb.2018.12.015
   Tsuda K, 2018, AM J HYPERTENS, V31, pE1, DOI 10.1093/ajh/hpy002
   Tyagi SC, 1999, CLIN EXP HYPERTENS, V21, P181, DOI 10.3109/10641969909068660
   Tyagi SC, 2021, MOL CELL BIOCHEM, V476, P507, DOI 10.1007/s11010-020-03895-4
   UNGER T, 1984, CIRC RES, V54, P30, DOI 10.1161/01.RES.54.1.30
   Veerabhadrappa P, 2017, AM J HYPERTENS, V30, P1151, DOI 10.1093/ajh/hpx141
   Veeranki S, 2015, BBA-MOL BASIS DIS, V1852, P732, DOI 10.1016/j.bbadis.2015.01.008
   Verhamme FM, 2015, AM J RESP CELL MOL, V52, P653, DOI 10.1165/rcmb.2014-0282RT
   Wang J, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0902-2
   Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011
   WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585
   Winbanks CE, 2013, J CELL BIOL, V203, P345, DOI 10.1083/jcb.201211134
   Yang YL, 2021, NUCLEIC ACIDS RES, V49, P1313, DOI 10.1093/nar/gkaa1203
   Yu HX, 2018, ARTERIOSCL THROM VAS, V38, P555, DOI 10.1161/ATVBAHA.117.310502
   Zhang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074422
   Zhang XY, 2020, NAT METAB, V2, P991, DOI 10.1038/s42255-020-00291-6
   Zhang XY, 2020, NAT METAB, V2, P110, DOI 10.1038/s42255-019-0162-4
   Zhao P, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1951-0
NR 77
TC 0
Z9 0
U1 0
U2 5
PU CANADIAN SCIENCE PUBLISHING
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4212
EI 1205-7541
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD 2023 DEC 21
PY 2023
DI 10.1139/cjpp-2023-0186
EA DEC 2023
PG 11
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA CY5V8
UT WOS:001128815000001
PM 37979203
DA 2024-11-01
ER

PT J
AU Chan, DC
AF Chan, David C.
TI Mitochondria: Dynamic organelles in disease, aging, and development
SO CELL
LA English
DT Review
ID DOMINANT OPTIC ATROPHY; RESPIRATORY-CHAIN FUNCTION; SUBSTANTIA-NIGRA
   NEURONS; HUMAN SKELETAL-MUSCLE; CYTOCHROME-C RELEASE; AXONAL-TRANSPORT;
   DNA MUTATIONS; HUMAN-CELLS; DEGENERATIVE DISEASES; MISSENSE MUTATION
AB Mitochondria are the primary energy-generating system in most eukaryotic cells. Additionally, they participate in intermediary metabolism, calcium signaling, and apoptosis. Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues. However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms. Clearly, much about the basic biology of mitochondria remains to be understood. Here we discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.
C1 CALTECH, Div Biol, Pasadena, CA 91125 USA.
C3 California Institute of Technology
RP Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.
EM dchan@caltech.edu
RI Chan, Doris/O-1227-2014
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059
   Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fransson Å, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200
   Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148
   Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200
   Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3
   Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a
   Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93
   MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699
   Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2
   Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200
   Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521
   YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
   Züchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9
NR 89
TC 1599
Z9 1851
U1 9
U2 414
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD JUN 30
PY 2006
VL 125
IS 7
BP 1241
EP 1252
DI 10.1016/j.cell.2006.06.010
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 064QP
UT WOS:000239104500009
PM 16814712
OA Bronze
DA 2024-11-01
ER

PT J
AU Oudbier, SJ
   Goh, J
   Looijaard, SMLM
   Reijnierse, EM
   Meskers, CGM
   Maier, AB
AF Oudbier, Susanne Janette
   Goh, Jorming
   Looijaard, Stephanie Marcella Leonie Maria
   Reijnierse, Esmee Marielle
   Meskers, Carolus Gerardus Maria
   Maier, Andrea Britta
TI Pathophysiological Mechanisms Explaining the Association Between Low
   Skeletal Muscle Mass and Cognitive Function
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Review
DE Dementia; Inflammation; Insulin; Myokines
ID ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION;
   NEUROTROPHIC FACTOR; ADIPOSE-TISSUE; OLDER-ADULTS; BRAIN; PROTEIN;
   INTERLEUKIN-6; SARCOPENIA
AB Low skeletal muscle mass is associated with cognitive impairment and dementia in older adults. This review describes the possible underlying pathophysiological mechanisms: systemic inflammation, insulin metabolism, protein metabolism, and mitochondrial function. We hypothesize that the central tenet in this pathophysiology is the dysfunctional myokine secretion consequent to minimal physical activity. Myokines, such as fibronectin type III domain containing 5/irisin and cathepsin B, are released by physically active muscle and cross the blood-brain barrier. These myokines upregulate local neurotrophin expression such as brain-derived neurotrophic factor (BDNF) in the brain microenvironment. BDNF exerts anti-inflammatory effects that may be responsible for neuroprotection. Altered myokine secretion due to physical inactivity exacerbates inflammation and impairs muscle glucose metabolism, potentially affecting the transport of insulin across the blood-brain barrier. Our working model also suggests other underlying mechanisms. A negative systemic protein balance, commonly observed in older adults, contributes to low skeletal muscle mass and may also reflect deficient protein metabolism in brain tissues. As a result of age-related loss in skeletal muscle mass, decrease in the abundance of mitochondria and detriments in their function lead to a decrease in tissue oxidative capacity. Dysfunctional mitochondria in skeletal muscle and brain result in the excessive production of reactive oxygen species, which drives tissue oxidative stress and further perpetuates the dysfunction in mitochondria. Both oxidative stress and accumulation of mitochondrial DNA mutations due to aging drive cellular senescence. A targeted approach in the pathophysiology of low muscle mass and cognition could be to restore myokine balance by physical activity.
C1 [Oudbier, Susanne Janette] Vrije Univ Amsterdam, Amsterdam UMC Locat, Amsterdam Publ Hlth Res Inst, Dept Outpatient Clin, Amsterdam, Netherlands.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Singapore, Yong Loo Lin Sch Med, Hlth Longev Translat Res Program, Singapore, Singapore.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.
   [Goh, Jorming; Maier, Andrea Britta] Natl Univ Hlth Syst, AgeSingapore, Ctr Hlth Longev, 28 Med Dr, Singapore 117456, Singapore.
   [Looijaard, Stephanie Marcella Leonie Maria] Alrijne Hosp, Dept Internal Med, Leiderdorp, Netherlands.
   [Reijnierse, Esmee Marielle; Meskers, Carolus Gerardus Maria] Vrije Univ Amsterdam, Amsterdam UMC Locat, Rehabil Med, Amsterdam, Netherlands.
   [Reijnierse, Esmee Marielle; Meskers, Carolus Gerardus Maria] Amsterdam Movement Sci Ageing & Vital, Amsterdam, Netherlands.
   [Reijnierse, Esmee Marielle; Maier, Andrea Britta] Univ Melbourne, Royal Melbourne Hosp, AgeMelbourne, Dept Med & Aged Care, Parkville, Vic, Australia.
   [Maier, Andrea Britta] Vrije Univ Amsterdam, Amsterdam Movement Sci, Fac Behav & Movement Sci, Dept Human Movement Sci,AgeAmsterdam, Amsterdam, Netherlands.
C3 Vrije Universiteit Amsterdam; National University of Singapore; National
   University of Singapore; National University of Singapore; Vrije
   Universiteit Amsterdam; Melbourne Health; Royal Melbourne Hospital;
   University of Melbourne; Vrije Universiteit Amsterdam
RP Maier, AB (corresponding author), Natl Univ Hlth Syst, AgeSingapore, Ctr Hlth Longev, 28 Med Dr, Singapore 117456, Singapore.
EM a.maier@nus.edu.sg
RI Goh, Jorming/Q-4565-2019; Maier, Andrea/W-7060-2019
OI Reijnierse, Esmee M./0000-0002-4197-4800; Maier,
   Andrea/0000-0001-7206-1724; Goh, Jorming/0000-0002-6250-8251
CR Akbari M, 2018, INFLAMMOPHARMACOLOGY, V26, P685, DOI 10.1007/s10787-018-0458-0
   Al Mamun A, 2020, NEUROTOX RES, V38, P8, DOI 10.1007/s12640-020-00185-1
   Allen MD, 2021, EXP GERONTOL, V152, DOI 10.1016/j.exger.2021.111465
   Anisimova AS, 2018, AGING-US, V10, P4269, DOI 10.18632/aging.101721
   [Anonymous], Fact Sheet - Dementia
   Barclay RD, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00146
   Beeri MS, 2021, J AM GERIATR SOC, V69, P1826, DOI 10.1111/jgs.17206
   Bian AL, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03236-y
   Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019
   Blasko I, 2003, DRUG AGING, V20, P101, DOI 10.2165/00002512-200320020-00002
   Brandt C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/520258
   Burd NA, 2013, EXERC SPORT SCI REV, V41, P169, DOI 10.1097/JES.0b013e318292f3d5
   Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54
   Burtscher J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126479
   Cipolli GC, 2019, J NUTR HEALTH AGING, V23, P525, DOI 10.1007/s12603-019-1188-8
   Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430
   Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014
   Cao Q, 2020, J ALZHEIMERS DIS, V73, P1157, DOI 10.3233/JAD-191092
   Chakrabarti S, 2011, AGING DIS, V2, P242
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498
   Chen WT, 2021, J CELL PHYSIOL, V236, P2393, DOI 10.1002/jcp.30033
   Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238
   Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008
   Chwieralski CE, 2006, APOPTOSIS, V11, P143, DOI 10.1007/s10495-006-3486-y
   Cleasby ME, 2016, J ENDOCRINOL, V229, pR67, DOI 10.1530/JOE-15-0533
   Correia JC, 2021, CELL METAB, V33, P2215, DOI 10.1016/j.cmet.2021.09.003
   Côté S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012
   Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
   Darweesh SKL, 2018, ALZHEIMERS DEMENT, V14, P1450, DOI 10.1016/j.jalz.2018.02.014
   de Freitas GB, 2020, J NEUROCHEM, V155, P602, DOI 10.1111/jnc.15039
   Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108
   Domínguez M, 2016, FREE RADICAL BIO MED, V95, P1, DOI 10.1016/j.freeradbiomed.2016.02.034
   Du Z, 2018, CLIN INTERV AGING, V13, P1593, DOI 10.2147/CIA.S169565
   Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253
   Ekblad LL, 2017, DIABETES CARE, V40, P751, DOI 10.2337/dc16-2001
   Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010
   Ferri E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155236
   Fulop T, 2023, CLIN REV ALLERG IMMU, V64, P109, DOI 10.1007/s12016-021-08899-6
   Funk JA, 2011, BRAIN BEHAV IMMUN, V25, P1063, DOI 10.1016/j.bbi.2011.03.012
   Gan ZJ, 2018, CELL RES, V28, P969, DOI 10.1038/s41422-018-0078-7
   Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45
   Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420
   Ismail R, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01820-6
   Jarmusch S, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04699-3
   Karssemeijer EGA, 2017, AGEING RES REV, V40, P75, DOI 10.1016/j.arr.2017.09.003
   Khacho M, 2019, NAT REV NEUROSCI, V20, P34, DOI 10.1038/s41583-018-0091-3
   Kim IY, 2020, ANN GERIATR MED RES, V24, P157
   Kim KH, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-23254-0, 10.1038/s41598-018-21168-5]
   KOMAKI G, 1992, AM J PHYSIOL, V262, pE246, DOI 10.1152/ajpendo.1992.262.2.E246
   Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014
   Koyama A, 2013, J GERONTOL A-BIOL, V68, P433, DOI 10.1093/gerona/gls187
   Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006
   Krabbe KS, 2009, J AM GERIATR SOC, V57, P1447, DOI 10.1111/j.1532-5415.2009.02345.x
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Kullmann S, 2016, PHYSIOL REV, V96, P1169, DOI 10.1152/physrev.00032.2015
   Kwan Ping, 2013, J Aging Res, V2013, P791679, DOI 10.1155/2013/791679
   Leuner K, 2012, ANTIOXID REDOX SIGN, V16, P1421, DOI 10.1089/ars.2011.4173
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Limoge M, 2017, ONCOTARGET, V8, P35592, DOI 10.18632/oncotarget.16022
   Liu PZ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00052
   Lourenco MV, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12034
   Lourenco MV, 2019, NAT MED, V25, P165, DOI 10.1038/s41591-018-0275-4
   Lovestone S, 2002, J NEUROL NEUROSUR PS, V72, P152, DOI 10.1136/jnnp.72.2.152
   Ma LN, 2015, CLIN CHIM ACTA, V444, P18, DOI 10.1016/j.cca.2015.01.027
   Maher FO, 2005, NEUROBIOL AGING, V26, P717, DOI 10.1016/j.neurobiolaging.2004.07.002
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Matthews VB, 2009, DIABETOLOGIA, V52, P1409, DOI 10.1007/s00125-009-1364-1
   McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x
   Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001
   Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025
   Murman Daniel L., 2015, Seminars in Hearing, V36, P111, DOI 10.1055/s-0035-1555115
   Nguyen TT, 2020, NEUROCHEM RES, V45, P1481, DOI 10.1007/s11064-020-03031-0
   Nishikawa H, 2021, INT J MOL MED, V48, DOI 10.3892/ijmm.2021.4989
   Ogawa Y, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00710
   Pacifico J, 2020, EXP GERONTOL, V131, DOI 10.1016/j.exger.2019.110801
   Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y
   Papadopoli David, 2019, F1000Res, V8, DOI 10.12688/f1000research.17196.1
   Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010
   Pedersen BK, 2011, J EXP BIOL, V214, P337, DOI 10.1242/jeb.048074
   Pedersen BK, 2019, NAT REV ENDOCRINOL, V15, P383, DOI 10.1038/s41574-019-0174-x
   Pedersen BK, 2005, BRAIN BEHAV IMMUN, V19, P371, DOI 10.1016/j.bbi.2005.04.008
   Perluigi M, 2015, NEUROBIOL DIS, V84, P39, DOI 10.1016/j.nbd.2015.03.014
   Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821
   Picca A, 2018, BIOL CHEM, V399, P421, DOI 10.1515/hsz-2017-0331
   Poddar J, 2019, J CHEM NEUROANAT, V95, P70, DOI 10.1016/j.jchemneu.2018.04.002
   Ramsey KA, 2021, AGEING RES REV, V67, DOI 10.1016/j.arr.2021.101266
   Rezus E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020592
   Rhea EM, 2021, J NEUROENDOCRINOL, V33, DOI 10.1111/jne.12929
   Rocha M, 2010, CURR PHARM DESIGN, V16, P3124, DOI 10.2174/138161210793292519
   Roh E, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.4
   Rose-John S, 2021, CYTOKINE, V144, DOI 10.1016/j.cyto.2021.155577
   Sadeghabadi ZA, 2019, J DIABETES METAB DIS, V18, P437, DOI 10.1007/s40200-019-00437-8
   Sakuma K, 2018, PFLUG ARCH EUR J PHY, V470, P449, DOI 10.1007/s00424-017-2077-9
   Schumertl T, 2022, BBA-MOL CELL RES, V1869, DOI 10.1016/j.bbamcr.2021.119143
   Severinsen MCK, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa016
   Shen XN, 2019, J NEUROL NEUROSUR PS, V90, P590, DOI 10.1136/jnnp-2018-319148
   Singh-Manoux A, 2014, NEUROLOGY, V83, P486, DOI 10.1212/WNL.0000000000000665
   Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585
   Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010
   Sylow L, 2021, CELL METAB, V33, P758, DOI 10.1016/j.cmet.2021.03.020
   Szekely CA, 2004, NEUROEPIDEMIOLOGY, V23, P159, DOI 10.1159/000078501
   Taekema DG, 2012, AGE AGEING, V41, P506, DOI 10.1093/ageing/afs013
   Thambisetty M, 2013, NEUROBIOL AGING, V34, P2271, DOI 10.1016/j.neurobiolaging.2013.03.025
   Tobore TO, 2019, NEUROL SCI, V40, P1527, DOI 10.1007/s10072-019-03863-x
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tuttle CSL, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101185
   Tuttle CSL, 2020, AGING CELL, V19, DOI 10.1111/acel.13083
   van Dam R, 2018, DEMENT GERIATR COGN, V45, P243, DOI 10.1159/000486711
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2
   Wang DXM, 2020, J CACHEXIA SARCOPENI, V11, P3, DOI 10.1002/jcsm.12502
   Wennberg AMV, 2018, NEUROBIOL AGING, V66, P68, DOI 10.1016/j.neurobiolaging.2017.11.017
   White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200
   Wong KY, 2020, AGING DIS, V11, P1291, DOI 10.14336/AD.2019.1125
   Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008
   Wu HX, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14575
   Xie B, 2020, INT J NEUROSCI, V130, P218, DOI 10.1080/00207454.2019.1667794
   Yakabe M., 2015, RNA Transcr, V1, P10, DOI DOI 10.11648/J.BS.20150102.11
   Yeung SSY, 2019, J CACHEXIA SARCOPENI, V10, P485, DOI 10.1002/jcsm.12411
NR 120
TC 37
Z9 39
U1 1
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD OCT 6
PY 2022
VL 77
IS 10
BP 1959
EP 1968
DI 10.1093/gerona/glac121
EA JUN 2022
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 5C6JY
UT WOS:000820943600001
PM 35661882
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Vital, A
   Lepreux, S
   Vital, C
AF Vital, Anne
   Lepreux, Sebastien
   Vital, Claude
TI Peripheral neuropathy and parkinsonism: a large clinical and pathogenic
   spectrum
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Review
DE levodopa; mitochondrial cytopathy; parkin; parkinsonism; peripheral
   neuropathy
ID MACHADO-JOSEPH-DISEASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   CHEDIAK-HIGASHI-SYNDROME; BRAIN IRON ACCUMULATION; TREMOR/ATAXIA
   SYNDROME FXTAS; DOPA-RESPONSIVE PARKINSONISM; X PREMUTATION CARRIERS;
   MITOCHONDRIAL-DNA; GAUCHER-DISEASE; NERVOUS-SYSTEM
AB Peripheral neuropathy (PN) has been reported in idiopathic and hereditary forms of parkinsonism, but the pathogenic mechanisms are unclear and likely heterogeneous. Levodopa-induced vitamin B12 deficiency has been discussed as a causal factor of PN in idiopathic Parkinson's disease, but peripheral nervous system involvement might also be a consequence of the underlying neurodegenerative process. Occurrence of PN with parkinsonism has been associated with a panel of mitochondrial cytopathies, more frequently related to a nuclear gene defect and mainly polymerase gamma (POLG1) gene. Parkin (PARK2) gene mutations are responsible for juvenile parkinsonism, and possible peripheral nervous system involvement has been reported. Rarely, an association of parkinsonism with PN may be encountered in other neurodegenerative diseases such as fragile X-associated tremor and ataxia syndrome related to premutation CGG repeat expansion in the fragile X mental retardation (FMR1) gene, Machado-Joseph disease related to an abnormal CAG repeat expansion in ataxin-3 (ATXN3) gene, Kufor-Rakeb syndrome caused by mutations in ATP13A2 gene, or in hereditary systemic disorders such as Gaucher disease due to mutations in the beta-glucocerebrosidase (GBA) gene and Chediak-Higashi syndrome due to LYST gene mutations. This article reviews conditions in which PN may coexist with parkinsonism.
C1 [Vital, Anne; Vital, Claude] Univ Bordeaux, Bordeaux, France.
   [Vital, Anne; Vital, Claude] CNRS, Inst Malad Neurodegenerat, Bordeaux, France.
   [Vital, Anne; Lepreux, Sebastien] Bordeaux Univ Hosp, Dept Pathol, Bordeaux, France.
C3 Universite de Bordeaux; Centre National de la Recherche Scientifique
   (CNRS); CHU Bordeaux
RP Vital, A (corresponding author), Hop Pellegrin, Serv Pathol, Pl Amelie Raba Leon, F-33076 Bordeaux, France.
EM anne.vital@chu-bordeaux.fr
CR Abbruzzese G, 2004, MOVEMENT DISORD, V19, P978, DOI 10.1002/mds.20113
   Apartis E, 2012, NEUROLOGY, V79, P1898, DOI 10.1212/WNL.0b013e318271f7ff
   Gondim FDA, 2010, ANN NEUROL, V68, P973, DOI 10.1002/ana.22258
   Baloh RH, 2007, ARCH NEUROL-CHICAGO, V64, P998, DOI 10.1001/archneur.64.7.998
   Berry-Kravis E, 2007, AM J MED GENET A, V143A, P19, DOI 10.1002/ajmg.a.31559
   Betts-Henderson J, 2009, NEUROPATH APPL NEURO, V35, P120, DOI 10.1111/j.1365-2990.2008.00981.x
   Biegstraaten M, 2008, J INHERIT METAB DIS, V31, P337, DOI 10.1007/s10545-008-0832-y
   Biegstraaten M, 2010, BRAIN, V133, P2909, DOI 10.1093/brain/awq198
   Bouillot S, 2002, J PERIPHER NERV SYST, V7, P213, DOI 10.1046/j.1529-8027.2002.02027.x
   Brandon BR, 2013, J NEUROL, V260, P1931, DOI 10.1007/s00415-013-6975-2
   BYRNE E, 1982, J NEUROL NEUROSUR PS, V45, P372, DOI 10.1136/jnnp.45.4.372
   Capelli LP, 2007, MOVEMENT DISORD, V22, P866, DOI 10.1002/mds.21347
   Capelli LP, 2010, ARQ NEURO-PSIQUIAT, V68, P791, DOI 10.1590/S0004-282X2010000500023
   Ceravolo R, 2013, MOVEMENT DISORD, V28, P1391, DOI 10.1002/mds.25585
   Chérin P, 2010, J INHERIT METAB DIS, V33, P331, DOI 10.1007/s10545-010-9095-5
   Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006
   D'Abreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012
   Davidzon G, 2006, ANN NEUROL, V59, P859, DOI 10.1002/ana.20831
   Dehay B, 2012, AUTOPHAGY, V8, P1389, DOI 10.4161/auto.21011
   di Poggio MB, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-105
   DiMauro S, 2006, BRAIN, V129, P1637, DOI 10.1093/brain/awl169
   Durcan TM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00046
   Eiberg H, 2012, CLIN GENET, V82, P256, DOI 10.1111/j.1399-0004.2011.01745.x
   Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132
   Fernandez HH, 2013, PARKINSONISM RELAT D, V19, P339, DOI 10.1016/j.parkreldis.2012.11.020
   Galassi G, 2008, NEUROMUSCULAR DISORD, V18, P465, DOI 10.1016/j.nmd.2008.03.013
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GIUNTI P, 1995, BRAIN, V118, P1077, DOI 10.1093/brain/118.5.1077
   Gokden M, 2009, NEUROPATHOLOGY, V29, P280, DOI 10.1111/j.1440-1789.2008.00948.x
   Graves TD, 2011, ARCH NEUROL-CHICAGO, V68, P653, DOI 10.1001/archneurol.2011.86
   Greco CM, 2006, BRAIN, V129, P243, DOI 10.1093/brain/awh683
   Hagerman RJ, 2007, AM J MED GENET A, V143A, P2256, DOI 10.1002/ajmg.a.31920
   Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700
   Hall DA, 2009, PARKINSONISM RELAT D, V15, P156, DOI 10.1016/j.parkreldis.2008.04.037
   Hartig MB, 2011, AM J HUM GENET, V89, P543, DOI 10.1016/j.ajhg.2011.09.007
   Hase A, 2002, BRAIN RES, V930, P143, DOI 10.1016/S0006-8993(02)02241-2
   Hauser RA, 2000, MOVEMENT DISORD, V15, P705, DOI 10.1002/1531-8257(200007)15:4<705::AID-MDS1016>3.0.CO;2-B
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549
   Hudson G, 2007, ARCH NEUROL-CHICAGO, V64, P553, DOI 10.1001/archneur.64.4.553
   Invernizzi F, 2008, NEUROMUSCULAR DISORD, V18, P460, DOI 10.1016/j.nmd.2008.04.005
   Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650
   Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2
   Karceski S, 2011, NEUROLOGY, V77, pE132, DOI 10.1212/WNL.0b013e31823df782
   Keogh MJ, 2012, SEMIN PEDIATR NEUROL, V19, P51, DOI 10.1016/j.spen.2012.03.004
   Khan NL, 2003, BRAIN, V126, P1279, DOI 10.1093/brain/awg142
   Kiferle L, 2013, NEUROSCI LETT, V556, P1, DOI 10.1016/j.neulet.2013.09.034
   Kimber T, 2013, PARKINSONISM RELAT D, V19, P847, DOI 10.1016/j.parkreldis.2013.05.002
   KINOSHITA A, 1995, J NEUROL SCI, V130, P48, DOI 10.1016/0022-510X(94)00285-V
   Kruer MC, 2012, SEMIN PEDIATR NEUROL, V19, P67, DOI 10.1016/j.spen.2012.04.001
   Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Manca D, 2009, MOVEMENT DISORD, V24, P2293, DOI 10.1002/mds.22807
   Mancini F, 2014, PARKINSONISM RELAT D, V20, P27, DOI 10.1016/j.parkreldis.2013.09.007
   Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777
   Martin-Negrier ML, 2011, EUR J NEUROL, V18, P436, DOI 10.1111/j.1468-1331.2010.03171.x
   Matos CA, 2011, PROG NEUROBIOL, V95, P26, DOI 10.1016/j.pneurobio.2011.06.007
   Merola A, 2014, ACTA NEUROL SCAND, V129, pE1, DOI 10.1111/ane.12164
   Milone M, 2011, NEUROLOGY, V77, P1847, DOI 10.1212/WNL.0b013e318238863a
   Miyakawa S, 2013, MOVEMENT DISORD, V28, P388, DOI 10.1002/mds.25346
   Montastruc JL, 2010, MOVEMENT DISORD, V25, P660, DOI 10.1002/mds.22878
   Müller T, 2013, PARKINSONISM RELAT D, V19, P501, DOI 10.1016/j.parkreldis.2013.02.006
   Müller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657
   Nolano M, 2011, ANN NEUROL, V69, P427, DOI 10.1002/ana.22330
   Ohsawa Y, 2005, NEUROLOGY, V65, P459, DOI 10.1212/01.wnl.0000171859.85078.3d
   Okuma Y, 2003, PARKINSONISM RELAT D, V9, P313, DOI 10.1016/S1353-8020(02)00114-1
   Onofrj M, 2009, PARKINSONISM RELAT D, V15, pS233, DOI 10.1016/S1353-8020(09)70821-1
   Orsucci D, 2011, J MOL NEUROSCI, V44, P17, DOI 10.1007/s12031-010-9488-9
   Paisán-Ruiz C, 2010, MOVEMENT DISORD, V25, P1791, DOI 10.1002/mds.23221
   Paulson Henry, 2012, Handb Clin Neurol, V103, P437, DOI 10.1016/B978-0-444-51892-7.00027-9
   Pedroso JL, 2013, MOVEMENT DISORD, V28, P1200, DOI 10.1002/mds.25513
   Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962
   Pramstaller PP, 2005, ANN NEUROL, V58, P411, DOI 10.1002/ana.20587
   Rajabally YA, 2013, J NEUROL, V260, P2844, DOI 10.1007/s00415-013-7079-8
   Rajabally YA, 2011, NEUROLOGY, V77, P1947, DOI 10.1212/WNL.0b013e31823a0ee4
   Remes AM, 2008, PARKINSONISM RELAT D, V14, P652, DOI 10.1016/j.parkreldis.2008.01.009
   Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960
   Santos-García D, 2012, J NEUROL, V259, P1668, DOI 10.1007/s00415-011-6396-z
   Schneider SA, 2012, SEMIN PEDIATR NEUROL, V19, P57, DOI 10.1016/j.spen.2012.03.005
   Seidel K, 2010, ACTA NEUROPATHOL, V120, P449, DOI 10.1007/s00401-010-0717-7
   Shahrizaila N, 2013, PARKINSONISM RELAT D, V19, P391, DOI 10.1016/j.parkreldis.2012.08.002
   Sharp ME, 2014, MOVEMENT DISORD, V29, P566, DOI 10.1002/mds.25792
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   Silveira-Moriyama L, 2004, MOVEMENT DISORD, V19, P472, DOI 10.1002/mds.10677
   Simon DK, 1999, NEUROLOGY, V53, P1787, DOI 10.1212/WNL.53.8.1787
   Sutton JP, 1997, NEUROLOGY, V48, P1285, DOI 10.1212/WNL.48.5.1285
   Swan M, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0368-x
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tardieu M, 2005, BLOOD, V106, P40, DOI 10.1182/blood-2005-01-0319
   Tassone F, 2012, GENES BRAIN BEHAV, V11, P577, DOI 10.1111/j.1601-183X.2012.00779.x
   Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4
   Teodoro T, 2011, MOVEMENT DISORD, V26, P1966, DOI 10.1002/mds.23760
   Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0
   Tison F, 2011, NEUROLOGY, V77, P1938, DOI 10.1212/WNL.0b013e31823de107
   Toth C, 2008, MOVEMENT DISORD, V23, P1850, DOI 10.1002/mds.22137
   Toth C, 2010, ANN NEUROL, V68, P28, DOI 10.1002/ana.22021
   TUITE PJ, 1995, ANN NEUROL, V38, P684, DOI 10.1002/ana.410380422
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Urban PP, 2010, MOVEMENT DISORD, V25, P1748, DOI 10.1002/mds.23342
   Usenovic M, 2012, HUM MOL GENET, V21, P3785, DOI 10.1093/hmg/dds206
   UYAMA E, 1994, ACTA NEUROL SCAND, V89, P175
   Van Goethem G, 2003, NEUROMOL MED, V3, P129, DOI 10.1385/NMM:3:3:129
   Vital A, 2014, J PERIPHER NERV SYST, V19, P44, DOI 10.1111/jns5.12056
   Vital A, 2012, J NEUROPATH EXP NEUR, V71, P1036, DOI 10.1097/NEN.0b013e3182764d47
   Weisfeld-Adams JD, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-46
   Yamada M, 2004, NEUROPATH APPL NEURO, V30, P665, DOI 10.1111/j.1365-2990.2004.00583.x
   Yamada M, 2008, ACTA NEUROPATHOL, V115, P71, DOI 10.1007/s00401-007-0287-5
NR 107
TC 14
Z9 16
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2014
VL 19
IS 4
BP 333
EP 342
DI 10.1111/jns.12099
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CA7JR
UT WOS:000349094100008
PM 25582874
DA 2024-11-01
ER

PT J
AU Vinciguerra, C
   Di Fonzo, A
   Monfrini, E
   Ronchi, D
   Cuoco, S
   Piscosquito, G
   Barone, P
   Pellecchia, MT
AF Vinciguerra, C.
   Di Fonzo, A.
   Monfrini, E.
   Ronchi, D.
   Cuoco, S.
   Piscosquito, G.
   Barone, P.
   Pellecchia, M. T.
TI Case report: Asp194Ala variant in MFN2 is associated with ALS-FTD in an
   Italian family
SO FRONTIERS IN GENETICS
LA English
DT Article
DE mitofusin 2-gene (MFN2); amyotrophic lateral sclerosis (ALS);
   frontotemporal dementia (FTD); whole exom sequencing; charcot marie
   tooth (CMT)
ID CHARCOT-MARIE-TOOTH; AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROPATHY;
   MUTATIONS
AB Background: MFN2 gene encodes the protein Mitofusin 2, involved in essential mitochondrial functions such as fusion, trafficking, turnover, and cellular interactions. We describe a family carrying a novel MFN2 mutation associated with ALS-frontotemporal dementia (FTD) clinical phenotype in the mother and Charcot-Marie-Tooth disease type 2A (CMT2A) in her son.Case presentation: The mother, a 67-year-old woman, referred to us for a three year-history of mood disturbance and gait impairment, and a more recent hypophonia, dysarthria, dysphagia, and diffuse muscle wasting. Family history was positive for psychiatric disorders and gait disturbances. Brain 18F-FDG PET showed severe hypometabolism in the fronto-temporal brain cortex bilaterally. Electrodiagnostic studies (EDX) showed severe motor axonopathy in the bulbar, cervical and lumbosacral districts. Her 41-year-old son had a history of mood depression and sensory disturbances in the limbs, along with mild muscle wasting, weakness, and reduced reflexes. Nerve conduction studies revealed a moderate sensory-motor polyneuropathy, while brain MRI was normal. Whole exome sequencing of the patients' DNA identified the novel MFN2 (NM_014874.4) variant c.581A>C p.(Asp194Ala).Conclusion: Our findings provide evidence of heterogenous clinical manifestations in family members sharing the same MFN2 molecular defect. Additionally, we present the first documented case of ASL-FTD associated with an MFN2 mutation, thereby expanding the range of MFN-related disorders. Further research involving larger cohorts of patients will be needed to better understand the role of MFN2 as a contributing gene in the development of ALS-FTD.
C1 [Vinciguerra, C.; Cuoco, S.; Piscosquito, G.; Barone, P.; Pellecchia, M. T.] Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Surg & Odontol Scuola Med Salernitana, Dept Med, Salerno, Italy.
   [Di Fonzo, A.; Monfrini, E.; Ronchi, D.] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Di Fonzo, A.; Monfrini, E.; Ronchi, D.] IRCCS Fdn CaGranda Osped Maggiore Policlin, Neurol Unit, Milan, Italy.
C3 University of Salerno; University of Milan; IRCCS Ca Granda Ospedale
   Maggiore Policlinico
RP Vinciguerra, C (corresponding author), Univ Salerno, Ctr Neurodegenerat Dis CEMAND, Surg & Odontol Scuola Med Salernitana, Dept Med, Salerno, Italy.
EM claudiavinci@hotmail.it
RI Vinciguerra, Claudia/AAC-4654-2020; Barone, Paolo/AAC-4886-2022; Di
   Fonzo, Alessio/A-5702-2013; Monfrini, Edoardo/P-1256-2018
OI Monfrini, Edoardo/0000-0003-4720-9234
CR Abati E, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10220-0
   Abramzon YA, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00042
   Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Burrell JR, 2011, BRAIN, V134, P2582, DOI 10.1093/brain/awr195
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cho HJ, 2007, CLIN GENET, V71, P267, DOI 10.1111/j.1399-0004.2007.00763.x
   Davis SA, 2018, NEUROSCI LETT, V678, P8, DOI 10.1016/j.neulet.2018.04.053
   Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025
   Gaweda-Walerych K, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.676478
   Gentile F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00601
   Ludolph A, 2015, AMYOTROPH LAT SCL FR, V16, P291, DOI 10.3109/21678421.2015.1049183
   Marchesi C, 2011, NEUROMUSCULAR DISORD, V21, P129, DOI 10.1016/j.nmd.2010.09.009
   Mou YC, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.727552
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Shammas MK, 2023, BIOCHEM SOC T, V51, P797, DOI 10.1042/BST20221365
   Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768
   Turner MR, 2017, J NEUROL NEUROSUR PS, V88, P1042, DOI 10.1136/jnnp-2017-315995
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Zhu D, 2005, NEUROLOGY, V65, P496, DOI 10.1212/01.wnl.0000171345.62270.29
NR 25
TC 3
Z9 3
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD JUL 20
PY 2023
VL 14
AR 1235887
DI 10.3389/fgene.2023.1235887
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA O2NH6
UT WOS:001042233900001
PM 37547466
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Wang, W
   Zhao, YY
   Xu, XB
   Ma, XT
   Sun, Y
   Lin, Y
   Zhao, Y
   Xu, ZH
   Wang, JY
   Ren, H
   Wang, B
   Zhao, DD
   Wang, DD
   Liu, FC
   Li, W
   Yan, CZ
   Ji, KQ
AF Wang, Wei
   Zhao, Yuying
   Xu, Xuebi
   Ma, Xiaotian
   Sun, Yuan
   Lin, Yan
   Zhao, Ying
   Xu, Zhihong
   Wang, Jiayin
   Ren, Hong
   Wang, Bin
   Zhao, Dandan
   Wang, Dongdong
   Liu, Fuchen
   Li, Wei
   Yan, Chuanzhu
   Ji, Kunqian
TI A different pattern of clinical, muscle pathology and brain MRI findings
   in MELAS with mt-ND variants
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID COMPLEX I DEFICIENCY; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS;
   DIAGNOSTIC-CRITERIA; CHINESE PATIENTS; COMMON-CAUSE; MUTATION; GENE;
   COHORT; ENCEPHALOMYOPATHY
AB Objective: To explore the clinical characteristics of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) caused by mitochondrial DNA-encoded complex I subunit (mt-ND) variants. Methods: In this retrospective study, the clinical, myopathological and brain MRI features of patients with MELAS caused by mt-ND variants (MELAS-mtND) were collected and compared with those of MELAS patients carrying the m.3243A > G variant (MELAS-A3243G). Result: A total of 18 MELAS-mtND patients (female: 7; median age: 24.5 years) represented 15.9% (n = 113) of all patients with MELAS caused by mtDNA variants in our neuromuscular center from January 2012 to June 2022. In this MELAS-mtND cohort, the two most common variants were m.10191 T > C (4/18, 22.2%) and m.13513 G > A (3/18, 16.7%). The most frequent symptoms were seizures (14/18, 77.8%) and muscle weakness (11/18, 61.1%). Compared with 87 MELAS-A3243G patients, MELASmtND patients were significantly more likely to have a variant that was absent in blood cells (40% vs. 1.4%). Furthermore, MELAS-mtND patients had a significantly lower MDC score (7.8 +/- 2.7 vs. 9.8 +/- 1.9); less hearing loss (27.8% vs. 54.0%), diabetes (11.1% vs. 37.9%), and migraine (33.3% vs. 62.1%); less short stature (males <= 165 cm; females <= 155 cm; 23.1% vs. 60.8%) and higher body mass index (20.4 +/- 2.5 vs. 17.8 +/- 2.7). MELAS-mtND patients had significantly more normal muscle pathology (31.3% vs. 4.1%) and fewer RRFs/ RBFs (62.5% vs. 91.9%), COX-deficient fibers/blue fibers (25.0% vs. 85.1%) and SSVs (50.0% vs. 81.1%). Moreover, brain MRI evaluated at the first strokelike episode showed significantly more small cortical lesions in MELAS-mtND patients (66.7% vs. 12.2%). Interpretation: Our results suggested that MELASmtND patients have distinct clinical, myopathological and brain MRI features compared with MELAS-A3243G patients.
C1 [Wang, Wei; Zhao, Yuying; Lin, Yan; Zhao, Ying; Xu, Zhihong; Wang, Jiayin; Ren, Hong; Wang, Bin; Zhao, Dandan; Wang, Dongdong; Liu, Fuchen; Li, Wei; Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, Jinan 250012, Shandong, Peoples R China.
   [Xu, Xuebi] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Nanbaixiang St, Wenzhou 325000, Peoples R China.
   [Ma, Xiaotian] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept Med Expt Ctr, Qingdao 266035, Shandong, Peoples R China.
   [Sun, Yuan] Shandong Univ, Qilu Hosp Qingdao, Cheeloo Coll Med, Dept neurol, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Brain Sci Res Inst, Jinan 250012, Shandong, Peoples R China.
   [Yan, Chuanzhu] Shandong Univ, Qilu Hosp Qingdao, Mitochondrial Med Lab, Qingdao 266035, Shandong, Peoples R China.
   [Yan, Chuanzhu; Ji, Kunqian] Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Wenzhou Medical University; Shandong University;
   Shandong University; Shandong University; Shandong University; Shandong
   University
RP Yan, CZ; Ji, KQ (corresponding author), Shandong Univ, Qilu Hosp, Res Inst Neuromuscular & Neurodegenerat Dis, Cheeloo Coll Med,Dept Neurol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China.
EM czyan@sdu.edu.cn; jikunqian@email.sdu.edu.cn
RI Wang, Yuanzhuo/A-9114-2012; Wang, Jiawei/KHC-8971-2024; lin,
   lin/KFB-9548-2024; zhao, dandan/AAP-3407-2021
OI Wang, Wei/0000-0001-7585-384X
FU National Key Research and Development Program of China [2021YFC2700904];
   National Natural Science Foundation of China [82171394]; Taishan
   Scholars Program of Shandong Province; Qingdao Key Health Discipline
   Development Fund
FX This work was supported by the National Key Research and Development
   Program of China (2021YFC2700904), National Natural Science Foundation
   of China (No. 82171394), and the Taishan Scholars Program of Shandong
   Province and the Qingdao Key Health Discipline Development Fund.
CR Alston CL, 2010, NEUROMUSCULAR DISORD, V20, P131, DOI 10.1016/j.nmd.2009.10.010
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Boal RL, 2019, J CLIN ENDOCR METAB, V104, P2057, DOI 10.1210/jc.2018-00957
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Flaquer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105116
   Forsström S, 2019, CELL METAB, V30, P1040, DOI [10.1016/j.cmet.2019.013.019, 10.1016/j.cmet.2019.08.019]
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Grady JP, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708262
   Hou Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219628
   Ji KQ, 2022, NEUROLOGY, V98, P80, DOI 10.1212/WNL.0000000000013015
   Keightley JA, 2000, AM J HUM GENET, V67, P1400, DOI 10.1086/316900
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   La Morgia C, 2020, J INTERN MED, V287, P592, DOI 10.1111/joim.13064
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Lebre AS, 2011, J MED GENET, V48, P16, DOI 10.1136/jmg.2010.079624
   LERTRIT P, 1992, AM J HUM GENET, V51, P457
   Li YX, 2018, J MAGN RESON IMAGING, V47, P583, DOI 10.1002/jmri.25736
   Lin J, 2014, MITOCHONDR DNA, V25, P56, DOI 10.3109/19401736.2013.779259
   Lin Y, 2020, MITOCHONDRION, V54, P57, DOI 10.1016/j.mito.2020.06.011
   Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435
   Lu YY, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116499
   Lyu JW, 2019, CHINESE MED J-PEKING, V132, P805, DOI 10.1097/CM9.0000000000000144
   Matsumoto M, 2017, NEUROMUSCULAR DISORD, V27, P1023, DOI 10.1016/j.nmd.2017.06.007
   Mick E, 2020, ELIFE, V9, DOI 10.7554/eLife.49178
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Oldfors A, 2013, Muscle biopsy: a practical approach
   PEARL GS, 1995, ARCH PATHOL LAB MED, V119, P303
   Ravn K, 2001, EUR J HUM GENET, V9, P805, DOI 10.1038/sj.ejhg.5200712
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tatlisumak T, 2016, J NEUROL, V263, P257, DOI 10.1007/s00415-015-7969-z
   Valentino ML, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037507
   Walker UA, 1996, EUR NEUROL, V36, P260, DOI 10.1159/000117269
   Wang W, 2021, NEUROMUSCULAR DISORD, V31, P558, DOI 10.1016/j.nmd.2021.02.020
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Xu XB, 2019, CHINESE MED J-PEKING, V132, P716, DOI 10.1097/CM9.0000000000000139
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
   Yu HO, 2019, J NEUROL, V266, P1459, DOI 10.1007/s00415-019-09283-3
   Zhang Z, 2018, J NEUROL SCI, V385, P151, DOI 10.1016/j.jns.2017.12.033
   Zhao D, 2011, J HUM GENET, V56, P759, DOI 10.1038/jhg.2011.96
NR 48
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN
PY 2023
VL 10
IS 6
BP 1035
EP 1045
DI 10.1002/acn3.51787
EA MAY 2023
PG 11
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA J2HB8
UT WOS:000994028900001
PM 37221696
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Davis, RL
   Kumar, KR
   Puttick, C
   Liang, C
   Ahmad, KE
   Edema-Hildebrand, F
   Park, JS
   Minoche, AE
   Gayevskiy, V
   Mallawaarachchi, AC
   Christodoulou, J
   Schofield, D
   Dinger, ME
   Cowley, MJ
   Sue, CM
AF Davis, Ryan L.
   Kumar, Kishore R.
   Puttick, Clare
   Liang, Christina
   Ahmad, Kate E.
   Edema-Hildebrand, Fabienne
   Park, Jin-Sung
   Minoche, Andre E.
   Gayevskiy, Velimir
   Mallawaarachchi, Amali C.
   Christodoulou, John
   Schofield, Deborah
   Dinger, Marcel E.
   Cowley, Mark J.
   Sue, Carolyn M.
TI Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
SO NEUROLOGY
LA English
DT Article
ID DNA MUTATIONS; PREVALENCE; GENETICS; MUSCLE
AB Background and Objectives Mitochondrial diseases (MDs) are the commonest group of heritable metabolic disorders. Phenotypic diversity can make molecular diagnosis challenging, and causative genetic variants may reside in either mitochondrial or nuclear DNA. A single comprehensive genetic diagnostic test would be highly useful and transform the field. We applied whole-genome sequencing (WGS) to evaluate the variant detection rate and diagnostic capacity of this technology with a view to simplifying and improving the MD diagnostic pathway. Methods Adult patients presenting to a specialist MD clinic in Sydney, Australia, were recruited to the study if they satisfied clinical MD (Nijmegen) criteria. WGS was performed on blood DNA, followed by clinical genetic analysis for known pathogenic MD-associated variants and MD mimics. Results Of the 242 consecutive patients recruited, 62 participants had "definite," 108 had "probable," and 72 had "possible" MD classification by the Nijmegen criteria. Disease-causing variants were identified for 130 participants, regardless of the location of the causative genetic variants, giving an overall diagnostic rate of 53.7% (130 of 242). Identification of causative genetic variants informed precise treatment, restored reproductive confidence, and optimized clinical management of MD. Discussion Comprehensive bigenomic sequencing accurately detects causative genetic variants in affected MD patients, simplifying diagnosis, enabling early treatment, and informing the risk of genetic transmission.
C1 [Davis, Ryan L.; Kumar, Kishore R.; Ahmad, Kate E.; Park, Jin-Sung; Sue, Carolyn M.] Univ Sydney, Kolling Inst, Fac Med & Hlth, Dept Neurogenet, Sydney, NSW, Australia.
   [Davis, Ryan L.; Kumar, Kishore R.; Ahmad, Kate E.; Park, Jin-Sung; Sue, Carolyn M.] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.
   [Davis, Ryan L.; Kumar, Kishore R.; Puttick, Clare; Minoche, Andre E.; Gayevskiy, Velimir; Mallawaarachchi, Amali C.; Dinger, Marcel E.; Cowley, Mark J.; Sue, Carolyn M.] Garvan Inst Med Res, Kinghorn Ctr Clin Genom, Darlinghurst, NSW, Australia.
   [Kumar, Kishore R.; Liang, Christina; Edema-Hildebrand, Fabienne; Sue, Carolyn M.] Royal North Shore Hosp, Northern Sydney Local Hlth Dist, Dept Neurol, St Leonards, NSW, Australia.
   [Kumar, Kishore R.] Concord Hosp, Mol Med Lab, Concord, NSW, Australia.
   [Park, Jin-Sung] Cenyx Biotech, Seoul, South Korea.
   [Christodoulou, John] Murdoch Childrens Res Inst, Brain & Mitochondrial Res Grp, Parkville, Vic, Australia.
   [Christodoulou, John] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Schofield, Deborah] GenIMPACT, Macquarie Pk, NSW, Australia.
   [Schofield, Deborah] Macquarie Univ, Ctr Econ Impacts Genom Med, Macquarie Pk, NSW, Australia.
   [Dinger, Marcel E.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Randwick, NSW, Australia.
   [Cowley, Mark J.] Univ New South Wales, Childrens Canc Inst, Computat Biol Grp, Randwick, NSW, Australia.
C3 University of Sydney; Kolling Institute of Medical Research; Royal North
   Shore Hospital; Northern Sydney Local Health District; Garvan Institute
   of Medical Research; Royal North Shore Hospital; Northern Sydney Local
   Health District; Concord Repatriation General Hospital; Murdoch
   Children's Research Institute; University of Melbourne; Macquarie
   University; University of New South Wales Sydney; Children's Cancer
   Institute; University of New South Wales Sydney
RP Sue, CM (corresponding author), Univ Sydney, Kolling Inst, Fac Med & Hlth, Dept Neurogenet, Sydney, NSW, Australia.; Sue, CM (corresponding author), Royal North Shore Hosp, Northern Sydney Local Hlth Dist, St Leonards, NSW, Australia.
EM carolyn.sue@sydney.edu.au
RI Christodoulou, John/M-3628-2019; Kumar, Kishore/KZM-8342-2024; Cowley,
   Mark/K-8731-2019; Dinger, Marcel/N-1398-2019; Davis, Ryan/A-7430-2015
OI Schofield, Deborah/0000-0002-1658-494X; Davis, Ryan/0000-0003-0512-8989;
   Mallawaarachchi, Amali/0000-0002-1229-1701; Kumar, Kishore
   Raj/0000-0003-3482-6962; Liang, Christina/0000-0002-2503-1917; Sue,
   Carolyn/0000-0003-1255-3617
FU New South Wales Ministry of Health Collaborative Genomics Grant
FX This project was funded by a New South Wales Ministry of Health
   Collaborative Genomics Grant (Sue_2014_Genomics; C.M.S., J.C., M.E.D.,
   D.S., R.L.D., K.R.K.).
CR [Anonymous], AB US
   Baldwin EJ, 2010, J NEUROL NEUROSUR PS, V81, P954, DOI 10.1136/jnnp.2008.161059
   Cabrera-Pérez R, 2019, HUM GENE THER, V30, P985, DOI 10.1089/hum.2018.217
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Carelli V, 2017, J NEURO-OPHTHALMOL, V37, P371, DOI 10.1097/WNO.0000000000000570
   Caspar SM, 2018, CLIN GENET, V93, P508, DOI 10.1111/cge.13190
   Clark MM, 2018, NPJ GENOM MED, V3, DOI 10.1038/s41525-018-0053-8
   Craven L, 2017, HUM REPROD UPDATE, V23, P501, DOI 10.1093/humupd/dmx018
   Davis Ryan L, 2018, Handb Clin Neurol, V147, P125, DOI 10.1016/B978-0-444-63233-3.00010-5
   Davis RL, 2011, SEMIN NEUROL, V31, P519, DOI 10.1055/s-0031-1299790
   Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004
   Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076
   Garret P, 2019, HUM MUTAT, V40, P2430, DOI 10.1002/humu.23885
   Garvan Institute, 2018, AB US
   Gayevskiy V, 2019, BIOINFORMATICS, V35, P122, DOI 10.1093/bioinformatics/bty540
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Grier J, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000230
   Halter JP, 2015, BRAIN, V138, P2847, DOI 10.1093/brain/awv226
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   Karaarslan C, 2019, ADV THER, V36, P3299, DOI 10.1007/s12325-019-01113-2
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Kumar KR, 2019, SEMIN THROMB HEMOST, V45, P661, DOI 10.1055/s-0039-1688446
   Liang C., 2011, AUSTR DOCTOR, V25, P27
   Liang C, 2014, BBA-GEN SUBJECTS, V1840, P1360, DOI 10.1016/j.bbagen.2013.10.040
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Manwaring N, 2008, ANN NEUROL, V64, P471, DOI 10.1002/ana.21469
   Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004
   Mattick JS, 2018, MED J AUSTRALIA, V209, P197, DOI 10.5694/mja17.01176
   Minoche AE, 2019, GENET MED, V21, P650, DOI 10.1038/s41436-018-0084-7
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Ohtake A, 2014, BBA-GEN SUBJECTS, V1840, P1355, DOI 10.1016/j.bbagen.2014.01.025
   Orphanet, AB US
   Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565
   Pinese M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14079-0
   Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9
   Pronicka E, 2011, MED SCI MONITOR, V17, pCR203, DOI 10.12659/MSM.881716
   Puttick C, 2019, bioRxiv, DOI [10.1101/852210, 10.1101/852210, DOI 10.1101/852210]
   Raymond FL, 2018, NAT REV GENET, V19, P399, DOI 10.1038/s41576-018-0022-1
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Cruz PMR, 2015, NEUROLOGY, V85, P1043, DOI 10.1212/WNL.0000000000001952
   Rudaks LI, 2022, AM J MED GENET A, V188, P2226, DOI 10.1002/ajmg.a.62755
   Schofield D, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0006-7
   Smith EH, 2010, J INHERIT METAB DIS, V33, pS349, DOI 10.1007/s10545-010-9183-6
   Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891
   Sue CM, 2010, MED J AUSTRALIA, V193, P195, DOI 10.5694/j.1326-5377.2010.tb03864.x
   Sue CM, 1998, J NEUROL SCI, V161, P36, DOI 10.1016/S0022-510X(98)00179-8
   Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188
   Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]
   Vandebona H, 2009, NEW ENGL J MED, V360, P642, DOI 10.1056/NEJMc0806397
   Watson E., 2020, J. Transl. Genet. Genomics, V4, P188, DOI [DOI 10.20517/JTGG.2020.31, 10.20517/jtgg.2020.31]
   Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y
   Zhang W, 2012, CLIN CHEM, V58, P1322, DOI 10.1373/clinchem.2011.181438
NR 54
TC 27
Z9 26
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD AUG 16
PY 2022
VL 99
IS 7
BP E730
EP E742
DI 10.1212/WNL.0000000000200745
PG 13
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 3U3NP
UT WOS:000840881900022
PM 35641312
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Pietiläinen, KH
   Naukkarinen, J
   Rissanen, A
   Saharinen, J
   Ellonen, P
   Keränen, H
   Suomalainen, A
   Götz, A
   Suortti, T
   Yki-Järvinen, H
   Oresic, M
   Kaprio, J
   Peltonen, L
AF Pietilainen, Kirsi H.
   Naukkarinen, Jussi
   Rissanen, Aila
   Saharinen, Juha
   Ellonen, Pekka
   Keranen, Heli
   Suomalainen, Anu
   Gotz, Alexandra
   Suortti, Tapani
   Yki-Jarvinen, Hannele
   Oresic, Matej
   Kaprio, Jaakko
   Peltonen, Leena
TI Global transcript profiles of fat in monozygotic twins discordant for
   BMI: Pathways behind acquired obesity
SO PLOS MEDICINE
LA English
DT Article
ID INFLAMMATION-RELATED GENES; NONOBESE PIMA-INDIANS; INSULIN-RESISTANCE;
   ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; METABOLIC-REGULATION;
   INCREASED EXPRESSION; MOTONEURON DISEASE; SKELETAL-MUSCLE; CELLS
AB Background
   The acquired component of complex traits is difficult to dissect in humans. Obesity represents such a trait, in which the metabolic and molecular consequences emerge from complex interactions of genes and environment. With the substantial morbidity associated with obesity, a deeper understanding of the concurrent metabolic changes is of considerable importance. The goal of this study was to investigate this important acquired component and expose obesity-induced changes in biological pathways in an identical genetic background.
   Methods and Findings
   We used a special study design of "clonal controls,'' rare monozygotic twins discordant for obesity identified through a national registry of 2,453 young, healthy twin pairs. A total of 14 pairs were studied ( eight male, six female; white), with a mean +/- standard deviation (SD) age 25.8 +/- 6 1.4 y and a body mass index (BMI) difference 5.2 +/- 6 1.8 kg/m(2). Sequence analyses of mitochondrial DNA ( mtDNA) in subcutaneous fat and peripheral leukocytes revealed no aberrant heteroplasmy between the co-twins. However, mtDNA copy number was reduced by 47% in the obese co-twin's fat. In addition, novel pathway analyses of the adipose tissue transcription profiles exposed significant down-regulation of mitochondrial branched-chain amino acid (BCAA) catabolism ( p < 0.0001). In line with this finding, serum levels of insulin secretion-enhancing BCAAs were increased in obese male co-twins ( 9% increase, p= 0.025). Lending clinical relevance to the findings, in both sexes the observed aberrations in mitochondrial amino acid metabolism pathways in fat correlated closely with liver fat accumulation, insulin resistance, and hyperinsulinemia, early aberrations of acquired obesity in these healthy young adults.
   Conclusions
   Our findings emphasize a substantial role of mitochondrial energy-and amino acid metabolism in obesity and development of insulin resistance.
C1 [Naukkarinen, Jussi; Saharinen, Juha; Ellonen, Pekka; Keranen, Heli; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland.
   [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res Unit, Helsinki, Finland.
   [Pietilainen, Kirsi H.; Yki-Jarvinen, Hannele] Univ Helsinki, Cent Hosp, Div Diabet, Dept Med, Helsinki, Finland.
   [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Finnish Twin Cohort Study, Helsinki, Finland.
   [Naukkarinen, Jussi; Saharinen, Juha; Ellonen, Pekka; Keranen, Heli; Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.
   [Naukkarinen, Jussi; Saharinen, Juha; Ellonen, Pekka; Keranen, Heli; Peltonen, Leena] Univ Helsinki, Res Program Mol Med, FIN-00014 Helsinki, Finland.
   [Suomalainen, Anu; Gotz, Alexandra] Univ Helsinki, Res Program Mol Neurol, FIN-00014 Helsinki, Finland.
   [Suomalainen, Anu; Gotz, Alexandra] Univ Helsinki, Dept Neurol, FIN-00014 Helsinki, Finland.
   [Suomalainen, Anu; Gotz, Alexandra] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland.
   [Suortti, Tapani; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland.
   [Kaprio, Jaakko] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland.
   [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge, England.
   [Peltonen, Leena] MIT, Broad Inst, Cambridge, MA 02139 USA.
C3 Finland National Institute for Health & Welfare; University of Helsinki;
   Helsinki University Central Hospital; University of Helsinki; Helsinki
   University Central Hospital; University of Helsinki; University of
   Helsinki; University of Helsinki; University of Helsinki; University of
   Helsinki; University of Helsinki; Helsinki University Central Hospital;
   VTT Technical Research Center Finland; Finland National Institute for
   Health & Welfare; Wellcome Trust Sanger Institute; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute
RP Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland.
EM leena.peltonen@ktl.fi
RI Oresic, Matej/K-7673-2016; Pietiläinen, Kirsi/HJA-4960-2022; Kaprio,
   Jaakko/A-1820-2008
OI Oresic, Matej/0000-0002-2856-9165; Gotz, Alexandra/0000-0001-9737-6861;
   Pietilainen, Kirsi/0000-0002-8522-1288; Suomalainen-Wartiovaara,
   Anu/0000-0003-4833-5195; Witkowski, Jacek M./0000-0003-2906-1109;
   Kaprio, Jaakko/0000-0002-3716-2455; Ellonen, Pekka/0000-0001-6072-0489
CR Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Clément K, 2004, FASEB J, V18, P1657, DOI 10.1096/fj.04-2204com
   DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
   FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503
   FLOYD JC, 1963, J CLIN INVEST, V42, P1714, DOI 10.1172/JCI104857
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4
   Hackl H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r108
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853
   Hinault C, 2006, J NUTR BIOCHEM, V17, P374, DOI 10.1016/j.jnutbio.2006.02.008
   Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006
   Hood DA, 2006, J EXP BIOL, V209, P2265, DOI 10.1242/jeb.02182
   Huang F, 2005, AM J PHYSIOL-LUNG C, V289, pL176, DOI 10.1152/ajplung.00003.2005
   Kannisto K, 2004, J CLIN ENDOCR METAB, V89, P4414, DOI 10.1210/jc.2004-0153
   Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/136905202320906101
   Kiialainen A, 2007, J MOL MED, V85, P971, DOI 10.1007/s00109-007-0191-4
   Lacasa D, 2007, ENDOCRINOLOGY, V148, P868, DOI 10.1210/en.2006-0687
   Lee YH, 2005, DIABETOLOGIA, V48, P1776, DOI 10.1007/s00125-005-1867-3
   Lelliott C, 2004, INT J OBESITY, V28, pS22, DOI 10.1038/sj.ijo.0802854
   Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Motley ED, 2002, HYPERTENSION, V39, P508, DOI 10.1161/hy02t2.102907
   Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512
   Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004
   Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2
   Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986
   Pakkasjärvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185
   Pakkasjärvi N, 2007, DEV NEUROBIOL, V67, P270, DOI 10.1002/dneu.20350
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pietiläien KH, 2004, TWIN RES, V7, P421
   Pietiläinen KH, 2005, AM J PHYSIOL-ENDOC M, V288, pE768, DOI 10.1152/ajpendo.00381.2004
   Pietiläinen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218
   Pietiläinen KH, 2006, J CLIN ENDOCR METAB, V91, P2776, DOI 10.1210/jc.2005-2848
   Pietiläinen KH, 2006, OBESITY, V14, P826, DOI 10.1038/oby.2006.96
   PIETILANIEN KH, 2007, IN PRESS OBESITY
   RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391
   Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589
   Schadt EE, 2006, J LIPID RES, V47, P2601, DOI 10.1194/jlr.R600026-JLR200
   Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]
   Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010
   Wang S, 2006, PLOS GENET, V2, P148, DOI 10.1371/journal.pgen.0020015
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Wick N, 2007, PHYSIOL GENOMICS, V28, P179, DOI 10.1152/physiolgenomics.00037.2006
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Yang TL, 2006, AAPS J, V8, pE632, DOI 10.1208/aapsj080472
   Yang XL, 2004, BIOCHEM BIOPH RES CO, V317, P1045, DOI 10.1016/j.bbrc.2004.03.152
   Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001
   Yki-Järvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031
NR 59
TC 245
Z9 258
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD MAR
PY 2008
VL 5
IS 3
AR e51
DI 10.1371/journal.pmed.0050051
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 287PL
UT WOS:000254928900020
PM 18336063
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Magistrati, M
   Gilea, AI
   Gerra, MC
   Baruffini, E
   Dallabona, C
AF Magistrati, Martina
   Gilea, Alexandru Ionut
   Gerra, Maria Carla
   Baruffini, Enrico
   Dallabona, Cristina
TI Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds
   for Mitochondrial Diseases Using Yeast <i>Saccharomyces cerevisiae</i>
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE drug drop test; yeast model; Saccharomyces cerevisiae; drug repurposing;
   mitochondrial diseases
ID DYNAMIN-RELATED GTPASE; DNA-POLYMERASE-GAMMA; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; KINASE-ASSOCIATED NEURODEGENERATION; ADENINE-NUCLEOTIDE
   TRANSLOCATOR; DOMINANT OPTIC ATROPHY; RESPIRATORY-CHAIN SUPERCOMPLEXES;
   COMPLEX-III DEFICIENCY; TO-C MUTATION; ATP SYNTHASE
AB Mitochondrial diseases (MDs) refer to a group of clinically and genetically heterogeneous pathologies characterized by defective mitochondrial function and energy production. Unfortunately, there is no effective treatment for most MDs, and current therapeutic management is limited to relieving symptoms. The yeast Saccharomyces cerevisiae has been efficiently used as a model organism to study mitochondria-related disorders thanks to its easy manipulation and well-known mitochondrial biogenesis and metabolism. It has been successfully exploited both to validate alleged pathogenic variants identified in patients and to discover potential beneficial molecules for their treatment. The so-called "drug drop test", a phenotype-based high-throughput screening, especially if coupled with a drug repurposing approach, allows the identification of molecules with high translational potential in a cost-effective and time-saving manner. In addition to drug identification, S. cerevisiae can be used to point out the drug's target or pathway. To date, drug drop tests have been successfully carried out for a variety of disease models, leading to very promising results. The most relevant aspect is that studies on more complex model organisms confirmed the effectiveness of the drugs, strengthening the results obtained in yeast and demonstrating the usefulness of this screening as a novel approach to revealing new therapeutic molecules for MDs.
C1 [Magistrati, Martina; Gilea, Alexandru Ionut; Gerra, Maria Carla; Baruffini, Enrico; Dallabona, Cristina] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
C3 University of Parma
RP Dallabona, C (corresponding author), Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parco Area Sci 11-A, I-43124 Parma, Italy.
EM martina.magistrati@unipr.it; alexandruionut.gilea@unipr.it;
   mariacarla.gerra@unipr.it; enrico.baruffini@unipr.it;
   cristina.dallabona@unipr.it
RI Gerra, Maria Carla/HCH-3557-2022; Baruffini, Enrico/C-1057-2015
OI DALLABONA, Cristina/0000-0003-4397-9143; Baruffini,
   Enrico/0000-0002-8280-7849
FU COMP-HUB Initiative; Departments of Excellence' program of the Italian
   Ministry for Education, University and Research; Consorzio
   Interuniversitario per le Biotecnologie (CIB); MUR [1059-09/08/2021];
   Italian "Fondazione Telethon" [GGP19287A]
FX M.C.G. is supported by a fixed-term research assistant contract by the
   COMP-HUB Initiative, funded by the Departments of Excellence' program of
   the Italian Ministry for Education, University and Research (MIUR,
   2018-2022). C.D. is supported by Consorzio Interuniversitario per le
   Biotecnologie (CIB), funded by MUR (ex D.M.n.1059-09/08/2021), protocol
   number 26/23. A.I.G. is supported by a doctoral fellowship co-funded by
   Italian "Fondazione Telethon", project number GGP19287A to E.B.
CR Aiyar RS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6585
   Aleo SJ, 2020, HUM MOL GENET, V29, P3631, DOI 10.1093/hmg/ddaa244
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509
   AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439
   Alvarez-Córdoba M, 2019, MOL NEUROBIOL, V56, P3638, DOI 10.1007/s12035-018-1333-0
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   Amemiya A., 1993, POLG RELATED DISORDE
   Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   [Anonymous], 1909, KLIN MON AUGENHEILKD
   Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083
   Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468
   Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855
   Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Barboni P, 2013, BRAIN, V136, DOI 10.1093/brain/aws280
   Barrientos A, 2003, IUBMB LIFE, V55, P83, DOI 10.1080/1521654031000098122
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1996, J INHERIT METAB DIS, V19, P157, DOI 10.1007/BF01799418
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Bassett DE, 1996, NATURE, V379, P589, DOI 10.1038/379589a0
   Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493
   Baumann M, 2019, CLIN GENET, V95, P182, DOI 10.1111/cge.13462
   Berti CC, 2021, GENES-BASEL, V12, DOI 10.3390/genes12020300
   Binieda K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020914
   Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Bonnefoy N, 2001, METHOD CELL BIOL, V65, P381, DOI 10.1016/S0091-679X(01)65022-2
   BOTSTEIN D, 1991, HOSP PRACT, V26, P157
   Bottani E, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111083
   Bottani E, 2014, MOL THER, V22, P10, DOI 10.1038/mt.2013.230
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325
   Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022
   Burrage LC, 2014, MOL GENET METAB, V113, P207, DOI 10.1016/j.ymgme.2014.06.004
   Cámara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641
   Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410
   Carelli V, 2015, BRAIN, V138, DOI 10.1093/brain/awu234
   Castagna AE, 2007, AM J MED GENET A, V143A, P808, DOI 10.1002/ajmg.a.31637
   Berti CC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010293
   Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011
   Chang XT, 2020, CNS NEUROSCI THER, V26, P754, DOI 10.1111/cns.13294
   Christou YP, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/3247034
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Couplan E, 2011, P NATL ACAD SCI USA, V108, P11989, DOI 10.1073/pnas.1101478108
   D'Aurelio M, 2010, HUM MOL GENET, V19, P374, DOI 10.1093/hmg/ddp503
   Dallabona C, 2017, BIOCHEM BIOPH RES CO, V493, P909, DOI 10.1016/j.bbrc.2017.09.122
   Dallabona C, 2010, HUM MOL GENET, V19, P1098, DOI 10.1093/hmg/ddp581
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   de Tilques MD, 2018, MICROB CELL, V5, P220, DOI 10.15698/mic2018.05.629
   de Tilques MD, 2017, DIS MODEL MECH, V10, P439, DOI 10.1242/dmm.027540
   deCoo IFM, 1996, AM J HUM GENET, V58, P636
   Del Dotto V, 2018, BBA-MOL BASIS DIS, V1864, P3496, DOI 10.1016/j.bbadis.2018.08.004
   Del Dotto V, 2018, PHARMACOL RES, V131, P199, DOI 10.1016/j.phrs.2018.02.018
   Delerue T, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.036558
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   DEMEIRLEIR L, 1995, PEDIATR NEUROL, V13, P242, DOI 10.1016/0887-8994(95)00184-H
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Di Meo I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11564-8
   di Punzio G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212223
   di Punzio G, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094461
   DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598
   Ding QJ, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090215
   Dionisi-Vici C, 1998, J INHERIT METAB DIS, V21, P2, DOI 10.1023/A:1005397227996
   DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V
   Dudek J, 2013, STEM CELL RES, V11, P806, DOI 10.1016/j.scr.2013.05.005
   Duina AA, 2014, GENETICS, V197, P33, DOI 10.1534/genetics.114.163188
   Dujon B, 2020, YEAST, V37, P191, DOI 10.1002/yea.3445
   El-Hattab A.W., 1993, GENEREVIEWS
   El-Hattab AW, 2017, MOL GENET METAB, V122, P1, DOI 10.1016/j.ymgme.2017.09.009
   El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017
   El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6
   Elachouri G, 2011, GENOME RES, V21, P12, DOI 10.1101/gr.108696.110
   Facchinello N, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03359-z
   Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Fernández-Vizarra E, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00134
   Ferri L, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-27
   Figuccia S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094524
   Fink G. R., 1991, GUIDE YEAST GENETICS
   Finsterer J, 2018, NEUROPEDIATRICS, V49, P231, DOI 10.1055/s-0037-1609039
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Foury F, 2002, CURR OPIN CHEM BIOL, V6, P106, DOI 10.1016/S1367-5931(01)00276-9
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Friggeri L, 2019, J MED CHEM, V62, P10391, DOI 10.1021/acs.jmedchem.9b01485
   Ganetzky RD, 2019, HUM MUTAT, V40, P499, DOI 10.1002/humu.23723
   Garone C, 2012, ARCH NEUROL-CHICAGO, V69, P1648, DOI 10.1001/archneurol.2012.405
   GENGA A, 1986, J BIOL CHEM, V261, P9328
   Gilberti M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205014
   Gilea AI, 2021, GENES-BASEL, V12, DOI 10.3390/genes12121866
   Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gregory A, 2009, J MED GENET, V46, P73, DOI 10.1136/jmg.2008.061929
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   GUAN KL, 1993, CURR GENET, V24, P141, DOI 10.1007/BF00324678
   Guthrie C., 2002, PART B METHODS ENZYM
   Hanisch F, 2015, J NEUROL NEUROSUR PS, V86, P630, DOI 10.1136/jnnp-2013-306748
   Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817
   HIGGINS JJ, 1992, NEUROLOGY, V42, P194, DOI 10.1212/WNL.42.1.194
   Hikmat O, 2017, GENET MED, V19, P1217, DOI 10.1038/gim.2017.35
   Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021
   Ho CH, 2009, NAT BIOTECHNOL, V27, P369, DOI 10.1038/nbt.1534
   Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200
   Hoon S, 2008, TRENDS PHARMACOL SCI, V29, P499, DOI 10.1016/j.tips.2008.07.006
   Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100
   Hörtnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026
   Hoshino A, 2019, NATURE, V575, P375, DOI 10.1038/s41586-019-1667-4
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Jeong SY, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910489
   Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023
   JOHNSTON SA, 1988, SCIENCE, V240, P1538, DOI 10.1126/science.2836954
   Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9
   JONES BA, 1992, GENE DEV, V6, P380, DOI 10.1101/gad.6.3.380
   Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024
   Kabala AM, 2014, BIOCHIMIE, V100, P200, DOI 10.1016/j.biochi.2013.11.024
   Kachroo AH, 2015, SCIENCE, V348, P921, DOI 10.1126/science.aaa0769
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kaminska J, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23095106
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   King MS, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000256
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Klopstock T, 2019, LANCET NEUROL, V18, P631, DOI 10.1016/S1474-4422(19)30142-5
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Körver-Keularts IMLW, 2015, JIMD REP, V22, P39, DOI 10.1007/8904_2015_409
   Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005
   Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132
   Kruer MC, 2011, BRAIN, V134, P947, DOI 10.1093/brain/awr042
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P817, DOI 10.1016/j.bbamcr.2009.02.011
   Kucharczyk R, 2009, BBA-MOL CELL RES, V1793, P186, DOI 10.1016/j.bbamcr.2008.06.012
   LAMMINEN T, 1995, AM J HUM GENET, V56, P1238
   LAWSON JE, 1988, J BIOL CHEM, V263, P14812
   Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200
   Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x
   Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200
   LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171
   Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422
   Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034
   Lodi T, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00106
   Löllgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198
   Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244
   López-Gallardo E, 2009, J MED GENET, V46, P64, DOI 10.1136/jmg.2008.060616
   Luna-Sanchez M, 2020, MOL THER, V28, P1918, DOI 10.1016/j.ymthe.2020.06.010
   Lynch DS, 2017, NEUROL-GENET, V3, DOI 10.1212/NXG.0000000000000188
   Magistrati M, 2023, INT J MOL SCI, V24, DOI 10.3390/ijms24032178
   Makino M, 1998, NEUROMUSCULAR DISORD, V8, P149, DOI 10.1016/S0960-8966(98)00017-0
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Martorano L, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.037226
   Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021
   Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015
   Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012
   Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217
   Moreno SNJ, 1996, ARCH BIOCHEM BIOPHYS, V326, P15, DOI 10.1006/abbi.1996.0041
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Nasca A, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0641-1
   Nolli C, 2015, MITOCHONDRION, V25, P38, DOI 10.1016/j.mito.2015.10.002
   Olzhausen J, 2009, CURR GENET, V55, P163, DOI 10.1007/s00294-009-0234-1
   Orellana DI, 2016, EMBO MOL MED, V8, P1197, DOI 10.15252/emmm.201606391
   Ostojic J, 2013, CELL METAB, V18, P567, DOI 10.1016/j.cmet.2013.08.017
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Panozzo C, 2017, BBA-MOL CELL RES, V1864, P2297, DOI 10.1016/j.bbamcr.2017.09.003
   Pellecchia MT, 2005, NEUROLOGY, V64, P1810, DOI 10.1212/01.WNL.0000161843.52641.EC
   Pelloquin L, 1998, BIOCHEM BIOPH RES CO, V251, P720, DOI 10.1006/bbrc.1998.9539
   Pitayu L, 2016, HUM MOL GENET, V25, P715, DOI 10.1093/hmg/ddv509
   Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109
   Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79
   Rahman S, 2019, NAT REV NEUROL, V15, P40, DOI 10.1038/s41582-018-0101-0
   Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200
   Rana A, 2010, P NATL ACAD SCI USA, V107, P6988, DOI 10.1073/pnas.0912105107
   Reeder NL, 2011, ANTIMICROB AGENTS CH, V55, P5753, DOI 10.1128/AAC.00724-11
   Reinhold R, 2012, MOL CELL BIOL, V32, P5009, DOI 10.1128/MCB.00843-12
   Remacle C, 2006, P NATL ACAD SCI USA, V103, P4771, DOI 10.1073/pnas.0509501103
   Resnick MA, 2000, MUTAT RES-FUND MOL M, V451, P1, DOI 10.1016/S0027-5107(00)00036-1
   Romagnoli M, 2020, ANN CLIN TRANSL NEUR, V7, P590, DOI 10.1002/acn3.51026
   Ronchi D, 2013, AM J HUM GENET, V92, P293, DOI 10.1016/j.ajhg.2012.12.014
   Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Santambrogio P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103664
   Sarzi E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20838-8
   SCHLAME M, 1993, J BIOL CHEM, V268, P74
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200
   Selvaag E, 2000, EUR J DERMATOL, V10, P91
   Seneca S, 1996, J INHERIT METAB DIS, V19, P115, DOI 10.1007/BF01799407
   Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788
   Siciliano G, 2003, NEUROMUSCULAR DISORD, V13, P162, DOI 10.1016/S0960-8966(02)00221-3
   Siddiqi S, 2013, J HUM GENET, V58, P819, DOI 10.1038/jhg.2013.101
   Soczewka P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052248
   Soczewka P, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070828
   Soczewka P, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.036830
   Sommerville Ewen W, 2014, J Neuromuscul Dis, V1, P119
   Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Spiegel R, 2016, J MED GENET, V53, P127, DOI 10.1136/jmedgenet-2015-103361
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2008, ARCH NEUROL-CHICAGO, V65, P1108, DOI 10.1001/archneur.65.8.1108
   St Onge R, 2012, MOLECULES, V17, P13098, DOI 10.3390/molecules171113098
   Stenton SL, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102784
   Stenton SL, 2018, ESSAYS BIOCHEM, V62, P399, DOI 10.1042/EBC20170110
   Steward CG, 2010, PRENATAL DIAG, V30, P970, DOI 10.1002/pd.2599
   Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454
   Su X, 2021, HUM MOL GENET, V30, P381, DOI 10.1093/hmg/ddab043
   Talevi A, 2020, EXPERT OPIN DRUG DIS, V15, P397, DOI 10.1080/17460441.2020.1704729
   Tan J, 2020, EBIOMEDICINE, V54, DOI 10.1016/j.ebiom.2020.102730
   Tang S, 2012, J NEUROL, V259, P862, DOI 10.1007/s00415-011-6268-6
   Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491
   THOMAS PK, 1984, J NEUROL SCI, V64, P137, DOI 10.1016/0022-510X(84)90032-7
   Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104
   Thompson K, 2016, AM J HUM GENET, V99, P860, DOI 10.1016/j.ajhg.2016.08.014
   THYAGARAJAN D, 1995, ANN NEUROL, V38, P468, DOI 10.1002/ana.410380321
   Tibbetts AS, 2002, ARCH BIOCHEM BIOPHYS, V406, P96, DOI 10.1016/S0003-9861(02)00419-8
   Tribouillard-Tanvier Deborah, 2022, Methods Mol Biol, V2497, P221, DOI 10.1007/978-1-0716-2309-1_14
   Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   Verny C, 2008, NEUROLOGY, V70, P1152, DOI 10.1212/01.wnl.0000289194.89359.a1
   Viscomi C, 2020, J INTERN MED, V287, P665, DOI 10.1111/joim.13046
   Voisset C, 2014, DIS MODEL MECH, V7, P435, DOI 10.1242/dmm.014308
   Votruba M, 1998, HUM GENET, V102, P79, DOI 10.1007/s004390050657
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Vu TH, 2001, HEPATOLOGY, V34, P116, DOI 10.1053/jhep.2001.25921
   Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149
   Wen SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36313
   White SL, 1999, J INHERIT METAB DIS, V22, P899, DOI 10.1023/A:1005639407166
   Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015
   Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341
   Xu Y, 2005, LAB INVEST, V85, P823, DOI 10.1038/labinvest.3700274
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
   Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038
   Zara V, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231810537
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572
NR 258
TC 4
Z9 4
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2023
VL 24
IS 13
AR 10696
DI 10.3390/ijms241310696
PG 34
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA M5TU1
UT WOS:001030848700001
PM 37445873
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Jones, AWE
   Yao, Z
   Vicencio, JM
   Karkucinska-Wieckowska, A
   Szabadkai, G
AF Jones, Aleck W. E.
   Yao, Zhi
   Vicencio, Jose Miguel
   Karkucinska-Wieckowska, Agnieszka
   Szabadkai, Gyorgy
TI PGC-1 family coactivators and cell fate: Roles in cancer,
   neurodegeneration, cardiovascular disease and retrograde
   mitochondria-nucleus signalling
SO MITOCHONDRION
LA English
DT Review
DE Mitochondrial biogenesis; Pgc-1; Retrograde signalling; Cancer;
   Apoptosis; Neurodegeneration; Cellular stress response
ID PPAR-GAMMA COACTIVATOR; HUMAN BREAST-CANCER; GENE-EXPRESSION;
   SKELETAL-MUSCLE; DNA MUTATIONS; HUNTINGTONS-DISEASE; PGC-1-RELATED
   COACTIVATOR; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; OXIDATIVE
   STRESS
AB Over the past two decades, a complex nuclear transcriptional machinery controlling mitochondrial biogenesis and function has been described. Central to this network are the PGC-1 family coactivators, characterised as master regulators of mitochondrial biogenesis. Recent literature has identified a broader role for PGC-1 coactivators in both cell death and cellular adaptation under conditions of stress, here reviewed in the context of the pathology associated with cancer, neurodegeneration and cardiovascular disease. Moreover, we propose that these studies also imply a novel conceptual framework on the general role of mitochondrial dysfunction in disease. It is now well established that the complex nuclear transcriptional control of mitochondrial biogenesis allows for adaptation of mitochondrial mass and function to environmental conditions. On the other hand, it has also been suggested that mitochondria alter their function according to prevailing cellular energetic requirements and thus function as sensors that generate signals to adjust fundamental cellular processes through a retrograde mitochondria-nucleus signalling pathway. Therefore, altered mitochondrial function can affect cell fate not only directly by modifying cellular energy levels or redox state, but also indirectly, by altering nuclear transcriptional patterns. The current literature on such retrograde signalling in both yeast and mammalian cells is thus reviewed, with an outlook on its potential contribution to disease through the regulation of PGC-1 family coactivators. We propose that further investigation of these pathways will lead to the identification of novel pharmacological targets and treatment strategies to combat disease. (C) 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Jones, Aleck W. E.; Yao, Zhi; Vicencio, Jose Miguel; Szabadkai, Gyorgy] UCL, Consortium Mitochondrial Res, Dept Cell & Dev Biol, London, England.
   [Karkucinska-Wieckowska, Agnieszka] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.
C3 University of London; University College London; Children's Memorial
   Health Institute
RP Szabadkai, G (corresponding author), UCL, Consortium Mitochondrial Res, Dept Cell & Dev Biol, London, England.
EM g.szabadkai@ucl.ac.uk
RI YAO, Zhi/C-6096-2009
OI Szabadkai, Gyorgy/0000-0002-3006-3577; Karkucinska-Wieckowska,
   Agnieszka/0000-0003-4936-1571
FU Parkinson's UK [G-0905]; Polish Ministry of Science and Higher Education
   [NN 407 075 137]; Childrens' Memorial Health Institute [117/09, 119/09];
   Becas Chile; MRC
FX We thank B. Szabadkai for help with preparing the figures. G.S. and Z.Y.
   are supported by Parkinson's UK (G-0905). A. K-W is supported by the
   Polish Ministry of Science and Higher Education (NN 407 075 137) and by
   the Internal Projects of The Childrens' Memorial Health Institute
   (117/09 and 119/09). J.M.V. holds a postdoctoral fellowship from Becas
   Chile, A.W.E J. holds an MRC PhD fellowship.
CR Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007
   Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910
   Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53
   Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983
   Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baker MJ, 2011, COLD SPRING HARBOR P, V3
   Basu A, 1997, J BIOL CHEM, V272, P5899, DOI 10.1074/jbc.272.9.5899
   Bianchi K, 2006, CELL DEATH DIFFER, V13, P586, DOI 10.1038/sj.cdd.4401784
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Biswas G, 2005, CELL DEATH DIFFER, V12, P266, DOI 10.1038/sj.cdd.4401553
   Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200
   Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1
   Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003
   Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   BUTOW RA, 1988, PHILOS T R SOC B, V319, P127
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037
   Chandra D., 2010, BIOCHIM BIOPHYS ACTA, V1807, P620
   Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025
   Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69
   Connaughton S, 2010, MOL CELL ENDOCRINOL, V315, P159, DOI 10.1016/j.mce.2009.08.011
   Cowell RM, 2009, BIOCHEM BIOPH RES CO, V379, P578, DOI 10.1016/j.bbrc.2008.12.109
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Czarnecka AM, 2010, FRONT BIOSCI-LANDMRK, V15, P437, DOI 10.2741/3629
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   Deblois G, 2010, CANCER RES, V70, P10277, DOI 10.1158/0008-5472.CAN-10-2840
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001
   Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/bse0470115, 10.1042/BSE0470115]
   Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297
   Esterbauer H, 1999, GENOMICS, V62, P98, DOI 10.1006/geno.1999.5977
   Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x
   Feilchenfeldt J, 2004, CANCER LETT, V203, P25, DOI 10.1016/j.canlet.2003.08.024
   Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077
   Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100
   Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148
   Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104
   Gasparre G, 2011, BBA-BIOENERGETICS, V1807, P633, DOI 10.1016/j.bbabio.2010.08.006
   Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127
   GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105
   Guerra F, 2011, HUM MOL GENET, V20, P2394, DOI 10.1093/hmg/ddr146
   Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200
   Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192
   Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296
   Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021
   Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Holt IJ, 2010, TRENDS GENET, V26, P103, DOI 10.1016/j.tig.2009.12.011
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960
   Horibe T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000835
   Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3
   Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007
   Ishikawa K, 2008, MITOCHONDRION, V8, P339, DOI 10.1016/j.mito.2008.07.006
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206
   Jiang WG, 2003, INT J CANCER, V106, P752, DOI 10.1002/ijc.11302
   Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008
   Joseph AM, 2004, AM J PHYSIOL-CELL PH, V286, pC867, DOI 10.1152/ajpcell.00191.2003
   Kaipparettu BA, 2010, ANN NY ACAD SCI, V1201, P137, DOI 10.1111/j.1749-6632.2010.05621.x
   Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108
   Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005
   Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604
   Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936
   Kong XX, 2009, MOL PHARMACOL, V76, P854, DOI 10.1124/mol.109.056424
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Kulawiec M, 2010, ENVIRON MOL MUTAGEN, V51, P427, DOI 10.1002/em.20582
   Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751
   Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729
   Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708
   Le Pennec S, 2011, J BIOL CHEM, V286, P18229, DOI 10.1074/jbc.M110.217521
   Lee CH, 2011, AM J PATHOL, V178, P2066, DOI 10.1016/j.ajpath.2011.01.056
   Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369
   Lenka N, 1996, J BIOL CHEM, V271, P30281, DOI 10.1074/jbc.271.47.30281
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38
   Liao XM, 2010, BRIT J PHARMACOL, V161, P771, DOI 10.1111/j.1476-5381.2010.00900.x
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344
   Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   LOMBES A, 1989, ANN NEUROL, V26, P20, DOI 10.1002/ana.410260104
   Luce K, 2010, ADV EXP MED BIOL, V694, P108
   Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705
   Luo Y, 2001, J ALZHEIMERS DIS, V3, P593, DOI 10.3233/JAD-2001-3610
   Luo Y, 2009, J MOL NEUROSCI, V39, P262, DOI 10.1007/s12031-009-9196-5
   Lynn EG, 2010, J MOL CELL CARDIOL, V49, P693, DOI 10.1016/j.yjmcc.2010.06.008
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022
   Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590
   Marín-García J, 2010, VASC PHARMACOL, V52, P120, DOI 10.1016/j.vph.2009.10.008
   Martin E, 2011, HUM MOL GENET, V20, P2422, DOI 10.1093/hmg/ddr148
   Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x
   Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6
   Maruszak A, 2011, J ALZHEIMERS DIS, V27, P197, DOI 10.3233/JAD-2011-110710
   McCammon MT, 2003, MOL BIOL CELL, V14, P958, DOI 10.1091/mbc.E02-07-0422
   Menzies KJ, 2009, AM J PHYSIOL-CELL PH, V296, pC355, DOI 10.1152/ajpcell.00415.2007
   Mercy L, 2005, FEBS J, V272, P5031, DOI 10.1111/j.1742-4658.2005.04913.x
   Miglio G, 2009, NEUROCHEM INT, V55, P496, DOI 10.1016/j.neuint.2009.05.001
   Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580
   Mirebeau-Prunier D, 2010, FEBS J, V277, P713, DOI 10.1111/j.1742-4658.2009.07516.x
   Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x
   Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   O'Malley BW, 2009, CANCER RES, V69, P8217, DOI 10.1158/0008-5472.CAN-09-2223
   Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892
   Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200
   Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169
   Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Qin WP, 2010, BIOCHEM BIOPH RES CO, V403, P473, DOI 10.1016/j.bbrc.2010.11.061
   Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588
   Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310
   Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Rhodes MA, 2009, AM J PHYSIOL-HEART C, V297, pH392, DOI 10.1152/ajpheart.00164.2009
   Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770
   Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104
   Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB
   Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351
   Savagner F, 2003, BIOCHEM BIOPH RES CO, V310, P779, DOI 10.1016/j.bbrc.2003.09.076
   Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010
   Shiota M, 2010, MOL ENDOCRINOL, V24, P114, DOI 10.1210/me.2009-0302
   SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A
   Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Siegelin MD, 2011, J CLIN INVEST, V121, P1349, DOI 10.1172/JCI44855
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Spiegelman BM, 2000, INT J OBESITY, V24, pS8, DOI 10.1038/sj.ijo.0801492
   Srinivasan V, 2010, AGING CELL, V9, P933, DOI 10.1111/j.1474-9726.2010.00622.x
   Srivastava S, 2007, HUM MOL GENET, V16, P993, DOI 10.1093/hmg/ddm045
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Suzuki H, 1998, BIOCHEM BIOPH RES CO, V249, P542, DOI 10.1006/bbrc.1998.9181
   Swerdlow RH, 2009, J ALZHEIMERS DIS, V17, P737, DOI 10.3233/JAD-2009-1095
   Taherzadeh-Fard E, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-32
   Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200
   Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026
   Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Vercauteren K, 2009, J BIOL CHEM, V284, P2307, DOI 10.1074/jbc.M806434200
   Verger A, 2006, MOL CELL BIOL, V26, P4882, DOI 10.1128/MCB.02402-05
   Wada T, 2009, TRENDS ENDOCRIN MET, V20, P273, DOI 10.1016/j.tem.2009.03.003
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WAN B, 1995, J BIOL CHEM, V270, P26433, DOI 10.1074/jbc.270.44.26433
   Wang H, 1997, BBA-GENE STRUCT EXPR, V1352, P325, DOI 10.1016/S0167-4781(97)00035-3
   Wang X, 2011, MOL ONCOL, V5, P399, DOI 10.1016/j.molonc.2011.07.008
   Watkins G, 2004, ONCOL REP, V12, P483
   Wenz T, 2010, J CELL MOL MED
   Wenz Tina, 2011, J Aging Res, V2011, P810619, DOI 10.4061/2011/810619
   Wenz T, 2009, IUBMB LIFE, V61, P1051, DOI 10.1002/iub.261
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
   Wojewoda M, 2011, INT J BIOCHEM CELL B, V43, P1178, DOI 10.1016/j.biocel.2011.04.011
   Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xiang ZM, 2011, J NEUROSCI, V31, P9544, DOI 10.1523/JNEUROSCI.1291-11.2011
   Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008
   Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104
   Zhang XT, 2001, J BIOL CHEM, V276, P47844, DOI 10.1074/jbc.M106285200
   Zhang Y, 2007, CELL RES, V17, P363, DOI 10.1038/cr.2007.11
   Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104
   Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556
   Zhao W, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-51
   Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059
   Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017
NR 213
TC 107
Z9 125
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JAN
PY 2012
VL 12
IS 1
SI SI
BP 86
EP 99
DI 10.1016/j.mito.2011.09.009
PG 14
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 895FS
UT WOS:000300482200011
PM 21983689
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Almeida, CM
   Rodrigues, E
   Campos, TA
   Vilarinho, L
   Teles, EL
AF Almeida, Catarina Maria
   Rodrigues, Esmeralda
   Campos, Teresa Almeida
   Vilarinho, Laura
   Teles, Elisa Leao
TI Novel MTO1 mutations associated with an intrafamilial phenotypic
   variability
SO EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS
LA English
DT Article
DE Mitochondrial disease; Mitochondrial translation optimization 1; Lactic
   acidosis
AB BackgroundMitochondrial diseases are a group of rare inborn metabolic disorders with multi-systemic manifestations. MTO1 gene mutations are associated with MTO1 (Mitochondrial tRNA Translation Optimization 1) protein deficiency, a mitochondrial disorder, which commonly presents with lactic acidosis and hypertrophic cardiomyopathy.Case presentationThe authors describe two siblings with mitochondrial cytopathy and distinct outcomes. The index case, a female born in 1989, presented hypotonia and lactic acidosis since birth. She developed a severe myoclonic encephalopathy, movement disorder and psychomotor and growth delay. Respiratory chain enzyme complex measurement in muscle revealed a partial deficiency of complex III and IV. Throughout the years she had multiple decompensations with severe acidemia and died at age of 16, due to a respiratory infection. She never presented cardiac alterations. The younger sibling, a male born in 2002, had a less severe clinical presentation. He presented hypotonia and lactic acidosis at birth. Metabolic study performed in the first days of life revealed elevated plasma alanine and hyperlactacidemia. At 8 months of age a partial deficiency of complex IV was reported. He had a mild persistent hyperlactacidemia, psychomotor development delay, generalized hypotonia, dilated cardiomyopathy and epilepsy. In 2017, at 15 years of age, a genetic study confirmed the mitochondrial disease with identification of two MTO1 likely pathogenic variants [c.413delT (p.M138Sfs*6) / c.1450C > T (p.R484W)]. Currently, he is clinically stable, maintaining a multidisciplinary follow up. The same genotype was confirmed in his sister's stored DNA.ConclusionsWith this case, report the authors emphasize mitochondrial diseases' phenotypic heterogeneity, even in the same family, and the significance of the new genetic diagnostic techniques. The authors also report a novel MTO1 likely pathogenic variant not described to date.
C1 [Almeida, Catarina Maria; Rodrigues, Esmeralda; Campos, Teresa Almeida; Teles, Elisa Leao] Ctr Hospitalar Univ Sao Joao, Reference Ctr Inherited Metab Dis, Serv Cardiol Pediat, Inborn Errors Metab Unit, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.
   [Almeida, Catarina Maria] Ctr Hospitalar Univ Sao Joao, Pediat Cardiol Dept, Porto, Portugal.
   [Vilarinho, Laura] Inst Nacl Saude Doutor Ricardo Jorge, Human Genet Dept, Lisbon, Portugal.
C3 Instituto Nacional de Saude Dr. Ricardo Jorge
RP Almeida, CM (corresponding author), Ctr Hospitalar Univ Sao Joao, Reference Ctr Inherited Metab Dis, Serv Cardiol Pediat, Inborn Errors Metab Unit, Alameda Prof Hernani Monteiro, P-4200319 Porto, Portugal.; Almeida, CM (corresponding author), Ctr Hospitalar Univ Sao Joao, Pediat Cardiol Dept, Porto, Portugal.
EM catarinalmeidalmeida@live.com.pt
OI Almeida, Catarina/0000-0001-6622-841X
CR Finsterer J, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/j.1600-0404.2012.01649.x
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Martín MA, 2017, CLIN GENET, V91, P46, DOI 10.1111/cge.12815
   O'Byrne JJ, 2018, MOL GENET METAB, V123, P28, DOI 10.1016/j.ymgme.2017.11.003
   Rahman S, 2020, J INTERN MED, V287, P609, DOI 10.1111/joim.13054
   Saudubray JM., 2016, Inborn Metabolic Diseases: Diagnosis and Treatment, V6th
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743
NR 8
TC 0
Z9 0
U1 1
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 1110-8630
EI 2090-2441
J9 EGYPTIAN J MED HUMAN
JI Egypt. J. Med. Human Genet.
PD JAN 20
PY 2023
VL 24
IS 1
AR 8
DI 10.1186/s43042-023-00387-0
PG 4
WC Genetics & Heredity
WE Emerging Sources Citation Index (ESCI)
SC Genetics & Heredity
GA 7W8JK
UT WOS:000913753500001
OA gold
DA 2024-11-01
ER

PT J
AU Baumgart, BR
   Gray, KL
   Woicke, J
   Bunch, RT
   Sanderson, TP
   Van Vleet, TR
AF Baumgart, Bethany R.
   Gray, Katherine L.
   Woicke, Jochen
   Bunch, Roderick T.
   Sanderson, Thomas P.
   Van Vleet, Terry R.
TI MicroRNA as biomarkers of mitochondrial toxicity
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE MicroRNA; Mitochondria; Toxicity; Drug safety
ID POTENTIAL BIOMARKERS; HUNTINGTONS-DISEASE; MESSENGER-RNAS; ROTENONE;
   PROTEIN; BRAIN; BIOGENESIS; EXPRESSION; TARGETS; LIVER
AB Mitochondrial toxicity can be difficult to detect as most cells can tolerate reduced activity as long as minimal capacity for function is maintained. However, once minimal capacity is lost, apoptosis or necrosis occurs quickly. Identification of more sensitive, early markers of mitochondrial toxicity was the objective of this work. Rotenone, a mitochondrial complex I inhibitor, and 3-nitropropionic acid (3-NP), a mitochondrial complex II inhibitor, were administered daily to male Sprague-Dawley rats at subcutaneous doses of 0.1 or 0.3 mg/kg/day and intraperitoneal doses of 5 or 10 mg/kg/day, respectively, for 1 week. Samples of kidney, skeletal muscle (quadriceps femoris), and serum were collected for analysis of mitochondrial DNA (mtDNA) copy number and microRNA (miRNA) expression patterns. MtDNA was significantly decreased with administration of rotenone at 03 mg/kg/day and 3-NP at 5 and 10 mg/kg/day in the quadriceps femoris and with 3-NP at 10 mg/kg/day in the kidney. Additionally, rotenone and 3-NP treatment produced changes to miRNA expression that were similar in direction (i.e. upregulation, downregulation) to those previously linked to mitochondrial functions, such as mitochondrial damage and biogenesis (miR-122, miR-202-3p); regulation of ATP synthesis, abolished oxidative phosphorylation, and loss of membrane potential due to increased reactive oxygen species (ROS) production (miR-338-5p, miR-546, miR-34c); and mitochondrial DNA damage and depletion (miR-546). These results suggest that miRNAs may be sensitive biomarkers for early detection of mitochondrial toxicity. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Baumgart, Bethany R.; Gray, Katherine L.; Bunch, Roderick T.; Sanderson, Thomas P.] Bristol Myers Squibb, Dept Toxicol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
   [Woicke, Jochen] Bristol Myers Squibb, Dept Pathol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
   [Van Vleet, Terry R.] Abbvie, Dept Investigat Toxicol & Pathol, 1 N Waukegan Rd, N Chicago, IL 60064 USA.
C3 Bristol-Myers Squibb; Bristol-Myers Squibb; AbbVie
RP Baumgart, BR (corresponding author), Bristol Myers Squibb, Dept Toxicol, Drug Safety Evaluat, 4401 Highway 62 East, Mt Vernon, IA 47620 USA.
EM bethany.baumgart@bms.com
CR Aschrafi A., 2012, LIFE SCI
   Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008
   Balasubramaniam S, 2012, JIMD REP, V5, P113, DOI 10.1007/8904_2011_107
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Binienda ZK, 2013, NEUROSCI LETT, V541, P233, DOI 10.1016/j.neulet.2013.02.047
   Borland MK, 2009, BBA-MOL BASIS DIS, V1792, P68, DOI 10.1016/j.bbadis.2008.09.014
   Brouillet Emmanuel, 2014, Curr Protoc Neurosci, V67, DOI 10.1002/0471142301.ns0948s67
   Brown AM, 2001, J MOL NEUROSCI, V16, P41, DOI 10.1385/JMN:16:1:41
   Brustoloni YM, 2007, MEM I OSWALDO CRUZ, V102, P497, DOI 10.1590/S0074-02762007005000036
   Burchard J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.58
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008
   Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013
   Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204
   Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12
   Gargalionis AN, 2013, CURR TOP MED CHEM, V13, P1493, DOI 10.2174/15680266113139990098
   Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7
   Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004
   Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001
   Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020
   Kumar P, 2011, BRIT J PHARMACOL, V164, P644, DOI 10.1111/j.1476-5381.2011.01418.x
   Lapointe Nicolas, 2004, FASEB J, V18, P717
   Lee WT, 2002, NEUROSCIENCE, V113, P699, DOI 10.1016/S0306-4522(02)00177-X
   Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553
   Miñones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210
   Mirandola SR, 2010, J NEUROSCI RES, V88, P630, DOI 10.1002/jnr.22239
   Mohamed JS, 2014, DIABETES, V63, P1546, DOI 10.2337/db13-1364
   Muniesa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093491
   Ohlenbusch A, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-69
   Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   Pereira CV, 2009, CURR DRUG SAF, V4, P34, DOI 10.2174/157488609787354440
   Pereira SP, 2009, ATLA-ALTERN LAB ANIM, V37, P355, DOI 10.1177/026119290903700406
   Picard M., 2013, AM J PHYSL REGUL INT, V304, pR393
   Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105
   Qiao C, 2011, GENE THER, V18, P403, DOI 10.1038/gt.2010.157
   Seyhan AA, 2015, MOL BIOSYST, V11, P1217, DOI 10.1039/c5mb00064e
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Suzuki Hiromu, 2013, Frontiers in Genetics, V4, P258, DOI 10.3389/fgene.2013.00258
   Tariq M, 2005, BRAIN RES BULL, V67, P161, DOI 10.1016/j.brainresbull.2005.06.024
   Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112
   Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68
   Verdejo HE, 2012, CURR HYPERTENS REP, V14, P532, DOI 10.1007/s11906-012-0305-4
   Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106
   Wang QF, 2014, CLIN CANCER RES, V20, P1146, DOI 10.1158/1078-0432.CCR-13-1023
   Watkins J, 2008, J PROTEOME RES, V7, P328, DOI 10.1021/pr070300g
   WEISS J, 1994, J CLIN MICROBIOL, V32, P1663, DOI 10.1128/JCM.32.7.1663-1668.1994
   White NMA, 2011, J UROLOGY, V186, P1077, DOI 10.1016/j.juro.2011.04.110
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Xiong N, 2012, CRIT REV TOXICOL, V42, P613, DOI 10.3109/10408444.2012.680431
   Yan YL, 2015, COMP BIOCHEM PHYS A, V183, P64, DOI 10.1016/j.cbpa.2014.12.011
   Yang Y, 2005, J NEUROSCI RES, V80, P440, DOI 10.1002/jnr.20467
   Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280
   Yu Zuoren, 2012, Frontiers in Genetics, V3, P191, DOI 10.3389/fgene.2012.00191
   Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85
   Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002
   Zhao Y., 2013, PLOS ONE, V8
NR 63
TC 10
Z9 10
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD DEC 1
PY 2016
VL 312
SI SI
BP 26
EP 33
DI 10.1016/j.taap.2015.10.007
PG 8
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA EE8JA
UT WOS:000389870300005
PM 26476301
DA 2024-11-01
ER

PT J
AU Valdivieso, AG
   Marcucci, F
   Taminelli, G
   Guerrico, AG
   Alvarez, S
   Teiber, ML
   Dankert, MA
   Santa-Coloma, TA
AF Valdivieso, Angel G.
   Marcucci, Florencia
   Taminelli, Guillermo
   Guerrico, Anatilde Gonzalez
   Alvarez, Sergio
   Teiber, Maria Luz
   Dankert, Marcelo A.
   Santa-Coloma, Tomas A.
TI The expression of the mitochondrial gene <i>MT-ND4</i> is downregulated
   in cystic fibrosis
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE mitochondria; mitochondrial expressed genes; cystic fibrosis; CFTR;
   MT-ND4; CFDE; glibenclamide; CFTR(inh)-172
ID DIFFERENTIAL DISPLAY; NADH DEHYDROGENASE; MESSENGER-RNA; CELLS;
   IDENTIFICATION; SKELETAL; CLONING; MUSCLE; CHAIN; DNA
AB Cystic fibrosis (CF) is a disease produced by mutations in the CFTR channel. We have previously reported that the CFTR chloride transport activity indirectly regulates the differential expression of several genes, including SRC and MUCI. Here we report that MTND4, a mitochondrial gene encoding a subunit of the mitochondrial Complex I (mtCx-1), is also a CFTR-dependent gene. A reduced expression of MT-ND4 was observed in CFDE cells (derived from a CF patient) when compared to CFDE cells ectopically expressing wild-type CFTR. The differential expression of MT-ND4 in CF was confirmed by RT-PCR. In situ hybridizations of deparaffinized human lung tissue slices derived from wt-CFTR or CF patients also showed downregulation of ND4 in CF. In addition, the CFTR chloride transport inhibitors glibenclamide and CFTR(inh)-172 also reduced MT-ND4 expression in CFDE cells ectopically expressing wt CFTR. These results suggest that the CFTR chloride transport activity indirectly up-regulates MT-ND4 expression. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina.
   Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1033 Buenos Aires, DF, Argentina.
   IIB Fdn Campomar, Buenos Aires, DF, Argentina.
   Pontificia Univ Catolica Argentina, Fac Ciencias Med, Programa Invest Biomed, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; Consejo Nacional de Investigaciones
   Cientificas y Tecnicas (CONICET); Leloir Institute; Pontificia
   Universidad Catolica Argentina
RP Santa-Coloma, TA (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, RA-1053 Buenos Aires, DF, Argentina.
EM tsantacoloma@gmail.com
RI Santa-Coloma, Tomas/I-1254-2019; Valdivieso, Ángel/AAP-3888-2020
OI Valdivieso, Angel Gabriel/0000-0002-7928-4880; Santa Coloma, Tomas
   Antonio/0000-0002-3266-1095
CR Cafferata EG, 1996, CELL MOL BIOL, V42, P797
   DECHECCHI MC, 1988, ENZYME, V40, P45, DOI 10.1159/000469141
   DEMEER K, 1995, THORAX, V50, P980, DOI 10.1136/thx.50.9.980
   DiMauro S, 1999, ITAL J NEUROL SCI, V20, P387
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   Gattermann N, 2004, NUCLEOS NUCLEOT NUCL, V23, P1275, DOI 10.1081/NCN-200027545
   González-Guerrico AM, 2002, J BIOL CHEM, V277, P17239, DOI 10.1074/jbc.M112456200
   Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8
   Lei DC, 1996, GENE THER, V3, P427
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LIANG P, 1993, NUCLEIC ACIDS RES, V21, P3269, DOI 10.1093/nar/21.14.3269
   Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   RIORDAN JR, 1989, SCIENCE, V245, P1066
   SHAPIRO BL, 1982, AM J HUM GENET, V34, P846
   SHAPIRO BL, 1989, LIFE SCI, V44, P1327, DOI 10.1016/0024-3205(89)90389-5
   SHAPIRO BL, 1988, LANCET, V2, P290
   SHAPIRO BL, 1979, P NATL ACAD SCI USA, V76, P2979, DOI 10.1073/pnas.76.6.2979
NR 18
TC 37
Z9 38
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD MAY 11
PY 2007
VL 356
IS 3
BP 805
EP 809
DI 10.1016/j.bbrc.2007.03.057
PG 5
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 157SJ
UT WOS:000245740900047
PM 17382898
OA Green Published
DA 2024-11-01
ER

PT J
AU Mercer, JR
AF Mercer, John R.
TI Mitochondrial bioenergetics and therapeutic intervention in
   cardiovascular disease
SO PHARMACOLOGY & THERAPEUTICS
LA English
DT Review
DE Vascular smooth muscle cell; Mitochondria; Energetic; Fluxomics; TALENS;
   Heteroplasmy
ID UBIQUITIN-PROTEASOME SYSTEM; SMOOTH-MUSCLE-CELLS; ACTIVATED
   PROTEIN-KINASE; ISCHEMIA-REPERFUSION INJURY; MTDNA COPY NUMBER;
   DNA-DAMAGE; ATHEROSCLEROTIC PLAQUE; INTRAPLAQUE HEMORRHAGE;
   ATAXIA-TELANGIECTASIA; RESPIRATORY-CHAIN
AB Cardiovascular disease remains the commonest form of mortality and morbidity in the Western World. It accounts for more deaths than the combined incidence of all cancers. There remains an urgency to identify and translate therapies to reduce the effects of this disease and its associated co-morbidities.
   Atherosclerotic disease accounts for over two thirds of all cardiovascular related deaths. Arterial vessel wall plaques rupture and cause death due to loss of integrity of the overlaying vascular smooth muscle cell (VSMC) cap. Although plaques contain a heterogeneous pool of different cell types, it is the VSMCs that by their nature are responsible for rupture. VSMC are the primary source of extracellular matrix and collagen and it has been suggested that loss of viability and vitality of these cells contributes to plaque vulnerability and rupture. While DNA damage has long been associated with atherosclerotic plaques only relatively recently has the contribution of mitochondrial DNA damage been suggested to play a role. The mitochondrial respiratory chain is a source of ATP that the cell requires for all its energetic functions but is also a source of free radicals that produce reactive species (RS). While these RS exacerbate DNA damage and attack lipids and proteins, it is the loss of ATP that may ultimately be more detrimental.
   Therapeutic intervention for mitochondria dysfunction is one route on alleviating this burden. Finding alternative sources of ATP synthesis by energetic reconfiguration may also provide a vital link in delaying the kinetics of plaque rupture. (C) 2013 Elsevier Inc. All rights reserved.
C1 Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland.
C3 University of Glasgow
RP Mercer, JR (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
EM john.mercer@glasgow.ac.uk
CR Adlam VJ, 2005, FASEB J, V19, P1088, DOI 10.1096/fj.05-3718com
   Amaral S, 2008, CURR DIABETES REV, V4, P46, DOI 10.2174/157339908783502398
   Bacman SR, 2007, METHOD CELL BIOL, V80, P503, DOI 10.1016/S0091-679X(06)80025-7
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106
   Bock H H, 2007, Handb Exp Pharmacol, P407
   Calise J, 2013, AM J PHYSIOL-HEART C, V304, pH337, DOI 10.1152/ajpheart.00604.2012
   Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206
   Cascante M, 2008, ESSAYS BIOCHEM, V45, P67, DOI 10.1042/BSE0450067
   Catalano D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-36
   Chan NC, 2011, AUTOPHAGY, V7, P771, DOI 10.4161/auto.7.7.15453
   Chan NN, 2001, J AM COLL CARDIOL, V38, P1814, DOI 10.1016/S0735-1097(01)01669-2
   Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107
   Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061
   Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212
   Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459
   Cochemé HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   D'Souza AD, 2013, MOL THER, V21, P42, DOI 10.1038/mt.2012.203
   Dandapani M, 2013, BIOCHEM SOC T, V41, P687, DOI 10.1042/BST20120351
   DAVIES MJ, 1985, BRIT HEART J, V53, P363
   de Grey ADNJ, 2002, EUR J BIOCHEM, V269, P1995, DOI 10.1046/j.1432-1033.2002.02866.x
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739
   Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196
   Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164
   Giorgi C., 2011, MITOCHONDRION
   Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334
   Graham D, 2009, HYPERTENSION, V54, P322, DOI 10.1161/HYPERTENSIONAHA.109.130351
   Gredilla Ricardo, 2010, J Aging Res, V2011, P257093, DOI 10.4061/2011/257093
   Grüning NM, 2011, CELL METAB, V14, P415, DOI 10.1016/j.cmet.2011.06.017
   Harrison CM, 2010, ENV HLTH PERSPECT, V119, P676
   Herrmann J, 2010, CARDIOVASC RES, V85, P291, DOI 10.1093/cvr/cvp333
   Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200
   Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/NMETH.2364, 10.1038/nmeth.2364]
   KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0
   Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007
   Launay N, 2013, BRAIN, V136, P891, DOI 10.1093/brain/aws370
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Levi F, 2009, EUR J CARDIOV PREV R, V16, P333, DOI 10.1097/HJR.0b013e328325d67d
   LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844
   Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002
   Manfred G, 1999, J BIOL CHEM, V274, P9386, DOI 10.1074/jbc.274.14.9386
   Marfella R, 2008, J GERONTOL A-BIOL, V63, P200, DOI 10.1093/gerona/63.2.200
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Matthews PM, 1997, ITAL J NEUROL SCI, V18, P341, DOI 10.1007/BF02048237
   Mercer J. R., 2011, FREE RADIC BIOL MED, DOI DOI 10.1016/J.FREERADBI0MED.2011.1011.1026
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moreno C, 2011, HYPERTENSION, V57, P614, DOI 10.1161/HYPERTENSIONAHA.110.163840
   Muratovska A, 2001, NUCLEIC ACIDS RES, V29, P1852, DOI 10.1093/nar/29.9.1852
   Murphy JL, 2008, BRAIN, V131, P2832, DOI 10.1093/brain/awn252
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Prime TA, 2012, FREE RADICAL BIO MED, V53, P544, DOI 10.1016/j.freeradbiomed.2012.05.033
   Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106
   Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062
   Ralser M, 2009, NAT BIOTECHNOL, V27, P604, DOI 10.1038/nbt0709-604
   Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009
   Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103
   Ross GF, 2003, BIOCONJUGATE CHEM, V14, P962, DOI 10.1021/bc034050f
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x
   Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333
   Shoubridge EA, 1997, HUM MOL GENET, V6, P2239, DOI 10.1093/hmg/6.13.2239
   Spelbrink JN, 1997, CURR GENET, V32, P115, DOI 10.1007/s002940050255
   Srivastava RAK, 2012, J LIPID RES, V53, P2490, DOI 10.1194/jlr.R025882
   Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727
   Suo Qi-Feng, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P610
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440
   Teng ZZ, 2012, ATHEROSCLEROSIS, V223, P321, DOI 10.1016/j.atherosclerosis.2012.06.015
   Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495
   Tosatol V, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00212
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18
   Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773
   Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9
   Weissig V, 2011, PHARM RES-DORDR, V28, P2657, DOI 10.1007/s11095-011-0556-9
   Winter G., 2012, ENV MICROBIOL
   Xu QA, 2010, J CELL MOL MED, V14, P2604, DOI 10.1111/j.1582-4934.2010.01179.x
   Yamano K, 2008, J BIOL CHEM, V283, P27325, DOI 10.1074/jbc.M805249200
   Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P1291, DOI 10.1161/ATVBAHA.110.218578
   Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5
NR 96
TC 22
Z9 24
U1 0
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7258
J9 PHARMACOL THERAPEUT
JI Pharmacol. Ther.
PD JAN
PY 2014
VL 141
IS 1
BP 13
EP 20
DI 10.1016/j.pharmthera.2013.07.011
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 290PY
UT WOS:000329772000002
PM 23911986
DA 2024-11-01
ER

PT J
AU Miller, DK
   Menezes, MJ
   Simons, C
   Riley, LG
   Cooper, ST
   Grimmond, SM
   Thorburn, DR
   Christodoulou, J
   Taft, RJ
AF Miller, David K.
   Menezes, Minal J.
   Simons, Cas
   Riley, Lisa G.
   Cooper, Sandra T.
   Grimmond, Sean M.
   Thorburn, David R.
   Christodoulou, John
   Taft, Ryan J.
TI Rapid Identification of a Novel Complex I <i>MT-ND3</i> m.10134C>A
   Mutation in a Leigh Syndrome Patient
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL-DNA MUTATION; ND3 GENE; DEFICIENCY; DISEASE
AB Leigh syndrome (LS) is a rare progressive multi-system neurodegenerative disorder, the genetics of which is frequently difficult to resolve. Rapid determination of the genetic etiology of LS in a 5-year-old girl facilitated inclusion in Edison Pharmaceutical's phase 2B clinical trial of EPI-743. SNP-arrays and high-coverage whole exome sequencing were performed on the proband, both parents and three unaffected siblings. Subsequent multi-tissue targeted high-depth mitochondrial sequencing was performed using custom long-range PCR amplicons. Tissue-specific mutant load was also assessed by qPCR. Complex I was interrogated by spectrophotometric enzyme assays and Western Blot. No putatively causal mutations were identified in nuclear-encoded genes. Analysis of low-coverage off-target mitochondrial reads revealed a previously unreported mitochondrial mutation in the proband in MT-ND3 (m.10134C>A, p.Q26K), a Complex I mitochondrial gene previously associated with LS. Targeted investigations demonstrated that this mutation was 1% heteroplasmic in the mother's blood and homoplasmic in the proband's blood, fibroblasts, liver and muscle. Enzyme assays revealed decreased Complex I activity. The identification of this novel LS MT-ND3 variant, the genomics of which was accomplished in less than 3.5 weeks, indicates that rapid genomic approaches may prove useful in time-sensitive cases with an unresolved genetic diagnosis.
C1 [Miller, David K.; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Gen, Inst Mol Biosci, St Lucia, Qld, Australia.
   [Menezes, Minal J.; Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia.
   [Menezes, Minal J.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Camperdown, NSW, Australia.
   [Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.
   [Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia.
   [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia.
   [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.
   [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Camperdown, NSW, Australia.
   [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Integrat Syst Biol, Washington, DC USA.
   [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA.
C3 University of Queensland; NSW Health; The Children's Hospital at
   Westmead; University of Sydney; University of Sydney; University of
   Queensland; NSW Health; The Children's Hospital at Westmead; University
   of Sydney; Royal Children's Hospital Melbourne; Murdoch Children's
   Research Institute; Royal Children's Hospital Melbourne; Murdoch
   Children's Research Institute; Victorian Clinical Genetics Services;
   University of Melbourne; University of Sydney; George Washington
   University; George Washington University
RP Christodoulou, J (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia.
EM john.christodoulou@health.nsw.gov.au; r.taft@uq.edu.au
RI Christodoulou, John/E-5866-2015; Grimmond, Sean/K-3246-2019; Taft,
   Ryan/B-2945-2010; Thorburn, David/G-6266-2013; Christodoulou,
   John/M-3628-2019; Simons, Cas/A-7905-2011; Grimmond, Sean/J-5304-2016
OI Christodoulou, John/0000-0002-8431-0641; Simons,
   Cas/0000-0003-3147-8042; Cooper, Sandra/0000-0002-7314-5097; thorburn,
   david/0000-0002-7725-9470; Grimmond, Sean/0000-0002-8102-7998; Taft,
   Ryan/0000-0003-4538-3343
FU Illumina Inc.; National Health and Medical Research Council of Australia
   (NHMRC) [1026891]; University of Queensland Foundation Research
   Excellence Award; Crane family; Perkins family
FX The authors thank Illumina Inc. for their support of this project, and
   the Queensland Center for Medical Genomics and the IMB Sequencing Core
   for their assistance. This research was supported by National Health and
   Medical Research Council of Australia (NHMRC) Project Grant 1026891, and
   a University of Queensland Foundation Research Excellence Award to RJT.
   MM is an Australian Mitochondrial Diseases Foundation (AMDF)
   Postgraduate Research Scholar. DRT is an NHMRC Principal Research
   Fellow. The authors thank Wendy Fagan for assistance with enzyme assays
   and are grateful to the Crane and Perkins families for their generous
   financial support. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Baertling F, 2013, J NEUROL NEUROSUR PS, P1
   Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688
   Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4
   Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6
   Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010
   Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565
   Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18
   Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Thorburn DR, 2003, GENEREVIEWS, P1
NR 20
TC 8
Z9 8
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 12
PY 2014
VL 9
IS 8
AR e104879
DI 10.1371/journal.pone.0104879
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AO3LJ
UT WOS:000341230400100
PM 25118196
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Gianotti, TF
   Sookoian, S
   Dieuzeide, G
   García, SI
   Gemma, C
   González, CD
   Pirola, CJ
AF Gianotti, Tomas F.
   Sookoian, Silvia
   Dieuzeide, Guillermo
   Garcia, Silvia I.
   Gemma, Carolina
   Gonzalez, Claudio D.
   Pirola, Carlos J.
TI A decreased mitochondrial DNA content is related to insulin resistance
   in adolescents
SO OBESITY
LA English
DT Article
ID REAL-TIME PCR; METABOLIC SYNDROME; DIABETES-MELLITUS; COACTIVATOR PGC-1;
   SKELETAL-MUSCLE; URIC-ACID; DISEASE; RISK; GENE; BIOGENESIS
AB The aim of this study was to investigate whether mitochondrial DNA ( mtDNA) content is associated with insulin resistance (IR) in a sample of adolescents with features of metabolic syndrome. We further studied the link between polymorphisms in three genes involved in mitochondrial biogenesis and the presence of deleted mtDNA and mtDNA content. Data and blood samples were collected from 175 adolescents out of a cross-sectional, population-based study of 934 high school students. On the basis of the median value of homeostasis model assessment of IR (HOMA-IR) of the whole sample (2.2), the population was divided into two groups: noninsulin resistance (NIR) and IR. mtDNA quantification using nuclear DNA (nDNA) as a reference was carried out using a real-time quantitative PCR method. Genotyping for peroxisome proliferator-activated receptor gamma. (PPAR-gamma) (pro12Ala), PPAR-gamma coactivator-1 alpha (PGC-1 alpha) (Gly482Ser), and Tfam (rs1937 and rs12247015) polymorphisms was performed by PCR-based restriction fragment length polymorphism. Long-extension PCR was performed to amplify the whole mitochondrial genome. The mtDNA/nDNA ratio was significantly lower in the IR group (median: 9.08, range: 68.94) in comparison with the NIR group (12.24, 71.92) (P < 0.03). Besides, the mtDNA/nDNA ratio was inversely correlated with HOMA (R: -0.18, P < 0.02), glucose (R: -0.21, P < 0.008), and uric acid (R: -0.18, P < 0.03). Genotypes for the PPAR-gamma, PGC-1 gamma, and Tfam variants were not associated with the mtDNA/nDNA ratio. Long-extension PCR did not show significant levels of mtDNA deletions. In conclusion, our findings indicate that reduced mtDNA content in peripheral leukocytes is associated with IR. This result seems not to be related with the previously mentioned variants in genes involved in the regulation of mitochondrial biogenesis.
C1 [Gianotti, Tomas F.; Sookoian, Silvia; Garcia, Silvia I.; Gemma, Carolina; Pirola, Carlos J.] Univ Buenos Aires, CONICET, Inst Med Res A Lanari, Mol Genet & Biol Complex Dis Dept, Ciudad Autonoma De Bueno, Argentina.
   [Gonzalez, Claudio D.] Univ Buenos Aires, Sch Med, Dept Pharmacol, Buenos Aires, DF, Argentina.
   [Dieuzeide, Guillermo] CAIDEM, Chacabuco, Argentina.
C3 Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET);
   University of Buenos Aires; University of Buenos Aires
RP Pirola, CJ (corresponding author), Univ Buenos Aires, CONICET, Inst Med Res A Lanari, Mol Genet & Biol Complex Dis Dept, Ciudad Autonoma De Bueno, Argentina.
EM pirola.carlos@lanari.fmed.uba.ar
RI Pirola, Carlos/H-2720-2019
OI Gonzalez, Claudio/0000-0002-3772-8850; Pirola, Carlos
   Jose/0000-0001-8234-4058; Gemma, Carolina/0000-0002-4890-9972; Fernandez
   Gianotti, Tomas/0000-0003-2569-9156
CR Alberio S, 2007, MITOCHONDRION, V7, P6, DOI 10.1016/j.mito.2006.11.010
   Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216
   Bai RK, 2004, ANN NY ACAD SCI, V1011, P304, DOI 10.1196/annals.1293.029
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052
   Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5
   Gemma C, 2006, OBESITY, V14, P2193, DOI 10.1038/oby.2006.257
   Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005
   Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   KAWASAKI ES, 1990, PCR PROTOCOLS GUIDE, V18, P146
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X
   Lee HK, 2005, ANN NY ACAD SCI, V1042, P1, DOI 10.1196/annals.1338.001
   Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7
   LEE J, 1995, AM J EPIDEMIOL, V142, P288, DOI 10.1093/oxfordjournals.aje.a117634
   Lee JW, 2007, HYPERTENS RES, V30, P5, DOI 10.1291/hypres.30.5
   Liang P, 1997, DIABETES, V46, P920, DOI 10.2337/diabetes.46.5.920
   Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002
   Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c
   Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200
   Porto PI, 2004, PEDIATR RES, V55, P836, DOI 10.1203/01.PDR.0000119367.21770.D7
   Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177
   Song J, 2001, DIABETES CARE, V24, P865, DOI 10.2337/diacare.24.5.865
   Sookoian S, 2005, AM J HYPERTENS, V18, P1271, DOI 10.1016/j.amjhyper.2005.04.014
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yen CJ, 1997, BIOCHEM BIOPH RES CO, V241, P270, DOI 10.1006/bbrc.1997.7798
NR 34
TC 62
Z9 68
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1930-7381
J9 OBESITY
JI Obesity
PD JUL
PY 2008
VL 16
IS 7
BP 1591
EP 1595
DI 10.1038/oby.2008.253
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 321RX
UT WOS:000257325300019
PM 18451773
DA 2024-11-01
ER

PT J
AU Whittaker, RG
   Turnbull, DM
AF Whittaker, R. G.
   Turnbull, D. M.
TI A diagnostic tattoo
SO CLINICAL GENETICS
LA English
DT Article
DE diagnosis; MERRF; mitochondrial disease
ID RAGGED-RED FIBERS; MITOCHONDRIAL TRNA(LYS); MYOCLONIC EPILEPSY;
   MUTATION; MERRF; GENE
AB The hallmarks of the myoclonic epilepsy with ragged red fibers (MERRF) syndrome are myoclonic epilepsy, ataxia and ragged red fibres detected on muscle biopsy. We present a case of a 25-year-old male who first presented to his general practitioner at the age of 22 years with myoclonic jerks affecting the arms and legs, fatigue and mild ataxia. He was found to carry an A > G transition at nucleotide 8344 in mitochondrial DNA. This mutation is the most common cause of the MERRF syndrome, found in more than 80% of affected patients. Our patient had the diagnosis tattooed on his arm, both out of frustration at how few people had heard of it, and as a way of accepting that his condition was a part of who he was. Although the MERRF syndrome is one of the more common forms of mitochondrial encephalomyopathy, with a prevalence estimated at between 0.25 and 0.39 per 100,000, it is still a rare disorder. We are always striving to increase the public's understanding of these important conditions. Our patient has perhaps helped more than most towards this aspiration.
C1 [Whittaker, R. G.; Turnbull, D. M.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
   [Whittaker, R. G.; Turnbull, D. M.] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK
RP Whittaker, RG (corresponding author), Newcastle Univ, Sch Med, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM r.whittaker@ncl.ac.uk
OI Whittaker, Roger/0000-0002-3403-0182
FU Wellcome Trust [074454] Funding Source: Medline
CR Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Ozawa M, 1997, MUSCLE NERVE, V20, P271, DOI 10.1002/(SICI)1097-4598(199703)20:3<271::AID-MUS2>3.0.CO;2-8
   Rossmanith W, 2003, ANN NEUROL, V54, P820, DOI 10.1002/ana.10753
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   SILVESTRI G, 1992, AM J HUM GENET, V51, P1213
NR 5
TC 5
Z9 5
U1 0
U2 9
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0009-9163
J9 CLIN GENET
JI Clin. Genet.
PD JAN
PY 2009
VL 75
IS 1
BP 37
EP 38
DI 10.1111/j.1399-0004.2008.01103.x
PG 2
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 389XP
UT WOS:000262129200004
PM 19128396
DA 2024-11-01
ER

PT J
AU Navarro-Hortal, MD
   Ramírez-Tortosa, CL
   Varela-López, A
   Romero-Márquez, JM
   Ochoa, JJ
   Ramírez-Tortosa, M
   Forbes-Hernández, TY
   Granados-Principal, S
   Battino, M
   Quiles, JL
AF Navarro-Hortal, Maria D.
   Ramirez-Tortosa, Cesar L.
   Varela-Lopez, Alfonso
   Romero-Marquez, Jose M.
   Ochoa, Julio J.
   Ramirez-Tortosa, MCarmen
   Forbes-Hernandez, Tamara Y.
   Granados-Principal, Sergio
   Battino, Maurizio
   Quiles, Jose L.
TI Heart Histopathology and Mitochondrial Ultrastructure in Aged Rats Fed
   for 24 Months on Different Unsaturated Fats (Virgin Olive Oil, Sunflower
   Oil or Fish Oil) and Affected by Different Longevity
SO NUTRIENTS
LA English
DT Article
DE aging; histology; inflammation; fibrosis; mitochondrial morphology;
   MUFA; PUFA; n-3; n-6
ID OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; ANTIOXIDANT CAPACITY;
   SKELETAL-MUSCLE; DNA DELETION; LIVER; ACIDS; SUPPLEMENTATION; LIFELONG;
   EXERCISE
AB Diet plays a decisive role in heart physiology, with lipids having especial importance in pathology prevention and development. This study aimed to investigate how dietary lipids varying in lipid profile (virgin olive oil, sunflower oil or fish oil) affected the heart of rats during aging. Heart histopathology, mitochondrial morphometry, and oxidative status were assessed. Typical histopathological features associated with aging, such as valvular lesions, endomyocardical hyperplasia, or papillary muscle calcification, were found at a low extent in all the experimental groups. The most relevant finding was that inflammation registered by fish oil group was lower compared to the other treatments. At the ultrastructural level, heart mitochondrial area, perimeter, and aspect ratio were higher in fish oil-fed rats than in those fed on sunflower oil. Concerning oxidative stress markers, there were differences only in coenzyme Q levels and catalase activity, lower in sunflower oil-fed animals compared with those fed on fish oil. In summary, dietary intake for a long period on dietary fats with different fatty acids profile led to differences in some aspects associated with the aging process at the heart. Fish oil seems to be the fat most protective of heart during aging.
C1 [Navarro-Hortal, Maria D.; Varela-Lopez, Alfonso; Romero-Marquez, Jose M.; Ochoa, Julio J.; Quiles, Jose L.] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Avda Conocimiento Sn, Granada 18100, Spain.
   [Ramirez-Tortosa, Cesar L.] Hosp San Cecilio Granada, UGC Anat Patol, Avda Conocimiento S-N, Granada 18100, Spain.
   [Ramirez-Tortosa, MCarmen] Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Avda Conocimiento Sn, Granada 18100, Spain.
   [Forbes-Hernandez, Tamara Y.; Battino, Maurizio] Univ Vigo, Dept Analyt & Food Chem, Nutr & Food Sci Grp, CITACA,CACTI, Vigo 36310, Spain.
   [Granados-Principal, Sergio] Hosp Univ Jaen, UGC Oncol Med, Ave Ejercito Espanol 10, Jaen 23007, Spain.
   [Granados-Principal, Sergio] Univ Granada, Ctr Genom & Oncol Res, Genyo, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain.
   [Battino, Maurizio] Univ Politecn Marche, Dipartimento Sci Clin Specialist Odontostomatol S, I-60131 Ancona, Italy.
   [Battino, Maurizio] Jiangsu Univ, Int Res Ctr Food Nutr & Safety, Zhenjiang 212013, Jiangsu, Peoples R China.
C3 University of Granada; University of Granada; Universidade de Vigo;
   Pfizer; University of Granada; Marche Polytechnic University; Jiangsu
   University
RP Quiles, JL (corresponding author), Univ Granada, Biomed Res Ctr, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Avda Conocimiento Sn, Granada 18100, Spain.
EM mdnavarro@ugr.es; cesarl.ramirez.sspa@juntadeandalucia.es;
   alvarela@ugr.es; josemanuelromeromarquez@gmail.com; jjoh@ugr.es;
   mramirez@ugr.es; tamaraforbe@gmail.com; sgranados@fibao.es;
   maurizio.battino@uvigo.es; jlquiles@ugr.es
RI Navarro-Hortal, María/AAB-9805-2019; Forbes Hernandez,
   Tamara/AAB-1872-2021; Battino, Maurizio/E-6103-2012; Ochoa,
   Julio/L-8733-2014; Quiles, Jose L./C-6911-2013; Varela-Lopez,
   Alfonso/F-8055-2016; Granados-Principal, Sergio/B-4987-2014; Romero
   Marquez, Jose Manuel/AAH-6806-2020; Ramirez-Tortosa, Cesar/F-2055-2016
OI Forbes Hernandez, Tamara/0000-0001-7021-9276; Battino,
   Maurizio/0000-0002-7250-1782; Ochoa, Julio/0000-0001-8976-6296; Quiles,
   Jose L./0000-0002-9048-9086; Navarro-Hortal, Maria
   D./0000-0002-6225-8379; Varela-Lopez, Alfonso/0000-0002-0504-5086;
   Granados-Principal, Sergio/0000-0001-8773-9489; Ramirez Tortosa, Maria
   Carmen/0000-0002-7999-0881; Romero Marquez, Jose
   Manuel/0000-0001-7033-969X; Ramirez-Tortosa, Cesar/0000-0002-3302-707X
FU Spanish Ministry of Education and Science [AGL2008-01057]; Government of
   Andalusia [AGR832]
FX This research was supported by R + D grants from the Spanish Ministry of
   Education and Science [AGL2008-01057] and the Government of Andalusia
   [AGR832]. Maria D. Navarro-Hortal and Jose M. Romero -Marquez are FPU
   fellow from the Spanish Ministry of EducaciOn y FormaciOn Profesional.
CR Aboulhoda BE, 2017, ANN ANAT, V214, P21, DOI 10.1016/j.aanat.2017.07.003
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Al-Okbi SY, 2018, J OLEO SCI, V67, P1551, DOI 10.5650/jos.ess18064
   Alvarado Garcia AM, 2014, Gerokomos, V25, P57, DOI DOI 10.4321/S1134-928X2014000200002
   Rincón-Cervera MA, 2016, NUTRITION, V32, P1254, DOI 10.1016/j.nut.2016.04.006
   [Anonymous], 2005, Diet, nutrition and the prevention of chronic diseases
   Beliveau P, 2015, COMPUT BIOL MED, V65, P103, DOI 10.1016/j.compbiomed.2015.07.027
   Chalmers S, 2016, J PHYSIOL-LONDON, V594, P4283, DOI 10.1113/JP271942
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Pedroza AAD, 2015, LIFE SCI, V137, P133, DOI 10.1016/j.lfs.2015.07.021
   Desnoyers M, 2018, CAN J PHYSIOL PHARM, V96, P916, DOI 10.1139/cjpp-2018-0043
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   El'darov CM, 2015, BIOCHEMISTRY-MOSCOW+, V80, P604, DOI 10.1134/S0006297915050132
   Fleischer S, 1979, Methods Enzymol, V55, P32
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   Halade GV, 2011, PHARMACOL RES, V63, P300, DOI 10.1016/j.phrs.2010.12.012
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Huet E, 2015, J PHYSIOL PHARMACOL, V66, P355
   Jahangir A, 2007, J APPL PHYSIOL, V103, P2120, DOI 10.1152/japplphysiol.00647.2007
   Kain V, 2018, AM J PHYSIOL-HEART C, V314, pH160, DOI 10.1152/ajpheart.00297.2017
   Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5
   Kim EJ, 2011, CARDIOL RES, V2, P127, DOI 10.4021/cr29w
   Kurz FT, 2017, ADV EXP MED BIOL, V982, P1, DOI 10.1007/978-3-319-55330-6_1
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Lewis D.J., 1992, PATHOBIOLOGY AGING R, V1
   Linton PJ, 2015, J MOL CELL CARDIOL, V83, P44, DOI 10.1016/j.yjmcc.2014.12.017
   Liu MY, 2016, HYPERTENSION, V68, P1245, DOI 10.1161/HYPERTENSIONAHA.116.07974
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mayyas F, 2018, NUTR METAB CARDIOVAS, V28, P592, DOI 10.1016/j.numecd.2018.02.012
   Naderi-Boldaji V, 2018, LIFE SCI, V209, P202, DOI 10.1016/j.lfs.2018.08.015
   Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024
   O'Connell TD, 2017, J MOL CELL CARDIOL, V103, P74, DOI 10.1016/j.yjmcc.2016.12.003
   Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Olgar Y, 2018, EXP GERONTOL, V110, P172, DOI 10.1016/j.exger.2018.06.012
   Orsavova J, 2015, INT J MOL SCI, V16, P12871, DOI 10.3390/ijms160612871
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2006, FREE RADICAL RES, V40, P199, DOI 10.1080/10715760500404805
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2001, J BIOENERG BIOMEMBR, V33, P127, DOI 10.1023/A:1010700515071
   Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004
   Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8
   Ramirez-Tortosa CL, 2020, J GERONTOL A-BIOL, V75, P442, DOI 10.1093/gerona/glz091
   Rasband W.S., 2012, ImageJ
   Reeves PG, 1997, J NUTR, V127, pS838
   Richard D, 2009, CELL MOL LIFE SCI, V66, P3277, DOI 10.1007/s00018-009-0085-4
   Roche E, 2014, J GERONTOL A-BIOL, V69, P934, DOI 10.1093/gerona/glt157
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Schwender F T, 2001, Heart, V86, pE8, DOI 10.1136/heart.86.3.e8
   Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Varela-Lopez A, 2018, J NUTR BIOCHEM, V52, P36, DOI 10.1016/j.jnutbio.2017.09.007
   Veno SK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071467
   Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417
   Wang YH, 2019, BBA-MOL BASIS DIS, V1865, P1853, DOI 10.1016/j.bbadis.2018.12.008
   Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095265
   World Health Organization, CARD DIS CVDS
NR 62
TC 10
Z9 10
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT
PY 2019
VL 11
IS 10
AR 2390
DI 10.3390/nu11102390
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA JP4HG
UT WOS:000498227300131
PM 31591312
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Quiles, JL
   Pamplona, R
   Ramirez-Tortosa, MC
   Naudí, A
   Portero-Otin, M
   Araujo-Nepomuceno, E
   López-Frías, M
   Battino, M
   Ochoa, JJ
AF Quiles, Jose L.
   Pamplona, Reinald
   Carmen Ramirez-Tortosa, M.
   Naudi, Alba
   Portero-Otin, Manuel
   Araujo-Nepomuceno, Eduardo
   Lopez-Frias, Magdalena
   Battino, Maurizio
   Ochoa, Julio J.
TI Coenzyme Q addition to an n-6 PUFA-rich diet resembles benefits on
   age-related mitochondrial DNA deletion and oxidative stress of a
   MUFA-rich diet in rat heart
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AIF; Carbonyls; Cytochrome c oxidase; Sunflower oil; Ubiquinone; Virgin
   olive oil
ID APOPTOSIS-INDUCING FACTOR; ELECTRON-TRANSPORT CHAIN; ACID (PUFA)-RICH
   DIET; DOUBLE-STRAND-BREAKS; LIFE-SPAN; CALORIC RESTRICTION;
   LIPID-PEROXIDATION; SKELETAL-MUSCLE; AGING HEART; FAT TYPE
AB Age-related changes in cardiomyocytes reduce the capacity to recover from acute injury or to adapt during chronic disease in advanced age N-6 polyunsaturated fatty acids (n-6PUFA) lead to higher lipid peroxidation during aging than the less oxidizable monosaturated fatty acids (MUFA); and coenzyme Q(CoQ)-supplemented n-6PUFA lengthens the lifespan and reduces peroxidation in comparison to non-supplemented n-6PUFA Here, lifelong feeding on MUFA, n-6PUFA, and n-6 PUFA + CoQ was compared regarding age-related alterations in rat heart. Less mitochondrial area and perimeter were reported for aged n-6 PUFA-fed animals while MUFA led to a higher density of mitochondrial cristae. Mitochondrial complexes and cyrochrome c oxidase activity decreased with aging (except complex I and cytochrome c oxidase in n-6 PUFA + CoQ), while increased apoptosis-inducing factor was found with aging MUFA led to lower mitochondrial DNA-deletion frequency.The lowest hydroperoxide levels for aged animals were found for n-6 PUFA + CoQ, which also showed lower concentrations than did n-6 PUFA. For protein oxidation, specific carbonyl compounds were lower in aged animals; meanwhile lipoxidation-derived protein-oxidation markers were higher The results suggest that MUFA can protect mitochondria from age-related changes, and that CoQ supplementation to n-6 PUFA partially resembles MUFA benefits. Moreover, under our experimental conditions, lipid-derived oxidative damage appears to be more important than the pure protein-derived oxidative damage during aging (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Quiles, Jose L.; Carmen Ramirez-Tortosa, M.; Araujo-Nepomuceno, Eduardo; Lopez-Frias, Magdalena; Ochoa, Julio J.] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, E-18071 Granada, Spain.
   [Quiles, Jose L.; Lopez-Frias, Magdalena; Ochoa, Julio J.] Univ Granada, Dept Physiol, E-18071 Granada, Spain.
   [Pamplona, Reinald; Naudi, Alba; Portero-Otin, Manuel] Univ Lleida, Dept Expt Med, Lleida, Spain.
   [Carmen Ramirez-Tortosa, M.] Univ Granada, Dept Biochem & Mol Biol 2, E-18071 Granada, Spain.
   [Battino, Maurizio] Polytech Univ Marche, Inst Biochem, Fac Med, Granada, Spain.
C3 University of Granada; University of Granada; Universitat de Lleida;
   University of Granada
RP Quiles, JL (corresponding author), Univ Granada, Inst Nutr & Tecnol Alimentos Jose Mataix Verdu, Ctr Invest Biomed, Parque Tecnol Ciencias Salud,Lab 120,Ave Conocimi, E-18071 Granada, Spain.
RI Lopez-frias, Magdalena/AAB-6832-2019; Portero-Otin, Manuel/B-7122-2009;
   Ochoa, Julio/L-8733-2014; Naudi, Alba/B-5594-2009; Battino,
   Maurizio/E-6103-2012; Quiles, Jose L./C-6911-2013; Pamplona,
   Reinald/A-7359-2010
OI Lopez Frias, Magdalena/0000-0002-8479-4658; Portero-Otin,
   Manuel/0000-0002-1823-0299; Ochoa, Julio/0000-0001-8976-6296; Naudi,
   Alba/0000-0003-0699-1004; Battino, Maurizio/0000-0002-7250-1782; Quiles,
   Jose L./0000-0002-9048-9086; Pamplona, Reinald/0000-0003-4337-6107
CR *AHA, 2007, HEART STROK STAT UPD
   AMICI A, 1989, J BIOL CHEM, V264, P3341
   [Anonymous], 2005, Dietary guidelines for Americans
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   BATTINO M, 1986, FEBS LETT, V199, P155, DOI 10.1016/0014-5793(86)80470-7
   Battino M, 2002, J BIOENERG BIOMEMBR, V34, P127, DOI 10.1023/A:1015128009826
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Choksi KB, 2008, FREE RADICAL BIO MED, V45, P826, DOI 10.1016/j.freeradbiomed.2008.06.006
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Fleischer S, 1979, Methods Enzymol, V55, P32
   Genova ML, 1999, BIOFACTORS, V9, P345, DOI 10.1002/biof.5520090234
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034
   Kukat A, 2009, EXP GERONTOL, V44, P101, DOI 10.1016/j.exger.2008.05.006
   Lakatta E G, 2001, Novartis Found Symp, V235, P172
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McMichael AJ, 2008, PUBLIC HEALTH NUTR, V11, P762, DOI 10.1017/S1368980008002358
   Miles MV, 2004, CLIN CHIM ACTA, V347, P139, DOI 10.1016/j.cccn.2004.04.003
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   MUSCARI C, 1993, MECH AGEING DEV, V67, P1, DOI 10.1016/0047-6374(93)90107-3
   NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357
   Ochoa JJ, 2005, J GERONTOL A-BIOL, V60, P970, DOI 10.1093/gerona/60.8.970
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614
   Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200
   Pamplona R, 2002, ANN NY ACAD SCI, V959, P475, DOI 10.1111/j.1749-6632.2002.tb02118.x
   Perez-Jimenez F, 2005, EUR J CLIN INVEST, V35, P421, DOI 10.1111/j.1365-2362.2005.01516.x
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2004, EXP GERONTOL, V39, P189, DOI 10.1016/j.exger.2003.10.002
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Quiles JL, 2005, BIOFACTORS, V25, P73, DOI 10.1002/biof.5520250109
   Rasband W.S., 2008, IMAGEJ
   Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582
   Sohal RS, 2007, MITOCHONDRION, V7, pS103, DOI 10.1016/j.mito.2007.03.006
   Sohal RS, 2006, FREE RADICAL BIO MED, V40, P480, DOI 10.1016/j.freeradbiomed.2005.08.037
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   van der Loo B, 2002, CIRCULATION, V105, P1635, DOI 10.1161/01.CIR.0000014986.29834.71
   VanTuyle GC, 1996, MUTAT RES-FUND MOL M, V349, P95, DOI 10.1016/0027-5107(95)00165-4
   Wessells RJ, 2007, SEMIN CELL DEV BIOL, V18, P111, DOI 10.1016/j.semcdb.2006.12.011
   Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002
NR 66
TC 41
Z9 42
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 2010
VL 131
IS 1
BP 38
EP 47
DI 10.1016/j.mad.2009.11.004
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 560ZU
UT WOS:000274945300006
PM 19948181
DA 2024-11-01
ER

PT S
AU Duchen, MR
   Szabadkai, G
AF Duchen, Michael R.
   Szabadkai, Gyorgy
BE Brown, GC
   Murphy, MP
TI Roles of mitochondria in human disease
SO ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION
SE Essays in Biochemistry
LA English
DT Review; Book Chapter
ID PERMEABILITY TRANSITION PORE; PANCREATIC BETA-CELLS; OXIDATIVE STRESS;
   DNA MUTATIONS; CYCLOPHILIN-D; NITRIC-OXIDE; PARKINSONS-DISEASE; MUSCLE
   APOPTOSIS; CANCER-CELLS; DOWN-REGULATION
AB The chapters throughout this volume illustrate the many contributions of mitochondria to the maintenance of normal cell and tissue function, experienced as the health of the individual. Mitochondria are essential for maintaining aspects of physiology as fundamental as cellular energy balance, the modulation of calcium signalling, in defining cellular redox balance, and they house significant biosynthetic pathways. Mitochondrial numbers and volume within cells are regulated and have an impact on their functional roles, while, especially in the CNS (central nervous system), mitochondrial trafficking is critical to ensure the cellular distribution and strategic localization of mitochondria, presumably driven by local energy demand. Maintenance of a healthy mitochondrial population involves a complex system of quality control, involving degrading misfolded proteins, while damaged mitochondria are renewed by fusion or removed by autophagy It seems evident that mechanisms that impair any of these processes will impair mitochondrial function and cell signalling pathways, leading to disordered cell function which manifests as disease. As gatekeepers of cell life and cell death, mitochondria regulate both apoptotic and necrotic cell death, and so at its most extreme, disturbances involving these pathways may trigger untimely cell death. Conversely, the lack of appropriate cell death can lead to inappropriate tissue growth and development of tumours, which are also characterized by altered mitochondrial metabolism. The centrality of mitochondrial dysfunction to a surprisingly wide range of major human diseases is slowly becoming recognized, bringing with it the prospect of novel therapeutic approaches to treat a multitude of unpleasant and pervasive diseases.
C1 [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England.
   UCL, Consortium Mitochondrial Res, London WC1E 6BT, England.
C3 University of London; University College London; University of London;
   University College London
RP Duchen, MR (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.
RI Duchen, Michael/A-2116-2009
OI Duchen, Michael/0000-0003-2548-4294; Szabadkai,
   Gyorgy/0000-0002-3006-3577
FU Medical Research Council [MC_G1000735, G0601943] Funding Source:
   Medline; Parkinson&apos;s UK [G-0905] Funding Source: Medline; Wellcome
   Trust [089698] Funding Source: Medline; MRC [G0601943, MC_G1000735]
   Funding Source: UKRI
CR Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017
   Anoopkumar-Dukie S, 2009, BRIT J RADIOL, V82, P847, DOI 10.1259/bjr/35746067
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200
   Beltrán B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602
   Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127
   Bernardi P, 2009, BRAIN, V132, DOI 10.1093/brain/awp021
   Bilsland LG, 2008, J NEUROCHEM, V107, P1271, DOI 10.1111/j.1471-4159.2008.05699.x
   Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017
   Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022
   Büeler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006
   Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001
   Campanella M, 2009, TRENDS BIOCHEM SCI, V34, P343, DOI 10.1016/j.tibs.2009.03.006
   Campanella M, 2009, BBA-BIOENERGETICS, V1787, P393, DOI 10.1016/j.bbabio.2009.02.023
   Casari G, 2001, CURR OPIN GENET DEV, V11, P336, DOI 10.1016/S0959-437X(00)00199-4
   Casley CS, 2002, NEUROBIOL DIS, V10, P258, DOI 10.1006/nbdi.2002.0516
   Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011
   Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006
   Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   Coppola D, 2008, CANCER-AM CANCER SOC, V113, P2665, DOI 10.1002/cncr.23892
   CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129
   Crichton PG, 2010, BIOSCIENCE REP, V30, P187, DOI 10.1042/BSR20090063
   Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8
   Da Cruz S, 2005, EXPERT REV PROTEOMIC, V2, P541, DOI 10.1586/14789450.2.4.541
   De Marchi U, 2009, BBA-BIOENERGETICS, V1787, P1425, DOI 10.1016/j.bbabio.2009.06.002
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   Deocaris C, 2008, BIOGERONTOLOGY, V9, P391, DOI 10.1007/s10522-008-9174-2
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006
   DUCHEN MR, 1993, CARDIOVASC RES, V27, P1790, DOI 10.1093/cvr/27.10.1790
   Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006
   Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104
   Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970
   Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104
   Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28
   Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598
   Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006
   Gogvadze V, 2009, APOPTOSIS, V14, P624, DOI 10.1007/s10495-009-0323-0
   Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2
   Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986
   Grover GJ, 2008, CARDIOVASC THER, V26, P287, DOI 10.1111/j.1755-5922.2008.00065.x
   Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Hicks D, 2009, BRAIN, V132, P147, DOI 10.1093/brain/awn289
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906
   Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052
   Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509
   Karbowski M, 2004, J CELL BIOL, V166, P1027, DOI 10.1083/jcb.200407046
   Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755
   Kim JS, 2008, HEPATOLOGY, V47, P1725, DOI 10.1002/hep.22187
   King A, 2009, CURR OPIN CELL BIOL, V21, P885, DOI 10.1016/j.ceb.2009.09.009
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011
   Lasorsa FM, 2003, J BIOL CHEM, V278, P38686, DOI 10.1074/jbc.M304988200
   Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007
   Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X
   Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.e02-06-0330
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255
   Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69
   Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006
   Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105
   Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Miller RA, 2005, SCIENCE, V310, P441, DOI 10.1126/science.310.5747.441
   Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108
   Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013
   Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327
   Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011
   NASS MMK, 1963, J CELL BIOL, V19, P593, DOI 10.1083/jcb.19.3.593
   Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409
   NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689
   Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P41271, DOI 10.1074/jbc.C400360200
   Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126
   Pan T, 2008, MED PHYS, V35, P4955, DOI 10.1118/1.2986145
   Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3
   Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993
   Rück A, 1998, FEBS LETT, V426, P97, DOI 10.1016/S0014-5793(98)00317-2
   Rugarli EI, 2006, TRENDS MOL MED, V12, P262, DOI 10.1016/j.molmed.2006.04.002
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Saldeen J, 2000, ENDOCRINOLOGY, V141, P2003, DOI 10.1210/endo.141.6.7523
   Santos C, 2008, CURR TOP MED CHEM, V8, P1351, DOI 10.2174/156802608786141151
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schapira AHV, 2007, CELL DEATH DIFFER, V14, P1261, DOI 10.1038/sj.cdd.4402160
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102
   Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015
   Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Suarez-Pinzon WL, 2003, DIABETES, V52, P1683, DOI 10.2337/diabetes.52.7.1683
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0
   Szabadkai G, 2009, APOPTOSIS, V14, P1405, DOI 10.1007/s10495-009-0363-5
   Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634
   Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122
   Taylor CT, 2010, ARTERIOSCL THROM VAS, V30, P643, DOI 10.1161/ATVBAHA.108.181628
   Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070
   THEAUTHORS J, 2010, SOCIETY
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Traba J, 2009, BIOCHEM J, V418, P125, DOI 10.1042/BJ20081262
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Wallace D.C., 2007, Emery and Rimoin's Principles and Practice of Medical Genetics, V5th, P194
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 2009, GENE DEV, V23, P1714, DOI 10.1101/gad.1784909
   WARBURG O, 1956, SCIENCE, V124, P269
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Wiederkehr A, 2008, CELL CALCIUM, V44, P64, DOI 10.1016/j.ceca.2007.11.004
   Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455
   Yaguchi T, 2007, ANN NY ACAD SCI, V1100, P306, DOI 10.1196/annals.1395.032
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
   Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270
   Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 151
TC 131
Z9 141
U1 0
U2 36
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FL, 90 HIGH HOLBORN, LONDON, WC1V 6LJ, ENGLAND
SN 0071-1365
EI 1744-1358
BN 978-1-85578-178-8
J9 ESSAYS BIOCHEM
JI Essays Biochem.
PY 2010
VL 47
BP 115
EP 137
DI 10.1042/BSE0470115
PG 23
WC Biochemistry & Molecular Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA BPO66
UT WOS:000279550900008
PM 20533904
DA 2024-11-01
ER

PT J
AU Naidu, S
   Bibat, G
   Lin, D
   Burger, P
   Barker, P
   Rosemberg, S
   Braverman, N
   Arroyo, H
   Dowling, M
   Hamosh, A
   Kimonis, V
   Blank, C
   Fiumara, A
   Facchini, S
   Singhal, B
   Moser, H
   Kelley, R
   DiMauro, S
AF Naidu, S
   Bibat, G
   Lin, D
   Burger, P
   Barker, P
   Rosemberg, S
   Braverman, N
   Arroyo, H
   Dowling, M
   Hamosh, A
   Kimonis, V
   Blank, C
   Fiumara, A
   Facchini, S
   Singhal, B
   Moser, H
   Kelley, R
   DiMauro, S
TI Progressive cavitating leukoencephalopathy: A novel childhood disease
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE NECROTIZING ENCEPHALOPATHY;
   HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; CHILDREN; ADRENOLEUKODYSTROPHY;
   SPECTROSCOPY; MUTATIONS; FEATURES; LESIONS; FORM
AB We report 19 patients with a previously undelineated neurodegenerative syndrome characterized by episodic acute onset of irritability or neurological deficits between 2 months and 3.5 years of age, followed by steady or intermittent clinical deterioration. Seven children died between 11 months and 14 years of age. Cranial magnetic resonance imaging (MRI) shows patchy leukoencephalopathy with cavities, and vascular permeability, in actively affected regions. Early lesions affect corpus callosum and centrum semiovale, with or without cerebellar or cord involvement. After repeated episodes, areas of tissue loss coalesce with older lesions to become larger cystic regions in brain or spinal cord. Diffuse spasticity, dementia, vegetative state, or death ensues. Gray matter is spared until late in the course. In some, incomplete clinical or MRI recovery occurs after episodes. The clinical course varies from rapid deterioration to prolonged periods of stability that are unpredictable by clinical or MRI changes. Elevated levels of lactate in brain, blood, and cerebrospinal fluid, abnormal urine organic acids, and changes in muscle respiratory chain enzymes are present but inconsistent, without identifiable mitochondrial DNA mutations or deletions. Pathological studies show severe loss of myelin sparing U-fibers, axonal disruption, and cavitary lesions without inflammation. Familial occurrence and consanguinity suggest autosomal recessive inheritance of this distinct entity.
C1 Kennedy Krieger Inst, Neurogenet Dept, Baltimore, MD 21205 USA.
   Johns Hopkins Med Inst, Dept Radiol, Baltimore, MD 21205 USA.
   Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.
   Univ Sao Paulo, Hosp Clin, Dept Pathol, Sao Paulo, Brazil.
   Johns Hopkins Med Inst, Inst Med Genet, Baltimore, MD 21205 USA.
   Hosp Pediat, Dept Neurol, Buenos Aires, DF, Argentina.
   Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA.
   Childrens Hosp, Dept Genet, Boston, MA 02115 USA.
   Gettysburg Pediat, Gettysburg, PA USA.
   Univ Catania, Pediat Clin, Dept Neurol, I-95124 Catania, Italy.
   Baylor Coll Med, Div Pediat Neurol, Houston, TX 77030 USA.
   Bombay Hosp & Med Res Ctr, Inst Med Sci, Med Res Ctr, Bombay, Maharashtra, India.
   Columbia Univ, Dept Neurol, New York, NY USA.
C3 Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins
   Medicine; Johns Hopkins University; Johns Hopkins Medicine; Universidade
   de Sao Paulo; Johns Hopkins University; Johns Hopkins Medicine;
   University of Buenos Aires; University of Texas System; University of
   Texas Southwestern Medical Center Dallas; University of Texas Dallas;
   Harvard University; Boston Children's Hospital; University of Catania;
   Baylor College of Medicine; Bombay Hospital & Medical Research Centre;
   Columbia University
RP Naidu, S (corresponding author), Kennedy Krieger Inst, Neurogenet Dept, 707 N Broadway,5th Floor Tower, Baltimore, MD 21205 USA.
EM naidu@kennedykrieger.org
RI Rosemberg, Sergio/F-4464-2012; Dowling, Michael/AAE-5263-2020; Fiumara,
   Agata/F-7200-2012
CR Bizzi A, 2001, AM J NEURORADIOL, V22, P1125
   Canavan M.M, 1931, NEUROLOGY, V15, P299
   deRecondo A, 1997, J NEUROL NEUROSUR PS, V63, P15, DOI 10.1136/jnnp.63.1.15
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9
   Golay X, 2002, MAGNET RESON MED, V47, P384, DOI 10.1002/mrm.10038
   Gorospe JR, 2004, NEUROLOGY, V62, P878, DOI 10.1212/01.WNL.0000115106.88813.5B
   Henneke M, 2005, NEUROLOGY, V64, P1411, DOI 10.1212/01.WNL.0000158472.82823.01
   Henter JI, 1997, J PEDIATR-US, V130, P358, DOI 10.1016/S0022-3476(97)70196-3
   Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308
   Johnson AB, 2003, J CHILD NEUROL, V18, P625, DOI 10.1177/08830738030180090901
   Kogawa K, 2002, BLOOD, V99, P61, DOI 10.1182/blood.V99.1.61
   Lim KE, 2003, CLIN IMAG, V27, P281, DOI 10.1016/S0899-7071(02)00552-1
   LOY TS, 1991, SEMIN ONCOL, V18, P34
   Mizuguchi M, 1997, BRAIN DEV-JPN, V19, P81, DOI 10.1016/S0387-7604(96)00063-0
   Neilson DE, 2004, ANN NEUROL, V55, P291, DOI 10.1002/ana.10849
   Pouwels PJW, 1998, NEUROPEDIATRICS, V29, P254, DOI 10.1055/s-2007-973571
   Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957
   Strauss KA, 2003, AM J MED GENET C, V121C, P38, DOI 10.1002/ajmg.c.20007
   TZIKA AA, 1993, RADIOLOGY, V189, P467, DOI 10.1148/radiology.189.2.8210375
   VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308
   zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076
NR 22
TC 27
Z9 28
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0364-5134
J9 ANN NEUROL
JI Ann. Neurol.
PD DEC
PY 2005
VL 58
IS 6
BP 929
EP 938
DI 10.1002/ana.20671
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 989WE
UT WOS:000233703900015
PM 16315274
OA Green Published
DA 2024-11-01
ER

PT J
AU Weber, TA
   Reichert, AS
AF Weber, Tobias A.
   Reichert, Andreas S.
TI Impaired quality control of mitochondria: Aging from a new perspective
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on Mitochondria in Aging and Age-related
   Disease
CY SEP 26-30, 2009
CL Les Diablerets, SWITZERLAND
DE Aging; Mitochondrial dysfunction; Fusion; Fission; Autophagy; Mitophagy;
   Sirtuins; Longevity; ROS
ID M-AAA PROTEASE; DOMINANT OPTIC ATROPHY; CALORIC RESTRICTION;
   SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; LIFE-SPAN; SKELETAL-MUSCLE;
   CELL-SURVIVAL; POINT MUTATIONS; DNA MUTATIONS
AB Mitochondria fulfill a number of essential cellular functions and play a key role in the aging process. Reactive oxygen species (ROS) are predominantly generated in this organelle but next to inducing oxidative damage they act as signaling molecules. Autophagy is regulated by signaling ROS and is known to affect aging as well as neurodegenerative diseases. Many cellular components that influence autophagy are linked to longevity such as members of the sirtuin protein family. Recent studies further link mitochondrial dynamics to the removal of dysfunctional mitochondria by mitophagy, thereby representing a novel mechanism for the quality control of mitochondria. Here we summarize the current views on how mitochondrial function is linked to aging and we propose that quality control of mitochondria has a crucial role in counteracting the aging process. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Weber, Tobias A.; Reichert, Andreas S.] Goethe Univ Frankfurt, CEF Makromol Komplexe, Fachbereich Med, D-60590 Frankfurt, Germany.
C3 Goethe University Frankfurt
RP Reichert, AS (corresponding author), Goethe Univ Frankfurt, CEF Makromol Komplexe, Fachbereich Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM reichert@zbc.kgu.de
RI Reichert, Andreas/A-4090-2012
OI Reichert, Andreas/0000-0001-9340-3113
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   Amr S, 2007, AM J HUM GENET, V81, P673, DOI 10.1086/520961
   Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011
   Banks WA, 2003, J CLIN ENDOCR METAB, V88, P1234, DOI 10.1210/jc.2002-021695
   Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017
   Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303
   Brigelius-Flohé R, 2009, GENES NUTR, V4, P161, DOI 10.1007/s12263-009-0131-8
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Cherra SJ, 2009, AUTOPHAGY, V5, P1213, DOI 10.4161/auto.5.8.10050
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Crighton D, 2007, CELL DEATH DIFFER, V14, P1071, DOI 10.1038/sj.cdd.4402108
   Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200
   Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1
   Dhahbi JM, 2001, MECH AGEING DEV, V122, P1033, DOI 10.1016/S0047-6374(01)00230-5
   Díaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555
   Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Efeyan A, 2007, CELL CYCLE, V6, P1006, DOI 10.4161/cc.6.9.4211
   Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084
   Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975
   Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Finlan LE, 2007, CELL CYCLE, V6, P1062, DOI 10.4161/cc.6.9.4162
   FLEMING JE, 1992, MUTAT RES, V275, P267, DOI 10.1016/0921-8734(92)90031-J
   Fontana L, 2010, AGE, V32, P97, DOI 10.1007/s11357-009-9118-z
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060
   Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012
   Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083
   Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022
   Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907
   Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145
   Juhász G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124
   Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445
   Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kirkwood TBL, 2000, ANN NY ACAD SCI, V908, P14
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Levrero M, 2000, J CELL SCI, V113, P1661
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708
   Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200
   Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045
   Morley JE, 2010, CURR OPIN CLIN NUTR, V13, P40, DOI 10.1097/MCO.0b013e3283331384
   Morselli E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.8
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167
   Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200
   Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233
   Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7
   Osiewacz HD, 2006, FREE RADICAL RES, V40, P1350, DOI 10.1080/10715760600921153
   Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05
   Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257
   Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Schäfer A, 2009, BIOL CHEM, V390, P707, DOI 10.1515/BC.2009.086
   Schatz G, 2007, ANNU REV BIOCHEM, V76, P673, DOI 10.1146/annurev.biochem.76.060806.091141
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Sesti F, 2010, TRENDS CELL BIOL, V20, P45, DOI 10.1016/j.tcb.2009.09.008
   Shanley DP, 2006, BIOGERONTOLOGY, V7, P165, DOI 10.1007/s10522-006-9006-1
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Skulachev VP, 2004, MOL CELL BIOCHEM, V256, P341, DOI 10.1023/B:MCBI.0000009880.94044.49
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Sommer M, 2006, CELL CYCLE, V5, P2005, DOI 10.4161/cc.5.17.3194
   Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110
   Steglich G, 1999, MOL CELL BIOL, V19, P3435
   Stewart JD, 2008, NEUROLOGY, V71, P1829, DOI 10.1212/01.wnl.0000335931.54095.0a
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200
   Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730
   TERAMOTO M, 2009, J SCI MED SPORT
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016
   Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065
   Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009
   Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351
   Wohlgemuth SE, 2010, EXP GERONTOL, V45, P138, DOI 10.1016/j.exger.2009.11.002
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
   Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105
   Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200
   Züchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341
NR 166
TC 97
Z9 104
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUL-AUG
PY 2010
VL 45
IS 7-8
SI SI
BP 503
EP 511
DI 10.1016/j.exger.2010.03.018
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Geriatrics & Gerontology
GA 619EU
UT WOS:000279412800006
PM 20451598
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Inbar-Feigenberg, M
   Blaser, S
   Hawkins, C
   Shannon, P
   Hewson, S
   Chitayat, D
AF Inbar-Feigenberg, Michal
   Blaser, Susan
   Hawkins, Cynthia
   Shannon, Patrick
   Hewson, Stacy
   Chitayat, David
TI Mitochondrial POLG related disorder presenting prenatally with fetal
   cerebellar growth arrest
SO METABOLIC BRAIN DISEASE
LA English
DT Article
DE Mitochondrial disorder; Polymerase gamma (POLG1) gene; POLG related
   disorders; Cerebellar growth arrest; Prenatal diagnosis; MRI; Fetal
ID RECESSIVE ATAXIA; MUTATIONS; DISEASE
AB We report the prenatal findings of severe cerebellar growth arrest in two siblings with POLG1 mutations. The first presented with seizures and lactic acidosis immediately after premature birth and was diagnosed with mitochondrial disease on muscle biopsy. Molecular DNA analysis confirmed homozygous missense mutation in the POLG1 gene. The pregnancy of the second sibling was monitored closely by repeat fetal ultrasounds since the parents declined invasive testing. A detailed fetal ultrasound at 19 weeks gestation showed a small cerebellum with transcerebellar diameter (TCD) on axial cranial imaging, measuring below the 5th centile for gestational age. Molecular analysis confirmed the same homozygous familial mutation in the POLG1gene. This report further delineates the phenotypic features of the POLG related disorders and expands it to the prenatal era. Subsequent pregnancies were monitored by molecular analysis, using chorionic villus sampling (CVS).
C1 [Inbar-Feigenberg, Michal; Hewson, Stacy; Chitayat, David] Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON, Canada.
   [Blaser, Susan] Univ Toronto, Hosp Sick Children, Div Neuroradiol, Dept Diagnost Imaging, Toronto, ON, Canada.
   [Hawkins, Cynthia] Univ Toronto, Hosp Sick Children, Div Neuropathol, Dept Paediat Lab Med, Toronto, ON, Canada.
   [Shannon, Patrick] Univ Toronto, Mt Sinai Hosp, Div Neuropathol, Dept Pathol & Lab Med, Toronto, ON, Canada.
   [Chitayat, David] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynecol, Prenatal Diag & Med Genet Program, Toronto, ON, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; Hospital for Sick Children (SickKids); University of
   Toronto; Hospital for Sick Children (SickKids); University of Toronto;
   Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute;
   University of Toronto; Sinai Health System Toronto; Lunenfeld Tanenbaum
   Research Institute
RP Inbar-Feigenberg, M (corresponding author), Univ Toronto, Hosp Sick Children, Div Clin & Metab Genet, Dept Paediat, Toronto, ON, Canada.
EM michal.inbar-feigenberg@sickkids.ca
RI Hawkins, Cynthia/M-2571-2019; Inbar-Feigenberg, Michal/AAS-3187-2021
OI /0000-0001-8128-5789
CR Cagnoli C, 2008, J NEUROL, V255, P1079, DOI 10.1007/s00415-008-0772-3
   Cohen BH, 2014, POLG RELATED DISORDE
   Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002
   Giordano C, 2009, NEUROLOGY, V72, P1103, DOI 10.1212/01.wnl.0000345002.47396.e1
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Klinghorn KJ, 2013, J NEUROL, V260, P3
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mehta AR, 2011, MOVEMENT DISORD, V26, P753, DOI 10.1002/mds.23510
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Poretti Andrea, 2015, Cerebellum Ataxias, V2, P8, DOI 10.1186/s40673-015-0027-x
   Saneto RP, 2010, DEV DISABIL RES REV, V16, P163, DOI 10.1002/ddrr.105
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222
   Tzoulis C, 2010, BRAIN, V133, P1428, DOI 10.1093/brain/awq067
NR 15
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0885-7490
EI 1573-7365
J9 METAB BRAIN DIS
JI Metab. Brain Dis.
PD AUG
PY 2018
VL 33
IS 4
BP 1369
EP 1373
DI 10.1007/s11011-018-0218-2
PG 5
WC Endocrinology & Metabolism; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA GL7QG
UT WOS:000437396300036
PM 29574624
DA 2024-11-01
ER

PT J
AU Hoefs, SJG
   van Spronsen, FJ
   Lenssen, EWH
   Nijtmans, LG
   Rodenburg, RJ
   Smeitink, JAM
   van den Heuvel, LP
AF Hoefs, Saskia J. G.
   van Spronsen, Francjan J.
   Lenssen, Ellen W. H.
   Nijtmans, Leo G.
   Rodenburg, Richard J.
   Smeitink, Jan A. M.
   van den Heuvel, Lambert P.
TI <i>NDUFA10</i> mutations cause complex I deficiency in a patient with
   Leigh disease
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
DE complex I deficiency; NDUFA10 gene; Leigh syndrome
ID MITOCHONDRIAL COMPLEX; UBIQUINONE OXIDOREDUCTASE;
   OXIDATIVE-PHOSPHORYLATION; GENE; NADH; IDENTIFICATION; PATHOLOGY;
   SUBUNITS; ELECTROPHORESIS; SUBCOMPLEXES
AB Mitochondrial complex I deficiency is the most common defect of the oxidative phosphorylation system. We report a patient with Leigh syndrome who showed a complex I deficiency expressed in cultured fibroblasts and muscle tissue. To find the genetic cause of the complex I deficiency, we screened the mitochondrial DNA and the nuclear-encoded subunits of complex I. We identified compound-heterozygous mutations in the NDUFA10 gene, encoding an accessory subunit of complex I. The first mutation disrupted the start codon and the second mutation resulted in an amino acid substitution. The fibroblasts of the patient displayed decreased amount and activity, and a disturbed assembly of complex I. These results indicate that NDUFA10 is a novel candidate gene to screen for disease-causing mutations in patients with complex I deficiency. European Journal of Human Genetics (2011) 19, 270-274; doi:10.1038/ejhg.2010.204; published online 8 December 2010
C1 [Hoefs, Saskia J. G.; Lenssen, Ellen W. H.; Nijtmans, Leo G.; Rodenburg, Richard J.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, NL-6500 HB Nijmegen, Netherlands.
   [van Spronsen, Francjan J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat, Groningen, Netherlands.
   [van den Heuvel, Lambert P.] Catholic Univ Louvain, Dept Pediat, B-3000 Louvain, Belgium.
C3 Radboud University Nijmegen; University of Groningen; Universite
   Catholique Louvain
RP van den Heuvel, LP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Paediat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM B.vandenHeuvel@cukz.umcn.nl
RI Nijtmans, L.G.J./L-4549-2015; Smeitink, Jan/C-1351-2013; van den Heuvel,
   Lambertus/AAM-1772-2021; Rodenburg, Richard/N-3579-2014
OI Rodenburg, Richard/0000-0001-5227-3527
FU European Community [LSHM-CT-2004-005260]
FX This work was supported by the European Community's sixth Framework
   Program for Research, Priority 1 'Life sciences, genomics and
   biotechnology for health', contract number LSHM-CT-2004-005260
   (MITOCIRCLE).
CR Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   CHEN S, 1984, J BIOL CHEM, V259, P5124
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   FINEL M, 1992, BIOCHEMISTRY-US, V31, P11425, DOI 10.1021/bi00161a022
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   Hoefs SJG, 2010, MOL GENET METAB, V100, P251, DOI 10.1016/j.ymgme.2010.03.015
   Hoefs SJG, 2009, HUM MUTAT, V30, pE728, DOI 10.1002/humu.21037
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Lazarou M, 2007, MOL CELL BIOL, V27, P4228, DOI 10.1128/MCB.00074-07
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Sazanov LA, 2000, BIOCHEMISTRY-US, V39, P7229, DOI 10.1021/bi000335t
   Schilling B, 2005, FEBS LETT, V579, P2485, DOI 10.1016/j.febslet.2005.03.061
   Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   Yamaguchi M, 2000, EUR J BIOCHEM, V267, P329, DOI 10.1046/j.1432-1327.2000.00999.x
NR 34
TC 63
Z9 71
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAR
PY 2011
VL 19
IS 3
BP 270
EP 274
DI 10.1038/ejhg.2010.204
PG 5
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 722PA
UT WOS:000287445600010
PM 21150889
OA Green Submitted, Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Saneto, RP
   Naviaux, RK
AF Saneto, Russell P.
   Naviaux, Robert K.
TI POLYMERASE GAMMA DISEASE THROUGH THE AGES
SO DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS
LA English
DT Review
DE polymerase gamma; mitochondrial disease; gene mutation; DNA; genetic
   inheritance; POLG spectrum disorders
ID MITOCHONDRIAL-DNA POLYMERASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   SENSORY ATAXIC NEUROPATHY; ALPERS-HUTTENLOCHER-SYNDROME; POLG MUTATIONS;
   NEURONAL DEGENERATION; AUTOSOMAL-DOMINANT; W748S MUTATION;
   REVERSE-TRANSCRIPTASE; GENETIC FEATURES
AB The most common group of mitochondrial disease is due to mutations within the mitochondrial DNA polymerase, polymerase gamma 1 (POLG). This gene product is responsible for replication and repair of the small mitochondrial DNA genome. The structure-function relationship of this gene product produces a wide variety of diseases that at times, seems to defy the common perceptions of genetics. The unique features of mitochondrial physiology are in part responsible, but POLG structure and function add to the conundrum of how one gene product can demonstrate autosomal recessive and autosomal dominant transmission, while also being responsible for pharmacogenetic disease, and exhibiting strong gene-environment interactions. The wide spectrum of clinical manifestations of POLG disease can arise from infancy to old age. The modulation of clinical findings relate in part to the molecular architecture of the POLG protein. POLG has three distinct molecular domains: exonuclease, linker, and polymerase domains. Most of the mutations leading to dominant forms of POLG disease are located in the Polymerase domain. Mutations leading to recessive inheritance are distributed in all three domains of the gene. Environmental factors like valproic acid and infection can unmask POLG disease, causing it to occur earlier in life than when not exposed to these factors. Other drugs like nucleoside reverse transcriptase inhibitors can produce genotype-specific POLG pharmacogenetic disease. Our current state of POLG understanding cannot account for many features of POLG disease. There is no answer for why the same mutation can give rise to varying diseases, disease severity, and age of onset. We introduce the term Ecogenetics in the context these features of POLG disease, to emphasize the important interactions between genes and environment in determining the expression of mitochondrial disease. In this article, we identify some of the key features that will help the reader understand POLG pathophysiology. When possible, we also identify genotype-phenotype relationships, give clues for diagnosis, and summarize the major clinical phenotypes in the spectrum of POLG disease presenting from birth to old age. (C) 2010 Wiley-Liss, Inc. Dev Disabil Res Rev 2010;16:163-174.
C1 [Saneto, Russell P.] Univ Washington, Seattle Children Hosp, Div Pediat Neurol, Seattle, WA 98105 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Naviaux, Robert K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
C3 Seattle Children's Hospital; University of Washington; University of
   Washington Seattle; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego
RP Saneto, RP (corresponding author), Univ Washington, Seattle Children Hosp, Div Pediat Neurol, Mail Stop B-5552,4800 Sand Point Way NE, Seattle, WA 98105 USA.
EM russ.saneto@seattlechildrens.org
CR Aitken H, 2009, NEUROLOGY, V72, pE86, DOI 10.1212/WNL.0b013e3181a411b8
   Aknin-Seifer IE, 2005, HUM REPROD, V20, P736, DOI 10.1093/humrep/deh666
   Alpers BJ, 1931, ARCH NEURO PSYCHIATR, V25, P469, DOI 10.1001/archneurpsyc.1931.02230030027002
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08
   BICKNESE AR, 1992, ANN NEUROL, V32, P767, DOI 10.1002/ana.410320610
   BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480
   Blok MJ, 2009, J MED GENET, V46, P776, DOI 10.1136/jmg.2009.067686
   BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0
   BOLDEN A, 1977, J BIOL CHEM, V252, P3351
   Brown TA, 2005, GENE DEV, V19, P2466, DOI 10.1101/gad.1352105
   Brusco A, 2006, J ENDOCRINOL INVEST, V29, P1
   Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776
   Chan SSL, 2006, HUM MOL GENET, V15, P3473, DOI 10.1093/hmg/ddl424
   Chan SSL, 2009, BBA-BIOENERGETICS, V1787, P312, DOI 10.1016/j.bbabio.2008.10.007
   Chan SSL, 2005, DNA REPAIR, V4, P1381, DOI 10.1016/j.dnarep.2005.08.010
   Chan SSL, 2005, J BIOL CHEM, V280, P31341, DOI 10.1074/jbc.M506762200
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   CHINNERY PF, 2007, NEUROMUSCULAR DISORD, V18, P259
   Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Deschauer M, 2007, NEUROLOGY, V68, P1741, DOI 10.1212/01.wnl.0000261929.92478.3e
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Fadic R, 1997, NEUROLOGY, V49, P239, DOI 10.1212/WNL.49.1.239
   Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   GALLO RC, 1971, ACTA HAEMATOL-BASEL, V45, P136, DOI 10.1159/000208619
   González-Vioque E, 2006, ARCH NEUROL-CHICAGO, V63, P107, DOI 10.1001/archneur.63.1.107
   Gramstad A, 2009, EPILEPSY BEHAV, V16, P172, DOI 10.1016/j.yebeh.2009.01.014
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Harrower T, 2008, ARCH NEUROL-CHICAGO, V65, P133, DOI 10.1001/archneurol.2007.4
   HERSKOWITZ A, 1992, ANN INTERN MED, V116, P311, DOI 10.7326/0003-4819-116-4-311
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672
   Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007
   Horvath R, 2006, BRAIN, V129, P1674, DOI 10.1093/brain/awl088
   Hudson G, 2006, NEUROLOGY, V66, P1439, DOI 10.1212/01.wnl.0000210486.32196.24
   Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233
   Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038
   Johnson AA, 2001, J BIOL CHEM, V276, P38097
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3
   KALF GF, 1968, J BIOL CHEM, V243, P4904
   Kasiviswanathan R, 2009, J BIOL CHEM, V284, P19501, DOI 10.1074/jbc.M109.011940
   Kollberg G, 2005, EUR J HUM GENET, V13, P463, DOI 10.1038/sj.ejhg.5201341
   Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e
   Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008
   Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278
   Lecrenier N, 1997, GENE, V185, P147, DOI 10.1016/S0378-1119(96)00663-4
   LEE HR, 2006, J BIOL CHEM, V276, P38090
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lim SE, 2003, J MOL BIOL, V329, P45, DOI 10.1016/S0022-2836(03)00405-4
   Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3
   Luoma PT, 2007, NEUROLOGY, V69, P1152, DOI 10.1212/01.wnl.0000276955.23735.eb
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Malyarchuk BA, 2005, HUM BIOL, V77, P355, DOI 10.1353/hub.2005.0050
   MEYER RR, 1968, P NATL ACAD SCI USA, V61, P130, DOI 10.1073/pnas.61.1.130
   Milone M, 2008, NEUROMUSCULAR DISORD, V18, P626, DOI 10.1016/j.nmd.2008.05.009
   Murakami E, 2003, J BIOL CHEM, V278, P36403, DOI 10.1074/jbc.M306236200
   Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   Naviaux RK, 1996, ANN NEUROL, V40, P29
   Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026
   Nowak R, 2005, ANN ONCOL, V16, P1211, DOI 10.1093/annonc/mdi205
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200
   RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402
   ROBBERSON DL, 1972, P NATL ACAD SCI USA, V69, P737, DOI 10.1073/pnas.69.3.737
   Ropp PA, 1996, GENOMICS, V36, P449, DOI 10.1006/geno.1996.0490
   Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759
   Rubio-Gozalbo ME, 2000, HUM MUTAT, V15, P522, DOI 10.1002/1098-1004(200006)15:6<522::AID-HUMU4>3.0.CO;2-Y
   Sanderson S, 2006, ARCH DIS CHILD, V91, P896, DOI 10.1136/adc.2005.091637
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Scaglia F, 2001, J CHILD NEUROL, V16, P136, DOI 10.1177/088307380101600214
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001
   Spelbrink JN, 2000, J BIOL CHEM, V275, P24818, DOI 10.1074/jbc.M000559200
   Spinazzola A, 2009, J INTERN MED, V265, P174, DOI 10.1111/j.1365-2796.2008.02059.x
   Stewart JD, 2009, J MED GENET, V46, P209, DOI 10.1136/jmg.2008.058180
   Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244
   Taanman JW, 2009, HUM MUTAT, V30, P248, DOI 10.1002/humu.20852
   Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380
   TULINIUS MH, 1991, J PEDIATR-US, V119, P242, DOI 10.1016/S0022-3476(05)80734-6
   TULINIUS MH, 1991, BRAIN DEV-JPN, V13, P167, DOI 10.1016/S0387-7604(12)80024-6
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Ulmer S, 2002, J COMPUT ASSIST TOMO, V26, P641, DOI 10.1097/00004728-200207000-00030
   Uusimaa J, 2008, EPILEPSIA, V49, P1038, DOI 10.1111/j.1528-1167.2008.01544.x
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Van Goethem G, 2003, NEUROLOGY, V61, P1811, DOI 10.1212/01.WNL.0000098997.23471.65
   Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002
   Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Weiss MD, 2010, MUSCLE NERVE, V41, P882, DOI 10.1002/mus.21636
   WEISSBACH A, 1975, SCIENCE, V190, P401, DOI 10.1126/science.1179222
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200
   Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872
   YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 117
TC 61
Z9 67
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1940-5510
EI 1940-5529
J9 DEV DISABIL RES REV
JI Dev. Disabil. Res. Rev.
PY 2010
VL 16
IS 2
BP 163
EP 174
DI 10.1002/ddrr.105
PG 12
WC Clinical Neurology; Neurosciences; Pediatrics; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics; Psychiatry
GA 642IB
UT WOS:000281201100009
PM 20818731
DA 2024-11-01
ER

PT J
AU Vafai, SB
   Mootha, VK
AF Vafai, Scott B.
   Mootha, Vamsi K.
TI Mitochondrial disorders as windows into an ancient organelle
SO NATURE
LA English
DT Review
ID SKELETAL-MUSCLE MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION;
   MEMBRANE-PROTEIN; INNER MEMBRANE; MUTATION; DNA; DISEASE; CELLS; CA2+;
   COMPLEXES
AB Much of our current knowledge about mitochondria has come from studying patients who have respiratory chain disorders. These disorders comprise a large collection of individually rare syndromes, each presenting in a unique and often devastating way. In recent years, there has been great progress in defining their genetic basis, but we still know little about the cascade of events that gives rise to such diverse pathology. Here, we review these disorders and explore them in the context of a contemporary understanding of mitochondrial evolution, biochemistry and genetics. Fully deciphering their pathogenesis is a challenging next step that will inspire the development of drug treatments for rare and common diseases.
C1 [Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Vafai, Scott B.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA.
   [Vafai, Scott B.; Mootha, Vamsi K.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.
   [Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Massachusetts General Hospital; Harvard University; Massachusetts
   Institute of Technology (MIT); Broad Institute; Harvard University;
   Harvard Medical School
RP Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Ctr Human Genet Res, Boston, MA 02114 USA.
EM vamsi@hms.harvard.edu
FU National Institutes of Health
FX We apologize to the many authors whose work we were unable to cite
   because of space limitations. We offer special thanks to D. Thorburn for
   careful review of the manuscript and his help with compiling an updated
   list of disease genes. We are grateful to S. Calvo, M. Jain, E. Rosen,
   V. Siegel and M. Gray for thoughtful feedback on the manuscript; J-.P.
   Mazat for providing a figure; M. Fleming, A. Sadun, M. Seidman, R.
   Mitchell, R. Saneto, D. McGuone and L. Rodriguez for providing clinical
   images; and G. Perkins and M. Ellisman for providing electron
   micrographs. We thank the National Institutes of Health for ongoing
   grant support.
CR Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53
   BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638
   Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234
   Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522
   Bitner-Glindzicz M, 2009, NEW ENGL J MED, V360, P640, DOI 10.1056/NEJMc0806396
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144
   Brini M, 1999, NAT MED, V5, P951, DOI 10.1038/11396
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Chan D. C., 2012, ANN REV GENET
   CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0
   CHANCE B, 1955, J BIOL CHEM, V217, P409
   COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383
   Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016
   Coté HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035
   Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200
   De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230
   DIMAURO S, 1976, J NEUROL SCI, V27, P217, DOI 10.1016/0022-510X(76)90063-0
   Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066
   ERNSTER L, 1959, NATURE, V184, P1851, DOI 10.1038/1841851a0
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909
   Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389
   HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010
   Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x
   Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053
   Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046
   Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595
   Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006
   Kacser H, 1973, Symp Soc Exp Biol, V27, P65
   Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158
   Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478
   Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056
   Lieber DS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-3
   MacAskill AF, 2010, TRENDS CELL BIOL, V20, P102, DOI 10.1016/j.tcb.2009.11.002
   Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   Miceli Michael V., 2012, Frontiers in Genetics, V2, P102, DOI 10.3389/fgene.2011.00102
   Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   MORAIS R, 1982, CAN J BIOCHEM CELL B, V60, P290, DOI 10.1139/o82-035
   Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642
   Munnich A., 2006, SCRIVERS ONLINE META
   Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012
   Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105
   Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   Pierron D, 2012, BBA-BIOENERGETICS, V1817, P590, DOI 10.1016/j.bbabio.2011.07.007
   PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289
   Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   Rugarli EI, 2012, EMBO J, V31, P1336, DOI 10.1038/emboj.2012.38
   RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3
   Sadun A, 1998, Trans Am Ophthalmol Soc, V96, P881
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107
   Sharma MR, 2003, CELL, V115, P97, DOI 10.1016/S0092-8674(03)00762-1
   Shoffner J., 2006, SCRIVERS ONLINE META
   Shoubridge EA, 2012, CELL METAB, V15, P271, DOI 10.1016/j.cmet.2012.02.009
   Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60
   Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Szklarczyk R, 2010, PROTEOMICS, V10, P4012, DOI 10.1002/pmic.201000329
   Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Vasta V, 2012, PEDIATR INT, V54, P585, DOI 10.1111/j.1442-200X.2012.03644.x
   Viscomi C, 2010, NAT MED, V16, P869, DOI 10.1038/nm.2188
   Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066
   von Kleist-Retzow JC, 2007, EXP CELL RES, V313, P3076, DOI 10.1016/j.yexcr.2007.04.015
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   Ward SM, 2000, J PHYSIOL-LONDON, V525, P355, DOI 10.1111/j.1469-7793.2000.t01-1-00355.x
   West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975
   Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
NR 98
TC 547
Z9 624
U1 0
U2 121
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 15
PY 2012
VL 491
IS 7424
BP 374
EP 383
DI 10.1038/nature11707
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 036MY
UT WOS:000311031600034
PM 23151580
DA 2024-11-01
ER

PT J
AU Zia, A
   Farkhondeh, T
   Pourbagher-Shahri, AM
   Samarghandian, S
AF Zia, Aliabbas
   Farkhondeh, Tahereh
   Pourbagher-Shahri, Ali Mohammad
   Samarghandian, Saeed
TI The Roles of Mitochondrial Dysfunction and Reactive Oxygen Species in
   Aging and Senescence
SO CURRENT MOLECULAR MEDICINE
LA English
DT Review
DE Mitochondrial dysfunction; reactive oxygen species; aging; senescente;
   oxidation stress; apoptosis
ID OXIDATIVE POSTTRANSLATIONAL MODIFICATIONS; STEM-CELL; LIFE-SPAN;
   DNA-DAMAGE; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; POINT
   MUTATIONS; QUALITY-CONTROL; SELF-RENEWAL; NUCLEAR-DNA
AB The aging process deteriorates organs' function at different levels, causing its progressive decline to resist stress, damage, and disease. In addition to alterations in metabolic control and gene expression, the rate of aging has been connected with the generation of high amounts of Reactive Oxygen Species (ROS). The essential perspective in free radical biology is that reactive oxygen species (ROS) and free radicals are toxic, mostly cause direct biological damage to targets, and are thus a major cause of oxidative stress. Different enzymatic and non-enzymatic compounds in the cells have roles in neutralizing this toxicity. Oxidative damage in aging is mostly high in particular molecular targets, such as mitochondrial DNA and aconitase, and oxidative stress in mitochondria can cause tissue aging across intrinsic apoptosis. Mitochondria's function and morphology are impaired through aging, following a decrease in the membrane potential by an increase in peroxide generation and size of the organelles. Telomeres may be the significant trigger of replicative senescence. Oxidative stress accelerates telomere loss, whereas antioxidants slow it down. Oxidative stress is a crucial modulator of telomere shortening, and that telomere-driven replicative senescence is mainly a stress response. The age-linked mitochondrial DNA mutation and protein dysfunction aggregate in some organs like the brain and skeletal muscle, thus contributing considerably to these post-mitotic tissues' aging. The aging process is mostly due to accumulated damage done by harmful species in some macromolecules such proteins, DNA, and lipids. The degradation of non-functional, oxidized proteins is a crucial part of the antioxidant defenses of cells, in which the clearance of these proteins occurs through autophagy in the cells, which is known as mitophagy for mitochondria.
C1 [Zia, Aliabbas] Univ Tehran, Inst Biochem & Biophys IBB, Dept Biochem, Tehran, Iran.
   [Farkhondeh, Tahereh; Pourbagher-Shahri, Ali Mohammad] Birjand Univ Med Sci, Med Toxicol & Drug Abuse Res Ctr MTDRC, Birjand, Iran.
   [Farkhondeh, Tahereh] Birjand Univ Med Sci, Fac Pharm, Birjand, Iran.
   [Samarghandian, Saeed] Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran.
C3 University of Tehran
RP Samarghandian, S (corresponding author), Neyshabur Univ Med Sci, Noncommunicable Dis Res Ctr, Neyshabur, Iran.
EM samarghandians1@nums.ac.ir
RI Farkhondeh, Tahereh/Y-2083-2018; Pourbagher-Shahri, Ali
   Mohammad/Y-5021-2018
OI Pourbagher-Shahri, Ali Mohammad/0000-0003-4462-9890
CR Aguiar PHN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002279
   Ahlqvist KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7494
   Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004
   Ahmed Samrein B M, 2017, J Mol Signal, V12, P2, DOI 10.5334/1750-2187-12-2
   Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Akasaki Y, 2014, ARTHRITIS RHEUMATOL, V66, P3349, DOI 10.1002/art.38868
   Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013
   Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003
   Betts DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086978
   Bhat SS, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0354-9
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Borodkina A, 2014, AGING-US, V6, P481, DOI 10.18632/aging.100673
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bullone M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122612
   Bulteau AL, 2006, EXP GERONTOL, V41, P653, DOI 10.1016/j.exger.2006.03.013
   Callahan A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0469-4
   Cenini G, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2105607
   Chen HQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00103
   Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Coluzzi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010019
   Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7
   Dai XZ, 2020, TRENDS MOL MED, V26, P185, DOI 10.1016/j.molmed.2019.09.007
   Davis T, 2005, BIOGERONTOLOGY, V6, P371, DOI 10.1007/s10522-005-4901-4
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Di Meo S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1245049
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Dunn RM, 2018, ALLERGY, V73, P284, DOI 10.1111/all.13258
   Elokil AA, 2019, POULTRY SCI, V98, P4172, DOI 10.3382/ps/pez201
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FLEMING JE, 1986, SCIENCE, V231, P1157, DOI 10.1126/science.3080809
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Fujimaki S, 2015, HISTOL HISTOPATHOL, V30, P1411, DOI 10.14670/HH-11-657
   Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200
   Georgakopoulou EA, 2013, AGING-US, V5, P37
   Ghatreh-Samani M, 2016, CENT EUR J IMMUNOL, V41, P116, DOI 10.5114/ceji.2015.56973
   Gonzalez-Hunt Claudia P., 2018, Current Opinion in Toxicology, V7, P87, DOI 10.1016/j.cotox.2017.11.001
   Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116480
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803
   Himmelfarb J, 2000, KIDNEY INT, V58, P2571, DOI 10.1046/j.1523-1755.2000.00443.x
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Ho JH, 2011, CELL TRANSPLANT, V20, P1209, DOI 10.3727/096368910X546562
   Hoffmann G, 2014, J BIOL CHEM, V289, P5208, DOI 10.1074/jbc.M113.487736
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Itahana Koji, 2013, Methods Mol Biol, V965, P143, DOI 10.1007/978-1-62703-239-1_8
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jung JW, 2010, CELL MOL LIFE SCI, V67, P1165, DOI 10.1007/s00018-009-0242-9
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200
   Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747
   Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014
   Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kim SH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2860642
   Kissová I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200
   Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097
   Lee HT, 2017, NUCLEIC ACIDS RES, V45, P11752, DOI 10.1093/nar/gkx789
   Lee S, 2019, BMB REP, V52, P35, DOI 10.5483/BMBRep.2019.52.1.294
   Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3
   Leon J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22086
   Liu H, 2013, INVEST OPHTH VIS SCI, V54, P5236, DOI 10.1167/iovs.13-11664
   Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6
   Marcotte R, 2002, J GERONTOL A-BIOL, V57, pB257, DOI 10.1093/gerona/57.7.B257
   Martinez M, 2013, FREE RADICAL BIO MED, V65, P411, DOI 10.1016/j.freeradbiomed.2013.06.039
   Matsumoto R, 2016, TELOMERE - A COMPLEX END OF A CHROMOSOME, P143, DOI 10.5772/64759
   Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155
   Naudi A., 2011, Free Radicals Antioxidants, V1, P3, DOI DOI 10.5530/ax.2011.3.2
   Naudí A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00372
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Neiman M, 2009, P ROY SOC B-BIOL SCI, V276, P1201, DOI 10.1098/rspb.2008.1758
   Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015
   Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   North BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-224
   Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256
   Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167
   Nyström T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599
   Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830
   Onodera Y, 2017, AGING CELL, V16, P1369, DOI 10.1111/acel.12680
   Ott C, 2018, MECH AGEING DEV, V170, P72, DOI 10.1016/j.mad.2017.07.007
   Ozcan A., 2015, Basic Principles and Clinical Significance of Oxidative Stress, DOI DOI 10.5772/61193
   Page MM, 2010, MECH AGEING DEV, V131, P242, DOI 10.1016/j.mad.2010.02.005
   Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x
   Parkinson Gemma M, 2014, Curr Aging Sci, V7, P155
   Paul MK, 2014, CELL STEM CELL, V15, P199, DOI 10.1016/j.stem.2014.05.009
   Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971
   Peroni LA, 2007, GENET MOL BIOL, V30, P872, DOI 10.1590/S1415-47572007000500016
   Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763
   Plataki M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37438-1
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Raghuram GV, 2014, INDIAN J MED RES, V140, P120
   Ramsey JJ, 2014, J GERONTOL A-BIOL, V69, P1177, DOI 10.1093/gerona/glt198
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rohrbach S, 2006, AM J PHYSIOL-REG I, V291, pR927, DOI 10.1152/ajpregu.00890.2005
   Ryan BJ, 2014, REDOX BIOL, V2, P715, DOI 10.1016/j.redox.2014.05.004
   Salminen A, 2008, AGEING RES REV, V7, P83, DOI 10.1016/j.arr.2007.09.002
   Samarghandian S, 2017, INDIAN HEART J, V69, P151, DOI 10.1016/j.ihj.2016.09.008
   Samarghandian S, 2017, DOSE-RESPONSE, V15, DOI 10.1177/1559325817711782
   Schiavi A, 2013, EXP GERONTOL, V48, P191, DOI 10.1016/j.exger.2012.12.002
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Scialò F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009
   Senchuk MM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007268
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001
   Smith JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200275
   Sonani RR, 2017, PROTOPLASMA, V254, P849, DOI 10.1007/s00709-016-0996-5
   Stauch KL, 2014, J PROTEOME RES, V13, P2620, DOI 10.1021/pr500295n
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Svensson MJ, 2007, HEREDITAS, V144, P25, DOI 10.1111/j.2007.0018-0661.01990.x
   Tian XP, 2010, APPL BIOCHEM BIOTECH, V160, P1460, DOI 10.1007/s12010-009-8633-9
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Toscano A, 2014, CURR MOL MED, V14, P1001, DOI 10.2174/1566524014666141010152340
   Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Uno M, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.10
   Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823
   Van Houten Bennett, 2018, Current Opinion in Toxicology, V7, P9, DOI 10.1016/j.cotox.2017.10.009
   Vergel Mar, 2010, J Aging Res, V2011, P725365, DOI 10.4061/2011/725365
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vomhof-DeKrey EE, 2012, J NUTR BIOCHEM, V23, P1201, DOI 10.1016/j.jnutbio.2012.03.005
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   WALFORD RL, 1964, GERONTOLOGIST, V4, P195, DOI 10.1093/geront/4.4.195
   Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019
   Weber TA, 2010, EXP GERONTOL, V45, P503, DOI 10.1016/j.exger.2010.03.018
   Whitaker AM, 2017, FRONT BIOSCI-LANDMRK, V22, P1493, DOI 10.2741/4555
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Xu Y, 2018, TOXICOL LETT, V289, P99, DOI 10.1016/j.toxlet.2018.02.001
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490
   Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z
   Yu KR, 2013, STEM CELL RES, V10, P156, DOI 10.1016/j.scr.2012.11.002
   Yu Y, 2018, J NUTR HEALTH AGING, V22, P710, DOI 10.1007/s12603-018-1015-7
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Yuan ZN, 2017, BIOCHEM BIOPH RES CO, V491, P228, DOI 10.1016/j.bbrc.2017.07.083
   Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397
   Zhang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080342
   Zhao L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07974-3
   ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0
NR 163
TC 22
Z9 23
U1 1
U2 41
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5240
EI 1875-5666
J9 CURR MOL MED
JI Curr. Mol. Med.
PY 2022
VL 22
IS 1
BP 37
EP 49
DI 10.2174/1566524021666210218112616
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Research & Experimental Medicine
GA YD9TR
UT WOS:000740776400004
PM 33602082
DA 2024-11-01
ER

PT J
AU Li, B
   Kaushik, S
   Kalinowski, P
   Kim, B
   Gershome, C
   Ching, J
   Poburko, D
AF Li, Brian
   Kaushik, Sonal
   Kalinowski, Pola
   Kim, BaRun
   Gershome, Cynthia
   Ching, Joyce
   Poburko, Damon
TI Droplet digital PCR shows the D-Loop to be an error prone locus for
   mitochondrial DNA copy number determination
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ALZHEIMERS-DISEASE; SMOOTH-MUSCLE; ASSAY; DEPLETION; MTDNA; GENE;
   QUANTITATION; ASSOCIATION; DUPLICATION; SENSITIVITY
AB Absolute quantification of mitochondrial DNA copy number (mCN) provides important insights in many fields of research including cancer, cardiovascular and reproductive health. Droplet digital PCR (ddPCR) natively reports absolute copy number, and we have developed a single-dye, multiplex assay to measure rat mCN that is accurate, precise and affordable. We demonstrate simple methods to optimize this assay and to determine nuclear reference pseudogene copy number to extend the range of mCN that can be measured with this assay. We evaluated two commonly used mitochondrial DNA reference loci to determine mCN, the ND1 gene and the D-Loop. Harnessing the absolute measures of ddPCR, we found that the D-Loop amplifies with a copy number of similar to 1.0-1.5 relative to other sites on the mitochondrial genome. This anomalous copy number varied significantly between rats and tissues (aorta, brain, heart, liver, soleus muscle). We advocate for avoiding the D-Loop as a mitochondrial reference in future studies of mCN. Further, we report a novel approach to quantifying immunolabelled mitochondrial DNA that provides single-cell estimates of mCN that closely agree with the population analyses by ddPCR. The combination of these assays represents a cost-effective and powerful suite of tools to study mCN.
C1 [Li, Brian; Kaushik, Sonal; Kalinowski, Pola; Kim, BaRun; Gershome, Cynthia; Ching, Joyce; Poburko, Damon] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.
   [Poburko, Damon] Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.
C3 Simon Fraser University; Simon Fraser University
RP Poburko, D (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.; Poburko, D (corresponding author), Simon Fraser Univ, Ctr Cell Biol Dev & Dis, Burnaby, BC, Canada.
EM dpoburko@sfu.ca
CR Abhyankar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008148
   Aguet F, 2008, IEEE T IMAGE PROCESS, V17, P1144, DOI 10.1109/TIP.2008.924393
   Akiyama T, 2017, MOL PHYLOGENET EVOL, V106, P158, DOI 10.1016/j.ympev.2016.09.026
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Belmonte FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25186
   Chalmers S, 2012, ARTERIOSCL THROM VAS, V32, P3000, DOI 10.1161/ATVBAHA.112.255174
   Coskun PE, 2010, J ALZHEIMERS DIS, V20, pS293, DOI 10.3233/JAD-2010-100351
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dai JZ, 2005, CELL CALCIUM, V37, P333, DOI 10.1016/j.ceca.2004.12.002
   Di Re M, 2009, NUCLEIC ACIDS RES, V37, P5701, DOI 10.1093/nar/gkp614
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545
   Janes MS, 2004, J HISTOCHEM CYTOCHEM, V52, P1011, DOI 10.1369/jhc.3a6209.2004
   Jemt E, 2015, NUCLEIC ACIDS RES, V43, P9262, DOI 10.1093/nar/gkv804
   Kirsty F., 2018, AGING CELL
   Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108
   Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009
   Lee CM, 1998, FREE RADICAL BIO MED, V25, P964, DOI 10.1016/S0891-5849(98)00185-3
   Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134
   Liu X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14491-w
   Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2
   McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n
   Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060
   Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j
   MORITZ C, 1986, SCIENCE, V233, P1425, DOI 10.1126/science.3018925
   Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052
   Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027
   Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050
   Phillips NR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03887
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Poburko D, 2004, TRENDS PHARMACOL SCI, V25, P8, DOI 10.1016/j.tips.2003.10.011
   Poburko D, 2009, CIRC RES, V104, P104, DOI 10.1161/CIRCRESAHA.108.180612
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SNYDER M, 1987, P NATL ACAD SCI USA, V84, P7595, DOI 10.1073/pnas.84.21.7595
   Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178
   Sze MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110351
   Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067642
   Tanaka T, 2017, IN VIVO, V31, P713, DOI 10.21873/invivo.11119
   Ungvari Z, 2010, J MOL MED, V88, P1021, DOI 10.1007/s00109-010-0667-5
   Var SR, 2016, AIDS, V30, P839, DOI 10.1097/QAD.0000000000001027
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811
   Weerakoon KG, 2016, J MICROBIOL METH, V125, P19, DOI 10.1016/j.mimet.2016.03.012
   Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213
   Xu YY, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0234-4
   Yu M, 2013, TRANSL RES, V161, P165, DOI 10.1016/j.trsl.2012.10.011
   Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035
   Zole E., 2017, MITOCHONDRIAL DNA A, P1
NR 49
TC 14
Z9 17
U1 0
U2 12
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 30
PY 2018
VL 8
AR 11392
DI 10.1038/s41598-018-29621-1
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GO6IS
UT WOS:000440144400009
PM 30061621
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Vartiainen, S
   Chen, S
   George, J
   Tuomela, T
   Luoto, KR
   O'Dell, KMC
   Jacobs, HT
AF Vartiainen, Suvi
   Chen, Shanjun
   George, Jack
   Tuomela, Tea
   Luoto, Kaisa R.
   O'Dell, Kevin M. C.
   Jacobs, Howard T.
TI Phenotypic rescue of a <i>Drosophila</i> model of mitochondrial ANT1
   disease
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Adenine nucleotide translocase; Mitochondrial disease; Mitochondrial
   biogenesis; Alternative oxidase
ID ADENINE-NUCLEOTIDE TRANSLOCASE; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA;
   ALTERNATIVE-OXIDASE; GENE-EXPRESSION; NUCLEAR GENES;
   OXIDATIVE-PHOSPHORYLATION; NEURONAL FAILURE; SENGERS-SYNDROME;
   CELL-MIGRATION; PROTEIN S12
AB A point mutation in the Drosophila gene that codes for the major adult isoform of adenine nuclear translocase (ANT) represents a model for human diseases that are associated with ANT insufficiency [stress-sensitive B-1 (sesB(1))]. We characterized the organismal, bioenergetic and molecular phenotype of sesB(1) flies then tested strategies to compensate the mutant phenotype. In addition to developmental delay and mechanical-stress-induced seizures, sesB(1) flies have an impaired response to sound, defective male courtship, female sterility and curtailed lifespan. These phenotypes, excluding the latter two, are shared with the mitoribosomal protein S12 mutant, tko(25t). Mitochondria from sesB(1) adults showed a decreased respiratory control ratio and downregulation of cytochrome oxidase. sesB(1) adults exhibited ATP depletion, lactate accumulation and changes in gene expression that were consistent with a metabolic shift towards glycolysis, characterized by activation of lactate dehydrogenase and anaplerotic pathways. Females also showed downregulation of many genes that are required for oogenesis, and their eggs, although fertilized, failed to develop to the larval stages. The sesB(1) phenotypes of developmental delay and mechanical-stress-induced seizures were alleviated by an altered mitochondrial DNA background. Female sterility was substantially rescued by somatic expression of alternative oxidase (AOX) from the sea squirt Ciona intestinalis, whereas AOX did not alleviate developmental delay. Our findings illustrate the potential of different therapeutic strategies for ANT-linked diseases, based on alleviating metabolic stress.
C1 [Vartiainen, Suvi; Chen, Shanjun; George, Jack; Tuomela, Tea; Luoto, Kaisa R.; Jacobs, Howard T.] Univ Tampere, BioMediTech, FI-33014 Tampere, Finland.
   [Vartiainen, Suvi; Chen, Shanjun; George, Jack; Tuomela, Tea; Luoto, Kaisa R.; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FI-33014 Tampere, Finland.
   [O'Dell, Kevin M. C.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.
   [Jacobs, Howard T.] Univ Helsinki, Res Program Mol Neurol, FI-00014 Helsinki, Finland.
C3 Tampere University; Tampere University; Tampere University Hospital;
   University of Glasgow; University of Helsinki
RP Jacobs, HT (corresponding author), Univ Tampere, BioMediTech, FI-33014 Tampere, Finland.
EM howard.t.jacobs@uta.fi
RI Jacobs, Howard/G-2434-2011
OI Jacobs, Howard/0000-0003-1895-6003; Morikka, Jack/0000-0002-0053-4171;
   Tuomela, Tea/0000-0002-1010-0561
FU Academy of Finland (FinMIT Centre of Excellence); Sigrid Juselius
   Foundation; Tampere University Hospital Medical Research Fund; European
   Research Council [2326738]; EU [IOF 255472]
FX This work was supported by Academy of Finland (FinMIT Centre of
   Excellence, Academy Professorship to H.T.J., Academy postdoctoral
   fellowship to S. V.); Sigrid Juselius Foundation; Tampere University
   Hospital Medical Research Fund; the European Research Council (Advanced
   Grant 2326738 to H.T.J.); and the EU Marie Curie Programme (IOF 255472
   to S.V.).
CR Barca E, 2013, NEUROL SCI, V34, P217, DOI 10.1007/s10072-012-0976-2
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890
   Charlier C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-560
   Chaturvedi RK, 2013, MOL CELL NEUROSCI, V55, P101, DOI 10.1016/j.mcn.2012.11.011
   Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719
   Chevrollier A, 2011, BBA-BIOENERGETICS, V1807, P562, DOI 10.1016/j.bbabio.2010.10.008
   Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105
   Deng WM, 1998, INT J DEV BIOL, V42, P541
   Deschauer M, 2005, NEUROMUSCULAR DISORD, V15, P311, DOI 10.1016/j.nmd.2004.12.004
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dobson SL, 2002, GENETICS, V160, P1087
   El-Khoury R, 2014, BRIT J PHARMACOL, V171, P2243, DOI 10.1111/bph.12570
   El-Khoury R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003182
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Farhadian SF, 2012, PHYSIOL BEHAV, V105, P544, DOI 10.1016/j.physbeh.2011.09.007
   Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463
   Fernández-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549
   Fernandez-Ayala DJM, 2009, CELL METAB, V9, P449, DOI 10.1016/j.cmet.2009.03.004
   Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108
   Forlani G, 2010, HUM MOL GENET, V19, P3114, DOI 10.1093/hmg/ddq214
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Hofer A, 2014, HUM MOL GENET, V23, P2400, DOI 10.1093/hmg/ddt631
   Humphrey DM, 2012, HUM MOL GENET, V21, P2698, DOI 10.1093/hmg/dds096
   Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002
   Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kawamata H, 2011, HUM MOL GENET, V20, P2964, DOI 10.1093/hmg/ddr200
   Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002
   Kemppainen KK, 2014, HUM MOL GENET, V23, P2078, DOI 10.1093/hmg/ddt601
   Komaki H, 2002, ANN NEUROL, V51, P645, DOI 10.1002/ana.10172
   Komen JC, 2014, BRIT J PHARMACOL, V171, P1818, DOI 10.1111/bph.12413
   Lee J, 2009, BBA-BIOENERGETICS, V1787, P364, DOI 10.1016/j.bbabio.2009.01.014
   Lomas MF, 2013, CELL REP, V4, P791, DOI 10.1016/j.celrep.2013.07.038
   Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   Michaud Sebastien, 2002, Prog Mol Subcell Biol, V28, P79
   Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7
   Morrow G, 2000, J BIOL CHEM, V275, P31204, DOI 10.1074/jbc.M002960200
   Napoli L, 2001, NEUROLOGY, V57, P2295, DOI 10.1212/WNL.57.12.2295
   Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018
   NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341
   Parker L, 2011, GENETICS, V187, P523, DOI 10.1534/genetics.110.123299
   PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2
   Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056
   Phillips MJ, 2010, INVEST OPHTH VIS SCI, V51, P6744, DOI 10.1167/iovs.10-5421
   Poulton JS, 2007, DEV BIOL, V311, P1, DOI 10.1016/j.ydbio.2007.08.030
   Rikhy R, 2003, GENETICS, V165, P1243
   Rorth P, 2000, MOL CELL, V6, P23
   Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9
   ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0
   ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9
   Saada A, 2004, DNA CELL BIOL, V23, P797
   Sanz A, 2010, AGING-US, V2, P200, DOI 10.18632/aging.100137
   Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107
   Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0
   Sharer JD, 2005, IUBMB LIFE, V57, P607, DOI 10.1080/15216540500217735
   Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058
   Srivastava S, 2009, HUM MOL GENET, V18, P1805, DOI 10.1093/hmg/ddp093
   Stein D, 2013, FLY, V7, P161, DOI 10.4161/fly.25141
   Strauss KA, 2013, P NATL ACAD SCI USA, V110, P3453, DOI 10.1073/pnas.1300690110
   Subrarnaniam V, 2008, BBA-BIOENERGETICS, V1777, P666, DOI 10.1016/j.bbabio.2008.03.015
   Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379
   Terhzaz S, 2010, PHYSIOL GENOMICS, V41, P33, DOI 10.1152/physiolgenomics.00147.2009
   Tiefenböck SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330
   Toivonen JM, 2001, GENETICS, V159, P241
   Tyynismaa H, 2009, AM J HUM GENET, V85, P290, DOI 10.1016/j.ajhg.2009.07.009
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968
   Wang XW, 2008, HUM MOL GENET, V17, P4036, DOI 10.1093/hmg/ddn306
   Wang Y, 2009, EXP PHYSIOL, V94, P220, DOI 10.1113/expphysiol.2008.044800
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183
   Zhang HG, 2002, GENETICS, V162, P1283
   Zhang YQ, 1999, GENETICS, V153, P891
NR 78
TC 28
Z9 29
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD JUN
PY 2014
VL 7
IS 6
BP 635
EP 648
DI 10.1242/dmm.016527
PG 14
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA AT5SQ
UT WOS:000345002600005
PM 24812436
OA Green Published, Green Accepted, gold
DA 2024-11-01
ER

PT S
AU Schaffer, SW
   Jong, CJ
   Warner, D
   Ito, T
   Azuma, J
AF Schaffer, Stephen W.
   Jong, Chian Ju
   Warner, Danielle
   Ito, Takashi
   Azuma, Junichi
BE ElIdrissi, A
   LAmoreaux, WJ
TI Taurine Deficiency and MELAS Are Closely Related Syndromes
SO TAURINE 8, VOL 2: NUTRITION AND METABOLISM, PROTECTIVE ROLE, AND ROLE IN
   REPRODUCTION, DEVELOPMENT, AND DIFFERENTIATION
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Proceedings Paper
CT 18th International Taurine Meeting
CY APR 07-13, 2012
CL Marrakesh, MOROCCO
SP Taisho Pharmaceut Co Ltd
ID STROKE-LIKE EPISODES; MITOCHONDRIAL-DNA; RETINAL DEGENERATION;
   TRANSPORTER KNOCKOUT; LACTIC-ACIDOSIS; MYOCARDIAL FAILURE;
   INSULIN-RESISTANCE; DEPLETION; GENE; RATS
AB MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes) is a mitochondrial disease caused by one or more mutations of tRNA(Leu(UUR)). These mutations reduce both the aminoacylation of tRNA(Leu(UUR)) and a posttranslational modification in the wobble position of tRNA(Leu(UUR)). Both changes result in reduced transcription of mitochondria-encoded proteins; however, reduced aminoacylation affects the decoding of both UUG and UUA while the wobble defect specifically diminishes UUG decoding. Because 12 out of the 13 mitochondria-encoded proteins are more dependent on UUA decoding than UUG decoding, the aminoacylation defect should have a more profound effect on protein synthesis than the wobble defect, which more specifically alters the expression of one mitochondria-encoded protein, ND6. Taurine serves as a substrate in the formation of 5-taurinomethyluridine-tRNA(Leu(UUR)); therefore, taurine deficiency should mimic 5-taurinomethyluridine-tRNA(Leu(UUR)) deficiency. Hence, the wobble hypothesis predicts that the symptoms of MELAS mimic those of taurine deficiency, provided that the dominant defect in MELAS is wobble modification deficiency. On the other hand, if the aminoacylation defect dominates, significant differences should exist between taurine deficiency and MELAS. The present review tests this hypothesis by comparing the symptoms of MELAS and taurine deficiency.
C1 [Schaffer, Stephen W.; Jong, Chian Ju; Warner, Danielle] Univ S Alabama, Sch Med, Dept Pharmacol, Mobile, AL 36688 USA.
   [Ito, Takashi; Azuma, Junichi] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo, Japan.
C3 University of South Alabama
RP Schaffer, SW (corresponding author), Univ S Alabama, Sch Med, Dept Pharmacol, Mobile, AL 36688 USA.
EM sschaffe@jaguar1.usouthal.edu
RI Jong, Chian/AAL-4026-2020; Ito, Takashi/ABC-2950-2021
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   ANDERSON PA, 1979, J ANIM SCI, V49, P1227, DOI 10.2527/jas1979.4951227x
   Arakawa K, 2010, CIRC J, V74, P2702, DOI 10.1253/circj.CJ-10-0044
   AZUMA J, 1983, CURR THER RES CLIN E, V34, P543
   BAGLEY PJ, 1995, J NUTR, V125, P933
   BLONDEL O, 1990, METABOLISM, V39, P787, DOI 10.1016/0026-0495(90)90120-2
   Chang KJ, 2000, ADV EXP MED BIOL, V483, P571
   Chiang Lin-Mei, 1995, Journal of the Formosan Medical Association, V94, P42
   DAVIES WE, 1994, ADV EXP MED BIOL, V359, P393
   GAULL GE, 1986, J AM COLL NUTR, V5, P121
   GEGGEL HS, 1985, NEW ENGL J MED, V312, P142, DOI 10.1056/NEJM198501173120302
   Golubnitschaja O, 2003, BIOCHEM PHARMACOL, V66, P511, DOI 10.1016/S0006-2952(03)00285-5
   Han XB, 2012, AMINO ACIDS, V43, P2249, DOI 10.1007/s00726-012-1314-y
   Hansen SH, 2001, DIABETES-METAB RES, V17, P330, DOI 10.1002/dmrr.229
   Harris NG, 1997, J NEUROCHEM, V68, P305
   HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364
   HAYES KC, 1980, J NUTR, V110, P2058, DOI 10.1093/jn/110.10.2058
   Heller-Stilb B, 2001, FASEB J, V15, P231, DOI 10.1096/fj.01-0691fje
   Hilton G, 1995, J Neurosci Nurs, V27, P278
   Hirano M, 2002, INTERNAL MED, V41, P113, DOI 10.2169/internalmedicine.41.113
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101
   Iizuka T, 2005, CURR NEUROVASC RES, V2, P29, DOI 10.2174/1567202052773544
   IMAKI H, 1987, J NEUROSCI RES, V18, P602, DOI 10.1002/jnr.490180414
   Ito T, 2008, J MOL CELL CARDIOL, V44, P927, DOI 10.1016/j.yjmcc.2008.03.001
   JACOBSEN JG, 1968, PHYSIOL REV, V48, P424, DOI 10.1152/physrev.1968.48.2.424
   Jong CJ, 2012, AMINO ACIDS, V42, P2223, DOI 10.1007/s00726-011-0962-7
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   LAKE N, 1988, VISION RES, V28, P1071, DOI 10.1016/0042-6989(88)90133-2
   LAKE N, 1987, LIFE SCI, V40, P997, DOI 10.1016/0024-3205(87)90322-5
   Latkany P, 1999, AM J OPHTHALMOL, V128, P112, DOI 10.1016/S0002-9394(99)00057-4
   Maassen JA, 2006, BIOCHEM SOC T, V34, P819, DOI 10.1042/BST0340819
   Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103
   Mozaffari M, 2006, KIDNEY INT, V70, P329, DOI 10.1038/sj.ki.5001503
   MOZAFFARI MS, 1986, BIOCHEM PHARMACOL, V35, P985, DOI 10.1016/0006-2952(86)90087-0
   NOVOTNY MJ, 1994, CAN J VET RES, V58, P6
   NOVOTNY MJ, 1991, AM J PHYSIOL, V261, pH121, DOI 10.1152/ajpheart.1991.261.1.H121
   Oermann E, 2005, ANAT EMBRYOL, V210, P363, DOI 10.1007/s00429-005-0024-6
   PASANTESMORALES H, 1987, NEUROPHARMACOLOGY, V26, P1721, DOI 10.1016/0028-3908(87)90123-7
   PION PD, 1987, SCIENCE, V237, P764, DOI 10.1126/science.3616607
   PION PD, 1992, J AM VET MED ASSOC, V201, P267
   Roysommuti S, 2009, ADV EXP MED BIOL, V643, P135, DOI 10.1007/978-0-387-75681-3_14
   RUMMELT V, 1993, OPHTHALMOLOGY, V100, P1757
   SCHAFFER SW, 1993, DIABETOLOGIA, V36, P195, DOI 10.1007/BF00399949
   SCHMIDT SY, 1977, INVEST OPHTH VIS SCI, V16, P673
   Sergeeva OA, 2007, J PHYSIOL-LONDON, V585, P539, DOI 10.1113/jphysiol.2007.141432
   Silbert L, 1996, J Stroke Cerebrovasc Dis, V6, P67, DOI 10.1016/S1052-3057(96)80005-X
   Smith PR, 1999, OPHTHALMOLOGY, V106, P1101, DOI 10.1016/S0161-6420(99)90244-0
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Sue CM, 1998, J NEUROL NEUROSUR PS, V65, P233, DOI 10.1136/jnnp.65.2.233
   Thambisetty M, 2002, NEUROLOGIST, V8, P302, DOI 10.1097/00127893-200209000-00003
   TRACHTMAN H, 1992, AM J PHYSIOL, V262, pF117, DOI 10.1152/ajprenal.1992.262.1.F117
   TRACHTMAN H, 1988, PEDIATR RES, V23, P35, DOI 10.1203/00006450-198801000-00008
   Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010
   TYSON JE, 1989, PEDIATRICS, V83, P406
   VALLECALLESANDOVAL MH, 1991, INT J DEV NEUROSCI, V9, P571, DOI 10.1016/0736-5748(91)90018-H
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VINTON NE, 1990, AM J CLIN NUTR, V52, P895, DOI 10.1093/ajcn/52.5.895
   VIONNET N, 1993, LANCET, V342, P1429, DOI 10.1016/0140-6736(93)92792-R
   Warskulat U, 2006, FASEB J, V20, P574, DOI 10.1096/fj.05-5016fje
   Warskulat U, 2004, FASEB J, V18, P577, DOI 10.1096/fj.03-0496fje
   Weisz C, 2009, NATURE, V461, P1126, DOI 10.1038/nature08487
   WEN GY, 1979, INVEST OPHTH VIS SCI, V18, P1200
   Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251
   Yatabe Yoshihisa, 2003, J Orthop Sci, V8, P415, DOI 10.1007/s10776-002-0636-1
NR 66
TC 13
Z9 14
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
EI 2214-8019
BN 978-1-4614-6093-0; 978-1-4614-6092-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2013
VL 776
BP 153
EP 165
DI 10.1007/978-1-4614-6093-0_16
PG 13
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Medicine, Research & Experimental; Nutrition & Dietetics
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Nutrition & Dietetics
GA BA5XW
UT WOS:000337057500016
PM 23392880
DA 2024-11-01
ER

PT J
AU Gai, XW
   Ghezzi, D
   Johnson, MA
   Biagosch, CA
   Shamseldin, HE
   Haack, TB
   Reyes, A
   Tsukikawa, M
   Sheldon, CA
   Srinivasan, S
   Gorza, M
   Kremer, LS
   Wieland, T
   Strom, TM
   Polyak, E
   Place, E
   Consugar, M
   Ostrovsky, J
   Vidoni, S
   Robinson, AJ
   Wong, LJ
   Sondheimer, N
   Salih, MA
   Al-Jishi, E
   Raab, CP
   Bean, C
   Furlan, F
   Parini, R
   Lamperti, C
   Mayr, JA
   Konstantopoulou, V
   Huemer, M
   Pierce, EA
   Meitinger, T
   Freisinger, P
   Sperl, W
   Prokisch, H
   Alkuraya, FS
   Falk, MJ
   Zeviani, M
AF Gai, Xiaowu
   Ghezzi, Daniele
   Johnson, Mark A.
   Biagosch, Caroline A.
   Shamseldin, Hanan E.
   Haack, Tobias B.
   Reyes, Aurelio
   Tsukikawa, Mai
   Sheldon, Claire A.
   Srinivasan, Satish
   Gorza, Matteo
   Kremer, Laura S.
   Wieland, Thomas
   Strom, Tim M.
   Polyak, Erzsebet
   Place, Emily
   Consugar, Mark
   Ostrovsky, Julian
   Vidoni, Sara
   Robinson, Alan J.
   Wong, Lee-Jun
   Sondheimer, Neal
   Salih, Mustafa A.
   Al-Jishi, Emtethal
   Raab, Christopher P.
   Bean, Charles
   Furlan, Francesca
   Parini, Rossella
   Lamperti, Costanza
   Mayr, Johannes A.
   Konstantopoulou, Vassiliki
   Huemer, Martina
   Pierce, Eric A.
   Meitinger, Thomas
   Freisinger, Peter
   Sperl, Wolfgang
   Prokisch, Holger
   Alkuraya, Fowzan S.
   Falk, Marni J.
   Zeviani, Massimo
TI Mutations in <i>FBXL4</i>, Encoding a Mitochondrial Protein, Cause
   Early-Onset Mitochondrial Encephalomyopathy
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID UBIQUITIN LIGASES; DISEASE; SCF; REVEALS
AB Whole-exome sequencing and autozygosity mapping studies, independently performed in subjects with defective combined mitochondrial OXPHOS-enzyme deficiencies, identified a total of nine disease-segregating FBXL4 mutations in seven unrelated mitochondrial disease families, composed of six singletons and three siblings. All subjects manifested early-onset lactic acidemia, hypotonia, and developmental delay caused by severe encephalomyopathy consistently associated with progressive cerebral atrophy and variable involvement of the white matter, deep gray nuclei, and brainstem structures. A wide range of other multisystem features were variably seen, including dysmorphism, skeletal abnormalities, poor growth, gastrointestinal dysmotility, renal tubular acidosis, seizures, and episodic metabolic failure. Mitochondrial respiratory chain deficiency was present in muscle or fibroblasts of all tested individuals, together with markedly reduced oxygen consumption rate and hyperfragmentation of the mitochondrial network in cultured cells. In muscle and fibroblasts from several subjects, substantially decreased mtDNA content was observed. FBXL4 is a member of the F-box family of proteins, some of which are involved in phosphorylation-dependent ubiquitination and/or G protein receptor coupling. We also demonstrate that FBXL4 is targeted to mitochondria and localizes in the intermembrane space, where it participates in an approximately 400 kDa protein complex. These data strongly support a role for FBXL4 in controlling bioenergetic homeostasis and mtDNA maintenance. FBXL4 mutations are a recurrent cause of mitochondrial encephalomyopathy onset in early infancy.
C1 [Gai, Xiaowu] Loyola Univ, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA.
   [Ghezzi, Daniele; Lamperti, Costanza; Zeviani, Massimo] Inst Neurol Besta, Dept Mol Neurogenet, I-23888 Milan, Italy.
   [Johnson, Mark A.; Reyes, Aurelio; Vidoni, Sara; Robinson, Alan J.; Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, D-81675 Munich, Germany.
   [Shamseldin, Hanan E.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
   [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet & Metab Dis, Philadelphia, PA 19104 USA.
   [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA.
   [Srinivasan, Satish; Ostrovsky, Julian] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.
   [Place, Emily; Pierce, Eric A.] Harvard Univ, Sch Med, MEEI, Ocular Genom Inst, Boston, MA 02114 USA.
   [Consugar, Mark; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Salih, Mustafa A.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia.
   [Salih, Mustafa A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia.
   [Al-Jishi, Emtethal] Arabian Gulf Univ, Manama, Bahrain.
   [Raab, Christopher P.; Bean, Charles] Thomas Jefferson Univ, Nemours AI DuPont Hosp Children, Dept Pediat, Wilmington, DE 19803 USA.
   [Furlan, Francesca; Parini, Rossella] Fdn MBBM, San Gerardo Univ Hosp, Dept Pediat, Unit Metab Disorders, I-20900 Monza, Italy.
   [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Paediat, A-5020 Salzburg, Austria.
   [Konstantopoulou, Vassiliki] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.
   [Huemer, Martina] LKH Bregenz, Dept Pediat, A-6900 Bregenz, Austria.
   [Pierce, Eric A.] Harvard Univ, Sch Med, Dept Ophthalmol, Berman Gund Lab Study Retinal Degenerat,MEEI, Boston, MA 02114 USA.
   [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia.
C3 Loyola University Chicago; Fondazione IRCCS Istituto Neurologico Carlo
   Besta; Technical University of Munich; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; King Faisal Specialist Hospital & Research Center; University of
   Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia;
   University of Pennsylvania; University of Pennsylvania; Harvard
   University; Harvard Medical School; Massachusetts Eye & Ear Infirmary;
   Baylor College of Medicine; King Saud University; King Khalid University
   Hospital; King Saud University; Arabian Gulf University; Nemours Alfred
   I. duPont Hospital for Children; Jefferson University; Paracelsus
   Private Medical University; Medical University of Vienna; Harvard
   University; Harvard Medical School; Massachusetts Eye & Ear Infirmary;
   Alfaisal University
RP Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.
EM falkuraya@kfshrc.edu.sa; mdz21@mrc-mbu.cam.ac.uk
RI Falk, Marni/K-1997-2014; Haack, Tobias/JLM-8099-2023; Parini,
   Rossella/J-9202-2018; Prokisch, Holger/N-8964-2013; Zeviani,
   Massimo/K-2891-2014; lamperti, costanza/J-8801-2016; Wieland,
   Thomas/ACE-6378-2022; Sondheimer, Neal/X-7846-2019; Meitinger,
   Thomas/O-1318-2015; Johnson, Mark/F-3980-2017; gai,
   Xiaowu/ISA-3238-2023; Salih, Mustafa/C-1222-2014; Alkuraya,
   Fowzan/A-1542-2009; Ghezzi, Daniele/J-7873-2016
OI Falk, Marni/0000-0002-1723-6728; Mayr, Johannes/0000-0001-6970-336X;
   Zeviani, Massimo/0000-0002-9067-5508; Sondheimer,
   Neal/0000-0001-9982-5712; gai, Xiaowu/0000-0001-8679-9703; Salih,
   Mustafa/0000-0002-4379-2111; Johnson, Mark/0009-0000-1772-2702; Pierce,
   Eric/0000-0002-2354-4102; Alkuraya, Fowzan/0000-0003-4158-341X; parini,
   rossella/0000-0003-4505-1306; Huemer, Martina/0000-0002-0590-678X;
   Kremer, Laura/0000-0002-1647-7538; Meitinger,
   Thomas/0000-0002-8838-8403; Ghezzi, Daniele/0000-0002-6564-3766;
   Prokisch, Holger/0000-0003-2379-6286
FU Fondazione Telethon [GGP11011, GPP10005]; CARIPLO Foundation, Italy
   [2011/0526]; Italian Ministry of Health [GR2010-2316392]; Pierfranco and
   Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial
   Disease Patients and Families (Mitocon); German Federal Ministry of
   Education and Research (BMBF) [0315494A]; German Network for
   Mitochondrial Disorders [01GM0867, 01GM1113C]; E-rare grant GenoMit
   [JTC2011, 01GM1207, FWF I 920-B13]; EU FP7 Mitochondrial European
   Educational Training project (Meet); European Research Council
   [FP7-322424]; Medical Research Council (UK); Deanship of Scientific
   Research at King Saud University, Riyadh [301]; Penn Genome Frontiers
   Institute; National Institutes of Health [R03-DK082446, R01-EY012910,
   P30EY014104-MEEI, 1G20RR030939]; Foerderer Award for Excellence from the
   Children's Hospital of Philadelphia Research Institute; Telethon Italy
   [GTB12001]; MRC [MC_UP_1002/1, MC_U105674181] Funding Source: UKRI
FX The study received financial support from Fondazione Telethon grants
   GGP11011 and GPP10005; the CARIPLO Foundation, Italy, grant 2011/0526;
   the Italian Ministry of Health (GR2010-2316392); the Pierfranco and
   Luisa Mariani Foundation of Italy, the Italian Association of
   Mitochondrial Disease Patients and Families (Mitocon); the German
   Federal Ministry of Education and Research (BMBF) funded Systems Biology
   of Metabotypes grant (SysMBo #0315494A); the German Network for
   Mitochondrial Disorders (mitoNET #01GM0867 and 01GM1113C); E-rare grant
   GenoMit (JTC2011, 01GM1207, and FWF I 920-B13); the EU FP7 Mitochondrial
   European Educational Training project (Meet); the European Research
   Council (grant "Mitcare" FP7-322424); the Medical Research Council (UK);
   the Deanship of Scientific Research at King Saud University, Riyadh,
   through the Research Group Project no 301 (M.A.S.); Penn Genome
   Frontiers Institute (E.A.P. and X.G.); the National Institutes of Health
   (R03-DK082446 to M.J.F., R01-EY012910 to E.A.P., P30EY014104-MEEI core
   support, and 1G20RR030939 to X.G.); the Foerderer Award for Excellence
   from the Children's Hospital of Philadelphia Research Institute (X.G.
   and M.J.F.); institutional support from Loyola University Stritch School
   of Medicine (X.G.); the Clinical and Translational Research Center at
   the Children's Hospital of Philadelphia (UL1-RR-024134); the Angelina
   Foundation Fund from the Division of Child Development and Metabolic
   Disease at the Children's Hospital of Philadelphia (M.J.F.); The Tristan
   Mullen Fund (M.J.F.); Canadian Institutes of Health Research (C.A.S.);
   DHFMR Collaborative Research Grant (F.S.A.); and the Center for
   Mitochondrial and Epigenomic Medicine (CMEM) at The Children's Hospital
   of Philadelphia. The cell lines and DNA bank of Paediatric Movement
   Disorders and Neurodegenerative Diseases, member of the Telethon Network
   of Genetic Biobanks (project no. GTB12001), funded by Telethon Italy,
   provided us with specimens. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health. The content of the article has not been
   influenced by the sponsors.
CR Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383
   Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624
   Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004
   Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549
   Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16
   Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0
   Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361
   Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001
   Ghezzi D, 2009, HUM MOL GENET, V18, P1058, DOI 10.1093/hmg/ddn441
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067
   HECKMATT JZ, 1984, ARCH DIS CHILD, V59, P528, DOI 10.1136/adc.59.6.528
   Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571
   Horvath IT, 2012, TOP CURR CHEM, V308, P1, DOI 10.1007/978-3-642-25234-1
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580
   Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620
   Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2
   Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533
   Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027
   Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964
NR 34
TC 117
Z9 124
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD SEP 5
PY 2013
VL 93
IS 3
BP 482
EP 495
DI 10.1016/j.ajhg.2013.07.016
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 297QB
UT WOS:000330268900007
PM 23993194
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Donato, AJ
   Morgan, RG
   Walker, AE
   Lesniewski, LA
AF Donato, Anthony J.
   Morgan, R. Garrett
   Walker, Ashley E.
   Lesniewski, Lisa A.
TI Cellular and molecular biology of aging endothelial cells
SO JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
LA English
DT Review
DE Aging; Endothelium; Oxidative stress; Inflammation; Senescence; Genomic
   instability
ID ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; REGULAR
   AEROBIC EXERCISE; SMOOTH-MUSCLE-CELLS; EXTENDS LIFE-SPAN; MITOCHONDRIAL
   OXIDATIVE STRESS; FOXO TRANSCRIPTION FACTORS; IMPROVES VASCULAR
   FUNCTION; DNA-DELETION MUTATIONS
AB Cardiovascular disease (CVD) is the leading cause of death in the United States and aging is a major risk factor for CVD development. One of the major age-related arterial phenotypes thought to be responsible for the development of CVD in older adults is endothelial dysfunction. Endothelial function is modulated by traditional CVD risk factors in young adults, but advancing age is independently associated with the development of vascular endothelial dysfunction. This endothelial dysfunction results from a reduction in nitric oxide bioavailability downstream of endothelial oxidative stress and inflammation that can be further modulated by traditional CVD risk factors in older adults. Greater endothelial oxidative stress with aging is a result of augmented production from the intracellular enzymes NADPH oxidase and uncoupled eNOS, as well as from mitochondrial respiration in the absence of appropriate increases in antioxidant defenses as regulated by relevant transcription factors, such as FOXO. Interestingly, it appears that NFlcB, a critical inflammatory transcription factor, is sensitive to this age-related endothelial redox change and its activation induces transcription of pro-inflammatory cytokines that can further suppress endothelial function, thus creating a vicious feed-forward cycle. This review will discuss the two macro-mechanistic processes, oxidative stress and inflammation, that contribute to endothelial dysfunction with advancing age as well as the cellular and molecular events that lead to the vicious cycle of inflammation and oxidative stress in the aged endothelium. Other potential mediators of this pro-inflammatory endothelial phenotype are increases in immune or senescent cells in the vasculature. Of note, genomic instability, telomere dysfunction or DNA damage has been shown to trigger cell senescence via the p53/p21 pathway and result in increased inflammatory signaling in arteries from older adults. This review will discuss the current state of knowledge regarding the emerging concepts of senescence and genomic instability as mechanisms underlying oxidative stress and inflammation in the aged endothelium. Lastly, energy sensitive/stress resistance pathways (SIRT-1, AMPK, mTOR) are altered in endothelial cells and/or arteries with aging and these pathways may modulate endothelial function via key oxidative stress and inflammation-related transcription factors. This review will also discuss what is known about the role of "energy sensing" longevity pathways in modulating endothelial function with advancing age. With the growing population of older adults, elucidating the cellular and molecular mechanisms of endothelial dysfunction with age is critical to establishing appropriate and measured strategies to utilize pharmacological and lifestyle interventions aimed at alleviating CVD risk. This article is part of a Special Issue entitled "SI: CV Aging". Published by Elsevier Ltd.
C1 [Donato, Anthony J.; Walker, Ashley E.; Lesniewski, Lisa A.] Univ Utah, Div Geriatr, Dept Internal Med, Salt Lake City, UT 84148 USA.
   [Donato, Anthony J.; Lesniewski, Lisa A.] Vet Affairs Med Ctr Salt Lake City, Geriatr Res Educ & Clin Ctr, Salt Lake City, UT USA.
   [Morgan, R. Garrett] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
C3 Utah System of Higher Education; University of Utah; Geriatric Research
   Education & Clinical Center; US Department of Veterans Affairs;
   University of Washington; University of Washington Seattle
RP Donato, AJ (corresponding author), Univ Utah, Div Geriatr, Dept Internal Med, 500 Foothill Dr, Salt Lake City, UT 84148 USA.
EM tony.donato@utah.edu
RI Walker, Ashley/AGV-9029-2022; LESNIEWSKI, LISA/ISV-5811-2023; Walker,
   Ashley/B-3791-2012
OI Walker, Ashley/0000-0003-1612-4545; LESNIEWSKI, LISA/0000-0002-2138-1450
FU NIH [NIA R01 AG040297, R21 AG043952, K02 AG045339, K01 AG029337, NIEHS
   T32 ES007032]; VA [1I01BX002151]
FX We would like to acknowledge the help of Grant Henson, Phillip Gates,
   Daniel Machin, Daniel Trott and Sarah Breevort for selected literature
   reviews and critical review of the manuscript. We would like to
   acknowledge Matthew Holmes for his assistance in design and editing of
   the figures. This manuscript was supported by NIH grants: NIA R01
   AG040297 (Donato), R21 AG043952 (Lesniewski/Donato), K02 AG045339
   (Donato) and K01 AG029337 (Walker), NIEHS T32 ES007032 (Morgan) and VA
   merit 1I01BX002151 (Lesniewski).
CR Ahluwalia A, 2011, J PHYSIOL PHARMACOL, V62, P583
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6
   [Anonymous], 2006, HDB EXP PHARM, V176
   Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200
   Arvanitis DA, 2005, J CELL MOL MED, V9, P153, DOI 10.1111/j.1582-4934.2005.tb00345.x
   Asai K, 2000, ARTERIOSCL THROM VAS, V20, P1493, DOI 10.1161/01.ATV.20.6.1493
   Baker CSR, 1999, ARTERIOSCL THROM VAS, V19, P646, DOI 10.1161/01.ATV.19.3.646
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Basu R, 2006, DIABETES, V55, P2001, DOI 10.2337/db05-1692
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   BELMIN J, 1995, AM J PHYSIOL-HEART C, V268, pH2288, DOI 10.1152/ajpheart.1995.268.6.H2288
   Blau CW, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.035
   Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027
   Brookes S, 2002, EMBO J, V21, P2936, DOI 10.1093/emboj/cdf289
   Brown KA, 2007, ARTERIOSCL THROM VAS, V27, P1941, DOI 10.1161/ATVBAHA.107.146852
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447
   Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177
   Cafueri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035312
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cardillo CM, 2000, HYPERTENSION, V35, P1237, DOI 10.1161/01.HYP.35.6.1237
   CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0
   Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279
   Chakrabarti S, 2009, J STEROID BIOCHEM, V117, P99, DOI 10.1016/j.jsbmb.2009.07.007
   Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567
   Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Chou TC, 1998, HYPERTENSION, V31, P643, DOI 10.1161/01.HYP.31.2.643
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Cohen RA, 1997, P NATL ACAD SCI USA, V94, P4193, DOI 10.1073/pnas.94.8.4193
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06
   Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005
   Csiszar A, 2007, AM J PATHOL, V170, P388, DOI 10.2353/ajpath.2007.060708
   Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006
   Csiszar A, 2009, MECH AGEING DEV, V130, P518, DOI 10.1016/j.mad.2009.06.004
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Das DK, 2006, MOL INTERV, V6, P36, DOI 10.1124/mi.6.1.7
   Davis B, 2012, EUR J PHARMACOL, V695, P88, DOI 10.1016/j.ejphar.2012.07.025
   Demaree SR, 1999, ACTA PHYSIOL SCAND, V166, P203
   DeSouza CA, 2000, CIRCULATION, V102, P1351, DOI 10.1161/01.CIR.102.12.1351
   DeVan AE, 2013, CLIN SCI, V124, P325, DOI 10.1042/CS20120291
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013
   Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013
   Donato AJ, 2008, J APPL PHYSIOL, V105, P1359, DOI 10.1152/japplphysiol.90629.2008
   Donato AJ, 2007, CIRC RES, V100, P1659, DOI 10.1161/01.RES.0000269183.13937.e8
   Donato AJ, 2013, AGING CELL, V12, P772, DOI 10.1111/acel.12103
   Donato AJ, 2012, AM J PHYSIOL-HEART C, V303, pH672, DOI 10.1152/ajpheart.00271.2012
   Donato AJ, 2011, J PHYSIOL-LONDON, V589, P4545, DOI 10.1113/jphysiol.2011.211219
   Donato AJ, 2010, AM J PHYSIOL-HEART C, V298, pH671, DOI 10.1152/ajpheart.00761.2009
   Donato AJ, 2009, AM J PHYSIOL-HEART C, V297, pH425, DOI 10.1152/ajpheart.00689.2008
   Donato AJ, 2008, AGING CELL, V7, P805, DOI 10.1111/j.1474-9726.2008.00438.x
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   Durrant JR, 2009, J PHYSIOL-LONDON, V587, P3271, DOI 10.1113/jphysiol.2009.169771
   Eskurza I, 2006, J PHYSIOL-LONDON, V571, P661, DOI 10.1113/jphysiol.2005.102566
   Eskurza I, 2005, J PHYSIOL-LONDON, V568, P1057, DOI 10.1113/jphysiol.2005.092734
   Eskurza I, 2004, J PHYSIOL-LONDON, V556, P315, DOI 10.1113/jphysiol.2003.057042
   Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102
   Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590
   Flouris George A., 2000, Molecular Cell Biology Research Communications, V4, P62, DOI 10.1006/mcbr.2000.0255
   Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D
   Franklin SS, 2001, CIRCULATION, V103, P1245
   Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354
   Franklin SS, 1997, CIRCULATION, V96, P308
   Franzoni F, 2005, AM J HYPERTENS, V18, P510, DOI 10.1016/j.amjhyper.2004.11.006
   Gano LB, 2010, CIRCULATION, V122
   Gano LB, 2014, AM J PHYSIOL-HEART C, V307, pH1754, DOI 10.1152/ajpheart.00377.2014
   Ganz P, 2003, CIRCULATION, V108, P2049, DOI 10.1161/01.CIR.0000089507.19675.F9
   Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849
   Gioscia-Ryan RA, 2014, J PHYSIOL-LONDON, V592, P2549, DOI 10.1113/jphysiol.2013.268680
   Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180
   Gong X, 2014, EXP GERONTOL, V52, P9, DOI 10.1016/j.exger.2014.01.015
   Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Hamilton CA, 2001, HYPERTENSION, V37, P529, DOI 10.1161/01.HYP.37.2.529
   Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72
   Hatzistamou J, 1996, BIOCHEM BIOPH RES CO, V225, P186, DOI 10.1006/bbrc.1996.1151
   HAUDENSCHILD CC, 1981, HYPERTENSION, V3, P148, DOI 10.1161/01.HYP.3.3_Pt_2.I148
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Health United States, 2010, SPEC FEAT DEATH DYIN
   Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235
   Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027
   Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Hung LM, 2000, CARDIOVASC RES, V47, P549, DOI 10.1016/S0008-6363(00)00102-4
   Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622
   Inafuku Masashi, 2004, Rinsho Byori, V52, P961
   Issa Jaqueline Scholz, 2005, Arq. Bras. Cardiol., V85, P15, DOI 10.1590/S0066-782X2005001400004
   Jablonski Kristen L, 2009, Ther Adv Cardiovasc Dis, V3, P347, DOI 10.1177/1753944709345790
   Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025
   Janjetovic K, 2011, EUR J PHARMACOL, V668, P373, DOI 10.1016/j.ejphar.2011.07.004
   Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976
   Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034
   Kang LS, 2009, AM J PHYSIOL-HEART C, V297, pH1087, DOI 10.1152/ajpheart.00356.2009
   Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kaplon RE, 2011, J APPL PHYSIOL, V111, P1416, DOI 10.1152/japplphysiol.00721.2011
   Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Katakam PVG, 2000, HYPERTENSION, V35, P108, DOI 10.1161/01.HYP.35.1.108
   Katerelos M, 2010, IMMUNOL CELL BIOL, V88, P754, DOI 10.1038/icb.2010.44
   KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66
   Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8
   Kobayashi Y, 2005, INT J MOL MED, V16, P237
   Kovacic JC, 2011, CIRCULATION, V123, P1650, DOI 10.1161/CIRCULATIONAHA.110.007021
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Krouwer VJD, 2012, VASC CELL, V4, DOI 10.1186/2045-824X-4-12
   Kuwano Y, 2006, AM J PHYSIOL-CELL PH, V290, pC433, DOI 10.1152/ajpcell.00135.2005
   Kyng KJ, 2005, ONCOGENE, V24, P5026, DOI 10.1038/sj.onc.1208692
   Labinskyy N, 2006, CURR MED CHEM, V13, P989, DOI 10.2174/092986706776360987
   Lafontaine-Lacasse M, 2010, NEUROSCI LETT, V480, P1, DOI 10.1016/j.neulet.2010.01.008
   LAI JH, 1994, J BIOL CHEM, V269, P30077
   Lakatta EG, 2009, MED CLIN N AM, V93, P583, DOI 10.1016/j.mcna.2009.02.008
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Leiro J, 2004, J LEUKOCYTE BIOL, V75, P1156, DOI 10.1189/jlb.1103561
   Lesniewski LA, 2012, MECH AGEING DEV, V133, P368, DOI 10.1016/j.mad.2012.03.011
   Lesniewski LA, 2011, AM J PHYSIOL-HEART C, V301, pH1025, DOI 10.1152/ajpheart.01276.2010
   Lesniewski LA, 2011, J GERONTOL A-BIOL, V66, P409, DOI 10.1093/gerona/glq233
   Lesniewski LA, 2009, J GERONTOL A-BIOL, V64, P9, DOI 10.1093/gerona/gln049
   Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200
   Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452
   Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116
   Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491
   Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010
   Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4
   Luscher TF, 1997, CLIN CARDIOL, V20, P3
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b
   MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499
   Majithiya JB, 2006, LIFE SCI, V78, P2615, DOI 10.1016/j.lfs.2005.10.020
   Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235
   Mannell HK, 2012, CARDIOVASC RES, V93, P111, DOI 10.1093/cvr/cvr265
   Marchand A, 2011, AGING CELL, V10, P220, DOI 10.1111/j.1474-9726.2010.00661.x
   Marchesi S, 2000, ATHEROSCLEROSIS, V153, P397, DOI 10.1016/S0021-9150(00)00415-9
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104
   Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc
   Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje
   Mervaala EMA, 2001, HYPERTENSION, V37, P414, DOI 10.1161/01.HYP.37.2.414
   Mihm MJ, 2000, J CARDIOVASC PHARM, V36, P182, DOI 10.1097/00005344-200008000-00007
   Miller SJ, 2007, AM J PHYSIOL-HEART C, V293, pH2634, DOI 10.1152/ajpheart.00397.2007
   Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17
   Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68
   Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031
   Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   Moreau KL, 2003, J PHYSIOL-LONDON, V547, P309, DOI 10.1113/jphysiol.2002.032524
   Morgan RG, 2013, AM J PHYSIOL-HEART C, V305, pH251, DOI 10.1152/ajpheart.00197.2013
   Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514
   Myatt L, 1996, HYPERTENSION, V28, P488, DOI 10.1161/01.HYP.28.3.488
   Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504
   Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Newby K, 1997, CLIN CARDIOL, V20, P11, DOI 10.1002/clc.4960201405
   Nicholson WT, 2009, HYPERTENSION, V53, P973, DOI 10.1161/HYPERTENSIONAHA.108.121483
   Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299
   Novella S, 2013, AGE, V35, P117, DOI 10.1007/s11357-011-9337-y
   Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114
   Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602
   Oikawa S, 2001, BIOCHEMISTRY-US, V40, P4763, DOI 10.1021/bi002721g
   Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460
   Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Paik JH, 2006, BIOCHEM SOC T, V34, P731, DOI 10.1042/BST0340731
   Papanicolaou KN, 2008, CIRC RES, V102, P16, DOI 10.1161/CIRCRESAHA.107.164186
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Pelegrí C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002
   PERSSON MG, 1990, BRIT J PHARMACOL, V100, P463, DOI 10.1111/j.1476-5381.1990.tb15829.x
   Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev
   Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294
   Pober JS, 2009, ANNU REV PATHOL-MECH, V4, P71, DOI 10.1146/annurev.pathol.4.110807.092155
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Price DT, 2000, ANTIOXID REDOX SIGN, V2, P919, DOI 10.1089/ars.2000.2.4-919
   Pu YF, 2013, CELL PHYSIOL BIOCHEM, V32, P1167, DOI 10.1159/000354516
   Quijano C, 2007, AM J PHYSIOL-HEART C, V293, pH3404, DOI 10.1152/ajpheart.00761.2007
   Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056
   READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503
   Reihl K, 2013, FASEB J, V27
   Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Romano MF, 2004, EUR J CANCER, V40, P2829, DOI 10.1016/j.ejca.2004.08.017
   Rudolph TK, 2007, AM J CLIN NUTR, V86, P334, DOI 10.1093/ajcn/86.2.334
   Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7
   Ryan NA, 2006, J APPL PHYSIOL, V100, P178, DOI 10.1152/japplphysiol.00827.2005
   Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Samper E, 2003, AGING CELL, V2, P277, DOI 10.1046/j.1474-9728.2003.00062.x
   Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254
   Sartoretto JL, 2005, LIFE SCI, V77, P2676, DOI 10.1016/j.lfs.2005.05.022
   SATO I, 1993, BIOCHEM BIOPH RES CO, V195, P1070, DOI 10.1006/bbrc.1993.2153
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708
   Schraufstatter IU, 2001, AM J PHYSIOL-LUNG C, V280, pL1094, DOI 10.1152/ajplung.2001.280.6.L1094
   SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515
   SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x
   Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476
   Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033
   Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196
   Sharp ZD, 2010, J GERONTOL A-BIOL, V65, P580, DOI 10.1093/gerona/glp212
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   Sindler AL, 2013, J APPL PHYSIOL, V114, P681, DOI 10.1152/japplphysiol.00341.2012
   Sindler AL, 2009, J PHYSIOL-LONDON, V587, P3885, DOI 10.1113/jphysiol.2009.172221
   Singh NP, 2003, FERTIL STERIL, V80, P1420, DOI 10.1016/j.fertnstert.2003.04.002
   Sitte N, 1998, FREE RADICAL BIO MED, V24, P885, DOI 10.1016/S0891-5849(97)00363-8
   Smith DT, 2003, J PHYSIOL-LONDON, V546, P289, DOI 10.1113/jphysiol.2002.027870
   Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31
   Spandidos DA, 1996, BIOCHEM BIOPH RES CO, V220, P137, DOI 10.1006/bbrc.1996.0370
   Spier SA, 2004, J PHYSIOL-LONDON, V556, P947, DOI 10.1113/jphysiol.2003.060301
   Spier SA, 2007, AM J PHYSIOL-HEART C, V292, pH3119, DOI 10.1152/ajpheart.00588.2006
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5
   Stivala LA, 2001, J BIOL CHEM, V276, P22586, DOI 10.1074/jbc.M101846200
   TADDEI S, 1995, CIRCULATION, V91, P1981, DOI 10.1161/01.CIR.91.7.1981
   Taddei S, 2001, HYPERTENSION, V38, P274, DOI 10.1161/01.HYP.38.2.274
   Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tang EHC, 2008, PHYSIOL GENOMICS, V32, P409, DOI 10.1152/physiolgenomics.00136.2007
   Tatchum-Talom R, 2004, CAN J PHYSIOL PHARM, V82, P200, DOI 10.1139/Y04-010
   Thoreen CC, 2005, CELL METAB, V1, P287, DOI 10.1016/j.cmet.2005.04.009
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Trott DW, 2011, J APPL PHYSIOL, V110, P1171, DOI 10.1152/japplphysiol.01037.2010
   Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703
   Tuñón MJ, 2003, BIOCHEM PHARMACOL, V66, P439, DOI 10.1016/S0006-2952(03)00288-0
   Uddin M, 2003, MECH AGEING DEV, V124, P811, DOI 10.1016/S0047-6374(03)00135-0
   Ungvari Z, 2008, AM J PHYSIOL-HEART C, V294, pH2121, DOI 10.1152/ajpheart.00012.2008
   Ungvari Z, 2011, J GERONTOL A-BIOL, V66, P866, DOI 10.1093/gerona/glr092
   VAITKEVICIUS PV, 1993, CIRCULATION, V88, P1456, DOI 10.1161/01.CIR.88.4.1456
   van den Berg R, 2001, BRIT J NUTR, V86, pS121, DOI 10.1079/BJN2001340
   van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731
   van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003
   Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X
   Veilai T, 2003, NATURE, V426
   Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945
   Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176
   Walker AE, 2014, CLIN SCI, V127, P645, DOI 10.1042/CS20140030
   Walker AE, 2014, AGE, V36, P559, DOI 10.1007/s11357-013-9585-0
   Walker AE, 2010, HYPERTENSION, V55, P363, DOI 10.1161/HYPERTENSIONAHA.109.145870
   Walker AE, 2009, AM J HYPERTENS, V22, P250, DOI 10.1038/ajh.2008.353
   Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409
   Westby CM, 2011, CLIN SCI, V120, P485, DOI 10.1042/CS20100475
   Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069
   Whittle JR, 2007, TRENDS ENDOCRIN MET, V18, P356, DOI 10.1016/j.tem.2007.07.007
   Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Wong AKF, 2009, CLIN SCI, V116, P607, DOI 10.1042/CS20080066
   Woodman CR, 2002, J APPL PHYSIOL, V93, P1685, DOI 10.1152/japplphysiol.00461.2002
   Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200
   Xiao J, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/185172
   Xin MG, 2003, MECH AGEING DEV, V124, P911, DOI 10.1016/S0047-6374(03)00163-5
   Yamamoto K, 2002, P NATL ACAD SCI USA, V99, P890, DOI 10.1073/pnas.022608799
   Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002
   Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100
   Zhu WQ, 2012, NATURE, V492, P252, DOI 10.1038/nature11603
   Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052
   Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483
NR 286
TC 351
Z9 376
U1 2
U2 99
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0022-2828
EI 1095-8584
J9 J MOL CELL CARDIOL
JI J. Mol. Cell. Cardiol.
PD DEC
PY 2015
VL 89
BP 122
EP 135
DI 10.1016/j.yjmcc.2015.01.021
PN B
PG 14
WC Cardiac & Cardiovascular Systems; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Cell Biology
GA CZ9KV
UT WOS:000367417400004
PM 25655936
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Hansson, A
   Hance, N
   Dufour, E
   Rantanen, A
   Hultenby, K
   Clayton, DA
   Wibom, R
   Larsson, NG
AF Hansson, A
   Hance, N
   Dufour, E
   Rantanen, A
   Hultenby, K
   Clayton, DA
   Wibom, R
   Larsson, NG
TI A switch in metabolism precedes increased mitochondrial biogenesis in
   respiratory chain-deficient mouse hearts
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID DNA GENE-EXPRESSION; FAILING HEART; KNOCKOUT MICE; ENZYME; MUSCLE;
   DISEASES; PHOSPHOFRUCTOKINASE; DIFFERENTIATION; CARDIOMYOPATHY;
   MAINTENANCE
AB We performed global gene expression analyses in mouse hearts with progressive respiratory chain deficiency and found a metabolic switch at an early disease stage. The tissue-specific mitochondrial transcription factor A (Tfam) knockout mice of this study displayed a progressive heart phenotype with depletion of mtDNA and an accompanying severe decline of respiratory chain enzyme activities along with a decreased mitochondrial ATP production rate. These characteristics were observed after 2 weeks of age and became gradually more severe until the terminal stage occurred at 10-12 weeks of age. Global gene expression analyses with microarrays showed that a metabolic switch occurred early in the progression of cardiac mitochondrial dysfunction. A large number of genes encoding critical enzymes in fatty acid oxidation showed decreased expression whereas several genes encoding glycolytic enzymes showed increased expression. These alterations are consistent with activation of a fetal gene expression program, a well-documented phenomenon in cardiac disease. An increase in mitochondrial mass was not observed until the disease had reached an advanced stage. In contrast to what we have earlier observed in respiratory chain-deficient skeletal muscle, the increased mitochondrial biogenesis in respiratory chain-deficient heart muscle did not increase the overall mitochondrial ATP production rate. The observed switch in metabolism is unlikely to benefit energy homeostasis in the respiratory chain-deficient hearts and therefore likely aggravates the disease. It can thus be concluded that at least some of the secondary gene expression alterations in mitochondrial cardiomyopathy do not compensate but rather directly contribute to heart failure progression.
C1 Karolinska Univ Hosp, Karolinska Inst, Dept Med Nutr & Biosci, Novum, S-14186 Huddinge, Sweden.
   Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Novum, S-14186 Huddinge, Sweden.
   Karolinska Univ Hosp, Karolinska Inst, Clin Res Ctr, Novum, S-14186 Huddinge, Sweden.
   Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
C3 Karolinska Institutet; Karolinska University Hospital; Karolinska
   Institutet; Karolinska University Hospital; Karolinska Institutet;
   Karolinska University Hospital; Howard Hughes Medical Institute
RP Karolinska Univ Hosp, Karolinska Inst, Dept Med Nutr & Biosci, Novum, S-14186 Huddinge, Sweden.
EM nils-goran.larsson@mednut.ki.se
RI Dufour, Eric/AAF-6210-2020; Larsson, Nils-Göran/GVS-5578-2022
OI Dufour, Eric/0000-0001-6690-5329; Larsson,
   Nils-Goran/0000-0001-5100-996X
CR ARAI M, 1994, CIRC RES, V74, P555, DOI 10.1161/01.RES.74.4.555
   BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x
   BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x
   Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   DIMAURO S, 1983, ANN NEUROL, V13, P11, DOI 10.1002/ana.410130104
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297
   Förster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299
   Giraud S, 1998, J MOL BIOL, V281, P409, DOI 10.1006/jmbi.1998.1955
   Graff C, 2002, BEST PRACT RES CL OB, V16, P715, DOI 10.1053/beog.2002.0315
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   KELLY DP, 1989, J BIOL CHEM, V264, P18921
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6
   Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   MANSOUR TE, 1965, J BIOL CHEM, V240, P2165
   OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391
   Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526
   Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Silva JP, 2002, BBA-BIOENERGETICS, V1555, P106, DOI 10.1016/S0005-2728(02)00263-3
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798
   WANKERL M, 1995, J MOL MED-JMM, V73, P487
   Weibel ER, 1979, STEREOLOGICAL METHOD, V1
   Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
NR 35
TC 174
Z9 188
U1 0
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 2
PY 2004
VL 101
IS 9
BP 3136
EP 3141
DI 10.1073/pnas.0308710100
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 800ZD
UT WOS:000220065300087
PM 14978272
OA Green Published
DA 2024-11-01
ER

PT J
AU Estep, PA
   Johnson, KA
AF Estep, Patricia A.
   Johnson, Kenneth A.
TI Effect of the Y955C Mutation on Mitochondrial DNA Polymerase Nucleotide
   Incorporation Efficiency and Fidelity
SO BIOCHEMISTRY
LA English
DT Article
ID REPLICATION; MECHANISM; GAMMA; DISCRIMINATION; CONSEQUENCES;
   SPECIFICITY; EXPLORER; DEFECTS
AB The human mitochondrial DNA polymerase (pol gamma) is responsible for the replication of the mitochondrial genome. Mutation Y955C in the active site of pol gamma results in early onset progressive external ophthalmoplegia, premature ovarian failure, and Parkinson's disease. In single-turnover kinetic studies, we show that the Y955C mutation results in a decrease in the maximal rate of polymerization and an increase in the K-m for correct incorporation. The mutation decreased the specificity constant for correct incorporation of dGTP, TTP, and ATP to values of 1.5, 0.35, and 0.044 mu M-1 s(-1), respectively, representing reductions of 30-, 110-, and 1300-fold, respectively, relative to the value for the wild-type enzyme. The fidelity of incorporation was reduced 6-130-fold, largely because of the significant decrease in the specificity constant for correct dATP:T incorporation. For example, K-cat/K-m for forming a TTP:T mismatch was decreased 10-fold from 0.0002 to 0.00002 mu M-1 s(-1) by the Y955C mutant, but the 1300-fold slower incorporation of the correct dATP:T relative to that of the wild type led to a 130-fold lower fidelity. While correct incorporation of 8-oxo-dGTP was largely unchanged, the level of incorporation of 8-oxo-dG with dA in the template strand was reduced 500-fold. These results support a role for Y955 in stabilizing A:T base pairs at the active site of pol gamma and suggest that the severe clinical symptoms of patients with this mutation may be due, in part, to the reduced efficiency of incorporation of dATP opposite T, and that the autosomal dominant phenotype may arise from the resulting higher mutation frequency.
C1 [Estep, Patricia A.; Johnson, Kenneth A.] Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.
C3 University of Texas System; University of Texas Austin
RP Johnson, KA (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, 2500 Speedway, Austin, TX 78712 USA.
EM kajohnson@mail.utexas.edu
FU National Institutes of Health [GM044613]; Welch Foundation [F-1604]
FX This work was supported by a grant from the National Institutes of
   Health (GM044613) and by the Welch Foundation (F-1604).
CR Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565
   Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219
   Batabyal D, 2010, J BIOL CHEM, V285, P34191, DOI 10.1074/jbc.M110.156182
   Bertram JG, 2010, BIOCHEMISTRY-US, V49, P20, DOI 10.1021/bi901653g
   BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689
   Copeland WC, 2004, ENVIRON MOL MUTAGEN, V44, P193
   DONLIN MJ, 1994, BIOCHEMISTRY-US, V33, P9
   Doublié S, 1998, NATURE, V391, P251, DOI 10.1038/34593
   Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805
   Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227
   Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695
   Hanes JW, 2008, ANAL BIOCHEM, V372, P125, DOI 10.1016/j.ab.2007.08.004
   Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200
   Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w
   Johnson AA, 2001, J BIOL CHEM, V276, P38090
   Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200
   JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345
   Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200
   Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006
   Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025
   Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024
   Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293, DOI 10.1146/annurev.biochem.72.121801.161455
   KATI WM, 1992, J BIOL CHEM, V267, P25988
   Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107
   Lee HR, 2006, J BIOL CHEM, V281, P36236, DOI 10.1074/jbc.M607964200
   Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050
   Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523
   Lim SE, 2001, J BIOL CHEM, V276, P23616, DOI 10.1074/jbc.M101114200
   Longley MJ, 2005, GENE, V354, P125, DOI 10.1016/j.gene.2005.03.029
   Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196
   Pagnamenta AT, 2006, HUM REPROD, V21, P2467, DOI 10.1093/humrep/del076
   PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029
   PONAMEREV MV, 2002, J BIOL CHEM, V277, P3
   PURSELL ZF, 2008, NUCLEIC ACIDS RES, V36, P7
   TAYLOR RW, 2005, NAT REV, V6, P14
   Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z
   Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39
   Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824
NR 38
TC 21
Z9 23
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 26
PY 2011
VL 50
IS 29
BP 6376
EP 6386
DI 10.1021/bi200280r
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 793UO
UT WOS:000292849600012
PM 21696159
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Dhawan, S
   Musa, AH
   Mantripragada, K
AF Dhawan, Saurav
   Musa, Abdel H.
   Mantripragada, Khyathi
TI Novel Mitochondrial Cytopathy Causing Mitochondrial Encephalomyopathy
   With Lactic Acidosis and Stroke-Like Episodes Syndrome and
   Tubulointerstitial Nephropathy
SO CUREUS JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE novel mutation; mitochondrial disorder; stroke; kidney transplant; melas
ID RENAL MANIFESTATIONS; DISEASE; ADULTS; MELAS
AB Mitochondrial cytopathies, predominantly MT-TL1 mutations and, to a lesser extent, MT-ND5, have been associated with mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), manifesting as multi-organ dysfunction. This is just the second instance of MELAS secondary to the pathogenic novel m.13091T>C variant of MT-ND5. Moreover, nephropathy associated with MT-ND5 mutation has only been reported in nine cases so far. A middle-aged man presented in a state of acute confusion with speech difficulty with both receptive and expressive aphasia. He had a background of refractory seizures, chronic atypical migraine, childhood-onset optic neuropathy, and end-stage renal disease requiring renal transplant. During admission, he had episodes of aggression and paranoid beliefs. Magnetic resonance (MR) imaging of the head showed multiple areas of cortical abnormality, unusual for age, including a large frontal infarct crossing arterial boundaries. Cerebrospinal fluid (CSF) protein and lactate were high, whereas, the electroencephalography (EEG) result was normal. Muscle biopsy mitochondrial DNA gene sequencing derived novel MT-ND5 gene variant m.13091T>C p.(Met252Thr). Kidney biopsy previously had shown interstitial fibrosis and tubular atrophy. He was managed as acute ischaemic stroke along with a combination of clobazam, levetiracetam, and eslicarbazepine for seizures. MELAS typically presents with seizures, stroke-like episodes, cortical visual loss, and recurrent migraine headaches. The previous reported case of m.13091T>C mutation followed a similar progression, however, there was no associated nephropathy and normal visual acuity. Kidney transplants in affected patients of MELAS have been associated with a high survival rate. MT-ND5 mutation-associated nephropathy has shown a variable manifestation, either as focal segmental glomerular sclerosis (FSGS) or tubulo-interstitial disease.
C1 [Dhawan, Saurav; Musa, Abdel H.] Manchester Univ Natl Hlth Serv NHS Fdn Trust, Internal Med, Manchester, Lancs, England.
   [Mantripragada, Khyathi] Stockport Natl Hlth Serv NHS Trust, Internal Med, Stockport, England.
RP Dhawan, S (corresponding author), Manchester Univ Natl Hlth Serv NHS Fdn Trust, Internal Med, Manchester, Lancs, England.
EM saurav322dhawan@gmail.com
CR Alcubilla-Prats P, 2017, MED CLIN-BARCELONA, V148, P357, DOI [10.1016/j.medcle.2017.04.002, 10.1016/j.medcli.2017.01.029]
   Bakis H, 2020, CLIN GENET, V97, P628, DOI 10.1111/cge.13670
   Barone V, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.887696
   Chinnery PF, 2020, Primary Mitochondrial Disorders Overview
   Danhelovska T, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-1912-x
   El-Hattab AW, 2001, MELAS. GeneReviews
   Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214
   Ferreira F, 2023, NEFROLOGIA, V43, P1, DOI [10.1016/j.nefro.2023.03.004, 10.1016/j.nefroe.2024.01.017]
   Finsterer J, 2017, BIOMED REP, V6, P487, DOI 10.3892/br.2017.892
   Hall AM, 2015, KIDNEY INT, V87, P610, DOI 10.1038/ki.2014.297
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   Naganuma T, 2023, MOL GENET METAB REP, V35, DOI 10.1016/j.ymgmr.2023.100963
   Parikh S, 2016, MOL GENET METAB, V118, P178, DOI 10.1016/j.ymgme.2016.04.009
   Swart Grace, 2024, J Neuroophthalmol, V44, P190, DOI 10.1097/WNO.0000000000001946
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2168-8184
J9 CUREUS J MED SCIENCE
JI Cureus J Med Sci
PD AUG 12
PY 2024
VL 16
IS 8
AR e66722
DI 10.7759/cureus.66722
PG 8
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA D3S2O
UT WOS:001295410900001
PM 39262552
OA gold
DA 2024-11-01
ER

PT J
AU Ramelli, GP
   Gallati, S
   Weis, J
   Krähenbühl, S
   Burgunder, JM
AF Ramelli, GP
   Gallati, S
   Weis, J
   Krähenbühl, S
   Burgunder, JM
TI Point mutation tRNA<i><SUP>Ser(UCN)</SUP></i> in a child with hearing
   loss and myoclonus epilepsy
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
ID MITOCHONDRIAL; DISEASE; GENE; MELAS; CHAIN; MERRF
AB We report on a family with a 12-year-old boy who suffered from a maternally inherited syndrome characterized by a combination of sensorineural hearing loss, myoclonus epilepsy, ataxia, severe psychomotor retardation, short stature, and diabetes mellitus. First, he showed a muscular hypotonia with hearing loss; later, he developed a myoclonus epilepsy, growth failure, and severe psychomotor retardation. At the age of 10 years, he developed diabetes mellitus. After initiation of combined ubiquinone and vitamin C treatment, we observed a progression in psychomotor development. Lactate and pyruvate levels in blood and cerebrospinal fluid were normal. No ragged red fibers or ultrastructural abnormalities were seen in a skeletal muscle biopsy. Biochemical assays of respiratory chain complex activities revealed decreased activity of complexes I and IV. By sequence analysis of mitochondrial DNA encoding transfer ribonucleic acids (RNAs), a homoplasmic T to C substitution at nucleotide position 7512 was found affecting a highly conserved base pair in the tRNA(ser(UCN)) acceptor stem. Asymptomatic family members of the maternal line were heteroplasmic for the mutation in blood samples. Analysis of mitochondrial DNA in patients with hearing loss and myoclonus epilepsy is recommended, even in the absence of laboratory findings. Therapeutically, ubiquinone and antioxidants can be beneficial.
C1 Osped San Giovanni Bellinzona, Dept Pediat, CH-6500 Bellinzona, Switzerland.
   Univ Bern, Dept Pediat, Div Human Genet, Bern, Switzerland.
   Univ Bern, Inst Pathol, Bern, Switzerland.
   Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel, Switzerland.
   Univ Bern, Inselspital, Dept Neurol, Bern, Switzerland.
C3 Regional Hospital of Bellinzona & Valleys, San Giovanni; University of
   Bern; University of Bern; University of Basel; University of Bern;
   University Hospital of Bern
RP Ramelli, GP (corresponding author), Osped San Giovanni Bellinzona, Dept Pediat, CH-6500 Bellinzona, Switzerland.
EM gianpaolo.ramelli@eoc.ch
RI Weis, Joachim/G-1984-2014; Krähenbühl, Stephan/Z-4744-2019
CR BRESOLIN N, 1990, J NEUROL SCI, V100, P70, DOI 10.1016/0022-510X(90)90015-F
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Ikejiri Y, 1996, NEUROLOGY, V47, P583, DOI 10.1212/WNL.47.2.583
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Kleinle S, 1998, BIOCHEM BIOPH RES CO, V247, P112, DOI 10.1006/bbrc.1998.8729
   Krahenbuhl S, 1996, CLIN CHIM ACTA, V253, P79, DOI 10.1016/0009-8981(96)06338-3
   Liechti-Gallati S, 1999, EUR J HUM GENET, V7, P590, DOI 10.1038/sj.ejhg.5200338
   MATTHEWS PM, 1993, NEUROLOGY, V43, P884, DOI 10.1212/WNL.43.5.884
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   NAKAMURA M, 1995, BIOCHEM BIOPH RES CO, V214, P86, DOI 10.1006/bbrc.1995.2260
   SARVIDEI S, 1996, NEUROMUSCULAR DISORD, V6, P11
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   TIRANTI V, 1995, HUM MOL GENET, V4, P1421, DOI 10.1093/hmg/4.8.1421
   Wallace D.C., 1995, HUMAN GENE MAPPING 1, P910
NR 14
TC 4
Z9 4
U1 0
U2 1
PU B C DECKER INC
PI HAMILTON
PA 20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7,
   CANADA
SN 0883-0738
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2006
VL 21
IS 3
BP 253
EP 255
DI 10.2310/7010.2006.00047
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 049FX
UT WOS:000238002500016
PM 16901431
DA 2024-11-01
ER

PT J
AU Zhang, J
   Shi, YG
AF Zhang, Jun
   Shi, Yuguang
TI In Search of the Holy Grail: Toward a Unified Hypothesis on
   Mitochondrial Dysfunction in Age-Related Diseases
SO CELLS
LA English
DT Review
DE ALCAT1; cardiolipin; mitochondrial dysfunction; aging; age-related
   diseases
ID ELECTRON-TRANSPORT CHAIN; ACETYL-L-CARNITINE; INCREASED OXIDATIVE
   STRESS; COMPLEX-I ACTIVITY; C-OXIDASE ACTIVITY; CYTOCHROME-C; RAT-HEART;
   SKELETAL-MUSCLE; TETRALINOLEOYL-CARDIOLIPIN; DOCOSAHEXAENOIC ACID
AB Cardiolipin (CL) is a mitochondrial signature phospholipid that plays a pivotal role in mitochondrial dynamics, membrane structure, oxidative phosphorylation, mtDNA bioenergetics, and mitophagy. The depletion or abnormal acyl composition of CL causes mitochondrial dysfunction, which is implicated in the pathogenesis of aging and age-related disorders. However, the molecular mechanisms by which mitochondrial dysfunction causes age-related diseases remain poorly understood. Recent development in the field has identified acyl-CoA:lysocardiolipin acyltransferase 1 (ALCAT1), an acyltransferase upregulated by oxidative stress, as a key enzyme that promotes mitochondrial dysfunction in age-related diseases. ALCAT1 catalyzes CL remodeling with very-long-chain polyunsaturated fatty acids, such as docosahexaenoic acid (DHA). Enrichment of DHA renders CL highly sensitive to oxidative damage by reactive oxygen species (ROS). Oxidized CL becomes a new source of ROS in the form of lipid peroxides, leading to a vicious cycle of oxidative stress, CL depletion, and mitochondrial dysfunction. Consequently, ablation or the pharmacological inhibition of ALCAT1 have been shown to mitigate obesity, type 2 diabetes, heart failure, cardiomyopathy, fatty liver diseases, neurodegenerative diseases, and cancer. The findings suggest that age-related disorders are one disease (aging) manifested by different mitochondrion-sensitive tissues, and therefore should be treated as one disease. This review will discuss a unified hypothesis on CL remodeling by ALCAT1 as the common denominator of mitochondrial dysfunction, linking mitochondrial dysfunction to the development of age-related diseases.
C1 [Zhang, Jun; Shi, Yuguang] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, Dept Pharmacol, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Shi, YG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, Dept Pharmacol, San Antonio, TX 78229 USA.
EM zhangj7@uthscsa.edu; shiy4@uthscsa.edu
RI Zhang, Jun/W-5146-2019
OI Shi, Yuguang/0000-0002-9979-5661; Zhang, Jun/0000-0002-8489-3699
FU National Institute on Aging [R01AG055747, P30AG013319]; American
   Diabetes Association [1-18 IBS-329]; Barth Syndrome Foundation; National
   Institute on Aging [R01AG055747] Funding Source: NIH RePORTER
FX This research was funded by the National Institute on Aging
   (R01AG055747, Y.S., P30AG013319, Y.S.), American Diabetes Association
   (#1-18 IBS-329, Y.S.), Barth Syndrome Foundation (Y.S. and J.Z.), and an
   endowment from Joe R. and Teresa Lozano Long Distinguished Chair in
   Metabolic Biology (Y.S.).
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Agrawal I, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00252
   Ahmadpour ST, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218031
   Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168
   Beltrán-Heredia E, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0471-x
   Bissler JJ, 2002, LAB INVEST, V82, P335, DOI 10.1038/labinvest.3780427
   Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601
   Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008
   Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200
   Chen DH, 2006, BIOCHEM J, V398, P169, DOI 10.1042/BJ20060303
   Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003
   DeBerardinis RJ, 2020, NAT METAB, V2, P127, DOI 10.1038/s42255-020-0172-2
   Desai R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc9955
   Deus CM, 2020, TRENDS MOL MED, V26, P71, DOI 10.1016/j.molmed.2019.10.009
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005
   Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039
   Fane M, 2020, NAT REV CANCER, V20, P89, DOI 10.1038/s41568-019-0222-9
   Feng HM, 2018, ONCOL LETT, V15, P2661, DOI 10.3892/ol.2017.7591
   Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015
   Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379
   HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054
   Hsu P, 2017, BBA-MOL CELL BIOL L, V1862, P114, DOI 10.1016/j.bbalip.2016.08.003
   Huang LS, 2020, J BIOL CHEM, V295, P13393, DOI 10.1074/jbc.RA120.012680
   Hulbert AJ, 2008, COMP BIOCHEM PHYS A, V150, P196, DOI 10.1016/j.cbpa.2006.05.014
   Jia DD, 2021, MOL THER, V29, P3498, DOI 10.1016/j.ymthe.2021.06.007
   Joubert F, 2021, MEMBRANES-BASEL, V11, DOI 10.3390/membranes11070465
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011
   Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200
   Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636
   Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2
   Li J, 2012, P NATL ACAD SCI USA, V109, P6975, DOI 10.1073/pnas.1120043109
   Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003
   Li XB, 2019, J CELL PHYSIOL, V234, P16238, DOI 10.1002/jcp.28287
   Liu XL, 2012, MOL CELL BIOL, V32, P4493, DOI 10.1128/MCB.01092-12
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu B, 2006, J LIPID RES, V47, P1140, DOI 10.1194/jlr.C600004-JLR200
   Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003
   Mejia EM, 2016, J BIOENERG BIOMEMBR, V48, P99, DOI 10.1007/s10863-015-9601-4
   Menshikova EV, 2007, J APPL PHYSIOL, V103, P21, DOI 10.1152/japplphysiol.01228.2006
   Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781
   Neuwald AF, 1997, CURR BIOL, V7, pR465
   Ng Y, 2005, CARCINOGENESIS, V26, P1914, DOI 10.1093/carcin/bgi163
   Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183
   Pamplona R, 1998, J LIPID RES, V39, P1989
   Pangborn MC, 1942, J BIOL CHEM, V143, P247
   Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Paradies G, 1999, FEBS LETT, V454, P207, DOI 10.1016/S0014-5793(99)00809-1
   Paradies G, 2004, CIRC RES, V94, P53, DOI 10.1161/01.RES.0000109416.56608.64
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   PARADIES G, 1994, FEBS LETT, V350, P213, DOI 10.1016/0014-5793(94)00763-2
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020
   Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012
   Pathak S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098317
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108
   RUSTOW B, 1989, BIOCHIM BIOPHYS ACTA, V1002, P261, DOI 10.1016/0005-2760(89)90296-8
   Ryan T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03241-9
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   SCHLAME M, 1986, BIOCHEM J, V240, P247, DOI 10.1042/bj2400247
   SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Schlame M, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2020.148305
   Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506
   Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6
   Song CJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12941
   Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200
   Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461
   Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200
   Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628
   Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322
   Tocchi A, 2015, BBA-BIOENERGETICS, V1847, P1424, DOI 10.1016/j.bbabio.2015.07.009
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wang L, 2015, HEPATOLOGY, V61, P486, DOI 10.1002/hep.27420
   Wang WD, 2010, DEV DYNAM, V239, P1827, DOI 10.1002/dvdy.22300
   Wang WZ, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00376-6
   Watkins SM, 1998, J LIPID RES, V39, P1583
   Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448
   Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907
   Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200
   YAMAOKAKOSEKI S, 1991, J NUTR, V121, P956, DOI 10.1093/jn/121.7.956
   Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103
   Zhang J, 2022, AUTOPHAGY, V18, P2134, DOI 10.1080/15548627.2021.2020979
   Zhong HQ, 2017, FREE RADICAL BIO MED, V102, P67, DOI 10.1016/j.freeradbiomed.2016.10.494
   Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25
NR 103
TC 12
Z9 13
U1 4
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD JUN
PY 2022
VL 11
IS 12
AR 1906
DI 10.3390/cells11121906
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 2M1PE
UT WOS:000817479700001
PM 35741033
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Godschalk, R
   Remels, A
   Hoogendoorn, C
   van Benthem, J
   Luijten, M
   Duale, N
   Brunborg, G
   Olsen, AK
   Bouwman, FG
   Munnia, A
   Peluso, M
   Mariman, E
   van Schooten, FJ
AF Godschalk, Roger
   Remels, Alex
   Hoogendoorn, Camiel
   van Benthem, Jan
   Luijten, Mirjam
   Duale, Nur
   Brunborg, Gunnar
   Olsen, Ann-Karin
   Bouwman, Freek G.
   Munnia, Armelle
   Peluso, Marco
   Mariman, Edwin
   van Schooten, Frederik Jan
TI Paternal Exposure to Environmental Chemical Stress Affects Male
   Offspring's Hepatic Mitochondria
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE paternal exposure; offspring; mitochondria; oxidative stress; DNA damage
ID OBSTRUCTIVE PULMONARY-DISEASE; ADAPTIVE RESPONSE HYPOTHESIS; OXIDATIVE
   STRESS; GENE-EXPRESSION; DNA-DAMAGE; GERM-CELLS; MOUSE; INHERITANCE;
   MUSCLE; BLOOD
AB Preconceptional paternal exposures may affect offspring's health, which cannot be explained by mutations in germ cells, but by persistent changes in the regulation of gene expression. Therefore, we investigated whether pre-conceptional paternal exposure to benzo[a] pyrene (B[a]P) could alter the offspring's phenotype. Male C57BL/6 mice were exposed to B[a] P by gavage for 6 weeks, 3 x per week, and were crossed with unexposed BALB-c females 6 weeks after the final exposure. The offspring was kept under normal feeding conditions and was sacrificed at 3 weeks of age. Analysis of the liver proteome by 2D-gel electrophoresis and mass spectrometry indicated that proteins involved in mitochondrial function were significantly downregulated in the offspring of exposed fathers. This down-regulation of mitochondrial proteins was paralleled by a reduction in mitochondrial DNA copy number and reduced activity of citrate synthase and b-hydroxyacyl-CoA dehydrogenase, but in male offspring only. Surprisingly, analysis of hepatic mRNA expression revealed a male-specific up-regulation of the genes, whose proteins were downregulated, including Aldh2 and Ogg1. This discrepancy could be related to several selected microRNA (miRNA)'s that regulate the translation of these proteins; miRNA-122, miRNA-129-2-5p, and miRNA-1941 were upregulated in a gender-specific manner. Since mitochondria are thought to be a source of intracellular reactive oxygen species, we additionally assessed oxidatively-induced DNA damage. Both 8-hydroxy-deoxyguanosine and malondialdehyde-dG adduct levels were significantly reduced in male offspring of exposed fathers. In conclusion, we show that paternal exposure to B[a]P can regulate mitochondrial metabolism in offspring, which may have profound implications for our understanding of health and disease risk inherited from fathers.
C1 [Godschalk, Roger; Remels, Alex; Hoogendoorn, Camiel; van Schooten, Frederik Jan] Maastricht Univ, Dept Pharmacol & Toxicol, NUTRIM, Sch Nutr & Translat Res Metab, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.
   [van Benthem, Jan; Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect, Bilthoven, Netherlands.
   [Duale, Nur; Brunborg, Gunnar; Olsen, Ann-Karin] Norwegian Inst Publ Hlth, Dept Mol Biol, Oslo, Norway.
   [Bouwman, Freek G.; Mariman, Edwin] Maastricht Univ, Sch Nutr & Translat Res Metab, Dept Human Biol, NUTRIM, Maastricht, Netherlands.
   [Munnia, Armelle; Peluso, Marco] ISPO Canc Prevent & Res Inst, Canc Risk Factor Branch, Canc Prevent Lab, Florence, Italy.
C3 Maastricht University; Netherlands National Institute for Public Health
   & the Environment; Norwegian Institute of Public Health (NIPH);
   Maastricht University; ISPRO Istituto per lo studio, la prevenzione e la
   rete oncologica
RP Godschalk, R (corresponding author), Maastricht Univ, Dept Pharmacol & Toxicol, NUTRIM, Sch Nutr & Translat Res Metab, Univ Singel 50,POB 616, NL-6200 MD Maastricht, Netherlands.
EM r.godschalk@maastrichtuniversity.nl
RI Peluso, Marco/I-5187-2018
OI Peluso, Marco/0000-0001-7646-7967; Olsen, Ann-Karin/0000-0003-3982-5213
CR Aarem Jeanette, 2016, BMC Res Notes, V9, P430, DOI 10.1186/s13104-016-2224-y
   Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190
   Bateson P, 2014, J PHYSIOL-LONDON, V592, P2357, DOI 10.1113/jphysiol.2014.271460
   Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008
   Brevik A, 2012, TOXICOL SCI, V129, P157, DOI 10.1093/toxsci/kfs187
   Chaby LE, 2016, PHYSIOL BEHAV, V164, P164, DOI 10.1016/j.physbeh.2016.05.032
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   de Roos B, 2008, J PROTEOME RES, V7, P2280, DOI 10.1021/pr700714x
   Delic D, 2010, STEROIDS, V75, P998, DOI 10.1016/j.steroids.2010.06.010
   Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485
   Filkowski JN, 2010, CARCINOGENESIS, V31, P1110, DOI 10.1093/carcin/bgp300
   Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695
   Godschalk RWL, 2015, TOXICOL RES-UK, V4, P718, DOI 10.1039/c4tx00114a
   Gosker HR, 2006, AM J PHYSIOL-ENDOC M, V290, pE976, DOI 10.1152/ajpendo.00336.2005
   Gosker HR, 2002, EUR RESPIR J, V19, P617, DOI 10.1183/09031936.02.00762001
   Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061
   Halappanavar S, 2011, TOXICOLOGY, V285, P133, DOI 10.1016/j.tox.2011.04.011
   Jin JC, 2014, MOL MED REP, V9, P1376, DOI 10.3892/mmr.2014.1930
   Laubenthal J, 2012, FASEB J, V26, P3946, DOI 10.1096/fj.11-201194
   Li JQ, 2004, J CELL SCI, V117, P4673, DOI 10.1242/jcs.01339
   Lindeman, 2012, INT J CELL BIOL, V2012, P1
   Linschooten JO, 2011, REPROD TOXICOL, V32, P106, DOI 10.1016/j.reprotox.2011.05.004
   Linschooten JO, 2009, MUTAT RES-FUND MOL M, V667, P70, DOI 10.1016/j.mrfmmm.2008.12.014
   Maclary E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5209
   McPherson NO, 2014, ANN NUTR METAB, V64, P231, DOI 10.1159/000365026
   Moyes CD, 1998, J EXP BIOL, V201, P299
   Nettle D, 2015, P ROY SOC B-BIOL SCI, V282, P23, DOI 10.1098/rspb.2015.1005
   Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491
   Northstone K, 2014, EUR J HUM GENET, V22, P1382, DOI 10.1038/ejhg.2014.31
   Peluso M, 2013, MUTAGENESIS, V28, P315, DOI 10.1093/mutage/get005
   Rando OJ, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022988
   Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1
   Sipinen V, 2010, MUTAGENESIS, V25, P417, DOI 10.1093/mutage/geq024
   Straubinger K, 2014, J ALLERGY CLIN IMMUN, V134, P1271, DOI 10.1016/j.jaci.2014.05.034
   Thundathil J, 2005, MOL REPROD DEV, V71, P405, DOI 10.1002/mrd.20260
   van Helden YGJ, 2009, CARCINOGENESIS, V30, P2070, DOI 10.1093/carcin/bgp186
   Vanhees K, 2014, CELL MOL LIFE SCI, V71, P271, DOI 10.1007/s00018-013-1427-9
   Verhofstad N, 2011, TOXICOL SCI, V119, P218, DOI 10.1093/toxsci/kfq325
   Verhofstad N, 2010, ENVIRON MOL MUTAGEN, V51, P123, DOI 10.1002/em.20516
   Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009
   Wattez JS, 2015, AM J PHYSIOL-ENDOC M, V308, pE393, DOI 10.1152/ajpendo.00452.2014
   Wells JCK, 2012, INT J EPIDEMIOL, V41, P229, DOI 10.1093/ije/dyr239
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
NR 45
TC 18
Z9 19
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD MAR
PY 2018
VL 162
IS 1
BP 241
EP 250
DI 10.1093/toxsci/kfx246
PG 10
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA FY7DD
UT WOS:000427020900024
PM 29145655
OA Bronze
DA 2024-11-01
ER

PT J
AU Haraux, F
   Lombès, A
AF Haraux, Francis
   Lombes, Anne
TI Kinetic analysis of ATP hydrolysis by complex V in four murine tissues:
   Towards an assay suitable for clinical diagnosis
SO PLOS ONE
LA English
DT Article
ID SYNTHASE DEFICIENCY; INHIBITOR PROTEIN; MITOCHONDRIAL-DNA; MUTATIONS;
   IF1; IDENTIFICATION; SPECIFICITY; GENE
AB Background
   ATP synthase, the mitochondrial complex V, plays a major role in bioenergetics and its defects lead to severe diseases. Lack of a consensual protocol for the assay of complex V activity probably explains the under-representation of complex V defect among mitochondrial diseases. The aim of this work was to elaborate a fast, simple and reliable method to check the maximal complex V capacity in samples relevant to clinical diagnosis.
   Methods
   Using homogenates from four different murine organs, we tested the use of dodecylmaltoside, stability of the activity, linearity with protein amount, sensitivity to oligomycin and to exogenous inhibitory factor 1 (IF1), influence of freezing, and impact of mitochondrial purification.
   Results
   We obtained organ-dependent, reproducible and stable complex V specific activities, similar with fresh and frozen organs. Similar inhibition by oligomycin and exogenous IF1 demonstrated tight coupling between F-1 and F-0 domains. The Michaelis constant for MgATP had close values for all organs, in the 150-220 mu M range. Complex V catalytic turnover rate, as measured in preparations solubilized in detergent using immunotitration and activity measurements, was more than three times higher in extracts from brain or muscle than in extracts from heart or liver. This tissue specificity suggested post-translational modifications. Concomitant measurement of respiratory activities showed only slightly different complex II/complex V ratio in the four organs. In contrast, complex I/complex V ratio differed in brain as compared to the three other organs because of a high complex I activity in brain. Mitochondria purification preserved these ratios, except for brain where selective degradation of complex I occurred. Therefore, mitochondrial purification could introduce a biased enzymatic evaluation.
   Conclusion
   Altogether, this work demonstrates that a reliable assay of complex V activity is perfectly possible with very small samples from frozen biopsies, which was confirmed using control and deficient human muscles.
C1 [Haraux, Francis] CEA, I2BC, Gif Sur Yvette, France.
   [Haraux, Francis] CNRS, UMR 9198, Gif Sur Yvette, France.
   [Haraux, Francis] Univ Paris Saclay, Univ Paris Sud, Gif Sur Yvette, France.
   [Lombes, Anne] INSERM, Unite U1016, Inst Cochin, Paris, France.
   [Lombes, Anne] CNRS, UMR 8104, Paris, France.
   [Lombes, Anne] Univ Paris 05, Paris, France.
C3 Universite Paris Saclay; CEA; Universite Paris Saclay; Centre National
   de la Recherche Scientifique (CNRS); CNRS - National Institute for
   Biology (INSB); Universite Paris Saclay; Universite Paris Cite;
   Universite Paris Cite; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); Universite Paris Cite;
   Universite Paris Cite
RP Lombès, A (corresponding author), INSERM, Unite U1016, Inst Cochin, Paris, France.; Lombès, A (corresponding author), CNRS, UMR 8104, Paris, France.; Lombès, A (corresponding author), Univ Paris 05, Paris, France.
EM anne.lombes@inserm.fr
RI Lombes, Anne/G-4684-2014
OI Lombes, Anne/0000-0002-9064-0399
FU Fondation pour la Recherche Medicale (FRM) [DPM20121125550]; AFM
   Telethon [16416]; French Infrastructure for Integrated Structural
   Biology (FRISBI)
FX The authors are grateful for the support of the Fondation pour la
   Recherche Medicale (FRM) (grant DPM20121125550 to AL and FH), the AFM
   Telethon (grant 16416 to AL), and the French Infrastructure for
   Integrated Structural Biology (FRISBI, http://frisbi.eu) (to FH).
CR Andrianaivomananjaona T, 2011, BBA-BIOENERGETICS, V1807, P197, DOI 10.1016/j.bbabio.2010.10.002
   Antonicka H, 2006, HUM MOL GENET, V15, P1835, DOI 10.1093/hmg/ddl106
   Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7
   Auré K, 2013, NEUROLOGY, V81, P1810, DOI 10.1212/01.wnl.0000436067.43384.0b
   Barca E, 2018, HUM MOL GENET, V27, P3305, DOI 10.1093/hmg/ddy231
   Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034
   Cabezón E, 2002, J BIOL CHEM, V277, P41334, DOI 10.1074/jbc.M207169200
   Cizková A, 2008, NAT GENET, V40, P1288, DOI 10.1038/ng.246
   Dautant A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00329
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Vazquez-Memije ME, 2009, J CELL BIOCHEM, V106, P878, DOI 10.1002/jcb.22055
   Franko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082392
   Giorgio V, 2010, J BIOENERG BIOMEMBR, V42, P117, DOI 10.1007/s10863-010-9270-2
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2
   Hatefi Y., 1967, METHODS ENZYMOL, V10, P235
   JAULT JM, 1993, J BIOL CHEM, V268, P1558
   Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086
   Kucharczyk R, 2010, BBA-BIOENERGETICS, V1797, P1105, DOI 10.1016/j.bbabio.2009.12.022
   Lombès A, 2014, BIOCHIMIE, V100, P171, DOI 10.1016/j.biochi.2013.08.012
   MATSUNOYAGI A, 1988, BIOCHEMISTRY-US, V27, P335, DOI 10.1021/bi00401a050
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   Oláhová M, 2018, AM J HUM GENET, V102, P494, DOI 10.1016/j.ajhg.2018.01.020
   Pecinová A, 2011, MITOCHONDRION, V11, P722, DOI 10.1016/j.mito.2011.05.006
   Pfeffer G, 2012, J NEUROL NEUROSUR PS, V83, P883, DOI 10.1136/jnnp-2012-302568
   PULLMAN ME, 1963, J BIOL CHEM, V238, P3762
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Schmitt S, 2013, ANAL BIOCHEM, V443, P66, DOI 10.1016/j.ab.2013.08.007
   Shibata T, 2015, BIOCHEM BIOPH RES CO, V463, P563, DOI 10.1016/j.bbrc.2015.05.095
   Sikorska M, 2009, MUSCLE NERVE, V40, P381, DOI 10.1002/mus.21355
   Song JY, 2018, P NATL ACAD SCI USA, V115, P2850, DOI 10.1073/pnas.1801697115
   Thompson K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809060
   vanRaaij MJ, 1996, BIOCHEMISTRY-US, V35, P15618, DOI 10.1021/bi960628f
   Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925
   Venard R, 2003, BIOCHEMISTRY-US, V42, P7626, DOI 10.1021/bi034394t
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   ZIEGLER D, 1967, METHOD ENZYMOL, V10, P231
NR 40
TC 12
Z9 12
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 28
PY 2019
VL 14
IS 8
AR e0221886
DI 10.1371/journal.pone.0221886
PG 24
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IW5XV
UT WOS:000485052300062
PM 31461494
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Yang, FY
AF Yang Fuyu
TI Keshan disease and mitochondrial cardiomyopathy
SO SCIENCE IN CHINA SERIES C-LIFE SCIENCES
LA English
DT Review
DE mitochondrial disease; Keshan disease; mitochondrial cardlomyopathy
ID MUTATION; DNA; SE
AB Keshan disease (KD) is a potentially fatal form of cardiornyopathy (disease of the heart muscle) endemic in certain areas of China. From 1984 to 1986, a national comprehensive scientific investigation on KD in Chuxiong region of Yunnan Province in the southwest China was conducted. The investigation team was composed of epidemiologists, clinic doctors, pathologists, biochemists, biophysicists and specialists in ecological environment. Results of pathological, biochemical and biophysical as well as clinical studies showed: an obvious increase of enlarged and swollen mitochondria with distended crista membranes in myocardium from patients with KD; significant reductions in the activity of oxidative phosphorylation (succinate dehydrogenase, cytochrome oxidase, succinate oxidase, H+-ATPase) of affected mitochondria; decrease in CoQ, cardiolipin, Se and GSHPx activity, while obvious increase in the Ca2+ content. So, it was suggested that mitochondria are the predominant target of the pathogenic factors of KD. Before Chuxiong KD survey only a few cases of mitochondrial cardiornyopathy were studied. During the multidisciplinary scientific investigation on KD in Chuxiong a large amount of samples from KD cases and the positive controls were examined. On the basis of the results obtained it was suggested that KD might be classified as a "Mitochondrial Cardiomyopathy" endemic in China. This is one of the achievements in the three years' survey in Chuxiong and is valuable not only to the deeper understanding of pathogenic mechanism of KD but also to the study of mitochondrial cardiomyopathy in general.
   Keshan disease is not a genetic disease, but is closely related to the malnutrition (especially microelement Se deficiency). KD occurs along a low Se belt, and Se supplementation has been effective in prevention of such disease. The incidence of KD has sharply decreased along with the steady raise of living standard and realization of preventive measures. At present, patients of KD are very sparse. In recent years the research on the non-KD mitochondrial cardiomyopathy has progressed rapidly. Given the advances in this aspect a minireview is written to evaluate the classification of KD as a kind of mitochondrial cardiomyopathy.
C1 Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Biophysics, CAS
RP Yang, FY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
EM Yangfy@sun5.ibp.ac.cn
RI Yang, Fangying/JBR-8994-2023
CR ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 1979, CHINESE MED J-PEKING, V92, P471
   Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2
   BOGOUSSLAVSKY J, 1982, J NEUROL SCI, V55, P351, DOI 10.1016/0022-510X(82)90132-0
   CHEN X, 1981, SELENIUM BIOL MED, P171
   CHINNERY PF, 2003, MITOCHONDRIAL DISORD
   *CHUX KESH DIS PAT, 1988, P COMPR SCI INV KD C, P138
   DAI GH, 1988, P COMPR SCI INV KD C, P193
   DENG XQ, 1988, P COMPR SCI INV KD C, P130
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737
   GRANTZOW R, 1982, MONATSSCHR KINDERH, V130, P909
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   Lane N, 2006, NATURE, V440, P600, DOI 10.1038/440600a
   LI FS, 1988, P COMPR SCI INV KD C, P178
   LI XZ, 1974, SCI SINICA, P415
   Li Y, 2000, HEART, V83, P696, DOI 10.1136/heart.83.6.696
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MARINGARCIA J, 1994, CARDIOVASC RES, V28, P456, DOI 10.1093/cvr/28.4.456
   MarinGarcia J, 1997, PEDIATR CARDIOL, V18, P251, DOI 10.1007/s002469900169
   NIU CL, 1988, P COMPR SCI INV KD C, P16
   Ren LQ, 2004, WORLD J GASTROENTERO, V10, P3299, DOI 10.3748/wjg.v10.i22.3299
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   Servidei Serenella, 2004, Neuromuscul Disord, V14, P107
   TAN JA, 1988, P COMPR SCI INV KD C, P48
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   *XIAN MED COLL LAB, 1979, NATL MED J CHINA, V59, P457
   YAGN FY, 1987, BIOCH INT, V15, P475
   YANG DS, 1982, ENDEMIC DIS COMM, V3, P1
   YANG FY, 1994, J CLIN BIOCHEM NUTR, V16, P101
   YANG FY, 1988, J TRACE ELEM ELECT H, V2, P157
   YANG FY, 1989, BIOCHEM INT, V18, P1085
   YANG FY, 1988, P COMPR SCI INV KD C, P184
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
NR 34
TC 24
Z9 27
U1 0
U2 11
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1006-9305
J9 SCI CHINA SER C
JI Sci. China Ser. C-Life Sci.
PD DEC
PY 2006
VL 49
IS 6
BP 513
EP 518
DI 10.1007/s11427-006-2041-y
PG 6
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 112SA
UT WOS:000242546100001
PM 17312989
DA 2024-11-01
ER

PT J
AU Gopan, A
   Sarma, MS
AF Gopan, Amrit
   Sarma, Moinak Sen
TI Mitochondrial hepatopathy: Respiratory chain disorders- 'breathing in
   and out of the liver'
SO WORLD JOURNAL OF HEPATOLOGY
LA English
DT Review
DE Mitochondrial hepatopathy; Respiratory chain defects; Maternal
   inheritance; Neonatal liver failure; DNA depletion syndrome; Pearson
   syndrome
ID CORRECTS BIOCHEMICAL DERANGEMENTS; RETROSPECTIVE COHORT; DNA; DISEASE;
   TRANSPLANTATION; SPECTRUM; FEATURES; MUTATIONS; DIAGNOSIS; MNGIE
AB Mitochondria, the powerhouse of a cell, are closely linked to the pathophysiology of various common as well as not so uncommon disorders of the liver and beyond. Evolution supports a prokaryotic descent, and, unsurprisingly, the organelle is worthy of being labeled an organism in itself. Since highly metabolically active organs require a continuous feed of energy, any dysfunction in the structure and function of mitochondria can have variable impact, with the worse end of the spectrum producing catastrophic consequences with a multisystem predisposition. Though categorized a hepatopathy, mitochondrial respiratory chain defects are not limited to the liver in time and space. The liver involvement is also variable in clinical presentation as well as in age of onset, from acute liver failure, cholestasis, or chronic liver disease. Other organs like eye, muscle, central and peripheral nervous system, gastrointestinal tract, hematological, endocrine, and renal systems are also variably involved. Diagnosis hinges on recognition of subtle clinical clues, screening metabolic investigations, evaluation of the extra-hepatic involvement, and role of genetics and tissue diagnosis. Treatment is aimed at both circumventing the acute metabolic crisis and long-term management including nutritional rehabilitation. This review lists and discusses the burden of mitochondrial respiratory chain defects, including various settings when to suspect, their evolution with time, including certain specific disorders, their tiered evaluation with diagnostic algorithms, management dilemmas, role of liver transplantation, and the future research tools.
C1 [Gopan, Amrit] Seth GS Med Coll & KEM Hosp, Dept Gastroenterol, Mumbai 400012, Maharashtra, India.
   [Sarma, Moinak Sen] Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Rae Bareilly Rd, Lucknow 226014, Uttar Pradesh, India.
C3 Seth Gordhandas Sunderdas Medical College & King Edward Memorial
   Hospital; Sanjay Gandhi Postgraduate Institute of Medical Sciences
RP Sarma, MS (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Pediat Gastroenterol, Rae Bareilly Rd, Lucknow 226014, Uttar Pradesh, India.
EM moinaksen@gmail.com
RI Sarma, Moinak/T-4846-2019; Gopan, Amrit/JQV-6951-2023
OI sen sarma, moinak/0000-0003-2015-4069
CR Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106
   Broomfield A, 2015, J INHERIT METAB DIS, V38, P445, DOI 10.1007/s10545-014-9778-4
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO;2-G
   Choi HS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17256-7
   Clarke C, 2013, MOL GENET METAB, V110, P145, DOI 10.1016/j.ymgme.2013.07.011
   CORMIERDAIRE V, 1994, J PEDIATR-US, V124, P63, DOI 10.1016/S0022-3476(94)70255-1
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   D'Angelo R, 2017, MITOCHONDRION, V34, P101, DOI 10.1016/j.mito.2017.02.006
   Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75
   De Giorgio R, 2016, ANN NEUROL, V80, P448, DOI 10.1002/ana.24724
   De Greef E, 2012, JIMD REP, V4, P5, DOI 10.1007/8904_2011_29
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015
   Dimmock DP, 2008, LIVER TRANSPLANT, V14, P1480, DOI 10.1002/lt.21556
   Dror Y., 2017, HEMATOLOGY BASIC PRI, P350
   Durand P, 2001, J PEDIATR-US, V139, P871, DOI 10.1067/mpd.2001.119989
   Farruggia P, 2016, JIMD REP, V26, P37, DOI 10.1007/8904_2015_470
   Finkenstedt A, 2013, JIMD REP, V10, P41, DOI 10.1007/8904_2012_199
   Finsterer J, 2017, THER ADV GASTROENTER, V10, P142, DOI 10.1177/1756283X16666806
   Fischel-Ghodsian N, 1998, AM J HUM GENET, V62, P15, DOI 10.1086/301695
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721
   Holve S, 1999, J PEDIATR-US, V135, P482, DOI 10.1016/S0022-3476(99)70172-1
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   Karadimas CL, 2006, AM J HUM GENET, V79, P544, DOI 10.1086/506913
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   Lian CX, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113716
   Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1
   Meyers DE, 2013, TEX HEART I J, V40, P385
   Molleston JP, 2013, J PEDIATR GASTR NUTR, V57, P269, DOI 10.1097/MPG.0b013e31829ef67a
   Munnich A, 1996, EUR J PEDIATR, V155, P262
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Muraki K, 1997, J INHERIT METAB DIS, V20, P697, DOI 10.1023/A:1005378527077
   NARKEWICZ MR, 1991, J PEDIATR-US, V119, P260, DOI 10.1016/S0022-3476(05)80736-X
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pacitti D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00669
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
   Pyeritz RE, 2012, GENET MED, V14, P171, DOI [10.1038/gim.2011.48, 10.1038/gim.2012.74]
   Rahman S, 2007, NEUROLOGY, V68, P1872, DOI 10.1212/01.wnl.0000265356.98295.be
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Salsaa M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68725-5
   Saneto Russell P, 2020, J Transl Genet Genom, V4, P384, DOI 10.20517/jtgg.2020.40
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sitarz KS, 2014, MOL GENET METAB, V112, P57, DOI 10.1016/j.ymgme.2014.03.006
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sokal EM, 1999, EUR J PEDIATR, V158, pS81, DOI 10.1007/PL00014328
   Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765
   Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Taylor SA, 2016, LIVER TRANSPLANT, V22, P677, DOI 10.1002/lt.24433
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Tyynismaa H, 2012, HUM MOL GENET, V21, P66, DOI 10.1093/hmg/ddr438
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Wortmann SB, 2009, PEDIATR RES, V65, P103, DOI 10.1203/PDR.0b013e31818d1c8a
NR 69
TC 4
Z9 4
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1948-5182
J9 WORLD J HEPATOL
JI World J. Hepatol.
PD NOV 27
PY 2021
VL 13
IS 11
BP 1707
EP 1726
DI 10.4254/wjh.v13.i11.1707
PG 20
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA YY3EI
UT WOS:000754673800017
PM 34904040
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Truong, HT
   Nguyen, VAT
   Nguyen, LV
   Pham, VA
   Phan, TN
AF Hue Thi Truong
   Van-Anh Thi Nguyen
   Lieu Van Nguyen
   Van-Anh Pham
   Tuan-Nghia Phan
TI Screening of common point-mutations and discovery of new T14727C change
   in mitochondrial genome of Vietnamese encephalomyopathy patients
SO MITOCHONDRIAL DNA PART A
LA English
DT Article
DE Heteroplasmy; homoplasmy; mitochondrial tRNA(Glu); PCR-RFLP
ID HEREDITARY OPTIC NEUROPATHY; DNA MUTATIONS; MUSCLE; MELAS; EXPRESSION;
   DISEASES; MERRF; GENE
AB Vietnamese patients (106) tentatively diagnosed with encephalomyopathy were screened for the presence of 15 common point mutations in mitochondria using PCR-RFLP. The screened mutations include A3243G, T3271C and T3291C for Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-like episodes (MELAS); A8344G and T8356C for Myoclonus Epilepsy and Rag-Red Fibers (MERRF); G11778A, G3460A and T14484C for Leber's Hereditary Optic Neuropathy (LHON); T8993G/C and T9176G for Leigh syndrome; A1555G for deafness syndrome; G4298A, T10010C, T14728C and T14709C for neuromuscular syndrome. As a result, 6 cases of A3243G (5.7%) and 2 cases of T14727C (3.9%) were found. The 6 cases of A3243G mutation were heteroplasmic at different levels (4.23-80.85%). The T14727C change was discovered for the first time in the MTTE gene encoding for tRNA(Glu) and showed homoplasmy. The T14727C change was probably a mutation because it was further confirmed as vertically inherited from the mother and not the result of isolated polymorphism.
C1 [Hue Thi Truong; Van-Anh Thi Nguyen; Tuan-Nghia Phan] VNU Univ Sci, Key Lab Enzyme & Prot Technol, Hanoi, Vietnam.
   [Lieu Van Nguyen] Bach Mai Hosp, Dept Neurol, Hanoi, Vietnam.
   [Van-Anh Pham] Natl Hosp Pediat, Hanoi, Vietnam.
C3 Vietnam National University Hanoi
RP Phan, TN (corresponding author), VNU Univ Sci, Key Lab Enzyme & Prot Technol, 334 Nguyen Trai, Hanoi, Vietnam.
EM phantuannghia@vnu.edu.vn
OI Nguyen, Anh Thi Van/0000-0003-1215-6910
FU National Foundation for Science and Technology (NAFOSTED) project
   [106.06.123.09]
FX The authors report no conflicts of interest. The authors alone are
   responsible for the content and writing of the paper. This work was
   financially supported by The National Foundation for Science and
   Technology (NAFOSTED) project, code 106.06.123.09.
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aniko G, 2010, CENT EUR J MED, V5, P322, DOI 10.2478/s11536-009-0118-2
   Black GCM, 1996, BRIT J OPHTHALMOL, V80, P915, DOI 10.1136/bjo.80.10.915
   BOULET L, 1992, AM J HUM GENET, V51, P1187
   Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   Enns GM, 2006, MOL GENET METAB, V88, P364, DOI 10.1016/j.ymgme.2006.02.001
   Gropman A L, 2001, Curr Neurol Neurosci Rep, V1, P185
   Kim DS, 2002, J KOREAN MED SCI, V17, P103, DOI 10.3346/jkms.2002.17.1.103
   Liu VWS, 2001, CANCER RES, V61, P5998
   Lorenzoni PJ, 2009, ARQ NEURO-PSIQUIAT, V67, P668, DOI 10.1590/S0004-282X2009000400018
   Marotta R, 2004, INTERN MED J, V34, P10, DOI 10.1111/j.1444-0903.2004.t01-3-.x
   Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005
   Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6
   Nogueira C, 2007, MITOCHONDRION, V7, P396, DOI 10.1016/j.mito.2007.08.002
   Pereira C, 2007, BIOCHEM BIOPH RES CO, V354, P937, DOI 10.1016/j.bbrc.2007.01.068
   Perucca-Lostanlen D, 2002, BBA-MOL BASIS DIS, V1588, P210, DOI 10.1016/S0925-4439(02)00167-9
   Pulkes T, 2001, ADV DRUG DELIVER REV, V49, P27, DOI 10.1016/S0169-409X(01)00124-7
   Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Solano A, 2001, SALUD PUBLICA MEXICO, V43, P151, DOI 10.1590/S0036-36342001000200010
   Trinh L. P., 2009, J GENET APPL, V4, P6
   Wani AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000942
   Yu Q, 2007, MITOCHONDRION, V7, P147, DOI 10.1016/j.mito.2006.11.019
NR 25
TC 3
Z9 3
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2470-1394
EI 2470-1408
J9 MITOCHONDRIAL DNA A
JI Mitochondrial DNA Part A
PD JAN 2
PY 2016
VL 27
IS 1
BP 441
EP 448
DI 10.3109/19401736.2014.900665
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CY4OR
UT WOS:000366388100187
PM 24708131
DA 2024-11-01
ER

PT J
AU Spiegler, J
   Stefanova, I
   Hellenbroich, Y
   Sperner, J
AF Spiegler, J.
   Stefanova, I.
   Hellenbroich, Y.
   Sperner, J.
TI Bowel Obstruction in Patients with Alpers-Huttenlocher Syndrome
SO NEUROPEDIATRICS
LA English
DT Article
DE Alpers-Huttenlocher syndrome (AHS); constipation; gastrointestinal
   dysmotility; urinary retention; ketogenic diet; lacosamide; refractory
   convulsive status; EEG; MRI
ID MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY; PROGRESSIVE
   EXTERNAL OPHTHALMOPLEGIA; POLYMERASE-GAMMA; GENE MUTATION; POLG;
   DISEASE; CAJAL
AB Alpers-Huttenlocher syndrome (AHS) is a very rare autosomal recessive disorder. AHS is caused by homozygous or compound heterozygous mutations in the nuclear gene encoding mitochondrial DNA polymerase gamma (POLG, chromosome 15q25). Most patients become symptomatic before the age of 2 years. We report 3 patients who were treated in our clinic between 2007 and 2010. All patients suffered from myoclonic seizures and had at least one refractory convulsive status which led to the diagnosis. All of them had varying degrees of developmental delay, 2 of them additionally ataxia. Gastrointestinal motility problems were severe in all patients despite only mildly deranged liver function. While in most aspects our patients present with typical AHS features, they also share intestinal problems, a feature that has not been recognized as typical for AHS before. AHS is a multisystem disorder that does affect all cell systems. Liver and brain are organs with the highest energy demand and are therefore usually affected early in the disease course of AHS. However, constipation and bowel obstruction should be regarded as typical complications in AHS and patients should be monitored and treated to improve quality of life. Regarding treatment options for epilepsy in AHS ketogenic diet as well as lacosamide might be considered.
C1 [Spiegler, J.] Univ Lubeck, Klin Kinder & Jugendmed, D-23538 Lubeck, Germany.
   [Stefanova, I.; Hellenbroich, Y.] Univ Lubeck, Inst Humangenet, D-23538 Lubeck, Germany.
C3 University of Lubeck; University of Lubeck
RP Spiegler, J (corresponding author), Univ Lubeck, Klin Kinder & Jugendmed, Ratzeburger Allee 160, D-23538 Lubeck, Germany.
EM uni@dr-spiegler.de
RI Spiegler, Juliane/AAK-1740-2020
CR Amiot A, 2009, GASTROENTEROLOGY, V137, P101, DOI 10.1053/j.gastro.2009.03.054
   Cardenas JF, 2010, SEMIN PEDIATR NEUROL, V17, P62, DOI 10.1016/j.spen.2010.02.012
   Chang TM, 2004, PEDIATR NEUROL, V31, P374, DOI 10.1016/j.pediatrneurol.2004.05.009
   COHEN BH, 2010, SOURCE GENEREVIEWS
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279
   Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252
   Horvath R, 2009, J NEUROL, V256, P810, DOI 10.1007/s00415-009-5023-8
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Kapur RP, 2011, AM J SURG PATHOL, V35, P714, DOI 10.1097/PAS.0b013e31821433af
   Kurt B, 2010, ARCH NEUROL-CHICAGO, V67, P239, DOI 10.1001/archneurol.2009.332
   Sergeant GP, 2008, J PHYSIOL-LONDON, V586, P4631, DOI 10.1113/jphysiol.2008.159194
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Zimmer V, 2009, NEUROGASTROENT MOTIL, V21, P627, DOI 10.1111/j.1365-2982.2009.01264.x
NR 14
TC 12
Z9 13
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0174-304X
J9 NEUROPEDIATRICS
JI Neuropediatrics
PD OCT
PY 2011
VL 42
IS 5
BP 194
EP 196
DI 10.1055/s-0031-1287812
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 859AN
UT WOS:000297846200006
PM 22006280
DA 2024-11-01
ER

PT J
AU Lin, DS
   Kao, SH
   Ho, CS
   Wei, YH
   Hung, PL
   Hsu, MH
   Wu, TY
   Wang, TJ
   Jian, YR
   Lee, TH
   Chiang, MF
AF Lin, Dar-Shong
   Kao, Shu-Huei
   Ho, Che-Sheng
   Wei, Yau-Huei
   Hung, Pi-Lien
   Hsu, Mei-Hsin
   Wu, Tsu-Yen
   Wang, Tuan-Jen
   Jian, Yuan-Ren
   Lee, Tsung-Han
   Chiang, Ming-Fu
TI Inflexibility of AMPK-mediated metabolic reprogramming in mitochondrial
   disease
SO ONCOTARGET
LA English
DT Article
DE mitochondrial diseases; oxidative phosphorylation; bioenergetics; AMPK;
   metabolic inflexibility; Autophagy
ID FATTY-ACID OXIDATION; PYRUVATE-DEHYDROGENASE ACTIVITY; MOUSE MODEL;
   COMPLEX I; SKELETAL-MUSCLE; ENERGY-METABOLISM; LACTIC-ACIDOSIS;
   GENE-EXPRESSION; BETA-OXIDATION; MUTATION
AB Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is most commonly caused by the A3243G mutation of mitochondrial DNA. The capacity to utilize fatty acid or glucose as a fuel source and how such dynamic switches of metabolic fuel preferences and transcriptional modulation of adaptive mechanism in response to energy deficiency in MELAS syndrome have not been fully elucidated. The fibroblasts from patients with MELAS syndrome demonstrated a remarkable deficiency of electron transport chain complexes I and IV, an impaired cellular biogenesis under glucose deprivation, and a decreased ATP synthesis. In situ analysis of the bioenergetic properties of MELAS cells demonstrated an attenuated fatty acid oxidation that concomitantly occurred with impaired mitochondrial respiration, while energy production was mostly dependent on glycolysis. Furthermore, the transcriptional modulation was mediated by the AMP-activated protein kinase (AMPK) signaling pathway, which activated its downstream modulators leading to a subsequent increase in glycolytic flux through activation of pyruvate dehydrogenase. In contrast, the activities of carnitine palmitoyltransferase for fatty acid oxidation and acetyl-CoA carboxylase-1 for fatty acid synthesis were reduced and transcriptional regulation factors for biogenesis were not altered. These results provide novel information that MELAS cells lack the adaptive mechanism to switch fuel source from glucose to fatty acid, as glycolysis rates increase in response to energy deficiency. The aberrant secondary cellular responses to disrupted metabolic homeostasis mediated by AMPK signaling pathway may contribute to the development of the clinical phenotype.
C1 [Lin, Dar-Shong; Ho, Che-Sheng] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.
   [Lin, Dar-Shong; Wei, Yau-Huei] Mackay Med Coll, Inst Biomed Sci, Dept Med, New Taipei, Taiwan.
   [Kao, Shu-Huei] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan.
   [Hung, Pi-Lien; Hsu, Mei-Hsin] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat Neurol, Kaohsiung, Taiwan.
   [Wu, Tsu-Yen; Jian, Yuan-Ren; Lee, Tsung-Han] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.
   [Wang, Tuan-Jen] Mackay Mem Hosp, Dept Lab Med, Taipei, Taiwan.
   [Chiang, Ming-Fu] Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan.
   [Chiang, Ming-Fu] Mackay Med Nursing & Management Coll, Taipei, Taiwan.
   [Chiang, Ming-Fu] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan.
   [Wei, Yau-Huei] Changhua Christian Hosp, Ctr Mitochondrial Med & Free Rad Res, Changhua, Taiwan.
C3 Mackay Memorial Hospital; Mackay Medical College; Taipei Medical
   University; Chang Gung Memorial Hospital; Chang Gung University; Mackay
   Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital;
   Mackay Junior College of Medicine, Nursing & Management; Taipei Medical
   University; Changhua Christian Hospital
RP Lin, DS (corresponding author), Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan.; Lin, DS (corresponding author), Mackay Med Coll, Inst Biomed Sci, Dept Med, New Taipei, Taiwan.; Chiang, MF (corresponding author), Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan.; Chiang, MF (corresponding author), Mackay Med Nursing & Management Coll, Taipei, Taiwan.; Chiang, MF (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan.
EM dslin@mmh.org.tw; chiang66@gmail.com
RI jian, yuan/ABE-1866-2020; 陈, 雨薇/HKF-1175-2023
OI Lin, Dar-Shong/0000-0002-1168-9857; Wei, Yau-Huei/0000-0002-6429-2546;
   Kao, Shu-Huei/0000-0003-4618-0898
FU Ministry of Science and Technology [MOST-102-2314-B-195-005-MY3,
   MOST-105-2314-B-195-011-MY2]; Mackay Memorial Hospital [MMH-E-104-02,
   MMH-E-105-02, MMH-E-106-02, MMH-CT-10410, MMH-CT-10510, MMH-106-114]
FX This work was supported by the Ministry of Science and Technology
   [MOST-102-2314-B-195-005-MY3, MOST-105-2314-B-195-011-MY2] and grants
   from Mackay Memorial Hospital [MMH-E-104-02, MMH-E-105-02, MMH-E-106-02,
   MMH-CT-10410, MMH-CT-10510, MMH-106-114].
CR Athéa Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187
   Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611
   Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199
   Crimi M, 2005, FASEB J, V19, P866, DOI 10.1096/fj.04-3045fje
   Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358
   de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917
   Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475
   Francis BM, 2014, J ALZHEIMERS DIS, V39, P347, DOI 10.3233/JAD-131499
   Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, pH347, DOI 10.1152/ajpheart.00900.2015
   Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008
   Gargus JJ, 2003, J INHERIT METAB DIS, V26, P659, DOI 10.1023/B:BOLI.0000005659.52200.c1
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968
   Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128561
   Janssen GMC, 2007, HUM MOL GENET, V16, P2472, DOI 10.1093/hmg/ddm203
   Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480
   Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101
   Klein DK, 2007, AM J PHYSIOL-ENDOC M, V293, pE1242, DOI 10.1152/ajpendo.00382.2007
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007
   Kühn K, 2015, PLANT PHYSIOL, V168, P1537, DOI 10.1104/pp.15.00589
   Lanning NJ, 2014, CELL REP, V7, P907, DOI 10.1016/j.celrep.2014.03.065
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Liemburg-Apers DC, 2015, BIOPHYS J, V109, P1372, DOI 10.1016/j.bpj.2015.08.002
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Mende S, 2011, NEUROL RES, V33, P638, DOI 10.1179/1743132810Y.0000000016
   Newman JC, 2012, J BIOL CHEM, V287, P42436, DOI 10.1074/jbc.R112.404863
   Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001
   Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111
   Rato L, 2014, BBA-BIOENERGETICS, V1837, P335, DOI 10.1016/j.bbabio.2013.12.008
   Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
   Sim KG, 2002, METABOLISM, V51, P366, DOI 10.1053/meta.2002.30521
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Touw CML, 2014, BBA-MOL BASIS DIS, V1842, P2021, DOI 10.1016/j.bbadis.2014.05.032
   Venizelos N, 1998, J INHERIT METAB DIS, V21, P409, DOI 10.1023/A:1005310809714
   Wang P, 2015, ONCOTARGET, V6, P3947, DOI 10.18632/oncotarget.2968
   Wang YD, 2010, J BIOL CHEM, V285, P29834, DOI 10.1074/jbc.M110.139493
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1
   Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10
   Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069282
NR 51
TC 19
Z9 20
U1 0
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
EI 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD SEP 26
PY 2017
VL 8
IS 43
BP 73627
EP 73639
DI 10.18632/oncotarget.20617
PG 13
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA FI2HT
UT WOS:000411760400024
PM 29088732
OA gold, Green Submitted, Green Published
DA 2024-11-01
ER

PT J
AU Karunadharma, PP
   Nordgaard, CL
   Olsen, TW
   Ferrington, DA
AF Karunadharma, Pabalu P.
   Nordgaard, Curtis L.
   Olsen, Timothy W.
   Ferrington, Deborah A.
TI Mitochondrial DNA Damage as a Potential Mechanism for Age-Related
   Macular Degeneration
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
ID RETINAL-PIGMENT EPITHELIUM; HYDROGEN-PEROXIDE; OXIDATIVE STRESS;
   SKELETAL-MUSCLE; PROGRESSIVE STAGES; COMMON DELETION; NUCLEAR-DNA;
   REPAIR; CELLS; PROTEOMICS
AB PURPOSE. Increasing evidence suggests a central role for mitochondrial (mt) dysfunction in age-related macular degeneration (AMD). Previous proteomic data from the retinal pigment epithelium (RPE) revealed significant changes to mt proteins, suggesting potential functional defects and damage to mitochondrial DNA (mtDNA) with AMD progression. The present study tests the hypothesis that mtDNA damage increases with aging and AMD.
   METHODS. Genomic DNA was isolated from the macular region of human donor RPE graded for stages of AMD (Minnesota Grading System [MGS] 1-4). Region-specific mtDNA damage with normal aging was evaluated in 45 control subjects (ages 34-88 years, MGS 1) and AMD-associated damage in diseased subjects (n = 46), compared with that in age-matched control subjects (n = 26). Lesions per 10 kb per genome in the mtDNA and nuclear DNA were measured with long-extension polymerase chain reaction (LX PCR). The level of deleted mtDNA in each donor was measured with quantitative real-time PCR (qPCR).
   RESULTS. With aging, an increase in mtDNA damage was observed only in the common deletion region of the mt genome. In contrast, with AMD, mtDNA lesions increased significantly in all regions of the mt genome beyond levels found in age-matched control subjects. mtDNA accumulated more lesions than did two nuclear genes, with total damage of the mt genome estimated to be eight times higher.
   CONCLUSIONS. Collectively, the data indicate that mtDNA is preferentially damaged with AMD progression. These results suggest a potential link between mt dysfunction due to increased mtDNA lesions and AMD. (Invest Ophthalmol Vis Sci. 2010; 51: 5470-5479) DOI: 10.1167/iovs.10-5429
C1 [Olsen, Timothy W.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA.
   [Karunadharma, Pabalu P.; Nordgaard, Curtis L.; Ferrington, Deborah A.] Univ Minnesota Twin Cities, Dept Ophthalmol, Minneapolis, MN USA.
   [Karunadharma, Pabalu P.; Ferrington, Deborah A.] Univ Minnesota Twin Cities, Grad Program Biochem Mol Biol & Biophys, Minneapolis, MN USA.
C3 Emory University; University of Minnesota System; University of
   Minnesota Twin Cities; University of Minnesota System; University of
   Minnesota Twin Cities
RP Ferrington, DA (corresponding author), Univ Minnesota, 380 Lions Res Bldg,2001 6th St SE, Minneapolis, MN 55455 USA.
EM ferri013@umn.edu
OI Nordgaard, Curtis/0000-0002-1409-8884; Ferrington,
   Deborah/0000-0003-2561-7464; Olsen, Timothy/0000-0002-2200-266X
FU National Institute on Aging [AG025392]; Research to Prevent Blindness;
   Emory University
FX Supported in part by National Institute on Aging Grant AG025392, an
   unrestricted grant from Research to Prevent Blindness to the Departments
   of Ophthalmology at the University of Minnesota and Emory University,
   and a generous donation from the Daniel and Helen Lindsay Family.
CR Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668
   Ayala-Torres S, 2000, METHODS, V22, P135, DOI 10.1006/meth.2000.1054
   Ballinger SW, 1999, EXP EYE RES, V68, P765, DOI 10.1006/exer.1998.0661
   Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barreau E, 1996, INVEST OPHTH VIS SCI, V37, P384
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Barron MJ, 2001, INVEST OPHTH VIS SCI, V42, P3016
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655
   Brown MM, 2006, CURR OPIN OPHTHALMOL, V17, P257
   Canter JA, 2008, PHARMACOGENOMICS J, V8, P71, DOI 10.1038/sj.tpj.6500470
   Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006
   Ethen CM, 2006, INVEST OPHTH VIS SCI, V47, P2280, DOI 10.1167/iovs.05-1395
   Ethen CM, 2005, INVEST OPHTH VIS SCI, V46, P769, DOI 10.1167/iovs.04-0810
   Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   GRAMAJO AL, 2007, INVEST OPHTH VIS SCI, V51, P1164
   Jarrett SG, 2008, PROG RETIN EYE RES, V27, P596, DOI 10.1016/j.preteyeres.2008.09.001
   Jin GF, 2001, CURR EYE RES, V22, P165, DOI 10.1076/ceyr.22.3.165.5517
   Jones MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1235, DOI 10.1001/archopht.125.9.1235
   KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485
   Kovalenko Olga A, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1901s62
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Nordgaard CL, 2006, INVEST OPHTH VIS SCI, V47, P815, DOI 10.1167/iovs.05-0976
   Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352
   Olsen TW, 2004, INVEST OPHTH VIS SCI, V45, P4484, DOI 10.1167/iovs.04-0342
   Poe BG, 2007, ANAL BIOCHEM, V362, P193, DOI 10.1016/j.ab.2006.12.035
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   SanGiovanni JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005508
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159
   Sawyer DE, 2001, REDOX REP, V6, P182, DOI 10.1179/135100001101536157
   SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Terman A, 2004, ANN NY ACAD SCI, V1019, P70, DOI 10.1196/annals.1297.015
   Wang AL, 2008, MOL VIS, V14, P644
   Xie L, 2008, INVEST OPHTH VIS SCI, V49, P4203, DOI 10.1167/iovs.07-1364
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200
NR 49
TC 194
Z9 216
U1 1
U2 14
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD NOV
PY 2010
VL 51
IS 11
BP 5470
EP 5479
DI 10.1167/iovs.10-5429
PG 10
WC Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Ophthalmology
GA 672BQ
UT WOS:000283558400009
PM 20505194
OA Green Published
DA 2024-11-01
ER

PT J
AU Joyce, E
   Ali, M
   Richard, G
   Kelly, S
   Martin, F
   Conlon, PJ
   Whelehan, A
   Ng, YS
   Lefter, S
AF Joyce, Eimear
   Ali, Mohib
   Richard, Georgia
   Kelly, Siobhan
   Martin, Fiachra
   Conlon, Peter J.
   Whelehan, Anna
   Ng, Yi Shiau
   Lefter, Stela
TI Adult presentation of a rare mitochondrial tRNA Val gene mutation-an
   expanding clinical phenotype
SO EUROPEAN JOURNAL OF NEUROLOGY
LA English
DT Article
DE late onset mitochondrial disorder; m.1659T > C; MT-TV gene variant
AB Background and purpose Late-onset mitochondrial disorders are diagnostically challenging with significant heterogeneity in disease presentation. A case is reported of a 67-year-old gentleman who presented with a 3-month history of seizures, recurrent encephalopathy, ataxia and weight loss, preceded by recent initiation of haemodialysis for end-stage chronic kidney disease. Methods Extensive work-up including serological, cerebrospinal fluid, magnetic resonance imaging and electroencephalography was performed. Whole exome sequencing and muscle biopsy confirmed the diagnosis. Results Magnetic resonance imaging brain demonstrated a single non-enhancing T2 fluid attenuated inversion recovery hyperintense cortical/subcortical signal change in the right temporal lobe and cerebellar atrophy. Given the subacute presentation of uncertain aetiology, he was empirically treated for autoimmune/paraneoplastic encephalitis. Despite radiological resolution of the cortical abnormality 2 weeks later, there was no clinical improvement. Further collateral history unveiled a mildly ataxic gait and longstanding hearing loss suggestive of a genetic cause. Whole exome sequencing revealed a likely pathogenic, heteroplasmic mitochondrial DNA variant in the MT-TV gene, m.1659T>C, present at higher levels of heteroplasmy in muscle (91%) compared to other mitotic tissues. A high fat/protein diet and multivitamins including co-enzyme Q10 were commenced. Treatment of the nutritional deficiency and avoidance of intermittent fasting due to unreliable oral intake secondary to encephalopathy probably contributed to the clinical improvement seen over the ensuing few months, with resolution of his encephalopathy and return to his baseline gait and weight. Conclusion An adult case is reported with an acute neurological presentation mimicking encephalitis, caused by a heteroplasmic m.1659T>C MT-TV variant, previously reported once in a child who displayed a different clinical phenotype.
C1 [Joyce, Eimear; Ali, Mohib; Richard, Georgia; Lefter, Stela] Beaumont Hosp, Dept Neurol, Dublin, Ireland.
   [Kelly, Siobhan] Sligo Univ Hosp, Dept Neurol, Sligo, Ireland.
   [Martin, Fiachra] Beaumont Hosp, Dept Plast Surg, Dublin, Ireland.
   [Conlon, Peter J.] Beaumont Hosp, Dept Nephrol & Transplantat, Dublin, Ireland.
   [Whelehan, Anna] Beaumont Hosp, Dept Neurophysiol, Dublin, Ireland.
   [Ng, Yi Shiau] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, England.
   [Ng, Yi Shiau] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Serv Rare Mitochondrial Dis, Newcastle Upon Tyne, England.
C3 Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation
   Trust
RP Lefter, S (corresponding author), Beaumont Hosp, Dept Neurol, Dublin, Ireland.
EM stelalefter2@beaumont.ie
OI Lefter, Stela/0000-0001-6555-6462
FX One of the authors of this publication is a member of the European
   Reference Network (ERN) for Rare Neuromuscular Diseases (Euro-NMD). The
   laboratory members of NHS Highly Specialized Service for Rare
   Mitochondrial Disorders in Newcastle upon Tyne are thanked for the
   measurements of heteroplasmy levels and single-fibre muscle study.
CR Blakely EL, 2004, J NEUROL SCI, V225, P99, DOI 10.1016/j.jns.2004.07.007
   Forny P, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000597
   Ng YS, 2022, BRAIN, V145, P542, DOI 10.1093/brain/awab353
   Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1
   Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1351-5101
EI 1468-1331
J9 EUR J NEUROL
JI Eur. J. Neurol.
PD OCT
PY 2024
VL 31
IS 10
AR e16405
DI 10.1111/ene.16405
EA JUL 2024
PG 4
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA G6L3K
UT WOS:001264984000001
PM 38973423
OA hybrid
DA 2024-11-01
ER

PT J
AU Willis, JCW
   Silva-Pinheiro, P
   Widdup, L
   Minczuk, M
   Liu, DR
AF Willis, Julian C. W.
   Silva-Pinheiro, Pedro
   Widdup, Lily
   Minczuk, Michal
   Liu, David R.
TI Compact zinc finger base editors that edit mitochondrial or nuclear DNA
   in vitro and in vivo
SO NATURE COMMUNICATIONS
LA English
DT Article
ID PROTEINS; GENOMES; MUTATIONS; RESIDUES
AB DddA-derived cytosine base editors (DdCBEs) use programmable DNA-binding TALE repeat arrays, rather than CRISPR proteins, a split double-stranded DNA cytidine deaminase (DddA), and a uracil glycosylase inhibitor to mediate C center dot G-to-T center dot A editing in nuclear and organelle DNA. Here we report the development of zinc finger DdCBEs (ZF-DdCBEs) and the improvement of their editing performance through engineering their architectures, defining improved ZF scaffolds, and installing DddA activity-enhancing mutations. We engineer variants with improved DNA specificity by integrating four strategies to reduce off-target editing. We use optimized ZF-DdCBEs to install or correct disease-associated mutations in mitochondria and in the nucleus. Leveraging their small size, we use a single AAV9 to deliver into heart, liver, and skeletal muscle in post-natal mice ZF-DdCBEs that efficiently install disease-associated mutations. While off-target editing of ZF-DdCBEs is likely too high for therapeutic applications, these findings demonstrate a compact, all-protein base editing research tool for precise editing of organelle or nuclear DNA without double-strand DNA breaks.
   Zinc finger (ZF) arrays are programmable DNA-binding proteins. Here the authors report ZF-DddA-derived cytosine base editors (DdCBEs) and optimise their architectures to improve targeting; they apply these variants in vitro and in vivo to mitochondrial base editing and show higher editing than ZF deaminases.
C1 [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.
   [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.
   [Willis, Julian C. W.; Widdup, Lily; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.
   [Silva-Pinheiro, Pedro; Minczuk, Michal] Univ Cambridge, MRC Mitochondria Biol Unit, Cambridge, England.
C3 Harvard University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Harvard University; Howard Hughes Medical Institute; Harvard
   University; University of Cambridge
RP Liu, DR (corresponding author), Broad Inst MIT & Harvard, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.; Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.
EM drliu@fas.harvard.edu
RI ; Minczuk, Michal/G-1638-2014
OI Silva-Pinheiro, Pedro/0000-0002-0872-5749; Minczuk,
   Michal/0000-0001-8242-1420; Widdup, Lily/0000-0002-0641-2618; Willis,
   Julian/0000-0002-2655-2183
FU Merkin Institute of Transformative Technologies in Healthcare; US
   National Institutes of Health (NIH) [RM1HG009490, R01EB027793,
   R01EB031172, R35GM118062, U01AI142756]; HHMI; Human Frontiers Science
   Program longterm fellowship; National Science Foundation Graduate
   Research Fellowship Program; Champ Foundation; Medical Research Council
   UK [MC_UU_00015/4, MC_UU_00028/3]; MRC [MC_UU_00028/3] Funding Source:
   UKRI; National Institute of General Medical Sciences [R35GM118062]
   Funding Source: NIH RePORTER
FX This work was supported by the Merkin Institute of Transformative
   Technologies in Healthcare; US National Institutes of Health (NIH)
   grants RM1HG009490, R01EB027793, R01EB031172, R35GM118062, and
   U01AI142756; and HHMI. We thank B. Mok, J. Nelson, A. Hsu, R. Krueger,
   P. Nash and K. Turner for materials, discussions and technical advice.
   J.C.W.W. is supported by the Human Frontiers Science Program longterm
   fellowship. L.W. is supported by the National Science Foundation
   Graduate Research Fellowship Program. P.S.-P. is supported by the Champ
   Foundation. M.M. is supported by Medical Research Council UK
   (MC_UU_00015/4 and MC_UU_00028/3).
CR Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242
   Agustín-Pavón C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0128-x
   Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j
   Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261
   Banskota S, 2022, CELL, V185, P250, DOI 10.1016/j.cell.2021.12.021
   Becker S., 2021, Gene Genome Editing, V2, P100007, DOI [10.1016/j.ggedit.2021.100007, DOI 10.1016/J.GGEDIT.2021.100007, 10.1016/J.GGEDIT.2021.100007]
   Bhakta MS, 2013, GENOME RES, V23, P530, DOI 10.1101/gr.143693.112
   Bhakta MS, 2010, METHODS MOL BIOL, V649, P3, DOI 10.1007/978-1-60761-753-2_1
   Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574
   Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3
   Cradick TJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-152
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124
   Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672
   Gehrke JM, 2018, NAT BIOTECHNOL, V36, P977, DOI 10.1038/nbt.4199
   Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w
   Giardine B, 2021, NUCLEIC ACIDS RES, V49, pD1192, DOI 10.1093/nar/gkaa959
   Gill JS, 2017, BRIT J OPHTHALMOL, V101, P1298, DOI 10.1136/bjophthalmol-2017-310370
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Huang TP, 2021, NAT PROTOC, V16, DOI 10.1038/s41596-020-00450-9
   Ibraheim R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26518-y
   Isalan M, 1997, P NATL ACAD SCI USA, V94, P5617, DOI 10.1073/pnas.94.11.5617
   Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004
   Kang BC, 2021, NAT PLANTS, V7, P899, DOI 10.1038/s41477-021-00943-9
   Kim JS, 1998, P NATL ACAD SCI USA, V95, P2812, DOI 10.1073/pnas.95.6.2812
   Leach KM, 2003, NUCLEIC ACIDS RES, V31, P1292, DOI 10.1093/nar/gkg209
   Li A, 2019, MOL THER-METH CLIN D, V12, P111, DOI 10.1016/j.omtm.2018.11.009
   Li JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079910
   Li Q, 2021, MOL THER-METH CLIN D, V20, P652, DOI 10.1016/j.omtm.2021.02.005
   Lim K, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-27962-0
   Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44
   Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016
   Maeder ML, 2009, NAT PROTOC, V4, P1471, DOI 10.1038/nprot.2009.98
   Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001
   Manickam AH, 2017, INDIAN J OPHTHALMOL, V65, P1087, DOI 10.4103/ijo.IJO_358_17
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Mok BY, 2022, NAT BIOTECHNOL, V40, P1378, DOI 10.1038/s41587-022-01256-8
   Mok BY, 2020, NATURE, V583, P631, DOI 10.1038/s41586-020-2477-4
   Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437
   Murphy E, 2016, CIRC RES, V118, P1960, DOI 10.1161/RES.0000000000000104
   Nagaoka M, 2001, BIOCHEMISTRY-US, V40, P2932, DOI 10.1021/bi001762+
   Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1
   ORKIN SH, 1983, NUCLEIC ACIDS RES, V11, P4727, DOI 10.1093/nar/11.14.4727
   Osellame LD, 2012, BEST PRACT RES CL EN, V26, P711, DOI 10.1016/j.beem.2012.05.003
   Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200
   Papworth M, 2006, GENE, V366, P27, DOI 10.1016/j.gene.2005.09.011
   Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w
   Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374
   Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1
   Rees HA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15790
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Richter U, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06471-z
   ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316
   Ryzhkova AI, 2018, THER CLIN RISK MANAG, V14, P1933, DOI 10.2147/TCRM.S154863
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Silva-Pinheiro P, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28358-w
   Silva-Pinheiro P, 2022, NAT REV GENET, V23, P199, DOI 10.1038/s41576-021-00432-x
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Tarnopolsky MA, 2019, MITOCHONDRION, V46, P69, DOI 10.1016/j.mito.2018.02.008
   Vassalli G, 2003, INT J CARDIOL, V90, P229, DOI 10.1016/S0167-5273(02)00554-5
   Waryah CB, 2018, METHODS MOL BIOL, V1767, P19, DOI 10.1007/978-1-4939-7774-1_2
   Wiedemann N, 2017, ANNU REV BIOCHEM, V86, P685, DOI 10.1146/annurev-biochem-060815-014352
   Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102
   Yang LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13330
   Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081
NR 68
TC 26
Z9 31
U1 2
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 23
PY 2022
VL 13
IS 1
AR 7204
DI 10.1038/s41467-022-34784-7
PG 16
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 6L1RO
UT WOS:000887967800021
PM 36418298
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Naganuma, T
   Imasawa, T
   Nukui, I
   Wakasugi, M
   Kitamura, H
   Yatsuka, Y
   Kishita, Y
   Okazaki, Y
   Murayama, K
   Jinguji, Y
AF Naganuma, Tsukasa
   Imasawa, Toshiyuki
   Nukui, Ikuo
   Wakasugi, Masakiyo
   Kitamura, Hiroshi
   Yatsuka, Yukiko
   Kishita, Yoshihito
   Okazaki, Yasushi
   Murayama, Kei
   Jinguji, Yoshimi
TI Focal segmental glomerulosclerosis with a mutation in the<i>
   mitochondrially</i> encoded NADH dehydrogenase 5 gene: A case report
SO MOLECULAR GENETICS AND METABOLISM REPORTS
LA English
DT Article
DE Focal segmental glomerulosclerosis; Mitochondrial nephropathy; NADH
   dehydrogenase 5; Podocyte; Case report
ID ND5 GENE; FANCONI SYNDROME; LEIGH-SYNDROME; DNA; MELAS; C1Q;
   DYSFUNCTION; PODOCYTE; DISEASE; BINDING
AB NADH dehydrogenase 5 (ND5) is one of 44 subunits composed of Complex I in mitochondrial respiratory chain. Therefore, a mitochondrially encoded ND5 (MT-ND5) gene mutation causes mitochondrial oxidative phosphorylation (OXPHOS) disorder, resulting in the development of mitochondrial diseases. Focal segmental glomerulosclerosis (FSGS) which had podocytes filled with abnormal mitochondria is induced by mitochondrial diseases. An MT-ND5 mutation also causes FSGS. We herein report a Japanese woman who was found to have proteinuria and renal dysfunction in an annual health check-up at 29 years old. Because her proteinuria and renal dysfunction were persistent, she had a kidney biopsy at 33 years of age. The renal histology showed FSGS with podocytes filled with abnormal mitochondria. The podocytes also had foot process effacement and cytoplasmic vacuolization. In addition, the renal pathological findings showed granular swollen epithelial cells (GSECs) in tubular cells, age-inappropriately disarranged and irregularly sized vascular smooth muscle cells (AiDIVs), and red-coloured podocytes (ReCPos) by acidic dye. A genetic analysis using peripheral mononuclear blood cells and urine sediment cells detected the m.13513 G > A variant in the MT-ND5 gene. Therefore, this patient was diagnosed with FSGS due to an MT-ND5 gene mutation. Although this is not the first case report to show that an MT-ND5 gene mutation causes FSGS, this is the first to demonstrate podocyte injuries accompanied with accumulation of abnormal mitochondria in the cytoplasm.
C1 [Naganuma, Tsukasa; Nukui, Ikuo; Wakasugi, Masakiyo; Jinguji, Yoshimi] Yamanashi Prefectural Cent Hosp, Dept Internal Med, Div Nephrol, 1-1-1 Fujimi, Kofu, Yamanashi 4000027, Japan.
   [Imasawa, Toshiyuki] Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Nephrol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
   [Kitamura, Hiroshi] Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Clin Pathol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
   [Yatsuka, Yukiko; Kishita, Yoshihito; Okazaki, Yasushi] Juntendo Univ, Intractable Dis Res Ctr, Grad Sch Med, Diagnost & Therapeut Intractable Dis, 2-1-1 Hongo,Bunkyo Ku, Tokyo 1138421, Japan.
   [Kishita, Yoshihito] Kindai Univ, Fac Sci & Engn, Dept Life Sci, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Ctr Med Genet, Dept Metab, 579-1 Heta Cho,Midori Ku, Chiba 2660007, Japan.
C3 Juntendo University; Kindai University (Kinki University); Chiba
   Children's Hospital
RP Imasawa, T (corresponding author), Higashi Natl Hosp, Natl Hosp Org Chiba, Dept Nephrol, 673 Nitona Cho,Chuoh Ku, Chiba, Chiba 2068712, Japan.
EM imasawa@nifty.com
RI Murayama, Kei/JGM-3674-2023
FU Practical Research Project for Rare/Intractable Diseases from the Japan
   Agency for Medical Research and Development, AMED [19ek0109273,
   20ek0109468]
FX This work was supported in part by the Practical Research Project for
   Rare/Intractable Diseases from the Japan Agency for Medical Research and
   Development, AMED (19ek0109273, 20ek0109468) (http://
   www.amed.go.jp/en/) to TI, YO, and KM.
CR Bakis H, 2020, CLIN GENET, V97, P628, DOI 10.1111/cge.13670
   Barone V, 2022, FRONT GENET, V13, DOI 10.3389/fgene.2022.887696
   Bates MGD, 2012, EUR HEART J, V33, P3023, DOI 10.1093/eurheartj/ehs275
   Brown EJ, 2014, KIDNEY INT, V85, P1030, DOI 10.1038/ki.2014.48
   Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024
   Chol M, 2003, J MED GENET, V40, P188, DOI 10.1136/jmg.40.3.188
   COMIS A, 1985, FEBS LETT, V185, P105, DOI 10.1016/0014-5793(85)80749-3
   D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024
   D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Geng X, 2019, DIABETIC MED, V36, P776, DOI 10.1111/dme.13874
   Ghose A, 2017, J CLIN MED, V6, DOI 10.3390/jcm6090090
   Güçer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z
   Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Imasawa T, 2022, KIDNEY INT REP, V7, P580, DOI 10.1016/j.ekir.2021.12.028
   Imasawa T, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0181-0
   Imasawa T, 2014, RENAL FAILURE, V36, P1461, DOI 10.3109/0886022X.2014.945181
   Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013
   JENNETTE JC, 1985, AM J KIDNEY DIS, V6, P103, DOI 10.1016/S0272-6386(85)80150-5
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kobayashi A, 2010, AM J SURG PATHOL, V34, P262, DOI 10.1097/PAS.0b013e3181cb4ed3
   Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x
   Lee WS, 2007, HEPATOLOGY, V45, P1555, DOI 10.1002/hep.21710
   LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216
   Maeoka Y, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02040-z
   Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046
   Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034
   McKenzie M, 2007, J BIOL CHEM, V282, P36845, DOI 10.1074/jbc.M704158200
   Mochizuki H, 1996, CLIN NEPHROL, V46, P347
   Motoda Atsuko, 2013, Rinsho Shinkeigaku, V53, P446
   Müller-Deile J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00209
   Nagata M, 2016, KIDNEY INT, V89, P1221, DOI 10.1016/j.kint.2016.01.012
   Ng PS, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000314
   Ogawa E, 2020, J INHERIT METAB DIS, V43, P819, DOI 10.1002/jimd.12218
   Olmos PR, 2011, J OTOLARYNGOL-HEAD N, V40, P93, DOI 10.2310/7070.2010.100078
   Pulkes T, 2000, ANN NEUROL, V47, P841
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   Santorelli FM, 1997, BIOCHEM BIOPH RES CO, V238, P326, DOI 10.1006/bbrc.1997.7167
   Shabaka A, 2020, NEPHRON, V144, P413, DOI 10.1159/000508099
   Shanske S, 2008, ARCH NEUROL-CHICAGO, V65, P368, DOI 10.1001/archneurol.2007.67
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   STORRS SB, 1981, J BIOL CHEM, V256, P924
   Strassheim D, 2013, J AM SOC NEPHROL, V24, P393, DOI 10.1681/ASN.2012020187
   Sun K, 2021, KIDNEY DIS-BASEL, V7, P350, DOI 10.1159/000517108
   Suzuki S, 2004, ANN NY ACAD SCI, V1011, P185, DOI 10.1196/annals.1293.019
   TEJANI A, 1983, NEPHRON, V35, P1, DOI 10.1159/000183035
   Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010
   THORNER P S, 1985, Pediatric Pathology, V4, P25
   Tsuchimoto A, 2020, NEPHROL DIAL TRANSPL, V35, P1219, DOI 10.1093/ndt/gfy374
   van den Ameele J, 2020, SEMIN CELL DEV BIOL, V97, P156, DOI 10.1016/j.semcdb.2019.10.001
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 52
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2214-4269
J9 MOL GENET METAB REP
JI Molec. Genet. Metab. Rep.
PD JUN
PY 2023
VL 35
AR 100963
DI 10.1016/j.ymgmr.2023.100963
EA MAR 2023
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA N9WU5
UT WOS:001040437200001
PM 36941957
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Duncan, GE
   Perkins, LA
   Theriaque, DW
   Neiberger, RE
   Stacpoole, PW
AF Duncan, GE
   Perkins, LA
   Theriaque, DW
   Neiberger, RE
   Stacpoole, PW
TI Dichloroacetate therapy attenuates the blood lactate response to
   submaximal exercise in patients with defects in mitochondrial energy
   metabolism
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID LACTIC-ACIDOSIS; OXIDASE DEFICIENCY; MYOPATHIES; INTOLERANCE;
   PERFORMANCE; ENDURANCE; MUTATIONS; INDEXES; DRUG; DNA
AB We determined acute and chronic effects of dichloroacetate (DCA) on maximal (MAX) and submaximal (SUB) exercise responses in patients with abnormal mitochondrial energetics. Subjects (n = 9) completed a MAX treadmill bout 1 h after ingesting 25 mg/kg DCA or placebo (PL). A 15-min SUB bout was completed the next day while receiving the same treatment. After a 1-d washout, MAX and SUB were repeated while receiving the alternate treatment (acute). Gas exchange and heart rate were measured throughout all tests. Blood lactate (Bla) was measured 0, 3, and 10 min after MAX, and 5, 10, and 15 min during SUB. MAX and SUB were repeated after 3 months of daily DCA or PL. After a 2-wk washout, a final MAX and SUB were completed after 3 months of alternate treatment (chronic). Average Bla during SUB was lower (P < 0.05) during both acute (1.99 +/- 1.10 vs. 2.49 +/- 1.52 mmol/liter) and chronic (1.71 +/- 1.37 vs. 2.39 +/- 1.32 mmol/liter) DCA vs. PL despite similar exercise intensities between conditions (similar to 75 and 70% maximal exercise capacity during acute and chronic treatment). Thus, although DCA does not alter MAX responses, acute and chronic DCA attenuate the Bla response to moderate exercise in patients with abnormal mitochondrial energetics.
C1 Univ Washington, Dept Epidemiol, Nutr Sci Program, Seattle, WA 98195 USA.
   Univ Florida, Dept Med, Gainesville, FL 32610 USA.
   Univ Florida, Dept Pediat, Gainesville, FL 32610 USA.
   Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.
   Univ Florida, Gen Clin Res Ctr, Gainesville, FL 32610 USA.
C3 University of Washington; University of Washington Seattle; State
   University System of Florida; University of Florida; State University
   System of Florida; University of Florida; State University System of
   Florida; University of Florida; State University System of Florida;
   University of Florida
RP Duncan, GE (corresponding author), Univ Washington, Dept Epidemiol, Nutr Sci Program, 305 Raitt Hall,Box 353410, Seattle, WA 98195 USA.
EM duncag@u.washington.edu
RI Duncan, Glen/A-3771-2008
OI Duncan, Glen/0000-0001-6909-1869; Stacpoole, Peter/0000-0003-0680-5881
FU NCRR NIH HHS [RR-00082] Funding Source: Medline; NIEHS NIH HHS
   [ES-07355] Funding Source: Medline
CR Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404
   CARRARO F, 1989, J APPL PHYSIOL, V66, P591, DOI 10.1152/jappl.1989.66.2.591
   DANDURAND RJ, 1995, CHEST, V108, P182, DOI 10.1378/chest.108.1.182
   DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193
   DiMauro S, 2001, ANN MED, V33, P472, DOI 10.3109/07853890109002096
   DIMAURO S, 1985, ANN NEUROL, V17, P521, DOI 10.1002/ana.410170602
   DURKOT MJ, 1995, INT J SPORTS MED, V16, P167, DOI 10.1055/s-2007-972986
   ELLIOT DL, 1989, MEDICINE, V68, P163, DOI 10.1097/00005792-198905000-00004
   Fernández J, 2000, MED CLIN-BARCELONA, V114, P121, DOI 10.1016/S0025-7753(00)71216-4
   HALLER RG, 1989, J CLIN INVEST, V84, P155, DOI 10.1172/JCI114135
   Hatta Hideo, 1992, Annals of Physiological Anthropology, V11, P339
   HENDERSON GN, 1994, DRUG DEV IND PHARM, V20, P2425, DOI 10.3109/03639049409042647
   Howlett RA, 1999, AM J PHYSIOL-ENDOC M, V277, pE18, DOI 10.1152/ajpendo.1999.277.1.E18
   KOHL HW, 1988, AM J EPIDEMIOL, V127, P1228, DOI 10.1093/oxfordjournals.aje.a114915
   LUDVIK B, 1993, PFLUG ARCH EUR J PHY, V423, P251, DOI 10.1007/BF00374403
   MERRILL GF, 1980, J APPL PHYSIOL, V48, P427, DOI 10.1152/jappl.1980.48.3.427
   NAITO E, 1989, BRAIN DEV-JPN, V11, P195, DOI 10.1016/S0387-7604(89)80098-1
   POLLOCK ML, 1990, EXERCISE HLTH DIS EV, P661
   SCHNEIDER SH, 1981, METABOLISM, V30, P590, DOI 10.1016/0026-0495(81)90137-2
   SLAUGHTER MH, 1988, HUM BIOL, V60, P709
   Stacpoole PW, 1997, ARCH DIS CHILD, V77, P535, DOI 10.1136/adc.77.6.535
   STACPOOLE PW, 1992, NEW ENGL J MED, V327, P1564, DOI 10.1056/NEJM199211263272204
   Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637
   STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6
   STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007
   Taivassalo T, 1998, NEUROLOGY, V50, P1055, DOI 10.1212/WNL.50.4.1055
   Taivassalo T, 1996, NEUROLOGY, V47, P529, DOI 10.1212/WNL.47.2.529
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2003, BRAIN, V126, P413, DOI 10.1093/brain/awg028
   Thompson D., 1997, Howley, Health Fitness Instructor's Handbook, V3A, P165
   Vissing J, 1996, ANN NEUROL, V40, P655, DOI 10.1002/ana.410400416
   Vissing J, 2001, ANN NEUROL, V49, P672, DOI 10.1002/ana.1026
   Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17
   ASCMS GUID EX TEST P
NR 34
TC 28
Z9 29
U1 0
U2 4
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0021-972X
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD APR
PY 2004
VL 89
IS 4
BP 1733
EP 1738
DI 10.1210/jc.2003-031684
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 810OV
UT WOS:000220714500034
PM 15070938
OA Bronze
DA 2024-11-01
ER

PT J
AU Kosowska, B
   Strzala, T
   Brzezinska, K
   Grabowski, K
   Moska, M
   Dobosz, T
   Lebioda, A
AF Kosowska, Barbara
   Strzala, Tomasz
   Brzezinska, Katarzyna
   Grabowski, Krzysztof
   Moska, Magdalena
   Dobosz, Tadeusz
   Lebioda, Arleta
TI Phylogenetic analysis of steroid 21-hydroxylase (CYP21) of the wolf and
   selected breeds of dogs in connection with the role of this enzyme in
   the pathogenesis of many diseases in the Canidae family
SO MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE
LA English
DT Article
DE canis lupus familiaris; 21steroid hydroxylase; pathogenesis;
   phylogenetics; CYP21
ID CONGENITAL ADRENAL-HYPERPLASIA; ALOPECIA-X; AUTOIMMUNE-DISEASE;
   MITOCHONDRIAL-DNA; GENE-EXPRESSION; CANDIDATE GENE; SEQUENCE; GENOME;
   ORGANIZATION; POMERANIANS
AB The aim of this study was to determine the nucleotide sequence of the CYP21 gene in the wolf and representatives of five breeds of dogs (selected according to a classification by Parker et al, 2004) in connection with the key role of the product of this gene in the genesis of many diseases in dogs. Nuclear DNA of dogs was obtained from peripheral blood, and the wolf's DNA was isolated from muscle tissue. The amplification of the 21HS gene was carried out in 10 fragments under standardized PCR conditions. The reaction products were sequenced. The sequence of amino acids in the protein was determined on the basis of the nucleotide sequence. The sequences obtained in our study and those retrieved from the GeneBank database were compared with the Mafft program (15) and subjected to phylogenetic analysis with the MrBayes 3.2 program (35). We detected a total of nine SNP mutations in introns and exons. Furthermore, a deletion of two nucleotides, that differentiates the breeds, was detected in the promoter region. Only two differences between the dogs and the wolf were found in SNP: one in an exon and one in an intron. Genetic distance was determined between the selected breeds of dogs and between the wolf and the dogs of each breed. In addition, we estimated the evolutionary distances between amino acid sequences of the dog/wolf and homologous 21HS sequences of eight different vertebrate species obtained from GeneBank. It was shown that, among mammals, the amino acid sequence of the dog/wolf is the most similar to the sequence of the pig, and the least similar to that of the human. The sequences determined in this study may provide a reference point for the research on the CYP21 gene structure and expression in various tissues of dogs for therapeutic purposes.
C1 [Kosowska, Barbara; Strzala, Tomasz; Brzezinska, Katarzyna; Grabowski, Krzysztof; Moska, Magdalena] Wroclaw Univ Environm & Life Sci, Dept Genet, PL-51631 Wroclaw, Poland.
   [Dobosz, Tadeusz; Lebioda, Arleta] Wroclaw Med Univ, Dept Forens Med, Inst Mol Tech, PL-50369 Wroclaw, Poland.
C3 Wroclaw University of Environmental & Life Sciences; Wroclaw Medical
   University
RP Kosowska, B (corresponding author), Ul Kozuchowska 7, PL-51631 Wroclaw, Poland.
EM barbara.kosowska@up.wroc.pl
RI Moska, Magdalena/A-1854-2017; Dobosz, Tadeusz/ABE-9988-2021; Grabowski,
   Krzysztof/V-6979-2018; Strzała, Tomasz/P-3357-2019; Kosowska,
   Barbara/B-7160-2014; Dobosz, Tadeusz/T-8250-2018; Strzala,
   Tomasz/F-4578-2011
OI Dobosz, Tadeusz/0000-0003-0413-9109; Strzala,
   Tomasz/0000-0002-7761-1630; Moska, Magdalena/0000-0001-9866-9906
CR [Anonymous], 2004, MrModeltest v2, DOI DOI 10.1093/SYSBIO/SYS029
   [Anonymous], [No title captured]
   Barg E., 2003, ADV CLIN EXP MED, V12, P507
   CAMERON PU, 1990, IMMUNOGENETICS, V31, P253, DOI 10.1007/BF00204897
   Cerundolo R, 2007, VET REC, V160, P393, DOI 10.1136/vr.160.12.393
   Corneli Patrice Showers, 2002, Journal of Mammalian Evolution, V9, P281, DOI 10.1023/A:1023926013667
   CRAWFORD RJ, 1992, J BIOL CHEM, V267, P16212
   Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088
   Frank LA, 2005, JAVMA-J AM VET MED A, V226, P1494, DOI 10.2460/javma.2005.226.1494
   Frank LA, 2004, VET DERMATOL, V15, P278, DOI 10.1111/j.1365-3164.2004.00372.x
   Galac S, 2010, DOMEST ANIM ENDOCRIN, V39, P259, DOI 10.1016/j.domaniend.2010.07.001
   GarciaMoreno J, 1996, CONSERV BIOL, V10, P376, DOI 10.1046/j.1523-1739.1996.10020376.x
   Hall T. A., NUCL ACIDS S SER, V41, P95
   HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841
   Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224
   KAWAGUCHI H, 1990, EUR J IMMUNOL, V20, P739, DOI 10.1002/eji.1830200405
   KAWAGUCHI H, 1992, HUM IMMUNOL, V33, P153, DOI 10.1016/0198-8859(92)90067-W
   Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519
   Klein SC, 2010, CAN VET J, V51, P63
   LAJIC S, 1995, J STEROID BIOCHEM, V52, P181, DOI 10.1016/0960-0760(94)00158-I
   Lessard CJ, 2012, AUTOIMMUN REV, V11, P267, DOI 10.1016/j.autrev.2011.10.003
   Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338
   Mausberg EM, 2007, ANIM BIOTECHNOL, V18, P391, DOI 10.1080/10495390701547461
   Mausberg EM, 2007, DEUT TIERARZTL WOCH, V114, P129, DOI 10.2377/0341-6593-114-129
   Mausberg EM, 2008, VET REC, V163, P121, DOI 10.1136/vr.163.4.121
   Miller W.L., 1986, P NATL ACAD SCI USA, V4, P211
   Mitchell AL, 2012, NAT REV ENDOCRINOL, V8, P306, DOI [10.1038/nrendo.2012.200, 10.1038/nrendo.2012.127, 10.1038/nrendo.2012.186, 10.1038/nrendo.2011.245, 10.1038/nrendo.2012.74, 10.1038/nrendo.2012.56]
   Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Novartis Animal Health, 2003, J VET MED S, V50
   PANG S, 1992, ENDOCRINOLOGY, V131, P181, DOI 10.1210/en.131.1.181
   Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406
   Rajpitt N., 2009, J VET PHARM TOX, V8
   Rogoff D, 2001, J STEROID BIOCHEM, V78, P77, DOI 10.1016/S0960-0760(01)00076-0
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   Schaer M., 2005, P 30 WORLD C WORLD S
   Schmeitzel L.P., 1995, KIRKS CURRENT VET TH, P600
   SPEISER PW, 1985, AM J HUM GENET, V37, P650
   Stafford D, 1999, VET TECH, V20, P490
   Takada K, 2002, RES VET SCI, V73, P159, DOI 10.1016/S0034-5288(02)00070-X
   Tsuda K, 1997, GENES GENET SYST, V72, P229, DOI 10.1266/ggs.72.229
   Vilà C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x
   WAYNE RK, 1993, TRENDS GENET, V9, P218, DOI 10.1016/0168-9525(93)90122-X
   WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111
   Wiebolt J, 2010, EUR J CLIN INVEST, V40, P1144, DOI 10.1111/j.1365-2362.2010.02366.x
   Yu L, 2002, MOL CELL ENDOCRINOL, V190, P9, DOI 10.1016/S0303-7207(02)00041-2
   Zhou MY, 1997, J STEROID BIOCHEM, V62, P277, DOI 10.1016/S0960-0760(97)00040-X
   Ziaja J., 2008, ENDOKRYNOL POL, V59
NR 48
TC 1
Z9 1
U1 0
U2 17
PU POLISH SOC VETERINARY SCIENCES EDITORIAL OFFICE
PI LUBLIN
PA AKADEMICKA 12, 20-950 LUBLIN, POLAND
SN 0025-8628
J9 MED WETER
JI Med. Weter.
PD SEP
PY 2012
VL 68
IS 9
BP 550
EP 556
PG 7
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 000IZ
UT WOS:000308381300008
DA 2024-11-01
ER

PT J
AU Gordon, N
AF Gordon, Neil
TI Alpers syndrome: progressive neuronal degeneration of children with
   liver disease
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Review
ID HUTTENLOCHER-SYNDROME; CEREBRAL DEGENERATION; CHILDHOOD; DEFICIENCY;
   FEATURES; BRAIN
AB Alpers syndrome was not clearly defined until the link between brain and liver disease was described. Alpers syndrome can now be clearly established as a disorder of oxidative metabolism related to mitochondrial dysfunction, and in most instances with an autosomal mode of inheritance. The symptoms and signs are discussed. The illness occurs in the first years of life with the sudden onset of intractable seizures associated with developmental delay, hypotonia, ataxia, cortical blindness, and hepatic failure, and death occurs within a short time. Treating the seizures with valproic acid can cause the rapid onset of liver failure and must be avoided. To establish a definite diagnosis, liver and muscle biopsies may be needed. The former shows bile duct proliferation with the evidence of cirrhosis, and the latter may support the involvement of the mitochondrial respiratory chain if there are ragged-red fibres. Genetic studies can show an association with mitochondrial DNA depletion and mutations in the polymerase gene. Cytochrome c oxidase deficiency has been demonstrated in some patients. Useful diagnostic tests include liver function tests, lactic acid levels in the blood and cerebrospinal fluid, electroencephalograms, computed tomography, and magnetic resonance imaging. The differential diagnosis will be from other forms of neuronal degeneration and disorders of mitochondrial function. There is no specific treatment, which must await further research into causes.
RP Gordon, N (corresponding author), Huntlywood,3 Styal Rd, Wilmslow SK9 4AE, Cheshire, England.
EM neil-gordon@doctors.org.uk
CR BOYD SG, 1986, NEUROPEDIATRICS, V17, P75, DOI 10.1055/s-2008-1052505
   Brett E., 1997, PEDIAT NEUROLOGY, V3, P143
   Davidzon G, 2005, ANN NEUROL, V57, P921, DOI 10.1002/ana.20498
   Delarue A, 2000, Pediatr Transplant, V4, P67, DOI 10.1034/j.1399-3046.2000.00090.x
   Flemming K, 2002, AM J NEURORADIOL, V23, P1421
   Gauthier-Villars M, 2001, NEUROPEDIATRICS, V32, P150, DOI 10.1055/s-2001-16614
   HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320
   HARDING BN, 1990, J CHILD NEUROL, V5, P273, DOI 10.1177/088307389000500402
   HUTTENLOCHER PR, 1976, ARCH NEUROL-CHICAGO, V33, P186, DOI 10.1001/archneur.1976.00500030042009
   Kayihan N, 2000, Pediatr Transplant, V4, P211, DOI 10.1034/j.1399-3046.2000.00115.x
   Martinez-Mena JM, 1998, REV NEUROLOGIA, V26, P70, DOI 10.33588/rn.26149.981087
   MONTINE TJ, 1995, CLIN NEUROPATHOL, V14, P322
   Naudé JTW, 2004, J NEUROL NEUROSUR PS, V75, P910, DOI 10.1136/jnnp.2003.015651
   Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B
   NIKLAS D, 2005, EUR J PAEDIATR NEURO, V9, P155
   Rasmussen M, 2000, J CHILD NEUROL, V15, P473, DOI 10.1177/088307380001500709
   Schwabe MJ, 1997, PEDIATR NEUROL, V16, P337, DOI 10.1016/S0887-8994(97)00030-1
   Simonati A, 2003, ACTA NEUROPATHOL, V106, P57, DOI 10.1007/s00401-003-0698-x
   Simonati A, 2003, J NEUROL, V250, P702, DOI 10.1007/s00415-003-1065-5
   Smith JK, 1996, CLIN IMAG, V20, P235, DOI 10.1016/0899-7071(95)00039-9
   Tesarova M, 2004, NEUROPEDIATRICS, V35, P217, DOI 10.1055/s-2004-821081
   Ulmer S, 2002, J COMPUT ASSIST TOMO, V26, P641, DOI 10.1097/00004728-200207000-00030
   UNSIMAA J, 2003, PEDIATRICS, V111, pE262
   Williams A, 1998, J PAEDIATR CHILD H, V34, P395, DOI 10.1046/j.1440-1754.1998.00249.x
   Worle H, 1998, CLIN NEUROPATHOL, V17, P63
NR 25
TC 35
Z9 38
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD DEC
PY 2006
VL 48
IS 12
BP 1001
EP 1003
DI 10.1017/S0012162206002209
PG 3
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 114LS
UT WOS:000242668300015
PM 17109792
DA 2024-11-01
ER

PT J
AU San-Millan, I
AF San-Millan, Inigo
TI The Key Role of Mitochondrial Function in Health and Disease
SO ANTIOXIDANTS
LA English
DT Review
DE mitochondrial dysfunction; cellular bioenergetics; diabetes;
   cardiovascular disease; cancer; Alzheimer's disease; metabolic
   flexibility; exercise
ID FATTY-ACID-METABOLISM; HUMAN SKELETAL-MUSCLE; BRAIN INSULIN-RESISTANCE;
   PHYSICAL-ACTIVITY; OXIDATIVE STRESS; ALZHEIMERS-DISEASE;
   CARDIOVASCULAR-DISEASE; IN-VIVO; DIABETES-MELLITUS; RESPIRATORY-CHAIN
AB The role of mitochondrial function in health and disease has become increasingly recognized, particularly in the last two decades. Mitochondrial dysfunction as well as disruptions of cellular bioenergetics have been shown to be ubiquitous in some of the most prevalent diseases in our society, such as type 2 diabetes, cardiovascular disease, metabolic syndrome, cancer, and Alzheimer's disease. However, the etiology and pathogenesis of mitochondrial dysfunction in multiple diseases have yet to be elucidated, making it one of the most significant medical challenges in our history. However, the rapid advances in our knowledge of cellular metabolism coupled with the novel understanding at the molecular and genetic levels show tremendous promise to one day elucidate the mysteries of this ancient organelle in order to treat it therapeutically when needed. Mitochondrial DNA mutations, infections, aging, and a lack of physical activity have been identified to be major players in mitochondrial dysfunction in multiple diseases. This review examines the complexities of mitochondrial function, whose ancient incorporation into eukaryotic cells for energy purposes was key for the survival and creation of new species. Among these complexities, the tightly intertwined bioenergetics derived from the combustion of alimentary substrates and oxygen are necessary for cellular homeostasis, including the production of reactive oxygen species. This review discusses different etiological mechanisms by which mitochondria could become dysregulated, determining the fate of multiple tissues and organs and being a protagonist in the pathogenesis of many non-communicable diseases. Finally, physical activity is a canonical evolutionary characteristic of humans that remains embedded in our genes. The normalization of a lack of physical activity in our modern society has led to the perception that exercise is an "intervention". However, physical activity remains the modus vivendi engrained in our genes and being sedentary has been the real intervention and collateral effect of modern societies. It is well known that a lack of physical activity leads to mitochondrial dysfunction and, hence, it probably becomes a major etiological factor of many non-communicable diseases affecting modern societies. Since physical activity remains the only stimulus we know that can improve and maintain mitochondrial function, a significant emphasis on exercise promotion should be imperative in order to prevent multiple diseases. Finally, in populations with chronic diseases where mitochondrial dysfunction is involved, an individualized exercise prescription should be crucial for the "metabolic rehabilitation" of many patients. From lessons learned from elite athletes (the perfect human machines), it is possible to translate and apply multiple concepts to the betterment of populations with chronic diseases.
C1 [San-Millan, Inigo] Univ Colorado, Dept Human Physiol & Nutr, Colorado Springs, CO 80198 USA.
   [San-Millan, Inigo] Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA.
   [San-Millan, Inigo] Univ Colorado Anschutz Med Campus, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado at Colorado
   Springs; University of Colorado System; University of Colorado Anschutz
   Medical Campus; University of Colorado System; University of Colorado
   Anschutz Medical Campus
RP San-Millan, I (corresponding author), Univ Colorado, Dept Human Physiol & Nutr, Colorado Springs, CO 80198 USA.; San-Millan, I (corresponding author), Univ Colorado Anschutz Med Campus, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80045 USA.; San-Millan, I (corresponding author), Univ Colorado Anschutz Med Campus, Dept Med, Div Med Oncol, Aurora, CO 80045 USA.
EM isanmill@uccs.edu
OI San-Millan, Inigo/0000-0002-7975-917X
FU IS-M Cellular Metabolism Laboratory funds.
FX This study was funded with IS-M Cellular Metabolism Laboratory funds.
CR Abdul-Ghani MA, 2008, CURR DIABETES REP, V8, P173, DOI 10.1007/s11892-008-0030-1
   Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25
   Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042
   Alam MM, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0082-9
   Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009
   Alonso A, 1997, ELECTROPHORESIS, V18, P682, DOI 10.1002/elps.1150180504
   Amara CE, 2008, METHODS, V46, P312, DOI 10.1016/j.ymeth.2008.10.001
   Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221
   Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   Arismendi-Morillo G, 2017, ULTRASTRUCT PATHOL, V41, P234, DOI 10.1080/01913123.2017.1300618
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   Arnold Dominguez Y., 2017, REV CUB ENDOCRINOL, V28, P1
   Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185
   Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661
   Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230
   Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200
   Aubert G, 2013, BBA-MOL CELL RES, V1833, P840, DOI 10.1016/j.bbamcr.2012.08.015
   Babbar N, 2006, CANCER RES, V66, P11125, DOI 10.1158/0008-5472.CAN-06-3174
   Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014
   Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012
   Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x
   Benedict FG., 1938, VITAL ENERGETICS STU
   Bergman BC, 2012, DIABETOLOGIA, V55, P1140, DOI 10.1007/s00125-011-2419-7
   Bergman BC, 2020, DIABETES, V69, P848, DOI 10.2337/dbi18-0042
   Bergman BC, 2018, AM J PHYSIOL-ENDOC M, V314, pE152, DOI 10.1152/ajpendo.00142.2017
   Bergouignan A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010027
   Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011
   BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012
   Bismuth J, 2008, ATHEROSCLEROSIS, V196, P497, DOI 10.1016/j.atherosclerosis.2007.09.018
   Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102
   Blair SN, 2009, BRIT J SPORT MED, V43, P1
   Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007
   Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Boutagy NE, 2015, JOVE-J VIS EXP, DOI 10.3791/53216
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brooks GA, 2020, J SPORT HEALTH SCI, V9, P446, DOI 10.1016/j.jshs.2020.02.006
   Brooks GA, 2018, CELL METAB, V27, P757, DOI 10.1016/j.cmet.2018.03.008
   Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350
   Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35
   Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6
   Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Campbell MD, 2016, BBA-MOL BASIS DIS, V1862, P716, DOI 10.1016/j.bbadis.2015.12.019
   Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062
   Carter HN, 2018, J APPL PHYSIOL, V124, P1605, DOI 10.1152/japplphysiol.01110.2017
   Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014
   Casademont Jordi, 2002, Heart Fail Rev, V7, P131, DOI 10.1023/A:1015372407647
   Cass SP, 2017, CURR SPORT MED REP, V16, P19, DOI 10.1249/JSR.0000000000000332
   Chatfield KC, 2022, J INHERIT METAB DIS, V45, P111, DOI 10.1002/jimd.12459
   Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002
   Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93
   Chen YN, 2021, HUM BRAIN MAPP, V42, P4671, DOI 10.1002/hbm.25575
   Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x
   Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822
   Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23
   Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988
   Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728
   Colombini M, 2017, J BIOENERG BIOMEMBR, V49, P57, DOI 10.1007/s10863-016-9646-z
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   COYLE EF, 1985, J APPL PHYSIOL, V59, P853, DOI 10.1152/jappl.1985.59.3.853
   Cuezva JM, 2002, CANCER RES, V62, P6674
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007
   Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d
   de Boer E, 2022, AM J RESP CRIT CARE, V205, P126, DOI 10.1164/rccm.202108-1903LE
   De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954
   de la Maza MP, 2015, J NUTR HEALTH AGING, V19, P389, DOI 10.1007/s12603-014-0548-7
   De la Rosa A, 2020, J SPORT HEALTH SCI, V9, P394, DOI 10.1016/j.jshs.2020.01.004
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   DeBerardinis RJ, 2020, NAT METAB, V2, P127, DOI 10.1038/s42255-020-0172-2
   DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000
   DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302
   Dembitskaya Y, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2212004119
   Devlin CM, 2008, ARTERIOSCL THROM VAS, V28, P1723, DOI 10.1161/ATVBAHA.108.173344
   Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002
   Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415
   DOLKAS CB, 1977, J APPL PHYSIOL, V43, P1033, DOI 10.1152/jappl.1977.43.6.1033
   Drochioiu G., 2008, BIOL SYSTEMS STRUCTU
   Dubé JJ, 2016, MED SCI SPORT EXER, V48, P472, DOI 10.1249/MSS.0000000000000789
   Dudek J, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00090
   Durstine JL, 2013, J SPORT HEALTH SCI, V2, P3, DOI 10.1016/j.jshs.2012.07.009
   Farina N, 2014, INT PSYCHOGERIATR, V26, P9, DOI 10.1017/S1041610213001385
   Fernández AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001
   Fields JA, 2016, NEUROBIOL DIS, V86, P154, DOI 10.1016/j.nbd.2015.11.015
   Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967
   Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177
   Friedenreich CM, 2021, MOL ONCOL, V15, P790, DOI 10.1002/1878-0261.12772
   Fritzen AM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030237
   Fritzen AM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9103113
   Ganji R, 2021, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.614650
   Gatti P, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.578599
   Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   GOLLNICK PD, 1973, J APPL PHYSIOL, V34, P107, DOI 10.1152/jappl.1973.34.1.107
   GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312
   GOLLNICK PD, 1969, AM J PHYSIOL, V216, P1502, DOI 10.1152/ajplegacy.1969.216.6.1502
   Gonzalez-Franquesa A, 2017, ADV EXP MED BIOL, V982, P465, DOI 10.1007/978-3-319-55330-6_25
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755
   Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015
   Gornik I, 2010, J CRIT CARE, V25, P263, DOI 10.1016/j.jcrc.2009.10.002
   Grill S, 2017, ARCH GYNECOL OBSTET, V296, P1135, DOI 10.1007/s00404-017-4546-y
   Gu CP, 2022, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.788505
   Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154
   Guntur VP, 2022, METABOLITES, V12, DOI 10.3390/metabo12111026
   Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500
   Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6
   HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B
   Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288
   Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681
   Hammond Tyler C, 2022, J Cell Immunol, V4, P15
   Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harris J.A.B., 1919, SCI MON, V8, P385
   Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370
   Hashimoto T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002915
   Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/mss.0b013e31815fcb04, 10.1249/MSS.0b013e31815fcb04]
   Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005
   Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263
   HOUMARD JA, 1992, INT J SPORTS MED, V13, P572, DOI 10.1055/s-2007-1024567
   HOUSTON ME, 1979, ACTA PHYSIOL SCAND, V105, P163, DOI 10.1111/j.1748-1716.1979.tb06328.x
   HOYER S, 1992, MOL CHEM NEUROPATHOL, V16, P207, DOI 10.1007/BF03159971
   Hsu CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122186
   Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021
   Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008
   Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087095
   Intlekofer KA, 2013, NEUROBIOL DIS, V57, P47, DOI 10.1016/j.nbd.2012.06.011
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474
   JANSSON E, 1987, J APPL PHYSIOL, V62, P999, DOI 10.1152/jappl.1987.62.3.999
   Jayaraman A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0476-2
   Jendrach M, 2005, MECH AGEING DEV, V126, P813, DOI 10.1016/j.mad.2005.03.002
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013
   Jiang HK, 2014, INT J MOL SCI, V15, P5304, DOI 10.3390/ijms15045304
   Jones DP, 2015, ANTIOXID REDOX SIGN, V23, P734, DOI 10.1089/ars.2015.6247
   Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509
   Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997
   Karwi QG, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00068
   Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677
   Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130
   Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758
   KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603
   Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307
   Khosravi M, 2019, J ALZHEIMERS DIS, V70, P1197, DOI 10.3233/JAD-190220
   KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Kirkman DL, 2021, AM J PHYSIOL-HEART C, V320, pH2080, DOI 10.1152/ajpheart.00917.2020
   KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395
   Kirwan JP, 2013, DIABETES, V62, P352, DOI 10.2337/db12-1427
   KLAUSEN K, 1981, ACTA PHYSIOL SCAND, V113, P9, DOI 10.1111/j.1748-1716.1981.tb06854.x
   Kohl HW, 2001, MED SCI SPORT EXER, V33, pS472, DOI 10.1097/00005768-200106001-00017
   Kolwicz SC, 2013, CIRC RES, V113, P603, DOI 10.1161/CIRCRESAHA.113.302095
   Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004
   Koziel R, 2013, BIOCHEM J, V452, P231, DOI 10.1042/BJ20121778
   Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748
   Kuehn BM, 2020, JAMA-J AM MED ASSOC, V323, P297, DOI 10.1001/jama.2019.20939
   LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Le CH, 2020, J BIOL CHEM, V295, P12485, DOI 10.1074/jbc.RA119.011229
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Leibson CL, 1997, AM J EPIDEMIOL, V145, P301
   Li WJ, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/823071
   Lim AY, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232012559
   Lin ML, 2021, THROMB HAEMOSTASIS, V121, P900, DOI 10.1055/s-0040-1722191
   Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   Ljubicic V, 2009, AGING-US, V1, P818, DOI 10.18632/aging.100083
   Lombardi AM, 1999, AM J PHYSIOL-ENDOC M, V276, pE922, DOI 10.1152/ajpendo.1999.276.5.E922
   Long QQ, 2019, METHODS MOL BIOL, V1966, P237, DOI 10.1007/978-1-4939-9195-2_19
   Lopez X, 2013, J PEDIATR ENDOCR MET, V26, P995, DOI 10.1515/jpem-2012-0407
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87
   Lutwak L., 1959, Clin. Res, V7, P143
   MACOVSCHI E, 1982, REV ROUM BIOCHIM, V19, P177
   Macovschi E., 1969, BIOSTRUCTURA, VVolume 57
   Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177
   Mah M, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.684448
   Mandolesi L, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00509
   Mankowski RT, 2019, INTENS CARE MED, V45, P78, DOI 10.1007/s00134-018-5173-1
   Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323
   Marcus C, 2014, CLIN NUCL MED, V39, pE413, DOI 10.1097/RLU.0000000000000547
   Martín-Timón I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444
   McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7
   McGurk KA, 2021, ATHEROSCLEROSIS, V327, P18, DOI 10.1016/j.atherosclerosis.2021.04.021
   McTiernan A, 2019, MED SCI SPORT EXER, V51, P1252, DOI 10.1249/MSS.0000000000001937
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   MIKINES KJ, 1991, J APPL PHYSIOL, V70, P1245, DOI 10.1152/jappl.1991.70.3.1245
   Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a
   Monlun M, 2017, J MOL BIOL, V429, P1, DOI 10.1016/j.jmb.2016.10.028
   MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719
   Moran C, 2013, DIABETES CARE, V36, P4036, DOI 10.2337/dc13-0143
   Murariu M, 2012, BIOSYSTEMS, V109, P126, DOI 10.1016/j.biosystems.2012.02.006
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nelson MAM, 2021, ELIFE, V10, DOI [10.7554/elife.63104, 10.7554/eLife.63104]
   Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052
   Newington Jordan T, 2013, J Neurodegener Dis, V2013, P234572, DOI 10.1155/2013/234572
   Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427
   Ng YS, 2016, J NEUROL, V263, P179, DOI 10.1007/s00415-015-7884-3
   Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5
   Ou YN, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0512-1
   Paradies G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070728
   Park K, 2009, DIABETES CARE, V32, P1302, DOI 10.2337/dc09-0259
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324
   Peng HL, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.626047
   Perreault L, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96805
   Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Petrocelli JJ, 2020, J GERONTOL A-BIOL, V75, P1663, DOI 10.1093/gerona/glaa072
   Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0
   Potenza MA, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081257
   POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.pu.08.050187.001345
   Poznyak AV, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9060137
   PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033
   Rahmel T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78195-4
   RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231
   Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186
   Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769
   Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624
   Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow
   Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8
   Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026
   Rolland Y, 2008, J AM MED DIR ASSOC, V9, P390, DOI 10.1016/j.jamda.2008.02.007
   Rome S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00929
   Rossin F, 2015, CELL DEATH DIFFER, V22, P408, DOI 10.1038/cdd.2014.106
   Rudwill F, 2018, J CLIN ENDOCR METAB, V103, P1910, DOI 10.1210/jc.2017-02267
   Rusecka J, 2018, J APPL GENET, V59, P43, DOI 10.1007/s13353-017-0424-3
   Safeliu C, 2001, NEUROTOXICOLOGY, V22, P317, DOI 10.1016/S0161-813X(01)00015-8
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   San-Millan I, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.809485
   San-Millán I, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01536
   San-Millán I, 2018, SPORTS MED, V48, P467, DOI 10.1007/s40279-017-0751-x
   San-Millán I, 2017, CARCINOGENESIS, V38, P119, DOI 10.1093/carcin/bgw127
   Sangwung P, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa017
   Santos-Lozano A, 2016, MAYO CLIN PROC, V91, P999, DOI 10.1016/j.mayocp.2016.04.024
   Sazonova MA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6934394
   Schaar CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004972
   Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076
   Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1
   Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009
   Sergi D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00532
   Sevini F, 2014, EXP GERONTOL, V56, P234, DOI 10.1016/j.exger.2014.03.022
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888
   Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3
   Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037
   Sies H, 2017, REDOX BIOL, V11, P613, DOI 10.1016/j.redox.2016.12.035
   Singer M, 2014, VIRULENCE, V5, P66, DOI 10.4161/viru.26907
   Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531
   Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11
   Sokolowska E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00577
   Stefanatos R, 2018, FEBS LETT, V592, P743, DOI 10.1002/1873-3468.12902
   Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011
   Stephen R, 2017, J GERONTOL A-BIOL, V72, P733, DOI 10.1093/gerona/glw251
   STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2
   Bon RS, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.669725
   Sulaiman N, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2017-000489
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018
   Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P1434, DOI 10.1089/ars.2011.4149
   Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138
   Taivassalo T, 2001, ANN NEUROL, V50, P133, DOI 10.1002/ana.1050
   Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282
   Talbot K, 2014, NEURODEGENER DIS MAN, V4, P31, DOI [10.2217/nmt.13.73, 10.2217/NMT.13.73]
   Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007
   Tan-Chen S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00491
   Tang XQ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00175
   Tauffenberger A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1877-6
   Terzo S, 2021, J DIABETES COMPLICAT, V35, DOI 10.1016/j.jdiacomp.2021.108026
   Thanan R, 2015, INT J MOL SCI, V16, P193, DOI 10.3390/ijms16010193
   Tiku V, 2020, TRENDS CELL BIOL, V30, P263, DOI [10.1016/j.tcb.2020.01.006, 10.1016/j.tcb.2020.07.001]
   Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429
   Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141
   Toledo FGS, 2006, J CLIN ENDOCR METAB, V91, P3224, DOI 10.1210/jc.2006-0002
   Tran DH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012673
   TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791
   Turner N, 2008, TRENDS ENDOCRIN MET, V19, P324, DOI 10.1016/j.tem.2008.08.001
   Turpin-Nolan SM, 2020, NAT REV ENDOCRINOL, V16, P224, DOI 10.1038/s41574-020-0320-5
   Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009
   van Loon LJC, 2003, J PHYSIOL-LONDON, V553, P611, DOI 10.1113/jphysiol.2003.052431
   Vasile VC, 2021, ARTERIOSCL THROM VAS, V41, P1558, DOI 10.1161/ATVBAHA.120.315530
   Verma M, 2003, NAT REV CANCER, V3, P789, DOI 10.1038/nrc1192
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Vorkas PA, 2015, J PROTEOME RES, V14, P1389, DOI 10.1021/pr5009898
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang D, 2022, J DIABETES RES, V2022, DOI 10.1155/2022/3780156
   Wang W, 2016, ANTIOXID REDOX SIGN, V25, P534, DOI 10.1089/ars.2016.6739
   Warburg O., 1923, Journal of Molecular Medicine, V2, P776, DOI DOI 10.1007/BF01712130
   Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [DOI 10.1158/JCR.1925.148, 10.1158/jcr.1925.148]
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820
   WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004
   Xia WQ, 2013, PSYCHONEUROENDOCRINO, V38, P2493, DOI 10.1016/j.psyneuen.2013.05.012
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Yetkin-Arik B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48676-2
   Yetkin-Arile B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46503-2
   Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu EPK, 2017, ARTERIOSCL THROM VAS, V37, P2322, DOI 10.1161/ATVBAHA.117.310042
   Yuan Huiping, 2018, Oncotarget, V9, P6718, DOI 10.18632/oncotarget.22961
   Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011
   Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1
   Zhang LX, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101284
   Zhang LY, 2010, BBA-MOL CELL BIOL L, V1801, P1, DOI 10.1016/j.bbalip.2009.09.014
   Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523
   Zhou J, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0113-2
   Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504
NR 327
TC 55
Z9 58
U1 24
U2 54
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD APR
PY 2023
VL 12
IS 4
AR 782
DI 10.3390/antiox12040782
PG 30
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA E7MO4
UT WOS:000977344100001
PM 37107158
OA gold, Green Published
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Mortiboys, HJ
   Schaefer, J
   Reichmann, H
   Jackson, S
AF Mortiboys, Heather Jane
   Schaefer, Jochen
   Reichmann, Heinz
   Jackson, Sandra
TI Mitochondrial dysfunction in Parkinson's disease - revisited
SO NEUROLOGIA I NEUROCHIRURGIA POLSKA
LA English
DT Review
DE mitochondria; Parkinson's disease; complex I; rotenone
ID ELECTRON-TRANSPORT CHAIN; COMPLEX-I DEFICIENCY; SYNUCLEIN TRANSGENIC
   MICE; SUBSTANTIA-NIGRA NEURONS; TRANSFER-RNA GENES; ALPHA-SYNUCLEIN;
   RESPIRATORY-CHAIN; SKELETAL-MUSCLE; OXIDATIVE STRESS; DNA MUTATIONS
AB In recent years much of the research conducted in the field of Parkinson's disease (PD) has been aimed at trying to elucidate the molecular mechanisms involved in the development of the rare familial forms of the disease, with the hope that an understanding of these mechanisms will shed some light into the pathogenesis of the more prevalent idiopathic form of the disease. These studies have implicated mitochondrial dysfunction in the pathogenesis of familial PD, either as a primary event, with disease causing mutations identified in genes encoding mitochondrial proteins, or as a secondary event. Thus, the role played by mitochondrial respiratory chain function in the pathogeneis of idiopathic PD, an area of research that was a main focus some 15-20 years ago, has come back to the forefront of the field. A number of studies have directly investigated respiratory chain function in a variety of tissues from idiopathic PD patients. Although abundant in number, these studies have provided contradictory results, which still require clarification. In this review we will examine the data indicating the presence of a respiratory chain defect in patients with idiopathic PD and attempt to link it with the pathways that have been implicated by familial studies.
C1 [Mortiboys, Heather Jane] Univ Sheffield, Sch Med, Acad Neurol Unit, Sheffield, S Yorkshire, England.
   [Mortiboys, Heather Jane; Schaefer, Jochen; Reichmann, Heinz; Jackson, Sandra] Tech Univ, Dept Neurol, Dresden, Germany.
C3 University of Sheffield; Technische Universitat Dresden
RP Mortiboys, HJ (corresponding author), Univ Sheffield, Sch Med, Acad Neurol Unit, Sheffield, S Yorkshire, England.
EM H.Mortiboys@sheffield.ac.uk
RI Mortiboys, Heather/E-8838-2010
OI Mortiboys, Heather/0000-0001-6439-0579
CR Adam-Vizi V, 2005, ANTIOXID REDOX SIGN, V7, P1140, DOI 10.1089/ars.2005.7.1140
   ANDERSON JJ, 1993, J NEUROL NEUROSUR PS, V56, P477, DOI 10.1136/jnnp.56.5.477
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Aomi Y, 2001, BIOCHEM BIOPH RES CO, V280, P265, DOI 10.1006/bbrc.2000.4113
   Autere J, 2004, HUM GENET, V115, P29, DOI 10.1007/s00439-004-1123-9
   BARROSO N, 1993, CLIN CHEM, V39, P667
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Blake CI, 1997, MOVEMENT DISORD, V12, P3, DOI 10.1002/mds.870120103
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X
   Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209
   Boveris A, 1977, Adv Exp Med Biol, V78, P67
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   BRAVI D, 1992, MOVEMENT DISORD, V7, P228, DOI 10.1002/mds.870070307
   Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   COLLINS MA, 1985, NEUROSCI LETT, V55, P179, DOI 10.1016/0304-3940(85)90016-3
   DAMATO RJ, 1986, SCIENCE, V231, P987, DOI 10.1126/science.3080808
   Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044
   Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599
   DAVIS GC, 1979, PSYCHIAT RES, V1, P249, DOI 10.1016/0165-1781(79)90006-4
   DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262
   Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353
   FORNO LS, 1986, ANN NEUROL, V20, P449, DOI 10.1002/ana.410200403
   Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114
   García-Lozano JR, 2002, EUR NEUROL, V48, P34, DOI 10.1159/000064955
   Grasbon-Frodl EM, 1999, NEUROGENETICS, V2, P121, DOI 10.1007/s100480050063
   Greene JC, 2005, HUM MOL GENET, V14, P799, DOI 10.1093/hmg/ddi074
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634
   Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Hanagasi HA, 2005, INT J NEUROSCI, V115, P479, DOI 10.1080/00207450590523017
   HATTORI N, 1993, ADV NEUROL, V60, P292
   Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1
   IKEBE S, 1995, MOL BRAIN RES, V28, P281, DOI 10.1016/0169-328X(94)00209-W
   Itoh K, 1997, MOVEMENT DISORD, V12, P9, DOI 10.1002/mds.870120104
   JANETZKY B, 1994, NEUROSCI LETT, V169, P126, DOI 10.1016/0304-3940(94)90372-7
   Kapsa RMI, 1996, J NEUROL SCI, V144, P204, DOI 10.1016/S0022-510X(96)00247-X
   Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kosel S, 1998, NEUROGENETICS, V1, P197, DOI 10.1007/s100480050029
   Kosel S, 1996, J NEUROSCI RES, V44, P174
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612
   Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006
   LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561
   Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
   LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x
   Limongelli A, 2004, J MED GENET, V41, P342, DOI 10.1136/jmg.2003.016048
   Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006
   Martin MA, 1996, NEUROLOGY, V46, P1343, DOI 10.1212/WNL.46.5.1343
   Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004
   Mawrin C, 2004, NEUROSCI LETT, V357, P111, DOI 10.1016/j.neulet.2003.11.073
   Mayr-Wohlfart U, 1997, Eur J Med Res, V2, P111
   Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4
   Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381
   MIZUNO Y, 1990, J NEUROL SCI, V96, P49, DOI 10.1016/0022-510X(90)90056-S
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Müftüoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695
   Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200
   MYTILINEOU C, 1994, J NEURAL TRANSM-PARK, V8, P223, DOI 10.1007/BF02260943
   NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8
   Orth M, 2003, NEUROSCI LETT, V351, P29, DOI 10.1016/S0304-3940(03)00941-8
   OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M
   Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Parker WD, 2005, BIOCHEM BIOPH RES CO, V326, P667, DOI 10.1016/j.bbrc.2004.11.093
   PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606
   Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095
   Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   REICHMANN H, 1994, EUR NEUROL, V34, P263, DOI 10.1159/000117053
   Richter G, 2002, J NEURAL TRANSM, V109, P721, DOI 10.1007/s007020200060
   Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8
   SANDY MS, 1993, MOVEMENT DISORD, V8, P74, DOI 10.1002/mds.870080114
   SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   SCHAPIRA AHV, 1990, MOVEMENT DISORD, V5, P294, DOI 10.1002/mds.870050406
   SHAN DE, 1995, ACTA NEUROL SCAND, V91, P149
   Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060
   SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Simon DK, 2004, NEUROBIOL AGING, V25, P71, DOI 10.1016/S0197-4580(03)00037-X
   Simon DK, 2000, NEUROLOGY, V54, P703, DOI 10.1212/WNL.54.3.703
   Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278
   Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020
   Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X
   Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166
   St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533
   TAYLOR DJ, 1994, J NEUROL SCI, V125, P77, DOI 10.1016/0022-510X(94)90245-3
   Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793
   Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9
   Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Vanderford ML, 2003, J HEALTH COMMUN, V8, P11, DOI 10.1080/10810730390224820
   Vives-Bauza C, 2002, BIOCHEM BIOPH RES CO, V290, P1593, DOI 10.1006/bbrc.2002.6388
   Wakabayashi K, 1997, MUTAT RES-FUND MOL M, V376, P253, DOI 10.1016/S0027-5107(97)00050-X
   West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102
   Wiedemann FR, 1999, ANN NY ACAD SCI, V893, P426, DOI 10.1111/j.1749-6632.1999.tb07870.x
   Winkler-Stuck K, 2004, J NEUROL SCI, V220, P41, DOI 10.1016/j.jns.2004.02.003
   YOSHINO H, 1992, J NEURAL TRANSM-PARK, V4, P27, DOI 10.1007/BF02257619
   Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4
   Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 118
TC 7
Z9 8
U1 1
U2 5
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 0028-3843
EI 1897-4260
J9 NEUROL NEUROCHIR POL
JI Neurol. Neurochir. Pol.
PY 2007
VL 41
IS 2
BP 150
EP 159
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 281TW
UT WOS:000254522800008
PM 17530578
DA 2024-11-01
ER

PT J
AU Ophuis, RJAO
   Wijers, M
   Bennink, MB
   de Loo, FAJV
   Fransen, JAM
   Wieringa, B
   Wansink, DG
AF Ophuis, Ralph J. A. Oude
   Wijers, Mietske
   Bennink, Miranda B.
   de Loo, Fons A. J. van
   Fransen, Jack A. M.
   Wieringa, Be
   Wansink, Derick G.
TI A Tail-Anchored Myotonic Dystrophy Protein Kinase Isoform Induces
   Perinuclear Clustering of Mitochondria, Autophagy, and Apoptosis
SO PLOS ONE
LA English
DT Article
ID MAMMALIAN-CELLS; SKELETAL-MUSCLE; FISSION; FUSION; LOCALIZATION;
   MORPHOLOGY; CALCIUM; OVEREXPRESSION; BIOENERGETICS; GENERATION
AB Background: Studies on the myotonic dystrophy protein kinase (DMPK) gene and gene products have thus far mainly concentrated on the fate of length mutation in the (CTG)n repeat at the DNA level and consequences of repeat expansion at the RNA level in DM1 patients and disease models. Surprisingly little is known about the function of DMPK protein products.
   Methodology/Principal Findings: We demonstrate here that transient expression of one major protein product of the human gene, the hDMPK A isoform with a long tail anchor, results in mitochondrial fragmentation and clustering in the perinuclear region. Clustering occurred in a variety of cell types and was enhanced by an intact tubulin cytoskeleton. In addition to morphomechanical changes, hDMPK A expression induces physiological changes like loss of mitochondrial membrane potential, increased autophagy activity, and leakage of cytochrome c from the mitochondrial intermembrane space accompanied by apoptosis. Truncation analysis using YFP-hDMPK A fusion constructs revealed that the protein's tail domain was necessary and sufficient to evoke mitochondrial clustering behavior.
   Conclusion/Significance: Our data suggest that the expression level of the DMPK A isoform needs to be tightly controlled in cells where the hDMPK gene is expressed. We speculate that aberrant splice isoform expression might be a codetermining factor in manifestation of specific DM1 features in patients.
C1 [Ophuis, Ralph J. A. Oude; Wijers, Mietske; Fransen, Jack A. M.; Wieringa, Be; Wansink, Derick G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.
   [Bennink, Miranda B.; de Loo, Fons A. J. van] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen
RP Wansink, DG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.
EM r.wansink@ncmls.ru.nl
RI van de Loo, Fons/A-3425-2014; Wijers-Rouw, Mietske/G-4456-2016; Wansink,
   Derick/F-3404-2010; Wieringa, Berend/A-5346-2011; Fransen,
   Jack/E-8924-2010
OI Fransen, Jack/0000-0002-0571-7639
FU Prinses Beatrix Fonds; Association Francaise contre les Myopathies (AFM)
FX This study was supported by the Prinses Beatrix Fonds (together with the
   Stichting Spieren voor Spieren) and the Association Francaise contre les
   Myopathies (AFM). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anesti V, 2006, BBA-BIOENERGETICS, V1757, P692, DOI 10.1016/j.bbabio.2006.04.013
   Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000
   Benders AAGM, 1997, J CLIN INVEST, V100, P1440, DOI 10.1172/JCI119664
   Cai Q, 2009, NEURON, V61, P493, DOI 10.1016/j.neuron.2009.02.003
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003
   Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996
   Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002
   Chou T, 2001, BIOPHYS J, V80, P1075, DOI 10.1016/S0006-3495(01)76086-9
   Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007
   Diaz G, 2003, HISTOCHEM CELL BIOL, V120, P319, DOI 10.1007/s00418-003-0566-8
   Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503
   Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2
   Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570
   Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163
   Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100
   GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59
   Groenen PJTA, 2000, HUM MOL GENET, V9, P605, DOI 10.1093/hmg/9.4.605
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hofmann MW, 2004, P NATL ACAD SCI USA, V101, P14776, DOI 10.1073/pnas.0405175101
   Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002
   James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200
   KALIMAN P, 2008, CELL SIGNAL
   Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9
   Lyamzaev KG, 2004, ACTA BIOCHIM POL, V51, P553
   Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857
   MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299
   Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052
   Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106
   Mounsey JP, 2000, J BIOL CHEM, V275, P23362, DOI 10.1074/jbc.M000899200
   O'Cochlain DF, 2004, HUM MOL GENET, V13, P2505, DOI 10.1093/hmg/ddh266
   Ollesch J, 2008, EUR BIOPHYS J BIOPHY, V37, P435, DOI 10.1007/s00249-007-0233-4
   Ophuis RJAO, 2009, MUSCLE NERVE, V40, P545, DOI 10.1002/mus.21352
   Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101
   Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479
   Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488
   Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7
   Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417
   Siciliano G, 2001, BRAIN RES BULL, V56, P405, DOI 10.1016/S0361-9230(01)00653-0
   Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020
   Spät A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015
   STADHOUDERS AM, 1994, P NATL ACAD SCI USA, V91, P5089, DOI 10.1073/pnas.91.11.5089
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Ueda H, 1999, J NEUROL SCI, V162, P38, DOI 10.1016/S0022-510X(98)00290-1
   van Herpen REMA, 2005, MOL CELL BIOL, V25, P1402, DOI 10.1128/MCB.25.4.1402-1414.2005
   Wansink DG, 2003, MOL CELL BIOL, V23, P5489, DOI 10.1128/MCB.23.16.5489-5501.2003
   WANSINK DG, 2006, GENETIC INSTABILITIE, P79
   Yaffe MP, 1996, P NATL ACAD SCI USA, V93, P11664, DOI 10.1073/pnas.93.21.11664
   Ylä-Anttila P, 2009, METHOD ENZYMOL, V452, P143, DOI 10.1016/S0076-6879(08)03610-0
   Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003
   Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697
NR 59
TC 16
Z9 16
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 25
PY 2009
VL 4
IS 11
AR e8024
DI 10.1371/journal.pone.0008024
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 533MK
UT WOS:000272827800015
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Pitceathly, RDS
   Rahman, S
   Wedatilake, Y
   Polke, JM
   Cirak, S
   Foley, AR
   Sailer, A
   Hurles, ME
   Stalker, J
   Hargreaves, I
   Woodward, CE
   Sweeney, MG
   Muntoni, F
   Houlden, H
   Taanman, JW
   Hanna, MG
AF Pitceathly, Robert D. S.
   Rahman, Shamima
   Wedatilake, Yehani
   Polke, James M.
   Cirak, Sebahattin
   Foley, A. Reghan
   Sailer, Anna
   Hurles, Matthew E.
   Stalker, Jim
   Hargreaves, Iain
   Woodward, Cathy E.
   Sweeney, Mary G.
   Muntoni, Francesco
   Houlden, Henry
   Taanman, Jan-Willem
   Hanna, Michael G.
CA UK10K Consortium
TI <i>NDUFA4</i> Mutations Underlie Dysfunction of a Cytochrome <i>c</i>
   Oxidase Subunit Linked to Human Neurological Disease
SO CELL REPORTS
LA English
DT Article
ID OXIDATIVE-PHOSPHORYLATION ENZYMES; MITOCHONDRIAL-DNA DEPLETION;
   COMPLEX-I; SEQUENCING DATA; QUANTIFICATION; FIBROBLASTS; DEFICIENCY;
   MECHANISMS; FRAMEWORK; MUSCLE
AB The molecular basis of cytochrome c oxidase (COX, complex IV) deficiency remains genetically undetermined in many cases. Homozygosity mapping and whole-exome sequencing were performed in a consanguineous pedigree with isolated COX deficiency linked to a Leigh syndrome neurological phenotype. Unexpectedly, affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH: ubiquinone oxidoreductase) subunit. Western blot analysis of denaturing gels and immunocytochemistry revealed undetectable steady-state NDUFA4 protein levels, indicating that the mutation causes a loss-of-function effect in the homozygous state. Analysis of one- and two-dimensional blue-native polyacrylamide gels confirmed an interaction between NDUFA4 and the COX enzyme complex in control muscle, whereas the COX enzyme complex without NDUFA4 was detectable with no abnormal subassemblies in patient muscle. These observations support recent work in cell lines suggesting that NDUFA4 is an additional COX subunit and demonstrate that NDUFA4 mutations cause human disease. Our findings support reassignment of the NDUFA4 protein to complex IV and suggest that patients with unexplained COX deficiency should be screened for NDUFA4 mutations.
C1 [Pitceathly, Robert D. S.; Rahman, Shamima; Houlden, Henry; Hanna, Michael G.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Pitceathly, Robert D. S.; Rahman, Shamima; Houlden, Henry; Hanna, Michael G.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Rahman, Shamima; Wedatilake, Yehani] UCL Inst Child Hlth, Clin & Mol Genet Unit, Mitochondrial Res Grp, London WC1N 1EH, England.
   [Polke, James M.; Woodward, Cathy E.; Sweeney, Mary G.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Hargreaves, Iain] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Cirak, Sebahattin; Foley, A. Reghan; Muntoni, Francesco] UCL Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England.
   [Cirak, Sebahattin; Foley, A. Reghan; Muntoni, Francesco] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 1EH, England.
   [Sailer, Anna; Houlden, Henry; Hanna, Michael G.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.
   [Hurles, Matthew E.; Stalker, Jim] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.
   [Taanman, Jan-Willem] UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England.
C3 University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust;
   University of London; University College London; UCL Medical School;
   University College London Hospitals NHS Foundation Trust; University of
   London; University College London; University of London; University
   College London; Great Ormond Street Hospital for Children NHS Foundation
   Trust; University of London; University College London; Wellcome Trust
   Sanger Institute; University of London; University College London
RP Hanna, MG (corresponding author), UCL Inst Neurol, MRC Ctr Neuromuscular Dis, Queen Sq, London WC1N 3BG, England.
EM m.hanna@ucl.ac.uk
RI Hurles, Matthew/ABO-7502-2022; Hargreaves, Iain/AAJ-6757-2020; Cirak,
   Sebahattin/AAZ-6829-2020; Houlden, Henry/C-1532-2008; Rahman,
   Shamima/C-5232-2008; Taanman, Jan-Willem/A-5379-2011
OI Pitceathly, Robert/0000-0002-6123-4551; Houlden,
   Henry/0000-0002-2866-7777; Hanna, Michael/0000-0003-0825-4075; Taanman,
   Jan-Willem/0000-0002-5476-9785; Kelly, Kirsten/0000-0003-4234-543X;
   Wedatilake, Yehani/0000-0002-9268-7385
FU Wellcome Trust [WT091310]; Medical Research Council (MRC) grant
   [G0800674]; Wellcome Research Training Fellowship; Great Ormond Street
   Hospital Children's Charity; MRC Centre grant [G0601943]; Myositis
   Support Group; EU FP7 Bio-NMD grant; UK NHS Specialised Service for Rare
   Mitochondrial Diseases of Adults and Children; NIHR UCLH/UCL Biomedical
   Research Centre; Department of Health's National Institute for Health
   Research Biomedical Research Centres funding scheme; MRC [G108/638,
   G1001253, G0601943, MR/J004758/1, G0802760, G0800674, MR/K000608/1]
   Funding Source: UKRI
FX We are extremely grateful to the family for their participation in this
   study and the UK10K consortium for making the research possible. We
   would like to dedicate this discovery to the memory of John Alun
   Morgan-Hughes (June 16, 1932 to August 2, 2012). Funding for UK10K was
   provided by the Wellcome Trust under award WT091310. R.D.S.P. is funded
   by Medical Research Council (MRC) grant (G0800674), and Y.W. was funded
   by a Wellcome Research Training Fellowship. S.R., F.M., and J.-W.T. are
   supported by Great Ormond Street Hospital Children's Charity. M.G.H. is
   supported by an MRC Centre grant (G0601943) and the Myositis Support
   Group. A.R.F. is a Muscular Dystrophy Campaign Fellow, and S.C. is
   supported by the EU FP7 Bio-NMD grant to F.M. This study was supported
   by the UK NHS Specialised Service for Rare Mitochondrial Diseases of
   Adults and Children and the NIHR UCLH/UCL Biomedical Research Centre and
   was undertaken at University College London Hospitals/University College
   London, which received a proportion of funding from the Department of
   Health's National Institute for Health Research Biomedical Research
   Centres funding scheme.
CR Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Carroll J, 2002, J BIOL CHEM, V277, P50311, DOI 10.1074/jbc.M209166200
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hargreaves IP, 2002, J INHERIT METAB DIS, V25, P7, DOI 10.1023/A:1015104910239
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415
   PETROVABENEDICT R, 1992, J INHERIT METAB DIS, V15, P943, DOI 10.1007/BF01800243
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Rahman S, 2000, BRAIN, V123, P591, DOI 10.1093/brain/123.3.591
   Rickwood D., 1987, Mitochondria: a pratical approach, P1
   Sambrook J, 1990, Cold Spring Harbor Laboratories, V186, P182
   SCHAGGER H, 1995, ELECTROPHORESIS, V16, P763, DOI 10.1002/elps.11501601125
   Shteyer E, 2009, AM J HUM GENET, V84, P412, DOI 10.1016/j.ajhg.2009.02.006
   SINJORGO KMC, 1987, BIOCHIM BIOPHYS ACTA, V890, P144, DOI 10.1016/0005-2728(87)90015-6
   Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005
   Taanman JW, 1997, HUM MOL GENET, V6, P935, DOI 10.1093/hmg/6.6.935
   Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192
   Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
NR 26
TC 93
Z9 102
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD JUN
PY 2013
VL 3
IS 6
BP 1795
EP 1805
DI 10.1016/j.celrep.2013.05.005
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 184ON
UT WOS:000321901200006
PM 23746447
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Zarrouk-Mahjoub, S
AF Finsterer, J.
   Zarrouk-Mahjoub, S.
TI The heart in m.3243A&gt;G carriers
SO HERZ
LA English
DT Review
DE DNA; mitochondrial; MELAS syndrome; Maternally inherited diabetes and
   deafness; Arrhythmias; Cardiomyopathy
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MELAS SYNDROME; MYOCARDIAL
   DYSFUNCTION; MITOCHONDRIAL; CARDIOMYOPATHY; MUTATION; ADULTS;
   MANIFESTATION; INVOLVEMENT; PREVALENCE
AB Objectives Little is known about cardiac involvement in m.3243A>G variant carriers. Thus, this study aimed to assess type and frequency of cardiac disease in symptomatic and asymptomatic m.3243A>G carriers. Methods Systematic literature review. Results The m.3243A>G variant may manifest phenotypically as mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), maternally inherited diabetes and deafness (MIDD), myoclonic epilepsy with ragged red fiber (MERRF), Leigh syndrome, or MELAS/KSS (Kearns-Sayre syndrome) overlap. Only few systematic studies which prospectively investigated m.3243A>G carriers for cardiac involvement were found. Cardiac abnormalities reported in m.3243A>G carriers include myocardial abnormalities, arrhythmias, or conduction defects. Myocardial abnormalities include myocardial thickening, hypertrophic cardiomyopathy, dilated cardiomyopathy, noncompaction, myocardial fibrosis, systolic dysfunction, heart failure, or arterial hypertension. Arrhythmias reported in m.3243A>G carriers include paroxysmal supraventricular or ventricular arrhythmias, including sinus tachycardia, atrial fibrillation and nonsustained ventricular tachycardia, and sudden cardiac death. Conduction defects in this group of patients include Wolff-Parkinson-White syndrome and left/right bundle branch block. Asymptomatic m.3243A>G carriers usually do not develop clinical or subclinical cardiac disease. Conclusions Cardiac involvement in m.3243A>G carriers has been only rarely systematically studied, which is perhaps why the incidence of cardiac diseases in MELAS is lower than would be expected. Myocardial abnormalities are much more frequent than arrhythmias or conduction defects. All symptomatic and asymptomatic m.3243A>G carriers should be systematically investigated for cardiac disease.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
   [Zarrouk-Mahjoub, S.] Univ Tunis El Manar, Pasteur Inst Tunis, Tunis, Tunisia.
   [Zarrouk-Mahjoub, S.] Genom Platform, Tunis, Tunisia.
C3 Rudolfstiftung Hospital; Pasteur Network; Universite de Tunis-El-Manar;
   Institut Pasteur Tunis
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
RI Finsterer, J/AAE-5733-2020
CR Alila OF, 2016, MITOCHONDRIAL DNA A, V27, P2873, DOI 10.3109/19401736.2015.1060417
   Bates MGD, 2013, EUR HEART J-CARD IMG, V14, P650, DOI 10.1093/ehjci/jes226
   Benyamine A, 2016, REV MED INTERNE, V37, P779, DOI 10.1016/j.revmed.2016.06.007
   Bhati RS, 2005, J HEART LUNG TRANSPL, V24, P2286, DOI 10.1016/j.healun.2005.05.012
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Cristofari M, 1995, G Ital Cardiol, V25, P69
   de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007
   DiMauro S, 2001, GENE REV
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Florian A, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0145-x
   Gal Aniko, 2008, Orvosi Hetilap, V149, P1593, DOI 10.1556/OH.2008.28398
   Gallego-Delgado M, 2015, REV ESP CARDIOL, V68, P153, DOI 10.1016/j.rec.2014.09.007
   Hannah-Shmouni F, 2014, JIMD REP, V12, P17, DOI 10.1007/8904_2013_239
   Hollingsworth KG, 2012, NEUROMUSCULAR DISORD, V22, P592, DOI 10.1016/j.nmd.2012.03.001
   Hsu YHR, 2016, HEART FAIL REV, V21, P103, DOI 10.1007/s10741-015-9524-5
   Jose T, 2011, INT J CARDIOL, V149, pE24, DOI 10.1016/j.ijcard.2009.03.057
   Koene S, 2017, J INHERIT METAB DIS, V40, P247, DOI 10.1007/s10545-016-0001-7
   Limongelli G, 2010, EUR J HEART FAIL, V12, P114, DOI 10.1093/eurjhf/hfp186
   Lindroos MM, 2016, J INHERIT METAB DIS, V39, P67, DOI 10.1007/s10545-015-9865-1
   Ma YY, 2013, MITOCHONDR DNA, V24, P297, DOI 10.3109/19401736.2012.760071
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Malfatti E, 2013, NEUROLOGY, V80, P100, DOI 10.1212/WNL.0b013e31827b1a2f
   Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3
   Narumi K, 2018, NEPHRON, V138, P243, DOI 10.1159/000485109
   Nemes A, 2009, SWISS MED WKLY, V139, P117, DOI smw-12390
   Ng YS, 2016, EUR HEART J, V37, P2552, DOI 10.1093/eurheartj/ehv306
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   Rosseel L, 2017, EUR HEART J-CARD IMG, V18, P112, DOI 10.1093/ehjci/jew184
   Rudnicki M, 2016, AM J KIDNEY DIS, V68, P949, DOI 10.1053/j.ajkd.2016.06.027
   Salles JE, 2006, DIABETES RES CLIN PR, V72, P100, DOI 10.1016/j.diabres.2005.09.005
   Seitun S, 2016, CASE REP CARDIOL, V2016, DOI 10.1155/2016/1490181
   Sproule D M, 2008, J Inherit Metab Dis, V31 Suppl 3, P497, DOI 10.1007/s10545-007-0735-3
   Taniguchi Akira, 2002, Nihon Rinsho, V60 Suppl 4, P606
   Thomas T, 2015, MOLEC GENET METAB RE, V4, P9, DOI 10.1016/j.ymgmr.2015.05.002
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Youssef AA, 2016, INT J CARDIOL, V203, P1020, DOI 10.1016/j.ijcard.2015.10.054
   Yu Nian, 2016, eNeurologicalSci, V4, P15, DOI 10.1016/j.ensci.2016.04.006
   Zhou Y, 2018, INT J NEUROSCI, V128, P231, DOI 10.1080/00207454.2017.1387113
NR 41
TC 18
Z9 20
U1 0
U2 3
PU URBAN & VOGEL
PI MUNICH
PA NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY
SN 0340-9937
EI 1615-6692
J9 HERZ
JI Herz
PD JUN
PY 2020
VL 45
IS 4
BP 356
EP 361
DI 10.1007/s00059-018-4739-6
PG 6
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA LX9MU
UT WOS:000540149400014
PM 30128910
DA 2024-11-01
ER

PT J
AU Adeva-Andany, M
   López-Ojén, M
   Funcasta-Calderón, R
   Ameneiros-Rodríguez, E
   Donapetry-García, C
   Vila-Altesor, M
   Rodríguez-Seijas, J
AF Adeva-Andany, M.
   Lopez-Ojen, M.
   Funcasta-Calderon, R.
   Ameneiros-Rodriguez, E.
   Donapetry-Garcia, C.
   Vila-Altesor, M.
   Rodriguez-Seijas, J.
TI Comprehensive review on lactate metabolism in human health
SO MITOCHONDRION
LA English
DT Review
DE Glycolysis; Tricarboxylic acid cycle; Respiratory chain;
   Gluconeogenesis; Insulin resistance; Diabetes mellitus
ID HUMAN SKELETAL-MUSCLE; SEVERE LACTIC-ACIDOSIS; PYRUVATE-DEHYDROGENASE
   ACTIVATION; MONOCARBOXYLATE TRANSPORTER MCT1; RENAL TUBULAR DYSFUNCTION;
   NA+-COUPLED TRANSPORTER; FOREARM GLUCOSE-UPTAKE; INSULIN-RESISTANCE;
   DIABETES-MELLITUS; ADIPOSE-TISSUE
AB Metabolic pathways involved in lactate metabolism are important to understand the physiological response to exercise and the pathogenesis of prevalent diseases such as diabetes and cancer. Monocarboxylate transporters are being investigated as potential targets for diagnosis and therapy of these and other disorders. Glucose and alanine produce pyruvate which is reduced to lactate by lactate dehydrogenase in the cytoplasm without oxygen consumption. Lactate removal takes place via its oxidation to pyruvate by lactate dehydrogenase. Pyruvate may be either oxidized to carbon dioxide producing energy or transformed into glucose. Pyruvate oxidation requires oxygen supply and the cooperation of pyruvate dehydrogenase, the tricarboxylic acid cycle, and the mitochondrial respiratory chain. Enzymes of the gluconeogenesis pathway sequentially convert pyruvate into glucose. Congenital or acquired deficiency on gluconeogenesis or pyruvate oxidation, including tissue hypoxia, may induce lactate accumulation. Both obese individuals and patients with diabetes show elevated plasma lactate concentration compared to healthy subjects, but there is no conclusive evidence of hyperlactatemia causing insulin resistance. Available evidence suggests an association between defective mitochondrial oxidative capacity in the pancreatic beta-cells and diminished insulin secretion that may trigger the development of diabetes in patients already affected with insulin resistance. Several mutations in the mitochondrial DNA are associated with diabetes mellitus, although the pathogenesis remains unsettled. Mitochondrial DNA mutations have been detected in a number of human cancers. D-lactate is a lactate enantiomer normally formed during glycolysis. Excess D-lactate is generated in diabetes, particularly during diabetic ketoacidosis. D-lactic acidosis is typically associated with small bowel resection. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Adeva-Andany, M.; Funcasta-Calderon, R.; Ameneiros-Rodriguez, E.; Donapetry-Garcia, C.; Vila-Altesor, M.; Rodriguez-Seijas, J.] Hosp Gen Juan Cardona, Div Nephrol, La Coruna 15406, Spain.
   [Lopez-Ojen, M.] Policlin Assistens, Div Internal Med, La Coruna 15009, Spain.
RP Adeva-Andany, M (corresponding author), Hosp Gen Juan Cardona, Div Nephrol, Ave Pardo Bazan S-N, La Coruna 15406, Spain.
EM madevaa@yahoo.com
CR Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x
   ABER GM, 1966, NATURE, V212, P1589, DOI 10.1038/2121589a0
   AHLBORG G, 1982, J CLIN INVEST, V69, P45, DOI 10.1172/JCI110440
   AHLBORG G, 1975, J APPL PHYSIOL, V39, P718, DOI 10.1152/jappl.1975.39.5.718
   AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645
   Ananth S, 2010, BIOCHEM BIOPH RES CO, V394, P75, DOI 10.1016/j.bbrc.2010.02.109
   Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048
   ANDRES R, 1956, J CLIN INVEST, V35, P671, DOI 10.1172/JCI103324
   Avogaro A, 1996, J CLIN INVEST, V98, P108, DOI 10.1172/JCI118754
   Bajpeyi S, 2011, J CLIN ENDOCR METAB, V96, P1160, DOI 10.1210/jc.2010-1621
   BARNETT AH, 1981, BMJ-BRIT MED J, V282, P1656, DOI 10.1136/bmj.282.6277.1656
   Battezzati A, 2004, AM J PHYSIOL-ENDOC M, V286, pE129, DOI 10.1152/ajpendo.00486.2002
   Baud FJ, 2002, CRIT CARE MED, V30, P2044, DOI 10.1097/00003246-200209000-00015
   BAVEREL G, 1979, FEBS LETT, V101, P282, DOI 10.1016/0014-5793(79)81026-1
   Beck-Nielsen H, 2012, DIABETES-METAB RES, V28, P635, DOI 10.1002/dmrr.2337
   Benaissa ML, 2003, INTENS CARE MED, V29, P1372, DOI 10.1007/s00134-003-1866-0
   BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307
   Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684
   Bergman BC, 2009, J PHYSIOL-LONDON, V587, P2087, DOI 10.1113/jphysiol.2008.168286
   Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7
   BIHARI D, 1985, J HEPATOL, V1, P405, DOI 10.1016/S0168-8278(85)80778-9
   Bokhari S, 2009, AM J PHYSIOL-ENDOC M, V296, pE440, DOI 10.1152/ajpendo.90505.2008
   Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516
   Bonen A, 1998, AM J PHYSIOL-ENDOC M, V274, pE102, DOI 10.1152/ajpendo.1998.274.1.E102
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647
   Borron SW, 2012, CURR PHARM BIOTECHNO, V13, P1940
   Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005
   Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010
   Bouteldja N, 2010, J INHERIT METAB DIS, V33, P105, DOI 10.1007/s10545-010-9053-2
   Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099
   Brindley PG, 2007, CAN MED ASSOC J, V176, P1097, DOI 10.1503/cmaj.061288
   Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659
   Brown SD, 1996, J CRIT CARE, V11, P2, DOI 10.1016/S0883-9441(96)90014-3
   Bruce CR, 2003, J CLIN ENDOCR METAB, V88, P5444, DOI 10.1210/jc.2003-030791
   CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481
   Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361
   CAPALDO B, 1990, J CLIN ENDOCR METAB, V71, P1220, DOI 10.1210/jcem-71-5-1220
   Cersosimo E, 2000, DIABETES, V49, P1186, DOI 10.2337/diabetes.49.7.1186
   Chan CB, 2006, CURR DIABETES REV, V2, P271, DOI 10.2174/157339906777950660
   CHEN YDI, 1993, DIABETES METAB, V19, P348
   CHEN YT, 1990, NEW ENGL J MED, V323, P590, DOI 10.1056/NEJM199008303230907
   Cheng C, 2012, CELL ONCOL, V35, P217, DOI 10.1007/s13402-012-0081-9
   Chi S, 2009, J CARDIOTHOR VASC AN, V23, P711, DOI 10.1053/j.jvca.2009.05.025
   Chioléro R, 1999, ANN SURG, V229, P505, DOI 10.1097/00000658-199904000-00009
   Choi SYC, 2013, J PATHOL, V230, P350, DOI 10.1002/path.4218
   CHRISTENSEN NJ, 1975, EUR J CLIN INVEST, V5, P415, DOI 10.1111/j.1365-2362.1975.tb00473.x
   Coady MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC124, DOI 10.1152/ajpcell.00220.2009
   Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859
   CONNOR H, 1983, ANN NUTR METAB, V27, P481, DOI 10.1159/000176723
   CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550
   CONSOLI A, 1990, AM J PHYSIOL, V259, pE677, DOI 10.1152/ajpendo.1990.259.5.E677
   Cope TE, 2011, MITOCHONDRION, V11, P992, DOI 10.1016/j.mito.2011.08.010
   COPPACK SW, 1990, METABOLISM, V39, P384, DOI 10.1016/0026-0495(90)90253-9
   Coppack SW, 1996, CLIN SCI, V90, P409, DOI 10.1042/cs0900409
   Cox K, 2012, J CRIT CARE, V27, P132, DOI 10.1016/j.jcrc.2011.07.071
   Crawford SO, 2008, AM J HYPERTENS, V21, P1337, DOI 10.1038/ajh.2008.282
   Crawford SO, 2010, INT J EPIDEMIOL, V39, P1647, DOI 10.1093/ije/dyq126
   CRUICKSHANK AM, 1988, INTENS CARE MED, V14, P384, DOI 10.1007/BF00262893
   Cuff MA, 2002, BIOCHEM BIOPH RES CO, V292, P1048, DOI 10.1006/bbrc.2002.6763
   Dahlman I, 2006, DIABETES, V55, P1792, DOI 10.2337/db05-1421
   Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053
   de Groot R, 2011, NETH J MED, V69, P120
   De Vriese AS, 2006, CLIN INFECT DIS, V42, P1111, DOI 10.1086/501356
   DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902
   DEFRONZO RA, 1991, J CLIN ENDOCR METAB, V73, P1294, DOI 10.1210/jcem-73-6-1294
   DELPRATO S, 1993, J CLIN INVEST, V91, P484, DOI 10.1172/JCI116226
   DEVRESE M, 1990, CLIN NUTR, V9, P23, DOI 10.1016/0261-5614(90)90069-5
   DIAMANT B, 1968, ACTA PHYSIOL SCAND, V72, P383, DOI 10.1111/j.1748-1716.1968.tb03861.x
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Donnino MW, 2007, ANN EMERG MED, V50, P722, DOI 10.1016/j.annemergmed.2006.10.022
   DRUML W, 1986, KLIN WOCHENSCHR, V64, P615, DOI 10.1007/BF01735263
   Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571
   Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270
   Epker JL, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-3
   Essa E, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-41
   Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112
   Faiz H, 2011, ARCH TOXICOL, V85, P1067, DOI 10.1007/s00204-010-0633-6
   Fannin RD, 2010, HEPATOLOGY, V51, P227, DOI 10.1002/hep.23330
   FELIG P, 1978, DIABETES, V27, P121, DOI 10.2337/diab.27.2.121
   FELIG P, 1971, J CLIN INVEST, V50, P1702, DOI 10.1172/JCI106659
   FELIG P, 1971, J CLIN INVEST, V50, P2703, DOI 10.1172/JCI106771
   FERNANDES J, 1982, LANCET, V1, P113
   Ferriero R, 2013, ONCOTARGET, V4, P804, DOI 10.18632/oncotarget.1000
   Fisher DS, 2013, CLIN TOXICOL, V51, P409, DOI 10.3109/15563650.2013.786833
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Fleming JC, 1999, NAT GENET, V22, P305, DOI 10.1038/10379
   Fontenot AP, 2002, CHEST, V122, P1436, DOI 10.1378/chest.122.4.1436
   FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686
   FRALEY DS, 1980, NEW ENGL J MED, V303, P1100, DOI 10.1056/NEJM198011063031907
   Frayn KN, 2012, AM J PHYSIOL-ENDOC M, V302, pE468, DOI 10.1152/ajpendo.00527.2011
   Frederiksen CM, 2008, DIABETOLOGIA, V51, P2068, DOI 10.1007/s00125-008-1122-9
   FRIEDMAN JE, 1994, METABOLISM, V43, P1047, DOI 10.1016/0026-0495(94)90188-0
   FULOP M, 1976, ARCH INTERN MED, V136, P987, DOI 10.1001/archinte.136.9.987
   Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202
   GARCIA CK, 1994, GENOMICS, V23, P500, DOI 10.1006/geno.1994.1532
   Garibotto G, 2004, J AM SOC NEPHROL, V15, P1606, DOI 10.1097/01.ASN.0000127865.26968.36
   Gaster M, 2002, DIABETES, V51, P921, DOI 10.2337/diabetes.51.4.921
   Gaster M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/716056
   Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006
   GERTZ EW, 1988, J CLIN INVEST, V82, P2017, DOI 10.1172/JCI113822
   Giebelstein J, 2012, DIABETOLOGIA, V55, P1114, DOI 10.1007/s00125-012-2456-x
   Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173
   GOLAY A, 1988, DIABETOLOGIA, V31, P585, DOI 10.1007/BF00264764
   GOODGAME JT, 1978, CANCER-AM CANCER SOC, V42, P800, DOI 10.1002/1097-0142(197808)42:2<800::AID-CNCR2820420253>3.0.CO;2-O
   Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558
   Gopal E, 2007, BBA-BIOMEMBRANES, V1768, P2690, DOI 10.1016/j.bbamem.2007.06.031
   Gopal E, 2007, PHARM RES-DORDR, V24, P575, DOI 10.1007/s11095-006-9176-1
   GRAHAM TE, 1989, J APPL PHYSIOL, V66, P561, DOI 10.1152/jappl.1989.66.2.561
   Hadjiagapiou C, 2000, AM J PHYSIOL-GASTR L, V279, pG775, DOI 10.1152/ajpgi.2000.279.4.G775
   HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888
   Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI
   HARRIS P, 1962, CLIN SCI, V23, P545
   HEINIG RE, 1979, ARCH INTERN MED, V139, P1229, DOI 10.1001/archinte.139.11.1229
   HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936
   Hey-Mogensen M, 2010, DIABETOLOGIA, V53, P1976, DOI 10.1007/s00125-010-1813-x
   Hojlund K, 2003, J BIOL CHEM, V278, P10436, DOI 10.1074/jbc.M212881200
   Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0
   Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006
   Holmäng A, 1998, AM J PHYSIOL-ENDOC M, V274, pE446, DOI 10.1152/ajpendo.1998.274.3.E446
   Hunt TK, 1997, ANN SURG, V226, P108, DOI 10.1097/00000658-199707000-00028
   Huttner HB, 2005, NEUROCRIT CARE, V3, P171, DOI 10.1385/NCC:3:2:171
   Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544
   Ide K, 2000, J PHYSIOL-LONDON, V522, P159, DOI 10.1111/j.1469-7793.2000.t01-2-00159.xm
   Ingaramo M, 2012, J BIOL CHEM, V287, P1813, DOI 10.1074/jbc.M111.275982
   Iwase Kazuhiro, 2002, Gastric Cancer, V5, P77, DOI 10.1007/s101200200013
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P594, DOI 10.1210/jcem-63-3-594
   JACKSON RA, 1986, J CLIN ENDOCR METAB, V63, P541, DOI 10.1210/jcem-63-3-541
   JACKSON RA, 1987, METABOLISM, V36, P144, DOI 10.1016/0026-0495(87)90008-4
   JANSSON PA, 1990, DIABETOLOGIA, V33, P253, DOI 10.1007/BF00404805
   JANSSON PA, 1994, J CLIN INVEST, V93, P240, DOI 10.1172/JCI116951
   Ji LN, 2001, CHINESE MED J-PEKING, V114, P1205
   Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709
   Jones DL, 2004, INTERN MED J, V34, P517, DOI 10.1111/j.1444-0903.2004.00659.x
   Jorens PG, 2004, J TOXICOL-CLIN TOXIC, V42, P163, DOI 10.1081/CLT-120030942
   JORFELDT L, 1970, ACTA PHYSIOL SCAND, P1
   Juel C, 2004, J PHYSIOL-LONDON, V556, P297, DOI 10.1113/jphysiol.2003.058222
   JUEL C, 1990, ACTA PHYSIOL SCAND, V140, P147, DOI 10.1111/j.1748-1716.1990.tb08986.x
   KADOWAKI T, 1994, NEW ENGL J MED, V330, P962, DOI 10.1056/NEJM199404073301403
   KATZ A, 1986, CLIN PHYSIOL, V6, P365, DOI 10.1111/j.1475-097X.1986.tb00242.x
   Katz J, 1999, AM J PHYSIOL-ENDOC M, V277, pE401, DOI 10.1152/ajpendo.1999.277.3.E401
   Kelleher JK, 1999, AM J PHYSIOL-ENDOC M, V277, pE395, DOI 10.1152/ajpendo.1999.277.3.E395
   KELLER U, 1978, BRIT MED J, V2, P606, DOI 10.1136/bmj.2.6137.606
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   KELLEY DE, 1993, DIABETES CARE, V16, P1158, DOI 10.2337/diacare.16.8.1158
   KELLEY DE, 1990, J CLIN INVEST, V86, P1999, DOI 10.1172/JCI114935
   KELNER MJ, 1985, J ANAL TOXICOL, V9, P40, DOI 10.1093/jat/9.1.40
   Kern PA, 1999, J CLIN ENDOCR METAB, V84, P4185, DOI 10.1210/jc.84.11.4185
   Kerr Caroline A, 2009, BMC Res Notes, V2, P164, DOI 10.1186/1756-0500-2-164
   Kiilerich K, 2011, J APPL PHYSIOL, V111, P751, DOI 10.1152/japplphysiol.00063.2011
   Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065283
   King P, 1998, CLIN SCI, V94, P157, DOI 10.1042/cs0940157
   King P, 1997, DIABETIC MED, V14, P19, DOI 10.1002/(SICI)1096-9136(199701)14:1<19::AID-DIA289>3.0.CO;2-0
   KISHIMOTO M, 1995, DIABETOLOGIA, V38, P193, DOI 10.1007/s001250050270
   Klein M, 2004, J EMERG MED, V26, P301, DOI 10.1016/j.jemermed.2003.11.014
   Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331
   Koeck T, 2011, CELL METAB, V13, P80, DOI 10.1016/j.cmet.2010.12.007
   KREISBERG RA, 1972, J CLIN ENDOCR METAB, V34, P29, DOI 10.1210/jcem-34-1-29
   KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227
   KUMAGAI S, 1982, EUR J APPL PHYSIOL, V49, P13, DOI 10.1007/BF00428959
   Kumar A, 2003, CHEST, V123, P1726, DOI 10.1378/chest.123.5.1726
   Landau BR, 1998, AM J PHYSIOL-ENDOC M, V274, pE954, DOI 10.1152/ajpendo.1998.274.5.E954
   Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   Larsen TS, 2008, J PHYSIOL-LONDON, V586, P2807, DOI 10.1113/jphysiol.2008.151449
   Lauritzen F, 2011, NEUROBIOL DIS, V41, P577, DOI 10.1016/j.nbd.2010.11.005
   Lazzeri C, 2011, DIABETES VASC DIS RE, V8, P35, DOI 10.1177/1479164110396744
   Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107
   Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108
   LEATHERDALE BA, 1980, CLIN SCI, V59, P191, DOI 10.1042/cs0590191
   Lefort N, 2010, DIABETES, V59, P2444, DOI 10.2337/db10-0174
   Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550
   LeStunff C, 1996, AM J PHYSIOL-ENDOC M, V271, pE814, DOI 10.1152/ajpendo.1996.271.5.E814
   Levraut J, 1998, AM J RESP CRIT CARE, V157, P1021, DOI 10.1164/ajrccm.157.4.9705037
   Levy B, 2006, CURR OPIN CRIT CARE, V12, P315, DOI 10.1097/01.ccx.0000235208.77450.15
   Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100
   Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959
   LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D
   LOVEJOY J, 1990, INT J OBESITY, V14, P843
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Lu JX, 2011, CLIN CHIM ACTA, V412, P286, DOI 10.1016/j.cca.2010.10.020
   Lubow JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE149, DOI 10.1152/ajpendo.00049.2005
   MACRAE HHS, 1995, PFLUG ARCH EUR J PHY, V430, P964, DOI 10.1007/BF01837410
   MAJANDER A, 1991, PEDIATR RES, V30, P327, DOI 10.1203/00006450-199110000-00007
   Majer M, 1998, MOL GENET METAB, V65, P181, DOI 10.1006/mgme.1998.2748
   Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x
   Matthews LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018736
   MCKELVIE RS, 1989, AM J PHYSIOL, V257, pR102, DOI 10.1152/ajpregu.1989.257.1.R102
   Meert KL, 2012, PEDIATR CRIT CARE ME, V13, P28, DOI 10.1097/PCC.0b013e3182196aa2
   Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004
   Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013
   Metz L, 2005, METABOLISM, V54, P1102, DOI 10.1016/j.metabol.2005.03.015
   Meyer C, 1998, J CLIN INVEST, V102, P619, DOI 10.1172/JCI2415
   Meyer C, 2003, AM J PHYSIOL-ENDOC M, V285, pE819, DOI 10.1152/ajpendo.00145.2003
   Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE428, DOI 10.1152/ajpendo.00116.2001
   Mikkelsen ME, 2009, CRIT CARE MED, V37, P1670, DOI 10.1097/CCM.0b013e31819fcf68
   Misu H, 2007, DIABETOLOGIA, V50, P268, DOI 10.1007/s00125-006-0489-8
   MITCHELL AM, 1955, J CLIN INVEST, V34, P471, DOI 10.1172/JCI103096
   MITRAKOU A, 1990, DIABETES, V39, P1381, DOI 10.2337/diabetes.39.11.1381
   Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200
   Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981
   Moon S, 2011, METABOLISM, V60, P107, DOI 10.1016/j.metabol.2009.12.021
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Muller M, 1996, AM J PHYSIOL-ENDOC M, V271, pE1003, DOI 10.1152/ajpendo.1996.271.6.E1003
   Munoz J, 2011, J CANCER RES THER, V7, P201, DOI 10.4103/0973-1482.82925
   Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744
   Nair KS, 2008, DIABETES, V57, P1166, DOI 10.2337/db07-1556
   NAITO E, 1994, PEDIATR RES, V36, P340, DOI 10.1203/00006450-199409000-00013
   NATALI A, 1990, DIABETES, V39, P490, DOI 10.2337/diabetes.39.4.490
   Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045
   Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888
   Nielsen HB, 2002, J APPL PHYSIOL, V92, P1677, DOI 10.1152/japplphysiol.00028.2001
   OHLSON LO, 1988, DIABETOLOGIA, V31, P798
   Olsson AH, 2011, EUR J ENDOCRINOL, V165, P589, DOI 10.1530/EJE-11-0282
   Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001
   Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960
   Overgaard M, 2012, FASEB J, V26, P3012, DOI 10.1096/fj.11-191999
   OWEN OE, 1981, J CLIN INVEST, V68, P240, DOI 10.1172/JCI110240
   OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016
   PAGLIARA AS, 1972, J CLIN INVEST, V51, P2115, DOI 10.1172/JCI107018
   Paksu MS, 2011, PEDIATR EMERG CARE, V27, P1180, DOI 10.1097/PEC.0b013e31823b412d
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   PERRIELLO G, 1995, AM J PHYSIOL-ENDOC M, V269, pE443, DOI 10.1152/ajpendo.1995.269.3.E443
   Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287
   Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE843, DOI 10.1152/ajpendo.1999.276.5.E843
   Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE255, DOI 10.1152/ajpendo.1999.276.2.E255
   Price NT, 1998, BIOCHEM J, V329, P321
   PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829
   Queirós O, 2012, J BIOENERG BIOMEMBR, V44, P141, DOI 10.1007/s10863-012-9418-3
   Quinonez SC, 2013, PEDIATR NEUROL, V48, P67, DOI 10.1016/j.pediatrneurol.2012.09.013
   Qvisth V, 2007, AM J PHYSIOL-ENDOC M, V292, pE709, DOI 10.1152/ajpendo.00104.2006
   RADZIUK J, 1983, DIABETES, V32, P977, DOI 10.2337/diabetes.32.11.977
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020
   RECORD CO, 1981, METABOLISM, V30, P638, DOI 10.1016/0026-0495(81)90076-7
   RECORD CO, 1975, GUT, V16, P144, DOI 10.1136/gut.16.2.144
   REMES AM, 1993, NEUROLOGY, V43, P1015, DOI 10.1212/WNL.43.5.1015
   Renault S, 2010, TOXICOL APPL PHARM, V242, P9, DOI 10.1016/j.taap.2009.09.002
   Richardson RS, 1998, J APPL PHYSIOL, V85, P627, DOI 10.1152/jappl.1998.85.2.627
   RINDI G, 1992, J INHERIT METAB DIS, V15, P231, DOI 10.1007/BF01799637
   Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x
   ROCHESTER DF, 1973, AM REV RESPIR DIS, V107, P442
   Roth B, 1999, ANN EMERG MED, V33, P452, DOI 10.1016/S0196-0644(99)70312-4
   ROTIG A, 1992, AM J HUM GENET, V50, P364
   SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551
   Saksena S, 2009, AM J PHYSIOL-GASTR L, V297, pG878, DOI 10.1152/ajpgi.00283.2009
   Salpeter SR, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002967.pub3, 10.1002/14651858.CD002967.pub4]
   Sandberg Y, 2010, NETH J MED, V68, P320
   Scale T, 2011, CLIN ENDOCRINOL, V74, P191, DOI 10.1111/j.1365-2265.2010.03891.x
   Segrè AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058
   Shah AD, 2011, BRIT J CLIN PHARMACO, V71, P20, DOI 10.1111/j.1365-2125.2010.03765.x
   Shangraw RE, 1998, AM J PHYSIOL-GASTR L, V274, pG569, DOI 10.1152/ajpgi.1998.274.3.G569
   Silverman B, 1997, JAMA-J AM MED ASSOC, V278, P109
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870
   Sjöstrand M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1097, DOI 10.1152/ajpendo.2000.279.5.E1097
   Snogdal LS, 2012, DIABETOLOGIA, V55, P340, DOI 10.1007/s00125-011-2377-0
   Soronen J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-9
   Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226
   Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x
   Stallknecht B, 1998, SCAND J MED SCI SPOR, V8, P127
   STANLEY WC, 1986, J APPL PHYSIOL, V60, P1116, DOI 10.1152/jappl.1986.60.4.1116
   Steller J, 2014, NEUROPEDIATRICS, V45, P56, DOI 10.1055/s-0033-1341601
   STRINGER W, 1994, J APPL PHYSIOL, V76, P1462, DOI 10.1152/jappl.1994.76.4.1462
   Stumvoll M, 1998, AM J PHYSIOL-ENDOC M, V274, pE817, DOI 10.1152/ajpendo.1998.274.5.E817
   STUMVOLL M, 1995, J CLIN INVEST, V96, P2528, DOI 10.1172/JCI118314
   Suter P M, 2000, J Nutr Health Aging, V4, P69
   Szendroedi J, 2009, DIABETES CARE, V32, P677, DOI 10.2337/dc08-2078
   Talasniemi JP, 2008, CLIN BIOCHEM, V41, P1099, DOI 10.1016/j.clinbiochem.2008.06.011
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468
   Toledo FGS, 2008, DIABETES, V57, P987, DOI 10.2337/db07-1429
   TONSGARD JH, 1982, PEDIATRICS, V69, P64
   Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200
   van der Merwe MT, 2001, J CLIN ENDOCR METAB, V86, P3296, DOI 10.1210/jc.86.7.3296
   van Hall G, 2009, J CEREBR BLOOD F MET, V29, P1121, DOI 10.1038/jcbfm.2009.35
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746
   Vermeulen RP, 2010, CRIT CARE, V14, DOI 10.1186/cc9253
   WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772
   Walker M, 2005, DIABETIC MED, V22, P18, DOI 10.1111/j.1464-5491.2005.1761f.x
   Walsh TS, 1999, CHEST, V116, P471, DOI 10.1378/chest.116.2.471
   Wang M, 2010, J INT MED RES, V38, P769
   WATERHOUSE C, 1969, J CLIN INVEST, V48, P2359, DOI 10.1172/JCI106202
   WATKINS PJ, 1969, BMJ-BRIT MED J, V1, P744, DOI 10.1136/bmj.1.5646.744
   Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1
   Willis MS, 2013, INT J BURNS TRAUMA, V3, P1
   WISNESKI JA, 1985, J CLIN INVEST, V76, P1819, DOI 10.1172/JCI112174
   Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE67, DOI 10.1152/ajpendo.00529.2004
   Woerle HJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE716, DOI 10.1152/ajpendo.00365.2002
   WOLL PJ, 1979, EUR J CLIN INVEST, V9, P397, DOI 10.1111/j.1365-2362.1979.tb00903.x
   Yánez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337
   YASUDA T, 1993, NEPHRON, V63, P416, DOI 10.1159/000187245
   YKIJARVINEN H, 1990, METABOLISM, V39, P859, DOI 10.1016/0026-0495(90)90133-W
   YKIJARVINEN H, 1985, J CLIN ENDOCR METAB, V61, P941, DOI 10.1210/jcem-61-5-941
   Zar T, 2007, NAT CLIN PRACT NEPHR, V3, P515, DOI 10.1038/ncpneph0573
   ZAWADZKI JK, 1988, DIABETES, V37, P154, DOI 10.2337/diabetes.37.2.154
   Zhang DL, 2003, POSTGRAD MED J, V79, P110, DOI 10.1136/pmj.79.928.110
   Zhang Y, 2010, CANCER GENET CYTOGEN, V196, P124, DOI 10.1016/j.cancergencyto.2009.09.004
   Zosel A, 2010, PHARMACOTHERAPY, V30, P219, DOI 10.1592/phco.30.2.219
   Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136
NR 306
TC 398
Z9 439
U1 8
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD JUL
PY 2014
VL 17
BP 76
EP 100
DI 10.1016/j.mito.2014.05.007
PG 25
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA AO1LD
UT WOS:000341072700010
PM 24929216
DA 2024-11-01
ER

PT J
AU Peng, LU
   Bai, GG
   Pang, YX
AF Peng, L. U.
   Bai, Gaigai
   Pang, Yingxin
TI Roles of NPAS2 in circadian rhythm and disease
SO ACTA BIOCHIMICA ET BIOPHYSICA SINICA
LA English
DT Review
DE neuronal PAS domain protein 2 (NPAS2); structure; SNP; function
ID SEASONAL AFFECTIVE-DISORDER; NIGHT-SHIFT WORK; PAS-A DOMAIN; CLOCK
   GENES; BREAST-CANCER; DNA-BINDING; REV-ERB; MITOCHONDRIAL BIOGENESIS;
   ALA394THR POLYMORPHISM; PROTEIN-2 NPAS2
AB NPAS2, a circadian rhythm gene encoding the neuronal PAS domain protein 2 (NPAS2), has received widespread attention because of its complex functions in cells and diverse roles in disease progression, especially tumorigenesis. NPAS2 binds with DNA at E-box sequences and forms heterodimers with another circadian protein, brain and muscle ARNT-like protein 1 (BMAL1). Nucleotide variations of the NPAS2 gene have been shown to influence the overall survival and risk of death of cancer patients, and differential expression of NPAS2 has been linked to patient outcomes in breast cancer, lung cancer, non-Hodgkin's lymphoma, and other diseases. Here, we review the latest advances in our understanding of NPAS2 with the aim of drawing attention to its potential clinical applications and prospects.
C1 [Peng, L. U.; Bai, Gaigai; Pang, Yingxin] Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250012, Peoples R China.
C3 Shandong University
RP Pang, YX (corresponding author), Shandong Univ, Dept Obstet & Gynecol, Qilu Hosp, Jinan 250012, Peoples R China.
EM yingxinpang@126.com
FU National Natural Science Foundation of China [81902657]
FX This work was supported by the grant from the National Natural Science
   Foundation of China (No. 81902657).
CR Akhisaroglu M, 2005, PHARMACOL BIOCHEM BE, V80, P371, DOI 10.1016/j.pbb.2004.11.016
   Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618
   Benna C, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1715-0
   Benna C, 2017, ONCOTARGET, V8, P23978, DOI 10.18632/oncotarget.15074
   Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1
   Cadenas C, 2014, CELL CYCLE, V13, P3282, DOI 10.4161/15384101.2014.954454
   Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012
   Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075
   Chen YB, 2019, CANCER MED-US, V8, P1919, DOI 10.1002/cam4.2050
   Chu LW, 2008, PROSTATE CANCER P D, V11, P342, DOI 10.1038/sj.pcan.4501024
   Chu LW, 2018, MOL CARCINOGEN, V57, P462, DOI 10.1002/mc.22770
   Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288
   Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557
   DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884
   Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456
   Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795
   Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5
   Esquifino AI, 1996, BRAIN BEHAV IMMUN, V10, P92, DOI 10.1006/brbi.1996.0010
   Evans DS, 2013, SLEEP, V36, P431, DOI 10.5665/sleep.2466
   Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103
   Fransquet PD, 2018, CLIN BIOCHEM, V58, P5, DOI 10.1016/j.clinbiochem.2018.05.020
   Franzoni A, 2017, EXP BIOL MED, V242, P1553, DOI 10.1177/1535370217724093
   Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3
   Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072
   Gamaleia N. F., 2006, Experimental Oncology, V28, P54
   Gao Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep30070
   Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226
   Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564
   Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768
   Grundy A, 2013, CANCER EPIDEMIOL, V37, P606, DOI 10.1016/j.canep.2013.04.006
   Gu FY, 2017, INT J CANCER, V141, P1794, DOI 10.1002/ijc.30883
   Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232
   Herichová I, 2017, PHYSIOL RES, V66, pS501, DOI 10.33549/physiolres.933799
   Hoffman AE, 2008, MOL CANCER RES, V6, P1461, DOI 10.1158/1541-7786.MCR-07-2094
   Ishida M, 2008, BIOCHEM BIOPH RES CO, V368, P292, DOI 10.1016/j.bbrc.2008.01.053
   Islam H, 2018, METABOLISM, V79, P42, DOI 10.1016/j.metabol.2017.11.001
   Iyyanki T, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02325-y
   Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121
   Jung JS, 2014, CHRONOBIOL INT, V31, P838, DOI 10.3109/07420528.2014.914034
   Kaeffer B, 2005, IN VITRO CELL DEV-AN, V41, P311
   Kim HI, 2015, CHRONOBIOL INT, V32, P785, DOI 10.3109/07420528.2015.1049613
   Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049
   Kovanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010007
   Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4
   Landgraf D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005882
   Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021
   Lee HM, 2011, P NATL ACAD SCI USA, V108, P16451, DOI 10.1073/pnas.1107178108
   Lesicka M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199622
   Lie JAS, 2006, CANCER CAUSE CONTROL, V17, P39, DOI 10.1007/s10552-005-3639-2
   Logan RW, 2014, BEHAV NEUROSCI, V128, P387, DOI 10.1037/a0036268
   Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y
   Markt SC, 2015, CANCER CAUSE CONTROL, V26, P25, DOI 10.1007/s10552-014-0478-z
   Masood N, 2017, PATHOL ONCOL RES, V23, P707, DOI 10.1007/s12253-016-0184-0
   McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019
   Beaupre LM, 2020, WORLD J BIOL PSYCHIA, V21, P80, DOI 10.1080/15622975.2018.1500028
   Mocellin S, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1010-1
   Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622
   Monsees GM, 2012, INT J CANCER, V131, P2547, DOI 10.1002/ijc.27564
   Mukaiyama Y, 2006, FEBS J, V273, P2528, DOI 10.1111/j.1742-4658.2006.05259.x
   Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953
   Ozburn AR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00360
   Parent MÉ, 2012, AM J EPIDEMIOL, V176, P751, DOI 10.1093/aje/kws318
   Partonen T, 2007, ANN MED, V39, P229, DOI 10.1080/07853890701278795
   Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5
   Qiu MJ, 2019, CHRONOBIOL INT, V36, P906, DOI 10.1080/07420528.2018.1477792
   Qiu MJ, 2019, CHRONOBIOL INT, V36, P739, DOI 10.1080/07420528.2018.1509080
   Rana S, 2014, ASIAN PAC J CANCER P, V15, P7169, DOI 10.7314/APJCP.2014.15.17.7169
   Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699
   ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72
   Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857
   Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698
   Sancar A, 2021, SCIENCE, V371, P42, DOI 10.1126/science.abb0738
   Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018
   Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825
   Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013
   Song B, 2019, J CELL BIOCHEM, V120, P8731, DOI 10.1002/jcb.28160
   Soria V, 2010, NEUROPSYCHOPHARMACOL, V35, P1279, DOI 10.1038/npp.2009.230
   Uchida T, 2005, J BIOL CHEM, V280, P21358, DOI 10.1074/jbc.M412350200
   Uchida T, 2012, J INORG BIOCHEM, V108, P188, DOI 10.1016/j.jinorgbio.2011.12.005
   Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051
   VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325
   Wang B, 2015, INT J CLIN EXP MED, V8, P7176
   Wang FR, 2011, BREAST CANCER RES TR, V127, P769, DOI 10.1007/s10549-010-1157-8
   Wendeu-Foyet MG, 2020, INT J CANCER, V147, P3119, DOI 10.1002/ijc.33139
   Wendeu-Foyet MG, 2019, INT J CANCER, V145, P1745, DOI 10.1002/ijc.32149
   Winter SL, 2007, NEOPLASIA, V9, P797, DOI 10.1593/neo.07595
   Wu YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02451
   Xiang Shulin, 2008, J Circadian Rhythms, V6, P4, DOI 10.1186/1740-3391-6-4
   Xue XF, 2014, BIOCHEM BIOPH RES CO, V450, P1058, DOI 10.1016/j.bbrc.2014.06.104
   Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18
   Yang T, 2019, MOL THER-NUCL ACIDS, V18, P1009, DOI 10.1016/j.omtn.2019.10.025
   Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x
   Yi CH, 2009, CANCER LETT, V284, P149, DOI 10.1016/j.canlet.2009.04.017
   Yi CH, 2010, BREAST CANCER RES TR, V120, P663, DOI 10.1007/s10549-009-0484-0
   Yoshino M, 2015, J NUTR BIOCHEM, V26, P1193, DOI 10.1016/j.jnutbio.2015.05.010
   Yu CC, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0811-4
   Yuan P, 2020, CANCER LETT, V469, P498, DOI 10.1016/j.canlet.2019.11.024
   Yuan P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.131
   Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428
   Zhao FF, 2017, ONCOTARGET, V8, P105873, DOI 10.18632/oncotarget.22411
   Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713
   Zhu Y, 2007, INT J CANCER, V120, P432, DOI 10.1002/ijc.22321
   Zhu Y, 2008, BREAST CANCER RES TR, V107, P421, DOI 10.1007/s10549-007-9565-0
   Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648
   Zienolddiny S, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3445
NR 105
TC 11
Z9 12
U1 1
U2 15
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, 100009,
   PEOPLES R CHINA
SN 1672-9145
EI 1745-7270
J9 ACTA BIOCH BIOPH SIN
JI Acta Biochim. Biophys. Sin.
PD OCT
PY 2021
VL 53
IS 10
BP 1257
EP 1265
DI 10.1093/abbs/gmab105
EA AUG 2021
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA WM6SD
UT WOS:000711212200001
PM 34415290
OA Bronze
DA 2024-11-01
ER

PT J
AU Fu, Y
   Dominissini, D
   Rechavi, G
   He, C
AF Fu, Ye
   Dominissini, Dan
   Rechavi, Gideon
   He, Chuan
TI Gene expression regulation mediated through reversible m<SUP>6</SUP>A
   RNA methylation
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID ARABIDOPSIS MESSENGER-RNA; FTO GENE; NUCLEAR-RNA; POSTTRANSCRIPTIONAL
   REGULATION; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL MYOPATHY; MISSENSE
   MUTATION; CRYSTAL-STRUCTURE; P-BODIES; DNA
AB Cellular RNAs carry diverse chemical modifications that used to be regarded as static and having minor roles in 'fine-tuning' structural and functional properties of RNAs. In this Review, we focus on reversible methylation through the most prevalent mammalian mRNA internal modification, N-6-methyladenosine (m(6)A). Recent studies have discovered protein 'writers', 'erasers' and 'readers' of this RNA chemical mark, as well as its dynamic deposition on mRNA and other types of nuclear RNA. These findings strongly indicate dynamic regulatory roles that are analogous to the well-known reversible epigenetic modifications of DNA and histone proteins. This reversible RNA methylation adds a new dimension to the developing picture of post-transcriptional regulation of gene expression.
C1 [Fu, Ye; Dominissini, Dan; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA.
   [Fu, Ye; Dominissini, Dan; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.
   [Dominissini, Dan; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.
   [Dominissini, Dan; Rechavi, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
C3 University of Chicago; University of Chicago; Chaim Sheba Medical
   Center; Tel Aviv University
RP He, C (corresponding author), Univ Chicago, Dept Chem, 929 East 57th St, Chicago, IL 60637 USA.
EM chuanhe@uchicago.edu
RI He, Chuan/HZJ-6319-2023
OI Dominissini, Dan/0000-0003-1121-5130; Fu, Ye/0000-0002-3807-9717; Fu,
   Ye/0000-0003-4434-6014
FU US National Institutes of Health [GM071440]; EUREKA [GM088599]; Israel
   Science Foundation; Flight Attendant Medical Research Institute (FAMRI);
   Israeli Centers of Research Excellence
FX The authors apologize to colleagues whose work was not cited owing to
   space limitation. They thank T. Pan, X. Wang, Y. Yue and J. Liu for
   discussion. C. H. is supported by the US National Institutes of Health
   grants GM071440 and the EUREKA grant GM088599. This work was also
   supported partly by grants from the Israel Science Foundation, the
   Flight Attendant Medical Research Institute (FAMRI) and the Israeli
   Centers of Research Excellence. S.F. Reichard contributed to editing of
   this manuscript.
CR Abdelmohsen K, 2010, WIRES RNA, V1, P214, DOI 10.1002/wrna.4
   Agarwala SD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002732
   Aik W., 2014, NUCL ACIDS RES
   Alexandrov A, 2002, RNA, V8, P1253, DOI 10.1017/S1355838202024019
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611
   Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021
   Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012
   BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X
   Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042
   Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726
   Bodi Z, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00048
   Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266
   Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002
   Bokar JA, 1997, RNA, V3, P1233
   Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365
   Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080
   Bujnicki JM, 2002, J MOL EVOL, V55, P431, DOI 10.1007/s00239-002-2339-8
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456
   Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990
   Chen WZ, 2014, FEBS LETT, V588, P892, DOI 10.1016/j.febslet.2014.02.021
   Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112
   Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713
   Clancy MJ, 2002, NUCLEIC ACIDS RES, V30, P4509, DOI 10.1093/nar/gkf573
   CSEPANY T, 1990, J BIOL CHEM, V265, P20117
   Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107
   Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388
   Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602
   Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080
   Fernández IS, 2013, NATURE, V500, P107, DOI 10.1038/nature12302
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848
   Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634
   Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822
   Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242
   Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026
   Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106
   Ge JH, 2013, TRENDS BIOCHEM SCI, V38, P210, DOI 10.1016/j.tibs.2013.01.002
   Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710
   Ghosh S, 2010, WIRES RNA, V1, P351, DOI 10.1002/wrna.25
   Grosjean H., 2005, FINE TUNING RNA FUNC
   Grosjean H.B. R., 1998, MODIFICATION EDITING
   Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110
   Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017
   Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921
   Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792
   Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881
   He CA, 2010, NAT CHEM BIOL, V6, P863, DOI 10.1038/nchembio.482
   He L., 2004, NAT REV GENET, V5, P522
   He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944
   Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449
   Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108
   Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397
   Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143
   Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402
   Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597
   Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580
   Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Karijolich J, 2011, NATURE, V474, P395, DOI 10.1038/nature10165
   Karikó K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1
   Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379
   Kierzek E, 2003, NUCLEIC ACIDS RES, V31, P4472, DOI 10.1093/nar/gkg633
   Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945
   Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008
   Leulliot N, 2008, STRUCTURE, V16, P52, DOI 10.1016/j.str.2007.10.025
   Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113
   Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007
   Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702
   Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79
   Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007
   NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541
   NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419
   Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873
   Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605
   Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861
   Robbens S, 2008, J MOL EVOL, V66, P80, DOI 10.1007/s00239-007-9059-z
   ROTTMAN F, 1974, CELL, V3, P197, DOI 10.1016/0092-8674(74)90131-7
   Rottman F M, 1976, Prog Nucleic Acid Res Mol Biol, V19, P21
   Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3
   Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160
   Schwanhäusser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047
   Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115
   Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312
   Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320
   Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218
   Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144
   Srikantan S, 2011, MOL CELL, V43, P319, DOI 10.1016/j.molcel.2011.07.016
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341
   Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116
   van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173
   Vilfan ID, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-8
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023
   WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0
   Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223
   Yang F, 2004, MOL CELL, V14, P435, DOI 10.1016/S1097-2765(04)00264-3
   Zheng GQ, 2013, RNA BIOL, V10, P915, DOI 10.4161/rna.24711
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883
NR 122
TC 1348
Z9 1515
U1 42
U2 678
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD MAY
PY 2014
VL 15
IS 5
BP 293
EP 306
DI 10.1038/nrg3724
PG 14
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AF3GM
UT WOS:000334599700008
PM 24662220
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Curtis, WM
   Seeds, WA
   Mattson, MP
   Bradshaw, PC
AF Curtis, William M.
   Seeds, William A.
   Mattson, Mark P.
   Bradshaw, Patrick C.
TI NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based
   Fasting and Exercise Therapy for the Treatment of Parkinson's Disease
SO CELLS
LA English
DT Review
DE Parkinson's disease; mitochondrial quality control; NADPH; DJ-1; PINK1;
   Parkin; IDH1; metabolic therapy; fasting; exercise; NAD; mitophagy;
   mitochondrial biogenesis; circadian; nicotinamide adenine dinucleotide;
   nicotinamide adenine dinucleotide phosphate; coffee
ID NICOTINAMIDE-ADENINE-DINUCLEOTIDE; PERMEABILITY TRANSITION PORE;
   TRANSCRIPTION FACTOR-4 ATF4; EXTENDS LIFE-SPAN; SKELETAL-MUSCLE; REDOX
   STATE; OXIDATIVE STRESS; DNA DELETIONS; BETA-HYDROXYBUTYRATE; DIETARY
   RESTRICTION
AB Dysfunctional mitochondrial quality control (MQC) is implicated in the pathogenesis of Parkinson's disease (PD). The improper selection of mitochondria for mitophagy increases reactive oxygen species (ROS) levels and lowers ATP levels. The downstream effects include oxidative damage, failure to maintain proteostasis and ion gradients, and decreased NAD(+) and NADPH levels, resulting in insufficient energy metabolism and neurotransmitter synthesis. A ketosis-based metabolic therapy that increases the levels of (R)-3-hydroxybutyrate (BHB) may reverse the dysfunctional MQC by partially replacing glucose as an energy source, by stimulating mitophagy, and by decreasing inflammation. Fasting can potentially raise cytoplasmic NADPH levels by increasing the mitochondrial export and cytoplasmic metabolism of ketone body-derived citrate that increases flux through isocitrate dehydrogenase 1 (IDH1). NADPH is an essential cofactor for nitric oxide synthase, and the nitric oxide synthesized can diffuse into the mitochondrial matrix and react with electron transport chain-synthesized superoxide to form peroxynitrite. Excessive superoxide and peroxynitrite production can cause the opening of the mitochondrial permeability transition pore (mPTP) to depolarize the mitochondria and activate PINK1-dependent mitophagy. Both fasting and exercise increase ketogenesis and increase the cellular NAD(+)/NADH ratio, both of which are beneficial for neuronal metabolism. In addition, both fasting and exercise engage the adaptive cellular stress response signaling pathways that protect neurons against the oxidative and proteotoxic stress implicated in PD. Here, we discuss how intermittent fasting from the evening meal through to the next-day lunch together with morning exercise, when circadian NAD(+)/NADH is most oxidized, circadian NADP(+)/NADPH is most reduced, and circadian mitophagy gene expression is high, may slow the progression of PD.
C1 [Curtis, William M.; Bradshaw, Patrick C.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.
   [Seeds, William A.] Spire Inst, Seeds Sci Performance Res, Geneva, OH 44041 USA.
   [Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
C3 East Tennessee State University; Johns Hopkins University
RP Bradshaw, PC (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA.
EM bradshawp@etsu.edu
RI Bradshaw, Patrick/AAR-9189-2020; Mattson, Mark/F-6038-2012
FU NIH [AG059096]
FX This research was funded by NIH grant number AG059096.
CR Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003
   Abraham MA, 2016, DIABETOLOGIA, V59, P1367, DOI 10.1007/s00125-016-3950-3
   Acosta-Rodríguez V, 2022, SCIENCE, V376, P1192, DOI 10.1126/science.abk0297
   ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P181, DOI 10.1016/0891-5849(93)90057-2
   Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653
   Almeida LM, 2022, BIOL REV, V97, P1737, DOI 10.1111/brv.12860
   Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200
   Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054
   Barber CN, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00212
   BEATTIE DS, 1967, J BIOL CHEM, V242, P4584
   Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896
   Bell SM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21238924
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Benderdour M, 2003, J BIOL CHEM, V278, P45154, DOI 10.1074/jbc.M306285200
   Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Blacker TS, 2016, FREE RADICAL BIO MED, V100, P53, DOI 10.1016/j.freeradbiomed.2016.08.010
   Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Bomba-Warczak E, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202005193
   Borst P, 2020, IUBMB LIFE, V72, P2241, DOI 10.1002/iub.2367
   Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Brakedal B, 2022, CELL METAB, V34, P396, DOI 10.1016/j.cmet.2022.02.001
   Breen DP, 2014, JAMA NEUROL, V71, P589, DOI 10.1001/jamaneurol.2014.65
   Brekk OR, 2020, P NATL ACAD SCI USA, V117, P27646, DOI 10.1073/pnas.2003021117
   Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0
   Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223
   Butkovich LM, 2020, J NEUROSCI, V40, P7559, DOI 10.1523/JNEUROSCI.1468-19.2020
   Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Cai Y, 2010, EUR J NEUROL, V17, P550, DOI 10.1111/j.1468-1331.2009.02848.x
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0
   Chen L, 2019, NAT METAB, V1, P404, DOI 10.1038/s42255-019-0043-x
   Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49
   Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264
   Chinta SJ, 2018, CELL REP, V22, P930, DOI 10.1016/j.celrep.2017.12.092
   Choi A, 2021, NEUROTHERAPEUTICS, V18, P1637, DOI 10.1007/s13311-021-01067-w
   Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837
   Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557
   Conlon N, 2022, BIOCHEM PHARMACOL, V198, DOI 10.1016/j.bcp.2022.114946
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   da Fonseca TL, 2015, BIOMOLECULES, V5, P435, DOI 10.3390/biom5020435
   Dai Y, 2013, MITOCHONDRION, V13, P282, DOI 10.1016/j.mito.2013.03.006
   Daneshmandi S, 2021, ELIFE, V10, DOI [10.7554/eLife.67476, 10.7554/eLife.67476.sa1, 10.7554/eLife.67476.sa2]
   de Abreu RM, 2019, BRAZ J PHYS THER, V23, P279, DOI 10.1016/j.bjpt.2018.09.010
   de Goede P, 2022, FASEB J, V36, DOI 10.1096/fj.202100707R
   de Goede P, 2018, J MOL ENDOCRINOL, V60, pR115, DOI 10.1530/JME-17-0196
   Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260
   Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200
   Di Benedetto S, 2017, NEUROSCI BIOBEHAV R, V75, P114, DOI 10.1016/j.neubiorev.2017.01.044
   Dolgacheva LP, 2019, J BIOENERG BIOMEMBR, V51, P175, DOI 10.1007/s10863-019-09798-4
   Dölle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548
   Dorninger F, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105061
   Du J, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2200923119
   Edwards C, 2014, AGING-US, V6, P621, DOI 10.18632/aging.100683
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Elamin M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00377
   Eldeeb MA, 2022, PHYSIOL REV, V102, P1721, DOI 10.1152/physrev.00041.2021
   Endo J, 2009, CIRC RES, V105, P1118, DOI 10.1161/CIRCRESAHA.109.206607
   Erlich AT, 2018, AM J PHYSIOL-CELL PH, V314, pC62, DOI 10.1152/ajpcell.00162.2017
   Estrada NM, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.005.2009
   Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109
   ForsmarkAndree P, 1996, ARCH BIOCHEM BIOPHYS, V336, P113, DOI 10.1006/abbi.1996.0538
   Francisco A, 2020, NEUROSCIENCE, V440, P210, DOI 10.1016/j.neuroscience.2020.05.042
   Gala MGF, 2021, FEBS LETT, V595, P1205, DOI 10.1002/1873-3468.14039
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gannon MC, 1996, METABOLISM, V45, P492, DOI 10.1016/S0026-0495(96)90225-5
   García N, 2005, LIFE SCI, V76, P2873, DOI 10.1016/j.lfs.2004.12.012
   Gendi F, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084235
   Georgakopoulos ND, 2017, NAT CHEM BIOL, V13, P136, DOI [10.1038/nchembio.2287, 10.1038/NCHEMBIO.2287]
   Ghosh D, 2014, AGING CELL, V13, P631, DOI 10.1111/acel.12216
   Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012
   Gialluisi A, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00455-2
   Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725
   Goodman RP, 2020, NATURE, V583, P122, DOI 10.1038/s41586-020-2337-2
   Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258
   Grammatikopoulou MG, 2022, MATURITAS, V163, P46, DOI 10.1016/j.maturitas.2022.06.001
   Green CL, 2022, NAT REV MOL CELL BIO, V23, P56, DOI 10.1038/s41580-021-00411-4
   Guo XH, 2010, BBA-BIOENERGETICS, V1797, P1159, DOI 10.1016/j.bbabio.2010.04.005
   Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536
   Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057
   Hao ZK, 2022, BRAIN SCI, V12, DOI 10.3390/brainsci12060698
   Harper C, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02737-1
   Harrison AP, 2008, J PHYSIOL PHARMACOL, V59, P91
   Harvey M, 2019, CLIN REHABIL, V33, P428, DOI 10.1177/0269215518815221
   He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200
   Heck DE, 2005, TOXICOLOGY, V208, P259, DOI 10.1016/j.tox.2004.11.027
   Hill CM, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29499-8
   Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048
   Hoehne MN, 2022, EMBO J, V41, DOI 10.15252/embj.2021109169
   Hoffman-Kuczynski B, 2005, NEUROCHEM RES, V30, P47, DOI 10.1007/s11064-004-9685-4
   Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002
   Hood DA, 2016, BIOCHEM J, V473, P2295, DOI 10.1042/BCJ20160009
   Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010
   Hou YJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2011226118
   Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903
   Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267
   Huang S, 2021, CELL COMMUN SIGNAL, V19, DOI 10.1186/s12964-020-00681-z
   Hunt J, 2022, MOL NEURODEGENER, V17, DOI 10.1186/s13024-021-00504-w
   Hvingelby VS, 2022, J NEUROL, V269, P4068, DOI 10.1007/s00415-022-11091-1
   Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044
   Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Izuta Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12699
   Jacobi D, 2015, CELL METAB, V22, P709, DOI 10.1016/j.cmet.2015.08.006
   Jayashankar V, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202013086
   Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629
   Jiménez-Jiménez FJ, 2020, EUR J NEUROL, V27, P2336, DOI 10.1111/ene.14470
   Jo DS, 2019, ARCH PHARM RES, V42, P393, DOI 10.1007/s12272-019-01131-2
   Marchissio MJ, 2012, TOXICOL APPL PHARM, V264, P246, DOI 10.1016/j.taap.2012.08.005
   Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727
   Kasai S, 2019, J CLIN BIOCHEM NUTR, V64, P1, DOI 10.3164/jcbn.18-37
   Kim J, 2018, MOL CELLS, V41, P742, DOI 10.14348/molcells.2018.0201
   Kim J, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11020192
   Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517
   Kimura T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900348
   KLAIDMAN LK, 1993, FREE RADICAL BIO MED, V15, P169, DOI 10.1016/0891-5849(93)90056-Z
   Klaus S, 2021, CELL MOL LIFE SCI, V78, P3369, DOI 10.1007/s00018-020-03748-9
   Kluever V, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abn4437
   Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113
   Koronowski KB, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109487
   Korshunov KS, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00091
   Koyanagi S, 2011, J BIOL CHEM, V286, P32416, DOI 10.1074/jbc.M111.258970
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishna S, 2021, DEV CELL, V56, P2952, DOI 10.1016/j.devcel.2021.10.008
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   KURZ GM, 1993, J NEUROCHEM, V60, P1467, DOI 10.1111/j.1471-4159.1993.tb03309.x
   Kwon JH, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040378
   Lamb DA, 2020, AGING-US, V12, P9447, DOI 10.18632/aging.103218
   Lamberts JT, 2015, NEUROBIOL DIS, V77, P276, DOI 10.1016/j.nbd.2014.07.002
   Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1
   Li H, 2019, NEUROTOX RES, V35, P421, DOI 10.1007/s12640-018-9968-1
   Li SY, 2017, CHINESE MED J-PEKING, V130, P1085, DOI 10.4103/0366-6999.204920
   Li W, 2021, NAT METAB, V3, P75, DOI 10.1038/s42255-020-00330-2
   Li WQ, 2014, AGING CELL, V13, P1012, DOI 10.1111/acel.12264
   Lin AL, 2015, NEUROBIOL AGING, V36, P2296, DOI 10.1016/j.neurobiolaging.2015.03.012
   Liu C, 2020, NEUROCHEM INT, V138, DOI 10.1016/j.neuint.2020.104754
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Liu Q, 2022, NAT METAB, V4, P559, DOI 10.1038/s42255-022-00575-z
   Liu WW, 2020, FASEB J, V34, P6570, DOI 10.1096/fj.201901565RR
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Luna A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004144
   Ma J K., 2013, Open J Mol Integr Physiol, V3, DOI [10.4236/ojmip.2013.34027, DOI 10.4236/OJMIP.2013.34027]
   MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202
   Magni G, 2006, MINI-REV MED CHEM, V6, P739, DOI 10.2174/138955706777698688
   Mahajan M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023079118
   MAKINO K, 1991, RADIAT PHYS CHEM, V37, P657
   Mancuso DJ, 2009, J BIOL CHEM, V284, P35632, DOI 10.1074/jbc.M109.055194
   Manini A, 2022, AGEING RES REV, V76, DOI 10.1016/j.arr.2022.101578
   MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333
   Marosi K, 2016, J NEUROCHEM, V139, P769, DOI 10.1111/jnc.13868
   Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006
   Martini H, 2023, FEBS J, V290, P1186, DOI 10.1111/febs.16361
   Mary C, 2022, MOL CELL, V82, P3299, DOI 10.1016/j.molcel.2022.06.026
   Mattson MP, 2018, NAT REV NEUROSCI, V19, P81, DOI 10.1038/nrn.2017.156
   Mawatari S, 2020, PARKINSONS DIS-US, V2020, DOI 10.1155/2020/2671070
   McCarthy CG, 2022, AM J PHYSIOL-HEART C, V322, pH466, DOI 10.1152/ajpheart.00486.2021
   McCarty MF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103624
   McKiernan SH, 2012, EXP GERONTOL, V47, P229, DOI 10.1016/j.exger.2011.12.009
   McReynolds MR, 2021, CELL SYST, V12, P1160, DOI 10.1016/j.cels.2021.09.001
   Mendoza J, 2014, NEUROSCIENCE, V282, P230, DOI 10.1016/j.neuroscience.2014.07.081
   MENZIES RA, 1972, J NEUROCHEM, V19, P1671, DOI 10.1111/j.1471-4159.1972.tb06212.x
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   MERRILL DK, 1981, BRAIN RES, V221, P307, DOI 10.1016/0006-8993(81)90780-0
   Mesquita PHC, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14526
   Minich T, 2003, J NEUROCHEM, V86, P605, DOI 10.1046/j.1471-4159.2003.01871.x
   Misgeld T, 2017, NEURON, V96, P651, DOI 10.1016/j.neuron.2017.09.055
   Mitchell SJ, 2019, CELL METAB, V29, P221, DOI 10.1016/j.cmet.2018.08.011
   Moebus S, 2011, EUR J EPIDEMIOL, V26, P719, DOI 10.1007/s10654-011-9608-z
   Monteiro-Cardoso VF, 2015, J ALZHEIMERS DIS, V43, P1375, DOI 10.3233/JAD-141002
   Murari A, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abl8716
   Murata K, 2021, P JPN ACAD B-PHYS, V97, P479, DOI 10.2183/pjab.97.024
   NAGHIZADEH F, 1977, CLIN CHIM ACTA, V81, P277, DOI 10.1016/0009-8981(77)90060-2
   Nalls MA, 2015, LANCET NEUROL, V14, P1002, DOI 10.1016/S1474-4422(15)00178-7
   Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916
   Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5
   OWEN OE, 1969, J CLIN INVEST, V48, P574, DOI 10.1172/JCI106016
   Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101
   Palma JA, 2018, MOVEMENT DISORD, V33, P372, DOI 10.1002/mds.27344
   Panicker N, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012095
   Panov A, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/472459
   Parekh PK, 2015, ALCOHOL, V49, P341, DOI 10.1016/j.alcohol.2014.09.034
   Parihar MS, 2008, J NEUROSCI RES, V86, P2339, DOI 10.1002/jnr.21679
   Park J, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.736905
   Pathak SS, 2019, NEURON, V104, P724, DOI 10.1016/j.neuron.2019.08.007
   Patrushev M, 2004, CELL MOL LIFE SCI, V61, P3100, DOI 10.1007/s00018-004-4424-1
   Pawlosky RJ, 2017, J NEUROCHEM, V141, P195, DOI 10.1111/jnc.13958
   Peluso A, 2022, NUTRIENTS, V14, DOI 10.3390/nu14010101
   Peng IC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1560, DOI 10.1152/ajpendo.00504.2011
   Perez MA, 2020, DEV CELL, V54, P447, DOI 10.1016/j.devcel.2020.06.019
   Perrin L, 2018, ELIFE, V7, DOI 10.7554/eLife.34114
   Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570
   Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002
   Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007
   Pfeiffer RF, 2020, NEUROTHERAPEUTICS, V17, P1464, DOI 10.1007/s13311-020-00897-4
   Pollak N, 2007, J BIOL CHEM, V282, P33562, DOI 10.1074/jbc.M704442200
   Prudon B, 2014, MOVEMENT DISORD, V29, P259, DOI 10.1002/mds.25730
   Qiu Z, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03295-y
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rabinovich-Nikitin I, 2021, AUTOPHAGY, V17, P3794, DOI 10.1080/15548627.2021.1938913
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Rafaeloff-Phail R, 2004, J BIOL CHEM, V279, P52934, DOI 10.1074/jbc.M409574200
   Ramamurthy S, 2014, NEUROSCIENCE, V259, P13, DOI 10.1016/j.neuroscience.2013.11.048
   RAMSAY RR, 1986, LIFE SCI, V39, P581, DOI 10.1016/0024-3205(86)90037-8
   Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641
   Rauckhorst AJ, 2015, FEBS LETT, V589, P2367, DOI 10.1016/j.febslet.2015.07.016
   Reiten OK, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111567
   Ren XP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.602697
   Renz PF, 2020, EXP CELL RES, V396, DOI 10.1016/j.yexcr.2020.112229
   Rhea EM, 2021, PHARM RES-DORDR, V38, P1469, DOI 10.1007/s11095-021-03098-6
   Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009
   Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049
   Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6
   Salnikov V, 2007, BIOPHYS J, V92, P1058, DOI 10.1529/biophysj.106.094318
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Santiago JA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23116223
   Sato S, 2022, CELL METAB, V34, P329, DOI 10.1016/j.cmet.2021.12.016
   Satpute R, 2013, HUM EXP TOXICOL, V32, P747, DOI 10.1177/0960327112468172
   Schmitt K, 2018, CELL METAB, V27, P657, DOI 10.1016/j.cmet.2018.01.011
   Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211
   Senanayake V, 2019, ALZH DEMENT-TRCI, V5, P524, DOI 10.1016/j.trci.2019.08.003
   Sengupta S, 2016, FREE RADICAL BIO MED, V93, P177, DOI 10.1016/j.freeradbiomed.2016.02.004
   Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004
   Shats I, 2020, CELL METAB, V31, P564, DOI 10.1016/j.cmet.2020.02.001
   Shaw E, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00212-19
   SHEN RS, 1985, FEBS LETT, V189, P225, DOI 10.1016/0014-5793(85)81028-0
   Shimokawa I, 2015, AGING CELL, V14, P707, DOI 10.1111/acel.12340
   Shkodina AD, 2022, AGEING RES REV, V74, DOI 10.1016/j.arr.2021.101554
   Shrimali NM, 2021, EBIOMEDICINE, V73, DOI 10.1016/j.ebiom.2021.103672
   Simeone TA, 2017, NEUROCHEM RES, V42, P2011, DOI 10.1007/s11064-017-2253-5
   Singh F, 2021, BIOCHEM SOC T, V49, P551, DOI 10.1042/BST20190236
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092
   Someya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171159
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017
   Stillman CM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00626
   Stotland A, 2015, BBA-MOL CELL RES, V1853, P2802, DOI 10.1016/j.bbamcr.2014.12.041
   Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577
   Stromland O, 2021, MECH AGEING DEV, V199, DOI 10.1016/j.mad.2021.111569
   Su Y, 2019, AGING-US, V11, P4183, DOI 10.18632/aging.102045
   Subrahmanian N, 2021, BRAIN RES, V1767, DOI 10.1016/j.brainres.2021.147434
   Sun XY, 2017, ONCOTARGET, V8, P75232, DOI 10.18632/oncotarget.20744
   Teresak P, 2022, AUTOPHAGY, V18, P24, DOI 10.1080/15548627.2021.1888244
   Terranova CJ, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110044
   Thomas M.H., 2020, BIORXIV, DOI [10.1101/2020.11.30.404293, DOI 10.1101/2020.11.30.404293]
   Torrence ME, 2021, ELIFE, V10, DOI 10.7554/eLife.63326
   Torres S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01168
   Tripathi A, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12010040
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004
   Vallée A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020314
   van Moorsel D, 2016, MOL METAB, V5, P635, DOI 10.1016/j.molmet.2016.06.012
   Veech RL, 2019, IUBMB LIFE, V71, P565, DOI 10.1002/iub.1997
   VEECH RL, 1969, BIOCHEM J, V115, P609, DOI 10.1042/bj1150609a
   Verma DK, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071694
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101
   Vogelauer M, 2012, J BIOL CHEM, V287, P32006, DOI 10.1074/jbc.M112.362467
   Wahl P, 2022, INT J SPORTS MED, V43, P195, DOI 10.1055/a-1551-9294
   Wan XS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/807874
   Wang HQ, 2021, NEUROPEPTIDES, V87, DOI 10.1016/j.npep.2021.102134
   Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011
   Wang XD, 2022, CIRC RES, V131, P91, DOI 10.1161/CIRCRESAHA.122.321050
   Wang Y, 2021, NATURE, V599, P136, DOI 10.1038/s41586-021-04025-w
   Wang Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19360-1
   Wasselin T, 2014, PROTEOMICS, V14, P1905, DOI 10.1002/pmic.201400051
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514
   Wood PL, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-227
   Xian HX, 2022, IMMUNITY, V55, P1370, DOI 10.1016/j.immuni.2022.06.007
   Xiao B, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.463
   Xu SQ, 2018, J NEUROCHEM, V145, P312, DOI 10.1111/jnc.14297
   Yamada N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2334-2
   Yanagi S, 2018, CELL METAB, V27, P786, DOI 10.1016/j.cmet.2018.02.008
   Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x
   Yang YR, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.602748
   Yao W, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01261-6
   Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804
   Yujnovsky I, 2006, P NATL ACAD SCI USA, V103, P6386, DOI 10.1073/pnas.0510691103
   Zago EB, 2000, FEBS LETT, V478, P29, DOI 10.1016/S0014-5793(00)01815-9
   Zeidler JD, 2022, AM J PHYSIOL-CELL PH, V322, pC521, DOI 10.1152/ajpcell.00451.2021
   Zhang J, 2018, FREE RADICAL BIO MED, V129, P268, DOI 10.1016/j.freeradbiomed.2018.09.032
   Zhang Q, 2012, NEUROSCIENCE, V205, P10, DOI 10.1016/j.neuroscience.2011.12.053
   Zhang Y, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abo0404
   Zhang Y, 2012, ELIFE, V1, DOI 10.7554/eLife.00065
   Zhang ZY, 2021, NAT METAB, V3, P1608, DOI 10.1038/s42255-021-00487-4
   Zhao YX, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10121917
   Zhu JJ, 2021, SCIENCE, V372, P968, DOI 10.1126/science.abd5491
   Zong ZH, 2012, BBA-MOL CELL RES, V1823, P1395, DOI 10.1016/j.bbamcr.2012.06.001
NR 298
TC 25
Z9 25
U1 2
U2 29
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD AUG
PY 2022
VL 11
IS 15
AR 2416
DI 10.3390/cells11152416
PG 38
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 3R9XT
UT WOS:000839258300001
PM 35954260
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Simard, ML
   Mourier, A
   Greaves, LC
   Taylor, RW
   Stewart, JB
AF Simard, Marie-Lune
   Mourier, Arnaud
   Greaves, Laura C.
   Taylor, Robert W.
   Stewart, James B.
TI A novel histochemistry assay to assess and quantify focal cytochrome
   <i>c</i> oxidase deficiency
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE mitochondrial diseases; COX deficiency; cytochrome c oxidase; enzyme
   histochemistry; nitrotetrazolium blue chloride
ID MITOCHONDRIAL-DNA MUTATIONS; PHENAZINE METHOSULFATE; SUCCINIC
   DEHYDROGENASE; DYSFUNCTION; KNOCKOUT; DEFECTS; DISEASE; MUSCLE; HEART;
   SURF1
AB Defects in the respiratory chain, interfering with energy production in the cell, are major underlying causes of mitochondrial diseases. In spite of this, the surprising variety of clinical symptoms, disparity between ages of onset, as well as the involvement of mitochondrial impairment in ageing and age-related diseases continue to challenge our understanding of the pathogenic processes. This complexity can be in part attributed to the unique metabolic needs of organs or of various cell types. In this view, it remains essential to investigate mitochondrial dysfunction at the cellular level. For this purpose, we developed a novel enzyme histochemical method that enables precise quantification in fresh-frozen tissues using competing redox reactions which ultimately lead to the reduction of tetrazolium salts and formazan deposition in cytochrome c oxidase-deficient mitochondria. We demonstrate that the loss of oxidative activity is detected at very low levels-this achievement is unequalled by previous techniques and opens up new opportunities for the study of early disease processes or comparative investigations. Moreover, human biopsy samples of mitochondrial disease patients of diverse genotypic origins were used and the successful detection of COX-deficient cells suggests a broad application for this new method. Lastly, the assay can be adapted to a wide range of tissues in the mouse and extends to other animal models, which we show here with the fruit fly, Drosophila melanogaster. Overall, the new assay provides the means to quantify and map, on a cell-by-cell basis, the full extent of COX deficiency in tissues, thereby expending new possibilities for future investigation. (C) 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
C1 [Simard, Marie-Lune; Mourier, Arnaud; Stewart, James B.] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.
   [Mourier, Arnaud] Univ Bordeaux, CNRS, Inst Biochim & Genet Cellulaires, UMR5095, Bordeaux, France.
   [Greaves, Laura C.] Newcastle Univ, Newcastle Univ LLHW Ctr Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England.
   [Greaves, Laura C.; Taylor, Robert W.] Newcastle Univ, Inst Neurosci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne, Tyne & Wear, England.
   [Taylor, Robert W.] Newcastle Upon Tyne Hosp NHS Fdn Trust, NHS Highly Specialised Mitochondrial Diagnost Lab, Newcastle Upon Tyne, Tyne & Wear, England.
C3 Max Planck Society; Centre National de la Recherche Scientifique (CNRS);
   CNRS - National Institute for Biology (INSB); Universite de Bordeaux;
   Newcastle University - UK; Newcastle University - UK; Newcastle Upon
   Tyne Hospitals NHS Foundation Trust
RP Stewart, JB (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9b, D-50931 Cologne, Germany.
EM jstewart@age.mpg.de
RI MOURIER, Arnaud/F-9657-2019; Stewart, Jim/C-9633-2011; MOURIER,
   Arnaud/I-8117-2012
OI Stewart, Jim/0000-0002-2902-4968; MOURIER, Arnaud/0000-0002-5413-611X;
   Greaves, Laura/0000-0002-8071-5916
FU Max Planck Society; Wellcome Centre for Mitochondrial Research
   [203105/Z/16/Z]; Newcastle University Centre for Ageing and Vitality
   [Biotechnology and Biological Sciences Research Council], UK; Newcastle
   University Centre for Ageing and Vitality [Engineering and Physical
   Sciences Research Council], UK; Newcastle University Centre for Ageing
   and Vitality [Economic and Social Research Council], UK; Newcastle
   University Centre for Ageing and Vitality [Medical Research Council], UK
   [G0700718]; Medical Research Council (MRC) Centre for Translational
   Research in Neuromuscular Disease, Mitochondrial Disease Patient Cohort
   (UK) [G0800674]; Lily Foundation; UK NIHR Biomedical Research Centre for
   Ageing and an age-related disease; MRC/EPSRC Molecular Pathology Node;
   UK NHS Highly Specialised Service for Rare Mitochondrial Disorders of
   Adults and Children; MRC [G0800674, G0700718] Funding Source: UKRI
FX We thank the FACS and Imaging Core Facility at the Max Planck Institute
   for Biology of Ageing for technical support as well as the CECAD Imaging
   Facility (University of Cologne, Cluster of Excellence in Ageing
   Research). We would like to acknowledge the contribution of Peter Zentis
   from the CECAD Imaging Facility for the Fiji macro which was used for
   quantitative analysis. We thank Gavin Falkous and Anna Smith (Wellcome
   Centre for Mitochondrial Research, Newcastle University) for technical
   assistance with obtaining the histochemical images of human tissue
   sections. We thank Ana Bratic and Luke Tain (Max Planck Institute for
   Biology of Ageing) for assistance with the Drosophila work. This work
   was supported by the Max Planck Society. LCG and RWT are supported by
   the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z). LCG is
   supported by the Newcastle University Centre for Ageing and Vitality
   [supported by the Biotechnology and Biological Sciences Research
   Council, Engineering and Physical Sciences Research Council, Economic
   and Social Research Council, and Medical Research Council (G0700718)],
   UK. RWT is supported by the Medical Research Council (MRC) Centre for
   Translational Research in Neuromuscular Disease, Mitochondrial Disease
   Patient Cohort (UK) (G0800674), the Lily Foundation, the UK NIHR
   Biomedical Research Centre for Ageing and an age-related disease award
   to the Newcastle upon Tyne Foundation Hospitals NHS Trust, the MRC/EPSRC
   Molecular Pathology Node, and the UK NHS Highly Specialised Service for
   Rare Mitochondrial Disorders of Adults and Children.
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Altman F P, 1976, Prog Histochem Cytochem, V9, P1
   Baggio F, 2014, NUCLEIC ACIDS RES, V42, P13920, DOI 10.1093/nar/gku1132
   Baines HL, 2014, AGING CELL, V13, P201, DOI 10.1111/acel.12199
   Bertoni-Freddari C, 2004, ANN NY ACAD SCI, V1019, P33, DOI 10.1196/annals.1297.007
   Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46
   Bratic A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9808
   BRODY IA, 1964, J HISTOCHEM CYTOCHEM, V12, P928, DOI 10.1177/12.12.928
   Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   FARBER E, 1956, J HISTOCHEM CYTOCHEM, V4, P357, DOI 10.1177/4.4.357
   GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Grünewald A, 2014, J NEUROSCI METH, V232, P143, DOI 10.1016/j.jneumeth.2014.05.026
   HEVNER RF, 1989, J NEUROSCI, V9, P3884
   HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K
   Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6
   Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037
   KEARNEY EB, 1956, J BIOL CHEM, V219, P963
   LOW H, 1964, BIOCHEM BIOPH RES CO, V14, P347, DOI 10.1016/S0006-291X(64)80008-5
   MCMILLAN PJ, 1967, J HISTOCHEM CYTOCHEM, V15, P21, DOI 10.1177/15.1.21
   Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010
   Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100
   Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   NACHLAS MM, 1960, J BIOL CHEM, V235, P499
   NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420, DOI 10.1177/5.4.420
   Nakae Y, 2001, HISTOCHEM CELL BIOL, V115, P413
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A., 2006, AM J PHYSIOL-CELL PH, V292, P670, DOI DOI 10.1152/AJPCELL.00213.2006
   OLD SL, 1989, HISTOCHEM J, V21, P545, DOI 10.1007/BF01753355
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Ross JM, 2013, NATURE, V501, P412, DOI 10.1038/nature12474
   Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266
   Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392
   Sánchez-Martínez A, 2006, BBA-BIOENERGETICS, V1757, P1190, DOI 10.1016/j.bbabio.2006.05.008
   Saneto RP, 2013, NEUROTHERAPEUTICS, V10, P199, DOI 10.1007/s13311-012-0167-0
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966
   Swerdlow RH, 2011, BBA-MOL BASIS DIS, V1812, P1630, DOI 10.1016/j.bbadis.2011.08.012
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turnbull DM, 2016, NEUROBIOL DIS, V92, P55, DOI 10.1016/j.nbd.2015.02.003
   WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3
   WORSFOLD M, 1977, ANAL BIOCHEM, V79, P152, DOI 10.1016/0003-2697(77)90389-X
NR 48
TC 14
Z9 14
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD JUL
PY 2018
VL 245
IS 3
BP 311
EP 323
DI 10.1002/path.5084
PG 13
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA GK0QF
UT WOS:000435815700007
PM 29660116
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Fayzullina, S
   Martin, LJ
AF Fayzullina, Saniya
   Martin, Lee J.
TI DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse
   Model of Spinal Muscular Atrophy
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE DNA damage; DNA repair; p53; Motor neuron disease; Satellite cell;
   Skeletal muscle; Spinal muscular atrophy
ID DIFFERENTIATED MUSCLE-CELLS; MOTOR-NEURON GENE; SATELLITE CELLS;
   MYOGENIC DIFFERENTIATION; INCREASED SUSCEPTIBILITY; STRAIN DIFFERENCES;
   IN-VITRO; APOPTOSIS; PROTEIN; MITOCHONDRIAL
AB We studied DNA damage response (DDR) and DNA repair capacities of skeletal muscle cells from a mouse model of infantile spinal muscular atrophy (SMA) caused by loss-of-function mutation of survival of motor neuron (Smn). Primary myocyte cultures derived from skeletal muscle satellite cells of neonatal control and mutant SMN mice had similar myotube length, myonuclei, satellite cell marker Pax7 and differentiated myotube marker myosin, and acetylcholine receptor clustering. DNA damage was induced in differentiated skeletal myotubes by gamma-irradiation, etoposide, and methyl methanesulfonate (MMS). Unexposed control and SMA myotubes had stable genome integrity. After gamma-irradiation and etoposide, myotubes repaired most DNA damage equally. Control and mutant myotubes exposed to MMS exhibited equivalent DNA damage without repair. Control and SMA myotube nuclei contained DDR proteins phospho-p53 and phospho-H2AX foci that, with DNA damage, dispersed and then re-formed similarly after recovery. We conclude that mouse primary satellite cell-derived myotubes effectively respond to and repair DNA strand-breaks, while DNA alkylation repair is underrepresented. Morphological differentiation, genome stability, genome sensor, and DNA strand-break repair potential are preserved in mouse SMA myocytes; thus, reduced SMN does not interfere with myocyte differentiation, genome integrity, and DNA repair, and faulty DNA repair is unlikely pathogenic in SMA.
C1 [Fayzullina, Saniya; Martin, Lee J.] Johns Hopkins Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD USA.
   [Fayzullina, Saniya; Martin, Lee J.] Johns Hopkins Sch Med, Pathobiol Grad Training Program, Baltimore, MD USA.
C3 Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins
   University; Johns Hopkins Medicine
RP Martin, LJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 558 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.
EM martinl@jhmi.edu
CR [Anonymous], ROUTE MAPS GENE TECH
   Bois PRJ, 2003, EMBO J, V22, P1147, DOI 10.1093/emboj/cdg116
   Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142
   Briese M, 2006, J COMP NEUROL, V497, P808, DOI 10.1002/cne.21010
   Brouillette J, 2005, CARDIOVASC RES, V65, P148, DOI 10.1016/j.cardiores.2004.09.012
   Burlet P, 1998, HUM MOL GENET, V7, P1927, DOI 10.1093/hmg/7.12.1927
   Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665
   Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249
   Cousin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063528
   Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010
   Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200
   DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707
   FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X
   Falsone SF, 2012, CELL REP, V2, P358, DOI 10.1016/j.celrep.2012.06.012
   Fayzullina S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093329
   Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Fortini P, 2010, MUTAT RES-FUND MOL M, V685, P38, DOI 10.1016/j.mrfmmm.2009.11.003
   Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004
   GARDNERMEDWIN D, 1967, J NEUROL SCI, V5, P121, DOI 10.1016/0022-510X(67)90013-5
   Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731
   Gogliotti RG, 2010, BIOCHEM BIOPH RES CO, V391, P517, DOI 10.1016/j.bbrc.2009.11.090
   Hammond SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015887
   Harford TJ, 2010, APOPTOSIS, V15, P71, DOI 10.1007/s10495-009-0428-5
   Hayhurst M, 2012, DEV BIOL, V368, P323, DOI 10.1016/j.ydbio.2012.05.037
   Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709
   Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794
   Jedrzejowska M, 2009, ACTA BIOCHIM POL, V56, P103
   Khanna A, 2015, CANCER RES, V75, P2133, DOI 10.1158/0008-5472.CAN-14-3247
   Kohn KW, 2005, BIOCHEM BIOPH RES CO, V331, P816, DOI 10.1016/j.bbrc.2005.03.186
   Komarova EA, 2000, ONCOGENE, V19, P3791, DOI 10.1038/sj.onc.1203717
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0
   Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760
   MacFarlane M, 1996, MOL PHARMACOL, V50, P900
   MacLeod M J, 1999, Eur J Paediatr Neurol, V3, P65, DOI 10.1016/S1090-3798(99)80015-4
   Mahmoudi M, 2008, CIRC RES, V103, P717, DOI 10.1161/CIRCRESAHA.108.182899
   Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780
   Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839
   Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015
   Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167
   Martin LJ, 2002, NEUROCHEM RES, V27, P1093, DOI 10.1023/A:1020961006216
   Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200
   MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407
   Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117
   Nicole S, 2002, MUSCLE NERVE, V26, P4, DOI 10.1002/mus.10110
   Okuno H, 2012, CELL BIOL INT, V36, P441, DOI 10.1042/CBI20100782
   OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X
   Pavlath G K, 1996, Methods Mol Med, V2, P307, DOI 10.1385/0-89603-335-X:307
   PEARN J, 1980, LANCET, V1, P919
   Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023
   Raats M. M., 1992, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D
   RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753
   Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920
   Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104
   Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Takaku M, 2011, BIOCHEMISTRY-US, V50, P6797, DOI 10.1021/bi200828g
   Takizawa Y, 2010, NUCLEIC ACIDS RES, V38, P5059, DOI 10.1093/nar/gkq271
   THIEME A, 1994, HUM GENET, V93, P344, DOI 10.1007/BF00212036
   THOMAS NH, 1994, NEUROMUSCULAR DISORD, V4, P497, DOI 10.1016/0960-8966(94)90090-6
   Vasconsuelo A, 2008, J ENDOCRINOL, V196, P385, DOI 10.1677/JOE-07-0250
   Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004
   Vincent SD, 2014, HUM MOL GENET, V23, P5087, DOI 10.1093/hmg/ddu232
   Vitte J, 2009, ADV EXP MED BIOL, V652, P237, DOI 10.1007/978-90-481-2813-6_16
   Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398
   Wang L, 2012, EXP CELL RES, V318, P2324, DOI 10.1016/j.yexcr.2012.06.018
   Wang WL, 2005, MOL GENET METAB, V85, P38, DOI 10.1016/j.ymgme.2004.12.015
   Wang Y, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-75
   Wiklund SJ, 2003, MUTAGENESIS, V18, P167, DOI 10.1093/mutage/18.2.167
   Wu CY, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-40
   Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e
   ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242
   Zhou B.B. S., 2004, NATURE REV, V4, P1
   Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006
NR 83
TC 9
Z9 9
U1 0
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD SEP
PY 2016
VL 75
IS 9
BP 889
EP 902
DI 10.1093/jnen/nlw064
PG 14
WC Clinical Neurology; Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA DX8WJ
UT WOS:000384671300007
PM 27452406
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Wang, YT
   Lu, MQ
   Xiong, LP
   Fan, JJ
   Zhou, Y
   Li, HY
   Peng, X
   Zhong, Z
   Wang, YH
   Huang, FX
   Chen, W
   Yu, XQ
   Mao, HP
AF Wang, Yating
   Lu, Miaoqing
   Xiong, Liping
   Fan, Jinjin
   Zhou, Yi
   Li, Huiyan
   Peng, Xuan
   Zhong, Zhong
   Wang, Yihan
   Huang, Fengxian
   Chen, Wei
   Yu, Xueqing
   Mao, Haiping
TI Drp1-mediated mitochondrial fission promotes renal fibroblast activation
   and fibrogenesis
SO CELL DEATH & DISEASE
LA English
DT Article
ID HISTONE ACETYLATION; DYNAMICS; PROGRESSION; DEFICIENCY; FUSION;
   DIFFERENTIATION; MYOFIBROBLASTS; INVOLVEMENT; GLYCOLYSIS; MECHANISMS
AB Excessive mitochondrial fission acts as a pro-proliferative marker in some cancers and organ fibrosis; its potential role in renal fibroblast activation and fibrogenesis has never been investigated. Here, we showed more pronounced fragmented mitochondria in fibrotic than in non-fibrotic renal fibroblast in humans and mice. In a mouse model of obstructive nephropathy, phosphorylation of Drp1 at serine 616 (p-Drp1S616) and acetylation of H3K27(H3K27ac) was increased in fibrotic kidneys; pharmacological inhibition of mitochondrial fission by mdivi-1 substantially reduced H3K27ac levels, fibroblasts accumulation, and interstitial fibrosis. Moreover, mdivi-1 treatment was able to attenuate the established renal fibrosis. In cultured renal interstitial fibroblasts, targeting Drp1 using pharmacological inhibitor or siRNA suppressed TGF-beta 1-elicited cell activation and proliferation, as evidenced by inhibiting expression of alpha-smooth muscle actin (alpha-SMA) and collagen I, as well as by reducing DNA synthesis. In contrast, Drp1 deletion enhanced cell apoptosis, along with decreased mitochondrial fragmentation, mtROS elevation, and glycolytic shift upon TGF-beta 1 stimulation. In Drp1 deletion fibroblasts, re-expression of wild-type Drp1 rather than Drp1S616A mutant restores the reduction of TGF-beta-induced-Drp1 phosphorylation, H3K27ac, and cell activation. Moreover, TGF-beta 1 treatment increased the enrichment of H3K27ac at the promoters of alpha-SMA and PCNA, which was reversed in Drp1-knockdown fibroblasts co-transfected with empty vector or Drp1S616A, but not wild-type Drp1. Collectively, our results imply that inhibiting p-Drp1S616-mediated mitochondrial fission attenuates fibroblast activation and proliferation in renal fibrosis through epigenetic regulation of fibrosis-related genes transcription and may serve as a therapeutic target for retarding progression of chronic kidney disease.
C1 [Wang, Yating; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China.
   [Wang, Yating; Lu, Miaoqing; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] NHC Key Lab Nephrol, Guangzhou, Peoples R China.
   [Wang, Yating; Lu, Miaoqing; Xiong, Liping; Fan, Jinjin; Zhou, Yi; Li, Huiyan; Peng, Xuan; Zhong, Zhong; Huang, Fengxian; Chen, Wei; Yu, Xueqing; Mao, Haiping] Guangdong Prov Key Lab Nephrol, Guangzhou, Peoples R China.
   [Lu, Miaoqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Peoples R China.
   [Wang, Yihan] Lab Kidney Pathol Inc, Nashville, TN USA.
C3 Sun Yat Sen University; Sun Yat Sen University
RP Mao, HP (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China.; Mao, HP (corresponding author), NHC Key Lab Nephrol, Guangzhou, Peoples R China.
EM maohp@mail.sysu.edu.cn
RI wang, yihan/HTN-8802-2023
OI Mao, Haiping/0000-0002-3608-3851
FU National Natural Science Foundation of China [81870464, 81670630,
   81270783, 81700583]; Guangzhou Science and Technology Plan
   [201807010002]; China Postdoctoral Science Foundation [2018M640873];
   National Key Research & Development Program of China [2016YFC0906101];
   Operational Grant of Guangdong Provincial Key Laboratory
   [2017B030314019]
FX This work is supported by grants from the National Natural Science
   Foundation of China (81870464, 81670630, and 81270783 to Dr. Mao,
   81700583 to Dr. Li), the Guangzhou Science and Technology Plan
   (201807010002 to Dr. Mao), the China Postdoctoral Science Foundation
   (2018M640873 to Dr. Wang), National Key Research & Development Program
   of China (2016YFC0906101), and Operational Grant of Guangdong Provincial
   Key Laboratory (2017B030314019).
CR Anderson GR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04033-x
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Ayanga BA, 2016, J AM SOC NEPHROL, V27, P2733, DOI 10.1681/ASN.2015101096
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035
   Cali T, 2018, CURR BIOL, V28, pR73, DOI 10.1016/j.cub.2017.11.040
   Cao SR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2649585
   Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chattopadhyay E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00043
   Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016
   Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258
   Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107
   Galvan DL, 2019, J CLIN INVEST, V129, P2807, DOI 10.1172/JCI127277
   Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144
   Humphreys BD, 2018, ANNU REV PHYSIOL, V80, P309, DOI 10.1146/annurev-physiol-022516-034227
   Jiang B, 2017, GENES DIS, V4, P25, DOI 10.1016/j.gendis.2017.02.003
   Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001
   Kang HM, 2015, NAT MED, V21, P37, DOI 10.1038/nm.3762
   Karvonen HM, 2012, LAB INVEST, V92, P1270, DOI 10.1038/labinvest.2012.95
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562
   LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218
   Lemos DR, 2018, J AM SOC NEPHROL, V29, P1690, DOI 10.1681/ASN.2017121283
   Li HY, 2016, AUTOPHAGY, V12, P1472, DOI 10.1080/15548627.2016.1190071
   Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149
   Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492
   Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002
   Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099
   Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011
   Perry HM, 2018, J AM SOC NEPHROL, V29, P194, DOI 10.1681/ASN.2017060659
   Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692
   Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543
   Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003
   Sun YBY, 2016, DIFFERENTIATION, V92, P102, DOI 10.1016/j.diff.2016.05.008
   Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001
   Wang P, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat2039
   Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009
   Wang YW, 2015, BBA-MOL BASIS DIS, V1852, P34, DOI 10.1016/j.bbadis.2014.11.006
   Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC
   Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012
   Zhou Y, 2016, AM J PATHOL, V186, P816, DOI 10.1016/j.ajpath.2015.11.016
NR 42
TC 94
Z9 101
U1 6
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JAN 16
PY 2020
VL 11
IS 1
AR 29
DI 10.1038/s41419-019-2218-5
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA KI6GN
UT WOS:000511447900005
PM 31949126
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Vempati, UD
   Torraco, A
   Moraes, CT
AF Vempati, Uma D.
   Torraco, Alessandra
   Moraes, Carlos T.
TI Mouse models of oxidative phosphorylation dysfunction and disease
SO METHODS
LA English
DT Review
DE Mitochondria; Mitochondrial disease; Knockout mouse; Knockin mouse;
   Conditional knockout mouse
ID CYTOCHROME-C-OXIDASE; MANGANESE SUPEROXIDE-DISMUTASE; ADENINE-NUCLEOTIDE
   TRANSLOCATOR; MITOCHONDRIAL-DNA POLYMERASE; APOPTOSIS-INDUCING FACTOR;
   IRON-SULFUR PROTEIN; DILATED CARDIOMYOPATHY; KNOCKOUT MICE;
   SKELETAL-MUSCLE; GENETIC-MODIFICATION
AB Oxidative phosphorylation (OXPHOS) deficiency results in a number of human diseases, affecting at least one in 5000 of the general population. Altering the function of genes by mutations are central to our understanding their function. Prior to the development of gene targeting, this approach was limited to rare spontaneous mutations that resulted in a phenotype. Since its discovery, targeted mutagenesis of the mouse germline has proved to be a powerful approach to understand the in vivo function of genes. Gene targeting has yielded remarkable understanding of the role of several gene products in the OXPHOS system. We provide a "tool box" of mouse models with OXPHOS defects that could be used to answer diverse scientific questions. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Dept Cell Biol & Anat, Miami, FL 33136 USA.
C3 University of Miami; University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.
EM CMoraes@med.miami.edu
RI Torraco, Alessandra/AAA-6212-2020; Moraes, Carlos/AAT-3818-2021
OI Torraco, Alessandra/0000-0002-8148-9295
FU Public Health Service [NS041777, CA85700, EY10804]; Muscular Dystrophy
   Association
FX Our work was supported by Public Health Service Grants NS041777,
   CA85700, and EY10804 and by the Muscular Dystrophy Association.
CR Abuin A, 2007, Handb Exp Pharmacol, P129
   Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143
   Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   Dufour E, 2008, HUM MOL GENET, V17, P1418, DOI 10.1093/hmg/ddn030
   Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103
   Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786
   Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104
   Garcia S, 2008, J INVEST DERMATOL, V128, P2343, DOI 10.1038/jid.2008.64
   Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226
   Gurung B, 2005, J BIOL CHEM, V280, P24895, DOI 10.1074/jbc.M503319200
   Hance N, 2005, HUM MOL GENET, V14, P1775, DOI 10.1093/hmg/ddi184
   Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016
   Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3
   Ikegami T, 2002, BIOCHEM BIOPH RES CO, V296, P729, DOI 10.1016/S0006-291X(02)00933-6
   Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826
   Jacobs LJAM, 2006, HUM REPROD UPDATE, V12, P119, DOI 10.1093/humupd/dmi042
   Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005
   Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467
   Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Lobe CG, 1998, BIOESSAYS, V20, P200, DOI 10.1002/(SICI)1521-1878(199803)20:3<200::AID-BIES3>3.0.CO;2-V
   Marth JD, 1996, J CLIN INVEST, V97, P1999, DOI 10.1172/JCI118634
   Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159
   Misawa H, 2006, NEUROBIOL DIS, V23, P169, DOI 10.1016/j.nbd.2006.02.014
   Moraes CT, 2004, BBA-BIOENERGETICS, V1659, P153, DOI 10.1016/j.bbabio.2004.09.002
   Murdock DG, 1999, J BIOL CHEM, V274, P14429, DOI 10.1074/jbc.274.20.14429
   Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002
   Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046
   Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004
   Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047
   Radford NB, 2002, AM J PHYSIOL-HEART C, V282, pH726, DOI 10.1152/ajpheart.00308.2001
   Rajewsky K, 1996, J CLIN INVEST, V98, P600, DOI 10.1172/JCI118828
   Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Sörensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001
   Strassburger M, 2005, FREE RADICAL BIO MED, V38, P1458, DOI 10.1016/j.freeradbiomed.2005.02.009
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Trounce I, 2000, NUCLEIC ACIDS RES, V28, P2164, DOI 10.1093/nar/28.10.2164
   Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102
   Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461
   Vempati UD, 2007, MOL CELL BIOL, V27, P1771, DOI 10.1128/MCB.00287-06
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510
   Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
   Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 69
TC 26
Z9 29
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD DEC
PY 2008
VL 46
IS 4
BP 241
EP 247
DI 10.1016/j.ymeth.2008.09.008
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 383AT
UT WOS:000261647200002
PM 18848991
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Saada, A
   Edvardson, S
   Shaag, A
   Chung, WK
   Segel, R
   Miller, C
   Jalas, C
   Elpeleg, O
AF Saada, Ann
   Edvardson, Shimon
   Shaag, Avraham
   Chung, Wendy K.
   Segel, Reeval
   Miller, Chaya
   Jalas, Chaim
   Elpeleg, Orly
TI Combined OXPHOS complex I and IV defect, due to mutated complex I
   assembly factor C20ORF7
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID MITOCHONDRIAL COMPLEX; MOLECULAR CHAPERONE; DEFICIENCY; DISEASE;
   MUTATIONS; GENE; ENCEPHALOPATHY; PREVALENCE; SUBUNITS; FOXRED1
AB Defects of the mitochondrial oxidative phosphorylation (OXPHOS) system are frequent causes of neurological disorders in children. Linkage analysis and DNA sequencing identified a new founder p.G250V substitution in the C20ORF7 complex I chaperone in five Ashkenazi Jewish patients from two families with a combined OXPHOS complex I and IV defect presenting with Leigh's syndrome in infancy. Complementation with the wild type gene restored complex I, but only partially complex IV activity. Although the pathogenic mechanism remains elusive, a C20ORF7 defect should be considered not only in isolated complex I deficiency, but also in combination with decreased complex IV. Given the significant 1:290 carrier rate for the p.G250V mutation among Ashkenazi Jews, this mutation should be screened in all Ashkenazi patients with Leigh's syndrome prior to muscle biopsy.
C1 [Saada, Ann; Shaag, Avraham; Miller, Chaya; Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel.
   [Saada, Ann; Shaag, Avraham; Miller, Chaya; Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel.
   [Edvardson, Shimon] Hadassah Med Ctr, Pediat Neurol Unit, IL-91120 Jerusalem, Israel.
   [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA.
   [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.
   [Segel, Reeval] Shaare Zedek Med Ctr, Dept Pediat, IL-91031 Jerusalem, Israel.
   [Segel, Reeval] Shaare Zedek Med Ctr, Dept Med Genet, IL-91031 Jerusalem, Israel.
   [Jalas, Chaim] Bonei Olam Ctr Rare Jewish Genet Disorders, Brooklyn, NY USA.
C3 Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew
   University of Jerusalem; Hadassah University Medical Center; Columbia
   University; Columbia University; Hebrew University of Jerusalem; Shaare
   Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek
   Medical Center
RP Saada, A (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, POB 1200, IL-91120 Jerusalem, Israel.
EM annsr@hadassah.org.il
RI Segel, Reeval/AAT-1498-2020; Saada, Ann/J-6864-2017
OI Edvardson, Simon/0000-0003-2878-1278; Jalas, Chaim/0000-0002-3788-0924;
   Saada, Ann/0000-0003-2951-0656
FU Israeli Ministry of Health [5914]; Israeli Academy of Sciences [1462/09]
FX The authors are most grateful to Prof. Thorburn and Dr. Alison Compton
   for supplying the viral vector. Dr. Phyllis Dan and Mrs. Sarah Weissman
   are acknowledged for technical assistance. Rabbi Shlomo Bochner is
   acknowledged for support. This work was also supported by the Israeli
   Ministry of Health, grant# 5914 (A.S. and O.E.) and by the Israeli
   Academy of Sciences, grant, # 1462/09 (A.S.)
CR Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Carroll J, 2005, MOL CELL PROTEOMICS, V4, P693, DOI 10.1074/mcp.M500014-MCP200
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   DiMauro S, 1998, NAT GENET, V19, P214, DOI 10.1038/883
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Fassone E, 2010, HUM MOL GENET, V19, P4837, DOI 10.1093/hmg/ddq414
   Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Jones CN, 2009, MITOCHONDRION, V9, P429, DOI 10.1016/j.mito.2009.08.001
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Mckenzie M, 2010, IUBMB LIFE, V62, P497, DOI 10.1002/iub.335
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pogozelski WK, 2003, MITOCHONDRION, V2, P415, DOI 10.1016/S1567-7249(03)00033-3
   Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037
NR 28
TC 44
Z9 50
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD JAN
PY 2012
VL 35
IS 1
BP 125
EP 131
DI 10.1007/s10545-011-9348-y
PG 7
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 870EU
UT WOS:000298652700015
PM 21607760
DA 2024-11-01
ER

PT J
AU Hoefs, SJG
   Dieteren, CEJ
   Distelmaier, F
   Janssen, RJRJ
   Epplen, A
   Swarts, HGP
   Forkink, M
   Rodenburg, RJ
   Nijtmans, LG
   Willems, PH
   Smeitink, JAM
   van den Heuvel, LP
AF Hoefs, Saskia J. G.
   Dieteren, Cindy E. J.
   Distelmaier, Felix
   Janssen, Rolf J. R. J.
   Epplen, Andrea
   Swarts, Herman G. P.
   Forkink, Marleen
   Rodenburg, Richard J.
   Nijtmans, Leo G.
   Willems, Peter H.
   Smeitink, Jan A. M.
   van den Heuvel, Lambert P.
TI <i>NDUFA2</i> complex I mutation leads to Leigh disease
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; SUBUNIT
   COMPOSITION; RESPIRATORY-CHAIN; HUMAN NADH; DEFICIENCY; GENE; PATHOLOGY;
   ENCEPHALOMYOPATHY; CARDIOMYOPATHY
AB Mitochondrial isolated complex I deficiency is the most frequently encountered OXPHOS defect. We report a patient with an isolated complex I deficiency expressed in skin fibroblasts as well as muscle tissue. Because the parents were consanguineous, we performed homozygosity mapping to identify homozygous regions containing candidate genes such as NDUFA2 on chromosome 5. Screening of this gene on genomic DNA revealed a mutation that interferes with correct splicing and results in the skipping of exon 2. Exon skipping was confirmed on the mRNA level. The mutation in this accessory subunit causes reduced activity and disturbed assembly of complex I. Furthermore, the mutation is associated with a mitochondrial depolarization. The expression and activity of complex I and the depolarization was (partially) rescued with a baculovirus system expressing the NDUFA2 gene.
C1 [Hoefs, Saskia J. G.; Dieteren, Cindy E. J.; Distelmaier, Felix; Janssen, Rolf J. R. J.; Forkink, Marleen; Rodenburg, Richard J.; Nijtmans, Leo G.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Dieteren, Cindy E. J.; Distelmaier, Felix; Swarts, Herman G. P.; Willems, Peter H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Membrane Biochem, NL-6500 HB Nijmegen, Netherlands.
   [Distelmaier, Felix] Univ Dusseldorf, Dept Gen Pediat, D-40225 Dusseldorf, Germany.
   [Epplen, Andrea] Ruhr Univ Bochum, Dept Human Genet, D-44801 Bochum, Germany.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Heinrich Heine
   University Dusseldorf; Ruhr University Bochum
RP van den Heuvel, LP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
EM b.vandenheuvel@cukz.umcn.nl
RI Dieteren, Cindy/D-6042-2011; van den Heuvel, Lambertus/AAM-1772-2021;
   Smeitink, Jan/C-1351-2013; Nijtmans, L.G.J./L-4549-2015; Rodenburg,
   Richard/N-3579-2014; Willems, Peter H.G.M./L-4759-2015
OI Rodenburg, Richard/0000-0001-5227-3527; Willems, Peter
   H.G.M./0000-0002-0915-1599
CR Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021
   Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200
   Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775
   Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379
   FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Gabaldón T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067
   Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Komen JC, 2007, CELL MOL LIFE SCI, V64, P3271, DOI 10.1007/s00018-007-7357-7
   Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063
   Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
NR 36
TC 96
Z9 103
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD JUN
PY 2008
VL 82
IS 6
BP 1306
EP 1315
DI 10.1016/j.ajhg.2008.05.007
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 312CP
UT WOS:000256647000008
PM 18513682
OA Green Published, Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Warren, C
   McDonald, D
   Capaldi, R
   Deehan, D
   Taylor, RW
   Filby, A
   Turnbull, DM
   Lawless, C
   Vincent, AE
AF Warren, Charlotte
   McDonald, David
   Capaldi, Roderick
   Deehan, David
   Taylor, Robert W.
   Filby, Andrew
   Turnbull, Doug M.
   Lawless, Conor
   Vincent, Amy E.
TI Decoding mitochondrial heterogeneity in single muscle fibres by imaging
   mass cytometry
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DEFICIENCY; MECHANISMS; PROTEOMICS; MUTATIONS; IV
AB The study of skeletal muscle continues to support the accurate diagnosis of mitochondrial disease and remains important in delineating molecular disease mechanisms. The heterogeneous expression of oxidative phosphorylation proteins and resulting respiratory deficiency are both characteristic findings in mitochondrial disease, hence the rigorous assessment of these at a single cell level is incredibly powerful. Currently, the number of proteins that can be assessed in individual fibres from a single section by immunohistochemistry is limited but imaging mass cytometry (IMC) enables the quantification of further, discrete proteins in individual cells. We have developed a novel workflow and bespoke analysis for applying IMC in skeletal muscle biopsies from patients with genetically-characterised mitochondrial disease, investigating the distribution of nine mitochondrial proteins in thousands of single muscle fibres. Using a semi-automated analysis pipeline, we demonstrate the accurate quantification of protein levels using IMC, providing an accurate measure of oxidative phosphorylation deficiency for complexes I-V at the single cell level. We demonstrate signatures of oxidative phosphorylation deficiency for common mtDNA variants and nuclear-encoded complex I variants and a compensatory upregulation of unaffected oxidative phosphorylation components. This technique can now be universally applied to evaluate a wide range of skeletal muscle disorders and protein targets.
C1 [Warren, Charlotte; Taylor, Robert W.; Turnbull, Doug M.; Lawless, Conor; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [McDonald, David; Filby, Andrew] Newcastle Univ, Biosci Inst, Flow Cytometry Core Facil, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Capaldi, Roderick] Cellstate Biosci, Tucson, AZ 85721 USA.
   [Deehan, David; Turnbull, Doug M.; Vincent, Amy E.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
   [Taylor, Robert W.] NHS Fdn Trust, Newcastle Upon Tyne Hosp, NHS Highly Specialised Rare Mitochondrial Disorde, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
C3 Newcastle University - UK; Newcastle University - UK; Newcastle
   University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust;
   Newcastle University - UK
RP Lawless, C; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Wellcome Ctr Mitochondrial Res, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Vincent, AE (corresponding author), Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
EM conor.lawless@ncl.ac.uk; amy.vincent@ncl.ac.uk
RI Vincent, Amy/J-7284-2019
OI Vincent, Amy/0000-0002-0360-6644
FU Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; Medical
   Research Council Centre for Ageing and Vitality [L016354]; Medical
   Research Council (MRC) Centre for Translational Research in
   Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674];
   NIHR Newcastle Biomedical Research Centre; UK National Institute for
   Health Research Biomedical Research Centre in Age and Age Related
   Diseases; MRC/Engineering and Physical Sciences Research Council
   Molecular Pathology Node; Lily Foundation; UK NHS Specialist
   Commissioners Rare Mitochondrial Disorders of Adults and Children
   Service; Sir Henry Wellcome Fellowship [215888/Z/19/Z]; MRC as part of
   the Centre for Ageing and Vitality [L016354/1]; Barbour Foundation; MRC
   [G0800674] Funding Source: UKRI; Wellcome Trust [215888/Z/19/Z] Funding
   Source: Wellcome Trust
FX The authors of this manuscript certify that they comply with the ethical
   guidelines for authorship and publishing in Scientific Reports. This
   work was supported by the Wellcome Centre for Mitochondrial Research
   (203105/Z/16/Z), Medical Research Council Centre for Ageing and Vitality
   (L016354), the Medical Research Council (MRC) Centre for Translational
   Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort
   G0800674, the NIHR Newcastle Biomedical Research Centre awarded to the
   Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle
   University, the UK National Institute for Health Research Biomedical
   Research Centre in Age and Age Related Diseases award to the Newcastle
   upon Tyne Hospitals National Health Service (NHS) Foundation Trust, the
   MRC/Engineering and Physical Sciences Research Council Molecular
   Pathology Node, the Lily Foundation, and the UK NHS Specialist
   Commissioners Rare Mitochondrial Disorders of Adults and Children
   Service. AEV is in receipt of a Sir Henry Wellcome Fellowship
   (215888/Z/19/Z). CW is supported by the MRC (L016354/1) as part of the
   Centre for Ageing and Vitality and the Barbour Foundation. We would also
   like to acknowledge the staff of the Newcastle University Flow Cytometry
   Core Facility for their support and technical expertise and thank
   Professor Robert Lightowlers for insightful comments on the manuscript.
CR Ahmed ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14623-2
   Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Elson JL, 2002, NEUROMUSCULAR DISORD, V12, P858, DOI 10.1016/S0960-8966(02)00047-0
   Giesen C, 2014, HIGHLY MULTIPLEXED I, V11
   Jayaprakash AD, 2015, NUCLEIC ACIDS RES, V43, P2177, DOI 10.1093/nar/gkv052
   Karbanová VH, 2012, BBA-BIOENERGETICS, V1817, P1037, DOI 10.1016/j.bbabio.2012.03.004
   Kovárová N, 2012, BBA-MOL BASIS DIS, V1822, P1114, DOI 10.1016/j.bbadis.2012.03.007
   Lang F, 2018, J PROTEOME RES, V17, P3333, DOI 10.1021/acs.jproteome.8b00093
   Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022
   Murgia M, 2019, CELL REP, V29, P3825, DOI 10.1016/j.celrep.2019.11.055
   Murgia M, 2015, EMBO REP, V16, P387, DOI 10.15252/embr.201439757
   Murphy JL, 2012, NEUROMUSCULAR DISORD, V22, P690, DOI 10.1016/j.nmd.2012.04.003
   Rocha MC, 2018, ANN NEUROL, V83, P115, DOI 10.1002/ana.25127
   Rocha MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15037
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082
   Rygiel KA, 2015, NEUROPATH APPL NEURO, V41, P288, DOI 10.1111/nan.12149
   Sardone V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194540
   Schilling B, 2006, BBA-MOL BASIS DIS, V1762, P213, DOI 10.1016/j.bbadis.2005.07.003
   Torralba D, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00107
   Villalta SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009925
   Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288
   Vincent AE, 2016, NEUROMUSCULAR DISORD, V26, P691, DOI 10.1016/j.nmd.2016.08.004
   Wählby C, 2002, CYTOMETRY, V47, P32, DOI 10.1002/cyto.10026
   Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009
NR 26
TC 14
Z9 15
U1 0
U2 5
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 18
PY 2020
VL 10
IS 1
AR 15336
DI 10.1038/s41598-020-70885-3
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NU6KJ
UT WOS:000573751100020
PM 32948797
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Venter, L
   Lindeque, Z
   van Rensburg, PJ
   van der Westhuizen, F
   Smuts, I
   Louw, R
AF Venter, Leonie
   Lindeque, Zander
   van Rensburg, Peet Jansen
   van der Westhuizen, Francois
   Smuts, Izelle
   Louw, Roan
TI Untargeted urine metabolomics reveals a biosignature for muscle
   respiratory chain deficiencies
SO METABOLOMICS
LA English
DT Article
DE Respiratory chain deficiency; Metabolomics; Urinary biomarker; LC-MS
ID MITOCHONDRIAL DISORDERS; DIAGNOSTIC-CRITERIA; BIOMARKER DISCOVERY;
   MONITOR PROGRESSION; DISEASE; ADULTS; SCALE
AB Mitochondrial diseases are a heterogeneous group of disorders characterised by impaired mitochondrial oxidative phosphorylation system. Most often for mitochondrial disease, where no metabolic diagnostic biomarkers exist, a deficiency is diagnosed after analysing the respiratory chain enzymes (complexes I-IV) in affected tissues or by identifying one of an ever expanding number of DNA mutations. This presents a great challenge to identify cases to undergo the invasive diagnostic procedures required. An untargeted liquid chromatography mass spectrometry metabolomics approach was used to search for a metabolic biosignature that can distinguish respiratory chain deficient (RCD) patients from clinical controls (CC). A cohort of 37 ethnically diverse cases was used. Sample preparation, liquid chromatography time-of-flight mass spectrometry methods and data processing methods were standardised. Furthermore the developed methodology used reverse phase chromatography in conjunction with positive electrospray ionisation and hydrophilic interaction chromatography with negative electrospray ionisation. Urine samples of 37 patients representing two different experimental groups were analysed. The two experimental groups comprised of patients with confirmed RCDs and CC. After a variety of data mining steps and statistical analyses a list of 12 features were compiled with the ability to distinguish between patients with RCDs and CC. Although the features of the biosignature needs to be identified and the biosignature validated, this study demonstrates the value of untargeted metabolomics to identify a metabolic biosignature to possibly be applied in the selection criteria for RCDs.
C1 [Venter, Leonie; Lindeque, Zander; van Rensburg, Peet Jansen; van der Westhuizen, Francois; Louw, Roan] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.
   [Smuts, Izelle] Univ Pretoria, Dept Paediat & Child Hlth, Steve Biko Acad Hosp, ZA-0002 Pretoria, South Africa.
C3 North West University - South Africa; University of Pretoria
RP Louw, R (corresponding author), North West Univ, Ctr Human Metabon, Potchefstroom Campus, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
RI Venter, Leonie/LFT-2707-2024; Lindeque, Jeremie/R-4491-2016; van
   Rensburg, Peet/F-9004-2010; van der Westhuizen, Francois/E-6959-2011
OI Smuts, Izelle/0000-0002-1091-5912; Lindeque, Zander/0000-0001-8017-4278;
   Louw, Roan/0000-0002-6542-8644; Jansen van Rensburg, Peet
   J/0000-0001-6911-1866; van der Westhuizen, Francois/0000-0002-7879-1776;
   Venter, Leonie/0000-0003-0019-3722
FU North-West University, Potchefstroom Campus
FX Essential funding was obtained from the North-West University,
   Potchefstroom Campus.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Christin C, 2013, MOL CELL PROTEOMICS, V12, P263, DOI 10.1074/mcp.M112.022566
   Ellis S.M., 2003, Management Dynamics, V12, P51, DOI 10.10520/EJC69666
   Hrydziuszko O, 2012, METABOLOMICS, V8, pS161, DOI 10.1007/s11306-011-0366-4
   Munnich A., 2011, ONLINE METABOLIC MOL, V10
   Pewsner D, 2004, BMJ-BRIT MED J, V329, P209, DOI 10.1136/bmj.329.7459.209
   Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006
   Reinecke CJ, 2012, METABOLOMICS, V8, P264, DOI 10.1007/s11306-011-0309-0
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Schaefer AM, 2006, NEUROLOGY, V66, P1932, DOI 10.1212/01.wnl.0000219759.72195.41
   Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005
   Smuts I, 2010, J INHERIT METAB DIS, V33, pS95, DOI 10.1007/s10545-009-9031-8
   Smuts I, 2013, METABOLOMICS, V9, P379, DOI 10.1007/s11306-012-0455-z
   Warrack BM, 2009, J CHROMATOGR B, V877, P547, DOI 10.1016/j.jchromb.2009.01.007
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
NR 17
TC 22
Z9 22
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD FEB
PY 2015
VL 11
IS 1
BP 111
EP 121
DI 10.1007/s11306-014-0675-5
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AZ6QH
UT WOS:000348343300011
DA 2024-11-01
ER

PT J
AU Korenev, S
   Morris, AAM
AF Korenev, Sergei
   Morris, Andrew A. M.
TI When to Suspect and How to Diagnose Mitochondrial Disorders?
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Review
DE Lactic acid; Neurodegeneration; mtDNA; Exome sequencing; Muscle biopsy;
   Histochemistry
ID DISEASE; MUTATIONS; DEFICIENCIES; BIOMARKER; GENE
AB Disorders of the mitochondrial respiratory chain are an exceedingly diverse group. The clinical features can affect any tissue or organ and occur at any age, with any mode of inheritance. The diagnosis of mitochondrial disorders requires knowledge of the clinical phenotypes and access to a wide range of laboratory techniques. A few syndromes are associated with a specific genetic defect and in these cases it is appropriate to proceed directly to an appropriate test of blood or urine. In most cases, however, the best strategy starts with biochemical and histochemical studies on a muscle biopsy. Appropriate molecular genetic studies can then be chosen, based on these results and the clinical picture. Unfortunately, there is currently limited availability of respiratory chain studies in India. Exome sequencing is undertaken increasingly often; without preceding mitochondrial studies, this can lead to misleading results.
C1 [Korenev, Sergei; Morris, Andrew A. M.] St Marys Hosp, NHS Fdn Trust, Cent Manchester Univ Hosp, Willink Biochem Genet Unit,Manchester Ctr Genom M, Oxford Rd, Manchester M13 9WL, Lancs, England.
C3 University of Manchester; Oxford University Hospitals NHS Foundation
   Trust
RP Korenev, S (corresponding author), St Marys Hosp, NHS Fdn Trust, Cent Manchester Univ Hosp, Willink Biochem Genet Unit,Manchester Ctr Genom M, Oxford Rd, Manchester M13 9WL, Lancs, England.
EM sergei.korenev@cmft.nhs.uk
RI Maier, Andrea/Q-5548-2019
CR Alston CL, 2011, EUR J HUM GENET, V19, P1226, DOI 10.1038/ejhg.2011.124
   Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328
   Bowron A, 2013, J INHERIT METAB DIS, V36, P741, DOI 10.1007/s10545-012-9552-4
   Davis RL, 2013, NEUROLOGY, V81, P1819, DOI 10.1212/01.wnl.0000436068.43384.ef
   Dhillon VS, 2014, MUTAT RES-REV MUTAT, V759, P1, DOI 10.1016/j.mrrev.2013.09.001
   DiMauro S, 2004, BBA-BIOENERGETICS, V1658, P80, DOI 10.1016/j.bbabio.2004.03.014
   DiMauro S, 2001, GENEREVIEWS, P1993
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Gropman AL, 2013, NEUROTHERAPEUTICS, V10, P273, DOI 10.1007/s13311-012-0161-6
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Rahman S, 2009, J NEUROL NEUROSUR PS, V80, P943, DOI 10.1136/jnnp.2008.158279
   Rodenburg RJT, 2011, J INHERIT METAB DIS, V34, P283, DOI 10.1007/s10545-010-9081-y
   Rollins S, 2001, AM J CLIN PATHOL, V116, P326
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Saneto RP, 2013, PEDIATR NEUROL, V48, P167, DOI 10.1016/j.pediatrneurol.2012.09.014
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Wallace DC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a021220
   Wortmann SB, 2013, J INHERIT METAB DIS, V36, P923, DOI 10.1007/s10545-012-9580-0
NR 24
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
PD OCT
PY 2016
VL 83
IS 10
BP 1157
EP 1163
DI 10.1007/s12098-015-1932-y
PG 7
WC Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pediatrics
GA DY0VI
UT WOS:000384813900018
PM 26759002
DA 2024-11-01
ER

PT J
AU Mietsch, M
   Hinkel, R
AF Mietsch, Matthias
   Hinkel, Rabea
TI "Empowering" Cardiac Cells via Stem Cell Derived Mitochondrial
   Transplantation- Does Age Matter?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE stem cell; aging; senescence; mitochondria; transplantation;
   cardiovascular; heart
ID SKELETAL-MUSCLE; MOLECULAR-PATTERNS; PLASMA NUCLEAR; SELF-RENEWAL;
   DNA-DAMAGE; IN-VIVO; MYOCARDIAL PROTECTION; AUTOPHAGY MAINTAINS;
   FUNCTIONAL DECLINE; ABSOLUTE NUMBERS
AB With cardiovascular diseases affecting millions of patients, new treatment strategies are urgently needed. The use of stem cell based approaches has been investigated during the last decades and promising effects have been achieved. However, the beneficial effect of stem cells has been found to being partly due to paracrine functions by alterations of their microenvironment and so an interesting field of research, the "stem- less" approaches has emerged over the last years using or altering the microenvironment, for example, via deletion of senescent cells, application of micro RNAs or by modifying the cellular energy metabolism via targeting mitochondria. Using autologous muscle-derived mitochondria for transplantations into the affected tissues has resulted in promising reports of improvements of cardiac functions in vitro and in vivo. However, since the targeted treatment group represents mainly elderly or otherwise sick patients, it is unclear whether and to what extent autologous mitochondria would exert their beneficial effects in these cases. Stem cells might represent better sources for mitochondria and could enhance the effect of mitochondrial transplantations. Therefore in this review we aim to provide an overview on aging effects of stem cells and mitochondria which might be important for mitochondrial transplantation and to give an overview on the current state in this field together with considerations worthwhile for further investigations.
C1 [Mietsch, Matthias; Hinkel, Rabea] Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Lab Anim Sci Unit, Kellnerweg 4, D-37077 Gottingen, Germany.
   [Mietsch, Matthias; Hinkel, Rabea] DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, D-37077 Gottingen, Germany.
C3 Deutsches Primatenzentrum (DPZ); German Centre for Cardiovascular
   Research
RP Hinkel, R (corresponding author), Deutsch Primatenzentrum GmbH, Leibniz Inst Primatenforsch, Lab Anim Sci Unit, Kellnerweg 4, D-37077 Gottingen, Germany.; Hinkel, R (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Gottingen, D-37077 Gottingen, Germany.
EM mmietsch@dpz.eu; rhinkel@dpz.eu
RI ; Hinkel, Rabea/I-9165-2014
OI Mietsch, Matthias/0000-0002-3520-5394; Hinkel, Rabea/0000-0002-2936-0400
CR Ahlqvist KJ, 2015, BBA-BIOENERGETICS, V1847, P1380, DOI 10.1016/j.bbabio.2015.05.014
   Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030
   Ahmadi M, 2021, CELL BIOCHEM FUNCT, V39, P60, DOI 10.1002/cbf.3602
   Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809
   Amartuvshin O, 2020, AGING CELL, V19, DOI 10.1111/acel.13191
   Angermueller C, 2016, NAT METHODS, V13, P229, DOI 10.1038/nmeth.3728
   Bakula D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00239
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Baseler WA, 2011, AM J PHYSIOL-REG I, V300, pR186, DOI 10.1152/ajpregu.00423.2010
   Bayeva M, 2013, J AM COLL CARDIOL, V61, P599, DOI 10.1016/j.jacc.2012.08.1021
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Behfar A, 2015, J AM COLL CARDIOL, V65, P148, DOI 10.1016/j.jacc.2014.10.041
   Bellows CG, 2003, MECH AGEING DEV, V124, P747, DOI 10.1016/S0047-6374(03)00088-5
   Belosludtsev KN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186559
   Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Boengler K, 2017, J CACHEXIA SARCOPENI, V8, P349, DOI 10.1002/jcsm.12178
   Borsche M, 2020, BRAIN, V143, P3041, DOI 10.1093/brain/awaa246
   Boudreau LH, 2014, BLOOD, V124, P2173, DOI 10.1182/blood-2014-05-573543
   Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602
   Brazhnik K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2659
   Broughton KM, 2016, CIRC RES, V118, P867, DOI 10.1161/CIRCRESAHA.115.305227
   Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203
   Caicedo A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7610414
   Caicedo A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09073
   Calloway CD, 2000, AM J HUM GENET, V66, P1384, DOI 10.1086/302844
   Castaldi A, 2017, J PHYSIOL-LONDON, V595, P6249, DOI 10.1113/JP274775
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chang CY, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0158-8
   Charles CJ, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.601990
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547
   Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cowan DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17813-0
   Cowan DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160889
   Croston TL, 2013, LIFE SCI, V93, P313, DOI 10.1016/j.lfs.2013.07.005
   Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, pH529, DOI 10.1152/ajpheart.00267.2010
   Dabkowski ER, 2009, AM J PHYSIOL-HEART C, V296, pH359, DOI 10.1152/ajpheart.00467.2008
   Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006
   DeBalsi KL, 2017, AGEING RES REV, V33, P89, DOI 10.1016/j.arr.2016.04.006
   Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376
   Doulamis IP, 2020, AM J PHYSIOL-RENAL, V319, pF403, DOI 10.1152/ajprenal.00255.2020
   Doulamis IP, 2020, EUR J CARDIO-THORAC, V57, P836, DOI 10.1093/ejcts/ezz326
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Fernández-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   García-Prat L, 2016, AUTOPHAGY, V12, P612, DOI 10.1080/15548627.2016.1143211
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gheorghiade M, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002727
   Giangreco A, 2008, AGING CELL, V7, P250, DOI 10.1111/j.1474-9726.2008.00372.x
   GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807
   Glauche I, 2011, AGING CELL, V10, P457, DOI 10.1111/j.1474-9726.2011.00692.x
   Guariento A, 2020, J HEART LUNG TRANSPL, V39, P1279, DOI 10.1016/j.healun.2020.06.023
   Guariento A, 2020, J THORAC CARDIOV SUR, V160, pE15, DOI 10.1016/j.jtcvs.2019.06.111
   Guo XX, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa065
   HAGINOYA K, 1990, ACTA NEUROPATHOL, V80, P642, DOI 10.1007/BF00307633
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Hashemi SM, 2008, EUR HEART J, V29, P251, DOI 10.1093/eurheartj/ehm559
   Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991
   Hazeldine J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00685
   Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Hollander JM, 2014, AM J PHYSIOL-HEART C, V307, pH1, DOI 10.1152/ajpheart.00747.2013
   Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725
   Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0
   Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308
   Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006
   Iqbal S, 2013, MUSCLE NERVE, V48, P963, DOI 10.1002/mus.23838
   Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736
   Jurecic R, 2019, ADV EXP MED BIOL, V1169, P195, DOI 10.1007/978-3-030-24108-7_10
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Kesner EE, 2016, SCI REP-UK, V6, DOI 10.1038/srep26057
   Kirschner K, 2017, CELL REP, V19, P1503, DOI 10.1016/j.celrep.2017.04.074
   Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316
   Kuribayashi W, 2021, J EXP MED, V218, DOI 10.1084/jem.20192283
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Kuznetsov AV, 2003, ANAL BIOCHEM, V319, P296, DOI 10.1016/S0003-2697(03)00326-9
   Lauridsen FKB, 2018, CELL REP, V24, P766, DOI 10.1016/j.celrep.2018.06.057
   Leduc-Gaudet JP, 2015, ONCOTARGET, V6, P17923, DOI 10.18632/oncotarget.4235
   Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505
   Li MK, 2015, P NATL ACAD SCI USA, V112, P2491, DOI 10.1073/pnas.1419651112
   Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029
   Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC
   Lin LW, 2019, AM J TRANSPLANT, V19, P1917, DOI 10.1111/ajt.15309
   Liu VWS, 1998, NUCLEIC ACIDS RES, V26, P1268, DOI 10.1093/nar/26.5.1268
   Lo Sardo V, 2017, NAT BIOTECHNOL, V35, P69, DOI 10.1038/nbt.3749
   Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201
   Maeda H, 2020, J CELL MOL MED, V24, P5007, DOI 10.1111/jcmm.15120
   Mahrouf-Yorgov M, 2017, CELL DEATH DIFFER, V24, P1224, DOI 10.1038/cdd.2017.51
   Mansell E, 2021, CELL STEM CELL, V28, P241, DOI 10.1016/j.stem.2020.09.018
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004
   McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Minet AD, 2011, BIOCHEM BIOPH RES CO, V409, P591, DOI 10.1016/j.bbrc.2011.04.028
   Mohsin S, 2015, CIRC RES, V117, P1024, DOI 10.1161/CIRCRESAHA.115.307362
   Morrison TJ, 2017, AM J RESP CRIT CARE, V196, P1275, DOI 10.1164/rccm.201701-0170OC
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, pL78, DOI 10.1152/ajplung.00221.2019
   Moskowitzova K, 2019, J HEART LUNG TRANSPL, V38, P92, DOI 10.1016/j.healun.2018.09.025
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   Nagendran J, 2008, J THORAC CARDIOV SUR, V136, P168, DOI 10.1016/j.jtcvs.2008.01.040
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Nicaise AM, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00247
   Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7
   Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017
   Orfany A, 2020, J VASC SURG, V71, P1014, DOI 10.1016/j.jvs.2019.03.079
   Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478
   Paliwal S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1012-0
   Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054
   Phadke R, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070064
   Pham TD, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071065
   Phinney DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9472
   Pollara J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121622
   Preble JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51682
   Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016
   Ramirez-Barbieri G, 2019, MITOCHONDRION, V46, P103, DOI 10.1016/j.mito.2018.03.002
   Ren L, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.580070
   Romine J, 2015, NEUROBIOL AGING, V36, P1716, DOI 10.1016/j.neurobiolaging.2015.01.003
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004
   Saha P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau1168
   Sansone P, 2017, P NATL ACAD SCI USA, V114, pE9066, DOI 10.1073/pnas.1704862114
   Sazonova MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/825468
   Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307
   Sheleg S, 2008, INT J CLIN EXP PATHO, V1, P440
   Shi Changyou, 2020, Transl Med Aging, V4, P121, DOI 10.1016/j.tma.2020.08.002
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shin B, 2019, JACC-BASIC TRANSL SC, V4, P871, DOI 10.1016/j.jacbts.2019.08.007
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simmons JD, 2017, J TRAUMA ACUTE CARE, V82, P1023, DOI 10.1097/TA.0000000000001421
   Simmons JD, 2015, CORONARY ARTERY DIS, V26, P286, DOI 10.1097/MCA.0000000000000244
   Sinha P, 2016, CURR OPIN GENET DEV, V38, P97, DOI 10.1016/j.gde.2016.05.002
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103
   Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004
   Stumpf PS, 2020, PHYS BIOL, V17, DOI 10.1088/1478-3975/abba85
   Sudakov NP, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-016-0241-x
   Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009
   Sun X, 2018, BIOCHEM BIOPH RES CO, V503, P2611, DOI 10.1016/j.bbrc.2018.08.012
   Tsai NW, 2011, CLIN CHIM ACTA, V412, P476, DOI 10.1016/j.cca.2010.11.036
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Valenti D, 2014, ANAL BIOCHEM, V444, P25, DOI 10.1016/j.ab.2013.08.030
   van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480
   Vandergriff AC, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/960926
   Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757
   Wallace DC, 2016, NATURE, V535, P498, DOI 10.1038/nature18902
   Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131
   Wang HC, 2014, J NEUROTRAUM, V31, P1039, DOI 10.1089/neu.2013.3070
   Wang L, 2015, CORONARY ARTERY DIS, V26, P296, DOI 10.1097/MCA.0000000000000231
   Wang LF, 2020, BMC EMERG MED, V20, DOI 10.1186/s12873-020-00320-3
   Wang MJ, 2019, AGING DIS, V10, P871, DOI 10.14336/AD.2018.1119
   Webb M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207580
   Weixler V, 2021, J THORAC CARDIOV SUR, V162, pE111, DOI 10.1016/j.jtcvs.2020.08.011
   who, Ageing and Health
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   World Health Organization, Cardiovascular diseases (CVDs) Fact sheet
   Xin Y, 2010, ARTIF ORGANS, V34, P215, DOI 10.1111/j.1525-1594.2009.00824.x
   Yamada Y, 2014, YAKUGAKU ZASSHI, V134, P1143, DOI 10.1248/yakushi.14-00191
   Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhang YL, 2016, STEM CELL REP, V7, P749, DOI 10.1016/j.stemcr.2016.08.009
   Zhang ZH, 2020, J ALZHEIMERS DIS, V78, P1161, DOI 10.3233/JAD-200686
NR 174
TC 5
Z9 6
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD FEB
PY 2021
VL 22
IS 4
AR 1824
DI 10.3390/ijms22041824
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA QP3XN
UT WOS:000623770700001
PM 33673127
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Pontifex, CS
   Zaman, M
   Fanganiello, RD
   Shutt, TE
   Pfeffer, G
AF Pontifex, Carly S.
   Zaman, Mashiat
   Fanganiello, Roberto D.
   Shutt, Timothy E.
   Pfeffer, Gerald
TI Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular
   Functions and Clinical Phenotypes
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE valosin-containing protein; multisystem proteinopathy; genetic
   diagnosis; genotype-phenotype correlation; autophagy; mitophagy;
   lysophagy; stress granules; ERAD; cell cycle control; DNA damage
   response; apoptosis; SUMOylation; ubiquitination; skeletal muscle;
   osteoclast; neuron
ID MITOCHONDRIAL QUALITY-CONTROL; ENDOPLASMIC-RETICULUM STRESS;
   DNA-REPLICATION TERMINATION; AAA-ATPASE; MULTISYSTEM PROTEINOPATHY;
   FRONTOTEMPORAL DEMENTIA; PAGET-DISEASE; DAMAGED MITOCHONDRIA; AUTOPHAGIC
   FLUX; REPAIR PATHWAY
AB In this review we examine the functionally diverse ATPase associated with various cellular activities (AAA-ATPase), valosin-containing protein (VCP/p97), its molecular functions, the mutational landscape of VCP and the phenotypic manifestation of VCP disease. VCP is crucial to a multitude of cellular functions including protein quality control, endoplasmic reticulum-associated degradation (ERAD), autophagy, mitophagy, lysophagy, stress granule formation and clearance, DNA replication and mitosis, DNA damage response including nucleotide excision repair, ATM- and ATR-mediated damage response, homologous repair and non-homologous end joining. VCP variants cause multisystem proteinopathy, and pathology can arise in several tissue types such as skeletal muscle, bone, brain, motor neurons, sensory neurons and possibly cardiac muscle, with the disease course being challenging to predict.
C1 [Pontifex, Carly S.; Zaman, Mashiat; Shutt, Timothy E.; Pfeffer, Gerald] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada.
   [Zaman, Mashiat; Shutt, Timothy E.; Pfeffer, Gerald] Univ Calgary, Alberta Child Hlth Res Inst, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada.
   [Zaman, Mashiat; Shutt, Timothy E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada.
   [Fanganiello, Roberto D.] Univ Laval, Fac Sci & Engn, Quebec City, PQ G1V 0A6, Canada.
   [Pfeffer, Gerald] Heritage Med Res Bldg 155,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
C3 University of Calgary; University of Calgary; University of Calgary;
   Laval University
RP Pfeffer, G (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada.; Pfeffer, G (corresponding author), Univ Calgary, Alberta Child Hlth Res Inst, Cumming Sch Med, Dept Med Genet, Calgary, AB T2N 1N4, Canada.; Pfeffer, G (corresponding author), Heritage Med Res Bldg 155,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.
EM cspontif@ucalgary.ca; mashiat.zaman1@ucalgary.ca;
   robertofanganiello@gmail.com; timothy.shutt@ucalgary.ca;
   gerald.pfeffer@ucalgary.ca
RI Fanganiello, Roberto D./GPP-1411-2022; Shutt, Tim/U-9047-2019
OI Pfeffer, Gerald/0000-0002-7657-7098; Shutt, Timothy/0000-0001-5299-2943;
   ZAMAN, MASHIAT/0000-0002-1385-6591; Fanganiello, Roberto
   D./0000-0002-5355-255X
CR Abramzon Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.005
   Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188
   Anversa P, 1998, CIRC RES, V83, P1, DOI 10.1161/01.RES.83.1.1
   Arhzaouy K, 2019, AUTOPHAGY, V15, P1082, DOI 10.1080/15548627.2019.1569933
   Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052
   Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Bastola P, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.65
   Bastola P, 2016, MOL ONCOL, V10, P1559, DOI 10.1016/j.molonc.2016.09.005
   Bayraktar O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164864
   Bento AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30963-z
   Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729
   Blythe EE, 2019, STRUCTURE, V27, P1820, DOI 10.1016/j.str.2019.09.011
   Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114
   Boock V, 2023, CURR OPIN NEUROL, V36, P432, DOI 10.1097/WCO.0000000000001184
   Borowik AK, 2022, FUNCTION, V4, DOI 10.1093/function/zqac059
   Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Cao XL, 2020, AGING CELL, V19, DOI 10.1111/acel.13136
   Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288
   Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029
   Chen JS, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071789
   Chen X, 2018, CONNECT TISSUE RES, V59, P99, DOI 10.1080/03008207.2017.1290085
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Cheng C, 2022, J TRANSL MED, V20, DOI 10.1186/s12967-021-03186-6
   Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524
   Chou TF, 2014, J MOL BIOL, V426, P2886, DOI 10.1016/j.jmb.2014.05.022
   Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486
   Cramer AAW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20058-7
   Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050
   Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056
   Dalal S, 2001, CELL, V104, P5, DOI 10.1016/S0092-8674(01)00186-6
   De Brito OM, 2008, ANTIOXID REDOX SIGN, V10, P621, DOI 10.1089/ars.2007.1934
   DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972
   Denton D, 2019, CELL DEATH DIFFER, V26, P605, DOI 10.1038/s41418-018-0252-y
   DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016
   Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887
   Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041
   Du YJ, 2021, MOL BIOL CELL, V32, P1474, DOI 10.1091/mbc.E21-03-0097
   Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200
   Fang L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00016
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Fernández-Sáiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49
   Finkelstein Y, 2010, CLIN TOXICOL, V48, P407, DOI 10.3109/15563650.2010.495348
   Forman MS, 2006, J NEUROPATH EXP NEUR, V65, P571, DOI 10.1097/00005072-200606000-00005
   Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028
   FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443
   Fujita K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2828
   Galarreta A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168796
   Garvin AJ, 2019, GENE DEV, V33, P333, DOI 10.1101/gad.321125.118
   Gomez-Suaga P, 2022, AGING CELL, V21, DOI 10.1111/acel.13549
   Gonzalez AE, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00256
   Gonzalez MA, 2014, BRAIN, V137, P2897, DOI 10.1093/brain/awu224
   Guo X, 2017, BBA-MOL BASIS DIS, V1863, P552, DOI 10.1016/j.bbadis.2016.11.026
   Gupta M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00553
   He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812
   Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021
   Hewitt G, 2016, AUTOPHAGY, V12, P1917, DOI 10.1080/15548627.2016.1210368
   Hong CJ, 2016, BRAIN RES, V1649, P166, DOI 10.1016/j.brainres.2016.02.048
   Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041
   Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022
   Isono M, 2017, CELL REP, V18, P520, DOI 10.1016/j.celrep.2016.12.042
   Ivanov P, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032813
   Izawa T, 2017, CELL, V171, P890, DOI 10.1016/j.cell.2017.10.002
   Jerath Nivedita U, 2015, Case Rep Genet, V2015, P239167, DOI 10.1155/2015/239167
   Jiang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.171
   Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785
   Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063
   Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115
   Kim H, 2021, MATERIALS, V14, DOI 10.3390/ma14113019
   Kim NC, 2013, NEURON, V78, P65, DOI 10.1016/j.neuron.2013.02.029
   Kim YS, 2023, EUR J NEUROL, V30, P2583, DOI 10.1111/ene.15824
   Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862
   Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003
   Kimura Y, 2013, GENES CELLS, V18, P1131, DOI 10.1111/gtc.12103
   Kirby AE, 2021, NEUROL-GENET, V7, DOI 10.1212/NXG.0000000000000595
   Klar J, 2013, HUM MUTAT, V34, P572, DOI 10.1002/humu.22282
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koerver L, 2019, EMBO REP, V20, DOI 10.15252/embr.201948014
   Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034
   Korb M, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02172-5
   Korb MK, 2021, MUSCLE NERVE, V63, P442, DOI 10.1002/mus.27097
   Koyano F, 2019, EMBO REP, V20, DOI 10.15252/embr.201947728
   Kravic B, 2020, AUTOPHAGY, V16, P179, DOI 10.1080/15548627.2019.1687217
   Kwon OC, 2017, AM J MED, V130, P583, DOI 10.1016/j.amjmed.2016.12.006
   Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372
   Lee Y, 2018, J CLIN INVEST, V128, P1164, DOI 10.1172/JCI97103
   Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200
   Li ZD, 2016, DNA REPAIR, V38, P94, DOI 10.1016/j.dnarep.2015.11.019
   Livingstone M, 2005, CANCER RES, V65, P7533, DOI 10.1158/0008-5472.CAN-04-3729
   Llambi F, 2016, CELL, V165, P421, DOI 10.1016/j.cell.2016.02.026
   Luijsterburg MS, 2012, CURR OPIN CELL BIOL, V24, P439, DOI 10.1016/j.ceb.2012.03.008
   Mah-Som AY, 2023, AM J HUM GENET, V110, P1959, DOI 10.1016/j.ajhg.2023.10.007
   Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040
   Majera D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020469
   Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x
   Markovinovic A, 2022, J CELL SCI, V135, DOI 10.1242/jcs.248534
   Mårtensson CU, 2019, NATURE, V569, P679, DOI 10.1038/s41586-019-1227-y
   Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140
   McLelland GL, 2018, AUTOPHAGY, V14, P1658, DOI 10.1080/15548627.2018.1505154
   McLelland GL, 2018, ELIFE, V7, DOI 10.7554/eLife.32866
   McMillan EM, 2014, BIOCHEM J, V462, P267, DOI 10.1042/BJ20140312
   Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367
   Mei L, 2021, BIOCHEM SOC T, V49, P2133, DOI 10.1042/BST20210161
   Mengus C, 2022, AUTOPHAGY, V18, P171, DOI 10.1080/15548627.2021.1922982
   Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831
   Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181
   Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Montalbano M, 2020, NEUROBIOL DIS, V146, DOI 10.1016/j.nbd.2020.105130
   Mori-Konya C, 2009, GENES CELLS, V14, P483, DOI 10.1111/j.1365-2443.2009.01286.x
   Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395
   Müller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206
   Nadeau ME, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1489-1
   Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004
   Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308
   Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522
   Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9
   Nightingale H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g459
   Niu ZY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00147
   Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778
   Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017
   Papadopoulos C, 2020, J MOL BIOL, V432, P231, DOI 10.1016/j.jmb.2019.08.010
   Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148
   Paré MF, 2017, BBA-MOL CELL RES, V1864, P708, DOI 10.1016/j.bbamcr.2016.12.015
   Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3
   Pfeffer G, 2022, GENES-BASEL, V13, DOI 10.3390/genes13060963
   Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911
   Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004
   Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695
   Qi L, 2017, TRENDS CELL BIOL, V27, P430, DOI 10.1016/j.tcb.2016.12.002
   Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002
   Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5
   Reddy S V, 2001, Rev Endocr Metab Disord, V2, P195
   Regensburger M, 2017, NEUROLOGY, V89, P746, DOI 10.1212/WNL.0000000000004240
   Roberts TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep28166
   Roy B, 2023, ANN CLIN TRANSL NEUR, V10, P686, DOI 10.1002/acn3.51760
   Seguin SJ, 2014, CELL DEATH DIFFER, V21, P1838, DOI 10.1038/cdd.2014.103
   Shao JY, 2020, MOL CELL ONCOL, V7, DOI 10.1080/23723556.2020.1796179
   Shih YT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11020
   Singh AN, 2019, EMBO J, V38, DOI 10.15252/embj.2019102361
   Sonneville R, 2017, NAT CELL BIOL, V19, P468, DOI 10.1038/ncb3500
   Spina S, 2013, EUR J NEUROL, V20, P251, DOI 10.1111/j.1468-1331.2012.03831.x
   Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545
   Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042
   Strifler G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166682
   Szurman-Zubrzycka M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01299
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Taylor JP, 2015, NEUROLOGY, V85, P658, DOI 10.1212/WNL.0000000000001862
   Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014
   Turakhiya A, 2018, MOL CELL, V70, P906, DOI 10.1016/j.molcel.2018.04.021
   Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028
   van den Boom J, 2016, MOL CELL, V64, P189, DOI 10.1016/j.molcel.2016.08.037
   Wang B, 2019, MOL CELL, V74, P742, DOI 10.1016/j.molcel.2019.03.027
   Wang FL, 2021, CANCERS, V13, DOI 10.3390/cancers13205076
   Wang G, 2004, CELL RES, V14, P303, DOI 10.1038/sj.cr.7290375
   Wang KZQ, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0466-18.2018
   Wang T, 2016, J BIOL CHEM, V291, P14373, DOI 10.1074/jbc.M116.729343
   Wang ZH, 2016, HUM MOL GENET, V25, P1946, DOI 10.1093/hmg/ddw067
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426
   Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327
   Wójcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432
   Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5
   Xu S, 2011, MOL BIOL CELL, V22, P291, DOI 10.1091/mbc.E10-09-0748
   Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602
   Yeo BK, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0212-8
   Zhang T, 2017, ELIFE, V6, DOI 10.7554/eLife.17834
   Zhao YG, 2021, NAT REV MOL CELL BIO, V22, P733, DOI 10.1038/s41580-021-00392-4
   Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284
   Zhu CG, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107745
NR 171
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUN
PY 2024
VL 25
IS 11
AR 5633
DI 10.3390/ijms25115633
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA UB9U2
UT WOS:001245727000001
PM 38891822
OA gold
DA 2024-11-01
ER

PT J
AU Shaibani, A
   Wong, LJ
   Zhang, VW
   Lewis, RA
   Shinawi, M
AF Shaibani, Aziz
   Wong, Lee-Jun
   Zhang, Victor Wei
   Lewis, Richard Alan
   Shinawi, Marwan
TI Autosomal recessive posterior column ataxia with retinitis pigmentosa
   caused by novel mutations in the <i>FLVCR1</i> gene
SO INTERNATIONAL JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE posterior column ataxia; neuropathy; autosomal recessive; retinitis
   pigmentosa; FLVCR1
ID MITOCHONDRIAL HEME; DIFFERENTIATION; EXPORTER
AB Posterior column ataxia with retinitis pigmentosa (PCARP) is an autosomal recessive disorder characterized by severe sensory ataxia, muscle weakness and atrophy, and progressive pigmentary retinopathy. Recently, mutations in the FLVCR1 gene were described in four families with this condition. We investigated the molecular basis and studied the phenotype of PCARP in a new family. The proband is a 33-year-old woman presented with sensory polyneuropathy and retinitis pigmentosa (RP). The constellation of clinical findings with normal metabolic and genetic evaluation, including mitochondrial DNA (mtDNA) analysis and normal levels of phytanic acid and vitamin E, prompted us to seek other causes of our patient's condition. Sequencing of FLVCR1 in the proband and targeted mutation testing in her two affected siblings revealed two novel variants, c.1547G>A (p.R516Q) and c.1593+5_+8delGTAA predicted, respectively, to be highly conserved throughout evolution and affecting the normal splicing, therefore, deleterious. This study supports the pathogenic role of FLVCR1 in PCARP and expands the molecular and clinical spectra of PCARP. We show for the first time that nontransmembrane domain (TMD) mutations in the FLVCR1 can cause PCARP, suggesting different mechanisms for pathogenicity. Our clinical data reveal that impaired sensation can be part of the phenotypic spectrum of PCARP. This study along with previously reported cases suggests that targeted sequencing of the FLVCR1 gene should be considered in patients with severe sensory ataxia, RP, and peripheral sensory neuropathy.
C1 [Shaibani, Aziz] Nerve & Muscle Ctr Texas, Houston, TX USA.
   [Wong, Lee-Jun; Zhang, Victor Wei; Lewis, Richard Alan] Baylor Coll Med, Dept Mol, Houston, TX 77030 USA.
   [Wong, Lee-Jun; Zhang, Victor Wei; Lewis, Richard Alan] Baylor Coll Med, Dept Human Genet, Houston, TX USA.
   [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA.
   [Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Washington University (WUSTL)
RP Shinawi, M (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, One Childrens Pl,Northwest Tower 9132, St Louis, MO 63110 USA.
EM shinawi_m@kids.wustl.edu
RI Shaibani, Aziz/AAE-1755-2022
OI shinawi, Marwan/0000-0003-1329-4100
FU Research to Prevent Blindness, New York, NY
FX Richard Alan Lewis received some unrestricted support for this
   investigation from Research to Prevent Blindness, New York, NY. Other
   authors report no conflict of interest. The authors alone are
   responsible for the content and writing of this paper.
CR Berciano J, 1998, NEUROLOGY, V51, P1772, DOI 10.1212/WNL.51.6.1772-a
   Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422
   Fleming MD, 2012, J CLIN INVEST, V122, P4328, DOI 10.1172/JCI66607
   Higgins JJ, 1997, NEUROLOGY, V49, P1717, DOI 10.1212/WNL.49.6.1717
   Higgins JJ, 1999, NEUROLOGY, V52, P146, DOI 10.1212/WNL.52.1.146
   Ishiura H, 2011, NEUROGENETICS, V12, P117, DOI 10.1007/s10048-010-0271-4
   Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133
   Khan AA, 2013, MOL ASPECTS MED, V34, P669, DOI 10.1016/j.mam.2012.07.013
   Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008
   Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0
   Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014
   Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013
   Shaibani A, 2009, ARCH NEUROL-CHICAGO, V66, P1028, DOI 10.1001/archneurol.2009.139
   Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999
   Yanatori I, 2012, BLOOD CELL MOL DIS, V49, P60, DOI 10.1016/j.bcmd.2012.03.004
NR 15
TC 23
Z9 24
U1 1
U2 3
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0020-7454
EI 1563-5279
J9 INT J NEUROSCI
JI Int. J. Neurosci.
PD JAN
PY 2015
VL 125
IS 1
BP 43
EP 49
DI 10.3109/00207454.2014.904858
PG 7
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA AU8EA
UT WOS:000345828000007
PM 24628582
DA 2024-11-01
ER

PT J
AU Honzik, T
   Tesarova, M
   Magner, M
   Mayr, J
   Jesina, P
   Vesela, K
   Wenchich, L
   Szentivanyi, K
   Hansikova, H
   Sperl, W
   Zeman, J
AF Honzik, Tomas
   Tesarova, Marketa
   Magner, Martin
   Mayr, Johannes
   Jesina, Pavel
   Vesela, Katerina
   Wenchich, Laszlo
   Szentivanyi, Karol
   Hansikova, Hana
   Sperl, Wolfgang
   Zeman, Jiri
TI Neonatal onset of mitochondrial disorders in 129 patients: clinical and
   laboratory characteristics and a new approach to diagnosis
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; PYRUVATE-DEHYDROGENASE DEFICIENCY;
   RESPIRATORY-CHAIN DEFICIENCIES; ACUTE METABOLIC DECOMPENSATION;
   BLUE-NATIVE-ELECTROPHORESIS; PEDIATRIC-PATIENTS; BARTH-SYNDROME; MUSCLE
   MITOCHONDRIA; SKELETAL-MUSCLE; DNA DEPLETION
AB Mitochondrial disorders (MD) may manifest in neonates, but early diagnosis is difficult. In this study, clinical and laboratory data were analyzed in 129 patients with neonatal onset of MD to identify any association between specific mitochondrial diseases and their symptoms with the aim of optimizing diagnosis.
   Retrospective clinical and laboratory data were evaluated in 461 patients (331 families) with confirmed MD.
   The neonatal onset of MD was reported in 28% of the patients. Prematurity, intrauterine growth retardation and hypotonia necessitating ventilatory support were present in one-third, cardiomyopathy in 40%, neonatal seizures in 16%, Leigh syndrome in 15%, and elevated lactate level in 87%. Hyperammonemia was observed in 22 out of 52 neonates. Complex I deficiency was identified in 15, complex III in one, complex IV in 23, complex V in 31, combined deficiency of several complexes in 53, and PDH complex deficiency was identified in six patients. Molecular diagnosis was confirmed in 49 cases, including a newborn with a 9134A > G mutation in the MTATP6 gene, which has not been described previously.
   The most significant finding is the high incidence of neonatal cardiomyopathy and hyperammonemia. Based on our experience, we propose a diagnostic flowchart applicable to critically ill neonates suspicious for MD. This tool will allow for the use of direct molecular genetic analyses without the need for muscle biopsies in neonates with Alpers, Barth, MILS and Pearson syndromes, SCO1, SCO2, TMEM70, ATP5E, SUCLG1 gene mutations and PDH complex deficiency.
C1 [Honzik, Tomas; Tesarova, Marketa; Magner, Martin; Jesina, Pavel; Vesela, Katerina; Wenchich, Laszlo; Szentivanyi, Karol; Hansikova, Hana; Zeman, Jiri] Charles Univ Prague, Dept Pediat & Adolescent Med, Fac Med 1, Prague 12000 2, Czech Republic.
   [Honzik, Tomas; Tesarova, Marketa; Magner, Martin; Jesina, Pavel; Vesela, Katerina; Wenchich, Laszlo; Szentivanyi, Karol; Hansikova, Hana; Zeman, Jiri] Gen Univ Hosp Prague, Prague 12000 2, Czech Republic.
   [Mayr, Johannes; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
C3 Charles University Prague; General University Hospital Prague;
   Paracelsus Private Medical University
RP Zeman, J (corresponding author), Charles Univ Prague, Dept Pediat & Adolescent Med, Fac Med 1, Ke Karlovu 2, Prague 12000 2, Czech Republic.
EM jzem@lf1.cuni.cz
RI Hansikova, Hana/E-9350-2017; Wenchich, Laszlo/Q-5147-2018; Tesarova,
   Marketa/I-1531-2016; Zeman, Jiri/K-2691-2017; Magner,
   Martin/J-3553-2017; Jesina, Pavel/A-9913-2012; Vesela,
   Katerina/K-3690-2017; Honzik, Tomas/N-7509-2017
OI Wenchich, Laszlo/0000-0002-8250-2981; Tesarova,
   Marketa/0000-0002-5141-2289; Zeman, Jiri/0000-0002-2678-7919; Magner,
   Martin/0000-0002-5883-9509; Jesina, Pavel/0000-0002-8513-0976; Vesela,
   Katerina/0000-0001-8665-3472; Mayr, Johannes/0000-0001-6970-336X;
   Honzik, Tomas/0000-0003-4300-2519
FU Ministry of Health of Czech Republic [IGA MZ NS 10561-3/2009, IGA MZ NS
   9782-4/2008, IGA MZ NT 11186-5/2010]; Center of Applied Genomics from
   Ministry of Education, Youth and Sports of Czech Republic [1 M520];
   Vereinigung zur Forschung und Fortbildung, Univ. Kinderklinik Salzburg,
   Austria
FX The study was supported by grants from the Ministry of Health of the
   Czech Republic IGA MZ NS 10561-3/2009 (TH, KS), IGA MZ NS 9782-4/2008
   (PJ, MM), IGA MZ NT 11186-5/2010 (MT, HH), by Center of Applied Genomics
   1 M520 (JZ, KV, LW) from the Ministry of Education, Youth and Sports of
   the Czech Republic, and by the Vereinigung zur Forschung und
   Fortbildung, Univ. Kinderklinik Salzburg, Austria (WS, JM).
CR Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Barnerias C, 2010, DEV MED CHILD NEUROL, V52, pe1, DOI 10.1111/j.1469-8749.2009.03541.x
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Böhm M, 2006, PEDIATR RES, V59, P21, DOI 10.1203/01.pdr.0000190572.68191.13
   Cameron JM, 2011, MITOCHONDRION, V11, P191, DOI 10.1016/j.mito.2010.09.008
   Capkova M, 2002, Cas Lek Cesk, V141, P636
   Cerna L, 2001, Med Sci Monit, V7, P1319
   CONSTANTINTEODOSIU D, 1991, ANAL BIOCHEM, V198, P347, DOI 10.1016/0003-2697(91)90437-X
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Donati MA, 2006, J INHERIT METAB DIS, V29, P684, DOI 10.1007/s10545-006-0388-7
   Fragaki K, 2009, MITOCHONDRION, V9, P346, DOI 10.1016/j.mito.2009.06.002
   García-Cazorla A, 2005, PEDIATRICS, V116, P1170, DOI 10.1542/peds.2004-2407
   Gibson K, 2008, PEDIATRICS, V122, P1003, DOI 10.1542/peds.2007-3502
   Honzik T, 2008, EARLY HUM DEV, V84, P269, DOI 10.1016/j.earlhumdev.2006.07.008
   Honzík T, 2010, ARCH DIS CHILD, V95, P296, DOI 10.1136/adc.2009.168096
   Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414
   KLEMENT P, 1995, ANAL BIOCHEM, V231, P218, DOI 10.1006/abio.1995.1523
   Leshinsky-Silver E, 2005, BIOCHEM BIOPH RES CO, V334, P582, DOI 10.1016/j.bbrc.2005.06.134
   Lui K, 2006, PEDIATRICS, V118, P2076, DOI 10.1542/peds.2006-1540
   Magner M, 2011, EUR J PAEDIATR NEURO, V15, P101, DOI 10.1016/j.ejpn.2010.10.001
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   Mayr JA, 2010, HUM MOL GENET, V19, P3430, DOI 10.1093/hmg/ddq254
   Morava E, 2006, NEUROLOGY, V67, P1823, DOI 10.1212/01.wnl.0000244435.27645.54
   Morel AS, 2009, EUR J PEDIATR, V168, P311, DOI 10.1007/s00431-008-0756-4
   Moslemi AR, 2008, NEUROPEDIATRICS, V39, P24, DOI 10.1055/s-2008-1076739
   Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391
   Ostergaard E, 2007, AM J HUM GENET, V81, P383, DOI 10.1086/519222
   Pejznochova M, 2010, MITOCHONDRION, V10, P321, DOI 10.1016/j.mito.2010.01.006
   Pontes Azevedo Luciano Cesar, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P214
   Rouzier C, 2010, J MED GENET, V47, P670, DOI 10.1136/jmg.2009.073445
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   SCHAGGER H, 1995, EUR J BIOCHEM, V230, P235, DOI 10.1111/j.1432-1033.1995.0235i.x
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schiff M, 2011, SEMIN FETAL NEONAT M, V16, P216, DOI 10.1016/j.siny.2011.04.002
   Shchelochkov OA, 2010, MOL GENET METAB, V101, P282, DOI 10.1016/j.ymgme.2010.07.012
   Skladal D, 2003, CLIN PEDIATR, V42, P703, DOI 10.1177/000992280304200806
   Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169
   Soares-Fernandes JP, 2008, PEDIATR RADIOL, V38, P559, DOI 10.1007/s00247-007-0721-9
   SPERL W, 1992, ANN CLIN BIOCHEM, V29, P638, DOI 10.1177/000456329202900604
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z
   Stiburek L, 2009, AM J PHYSIOL-CELL PH, V296, pC1218, DOI 10.1152/ajpcell.00564.2008
   Strassburg HM, 2006, NEUROPEDIATRICS, V37, P137, DOI 10.1055/s-2006-924555
   Suomalainen A, 2011, LANCET NEUROL, V10, P806, DOI 10.1016/S1474-4422(11)70155-7
   Suomalainen A, 2011, J INHERIT METAB DIS, V34, P277, DOI 10.1007/s10545-010-9222-3
   Taylor GP, 2004, PEDIATR DEVEL PATHOL, V7, P620, DOI 10.1007/s10024-004-5050-5
   Tesarova M, 2002, Cas Lek Cesk, V141, P551
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Valnot I, 2000, AM J HUM GENET, V67, P1104
   Vary TC, 1999, MOL CELL BIOCHEM, V198, P113, DOI 10.1023/A:1006993910781
   Verdijk RM, 2008, AM J MED GENET A, V146A, P2822, DOI 10.1002/ajmg.a.32523
   Vesela K, 2004, ACTA PAEDIATR, V93, P1312, DOI 10.1080/08035250410031341
   von Kleist-Retzow JC, 2003, J PEDIATR-US, V143, P208, DOI 10.1067/S0022-3476(03)00130-6
   Wexler ID, 1997, NEUROLOGY, V49, P1655, DOI 10.1212/WNL.49.6.1655
   Wolf NI, 2002, NEUROLOGY, V59, P1402, DOI 10.1212/01.WNL.0000031795.91814.D8
   Wong LJC, 2010, MOL GENET METAB, V100, P111, DOI 10.1016/j.ymgme.2010.02.024
   Wortmann SB, 2007, ACTA PAEDIATR, V96, P450, DOI 10.1111/j.1651-2227.2006.00158.x
   Yen TY, 2008, EUR J PEDIATR, V167, P941, DOI 10.1007/s00431-007-0592-y
   Zand DJ, 2003, AM J NEURORADIOL, V24, P1471
NR 63
TC 59
Z9 65
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD SEP
PY 2012
VL 35
IS 5
BP 749
EP 759
DI 10.1007/s10545-011-9440-3
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 998NO
UT WOS:000308247000002
PM 22231385
DA 2024-11-01
ER

PT J
AU Kondo, H
   Tanda, K
   Tabata, C
   Hayashi, K
   Kihara, M
   Kizaki, Z
   Taniguchi-Ikeda, M
   Mori, M
   Murayama, K
   Ohtake, A
AF Kondo, Hidehito
   Tanda, Koichi
   Tabata, Chihiro
   Hayashi, Kohei
   Kihara, Minako
   Kizaki, Zenro
   Taniguchi-Ikeda, Mariko
   Mori, Masato
   Murayama, Kei
   Ohtake, Akira
TI Leigh syndrome with Fukuyama congenital muscular dystrophy: A case
   report
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; FCMD; Mitochondria; Complex I plus II deficiency
ID DEFICIENCY; SUCCINATE; CHILDREN; ADULTS
AB We report the first case of Leigh syndrome (LS) with Fukuyama congenital muscular dystrophy (FCMD). A neonate suffered from lactic acidosis and subsequently presented with poor feeding, muscle weakness, hypotonia, cardiopulmonary dysfunction, and hydrocephalus. He died at 17 months. The findings of brain magnetic resonance imaging indicated some specific features of both LS and FCMD, and FCMD gene mutation was detected. Decreased mitochondrial respiratory complex I and II activity was noted. Mitochondrial DNA sequencing showed no pathogenic mutation. A case with complex I + II deficiency has rarely been reported, suggesting a nuclear gene mutation. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Kondo, Hidehito; Tanda, Koichi; Tabata, Chihiro; Hayashi, Kohei; Kihara, Minako; Kizaki, Zenro] Japanese Red Cross Kyoto Daiichi Hosp, Dept Pediat & Neonatol, Kyoto, Japan.
   [Kondo, Hidehito] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan.
   [Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Div Pediat, Kobe, Hyogo, Japan.
   [Mori, Masato] Jichi Med Univ, Dept Pediat, Shimotsuke, Tochigi, Japan.
   [Ohtake, Akira] Saitama Med Univ Hosp, Dept Pediat, Saitama, Japan.
C3 Osaka University; Kobe University; Jichi Medical University; Saitama
   Medical University
RP Kondo, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Pediat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM hkondo@ped.med.osaka-u.ac.jp
RI Taniguchi-Ikeda, Mariko/AGE-3152-2022; Murayama, Kei/JGM-3674-2023
OI Ohtake, Akira/0000-0003-1147-3113
FU Innovative Cell Biology grant from Innovative Technology (Cell
   Innovation Program) of the Ministry of Education, Culture, Sports,
   Science, and Technology, Japan; Ministry of Health, Labour and Welfare
   of Japan
FX This study was supported, in part, by an Innovative Cell Biology grant
   from Innovative Technology (Cell Innovation Program) of the Ministry of
   Education, Culture, Sports, Science, and Technology, Japan. Our work was
   also supported by grants-in-aid of the research on intractable diseases
   (mitochondrial disorders) of the Ministry of Health, Labour and Welfare
   of Japan.
CR Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00
   Brockmann K, 2002, ANN NEUROL, V52, P38, DOI 10.1002/ana.10232
   Burgeois M, 1992, BRAIN DEV, V14, P404
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Kato T, 2000, PEDIATR NEUROL, V23, P385, DOI 10.1016/S0887-8994(00)00210-1
   Kirby DM, 1999, NEUROLOGY, V52, P1255, DOI 10.1212/WNL.52.6.1255
   Saito K, 2000, AM J MED GENET, V92, P184, DOI 10.1002/(SICI)1096-8628(20000529)92:3<184::AID-AJMG5>3.0.CO;2-N
   Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020
   Watanabe M, 2005, AM J MED GENET A, V138A, P344, DOI 10.1002/ajmg.a.30978
NR 10
TC 2
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD SEP
PY 2014
VL 36
IS 8
BP 730
EP 733
DI 10.1016/j.braindev.2013.09.005
PG 4
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA CB2AN
UT WOS:000349429200014
PM 24113355
DA 2024-11-01
ER

PT J
AU Wang, X
   Posey, JE
   Rosenfeld, JA
   Bacino, CA
   Scaglia, F
   Immken, L
   Harris, JM
   Hickey, SE
   Mosher, TM
   Slavotinek, A
   Zhang, J
   Beuten, J
   Leduc, MS
   He, WM
   Vetrini, F
   Walkiewicz, MA
   Bi, WM
   Xiao, R
   Liu, PF
   Shao, YR
   Gezdirici, A
   Gulec, EY
   Jiang, YY
   Darilek, SA
   Hansen, AW
   Khayat, MM
   Pehlivan, D
   Piard, J
   Muzny, DM
   Hanchard, N
   Belmont, JW
   Van Maldergem, L
   Gibbs, RA
   Eldomery, MK
   Akdemir, ZC
   Adesina, AM
   Chen, S
   Lee, YC
   Lee, B
   Lupski, JR
   Eng, CM
   Xia, F
   Yang, YP
   Graham, BH
   Moretti, P
AF Wang, Xia
   Posey, Jennifer E.
   Rosenfeld, Jill A.
   Bacino, Carlos A.
   Scaglia, Fernando
   Immken, LaDonna
   Harris, Jill M.
   Hickey, Scott E.
   Mosher, Theresa M.
   Slavotinek, Anne
   Zhang, Jing
   Beuten, Joke
   Leduc, Magalie S.
   He, Weimin
   Vetrini, Francesco
   Walkiewicz, Magdalena A.
   Bi, Weimin
   Xiao, Rui
   Liu, Pengfei
   Shao, Yunru
   Gezdirici, Alper
   Gulec, Elif Y.
   Jiang, Yunyun
   Darilek, Sandra A.
   Hansen, Adam W.
   Khayat, Michael M.
   Pehlivan, Davut
   Piard, Juliette
   Muzny, Donna M.
   Hanchard, Neil
   Belmont, John W.
   Van Maldergem, Lionel
   Gibbs, Richard A.
   Eldomery, Mohammad K.
   Akdemir, Zeynep C.
   Adesina, Adekunle M.
   Chen, Shan
   Lee, Yi-Chien
   Lee, Brendan
   Lupski, James R.
   Eng, Christine M.
   Xia, Fan
   Yang, Yaping
   Graham, Brett H.
   Moretti, Paolo
CA Undiagnosed Dis Network
TI Phenotypic expansion in <i>DDX3X</i> - a common cause of intellectual
   disability in females
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID DE-NOVO MUTATIONS; MALFORMATIONS; DOMINANT
AB De novo variants in DDX3X account for 1-3% of unexplained intellectual disability (ID) cases and are amongst the most common causes of ID especially in females. Forty-seven patients (44 females, 3 males) have been described. We identified 31 additional individuals carrying 29 unique DDX3X variants, including 30 postnatal individuals with complex clinical presentations of developmental delay or ID, and one fetus with abnormal ultrasound findings. Rare or novel phenotypes observed include respiratory problems, congenital heart disease, skeletal muscle mitochondrial DNA depletion, and late-onset neurologic decline. Our findings expand the spectrum of DNA variants and phenotypes associated with DDX3X disorders.
C1 [Wang, Xia; Posey, Jennifer E.; Rosenfeld, Jill A.; Bacino, Carlos A.; Scaglia, Fernando; Leduc, Magalie S.; Walkiewicz, Magdalena A.; Bi, Weimin; Xiao, Rui; Liu, Pengfei; Shao, Yunru; Jiang, Yunyun; Darilek, Sandra A.; Hansen, Adam W.; Khayat, Michael M.; Pehlivan, Davut; Muzny, Donna M.; Hanchard, Neil; Belmont, John W.; Gibbs, Richard A.; Eldomery, Mohammad K.; Akdemir, Zeynep C.; Chen, Shan; Lee, Yi-Chien; Lee, Brendan; Lupski, James R.; Eng, Christine M.; Xia, Fan; Yang, Yaping; Graham, Brett H.; Moretti, Paolo] Baylor Coll Med, Mol & Human Genet, Houston, TX 77030 USA.
   [Wang, Xia; Zhang, Jing; Beuten, Joke; Leduc, Magalie S.; He, Weimin; Vetrini, Francesco; Walkiewicz, Magdalena A.; Bi, Weimin; Xiao, Rui; Liu, Pengfei; Eng, Christine M.; Xia, Fan; Yang, Yaping] Baylor Genet, Houston, TX USA.
   [Bacino, Carlos A.; Scaglia, Fernando; Shao, Yunru; Adesina, Adekunle M.; Lupski, James R.; Graham, Brett H.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Moretti, Paolo] Baylor Coll Med, Neurol, Houston, TX 77030 USA.
   [Moretti, Paolo] Michael E DeBakey VA Med Ctr, Houston, TX USA.
   [Immken, LaDonna; Harris, Jill M.] Specially Children, Austin, TX USA.
   [Hickey, Scott E.] Ohio State Univ, Pediat Clin, Columbus, OH 43210 USA.
   [Hickey, Scott E.; Mosher, Theresa M.] Nationwide Childrens Hosp, Div Mol & Human Genet, Columbus, OH USA.
   [Slavotinek, Anne] Univ Calif San Francisco, Div Genet, Dept Pediat, San Francisco, CA 94143 USA.
   [Gezdirici, Alper; Gulec, Elif Y.] Kanuni Sultan Suleyman Training & Res Hosp, Dept Genet, Istanbul, Turkey.
   [Pehlivan, Davut] Baylor Coll Med, Dept Pediat, Neurol Sect, Houston, TX 77030 USA.
   [Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.
   [Piard, Juliette; Van Maldergem, Lionel] Univ Franche Comte, Ctr Genet Humaine, Besancon, France.
   [Adesina, Adekunle M.] Baylor Coll Med, Pathol, Houston, TX 77030 USA.
   [Graham, Brett H.] Indiana Univ Sch Med, Med & Mol Genet, Indianapolis, IN 46202 USA.
   [Moretti, Paolo] Univ Utah, Neurol, Salt Lake City, UT USA.
   [Moretti, Paolo] George E Wahlen VA Med Ctr, Salt Lake City, UT USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; University System of Ohio; Ohio
   State University; University System of Ohio; Ohio State University;
   Nationwide Childrens Hospital; Research Institute at Nationwide
   Children's Hospital; University of California System; University of
   California San Francisco; Istanbul Kanuni Sultan Suleyman Training &
   Research Hospital; Baylor College of Medicine; Baylor College of
   Medicine; Universite de Franche-Comte; Baylor College of Medicine;
   Indiana University System; Indiana University Bloomington; Utah System
   of Higher Education; University of Utah
RP Wang, X (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 2450 Holcombe Blvd, Houston, TX 77021 USA.; Moretti, P (corresponding author), Univ Utah, Dept Neurol, 729 Arapeen Dr, Salt Lake City, UT 84108 USA.; Graham, BH (corresponding author), Indiana Univ, Dept Med & Mol Genet, IUPUI Nuys Med Sci Bldg,635 Barnhill Dr,MS 1015, Indianapolis, IN 46202 USA.
EM xiaw@bcm.edu; bregraha@iu.edu; paolo.moretti@hsc.utah.edu
RI Slavotinek, Anne/AAK-6794-2020; Posey, Jennifer/J-3048-2019; Leduc,
   Magalie/R-9884-2019; Gezdirici, Alper/AAG-5480-2019; Cardona,
   Carlos/AAS-6241-2020; Pehlivan, Davut/I-3235-2019; Graham,
   Brett/R-8685-2018; Van Maldergem, Lionel/O-3242-2019; Hickey,
   Scott/E-3245-2011; Hanchard, Neil/AAY-9075-2021; Xia, Fan/GQP-4575-2022;
   Yilmaz Gulec, Elif/GPS-8141-2022; Moretti, Paolo/ABH-7426-2020; Belmont,
   John/AAI-2494-2019; Wang, Xia/O-4036-2014; Gezdirici, Alper/W-8459-2018
OI Posey, Jennifer/0000-0003-4814-6765; Wang, Xia/0000-0002-7750-1167;
   Rosenfeld, Jill/0000-0001-5664-7987; Piard,
   Juliette/0000-0001-5244-5325; Gezdirici, Alper/0000-0002-2432-9279;
   Khayat, Michael M./0000-0001-5452-3147; Brown,
   Donna/0000-0002-8805-7225; Yilmaz Gulec, Elif/0000-0003-0872-3898
FU NIH Common Fund, through the Office of Strategic Coordination/Office of
   the NIH Director [U01HG007709]; National Human Genome Research Institute
   (NHGRI)/National Heart Lung and Blood Institute (NHLBI) [UM1 HG006542];
   National Human Genome Research Institute [K08 HG008986]
FX Research reported in this manuscript was supported by the NIH Common
   Fund, through the Office of Strategic Coordination/Office of the NIH
   Director under Award Number U01HG007709, and the National Human Genome
   Research Institute (NHGRI)/National Heart Lung and Blood Institute
   (NHLBI) UM1 HG006542 to the Baylor Hopkins Center for Mendelian
   Genomics. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health. J. E. P. was supported by K08 HG008986 through the
   National Human Genome Research Institute.
CR Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010
   Bassani S, 2013, NEUROSCIENTIST, V19, P541, DOI 10.1177/1073858413493972
   Blok LS, 2015, AM J HUM GENET, V97, P343, DOI 10.1016/j.ajhg.2015.07.004
   de Lange IM, 2016, J MED GENET, V53, P850, DOI 10.1136/jmedgenet-2016-103909
   Dikow N, 2017, AM J MED GENET A, V173, P1369, DOI 10.1002/ajmg.a.38164
   Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123
   Eldomery MK, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0412-6
   Garbelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019810
   Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lessel D, 2017, AM J HUM GENET, V101, P716, DOI 10.1016/j.ajhg.2017.09.014
   Lubs HA, 2012, AM J HUM GENET, V90, P579, DOI 10.1016/j.ajhg.2012.02.018
   Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018
   Posey JE, 2017, NEW ENGL J MED, V376, P21, DOI 10.1056/NEJMoa1516767
   Posey JE, 2016, GENET MED, V18, P678, DOI 10.1038/gim.2015.142
   Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715
   Reijnders MRF, 2016, AM J HUM GENET, V98, P373, DOI 10.1016/j.ajhg.2015.12.015
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Wang X, 2017, NAT GENET, V49, P613, DOI 10.1038/ng.3815
   Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zweier C, 2013, J MED GENET, V50, P838, DOI 10.1136/jmedgenet-2013-101918
NR 22
TC 52
Z9 62
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD OCT
PY 2018
VL 5
IS 10
BP 1277
EP 1285
DI 10.1002/acn3.622
PG 9
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA GW8WW
UT WOS:000447263000014
PM 30349862
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Bugiardini, E
   Pope, S
   Feichtinger, RG
   Poole, OV
   Pittman, AM
   Woodward, CE
   Heales, S
   Quinlivan, R
   Houlden, H
   Mayr, JA
   Hanna, MG
   Pitceathly, RDS
AF Bugiardini, Enrico
   Pope, Simon
   Feichtinger, Rene G.
   Poole, Olivia, V
   Pittman, Alan M.
   Woodward, Cathy E.
   Heales, Simon
   Quinlivan, Rosaline
   Houlden, Henry
   Mayr, Johannes A.
   Hanna, Michael G.
   Pitceathly, Robert D. S.
TI Utility of Whole Blood Thiamine Pyrophosphate Evaluation in TPK1-Related
   Diseases
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE mitochondrial diseases; TPK1; thiamine pyrophosphate; Leigh syndrome;
   thiamine deficiency
ID CHROMOSOMAL NDUFA1 GENE; HETEROZYGOUS MUTATION; PHOSPHATE-ESTERS;
   DEFICIENCY; VITAMIN-B1; CHILDHOOD; DEFECTS; GIRL
AB TPK1 mutations are a rare, but potentially treatable, cause of thiamine deficiency. Diagnosis is challenging given the phenotypic overlap that exists with other metabolic and neurological disorders. We report a case of TPK1-related disease presenting with Leigh-like syndrome and review the diagnostic utility of thiamine pyrophosphate (TPP) blood measurement. The proband, a 35-year-old male, presented at four months of age with recurrent episodes of post-infectious encephalopathy. He subsequently developed epilepsy, learning difficulties, sensorineural hearing loss, spasticity, and dysphagia. There was a positive family history for Leigh syndrome in an older brother. Plasma lactate was elevated (3.51 mmol/L) and brain MRI showed bilateral basal ganglia hyperintensities, indicative of Leigh syndrome. Histochemical and spectrophotometric analysis of mitochondrial respiratory chain complexes I, II+III, and IV was normal. Genetic analysis of muscle mitochondrial DNA was negative. Whole exome sequencing of the proband confirmed compound heterozygous variants in TPK1: c. 426G>C (p. Leu142Phe) and c. 258+1G>A (p.?). Blood TPP levels were reduced, providing functional evidence for the deleterious effects of the variants. We highlight the clinical and bioinformatics challenges to diagnosing rare genetic disorders and the continued utility of biochemical analyses, despite major advances in DNA sequencing technology, when investigating novel, potentially disease-causing, genetic variants. Blood TPP measurement represents a fast and cost-effective diagnostic tool in TPK1-related diseases.
C1 [Bugiardini, Enrico; Poole, Olivia, V; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.
   [Bugiardini, Enrico; Poole, Olivia, V; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.
   [Bugiardini, Enrico; Poole, Olivia, V; Pittman, Alan M.; Quinlivan, Rosaline; Houlden, Henry; Hanna, Michael G.; Pitceathly, Robert D. S.] UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
   [Pope, Simon; Heales, Simon] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London WC1N 3BG, England.
   [Feichtinger, Rene G.; Mayr, Johannes A.] Paracelsus Med Univ, Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Woodward, Cathy E.] Natl Hosp Neurol & Neurosurg, Neurogenet Unit, London WC1N 3BG, England.
   [Quinlivan, Rosaline] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England.
C3 University of London; University College London; University of London;
   University College London; UCL Medical School; University College London
   Hospitals NHS Foundation Trust; University of London; University College
   London; University of London; University College London; UCL Medical
   School; University College London Hospitals NHS Foundation Trust;
   Paracelsus Private Medical University; University of London; University
   College London; UCL Medical School; University College London Hospitals
   NHS Foundation Trust; University of London; University College London;
   Great Ormond Street Hospital for Children NHS Foundation Trust
RP Pitceathly, RDS (corresponding author), UCL Queen Sq Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England.; Pitceathly, RDS (corresponding author), Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England.; Pitceathly, RDS (corresponding author), UCL Queen Sq Inst Neurol, Dept Neuromuscular Dis, London WC1N 3BG, England.
EM r.pitceathly@ucl.ac.uk
RI Houlden, Henry/C-1532-2008; MEJAT, Alexandre/G-8635-2013; Pittman,
   Alan/D-6231-2012
OI Quinlivan, Rosaline/0000-0002-2306-4782; Hanna,
   Michael/0000-0003-0825-4075; Houlden, Henry/0000-0002-2866-7777;
   Bugiardini, Enrico/0000-0002-9709-6699; Pope, Simon Alexander
   Samuel/0000-0002-2991-3722; Pittman, Alan/0000-0002-8112-2987
FU Medical Research Council Centre grant [G0601943]; European Community
   [2012-305121]; Department of Health's National Institute for Health
   Research Biomedical Research Centres funding scheme; Medical Research
   Council Clinician Scientist Fellowship [MR/S002065/1]; Lily Foundation;
   E-Rare project GENOMIT FWF I [2741-B26]; Austrian Science Fund (FWF)
   [I2741] Funding Source: Austrian Science Fund (FWF); MRC [G0601943,
   MR/S002065/1, MR/S005021/1, MR/K000608/1, MR/S01165X/1] Funding Source:
   UKRI
FX This research was funded by a Medical Research Council Centre grant
   (G0601943) and a European Community's Seventh Framework Programme
   (FP7/2007-2013), under grant agreement no 2012-305121 "Integrated
   European-omics research project for diagnosis and therapy in rare
   neuromuscular and neurodegenerative diseases (NEUROMICS)". Part of this
   work was undertaken in the University College London
   Hospitals/University College London Queen Square Institute of Neurology
   sequencing facility, which received a proportion of funding from the
   Department of Health's National Institute for Health Research Biomedical
   Research Centres funding scheme. The clinical and diagnostic "Rare
   Mitochondrial Disorders" Service in London is funded by the UK NHS
   Highly Specialised Commissioners. R.D.S.P. is supported by a Medical
   Research Council Clinician Scientist Fellowship (MR/S002065/1). O.V.P.
   has received funding from the Lily Foundation. J.A.M was supported by
   the E-Rare project GENOMIT FWF I 2741-B26.
CR Banka S, 2014, MOL GENET METAB, V113, P301, DOI 10.1016/j.ymgme.2014.09.010
   Brown G, 2014, J INHERIT METAB DIS, V37, P577, DOI 10.1007/s10545-014-9712-9
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cheng XQ, 2018, J CHROMATOGR B, V1095, P103, DOI 10.1016/j.jchromb.2018.07.030
   Collie JTB, 2017, CLIN CHEM LAB MED, V55, P1652, DOI 10.1515/cclm-2017-0054
   Ortigoza-Escobar JD, 2016, BRAIN, V139, P31, DOI 10.1093/brain/awv342
   Desvignes JP, 2018, NUCLEIC ACIDS RES, V46, pW545, DOI 10.1093/nar/gky471
   Edwards KA, 2017, CHEMISTRYOPEN, V6, P178, DOI 10.1002/open.201600160
   Fraser JL, 2014, MOLEC GENET METAB RE, V1, P66, DOI 10.1016/j.ymgmr.2013.12.007
   Invernizzi F, 2017, NEUROLOGY, V89, P870, DOI 10.1212/WNL.0000000000004270
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lu J, 2008, CLIN CHEM, V54, P901, DOI 10.1373/clinchem.2007.099077
   Mahajan A, 2017, J NEUROL SCI, V376, P42, DOI 10.1016/j.jns.2017.02.063
   Mayr JA, 2011, AM J HUM GENET, V89, P806, DOI 10.1016/j.ajhg.2011.11.007
   Mayr JA, 2011, MOL GENET METAB, V103, P358, DOI 10.1016/j.ymgme.2011.04.010
   Ortigoza-Escobar JD, 2017, ANN NEUROL, V82, P317, DOI 10.1002/ana.24998
   Potluri P, 2009, MOL GENET METAB, V96, P189, DOI 10.1016/j.ymgme.2008.12.004
   Roelofsen-de Beer RJAC, 2017, J CHROMATOGR B, V1063, P67, DOI 10.1016/j.jchromb.2017.08.011
   Xu JJ, 2017, MOL GENET METAB REP, V13, P30, DOI 10.1016/j.ymgmr.2017.07.008
NR 19
TC 14
Z9 15
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUL
PY 2019
VL 8
IS 7
AR 991
DI 10.3390/jcm8070991
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA IN9MO
UT WOS:000479003300076
PM 31288420
OA Green Published, Green Submitted, gold, Green Accepted
DA 2024-11-01
ER

PT J
AU Siriwardena, K
   MacKay, N
   Levandovskiy, V
   Blaser, S
   Raiman, J
   Kantor, PF
   Ackerley, C
   Robinson, BH
   Schulze, A
   Cameron, JM
AF Siriwardena, Komudi
   MacKay, Nevena
   Levandovskiy, Valeriy
   Blaser, Susan
   Raiman, Julian
   Kantor, Paul F.
   Ackerley, Cameron
   Robinson, Brian H.
   Schulze, Andreas
   Cameron, Jessie M.
TI Mitochondrial citrate synthase crystals: Novel finding in Sengers
   syndrome caused by acylglycerol kinase (<i>AGK</i>) mutations
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Sengers syndrome; Mitochondria; Free radicals; Exome sequencing;
   Acylglycerol kinase
ID COMPLEX-I DEFICIENCY; OXYGEN-FREE RADICALS; CONGENITAL CATARACT;
   LIPID-PEROXIDATION; LACTIC-ACIDOSIS; PROTEIN; CARDIOLIPIN; GENERATION;
   ALIGNMENT; CARDIOMYOPATHY
AB We report on two families with Sengers syndrome and mutations in the acylglycerol kinase gene (AGK). In the first family, two brothers presented with vascular strokes, lactic acidosis, cardiomyopathy and cataracts, abnormal muscle cell histopathology and mitochondrial function. One proband had very abnormal mitochondria with citrate synthase crystals visible in electron micrographs, associated with markedly high citrate synthase activity. Exome sequencing was used to identify mutations in the AGK gene in the index patient. Targeted sequencing confirmed the same homozygous mutation (c.3G>A, p.M1I) in the brother. The second family had four affected members, of which we examined two. They also presented with similar clinical symptoms, but no strokes. Postmortem heart and skeletal muscle tissues showed low complex I, Ill and IV activities in the heart, but normal in the muscle. Skin fibroblasts showed elevated lactate/pyruvate ratios and low complex I + III activity. Targeted sequencing led to identification of a homozygous c.979A>T, p.K327* mutation.
   AGK is located in the mitochondria and phosphorylates monoacylglycerol and diacylglycerol to lysophosphatidic acid and phosphatidic acid. Disruption of these signaling molecules affects the mitochondria's response to superoxide radicals, resulting in oxidative damage to mitochondrial DNA, lipids and proteins, and stimulation of cellular detoxification pathways. High levels of manganese superoxide dismutase protein were detected in all four affected individuals, consistent with increased free radical damage. Phosphatidic acid is also involved in the synthesis of phospholipids and its loss will result in changes to the lipid composition of the inner mitochondrial membrane. These effects manifest as cataract formation in the eye, respiratory chain dysfunction and cardiac hypertrophy in heart tissue.
   These two pedigrees confirm that mutation of AGK is responsible for the severe neonatal presentation of Sengers syndrome. The identification of citrate synthase precipitates by electron microscopy and the presence of vascular strokes in two siblings may expand the cellular and clinical phenotype of this disease. (C) 2012 Elsevier Inc. All rights reserved.
C1 [Siriwardena, Komudi; Raiman, Julian; Schulze, Andreas] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada.
   [Siriwardena, Komudi; Raiman, Julian; Robinson, Brian H.; Schulze, Andreas] Univ Toronto, Toronto, ON M5G 1X8, Canada.
   [MacKay, Nevena; Ackerley, Cameron] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada.
   [Levandovskiy, Valeriy; Robinson, Brian H.; Schulze, Andreas; Cameron, Jessie M.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada.
   [Blaser, Susan] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON M5G 1X8, Canada.
   [Kantor, Paul F.] Hosp Sick Children, Div Cardiol, Toronto, ON M5G 1X8, Canada.
   [Robinson, Brian H.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.
C3 University of Toronto; Hospital for Sick Children (SickKids); University
   of Toronto; University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto; Hospital for Sick Children
   (SickKids); University of Toronto
RP Cameron, JM (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
EM jessie.cameron@sickkids.ca
RI Robinson, B/LBH-2242-2024; Kantor, Paul/AAF-6980-2021; Schulze,
   Andreas/I-5706-2019
OI Kantor, Paul/0000-0003-3071-9289; Kantor, Paul/0000-0002-4244-1563
FU MitoMarch for Kirkland
FX We thank "MitoMarch for Kirkland" for funding this project.
CR Abramoff M.D., 2004, Biophotonics Int, V11, P36
   Aldahmesh MA, 2012, HUM MUTAT, V33, P960, DOI 10.1002/humu.22071
   Badawi R A, 2012, Scott Med J, V57, P60, DOI 10.1258/smj.2011.011280
   Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123
   Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   CRUYSBERG JRM, 1986, AM J OPHTHALMOL, V102, P740, DOI 10.1016/0002-9394(86)90402-2
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   GLERUM DM, 1988, FEBS LETT, V236, P100, DOI 10.1016/0014-5793(88)80293-X
   Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99
   Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Jordens EZ, 2002, ANN NEUROL, V52, P95, DOI 10.1002/ana.10214
   Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008
   KATSUMATA K, 1994, BIOCHEM BIOPH RES CO, V202, P102, DOI 10.1006/bbrc.1994.1899
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Luo XP, 1997, J CLIN INVEST, V99, P2877, DOI 10.1172/JCI119481
   Maj MC, 2005, J CLIN ENDOCR METAB, V90, P4101, DOI 10.1210/jc.2005-0123
   Mayr JA, 2012, AM J HUM GENET, V90, P314, DOI 10.1016/j.ajhg.2011.12.005
   McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057
   Morava E, 2004, EUR J PEDIATR, V163, P467, DOI 10.1007/s00431-004-1465-2
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Perry MS, 2008, PEDIATR NEUROL, V39, P113, DOI 10.1016/j.pediatrneurol.2008.05.003
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Pitkanen S, 1996, BIOCHEM MOL MED, V59, P134, DOI 10.1006/bmme.1996.0078
   Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798
   Pitkanen S, 1996, PEDIATR RES, V39, P513, DOI 10.1203/00006450-199603000-00021
   Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ragan C.I., 1987, MITOCHONDRIA PRACTIC, P79
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RAHA S, 2003, HEART AND METABOLISM, V19, P4
   ROBINSON BH, 1990, PEDIATR RES, V28, P549, DOI 10.1203/00006450-199011000-00027
   Robinson BH, 1998, BBA-BIOENERGETICS, V1364, P271, DOI 10.1016/S0005-2728(98)00033-4
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SENGERS RCA, 1975, J PEDIATR-US, V86, P873, DOI 10.1016/S0022-3476(75)80217-4
   Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005
   Storz P, 2007, TRENDS CELL BIOL, V17, P13, DOI 10.1016/j.tcb.2006.11.003
   Waggoner DW, 2004, J BIOL CHEM, V279, P38228, DOI 10.1074/jbc.M405932200
   WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97
NR 43
TC 27
Z9 29
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JAN
PY 2013
VL 108
IS 1
BP 40
EP 50
DI 10.1016/j.ymgme.2012.11.282
PG 11
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 075BW
UT WOS:000313859800007
PM 23266196
DA 2024-11-01
ER

PT J
AU Siu, PM
   Alway, SE
AF Siu, Parco M.
   Alway, Stephen E.
TI Response and adaptation of skeletal muscle to denervation stress: the
   role of apoptosis in muscle loss
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Review
DE Apoptosis; Skeletal Myofiber; Satellite Cell; Nerve Innervation;
   Denervation; Review
ID SPINAL MUSCULAR-ATROPHY; PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE;
   BCL-2 FAMILY PROTEINS; PERMEABILITY TRANSITION PORE; LIFELONG CALORIE
   RESTRICTION; MITOCHONDRIAL-DNA MUTATIONS; NITRIC-OXIDE SYNTHASE;
   SATELLITE CELLS; RAT MUSCLES
AB Apoptosis is a well-conserved cellular destructive event which has been implicated in a variety of diseases such as cancers and neurodegenerative diseases. The comprehensive investigation of apoptosis has been emerged in the field of skeletal muscle biology. Results have been consistent in demonstrating the activation of apoptotic machinery in different pathologic and physiologic muscle atrophic conditions including muscle disuse, hindlimb unloading, muscle dystrophy, sarcopenia, and neuromuscular diseases. Together with the other identified muscle atrophy-related signaling mechanisms such as NF kappa B, FOXOs/MuRF1/MAFbx and ubiquitin-proteasome, apoptosis has been advocated as an important candidate in regulating denervation-induced muscle loss. The purpose of this article is to review the role and signaling mechanisms of apoptosis during denervation in skeletal muscle including myofibers and satellite cells.
C1 [Siu, Parco M.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
   [Alway, Stephen E.] W Virginia Univ, Sch Med, Div Exercise Physiol, Morgantown, WV 26506 USA.
C3 Hong Kong Polytechnic University; West Virginia University
RP Siu, PM (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
EM htpsiu@inet.polyu.edu.hk
RI Alway, Stephen/AAF-8834-2020
OI Alway, Stephen/0000-0002-0378-4707; Siu, Parco/0000-0002-3548-5058
FU National Institute on Aging Grant [R01 AG-021530]; The Hong Kong
   Polytechnic University ICRG funds
FX The authors apologize to the researchers whose scientific contributions
   were not included in this article due to the space constraint. During
   the written process of the present article, the research work of SE
   Alway was supported by National Institute on Aging Grant R01 AG-021530
   and PM Siu was supported by The Hong Kong Polytechnic University ICRG
   funds.
CR Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018
   Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2
   Adams GR, 2006, APPL PHYSIOL NUTR ME, V31, P782, DOI [10.1139/H06-053, 10.1139/h06-053]
   Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Adhihetty PJ, 2005, AM J PHYSIOL-CELL PH, V289, pC994, DOI 10.1152/ajpcell.00031.2005
   Agustí AGN, 2002, AM J RESP CRIT CARE, V166, P485, DOI 10.1164/rccm.2108013
   Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8
   Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579
   Almendro V, 2003, EUR CYTOKINE NETW, V14, P256
   Alway SE, 2003, J GERONTOL A-BIOL, V58, P687
   ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102
   Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271
   ASAYAMA K, 1986, J NEUROCHEM, V46, P604, DOI 10.1111/j.1471-4159.1986.tb13010.x
   Astrakas LG, 2005, FASEB J, V19, P1431, DOI 10.1096/fj.04-2005com
   Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173
   Basañez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492
   Blink E, 2004, CELL DEATH DIFFER, V11, P937, DOI 10.1038/sj.cdd.4401409
   Borisov AB, 2000, ANAT RECORD, V258, P305
   Broccolini A, 1999, NEUROREPORT, V10, P1637, DOI 10.1097/00001756-199906030-00003
   Candé C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210
   Candé C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3
   Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821
   Chargé SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827
   DAWSON BA, 1988, DEV BIOL, V127, P362, DOI 10.1016/0012-1606(88)90322-3
   Rodrigues ADC, 2006, MICROSURG, V26, P396, DOI 10.1002/micr.20258
   Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Deveraux QL, 1999, J CLIN IMMUNOL, V19, P388, DOI 10.1023/A:1020502800208
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Duke RC, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican1296-80
   Dupont-Versteegden EE, 2005, EXP GERONTOL, V40, P473, DOI 10.1016/j.exger.2005.04.003
   Dupont-Versteegden EE, 2006, WORLD J GASTROENTERO, V12, P7463, DOI 10.3748/wjg.v12.i46.7463
   Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   Edelblum KL, 2006, INFLAMM BOWEL DIS, V12, P413, DOI 10.1097/01.MIB.0000217334.30689.3e
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663
   ER E, 2007, J BIOL CHEM
   Fernández-Solà J, 2003, HUM PATHOL, V34, P1247, DOI 10.1016/j.humpath.2003.07.017
   FIDZIANSKA A, 1991, ACTA NEUROPATHOL, V81, P572, DOI 10.1007/BF00310140
   FIDZIANSKA A, 1990, BRAIN, V113, P433, DOI 10.1093/brain/113.2.433
   Fidzianska A, 2002, FOLIA NEUROPATHOL, V40, P27
   Filippatos GS, 2003, INT J CARDIOL, V90, P107, DOI 10.1016/S0167-5273(02)00535-1
   Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45
   GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2
   Golding JP, 2007, EXP CELL RES, V313, P341, DOI 10.1016/j.yexcr.2006.10.019
   Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Grütter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9
   Gustafsson ÅB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200
   HALL PA, 1994, J CELL SCI, V107, P3569
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Heslop L, 2000, J CELL SCI, V113, P2299
   Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668
   Hughes SM, 1998, CURR BIOL, V8, pR892, DOI 10.1016/S0960-9822(07)00554-4
   Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003
   Ikezoe K, 2002, ACTA NEUROPATHOL, V103, P531, DOI 10.1007/s00401-001-0502-8
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004
   Ishiko O, 2001, ANTICANCER RES, V21, P2363
   Ishiko O, 2001, INT J MOL MED, V8, P279
   Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457
   Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027
   JEJURIKAR SS, 2006, EXP GERONTOL
   Jin HM, 2001, J TRAUMA, V50, P31, DOI 10.1097/00005373-200101000-00005
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510
   Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Korsmeyer SJ, 1999, CANCER RES, V59, p1693S
   KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1
   KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R
   Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156
   Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005
   Krajnak K, 2006, MUSCLE NERVE, V34, P720, DOI 10.1002/mus.20656
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kusner LL, 1996, BRAIN RES, V730, P238
   Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1
   Lawler JM, 2003, FREE RADICAL BIO MED, V35, P9, DOI 10.1016/S0891-5849(03)00186-2
   Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   Lefebvre S, 1998, HUM MOL GENET, V7, P1531, DOI 10.1093/hmg/7.10.1531
   LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3
   Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1
   Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620
   Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2
   Lu DX, 1997, ANAT REC, V248, P355
   Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   Menasché P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5
   Migheli A, 1997, NEUROGENETICS, V1, P81, DOI 10.1007/s100480050012
   Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200
   Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200
   Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003
   Miró O, 2005, AIDS RES HUM RETROV, V21, P702, DOI 10.1089/aid.2005.21.702
   Mitch WE, 2006, J RENAL NUTR, V16, P208, DOI 10.1053/j.jrn.2006.04.014
   Mukasa T, 1999, BIOCHEM BIOPH RES CO, V260, P139, DOI 10.1006/bbrc.1999.0829
   Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887
   Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681
   Negroni E, 2006, PATHOL BIOL, V54, P100, DOI 10.1016/j.patbio.2005.09.001
   Olivé M, 2000, MUSCLE NERVE, V23, P1862, DOI 10.1002/1097-4598(200012)23:12<1862::AID-MUS10>3.0.CO;2-Q
   Olivé M, 2004, MUSCLE NERVE, V29, P261, DOI 10.1002/mus.10550
   Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245
   Pistilli EE, 2007, AM J PHYSIOL-CELL PH, V292, pC1298, DOI 10.1152/ajpcell.00496.2006
   Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867
   Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X
   Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x
   RODRIGUES AD, 1995, ANAT RECORD, V243, P430
   ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sandri M, 1998, LAB INVEST, V78, P1005
   Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1
   SANDRI M, 1995, FEBS LETT, V373, P291, DOI 10.1016/0014-5793(95)00908-R
   Schmalbruch H, 1996, J NEUROPATH EXP NEUR, V55, P310, DOI 10.1097/00005072-199603000-00006
   Schoser BGH, 2001, MUSCLE NERVE, V24, P1083, DOI 10.1002/mus.1114
   SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904
   SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980
   Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016
   Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3
   Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804
   Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399
   Siu PM, 2006, APOPTOSIS, V11, P967, DOI 10.1007/s10495-006-6315-4
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC1058, DOI 10.1152/ajpcell.00495.2004
   Siu PM, 2005, AM J PHYSIOL-REG I, V289, pR1015, DOI 10.1152/ajpregu.00198.2005
   Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004
   Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105
   STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463
   Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359
   Stockholm D, 2001, AM J PHYSIOL-CELL PH, V280, pC1561, DOI 10.1152/ajpcell.2001.280.6.C1561
   Strassburg S, 2005, INT J BIOCHEM CELL B, V37, P1938, DOI 10.1016/j.biocel.2005.03.013
   SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0
   Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053
   Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343
   Tang H, 2000, MOL CELL NEUROSCI, V16, P127, DOI 10.1006/mcne.2000.0864
   Tews DS, 1997, ACTA NEUROL SCAND, V96, P380
   Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x
   Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   Tews DS, 2005, MUSCLE NERVE, V31, P175, DOI 10.1002/mus.20253
   Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P150, DOI 10.1097/00005072-199702000-00005
   Tews DS, 1996, NEUROMUSCULAR DISORD, V6, P265, DOI 10.1016/0960-8966(96)00018-1
   Tews DS, 2002, NEUROMUSCULAR DISORD, V12, P613, DOI 10.1016/S0960-8966(02)00030-5
   Tews DS, 2001, MICROSC RES TECHNIQ, V55, P181, DOI 10.1002/jemt.1169
   Tews DS, 1997, J NEUROPATH EXP NEUR, V56, P1283, DOI 10.1097/00005072-199712000-00003
   Tews DS, 1997, NEUROPATH APPL NEURO, V23, P141
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Trachtenberg JT, 1998, DEV BIOL, V196, P193, DOI 10.1006/dbio.1998.8871
   Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777
   Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780
   Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017
   Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de
   Vescovo G, 2000, HEART, V84, P431, DOI 10.1136/heart.84.4.431
   Viguie CA, 1997, ANAT REC, V248, P346
   VOYTIK SL, 1993, DEV DYNAM, V198, P214, DOI 10.1002/aja.1001980307
   Walters EH, 2000, J MUSCLE RES CELL M, V21, P647, DOI 10.1023/A:1005683825960
   Webb J N, 1971, J Pathol, V104, pv
   WEBB JN, 1972, J PATHOL, V106, P221, DOI 10.1002/path.1711060403
   WEBB JN, 1977, J PATHOL, V123, P175, DOI 10.1002/path.1711230307
   WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G
   Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281
   WOOD KA, 1993, NEURON, V11, P621, DOI 10.1016/0896-6273(93)90074-2
   Yamada H, 2000, J NEUROL SCI, V173, P97, DOI 10.1016/S0022-510X(99)00306-8
   Yasuhara S, 1999, J BURN CARE REHABIL, V20, P462, DOI 10.1097/00004630-199920060-00007
   Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836
   YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0
   Yoshimura K, 1999, J SURG RES, V81, P139, DOI 10.1006/jsre.1998.5504
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   YUAN JY, 1995, CURR OPIN CELL BIOL, V7, P211, DOI 10.1016/0955-0674(95)80030-1
   Yuan JY, 1996, J CELL BIOCHEM, V60, P4, DOI 10.1002/(SICI)1097-4644(19960101)60:1<4::AID-JCB2>3.0.CO;2-1
   Yuan JY, 1997, CURR OPIN CELL BIOL, V9, P247, DOI 10.1016/S0955-0674(97)80069-5
   Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440
NR 202
TC 46
Z9 54
U1 0
U2 20
PU BIOSCIENCE RESEARCH INST-BRI
PI SINGAPORE
PA 7 TEMZASEK BLVD, SUNTEC TOWER ONE, SINGAPORE, SINGAPORE
SN 2768-6701
EI 2768-6698
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2009
VL 14
BP 432
EP 452
DI 10.2741/3253
PG 21
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 393DZ
UT WOS:000262352400026
PM 19273076
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Cheng, G
   Merriam, AP
   Gong, B
   Leahy, P
   Khanna, S
   Porter, JD
AF Cheng, G
   Merriam, AP
   Gong, B
   Leahy, P
   Khanna, S
   Porter, JD
TI Conserved and muscle-group-specific gene expression patterns shape
   postnatal development of the novel extraocular muscle phenotype
SO PHYSIOLOGICAL GENOMICS
LA English
DT Article
DE skeletal muscle; hindlimb; microarray; allotype
ID AVIAN CRANIOFACIAL MUSCLES; DEFICIENT MDX MICE; SKELETAL-MUSCLE; FIBER
   TYPES; MYOSIN EXPRESSION; NEUROMUSCULAR-JUNCTION; CALCIUM HOMEOSTASIS;
   MUSCULAR-DYSTROPHY; MITOCHONDRIAL-DNA; BINDING PROTEIN
AB Current models in skeletal muscle biology do not fully account for the breadth, causes, and consequences of phenotypic variation among skeletal muscle groups. The muscle allotype concept arose to explain frank differences between limb, masticatory, and extraocular (EOM) muscles, but there is little understanding of the developmental regulation of the skeletal muscle phenotypic range. Here, we used morphological and DNA microarray analyses to generate a comprehensive temporal profile for rat EOM development. Based upon coordinate regulation of morphologic/gene expression traits with key events in visual, vestibular, and oculomotor system development, we propose a model that the EOM phenotype is a consequence of extrinsic factors that are unique to its local environment and sensory-motor control system, acting upon a novel myoblast lineage. We identified a broad spectrum of differences between the postnatal transcriptional patterns of EOM and limb muscle allotypes, including numerous transcripts not traditionally associated with muscle fiber/group differences. Several transcription factors were differentially regulated and may be responsible for signaling muscle allotype specificity. Significant differences in cellular energetic mechanisms defined the EOM and limb allotypes. The allotypes were divergent in many other functional transcript classes that remain to be further explored. Taken together, we suggest that the EOM allotype is the consequence of tissue-specific mechanisms that direct expression of a limited number of EOM-specific transcripts and broader, incremental differences in transcripts that are conserved by the two allotypes. This represents an important first step in dissecting allotype-specific regulatory mechanisms that may, in turn, explain differential muscle group sensitivity to a variety of metabolic and neuromuscular diseases.
C1 Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Visual Sci Res Ctr, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Ctr Comprehens Canc, Cleveland, OH 44106 USA.
   Univ Hosp Cleveland, Cleveland, OH 44106 USA.
C3 University System of Ohio; Case Western Reserve University; University
   System of Ohio; Case Western Reserve University; University System of
   Ohio; Case Western Reserve University; University System of Ohio; Case
   Western Reserve University; University Hospitals of Cleveland
RP Case Western Reserve Univ, Dept Neurol, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM john.porter@case.edu
FU NCI NIH HHS [P30-CA-43703] Funding Source: Medline; NEI NIH HHS
   [R01-EY-12779, R01-EY-015306, P30-EY-11371, R01-EY-09834] Funding
   Source: Medline
CR Andrade FH, 2000, MICROSC RES TECHNIQ, V48, P192, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<192::AID-JEMT7>3.0.CO;2-J
   Andrade FH, 2003, J APPL PHYSIOL, V95, P692, DOI 10.1152/japplphysiol.00358.2003
   Briggs MM, 2000, J EXP BIOL, V203, P2485
   BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010
   Brueckner JK, 1998, J APPL PHYSIOL, V85, P584, DOI 10.1152/jappl.1998.85.2.584
   Brueckner JK, 1996, J MUSCLE RES CELL M, V17, P297
   Brueckner JK, 1999, CELL TISSUE RES, V295, P477, DOI 10.1007/s004410051253
   BURKE RE, 1971, SCIENCE, V174, P709, DOI 10.1126/science.174.4010.709
   Calvo S, 2001, MOL CELL BIOL, V21, P8490, DOI 10.1128/MCB.21.24.8490-8503.2001
   CELIO MR, 1982, NATURE, V297, P504, DOI 10.1038/297504a0
   Cheng G, 2003, INVEST OPHTH VIS SCI, V44, P3842, DOI 10.1167/iovs.03-0170
   Cheng G, 2002, INVEST OPHTH VIS SCI, V43, P1048
   COULY GF, 1992, DEVELOPMENT, V114, P1
   Degenhardt K, 2001, DEV BIOL, V231, P175, DOI 10.1006/dbio.2000.0131
   Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261
   Dietrich S, 1999, CELL TISSUE RES, V296, P175, DOI 10.1007/s004410051278
   Dietrich S, 1998, DEVELOPMENT, V125, P2235
   Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001
   Gage PJ, 1999, DEVELOPMENT, V126, P4643
   HANSON J, 1980, ACTA PHYSIOL SCAND, V108, P61, DOI 10.1111/j.1748-1716.1980.tb06500.x
   HAUNERLAND NH, 1994, COMP BIOCHEM PHYS B, V109, P199, DOI 10.1016/0305-0491(94)90003-5
   Hoefler G, 1997, BIOCHIMIE, V79, P163, DOI 10.1016/S0300-9084(97)81509-X
   HOH JFY, 1988, J MUSCLE RES CELL M, V9, P59
   HOH JFY, 1989, CELLULAR MOL BIOL MU, P15
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   JACOBY J, 1990, J MUSCLE RES CELL M, V11, P25, DOI 10.1007/BF01833323
   KADENBACH B, 1995, MUTAT RES-DNAGING G, V338, P161, DOI 10.1016/0921-8734(95)00021-W
   Kaminski HJ, 1996, INVEST OPHTH VIS SCI, V37, P345
   Kaminski HJ, 2003, ANN NY ACAD SCI, V998, P362, DOI 10.1196/annals.1254.043
   KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418
   KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407
   KELLY AM, 1978, DEV BIOL, V65, P1, DOI 10.1016/0012-1606(78)90174-4
   KELLY AM, 1969, J CELL BIOL, V42, P135, DOI 10.1083/jcb.42.1.135
   Khanna S, 2003, FASEB J, V17, P1370, DOI 10.1096/fj.02-1108fje
   Khanna S, 2003, INVEST OPHTH VIS SCI, V44, P1918, DOI 10.1167/iovs.02-0890
   KHANNA S, IN PRESS INVEST OPHT
   KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467
   Kitamura K, 1999, DEVELOPMENT, V126, P5749
   Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273
   LUFF AR, 1971, J CELL BIOL, V51, P369, DOI 10.1083/jcb.51.2.369
   Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892
   MASCARELLO F, 1992, ANAT EMBRYOL, V185, P143
   McLoon LK, 1996, INVEST OPHTH VIS SCI, V37, P318
   Mitchell PO, 2002, CLIN ORTHOP RELAT R, pS197, DOI 10.1097/01.blo.0000031981.92980.01
   Mootoosamy RC, 2002, DEVELOPMENT, V129, P573
   MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127
   NAG AC, 1982, J EMBRYOL EXP MORPH, V71, P171
   Noden DM, 1999, DEV DYNAM, V216, P96, DOI 10.1002/(SICI)1097-0177(199910)216:2<96::AID-DVDY2>3.3.CO;2-Y
   NODEN DM, 1986, DEV BIOL, V116, P347, DOI 10.1016/0012-1606(86)90138-7
   PATAPOUTIAN A, 1993, DEVELOPMENT, V118, P61
   PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013
   Porter JD, 1998, CELL TISSUE RES, V292, P495, DOI 10.1007/s004410051078
   Porter JD, 1999, BIOCHEM BIOPH RES CO, V257, P678, DOI 10.1006/bbrc.1999.0536
   Porter JD, 2001, NEUROMUSCULAR DISORD, V11, P197, DOI 10.1016/S0960-8966(00)00171-1
   Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298
   Porter JD, 2003, J EXP BIOL, V206, P3101, DOI 10.1242/jeb.00511
   PORTER JD, 1993, DEV BIOL, V160, P39, DOI 10.1006/dbio.1993.1284
   PORTER JD, 1992, INVEST OPHTH VIS SCI, V33, P657
   PORTER JD, 1993, ACTA ANAT, V147, P197
   Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje
   Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197
   Porter JD, 1998, J CELL SCI, V111, P1801
   PORTER JD, 1995, SURV OPHTHALMOL, V39, P451, DOI 10.1016/S0039-6257(05)80055-4
   Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263
   Porter JD, 1996, NEUROLOGY, V46, P30, DOI 10.1212/WNL.46.1.30
   PORTER JD, 2003, PERSPECTIVES GENE EX, P221
   Ragusa RJ, 1996, J NEUROL SCI, V139, P180
   Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399
   RUBINSTEIN NA, 1981, J CELL BIOL, V90, P128, DOI 10.1083/jcb.90.1.128
   RUSHBROOK JI, 1994, J MUSCLE RES CELL M, V15, P505, DOI 10.1007/BF00121157
   Schäfer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843
   Schiaffino S, 2002, TRENDS PHARMACOL SCI, V23, P569, DOI 10.1016/S0165-6147(02)02111-9
   Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x
   Spencer R F, 1988, Rev Oculomot Res, V2, P33
   Summerbell D, 2000, DEVELOPMENT, V127, P3745
   TERMIN A, 1989, HISTOCHEMISTRY, V92, P453, DOI 10.1007/BF00524756
   TRAINOR PA, 1995, DEVELOPMENT, V121, P2569
   TSUZUKI S, 1995, NEUROSCI RES, V23, P389, DOI 10.1016/0168-0102(95)00966-W
   Tzahor E, 2003, GENE DEV, V17, P3087, DOI 10.1101/gad.1154103
   WIECZOREK DF, 1985, J CELL BIOL, V101, P618, DOI 10.1083/jcb.101.2.618
NR 81
TC 28
Z9 29
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1094-8341
EI 1531-2267
J9 PHYSIOL GENOMICS
JI Physiol. Genomics
PD JUL 8
PY 2004
VL 18
IS 2
BP 184
EP 195
DI 10.1152/physiolgenomics.00222.2003
PG 12
WC Cell Biology; Genetics & Heredity; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity; Physiology
GA 841LQ
UT WOS:000222931700005
PM 15138310
DA 2024-11-01
ER

PT J
AU Kim, HC
   Zhang, Y
   King, PH
   Lu, L
AF Kim, Han-Cheon
   Zhang, Yan
   King, Peter H. H.
   Lu, Liang
TI MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via
   SQSTM1/p62 in amyotrophic lateral sclerosis
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE aggregation; amyotrophic lateral sclerosis (ALS); microRNAs;
   neurotoxicity; SQSTM1; p62; TAR DNA-binding protein 43 (TDP-43)
ID NONCODING RNAS; TDP-43; AGGREGATION; MECHANISM; BIOLOGY; DISEASE;
   MIRNAS; P62
AB Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that selectively attacks motor neurons, and leads to progressive muscle weakness and death. A common pathological feature is the misfolding, aggregation, and cytoplasmic mislocalization of TAR DNA-binding protein 43 (TDP-43) proteins in more than 95% of ALS patients, suggesting a universal role TDP-43 proteinopathy in ALS. Mutations in SQSTM1/p62 have been identified in familial and sporadic cases of ALS. MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate their target genes. Emerging evidence indicates that miRNA dysregulation is associated with neuronal toxicity and mitochondrial dysfunction, and also plays a pivotal role in ALS pathogenesis. Here, we report the first evidence that miR-183-5p is aberrantly upregulated in spinal cords of patients with ALS. Using luciferase reporter assays and miR-183-5p agomirs, we demonstrate that miR-183-5p regulates the SQSTM1/p62 3 & PRIME;-untranslated region to suppress expression. A miR-183-5p agomir attenuated SOSTM1/p62 expression and led to an increase in TDP-43 protein levels in neuronal and non-neuronal cells. In contrast, a miR-183-5p antagomir decreased TDP-43 but increased SQSTM1/p62 protein levels. The antagomir repressed formation of stress granules and aggregated TDP43 protein in neuronal cells under stress-induced conditions and protected against cytotoxicity. Knockdown of SQSTM1/p62 decreased total ubiquitination and increased TDP-43 protein aggregation, indicating that SQSTM1/p62 may play a protective role in cells. In summary, our study reveals a novel mechanism of TDP-43 proteinopathy mediated by the miR-183-5p and provides a molecular link between aberrant RNA processing and protein degradation, two major pillars in ALS pathogenesis.
C1 [Kim, Han-Cheon; Zhang, Yan; Lu, Liang] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.
   [Kim, Han-Cheon; Zhang, Yan; Lu, Liang] Michael E DeBakey VA Med Ctr, Dept Neurol, Houston, TX USA.
   [King, Peter H. H.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA.
   [King, Peter H. H.] Birmingham VA Med Ctr, Birmingham, AL USA.
C3 Baylor College of Medicine; Baylor College of Medicine; University of
   Alabama System; University of Alabama Birmingham; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs
   Medical Center - Birmingham
RP Kim, HC; Lu, L (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.
EM hancheon.kim@bcm.edu; liang.lu@bcm.edu
OI Lu, Liang/0000-0002-1276-2358; Kim, Han-Cheon/0000-0002-1960-5048
FU National Institute of Health (NIH)/Veterans Affairs (VA)
   [5I01BX003035-03, I01BX004419, R01NS092651, R21NS111275]; MEDVAMC Bridge
   and Seed Award Program the Michael E. DeBakey VA Medical Center
FX We are thankful to Dr. Wilfried Rossoll for sharing the mCherry
   C-terminal fragment of TDP-43 (mCherry TDP-43 CTF). This study was
   supported by National Institute of Health (NIH)/Veterans Affairs (VA)
   5I01BX003035-03 (L.L.), I01BX004419 (PHK), R01NS092651 (PHK),
   R21NS111275 (PHK), and MEDVAMC Bridge and Seed Award Program the Michael
   E. DeBakey VA Medical Center (L.L.). We are grateful to our ALS patients
   who donated their tissues postmortem in a desire to help others by
   advancing ALS research.
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6
   Brady OA, 2011, J NEUROCHEM, V116, P248, DOI 10.1111/j.1471-4159.2010.07098.x
   Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Chen ML, 2021, THERANOSTICS, V11, P2395, DOI 10.7150/thno.47408
   Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Cohen TJ, 2011, TRENDS MOL MED, V17, P659, DOI 10.1016/j.molmed.2011.06.004
   Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029
   de Boer EMJ, 2021, J NEUROL NEUROSUR PS, V92, P86, DOI 10.1136/jnnp-2020-322983
   De Felice B, 2012, GENE, V508, P35, DOI 10.1016/j.gene.2012.07.058
   Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074
   Foster AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90822-2
   Gregory JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031899
   Gupta R, 2021, CELL MOL LIFE SCI, V78, P8001, DOI 10.1007/s00018-021-04004-4
   Hadano S, 2016, HUM MOL GENET, V25, P3321, DOI 10.1093/hmg/ddw180
   Kaur P, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/870150
   Kosik KS, 2018, ANNU REV NEUROSCI, V41, P119, DOI 10.1146/annurev-neuro-080317-061822
   Lin XL, 2013, DNA CELL BIOL, V32, P220, DOI 10.1089/dna.2012.1915
   Lin YC, 2017, ASIAN J SURG, V40, P396, DOI 10.1016/j.asjsur.2016.07.001
   Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z
   Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Pham J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103464
   Prasad A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00025
   Rajgor Dipen, 2018, Noncoding RNA Res, V3, P154, DOI 10.1016/j.ncrna.2018.07.001
   Ravnik-Glavac M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051714
   Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543
   Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246
   Russell AP, 2013, NEUROBIOL DIS, V49, P107, DOI 10.1016/j.nbd.2012.08.015
   Saucier D, 2019, BRAIN RES, V1708, P100, DOI 10.1016/j.brainres.2018.12.016
   Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748
   Soliman AM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00038
   Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184
   Tal TL, 2012, NEUROTOXICOLOGY, V33, P530, DOI 10.1016/j.neuro.2012.02.013
   Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0
   Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001
   Wang XJ, 2013, J MOL CELL CARDIOL, V55, P73, DOI 10.1016/j.yjmcc.2012.09.012
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3
   Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200
   Zhang T, 2011, HUM MOL GENET, V20, P1952, DOI 10.1093/hmg/ddr076
NR 43
TC 3
Z9 3
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD MAR
PY 2023
VL 164
IS 5
BP 643
EP 657
DI 10.1111/jnc.15744
EA JAN 2023
PG 15
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 9U5VG
UT WOS:000920538700001
PM 36527420
DA 2024-11-01
ER

PT J
AU Huang, CC
   Lin, TJ
   Chen, CC
   Lin, WT
AF Huang, Chi-Chang
   Lin, Tien-Jen
   Chen, Chun-Chieh
   Lin, Wan-Teng
TI Endurance training accelerates exhaustive exercise-induced mitochondrial
   DNA deletion and apoptosis of left ventricle myocardium in rats
SO EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE Endurance training; Exhaustive exercise; Left ventricular; Mitochondrial
   DNA deletion; Apotosis
ID SKELETAL-MUSCLE; MYELOPEROXIDASE ACTIVITIES; MATRIX METALLOPROTEINASES;
   CARDIAC-HYPERTROPHY; XANTHINE-OXIDASE; COPY NUMBER; L-ARGININE; STRESS;
   HEAT-SHOCK-PROTEIN-70; TISSUES
AB Even though exhaustive exercise-induced oxidative stress increases the risk of tissue damage, regular endurance training is widely assumed to improve cardiac function and protects against heart disease. We tested the hypothesis that an endurance training program prevents exhaustive exercise-induced increases in cardiac dysfunction and apoptosis in left ventricle (LV). Thirty-two male Sprague-Dawley rats were randomly divided into four groups: sedentary control (C), trained (T), exhaustively exercised (E), and trained plus exhaustively exercised (TE). Rats in T and TE groups ran on a motorized treadmill for 12 weeks. Rats in groups E and TE performed an exhaustive running test on a treadmill. The main effects of training were indicated by increased running time to exhaustion (80 +/- A 5 and 151 +/- A 13 min for groups E and TE, respectively, P = 0.0001), myocardial hypertrophy (0.38% and 0.47% for untrained and trained rats, respectively, P = 0.0002), decreased LV ejection fraction (88% and 71% for untrained and trained rats, respectively, P < 0.0001), accelerated mitochondrial DNA 4834-bp large deletion (mtDNA(4834) deletion), and up-regulated protein levels of heat shock protein-70, cytochrome C, cleaved capsase-3, and cleaved PARP in LV following a bout of exhaustive exercise. Contrary to our hypothesis, these results suggest that endurance training induced significant impairment of regional systolic and diastolic LV myocardial function and ejection fraction in rats. Our findings show that endurance training accelerates exhaustive exercise-induced mtDNA(4834) deletion and apoptosis in the LV.
C1 [Lin, Wan-Teng] Tunghai Univ, Coll Agr, Dept Hosp Management, Taichung 40704, Taiwan.
   [Huang, Chi-Chang; Chen, Chun-Chieh] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 11529, Taiwan.
   [Lin, Tien-Jen] Municipal Fang Hosp, Div Neurosurg, Dept Surg, Taipei 11031, Taiwan.
   [Lin, Tien-Jen] Taipei Med Univ, Grad Inst Injury Prevent, Taipei 11031, Taiwan.
C3 Tunghai University; Academia Sinica - Taiwan; Taipei Medical University
RP Lin, WT (corresponding author), Tunghai Univ, Coll Agr, Dept Hosp Management, 181,Sec 3,Taichung Port Rd, Taichung 40704, Taiwan.
EM 040770@thu.edu.tw
RI Wu, Jia-Ping/E-3513-2013; Huang, Chi-Chang/A-3280-2013
OI Huang, Chi-Chang/0000-0003-1446-6787; Lin, Wan-Teng/0000-0001-7700-3398
FU National Science Council of Taiwan [NSC-96-2413-H-029-003,
   NSC-972-410-H029-037-MY2]
FX This study was supported by the National Science Council of Taiwan
   (NSC-96-2413-H-029-003 and NSC-972-410-H029-037-MY2). We thank Drs.
   Ming-Dar Tsa (Department of Neurological Surgery, Shin Kong Wu Ho-Su
   Memorial Hospital) and Shiow-Chwen Tsai (Taipei Physical Education
   College) for their technical support.
CR Antunes-Neto JMF, 2006, STRESS, V9, P107, DOI 10.1080/10253890600772211
   BEDFORD TG, 1979, J APPL PHYSIOL, V47, P1278, DOI 10.1152/jappl.1979.47.6.1278
   Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501
   Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3
   Callejas NA, 2001, HEPATOLOGY, V33, P860, DOI 10.1053/jhep.2001.23002
   Chou YF, 2007, J NUTR, V137, P2036, DOI 10.1093/jn/137.9.2036
   Clarkson PM, 2000, AM J CLIN NUTR, V72, p637S, DOI 10.1093/ajcn/72.2.637S
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Demirel HA, 2003, AM J PHYSIOL-HEART C, V285, pH1609, DOI 10.1152/ajpheart.00982.2002
   FrankiewiczJozko A, 1996, EUR J APPL PHYSIOL, V74, P470
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Hamilton KL, 2003, FREE RADICAL BIO MED, V34, P800, DOI 10.1016/S0891-5849(02)01431-4
   Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002
   Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031
   Kavazis AN, 2008, AM J PHYSIOL-HEART C, V294, pH928, DOI 10.1152/ajpheart.01231.2007
   Kim SH, 1997, MOL CELLS, V7, P726
   Le Page C, 2009, EXP GERONTOL, V44, P177, DOI 10.1016/j.exger.2008.10.003
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lee SD, 2008, J APPL PHYSIOL, V104, P1144, DOI 10.1152/japplphysiol.00152.2007
   Lee YI, 2006, EUR J APPL PHYSIOL, V97, P216, DOI 10.1007/s00421-006-0161-5
   Lin WT, 2006, BRIT J NUTR, V95, P67, DOI 10.1079/BJN20051602
   Linnane AW, 1998, ANN NY ACAD SCI, V854, P202, DOI 10.1111/j.1749-6632.1998.tb09903.x
   Liu CC, 2005, BRIT J NUTR, V94, P595, DOI 10.1079/BJN20051541
   Mansouri A, 1997, GASTROENTEROLOGY, V113, P599, DOI 10.1053/gast.1997.v113.pm9247482
   Marini M, 2007, EUR J APPL PHYSIOL, V99, P503, DOI 10.1007/s00421-006-0369-4
   Mikami T, 2004, J APPL PHYSIOL, V96, P1776, DOI 10.1152/japplphysiol.00795.2002
   Mooren FC, 2002, J APPL PHYSIOL, V93, P147, DOI 10.1152/japplphysiol.01262.2001
   Pagenstecher A, 2000, AM J PATHOL, V157, P197, DOI 10.1016/S0002-9440(10)64531-2
   Powers SK, 2004, ANN NY ACAD SCI, V1019, P462, DOI 10.1196/annals.1297.084
   Powers SK, 2001, MED SCI SPORT EXER, V33, P386, DOI 10.1097/00005768-200103000-00009
   Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839
   Roldán V, 2008, AM HEART J, V156, P85, DOI 10.1016/j.ahj.2008.01.035
   Rullman E, 2009, J APPL PHYSIOL, V106, P804, DOI 10.1152/japplphysiol.90872.2008
   Sakai Y, 1999, MUSCLE NERVE, V22, P258, DOI 10.1002/(SICI)1097-4598(199902)22:2<258::AID-MUS15>3.0.CO;2-1
   Shyur LF, 2008, PHYTOCHEMISTRY, V69, P1348, DOI 10.1016/j.phytochem.2008.01.017
   Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje
   Smolka MB, 2000, AM J PHYSIOL-REG I, V279, pR1539, DOI 10.1152/ajpregu.2000.279.5.R1539
   Tanimura Y, 2008, MED SCI SPORT EXER, V40, P1455, DOI 10.1249/MSS.0b013e31817242cf
   Taylor RP, 1999, AM J PHYSIOL-HEART C, V276, pH1098, DOI 10.1152/ajpheart.1999.276.3.H1098
   Thorp DB, 2007, AM J PHYSIOL-REG I, V293, pR363, DOI 10.1152/ajpregu.00363.2006
   Tsai K, 2001, FREE RADICAL BIO MED, V31, P1465, DOI 10.1016/S0891-5849(01)00729-8
   Tupling AR, 2008, APPL PHYSIOL NUTR ME, V33, P1023, DOI 10.1139/H08-067
   Wang S, 2008, EUR J APPL PHYSIOL, V104, P549, DOI 10.1007/s00421-008-0803-x
   Watson PA, 2007, AM J PHYSIOL-HEART C, V293, pH246, DOI 10.1152/ajpheart.00734.2006
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
NR 45
TC 44
Z9 55
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1439-6319
EI 1439-6327
J9 EUR J APPL PHYSIOL
JI Eur. J. Appl. Physiol.
PD DEC
PY 2009
VL 107
IS 6
BP 697
EP 706
DI 10.1007/s00421-009-1177-4
PG 10
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 519KB
UT WOS:000271764100008
PM 19730878
DA 2024-11-01
ER

PT J
AU Liu, MC
   Yu, ST
   Wang, JW
   Qiao, JH
   Liu, Y
   Wang, SM
   Zhao, Y
AF Liu, Meichen
   Yu, Shiting
   Wang, Jiawen
   Qiao, Juhui
   Liu, Ying
   Wang, Siming
   Zhao, Yu
TI Ginseng protein protects against mitochondrial dysfunction and
   neurodegeneration by inducing mitochondrial unfolded protein response in
   <i>Drosophila melanogaster</i> PINK1 model of Parkinson's disease
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Parkinson's disease; Drosophila melanogaster; Ginseng protein;
   Mitochondria; Oxidative stress
ID DEGENERATION; MUTATIONS; PATHWAY
AB Ethnopharmacological relevance: Historical literature and pharmacological studies demonstrate that ginseng, one of the most popular herbal medicines in China, holds potential benefits for Parkinson's disease (PD).
   Aim of the study: Studies in Drosophila melanogaster (Dm) have highlighted mitochondria] dysfunction upon loss of PTEN-induced putative kinase 1 (PINK1) as a central mechanism of PD pathogenesis. Using PINK1(B9) mutant Dm, we aimed to explore the therapeutic action of ginseng total protein (GTP) on PD and provide in-depth scientific interpretation about the traditional efficacy of ginseng.
   Materials and methods: We first used gel chromatography to purify GTP and confirmed its molecular weight by SDS-PAGE. Effects of GTP on PINK1(B9) mutants, which were supplied with standard diet from larvae to adult stages, were assayed in flies aged 3-6 (I), 10-15 (II), and 20-25 (III) days. Parkinson-like phenotypes were analyzed by evaluating lifespan, dopaminergic neurons, dopamine levels, and locomotor ability. Mitochondrial function was assessed by evaluating ATP production, respirometry, and mitochondrial DNA. In addition, reactive oxygen species were measured using dihydroethidium and 2',7'-dichlorodihydrofluorescein diacetate staining. PD-related oxidative stress was simulated by paraquat and rotenone, and mitochondrial membrane potential was measured using JC-10 reagent. Protein and mRNA expression was detected by Western blot and real-time quantitative reverse transcription polymerase chain reaction, respectively.
   Results: This study demonstrates for the first time that GTP treatment delays the onset of a Parkinson-like phenotype in PINK1(B9) Dm, including prolongation of lifespan and rescue of climbing ability, as well as rescue of the progressive loss of a cluster of dopaminergic neurons in the protocerebral posterior lateral 1 region, which was accompanied by a significant increase of dopamine content in the brain. In addition, GTP notably reduced the penetrance of abnormal wing position, indicating a strong inhibitory effect on indirect flight muscle degeneration. We further showed that GTP could promote maintenance of mitochondrial function and protect mitochondria from PD-associated oxidative stress by activating the mitochondrial unfolded protein response (UPRmt).
   Conclusions: GTP protected against mitochondrial dysfunction and neurodegeneration by inducing UPRmt in the Dm PINK1(B9) model of PD. Our results suggest that GTP is a promising candidate for PD, and reveal a new mechanism by which ginseng is neuroprotective.
C1 [Liu, Meichen; Yu, Shiting; Wang, Jiawen; Qiao, Juhui; Liu, Ying; Wang, Siming; Zhao, Yu] Changchun Univ Chinese Med, Jilin Ginseng Acad, Changchun 130117, Jilin, Peoples R China.
C3 Changchun University of Chinese Medicine
RP Wang, SM; Zhao, Y (corresponding author), Changchun Univ Chinese Med, Jilin Ginseng Acad, Changchun 130117, Jilin, Peoples R China.
EM liumc0367@163.com; 18843196008@163.com; wangjiawen1229@163.com;
   3022336742@qq.com; 2362943206@qq.com; lwsm126030@126.com;
   cnzhaoyu1972@126.com
FU Edanz Group China; National Natural Foundation of China [81703663];
   National Key Research and Development Program of China [2017YFC1702104]
FX We thank Edanz Group China (www.liwenbianji.cn/ac), for editing the
   English text of a draft of this manuscript. This work was supported by
   grants from the National Natural Foundation of China (81703663); and the
   National Key Research and Development Program of China (2017YFC1702104).
CR Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Basil AH, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00241
   Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003
   Brooks David J, 2008, Neuropsychiatr Dis Treat, V4, P39
   Chen Liang-Wei, 2007, CNS & Neurological Disorders-Drug Targets, V6, P273
   Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779
   Cooper JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16637-2
   de Castro IP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.394
   de Castro P, 2012, CELL DEATH DIFFER, V19, P1308, DOI 10.1038/cdd.2012.5
   Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03
   González-Burgos E, 2015, J NEUROIMMUNE PHARM, V10, P14, DOI 10.1007/s11481-014-9569-6
   Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11
   Lehmann S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.72
   Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020
   Liu ZY, 2008, GEN COMP ENDOCR, V156, P164, DOI 10.1016/j.ygcen.2008.01.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu BW, 2009, ANNU REV PATHOL-MECH, V4, P315, DOI 10.1146/annurev.pathol.3.121806.151529
   Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560
   Ong WY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00129
   Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788
   Rascol O, 2011, MOVEMENT DISORD, V26, P1072, DOI 10.1002/mds.23714
   Straka I, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010962
   Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284
   Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256
   Wang Y, 2019, CNS NEUROSCI THER, V25, P816, DOI 10.1111/cns.13116
   Whitworth AJ, 2005, P NATL ACAD SCI USA, V102, P8024, DOI 10.1073/pnas.0501078102
   Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802
   Wu ZH, 2018, EXP GERONTOL, V113, P10, DOI 10.1016/j.exger.2018.09.014
   Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103
   Yang YF, 2009, J NEUROPATH EXP NEUR, V68, P953, DOI 10.1097/NEN.0b013e3181b2048c
NR 30
TC 54
Z9 59
U1 2
U2 98
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD JAN 30
PY 2020
VL 247
AR 112213
DI 10.1016/j.jep.2019.112213
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA JO0BT
UT WOS:000497253400005
PM 31562951
DA 2024-11-01
ER

PT B
AU Babusikova, E
   Jesenak, M
AF Babusikova, Eva
   Jesenak, Milos
BE Svensson, OL
TI MITOCHONDRIA AND AGEING: DO MITOCHONDRIA PLAY A (KEY) ROLE?
SO MITOCHONDRIA: STRUCTURE, FUNCTIONS AND DYSFUNCTIONS
SE Cell Biology Research Progress
LA English
DT Article; Book Chapter
ID NITRIC-OXIDE-SYNTHASE; FREE-RADICAL THEORY; HYDROGEN-PEROXIDE
   PRODUCTION; MEMBRANE-LIPID-PEROXIDATION; OXIDATIVE STRESS;
   ALZHEIMERS-DISEASE; PROTEIN OXIDATION; DNA DELETIONS; SKELETAL-MUSCLE;
   DEGENERATIVE DISEASES
AB Ageing is a fascinating topic that engaged philosophers and scientists for centuries. Nevertheless, it is very difficult to define precisely the term "ageing". There is no simple definition, which would be universally accepted. Ageing is inevitable, a complex biological process which can be characterized as a progressive deterioration of physiological functions and metabolic processes after the reproductive phase of life. In the process of ageing is the gradual accumulation of changes with time, which are connected or responsible for the ever-increasing susceptibility to disease and death with increasing age. One of theory which tries to explain senescence is free radical theory of ageing or oxidative damage theory of ageing. There is an increase level of reactive oxygen species and sequential accumulation of oxidative damage of biomolecules during ageing. This damage may by the most important contribution to ageing and ageing-related diseases. All organisms live in an environment containing reactive oxygen species and mitochondrial respiratory chain which generate reactive species. Mitochondrial theory of ageing, a hypothesis of free radical theory of ageing, suggests that accumulation of mitochondrial oxidative damage leads to human and animal ageing because mitochondria are the main source and target of reactive oxygen species. There is increasing evidence that bioenergetic function of mitochondria and mitochondrial antioxidant pool decrease with advancing of age in several tissues. Literature is full of controversy results. Oxidative modification of proteins, saccharides, nucleic acid (nuclear and mitochondria!) and lipid peroxidation were observed in different tissues, cells, compartments, including mitochondria with advancing of age. On the other hand also no significant changes in level of oxidative damage products were observed during ageing. We observed different kind of mitochondrial oxidative changes in the brain and in the heart during ageing. Our understanding of the role played by reactive oxygen species and by mitochondria in disease pathology and ageing is still insufficient. Little is known about mechanisms responsible for the deleterious changes seen during both normal ageing and diseases. Mitochondrial changes, oxidative damages in mitochondria with advancing age and mitochondrial dysfunction in cardiovascular and neurodegenerative diseases will be discussed in this chapter.
C1 [Babusikova, Eva] Comenius Univ, Dept Med Biochem, Jessenius Fac Med Martin, Martin 03601, Slovakia.
   [Jesenak, Milos] Comenius Univ, Dept Paediat, Jessenius Fac Med Martin, Martin 03601, Slovakia.
C3 Comenius University Bratislava; Comenius University Bratislava
RP Babusikova, E (corresponding author), Comenius Univ, Dept Med Biochem, Jessenius Fac Med Martin, Mala Flora 4, Martin 03601, Slovakia.
EM babusikova@jfmed.uniba.sk
RI Jesenak, Milos/X-8360-2018
CR Agarwal S, 1995, MECH AGEING DEV, V85, P55, DOI 10.1016/0047-6374(95)01655-4
   Agarwal S, 1996, EXP GERONTOL, V31, P365, DOI 10.1016/0531-5565(95)02039-X
   AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   Alonso AD, 2008, CURR ALZHEIMER RES, V5, P375, DOI 10.2174/156720508785132307
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ATAKA K, 1992, CIRCULATION, V86, P371
   Babusikova E, 2008, GEN PHYSIOL BIOPHYS, V27, P115
   Babusikova E, 2007, NEUROCHEM RES, V32, P1351, DOI 10.1007/s11064-007-9314-0
   Babusíková E, 2004, GEN PHYSIOL BIOPHYS, V23, P327
   Babusíková E, 2008, PHYSIOL RES, V57, pS49, DOI 10.33549/physiolres.931551
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839
   Bauer V, 1994, Bratisl Lek Listy, V95, P243
   Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624
   BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BERGENDI L, 1999, BIOCHEM BIOPH RES CO, V186, P782
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   BURDON RH, 1989, FREE RADICAL RES COM, V6, P345, DOI 10.3109/10715768909087918
   Byrne E, 2002, J CLIN NEUROSCI, V9, P497, DOI 10.1054/jocn.2001.0991
   Çakatay U, 2001, EXP GERONTOL, V36, P221, DOI 10.1016/S0531-5565(00)00197-2
   Cash AD, 2002, NEUROSCIENTIST, V8, P489, DOI 10.1177/107385802236968
   Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002
   CHEN JJ, 1995, FREE RADICAL BIO MED, V19, P583, DOI 10.1016/0891-5849(95)00066-7
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   Choksi KB, 2004, BBA-MOL BASIS DIS, V1688, P95, DOI 10.1016/j.bbadis.2003.11.007
   CITRON M, 1940, P NATL ACAD SCI USA, V93, P13170
   COMMONER B, 1954, NATURE, V174, P689, DOI 10.1038/174689a0
   David H, 1981, Exp Pathol Suppl (1981), V7, P1
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9895
   Davies SMK, 2001, FREE RADICAL BIO MED, V31, P181, DOI 10.1016/S0891-5849(01)00576-7
   DAVIS LJ, 1993, MECH AGEING DEV, V72, P155, DOI 10.1016/0047-6374(93)90097-B
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302
   Dean RT, 1997, BIOCHEM J, V324, P1
   deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211
   DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567
   Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002
   Dhalla NS, 1999, CAN J CARDIOL, V15, P587
   DiMauro S, 2002, MUSCLE NERVE, V26, P597, DOI 10.1002/mus.10194
   DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302
   DREW B, 2002, ANN NY ACAD SCI, V659, P66
   Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497
   DUPUY C, 1991, J BIOL CHEM, V266, P3739
   DUTHIE GG, 1991, AM J CLIN NUTR, V53, pS1061, DOI 10.1093/ajcn/53.4.1061S
   ERMINI M, 1976, GERONTOLOGY, V22, P301, DOI 10.1159/000212145
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FOLKOW B, 1993, PHYSIOL REV, V73, P725, DOI 10.1152/physrev.1993.73.4.725
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Fu S., 1998, MOL BIOL FREE RADICA, P29
   Fukagawa NK, 2000, ANTIOXID REDOX SIGN, V2, P379, DOI 10.1089/15230860050192152
   Fukagawa NK, 1999, P SOC EXP BIOL MED, V222, P293, DOI 10.1046/j.1525-1373.1999.d01-146.x
   Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877
   Gerbitz KD, 1996, DIABETES, V45, P113, DOI 10.2337/diabetes.45.2.113
   Girotti AW, 1998, J LIPID RES, V39, P1529
   GIULIVI C, 1994, METHOD ENZYMOL, V233, P363
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Good PF, 1998, J NEUROPATH EXP NEUR, V57, P338, DOI 10.1097/00005072-199804000-00006
   GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913
   HALLIWELL B, 1989, FREE RADICAL RES COM, V5, P315, DOI 10.3109/10715768909073413
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   Halliwell B., 1999, FREE RADICAL BIOL ME
   Hanafy K A, 2001, Med Sci Monit, V7, P801
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111
   HAYAKAWA M, 1992, BIOCHEM BIOPH RES CO, V189, P979, DOI 10.1016/0006-291X(92)92300-M
   Hayashi H, 1998, EUR J PHARMACOL, V349, P133, DOI 10.1016/S0014-2999(98)00266-0
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270
   Hernanz A, 2000, LIFE SCI, V67, P1317, DOI 10.1016/S0024-3205(00)00722-0
   HIRSCH EC, 1993, EUR NEUROL, V33, P52, DOI 10.1159/000118538
   Humphries KM, 1998, BIOCHEMISTRY-US, V37, P552, DOI 10.1021/bi971958i
   James T N, 1994, Trans Am Clin Climatol Assoc, V105, P145
   Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483
   Jourd'heuil D, 2001, J BIOL CHEM, V276, P28799, DOI 10.1074/jbc.M102341200
   KANUNGO MS, 1975, J THEOR BIOL, V53, P253, DOI 10.1016/S0022-5193(75)80002-6
   Kaplan P, 2007, MOL CELL BIOCHEM, V301, P219, DOI 10.1007/s11010-007-9414-9
   Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616
   KAUL N, 1993, J PHARMACOL TOX MET, V30, P55, DOI 10.1016/1056-8719(93)90008-3
   Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200
   Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1
   Kelley EE, 1999, ARCH BIOCHEM BIOPHYS, V370, P97, DOI 10.1006/abbi.1999.1386
   KING PA, 1992, J AM CHEM SOC, V114, P5430, DOI 10.1021/ja00039a068
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   KOSHLAND DE, 1992, SCIENCE, V258, P1861, DOI 10.1126/science.1470903
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kröncke KD, 2001, FASEB J, V15, P2503, DOI 10.1096/fj.01-0240hyp
   KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q
   Kumaran S, 2004, CHEM-BIOL INTERACT, V148, P11, DOI 10.1016/j.cbi.2003.10.010
   LAGANIERE S, 1993, GERONTOLOGY, V39, P7, DOI 10.1159/000213509
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LAKATTA EG, 1990, EUR HEART J, V11, P22, DOI 10.1093/eurheartj/11.suppl_C.22
   Lakatta EG, 1999, J AM GERIATR SOC, V47, P613, DOI 10.1111/j.1532-5415.1999.tb02579.x
   Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419
   Lamperti C, 2009, Acta Myol, V28, P2
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172
   Lee HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P309, DOI 10.1006/abbi.1998.1036
   Lee HC, 2009, INT J MOL SCI, V10, P674, DOI 10.3390/ijms10020674
   Lee J, 1999, FREE RADICAL BIO MED, V26, P260, DOI 10.1016/S0891-5849(98)00195-6
   LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488
   Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   LESNEFSKY EJ, 1991, CIRC RES, V68, P605, DOI 10.1161/01.RES.68.2.605
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu CY, 2009, J FORMOS MED ASSOC, V108, P599, DOI 10.1016/S0929-6646(09)60380-6
   Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510
   Lucas DT, 1999, P NATL ACAD SCI USA, V96, P6689, DOI 10.1073/pnas.96.12.6689
   LUCKING CB, 1995, BIOCHEM BIOPH RES CO, V211, P700, DOI 10.1006/bbrc.1995.1868
   LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731
   Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004
   Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   Müller-Strahl G, 2000, J PHYSIOL-LONDON, V522, P311, DOI 10.1111/j.1469-7793.2000.00311.x
   NATHAN C, 1994, J BIOL CHEM, V269, P13725
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   Oldfors A, 2003, J NEUROPATH EXP NEUR, V62, P217, DOI 10.1093/jnen/62.3.217
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x
   Perry G, 2002, COMP BIOCHEM PHYS C, V133, P507, DOI 10.1016/S1532-0456(02)00119-9
   Phillips JP, 2000, EXP GERONTOL, V35, P1157, DOI 10.1016/S0531-5565(00)00117-0
   Pignatelli B, 2001, CANCER RES, V61, P778
   PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x
   Pollack ML., 1999, Handbook of Oxidants and Antioxidants in Exercise
   Probst A, 1991, BRAIN PATHOL, V1, P229, DOI 10.1111/j.1750-3639.1991.tb00666.x
   RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7
   RADI R, 1991, J BIOL CHEM, V266, P4244
   Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x
   Reddy PH, 2005, BRAIN RES REV, V49, P618, DOI 10.1016/j.brainresrev.2005.03.004
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   RICHTER C, 1995, INT J BIOCHEM CELL B, V27, P647, DOI 10.1016/1357-2725(95)00025-K
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Robert M, 2007, NEUROL INDIA, V55, P11, DOI 10.4103/0028-3886.30420
   SACHS HG, 1977, AM J ANAT, V150, P63, DOI 10.1002/aja.1001500105
   Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   Sastre J, 2000, IUBMB LIFE, V49, P427
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHECTMAN G, 1991, AM J CLIN NUTR, V53, P1466, DOI 10.1093/ajcn/53.6.1466
   Schon Eric A., 1998, Biofactors, V7, P191
   Schöneich C, 1999, EXP GERONTOL, V34, P19, DOI 10.1016/S0531-5565(98)00066-7
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Semsei I, 2000, MECH AGEING DEV, V117, P93, DOI 10.1016/S0047-6374(00)00147-0
   Shacter E, 2000, METHOD ENZYMOL, V319, P428
   SHOFFNER JM, 1994, ANNU REV NUTR, V14, P535, DOI 10.1146/annurev.nu.14.070194.002535
   Shoffner JM, 2001, SEMIN NEUROL, V21, P237, DOI 10.1055/s-2001-17941
   Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9
   Singal PK, 1998, CARDIOVASC RES, V40, P426, DOI 10.1016/S0008-6363(98)00244-2
   SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540
   Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002
   Smith MA, 1998, J HISTOCHEM CYTOCHEM, V46, P731, DOI 10.1177/002215549804600605
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   Sohal RS, 1997, FASEB J, V11, P1269, DOI 10.1096/fasebj.11.14.9409545
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   Sohal RS, 1995, LIFE SCI R, V56, P109
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r
   STEIN G, 1948, NATURE, V161, P650, DOI 10.1038/161650a0
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045
   Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008
   TATE EL, 1976, J GERONTOL, V31, P129, DOI 10.1093/geronj/31.2.129
   Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044
   Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1
   Valdez Laura B., 2004, Molecular Aspects of Medicine, V25, P49, DOI 10.1016/j.mam.2004.02.008
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004
   WALLACE DC, 1995, BBA-MOL BASIS DIS, V1271, P141, DOI 10.1016/0925-4439(95)00021-U
   Wei Y H, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P259
   Wei YH, 1996, ANN NY ACAD SCI, V786, P24, DOI 10.1111/j.1749-6632.1996.tb39049.x
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6
   Wink DA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P802
   WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813
   Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yang ZW, 1997, BIOSCIENCE REP, V17, P557, DOI 10.1023/A:1027316424985
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
   Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x
   Yu BP, 1996, ANN NY ACAD SCI, V786, P44, DOI 10.1111/j.1749-6632.1996.tb39050.x
NR 207
TC 0
Z9 0
U1 0
U2 6
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
BN 978-1-61668-346-7
J9 CELL BIO RES PROG
PY 2010
BP 377
EP 410
PG 34
WC Cell Biology
WE Book Citation Index – Science (BKCI-S)
SC Cell Biology
GA BTG89
UT WOS:000286916800007
DA 2024-11-01
ER

PT J
AU Mori, D
   Matsui, I
   Shimomura, A
   Hashimoto, N
   Matsumoto, A
   Shimada, K
   Yamaguchi, S
   Oka, T
   Kubota, K
   Yonemoto, S
   Sakaguchi, Y
   Takahashi, A
   Shintani, Y
   Takashima, S
   Takabatake, Y
   Hamano, T
   Isaka, Y
AF Mori, Daisuke
   Matsui, Isao
   Shimomura, Akihiro
   Hashimoto, Nobuhiro
   Matsumoto, Ayumi
   Shimada, Karin
   Yamaguchi, Satoshi
   Oka, Tatsufumi
   Kubota, Keiichi
   Yonemoto, Sayoko
   Sakaguchi, Yusuke
   Takahashi, Atsushi
   Shintani, Yasunori
   Takashima, Seiji
   Takabatake, Yoshitsugu
   Hamano, Takayuki
   Isaka, Yoshitaka
TI Protein carbamylation exacerbates vascular calcification
SO KIDNEY INTERNATIONAL
LA English
DT Article
DE oxidative stress; urea; vascular calcification
ID OXIDATIVE STRESS; INORGANIC PYROPHOSPHATE; KIDNEY-DISEASE;
   HEART-FAILURE; NARP MUTATION; ATP SYNTHASE; MINERALIZATION; RISK; UREA;
   NEPHROCALCINOSIS
AB Protein carbamylation is a posttranslational modification that can occur non-enzymatically in the presence of high concentrations of urea. Although carbamylation is recognized as a prognostic biomarker, the contribution of protein carbamylation to organ dysfunction remains uncertain. Because vascular calcification is common under carbamylation-prone situations, we investigated the effects of carbamylation on this pathologic condition. Protein carbamylation exacerbated the calcification of human vascular smooth muscle cells (hVSMCs) by suppressing the expression of ectonucleotide pyrophosphate/phosphodiesterase 1 (ENPP1), a key enzyme in the generation of pyrophosphate, which is a potent inhibitor of ectopic calcification. Several mitochondrial proteins were carbamylated, although ENPP1 itself was not identified as a carbamylated protein. Rather, protein carbamylation reduced mitochondrial membrane potential and exaggerated mitochondria-derived oxidative stress, which down-regulated ENPP1. The effects of carbamylation on ectopic calcification were abolished in hVSMCs by ENPP1 knockdown, in mitochondrial-DNA-depleted hVSMCs, and in hVSMCs treated with a mitochondria-targeted superoxide scavenger. We also evaluated the carbamylation effects using ex vivo and in vivo models. The tunica media of a patient with end-stage renal disease was carbamylated. Thus, our findings have uncovered a previously unrecognized aspect of uremia-related vascular pathology.
C1 [Mori, Daisuke; Matsui, Isao; Hashimoto, Nobuhiro; Matsumoto, Ayumi; Shimada, Karin; Yamaguchi, Satoshi; Oka, Tatsufumi; Kubota, Keiichi; Yonemoto, Sayoko; Takahashi, Atsushi; Takabatake, Yoshitsugu; Isaka, Yoshitaka] Osaka Univ, Grad Sch Med, Dept Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
   [Shimomura, Akihiro] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.
   [Sakaguchi, Yusuke; Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Suita, Osaka 5650871, Japan.
   [Shintani, Yasunori; Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan.
C3 Osaka University; University of California System; University of
   California Irvine; Osaka University; Osaka University
RP Matsui, I (corresponding author), Osaka Univ, Grad Sch Med, Dept Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM matsui@kid.med.osaka-u.ac.jp
RI Hamano, TAKAYUKI/AAZ-4837-2021; Oka, Tatsufumi/ACR-8336-2022
OI Matsui, Isao/0000-0001-8378-6130; Shintani, Yasunori/0000-0001-9579-0727
FU Japan Society for the Promotion of Science KAKENHI grant [JP15K19454];
   Osaka Kidney Foundation; Kidney Foundation Japan; Takeda Research
   Support; Novartis Research Support
FX We thank Naoko Horimoto for technical assistance, and we are also
   grateful to the Center of Medical Research and Education, Osaka
   University Graduate School of Medicine, for technical support. This
   research was supported by Japan Society for the Promotion of Science
   KAKENHI grant JP15K19454 (to SA) and grants from the Osaka Kidney
   Foundation (to SA), the Kidney Foundation Japan (to IM), Takeda Research
   Support (to IM), and Novartis Research Support (to IM).
CR Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200
   Baracca A, 2000, J BIOL CHEM, V275, P4177, DOI 10.1074/jbc.275.6.4177
   Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218
   Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516
   Cannata-Andia JB, 2011, NEPHROL DIAL TRANSPL, V26, P3429, DOI 10.1093/ndt/gfr591
   Chernoivanenko IS, 2015, FASEB J, V29, P820, DOI 10.1096/fj.14-259903
   Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   FLEISCH H, 1966, NATURE, V212, P901, DOI 10.1038/212901a0
   García JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075
   Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221
   Gorissea L, 2016, P NATL ACAD SCI USA, V113, P1191, DOI 10.1073/pnas.1517096113
   Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7
   Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485
   Hernández D, 2005, KIDNEY INT, V67, P2015, DOI 10.1111/j.1523-1755.2005.00303.x
   Hirose J, 2002, ARTHRITIS RHEUM-US, V46, P3218, DOI 10.1002/art.10632
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W
   Inoue K, 2012, LAB INVEST, V92, P1686, DOI 10.1038/labinvest.2012.107
   Jaisson S, 2011, CLIN CHEM, V57, P1499, DOI 10.1373/clinchem.2011.163188
   Kalim S, 2014, AM J KIDNEY DIS, V64, P793, DOI 10.1053/j.ajkd.2014.04.034
   Kempf H, 2011, J BONE MINER RES, V26, P1543
   Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254
   Leening MJG, 2012, JACC-CARDIOVASC IMAG, V5, P874, DOI 10.1016/j.jcmg.2012.03.016
   Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313
   Li QL, 2014, LAB INVEST, V94, P623, DOI 10.1038/labinvest.2014.52
   Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694
   LOTZ M, 1995, P NATL ACAD SCI USA, V92, P10364, DOI 10.1073/pnas.92.22.10364
   Matsui I, 2013, AM J PHYSIOL-RENAL, V304, pF751, DOI 10.1152/ajprenal.00329.2012
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4
   MOSS DW, 1967, BIOCHEM J, V102, P53, DOI 10.1042/bj1020053
   Mrácek T, 2006, EXP GERONTOL, V41, P683, DOI 10.1016/j.exger.2006.02.009
   Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205
   Namba T, 2014, J AM SOC NEPHROL, V25, P2254, DOI 10.1681/ASN.2013090986
   Nilsson L, 1996, CLIN CHEM, V42, P482
   O'Neill WC, 2011, KIDNEY INT, V79, P512, DOI 10.1038/ki.2010.461
   Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956
   Olmez U, 1994, Osteoarthritis Cartilage, V2, P149, DOI 10.1016/S1063-4584(05)80065-2
   Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001
   Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841
   Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X
   Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221
   Schultz BE, 2001, ANNU REV BIOPH BIOM, V30, P23, DOI 10.1146/annurev.biophys.30.1.23
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Shimokado A, 2014, EXP MOL PATHOL, V97, P458, DOI 10.1016/j.yexmp.2014.10.005
   Shimomura A, 2014, J AM SOC NEPHROL, V25, P1954, DOI 10.1681/ASN.2013090967
   Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111
   STARK GR, 1960, J BIOL CHEM, V235, P3177
   Verbrugge FH, 2015, KIDNEY INT, V88, P474, DOI 10.1038/ki.2015.166
   VERONESE FM, 1972, J BIOL CHEM, V247, P754
   Walsh CR, 2002, AM HEART J, V144, P733, DOI 10.1067/mhj.2002.124404
   Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637
   Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529
   Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101
   Zhang Z, 1999, AM J PHYSIOL-RENAL, V276, pF786, DOI 10.1152/ajprenal.1999.276.5.F786
NR 56
TC 49
Z9 52
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0085-2538
EI 1523-1755
J9 KIDNEY INT
JI Kidney Int.
PD JUL
PY 2018
VL 94
IS 1
BP 72
EP 90
DI 10.1016/j.kint.2018.01.033
PG 19
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA GL9MY
UT WOS:000437660400012
PM 29716796
OA Bronze
DA 2024-11-01
ER

PT J
AU Wu, G
   Shen, YG
   Zhu, F
   Tao, WW
   Zhou, YL
   Ke, SF
   Jiang, HH
AF Wu, Gang
   Shen, Yuguang
   Zhu, Feng
   Tao, Weiwei
   Zhou, Yuanlin
   Ke, Shaofa
   Jiang, Huihua
TI Comprehensive Diagnostic Criteria for MELAS Syndrome; a Case Study
   Involving an Elderly Patient With MT-TWm.5541C&gt;T Mutation
SO NEUROLOGIST
LA English
DT Article
DE MELAS; recurrent stroke; MRI; lactate; MT-TW mutation
ID STROKE-LIKE EPISODES; MITOCHONDRIAL ENCEPHALOMYOPATHY; LACTIC-ACIDOSIS
AB Introduction:The mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a matrilineal hereditary multisystem disease caused by mutations in the mitochondrial DNA. Although the initial diagnostic criteria correlate with a range of clinical phenotypes, including clinical onset after the age of 40, there is still lack of a unified single diagnostic standard for MELAS. Case Report:A 71-year-old female patient with recurrent stroke was reported. Magnetic resonance imaging showed a cerebral gyrus-like diffusion weighted imaging high signal lesion in the parietal-occipital lobe and the area of this lesion expanded with disease progression. The MRS result showed significantly inverted Lac/Lip peaks. The nucleic acid sequencing result displayed a MT-TWm.5541C>T mutation, and a 12.86% mutation rate in the blood sample. The patient had a 6-year history of type 2 diabetes. Conclusion:Patients with the MELAS syndrome may present with a variety of clinical manifestations. Our data demonstrated that, for patients with atypical cerebral infarction and suspected MELAS syndrome, gene sequencing and muscle biopsy should be performed in time. This case provides a reference for the diagnostic criteria of MELAS syndrome.
C1 [Wu, Gang; Shen, Yuguang; Zhu, Feng; Tao, Weiwei; Zhou, Yuanlin; Ke, Shaofa; Jiang, Huihua] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Neurol, Linhai, Zhejiang, Peoples R China.
   [Wu, Gang] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Dept Pharm, Linhai, Zhejiang, Peoples R China.
   [Jiang, Huihua] Taizhou Hosp Zhejiang Prov, Taizhou, Zhejiang, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University
RP Jiang, HH (corresponding author), Taizhou Hosp Zhejiang Prov, Taizhou, Zhejiang, Peoples R China.
EM wug5937@enzemed.com; shenyg@enzemed.com; zhufeng@enzemed.com;
   taoww1594@enzemed.com; zyl@enzemed.com; kesf@enzemed.com;
   jianghh@enzemed.com
CR Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358
   Dickerson BC, 2005, NEW ENGL J MED, V353, P2271, DOI 10.1056/NEJMcpc059032
   Dimauro S, 2004, ANN NY ACAD SCI, V1011, P217, DOI 10.1196/annals.1293.022
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fang GL, 2018, CLIN INTERV AGING, V13, P2421, DOI 10.2147/CIA.S186636
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0227-x
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Ikeda T, 2018, HUM GENOME VAR, V5, DOI 10.1038/s41439-018-0026-6
   Ji KQ, 2022, J MED GENET, V59, P79, DOI 10.1136/jmedgenet-2020-107323
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Li WW, 2015, INT J CLIN EXP PATHO, V8, P7022
   Malhotra K, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0583-7
   Scaglia F, 2018, PEDIATR CLIN N AM
   Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616
   Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575
   Yatsuga S, 2012, BBA-GEN SUBJECTS, V1820, P619, DOI 10.1016/j.bbagen.2011.03.015
NR 16
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1074-7931
EI 2331-2637
J9 NEUROLOGIST
JI Neurologist
PD MAY
PY 2023
VL 28
IS 3
BP 190
EP 194
DI 10.1097/NRL.0000000000000457
PG 5
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA F3YW5
UT WOS:000981746000011
PM 36125978
OA hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Bullock, G
   Johnson, GS
   Mhlanga-Mutangadura, T
   Petesch, SC
   Thompson, S
   Goebbels, S
   Katz, ML
AF Bullock, Garrett
   Johnson, Gary S.
   Mhlanga-Mutangadura, Tendai
   Petesch, Scott C.
   Thompson, Samantha
   Goebbels, Sandra
   Katz, Martin L.
TI Lysosomal storage disease associated with a CNP sequence variant in
   Dalmatian dogs
SO GENE
LA English
DT Article
ID 2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; NEURONAL
   CEROID-LIPOFUSCINOSIS; MITOCHONDRIAL ATP SYNTHASE; ENZYME REPLACEMENT
   THERAPY; SUBUNIT-C; CARDIAC TELOCYTES; MEMBRANE ANCHOR; DEFICIENCY;
   GENE; MUTATION
AB A progressive neurological disorder was identified in purebred Dalmatian dogs. The disease is characterized by anxiety, pacing and circling, hypersensitivity, cognitive decline, sleep disturbance, loss of coordination, loss of control over urination and defecation, and visual impairment. Neurological signs first became apparent when the dogs were approximately 18 months of age and progressed slowly. Two affected littermates were euthanized at approximately 7 years, 5 months and 8 years, 2 months of age due to the severity of neurological impairment. The mother of the affected dogs and four other relatives exhibited milder, later-onset neurological signs. Pronounced accumulations of autofluorescent intracellular inclusions were found in cerebral cortex, cerebellum, optic nerve, and cardiac muscle of the affected dogs. These inclusions co-localized with immunolabeling of the lysosomal marker protein LAMP2 and bound antibodies to mitochondrial ATPase subunit c, indicating that the dogs suffered from a lysosomal storage disease with similarities to the neuronal ceroid lipofuscinoses. Ultrastructural analysis indicated that the storage bodies were surrounded by a single-layer membrane, but the storage granules were distinct from those reported for other lysosomal storage diseases. Whole genome sequences, generated with DNA from the two euthanized Dalmatians, both contained a rare, homozygous single-base deletion and reading-frame shift in CNP which encodes the enzyme CNPase (EC 3.1.4.37). The late-onset disease was exhibited by five of seven related Dalmatians that were heterozygous for the deletion allele and over 8 years of age, whereas none of 16 age-matched reference-allele homozygotes developed neurologic signs. No CNPase antigen could be detected with immunohistochemical labeling in tissues from the dogs with the earlier-onset disorder. Similar to the later-onset Dalmatians, autofluorescent storage granules were apparent in brain and cardiac tissue from transgenic mice that were nullizygous for Cnp. Based on the clinical signs, the histopathological, immu-nohistochemical, ultrastructural, and molecular-genetic findings, and the finding that nullizygous Cnp mice accumulate autofluorescent storage granules, we propose that the earlier-onset Dalmatian disorder is a novel lysosomal storage disease that results from a loss-of-function mutation in CNP and that shares features char-acteristic of the neuronal ceroid lipofuscinoses. That the later-onset disorder occurred only in dogs heterozygous for the CNP deletion variant suggests that this disorder is a result of the variant allele's presence.
C1 [Bullock, Garrett; Johnson, Gary S.; Mhlanga-Mutangadura, Tendai] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA.
   [Petesch, Scott C.] Univ Penn, Sch Vet Med, Philadelphia, PA USA.
   [Thompson, Samantha] Pocono Peak Vet Ctr, Stroudsburg, PA USA.
   [Goebbels, Sandra] Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.
   [Katz, Martin L.] Univ Missouri, Neurodegenerat Dis Res Lab, Sch Med, Columbia, MO USA.
C3 University of Missouri System; University of Missouri Columbia;
   University of Pennsylvania; Max Planck Society; University of Missouri
   System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Neurodegenerat Dis Res Lab, Sch Med, Columbia, MO USA.
EM katzm@health.missouri.edu
OI Bullock, Garrett/0000-0002-9231-8758
FU American Kennel Club Canine Health Foundation [02604]
FX Acknowledgements Our thanks to the dog owners who provided phenotypic
   information and tissue and DNA samples from their dogs. Our thanks to
   Dr. Lixing Reneker for providing us with some of the mouse tissue
   samples. Technical and logistical assistance provided by Liz Hansen and
   Cheryl Jensen played important roles in these studies. Funding for this
   work was provided by the American Kennel Club Canine Health Foundation
   Grant No. 02604 and the Patton Trust/BioNexus KC.
CR Abitbol M, 2010, P NATL ACAD SCI USA, V107, P14775, DOI 10.1073/pnas.0914206107
   Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915
   Al-Abdi L, 2020, HUM GENET, V139, P615, DOI 10.1007/s00439-020-02144-4
   Anitei M, 2012, NAT CELL BIOL, V14, P11, DOI 10.1038/ncb2409
   Awano T, 2006, MOL GENET METAB, V87, P341, DOI 10.1016/j.ymgme.2005.11.005
   Azarashvili T, 2009, AM J PHYSIOL-CELL PH, V296, pC1428, DOI 10.1152/ajpcell.00006.2009
   Beck-Wödl S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0646-6
   Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799
   BRAUN PE, 1991, J NEUROSCI RES, V30, P540, DOI 10.1002/jnr.490300311
   Butz ES, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165571
   Cannon DM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.82
   Cao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017118
   Che RL, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-31
   COOPER A, 1988, J INHERIT METAB DIS, V11, P17, DOI 10.1007/BF01800054
   Damme M, 2011, J NEUROPATH EXP NEUR, V70, P83, DOI 10.1097/NEN.0b013e31820428fa
   DeAngelis DA, 1996, J NEUROCHEM, V67, P943
   DWORZAK F, 1994, NEUROMUSCULAR DISORD, V4, P243, DOI 10.1016/0960-8966(94)90025-6
   Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893
   El Haddad S, 2012, ELECTROPHORESIS, V33, P3798, DOI 10.1002/elps.201200472
   Esposito C, 2008, BIOCHEMISTRY-US, V47, P308, DOI 10.1021/bi701474t
   EVANS A, 1992, EXP BRAIN RES, V91, P79
   Farias FHG, 2011, NEUROBIOL DIS, V42, P468, DOI 10.1016/j.nbd.2011.02.009
   Gherghiceanu M, 2012, CELL TISSUE RES, V348, P265, DOI 10.1007/s00441-012-1333-8
   Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939
   Gupta P, 2003, P NATL ACAD SCI USA, V100, P12325, DOI 10.1073/pnas.2033229100
   Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230
   HOSAIN S, 1995, AM J MED GENET, V57, P239, DOI 10.1002/ajmg.1320570226
   Iwamoto K, 2008, PSYCHIAT CLIN NEUROS, V62, P103, DOI 10.1111/j.1440-1819.2007.01786.x
   Janova H, 2018, J CLIN INVEST, V128, P734, DOI 10.1172/JCI97032
   JONES MZ, 1981, J BIOL CHEM, V256, P5185
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   KATZ ML, 1995, BIOCHEM J, V310, P887, DOI 10.1042/bj3100887
   KATZ ML, 1982, EXP EYE RES, V34, P339, DOI 10.1016/0014-4835(82)90082-3
   Kolicheski A, 2017, J VET INTERN MED, V31, P1520, DOI 10.1111/jvim.14794
   KOMINAMI E, 1992, J BIOCHEM, V111, P278, DOI 10.1093/oxfordjournals.jbchem.a123749
   Kostin S, 2016, SEMIN CELL DEV BIOL, V55, P22, DOI 10.1016/j.semcdb.2016.02.023
   Kowalewski B, 2012, P NATL ACAD SCI USA, V109, P10310, DOI 10.1073/pnas.1202071109
   Kowalewski B, 2021, BIOCHEM J, V478, P3221, DOI 10.1042/BCJ20210415
   KURIHARA T, 1990, BIOCHEM BIOPH RES CO, V170, P1074, DOI 10.1016/0006-291X(90)90502-E
   Laezza C, 1997, FEBS LETT, V413, P260, DOI 10.1016/S0014-5793(97)00924-1
   Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095
   Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017
   Lee J, 2005, J CELL BIOL, V170, P661, DOI 10.1083/jcb.200411047
   LOWDEN JA, 1981, NEUROLOGY, V31, P719, DOI 10.1212/WNL.31.6.719
   Mitkus SN, 2008, SCHIZOPHR RES, V98, P129, DOI 10.1016/j.schres.2007.09.032
   Morgan BR, 2013, J NEUROSCI RES, V91, P1639, DOI 10.1002/jnr.23287
   Naseri N, 2021, CLIN GENET, V99, P111, DOI 10.1111/cge.13829
   OLDFORS A, 1981, ACTA NEUROPATHOL, V54, P287, DOI 10.1007/BF00697002
   Olga K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093217
   Pastores GM, 2013, NEUROL CLIN, V31, P1051, DOI 10.1016/j.ncl.2013.04.007
   Peirce TR, 2006, ARCH GEN PSYCHIAT, V63, P18, DOI 10.1001/archpsyc.63.1.18
   Platt FM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0025-4
   Poët M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103
   Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165
   ROWAN SA, 1995, AM J MED GENET, V57, P172, DOI 10.1002/ajmg.1320570213
   Siintola E, 2006, BRAIN, V129, P1438, DOI 10.1093/brain/awl107
   Smith KR, 2013, HUM MOL GENET, V22, P1417, DOI 10.1093/hmg/dds558
   Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021
   Snaidero N, 2017, CELL REP, V18, P314, DOI 10.1016/j.celrep.2016.12.053
   Stypmann J, 2002, P NATL ACAD SCI USA, V99, P6234, DOI 10.1073/pnas.092637699
   Tang CH, 2006, MOL CELL BIOL, V26, P2309, DOI 10.1128/MCB.26.6.2309-2316.2006
   Tang FL, 2007, NEUROSCI LETT, V416, P113, DOI 10.1016/j.neulet.2007.01.054
   Trabszo C, 2020, BIOCHEM J, V477, P3433, DOI 10.1042/BCJ20200546
   Tyynelä J, 2000, EMBO J, V19, P2786, DOI 10.1093/emboj/19.12.2786
   Usui H, 2006, SCHIZOPHR RES, V88, P245, DOI 10.1016/j.schres.2006.07.019
   Verrier JD, 2013, GLIA, V61, P1595, DOI 10.1002/glia.22523
   Vesa J., 2002, Current Molecular Medicine (Hilversum), V2, P439, DOI 10.2174/1566524023362311
   Villani NA, 2019, MOL GENET METAB, V127, P107, DOI 10.1016/j.ymgme.2019.04.003
   Vizovisek M, 2019, MATRIX BIOL, V75-76, P141, DOI 10.1016/j.matbio.2018.01.024
   Voineskos AN, 2008, PSYCHIAT GENET, V18, P143, DOI 10.1097/YPG.0b013e3282fa1874
   Wang RY, 2011, GENET MED, V13, P457, DOI 10.1097/GIM.0b013e318211a7e1
   WENGER DA, 1986, NEW ENGL J MED, V315, P1201, DOI 10.1056/NEJM198611063151906
   Whiting REH, 2020, EXP EYE RES, V197, DOI 10.1016/j.exer.2020.108130
   Whiting REH, 2014, EXP EYE RES, V125, P164, DOI 10.1016/j.exer.2014.06.008
   WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531
   WISNIEWSKI K, 1985, NEUROPEDIATRICS, V16, P98, DOI 10.1055/s-2008-1052551
   Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200
NR 77
TC 7
Z9 7
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUL 1
PY 2022
VL 830
AR 146513
DI 10.1016/j.gene.2022.146513
EA APR 2022
PG 17
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 1L1WE
UT WOS:000799082700001
PM 35447247
OA hybrid
DA 2024-11-01
ER

PT J
AU Tower, J
AF Tower, John
TI Programmed cell death in aging
SO AGEING RESEARCH REVIEWS
LA English
DT Review
DE Apoptosis; Necrosis; Aging; Sarcopenia; Mitochondria; Senescence
ID MITOCHONDRIAL-DNA MUTATIONS; CHRONOLOGICAL LIFE-SPAN; NUCLEAR
   SERINE-PROTEASE; SMOOTH-MUSCLE-CELLS; SACCHAROMYCES-CEREVISIAE;
   APOPTOSIS RESISTANCE; IMMUNE-SYSTEM; INCREASED SUSCEPTIBILITY;
   CAENORHABDITIS-ELEGANS; REDUCES SUSCEPTIBILITY
AB Programmed cell death (PCD) pathways, including apoptosis and regulated necrosis, are required for normal cell turnover and tissue homeostasis. Mis-regulation of PCD is increasingly implicated in aging and aging-related disease. During aging the cell turnover rate declines for several highly-mitotic tissues. Aging-associated disruptions in systemic and inter-cell signaling combined with cell-autonomous damage and mitochondrial malfunction result in increased PCD in some cell types, and decreased PCD in other cell types. Increased PCD during aging is implicated in immune system decline, skeletal muscle wasting (sarcopenia), loss of cells in the heart, and neurodegenerative disease. In contrast, cancer cells and senescent cells are resistant to PCD, enabling them to increase in abundance during aging. PCD pathways limit life span in fungi, but whether PCD pathways normally limit adult metazoan life span is not yet clear. PCD is regulated by a balance of negative and positive factors, including the mitochondria, which are particularly subject to aging-associated malfunction. (C) 2015 Elsevier B.V. All rights reserved.
C1 Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.
C3 University of Southern California
RP Tower, J (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, 1050 Childs Way,RRI 201, Los Angeles, CA 90089 USA.
EM jtower@usc.edu
FU Department of Health and Human Services [AG011833]; Southern California
   Environmental Health Sciences Center [5P30ES007048]
FX This work was supported by a grant from the Department of Health and
   Human Services (AG011833) and by pilot project funds from the Southern
   California Environmental Health Sciences Center (5P30ES007048).
CR Ahn SH, 2005, CELL CYCLE, V4, P780, DOI 10.4161/cc.4.6.1745
   Ahn SH, 2006, MOL CELL, V24, P211, DOI 10.1016/j.molcel.2006.09.008
   Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002
   Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884
   Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bernhardt D, 2014, CURR OPIN MICROBIOL, V22, P1, DOI 10.1016/j.mib.2014.09.007
   Bosserman L, 2012, CANCER RES, V72, P3901, DOI 10.1158/0008-5472.CAN-12-0681
   Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x
   Brust D, 2010, CURR GENET, V56, P225, DOI 10.1007/s00294-010-0295-1
   Büttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Büttner S, 2011, EMBO J, V30, P2779, DOI 10.1038/emboj.2011.197
   Burek MJ, 1996, BRAIN PATHOL, V6, P427, DOI 10.1111/j.1750-3639.1996.tb00874.x
   Camplejohn RS, 2003, BRIT J CANCER, V88, P487, DOI 10.1038/sj.bjc.6600767
   Carmona-Gutiérrez D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.43
   Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219
   Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P377, DOI 10.1038/cdd.2009.198
   Chihara T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004437
   Childs B. G., 2014, EMBO REP
   Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563
   Chou JP, 2013, CURR PHARM DESIGN, V19, P1680
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Degterev A, 2014, METHOD ENZYMOL, V545, P1, DOI 10.1016/B978-0-12-801430-1.00001-9
   Delaney JR, 2011, AGING CELL, V10, P1089, DOI 10.1111/j.1474-9726.2011.00742.x
   Delavallée L, 2011, IUBMB LIFE, V63, P221, DOI 10.1002/iub.432
   Denton D, 2013, BBA-MOL CELL RES, V1833, P3499, DOI 10.1016/j.bbamcr.2013.06.014
   Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095
   Eckhart L, 2013, BBA-MOL CELL RES, V1833, P3471, DOI 10.1016/j.bbamcr.2013.06.010
   EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321
   Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7
   Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fahrenkrog B, 2011, BIOCHEM SOC T, V39, P1499, DOI 10.1042/BST0391499
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849
   FUKAGAWA NK, 1990, AM J PHYSIOL, V259, pE233, DOI 10.1152/ajpendo.1990.259.2.E233
   Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137
   Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96
   Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007
   Garigan D, 2002, GENETICS, V161, P1101
   Gelino Sara, 2012, J Clin Exp Pathol, VSuppl 4
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Giannaris EL, 2012, J COMP NEUROL, V520, P3492, DOI 10.1002/cne.23101
   Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110
   Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010
   Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986
   Günther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364
   Gumienny TL, 1999, DEVELOPMENT, V126, P1011
   Gupta S, 2005, IMMUNOL REV, V205, P114, DOI 10.1111/j.0105-2896.2005.00261.x
   Gupta S., 2006, IMMUN AGEING, VI & A 3, P5
   Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794
   Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Hernández-Martínez R, 2011, DEV GROWTH DIFFER, V53, P245, DOI 10.1111/j.1440-169X.2010.01246.x
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Hiebert PR, 2012, TRENDS MOL MED, V18, P732, DOI 10.1016/j.molmed.2012.09.009
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Hill S. M., 2015, BIOESSAYS
   Hroudová J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062
   Hua Y., 2015, AGING CELL
   Hur JH, 2014, J BIOENERG BIOMEMBR, V46, P329, DOI 10.1007/s10863-014-9553-0
   Jazwinski SM, 2014, PROG MOL BIOL TRANSL, V127, P133, DOI 10.1016/B978-0-12-394625-6.00005-2
   Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014
   Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122
   Kavathia N, 2009, AGING-US, V1, P652, DOI 10.18632/aging.100069
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kile BT, 2014, BRIT J HAEMATOL, V165, P217, DOI 10.1111/bjh.12757
   Kinet MJ, 2014, METHOD ENZYMOL, V545, P157, DOI 10.1016/B978-0-12-801430-1.00007-X
   King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601
   KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206
   Kirchman PA, 1999, GENETICS, V152, P179
   Kirkland J. L., 2014, EXP GERONTOL
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730
   Kwak H. B., 2014, J GERONTOL A     JUL
   Kwak HB, 2013, J EXERC REHABIL, V9, P212, DOI 10.12965/jer.130002
   Lanni C, 2012, FREE RADICAL BIO MED, V52, P1727, DOI 10.1016/j.freeradbiomed.2012.02.034
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1111/j.1365-2958.2001.02317.x
   Lee M, 2014, BMB REP, V47, P51, DOI 10.5483/BMBRep.2014.47.2.005
   Lee Y, 2014, BMB REP, V47, P424, DOI 10.5483/BMBRep.2014.47.8.119
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004
   Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234
   Liu J, 2013, CELL METAB, V18, P392, DOI 10.1016/j.cmet.2013.08.007
   Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75
   Long JM, 1999, J GERONTOL A-BIOL, V54, pB407, DOI 10.1093/gerona/54.10.B407
   Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002
   Lu B., 2012, ADV BIOSCI BIOTECH, V3, P705, DOI DOI 10.4236/ABB.2012.326091
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Maklakov AA, 2013, BIOESSAYS, V35, P717, DOI 10.1002/bies.201300021
   Marcotte R, 2004, MECH AGEING DEV, V125, P777, DOI 10.1016/j.mad.2004.07.007
   Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028
   Marzetti E, 2013, INT J BIOCHEM CELL B, V45, P2288, DOI 10.1016/j.biocel.2013.06.024
   Maurer CW, 2007, DEVELOPMENT, V134, P1357, DOI 10.1242/dev.02818
   McGee MD, 2012, AGING-US, V4, P256, DOI 10.18632/aging.100448
   Merrill DA, 2001, J COMP NEUROL, V438, P445, DOI 10.1002/cne.1327
   Metzstein MM, 1998, TRENDS GENET, V14, P410, DOI 10.1016/S0168-9525(98)01573-X
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Misell LM, 2005, BREAST CANCER RES TR, V89, P257, DOI 10.1007/s10549-004-2228-5
   Nixon Ralph A, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a008839
   Nolan LA, 1999, J NEUROENDOCRINOL, V11, P393
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453
   Oshiro S, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/378278
   Osiewacz HD, 2000, EXP GERONTOL, V35, P677, DOI 10.1016/S0531-5565(00)00142-X
   Osiewacz HD, 2010, ANN NY ACAD SCI, V1197, P54, DOI 10.1111/j.1749-6632.2010.05190.x
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   PANDEY S, 1995, J CELL BIOCHEM, V58, P135, DOI 10.1002/jcb.240580203
   Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026
   Papucci L, 2004, CELL TISSUE RES, V316, P197, DOI 10.1007/s00441-004-0872-z
   Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608
   Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191
   Polyak K, 1997, CELL DEATH DIFFER, V4, P242, DOI 10.1038/sj.cdd.4400226
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145
   Proskuryakov SY, 2010, CURR PHARM DESIGN, V16, P56, DOI 10.2174/138161210789941793
   Qian DH, 2011, INT J MOL MED, V28, P207, DOI 10.3892/ijmm.2011.671
   RAFF MC, 1994, PHILOS T ROY SOC B, V345, P265, DOI 10.1098/rstb.1994.0104
   Rai Nirendra K, 2005, Int J Low Extrem Wounds, V4, P138, DOI 10.1177/1534734605280018
   Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926
   Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619
   Refaat A, 2014, ONCOL LETT, V7, P1327, DOI 10.3892/ol.2014.1922
   Renehan AG, 2001, BMJ-BRIT MED J, V322, P1536, DOI 10.1136/bmj.322.7301.1536
   Rérole AL, 2011, METHODS MOL BIOL, V787, P205, DOI 10.1007/978-1-61779-295-3_16
   Richard VR, 2013, AGING-US, V5, P234, DOI 10.18632/aging.100547
   Richardson RB, 2014, EXP GERONTOL, V55, P80, DOI 10.1016/j.exger.2014.03.015
   Rinnerthaler M., 2014, EXP GERONTOL
   Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007
   Ryu SJ, 2007, CELL DEATH DIFFER, V14, P1020, DOI 10.1038/sj.cdd.4402091
   Sainz RM, 2003, MICROSC RES TECHNIQ, V62, P524, DOI 10.1002/jemt.10414
   Salminen A, 2011, CELL MOL LIFE SCI, V68, P1021, DOI 10.1007/s00018-010-0597-y
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Savage VM, 2007, P NATL ACAD SCI USA, V104, P4718, DOI 10.1073/pnas.0611235104
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seiberg M, 2013, INT J COSMETIC SCI, V35, P532, DOI 10.1111/ics.12090
   Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5
   Sevini F., 2014, EXP GERONTOL
   Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216
   Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003
   Shen Jie, 2009, Discov Med, V8, P223
   Shen J, 2009, AGING-US, V1, P191, DOI 10.18632/aging.100018
   Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x
   Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465
   Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355
   Stegh AH, 2012, EXPERT OPIN THER TAR, V16, P67, DOI 10.1517/14728222.2011.643299
   Suh Y, 2002, NAT MED, V8, P3, DOI 10.1038/nm0102-3
   Suh Y, 2002, MECH AGEING DEV, V123, P881, DOI 10.1016/S0047-6374(02)00025-8
   Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000
   Tarnawski AS, 2014, WORLD J GASTROENTERO, V20, P4467, DOI 10.3748/wjg.v20.i16.4467
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Tower J., 2014, ARCH BIOCH BIOPHYS
   Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001
   Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012
   Vasconsuelo A, 2011, STEROIDS, V76, P1223, DOI 10.1016/j.steroids.2011.08.001
   Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807
   Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656
   Vazquez-Padron RI, 2004, J VASC SURG, V40, P1199, DOI 10.1016/j.jvs.2004.08.034
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com
   WANG E, 1995, CANCER RES, V55, P2284
   Wang E, 1997, EXP GERONTOL, V32, P471, DOI 10.1016/S0531-5565(96)00156-8
   Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194
   Wang XH, 2014, INT J MOL SCI, V15, P15358, DOI 10.3390/ijms150915358
   Warner HR, 1997, CURR TOP CELL REGUL, V35, P107, DOI 10.1016/S0070-2137(97)80004-0
   Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013
   Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139
   Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Yakovlev Alexander G, 2004, NeuroRx, V1, P5, DOI 10.1602/neurorx.1.1.5
   Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055
   Yeo EJ, 2000, MOL CELLS, V10, P415
   Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040
   Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102
   Zhong XL, 2012, CELL SIGNAL, V24, P393, DOI 10.1016/j.cellsig.2011.10.005
   Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584
NR 193
TC 267
Z9 293
U1 9
U2 75
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 1568-1637
EI 1872-9649
J9 AGEING RES REV
JI Ageing Res. Rev.
PD SEP
PY 2015
VL 23
SI SI
BP 90
EP 100
DI 10.1016/j.arr.2015.04.002
PN A
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CN0HG
UT WOS:000358094100009
PM 25862945
OA Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Hatakeyama, H
   Goto, Y
AF Hatakeyama, Hideyuki
   Goto, Yu-ichi
TI Respiratory Chain Complex Disorganization Impairs Mitochondrial and
   Cellular Integrity <i>Phenotypic Variation in Cytochrome</i> c
   <i>Oxidase Deficiency</i>
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; HUMAN MTDNA; MUTATION; DISEASE; SUBUNIT;
   PATIENT; CODON; ENCEPHALOMYOPATHY; SUPERCOMPLEXES; MICRODELETION
AB The relationships between the molecular abnormalities in mitochondrial respiratory chain complexes and their negative contributions to mitochondrial and cellular functions have been proved to be essential for better understandings in mitochondrial medicine. Herein, we established the method to identify disease phenotypic differences among patients with muscle histopathological cytochrome c oxidase (COX) deficiency, as one of the representative clinical features in mitochondrial diseases, by using patients' myoblasts that are derived from biopsied skeletal muscle tissues. We identified two obviously different severities in molecular diagnostic criteria of COX deficiency among patients: structurally stable, but functionally mild/moderate defect and severe functional defect with the disrupted COX holoenzyme structure. COX holoenzyme disorganization actually triggered several mitochondrial dysfunctions, including the decreased ATP level, the increased oxidative stress Level, and the damaged membrane potential Level, all of which Lead to the deteriorated cellular growth, the accelerated cellular senescence, and the induced apoptotic cell death. Our cell-based in vitro diagnostic approaches would be widely applicable to understanding patient-specific pathomechanism in various types of mitochondrial diseases, including other respiratory chain complex deficiencies and other mitochondrial metabolic enzyme deficiencies.
C1 [Hatakeyama, Hideyuki; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.
   [Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Med Genome Ctr, Tokyo, Japan.
   [Hatakeyama, Hideyuki; Goto, Yu-ichi] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.
C3 National Center for Neurology & Psychiatry - Japan; National Center for
   Neurology & Psychiatry - Japan
RP Hatakeyama, H; Goto, Y (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.
EM hideyuki@ncnp.go.jp; goto@ncnp.go.jp
FU Japan Society for the Promotion of Science [20790760]; Ministry of
   Health, Labour, and Welfare, Japan; Japan Agency for Medical Research
   and Development AMED-CREST; Grants-in-Aid for Scientific Research
   [20790760] Funding Source: KAKEN
FX Supported in part by Japan Society for the Promotion of Science
   grant-in-aid for Young Researcher B 20790760 (H.H.); a Ministry of
   Health, Labour, and Welfare, Japan grant-in-aid of the Research on
   Intractable Diseases (Mitochondrial Disorder) (Y.G.); and Japan Agency
   for Medical Research and Development AMED-CREST.
CR Akanuma J, 2000, J HUM GENET, V45, P337, DOI 10.1007/s100380070004
   Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Cherry ABC, 2013, STEM CELLS, V31, P1287, DOI 10.1002/stem.1354
   Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361
   Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119
   Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389
   Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2
   Hämäläinen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hatakeyama H, 2016, STEM CELLS, V34, P801, DOI 10.1002/stem.2292
   Hatakeyama H, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0227-x
   Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221
   Indrieri A, 2012, AM J HUM GENET, V91, P942, DOI 10.1016/j.ajhg.2012.09.016
   Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410
   Kodaira M, 2015, FEBS OPEN BIO, V5, P219, DOI 10.1016/j.fob.2015.03.008
   Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111
   Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590
   Schäfer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200
   Schägger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Schägger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
NR 30
TC 8
Z9 11
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD JAN
PY 2017
VL 187
IS 1
BP 110
EP 121
DI 10.1016/j.ajpath.2016.09.003
PG 12
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA EG1YC
UT WOS:000390829300012
PM 27855277
OA Bronze
DA 2024-11-01
ER

PT J
AU Archer, SL
   Marsboom, G
   Kim, GH
   Zhang, HJ
   Toth, PT
   Svensson, EC
   Dyck, JRB
   Gomberg-Maitland, M
   Thébaud, B
   Husain, AN
   Cipriani, N
   Rehman, J
AF Archer, Stephen L.
   Marsboom, Glenn
   Kim, Gene H.
   Zhang, Hannah J.
   Toth, Peter T.
   Svensson, Eric C.
   Dyck, Jason R. B.
   Gomberg-Maitland, Mardi
   Thebaud, Bernard
   Husain, Aliya N.
   Cipriani, Nicole
   Rehman, Jalees
TI Epigenetic Attenuation of Mitochondrial Superoxide Dismutase 2 in
   Pulmonary Arterial Hypertension A Basis for Excessive Cell Proliferation
   and a New Therapeutic Target
SO CIRCULATION
LA English
DT Article
DE epigenesis, genetic; gene silencing; hypoxia-inducible factor-1,
   alpha-subunit; hypertension, pulmonary; mitochondrial diseases;
   oxidation-reduction; superoxide dismutase 2
ID DNA METHYLTRANSFERASE; SOD2 EXPRESSION; CANCER; OVEREXPRESSION;
   METHYLATION; PATHWAY; DNMT3B
AB Background-Excessive proliferation and impaired apoptosis of pulmonary artery (PA) smooth muscle cells (PASMCs) contribute to vascular obstruction in patients and fawn-hooded rats (FHRs) with PA hypertension (PAH). Expression and activity of mitochondrial superoxide dismutase-2 (SOD2), the major generator of H2O2, is known to be reduced in PAH; however, the mechanism and therapeutic relevance of this are unknown.
   Methods and Results-SOD2 expression in PASMCs is decreased in PAH patients and FHRs with PAH. FHR PASMCs have higher proliferation and lower apoptosis rates than Sprague-Dawley rat PASMCs. Moreover, FHR PASMCs have hyperpolarized mitochondria, low H2O2 production, and reduced cytoplasmic and mitochondrial redox state. Administration of SOD2 small interfering RNA to normal PASMCs recapitulates the FHR PAH phenotype, hyperpolarizing mitochondria, decreasing H2O2, and inhibiting caspase activity. Conversely, SOD2 overexpression in FHR PASMCs or therapy with the SOD-mimetic metalloporphyrin Mn(III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) reverses the hyperproliferative PAH phenotype. Importantly, SOD-mimetic therapy regresses PAH in vivo. Investigation of the SOD2 gene revealed no mutation, suggesting a possible epigenetic dysregulation. Genomic bisulfite sequencing demonstrates selective hypermethylation of a CpG island in an enhancer region of intron 2 and another in the promoter. Differential methylation occurs selectively in PAs versus aortic SMCs and is reversed by the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine, restoring both SOD2 expression and the ratio of proliferation to apoptosis. Expression of the enzymes that mediate gene methylation, DNA methyltransferases 1 and 3B, is upregulated in FHR lungs.
   Conclusions-Tissue-specific, epigenetic SOD2 deficiency initiates and sustains a heritable form of PAH by impairing redox signaling and creating a proliferative, apoptosis-resistant PASMC. SOD augmentation regresses experimental PAH. The discovery of an epigenetic component to PAH may offer new therapeutic targets. (Circulation. 2010; 121: 2661-2671.)
C1 [Archer, Stephen L.; Marsboom, Glenn; Kim, Gene H.; Zhang, Hannah J.; Toth, Peter T.; Svensson, Eric C.; Gomberg-Maitland, Mardi; Rehman, Jalees] Univ Chicago, Dept Med, Chicago, IL 60637 USA.
   [Husain, Aliya N.; Cipriani, Nicole] Univ Chicago, Dept Pathol, Cardiol Sect, Chicago, IL 60637 USA.
   [Dyck, Jason R. B.] Univ Alberta, Dept Pharmacol, Alberta, ON, Canada.
   [Thebaud, Bernard] Univ Alberta, Dept Pediat, Alberta, ON, Canada.
C3 University of Chicago; University of Chicago; University of Alberta;
   University of Alberta
RP Archer, SL (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC6080, Chicago, IL 60637 USA.
EM sarcher@medicine.bsd.uchicago.edu
RI Marsboom, Glenn/KCL-0220-2024; Archer, Stephen/C-3621-2013;
   Gomberg-Maitland, Mardi/N-7158-2019; Rehman, Jalees/J-8258-2012
OI Rehman, Jalees/0000-0002-2787-9292; Marsboom, Glenn/0000-0001-6309-7557;
   Kim, Gene/0000-0001-6461-1992; Toth, Peter/0000-0003-2168-0124; Dyck,
   Jason/0000-0002-7045-2884
FU National Institutes of Health [RO1-HL071115, 1RC1HL099462-01]; American
   Heart Association; Roche Foundation for Anemia Research
FX This work is supported by National Institutes of Health grants
   RO1-HL071115 and 1RC1HL099462-01, the American Heart Association, and
   the Roche Foundation for Anemia Research.
CR Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200
   Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200
   BelAiba RS, 2004, BIOL CHEM, V385, P249, DOI 10.1515/BC.2004.019
   Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC
   BRAVARD A, 1992, INT J CANCER, V51, P476, DOI 10.1002/ijc.2910510323
   Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200
   Elmedal B, 2004, BRIT J PHARMACOL, V141, P105, DOI 10.1038/sj.bjp.0705580
   Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721
   Harju T, 2004, EUR RESPIR J, V24, P765, DOI 10.1183/09031936.04.00121203
   Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005
   Hodge DR, 2005, CANCER RES, V65, P6255, DOI 10.1158/0008-5472.CAN-04-4482
   Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253
   Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051
   Hurt EM, 2007, BRIT J CANCER, V97, P1116, DOI 10.1038/sj.bjc.6604000
   Hurt EM, 2007, BLOOD, V109, P3953, DOI 10.1182/blood-2006-07-035162
   Kaewpila S, 2008, CANCER RES, V68, P2781, DOI 10.1158/0008-5472.CAN-07-2635
   Kim A, 2004, ANTIOXID REDOX SIGN, V6, P489, DOI 10.1089/152308604773934251
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   Li N, 1998, PROSTATE, V35, P221, DOI 10.1002/(SICI)1097-0045(19980515)35:3<221::AID-PROS8>3.0.CO;2-J
   Martin RCG, 2007, CLIN CANCER RES, V13, P5176, DOI 10.1158/1078-0432.CCR-07-1152
   NGO VM, 1995, MOL CELL ENDOCRINOL, V108, P95, DOI 10.1016/0303-7207(94)03462-3
   Platoshyn O, 2001, AM J PHYSIOL-LUNG C, V280, pL801, DOI 10.1152/ajplung.2001.280.4.L801
   Razin A, 2005, PROG MOLEC, V38, P151
   Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291
   Rodríguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2
   Schröder E, 2008, CURR OPIN PHARMACOL, V8, P153, DOI 10.1016/j.coph.2007.12.012
   Steinhorn RH, 2001, AM J RESP CRIT CARE, V164, P834, DOI 10.1164/ajrccm.164.5.2010104
   TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3
   Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Voelkel NF, 1998, CHEST, V114, p225S, DOI 10.1378/chest.114.3_Supplement.225S
   WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005
   Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002
   Zhao YD, 2006, AM J RESP CELL MOL, V35, P182, DOI 10.1165/rcmb.2005-0115OC
NR 38
TC 325
Z9 348
U1 0
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD JUN 22
PY 2010
VL 121
IS 24
BP 2661
EP U108
DI 10.1161/CIRCULATIONAHA.109.916098
PG 24
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 613MY
UT WOS:000278984600010
PM 20529999
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Picca, A
   Fracasso, F
   Pesce, V
   Cantatore, P
   Joseph, AM
   Leeuwenburgh, C
   Gadaleta, MN
   Lezza, AMS
AF Picca, Anna
   Fracasso, Flavio
   Pesce, Vito
   Cantatore, Palmiro
   Joseph, Anna-Maria
   Leeuwenburgh, Christiaan
   Gadaleta, Maria Nicola
   Lezza, Angela Maria Serena
TI Age- and calorie restriction-related changes in rat brain mitochondrial
   DNA and TFAM binding
SO AGE
LA English
DT Article
DE Aging rat frontal cortex mitochondria; Calorie restriction diet; TFAM
   amount; mtDNA content; mtDNA 4,8-kb deletion content; mtDNA-TFAM binding
ID TRANSCRIPTION FACTOR-A; AGING SKELETAL-MUSCLE; BASE EXCISION-REPAIR;
   OXIDATIVE STRESS; LON PROTEASE; COPY NUMBER; DIETARY RESTRICTION;
   GENE-EXPRESSION; PHENOTYPIC ALTERATIONS; DEGENERATIVE DISEASES
AB Aging markedly affects mitochondrial biogenesis and functions particularly in tissues highly dependent on the organelle's bioenergetics capability such as the brain's frontal cortex. Calorie restriction (CR) diet is, so far, the only intervention able to delay or prevent the onset of several age-related alterations in different organisms. We determined the contents of mitochondrial transcription factor A (TFAM), mitochondrial DNA (mtDNA), and the 4.8-kb mtDNA deletion in the frontal cortex from young (6-month-old) and aged (26-month-old), ad libitum-fed (AL) and calorie-restricted (CR), rats. We found a 70 % increase in TFAM amount, a 25 % loss in mtDNA content, and a 35 % increase in the 4.8-kb deletion content in the aged AL animals with respect to the young rats. TFAM-specific binding to six mtDNA regions was analyzed by mtDNA immunoprecipitation and semiquantitative polymerase chain reaction (PCR), showing a marked age-related decrease. Quantitative real-time PCR at two subregions involved in mtDNA replication demonstrated, in aged AL rats, a remarkable decrease (60-70 %) of TFAM-bound mtDNA. The decreased TFAM binding is a novel finding that may explain the mtDNA loss in spite of the compensatory TFAM increased amount. In aged CR rats, TFAM amount increased and mtDNA content decreased with respect to young rats' values, but the extent of the changes was smaller than in aged AL rats. Attenuation of the age-related effects due to the diet in the CR animals was further evidenced by the unchanged content of the 4.8-kb deletion with respect to that of young animals and by the partial prevention of the age-related decrease in TFAM binding to mtDNA.
C1 [Picca, Anna; Fracasso, Flavio; Pesce, Vito; Cantatore, Palmiro; Gadaleta, Maria Nicola; Lezza, Angela Maria Serena] Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, I-70125 Bari, Italy.
   [Cantatore, Palmiro; Gadaleta, Maria Nicola] CNR Natl Res Council Italy, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.
   [Joseph, Anna-Maria; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Dept Aging & Geriatr Res, Div Biol Aging, Gainesville, FL USA.
C3 Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle
   Ricerche (CNR); State University System of Florida; University of
   Florida
RP Lezza, AMS (corresponding author), Univ Bari, Dept Biosci Biotechnol & Pharmacol Sci, Via Orabona 4, I-70125 Bari, Italy.
EM a.lezza@biologia.uniba.it
RI PESCE, VITO/KBD-4096-2024; Picca, Anna/K-2305-2018
OI PESCE, VITO/0000-0002-9148-3129; Picca, Anna/0000-0001-7032-3487;
   Leeuwenburgh, Christiaan/0000-0003-0826-4257
FU University of Florida Institute on Aging; Claude D. Pepper Older
   Americans Independence Center [1 P30 AG028740];  [RBNE08HWLZ_012];  [NIA
   R01 AG17994]
FX This research was supported by grants to VP (Contributo d'Ateneo Bari
   2009), MNG (Contributo d'Ateneo Bari 2008, fiRSt s.r.l. 2009 and
   FIRB-MERIT 2008 No. RBNE08HWLZ_012), AMSL (Contributo d'Ateneo Bari
   2007), and CL (NIA R01 AG17994), the University of Florida Institute on
   Aging, and the Claude D. Pepper Older Americans Independence Center (1
   P30 AG028740). We thank Dr. C. F. Minervini for the helpful discussions,
   Dr. F. P. Fallacara for the assistance with the experiments, and Ms. R.
   Longo for the expert secretarial assistance.
CR Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479
   Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005
   Aspnes LE, 1997, FASEB J, V11, P573, DOI 10.1096/fasebj.11.7.9212081
   Bagh MB, 2011, BIOGERONTOLOGY, V12, P119, DOI 10.1007/s10522-010-9301-8
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264
   Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516
   Barrientos A, 1997, MOL BRAIN RES, V52, P284, DOI 10.1016/S0169-328X(97)00278-7
   Bender A, 2008, J NEUROL, V255, P1231, DOI 10.1007/s00415-008-0892-9
   Blokhin A, 2008, J MOL NEUROSCI, V35, P283, DOI 10.1007/s12031-008-9115-1
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Bua EA, 2004, FASEB J, V18, P582, DOI 10.1096/fj.03-0668fje
   Canugovi C, 2010, DNA REPAIR, V9, P1080, DOI 10.1016/j.dnarep.2010.07.009
   Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085
   Cassano P, 2006, REJUV RES, V9, P211, DOI 10.1089/rej.2006.9.211
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076
   Cotrina ML, 2002, J NEUROSCI RES, V67, P1
   Dinardo MM, 2003, BIOCHEM BIOPH RES CO, V301, P187, DOI 10.1016/S0006-291X(02)03008-5
   Druzhyna NM, 2008, MECH AGEING DEV, V129, P383, DOI 10.1016/j.mad.2008.03.002
   Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109
   FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496
   Fontana L, 2009, CURR OPIN GASTROEN, V25, P144, DOI 10.1097/MOG.0b013e32831ef1ba
   Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gilmer LK, 2010, MECH AGEING DEV, V131, P133, DOI 10.1016/j.mad.2009.12.011
   Grill JD, 2002, BRAIN RES, V937, P8, DOI 10.1016/S0006-8993(02)02457-5
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Guevara R, 2011, CELL PHYSIOL BIOCHEM, V27, P201, DOI 10.1159/000327945
   Guevara R, 2009, FREE RADICAL BIO MED, V46, P169, DOI 10.1016/j.freeradbiomed.2008.09.035
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Hiona A, 2004, ANN NY ACAD SCI, V1019, P96, DOI 10.1196/annals.1297.018
   Kadish I, 2009, J NEUROSCI, V29, P1805, DOI 10.1523/JNEUROSCI.4599-08.2009
   Kang CM, 1998, FREE RADICAL BIO MED, V24, P148, DOI 10.1016/S0891-5849(97)00204-9
   Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004
   Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404
   Kaur M, 2008, BIOGERONTOLOGY, V9, P441, DOI 10.1007/s10522-008-9168-0
   Kim JH, 2008, EXP GERONTOL, V43, P317, DOI 10.1016/j.exger.2007.12.012
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lezza AMS, 2001, FEBS LETT, V501, P74, DOI 10.1016/S0014-5793(01)02628-X
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200
   Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x
   Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X
   Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107
   McInerny SC, 2009, MECH AGEING DEV, V130, P343, DOI 10.1016/j.mad.2009.01.008
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007
   Navarro A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00034
   Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020
   Opalach K, 2010, REJUV RES, V13, P65, DOI 10.1089/rej.2009.0892
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   PEINADO MA, 1993, ANAT REC, V237, P104, DOI 10.1002/ar.1092370110
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2005, J GERONTOL A-BIOL, V60, P715, DOI 10.1093/gerona/60.6.715
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475
   Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3
   Quintas A, 2012, EXP GERONTOL, V47, P198, DOI 10.1016/j.exger.2011.11.010
   Rangaraju S, 2009, AGING CELL, V8, P178, DOI 10.1111/j.1474-9726.2009.00460.x
   Sanz A, 2005, J BIOENERG BIOMEMBR, V37, P83, DOI 10.1007/s10863-005-4131-0
   Seo AY, 2006, ANTIOXID REDOX SIGN, V8, P529, DOI 10.1089/ars.2006.8.529
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shi L, 2007, EXP NEUROL, V206, P70, DOI 10.1016/j.expneurol.2007.03.026
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SOONG NW, 1992, NAT GENET, V2, P318
   Stuart JA, 2004, FASEB J, V18, P595, DOI 10.1096/fj.03-0890fje
   Turlejski K, 2002, PROG BRAIN RES, V136, P39
   Ugarte N, 2010, ANTIOXID REDOX SIGN, V13, P539, DOI 10.1089/ars.2009.2998
   Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168
   Yoshida Y, 2002, BIOCHEM BIOPH RES CO, V295, P945, DOI 10.1016/S0006-291X(02)00757-X
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
NR 87
TC 47
Z9 51
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
J9 AGE
JI Age
PD OCT
PY 2013
VL 35
IS 5
BP 1607
EP 1620
DI 10.1007/s11357-012-9465-z
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 219XO
UT WOS:000324545200007
PM 22945739
OA Green Published
DA 2024-11-01
ER

PT J
AU Terburgh, K
   Lindeque, Z
   Mason, S
   van der Westhuizen, F
   Louw, R
AF Terburgh, Karin
   Lindeque, Zander
   Mason, Shayne
   van der Westhuizen, Francois
   Louw, Roan
TI Metabolomics of <i>Ndufs4</i><SUP>-/-</SUP> skeletal muscle: Adaptive
   mechanisms converge at the ubiquinone-cycle
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Ndufs4 knockout mice; Skeletal muscle; Metabolomics; Mitochondrial
   disease; Complex I deficiency; Ubiquinone-cycle
ID COMPLEX-I DEFICIENCY; CLINICAL-FEATURES; MITOCHONDRIAL-DNA; MICE
   DISPLAY; MOUSE MODEL; SAMPLES; MUTATIONS; GENE
AB Leigh syndrome is one of the most common childhood-onset neurometabolic disorders resulting from a primary oxidative phosphorylation dysfunction and affecting mostly brain tissues. Ndufs4(-/-) mice have been widely used to study the neurological responses in this syndrome, however the reason why these animals do not display strong muscle involvement remains elusive. We combined biochemical strategies and multi-platform metabolomics to gain insight into the metabolism of both glycolytic (white quadriceps) and oxidative (soleus) skeletal muscles from Ndufs4(-/-) mice. Enzyme assays confirmed severely reduced (80%) CI activity in both Ndufs4(-/-) muscle types, compared to WTs. No significant alterations were evident in other respiratory chain enzyme activities; however, Ndufs4(-/-) solei displayed moderate decreases in citrate synthase (12%) and CIII (18%) activities. Through hypothesis-generating metabolic profiling, we provide the first evidence of adaptive responses to Cl dysfunction involving non-classical pathways fueling the ubiquinone (Q) cycle. We report a respective 48 and 34 discriminatory metabolites between Ndufs4(-/-) and WT white quadriceps and soleus muscles, among which the most prominent alterations indicate the involvement of the glycerol-3-phosphate shuttle, electron transfer flavoprotein system, CII, and proline cycle in fueling the Q cycle. By restoring the electron flux to CIII via the Q cycle, these adaptive mechanisms could maintain adequate oxidative ATP production, despite CI deficiency. Taken together, our results shed light on the underlying pathogenic mechanisms of CI dysfunction in skeletal muscle. Upon further investigation, these pathways could provide novel targets for therapeutic intervention in Cl deficiency and potentially lead to the development of new treatment strategies.
C1 [Terburgh, Karin; Lindeque, Zander; Mason, Shayne; van der Westhuizen, Francois; Louw, Roan] North West Univ Potchefstroom Campus, Fac Nat & Agr Sci, Human Metabol, Private Bag X6001, Potchefstroom, South Africa.
C3 North West University - South Africa
RP Louw, R (corresponding author), North West Univ Potchefstroom Campus, Fac Nat & Agr Sci, Human Metabol, Private Bag X6001, Potchefstroom, South Africa.
EM Roan.Louw@nwu.ac.za
RI Lindeque, Jeremie/R-4491-2016; van der Westhuizen, Francois/E-6959-2011
OI Lindeque, Zander/0000-0001-8017-4278; Louw, Roan/0000-0002-6542-8644;
   Mason, Shayne/0000-0002-2945-5768; Terburgh, Karin/0000-0001-5700-6890;
   van der Westhuizen, Francois/0000-0002-7879-1776
FU National Research Foundation of South Africa (NRF) [92736, 111247];
   Technological Innovation Agency of the Department of Science and
   Technology, Republic of South Africa (TIA) [Metabol. 01]
FX This work was supported by the National Research Foundation of South
   Africa (NRF; Grant numbers 92736 and 111247) and the Technological
   Innovation Agency of the Department of Science and Technology, Republic
   of South Africa (TIA; Grant number Metabol. 01). Opinions expressed and
   conclusions arrived at, are those of the authors and are not necessarily
   to be attributed to the NRF or the TIA. We thank Kobus Venter and
   Antoinette Fick from the Pre-Clinical Drug Development Platform (PCDDP,
   NWU, RSA), for their assistance regarding animal handling.
CR Alam MT, 2015, BBA-BIOENERGETICS, V1847, P526, DOI 10.1016/j.bbabio.2015.02.006
   Bogner-Strauss JG, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00240
   Breuer ME, 2013, IUBMB LIFE, V65, P202, DOI 10.1002/iub.1127
   Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257
   Budde SMS, 2003, J INHERIT METAB DIS, V26, P813, DOI 10.1023/B:BOLI.0000010003.14113.af
   Calvaruso MA, 2012, HUM MOL GENET, V21, P115, DOI 10.1093/hmg/ddr446
   Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200
   de Haas R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09417-5
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Ellis S.M., 2003, Management Dynamics, V12, P51, DOI 10.10520/EJC69666
   Esterhuizen K, 2017, MITOCHONDRION, V35, P97, DOI 10.1016/j.mito.2017.05.012
   Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159
   Foriel S, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032482
   Goody MF, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0154-1
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Jin ZX, 2014, CELL METAB, V20, P483, DOI 10.1016/j.cmet.2014.07.011
   Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360
   Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Lindeque JZ, 2013, METABOLOMICS, V9, P418, DOI 10.1007/s11306-012-0459-8
   Mason S, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1372-6
   McDonald AE, 2018, COMP BIOCHEM PHYS B, V224, P185, DOI 10.1016/j.cbpb.2017.11.006
   Mels Catharina M C, 2011, ISRN Pharmacol, V2011, P851870, DOI 10.5402/2011/851870
   Phang JM, 2019, ANTIOXID REDOX SIGN, V30, P635, DOI 10.1089/ars.2017.7350
   QURESHI GA, 1986, J CHROMATOGR, V374, P363, DOI 10.1016/S0378-4347(00)83293-4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Russell AP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00314
   Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597
   Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016
   Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2
   Terburgh K., 2018, MULTIPLATFORM METABO
   Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071
   Valsecchi F, 2012, BBA-BIOENERGETICS, V1817, P1925, DOI 10.1016/j.bbabio.2012.03.006
   Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107
   Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007
   Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475
   Wu GY, 2011, AMINO ACIDS, V40, P1053, DOI 10.1007/s00726-010-0715-z
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
NR 43
TC 20
Z9 21
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JAN
PY 2019
VL 1865
IS 1
BP 98
EP 106
DI 10.1016/j.bbadis.2018.10.034
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA HC0MM
UT WOS:000451492500010
PM 30391276
OA Bronze
DA 2024-11-01
ER

PT J
AU Gispert, S
   Parganlija, D
   Klinkenberg, M
   Dröse, S
   Wittig, I
   Mittelbronn, M
   Grzmil, P
   Koob, S
   Hamann, A
   Walter, M
   Büchel, F
   Adler, T
   de Angelis, MH
   Busch, DH
   Zell, A
   Reichert, AS
   Brandt, U
   Osiewacz, HD
   Jendrach, M
   Auburger, G
AF Gispert, Suzana
   Parganlija, Dajana
   Klinkenberg, Michael
   Droese, Stefan
   Wittig, Ilka
   Mittelbronn, Michel
   Grzmil, Pawel
   Koob, Sebastian
   Hamann, Andrea
   Walter, Michael
   Buechel, Finja
   Adler, Thure
   de Angelis, Martin Hrabe
   Busch, Dirk H.
   Zell, Andreas
   Reichert, Andreas S.
   Brandt, Ulrich
   Osiewacz, Heinz D.
   Jendrach, Marina
   Auburger, Georg
TI Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss
   plus growth retardation via accumulation of CLPX, mtDNA and inflammatory
   factors
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; CAUSE OVARIAN DYSGENESIS; PERRAULT SYNDROME;
   TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; STRESS-RESPONSE; QUALITY-CONTROL;
   ANIMAL-MODELS; MICE LACKING; MOUSE MODEL
AB The caseinolytic peptidase P (CLPP) is conserved from bacteria to humans. In the mitochondrial matrix, it multi-merizes and forms a macromolecular proteasome-like cylinder together with the chaperone CLPX. In spite of a known relevance for the mitochondrial unfolded protein response, its substrates and tissue-specific roles are unclear in mammals. Recessive CLPP mutations were recently observed in the human Perrault variant of ovarian failure and sensorineural hearing loss. Here, a first characterization of CLPP null mice demonstrated complete female and male infertility and auditory deficits. Disrupted spermatogenesis already at the spermatid stage and ovarian follicular differentiation failure were evident. Reduced pre-/post-natal survival and marked ubiquitous growth retardation contrasted with only light impairment of movement and respiratory activities. Interestingly, the mice showed resistance to ulcerative dermatitis. Systematic expression studies detected up-regulation of other mitochondrial chaperones, accumulation of CLPX and mtDNA as well as inflammatory factors throughout tissues. T-lymphocytes in the spleen were activated. Thus, murine Clpp deletion represents a faithful Perrault model. The disease mechanism probably involves deficient clearance of mitochondrial components and inflammatory tissue destruction.
C1 [Gispert, Suzana; Parganlija, Dajana; Klinkenberg, Michael; Jendrach, Marina; Auburger, Georg] Goethe Univ Frankfurt, Sch Med, D-60590 Frankfurt, Germany.
   [Droese, Stefan; Wittig, Ilka; Brandt, Ulrich] Goethe Univ Frankfurt, Sch Med, Mol Bioenerget Grp, Ctr Biol Chem,Cluster Excellence Macromol Complex, D-60590 Frankfurt, Germany.
   [Mittelbronn, Michel] Goethe Univ Frankfurt, Sch Med, Edinger Inst, Neurol Inst, D-60590 Frankfurt, Germany.
   [Grzmil, Pawel] Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany.
   [Grzmil, Pawel] Jagiellonian Univ, Dept Genet & Evolut, PL-30387 Krakow, Poland.
   [Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Ctr Mol Med, Buchmann Inst Mol Life Sci & Mitochondrial Biol, D-60438 Frankfurt, Germany.
   [Hamann, Andrea; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Fac Biosci, Cluster Excellence Macromol Complexes, D-60590 Frankfurt, Germany.
   [Walter, Michael] Univ Tubingen, Inst Med Genet, D-72076 Tubingen, Germany.
   [Buechel, Finja; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, D-72076 Tubingen, Germany.
   [Adler, Thure; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Munich, Germany.
   [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.
C3 Goethe University Frankfurt; Goethe University Frankfurt; Goethe
   University Frankfurt; University of Gottingen; Jagiellonian University;
   Goethe University Frankfurt; Goethe University Frankfurt; Eberhard Karls
   University of Tubingen; Eberhard Karls University of Tubingen; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Technical University of Munich
RP Auburger, G (corresponding author), Goethe Univ Frankfurt, Sch Med, Bldg 89,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM auburger@em.uni-frankfurt.de
RI Klinkenberg, Michael/AAL-5127-2021; Dröse, Stefan/E-4903-2010;
   Mittelbronn, Michel/LOR-7739-2024; Osiewacz, Heinz/D-3454-2011;
   Reichert, Andreas/A-4090-2012; Brandt, Ulrich/C-4406-2008; Hrabe de
   Angelis, Martin/F-5531-2012
OI Klinkenberg, Michael/0000-0002-0241-4712; Reichert,
   Andreas/0000-0001-9340-3113; Grzmil, Pawel/0000-0001-9780-2007;
   Mittelbronn, Michel/0000-0002-2998-052X; Brandt,
   Ulrich/0000-0003-1869-6811; Walter, Michael/0000-0003-4115-5458; Hrabe
   de Angelis, Martin/0000-0002-7898-2353; Hamann,
   Andrea/0000-0001-9821-7491; Wrzodek, Finja/0000-0001-5031-1016
FU German Federal Ministry for Education and Research (BMBF) [0315584A];
   German Federal Ministry for Education and Research (BMBF) through the
   National Genome Research Network NGFN-Plus [01GS08134/01GS08138]; German
   Federal Ministry for Education and Research (BMBF) through the German
   Network for Mitochondrial Disorders mito NET [01GM1113B]; Deutsche
   Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 815, A02, Z1];
   Cluster of Excellence Frankfurt Macromolecular Complexes [EXC115]
FX The study was financed by the German Federal Ministry for Education and
   Research (BMBF, through the GerontoMitoSys project under grant number
   0315584A, the National Genome Research Network NGFN-Plus under grant
   numbers 01GS08134/01GS08138, and the German Network for Mitochondrial
   Disorders mito NET under grant number 01GM1113B), by the Deutsche
   Forschungsgemeinschaft (DFG, Sonderforschungsbereich 815, projects A02
   and Z1), as well as the Cluster of Excellence Frankfurt Macromolecular
   Complexes (EXC115).
CR Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874
   Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Andresen BS, 2000, MAMM GENOME, V11, P275, DOI 10.1007/s003350010052
   Angeles A, 2012, FRONT BIOSCI-LANDMRK, V17, P1904, DOI 10.2741/4027
   Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157
   Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004
   Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06
   Broadley SA, 2008, TRENDS CELL BIOL, V18, P1, DOI 10.1016/j.tcb.2007.11.003
   Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200
   Cacace AT, 2011, AUDIOL NEURO-OTOL, V16, P398, DOI 10.1159/000323276
   Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342
   Corydon TJ, 2000, MAMM GENOME, V11, P899, DOI 10.1007/s003350010173
   Czyz A, 2001, ARCH VIROL, V146, P1487, DOI 10.1007/s007050170073
   Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544
   Dröse S, 2006, J BIOL CHEM, V281, P23733, DOI 10.1074/jbc.M602570200
   Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Fischer F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2397
   Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004
   Fiumara A, 2004, AM J MED GENET A, V128A, P246, DOI 10.1002/ajmg.a.20616
   Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104
   Frees D, 2012, J PROTEOME RES, V11, P95, DOI 10.1021/pr200956s
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   George SK, 2011, AGING CELL, V10, P584, DOI 10.1111/j.1474-9726.2011.00686.x
   Gerth U, 1998, MOL MICROBIOL, V28, P787, DOI 10.1046/j.1365-2958.1998.00840.x
   Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777
   Gnaiger E., 2007, MITOCHONDRIAL PATHWA, P1
   Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317
   Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14
   Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x
   Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003
   Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0
   Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108
   Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016
   Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015
   Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014
   Ibdah JA, 2001, J CLIN INVEST, V107, P1403, DOI 10.1172/JCI12590
   Imai H, 2009, J BIOL CHEM, V284, P32522, DOI 10.1074/jbc.M109.016139
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Ishii T, 2011, BMB REP, V44, P298, DOI 10.5483/BMBRep.2011.44.5.298
   Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013
   Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084
   Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200
   Kasashima K, 2012, EXP CELL RES, V318, P2335, DOI 10.1016/j.yexcr.2012.07.012
   Kastenmayer RJ, 2006, J AM ASSOC LAB ANIM, V45, P8
   Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967
   Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587
   Laker RC, 2012, AM J PHYSIOL-ENDOC M, V302, pE1221, DOI 10.1152/ajpendo.00583.2011
   Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231
   Larsson NG, 2001, TRENDS MOL MED, V7, P578, DOI 10.1016/S1471-4914(01)02167-0
   Leong DW, 2012, J BIOL CHEM, V287, P20652, DOI 10.1074/jbc.M111.327601
   Levéen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031
   Liang HY, 2009, J BIOL CHEM, V284, P30836, DOI 10.1074/jbc.M109.032839
   LINSSEN WHJP, 1994, AM J MED GENET, V51, P81, DOI 10.1002/ajmg.1320510117
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu B, 2008, BIOL REPROD, V78, P601, DOI 10.1095/biolreprod.107.065987
   Manfredi AA, 2010, NEW ENGL J MED, V362, P2132, DOI 10.1056/NEJMcibr1003521
   Martinelli P, 2010, BBA-BIOENERGETICS, V1797, P1, DOI 10.1016/j.bbabio.2009.07.013
   Meek K, 2009, J IMMUNOL, V183, P2529, DOI 10.4049/jimmunol.0801406
   Nagashima K, 2006, J BIOL CHEM, V281, P30941, DOI 10.1074/jbc.M606566200
   Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103
   Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980
   Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002
   Neher SB, 2006, MOL CELL, V22, P193, DOI 10.1016/j.molcel.2006.03.007
   NISHI Y, 1988, AM J MED GENET, V31, P623, DOI 10.1002/ajmg.1320310317
   Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003
   O'Handley D, 2002, J MOL BIOL, V322, P311, DOI 10.1016/S0022-2836(02)00755-6
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PALLISTER PD, 1979, AM J MED GENET, V4, P239, DOI 10.1002/ajmg.1320040306
   Paul E, 2009, MAMM GENOME, V20, P92, DOI 10.1007/s00335-008-9168-z
   Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521
   Pettan-Brewer C, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7202
   Pewe L, 1998, J VIROL, V72, P5912, DOI 10.1128/JVI.72.7.5912-5918.1998
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007
   Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325
   Raineri I, 2001, FREE RADICAL BIO MED, V31, P1018, DOI 10.1016/S0891-5849(01)00686-4
   Ranquet C, 2005, J MOL BIOL, V353, P186, DOI 10.1016/j.jmb.2005.08.015
   Rantanen A, 2000, Hum Reprod, V15 Suppl 2, P86
   Robertson SA, 2007, BIOL REPROD, V76, P738, DOI 10.1095/biolreprod.106.056143
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200
   Santagata S, 1999, J BIOL CHEM, V274, P16311, DOI 10.1074/jbc.274.23.16311
   Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623
   Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795
   Scott I, 2010, MITOCHONDRION, V10, P316, DOI 10.1016/j.mito.2010.02.005
   SHAH AJ, 1982, J NEUROL SCI, V55, P25, DOI 10.1016/0022-510X(82)90167-8
   Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304
   Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597
   Smyth GK., 2004, Stat Appl Genet Mol Biol, V3, P1, DOI DOI 10.2202/1544-6115.1027
   Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200
   Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215
   Sundberg JP, 2011, VET PATHOL, V48, P513, DOI 10.1177/0300985810379431
   Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972
   von Ameln S, 2012, AM J HUM GENET, V91, P919, DOI 10.1016/j.ajhg.2012.09.002
   Voos W, 2009, RES MICROBIOL, V160, P718, DOI 10.1016/j.resmic.2009.08.003
   Wallace DC, 2011, COLD SH Q B, V76, P1, DOI 10.1101/sqb.2011.76.010462
   Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wells T, 2012, HUM MOL GENET, V21, P4836, DOI 10.1093/hmg/dds315
   Will Y, 2000, HEPATOLOGY, V32, P740, DOI 10.1053/jhep.2000.17913
   Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Yoda E, 2010, J LIPID RES, V51, P3003, DOI 10.1194/jlr.M008060
   Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zheng B, 2002, PHYSIOL PLANTARUM, V114, P92, DOI 10.1034/j.1399-3054.2002.1140113.x
   Zhou RR, 2010, CURR GENET, V56, P101, DOI 10.1007/s00294-010-0291-5
   Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133
NR 116
TC 147
Z9 170
U1 2
U2 30
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD DEC 15
PY 2013
VL 22
IS 24
BP 4871
EP 4887
DI 10.1093/hmg/ddt338
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 259QY
UT WOS:000327542600001
PM 23851121
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Carelli, V
   Franceschini, F
   Venturi, S
   Barboni, P
   Savini, G
   Barbieri, G
   Pirro, E
   La Morgia, C
   Valentino, ML
   Zanardi, F
   Violante, FS
   Mattioli, S
AF Carelli, Valerio
   Franceschini, Flavia
   Venturi, Silvia
   Barboni, Piero
   Savini, Giacomo
   Barbieri, Giuseppe
   Pirro, Ettore
   La Morgia, Chiara
   Valentino, Maria L.
   Zanardi, Francesca
   Violante, Francesco S.
   Mattioli, Stefano
TI Grand rounds:: Could occupational exposure to <i>n</i>-hexane and other
   solvents precipitate visual failure in Leber hereditary optic
   neuropathy?
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
DE environmental trigger; Leber hereditary optic neuropathy; mitochondrial
   DNA; neurotoxin; n-hexane; occupational exposure; solvents
ID HEARING-LOSS; MITOCHONDRIA; EXPRESSION; MUTATION; WORKERS
AB CONTEXT: Leber hereditary optic neuropathy (LHON) is a maternally inherited loss of central vision related to pathogenic mutations in the mitochondrial genome, which are a necessary but not sufficient condition to develop the disease. Investigation of precipitating environmental/occupational (and additional genetic) factors could be relevant for prevention.
   CASE PRESENTATION: After a 6-month period of occupational exposure to n-hexane and other organic solvents, a 27-year-old man (a moderate smoker) developed an optic neuropathy. The patient had a full oplithalmologic and neurologic investigation, including standardized cycloergometer test for serum lactic acid levels and a skeletal muscle biopsy. His exposure history was also detailed, and he underwent genetic testing for LHON mitochondrial DNA mutations. The patient suffered a sequential optic neuropathy with the hallmarks of LHON and tested positive for the homoplasmic 11778G -> A/ND4 mutation. Routine laboratory monitoring revealed increased concentrations of urinary 2.5 hexandione (n-hexane metabolite) and hippuric acid (toluene metabolite) in the period immediately preceding the visual loss.
   DISCUSSION: In a subject carrying an LHON mutation, the strict temporal sequence of prolonged appreciable occupational exposure followed by sudden onset of visual loss must raise a suspicion of causality (with a possible further interaction with tobacco smoke).
   RELEVANCE: In this article, we add to the candidate occupational/environmental triggers of LHON and highlight the need for appropriate case-control (and laboratory) studies to validate the causal effect of mixed toxic exposures.
C1 Univ Bologna, Lab Epidemiol, UO Med Lavoro, Policlin S Orsola Malphighi,Alma Mater Studiorum, I-40138 Bologna, Italy.
   Univ Bologna, Dipartimento Sci Neurol, Alma Mater Studiorum, I-40138 Bologna, Italy.
   Azienda USL Bologna, Dipartimento Sanita Pubbl, Bologna, Italy.
   Ctr Oftalmol Salus, Bologna, Italy.
C3 University of Bologna; University of Bologna; AUSL di Bologna
RP Mattioli, S (corresponding author), Univ Bologna, Lab Epidemiol, UO Med Lavoro, Policlin S Orsola Malphighi,Alma Mater Studiorum, Via Pelagio Palagi 9, I-40138 Bologna, Italy.
EM s.mattioli@unibo.it
RI Savini, Giacomo/J-9196-2018; La Morgia, Chiara/H-6765-2012; Violante,
   Francesco/A-6934-2009; BARBIERI, Giuseppe/A-8134-2011; ZANARDI,
   FRANCESCA/AAF-3557-2021; ZANARDI, FRANCESCA/I-9550-2016; Barboni,
   Piero/AAA-9936-2020
OI Mattioli, Stefano/0000-0002-9639-7430; LA MORGIA,
   Chiara/0000-0002-4639-8929; Savini, Giacomo/0000-0003-0075-3582;
   CARELLI, VALERIO/0000-0003-4923-6404; ZANARDI,
   FRANCESCA/0000-0001-5185-3204; VALENTINO, MARIA
   LUCIA/0000-0001-5323-0115; Barboni, Piero/0000-0002-0118-4177
CR *ACGIH, 2005, TLVS BEIS
   Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034
   Canton M, 1996, BBA-BIOENERGETICS, V1274, P39, DOI 10.1016/0005-2728(96)00008-4
   Carelli V, 2003, TRENDS GENET, V19, P257, DOI 10.1016/S0168-9525(03)00072-6
   Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003
   Daré E, 2004, TOXICOLOGY, V201, P125, DOI 10.1016/j.tox.2004.04.010
   EHYAI A, 1983, J NEUROL NEUROSUR PS, V46, P349, DOI 10.1136/jnnp.46.4.349
   Gobba F, 2003, NEUROTOXICOLOGY, V24, P693, DOI 10.1016/S0161-813X(03)00037-8
   JOHNS DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1577, DOI 10.1001/archopht.1992.01080230077025
   Kerrison JB, 2000, AM J OPHTHALMOL, V130, P803, DOI 10.1016/S0002-9394(00)00603-6
   Kiyokawa M, 1999, JPN J OPHTHALMOL, V43, P438, DOI 10.1016/S0021-5155(99)00102-1
   Lachmund U, 2006, KLIN MONATSBL AUGENH, V223, P393, DOI 10.1055/s-2006-926559
   Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162
   Maruff P, 1998, BRAIN, V121, P1903, DOI 10.1093/brain/121.10.1903
   Mashima Y, 2000, J NEURO-OPHTHALMOL, V20, P166, DOI 10.1097/00041327-200020030-00006
   Meadows R, 1996, SOUTHERN MED J, V89, P455, DOI 10.1097/00007611-199605000-00001
   MONTAGNA P, 1995, J NEUROL NEUROSUR PS, V58, P640, DOI 10.1136/jnnp.58.5.640
   Moshe S, 2002, ARCH ENVIRON HEALTH, V57, P127, DOI 10.1080/00039890209602927
   Newman NJ, 2005, AM J OPHTHALMOL, V140, P407, DOI 10.1016/j.ajo.2005.03.058
   Noraberg J, 2000, NEUROTOXICOLOGY, V21, P409
   OGAWA Y, 1998, IND HLTH, V26, P239
   RAITTA C, 1978, A GRAEF ARCH KLIN EX, V209, P99, DOI 10.1007/BF00407843
   Rufa A, 2005, EUR NEUROL, V53, P32, DOI 10.1159/000083927
   Sadun AA, 2003, AM J OPHTHALMOL, V136, P231, DOI 10.1016/S0002-9394(03)00099-0
   SCHAUMBURG HH, 1978, SCIENCE, V199, P199, DOI 10.1126/science.413192
   SICKLES DW, 1990, BRAIN RES, V528, P25, DOI 10.1016/0006-8993(90)90190-M
   SPENCER PS, 1985, SCAN J WORK ENV H S1, V11, pS53
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   WILLIAMS DML, 1988, J OTOLARYNGOL, V17, P321
   ZAHLSEN K, 1984, ARCH TOXICOL, P268
NR 30
TC 41
Z9 43
U1 0
U2 8
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD JAN
PY 2007
VL 115
IS 1
BP 113
EP 115
DI 10.1289/ehp.9245
PG 3
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA 123ME
UT WOS:000243299200042
PM 17366829
OA gold, Green Submitted, Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU Zeng, LL
   Yang, Y
   Hu, YJ
   Sun, Y
   Du, ZD
   Xie, Z
   Zhou, T
   Kong, WJ
AF Zeng, Lingling
   Yang, Yang
   Hu, Yujuan
   Sun, Yu
   Du, Zhengde
   Xie, Zhen
   Zhou, Tao
   Kong, Weijia
TI Age-Related Decrease in the Mitochondrial Sirtuin Deacetylase Sirt3
   Expression Associated with ROS Accumulation in the Auditory Cortex of
   the Mimetic Aging Rat Model
SO PLOS ONE
LA English
DT Article
ID 4977 BP DELETION; SUPEROXIDE-DISMUTASE; DNA-DAMAGE; OXIDATIVE DAMAGE;
   SKELETAL-MUSCLE; CELL-DEATH; METABOLISM; RESTRICTION; DEFICIENCY;
   PROTEINS
AB Age-related dysfunction of the central auditory system, also known as central presbycusis, can affect speech perception and sound localization. Understanding the pathogenesis of central presbycusis will help to develop novel approaches to prevent or treat this disease. In this study, the mechanisms of central presbycusis were investigated using a mimetic aging rat model induced by chronic injection of D-galactose (D-Gal). We showed that malondialdehyde (MDA) levels were increased and manganese superoxide dismutase (SOD2) activity was reduced in the auditory cortex in natural aging and D-Gal-induced mimetic aging rats. Furthermore, mitochondrial DNA (mtDNA) 4834 bp deletion, abnormal ultrastructure and cell apoptosis in the auditory cortex were also found in natural aging and D-Gal mimetic aging rats. Sirt3, a mitochondrial NAD+dependent deacetylase, has been shown to play a crucial role in controlling cellular reactive oxygen species (ROS) homeostasis. However, the role of Sirt3 in the pathogenesis of age-related central auditory cortex deterioration is still unclear. Here, we showed that decreased Sirt3 expression might be associated with increased SOD2 acetylation, which negatively regulates SOD2 activity. Oxidative stress accumulation was likely the result of low SOD2 activity and a decline in ROS clearance. Our findings indicate that Sirt3 might play an essential role, via the mediation of SOD2, in central presbycusis and that manipulation of Sirt3 expression might provide a new approach to combat aging and oxidative stress-related diseases.
C1 [Zeng, Lingling; Yang, Yang; Hu, Yujuan; Sun, Yu; Xie, Zhen; Zhou, Tao; Kong, Weijia] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.
   [Du, Zhengde] Guangdong Med Coll, Dept Otorhinolaryngol, Nanshan Affiliated Hosp, Shenzhen, Peoples R China.
C3 Huazhong University of Science & Technology; Guangdong Medical
   University
RP Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.
EM entwjkong@hust.edu.cn
RI hu, yujuan/GNQ-9970-2022; Sun, Yu/AAX-9942-2021
OI Kong, Wei-Jia/0000-0001-5410-2297; Sun, Yu/0000-0002-1771-3715
FU Major State Basic Research Development Program of China (973 Program)
   [2011CB504504]; National twelfth-Five Year Research Program of China
   [2012BAI12B02]; National Natural Science Foundation of China [81230021,
   30872865, 30672309]; National Nature Science Foundation of China
   [81200745, 81000409]
FX This work was supported by grants from the Major State Basic Research
   Development Program of China (973 Program) (No. 2011CB504504), the
   National twelfth-Five Year Research Program of China (No. 2012BAI12B02),
   the National Natural Science Foundation of China (No. 81230021, No.
   30872865 and No. 30672309), the National Nature Science Foundation of
   China (No. 81200745), National Nature Science Foundation of China (No.
   81000409). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   BOHR VA, 1995, MUTAT RES-DNAGING G, V338, P25, DOI 10.1016/0921-8734(95)00008-T
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863
   Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5
   Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65
   Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   CUATRECASAS P, 1966, SCIENCE, V153, P549, DOI 10.1126/science.153.3735.549
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   D'Aquila P, 2012, GENE, V497, P323, DOI 10.1016/j.gene.2012.01.042
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026
   Engle JR, 2012, FRONT AGING NEUROSCI, V4, DOI [10.3389/fnagi.2012.00036, 10.3389/fnagi.2012.00010]
   Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003
   Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295
   Fortunato G, 2004, CLIN CHEM, V50, P2012, DOI 10.1373/clinchem.2004.037788
   Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   He WJ, 2012, TRENDS ENDOCRIN MET, V23, P467, DOI 10.1016/j.tem.2012.07.004
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Humes LE, 2012, J AM ACAD AUDIOL, V23, P635, DOI 10.3766/jaaa.23.8.5
   Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297
   Jacono AA, 1998, HEARING RES, V117, P31, DOI 10.1016/S0378-5955(97)00214-1
   Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025
   Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108
   Jordens RG, 1999, NEUROCHEM RES, V24, P227, DOI 10.1023/A:1022510004220
   King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001
   Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008
   Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Lei H, 2003, ACTA PHARMACOL SIN, V24, P230
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Mao PZ, 2012, BBA-MOL BASIS DIS, V1822, P111, DOI 10.1016/j.bbadis.2011.10.014
   Mao PZ, 2011, BBA-MOL BASIS DIS, V1812, P1359, DOI 10.1016/j.bbadis.2011.08.005
   Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218
   McFadden SL, 1999, NEUROBIOL AGING, V20, P1, DOI 10.1016/S0197-4580(99)00018-4
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033
   Patten DA, 2010, J ALZHEIMERS DIS, V20, pS357, DOI 10.3233/JAD-2010-100498
   Pellegrini L, 2012, CELL DEATH DIFFER, V19, P1815, DOI 10.1038/cdd.2012.62
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010
   Reddy, 2009, CNS SPECTRUMS, V14, P16
   Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Ross OA, 2002, EXP GERONTOL, V37, P329, DOI 10.1016/S0531-5565(01)00200-5
   Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102
   Seidman MD, 2000, LARYNGOSCOPE, V110, P727, DOI 10.1097/00005537-200005000-00003
   Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102
   Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225
   Wu YT, 2013, BBA-MOL BASIS DIS, V1832, P216, DOI 10.1016/j.bbadis.2012.10.002
   Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126
NR 65
TC 92
Z9 103
U1 1
U2 41
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 4
PY 2014
VL 9
IS 2
AR e88019
DI 10.1371/journal.pone.0088019
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA AI6GY
UT WOS:000336971300037
PM 24505357
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Pich, MM
   Raule, N
   Catani, L
   Fagioli, ME
   Faenza, I
   Cocco, L
   Lenaz, G
AF Pich, MM
   Raule, N
   Catani, L
   Fagioli, ME
   Faenza, I
   Cocco, L
   Lenaz, G
TI Increased transcription of mitochondrial genes for Complex I in human
   platelets during ageing
SO FEBS LETTERS
LA English
DT Article
DE mitochondrial mRNA; ageing; oxidative phosphorylation system; gene
   expression
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; SENESCENT RAT; DNA; LIVER; HEART;
   AGE; EXPRESSION; MUTATION; DISEASES
AB We studied the effect of ageing on the mRNA levels of mitochondria-encoded polypeptides in human platelets. We used quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate the expression of selected cytochrome c oxidase (COX) genes (subunits I and III) and Complex I genes (subunits reduced nicotinamide adenine dinucleotide (NADH) dehydrogenase (ND)1 and ND5) in platelets from young and aged healthy subjects. Northern blot analysis confirmed the PCR results. COX I expression is higher than that of COX III in both young and aged platelets. A significant increase of transcripts for Complex I was found during ageing. On the contrary, the mRNA levels of the two COX subunits did not significantly vary during ageing. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 Univ Bologna, Dept Biochem G Moruzzi, I-40126 Bologna, Italy.
   Univ Bologna, Inst Hematol & Med Oncol Le A Seragnoli, I-40126 Bologna, Italy.
   Univ Bologna, Inst Anat, Cellular Signalling Lab, I-40126 Bologna, Italy.
C3 University of Bologna; University of Bologna; University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dept Biochem G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Catani, Lucia/K-3814-2018; Lenaz, Giorgio/B-5751-2013
OI Catani, Lucia/0000-0002-4650-201X
CR Andreu AL, 1998, BIOCHEM BIOPH RES CO, V252, P577, DOI 10.1006/bbrc.1998.9703
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Catani L, 2002, LEUKEMIA, V16, P1773, DOI 10.1038/sj.leu.2402597
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   D'Aurelio M, 2001, MECH AGEING DEV, V122, P823, DOI 10.1016/S0047-6374(01)00239-1
   Drouet M, 1999, EXP GERONTOL, V34, P843, DOI 10.1016/S0531-5565(99)00058-3
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   Grossman LI, 1998, ELECTROPHORESIS, V19, P1254, DOI 10.1002/elps.1150190805
   HAYAKAWA M, 1991, BIOCHEM BIOPH RES CO, V176, P87, DOI 10.1016/0006-291X(91)90893-C
   HOLMSEN H, 1987, HEMOSTASIS THROMBOSI, P631
   KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x
   Lenaz G, 1998, BIOFACTORS, V8, P195, DOI 10.1002/biof.5520080305
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Ozawa T, 1999, J BIOENERG BIOMEMBR, V31, P377, DOI 10.1023/A:1005479920097
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   Schapira AHV, 1998, BBA-BIOENERGETICS, V1364, P261, DOI 10.1016/S0005-2728(98)00032-2
   Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P99, DOI 10.1016/S0005-2728(98)00160-1
   Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8
   Wei YH, 1998, ANN NY ACAD SCI, V854, P155, DOI 10.1111/j.1749-6632.1998.tb09899.x
NR 23
TC 14
Z9 19
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JAN 30
PY 2004
VL 558
IS 1-3
BP 19
EP 22
DI 10.1016/S0014-5793(03)01520-5
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 772AJ
UT WOS:000188817900005
PM 14759509
DA 2024-11-01
ER

PT J
AU Phua, QH
   Ng, SY
   Soh, BS
AF Phua, Qian Hua
   Ng, Shi Yan
   Soh, Boon-Seng
TI Mitochondria: A Potential Rejuvenation Tool against Aging
SO AGING AND DISEASE
LA English
DT Review
DE aging; mitochondria; mitotherapy; lifespan; healthspan
ID CALORIC RESTRICTION; LIFE-SPAN; SKELETAL-MUSCLE; BIOCHEMICAL
   ADAPTATIONS; PARKINSONS-DISEASE; DNA MUTATIONS; TRANSPLANTATION;
   REPERFUSION; EXPRESSION; EXERCISE
AB Aging is a complex physiological process encompassing both physical and cognitive decline over time. This intricate process is governed by a multitude of hallmarks and pathways, which collectively contribute to the emergence of numerous age-related diseases. In response to the remarkable increase in human life expectancy, there has been a substantial rise in research focusing on the development of anti-aging therapies and pharmacological interventions. Mitochondrial dysfunction, a critical factor in the aging process, significantly impacts overall cellular health. In this extensive review, we will explore the contemporary landscape of anti-aging strategies, placing particular emphasis on the promising potential of mitotherapy as a ground-breaking approach to counteract the aging process. Moreover, we will investigate the successful application of mitochondrial transplantation in both animal models and clinical trials, emphasizing its translational potential. Finally, we will discuss the inherent challenges and future possibilities of mitotherapy within the realm of aging research and intervention.
C1 [Phua, Qian Hua; Ng, Shi Yan; Soh, Boon-Seng] ASTAR, Inst Mol & Cell Biol IMCB, Proteos, Singapore.
   [Phua, Qian Hua; Soh, Boon-Seng] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
   [Ng, Shi Yan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.
   [Soh, Boon-Seng] Natl Neurosci Inst, Singapore, Singapore.
   [Soh, Boon-Seng] ASTAR, 61 Biopolis Dr, Proteos 138673, Singapore.
C3 Agency for Science Technology & Research (A*STAR); A*STAR - Institute of
   Molecular & Cell Biology (IMCB); National University of Singapore;
   National University of Singapore; National Neuroscience Institute (NNI);
   Agency for Science Technology & Research (A*STAR)
RP Soh, BS (corresponding author), ASTAR, 61 Biopolis Dr, Proteos 138673, Singapore.
EM bssoh@imcb.a-star.edu.sg
FU Agency for Science, Technology and Research (Singapore); A*STAR Graduate
   Scholarship
FX We express our gratitude to Jeremy Kah Sheng Pang for proofreading and
   providing comments on the manuscript. This work is supported by the
   Agency for Science, Technology and Research (Singapore). Qian Hua Phua
   is supported by the A*STAR Graduate Scholarship.
CR Acquistapace A, 2011, STEM CELLS, V29, P812, DOI 10.1002/stem.632
   Amari L, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.767219
   Amartuvshin O, 2020, AGING CELL, V19, DOI 10.1111/acel.13191
   Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   BALDWIN KM, 1972, AM J PHYSIOL, V222, P373, DOI 10.1152/ajplegacy.1972.222.2.373
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340
   Berridge MV, 2017, CLIN EXP PHARMACOL P, V44, P15, DOI 10.1111/1440-1681.12764
   Blitzer D, 2020, ANN THORAC SURG, V109, P711, DOI 10.1016/j.athoracsur.2019.06.075
   Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109
   Burgstaller JP, 2015, MOL HUM REPROD, V21, P11, DOI 10.1093/molehr/gau090
   Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035
   Caicedo A, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7610414
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003
   Chen G, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00200
   Chinnery PF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004315
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Coletta DK, 2009, DIABETOLOGIA, V52, P723, DOI 10.1007/s00125-008-1256-9
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Cowan DB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160889
   Dimond R, 2015, BRIT MED BULL, V115, P173, DOI 10.1093/bmb/ldv037
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Emani SM, 2017, J THORAC CARDIOV SUR, V154, P286, DOI 10.1016/j.jtcvs.2017.02.018
   Fang EF, 2019, NAT NEUROSCI, V22, P401, DOI 10.1038/s41593-018-0332-9
   Fu AL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00241
   Gabbita SP, 1997, FREE RADICAL BIO MED, V23, P191, DOI 10.1016/S0891-5849(97)00043-9
   Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001
   Gollihue JL, 2017, J NEUROSCI METH, V287, P1, DOI 10.1016/j.jneumeth.2017.05.023
   Gomzikova MO, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.653322
   Greaves LC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003082
   Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100
   Guariento A, 2021, J THORAC CARDIOV SUR, V162, P992, DOI 10.1016/j.jtcvs.2020.10.151
   Guariento A, 2020, J THORAC CARDIOV SUR, V160, pE15, DOI 10.1016/j.jtcvs.2019.06.111
   Guo J, 2022, IUBMB LIFE, V74, P296, DOI 10.1002/iub.2585
   Han HA, 2020, J MOL MED, V98, P615, DOI 10.1007/s00109-020-01893-z
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928
   Hayashida K, 2023, BMC MED, V21, DOI 10.1186/s12916-023-02759-0
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   Jacobs RA, 2013, J APPL PHYSIOL, V114, P344, DOI 10.1152/japplphysiol.01081.2012
   Janikiewicz J, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0105-5
   Jassem W, 2006, J BIOENERG BIOMEMBR, V38, P49, DOI 10.1007/s10863-006-9005-6
   Jaul Efraim, 2017, Front Public Health, V5, P335, DOI 10.3389/fpubh.2017.00335
   Javani G, 2022, MECH AGEING DEV, V202, DOI 10.1016/j.mad.2022.111632
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Ji ZJ, 2022, J GENET GENOMICS, V49, P287, DOI 10.1016/j.jgg.2021.11.005
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077
   Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9
   Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009
   Lanza IR, 2012, CELL METAB, V16, P777, DOI 10.1016/j.cmet.2012.11.003
   LEE HC, 1994, BBA-MOL BASIS DIS, V1226, P37, DOI 10.1016/0925-4439(94)90056-6
   Lin HC, 2013, SHOCK, V39, P543, DOI 10.1097/01.shk.0000430660.63077.7f
   Lin LW, 2019, AM J TRANSPLANT, V19, P1917, DOI 10.1111/ajt.15309
   Liu JK, 2022, NAT PRODUCT BIOPROSP, V12, DOI 10.1007/s13659-022-00339-y
   Liu ZH, 2022, CELL BIOSCI, V12, DOI 10.1186/s13578-022-00805-7
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018
   Madreiter-Sokolowski CT, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030165
   Mäkelä J, 2016, NEUROPHARMACOLOGY, V102, P266, DOI 10.1016/j.neuropharm.2015.11.020
   Manoli I, 2007, TRENDS ENDOCRIN MET, V18, P190, DOI 10.1016/j.tem.2007.04.004
   Markin AM, 2021, LIFE-BASEL, V11, DOI 10.3390/life11020165
   Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012
   McCully JD, 2017, MITOCHONDRION, V34, P127, DOI 10.1016/j.mito.2017.03.004
   McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008
   Mehlman MJ, 2004, GERONTOLOGIST, V44, P304, DOI 10.1093/geront/44.3.304
   Mehrabani S, 2020, J CACHEXIA SARCOPENI, V11, P1447, DOI 10.1002/jcsm.12611
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Miliotis S, 2019, MITOCHONDRION, V48, P16, DOI 10.1016/j.mito.2019.02.002
   Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103
   Moskowitzova K, 2020, AM J PHYSIOL-LUNG C, V318, pL78, DOI 10.1152/ajplung.00221.2019
   Nakano T, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03719-9
   Nawaz M, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00050
   Nicolson GL, 2014, ALTERN THER HEALTH M, V20, P18
   Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728
   Nitzan K, 2019, J ALZHEIMERS DIS, V72, P587, DOI 10.3233/JAD-190853
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Pansarasa O, 1999, FREE RADICAL BIO MED, V27, P617, DOI 10.1016/S0891-5849(99)00108-2
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pinto M, 2013, NEUROBIOL AGING, V34, P2399, DOI 10.1016/j.neurobiolaging.2013.04.014
   Porter C, 2015, MED SCI SPORT EXER, V47, P1922, DOI 10.1249/MSS.0000000000000605
   Ramirez-Barbieri G, 2019, MITOCHONDRION, V46, P103, DOI 10.1016/j.mito.2018.03.002
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Rizza W, 2014, AGEING RES REV, V13, P38, DOI 10.1016/j.arr.2013.11.002
   RUBY JR, 1969, J MORPHOL, V127, P307, DOI 10.1002/jmor.1051270304
   Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Serna JDC, 2020, J BIOENERG BIOMEMBR, V52, P269, DOI 10.1007/s10863-020-09838-4
   Sharma A, 2019, EMBO REP, V20, DOI 10.15252/embr.201948395
   Shi XX, 2017, MITOCHONDRION, V34, P91, DOI 10.1016/j.mito.2017.02.005
   Shindyapina AV, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abo5482
   Sinclair KA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0354-8
   Singh A, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103244
   Stephens OR, 2020, MITOCHONDRION, V54, P102, DOI 10.1016/j.mito.2020.08.002
   Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Tian T, 2018, BIOMATERIALS, V150, P137, DOI 10.1016/j.biomaterials.2017.10.012
   Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6
   Tranah GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30255-6
   Tranah GJ, 2015, J GERONTOL A-BIOL, V70, P1418, DOI 10.1093/gerona/glv097
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vainshtein A, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0033-y
   van der Rijt S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.594416
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vignais ML, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6917941
   Wu SH, 2018, ADV SCI, V5, DOI 10.1002/advs.201700530
   Yang XB, 2021, COMPUT STRUCT BIOTEC, V19, P3319, DOI 10.1016/j.csbj.2021.06.003
   Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y
   Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002
   Zhang ZQ, 2019, BEHAV BRAIN RES, V356, P322, DOI 10.1016/j.bbr.2018.09.005
   Zhao ZZ, 2020, INT J BIOL SCI, V16, P849, DOI 10.7150/ijbs.40886
NR 125
TC 5
Z9 5
U1 0
U2 23
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD APR
PY 2024
VL 15
IS 2
BP 503
EP 516
DI 10.14336/AD.2023.0712
EA OCT 2023
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LI6V5
UT WOS:001081924800001
PM 37815912
OA Green Published, gold
DA 2024-11-01
ER

PT S
AU Biancheri, R
   Lamantea, E
   Severino, M
   Diodato, D
   Pedemonte, M
   Cassandrini, D
   Ploederl, A
   Trucco, F
   Fiorillo, C
   Minetti, C
   Santorelli, FM
   Zeviani, M
   Bruno, C
AF Biancheri, Roberta
   Lamantea, Eleonora
   Severino, Mariasavina
   Diodato, Daria
   Pedemonte, Marina
   Cassandrini, Denise
   Ploederl, Alexandra
   Trucco, Federica
   Fiorillo, Chiara
   Minetti, Carlo
   Santorelli, Filippo M.
   Zeviani, Massimo
   Bruno, Claudio
BE Zschocke, J
   Baumgartner, M
   Morava, E
   Patterson, M
   Rahman, S
   Peters, V
TI Expanding the Clinical and Magnetic Resonance Spectrum of
   Leukoencephalopathy with Thalamus and Brainstem Involvement and High
   Lactate (LTBL) in a Patient Harboring a Novel <i>EARS2</i> Mutation
SO JIMD REPORTS, VOL 23
SE JIMD Reports
LA English
DT Article; Book Chapter
ID DEFICIENCY
AB Leukoencephalopathy with thalamus and brainstem involvement and high lactate (LTBL) is a novel mitochondrial disease caused by mutations in EARS2, which encodes the mitochondrial glutamyl-tRNA synthetase (mtGluRS). A distinctive brain MRI pattern is the hallmark of the disease.
   A 6-year-old boy presented at 3 months with feeding difficulties and muscle hypotonia. Brain MRI, at 8 months, showed hyperintensity of the deep cerebral and cerebellar white matter, thalamus, basal ganglia, brainstem, and thin corpus callosum. From the second year of life onward, the child reported global clinical improvement, parallel to partial resolution of brain MRI pattern. However, the last neuroimaging assessment revealed novel lesions within the left caudate and pallidum nuclei. DNA genomic sequencing analysis identified a novel EARS2 mutation.
   This case expands the clinical and neuroradiological phenotype of LTBL presenting intermediate clinical manifestations between the severe and milder forms of the disease and previously unreported brain MRI features.
C1 [Biancheri, Roberta; Ploederl, Alexandra] Ist Giannina Gaslini, Child Neurol & Psychiat, I-16148 Genoa, Italy.
   [Lamantea, Eleonora; Diodato, Daria; Zeviani, Massimo] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Mitochondria, Milan, Italy.
   [Severino, Mariasavina] Ist Giannina Gaslini, Neuroradiol Unit, I-16148 Genoa, Italy.
   [Pedemonte, Marina; Trucco, Federica; Minetti, Carlo] Ist Giannina Gaslini, Pediat Neurol Unit, I-16148 Genoa, Italy.
   [Cassandrini, Denise; Fiorillo, Chiara; Santorelli, Filippo M.] IRCCS Stella Maris, Neuromuscular & Mol Med Unit, Pisa, Italy.
   [Bruno, Claudio] Ist Giannina Gaslini, Dept Neurosci, Ctr Myol & Neurodegenerat Disorders, I-16148 Genoa, Italy.
C3 University of Genoa; IRCCS Istituto Giannina Gaslini; Fondazione IRCCS
   Istituto Neurologico Carlo Besta; University of Genoa; IRCCS Istituto
   Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini;
   IRCCS Fondazione Stella Maris; University of Genoa; IRCCS Istituto
   Giannina Gaslini
RP Bruno, C (corresponding author), Ist Giannina Gaslini, Dept Neurosci, Ctr Myol & Neurodegenerat Disorders, I-16148 Genoa, Italy.
EM claudio2246@gmail.com
RI Zeviani, Massimo/AAU-2632-2021; Bruno, Claudio/A-3148-2015; Trucco,
   Federica/HLP-7852-2023; Lamantea, Eleonora/J-8339-2016; cassandrini,
   denise/J-7783-2016; MINETTI, Carlo/K-4666-2018; Severino,
   Mariasavina/F-8367-2011; Santorelli, Filippo M/ABE-5124-2020; Fiorillo,
   Chiara/AAB-4142-2021; Diodato, Daria/K-2639-2016
OI Pedemonte, Marina/0000-0001-8410-6918; Lamantea,
   Eleonora/0000-0001-5090-6028; cassandrini, denise/0000-0002-3556-8638;
   MINETTI, Carlo/0000-0002-0640-1804; Severino,
   Mariasavina/0000-0003-4730-5322; Trucco, Federica/0000-0002-1147-0126;
   Zeviani, Massimo/0000-0002-9067-5508; Santorelli, Filippo
   M/0000-0002-1359-9062; Fiorillo, Chiara/0000-0001-9027-343X; Diodato,
   Daria/0000-0003-3607-8523
CR Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9
   Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   Giribaldi G, 2012, DEV MED CHILD NEUROL, V54, P472, DOI 10.1111/j.1469-8749.2011.04151.x
   Konovalova S, 2013, MOL GENET METAB, V108, P206, DOI 10.1016/j.ymgme.2013.01.010
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Steenweg ME, 2012, ARCH NEUROL-CHICAGO, V69, P718, DOI 10.1001/archneurol.2011.1048
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Talim B, 2013, BRAIN, V136, DOI 10.1093/brain/aws197
   van Berge L, 2012, BIOCHEM J, V441, P955, DOI 10.1042/BJ20110795
NR 10
TC 18
Z9 20
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 2192-8304
BN 978-3-662-47467-9; 978-3-662-47466-2
J9 JIMD REP
PY 2015
VL 23
BP 85
EP 89
DI 10.1007/8904_2015_434
D2 10.1007/978-3-662-47467-9
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity
WE Book Citation Index – Science (BKCI-S)
SC Endocrinology & Metabolism; Genetics & Heredity
GA BE8SP
UT WOS:000376988300011
PM 25854774
OA Green Published
DA 2024-11-01
ER

PT J
AU Montecchiani, C
   Pedace, L
   Lo Giudice, T
   Casella, A
   Mearini, M
   Gaudiello, F
   Pedroso, JL
   Terracciano, C
   Caltagirone, C
   Massa, R
   St George-Hyslop, PH
   Barsottini, OGP
   Kawarai, T
   Orlacchio, A
AF Montecchiani, Celeste
   Pedace, Lucia
   Lo Giudice, Temistocle
   Casella, Antonella
   Mearini, Marzia
   Gaudiello, Fabrizio
   Pedroso, Jose L.
   Terracciano, Chiara
   Caltagirone, Carlo
   Massa, Roberto
   St George-Hyslop, Peter H.
   Barsottini, Orlando G. P.
   Kawarai, Toshitaka
   Orlacchio, Antonio
TI ALS5/SPG11/<i>KIAA1840</i> mutations cause autosomal recessive axonal
   Charcot-Marie-Tooth disease
SO BRAIN
LA English
DT Article
DE ALS5/SPG11/KIAA1840 mutations; axonal degeneration; Charcot-Marie-Tooth
   disease; spatacsin
ID HEREDITARY SPASTIC PARAPLEGIA; MOTOR NEUROPATHY; SPG11 GENE; SPATACSIN;
   PHENOTYPE; FORM; FAMILY; HETEROGENEITY; RELIABILITY; VARIABILITY
AB Charcot-Marie-Tooth disease is a group of hereditary peripheral neuropathies that share clinical characteristics of progressive distal muscle weakness and atrophy, foot deformities, distal sensory loss, as well as diminished tendon reflexes. Hundreds of causative DNA changes have been found, but much of the genetic basis of the disease is still unexplained. Mutations in the ALS5/SPG11/KIAA1840 gene are a frequent cause of autosomal recessive hereditary spastic paraplegia with thin corpus callosum and peripheral axonal neuropathy, and account for similar to 40% of autosomal recessive juvenile amyotrophic lateral sclerosis. The overlap of axonal Charcot-Marie-Tooth disease with both diseases, as well as the common autosomal recessive inheritance pattern of thin corpus callosum and axonal Charcot-Marie-Tooth disease in three related patients, prompted us to analyse the ALS5/SPG11/KIAA1840 gene in affected individuals with autosomal recessive axonal Charcot-Marie-Tooth disease. We investigated 28 unrelated families with autosomal recessive axonal Charcot-Marie-Tooth disease defined by clinical, electrophysiological, as well as pathological evaluation. Besides, we screened for all the known genes related to axonal autosomal recessive Charcot-Marie-Tooth disease (CMT2A2/HMSN2A2/MFN2, CMT2B1/LMNA, CMT2B2/MED25, CMT2B5/NEFL, ARCMT2F/dHMN2B/HSPB1, CMT2K/GDAP1, CMT2P/LRSAM1, CMT2R/TRIM2, CMT2S/IGHMBP2, CMT2T/HSJ1, CMTRID/COX6A1, ARAN-NM/HINT and GAN/GAN), for the genes related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal peripheral neuropathy (SPG7/PGN, SPG15/ZFYVE26, SPG21/ACP33, SPG35/FA2H, SPG46/GBA2, SPG55/C12orf65 and SPG56/CYP2U1), as well as for the causative gene of peripheral neuropathy with or without agenesis of the corpus callosum (SLC12A6). Mitochondrial disorders related to Charcot-Marie-Tooth disease type 2 were also excluded by sequencing POLG and TYMP genes. An additional locus for autosomal recessive Charcot-Marie-Tooth disease type 2H on chromosome 8q13-21.1 was excluded by linkage analysis. Pedigrees originated in Italy, Brazil, Canada, England, Iran, and Japan. Interestingly, we identified 15 ALS5/SPG11/KIAA1840 mutations in 12 families (two sequence variants were never reported before, p.Gln198* and p.Pro2212fs*5). No large deletions/duplications were detected in these patients. The novel mutations seemed to be pathogenic since they co-segregated with the disease in all pedigrees and were absent in 300 unrelated controls. Furthermore, in silico analysis predicted their pathogenic effect. Our results indicate that ALS5/SPG11/KIAA1840 is the causative gene of a wide spectrum of clinical features, including autosomal recessive axonal Charcot-Marie-Tooth disease.
C1 [Montecchiani, Celeste; Pedace, Lucia; Lo Giudice, Temistocle; Casella, Antonella; Mearini, Marzia; Gaudiello, Fabrizio; Orlacchio, Antonio] CERC IRCCS Santa Lucia, Lab Neurogenet, Rome, Italy.
   [Lo Giudice, Temistocle; Terracciano, Chiara; Caltagirone, Carlo; Massa, Roberto; Orlacchio, Antonio] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy.
   [Pedroso, Jose L.; Barsottini, Orlando G. P.] Univ Fed Sao Paulo, Dept Neurol, Sao Paulo, Brazil.
   [Caltagirone, Carlo] IRCCS Santa Lucia, Lab Neurol Clin & Comportamentale, Rome, Italy.
   [St George-Hyslop, Peter H.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.
   [St George-Hyslop, Peter H.] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [St George-Hyslop, Peter H.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England.
   [Kawarai, Toshitaka] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Clin Neurosci, Tokushima 770, Japan.
C3 IRCCS Santa Lucia; University of Rome Tor Vergata; Universidade Federal
   de Sao Paulo (UNIFESP); IRCCS Santa Lucia; University of Toronto;
   University of Toronto; University of Cambridge; Tokushima University
RP Orlacchio, A (corresponding author), Ist Ricovero & Cura Carattere Sci IRCCS Santa Luc, CERC, Lab Neurogenet, 64 Via Fosso Fiorano, I-00143 Rome, Italy.
EM a.orlacchio@hsantalucia.it
RI Barsottini, O/E-9117-2010; Pedace, Lucia/ABF-1102-2021; TERRACCIANO,
   CHIARA/ABA-5492-2020; Kawarai, Toshitaka/C-2822-2013; Casella,
   Antonella/AAC-1230-2022; TERRACCIANO, CHIARA/C-2955-2018; Pedroso, Jose
   Luiz/F-1757-2013; Orlacchio, Antonio/A-1968-2014; Massa,
   Roberto/I-7223-2012
OI TERRACCIANO, CHIARA/0000-0002-1853-5578; Casella,
   Antonella/0000-0002-1514-2824; Pedroso, Jose Luiz/0000-0002-1672-8894;
   Orlacchio, Antonio/0000-0002-2602-3281; St George-Hyslop,
   Peter/0000-0003-0796-7209; Massa, Roberto/0000-0001-7523-6956; Pedace,
   Lucia/0000-0001-8552-3641; Lo Giudice, Temistocle/0000-0002-7083-6925;
   Barsottini, Orlando/0000-0002-0107-0831
FU Italian Ministero della Salute [GR09.109]; Comitato Telethon Fondazione
   Onlus, Italy [GGP10121]; Universita di Roma "Tor Vergata", Rome, Italy
   [E82I15000190005]; Rotary Club Sanluri Medio Campidano, Sanluri (VS),
   Italy (Grant Noi per Voi); Japan Society for the Promotion of Science
   (JSPS KAKENHI) [26461294]; Ministry of Health, Labour, and Welfare of
   Japan; Brain Science Foundation, Japan; MRC [MR/N012453/1, MC_G1000734]
   Funding Source: UKRI
FX This work was supported by the Italian Ministero della Salute (Grant no.
   GR09.109 to A.O.), the Comitato Telethon Fondazione Onlus, Italy (Grant
   no. GGP10121 to A.O.), the Universita di Roma "Tor Vergata", Rome, Italy
   (Grant no. E82I15000190005 to A.O.), the Rotary Club Sanluri Medio
   Campidano, Sanluri (VS), Italy (Grant Noi per Voi to A.O.), the Japan
   Society for the Promotion of Science (JSPS KAKENHI Grant no. 26461294 to
   T.K.), the Ministry of Health, Labour, and Welfare of Japan (Grant for
   research on rare and intractable diseases and establishment of novel
   treatments for amyotrophic lateral sclerosis to T.K.), and the Brain
   Science Foundation, Japan (Grant to T.K.).
CR American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, fourth edition, text revision, V5, DOI DOI 10.1176/APPI.BOOKS.9780890423349
   Barhoumi C, 2001, NEUROMUSCULAR DISORD, V11, P27, DOI 10.1016/S0960-8966(00)00162-0
   Bettencourt C, 2014, CLIN GENET, V85, P154, DOI 10.1111/cge.12133
   Bienfait HME, 2007, AXONAL PHENOTYPES CH
   Bird DT, 1993, CHARCOT MARIE TOOTH
   Birouk N, 1997, BRAIN, V120, P813, DOI 10.1093/brain/120.5.813
   Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701
   Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108
   Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297
   Carosi L, 2015, J NEUROL NEUROSUR PS, V86, P702, DOI 10.1136/jnnp-2014-308625
   Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chiurchiù V, 2014, NEUROMOL MED, V16, P3, DOI 10.1007/s12017-013-8271-9
   Claramunt R, 2005, J MED GENET, V42, P358, DOI 10.1136/jmg.2004.022178
   Cottenie E, 2014, AM J HUM GENET, V95, P590, DOI 10.1016/j.ajhg.2014.10.002
   Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x
   Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.012
   De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274
   Del Bo R, 2007, NEUROGENETICS, V8, P301, DOI 10.1007/s10048-007-0095-z
   Denora PS, 2009, HUM MUTAT, V30, pE500, DOI 10.1002/humu.20945
   DYCK PJ, 1968, MAYO CLIN PROC, V43, P81
   Dyck PJ, 2005, PERIPHEAL NEUROPATHY
   Feely SME, 2011, NEUROLOGY, V76, P1690, DOI 10.1212/WNL.0b013e31821a441e
   Fridman V, 2014, NEUROLOGY, V83, P580, DOI 10.1212/WNL.0000000000000700
   Fusco C, 2010, BRAIN DEV-JPN, V32, P592, DOI 10.1016/j.braindev.2009.08.003
   Genari AB, 2011, NEUROMUSCULAR DISORD, V21, P428, DOI 10.1016/j.nmd.2011.03.008
   Gess B, 2014, NEUROLOGY, V83, P1726, DOI 10.1212/WNL.0000000000000966
   Goizet C, 2009, HUM MUTAT, V30, pE376, DOI 10.1002/humu.20920
   Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003
   Guernsey DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001081
   Hammer MB, 2013, AM J HUM GENET, V92, P245, DOI 10.1016/j.ajhg.2012.12.012
   Hanein S, 2008, AM J HUM GENET, V82, P992, DOI 10.1016/j.ajhg.2008.03.004
   Hegele RA, 2005, CLIN GENET, V68, P31, DOI 10.1111/j.1399-0004.2005.00447.x
   Hehr U, 2007, ANN NEUROL, V62, P656, DOI 10.1002/ana.21310
   Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170
   Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67
   Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002
   Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216
   Jerath NU, 2015, BBA-MOL BASIS DIS, V1852, P667, DOI 10.1016/j.bbadis.2014.07.031
   Landouré G, 2013, HUM MUTAT, V34, P1357, DOI 10.1002/humu.22378
   Leal A, 2009, NEUROGENETICS, V10, P275, DOI 10.1007/s10048-009-0183-3
   Lee MJ, 2008, J NEUROL NEUROSUR PS, V79, P607, DOI 10.1136/jnnp.2007.136390
   Leonardis L, 2012, EUR J NEUROL, V19, P992, DOI 10.1111/j.1468-1331.2012.03665.x
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Martin E, 2013, AM J HUM GENET, V92, P238, DOI 10.1016/j.ajhg.2012.11.021
   Martin E, 2012, NEUROBIOL DIS, V48, P299, DOI 10.1016/j.nbd.2012.07.003
   Medical Research Council, 1981, 45 MED RES COUNC
   Murphy SM, 2011, J PERIPHER NERV SYST, V16, P191, DOI 10.1111/j.1529-8027.2011.00350.x
   Nicholson GA, 2008, NEUROLOGY, V70, P1678, DOI 10.1212/01.wnl.0000311275.89032.22
   Nishino I, 2000, ANN NEUROL, V47, P792
   Orlacchio A, 2008, NEUROLOGY, V70, P1959, DOI 10.1212/01.wnl.0000294330.27058.61
   Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325
   OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x
   Paisan-Ruiz C, 2008, EUR J NEUROL, V15, P1065, DOI 10.1111/j.1468-1331.2008.02247.x
   Palumbo C, 2002, ACTA NEUROPATHOL, V104, P287, DOI 10.1007/s00401-002-0558-0
   Pehlivan D, 2015, HUM GENET, V134, P671, DOI 10.1007/s00439-015-1548-3
   Pensato V, 2014, BRAIN, V137, P1907, DOI 10.1093/brain/awu121
   Pérez-Branguli F, 2014, HUM MOL GENET, V23, P4859, DOI 10.1093/hmg/ddu200
   Pierson TM, 2012, EUR J HUM GENET, V20, P476, DOI 10.1038/ejhg.2011.222
   Pippucci T, 2009, EUR J NEUROL, V16, P121, DOI 10.1111/j.1468-1331.2008.02367.x
   Querin G, 2014, EUR J NEUROL, V21, pE85, DOI 10.1111/ene.12481
   Reyes-Marin K, 2011, CLIN NEUROL NEUROSUR, V113, P243, DOI 10.1016/j.clineuro.2010.10.015
   Sagnelli A, 2014, J PERIPHER NERV SYST, V19, P183, DOI 10.1111/jns5.12070
   Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522
   Spiegel R, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.284
   Stevanin G, 2008, BRAIN, V131, P772, DOI 10.1093/brain/awm293
   Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tazir M, 2014, J NEUROL SCI, V347, P14, DOI 10.1016/j.jns.2014.10.013
   Tazir M, 2013, J PERIPHER NERV SYST, V18, P113, DOI 10.1111/jns5.12026
   Tessa A, 2014, CURR MOL MED, V14, P1034, DOI 10.2174/1566524014666141010154526
   Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001
   Timmerman V, 2013, EXP NEUROL, V246, P14, DOI 10.1016/j.expneurol.2012.01.010
   Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034
   Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313
   Yum SW, 2009, ANN NEUROL, V66, P759, DOI 10.1002/ana.21728
   Zimon M, 2012, NAT GENET, V44, P1080, DOI 10.1038/ng.2406
NR 77
TC 73
Z9 79
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN 1
PY 2016
VL 139
BP 73
EP 85
DI 10.1093/brain/awv320
PN 1
PG 13
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DD8VM
UT WOS:000370205000020
PM 26556829
OA Green Published, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Lima, ML
   Abengozar, MA
   Torres-Santos, EC
   Borborema, SET
   Godzien, J
   Lopez-Gonzalvezd, A
   Barbas, C
   Rivas, L
   Tempone, AG
AF Lima, Marta Lopes
   Abengozar, Maria A.
   Torres-Santos, Eduardo Caio
   Borborema, Samanta Etel Treiger
   Godzien, Joanna
   Lopez-Gonzalvezd, Angeles
   Barbas, Coral
   Rivas, Luis
   Tempone, Andre Gustavo
TI Energy metabolism as a target for cyclobenzaprine: A drug candidate
   against Visceral Leishmaniasis
SO BIOORGANIC CHEMISTRY
LA English
DT Article
DE Leishmania; Cyclobenzaprine; Drug repurposing; Mechanism of action;
   Leishmaniasis; Neglected diseases
ID PROGRAMMED CELL-DEATH; TRYPANOSOMA-CRUZI; DONOVANI PROMASTIGOTES;
   ANTIDEPRESSANTS; INHIBITION; INDUCTION; INFANTUM
AB Leishmaniases have a broad spectrum of clinical manifestations, ranging from a cutaneous to a progressive and fatal visceral disease. Chemotherapy is nowadays the almost exclusive way to fight the disease but limited by its scarce therapeutic arsenal, on its own compromised by adverse side effects and clinical resistance. Cyclobenzaprine (CBP), an FDA-approved oral muscle relaxant drug has previously demonstrated in vitro and in vivo activity against Leishmania sp., but its targets were not fully unveiled. This study aimed to define the role of energy metabolism as a target for the leishmanicidal mechanisms of CBP. Methodology to assess CBP leishmanicidal mechanism variation of intracellular ATP levels using living Leishmania transfected with a cytoplasmic luciferase. Induction of plasma membrane permeability by assessing depolarization with DiSBAC(2)3 and entrance of the vital dye SYTOX (R) Green. Mitochondrial depolarization by rhodamine 123 accumulation. Mapping target site within the respiratory chain by oxygen consumption rate. Reactive oxygen species (ROS) production using MitoSOX. Morphological changes by transmission electron microscopy. CBP caused on L. infantum promastigotes a decrease of intracellular ATP levels, with irreversible depolarization of plasma membrane, the collapse of the mitochondrial electrochemical potential, mild uncoupling of the respiratory chain, and ROS production, with ensuing intracellular Ca2+ imbalance and DNA fragmentation. Electron microscopy supported autophagic features but not a massive plasma membrane disruption. The severe and irreversible mitochondrial damage induced by CBP endorsed the bioenergetics metabolism as a relevant target within the lethal programme induced by CBP in Leishmania. This, together with the mild-side effects of this oral drug, endorses CBP as an appealing novel candidate as a leishmanicidal drug under a drug repurposing strategy.
C1 [Lima, Marta Lopes; Borborema, Samanta Etel Treiger; Tempone, Andre Gustavo] Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, SP, Brazil.
   [Abengozar, Maria A.; Rivas, Luis] Ctr Invest Biol Margarita Salas CSIC, Madrid, Spain.
   [Torres-Santos, Eduardo Caio] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim Tripanosomatideos, Rio De Janeiro, Brazil.
   [Godzien, Joanna; Lopez-Gonzalvezd, Angeles; Barbas, Coral] Univ CEU San Pablo, Fac Pharm, Ctr Metabol & Bioanal CEMBIO, Madrid, Spain.
C3 Instituto Adolfo Lutz; Consejo Superior de Investigaciones Cientificas
   (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Fundacao
   Oswaldo Cruz; San Pablo CEU University
RP Tempone, AG (corresponding author), Adolfo Lutz Inst, Ctr Parasitol & Mycol, Sao Paulo, SP, Brazil.; Rivas, L (corresponding author), Ctr Invest Biol Margarita Salas CSIC, Madrid, Spain.; Barbas, C (corresponding author), Univ CEU San Pablo, Fac Pharm, Ctr Metabol & Bioanal CEMBIO, Madrid, Spain.
EM cbarbas@ceu.es; luis.rivas@cib.csic.es; andre.tempone@ial.sp.gov.br
RI Godzien, Joanna/J-7401-2017; Borborema, Samanta/I-8063-2012; Lima,
   Marta/K-4575-2017; Rivas, Luis/O-8657-2017; Tempone,
   Andre/HRE-2073-2023; Torres-Santos, Eduardo/J-9908-2014;
   Lopez-Gonzalvez, Angeles/K-4361-2014; Barbas, Coral/K-3871-2014
OI Lopez-Gonzalvez, Angeles/0000-0002-6363-7135; Barbas,
   Coral/0000-0003-4722-491X
FU Sao Paulo State Research Foundation [FAPESP 2019/10434-4, 2021/04464-8,
   2017/50333-7]; Subdireccion General de Redes y Centros de Investigacion
   Cooperativa -FEDER [RICET RD16/0027/0010]; Ministerio de Ciencia e
   Innovacion Espana. Plan Estatal de Investigacion Cientifica y Tecnica y
   de Innovacion 2017-2020-FEDER
   [PID2019108166GB-100/AEI/10.13039/501100011033]; EADS-CASA/Brazilian Air
   Force (FAB) mobility program; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES); Swedish Research Council [2021-04464] Funding
   Source: Swedish Research Council
FX This work was supported by grants of Sao Paulo State Research Foundation
   (FAPESP 2019/10434-4 to S.E.T.B. and 2021/04464-8 and 2017/50333-7 to
   A.G.T.); Subdireccion General de Redes y Centros de Investigacion
   Cooperativa -FEDER (RICET RD16/0027/0010, and Ministerio de Ciencia e
   Innovacion Espana. Plan Estatal de Investigacion Cientifica y Tecnica y
   de Innovacion 2017-2020-FEDER
   PID2019108166GB-100/AEI/10.13039/501100011033 to L. R.),
   EADS-CASA/Brazilian Air Force (FAB) mobility program to M.L.L., and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to
   M. L.L. The authors declare no conflicts of interest.
CR ABOOD LG, 1955, P SOC EXP BIOL MED, V88, P688
   Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
   Andrade-Neto VV, 2018, FRONT BIOSCI-LANDMRK, V23, P967, DOI 10.2741/4629
   Abengózar MA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02288-16
   Abengózar MA, 2015, ANTIMICROB AGENTS CH, V59, P1211, DOI 10.1128/AAC.04003-14
   Basmaciyan L, 2018, MICROB CELL, V5, P404, DOI 10.15698/mic2018.09.646
   Benaim G, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00046
   Bera A, 2003, MOL BIOCHEM PARASIT, V127, P23, DOI 10.1016/S0166-6851(02)00300-6
   Carvalho L, 2010, ANTIMICROB AGENTS CH, V54, P5344, DOI 10.1128/AAC.00790-10
   Cha Y, 2018, BRIT J PHARMACOL, V175, P168, DOI 10.1111/bph.13798
   Cimolai Nevio, 2009, Expert Rev Clin Pharmacol, V2, P255, DOI 10.1586/ecp.09.5
   Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x
   Cunha EF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005281
   Docampo R, 2022, J EUKARYOT MICROBIOL, V69, DOI 10.1111/jeu.12899
   El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631
   EVANS AT, 1994, BIOCHEM PHARMACOL, V48, P613, DOI 10.1016/0006-2952(94)90293-3
   Field MC, 2017, NAT REV MICROBIOL, V15, P447, DOI 10.1038/nrmicro.2017.69
   Fisar Z, 2005, GEN PHYSIOL BIOPHYS, V24, P161
   Gillespie PM, 2016, VACCINE, V34, P2992, DOI 10.1016/j.vaccine.2015.12.071
   GLASER TA, 1992, MOL BIOCHEM PARASIT, V51, P1, DOI 10.1016/0166-6851(92)90194-O
   Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731
   Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated
   Honda M, 2003, EUR J PHARMACOL, V458, P91, DOI 10.1016/S0014-2999(02)02735-8
   Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002
   Kaiser A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010138
   Kapoor R, 2019, J GEN PHYSIOL, V151, P342, DOI 10.1085/jgp.201812263
   Kathuria M, 2014, ANTIMICROB AGENTS CH, V58, P5916, DOI 10.1128/AAC.02459-14
   Leroux AE, 2016, MOL BIOCHEM PARASIT, V206, P67, DOI 10.1016/j.molbiopara.2015.11.003
   Luque-Ortega JR, 2003, BIOCHEM J, V375, P221, DOI 10.1042/BJ20030544
   Luque-Ortega JR, 2001, ANTIMICROB AGENTS CH, V45, P1121, DOI 10.1128/AAC.45.4.1121-1125.2001
   Maarouf M, 1997, EXP CELL RES, V232, P339, DOI 10.1006/excr.1997.3500
   Mallick K., 2022, INT J APPL PHARM, V14, P1
   Manglik A, 2017, BIOCHEMISTRY-US, V56, P5628, DOI 10.1021/acs.biochem.7b00747
   McConville Malcolm J, 2015, F1000Res, V4, P938, DOI 10.12688/f1000research.6724.1
   Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200
   Opperdoes FR, 2008, TRENDS PARASITOL, V24, P310, DOI 10.1016/j.pt.2008.03.013
   Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004
   Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004
   Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281
   Luque-Ortega JR, 2010, J MED CHEM, V53, P1788, DOI 10.1021/jm901677h
   Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06
   Luque-Ortega JR, 2010, METHODS MOL BIOL, V618, P393, DOI 10.1007/978-1-60761-594-1_25
   Menna-Barreto RFS, 2014, BIOMED RES INT-UK, V2014, DOI 10.1155/2014/614014
   Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553
   Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200
   Shabalina IG, 2011, BIOCHEM SOC T, V39, P1305, DOI 10.1042/BST0391305
   Shrestha R, 2021, MOL METAB, V51, DOI 10.1016/j.molmet.2021.101222
   Tempone AG, 2017, EUR J MED CHEM, V139, P947, DOI 10.1016/j.ejmech.2017.08.055
   Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007
   VanHellemond JJ, 1997, PARASITOLOGY, V114, P351, DOI 10.1017/S0031182096008591
   VERCESI AE, 1991, J BIOL CHEM, V266, P14431
   Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004
   Vieira LL, 1995, MOL BIOCHEM PARASIT, V75, P15, DOI 10.1016/0166-6851(95)02505-7
   Villanueva-Paz Marina, 2016, Genes Cancer, V7, P260
   WEINBACH EC, 1986, BIOCHEM PHARMACOL, V35, P1445, DOI 10.1016/0006-2952(86)90108-5
   ZILBERSTEIN D, 1984, SCIENCE, V226, P977, DOI 10.1126/science.6505677
NR 56
TC 1
Z9 1
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0045-2068
EI 1090-2120
J9 BIOORG CHEM
JI Bioorganic Chem.
PD OCT
PY 2022
VL 127
AR 106009
DI 10.1016/j.bioorg.2022.106009
EA JUL 2022
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 3G1CS
UT WOS:000831094000005
PM 35841672
DA 2024-11-01
ER

PT J
AU Zhang, J
   Cui, L
   Ma, J
   Chen, C
   Yang, B
   Huang, L
AF Zhang, J.
   Cui, L.
   Ma, J.
   Chen, C.
   Yang, B.
   Huang, L.
TI Transcriptome analyses reveal genes and pathways associated with fatty
   acid composition traits in pigs
SO ANIMAL GENETICS
LA English
DT Article
DE candidate gene; co-expression network; fatty acid contents; quantitative
   trait transcript; swine
ID GENOME-WIDE ASSOCIATION; ADIPOSE-TISSUE; MEAT QUALITY; POPULATION;
   INSULIN; CELLS; IDENTIFICATION; INTERFERON; SAMPLES; HUMANS
AB Fatty acid composition is associated with meat quality in pigs as well as with obesity-and diabetes-related traits in humans. Liver and muscle are important tissues for fatty acid metabolism. In this study, we evaluated correlations between liver and muscle transcriptomes and fatty acid composition traits in muscle and abdominal fat tissues in 335 F-2 pigs from a White Duroc x Erhualian F-2 pig resource population. Transcripts significantly correlated with fatty acid composition traits were enriched for genes involved in the categories of triglyceride catabolic process, mitochondrial function, hematological and immune system, and disease such as Type II diabetes. Gene co-expression network analysis further identified liver network modules relevant to fatty acid unsaturation index that were enriched in platelet activation and the type I interferon signaling pathway and highlighted the connections between variations in fatty acid composition and genes involved in hematological and immune system. Integrative analysis of the expression QTL identified ELOVL6 and SCD as plausible candidate genes underlying the loci for muscle C18:1n-9/C16:1n-7 values on chromosome 8 and the loci for muscle C18:1n-9/C18:0 contents on chromosome 14 respectively.
C1 [Zhang, J.; Cui, L.; Ma, J.; Chen, C.; Yang, B.; Huang, L.] Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang 330045, Jiangxi, Peoples R China.
C3 Jiangxi Agricultural University
RP Yang, B (corresponding author), Jiangxi Agr Univ, State Key Lab Pig Genet Improvement & Prod Techno, Nanchang 330045, Jiangxi, Peoples R China.
EM binyang@live.cn
RI Chen, Congying/AFU-8515-2022; Yang, Bin/JFS-4830-2023
FU Natural Science Foundation of China [31572379]
FX This work was funded by the Natural Science Foundation of China
   (31572379). We appreciate all colleagues in our lab for their work on
   animal management, sample collection and measurement of transcriptome.
CR Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222
   APOSTOLOV K, 1981, FEBS LETT, V126, P261, DOI 10.1016/0014-5793(81)80256-6
   Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108
   Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101
   BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404
   BOUGNOUX P, 1985, MOL IMMUNOL, V22, P1107, DOI 10.1016/0161-5890(85)90114-2
   Calder PC, 2002, BRIT J NUTR, V87, pS31, DOI 10.1079/BJN2001455
   Corominas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053687
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Garaulet M, 2001, AM J CLIN NUTR, V74, P585
   Garaulet M, 2006, INT J OBESITY, V30, P899, DOI 10.1038/sj.ijo.0803219
   GOODNIGHT SH, 1981, BLOOD, V58, P880
   Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004
   Kew S, 2003, AM J CLIN NUTR, V77, P1278, DOI 10.1093/ajcn/77.5.1278
   Kriketos AD, 1996, AM J PHYSIOL-REG I, V270, pR1332, DOI 10.1152/ajpregu.1996.270.6.R1332
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900
   RENAUD S, 1970, CIRC RES, V26, P553, DOI 10.1161/01.RES.26.5.553
   Ros-Freixedes R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152496
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x
   Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029
   Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019
   Xiong XW, 2015, PHYSIOL GENOMICS, V47, P274, DOI 10.1152/physiolgenomics.00005.2015
   Xu P, 2016, PHYSIOL GENOMICS, V48, P573, DOI 10.1152/physiolgenomics.00123.2015
   Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065554
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
   Zhang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep24718
   Zhang WC, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0184-2
NR 30
TC 16
Z9 18
U1 0
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-9146
EI 1365-2052
J9 ANIM GENET
JI Anim. Genet.
PD DEC
PY 2017
VL 48
IS 6
BP 645
EP 652
DI 10.1111/age.12597
PG 8
WC Agriculture, Dairy & Animal Science; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Genetics & Heredity
GA FM8VF
UT WOS:000415368600002
PM 29034492
DA 2024-11-01
ER

PT J
AU Bakker, JA
   Schlesser, P
   Smeets, HJM
   Francois, B
   Bierau, J
AF Bakker, Jaap A.
   Schlesser, Patrick
   Smeets, Hubert J. M.
   Francois, Baudouin
   Bierau, Jorgen
TI Biochemical abnormalities in a patient with thymidine phosphorylase
   deficiency with fatal outcome
SO JOURNAL OF INHERITED METABOLIC DISEASE
LA English
DT Article
AB Deficiency of the cytosolic enzyme thymidine phosphorylase (TP) causes a multisystem disorder called mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome. Clinical symptoms are gastrointestinal dysfunction, muscle involvement and neurological deterioration. TP deficiency is biochemically characterised by accumulation of thymidine and deoxyuridine in body fluids and compromised mitochondrial deoxyribose nucleic acid (mtDNA) integrity (depletion and multiple deletions). In this report we describe a patient with the clinical and biochemical features related to the end stage of the disease. Home parenteral nutrition had started to improve the clinical condition and preparations were initiated for stem cell transplantation (SCT) as a last resort treatment. Unfortunately, the patient died during the induction phase of SCT. This report shows that TP deficiency is a severe clinical condition with a broad spectrum of affected tissues. TP deficiency can be easily determined by the measurement of pyrimidine metabolites in body fluids and TP activity in peripheral blood leucocytes. Early detection and treatment may prevent the progress of the clinical symptoms and, therefore, should be considered for inclusion in newborn screening programmes.
C1 [Bakker, Jaap A.; Bierau, Jorgen] Maastricht Univ, Med Ctr, Dept Clin Genet, Lab Biochem Genet, NL-6229 HX Maastricht, Netherlands.
   [Schlesser, Patrick; Francois, Baudouin] CHC Clin Esperance, Dept Paediat, Montegnee Liege, Belgium.
   [Smeets, Hubert J. M.] Maastricht Univ, Med Ctr, Dept Clin Genet, Clin Genom Unit, NL-6229 HX Maastricht, Netherlands.
C3 Maastricht University; Maastricht University
RP Bakker, JA (corresponding author), Maastricht Univ, Med Ctr, Dept Clin Genet, Lab Biochem Genet, P Debyelaan 25, NL-6229 HX Maastricht, Netherlands.
EM jaap.bakker@gen.unimaas.nl
RI Bakker, J./H-7910-2019
OI Bakker, Jaap A./0000-0002-2918-7361
CR Blondon H, 2005, GASTROEN CLIN BIOL, V29, P773, DOI 10.1016/S0399-8320(05)86346-8
   Fairbanks LD, 2002, J INHERIT METAB DIS, V25, P603, DOI 10.1023/A:1022007827133
   Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24
   la Marca G, 2006, J MASS SPECTROM, V41, P586, DOI 10.1002/jms.1013
   Laforce R, 2009, CLIN NEUROL NEUROSUR, V111, P691, DOI 10.1016/j.clineuro.2009.05.005
   Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52
   López LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401
   Martí R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615
   Martí R, 2004, CLIN CHEM, V50, P120, DOI 10.1373/clinchem.2003.026179
   Martí R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8
   Nishigaki Y, 2003, J CLIN INVEST, V111, P1913, DOI 10.1172/JCI200317828
   Nishino I, 2000, ANN NEUROL, V47, P792
   Nishino I, 2001, NEUROMUSCULAR DISORD, V11, P7, DOI 10.1016/S0960-8966(00)00159-0
   Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200
   Taanman JW, 2009, NEUROMUSCULAR DISORD, V19, P151, DOI 10.1016/j.nmd.2008.11.002
   Teitelbaum JE, 2002, J PEDIATR GASTR NUTR, V35, P377, DOI 10.1097/00005176-200209000-00029
   Temmink OH, 2007, INT J BIOCHEM CELL B, V39, P565, DOI 10.1016/j.biocel.2006.10.009
   van Kuilenburg ABP, 2005, J CHROMATOGR B, V820, P271, DOI 10.1016/j.jchromb.2005.04.009
   VanKuilenburg ABP, 1997, J INHERIT METAB DIS, V20, P331, DOI 10.1023/A:1005305323052
NR 19
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-8955
EI 1573-2665
J9 J INHERIT METAB DIS
JI J. Inherit. Metab. Dis.
PD DEC
PY 2010
VL 33
SU 3
BP S139
EP S143
DI 10.1007/s10545-010-9049-y
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA V33ME
UT WOS:000209022100021
PM 20151198
OA Green Published
DA 2024-11-01
ER

PT J
AU Ye, CQ
   Lou, WJ
   Li, YR
   Chatzispyrou, IA
   Hüttemann, M
   Lee, I
   Houtkooper, RH
   Vaz, FM
   Chen, SL
   Greenberg, ML
AF Ye, Cunqi
   Lou, Wenjia
   Li, Yiran
   Chatzispyrou, Iliana A.
   Huettemann, Maik
   Lee, Icksoo
   Houtkooper, Riekelt H.
   Vaz, Frederic M.
   Chen, Shuliang
   Greenberg, Miriam L.
TI Deletion of the Cardiolipin-specific Phospholipase Cld1 Rescues Growth
   and Life Span Defects in the Tafazzin Mutant <i>IMPLICATIONS FOR BARTH
   SYNDROME</i>
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE Cardiolipin; Mitochondria; Phospholipase; Phospholipid; Respiration;
   Barth Syndrome; Tafazzin
ID CYTOCHROME-C-OXIDASE; SUPPRESSES TEMPERATURE SENSITIVITY; LINKED
   CARDIOSKELETAL MYOPATHY; ADP/ATP CARRIER PROTEIN; RESPIRATORY-CHAIN;
   SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL-DNA; MASS-SPECTROMETRY; BC(1)
   COMPLEX; UP-REGULATION
AB Background: Cardiolipin (CL) is deacylated by Cld1 to monolysocardiolipin, which is transacylated by tafazzin (Taz1) to form unsaturated CL. Results: Deletion of CLD1 rescues growth and respiration defects in taz1, whereas overexpression is deleterious to growth and respiration. Conclusion: Decreased CL/MLCL, not decreased unsaturated CL, causes defects in tafazzin-deficient cells. Significance: Attenuation of CL phospholipases may potentially treat Barth syndrome.
   Cardiolipin (CL) that is synthesized de novo is deacylated to monolysocardiolipin (MLCL), which is reacylated by tafazzin. Remodeled CL contains mostly unsaturated fatty acids. In eukaryotes, loss of tafazzin leads to growth and respiration defects, and in humans, this results in the life-threatening disorder Barth syndrome. Tafazzin deficiency causes a decrease in the CL/MLCL ratio and decreased unsaturated CL species. Which of these biochemical outcomes contributes to the physiological defects is not known. Yeast cells have a single CL-specific phospholipase, Cld1, that can be exploited to distinguish between these outcomes. The cld1 mutant has decreased unsaturated CL, but the CL/MLCL ratio is similar to that of wild type cells. We show that cld1 rescues growth, life span, and respiratory defects of the taz1 mutant. This suggests that defective growth and respiration in tafazzin-deficient cells are caused by the decreased CL/MLCL ratio and not by a deficiency in unsaturated CL. CLD1 expression is increased during respiratory growth and regulated by the heme activator protein transcriptional activation complex. Overexpression of CLD1 leads to decreased mitochondrial respiration and growth and instability of mitochondrial DNA. However, ATP concentrations are maintained by increasing glycolysis. We conclude that transcriptional regulation of Cld1-mediated deacylation of CL influences energy metabolism by modulating the relative contribution of glycolysis and respiration.
C1 [Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.
   [Huettemann, Maik] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA.
   [Huettemann, Maik] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA.
   [Lee, Icksoo] Dankook Univ, Coll Med, Cheonan Si 330714, Chungcheongnam, South Korea.
   [Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.; Vaz, Frederic M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
C3 Wayne State University; Wayne State University; Wayne State University;
   Dankook University; University of Amsterdam; Academic Medical Center
   Amsterdam
RP Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.
EM mlgreen@sun.science.wayne.edu
RI Houtkooper, Riekelt/P-5001-2019; Vaz, Frederic/JJE-4884-2023; lou,
   wenjia/I-7612-2019; Chen, Shuliang/N-9498-2013
OI Houtkooper, Riekelt/0000-0001-9961-0842; Lou,
   Wenjia/0000-0003-3772-4830; Huttemann, Maik/0000-0001-6310-7081; Vaz,
   Frederic/0000-0002-9048-1041; Chen, Shuliang/0000-0002-7175-7604
FU Barth Syndrome Foundation; Barth Syndrome Foundation of Canada;
   Association Barth France; Wayne State University Thomas C. Rumble
   University Fellowship; Wayne State University Summer Dissertation
   Fellowship; Wayne State University; Academisch Medisch Centrum Ph.D.
   fellowship; ZonMw/Veni [91613050]; AMC
FX This work was supported by grants from the Barth Syndrome Foundation,
   Barth Syndrome Foundation of Canada, and Association Barth France (to M.
   L. G.), Wayne State University Thomas C. Rumble University Fellowship
   and Summer Dissertation Fellowship (to C. Y.), Wayne State University
   graduate enhancement research funds (to C. Y., W. L., and Y. L.),
   Academisch Medisch Centrum Ph.D. fellowship (to I. A. C.), and
   ZonMw/Veni Grant 91613050 and AMC postdoctoral fellowship (to R. H. H.).
CR Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439
   Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733
   Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5
   Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936
   Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200
   BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   Bu Y, 1998, NUCLEIC ACIDS RES, V26, P1002, DOI 10.1093/nar/26.4.1002
   Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829
   Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933
   Chen SL, 2010, J BIOL CHEM, V285, P10397, DOI 10.1074/jbc.M110.100784
   Chen S, 2008, MOL BIOL CELL, V19, P5047, DOI 10.1091/mbc.E08-05-0486
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152
   Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020
   Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896
   DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098
   Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9
   Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497
   EBLE KS, 1990, J BIOL CHEM, V265, P19434
   Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x
   Fontanesi F, 2008, HUM MOL GENET, V17, P775, DOI 10.1093/hmg/ddm349
   Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2
   Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074
   Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200
   Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8
   Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x
   HOSTETLER KY, 1972, BIOCHIM BIOPHYS ACTA, V260, P507, DOI 10.1016/0005-2760(72)90065-3
   Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5
   Houtkooper RH, 2006, FEBS LETT, V580, P3059, DOI 10.1016/j.febslet.2006.04.054
   Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032
   Hsu Y. H., 2013, PLOS ONE, V8
   Hu Jia, 2013, Methods Mol Biol, V965, P463, DOI 10.1007/978-1-62703-239-1_30
   Hüttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10
   JAKOVCIC S, 1971, J CELL BIOL, V48, P490, DOI 10.1083/jcb.48.3.490
   Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x
   Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199
   Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167
   Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024
   KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V
   Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728
   Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007
   KOHRER K, 1991, METHOD ENZYMOL, V194, P398
   Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687
   Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446
   Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591
   LECOCQ J, 1964, BIOCHEMISTRY-US, V3, P976, DOI 10.1021/bi00895a023
   Lee I, 2010, BBA-MOL BASIS DIS, V1802, P275, DOI 10.1016/j.bbadis.2009.10.005
   Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106
   NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x
   Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013
   Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98
   Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200
   PANGBORN MC, 1947, J BIOL CHEM, V168, P351
   Paradies G, 2001, MITOCHONDRION, V1, P151, DOI 10.1016/S1567-7249(01)00011-3
   Paradies G, 1998, FEBS LETT, V424, P155, DOI 10.1016/S0014-5793(98)00161-6
   Paradies G, 2000, FEBS LETT, V466, P323, DOI 10.1016/S0014-5793(00)01082-6
   Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011
   PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3
   Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200
   Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006
   Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9
   Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015
   Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176
   Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022
   Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019
   Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004
   Schüller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8
   Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618
   Su XF, 2006, MOL CELL BIOL, V26, P743, DOI 10.1128/MCB.26.3.743-753.2006
   Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908
   TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z
   Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491
   Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1
   Valianpour F, 2003, J LIPID RES, V44, P560, DOI 10.1194/jlr.M200217-JLR200
   Valianpour F, 2002, CLIN CHEM, V48, P1390
   Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200
   Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952
   Wu JP, 1998, YEAST, V14, P985, DOI 10.1002/(SICI)1097-0061(199808)14:11<985::AID-YEA294>3.3.CO;2-3
   Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200
   Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103
   Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200
   Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808
   Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200
   Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236
NR 87
TC 47
Z9 61
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 7
PY 2014
VL 289
IS 6
BP 3114
EP 3125
DI 10.1074/jbc.M113.529487
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AA8TU
UT WOS:000331368700002
PM 24318983
OA Green Published
DA 2024-11-01
ER

PT J
AU Pinto, M
   Nissanka, N
   Peralta, S
   Brambilla, R
   Diaz, F
   Moraes, CT
AF Pinto, Milena
   Nissanka, Nadee
   Peralta, Susana
   Brambilla, Roberta
   Diaz, Francisca
   Moraes, Carlos T.
TI Pioglitazone ameliorates the phenotype of a novel Parkinson's disease
   mouse model by reducing neuroinflammation
SO MOLECULAR NEURODEGENERATION
LA English
DT Article
DE Mitochondria; Pioglitazone; Neuroinflammation
ID ACTIVATED RECEPTOR-GAMMA; MITOCHONDRIAL-DNA DELETIONS; SKELETAL-MUSCLE;
   SUBSTANTIA-NIGRA; AGONIST PIOGLITAZONE; ANIMAL-MODELS; COMPLEX-I;
   MECHANISMS; NEURONS; MPTP
AB Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The cause of the motor symptoms is the loss of dopaminergic neurons in the substantia nigra with consequent depletion of dopamine in the striatum. Although the etiology of PD is unknown, mitochondrial dysfunctions, including cytochrome c oxidase (Complex IV) impairment in dopaminergic neurons, have been associated with the disease's pathophysiology. In order to analyze the role of Complex IV in PD, we knocked out Cox10 (essential for the maturation of COXI, a catalytic subunit of Complex IV) in dopaminergic neurons. We also tested whether the resulting phenotype was improved by stimulating the PPAR-gamma pathway.
   Results: Cox10/DAT-cre mice showed decreased numbers of TH+ and DAT+ cells in the substantia nigra, early striatal dopamine depletion, motor defects reversible with L-DOPA treatment and hypersensitivity to L-DOPA with hyperkinetic behavior. We found that chronic pioglitazone (PPAR-gamma agonist) treatment ameliorated the motor phenotype in Cox10/DAT-cre mice. Although neither mitochondrial function nor the number of dopaminergic neurons was improved, neuroinflammation in the midbrain and the striatum was decreased.
   Conclusions: By triggering a mitochondrial Complex IV defect in dopaminergic neurons, we created a new mouse model resembling the late stages of PD with massive degeneration of dopaminergic neurons and striatal dopamine depletion. The motor phenotypes were improved by Pioglitazone treatment, suggesting that targetable secondary pathways can influence the development of certain forms of PD.
C1 [Pinto, Milena; Peralta, Susana; Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Dept Neurol, Miller Sch Med, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.
   [Nissanka, Nadee; Brambilla, Roberta] Univ Miami, Miller Sch Med, Neurosci Grad Program, Miami, FL 33136 USA.
   [Brambilla, Roberta] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.
   [Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
C3 University of Miami; University of Miami; University of Miami;
   University of Miami
RP Moraes, CT (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, 1420 NW 9th Ave,Rm 229, Miami, FL 33136 USA.; Moraes, CT (corresponding author), Univ Miami, Miller Sch Med, Dept Cell Biol, Miami, FL 33136 USA.
EM cmoraes@med.miami.edu
RI Moraes, Carlos/AAT-3818-2021; pinto, milena/K-6095-2017
OI pinto, milena/0000-0001-9202-1527; Nissanka, Nadee/0000-0002-4639-7192;
   Brambilla, Roberta/0000-0001-5792-7497
FU US National Institutes of Health [5R01EY010804, 1R01AG036871,
   1R01NS079965]; Florida Department of Health Ed and Ethel Moore
   Alzheimer's Disease Research Program [5AZ06]; Miami Center for AIDS
   Research (CFAR) at the University of Miami Miller School of Medicine;
   National Institutes of Health (NIH) [P30AI073961]
FX This work was supported by the US National Institutes of Health Grants
   5R01EY010804, 1R01AG036871, 1R01NS079965, and the Florida Department of
   Health Ed and Ethel Moore Alzheimer's Disease Research Program grant
   5AZ06.We acknowledge support from the Miami Center for AIDS Research
   (CFAR) at the University of Miami Miller School of Medicine, which is
   funded by a grant (P30AI073961) from the National Institutes of Health
   (NIH).
CR Aviles-Olmos I, 2013, BRAIN, V136, P374, DOI 10.1093/brain/aws009
   Bäckman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Barbiero JK, 2014, BEHAV BRAIN RES, V274, P390, DOI 10.1016/j.bbr.2014.08.014
   Bargiotas P, 2013, NEUROPSYCH DIS TREAT, V9, P1605, DOI 10.2147/NDT.S36693
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Carta AR, 2013, NEUROTOX RES, V23, P112, DOI 10.1007/s12640-012-9342-7
   Cenci MA, 2007, PARKINSONISM RELAT D, V13, pS263, DOI 10.1016/S1353-8020(08)70014-2
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034
   Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307
   Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x
   Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002
   Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9
   Hatami A, 2015, CURR TOP BEHAV NEURO, V22, P303, DOI 10.1007/7854_2014_355
   Heneka MT, 2007, NAT CLIN PRACT NEURO, V3, P496, DOI 10.1038/ncpneuro0586
   Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342
   Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000
   Kim HW, 2015, NEUROBIOL AGING, V36, P2617, DOI 10.1016/j.neurobiolaging.2015.05.008
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Maeshiba Y, 1997, ARZNEIMITTEL-FORSCH, V47, P29
   Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012
   MOGI T, 1994, MOL MICROBIOL, V14, P391, DOI 10.1111/j.1365-2958.1994.tb02174.x
   Morató L, 2013, BRAIN, V136, P2432, DOI 10.1093/brain/awt143
   Napolitano M, 2011, BRAIN RES BULL, V85, P231, DOI 10.1016/j.brainresbull.2011.03.011
   Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125
   Navarro A., 2010, FRONT AGING NEUROSCI, P2
   Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003
   Peralta S, 2015, MITOCHONDRION, V23, P71, DOI 10.1016/j.mito.2015.01.007
   Pickrell AM, 2013, MOL CELL NEUROSCI, V55, P87, DOI 10.1016/j.mcn.2012.08.002
   Pickrell AM, 2011, J NEUROSCI, V31, P17649, DOI 10.1523/JNEUROSCI.4871-11.2011
   Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x
   Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905
   Quinn L, 2008, BRIT J PHARMACOL, V154, P226, DOI 10.1038/bjp.2008.78
   Rocha NP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/628192
   Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2
   Simuni T, 2015, LANCET NEUROL, V14, P795, DOI 10.1016/S1474-4422(15)00144-1
   Swanson C, 2014, NEUROL RES, V36, P634, DOI 10.1179/1743132813Y.0000000305
   Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91
   Ulusoy GK, 2011, BRAIN RES BULL, V85, P380, DOI 10.1016/j.brainresbull.2011.05.001
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012
   Yu Y, 2014, J NEURAL TRANSM, V13
NR 51
TC 57
Z9 61
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1326
J9 MOL NEURODEGENER
JI Mol. Neurodegener.
PD APR 2
PY 2016
VL 11
AR 25
DI 10.1186/s13024-016-0090-7
PG 15
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DI0OS
UT WOS:000373197200001
PM 27038906
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Kim, J
   Daadi, MM
AF Kim, Jeffrey
   Daadi, Marcel M.
TI Non-cell autonomous mechanism of Parkinson's disease pathology caused by
   G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis
SO BRAIN RESEARCH
LA English
DT Review
DE Induced pluripotent stem cells; Neural stem cells; Single cell
   technologies; Mitochondrial function; Non-cell autonomous pathology;
   Parkinson's disease
ID MITOCHONDRIAL COMPLEX-I; KINASE 2 LRRK2; DIAGNOSTIC-CRITERIA;
   SKELETAL-MUSCLE; EARLY ENDOSOMES; GENE; NEURONS; EXPRESSION;
   PHOSPHORYLATION; DIFFERENTIATION
AB Parkinson's disease (PD) is the second most prevalent neurodegenerative disease, characterized by the loss of the midbrain dopaminergic neurons, which leads to impaired motor and cognitive functions. PD is predominantly an idiopathic disease, however about 5% of cases are linked to hereditary mutations. The most common mutation in both familial and sporadic PD is the G2019S mutation of leucine-rich repeat kinase 2 (LRRK2) with high prevalence in Ashkenazi Jewish patients and in North African Berber and Arab patients. It is still not fully understood how this mutation leads to PD pathology. In this study, we derived induced pluripotent stem cells (iPSCs) from an Ashkenazi Jewish patient with G2019S LRRK2 mutation to isolate self-renewable multipotent neural stem cells (NSCs) and to model this form of PD in vitro. To investigate the cellular diversity and disease pathology in the NSCs, we used single cell RNA-seq transcriptomic profiling. The evidence suggests there are three subpopulations within the NSCs: a committed neuronal population, intermediate stage population and undifferentiated stage population. Unbiased single-cell transcriptomic analysis revealed differential expression and dysregulation of genes involved in PD pathology. The significantly affected genes were involved in mitochondrial function, DNA repair, protein degradation, oxidative stress, lysosome biogenesis, ubiquitination, endosome function, autophagy and mitochondrial quality control. The results suggest that G2019S LRRK2 mutation may affect multiple cell types in a non-cell autonomous mechanism of PD pathology and that unbiased single-cell transcriptomics holds promise for personalized medicine.
C1 [Kim, Jeffrey; Daadi, Marcel M.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, POB 760549, San Antonio, TX 78245 USA.
   [Kim, Jeffrey; Daadi, Marcel M.] Dept Cell Syst & Anat, San Antonio, TX USA.
   [Kim, Jeffrey; Daadi, Marcel M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA.
C3 Texas Biomedical Research Institute; University of Texas System;
   University of Texas Health Science Center at San Antonio
RP Daadi, MM (corresponding author), Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, POB 760549, San Antonio, TX 78245 USA.
EM mdaadi@txbiomed.org
OI Kim, Jeffrey/0000-0001-7091-0542
FU Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Perry & Ruby
   Stevens Charitable Foundation; Marmion Family Fund; Worth Family Fund;
   NIH [P51 OD011133, R56 AG059284]
FX This work was supported by the Robert J. Kleberg, Jr. and Helen C.
   Kleberg Foundation, The Perry & Ruby Stevens Charitable Foundation, the
   Marmion Family Fund, the Worth Family Fund, NIH P51 OD011133 and NIH R56
   AG059284 to MD.
CR Araki M, 2002, NEUROSCI RES, V44, P379, DOI 10.1016/S0168-0102(02)00156-6
   Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007
   Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111
   Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019
   BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8
   Borgs L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33377
   Boulet A., 2017, J BIOL CHEM, P1
   Braak H, 1995, J NEURAL TRANSM-SUPP, P15
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71
   Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935
   Cooper P, 2012, INT J EMOT EDUC, V4, P1
   Daadi MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001644
   Daadi MM, 2019, METHODS MOL BIOL, V1919, P1, DOI 10.1007/978-1-4939-9007-8_1
   Daadi MM, 1999, J NEUROSCI, V19, P4484
   Dächsel JC, 2010, ARCH NEUROL-CHICAGO, V67, P542, DOI 10.1001/archneurol.2010.79
   de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9
   Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060
   Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507
   Fung HC, 2006, MOVEMENT DISORD, V21, P880, DOI 10.1002/mds.20814
   Gandhi PN, 2009, J NEUROSCI RES, V87, P1283, DOI 10.1002/jnr.21949
   Gao F, 2015, HUM MOL GENET, V24, P2528, DOI 10.1093/hmg/ddv017
   Garcia-Miralles M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118947
   Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33
   Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1
   Greggio E., 2006, NEUROBIOL DIS
   Hanagasi HA, 2005, INT J NEUROSCI, V115, P479, DOI 10.1080/00207450590523017
   Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0
   Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181
   Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080
   Ida M, 2004, NEUROSCI RES, V50, P199, DOI 10.1016/j.neures.2004.06.018
   Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163
   Isosomppi J, 2002, HUM MOL GENET, V11, P885, DOI 10.1093/hmg/11.8.885
   Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209
   Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045
   JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935
   Kalinderi K, 2007, EUR J NEUROL, V14, P1088, DOI 10.1111/j.1468-1331.2007.01867.x
   Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289
   Kim J, 2019, METHODS MOL BIOL, V1919, P145, DOI 10.1007/978-1-4939-9007-8_11
   Kim J, 2019, METHODS MOL BIOL, V1919, P129, DOI 10.1007/978-1-4939-9007-8_10
   Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540
   Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006
   Luzón-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151
   MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008
   Marras C, 2016, MOVEMENT DISORD, V31, P1192, DOI 10.1002/mds.26614
   Marrone L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192497
   Migheli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077198
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Noureddine MA, 2005, MOVEMENT DISORD, V20, P1299, DOI 10.1002/mds.20573
   Ohnishi T., 2017, Scientific reports, V7, P1
   Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509
   Paisán-Ruíz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023
   Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318
   Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009
   Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324
   Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x
   Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448
   Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098
   Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445
   Sánchez-Danés A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215
   Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576
   Sandor C, 2017, HUM MOL GENET, V26, P552, DOI 10.1093/hmg/ddw412
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104
   Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066
   Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003
   Shin N, 2008, EXP CELL RES, V314, P2055, DOI 10.1016/j.yexcr.2008.02.015
   Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776
   Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Tan EK, 2005, NEUROSCI LETT, V384, P327, DOI 10.1016/j.neulet.2005.04.103
   Tan EK, 2007, MOVEMENT DISORD, V22, P105, DOI 10.1002/mds.21206
   Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]
   Tomiyama H, 2006, MOVEMENT DISORD, V21, P1102, DOI 10.1002/mds.20886
   West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102
   Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008
   Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X
   Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098
   Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727
   Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005
NR 88
TC 7
Z9 8
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD NOV 1
PY 2019
VL 1722
AR 146342
DI 10.1016/j.brainres.2019.146342
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA JF3QF
UT WOS:000491301400024
PM 31330122
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Yu, M
   Zhang, Z
   Wang, QQ
   Liu, J
   Zuo, YH
   Yu, L
   Xiao, JX
   Zhang, W
   Yuan, Y
   Wang, ZX
AF Yu, Meng
   Zhang, Zhe
   Wang, Qing-Qing
   Liu, Jing
   Zuo, Yue-Huan
   Yu, Lei
   Xiao, Jiang-Xi
   Zhang, Wei
   Yuan, Yun
   Wang, Zhao-Xia
TI Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of
   Chinese Patients with Kearns-Sayre Syndrome
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Brain Magnetic Resonance Imaging; Heart Conduction Block; Kearns-Sayre
   Syndrome
ID MITOCHONDRIAL-DNA DELETIONS; EXTERNAL OPHTHALMOPLEGIA; MRI FINDINGS;
   DISEASE; SINGLE
AB Background: Kearns-Sayre syndrome (KSS) is a mitochondrial DNA (mtDNA) deletion disorder characterized by a triad of onset before 20 years of age, ophthalmoplegia, and pigmentary retinopathy. The heart and central nervous system are commonly involved. We summarized clinical and brain magnetic resonance imaging (MRI) features of a cohort of Chinese KSS patients.
   Methods: Nineteen patients confirmed by muscle biopsy and mtDNA analysis were enrolled. We examined clinical profiles, mainly focusing on changes in electrocardiogram (ECG) and brain MRL The correlation between genotype and phenotype was statistically analyzed.
   Results: The mean age of onset was 9.6 +/- 4.3 years, with all developing the classic triad at the time of diagnosis. Heart conduction block was detected in 63.2%, with four initially presenting as bundle branch block and developing into complete atrioventricular block over 3-72 months. Brain MRI showed symmetric high-T2 signals in 100% of cerebral and cerebellar white matter, as well as brainstem, 46.7% of basal ganglia, and 53.3% of thalamus. There were two patterns of cerebral white matter involvements, one with selective subcortical U-fibers and the other with periventricular white matter. The size of mtDNA deletion did not significantly correlate with age of onset or percentage of ragged blue fibers on muscle pathology.
   Conclusions: The clinical features of KSS evolve dynamically, affecting the cardiac conduction system predominantly, highlighting the significance of ECG monitoring. Brain MRI showed changes involving both the white matter and deep gray nuclei. Clinical presentation or severity of muscle pathological changes is not related to the size of mtDNA deletions.
C1 [Yu, Meng; Zhang, Zhe; Wang, Qing-Qing; Liu, Jing; Zuo, Yue-Huan; Zhang, Wei; Yuan, Yun; Wang, Zhao-Xia] Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
   [Yu, Lei; Xiao, Jiang-Xi] Peking Univ, Dept Radiol, Hosp 1, Beijing 100034, Peoples R China.
C3 Peking University; Peking University
RP Wang, ZX (corresponding author), Peking Univ, Dept Neurol, Hosp 1, 8 Xishiku St, Beijing 100034, Peoples R China.
EM drwangzx@163.com
FU Ministry of Science and Technology of China [2011ZX09307-001-07];
   Beijing Municipal Science and Technology Commission [Z151100003915126]
FX This work was supported by grants from the Ministry of Science and
   Technology of China (No. 2011ZX09307-001-07) and Beijing Municipal
   Science and Technology Commission (No. Z151100003915126).
CR Agrawal H, 2013, PEDIATR CARDIOL, V34, P1044, DOI 10.1007/s00246-012-0365-x
   Berardo A, 2010, CURR NEUROL NEUROSCI, V10, P118, DOI 10.1007/s11910-010-0096-4
   [方方 Fang Fang], 2011, [中国循证儿科杂志, Chinese Journal of Evidence Based Pediatrics], V6, P431
   Filosto M, 2007, BIOSCIENCE REP, V27, P23, DOI 10.1007/s10540-007-9034-3
   Grady JP, 2014, BRAIN, V137, P323, DOI 10.1093/brain/awt321
   Kabunga P, 2015, INT J CARDIOL, V181, P303, DOI 10.1016/j.ijcard.2014.12.038
   Kamata Y, 1998, J NEURO-OPHTHALMOL, V18, P284
   KEARNS TP, 1958, ARCH OPHTHALMOL-CHIC, V60, P280, DOI 10.1001/archopht.1958.00940080296016
   Khambatta S, 2014, INT J GEN MED, V7, P325, DOI 10.2147/IJGM.S65560
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008
   [刘祺 Liu Qi], 2015, [中华神经科杂志, Chinese Journal of Neurology], V48, P382
   Liu YH, 2014, CHINESE MED J-PEKING, V127, P2304, DOI 10.3760/cma.j.issn.0366-6999.20132799
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   NAKAGAWA E, 1994, BRAIN DEV-JPN, V16, P416, DOI 10.1016/0387-7604(94)90133-3
   Park SB, 2004, YONSEI MED J, V45, P727, DOI 10.3349/ymj.2004.45.4.727
   Phadke M, 2012, INDIAN J PEDIATR, V79, P650, DOI 10.1007/s12098-011-0618-3
   Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z
   Saneto RP, 2008, MITOCHONDRION, V8, P396, DOI 10.1016/j.mito.2008.05.003
   Schoser BGH, 2006, STRABISMUS, V14, P107, DOI 10.1080/09273970600701218
   Serrano M, 2010, MITOCHONDRION, V10, P429, DOI 10.1016/j.mito.2010.04.001
   van Beynum I, 2012, JIMD REP, V2, P7, DOI 10.1007/8904_2011_32
   WRAY SH, 1995, AM J NEURORADIOL, V16, P1167
   Yamashita S, 2008, J HUM GENET, V53, P598, DOI 10.1007/s10038-008-0289-8
   Yau Eric K. C., 2009, Hong Kong Medical Journal, V15, P374
   Zeviani M, 1998, NEUROLOGY, V51, P1525, DOI 10.1212/WNL.51.6.1525-a
NR 26
TC 18
Z9 20
U1 0
U2 8
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD JUN 20
PY 2016
VL 129
IS 12
BP 1419
EP 1424
DI 10.4103/0366-6999.183417
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA DT1DC
UT WOS:000381220900006
PM 27270536
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Gerards, M
   van den Bosch, BJC
   Danhauser, K
   Serre, V
   van Weeghel, M
   Wanders, RJA
   Nicolaes, GAF
   Sluiter, W
   Schoonderwoerd, K
   Scholte, HR
   Prokisch, H
   Rötig, A
   de Coo, IFM
   Smeets, HJM
AF Gerards, Mike
   van den Bosch, Bianca J. C.
   Danhauser, Katharina
   Serre, Valerie
   van Weeghel, Michel
   Wanders, Ronald J. A.
   Nicolaes, Gerry A. F.
   Sluiter, Wim
   Schoonderwoerd, Kees
   Scholte, Hans R.
   Prokisch, Holger
   Roetig, Agnes
   de Coo, Irenaeus F. M.
   Smeets, Hubert J. M.
TI Riboflavin-responsive oxidative phosphorylation complex I deficiency
   caused by defective <i>ACAD9</i>: new function for an old gene
SO BRAIN
LA English
DT Article
DE ACAD9; oxidative phosphorylation; riboflavin
ID HEREDITARY OPTIC NEUROPATHY; MITOCHONDRIAL-COMPLEX; LEIGH-SYNDROME;
   RESPIRATORY-CHAIN; BETA-OXIDATION; ND3 GENE; MUTATION; DISEASE; SUBUNIT;
   DNA
AB Mitochondrial complex I deficiency is the most common oxidative phosphorylation defect. Mutations have been detected in mitochondrial and nuclear genes, but the genetics of many patients remain unresolved and new genes are probably involved. In a consanguineous family, patients presented easy fatigability, exercise intolerance and lactic acidosis in blood from early childhood. In muscle, subsarcolemmal mitochondrial proliferation and a severe complex I deficiency were observed. Exercise intolerance and complex I activity was improved by a supplement of riboflavin at high dosage. Homozygosity mapping revealed a candidate region on chromosome three containing six mitochondria-related genes. Four genes were screened for mutations and a homozygous substitution was identified in ACAD9 (c.1594C > T), changing the highly conserved arginine-532 into tryptophan. This mutation was absent in 188 ethnically matched controls. Protein modelling suggested a functional effect due to the loss of a stabilizing hydrogen bond in an alpha-helix and a local flexibility change. To test whether the ACAD9 mutation caused the complex I deficiency, we transduced fibroblasts of patients with wild-type and mutant ACAD9. Wild-type, but not mutant, ACAD9 restored complex I activity. An unrelated patient with the same phenotype was compound heterozygous for c.380G > A and c.1405C > T, changing arginine-127 into glutamine and arginine-469 into tryptophan, respectively. These amino acids were highly conserved and the substitutions were not present in controls, making them very probably pathogenic. Our data support a new function for ACAD9 in complex I function, making this gene an important new candidate for patients with complex I deficiency, which could be improved by riboflavin treatment.
C1 [Gerards, Mike; van den Bosch, Bianca J. C.; Smeets, Hubert J. M.] Maastricht Univ, Clin Genom Unit, Dept Genet & Cell Biol, NL-6200 MD Maastricht, Netherlands.
   [Gerards, Mike; van den Bosch, Bianca J. C.; Smeets, Hubert J. M.] Maastricht Univ, Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands.
   [Danhauser, Katharina; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, Munich, Germany.
   [Danhauser, Katharina] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Serre, Valerie; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.
   [Serre, Valerie; Roetig, Agnes] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [van Weeghel, Michel; Wanders, Ronald J. A.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem,Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands.
   [Nicolaes, Gerry A. F.] Maastricht Univ, Cardiovasc Res Inst, Dept Biochem, NL-6200 MD Maastricht, Netherlands.
   [Sluiter, Wim] Erasmus MC, Ctr Lysosomal & Metab Dis, Rotterdam, Netherlands.
   [Schoonderwoerd, Kees] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.
   [Scholte, Hans R.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.
   [de Coo, Irenaeus F. M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
C3 Maastricht University; Maastricht University; Technical University of
   Munich; Helmholtz Association; Helmholtz-Center Munich - German Research
   Center for Environmental Health; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite Paris Cite; Assistance Publique Hopitaux
   Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Vrije
   Universiteit Amsterdam; Emma Children's Hospital; University of
   Amsterdam; Academic Medical Center Amsterdam; Maastricht University;
   Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam;
   Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University
   Rotterdam; Erasmus MC
RP Smeets, HJM (corresponding author), Maastricht Univ, Clin Genom Unit, Dept Genet & Cell Biol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM Bert.Smeets@maastrichtuniversity.nl
RI van Weeghel, Michel/A-2766-2010; Prokisch, Holger/N-8964-2013; ROTIG,
   AGNES/G-9592-2017; Nicolaes, Gerry/A-8421-2016
OI Gerards, Mike/0000-0003-4886-8055; Prokisch, Holger/0000-0003-2379-6286;
   ROTIG, AGNES/0000-0003-0589-0703; van Weeghel,
   Michel/0000-0002-4916-2866; Nicolaes, Gerry/0000-0002-2482-0412; de Coo,
   Irenaeus/0000-0003-0533-7422
FU EU [005260]; Helmholtz Association in the framework of the Helmholtz
   Alliance for Mental Health in an Ageing Society [HA-215]; German Network
   for Mitochondrial Disorders [01GM0862, 01GM0867]; Systems Biology of
   Metabotypes [0315494A]
FX Our work was supported by a EU grant to the MitoCircle project (Sixth
   Framework Program, contr. no. 005260). H. P. was supported by the
   Impulse and Networking Fund of the Helmholtz Association in the
   framework of the Helmholtz Alliance for Mental Health in an Ageing
   Society (HA-215), the German Network for Mitochondrial Disorders
   (mitoNET #01GM0862 and 01GM0867) and Systems Biology of Metabotypes
   (SysMBo #0315494A).
CR Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786
   BAKKER HD, 1994, J INHERIT METAB DIS, V17, P196, DOI 10.1007/BF00711617
   Bénit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316
   Bénit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332
   BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B
   Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200
   de Wit LEA, 2008, CLIN CHEM, V54, P1921, DOI 10.1373/clinchem.2008.104802
   Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748
   Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200
   Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Gerards M, 2010, J MED GENET, V47, P507, DOI 10.1136/jmg.2009.067553
   Grad LI, 2006, BBA-BIOENERGETICS, V1757, P115, DOI 10.1016/j.bbabio.2005.11.009
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   Hoefs SJG, 2008, AM J HUM GENET, V82, P1306, DOI 10.1016/j.ajhg.2008.05.007
   HUOPONEN K, 1991, AM J HUM GENET, V48, P1147
   JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5
   King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116
   Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   MATTHEWS PM, 1993, NEUROLOGY, V43, P2484, DOI 10.1212/WNL.43.12.2484
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7
   NAGAO M, 1992, J BIOL CHEM, V267, P17925
   Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5
   Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020
   Olsen RKJ, 2007, BRAIN, V130, P2045, DOI 10.1093/brain/awm135
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saada A, 2009, AM J HUM GENET, V84, P718, DOI 10.1016/j.ajhg.2009.04.020
   SAIJO T, 1995, J BIOL CHEM, V270, P1899, DOI 10.1074/jbc.270.4.1899
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350
   Sgobbo P, 2007, BBA-BIOENERGETICS, V1767, P222, DOI 10.1016/j.bbabio.2007.01.023
   SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Taylor RW, 2002, EUR J HUM GENET, V10, P141, DOI 10.1038/sj.ejhg.5200773
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6
   van den Bosch BJC, 2005, CARDIOVASC RES, V65, P411, DOI 10.1016/j.cardiores.2004.10.025
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   Vockley J, 2008, J INHERIT METAB DIS, V31, P619, DOI 10.1007/s10545-008-1005-8
   Vogel RO, 2007, BBA-BIOENERGETICS, V1767, P1215, DOI 10.1016/j.bbabio.2007.07.008
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
NR 50
TC 98
Z9 109
U1 0
U2 17
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD JAN
PY 2011
VL 134
BP 210
EP 219
DI 10.1093/brain/awq273
PN 1
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 698WK
UT WOS:000285625000019
PM 20929961
DA 2024-11-01
ER

PT J
AU Varela-Lopez, A
   Pérez-López, MP
   Ramirez-Tortosa, CL
   Battino, M
   Granados-Principal, S
   Ramirez-Tortosa, MD
   Ochoa, JJ
   Vera-Ramirez, L
   Giampieri, F
   Quiles, JL
AF Varela-Lopez, Alfonso
   Patricia Perez-Lopez, Maria
   Luis Ramirez-Tortosa, Cesar
   Battino, Maurizio
   Granados-Principal, Sergio
   del Carmen Ramirez-Tortosa, Maria
   Jose Ochoa, Julio
   Vera-Ramirez, Laura
   Giampieri, Francesca
   Luis Quiles, Jose
TI Gene pathways associated with mitochondrial function, oxidative stress
   and telomere length are differentially expressed in the liver of rats
   fed lifelong on virgin olive, sunflower or fish oils
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Gene expression; Mitochondria; MUFA; Oxidative stress; PUFA; Telomere
ID AGE-RELATED-CHANGES; QUANTITATIVE PCR; SKELETAL-MUSCLE; DNA DELETION;
   DISEASE; ACID; DIET; STEATOHEPATITIS; PROTEINS; SUPPLEMENTATION
AB This study investigates the effect of lifelong intake of different fat sources rich in monounsaturated (virgin olive oil), n6 polyunsaturated (sunflower oil) or n3 polyunsaturated (fish oil) fatty acids in the aged liver. Male Wistar rats fed lifelong on diets differing in the fat source were killed at 6 and at 24 months of age. Liver histopathology, mitochondrial ultrastructure, biogenesis, oxidative stress, mitochondrial electron transport chain, relative telomere length and gene expression profiles were studied. Aging led to lipid accumulation in the liver. Virgin olive oil led to the lowest oxidation and ultrastructural alterations. Sunflower oil induced fibrosis, ultrastructural alterations and high oxidation. Fish oil intensified oxidation associated with age, lowered electron transport chain activity and enhanced the relative telomere length. Gene expression changes associated with age in animals fed virgin olive oil and fish oil were related mostly to mitochondria] function and oxidative stress pathways, followed by cell cycle and telomere length control. Sunflower oil avoided gene expression changes related to age. According to the results, virgin olive oil might be considered the dietary fat source that best preserves the liver during the aging process. (C) 2017 Published by Elsevier Inc.
C1 [Varela-Lopez, Alfonso; Patricia Perez-Lopez, Maria; Jose Ochoa, Julio; Luis Quiles, Jose] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Physiol, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Luis Ramirez-Tortosa, Cesar] Complejo Hosp Jaen, Dept Pathol, Av Ejercito Espanol 10, Jaen 23007, Spain.
   [Battino, Maurizio; Giampieri, Francesca] Univ Politecn Marche, Dip Sci Clin Specialist & Odontostomatol, Via Ranieri 65, I-60131 Ancona, Italy.
   [Granados-Principal, Sergio] Hosp Complex Jaen, Dept Oncol, Av Ilustrac 114, Granada 18007, Spain.
   [Granados-Principal, Sergio] Univ Granada Junta Andalucia Genom & Invest Oncol, Ctr Pfizer, Av Ilustrac 114, Granada 18007, Spain.
   [del Carmen Ramirez-Tortosa, Maria] Univ Granada, Inst Nutr & Food Technol Jose Mataix Verdu, Dept Biochem & Mol Biol 2, Biomed Res Ctr, Av Conocimiento S-N, Armilla 18100, Granada, Spain.
   [Vera-Ramirez, Laura] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.
C3 University of Granada; Complejo Hospitalario de Jaen; Marche Polytechnic
   University; Pfizer; University of Granada; National Institutes of Health
   (NIH) - USA; NIH National Cancer Institute (NCI)
RP Quiles, JL (corresponding author), Inst Nutr & Tecnol Alimentos Jose Mataix Verdu, Dept Fisiol, Lab 250,Parque Tecnol Ciencias Salud, Armilla 18100, Granada, Spain.
EM alvarela@ugr.es; patriciapl@ugr.es;
   cesarl.ramirez.sspa@juntadeandalucia.es; m.a.battino@univpm.it;
   sgranados@fibao.es; mramirez@ugr.es; jjoh@ugr.es;
   laura.veraramirez@nih.gov; f.giampieri@univpm.it; jlquiles@ugr.es
RI Battino, Maurizio/E-6103-2012; Ramírez-Tortosa, César/F-2055-2016;
   Granados-Principal, Sergio/B-4987-2014; Ochoa, Julio/L-8733-2014;
   Quiles, Jose L./C-6911-2013; Vera Ramirez, Laura/S-3375-2018; Giampieri,
   Francesca/I-1911-2015; Varela-Lopez, Alfonso/F-8055-2016
OI Granados-Principal, Sergio/0000-0001-8773-9489; Ochoa,
   Julio/0000-0001-8976-6296; Quiles, Jose L./0000-0002-9048-9086; Vera
   Ramirez, Laura/0000-0001-9184-9875; Giampieri,
   Francesca/0000-0002-8151-9132; Varela-Lopez, Alfonso/0000-0002-0504-5086
FU Spanish Ministry of Education and Science [AGL2008-01057]; Government of
   Andalusia [AGR832]; CEI BioTic Granada [CEI2013-P-20]; FPU program from
   the Spanish Ministry of Education; FPI program from the Spanish Ministry
   of Education
FX This work was supported by I+D grants from the Spanish Ministry of
   Education and Science (AGL2008-01057), the Government of Andalusia
   (AGR832) and CEI BioTic Granada (CEI2013-P-20). A. Varela-Lopez and P.
   Perez-Lopez were recipients, respectively, of a fellowship of FPU and
   FPI programs from the Spanish Ministry of Education.
CR AI-Dwairi A, 2012, PLOS ONE, V7
   Amano A, 2013, J NUTR SCI VITAMINOL, V59, P489, DOI 10.3177/jnsv.59.489
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X
   Bakala H, 2013, BBA-MOL BASIS DIS, V1832, P2057, DOI 10.1016/j.bbadis.2013.07.015
   Barden A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030175
   Bardia A, 2012, INFLAMM RES, V61, P359, DOI 10.1007/s00011-011-0418-2
   Barja G, 2013, ANTIOXID REDOX SIGN, V19, P1420, DOI 10.1089/ars.2012.5148
   Bose C, 2005, MECH AGEING DEV, V126, P740, DOI 10.1016/j.mad.2005.02.003
   Cakatay Ufuk, 2013, Curr Aging Sci, V6, P135
   Ramirez-Tortosa MC, 2009, FREE RADICAL BIO MED, V47, P924, DOI 10.1016/j.freeradbiomed.2009.06.015
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Chou HC, 2007, CANCER LETT, V253, P138, DOI 10.1016/j.canlet.2007.01.016
   Clichici S, 2011, ACTA PHYSIOL HUNG, V98, P195, DOI 10.1556/APhysiol.98.2011.2.11
   Cogger VC, 2014, J GERONTOL A-BIOL, V69, P1076, DOI 10.1093/gerona/glt169
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Diamanti J, 2014, J AGR FOOD CHEM
   Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008
   Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132
   Fleischer S, 1979, Methods Enzymol, V55, P32
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan L., 2011, CURR GERONTOL GERIAT
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hsieh CC, 2003, MECH AGEING DEV, V124, P733, DOI 10.1016/S0047-6374(03)00083-6
   Jiang WQ, 2012, CANCER RES, V72, P3795, DOI 10.1158/0008-5472.CAN-12-1047
   Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Li SP, 2016, J NUTR BIOCHEM, V27, P96, DOI 10.1016/j.jnutbio.2015.08.021
   Lin CF, 2007, J CELL SCI, V120, P2935, DOI 10.1242/jcs.03473
   Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Cruzan M, 2013, BIOGERONTOLOGY, V14, P121, DOI 10.1007/s10522-013-9415-x
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   O'Leary MF, 2013, AM J PHYSIOL-CELL PH, V304, pC422, DOI 10.1152/ajpcell.00240.2012
   Ochoa JJ, 2003, J BIOENERG BIOMEMBR, V35, P267, DOI 10.1023/A:1024615816839
   Ochoa JJ, 2007, J GERONTOL A-BIOL, V62, P1211, DOI 10.1093/gerona/62.11.1211
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Ochoa-Herrera JJ, 2001, J NUTR BIOCHEM, V12, P357, DOI 10.1016/S0955-2863(01)00150-4
   Penumathsa SV, 2006, TOXICOL MECH METHOD, V16, P267, DOI 10.1080/15376520500194734
   Pereira AF, 2012, J BIOENERG BIOMEMBR, V44, P587, DOI 10.1007/s10863-012-9463-y
   Picca A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074644
   Pierce AA, 2016, J NUTR BIOCHEM, V29, P12, DOI 10.1016/j.jnutbio.2015.10.020
   Port M, 2012, HEALTH PHYS, V103, P159, DOI 10.1097/HP.0b013e31824ac318
   Quiles JL, 2006, J GERONTOL A-BIOL, V61, P107, DOI 10.1093/gerona/61.2.107
   Quiles JL, 2004, EXP GERONTOL, V39, P1189, DOI 10.1016/j.exger.2004.05.002
   Quiles JL, 2002, BRIT J NUTR, V88, P57, DOI 10.1079/BJNBJN2002588
   Quiles JL, 2004, ENDOCRINOL NUTR, V51, P107
   Quiles JL, 2010, MECH AGEING DEV, V131, P38, DOI 10.1016/j.mad.2009.11.004
   Rasband WS, IMAGEJ SOFTWARE, P1997
   Reeves PG, 1997, J NUTR, V127, pS838
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Sohal RS, 2012, FREE RADICAL BIO MED, V52, P539, DOI 10.1016/j.freeradbiomed.2011.10.445
   Solanas M, 2010, CARCINOGENESIS, V31, P871, DOI 10.1093/carcin/bgp243
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Tao LL, 2012, CHIN J INTEGR MED, V18, P582, DOI 10.1007/s11655-012-1180-1
   Yeh MM, 2007, AM J CLIN PATHOL, V128, P837, DOI 10.1309/RTPM1PY6YGBL2G2R
NR 61
TC 35
Z9 35
U1 1
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD FEB
PY 2018
VL 52
BP 36
EP 44
DI 10.1016/j.jnutbio.2017.09.007
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA FX1VQ
UT WOS:000425840400005
PM 29144994
OA Green Published
DA 2024-11-01
ER

PT J
AU Sharma, S
   Aldred, MA
AF Sharma, Samantha
   Aldred, Micheala A.
TI DNA Damage and Repair in Pulmonary Arterial Hypertension
SO GENES
LA English
DT Review
DE pulmonary arterial hypertension; endothelial cells; smooth muscle cells;
   DNA damage; DNA repair
ID SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; EXCISION-REPAIR; RECEPTOR; ATR;
   INFLAMMATION; MUTATIONS; APOPTOSIS; SURVIVAL; HYPOXIA
AB Pulmonary arterial hypertension (PAH) is a complex multifactorial disease with both genetic and environmental dynamics contributing to disease progression. Over the last decade, several studies have demonstrated the presence of genomic instability and increased levels of DNA damage in PAH lung vascular cells, which contribute to their pathogenic apoptosis-resistant and proliferating characteristics. In addition, the dysregulated DNA damage response pathways have been indicated as causal factors for the presence of persistent DNA damage. To understand the significant implications of DNA damage and repair in PAH pathogenesis, the current review summarizes the recent advances made in this field. This includes an overview of the observed DNA damage in the nuclear and mitochondrial genome of PAH patients. Next, the irregularities observed in various DNA damage response pathways and their role in accumulating DNA damage, escaping apoptosis, and proliferation under a DNA damaging environment are discussed. Although the current literature establishes the pertinence of DNA damage in PAH, additional studies are required to understand the temporal sequence of the above-mentioned events. Further, an exploration of different types of DNA damage in conjunction with associated impaired DNA damage response in PAH will potentially stimulate early diagnosis of the disease and development of novel therapeutic strategies.
C1 [Sharma, Samantha; Aldred, Micheala A.] Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Sch Med, Indianapolis, IN 46202 USA.
C3 Indiana University System; Indiana University Indianapolis
RP Aldred, MA (corresponding author), Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Dept Med, Sch Med, Indianapolis, IN 46202 USA.
EM samshar@iu.edu; maaldred@iu.edu
RI Sharma, Dr. Samantha/AAY-7184-2021
OI SHARMA, Dr. SAMANTHA/0000-0001-9599-4455
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R35HL140019]
FX The authors are supported by the National Heart, Lung, and Blood
   Institute of the National Institutes of Health under Award Number
   R35HL140019. The content of this work is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Boucherat O, 2018, AM J RESP CRIT CARE, V198, P90, DOI 10.1164/rccm.201708-1751OC
   Boucherat O, 2017, PULM CIRC, V7, P285, DOI 10.1177/2045893217701438
   Bourgeois A, 2019, ARTERIOSCL THROM VAS, V39, P1667, DOI 10.1161/ATVBAHA.119.312537
   Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7
   Carrassa L, 2004, CELL CYCLE, V3, P1177
   Chan N, 2014, MOL CANCER RES, V12, P1407, DOI 10.1158/1541-7786.MCR-14-0246
   Chen PI, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90427
   Cohen-Kaminsky S, 2014, DRUG DISCOV TODAY, V19, P1251, DOI 10.1016/j.drudis.2014.04.007
   Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   DeMarco VG, 2010, WORLD J CARDIOL, V2, P316, DOI 10.4330/wjc.v2.i10.316
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Diebold I, 2015, CELL METAB, V21, P596, DOI 10.1016/j.cmet.2015.03.010
   Drake KM, 2017, PULM CIRC, V7, P421, DOI 10.1177/2045893217700901
   Drake KM, 2015, AM J RESP CRIT CARE, V191, P850, DOI 10.1164/rccm.201411-1985LE
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fessel JP, 2015, PULM CIRC, V5, P599, DOI 10.1086/683814
   GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W
   Gräf S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03672-4
   Guignabert C, 2009, AM J PHYSIOL-LUNG C, V297, pL1082, DOI 10.1152/ajplung.00199.2009
   Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200
   Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231
   Heikal AA, 2010, BIOMARK MED, V4, P241, DOI 10.2217/BMM.10.1
   Hoeper MM, 2016, LANCET RESP MED, V4, P323, DOI 10.1016/S2213-2600(15)00542-1
   Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3
   Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004
   Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003
   Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0
   Kherbeck N, 2013, CLIN REV ALLERG IMMU, V44, P31, DOI 10.1007/s12016-011-8265-z
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Lampron MC, 2020, ARTERIOSCL THROM VAS, V40, P783, DOI 10.1161/ATVBAHA.119.313763
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Lau EMT, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.84
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Li CYG, 2019, CELL REP, V26, P1333, DOI 10.1016/j.celrep.2019.01.013
   Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Liu QH, 2000, GENE DEV, V14, P1448
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Loyd James E, 2011, Proc Am Thorac Soc, V8, P154, DOI 10.1513/pats.201007-047MS
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2005, CIRCULATION, V111, P607, DOI 10.1161/01.CIR.0000154543.07679.08
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000
   McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004
   Meloche J, 2015, AM J PHYSIOL-CELL PH, V309, pC363, DOI 10.1152/ajpcell.00149.2015
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Modesti M, 2001, GENOME BIOL, V2
   Morrell NW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01899-2018
   Murata MM, 2019, MOL BIOL CELL, V30, P2584, DOI 10.1091/mbc.E18-10-0650
   Paulin R, 2011, AM J PHYSIOL-HEART C, V301, pH1798, DOI 10.1152/ajpheart.00654.2011
   Perez VD, 2011, INT J CLIN PRACT, V65, P8, DOI 10.1111/j.1742-1241.2010.02606.x
   Perez VADJ, 2014, AM J RESP CRIT CARE, V189, P1260, DOI [10.1164/rccm.201310-17490C, 10.1164/rccm.201310-1749OC]
   Perros F, 2015, CIRCULATION, V132, P834, DOI 10.1161/CIRCULATIONAHA.115.014207
   Pilié PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z
   Potus F, 2014, PULM CIRC, V4, P175, DOI 10.1086/675980
   Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658
   Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609
   Rhodes CJ, 2019, LANCET RESP MED, V7, P227, DOI [10.1016/S2213-2600(18)30409-0, 10.1016/s2213-2600(18)30409-0]
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355
   Scanlon SE, 2015, DNA REPAIR, V32, P180, DOI 10.1016/j.dnarep.2015.04.030
   Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703
   Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018
   Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762
   Tuder RM, 1998, AM J RESP CRIT CARE, V158, P1999, DOI 10.1164/ajrccm.158.6.9805002
   Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025
   van Houten B, 2015, AM J RESP CRIT CARE, V192, P129, DOI 10.1164/rccm.201505-0904ED
   Vattulainen-Collanus S, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0152-1
   Voelkel NF, 1998, CHEST, V114, p225S, DOI 10.1378/chest.114.3_Supplement.225S
   Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103
   Wang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12226-1
   Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5
   Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013
   Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamamoto BK, 2008, J NEUROIMMUNE PHARM, V3, P203, DOI 10.1007/s11481-008-9121-7
   Yeager ME, 2001, CIRC RES, V88, pE2
   Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001
   Zhu N, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0685-z
NR 91
TC 21
Z9 21
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD OCT
PY 2020
VL 11
IS 10
AR 1224
DI 10.3390/genes11101224
PG 18
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA ON7KE
UT WOS:000586874100001
PM 33086628
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ozes, B
   Moss, K
   Myers, M
   Ridgley, A
   Chen, L
   Murrey, D
   Sahenk, Z
AF Ozes, Burcak
   Moss, Kyle
   Myers, Morgan
   Ridgley, Alicia
   Chen, Lei
   Murrey, Darren
   Sahenk, Zarife
TI AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in
   <i>Gars<SUP>P278KY/+</SUP></i> mice
SO BRAIN COMMUNICATIONS
LA English
DT Article
DE NT-3; CMT2D; gars; AAV
ID DISEASE TYPE 2D; MITOCHONDRIAL-DNA; MAMMALIAN TARGET; SKELETAL-MUSCLE;
   GROWTH-FACTOR; MOUSE MODELS; NEUROPATHY; MUTATIONS; NERVE;
   NEUROTROPHIN-3
AB Glycyl-tRNA synthetase mutations are associated to the Charcot-Marie-Tooth disease type-2D. The Gars(P278KY/+) model for Charcot-Marie-Tooth disease type-2D is known best for its early onset severe neuropathic phenotype with findings including reduced axon size, slow conduction velocities and abnormal neuromuscular junction. Muscle involvement remains largely unexamined. We tested the efficacy of neurotrophin 3 gene transfer therapy in two Gars mutants with severe (Gars(P278KY/+)) and milder (Gars(Delta ETAQ/+)) phenotypes via intramuscular injection of adeno-associated virus setoype-1, triple tandem muscle creatine kinase promoter, neurotrophin 3 (AAV1.tMCK.NT-3) at 1 x 10(11) vg dose. In the Gars(P278KY/+) mice, the treatment efficacy was assessed at 12 weeks post-injection using rotarod test, electrophysiology and detailed quantitative histopathological studies of the peripheral nervous system including neuromuscular junction and muscle. Neurotrophin 3 gene transfer therapy in Gars(P278KY/+) mice resulted in significant functional and electrophysiological improvements, supported with increases in myelin thickness and improvements in the denervated status of neuromuscular junctions as well as increases in muscle fibre size along with attenuation of myopathic changes. Improvements in the milder phenotype Gars(Delta ETAQ/+) was less pronounced. Furthermore, oxidative enzyme histochemistry in muscles from Gars mutants revealed alterations in the content and distribution of oxidative enzymes with increased expression levels of Pgc1a. Cox1, Cox3 and Atp5d transcripts were significantly decreased suggesting that the muscle phenotype might be related to mitochondrial dysfunction. Neurotrophin 3 gene therapy attenuated these abnormalities in the muscle. This study shows that neurotrophin 3 gene transfer therapy has disease modifying effect in a mouse model for Charcot-Marie-Tooth disease type-2D, leading to meaningful improvements in peripheral nerve myelination and neuromuscular junction integrity as well as in a unique myopathic process, associated with mitochondria dysfunction, all in combination contributing to functional outcome. Based on the multiple biological effects of this versatile molecule, we predict neurotrophin 3 has the potential to be beneficial in other aminoacyl-tRNA synthetase-linked Charcot-Marie-Tooth disease subtypes.
   Ozes et al. report that Adeno-associated virus serotype 1-neurotrophin 3 gene therapy has disease modifying effect in a Gars mouse model of Charcot-Marie-Tooth disease type 2D leading to functional and, electrophysiological improvements correlating with increased myelin thickness, neuromuscular junction integrity attenuation of a myopathic process associated with mitochondrial dysfunction.
C1 [Ozes, Burcak; Moss, Kyle; Myers, Morgan; Ridgley, Alicia; Chen, Lei; Murrey, Darren; Sahenk, Zarife] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Gene Therapy, Dept Pediat, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Nationwide Childrens Hosp, Dept Pediat & Neurol, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Ohio State Univ, Columbus, OH 43205 USA.
   [Sahenk, Zarife] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA.
C3 University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; Research Institute at Nationwide Children's Hospital;
   University System of Ohio; Ohio State University; Nationwide Childrens
   Hospital; University System of Ohio; Ohio State University; University
   System of Ohio; Ohio State University; Nationwide Childrens Hospital
RP Sahenk, Z (corresponding author), Neuromuscular Pathol, 700 Childrens Dr,Rm WA 3024, Columbus, OH 43205 USA.
EM zarife.sahenk@nationwidechildrens.org
RI Ozes, Burcak/AAH-4463-2021
OI sahenk, Zarife/0000-0003-2974-3943; Ozes, Burcak/0000-0001-5739-5419
FU Sarepta Therapeutics, Inc. [820344-0322-00]
FX This study was funded by Sarepta Therapeutics, Inc. Grant number is
   820344-0322-00.
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Benoy V, 2018, BRAIN, V141, P673, DOI 10.1093/brain/awx375
   Boczonadi V, 2018, HUM MOL GENET, V27, P2187, DOI 10.1093/hmg/ddy127
   Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110
   Chiu YH, 2009, HUM MOL GENET, V18, P1976, DOI 10.1093/hmg/ddp121
   Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107
   Coelho RP, 2009, GLIA, V57, P1754, DOI 10.1002/glia.20888
   Dachs E, 2011, J NEUROPATH EXP NEUR, V70, P444, DOI 10.1097/NEN.0b013e31821cbd8b
   Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac
   Dubourg O, 2006, NEUROMOL MED, V8, P75, DOI 10.1385/NMM:8:1:75
   Forrester N, 2020, J NEUROMUSCULAR DIS, V7, P137, DOI 10.3233/JND-200472
   Grice SJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00055
   Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176
   GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104
   Griffin DA, 2016, HUM MOL GENET, V25, P1900, DOI 10.1093/hmg/ddw063
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510
   He WW, 2011, P NATL ACAD SCI USA, V108, P12307, DOI 10.1073/pnas.1104293108
   Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248
   James PA, 2006, NEUROLOGY, V67, P1710, DOI 10.1212/01.wnl.0000242619.52335.bc
   Jousse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104896
   Karpati George, 2008, V3, P199
   Kim JK, 2020, J CLIN INVEST, V130, P1271, DOI 10.1172/JCI131989
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36
   MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716
   Meier C, 1999, J NEUROSCI, V19, P3847
   Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251
   Mo ZY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03461-z
   Morelli KH, 2019, J CLIN INVEST, V129, P5568, DOI 10.1172/JCI130600
   Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399
   Motley WW, 2010, TRENDS NEUROSCI, V33, P59, DOI 10.1016/j.tins.2009.11.001
   Nafisinia M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178125
   Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009
   Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520
   Oprescu SN, 2017, HUM MUTAT, V38, P1412, DOI 10.1002/humu.23287
   Ozes B, 2022, GENE THER, V29, P127, DOI 10.1038/s41434-021-00231-3
   Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3
   SAHENK Z, 1980, BRAIN RES, V186, P343, DOI 10.1016/0006-8993(80)90980-4
   SAHENK Z, 1991, J NEUROCYTOL, V20, P365, DOI 10.1007/BF01355533
   SAHENK Z, 1979, J NEUROPATH EXP NEUR, V38, P532, DOI 10.1097/00005072-197909000-00007
   Sahenk Z, 2005, NEUROLOGY, V65, P681, DOI 10.1212/01.WNL.0000171978.70849.c5
   SAHENK Z, 1990, ACTA NEUROPATHOL, V81, P141, DOI 10.1007/BF00334502
   Sahenk Z, 2020, BRAIN RES, V1727, DOI 10.1016/j.brainres.2019.146533
   Sahenk Z, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1118
   Sahenk Z, 2014, MOL THER, V22, P511, DOI 10.1038/mt.2013.250
   Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0
   Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027
   Sheard PW, 2010, EUR J NEUROSCI, V31, P29, DOI 10.1111/j.1460-9568.2009.07032.x
   Sherman DL, 2012, J NEUROSCI, V32, P1817, DOI 10.1523/JNEUROSCI.4814-11.2012
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Sleigh JN, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02798-y
   Sleigh JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10005-w
   Sleigh JN, 2017, P NATL ACAD SCI USA, V114, pE3324, DOI 10.1073/pnas.1614557114
   Sleigh JN, 2014, HUM MOL GENET, V23, P2639, DOI 10.1093/hmg/ddt659
   Spaulding EL, 2016, J NEUROSCI, V36, P3254, DOI 10.1523/JNEUROSCI.1762-15.2016
   SPENCER PS, 1977, J NEUROPATH EXP NEUR, V36, P300, DOI 10.1097/00005072-197703000-00006
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009
   Valdez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093140
   Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104
   Wang LL, 2020, FEBS J, V287, P108, DOI 10.1111/febs.15024
   WANG T, 1995, J NEUROSCI, V15, P4796
   Wei N, 2019, J BIOL CHEM, V294, P5321, DOI 10.1074/jbc.REV118.002955
   Yalvac ME, 2018, GENE THER, V25, P129, DOI 10.1038/s41434-018-0009-8
   Yalvac ME, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0146-6
   Yalvac ME, 2014, MOL THER, V22, P1353, DOI 10.1038/mt.2014.77
   Young C, 2001, RESTOR NEUROL NEUROS, V18, P167
NR 70
TC 16
Z9 16
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
EI 2632-1297
J9 BRAIN COMMUN
JI Brain Commun.
PD OCT 1
PY 2021
VL 3
IS 4
AR fcab252
DI 10.1093/braincomms/fcab252
PG 16
WC Clinical Neurology; Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA 1T5TZ
UT WOS:000804791900034
PM 34755111
OA Green Published
DA 2024-11-01
ER

PT J
AU Wang, XB
   Cui, NH
   Liu, XN
   Liu, X
AF Wang, Xue-bin
   Cui, Ning-hua
   Liu, Xia'nan
   Liu, Xin
TI Joint effects of mitochondrial DNA<SUP>4977</SUP> deletion and serum
   folate deficiency on coronary artery disease in type 2 diabetes mellitus
SO CLINICAL NUTRITION
LA English
DT Article
DE mtDNA(4977) deletion; Folate deficiency; Coronary artery disease; Type 2
   diabetes mellitus
ID SMOOTH-MUSCLE-CELLS; DNA COPY NUMBER; CARDIOVASCULAR-DISEASE; OXIDATIVE
   STRESS; FOLLOW-UP; RISK; MORTALITY; DAMAGE; ATHEROSCLEROSIS; ADULTS
AB Background & aims: The 4977-bp mitochondrial deletion (mtDNA(4977) deletion), as a hallmark of mitochondrial oxidative damage, may play an important role in coronary artery disease (CAD), but its interaction with folate deficiency among diabetic patients is largely unknown. We aimed to explore the joint association of leukocyte mtDNA(4977) deletion and serum folate status with obstructive CAD in Chinese adults with type 2 diabetes.
   Methods: We cross-sectionally analyzed the angiographic data of 2017 diabetic patients without B-vitamin supplementation. Of the 2017 participants, 756 who received percutaneous coronary intervention (PCI) completed prospective follow-up of one year. In vitro, we explored the mediation effects of mitochondrial reactive oxygen species (mtROS) in folic acid (FA)-deficient human aortic smooth muscle cells (HASMCs) under hyperglycemic conditions.
   Results: Cross-sectionally, the multivariate odds ratios (ORs) for obstructive CAD were 1.41 (95% CI: 1.29-1.55) for greater mtDNA(4977) deletion, and 1.15 (95% CI: 1.05-1.25) for lower folate levels. Particularly, the combination of high mtDNA(4977) deletion (top tertile) and folate deficiency (serum folate < 6 ng/mL) was associated with more than 2-fold increased odds of having obstructive CAD and higher degrees of coronary stenosis. Prospectively, the hazard ratio for all-cause death at 1-year after PCI was up to 2.37 (95% CI: 1.21-4.63) for folate-deficient participants in the top tertile of mtDNA(4977) deletion. In HASMCs, the adverse effects of FA deficiency were aggravated by induction of mtROS, and attenuated by scavenging of mtROS.
   Conclusions: The risk of obstructive CAD may be greatly increased by the interaction between greater mtDNA(4977) deletion and folate deficiency among diabetic patients. (C) 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [Wang, Xue-bin; Liu, Xia'nan; Liu, Xin] Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Jianshe East Rd 1, Zhengzhou 450000, Henan, Peoples R China.
   [Cui, Ning-hua] Zhengzhou Univ, Childrens Hosp, Zhengzhou Key Lab Childrens Infect & Immun, Zhengzhou 450000, Henan, Peoples R China.
C3 Zhengzhou University; Zhengzhou University
RP Wang, XB (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Clin Lab, Jianshe East Rd 1, Zhengzhou 450000, Henan, Peoples R China.
EM xbwang2017@163.com
RI LIU, XIANAN/JSK-4835-2023
FU National Basic Research Program of China [81800317]; Union Program of
   the Key Scientific and Technological Project of Henan Province
   [2018020008]
FX This study was supported by the National Basic Research Program of China
   (81800317; to X.W.) and the Union Program of the Key Scientific and
   Technological Project of Henan Province (2018020008; to X.W.).
CR Afriyie-Gyawu E, 2016, NUTRITION, V32, P468, DOI 10.1016/j.nut.2015.10.021
   Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc12-s011, 10.2337/dc10-S011, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc13-S011, 10.2337/dc10-S062]
   Bhattacharjee A, 2018, ENVIRON TOXICOL, V33, P988, DOI 10.1002/tox.22586
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Borghini A, 2019, EUR J PREV CARDIOL, V26, P976, DOI 10.1177/2047487319831495
   Chen TF, 2011, BRIT J NUTR, V105, P1294, DOI 10.1017/S0007114510005052
   Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254
   Chou YF, 2007, J NUTR, V137, P2036, DOI 10.1093/jn/137.9.2036
   Dang SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112586
   Ding ZF, 2016, ANTIOXID REDOX SIGN, V25, P997, DOI 10.1089/ars.2016.6631
   Faria A, 2017, PHARMACOL THERAPEUT, V172, P50, DOI 10.1016/j.pharmthera.2016.11.013
   Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI 10.1016/j.jacc.2013.11.005
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198
   Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI [10.1001/jama.2013.284427, 10.1001/jama.2014.4346]
   Jhund PS, 2015, EUR HEART J, V36, P2463, DOI 10.1093/eurheartj/ehv295
   Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171
   Kitazawa M, 2019, METABOLISM, V101, DOI 10.1016/j.metabol.2019.153991
   Kolb AF, 2019, BIOCHEM J, V476, P2769, DOI 10.1042/BCJ20190275
   Kyte B, 2015, NUTR METAB CARDIOVAS, V25, P997, DOI 10.1016/j.numecd.2015.08.007
   Li Z, 2018, CLIN NUTR, V37, P1700, DOI 10.1016/j.clnu.2017.07.008
   Loria CM, 2000, ARCH INTERN MED, V160, P3258, DOI 10.1001/archinte.160.21.3258
   Maddox TM, 2014, JAMA-J AM MED ASSOC, V312, P1754, DOI 10.1001/jama.2014.14681
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Montorsi P, 2006, EUR HEART J, V27, P2632, DOI 10.1093/eurheartj/ehl142
   Niu CG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004099
   Ouellette ML, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007965
   Pak O, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01024-2017
   Peng Y, 2016, INT J CARDIOL, V219, P136, DOI 10.1016/j.ijcard.2016.06.024
   Petrie JR, 2018, CAN J CARDIOL, V34, P575, DOI 10.1016/j.cjca.2017.12.005
   Rampidis GP, 2019, ATHEROSCLEROSIS, V287, P181, DOI 10.1016/j.atherosclerosis.2019.05.012
   Siasos G, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.21
   Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335
   Su SC, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0550-9
   Suzuki S, 1999, DIABETES RES CLIN PR, V45, P161, DOI 10.1016/S0168-8227(99)00046-7
   Valle JA, 2019, JAMA CARDIOL, V4, P727, DOI 10.1001/jamacardio.2019.1923
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Wang XB, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-00998-6
   Wang XB, 2019, ATHEROSCLEROSIS, V284, P165, DOI 10.1016/j.atherosclerosis.2019.03.010
   Westermeier F, 2015, BBA-MOL CELL RES, V1853, P1113, DOI 10.1016/j.bbamcr.2015.02.005
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang C, 2019, EUR HEART J, V40, P3397, DOI 10.1093/eurheartj/ehz394
   Zheng YX, 2018, CELL, V175, P1546, DOI 10.1016/j.cell.2018.09.041
   Zhou ZY, 2018, STROKE, V49, P114, DOI [10.1161/strokeaha.117.018273, 10.1161/STROKEAHA.117.018273]
NR 46
TC 6
Z9 6
U1 0
U2 4
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD DEC
PY 2020
VL 39
IS 12
BP 3771
EP 3778
DI 10.1016/j.clnu.2020.04.006
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA PH6YQ
UT WOS:000600555900026
PM 32334879
DA 2024-11-01
ER

PT J
AU Gardeitchik, T
   Mohamed, M
   Ruzzenente, B
   Karall, D
   Guerrero-Castillo, S
   Dalloyaux, D
   van den Brand, M
   van Kraaij, S
   van Asbeck, E
   Assouline, Z
   Rio, M
   de Lonlay, P
   Scholl-Buergi, S
   Wolthuis, DFGJ
   Hoischen, A
   Rodenburg, RJ
   Sperl, W
   Urban, Z
   Brandt, U
   Mayr, JA
   Wong, S
   de Brouwer, APM
   Nijtmans, L
   Munnich, A
   Rötig, A
   Wevers, RA
   Metodiev, MD
   Morava, E
AF Gardeitchik, Thatjana
   Mohamed, Miski
   Ruzzenente, Benedetta
   Karall, Daniela
   Guerrero-Castillo, Sergio
   Dalloyaux, Daisy
   van den Brand, Mariel
   van Kraaij, Sanne
   van Asbeck, Ellyze
   Assouline, Zahra
   Rio, Marlene
   de Lonlay, Pascale
   Scholl-Buergi, Sabine
   Wolthuis, David F. G. J.
   Hoischen, Alexander
   Rodenburg, Richard J.
   Sperl, Wolfgang
   Urban, Zsolt
   Brandt, Ulrich
   Mayr, Johannes A.
   Wong, Sunnie
   de Brouwer, Arjan P. M.
   Nijtmans, Leo
   Munnich, Arnold
   Rotig, Agnes
   Wevers, Ron A.
   Metodiev, Metodi D.
   Morava, Eva
TI Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause
   Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex
   Deficiencies
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID RECESSIVE CUTIS LAXA; SUBUNIT; RNA; CARDIOMYOPATHY; ALDH18A1; DISEASE
AB Biogenesis of the mitochondrial oxidative phosphorylation system, which produces the bulk of ATP for almost all eukaryotic cells, depends on the translation of 13 mtDNA-encoded polypeptides by mitochondria-specific ribosomes in the mitochondrial matrix. These mitoribosomes are dual-origin ribonucleoprotein complexes, which contain mtDNA-encoded rRNAs and tRNAs and similar to 80 nucleus-encoded proteins. An increasing number of gene mutations that impair mitoribosomal function and result in multiple OXPHOS deficiencies are being linked to human mitochondrial diseases. Using exome sequencing in two unrelated subjects presenting with sensorineural hearing impairment, mild developmental delay, hypoglycemia, and a combined OXPHOS deficiency, we identified mutations in the gene encoding the mitochondrial ribosomal protein S2, which has not previously been implicated in disease. Characterization of subjects' fibroblasts revealed a decrease in the steady-state amounts of mutant MRPS2, and this decrease was shown by complexome profiling to prevent the assembly of the small mitoribosomal subunit. In turn, mitochondrial translation was inhibited, resulting in a combined OXPHOS deficiency detectable in subjects' muscle and liver biopsies as well as in cultured skin fibroblasts. Reintroduction of wild-type MRPS2 restored mitochondrial translation and OXPHOS assembly. The combination of lactic acidemia, hypoglycemia, and sensorineural hearing loss, especially in the presence of a combined OXPHOS deficiency, should raise suspicion for a ribosomal-subunit-related mitochondrial defect, and clinical recognition could allow for a targeted diagnostic approach. The identification of MRPS2 as an additional gene related to mitochondrial disease further expands the genetic and phenotypic spectra of OXPHOS deficiencies caused by impaired mitochondrial translation.
C1 [Gardeitchik, Thatjana; Mohamed, Miski; Guerrero-Castillo, Sergio; Dalloyaux, Daisy; van den Brand, Mariel; van Kraaij, Sanne; van Asbeck, Ellyze; Wolthuis, David F. G. J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.
   [Gardeitchik, Thatjana; Hoischen, Alexander; de Brouwer, Arjan P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.
   [Ruzzenente, Benedetta; Munnich, Arnold; Rotig, Agnes; Metodiev, Metodi D.] Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France.
   [Karall, Daniela; Scholl-Buergi, Sabine; Sperl, Wolfgang] Med Univ Innsbruck, Pediat Clin, Inherited Metab Disorders, A-6020 Innsbruck, Austria.
   [Guerrero-Castillo, Sergio; van den Brand, Mariel; Rodenburg, Richard J.; Brandt, Ulrich; Nijtmans, Leo] Radboud Ctr Mitochondrial Med, Dept Pediat, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Guerrero-Castillo, Sergio; van Kraaij, Sanne; Rodenburg, Richard J.; Brandt, Ulrich; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6500 HB Nijmegen, Netherlands.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Neurol, F-75015 Paris, France.
   [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.
   [Urban, Zsolt] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.
   [Mayr, Johannes A.] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria.
   [Wong, Sunnie] Tulane Univ, Hayward Genet Ctr, New Orleans, LA 70112 USA.
   [de Brouwer, Arjan P. M.] Donders Inst Brain Cognit & Behav, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Morava, Eva] Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.
   [de Lonlay, Pascale] Univ Paris 05, Hop Necker Enfants Malad, AP HP, Reference Ctr Inherited Metab Dis,Inst Imagine, F-75015 Paris, France.
C3 Radboud University Nijmegen; Radboud University Nijmegen; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Paris Cite; Medical University of Innsbruck; Radboud University
   Nijmegen; Assistance Publique Hopitaux Paris (APHP); Universite Paris
   Cite; Hopital Universitaire Necker-Enfants Malades - APHP; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Necker-Enfants Malades - APHP; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Necker-Enfants Malades - APHP; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Paracelsus Private
   Medical University; Tulane University; Radboud University Nijmegen; Mayo
   Clinic; Assistance Publique Hopitaux Paris (APHP); Universite Paris
   Cite; Hopital Universitaire Necker-Enfants Malades - APHP
RP Metodiev, MD (corresponding author), Univ Paris 05, INSERM, U1163, Sorbonne Paris Cite,Inst Imagine, F-75015 Paris, France.; Morava, E (corresponding author), Mayo Clin, Dept Clin Genom, Rochester, MN 55905 USA.
EM metodi.metodiev@inserm.fr; emoravakozicz@tulane.edu
RI Nijtmans, L.G.J./L-4549-2015; de Brouwer, Arjan/P-5949-2015; Rodenburg,
   Richard/N-3579-2014; Guerrero-Castillo, Sergio/T-1515-2019; Ruzzenente,
   Benedetta/H-4793-2017; van den Brand, Mariel/S-1215-2017; Dalloyaux,
   Daisy/L-7379-2016; Metodiev, Metodi D/C-4780-2015; Hoischen,
   Alexander/D-1282-2013; Wevers, Ron/H-8116-2014; Guerrero-Castillo,
   Sergio/E-2285-2016; ROTIG, AGNES/G-9592-2017; Brandt,
   Ulrich/C-4406-2008; Urban, Zsolt/A-2018-2013
OI Ruzzenente, Benedetta/0000-0001-7366-114X; Metodiev, Metodi
   D/0000-0002-9596-2434; Hoischen, Alexander/0000-0002-8072-4476; Wevers,
   Ron/0000-0003-2278-9746; Guerrero-Castillo, Sergio/0000-0002-6630-0562;
   Dalloyaux, Daisy/0009-0001-9700-5443; ROTIG, AGNES/0000-0003-0589-0703;
   Brandt, Ulrich/0000-0003-1869-6811; Urban, Zsolt/0000-0003-3890-1843
FU Dutch Metakids foundation; Netherlands Organisation for Scientific
   Research (NWO) [017.008.052]; E-Rare project GENOMIT [01GM1207];
   National Institutes of Health [HL090648]; Association Francais contre
   les Myopathies [19876]
FX We thank the subjects and their parents for their participation. This
   study was financially supported by the Dutch Metakids foundation (2012,
   M.M.), the Netherlands Organisation for Scientific Research (2011, NWO
   project 017.008.052, M.M.), the E-Rare project GENOMIT (01GM1207, A.R.),
   the National Institutes of Health (HL090648, Z.U.), and the Association
   Francais contre les Myopathies (19876, M.D.M). B.R., A.R., and M.D.M
   would like to acknowledge the technical assistance with cell culture
   from Ms. Coralie Zangarelli. Exome sequencing of subject 2 was done in
   collaboration with the Centre National de Genotypage.
CR Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Aseev LV, 2008, RNA, V14, P1882, DOI 10.1261/rna.1099108
   Baertling F, 2015, NEUROGENETICS, V16, P237, DOI 10.1007/s10048-015-0440-6
   Berk DR, 2012, J AM ACAD DERMATOL, V66, DOI 10.1016/j.jaad.2011.01.004
   Bicknell LS, 2008, EUR J HUM GENET, V16, P1176, DOI 10.1038/ejhg.2008.91
   Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359
   Dimopoulou A, 2013, MOL GENET METAB, V110, P352, DOI 10.1016/j.ymgme.2013.08.009
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gardeitchik T, 2014, EUR J HUM GENET, V22, P888, DOI 10.1038/ejhg.2013.154
   Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Haque ME, 2008, MITOCHONDRION, V8, P254, DOI 10.1016/j.mito.2008.04.004
   Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009
   Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008
   Kaushal PS, 2014, P NATL ACAD SCI USA, V111, P7284, DOI 10.1073/pnas.1401657111
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   LAUGHREA M, 1978, J MOL BIOL, V122, P109, DOI 10.1016/0022-2836(78)90111-0
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   Mohamed M, 2011, J INHERIT METAB DIS, V34, P907, DOI 10.1007/s10545-011-9305-9
   Morava É, 2009, EUR J HUM GENET, V17, P1099, DOI 10.1038/ejhg.2009.22
   Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013
   Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Wessels HJCT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068340
   Wolthuis DFGJ, 2014, EUR J PAEDIATR NEURO, V18, P511, DOI 10.1016/j.ejpn.2014.01.003
NR 32
TC 56
Z9 58
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD APR 5
PY 2018
VL 102
IS 4
BP 685
EP 695
DI 10.1016/j.ajhg.2018.02.012
PG 11
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GB8QQ
UT WOS:000429340800014
PM 29576219
OA Green Published
DA 2024-11-01
ER

PT J
AU Gao, J
   Collyer, J
   Wang, MC
   Sun, FP
   Xu, FY
AF Gao, Jun
   Collyer, John
   Wang, Maochun
   Sun, Fengping
   Xu, Fuyi
TI Genetic Dissection of Hypertrophic Cardiomyopathy with Myocardial
   RNA-Seq
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hypertrophic cardiomyopathy; RNA-seq; pathogenic variants; differential
   gene expression; gene network
ID GENOTYPE-PHENOTYPE ASSOCIATIONS; DELTA-SARCOGLYCAN GENE; MUSCLE LIM
   PROTEIN; DILATED CARDIOMYOPATHY; MITOCHONDRIAL-DNA; MUTATIONS; TITIN;
   POWERFUL; CHILDREN; FIBROSIS
AB Hypertrophic cardiomyopathy (HCM) is an inherited disorder of the myocardium, and pathogenic mutations in the sarcomere genes myosin heavy chain 7 (MYH7) and myosin-binding protein C (MYBPC3) explain 60%-70% of observed clinical cases. The heterogeneity of phenotypes observed in HCM patients, however, suggests that novel causative genes or genetic modifiers likely exist. Here, we systemically evaluated RNA-seq data from 28 HCM patients and 9 healthy controls with pathogenic variant identification, differential expression analysis, and gene co-expression and protein-protein interaction network analyses. We identified 43 potential pathogenic variants in 19 genes in 24 HCM patients. Genes with more than one variant included the following: MYBPC3, TTN, MYH7, PSEN2, and LDB3. A total of 2538 protein-coding genes, six microRNAs (miRNAs), and 1617 long noncoding RNAs (lncRNAs) were identified differentially expressed between the groups, including several well-characterized cardiomyopathy-related genes (ANKRD1, FHL2, TGFB3, miR-30d, and miR-154). Gene enrichment analysis revealed that those genes are significantly involved in heart development and physiology. Furthermore, we highlighted four subnetworks: mtDNA-subnetwork, DSP-subnetwork, MYH7-subnetwork, and MYBPC3-subnetwork, which could play significant roles in the progression of HCM. Our findings further illustrate that HCM is a complex disease, which results from mutations in multiple protein-coding genes, modulation by non-coding RNAs and perturbations in gene networks.
C1 [Gao, Jun; Xu, Fuyi] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA.
   [Gao, Jun; Sun, Fengping] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai 201106, Peoples R China.
   [Collyer, John] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA.
   [Wang, Maochun] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
C3 University of Tennessee System; University of Tennessee Health Science
   Center; Shanghai Academy of Agricultural Sciences; University of
   Tennessee System; University of Tennessee Health Science Center; Donghua
   University
RP Xu, FY (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA.; Sun, FP (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai 201106, Peoples R China.
EM jgao21@uthsc.edu; jcollyer@uthsc.edu; wangmaochun0815@163.com;
   sfp_hot@163.com; fxu10@uthsc.edu
RI xu, fuyi/HIK-3316-2022; Wang, Maochun/GXG-4030-2022
OI Wang, Maochun/0000-0002-6056-1606; XU, FUYI/0000-0002-5952-5771; GAO,
   JUN/0000-0002-2372-4445
CR Akhtar M., 2018, GLOB CARDIOL SCI PRA, V36, P1
   Alila-Fersi O, 2017, BIOCHEM BIOPH RES CO, V484, P71, DOI 10.1016/j.bbrc.2017.01.070
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Arimura T, 2000, HUM GENET, V107, P440, DOI 10.1007/s004390000389
   Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bernardo BC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22442
   Bhandary B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010013
   Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329
   Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580
   Bos JM, 2006, MOL GENET METAB, V88, P78, DOI 10.1016/j.ymgme.2005.10.008
   Bukauskas T, 2019, MED SCI MONITOR, V25, P3925, DOI 10.12659/MSM.913743
   Burns C, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.116.001666
   Carniel E, 2005, CIRCULATION, V112, P54, DOI 10.1161/CIRCULATIONAHA.104.507699
   Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560
   Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4
   De Bortoli M, 2017, EUR J HUM GENET, V25, P1165, DOI 10.1038/ejhg.2017.109
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong P, 2018, EUR REV MED PHARMACO, V22, P2052, DOI 10.26355/eurrev_201804_14735
   Duggan DJ, 1997, NEUROGENETICS, V1, P49, DOI 10.1007/s100480050008
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Fang L, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0672-0
   Forleo C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181842
   Friedrich FW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0451-8
   FUJII J, 1991, J BIOL CHEM, V266, P11669
   Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160
   Gupte TM, 2015, J BIOL CHEM, V290, P7003, DOI 10.1074/jbc.M114.596676
   Ha KN, 2011, P NATL ACAD SCI USA, V108, P2735, DOI 10.1073/pnas.1013987108
   Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065
   Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058
   He Y, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-68
   Hobuss L, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00030
   Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6
   Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448
   Jacoby D, 2012, EUR HEART J, V33, P296, DOI 10.1093/eurheartj/ehr260
   Jensen MK, 2013, CIRCULATION, V127, P48, DOI 10.1161/CIRCULATIONAHA.111.090514
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900
   Li YY, 1997, J MOL CELL CARDIOL, V29, P2699, DOI 10.1006/jmcc.1997.0501
   Liu XY, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0094-6
   Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M
   Lopes LR, 2015, HEART, V101, P294, DOI 10.1136/heartjnl-2014-306387
   Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2
   Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3
   Maron MS, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-13
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mimaki M, 2003, J HUM GENET, V48, P47, DOI 10.1007/s100380300005
   Minamisawa S, 2003, BIOCHEM BIOPH RES CO, V304, P1, DOI 10.1016/S0006-291X(03)00526-6
   Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2
   Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463
   Ono H, 2010, INTERNAL MED, V49, P2039, DOI 10.2169/internalmedicine.49.3710
   Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rader EP, 2016, P NATL ACAD SCI USA, V113, P10992, DOI 10.1073/pnas.1605265113
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Ramírez Carlos Darío, 2004, Invest. clín, V45, P69
   Rampazzo A, 2002, AM J HUM GENET, V71, P1200, DOI 10.1086/344208
   Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104
   Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54
   Sabater-Molina M, 2018, CLIN GENET, V93, P3, DOI 10.1111/cge.13027
   Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5
   Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019
   Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]
   Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076
   Toepfer CN, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1199
   Tomita Y, 1997, AM HEART J, V134, P779, DOI 10.1016/S0002-8703(97)70064-4
   Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224
   Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521
   Verdonschot JAJ, 2018, EUR HEART J, V39, P864, DOI 10.1093/eurheartj/ehx808
   Vite A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075082
   Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013
   Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356
   Xiao JJ, 2017, CELL PHYSIOL BIOCHEM, V41, P865, DOI 10.1159/000459899
   Xu TH, 2010, J AM COLL CARDIOL, V55, P587, DOI 10.1016/j.jacc.2009.11.020
   Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105
NR 78
TC 25
Z9 26
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2020
VL 21
IS 9
AR 3040
DI 10.3390/ijms21093040
PG 23
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA LR3GK
UT WOS:000535581700011
PM 32344918
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Bunkar, N
   Bhargava, A
   Khare, NK
   Mishra, PK
AF Bunkar, Neha
   Bhargava, Arpit
   Khare, Naveen Kumar
   Mishra, Pradyumna Kumar
TI Mitochondrial anomalies: driver to age associated degenerative human
   ailments
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE Mitochondrial Dysfunction; Oxidative Stress; Oxidative Damage; Redox
   Signaling; Review; Mitochondria Targeting; Review
ID AMYOTROPHIC-LATERAL-SCLEROSIS; LIPOSOME-BASED CARRIER; NUCLEAR
   CROSS-TALK; OXIDATIVE STRESS; MITO-PORTER; SKELETAL-MUSCLE; CELL-DEATH;
   TARGETED NANOPARTICLES; EXPRESSION CHANGES; DENDRITIC CELLS
AB Mitochondria play a fundamental role in regulating a variety of complex metabolic processes to maintain adequate energy balance for cellular existence. To orchestrate these functions, an undisturbed mitochondrial dynamics is imperative through a set of tightly guided mechanisms. Interference in key signature processes by several genetic, epigenetic and age-linked factors triggers mitochondrial dysfunction through decrease in mitochondrial biogenesis, reduced mitochondrial content, aberrant mtDNA mutations, increased oxidative stress, deficient mitophagy, energy dysfunction, decrease in anti oxidant defense and impaired calcium homeostasis. Mitochondrial dysfunction is widely implicated in origin and development of various age associated degenerative human ailments including metabolic syndromes, cardiovascular diseases, cancer, diabetes and neurodegenerative disorders. The present review revisits the mitochondrial anomalies involved in aetiology of different human diseases and also highlights the translational significance of nano-vectors aimed for selective mitochondrial engineering which might pave way for development of novel therapeutics.
C1 [Bunkar, Neha; Bhargava, Arpit; Mishra, Pradyumna Kumar] Dr HS Gour Cent Univ, Sch Biol Sci, Sagar, India.
   [Bhargava, Arpit; Khare, Naveen Kumar; Mishra, Pradyumna Kumar] ACTREC, Tata Mem Ctr, Div Translat Res, Bombay, Maharashtra, India.
C3 Dr. Hari Singh Gour University; Tata Memorial Centre (TMC); Advance
   Centre for Treatment, Research & Education in Cancer (ACTREC)
RP Mishra, PK (corresponding author), Dr HS Gour Cent Univ, Sch Biol Sci, Translat Res Lab, Sagar 470003, India.
EM pkm_8bh@yahoo.co.uk
RI BUNKAR, NEHA/S-5174-2019; Mishra, Pradyumna Kumar/AAG-2165-2019
OI Mishra, Pradyumna Kumar/0000-0002-0795-2819; BHARGAVA, Dr.
   ARPIT/0000-0002-0855-2753
CR [Anonymous], J GERONTOL A
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288
   Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029
   Bennett GJ, 2014, NAT REV NEUROL, V10, P326, DOI 10.1038/nrneurol.2014.77
   Bhargava A, 2014, NANOMEDICINE-UK, V9, P2187, DOI [10.2217/NNM.14.115, 10.2217/nnm.14.115]
   Biala AK, 2015, J MOL CELL CARDIOL, V83, P37, DOI 10.1016/j.yjmcc.2015.04.015
   Biswas S, 2012, J CONTROL RELEASE, V159, P393, DOI 10.1016/j.jconrel.2012.01.009
   Biswas S, 2012, BIOMATERIALS, V33, P4773, DOI 10.1016/j.biomaterials.2012.03.032
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Blokhuis AM, 2013, ACTA NEUROPATHOL, V125, P777, DOI 10.1007/s00401-013-1125-6
   Boddapati SV, 2008, NANO LETT, V8, P2559, DOI 10.1021/nl801908y
   Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905
   Chandel NS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-34
   CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103
   Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193
   Chinnery PF, 2012, INT J EPIDEMIOL, V41, P177, DOI 10.1093/ije/dyr232
   Chourasia AH, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0130-8
   Cuchelkar V, 2008, MOL PHARMACEUT, V5, P776, DOI 10.1021/mp800019g
   D'Souza GGM, 2008, J DRUG TARGET, V16, P578, DOI 10.1080/10611860802228855
   D'Souza GGM, 2003, J CONTROL RELEASE, V92, P189, DOI 10.1016/S0168-3659(03)00297-9
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Dikalov SI, 2013, ANTIOXID REDOX SIGN, V19, P1085, DOI 10.1089/ars.2012.4604
   DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423
   Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   Durazo SA, 2012, MITOCHONDRION, V12, P190, DOI 10.1016/j.mito.2011.11.001
   Edeas M, 2013, MITOCHONDRION, V13, P389, DOI 10.1016/j.mito.2013.03.009
   Edrey YH, 2014, FREE RADICAL BIO MED, V71, P368, DOI 10.1016/j.freeradbiomed.2014.03.038
   Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066
   Fernández-Checa JC, 2010, CNS NEUROL DISORD-DR, V9, P439, DOI 10.2174/187152710791556113
   Fernández-Moriano C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/408927
   Finsterer J, 2015, PEDIATR NEUROL, V52, P302, DOI 10.1016/j.pediatrneurol.2014.06.023
   Finsterer J, 2011, J NEUROL SCI, V304, P9, DOI 10.1016/j.jns.2011.02.012
   Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005
   Flierl A, 2003, MOL THER, V7, P550, DOI 10.1016/S1525-0016(03)00037-6
   Gage MC, 2013, ATHEROSCLEROSIS, V230, P131, DOI 10.1016/j.atherosclerosis.2013.06.017
   Gao AW, 2014, EMBO MOL MED, V6, P580, DOI 10.1002/emmm.201303782
   García-Pérez AI, 2011, LEUKEMIA RES, V35, P1395, DOI 10.1016/j.leukres.2011.03.012
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Gonzalez-Freire M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00208
   Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295
   Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007
   Gupta Ankur, 2014, Nanomedicine (Lond), V9, P2725, DOI 10.2217/nnm.14.180
   Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123
   Hardas SS, 2013, REDOX BIOL, V1, P80, DOI 10.1016/j.redox.2013.01.002
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Hsu CC, 2013, WORLD J GASTROENTERO, V19, P8880, DOI 10.3748/wjg.v19.i47.8880
   Inoki Y, 2000, BIOCHEM BIOPH RES CO, V278, P183, DOI 10.1006/bbrc.2000.3765
   Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje
   Kabekkodu S. P., 2015, MITOCHONDRION
   Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679
   Kang CH, 2013, EXP GERONTOL, V48, P1343, DOI 10.1016/j.exger.2013.08.004
   Khan S, 2014, INDIAN J CLIN BIOCHE, V29, P38, DOI 10.1007/s12291-013-0321-4
   Khan S, 2011, TRANSL RES, V158, P344, DOI 10.1016/j.trsl.2011.08.007
   Kim UK, 2000, BASIC RES CARDIOL, V95, P163, DOI 10.1007/s003950050178
   Kizhakekuttu TJ, 2012, ARTERIOSCL THROM VAS, V32, P2531, DOI 10.1161/ATVBAHA.112.256024
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534
   Kröller-Schön S, 2014, ANTIOXID REDOX SIGN, V20, P247, DOI 10.1089/ars.2012.4953
   Kroeller-Schoen S, 2013, ARTERIOSCL THROM VAS, V33, P1928, DOI 10.1161/ATVBAHA.113.301717
   Kruk J, 1997, CHEM PHYS LIPIDS, V87, P73, DOI 10.1016/S0009-3084(97)00027-3
   Lane RK., 2015, BIOCH BIOPHYS ACTA
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Lee HC, 2014, WORLD J GASTROENTERO, V20, P3950, DOI 10.3748/wjg.v20.i14.3950
   Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14
   Lee JH, 2013, PHARMACOL THERAPEUT, V137, P153, DOI 10.1016/j.pharmthera.2012.09.008
   Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004
   Leszczynska G, 2014, RNA, V20, P938, DOI 10.1261/rna.044412.114
   Lezi E, 2012, ADV EXP MED BIOL, V942, P269, DOI 10.1007/978-94-007-2869-1_12
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   López-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003
   Lund M, 2015, BRIT J CANCER, V112, P1134, DOI 10.1038/bjc.2015.66
   Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538
   Mabalirajan Ulaganathan, 2013, J Allergy (Cairo), V2013, P340476, DOI 10.1155/2013/340476
   Madamanchi NR, 2013, FREE RADICAL BIO MED, V61, P473, DOI 10.1016/j.freeradbiomed.2013.04.001
   Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010
   Marrache S, 2013, ACS NANO, V7, P7392, DOI 10.1021/nn403158n
   Marrache S, 2012, P NATL ACAD SCI USA, V109, P16288, DOI 10.1073/pnas.1210096109
   Marzetti E, 2013, AM J PHYSIOL-HEART C, V305, pH459, DOI 10.1152/ajpheart.00936.2012
   Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966
   Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038
   Milane L, 2015, J CONTROL RELEASE, V207, P40, DOI 10.1016/j.jconrel.2015.03.036
   Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180
   Mishra PK, 2015, REPROD TOXICOL, V52, P40, DOI 10.1016/j.reprotox.2015.02.006
   Mishra PK, 2009, FREE RADICAL RES, V43, P718, DOI 10.1080/10715760903037699
   Mishra PK, 2014, INT J TOXICOL, V33, P116, DOI 10.1177/1091581814524064
   Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007
   Orsucci D, 2013, CURR NEUROVASC RES, V10, P76, DOI 10.2174/156720213804805972
   Panwar H, 2013, REDOX BIOL, V1, P163, DOI 10.1016/j.redox.2013.01.009
   Pathak RK, 2015, WIRES NANOMED NANOBI, V7, P315, DOI 10.1002/wnan.1305
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Paunesku T, 2007, NANO LETT, V7, P596, DOI 10.1021/nl0624723
   Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005
   Qu AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC645, DOI 10.1152/ajpcell.00469.2008
   Raghuram GV, 2014, INDIAN J MED RES, V140, P120
   Reddy MK, 2008, APPL BIOCHEM BIOTECH, V151, P565, DOI 10.1007/s12010-008-8232-1
   Reddy PH, 2008, NEUROMOL MED, V10, P291, DOI 10.1007/s12017-008-8044-z
   Redmann M, 2014, INT J BIOCHEM CELL B, V53, P127, DOI 10.1016/j.biocel.2014.05.010
   Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9
   Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029
   Riehle C, 2011, CIRC RES, V109, P783, DOI 10.1161/CIRCRESAHA.111.243964
   Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006
   Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5
   Rubattu S, 2015, INT J MOL SCI, V16, P823, DOI 10.3390/ijms16010823
   Rubin TG, 2014, BIOESSAYS, V36, P1072, DOI 10.1002/bies.201400095
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Salminen A, 2014, CELL SIGNAL, V26, P1598, DOI 10.1016/j.cellsig.2014.03.030
   Salnikov V, 2007, BIOPHYS J, V92, P1058, DOI 10.1529/biophysj.106.094318
   Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x
   Sauvanet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049639
   Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019
   Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6
   Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003
   SEIBEL P, 1995, NUCLEIC ACIDS RES, V23, P10, DOI 10.1093/nar/23.1.10
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Shantha GPS, 2013, ATHEROSCLEROSIS, V228, P249, DOI 10.1016/j.atherosclerosis.2013.02.014
   Sharma D, 2015, EXP BIOL MED, V240, P242, DOI 10.1177/1535370214551688
   Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418
   Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108
   Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800
   Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215
   Sobenin IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068070
   Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348
   Strappazzona F., 2015, PHARM RES, DOI 10.1.016/j.phrs.2015.0.3.0.07
   Szeto HH, 2006, AAPS J, V8, pE521, DOI 10.1208/aapsj080362
   Szeto HH, 2006, AAPS J, V8, pE277, DOI 10.1007/BF02854898
   Tamargo J, 2011, NAT REV DRUG DISCOV, V10, P536, DOI 10.1038/nrd3431
   Thouvenot E, 2012, J PROTEOMICS, V77, P394, DOI 10.1016/j.jprot.2012.09.013
   Tocchi A., 2015, BIOCH BIOPHYS ACTA, DOI 10.1.016/j.bbabio.2015.0.7.0.09
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280
   Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006
   VESTWEBER D, 1989, NATURE, V338, P170, DOI 10.1038/338170a0
   Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571
   Villeneuve C, 2013, ANTIOXID REDOX SIGN, V18, P5, DOI 10.1089/ars.2011.4373
   Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398
   Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006
   Wang LM, 2011, NANO LETT, V11, P772, DOI 10.1021/nl103992v
   Weissig V, 2001, ADV DRUG DELIVER REV, V49, P1
   Weissig V, 2007, NANOMEDICINE-UK, V2, P275, DOI 10.2217/17435889.2.3.275
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wilding M, 2015, FERTIL STERIL, V103, P1397, DOI 10.1016/j.fertnstert.2015.03.034
   Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007
   Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106
   Wongrakpanich A, 2014, NANOMEDICINE-UK, V9, P2531, DOI [10.2217/NNM.14.161, 10.2217/nnm.14.161]
   Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1
   Wu SB, 2014, BBA-GEN SUBJECTS, V1840, P1331, DOI 10.1016/j.bbagen.2013.10.034
   Xiong SQ, 2013, ARTERIOSCL THROM VAS, V33, P988, DOI 10.1161/ATVBAHA.112.301019
   Yamada Y, 2008, BBA-BIOMEMBRANES, V1778, P423, DOI 10.1016/j.bbamem.2007.11.002
   Yamada Y, 2013, J PHARM SCI-US, V102, P1008, DOI 10.1002/jps.23442
   Yamada Y, 2011, MOL THER, V19, P1449, DOI 10.1038/mt.2011.99
   Yasuzaki Y, 2010, BIOCHEM BIOPH RES CO, V397, P181, DOI 10.1016/j.bbrc.2010.05.070
   Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Zhang SW, 2015, AM J CANCER RES, V5, P1265
   Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200
   Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287
NR 166
TC 19
Z9 19
U1 0
U2 23
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD JAN 1
PY 2016
VL 21
BP 769
EP 793
DI 10.2741/4420
PG 25
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA DC2WT
UT WOS:000369080200007
PM 26709805
DA 2024-11-01
ER

PT J
AU Acin-Perez, R
   Salazar, E
   Brosel, S
   Yang, H
   Schon, EA
   Manfredi, G
AF Acin-Perez, Rebeca
   Salazar, Eric
   Brosel, Sonja
   Yang, Hua
   Schon, Eric A.
   Manfredi, Giovanni
TI Modulation of mitochondrial protein phosphorylation by soluble adenylyl
   cyclase ameliorates cytochrome oxidase defects
SO EMBO MOLECULAR MEDICINE
LA English
DT Article
DE mitochondria; sAC; cytochrome oxidase; mtDNA; ROS
ID CAMP-DEPENDENT PHOSPHORYLATION; BOVINE HEART-MITOCHONDRIA; STOP-CODON
   MUTATION; C-OXIDASE; OXIDATIVE-PHOSPHORYLATION; COMPLEX-I; SUBUNIT-I;
   TYROSINE PHOSPHORYLATION; SKELETAL-MUSCLE; CULTURED-CELLS
AB Phosphorylation of respiratory chain components has emerged as a mode of regulation of mitochondrial energy metabolism, but its mechanisms are still largely unexplored. A recently discovered intramitochondrial signalling pathway links CO2 generated by the Krebs cycle with the respiratory chain, through the action of a mitochondrial soluble adenylyl cyclase (mt-sAC). Cytochrome oxidase (COX), whose deficiency causes a number of fatal metabolic disorders, is a key mitochondrial enzyme activated by mt-sAC. We have now discovered that the mt-sAC pathway modulates mitochondrial biogenesis in a reactive oxygen species dependent manner, in cultured cells and in animals with COX deficiency. We show that upregulation of mt-sAC normalizes ROS production and mitochondrial biogenesis, thereby restoring mitochondrial function. This is the first example of manipulation of a mitochondrial signalling pathway to achieve a direct positive modulation of COX, with clear implications for the development of novel approaches to treat mitochondrial diseases.
C1 [Acin-Perez, Rebeca; Manfredi, Giovanni] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.
   [Salazar, Eric] Cornell Univ, Weill Med Coll, Triinst MD PhD Program, New York, NY 10021 USA.
   [Salazar, Eric] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA.
   [Brosel, Sonja; Yang, Hua; Schon, Eric A.] Cornell Univ, Dept Neurol, New York, NY 10021 USA.
C3 Cornell University; Weill Cornell Medicine; Cornell University; Weill
   Cornell Medicine; Cornell University; Weill Cornell Medicine; Cornell
   University
RP Manfredi, G (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.
EM gim2004@mail.med.cornell.edu
RI Acin-Perez, Rebeca/AAU-4913-2020; Acin-Perez, Rebeca/H-6160-2015
OI Acin-Perez, Rebeca/0000-0001-9553-8337
FU NIH; Muscular Dystrophy Association; United Mitochondrial Disease
   Foundation; Milstein Foundation; MSTP; Marriot Foundation
FX We thank Dr Jose 'Antonio Enriquez (University of Zaragoza, Spain) for
   the mouse cybrids. Dr Lonny Levin and Dr Jochen Buck (Weill Medical
   College of Cornell University, New York) for the KH7 inhibitor, the rat
   sAC cDNA, the R21 antibody. Dr Carlos Moraes (University of Miami) and
   Dr Ireneaus de Coo (Erasmus Medical Center, Rotterdam, Netherlands) for
   the Cyt b cybrids. This work was supported by NIH (GM, EAS), the
   Muscular Dystrophy Association (GM, EAS), United Mitochondrial Disease
   Foundation (RA-P), Milstein Foundation, MSTP funding (ES) and The
   Marriot Foundation (EAS). All authors declare not to have any competing
   commercial interest in relation to this work.
CR Acín-Pérez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021
   Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012
   Bender E, 2000, FEBS LETT, V466, P130, DOI 10.1016/S0014-5793(99)01773-1
   Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4
   Bronner M, 2004, BIOCHEM J, V384, P295, DOI 10.1042/BJ20040955
   Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546
   Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200
   Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625
   CHIJIWA T, 1990, J BIOL CHEM, V265, P5267
   D'Aurelio M, 2001, J BIOL CHEM, V276, P46925, DOI 10.1074/jbc.M106429200
   D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141
   De Rasmo D, 2008, CELL SIGNAL, V20, P989, DOI 10.1016/j.cellsig.2008.01.017
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   Feliciello A, 2005, CELL SIGNAL, V17, P279, DOI 10.1016/j.cellsig.2004.09.009
   Fernández-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004
   Hao HL, 1996, J BIOL CHEM, V271, P2347, DOI 10.1074/jbc.271.4.2347
   Helling S, 2008, MOL CELL PROTEOMICS, V7, P1714, DOI 10.1074/mcp.M800137-MCP200
   Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007
   Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9
   Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030
   Irrcher I, 2009, AM J PHYSIOL-CELL PH, V296, pC116, DOI 10.1152/ajpcell.00267.2007
   Jäger S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6
   Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x
   Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200
   Lewitt M. S., 2001, Growth Hormone and IGF Research, V11, P303
   LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234
   Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827
   Lochmüller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407
   Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107
   Manfredi G, 2002, NAT GENET, V30, P394, DOI 10.1038/ng851
   MANFREDI G, 2002, NAT GENET, V25, P25
   Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103
   Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098
   Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897
   Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005
   Papa S, 1996, FEBS LETT, V379, P299, DOI 10.1016/0014-5793(95)01532-9
   Papadopoulou LC, 1999, NAT GENET, V23, P333
   Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085
   Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200
   Rana M, 2000, ANN NEUROL, V48, P774, DOI 10.1002/1531-8249(200011)48:5<774::AID-ANA11>3.3.CO;2-9
   Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102
   Salviati L, 2002, BIOCHEM J, V363, P321, DOI 10.1042/0264-6021:3630321
   Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200
   Sardanelli AM, 1995, FEBS LETT, V377, P470, DOI 10.1016/0014-5793(95)01407-1
   Scacco S, 2000, J BIOL CHEM, V275, P17578, DOI 10.1074/jbc.M001174200
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SCHWOCH G, 1990, BIOCHEM J, V270, P181, DOI 10.1042/bj2700181
   Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378
   Signorile A, 2002, FEBS LETT, V512, P91, DOI 10.1016/S0014-5793(02)02226-3
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Steenaart NAE, 1997, FEBS LETT, V415, P294, DOI 10.1016/S0014-5793(97)01145-9
   Thomson M, 2002, CELL MOL LIFE SCI, V59, P213, DOI 10.1007/s00018-002-8417-7
   Vives-Bauza C, 2006, NEUROSCI LETT, V391, P136, DOI 10.1016/j.neulet.2005.08.049
   Vives-Bauza C, 2007, METHOD CELL BIOL, V80, P155, DOI 10.1016/S0091-679X(06)80007-5
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Xia Y, 1997, P NATL ACAD SCI USA, V94, P11399, DOI 10.1073/pnas.94.21.11399
   Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje
   Zippin JH, 2001, TRENDS ENDOCRIN MET, V12, P366, DOI 10.1016/S1043-2760(01)00454-4
   Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com
NR 65
TC 94
Z9 108
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-4676
EI 1757-4684
J9 EMBO MOL MED
JI EMBO Mol. Med.
PD NOV-DEC
PY 2009
VL 1
IS 8-9
BP 392
EP 406
DI 10.1002/emmm.200900046
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 543HB
UT WOS:000273563500006
PM 20049744
OA Green Published
DA 2024-11-01
ER

PT J
AU Kim, DS
   Wheeler, MT
   Ashley, EA
AF Kim, Daniel Seung
   Wheeler, Matthew T.
   Ashley, Euan A.
TI The genetics of human performance
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID GENOME-WIDE ASSOCIATION; HUMAN SKELETAL-MUSCLE; EXERCISE HEART-RATE;
   BLOOD-PRESSURE; MITOCHONDRIAL BIOGENESIS; FAMILIAL AGGREGATION;
   ENERGY-EXPENDITURE; ALCOHOL DEPENDENCE; CARDIAC STRUCTURE; ACTN3
   GENOTYPE
AB Human physiology is likely to have been selected for endurance physical activity. However, modern humans have become largely sedentary, with physical activity becoming a leisure-time pursuit for most. Whereas inactivity is a strong risk factor for disease, regular physical activity reduces the risk of chronic disease and mortality. Although substantial epidemiological evidence supports the beneficial effects of exercise, comparatively little is known about the molecular mechanisms through which these effects operate. Genetic and genomic analyses have identified genetic variation associated with human performance and, together with recent proteomic, metabolomic and multi-omic analyses, are beginning to elucidate the molecular genetic mechanisms underlying the beneficial effects of physical activity on human health.
   Regular physical activity reduces the risk of chronic disease and mortality, but the mechanisms underpinning this protective effect are poorly understood. Here, Kim et al. review candidate genes and pathways implicated in human performance by genetic, genomic and multi-omic studies.
C1 [Kim, Daniel Seung; Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
   [Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.
   [Ashley, Euan A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.
   [Ashley, Euan A.] Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA.
C3 Stanford University; Stanford University; Stanford University; Stanford
   University
RP Ashley, EA (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Ashley, EA (corresponding author), Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA.
EM euan@stanford.edu
OI Kim, Daniel Seung/0000-0003-2971-1909
CR Ahmetov II, 2015, BIOL SPORT, V32, P3, DOI 10.5604/20831862.1124568
   AIello L., 2002, INTRO HUMAN EVOLUTIO, V15, DOI 10.1016/b978-0-08-057100-3.50019-5
   Al-Khelaifi F, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00595
   Amar D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23579-x
   An P, 2003, INT J SPORTS MED, V24, P57, DOI 10.1055/s-2003-37200
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613
   Aung N, 2019, CIRCULATION, V140, P1318, DOI 10.1161/CIRCULATIONAHA.119.041161
   BACCAREDDABOY A, 1964, ANGIOLOGICA, V1, P209
   Barrès R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001
   Benton ML, 2021, NAT REV GENET, V22, P269, DOI 10.1038/s41576-020-00305-9
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   Bohannon RW, 2017, J FRALITY AGING, V6, P83, DOI 10.14283/jfa.2017.8
   Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016
   BOUCHARD C, 1995, MED SCI SPORT EXER, V27, P721
   Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003
   Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013
   Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010
   Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052
   Brodde OE, 1999, PHARMACOL REV, V51, P651
   Bye A, 2020, PROG CARDIOVASC DIS, V63, P341, DOI 10.1016/j.pcad.2020.02.001
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165
   Chan JPL, 2015, AGE, V37, DOI 10.1007/s11357-015-9745-5
   Chapman MA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107808
   Chen MH, 2020, CELL, V182, P1198, DOI 10.1016/j.cell.2020.06.045
   Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771
   Choquet H, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/CIRCGEN.119.002804
   CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605
   Contrepois K, 2020, CELL, V181, P1112, DOI 10.1016/j.cell.2020.04.043
   Crittenden A. N., 2013, ATTACHMENT RECONSIDE
   Del Coso J, 2019, EUR J APPL PHYSIOL, V119, P49, DOI 10.1007/s00421-018-4010-0
   DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495
   Dikilitas O, 2020, AM J HUM GENET, V106, P707, DOI 10.1016/j.ajhg.2020.04.002
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809
   Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708
   Eynon N, 2011, PHYSIOL GENOMICS, V43, P789, DOI 10.1152/physiolgenomics.00029.2011
   Eynon N, 2011, MITOCHONDRION, V11, P64, DOI 10.1016/j.mito.2010.07.004
   Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Fox ER, 2013, CIRC-CARDIOVASC GENE, V6, P37, DOI 10.1161/CIRCGENETICS.111.962365
   Frampton J, 2020, NAT METAB, V2, P840, DOI 10.1038/s42255-020-0188-7
   Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815
   Ghosh S, 2013, J APPL PHYSIOL, V115, P1343, DOI 10.1152/japplphysiol.01487.2012
   Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Harvey NR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67870-1
   Harvey NR, 2020, MOL GENET GENOMICS, V295, P515, DOI 10.1007/s00438-019-01639-8
   Hautala AJ, 2009, ANN MED, V41, P197, DOI 10.1080/07853890802477866
   Heinicke K, 2001, INT J SPORTS MED, V22, P504, DOI 10.1055/s-2001-17613
   HIGGINBOTHAM MB, 1986, CIRC RES, V58, P281, DOI 10.1161/01.RES.58.2.281
   Illig T, 2004, J CLIN ENDOCR METAB, V89, P5053, DOI 10.1210/jc.2004-0355
   Ingelsson E, 2007, CIRCULATION, V115, P2917, DOI 10.1161/CIRCULATIONAHA.106.683821
   Jacques M, 2019, EPIGENETICS-US, V14, P633, DOI 10.1080/15592294.2019.1614416
   Kamberov YG, 2018, J HUM EVOL, V125, P99, DOI 10.1016/j.jhevol.2018.10.008
   Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100
   Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6
   Kim DS, 2021, J AM COLL CARDIOL, V78, P496, DOI 10.1016/j.jacc.2021.03.346
   Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049
   KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0
   La Rovere MT, 1998, LANCET, V351, P478
   Landen S, 2019, EPIGENETICS-US, V14, P523, DOI 10.1080/15592294.2019.1603961
   Lantier L, 2014, FASEB J, V28, P3211, DOI 10.1096/fj.14-250449
   Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6
   Liebenberg L, 2006, CURR ANTHROPOL, V47, P1017, DOI 10.1086/508695
   Lieberman DE, 2015, CURR SPORT MED REP, V14, P313, DOI 10.1249/JSR.0000000000000168
   Lieberman DE, 2015, COMPR PHYSIOL, V5, P99, DOI 10.1002/cphy.c140011
   Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lindholm ME, 2014, AM J PHYSIOL-REG I, V307, pR248, DOI 10.1152/ajpregu.00036.2013
   Lindholm ME, 2016, EXP PHYSIOL, V101, P28, DOI 10.1113/EP085318
   Lindholm ME, 2014, EPIGENETICS-US, V9, P1557, DOI 10.4161/15592294.2014.982445
   Liu XJ, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029850
   Lorenzo FR, 2014, NAT GENET, V46, P951, DOI 10.1038/ng.3067
   Lundby C, 2006, EUR J APPL PHYSIOL, V96, P363, DOI 10.1007/s00421-005-0085-5
   Luo XG, 2005, HUM MOL GENET, V14, P2421, DOI 10.1093/hmg/ddi244
   Ma PC, 2014, MOL CELL BIOL, V34, P4355, DOI 10.1128/MCB.00731-14
   MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122
   MACDOUGALL JD, 1985, J APPL PHYSIOL, V58, P785, DOI 10.1152/jappl.1985.58.3.785
   MALCZEWSKALENCZ.J, 2020, J STRENGTH COND RES
   Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288
   Matteini AM, 2016, AGING CELL, V15, P792, DOI 10.1111/acel.12468
   McGee SL, 2019, TRENDS ENDOCRIN MET, V30, P636, DOI 10.1016/j.tem.2019.06.002
   McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065
   Medrano JL, 2017, J BIOL CHEM, V292, P20975, DOI 10.1074/jbc.M117.806422
   Meyer HV, 2020, NATURE, V584, P589, DOI 10.1038/s41586-020-2635-8
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Minetti AE, 2003, NATURE, V426, P785, DOI 10.1038/426785a
   Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051
   Nezhad FY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00262
   Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653
   North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675
   Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016
   Papadimitriou ID, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4412-0
   Paré G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286
   Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040
   Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103
   Persson HC, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0436-8
   Pettersen IKN, 2019, MITOCHONDRION, V49, P97, DOI 10.1016/j.mito.2019.07.009
   Pillon NJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13869-w
   Pirruccello JP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15823-7
   Pitsiladis YP, 2016, PHYSIOL GENOMICS, V48, P183, DOI 10.1152/physiolgenomics.00105.2015
   Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4
   Ramírez J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04148-1
   Rankinen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147330
   Rankinen T, 2012, J APPL PHYSIOL, V112, P892, DOI 10.1152/japplphysiol.01287.2011
   REED T, 2009, ANN HUM BIOL, V18
   Rice T, 2002, MED SCI SPORT EXER, V34, P972, DOI 10.1097/00005768-200206000-00011
   ROBERTSHAW D, 1985, J HUM EVOL, V14, P63, DOI 10.1016/S0047-2484(85)80096-8
   SALE DG, 1988, MED SCI SPORT EXER, V20, pS135, DOI 10.1249/00005768-198810001-00009
   Sanford JA, 2020, CELL, V181, P1464, DOI 10.1016/j.cell.2020.06.004
   Sarzynski MA, 2020, NAT METAB, V2, P796, DOI 10.1038/s42255-020-0233-6
   Sarzynski MA, 2017, J PHYSIOL-LONDON, V595, P2931, DOI 10.1113/JP272559
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Scheiman J, 2019, NAT MED, V25, P1104, DOI 10.1038/s41591-019-0485-4
   SCHMIDTNIELSEN K, 1970, SCIENCE, V169, P1102, DOI 10.1126/science.169.3950.1102
   Schnohr P, 2015, J AM COLL CARDIOL, V65, P411, DOI 10.1016/j.jacc.2014.11.023
   Semenova EA, 2020, EUR J APPL PHYSIOL, V120, P665, DOI 10.1007/s00421-020-04306-8
   Semenova EA, 2019, SPORTS, EXERCISE, AND NUTRITIONAL GENOMICS: CURRENT STATUS AND FUTURE DIRECTIONS, P73, DOI 10.1016/B978-0-12-816193-7.00004-X
   Seto JT, 2013, J CLIN INVEST, V123, P4255, DOI 10.1172/JCI67691
   Shave RE, 2019, P NATL ACAD SCI USA, V116, P19905, DOI 10.1073/pnas.1906902116
   Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886
   Song DS, 2020, P NATL ACAD SCI USA, V117, P12230, DOI 10.1073/pnas.1920546117
   Stefano E, 2019, MITOCHONDRION, V47, P125, DOI 10.1016/j.mito.2019.06.004
   Surendran P, 2020, NAT GENET, V52, P1314, DOI 10.1038/s41588-020-00713-x
   Tadros R, 2021, NAT GENET, V53, P128, DOI 10.1038/s41588-020-00762-2
   Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986
   TAYLOR CR, 1973, AM J PHYSIOL, V224, P848, DOI 10.1152/ajplegacy.1973.224.4.848
   Theilen NT, 2017, J CELL PHYSIOL, V232, P2348, DOI 10.1002/jcp.25737
   Tikkanen E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24735-y
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003
   Turner DC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72730-z
   van de Vegte YJ, 2019, CELL MOL LIFE SCI, V76, P2391, DOI 10.1007/s00018-019-03079-4
   Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2
   Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a
   Verweij N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03395-6
   Vuckovic D, 2020, CELL, V182, P1214, DOI 10.1016/j.cell.2020.08.008
   Vujkovic M, 2020, NAT GENET, V52, P680, DOI 10.1038/s41588-020-0637-y
   Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194
   Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17
   Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294
   WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434
   Wild PS, 2017, J CLIN INVEST, V127, P1798, DOI 10.1172/JCI84840
   Willems SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16015
   Wilmore JH, 2001, MED SCI SPORT EXER, V33, P107
   Wone BWM, 2019, MITOCHONDRION, V46, P134, DOI 10.1016/j.mito.2018.04.002
   Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590
   Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4
NR 154
TC 24
Z9 24
U1 3
U2 38
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD JAN
PY 2022
VL 23
IS 1
BP 40
EP 54
DI 10.1038/s41576-021-00400-5
EA SEP 2021
PG 15
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Genetics & Heredity
GA XO5FF
UT WOS:000695804900002
PM 34522035
DA 2024-11-01
ER

PT J
AU Benazzo, A
   Trucchi, E
   Cahill, JA
   Delser, PM
   Mona, S
   Fumagalli, M
   Bunnefeld, L
   Cornetti, L
   Ghirotto, S
   Girardi, M
   Ometto, L
   Panziera, A
   Rota-Stabelli, O
   Zanetti, E
   Karamanlidis, A
   Groff, C
   Paule, L
   Gentile, L
   Vilà, C
   Vicario, S
   Boitani, L
   Orlando, L
   Fuselli, S
   Vernesi, C
   Shapiro, B
   Ciucci, P
   Bertorelle, G
AF Benazzo, Andrea
   Trucchi, Emiliano
   Cahill, James A.
   Delser, Pierpaolo Maisano
   Mona, Stefano
   Fumagalli, Matteo
   Bunnefeld, Lynsey
   Cornetti, Luca
   Ghirotto, Silvia
   Girardi, Matteo
   Ometto, Lino
   Panziera, Alex
   Rota-Stabelli, Omar
   Zanetti, Enrico
   Karamanlidis, Alexandros
   Groff, Claudio
   Paule, Ladislav
   Gentile, Leonardo
   Vila, Carles
   Vicario, Saverio
   Boitani, Luigi
   Orlando, Ludovic
   Fuselli, Silvia
   Vernesi, Cristiano
   Shapiro, Beth
   Ciucci, Paolo
   Bertorelle, Giorgio
TI Survival and divergence in a small group: The extraordinary genomic
   history of the endangered Apennine brown bear stragglers
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE balancing selection; genetic drift; genetic load; Ursus arctos;
   Neolithic impact
ID POPULATION-SIZE; URSUS-ARCTOS; BIASED DISPERSAL; SPATIAL-PATTERNS; NATAL
   DISPERSAL; GENETIC RESCUE; EVOLUTION; SELECTION; REVEAL; CONSERVATION
AB About 100 km east of Rome, in the central Apennine Mountains, a critically endangered population of similar to 50 brown bears live in complete isolation. Mating outside this population is prevented by several 100 km of bear-free territories. We exploited this natural experiment to better understand the gene and genomic consequences of surviving at extremely small population size. We found that brown bear populations in Europe lost connectivity since Neolithic times, when farming communities expanded and forest burning was used for land clearance. In central Italy, this resulted in a 40-fold population decline. The overall genomic impact of this decline included the complete loss of variation in the mitochondrial genome and along long stretches of the nuclear genome. Several private and deleterious amino acid changes were fixed by random drift; predicted effects include energy deficit, muscle weakness, anomalies in cranial and skeletal development, and reduced aggressiveness. Despite this extreme loss of diversity, Apennine bear genomes show nonrandom peaks of high variation, possibly maintained by balancing selection, at genomic regions significantly enriched for genes associated with immune and olfactory systems. Challenging the paradigm of increased extinction risk in small populations, we suggest that random fixation of deleterious alleles (i) can be an important driver of divergence in isolation, (ii) can be tolerated when balancing selection prevents random loss of variation at important genes, and (iii) is followed by or results directly in favorable behavioral changes.
C1 [Benazzo, Andrea; Trucchi, Emiliano; Ghirotto, Silvia; Panziera, Alex; Zanetti, Enrico; Fuselli, Silvia; Bertorelle, Giorgio] Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy.
   [Trucchi, Emiliano] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, N-1066 Oslo, Norway.
   [Cahill, James A.; Shapiro, Beth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.
   [Delser, Pierpaolo Maisano; Mona, Stefano] Univ Paris 06, EPHE, Museum Natl Hist Nat, Inst Systemat Evolut Biodiversite,UMR 7205,CNRS, CP39, F-75005 Paris, France.
   [Delser, Pierpaolo Maisano; Mona, Stefano] Paris Sci & Lettres Res Univ, EPHE, F-75005 Paris, France.
   [Delser, Pierpaolo Maisano] Univ Dublin, Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.
   [Fumagalli, Matteo] Imperial Coll London, Dept Life Sci, Ascot SL5 7PY, Berks, England.
   [Bunnefeld, Lynsey] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.
   [Bunnefeld, Lynsey] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland.
   [Cornetti, Luca] Univ Basel, Zool Inst, CH-4051 Basel, Switzerland.
   [Girardi, Matteo; Vernesi, Cristiano] Fdn Edmund Mach, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, Italy.
   [Ometto, Lino; Rota-Stabelli, Omar] Fdn Edmund Mach, Dept Sustainable Agroecosyst & Bioresources, I-38010 San Michele All Adige, Italy.
   [Karamanlidis, Alexandros] ARCTUROS, Protect & Management Wildlife & Nat Environm, Aetos 53075, Florina, Greece.
   [Groff, Claudio] Provincia Autonoma Trento, Forest & Wildlife Serv, I-38100 Trento, Italy.
   [Paule, Ladislav] Tech Univ, Fac Forestry, Dept Phytol, Zvolen 96053, Slovakia.
   [Gentile, Leonardo] Natl Pk Abruzzo Lazio & Molise, Vet Serv, I-67032 Pescasseroli, Italy.
   [Vila, Carles] Consejo Super Invest Cientif, Donana Biol Stn, Dept Integrat Ecol, Seville 4102, Spain.
   [Vicario, Saverio] CNR, Inst Atmospher Pollut Res & Technol, I-70126 Bari, Italy.
   [Boitani, Luigi; Ciucci, Paolo] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy.
   [Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark.
C3 University of Ferrara; University of Oslo; University of California
   System; University of California Santa Cruz; Universite PSL; Ecole
   Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Museum National
   d'Histoire Naturelle (MNHN); Centre National de la Recherche
   Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE);
   Universite PSL; Ecole Pratique des Hautes Etudes (EPHE); Trinity College
   Dublin; Imperial College London; University of Edinburgh; University of
   Stirling; University of Basel; Fondazione Edmund Mach; Fondazione Edmund
   Mach; Technical University Zvolen; Consejo Superior de Investigaciones
   Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consiglio
   Nazionale delle Ricerche (CNR); Sapienza University Rome; University of
   Copenhagen
RP Bertorelle, G (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy.
EM ggb@unife.it
RI Paule, Ladislav/K-5373-2012; Fumagalli, Matteo/H-6448-2019; Mona,
   Stefano/AAF-5061-2019; Cahill, James/AAC-3145-2021; Delser,
   Pierpaolo/M-6229-2019; Bertorelle, Giorgio/JBR-9056-2023; Fuselli,
   Silvia/AAG-9332-2020; vicario, saverio/AAX-8105-2020; Karamanlidis,
   Alexandros/S-8239-2017; vicario, saverio/C-4427-2015; Ometto,
   Lino/C-3609-2008; Rota Stabelli, Omar/G-8477-2011; Vila,
   Carles/H-4893-2013; Orlando, Ludovic/A-8932-2013; CIUCCI,
   Paolo/C-7677-2009
OI Girardi, Matteo/0000-0002-1176-0764; Shapiro, Beth/0000-0002-2733-7776;
   Bertorelle, Giorgio/0000-0002-2498-2702; vicario,
   saverio/0000-0003-1140-0483; Vernesi, Cristiano/0000-0001-7534-5669;
   Paule, Ladislav/0000-0002-5097-7472; Ometto, Lino/0000-0002-2679-625X;
   Fumagalli, Matteo/0000-0002-4084-2953; Maisano Delser,
   Pierpaolo/0000-0002-1844-1715; Mona, Stefano/0000-0001-9087-0656;
   Cahill, James/0000-0002-7145-0215; BUNNEFELD,
   LYNSEY/0000-0002-9226-7153; Rota Stabelli, Omar/0000-0002-0030-7788;
   Vila, Carles/0000-0002-4206-5246; Orlando, Ludovic/0000-0003-3936-1850;
   CIUCCI, Paolo/0000-0002-0994-3422; Fuselli, Silvia/0000-0002-1442-6171
FU Vodafone Greece; Vodafone Group Foundation; Fondo Ateneo Ricerca (FAR)
   grants from University of Ferrara; Agence Nationale de la Recherche
   Demochips Grant [ANR-12-BSV7-0012]; Agence Nationale de la Recherche
   (ANR) [ANR-12-BSV7-0012] Funding Source: Agence Nationale de la
   Recherche (ANR)
FX We thank coworkers at the State Nature Conservancy of Slovakia for
   tissue samples from legally culled brown bears. We also thank Anna
   Mazzarella for revising the manuscript. We thank the regional
   governments of Asturias and Castilla y Leon in Spain for providing
   tissue samples of Cantabrian bears. We thank the genotoul bioinformatics
   platform Toulouse Midi-Pyrenees (Bioinfo Genotoul) for providing
   computing resources. We also thank the Abruzzo Lazio and Molise National
   Park for permissions and assistance with logistics and the Istituto di
   Ecologia Applicata for financial support of genomic analyses. Apennine
   bear samples were obtained during a live-trapping and telemetry project
   funded by a US private citizen through the Wildlife Conservation
   Society. The samples were exported from Greece with Convention on
   International Trade in Endangered Species (CITES) Permit 86731.
   Financial support for the collection of the samples was provided by
   Vodafone Greece and the Vodafone Group Foundation. Fondo Ateneo Ricerca
   (FAR) grants from the University of Ferrara supported the study. P.M.D.
   was funded by Agence Nationale de la Recherche Demochips Grant
   ANR-12-BSV7-0012.
CR Abascal F, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1090-1
   Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248
   Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257
   Aguilar A, 2004, P NATL ACAD SCI USA, V101, P3490, DOI 10.1073/pnas.0306582101
   Alonso S, 2008, MOL BIOL EVOL, V25, P997, DOI 10.1093/molbev/msn049
   Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x
   Bidon T, 2014, MOL BIOL EVOL, V31, P1353, DOI 10.1093/molbev/msu109
   Blomqvist D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-33
   Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x
   Brauer A, 2007, P NATL ACAD SCI USA, V104, P450, DOI 10.1073/pnas.0603321104
   Bunnefeld L, 2015, GENETICS, V201, P1157, DOI 10.1534/genetics.115.179861
   BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x
   Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002
   Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664
   Ciucci P, 2015, J MAMMAL, V96, P206, DOI 10.1093/jmammal/gyu029
   Ciucci P, 2014, J MAMMAL, V95, P572, DOI 10.1644/13-MAMM-A-218
   Ciucci P, 2008, URSUS, V19, P130, DOI 10.2192/07PER012.1
   Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483
   Colangelo P, 2012, BIOL J LINN SOC, V107, P15, DOI 10.1111/j.1095-8312.2012.01926.x
   Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x
   Curry-Lindahl K., 1972, International Association for Bear Research and Management, V2, P74
   Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023
   Delser PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33753
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x
   Falush D, 2003, GENETICS, V164, P1567
   FEBBO D, 1990, Aquilo Ser Zoologica, V27, P85
   Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703
   Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002
   Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139
   Fyfe RM, 2015, GLOBAL CHANGE BIOL, V21, P1197, DOI 10.1111/gcb.12776
   Gilpin M.E., 1986, P19
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5
   Henry RC, 2016, AM NAT, V188, P423, DOI 10.1086/688170
   Jerina K, 2008, J MAMMAL, V89, P1491, DOI 10.1644/07-MAMM-A-357.1
   Kaplan JO, 2011, HOLOCENE, V21, P775, DOI 10.1177/0959683610386983
   Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4
   Kronenberger JA, 2017, ANIM CONSERV, V20, P3, DOI 10.1111/acv.12286
   LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054
   Liu XM, 2015, NAT GENET, V47, P555, DOI 10.1038/ng.3254
   Marlon JR, 2013, QUATERNARY SCI REV, V65, P5, DOI 10.1016/j.quascirev.2012.11.029
   MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0
   Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448
   Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109
   Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221
   Nadachowska-Brzyska K, 2016, MOL ECOL, V25, P1058, DOI 10.1111/mec.13540
   Norén K, 2016, MOL ECOL, V25, P3309, DOI 10.1111/mec.13674
   OHTA T, 1982, P NATL ACAD SCI-BIOL, V79, P3251, DOI 10.1073/pnas.79.10.3251
   Ottaviani D, 2014, TRENDS GENET, V30, P85, DOI 10.1016/j.tig.2014.01.001
   Palomares F, 2012, CONSERV BIOL, V26, P689, DOI 10.1111/j.1523-1739.2012.01870.x
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   Preatoni D, 2005, ACTA OECOL, V28, P189, DOI 10.1016/j.actao.2005.04.002
   Prüfer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886
   Radwan J, 2010, BIOL CONSERV, V143, P537, DOI 10.1016/j.biocon.2009.07.026
   RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146
   Robinson JA, 2016, CURR BIOL, V26, P1183, DOI 10.1016/j.cub.2016.02.062
   Rogers RL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006601
   Sarkissian CD, 2015, CURR BIOL, V25, P2577, DOI 10.1016/j.cub.2015.08.032
   Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015
   Schubert M, 2014, P NATL ACAD SCI USA, V111, pE5661, DOI 10.1073/pnas.1416991111
   Steyaert SMJG, 2016, WILDLIFE BIOL, V22, P144, DOI 10.2981/wlb.00165
   Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5
   Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x
   Swenson JE, 2011, MAMMAL REV, V41, P87, DOI 10.1111/j.1365-2907.2010.00179.x
   TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028
   Tallmon DA, 2017, ANIM CONSERV, V20, P16, DOI 10.1111/acv.12335
   Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Valdiosera CE, 2008, P NATL ACAD SCI USA, V105, P5123, DOI 10.1073/pnas.0712223105
   Wang L, 2016, MOL ECOL, V25, P3605, DOI 10.1111/mec.13714
   Whiteley AR, 2015, TRENDS ECOL EVOL, V30, P42, DOI 10.1016/j.tree.2014.10.009
   Wood JLA, 2016, EVOL APPL, V9, P640, DOI 10.1111/eva.12375
   Wright S, 1931, GENETICS, V16, P0097
   Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952
   Young JM, 2008, AM J HUM GENET, V83, P228, DOI 10.1016/j.ajhg.2008.07.005
   Zennaro P, 2015, GEOPHYS RES LETT, V42, P5023, DOI 10.1002/2015GL064259
NR 79
TC 93
Z9 96
U1 3
U2 69
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 7
PY 2017
VL 114
IS 45
BP E9589
EP E9597
DI 10.1073/pnas.1707279114
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FM0DT
UT WOS:000414631200021
PM 29078308
OA Green Published, Bronze, Green Accepted
DA 2024-11-01
ER

PT J
AU Pulliero, A
   Godschalk, R
   Andreassi, MG
   Curfs, D
   Van Schooten, FJ
   Izzotti, A
AF Pulliero, A.
   Godschalk, R.
   Andreassi, M. G.
   Curfs, D.
   Van Schooten, F. J.
   Izzotti, A.
TI Environmental carcinogens and mutational pathways in atherosclerosis
SO INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
LA English
DT Review
DE Carcinogens; DNA damage; Atherosclerosis; Cardiovascular diseases;
   Polycyclic aromatic hydrocarbons; Radiation
ID SMOOTH-MUSCLE-CELLS; POLYCYCLIC AROMATIC-HYDROCARBONS;
   CORONARY-HEART-DISEASE; PERSISTENT ORGANIC POLLUTANTS; NUCLEOTIDE
   EXCISION-REPAIR; ACTIVATED PROTEIN-KINASES; LOW-DENSITY-LIPOPROTEIN;
   AGE-DEPENDENT CHANGES; INDUCED DNA-DAMAGE; CIGARETTE-SMOKE
AB Atherosclerosis is associated with DNA damage in both circulating and vessel-wall cells and DNA adducts derived from exposure to environmental mutagens are abundant in atherosclerotic vessels. Environmental chemical carcinogens identified as risk factor for atherosclerosis include polycyclic aromatic hydrocarbons (benzo(a)pyrene, dimethylbenz(a)anthracene, beta-naphthoflavone, pyrene, 3methylcolanthrene), arsenic, cadmium, 1,3-butadiene, cigarette smoke. Accordingly, polymorphisms of genes encoding for phase I/II metabolic reaction and DNA repair are risk factor for cardiovascular diseases, although their role is negligible as compared to other risk factors. The pathogenic relevance of mutation-related molecular damage in atherosclerosis has been demonstrated in experimental animal models involving the exposure to chemical mutagens. The relevance of mutation-related events in worsening atherosclerosis prognosis has been demonstrated in human clinical studies mainly as referred to mitochondrial DNA damage. Atherosclerosis is characterized by the occurrence of high level of oxidative damage in blood vessel resulting from both endogenous and exogenous sources. Mitochondrial damage is a main endogenous source of oxidative stress whose accumulation causes activation of intrinsic apoptosis through BIRC2 inhibition and cell loss contributing to plaque development and instability. Environmental physical mutagens, including ionizing radiation, are a risk factor for atherosclerosis even at the low exposure dose occurring in case of occupational exposure or the high exposure doses occurring during radiotherapy. Conversely, the role of exciting UV radiation in atherosclerosis is still uncertain.
   This review summarizes the experimental and clinical evidence supporting the pathogenic role of mutation-related pathway in atherosclerosis examining the underlying molecular mechanisms. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Pulliero, A.; Izzotti, A.] Univ Genoa, Dept Hlth Sci, I-16126 Genoa, Italy.
   [Godschalk, R.; Curfs, D.; Van Schooten, F. J.] Maastricht Univ, Maastricht UMC, Sch Nutr Toxicol & Metab NUTRIM, Dept Toxicol, NL-6200 MD Maastricht, Netherlands.
   [Andreassi, M. G.] CNR, Inst Clin Physiol, I-56124 Pisa, Italy.
   [Izzotti, A.] IRCCS AOU San Martino IST, Genoa, Italy.
C3 University of Genoa; Maastricht University; Maastricht University
   Medical Centre (MUMC); Consiglio Nazionale delle Ricerche (CNR);
   Istituto di Fisiologia Clinica (IFC-CNR); University of Genoa; IRCCS AOU
   San Martino IST
RP Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, I-16126 Genoa, Italy.
EM izzotti@unige.it
OI izzotti, alberto/0000-0002-8588-0347
CR Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
   AGIR (Advisory Group on Ionising Radiation), 2010, REPORT OF THE INDEPE
   Akbas HS, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-92
   ALBERT RE, 1977, CANCER RES, V37, P2232
   Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047
   Ammit AJ, 2001, J APPL PHYSIOL, V91, P1431, DOI 10.1152/jappl.2001.91.3.1431
   Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   Annas A, 2000, MUTAT RES-GEN TOX EN, V471, P145, DOI 10.1016/S1383-5718(00)00127-3
   Arroyo LH, 1999, CARDIOVASC RES, V41, P369, DOI 10.1016/S0008-6363(98)00308-3
   AUGE N, 1995, BIOCHEM J, V309, P1015, DOI 10.1042/bj3091015
   Aviram M, 2005, HANDB EXP PHARM, V170, P263
   Bäckhed F, 2013, NAT MED, V19, P533, DOI 10.1038/nm.3178
   Bakhru A, 2005, PLOS MED, V2, P528, DOI 10.1371/journal.pmed.0020160
   Balansky R, 1996, CANCER RES, V56, P1642
   BATASTINI G, 1984, AM J PATHOL, V114, P403
   Bazo A.P., 2001, CARDIOVASC PATHOL, V20, pe9
   Becker AE, 2001, ANNU REV MED, V52, P289, DOI 10.1146/annurev.med.52.1.289
   BEIR, 2006, HEALTH RISKS FROM EX
   Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje
   Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Binková B, 2001, INT J HYG ENVIR HEAL, V204, P49, DOI 10.1078/1438-4639-00072
   Bjorkerud B, 1996, ARTERIOSCL THROM VAS, V16, P416, DOI 10.1161/01.ATV.16.3.416
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   BOLOTNIKOVA MG, 1994, SCI TOTAL ENVIRON, V142, P29, DOI 10.1016/0048-9697(94)90070-1
   BOND JA, 1981, J TOXICOL ENV HEALTH, V7, P327, DOI 10.1080/15287398109529983
   BOND JA, 1980, TOXICOL APPL PHARM, V52, P323, DOI 10.1016/0041-008X(80)90119-2
   BOND JA, 1979, LIFE SCI, V25, P425, DOI 10.1016/0024-3205(79)90574-5
   Borghini A, 2013, ATHEROSCLEROSIS, V230, P40, DOI 10.1016/j.atherosclerosis.2013.06.010
   Briedé JJ, 2004, FREE RADICAL RES, V38, P995, DOI 10.1080/10715760400000976
   Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8
   Brunnemann K.D., 1994, CARCINOGENESIS, V10, P1863
   BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434
   BUENING MK, 1978, P NATL ACAD SCI USA, V75, P5358, DOI 10.1073/pnas.75.11.5358
   California Air Resources Board, 1991, PROPOSED IDENTIFICAT
   CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020
   Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708
   Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P131
   Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801
   Curfs DMJ, 2005, FASEB J, V19, P1290, DOI 10.1096/fj.04-2269fje
   Curfs DMJ, 2004, AM J PATHOL, V164, P101, DOI 10.1016/S0002-9440(10)63101-X
   Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1
   Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825
   DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938
   den Hartigh LJ, 2010, TOXICOL IN VITRO, V24, P1993, DOI 10.1016/j.tiv.2010.08.017
   Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430
   DIPPLE A, 1976, ACS MONOGR SER, V173, P245
   Djoussé L, 2002, STROKE, V33, P1357, DOI 10.1161/01.STR.0000014325.54063.1A
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Dumrese C, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-2
   Durik M, 2012, CIRCULATION, V126, P468, DOI 10.1161/CIRCULATIONAHA.112.104380
   FRIBERG L, 1983, ANNU REV PUBL HEALTH, V4, P367, DOI 10.1146/annurev.pu.04.050183.002055
   Fukagawa NK, 2008, ENVIRON HEALTH PERSP, V116, P1218, DOI 10.1289/ehp.11172
   Gairola CG, 2001, ATHEROSCLEROSIS, V156, P49, DOI 10.1016/S0021-9150(00)00621-3
   Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328
   Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023
   Gianicolo ME, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-8
   GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047
   Godschalk R, 2003, FREE RADICAL RES, V37, P1299, DOI 10.1080/10715760310001621333
   Godschalk RWL, 2007, MUTAT RES-FUND MOL M, V621, P87, DOI 10.1016/j.mrfmmm.2007.02.012
   Gong Z, 2006, TOXICOL LETT, V166, P229, DOI 10.1016/j.toxlet.2006.07.307
   Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004
   Gorog P, 1997, ATHEROSCLEROSIS, V129, P1, DOI 10.1016/S0021-9150(96)06000-5
   Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835
   Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585
   Güngör N, 2007, FASEB J, V21, P2359, DOI 10.1096/fj.07-8163com
   Güngör N, 2010, MUTAGENESIS, V25, P149, DOI 10.1093/mutage/gep053
   Güngör N, 2010, MUTAGENESIS, V25, P77, DOI 10.1093/mutage/gep049
   Haegens A, 2007, J IMMUNOL, V178, P1800, DOI 10.4049/jimmunol.178.3.1800
   Hall M., 1990, CHEM CARCINOGENESIS, P327
   HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307
   HATTEMERFREY HA, 1991, TOXICOL IND HEALTH, V7, P141, DOI 10.1177/074823379100700303
   Hauptmann M, 2003, AM J EPIDEMIOL, V157, P239, DOI 10.1093/aje/kwf189
   Hayashi T, 2003, INT J RADIAT BIOL, V79, P129, DOI 10.1080/0955300021000038662
   Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379
   Hendry JH, 2008, RADIAT ENVIRON BIOPH, V47, P189, DOI 10.1007/s00411-007-0155-7
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   HOWARD G, 1994, ARCH INTERN MED, V154, P1277
   IACOPETTA B, 1995, INT J ONCOL, V7, P399
   INOUE T, 1995, CARDIOLOGY, V86, P374, DOI 10.1159/000176904
   Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x
   Itsara L.S., 2014, PLOS GENET, V610
   Ivanov V. K., 2011, Radiatsionnaya Biologiya Radioekologiya, V51, P41
   IZZOTTI A, 1994, CANCER RES, V54, pS1994
   Izzotti A, 2001, MUTAT RES-GEN TOX EN, V494, P97, DOI 10.1016/S1383-5718(01)00183-8
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   IZZOTTI A, 1995, CANCER EPIDEM BIOMAR, V4, P105
   Izzotti A, 2008, MUTAT RES-FUND MOL M, V644, P38, DOI 10.1016/j.mrfmmm.2008.06.012
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Izzotti A, 2011, ANN NY ACAD SCI, V1229, P103, DOI 10.1111/j.1749-6632.2011.06091.x
   Izzotti A, 2009, MUTAT RES-FUND MOL M, V667, P1, DOI 10.1016/j.mrfmmm.2009.06.001
   Jakovljevic I, 2011, ARH HIG RADA TOKSIKO, V62, P357, DOI 10.2478/10004-1254-62-2011-2095
   Järup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032
   Jaworski C., 2013, J AM COLL CARDIOL, V13, P01405
   Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149
   JELINSKY SA, 1995, BIOCHEMISTRY-US, V34, P13545, DOI 10.1021/bi00041a034
   Ji KT, 2013, INT J MOL MED, V31, P922, DOI 10.3892/ijmm.2013.1288
   Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59
   Kalayoglu MV, 1998, INFECT IMMUN, V66, P5067, DOI 10.1128/IAI.66.11.5067-5072.1998
   Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266
   Kawachi I, 1997, CIRCULATION, V95, P2374, DOI 10.1161/01.CIR.95.10.2374
   Kerley-Hamilton JS, 2012, TOXICOL SCI, V126, P391, DOI 10.1093/toxsci/kfs002
   Kerzee JK, 2000, MOL PHARMACOL, V58, P152, DOI 10.1124/mol.58.1.152
   Kim EJ, 2011, J INVEST DERMATOL, V131, P1720, DOI 10.1038/jid.2011.106
   Kitchin KT, 2001, TOXICOL APPL PHARM, V172, P249, DOI 10.1006/taap.2001.9157
   Knaapen AM, 2007, MUTAT RES-FUND MOL M, V621, P31, DOI 10.1016/j.mrfmmm.2006.12.010
   Knaapen AM, 2006, MUTAGENESIS, V21, P225, DOI 10.1093/mutage/gel032
   Knight-Lozano CA, 2002, CIRCULATION, V105, P849, DOI 10.1161/hc0702.103977
   Kowalski M, 2001, J Physiol Pharmacol, V52, P3
   Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f
   Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x
   Lind PM, 2012, ENVIRON HEALTH PERSP, V120, P38, DOI 10.1289/ehp.1103563
   Lind YS, 2013, ENVIRON RES, V123, P39, DOI 10.1016/j.envres.2013.02.007
   Little MP, 2012, ENVIRON HEALTH PERSP, V120, P1503, DOI 10.1289/ehp.1204982
   Lu KP, 2000, MUTAT RES-FUND MOL M, V454, P35, DOI 10.1016/S0027-5107(00)00095-6
   Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203
   Lynn S, 2000, CIRC RES, V86, P514, DOI 10.1161/01.RES.86.5.514
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Magalhaes MCF, 2002, PURE APPL CHEM, V74, P1843, DOI 10.1351/pac200274101843
   MAJESKY MW, 1985, P NATL ACAD SCI USA, V82, P3450, DOI 10.1073/pnas.82.10.3450
   MAJESKY MW, 1983, CARCINOGENESIS, V4, P647, DOI 10.1093/carcin/4.6.647
   Mali VR, 2014, FREE RADICAL RES, V48, P251, DOI 10.3109/10715762.2013.864761
   Malik Q, 2012, FREE RADICAL RES, V46, P554, DOI 10.3109/10715762.2012.663913
   Marinkovic N, 2013, BIOCHEM MEDICA, V23, P255
   Marinkovic N, 2010, ARH HIG RADA TOKSIKO, V61, P445, DOI 10.2478/10004-1254-61-2010-2024
   Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361
   McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018
   Meng D, 2009, TOXICOL LETT, V184, P44, DOI 10.1016/j.toxlet.2008.10.016
   Messner B, 2009, ARTERIOSCL THROM VAS, V29, P1392, DOI 10.1161/ATVBAHA.109.190082
   Miller KP, 2001, DRUG METAB REV, V33, P1, DOI 10.1081/DMR-100000138
   Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200
   Moorthy B, 2003, J PHARMACOL EXP THER, V305, P394, DOI 10.1124/jpet.102.044271
   Moorthy B, 2002, CARDIOVASC RES, V53, P1002, DOI 10.1016/S0008-6363(01)00536-3
   Moran AE, 2012, GLOB HEART, V7, P315, DOI 10.1016/j.gheart.2012.10.004
   Morrow JD, 2005, ARTERIOSCL THROM VAS, V25, P279, DOI 10.1161/01.ATV.0000152605.64964.c0
   Mossman BT, 2000, INHAL TOXICOL, V12, P307, DOI 10.1080/08958378.2000.11463240
   Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606
   Naira J, 2007, MUTAT RES-FUND MOL M, V621, P95, DOI 10.1016/j.mrfmmm.2007.02.013
   Narne P, 2013, GENET TEST MOL BIOMA, V17, P236, DOI 10.1089/gtmb.2012.0330
   Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752
   Ng D, 1998, J IMMUNOL, V161, P942
   Nishio E, 1998, LIFE SCI, V62, P1339, DOI 10.1016/S0024-3205(98)00068-X
   Oesterling E, 2008, TOXICOL APPL PHARM, V232, P309, DOI 10.1016/j.taap.2008.07.001
   Orosz Z, 2007, AM J PHYSIOL-HEART C, V292, pH130, DOI 10.1152/ajpheart.00599.2006
   OU XL, 1994, CHEM-BIOL INTERACT, V93, P29, DOI 10.1016/0009-2797(94)90083-3
   Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   PAIGEN B, 1986, CANCER RES, V46, P3321
   Park JH, 2005, CHEM RES TOXICOL, V18, P1026, DOI 10.1021/tx050001a
   PENN A, 1993, CIRCULATION, V88, P1820, DOI 10.1161/01.CIR.88.4.1820
   PENN A, 1981, CANCER RES, V41, P588
   PENN A, 1991, ARTERIOSCLER THROMB, V11, P1053, DOI 10.1161/01.ATV.11.4.1053
   Penn A, 1996, CIRCULATION, V93, P552, DOI 10.1161/01.CIR.93.3.552
   PENN A, 1988, CARCINOGENESIS, V9, P2185, DOI 10.1093/carcin/9.12.2185
   PENN AL, 1981, ARTERY, V9, P382
   PESSAHRASMUSSEN H, 1991, ARTERY, V18, P240
   Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736
   Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9
   Podechard N, 2009, CARDIOVASC RES, V82, P361, DOI 10.1093/cvr/cvp007
   Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132
   Prozialeck WC, 2006, LIFE SCI, V79, P1493, DOI 10.1016/j.lfs.2006.05.007
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   REVIS NW, 1984, TOXICOLOGY, V32, P215, DOI 10.1016/0300-483X(84)90075-1
   Riccioni G, 2012, J GERIATR CARDIOL, V9, P305, DOI 10.3724/SP.J.1263.2012.02132
   Richardson RB, 2008, INT J RADIAT BIOL, V84, P838, DOI 10.1080/09553000802392748
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rozankovic PB, 2011, J NEUROL, V258, P753, DOI 10.1007/s00415-010-5824-9
   SADHU DN, 1993, ARCH BIOCHEM BIOPHYS, V300, P124, DOI 10.1006/abbi.1993.1017
   SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6
   Salama SA, 2002, ENVIRON MOL MUTAGEN, V40, P153, DOI 10.1002/em.10106
   Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8
   Sasaki H, 2002, J CLIN EPIDEMIOL, V55, P974, DOI 10.1016/S0895-4356(02)00439-0
   Schultz-Hector S, 2007, INT J RADIAT ONCOL, V67, P10, DOI 10.1016/j.ijrobp.2006.08.071
   Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0
   Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130
   Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779
   Shimizu Y., 2010, BMJ-BRIT MED J, V34, p[1950, b5349]
   Shyu HY, 2012, J ATHEROSCLER THROMB, V19, P316, DOI 10.5551/jat.10967
   Siasos G, 2009, AM J HYPERTENS, V22, P586, DOI 10.1038/ajh.2009.57
   Simonelli V, 2012, MUTAT RES-FUND MOL M, V731, P1, DOI 10.1016/j.mrfmmm.2011.10.012
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Sjögren B, 2001, SCAND J WORK ENV HEA, V27, P420
   SLAGA TJ, 1980, CANCER RES, V40, P1981
   Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P371, DOI 10.1016/S0278-6915(99)00156-8
   Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803
   Speir E, 1998, CIRC RES, V83, P210, DOI 10.1161/01.RES.83.2.210
   Sram RJ, 2011, AIR QUAL ATMOS HLTH, V4, P161, DOI 10.1007/s11869-011-0133-8
   Starke RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071954
   STAVENOW L, 1988, ARTERY, V15, P94
   Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003
   Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414
   Tiirola T, 2007, ATHEROSCLEROSIS, V194, P403, DOI 10.1016/j.atherosclerosis.2006.08.013
   Topinka J, 2011, TOXICOL LETT, V202, P186, DOI 10.1016/j.toxlet.2011.02.005
   Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P2167, DOI 10.1161/01.ATV.17.10.2167
   Tribble DL, 1999, ARTERIOSCL THROM VAS, V19, P1387, DOI 10.1161/01.ATV.19.6.1387
   Uno S, 2014, TOXICOLOGY, V316, P34, DOI 10.1016/j.tox.2013.12.005
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   van Grevenynghe J, 2006, BIOCHEM BIOPH RES CO, V341, P763, DOI 10.1016/j.bbrc.2006.01.028
   van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374
   Van Schooten FJ, 1998, FASEB J, V12, P1409, DOI 10.1096/fasebj.12.13.1409
   Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, pH1293, DOI 10.1152/ajpheart.2001.280.3.H1293
   Verschuren JJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056262
   VLADIMIROV YA, 1980, ADV LIPID RES, V17, P173
   Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb
   Wang Y, 2014, CIRC RES, V114, P421, DOI 10.1161/CIRCRESAHA.114.302153
   Wang ZF, 2009, FREE RADICAL BIO MED, V47, P1221, DOI 10.1016/j.freeradbiomed.2009.08.001
   WHO, 2006, ALMOST A QUARTER OF
   Winczura A, 2012, FREE RADICAL RES, V46, P442, DOI 10.3109/10715762.2012.658516
   Winkelmann BR, 2001, CURR MED RES OPIN, V17, P132, DOI 10.1185/0300799039117049
   Yalin S, 2007, CELL BIOCHEM FUNCT, V25, P509, DOI 10.1002/cbf.1339
   Yamaguchi H, 2004, TRANSFUSION, V44, P1072, DOI 10.1111/j.1537-2995.2004.04005.x
   Yamaguchi H, 2002, INFECT IMMUN, V70, P2392, DOI 10.1128/IAI.70.5.2392-2398.2002
   Yan ZP, 2000, J BIOL CHEM, V275, P4949, DOI 10.1074/jbc.275.7.4949
   Yang H, 2009, ATHEROSCLEROSIS, V207, P51, DOI 10.1016/j.atherosclerosis.2009.03.052
   Yang Z., 2004, ANNU MEETING SOC FRE
   Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
   Yu XH, 2014, THROMB RES, V133, P229, DOI 10.1016/j.thromres.2013.11.017
   Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1
   ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094
   Zielinski JM, 2009, INT J OCCUP MED ENV, V22, P27, DOI 10.2478/v10001-009-0001-z
   ZWIJSEN RML, 1990, ATHEROSCLEROSIS, V85, P71, DOI 10.1016/0021-9150(90)90184-K
NR 229
TC 27
Z9 32
U1 1
U2 29
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 1438-4639
EI 1618-131X
J9 INT J HYG ENVIR HEAL
JI Int. J. Hyg. Environ. Health.
PD MAY
PY 2015
VL 218
IS 3
BP 293
EP 312
DI 10.1016/j.ijheh.2015.01.007
PG 20
WC Public, Environmental & Occupational Health; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Public, Environmental & Occupational Health; Infectious Diseases
GA CG2IF
UT WOS:000353097400002
PM 25704189
DA 2024-11-01
ER

PT J
AU Kouga, T
   Takagi, M
   Miyauchi, A
   Shimbo, H
   Iai, M
   Yamashita, S
   Murayama, K
   Klein, MB
   Miller, G
   Goto, T
   Osaka, H
AF Kouga, Takeshi
   Takagi, Mariko
   Miyauchi, Akihiko
   Shimbo, Hiroko
   Iai, Mizue
   Yamashita, Sumimasa
   Murayama, Kei
   Klein, Matthew B.
   Miller, Guy
   Goto, Tomohide
   Osaka, Hitoshi
TI Japanese Leigh syndrome case treated with EPI-743
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; EPI-743; Succinate; Mitochondria DNA
ID MITOCHONDRIAL DISEASE; ND3 GENE; GLUTATHIONE; SUCCINATE; MUTATIONS;
   DIAGNOSIS
AB Background: Leigh syndrome is a mitochondria] disease caused by respiratory chain deficiency, and there are no proven effective therapies. EPI-743 is a potent cellular oxidative stress protectant and results of clinical trials for mitochondria] diseases are accumulating.
   Case: At 5 months, a girl presented with the scarce eye movement and diminished muscle tone. She was diagnosed with Leigh encephalopathy from blood and cerebrospinal fluid lactate elevation and MRI findings. Sequence analysis for mitochondria] DNA revealed a T10158C mutation in the mitochondrial encoded ND3 gene in complex I.
   Results: At 8 months, succinate was prescribed expected to restore the electron transport chain system. After that her condition got worse and succinate was discontinued. Subsequent administration of EPI-743 improved her eye movement, fine motor movements of the extremities, and bowel movement. She is now 5 years old. Although brain atrophy has progressed, she has still respiratory free time.
   Conclusion: Our patient showed visible improvement with EPI-743 treatment and the only patient surviving after 4 years. There is a possibility that EPI-743 is modifying the natural course of the syndrome. (C) 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Kouga, Takeshi; Takagi, Mariko; Shimbo, Hiroko; Iai, Mizue; Yamashita, Sumimasa; Goto, Tomohide; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa, Japan.
   [Kouga, Takeshi; Miyauchi, Akihiko; Osaka, Hitoshi] Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
   [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba, Japan.
   [Klein, Matthew B.; Miller, Guy] BioElectron Technol Corp, Mountain View, CA USA.
C3 Jichi Medical University; Chiba Children's Hospital
RP Osaka, H (corresponding author), Jichi Med Univ, Dept Pediat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.
EM hosaka@jichi.ac.jp
RI Murayama, Kei/JGM-3674-2023
OI Goto, Tomohide/0000-0002-5791-4837
FU Agency of Medical Research and Development; JSPS KAKENHI [15552768]
FX We thank Taro Inaba, Masashi Suganuma, Tomoaki Shinohara from Koinobori
   and Tomoko Ohmae from PRARD Corporation for generous contribution to
   EPI-743 import. This work was supported by a project grant for Health
   Research on Infants, Children, Adolescents, and Young Adults, from the
   Agency of Medical Research and Development to YT and also supported by
   JSPS KAKENHI Grant Number 15552768 for HO.
CR Baertling F, 2014, J NEUROL NEUROSUR PS, V85, P257, DOI 10.1136/jnnp-2012-304426
   Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909
   Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68
   Enns GM, 2017, J CLIN MED, V6, DOI 10.3390/jcm6050050
   Enns GM, 2012, MOL GENET METAB, V105, P91, DOI 10.1016/j.ymgme.2011.10.009
   Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896
   Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007
   McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Pastore A, 2013, MOL GENET METAB, V109, P208, DOI 10.1016/j.ymgme.2013.03.011
   Pfeffer G, 2012, COCHRANE DB SYST REV, V18, P4
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Shimbo H, 2014, MOL GENET METAB REP, V1, P133, DOI 10.1016/j.ymgmr.2014.02.006
   Shrader WD, 2011, BIOORG MED CHEM LETT, V21, P3693, DOI 10.1016/j.bmcl.2011.04.085
   Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007
NR 15
TC 18
Z9 19
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD FEB
PY 2018
VL 40
IS 2
BP 145
EP 149
DI 10.1016/j.braindev.2017.08.005
PG 5
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA FV7AW
UT WOS:000424734600010
PM 28916229
DA 2024-11-01
ER

PT J
AU Gonzalez, AS
   Elguero, ME
   Finocchietto, P
   Holod, S
   Romorini, L
   Miriuka, SG
   Peralta, JG
   Poderoso, JJ
   Carreras, MC
AF Gonzalez, A. S.
   Elguero, M. E.
   Finocchietto, P.
   Holod, S.
   Romorini, L.
   Miriuka, S. G.
   Peralta, J. G.
   Poderoso, J. J.
   Carreras, M. C.
TI Abnormal mitochondrial fusion-fission balance contributes to the
   progression of experimental sepsis
SO FREE RADICAL RESEARCH
LA English
DT Article
DE nitric oxide; mitochondria; lipopolysaccharide; reactive oxygen species;
   iNOS
ID NITRIC-OXIDE SYNTHASE; COMPLEX-I; OXIDATIVE STRESS; S-NITROSYLATION;
   PEROXYNITRITE; DYSFUNCTION; INHIBITION; BIOGENESIS; DYNAMICS; MUSCLE
AB Sepsis-associated multiple organ failure is a major cause of mortality characterized by a massive increase of reactive oxygen and nitrogen species (ROS/RNS) and mitochondrial dysfunction. Despite intensive research, determining events in the progression or reversal of the disease are incompletely understood. Herein, we studied two prototype sepsis models: endotoxemia and cecal ligation and puncture (CLP)-which showed very diff erent lethality rates (2.5% and 67%, respectively)-, evaluated iNOS, ROS and respiratory chain activity, and investigated mitochondrial biogenesis and dynamics, as possible processes involved in sepsis outcome. Endotoxemia and CLP showed diff erent iNOS, ROS/RNS, and complex activities time-courses. Moreover, these alterations reverted after 24-h endotoxemia but not after CLP. Mitochondrial biogenesis was not elicited during the fi rst 24 h in either model but instead, 50% mtDNA depletion was observed. Mitochondrial fusion and fi ssion were evaluated using real-time PCR of mitofusin-2 (Mfn2), dynamin-related protein-1 (Drp1), and using electron microscopy. During endotoxemia, we observed a decrease of Mfn2-mRNA levels at 4-6 h, and an increase of mitochondrial fragmentation at 6 h. These parameters reverted at 24 h. In contrast, CLP showed not only decreased Mfn2-mRNA levels at 12-18 h but also increased Drp1-mRNA levels at 4 h, and enhanced and sustained mitochondrial fragmentation. The in vivo pretreatment with mdivi-1 (Drp1 inhibitor) signifi cantly attenuated mitochondrial dysfunction and apoptosis in CLP. Therefore, abnormal fusion-to-fi ssion balance, probably evoked by ROS/RNS secondary to iNOS induction, contributes to the progression of sepsis. Pharmacological targeting of Drp1 may be a potential novel therapeutic tool for sepsis.
C1 [Gonzalez, A. S.; Elguero, M. E.; Finocchietto, P.; Peralta, J. G.; Poderoso, J. J.; Carreras, M. C.] Univ Buenos Aires, Lab Oxygen Metab, INIGEM CONICET, Buenos Aires, DF, Argentina.
   [Gonzalez, A. S.; Holod, S.; Carreras, M. C.] Univ Buenos Aires, INFIBIOC, Sch Pharm & Biochem, Dept Clin Biochem, Buenos Aires, DF, Argentina.
   [Romorini, L.; Miriuka, S. G.] FLENI, LIAN, Lab Biol Desarrollo Celular, Buenos Aires, DF, Argentina.
C3 University of Buenos Aires; University of Buenos Aires
RP Carreras, MC (corresponding author), Univ Buenos Aires, Lab Oxygen Metab, INIGEM CONICET, Cordoba 2351,C1120AAR, Buenos Aires, DF, Argentina.
EM carreras@ffyb.uba.ar
RI Miriuka, Santiago/AAM-4051-2020; Romorini, Leonardo/AGK-7429-2022
OI Miriuka, Santiago/0000-0003-2402-3920
FU Agencia Nacional de Promocion Cientfica y Tecnologica (FONCyT) [PICT
   01625]; University of Buenos Aires [UBACyT M058, W443]; CONICET [PIP
   0422]; Fundacion Perez Companc, Buenos Aires, Argentina
FX This work was supported by the Agencia Nacional de Promocion Cientfica y
   Tecnologica (FONCyT) grant PICT 01625 (to M.C.C.), University of Buenos
   Aires grant UBACyT M058 and W443 (to J.J.P. and M.C.C.), CONICET grant
   PIP 0422 (to M.C.C.), and Fundacion Perez Companc, Buenos Aires,
   Argentina.
CR Alvarez S, 2004, FREE RADICAL BIO MED, V37, P1472, DOI 10.1016/j.freeradbiomed.2004.06.034
   Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085
   Beal AL, 1991, JAMA-J AM MED ASSOC, V271, P226
   Beltrán B, 2000, BRIT J PHARMACOL, V129, P953, DOI 10.1038/sj.bjp.0703147
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   Bhatia M, 2009, FRONT BIOSCI-LANDMRK, V14, P4703, DOI 10.2741/3561
   Boczkowski J, 1999, FASEB J, V13, P1637, DOI 10.1096/fasebj.13.12.1637
   Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X
   Brealey D, 2004, AM J PHYSIOL-REG I, V286, pR491, DOI 10.1152/ajpregu.00432.2003
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016
   Campello S, 2010, EMBO REP, V11, P678, DOI 10.1038/embor.2010.115
   Cardoso SM, 1999, FREE RADICAL BIO MED, V26, P3, DOI 10.1016/S0891-5849(98)00205-6
   Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014
   Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006
   Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255
   Cauwels A, 2007, KIDNEY INT, V72, P557, DOI 10.1038/sj.ki.5002340
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091
   Choumar A, 2011, ANTIOXID REDOX SIGN, V15, P2837, DOI 10.1089/ars.2010.3713
   Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21
   Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x
   DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
   Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3
   Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje
   Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007
   Franco MC, 2006, J BIOL CHEM, V281, P4779, DOI 10.1074/jbc.M512080200
   Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686
   Hauser B, 2005, ANESTH ANALG, V101, P488, DOI 10.1213/01.ANE.0000177117.80058.4D
   Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119
   Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e
   Jagnandan D, 2005, AM J PHYSIOL-CELL PH, V289, pC1024, DOI 10.1152/ajpcell.00162.2005
   Kurose I, 1996, HEPATOLOGY, V24, P1185
   Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010
   Lisdero CL, 2004, METHOD ENZYMOL, V382, P67
   López LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008
   López-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748
   Muster B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011910
   Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006
   Palmer CS, 2011, CELL SIGNAL, V23, P1534, DOI 10.1016/j.cellsig.2011.05.021
   Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014
   Poderoso JJ, 1999, J BIOL CHEM, V274, P37709, DOI 10.1074/jbc.274.53.37709
   Protti A, 2007, CRIT CARE MED, V35, P2150, DOI 10.1097/01.ccm.0000281448.00095.4d
   Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200
   Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85
   Riobó NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139
   Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
NR 52
TC 80
Z9 92
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-5762
EI 1029-2470
J9 FREE RADICAL RES
JI Free Radic. Res.
PD JUL
PY 2014
VL 48
IS 7
BP 769
EP 783
DI 10.3109/10715762.2014.906592
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AI7AP
UT WOS:000337031900005
PM 24720571
OA Green Published
DA 2024-11-01
ER

PT J
AU Compston, A
AF Compston, A
TI 'The marvellous harmony of the nervous parts': The origins of multiple
   sclerosis
SO CLINICAL MEDICINE
LA English
DT Article
DE epidemiology; genetics; MHC; mitochondrial haplogroups; multiple
   sclerosis; neuromyelitis optica; optico-spinal; TH1; TH2; William Croone
ID MITOCHONDRIAL-DNA MUTATIONS; NO PATHOGENIC MUTATIONS;
   NEUROMYELITIS-OPTICA; ASSOCIATION; MECHANISMS; INFECTION; AXONS
AB Working in the 1660s, William Croone wrote on the nature of connections between nerve and muscle. A previously unknown copy of his essay, wrongly attributed to Thomas Willis, has recently come to light. Croone left the challenges of clinical neurology to his successors. The story of multiple sclerosis begins early in the nineteenth century. Despite much information on the aetiology and pathogenesis, the origins of that disease remain obscure. Here, the hypothesis is advanced - based on the epidemiology, clinical neurology, immunology and genetics of demyelinating disease, linked to European history and population genetics - that multiple sclerosis evolved from a related disorder, neuromyelitis optica (or Devic's disease). Genetic drift and stratification altered the immune response to a common pathogen and changed the disease, phenotype. Against this background, the sustained epidemic of multiple sclerosis arose when cultural changes led to a subtle but crucial alteration in the age at which genetically vulnerable individuals are exposed to Epstein Barr infection.
C1 Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England.
C3 University of Cambridge; Cambridge University Hospitals NHS Foundation
   Trust; Addenbrooke's Hospital
RP Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Hills Rd, Cambridge CB2 2QQ, England.
CR [Anonymous], ARCHAEOLOGY WIDENING
   Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853
   Cabre P, 2001, NEUROLOGY, V56, P507, DOI 10.1212/WNL.56.4.507
   Cock H, 1997, J NEUROL NEUROSUR PS, V62, P85, DOI 10.1136/jnnp.62.1.85
   COLES AJ, IN PRESS ANN NEUROL
   COMPSTON DAS, 1986, BRAIN, V109, P325, DOI 10.1093/brain/109.2.325
   COSNETT JE, 1981, MED HYPOTHESES, V7, P61, DOI 10.1016/0306-9877(81)90022-0
   Cree BAC, 2002, SEMIN NEUROL, V22, P105, DOI 10.1055/s-2002-36534
   CREE BAC, UNPUB CLIN CHARACTER
   CROONE W, VERKLARINGE OVER OOR, V1667, P45
   DEAN G, 1994, J NEUROL NEUROSUR PS, V57, P1064, DOI 10.1136/jnnp.57.9.1064
   DEVIC E, 1894, B MED LYON, V35, P18
   Firth D., 1948, The case of Augustus d' Este
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   HEYER E, 1995, AM J HUM GENET, V56, P1450
   Hwang JM, 2001, OPHTHALMOLOGICA, V215, P398, DOI 10.1159/000050896
   JAIN S, 1985, Neuroepidemiology, V4, P96, DOI 10.1159/000110220
   John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781
   Kalman B, 1997, Mult Scler, V2, P279
   Kalman B, 2002, ANN NEUROL, V51, P661, DOI 10.1002/ana.10166
   Kalman B, 1999, ACTA NEUROL SCAND, V99, P16
   KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121
   Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]
   Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9
   KURZKE JF, 1968, J NEUROL SCI, V6, P463
   Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835
   Le Souëf PN, 2000, LANCET, V356, P242
   Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
   Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151
   MARTYN CN, 1993, J NEUROL NEUROSUR PS, V56, P167, DOI 10.1136/jnnp.56.2.167
   MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x
   McGeoch DJ, 2001, PHILOS T ROY SOC B, V356, P421, DOI 10.1098/rstb.2000.0775
   Mirsattari SM, 2001, NEUROLOGY, V56, P317, DOI 10.1212/WNL.56.3.317
   Mitra DK, 1997, CLIN IMMUNOL IMMUNOP, V82, P60, DOI 10.1006/clin.1996.4282
   Modi G, 2001, J NEUROL NEUROSUR PS, V70, P500, DOI 10.1136/jnnp.70.4.500
   Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055
   NISHIMURA M, 1995, NEUROLOGY, V45, P1333, DOI 10.1212/WNL.45.7.1333
   OKINAKA S, 1958, NEUROLOGY, V8, P756, DOI 10.1212/WNL.8.10.756
   OSUNTOKUN BO, 1973, TROPICAL NEUROLOGY, P161
   OTEGUI D, IN PRESS MULTIPLE SC
   Papais-Alvarenga RM, 2002, J NEUROL NEUROSUR PS, V73, P429, DOI 10.1136/jnnp.73.4.429
   POSER CM, 1994, ANN NEUROL, V36, pS231, DOI 10.1002/ana.410360810
   Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149
   Reynier P, 1999, EUR J HUM GENET, V7, P404, DOI 10.1038/sj.ejhg.5200293
   Richards M, 1996, AM J HUM GENET, V59, P185
   RIORDANEVA P, 1995, BRAIN, V118, P319, DOI 10.1093/brain/118.2.319
   Roberts D F, 1986, Anthropol Anz, V44, P93
   SHIBASAKI H, 1981, J NEUROL SCI, V49, P253, DOI 10.1016/0022-510X(81)90083-6
   Smith KJ, 2001, ANN NEUROL, V49, P470
   SUTHERLAND JM, 1956, BRAIN, V79, P635, DOI 10.1093/brain/79.4.635
   Sykes B, 1999, PHILOS T ROY SOC B, V354, P131, DOI 10.1098/rstb.1999.0366
   TAN CT, 1988, ARCH NEUROL-CHICAGO, V45, P624, DOI 10.1001/archneur.1988.00520300042016
   VRIES RRPD, 1979, J IMMUNOGENET, V6, P271
   Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2
   Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003
   Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107
   Wolswijk G, 2002, BRAIN, V125, P338, DOI 10.1093/brain/awf031
   YU YL, 1989, BRAIN, V112, P1445, DOI 10.1093/brain/112.6.1445
NR 60
TC 20
Z9 24
U1 0
U2 1
PU ROY COLL PHYS LONDON EDITORIAL OFFICE
PI LONDON
PA 11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND
SN 1470-2118
EI 1473-4893
J9 CLIN MED
JI Clin. Med.
PD JUL-AUG
PY 2004
VL 4
IS 4
BP 346
EP 354
DI 10.7861/clinmedicine.4-4-346
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 852DJ
UT WOS:000223735100012
PM 15372896
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Bai, P
   Cantó, C
   Oudart, H
   Brunyánszki, A
   Cen, YN
   Thomas, C
   Yamamoto, H
   Huber, A
   Kiss, B
   Houtkooper, RH
   Schoonjans, K
   Schreiber, V
   Sauve, AA
   Menissier-de Murcia, J
   Auwerx, J
AF Bai, Peter
   Canto, Caries
   Oudart, Hugues
   Brunyanszki, Attila
   Cen, Yana
   Thomas, Charles
   Yamamoto, Hiroyasu
   Huber, Aline
   Kiss, Borbala
   Houtkooper, Riekelt H.
   Schoonjans, Kristina
   Schreiber, Valerie
   Sauve, Anthony A.
   Menissier-de Murcia, Josiane
   Auwerx, Johan
TI PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1
   Activation
SO CELL METABOLISM
LA English
DT Article
ID SMALL-MOLECULE ACTIVATORS; POLY(ADP-RIBOSE) POLYMERASE; DNA-DAMAGE;
   EXCISION-REPAIR; ENZYME CD38; CELL-DEATH; NICOTINAMIDE; DEACETYLASE;
   NAD; DEPLETION
AB SIRT1 regulates energy homeostasis by controlling the acetylation status and activity of a number of enzymes and transcriptional regulators. The fact that NAD(+) levels control SIRT1 activity confers a hypothetical basis for the design of new strategies to activate SIRT1 by increasing NAD(+) availability. Here we show that the deletion of the poly(ADPribose) polymerase-1 (PARP-1) gene, encoding a major NAD(+)-consuming enzyme, increases NAD(+) content and SIRT1 activity in brown adipose tissue and muscle. PARP-1(-/-) mice phenocopied many aspects of SIRT1 activation, such as a higher mitochondrial content, increased energy expenditure, and protection against metabolic disease. Also, the pharmacologic inhibition of PARP in vitro and in vivo increased NAD(+) content and SIRT1 activity and enhanced oxidative metabolism. These data show how PARP-1 inhibition has strong metabolic implications through the modulation of SIRT1 activity, a property that could be useful in the management not only of metabolic diseases, but also of cancer.
C1 [Canto, Caries; Thomas, Charles; Yamamoto, Hiroyasu; Houtkooper, Riekelt H.; Schoonjans, Kristina; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.
   [Bai, Peter; Huber, Aline; Kiss, Borbala; Schreiber, Valerie; Menissier-de Murcia, Josiane] Univ Strasbourg, ESBS, CNRS, UMR7242, Illkirch Graffenstaden, France.
   [Bai, Peter; Brunyanszki, Attila] Univ Debrecen, Dept Med Chem, Debrecen, Hungary.
   [Oudart, Hugues] CNRS, UPR9010, CEPE, Strasbourg, France.
   [Cen, Yana; Sauve, Anthony A.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10021 USA.
C3 Swiss Federal Institutes of Technology Domain; Ecole Polytechnique
   Federale de Lausanne; Centre National de la Recherche Scientifique
   (CNRS); CNRS - National Institute for Biology (INSB); Universites de
   Strasbourg Etablissements Associes; Universite de Strasbourg; University
   of Debrecen; Centre National de la Recherche Scientifique (CNRS);
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Cornell University; Weill Cornell Medicine
RP Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.
EM admin.auwerx@epfl.ch
RI Houtkooper, Riekelt/P-5001-2019; Auwerx, Johan/ABE-9307-2021; Bai,
   Peter/C-8005-2014; SCHREIBER, Valerie/M-5007-2016; THOMAS,
   charles/C-7130-2019; Cen, Yana/F-4731-2014
OI SCHREIBER, Valerie/0000-0003-0507-639X; Brunyanszki,
   Attila/0009-0003-8817-977X; Canto, Carles/0000-0002-5167-7922; THOMAS,
   charles/0000-0001-9998-6698; Cen, Yana/0000-0001-6436-5744; Schoonjans,
   Kristina/0000-0003-1247-4265; Houtkooper, Riekelt/0000-0001-9961-0842;
   Auwerx, Johan/0000-0002-5065-5393
FU Bolyai; SNSF; EMBO; FEBS; NWO; NKTH; OTKA [NFF78498, IN80481];
   Mecenatura [DE OEC Mec-1/2008]; NIH [DK59820, DK73466]; ERC
   [2008-AdG-23118]; CNRS; ANR EGIDE [22873YC]; Ellison Medical Foundation
FX This work was supported by fellowships awarded by Bolyai (P.B.), SNSF
   (P.B.), EMBO (C.C.), FEBS (A.B.), and NWO (R.H.H.), as well as grants
   from the NKTH, OTKA (NFF78498, IN80481), Mecenatura (DE OEC Mec-1/2008),
   the NIH (DK59820 and DK73466), the ERC (2008-AdG-23118), the CNRS, ANR
   EGIDE (22873YC), and the Ellison Medical Foundation New Scholar in Aging
   2007.
CR ADAMIETZ P, 1987, EUR J BIOCHEM, V169, P365, DOI 10.1111/j.1432-1033.1987.tb13621.x
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066
   Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169
   Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016
   Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com
   Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200
   Cantó C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303
   Devalaraja-Narashimha K, 2010, J ENDOCRINOL, V205, P242, DOI 10.1677/JOE-09-0402
   DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0
   Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Knight MI, 2001, PROTEIN EXPRES PURIF, V23, P453, DOI 10.1006/prep.2001.1513
   Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690
   Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8
   Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682
   Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200
   Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032
   SCHRAUFSTATTER IU, 1986, J CLIN INVEST, V77, P1312, DOI 10.1172/JCI112436
   SIMS JL, 1981, J SUPRAMOL STR CELL, V16, P281, DOI 10.1002/jsscb.1981.380160308
   Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019
   Soriano FG, 2001, NAT MED, V7, P108, DOI 10.1038/83241
   Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035
NR 27
TC 637
Z9 699
U1 1
U2 68
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD APR 6
PY 2011
VL 13
IS 4
BP 461
EP 468
DI 10.1016/j.cmet.2011.03.004
PG 8
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA 748HM
UT WOS:000289381300016
PM 21459330
OA Green Published, Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Primiano, G
   Brunetti, V
   Vollono, C
   Losurdo, A
   Moroni, R
   Della Marca, G
   Servidei, S
AF Primiano, Guido
   Brunetti, Valerio
   Vollono, Catello
   Losurdo, Anna
   Moroni, Rossana
   Della Marca, Giacomo
   Servidei, Serenella
TI Sleep-Disordered Breathing in Adult Patients With Mitochondrial Diseases
   A Cohort Study
SO NEUROLOGY
LA English
DT Article
ID MUTATION
AB Objective To describe the prevalence and characteristics of sleep-disordered breathing (SDB) in a large cohort of patients with genetically confirmed mitochondrial diseases. Methods This is a prospective observational study performed at the Neurophysiopatology Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS. All participants had a defined mitochondrial disease and were investigated by full-night polysomnography. Results One hundred three consecutive patients were enrolled. SDB was demonstrated in 49 patients (47.6%). Regarding phenotypes, we found differences in distribution between the groups: patients affected by progressive external ophthalmoplegia with single or multiple mtDNA deletions frequently had obstructive apneas (50% and 43.8%) or REM-related hypoventilation when associated with m.3243A>G mutations (75%). Furthermore, a high percentage of participants with maternally inherited diabetes and deafness and myoclonic epilepsy with ragged-red fibers syndromes were characterized by obstructive sleep apnea and REM-related hypoventilation, respectively. In contrast to what has been described in previous studies, central sleep apnea was rarely reported in our cohort. Conclusions SDB has a higher prevalence in mitochondrial diseases compared to general population-based data. Overall, these results suggest that patients characterized by a specific phenotype-genotype combination are most at risk of developing a specific subgroup of SDB. The early identification of this disorder is crucial in the management of these fragile patients.
C1 [Primiano, Guido; Vollono, Catello; Losurdo, Anna; Servidei, Serenella] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.
   [Brunetti, Valerio; Della Marca, Giacomo] Fdn Policlin Univ A Gemelli IRCCS, UOC Neurol, Rome, Italy.
   [Moroni, Rossana] Fdn Policlin Univ A Gemelli IRCCS, Direz Sci, Rome, Italy.
   [Primiano, Guido; Della Marca, Giacomo; Servidei, Serenella] Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Primiano, G (corresponding author), Fdn Policlin Univ A Gemelli IRCCS, UOC Neurofisiopatol, Rome, Italy.; Primiano, G (corresponding author), Univ Cattolica Sacro Cuore, Dipartimento Univ Neurosci, Rome, Italy.
EM guido.primiano@gmail.com
RI Primiano, Guido/AAB-7829-2019; Moroni, Rossana/AAO-2379-2020; Vollono,
   Catello/AAU-7072-2021; Servidei, Serenella/ABC-4262-2021; Brunetti,
   Valerio/AAC-4829-2022; Della Marca, Giacomo/A-8159-2010
OI Primiano, Guido/0000-0001-7616-7008; Brunetti,
   Valerio/0000-0002-5714-5353; Della Marca, Giacomo/0000-0001-6914-799X;
   Vollono, Catello/0000-0001-9371-8035; Moroni,
   Rossana/0000-0002-3477-6136; SERVIDEI, Serenella/0000-0001-8478-2799
CR Albdewi MA, 2018, SLEEP BREATH, V22, P277, DOI 10.1007/s11325-017-1538-x
   [Anonymous], 2014, INT CLASSIFICATION S
   Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5
   Blakely EL, 2014, NEUROMUSCULAR DISORD, V24, P533, DOI 10.1016/j.nmd.2014.03.011
   Catteruccia M, 2015, J NEUROL, V262, P701, DOI 10.1007/s00415-014-7632-0
   Della Marca G, 2009, J NEUROL SCI, V285, P54, DOI 10.1016/j.jns.2009.05.014
   Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80
   Gorman GS, 2015, NEUROMUSCULAR DISORD, V25, P563, DOI 10.1016/j.nmd.2015.03.001
   Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362
   Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008
   Guilleminault C, 2001, EUR RESPIR J, V17, P838, DOI 10.1183/09031936.01.17508380
   Iber C, 2007, AASM MANUAL SCORING, V1st
   Javaheri Shahrokh, 2011, Handb Clin Neurol, V98, P327, DOI 10.1016/B978-0-444-52006-7.00020-4
   Mosquera RA, 2014, PULM MED, V2014, DOI 10.1155/2014/467576
   Parikh S, 2017, GENET MED, V19, DOI 10.1038/gim.2017.107
   Perrin C, 2004, MUSCLE NERVE, V29, P5, DOI 10.1002/mus.10487
   Ramezani RJ, 2014, J CLIN SLEEP MED, V10, P1233, DOI 10.5664/jcsm.4212
   Smits BW, 2012, EUR J NEUROL, V19, P176, DOI 10.1111/j.1468-1331.2011.03496.x
   Wahbi K, 2010, NEUROLOGY, V74, P674, DOI 10.1212/WNL.0b013e3181d0ccf4
   Wahbi K, 2015, EUR HEART J, V36, P2886, DOI 10.1093/eurheartj/ehv307
   Wiedemann FR, 2008, CLIN NEUROL NEUROSUR, V110, P859, DOI 10.1016/j.clineuro.2008.06.010
   Witters P, 2018, GENET MED, V20, P444, DOI 10.1038/gim.2017.125
   YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704
NR 23
TC 2
Z9 2
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN 12
PY 2021
VL 96
IS 2
BP E241
EP E249
DI 10.1212/WNL.0000000000011005
PG 9
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA SL0VN
UT WOS:000656634500014
PM 33024021
DA 2024-11-01
ER

PT J
AU Rendtorff, ND
   Lodahl, M
   Boulahbel, H
   Johansen, IR
   Pandya, A
   Welch, KO
   Norris, VW
   Arnos, KS
   Bitner-Glindzicz, M
   Emery, SB
   Mets, MB
   Fagerheim, T
   Eriksson, K
   Hansen, L
   Bruhn, H
   Möller, C
   Lindholm, S
   Ensgaard, S
   Lesperance, MM
   Tranebjaerg, L
AF Rendtorff, Nanna D.
   Lodahl, Marianne
   Boulahbel, Houda
   Johansen, Ida R.
   Pandya, Arti
   Welch, Katherine O.
   Norris, Virginia W.
   Arnos, Kathleen S.
   Bitner-Glindzicz, Maria
   Emery, Sarah B.
   Mets, Marilyn B.
   Fagerheim, Toril
   Eriksson, Kristina
   Hansen, Lars
   Bruhn, Helene
   Moller, Claes
   Lindholm, Sture
   Ensgaard, Stefan
   Lesperance, Marci M.
   Tranebjaerg, Lisbeth
TI Identification of p.A684V Missense Mutation in the <i>WFS1</i> Gene as a
   Frequent Cause of Autosomal Dominant Optic Atrophy and Hearing
   Impairment
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE autosomal dominant; hearing loss; optic atrophy; mutation; WFS1; Wolfram
   syndrome
ID WOLFRAM-SYNDROME; OPA1 MUTATIONS; R445H MUTATION; DEAFNESS; PEDIGREES;
   CATARACTS; JAPANESE; DISEASE; FAMILY; COMMON
AB Optic atrophy (OA) and sensorineural hearing loss (SNHL) are key abnormalities in several syndromes, including the recessively inherited Wolfram syndrome, caused by mutations in WFS1. In contrast, the association of autosomal dominant OA and SNHL without other phenotypic abnormalities is rare, and almost exclusively attributed to mutations in the Optic Atrophy-1 gene (OPA1), most commonly the p.R445H mutation. We present eight probands and their families from the US, Sweden, and UK with OA and SNHL, whom we analyzed for mutations in OPA1 and WFS1. Among these families, we found three heterozygous missense mutations in WFS1 segregating with OA and SNHL: p.A684V (six families), and two novel mutations, p.G780S and p.D797Y, all involving evolutionarily conserved amino acids and absent from 298 control chromosomes. Importantly, none of these families harbored the OPA1 p.R445H mutation. No mitochondrial DNA deletions were detected in muscle from one p.A684V patient analyzed. Finally, wolframin p.A684V mutant ectopically expressed in HEK cells showed reduced protein levels compared to wild-type wolframin, strongly indicating that the mutation is disease-causing. Our data support OA and SNHL as a phenotype caused by dominant mutations in WFS1 in these additional eight families. Importantly, our data provide the first evidence that a single, recurrent mutation in WFS1, p.A684V, may be a common cause of ADOA and SNHL, similar to the role played by the p.R445H mutation in OPA1. Our findings suggest that patients who are heterozygous for WFS1 missense mutations should be carefully clinically examined for OA and other manifestations of Wolfram syndrome. (C) 2011 Wiley-Liss, Inc.
C1 [Tranebjaerg, Lisbeth] HS Bispebjerg Hosp, Dept Audiol, DK-2400 Copenhagen NV, Denmark.
   [Rendtorff, Nanna D.; Lodahl, Marianne; Johansen, Ida R.; Hansen, Lars; Tranebjaerg, Lisbeth] Univ Copenhagen, Panum Inst, Wilhelm Johannsen Ctr Funct Genome Res, Dept Cellular & Mol Med ICMM, DK-2200 Copenhagen, Denmark.
   [Boulahbel, Houda] Univ Copenhagen, BRIC, Copenhagen, Denmark.
   [Pandya, Arti] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA USA.
   [Welch, Katherine O.; Norris, Virginia W.; Arnos, Kathleen S.] Gallaudet Univ, Dept Biol, Washington, DC 20002 USA.
   [Bitner-Glindzicz, Maria] UCL Inst Child Hlth, London, England.
   [Emery, Sarah B.; Lesperance, Marci M.] Univ Michigan Hlth Syst, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI USA.
   [Mets, Marilyn B.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Evanston, IL USA.
   [Mets, Marilyn B.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Evanston, IL USA.
   [Fagerheim, Toril] Univ Hosp N Norway, Div Child & Adolescent Hlth, Dept Med Genet, Tromso, Norway.
   [Eriksson, Kristina] Lundby Hosp, Dept Ophthalmol, Gothenburg, Sweden.
   [Bruhn, Helene] Karolinska Inst, Karolinska Univ Hosp, Div Metab Dis, Dept Lab Med, Stockholm, Sweden.
   [Moller, Claes] Univ Orebro, Dept Audiol Disabil Res SIDR, Orebro, Sweden.
   [Lindholm, Sture] Cty Hosp, Dept Audiol, Kalmar, Sweden.
   [Ensgaard, Stefan] Karolinska Inst, Dept Psychiat, S-10401 Stockholm, Sweden.
C3 University of Copenhagen; University of Copenhagen; University of
   Copenhagen; Virginia Commonwealth University; University of London;
   University College London; University of Michigan System; University of
   Michigan; Northwestern University; Feinberg School of Medicine;
   Northwestern University; Feinberg School of Medicine; UiT The Arctic
   University of Tromso; University Hospital of North Norway; Karolinska
   Institutet; Karolinska University Hospital; Orebro University;
   Karolinska Institutet
RP Tranebjaerg, L (corresponding author), HS Bispebjerg Hosp, Dept Audiol, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
EM tranebjaerg@sund.ku.dk
RI Bitner-Glindzicz, Maria/A-4231-2009
OI Bruhn, Helene/0009-0007-4449-5382
FU Lundbeck Foundation [32011]; Widex AS; US National Institutes of Health
   [0R01DC006707]
FX We are grateful to the families who participated in this study. We
   acknowledge valuable technical assistance from Elvira Chapka at
   Department of Cellular and Molecular Medicine, University of Copenhagen.
   Bernd Wissinger, Tubingen, Germany, is acknowledged for OPA1 sequencing
   in family KW200128. The Lundbeck Foundation (grant no. 32011) and Widex
   AS are acknowledged for financial support to the Audiogenetic Research
   Group at ICMM. This work was also supported by the US National
   Institutes of Health grant 0R01DC006707 awarded to KSA. The project was
   hosted by Wilhelm Johannsen Centre for Functional Genome Research,
   established by the Danish National Research Foundation.
CR Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Amati-Bonneau P, 2009, INT J BIOCHEM CELL B, V41, P1855, DOI 10.1016/j.biocel.2009.04.012
   [Anonymous], EMERGING LINK EMOTIO
   Arnos KS, 2008, AM J HUM GENET, V83, P200, DOI 10.1016/j.ajhg.2008.07.001
   BARRETT TG, 1995, LANCET, V346, P1458, DOI 10.1016/S0140-6736(95)92473-6
   Bespalova IN, 2001, HUM MOL GENET, V10, P2501, DOI 10.1093/hmg/10.22.2501
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002
   Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892
   Fujikawa T, 2010, LARYNGOSCOPE, V120, P166, DOI 10.1002/lary.20691
   Fukuoka H, 2007, J HUM GENET, V52, P510, DOI 10.1007/s10038-007-0144-3
   Gómez-Zaera M, 2001, MOL GENET METAB, V72, P72, DOI 10.1006/mgme.2000.3107
   Hansen L, 2005, EUR J HUM GENET, V13, P1275, DOI 10.1038/sj.ejhg.5201491
   Hofmann S, 2003, HUM MOL GENET, V12, P2003, DOI 10.1093/hmg/ddg214
   Hogewind BFT, 2010, MOL VIS, V16, P26
   Ke Tie, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P481
   LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011
   Li CM, 2005, AM J MED GENET A, V138A, P208, DOI 10.1002/ajmg.a.30794
   Mellersh CS, 2006, VET OPHTHALMOL, V9, P369, DOI 10.1111/j.1463-5224.2006.00496.x
   Mets RB, 2010, OPHTHALMIC GENET, V31, P227, DOI 10.3109/13816810.2010.516056
   Pandya A, 2003, GENET MED, V5, P295, DOI 10.1097/01.GIM.0000078026.01140.68
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Puomila A, 2005, ACTA OPHTHALMOL SCAN, V83, P337, DOI 10.1111/j.1600-0420.2005.00448.x
   SAMUELSON A, 1940, NORDISK MED HYGIEA, V6, P769
   Shimizu S, 2003, AM J OPHTHALMOL, V135, P256, DOI 10.1016/S0002-9394(02)01929-3
   Tessa A, 2001, Hum Mutat, V17, P348, DOI 10.1002/humu.32
   Tranebjaerg L, 2009, WFSI RELATED DISORDE
   Valero R, 2008, DIABETIC MED, V25, P657, DOI 10.1111/j.1464-5491.2008.02448.x
   Young TL, 2001, HUM MOL GENET, V10, P2509, DOI 10.1093/hmg/10.22.2509
   Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007
NR 32
TC 88
Z9 93
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4825
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD JUN
PY 2011
VL 155A
IS 6
BP 1298
EP 1313
DI 10.1002/ajmg.a.33970
PG 16
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 781OV
UT WOS:000291944200013
PM 21538838
OA Green Accepted, Green Submitted
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Haberler, C
   Schmiedel, J
AF Finsterer, J
   Haberler, C
   Schmiedel, J
TI Deterioration of Kearns-Sayre syndrome following articaine
   administration for local anesthesia
SO CLINICAL NEUROPHARMACOLOGY
LA English
DT Review
DE respiratory chain; local anesthetic; neuromuscular; side effect; adverse
   reaction
ID MITOCHONDRIAL ENERGY-METABOLISM; BUPIVACAINE
AB Worsening of the neuromuscular manifestations in Kearns-Sayre syndrome after administering local anesthesia with articaine has not been reported. The authors describe a severe adverse reaction to local anesthesia with articaine for tooth extraction in a 28-year-old woman with Kearns-Sayre syndrome due to a 5.9-kb mitochondrial DNA deletion. The patient was subjected to local anesthesia with 1.5 mL (60 mg) articaine in the left submandibular nerve for tooth extraction. Five minutes after the injection the patient developed weakness of the limb muscles, extreme fatigue with increased desire to sleep, a feeling of heat, inappetence, and frequent urination. The adverse reaction resolved spontaneously within 48 hours without sequelae. Administration of articaine may cause severe side effects in patients with Kearns-Sayre syndrome. Articaine should be used with caution in these patients.
C1 Krankenanstalt Rudolfstiftung Wien, Dept Neurol, Vienna, Austria.
   Univ Vienna, Gen Hosp, Clin Inst Neurol, Sch Med, Vienna, Austria.
   Carl Gustav Carus Univ Dresden, Dept Neurol, Dresden, Germany.
C3 Rudolfstiftung Hospital; University of Vienna; Technische Universitat
   Dresden; Carl Gustav Carus University Hospital
RP Postfach 20, A-1180 Vienna, Austria.
EM duarte@aonmail.at
CR Irwin W, 2002, J BIOL CHEM, V277, P12221, DOI 10.1074/jbc.M108938200
   Nouette-Gaulain K, 2002, ANESTHESIOLOGY, V97, P1507, DOI 10.1097/00000542-200212000-00024
   Peñarrocha-Diago M, 2000, ORAL SURG ORAL MED O, V90, P21, DOI 10.1067/moe.2000.107506
   Scutari G, 1998, BIOCHEM PHARMACOL, V56, P1633, DOI 10.1016/S0006-2952(98)00192-0
   Sztark F, 1997, BIOCHEM MOL BIOL INT, V43, P997
   Tsutsumi Y, 2001, ANESTHESIOLOGY, V95, P766, DOI 10.1097/00000542-200109000-00032
NR 6
TC 20
Z9 20
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0362-5664
EI 1537-162X
J9 CLIN NEUROPHARMACOL
JI Clin. Neuropharmacol.
PD MAY-JUN
PY 2005
VL 28
IS 3
BP 148
EP 149
DI 10.1097/01.wnf.0000165352.10841.21
PG 2
WC Clinical Neurology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 941ND
UT WOS:000230220600012
PM 15965317
DA 2024-11-01
ER

PT J
AU Ansari, F
   Yoval, B
   Niatsetskaya, Z
   Ten, V
   Wittig, I
   Galkin, A
AF Ansari, Fariha
   Yoval, Belem
   Niatsetskaya, Zoya
   Ten, Vadim
   Wittig, Ilka
   Galkin, Alexander
TI How many molecules of mitochondrial complex I are in a cell?
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE Mitochondrial complex I; Flavin mononucleotide; Fluorescence;
   Respiratory chain; Astrocytes
ID NADH-UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; FLUORESCENT
   FLAVOPROTEINS; NATIVE ELECTROPHORESIS; DYSFUNCTION; ENZYMES; PROTEIN;
   MUSCLE; LIVER; SUBUNITS
AB Mitochondrial complex I is the only enzyme responsible for oxidation of matrix NADH and regeneration of NAD+ for catabolism. Nuclear and mtDNA mutations, assembly impairments, and enzyme damage are implicated in inherited diseases, ischemia-reperfusion injury, neurodegeneration, and tumorogenesis.
   Here we introduce a novel method to measure the absolute content of complex I. The method is based on flavin fluorescence scanning of a polyacrylamide gel after separation of complexes by Clear Native electrophoresis. Using mouse primary astrocytes as an example, we calculated an average value of 2.2 x 10(5) complex I molecules/cell. Our method can be used for accurate quantification of complex I content.
C1 [Ansari, Fariha; Yoval, Belem; Galkin, Alexander] Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10021 USA.
   [Niatsetskaya, Zoya; Ten, Vadim] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA.
   [Niatsetskaya, Zoya; Ten, Vadim] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA.
   [Wittig, Ilka] Goethe Univ, Inst Cardiovasc Physiol, Funct Prote, D-60590 Frankfurt, Germany.
   [Wittig, Ilka] German Ctr Cardiovasc Res DZHK, Partner site RheinMain, Frankfurt, Germany.
C3 Cornell University; Weill Cornell Medicine; Rutgers University System;
   Rutgers University New Brunswick; Rutgers University Biomedical & Health
   Sciences; Rutgers University System; Rutgers University New Brunswick;
   Rutgers University Biomedical & Health Sciences; Goethe University
   Frankfurt; German Centre for Cardiovascular Research
RP Galkin, A (corresponding author), Feil Family Brain & Mind Res Inst, Weill Cornell Med, New York, NY 10021 USA.
EM alg2057@med.cornell.edu
OI Yoval-Sanchez, Belem/0000-0002-7276-278X; Galkin,
   Alexander/0000-0001-8469-2283
FU NIH [RO1NS112381, NS100850]; BMBF mitoNET-German Network for
   Mitochondrial Disorders [01GM1906D]
FX This work was partially supported by the grants NIH RO1NS112381 (A.G.) ,
   NS100850 (V.T.) and by BMBF mitoNET-German Network for Mitochondrial
   Disorders 01GM1906D (I.W.) . We also thank Prof. Eric Green, Department
   of Biochemistry and Molecular Biophysics Columbia University Medical
   Center for access to the Typhoon instrument.
CR ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8
   Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x
   Ansari F, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101204
   Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006
   BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018
   Beutner G, 2021, METHODS MOL BIOL, V2276, P103, DOI 10.1007/978-1-0716-1266-8_7
   Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   Fernández-Vizarra E, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2021.148414
   Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006
   Formosa LE, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107541
   Grosche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069143
   Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002
   Hassinen IE, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813500582
   Hatefi Y., 1967, METHODS ENZYMOL, V10, P235
   He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361
   Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700
   Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873
   Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006
   KUNZ WS, 1986, FEBS LETT, V195, P92, DOI 10.1016/0014-5793(86)80137-5
   KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051
   KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9
   Maughan DW, 2005, MOL CELL PROTEOMICS, V4, P1541, DOI 10.1074/mcp.M500053-MCP200
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Nadtochiy SM, 2021, METHODS MOL BIOL, V2276, P227, DOI 10.1007/978-1-0716-1266-8_17
   O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324
   Parey K, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj3221
   Pereira B, 2013, MOL CELL BIOL, V33, P2623, DOI 10.1128/MCB.01476-12
   Pérez-Pérez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081
   RAGAN CI, 1976, BIOCHEM J, V154, P295, DOI 10.1042/bj1540295
   Rais I, 2004, PROTEOMICS, V4, P2567, DOI 10.1002/pmic.200400829
   Rao N., 1967, METHODS ENZYMOL, P494
   Salehi MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094069
   Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SLED VD, 1993, BIOCHIM BIOPHYS ACTA, V1141, P262, DOI 10.1016/0005-2728(93)90051-G
   Smeitink JAM, 2004, CURR NEUROVASC RES, V1, P29, DOI 10.2174/1567202043480224
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669
   Ugalde C, 2004, HUM MOL GENET, V13, P2461, DOI 10.1093/hmg/ddh262
   Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003
   Urra FA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00118
   Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686
   Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200
   VOLTTI H, 1979, J BIOENERG BIOMEMBR, V10, P45
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Wisniewski JR, 2015, J PROTEOME RES, V14, P3263, DOI 10.1021/acs.jproteome.5b00276
   Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259
NR 51
TC 3
Z9 3
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD JUN 1
PY 2022
VL 646
AR 114646
DI 10.1016/j.ab.2022.114646
EA APR 2022
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 1K6TA
UT WOS:000798729400007
PM 35259403
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Morén, C
   González-Casacuberta, I
   Navarro-Otano, J
   Juárez-Flores, D
   Vilas, D
   Garrabou, G
   Milisenda, JC
   Pont-Sunyer, C
   Catalán-García, M
   Guitart-Mampel, M
   Tobías, E
   Cardellach, F
   Valldeoriola, F
   Iranzo, A
   Tolosa, E
AF Moren, C.
   Gonzalez-Casacuberta, I.
   Navarro-Otano, J.
   Juarez-Flores, D.
   Vilas, D.
   Garrabou, G.
   Milisenda, J. C.
   Pont-Sunyer, C.
   Catalan-Garcia, M.
   Guitart-Mampel, M.
   Tobias, E.
   Cardellach, F.
   Valldeoriola, F.
   Iranzo, A.
   Tolosa, E.
TI Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and
   Idiopathic REM Sleep Behavior Disorder
SO PARKINSONS DISEASE
LA English
DT Article
ID ENTERIC NERVOUS-SYSTEM; COMPLEX-I DEFICIENCY; ALPHA-SYNUCLEIN;
   RESPIRATORY-CHAIN; SKELETAL-MUSCLE; PREMOTOR STAGE; WAKE CHANGES;
   DYSFUNCTION; PROGRESSION; PATHOLOGY
AB Objective. To determine potential mitochondrial and oxidative alterations in colon biopsies from idiopathic REM sleep behavior disorder (iRBD) and Parkinson's disease (PD) subjects. Methods. Colonic biopsies from 7 iRBD subjects, 9 subjects with clinically diagnosed PD, and 9 healthy controls were homogenized in 5% w/v mannitol. Citrate synthase (CS) and complex I (CI) were analyzed spectrophotometrically. Oxidative damage was assessed either by lipid peroxidation, through malondialdehyde and hydroxyalkenal content by spectrophotometry, or through antioxidant enzyme levels of superoxide dismutase-2 (SOD2), glutathione peroxidase-1 (Gpx1), and catalase (CAT) by western blot. The presence of mitochondrial DNA (mtDNA) deletions was assessed by long PCR and electrophoresis. Results. Nonsignificant trends to CI decrease in both iRBD (45.69 +/- 18.15; 23% decrease) and PD patients (37.57 +/- 12.41; 37% decrease) were found compared to controls (59.51 +/- 12.52, p: NS). Lipid peroxidation was maintained among groups (iRBD: 27.46 +/- 3.04, PD: 37.2 +/- 3.92, and controls: 31.71 +/- 3.94; p: NS). Antioxidant enzymes SOD2 (iRBD: 2.30 +/- 0.92, PD: 1.48 +/- 0.39, and controls: 1.09 +/- 0.318) and Gpx1 (iRBD 0.29 +/- 0.12, PD: 0.56 +/- 0.33, and controls: 0.38 +/- 0.16) did not show significant differences between groups. CAT was only detected in 2 controls and 1 iRBD subject. One iRBD patient presented a single mtDNA deletion.
C1 [Moren, C.; Gonzalez-Casacuberta, I.; Juarez-Flores, D.; Garrabou, G.; Milisenda, J. C.; Catalan-Garcia, M.; Guitart-Mampel, M.; Tobias, E.; Cardellach, F.] Univ Barcelona, Internal Med Dept, Fac Med & Hlth Sci,Hosp Clin Barcelona,CIBERER U7, Muscle Res & Mitochondrial Funct Lab,Cellex IDIBA, Barcelona, Spain.
   [Navarro-Otano, J.; Iranzo, A.] Hosp Clin Barcelona, IDIBAPS, CIBERNED, Neurol Serv, Barcelona, Spain.
   [Vilas, D.; Pont-Sunyer, C.; Valldeoriola, F.; Tolosa, E.] Hosp Clin Barcelona, IDIBAPS, CIBERNED, Movement Disorder Unit,Neurol Serv, Barcelona, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of
   Barcelona; Hospital Clinic de Barcelona; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of
   Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED
RP González-Casacuberta, I (corresponding author), Univ Barcelona, Internal Med Dept, Fac Med & Hlth Sci,Hosp Clin Barcelona,CIBERER U7, Muscle Res & Mitochondrial Funct Lab,Cellex IDIBA, Barcelona, Spain.
EM ingrid@clinic.ub.es
RI Vilas, Dolores/AAB-7244-2019; Morén, Constanza/AAB-6895-2021; Milisenda,
   Jose/ISU-0307-2023
OI Iranzo de Riquer, Alejandro/0000-0002-5618-8271; Vilas,
   Dolores/0000-0003-3084-053X; Pont-Sunyer, Claustre/0000-0003-1102-7746;
   Navarro-Otano, Judith/0000-0002-2949-947X; Milisenda, Jose
   Cesar/0000-0003-0151-7872; Garrabou, Gloria/0000-0001-8973-9933;
   Gonzalez-Casacuberta, Ingrid/0000-0003-3217-4569; MOREN,
   CONSTANZA/0000-0001-6848-7407; Catalan Garcia, Marc/0000-0003-1073-7383
FU Fundacio Privada Cellex; Fondo de Investigacion Sanitaria [PI00462/11,
   PI13/01455, PI13/01738, PI15/00903, PI15/00817]; ISCIII-Subdireccion
   General de Evaluacion and European Regional Development Fund (ERDF);
   Grups de Recerca de la Generalitat de Catalunya [SGR 2014/376];
   InterCiber [PIE1400061]; Spanish Ministry (Ministerio de Educacion,
   Cultura y Deporte) [CAS15/00140]; CIBER de Enfermedades Raras (CIBERER,
   an initiative of ISCIII)
FX This work was supported by Fundacio Privada Cellex, Fondo de
   Investigacion Sanitaria [Grants nos. PI00462/11, PI13/01455, PI13/01738,
   PI15/00903, and PI15/00817], integrated in the Plan Estatal I+D+I and
   cofunded by ISCIII-Subdireccion General de Evaluacion and European
   Regional Development Fund (ERDF); Suports a Grups de Recerca de la
   Generalitat de Catalunya 2014-2016 [Grant no. SGR 2014/376]; InterCiber
   PIE1400061 and CIBER de Enfermedades Raras (CIBERER, an initiative of
   ISCIII). C. Moren was granted by a Jose Castillejo (CAS15/00140)
   postdoctoral grant from Spanish Ministry (Ministerio de Educacion,
   Cultura y Deporte).
CR Antunes L, 2016, MOVEMENT DISORD, V31, P1567, DOI 10.1002/mds.26702
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   BINDOFF LA, 1991, J NEUROL SCI, V104, P203, DOI 10.1016/0022-510X(91)90311-T
   Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Braidy N, 2014, NEUROTOX RES, V25, P170, DOI 10.1007/s12640-013-9420-5
   CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258
   Corbillé AG, 2016, NEUROGASTROENT MOTIL, V28, P966, DOI 10.1111/nmo.12797
   Corbillé AG, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0305-8
   Cuervo AM, 2010, MOVEMENT DISORD, V25, pS49, DOI 10.1002/mds.22718
   de Farias CC, 2016, NEUROSCI LETT, V617, P66, DOI 10.1016/j.neulet.2016.02.011
   Deas E, 2016, ANTIOXID REDOX SIGN, V24, P376, DOI 10.1089/ars.2015.6343
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Fedorova TD, 2017, NEUROLOGY, V88, P775, DOI 10.1212/WNL.0000000000003633
   Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x
   Gatt AP, 2016, MOVEMENT DISORD, V31, P352, DOI 10.1002/mds.26513
   Grünewald A, 2016, ANN NEUROL, V79, P366, DOI 10.1002/ana.24571
   HAAS RH, 1995, ANN NEUROL, V37, P714, DOI 10.1002/ana.410370604
   Iranzo A, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0373-0
   Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049
   Keane PC, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/716871
   Knudsen K, 2017, J PARKINSON DIS, V7, P359, DOI 10.3233/JPD-161050
   Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001
   MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8
   Mortiboys H, 2015, NEUROLOGY, V85, P846, DOI 10.1212/WNL.0000000000001905
   Mrabet S, 2016, J CLIN GASTROENTEROL, V50, pE85, DOI 10.1097/MCG.0000000000000606
   Müller SK, 2013, NEUROBIOL AGING, V34, P2231, DOI 10.1016/j.neurobiolaging.2013.03.016
   Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898
   Pan-Montojo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008762
   Postuma RB, 2012, NEUROBIOL DIS, V46, P553, DOI 10.1016/j.nbd.2011.10.003
   SCHAPIRA AHV, 1990, J NEUROCHEM, V55, P2142, DOI 10.1111/j.1471-4159.1990.tb05809.x
   SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x
   Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52
   Schneider SA, 2016, EUR J NEUROL, V23, P247, DOI 10.1111/ene.12753
   Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838
   Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004
   Sprenger FS, 2015, NEUROLOGY, V85, P1761, DOI 10.1212/WNL.0000000000002126
   Stokholm MG, 2016, ANN NEUROL, V79, P940, DOI 10.1002/ana.24648
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   Trudler D, 2015, J NEURAL TRANSM, V122, P1409, DOI 10.1007/s00702-015-1399-z
   Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2
NR 41
TC 3
Z9 3
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8083
EI 2042-0080
J9 PARKINSONS DIS-US
JI Parkinsons Dis.
PY 2017
VL 2017
AR 9816095
DI 10.1155/2017/9816095
PG 7
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EY2KH
UT WOS:000403796600001
PM 28660090
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Mohlke, KL
   Jackson, AU
   Scott, LJ
   Peck, EC
   Suh, YD
   Chines, PS
   Watanabe, RM
   Buchanan, TA
   Conneely, KN
   Erdos, MR
   Narisu, N
   Enloe, S
   Valle, TT
   Tuomilehto, J
   Bergman, RN
   Boehnke, M
   Collins, FS
AF Mohlke, KL
   Jackson, AU
   Scott, LJ
   Peck, EC
   Suh, YD
   Chines, PS
   Watanabe, RM
   Buchanan, TA
   Conneely, KN
   Erdos, MR
   Narisu, N
   Enloe, S
   Valle, TT
   Tuomilehto, J
   Bergman, RN
   Boehnke, M
   Collins, FS
TI Mitochondrial polymorphisms and susceptibility to type 2
   diabetes-related traits in Finns
SO HUMAN GENETICS
LA English
DT Article
ID MAJOR NONCODING REGION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; MAPPING
   GENES; DNA MUTATION; D-LOOP; MELLITUS; VARIANT; PREVALENCE; POPULATION
AB Mitochondria play an integral role in ATP production in cells and are involved in glucose metabolism and insulin secretion, suggesting that variants in the mitochondrial genome may contribute to diabetes susceptibility. In a study of Finnish families ascertained for type 2 diabetes mellitus (T2DM), we genotyped single nucleotide polymorphisms (SNPs) based on phylogenetic networks. These SNPs defined eight major haplogroups and subdivided groups H and U, which are common in Finns. We evaluated association with both diabetes disease status and up to 14 diabetes-related traits for 762 cases, 402 non-diabetic controls, and 465 offspring of genotyped females. Haplogroup J showed a trend toward association with T2DM affected status (OR 1.69, P=0.056) that became slightly more significant after excluding cases with affected fathers (OR 1.77, P=0.045). We also genotyped non-haplogroup-tagging SNPs previously reported to show evidence for association with diabetes or related traits. Our data support previous evidence for association of T16189C with reduced ponderal index at birth and also show evidence for association with reduced birthweight but not with diabetes status. Given the multiple tests performed and the significance levels obtained, this study suggests that mitochondrial genome variants may play at most a modest role in glucose metabolism in the Finnish population. Furthermore, our data do not support a reported maternal inheritance pattern of T2DM but instead show a strong effect of recall bias.
C1 Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.
   NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA.
   Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA.
   Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA.
   Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA USA.
   Natl Publ Hlth Inst, Diabet & Genet Epidemiol Unit, Dept Epidemiol & Hlth Promot, Helsinki, Finland.
   Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland.
   Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.
   So Ostrobothnia Cent Hosp, Seinajoki, Finland.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   National Institutes of Health (NIH) - USA; NIH National Human Genome
   Research Institute (NHGRI); University of Michigan System; University of
   Michigan; University of Southern California; University of Southern
   California; Finland National Institute for Health & Welfare; Finland
   National Institute for Health & Welfare; University of Helsinki
RP Univ N Carolina, Dept Genet, 4109-F Neurosci Res Bldg,103 Mason Farm Rd,CB 726, Chapel Hill, NC 27599 USA.
EM mohlke@med.unc.edu
RI tuomilehto, jaakko/E-6504-2011; Narisu, Narisu/T-6908-2019; Richards,
   J/AAF-4225-2019
OI Bergman, Richard/0000-0003-1539-4471
FU Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [HG00376]
   Funding Source: Medline; NIDDK NIH HHS [DK62370, DK27619, DK29867]
   Funding Source: Medline
CR Alcolado JC, 2002, DIABETIC MED, V19, P89, DOI 10.1046/j.1464-5491.2002.00675.x
   Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   Barrett TG, 2001, BEST PRACT RES CL EN, V15, P325, DOI 10.1053/beem.2001.0149
   Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6
   Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1
   Finnilä S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591
   Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436
   Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6
   Gill-Randall R, 2001, DIABETIC MED, V18, P413, DOI 10.1046/j.1464-5491.2001.00477.x
   Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933
   Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437
   KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682
   Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   Littell R.C., 1996, SAS SYSTEMS MIXED MO
   Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13
   Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204
   Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a
   Marchington DR, 1996, HUM MOL GENET, V5, P473, DOI 10.1093/hmg/5.4.473
   McCarthy MI, 2004, HUM MOL GENET, V13, pR33, DOI 10.1093/hmg/ddh057
   Mohlke KL, 2002, P NATL ACAD SCI USA, V99, P16928, DOI 10.1073/pnas.262661399
   Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   NEWMAN B, 1987, DIABETOLOGIA, V30, P763
   Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314
   PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622
   Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866
   Poulton J, 2004, J MED GENET, V41, P957, DOI 10.1136/jmg.2004.019208
   Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581
   Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x
   REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3
   RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315
   Richards M, 1996, AM J HUM GENET, V59, P185
   Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x
   Sbisà E, 1997, GENE, V205, P125, DOI 10.1016/S0378-1119(97)00404-6
   SHERROD LR, 1999, NATL HEAD START ASS, V2, P412
   Silander K, 2004, DIABETES, V53, P821, DOI 10.2337/diabetes.53.3.821
   Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649
   SILVERMAN BL, 1991, DIABETES, V40, P121, DOI 10.2337/diab.40.2.S121
   Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166
   Suzuki Y, 1997, METABOLISM, V46, P1019, DOI 10.1016/S0026-0495(97)90272-9
   Tawata M, 1998, DIABETES, V47, P276, DOI 10.2337/diab.47.2.276
   Tawata M, 2000, DIABETES, V49, P1269, DOI 10.2337/diabetes.49.7.1269
   Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253
   Torroni A, 1996, GENETICS, V144, P1835
   Torroni A, 1997, AM J HUM GENET, V60, P1107
   TUOMILEHTO J, 1991, INT J EPIDEMIOL, V20, P1010, DOI 10.1093/ije/20.4.1010
   Valle T, 1998, DIABETES CARE, V21, P949, DOI 10.2337/diacare.21.6.949
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4
   Yasukawa T, 2005, MOL CELL, V18, P651, DOI 10.1016/j.molcel.2005.05.002
   ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248
NR 56
TC 65
Z9 68
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0340-6717
EI 1432-1203
J9 HUM GENET
JI Hum. Genet.
PD NOV
PY 2005
VL 118
IS 2
BP 245
EP 254
DI 10.1007/s00439-005-0046-4
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 993YN
UT WOS:000233996300010
PM 16142453
DA 2024-11-01
ER

PT J
AU Almutawa, W
   Smith, C
   Sabouny, R
   Smit, RB
   Zhao, T
   Wong, R
   Lee-Glover, L
   Desrochers-Goyette, J
   Ilamathi, HS
   Suchowersky, O
   Germain, M
   Mains, PE
   Parboosingh, JS
   Pfeffer, G
   Innes, AM
   Shutt, TE
AF Almutawa, Walaa
   Smith, Christopher
   Sabouny, Rasha
   Smit, Ryan B.
   Zhao, Tian
   Wong, Rachel
   Lee-Glover, Laurie
   Desrochers-Goyette, Justine
   Ilamathi, Hema Saranya
   Suchowersky, Oksana
   Germain, Marc
   Mains, Paul E.
   Parboosingh, Jillian S.
   Pfeffer, Gerald
   Innes, A. Micheil
   Shutt, Timothy E.
CA Care4Rare Canada Consortium
TI The R941L mutation in <i>MYH14</i> disrupts mitochondrial fission and
   associates with peripheral neuropathy
SO EBIOMEDICINE
LA English
DT Article
DE Mitochondria; Mitochondrial fission; Peripheral neuropathy; Non-muscle
   myosin; mtDNA; Caenorhabditis elegans
ID MYOSIN-II; HEARING-LOSS; DYNAMICS; DISEASE; ACTIN; GENE; FUSION;
   CONTRIBUTES; EXPRESSION; PHENOTYPE
AB Background: Peripheral neuropathies are often caused by disruption of genes responsible for myelination or axonal transport. In particular, impairment inmitochondrial fission and fusion are known causes of peripheral neuropathies. However, the causal mechanisms for peripheral neuropathy gene mutations are not always known. While loss of function mutations in MYH14 typically cause non-syndromic hearing loss, the recently described R941L mutation in MYH14, encoding the non-muscle myosin protein isoform NMIIC, leads to a complex clinical presentation with an unexplained peripheral neuropathy phenotype.
   Methods: Confocal microscopywas used to examine mitochondrial dynamics in MYH14 patient fibroblast cells, as well as U2OS and M17 cells overexpressing NMIIC. The consequence of the R941L mutation on myosin activity was modeled in C. elegans.
   Findings: We describe the third family carrying the R941L mutation in MYH14, and demonstrate that the R941L mutation impairs non-muscle myosin protein function. To better understand the molecular basis of the peripheral neuropathy phenotype associatedwith the R941Lmutation, which has been hindered by the fact that NMIIC is largely uncharacterized, we have established a previously unrecognized biological role for NMIIC inmediating mitochondrial fission in human cells. Notably, the R941L mutation acts in a dominant-negative fashion to inhibit mitochondrial fission, especially in the cell periphery. In addition, we observed alterations to the organization of the mitochondrial genome.
   Interpretation: As impairments in mitochondrial fission cause peripheral neuropathy, this insight into the function of NMIIC likely explains the peripheral neuropathy phenotype associated with the R941L mutation.
C1 [Almutawa, Walaa; Smith, Christopher; Sabouny, Rasha; Smit, Ryan B.; Zhao, Tian; Wong, Rachel; Lee-Glover, Laurie; Mains, Paul E.; Parboosingh, Jillian S.; Pfeffer, Gerald; Innes, A. Micheil; Shutt, Timothy E.] Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Med Genet, Cumming Sch Med, Calgary, AB, Canada.
   [Almutawa, Walaa; Sabouny, Rasha; Smit, Ryan B.; Zhao, Tian; Wong, Rachel; Lee-Glover, Laurie; Mains, Paul E.; Pfeffer, Gerald; Shutt, Timothy E.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Grp Rech Signalisat Cellulaire, Trois Rivieres, PQ, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Dept Biol Med, Trois Rivieres, PQ, Canada.
   [Desrochers-Goyette, Justine; Ilamathi, Hema Saranya; Germain, Marc] Univ Quebec Trois Rivieres, Ctr Rech Biomed, Trois Rivieres, PQ, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.
   [Suchowersky, Oksana] Univ Alberta, Dept Pediat, Edmonton, AB, Canada.
   [Innes, A. Micheil; Shutt, Timothy E.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.
C3 University of Calgary; University of Calgary; University of Quebec;
   University of Quebec Trois Rivieres; University of Quebec; University of
   Quebec Trois Rivieres; University of Quebec; University of Quebec Trois
   Rivieres; University of Alberta; University of Alberta; University of
   Alberta; University of Calgary
RP Innes, AM; Shutt, TE (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Dept Med Genet, Cumming Sch Med, Calgary, AB, Canada.
EM micheil.innes@ahs.ca; timothy.shutt@ucalgary.ca
RI innes, allan/A-9955-2017; Shutt, Tim/U-9047-2019
OI Lee-Glover, Laurie/0009-0004-8402-1542; Zhao, Tian
   Rui/0009-0005-6742-4363; Innes, Micheil/0000-0001-9881-5467; Pfeffer,
   Gerald/0000-0002-7657-7098; Ilamathi, Hema Saranya/0009-0000-8581-8597;
   Shutt, Timothy/0000-0001-5299-2943
FU Alberta Children's Hospital Research Institute; UQTR Foundation;
   Canadian Institutes of Health Research; Saudi Cultural Bureau; QEII
   Graduate Scholarship; FRQ-NT scholarship; Genome Canada; Ontario
   Genomics Institute; Ontario Research Fund; Genome Alberta; Genome BC;
   Genome Quebec; Children's Hospital of Eastern Ontario Foundation
FX This work was supported by funds provided by the Alberta Children's
   Hospital Research Institute (T.S.), the UQTR Foundation (M.G.), and the
   Canadian Institutes of Health Research (P.E.M). W.A. was supported by
   the Saudi Cultural Bureau. R.S. was supported by a QEII Graduate
   Scholarship. H.S.I. was supported by a FRQ-NT scholarship. This work was
   performed under the Care4Rare Canada Consortium funded by Genome Canada,
   the Canadian Institutes of Health Research, the Ontario Genomics
   Institute, Ontario Research Fund, Genome Alberta, Genome BC, Genome
   Quebec, and Children's Hospital of Eastern Ontario Foundation. The
   funders had no role in study design, data collection and interpretation,
   or the decision to submit the work for publication.
CR Andres D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-49
   Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730
   Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013
   Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070
   Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110
   Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071
   Beaulieu CL, 2014, AM J HUM GENET, V94, P809, DOI 10.1016/j.ajhg.2014.05.003
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Bobylev I, 2018, MOL NEUROBIOL, V55, P1227, DOI 10.1007/s12035-016-0364-7
   Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122
   BRENNER S, 1974, GENETICS, V77, P71
   Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198
   Cassereau J, 2014, REV NEUROL-FRANCE, V170, P366, DOI 10.1016/j.neurol.2013.11.005
   Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326
   Choi BO, 2011, HUM MUTAT, V32, P669, DOI 10.1002/humu.21488
   Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080
   Donaudy F, 2004, AM J HUM GENET, V74, P770, DOI 10.1086/383285
   Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604
   Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385
   Fu XL, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6720420
   Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117
   Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399
   Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200
   Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023
   Hartley T, 2018, CLIN GENET, V93, P301, DOI 10.1111/cge.13101
   Hatch AL, 2016, MOL BIOL CELL, V27, P3109, DOI 10.1091/mbc.E16-03-0193
   He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Iyadurai S, 2017, MUSCLE NERVE, V56, P341, DOI 10.1002/mus.25491
   Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kim B, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0223-4
   Kim KY, 2005, J BIOL CHEM, V280, P22769, DOI 10.1074/jbc.M503488200
   Kim SJ, 2016, GENE, V591, P177, DOI 10.1016/j.gene.2016.07.011
   Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445
   Koch J, 2016, J MED GENET, V53, P270, DOI 10.1136/jmedgenet-2015-103500
   Korobova F, 2014, CURR BIOL, V24, P409, DOI 10.1016/j.cub.2013.12.032
   Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360
   Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562
   Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Macias MP, 2014, J NEUROSCI METH, V223, P114, DOI 10.1016/j.jneumeth.2013.11.024
   Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120
   Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165
   Nishigaki Y, 2004, HUM MOL GENET, V13, P91, DOI 10.1093/hmg/ddh010
   Ouellet M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005612
   Pareyson D, 2015, NEUROSCI LETT, V596, P66, DOI 10.1016/j.neulet.2015.04.001
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Piekny AJ, 2003, DEVELOPMENT, V130, P5695, DOI 10.1242/dev.00807
   Prudent J, 2016, CURR BIOL, V26, pR207, DOI 10.1016/j.cub.2016.01.009
   Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098
   Yang Rong, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P259, DOI [10.3760/cma.j.issn.1003-940.2010.03.005, 10.3760/cma.j.issn.1003-9406.2010.0.005]
   Yang T, 2005, AM J MED GENET A, V139A, P9, DOI 10.1002/ajmg.a.30989
   Zhao T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900353
NR 59
TC 30
Z9 31
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD JUL
PY 2019
VL 45
BP 379
EP 392
DI 10.1016/j.ebiom.2019.06.018
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA IJ4FN
UT WOS:000475860000040
PM 31231018
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Narciso, L
   Parlanti, E
   Racaniello, M
   Simonelli, V
   Cardinale, A
   Merlo, D
   Dogliotti, E
AF Narciso, Laura
   Parlanti, Eleonora
   Racaniello, Mauro
   Simonelli, Valeria
   Cardinale, Alessio
   Merlo, Daniela
   Dogliotti, Eugenia
TI The Response to Oxidative DNA Damage in Neurons: Mechanisms and Disease
SO NEURAL PLASTICITY
LA English
DT Review
ID BASE EXCISION-REPAIR; STRAND BREAK REPAIR; DIFFERENTIATED MUSCLE-CELLS;
   HUMAN POLYNUCLEOTIDE KINASE; DEPENDENT PROTEIN-KINASE;
   ALZHEIMERS-DISEASE; SPINOCEREBELLAR ATAXIA; CEREBELLAR ATROPHY;
   POLYMERASES DELTA; MITOCHONDRIAL-DNA
AB There is a growing body of evidence indicating that the mechanisms that control genome stability are of key importance in the development and function of the nervous system. The major threat for neurons is oxidative DNA damage, which is repaired by the base excision repair (BER) pathway. Functional mutations of enzymes that are involved in the processing of single-strand breaks (SSB) that are generated during BER have been causally associated with syndromes that present important neurological alterations and cognitive decline. In this review, the plasticity of BER during neurogenesis and the importance of an efficient BER for correct brain function will be specifically addressed paying particular attention to the brain region and neuron-selectivity in SSB repair-associated neurological syndromes and age-related neurodegenerative diseases.
C1 [Narciso, Laura; Parlanti, Eleonora; Simonelli, Valeria; Dogliotti, Eugenia] Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Narciso, Laura] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Racaniello, Mauro; Merlo, Daniela] Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.
   [Cardinale, Alessio] IRCCS San Raffaele Pisana, I-00166 Rome, Italy.
C3 Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS);
   Istituto Superiore di Sanita (ISS); IRCCS San Raffaele Pisana
RP Dogliotti, E (corresponding author), Ist Super Sanita, Dept Environm & Hlth, Viale Regina Elena 299, I-00161 Rome, Italy.; Merlo, D (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.
EM daniela.merlo@iss.it; eugenia.dogliotti@iss.it
RI Parlanti, Eleonora/AAC-5978-2021; NARCISO, LAURA/C-6069-2015; Merlo,
   Daniela/K-7986-2016
OI Merlo, Daniela/0000-0003-4240-5762; Narciso, Laura/0000-0002-0984-0466;
   Simonelli, Valeria/0000-0002-3726-518X
CR Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Andersen BB, 2003, J COMP NEUROL, V466, P356, DOI 10.1002/cne.10884
   Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9
   Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796
   Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005
   Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09
   Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6
   Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413
   Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15
   Canugovi C, 2014, NEUROBIOL AGING, V35, P1293, DOI 10.1016/j.neurobiolaging.2014.01.004
   Cardinale A, 2015, NEUROCHEM RES, V40, P59, DOI 10.1007/s11064-014-1465-1
   Cardinale A, 2012, J BIOL CHEM, V287, P2618, DOI 10.1074/jbc.M111.276550
   Cardozo-Pelaez F, 2012, NEUROCHEM INT, V61, P721, DOI 10.1016/j.neuint.2012.06.013
   Carlessi L, 2009, CELL DEATH DIFFER, V16, P795, DOI 10.1038/cdd.2009.10
   Chakraborty A, 2015, J BIOL CHEM, V290, P24636, DOI 10.1074/jbc.M115.658146
   Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029
   Chappell C, 2002, EMBO J, V21, P2827, DOI 10.1093/emboj/21.11.2827
   Cheng AW, 2007, J NEUROSCI, V27, P3722, DOI 10.1523/JNEUROSCI.0590-07.2007
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clements PM, 2004, DNA REPAIR, V3, P1493, DOI 10.1016/j.dnarep.2004.06.017
   Copani A, 2006, J NEUROSCI, V26, P10949, DOI 10.1523/JNEUROSCI.2793-06.2006
   Coppedè F, 2015, MUTAT RES-FUND MOL M, V776, P84, DOI 10.1016/j.mrfmmm.2014.11.010
   D'Arcangelo G, 2011, BRAIN RES, V1396, P11, DOI 10.1016/j.brainres.2011.04.020
   Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941
   Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138
   Fan JS, 2004, NUCLEIC ACIDS RES, V32, P2193, DOI 10.1093/nar/gkh556
   Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003
   Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Fortini P, 2010, MUTAT RES-FUND MOL M, V685, P38, DOI 10.1016/j.mrfmmm.2009.11.003
   Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230
   Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h
   Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008
   Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137
   Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185
   Fukae J, 2005, ACTA NEUROPATHOL, V109, P256, DOI 10.1007/s00401-004-0937-9
   Furuta A, 2001, NEUROREPORT, V12, P2895, DOI 10.1097/00001756-200109170-00028
   Gao R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004834
   Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749
   GOULIAN M, 1980, P NATL ACAD SCI-BIOL, V77, P1956, DOI 10.1073/pnas.77.4.1956
   GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875
   Gueven N, 2004, HUM MOL GENET, V13, P1081, DOI 10.1093/hmg/ddh122
   Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524
   Hayashi H, 2002, CURR BIOL, V12, P335, DOI 10.1016/S0960-9822(02)00686-3
   Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8
   Hegde ML, 2012, MECH AGEING DEV, V133, P157, DOI 10.1016/j.mad.2012.01.005
   Hernandes MS, 2012, CURR NEUROPHARMACOL, V10, P321, DOI 10.2174/157015912804143540
   Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885
   Huang E, 2010, NAT CELL BIOL, V12, P563, DOI 10.1038/ncb2058
   Ichinoe A, 2004, NUCLEIC ACIDS RES, V32, P477, DOI 10.1093/nar/gkh214
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4
   JENSEN PK, 1966, BIOCHIM BIOPHYS ACTA, V122, P167, DOI 10.1016/0926-6593(66)90058-0
   Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173
   Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Karimi-Busheri F, 2007, CANCER RES, V67, P6619, DOI 10.1158/0008-5472.CAN-07-0480
   Khoronenkova SV, 2015, P NATL ACAD SCI USA, V112, P3997, DOI 10.1073/pnas.1416031112
   Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842
   Kisby GE, 2009, DNA REPAIR, V8, P400, DOI 10.1016/j.dnarep.2008.12.002
   Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583
   Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026
   Kronenberg G, 2008, J NEUROSCI, V28, P7219, DOI 10.1523/JNEUROSCI.0940-08.2008
   Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200
   Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480
   Lauritzen KH, 2011, MECH AGEING DEV, V132, P424, DOI 10.1016/j.mad.2011.02.006
   Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283
   Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375
   Liu D, 2011, J CEREBR BLOOD F MET, V31, P680, DOI 10.1038/jcbfm.2010.147
   Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200
   Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286
   Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5
   Lovell MA, 2000, BRAIN RES, V855, P116, DOI 10.1016/S0006-8993(99)02335-5
   Madabhushi R, 2014, NEURON, V83, P266, DOI 10.1016/j.neuron.2014.06.034
   Markkanen E, 2012, CELL CYCLE, V11, P1070, DOI 10.4161/cc.11.6.19448
   Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822
   Mason AG, 2014, HUM MOL GENET, V23, P1606, DOI 10.1093/hmg/ddt551
   McKinnon PJ, 2013, NAT NEUROSCI, V16, P1523, DOI 10.1038/nn.3537
   McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509
   Mellor JR, 1998, J NEUROSCI, V18, P2822
   Mighore L, 2005, NEUROBIOL AGING, V26, P567, DOI 10.1016/j.neurobiolaging.2004.07.016
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Nakashima M, 2014, J HUM GENET, V59, P471, DOI 10.1038/jhg.2014.51
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703
   Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117
   Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750
   Nilsen L, 2012, NUCLEIC ACIDS RES, V40, P2000, DOI 10.1093/nar/gkr933
   Nishioka K, 1999, MOL BIOL CELL, V10, P1637, DOI 10.1091/mbc.10.5.1637
   Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000
   Nouspikel TP, 2006, MOL CELL BIOL, V26, P8722, DOI 10.1128/MCB.01263-06
   O'Driscoll M, 2007, AM J HUM GENET, V81, P77, DOI 10.1086/518696
   Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103
   Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47
   Parlanti E, 2002, ONCOGENE, V21, P5204, DOI 10.1038/sj.onc.1205561
   Pascucci B, 2002, NUCLEIC ACIDS RES, V30, P2124, DOI 10.1093/nar/30.10.2124
   Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696
   Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i
   Poulton C, 2013, NEUROGENETICS, V14, P43, DOI 10.1007/s10048-012-0351-8
   Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460
   Ramamoorthy M, 2012, FREE RADICAL BIO MED, V53, P1371, DOI 10.1016/j.freeradbiomed.2012.07.018
   Regnell CE, 2012, CELL REPORTS, V2, P503, DOI 10.1016/j.celrep.2012.08.008
   Renovell A., 1996, Int. J. Dev. Biol, V40, p193S
   Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08
   Rolseth V, 2008, DNA REPAIR, V7, P1578, DOI 10.1016/j.dnarep.2008.06.007
   Salvatore E, 2008, J NEUROL, V255, P45, DOI 10.1007/s00415-007-0657-x
   Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96
   Sejersted Y, 2011, P NATL ACAD SCI USA, V108, P18802, DOI 10.1073/pnas.1106880108
   Sekijima Y, 1998, J NEUROL SCI, V158, P30, DOI 10.1016/S0022-510X(98)00103-8
   Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009
   Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526
   Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053
   Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363
   Silva ART, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099897
   Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794
   Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598
   Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001
   Sugawara M, 2008, EUR NEUROL, V59, P18, DOI 10.1159/000109256
   Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397
   Sulzer D, 2013, MOVEMENT DISORD, V28, P41, DOI 10.1002/mds.25095
   Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x
   Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356
   Sykora P, 2013, NEUROBIOL AGING, V34, P1717, DOI 10.1016/j.neurobiolaging.2012.12.016
   Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987
   Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232
   Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194
   Vasko MR, 2005, DNA REPAIR, V4, P367, DOI 10.1016/j.dnarep.2004.11.006
   Wallace SS, 2013, ENVIRON MOL MUTAGEN, V54, P691, DOI 10.1002/em.21820
   Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831
   Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x
   Wang XK, 2007, GENOMICS, V90, P201, DOI 10.1016/j.ygeno.2007.03.007
   Wang XK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-12
   Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605
   Wilde GJC, 1997, J NEUROCHEM, V69, P883
   Yang JL, 2010, J BIOL CHEM, V285, P28191, DOI 10.1074/jbc.M109.082883
   Zhou T, 2009, DNA REPAIR, V8, P901, DOI 10.1016/j.dnarep.2009.05.003
   Zoccarato F, 2004, J BIOL CHEM, V279, P4166, DOI 10.1074/jbc.M308143200
   Zoghbi HY, 2000, NEUROBIOL DIS, V7, P523, DOI 10.1006/nbdi.2000.0346
   Zolner AE, 2011, NUCLEIC ACIDS RES, V39, P9224, DOI 10.1093/nar/gkr647
NR 147
TC 57
Z9 65
U1 0
U2 13
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-5904
EI 1687-5443
J9 NEURAL PLAST
JI Neural. Plast.
PY 2016
VL 2016
AR 3619274
DI 10.1155/2016/3619274
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DH2YK
UT WOS:000372653200001
PM 26942017
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Leopold, JA
   Maron, BA
AF Leopold, Jane A.
   Maron, Bradley A.
TI Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary
   Arterial Hypertension
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE pulmonary arterial hypertension; DNA damage; microRNA; metabolism;
   mitochondria; endothelial-to-mesenchymal transition
ID SMOOTH-MUSCLE-CELLS; CHRONIC HYPOXIA; MESENCHYMAL TRANSITION;
   DNA-DAMAGE; RECEPTOR; GENE; CONTRIBUTES; EXPRESSION; PROLIFERATION;
   EPIDEMIOLOGY
AB Pulmonary arterial hypertension (PAH) is a devastating disease that is precipitated by hypertrophic pulmonary vascular remodeling of distal arterioles to increase pulmonary artery pressure and pulmonary vascular resistance in the absence of left heart, lung parenchymal, or thromboembolic disease. Despite available medical therapy, pulmonary artery remodeling and its attendant hemodynamic consequences result in right ventricular dysfunction, failure, and early death. To limit morbidity and mortality, attention has focused on identifying the cellular and molecular mechanisms underlying aberrant pulmonary artery remodeling to identify pathways for intervention. While there is a well-recognized heritable genetic component to PAH, there is also evidence of other genetic perturbations, including pulmonary vascular cell DNA damage, activation of the DNA damage response, and variations in microRNA expression. These findings likely contribute, in part, to dysregulation of proliferation and apoptosis signaling pathways akin to what is observed in cancer; changes in cellular metabolism, metabolic flux, and mitochondrial function; and endothelial-to-mesenchymal transition as key signaling pathways that promote pulmonary vascular remodeling. This review will highlight recent advances in the field with an emphasis on the aforementioned molecular mechanisms as contributors to the pulmonary vascular disease pathophenotype.
C1 [Leopold, Jane A.; Maron, Bradley A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
   [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Div Cardiol, Boston, MA 02132 USA.
C3 Harvard University; Harvard Medical School; Brigham & Women's Hospital;
   US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Harvard University; VA Boston Healthcare System
RP Leopold, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
EM jleopold@partners.org; bmaron@partners.org
FU NIH/NHLBI [U01HL125215, K08HL11207-01A1]; Thomas W. Smith, MD
   Foundation; American Heart Association; Pulmonary Hypertension
   Association; Cardiovascular Medical Research and Education Fund (CMREF);
   Klarman Foundation at Brigham and Women's Hospital; Gilead Young
   Scholars Foundation
FX This work was supported by NIH/NHLBI U01HL125215 and the Thomas W.
   Smith, MD Foundation (Jane A. Leopold) and NIH/NHLBI K08HL11207-01A1,
   American Heart Association, Pulmonary Hypertension Association,
   Cardiovascular Medical Research and Education Fund (CMREF), and Klarman
   Foundation at Brigham and Women's Hospital, Gilead Young Scholars
   Foundation (Bradley A. Maron).
CR Aguero J, 2016, J AM COLL CARDIOL, V67, P2032, DOI 10.1016/j.jacc.2016.02.049
   Aguero J, 2014, AM J PHYSIOL-HEART C, V307, pH1204, DOI 10.1152/ajpheart.00246.2014
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Bertero T, 2015, J BIOL CHEM, V290, P2069, DOI 10.1074/jbc.M114.617845
   Bertero T, 2014, J CLIN INVEST, V124, P3514, DOI 10.1172/JCI74773
   Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010
   Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028
   Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195
   Cotroneo E, 2015, CIRC RES, V116, P1680, DOI 10.1161/CIRCRESAHA.116.305265
   Courboulin Audrey, 2011, Respir Res, V12, P128, DOI 10.1186/1465-9921-12-128
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   Deng ZM, 2000, AM J RESP CRIT CARE, V161, P1055, DOI 10.1164/ajrccm.161.3.9906051
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fernandez RA, 2015, AM J PHYSIOL-CELL PH, V308, pC581, DOI 10.1152/ajpcell.00202.2014
   Frid MG, 2002, CIRC RES, V90, P1189, DOI 10.1161/01.RES.0000021432.70309.28
   Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581
   Gilbert G, 2014, CARDIOVASC RES, V103, P313, DOI 10.1093/cvr/cvu069
   Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019
   Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664
   Hadri L, 2013, CIRCULATION, V128, P512, DOI 10.1161/CIRCULATIONAHA.113.001585
   Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032
   KENNEDY EP, 1949, J BIOL CHEM, V179, P957
   Krenning G, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9762959
   Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2015, HUM MUTAT, V36, P1113, DOI 10.1002/humu.22904
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269
   Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130
   Peng GY, 2015, CIRC J, V79, P2058, DOI 10.1253/circj.CJ-15-0067
   Perez VADJ, 2014, AM J RESP CRIT CARE, V189, P1260, DOI [10.1164/rccm.201310-17490C, 10.1164/rccm.201310-1749OC]
   Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0
   Potus F, 2015, CIRCULATION, V132, P932, DOI 10.1161/CIRCULATIONAHA.115.016382
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qiao LN, 2014, CIRCULATION, V129, P692, DOI 10.1161/CIRCULATIONAHA.113.003734
   Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750
   RANDLE PJ, 1963, LANCET, V1, P785
   Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC
   Ruiter G, 2015, PULM CIRC, V5, P466, DOI 10.1086/682217
   Sheikh AQ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9712
   Sheikh AQ, 2014, CELL REP, V6, P809, DOI 10.1016/j.celrep.2014.01.042
   Stevens HC, 2016, PULM CIRC, V6, P109, DOI 10.1086/685079
   Thomson J., 2001, Journal of Heart and Lung Transplantation, V20, P149, DOI 10.1016/S1053-2498(01)00259-5
   Tuder RM, 1998, CHEST, V114, p1S, DOI 10.1378/chest.114.1_Supplement.1S-a
   Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025
   Wang GL, 2014, INT J CARDIOL, V177, pE167, DOI 10.1016/j.ijcard.2014.08.124
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511
   Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104
   Yeager ME, 2001, CIRC RES, V88, pE2
   Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912
   Zhao L, 2015, NATURE, V524, P356, DOI 10.1038/nature14620
   Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR
NR 72
TC 114
Z9 128
U1 0
U2 35
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAY
PY 2016
VL 17
IS 5
AR 761
DI 10.3390/ijms17050761
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA DP9BJ
UT WOS:000378791400150
PM 27213345
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU Askanas, V
   Engel, WK
AF Askanas, V
   Engel, WK
TI Inclusion-body myositis -: A myodegenerative conformational disorder
   associated with Aβ, protein misfolding, and proteasome inhibition
SO NEUROLOGY
LA English
DT Article
ID AMYLOID PRECURSOR PROTEIN; CULTURED HUMAN MUSCLE; MITOCHONDRIAL-DNA
   DELETIONS; ALZHEIMERS-DISEASE; CYSTATIN-C; MUTANT UBIQUITIN; TRANSGENIC
   MICE; ALPHA-SYNUCLEIN; SECRETASE SITE; 26S PROTEASOME
AB Sporadic inclusion-body myositis (s-IBM), the most common muscle disease of older persons, is of unknown cause and there is no successful treatment. We summarize our most recent findings, which provide a better understanding of the steps in the pathogenetic cascade. We suggest that s-IBM is primarily a myodegenerative disease. Intriguing are the phenotypic similarities between s-IBM muscle fibers and the brains of Alzheimer disease, the most common neurodegenerative disease of older persons. In s-IBM, abnormal accumulation of the amyloid-beta (A beta) precursor protein and its proteolytic fragment, A beta, associated with the aging intracellular milieu of the muscle fiber, appear to be key upstream pathogenic events. We propose that the identified abnormal accumulation, misfolding, and aggregation of proteins, perhaps provoked by the aging milieu and aggravated by the oxidative stress, lead to the s-IBM-specific vacuolar degeneration and atrophy of muscle fibers.
C1 USC, Good Samaritan Hosp, Neuromuscular Ctr,Keck Sch Med, Dept Neurol, Los Angeles, CA 90017 USA.
C3 University of Southern California; University of Southern California
   Keck Hospital
RP USC, Good Samaritan Hosp, Neuromuscular Ctr,Keck Sch Med, Dept Neurol, 637 S Lucas Ave, Los Angeles, CA 90017 USA.
EM askanas@usc.edu
FU NIA NIH HHS [AG16768] Funding Source: Medline; NINDS NIH HHS [NS34103,
   NS31836] Funding Source: Medline
CR Acquati F, 2000, FEBS LETT, V468, P59, DOI 10.1016/S0014-5793(00)01192-3
   Alvarez RB, 1998, NEUROLOGY, V50, pA204
   Askanas V, 1998, AM J PATHOL, V153, P1673, DOI 10.1016/S0002-9440(10)65680-5
   Askanas V, 2000, J NEUROPATH EXP NEUR, V59, P592, DOI 10.1093/jnen/59.7.592
   Askanas V, 2003, CURR OPIN RHEUMATOL, V15, P737, DOI 10.1097/00002281-200311000-00009
   Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002
   Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314
   ASKANAS V, 1992, NEUROSCI LETT, V143, P96, DOI 10.1016/0304-3940(92)90241-X
   Askanas V, 2001, J NEUROPATH EXP NEUR, V60, P1
   Askanas V, 1997, NEUROREPORT, V8, P2155, DOI 10.1097/00001756-199707070-00012
   AVLAREZ RB, 2000, NEUROLOGY, V54, P240
   Banwell BL, 2000, NEUROLOGY, V54, P1033, DOI 10.1212/WNL.54.5.1033
   Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Broccolini A, 2000, NEUROLOGY, V54, pA241
   Choi YC, 2000, J BIOL CHEM, V275, P8703, DOI 10.1074/jbc.275.12.8703
   Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8
   Cuello AC, 2005, BRAIN PATHOL, V15, P66
   Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200
   Dalakas Marinos C., 2001, Current Opinion in Pharmacology, V1, P300, DOI 10.1016/S1471-4892(01)00053-4
   Deng A, 2001, AM J PATHOL, V159, P1061, DOI 10.1016/S0002-9440(10)61781-6
   DESNUELLE C, 1998, INCLUSION BODY MYOSI, P318
   Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299
   Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a
   Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb
   Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5
   Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425
   Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com
   Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999
   Forloni G, 2002, NEUROBIOL AGING, V23, P957, DOI 10.1016/S0197-4580(02)00076-3
   Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X
   Fratta P, 2004, NEUROLOGY, V63, P1114, DOI 10.1212/01.WNL.0000138574.56908.5D
   Fukuchi K, 1998, AM J PATHOL, V153, P1687, DOI 10.1016/S0002-9440(10)65682-9
   Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x
   Gestwicki JE, 2004, SCIENCE, V306, P865, DOI 10.1126/science.1101262
   Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167
   GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4
   Gonzalez-Cadavid NF, 2004, CURR OPIN CLIN NUTR, V7, P451, DOI 10.1097/01.mco.0000134365.99523.7f
   Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1
   Griggs RC, 2006, NEUROLOGY, V66, pS30, DOI 10.1212/01.wnl.0000192262.29924.9e
   Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21
   Hussain I, 2000, MOL CELL NEUROSCI, V16, P609, DOI 10.1006/mcne.2000.0884
   Jaworska-Wilczynska M, 2002, NEUROLOGY, V58, P438, DOI 10.1212/WNL.58.3.438
   Jin LW, 1998, AM J PATHOL, V153, P1679, DOI 10.1016/S0002-9440(10)65681-7
   Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x
   Kefi M, 2002, NEUROLOGY, V58, pA391
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8
   Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139
   Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3
   Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94
   Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456
   Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200
   Mastaglia FL, 2003, MUSCLE NERVE, V27, P407, DOI 10.1002/mus.10313
   McFerrin J, 1998, NEUROREPORT, V9, P3201, DOI 10.1097/00001756-199810050-00013
   McFerrin J, 2005, NEUROLOGY, V64, pA337
   McFerrin J, 2002, NEUROLOGY, V58, pA489
   MIKOL J, 2004, MYOLOGY BASIC CLIN
   Nogalska A, 2005, NEUROLOGY, V64, pA159
   OLDFORS A, 1995, J NEUROPATH EXP NEUR, V54, P581, DOI 10.1097/00005072-199507000-00012
   OLDFORS A, 1998, INCLUSION BODY MYOSI, P306
   Ozturk A, 2004, NEUROLOGY, V62, pA168
   POCKLEY AG, 2001, EXPERT REV MOL MED, P1
   Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798
   Salon ML, 2003, EXP NEUROL, V180, P131, DOI 10.1016/S0014-4886(02)00060-2
   Santorelli FM, 1996, ANN NEUROL, V39, P789, DOI 10.1002/ana.410390615
   SARKOZI E, 1993, NEUROREPORT, V4, P815, DOI 10.1097/00001756-199306000-00055
   Schröder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056
   Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741
   Selkoe DJ, 2003, NEUROCHEM RES, V28, P1705, DOI 10.1023/A:1026065122854
   Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785
   Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167
   Sugarman MC, 2002, P NATL ACAD SCI USA, V99, P6334, DOI 10.1073/pnas.082545599
   van Leeuwen FW, 2000, NEUROBIOL AGING, V21, P879, DOI 10.1016/S0197-4580(00)00151-2
   van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242
   Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1
   Vattemi G, 2003, J NEUROCHEM, V85, P1539, DOI 10.1046/j.1471-4159.2003.01798.x
   Vattemi G, 2003, EXP NEUROL, V179, P150, DOI 10.1016/S0014-4886(02)00025-0
   Vattemi G, 2001, LANCET, V358, P1962, DOI 10.1016/S0140-6736(01)06969-0
   Vattemi G., 2003, NEUROLOGY, V60, P315
   VATTEMI G, 2003, NEUROLOGY, V60, P333
   Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015
   Walsh DM, 2005, J NEUROSCI, V25, P2455, DOI 10.1523/JNEUROSCI.4391-04.2005
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014
   Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332
   Wójcik S, 2005, ACTA NEUROPATHOL, V110, P173, DOI 10.1007/s00401-005-1035-3
   YUNIS EJ, 1971, LAB INVEST, V25, P240
NR 93
TC 126
Z9 148
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD JAN
PY 2006
VL 66
SU 1
BP S39
EP S48
DI 10.1212/01.wnl.0000192128.13875.1e
PG 10
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 005RX
UT WOS:000234842600007
PM 16432144
DA 2024-11-01
ER

PT J
AU de Beaurepaire, I
   Grévent, D
   Rio, M
   Desguerre, I
   de Lonlay, P
   Levy, R
   Dangouloff-Ros, V
   Bonnefont, JP
   Barcia, G
   Funalot, B
   Besmond, C
   Metodiev, MD
   Ruzzenente, B
   Assouline, Z
   Munnich, A
   Rötig, A
   Boddaert, N
AF de Beaurepaire, Isaure
   Grevent, David
   Rio, Marlene
   Desguerre, Isabelle
   de Lonlay, Pascale
   Levy, Raphael
   Dangouloff-Ros, Volodia
   Bonnefont, Jean-Paul
   Barcia, Giulia
   Funalot, Benoit
   Besmond, Claude
   Metodiev, Metodi D.
   Ruzzenente, Benedetta
   Assouline, Zahra
   Munnich, Arnold
   Rotig, Agnes
   Boddaert, Nathalie
TI High predictive value of brain MRI imaging in primary mitochondrial
   respiratory chain deficiency
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
ID NEURORADIOLOGIC FINDINGS; MAGNETIC-RESONANCE; LEIGH-SYNDROME; DISORDERS;
   DISEASE; ENCEPHALOPATHY; SPECTROSCOPY; DIAGNOSIS; THIAMINE; CHILDREN
AB Background Because the mitochondrial respiratory chain (RC) is ubiquitous, its deficiency can theoretically give rise to any symptom in any organ or tissue at any age with any mode of inheritance, owing to the twofold genetic origin of respiratory enzyme machinery, that is, nuclear and mitochondrial. Not all respiratory enzyme deficiencies are primary and secondary or artefactual deficiency is frequently observed, leading to a number of misleading conclusions and inappropriate investigations in clinical practice. This study is aimed at investigating the potential role of brain MRI in distinguishing primary RC deficiency from phenocopies and other aetiologies.
   Methods Starting from a large series of 189 patients (median age: 3.5 years (8 days-56 years), 58% males) showing signs of RC enzyme deficiency, for whom both brain MRIs and disease-causing mutations were available, we retrospectively studied the positive predictive value (PPV) and the positive likelihood ratio (LR+) of brain MRI imaging and its ability to discriminate between two groups: primary deficiency of the mitochondrial RC machinery and phenocopies.
   Results Detection of (1) brainstem hyperintensity with basal ganglia involvement (P <= 0.001) and (2) lactate peak with either brainstem or basal ganglia hyperintensity was highly suggestive of primary RC deficiency (P <= 0.01). Fourteen items had a PPV>95% and LR+ was greater than 9 for seven signs. Biallelic SLC19A3 mutations represented the main differential diagnosis. Non-significant differences between the two groups were found for cortical/subcortical atrophy, leucoencephalopathy and involvement of caudate nuclei, spinothalamic tract and corpus callosum.
   Conclusion Based on these results and owing to invasiveness of skeletal muscle biopsies and cost of high-throughput DNA sequencing, we suggest giving consideration to brain MRI imaging as a diagnostic marker and an informative investigation to be performed in patients showing signs of RC enzyme deficiency.
C1 [de Beaurepaire, Isaure; Grevent, David; Levy, Raphael; Dangouloff-Ros, Volodia; Boddaert, Nathalie] INSERM UMR 1163, Dept Pediat Radiol, Paris, France.
   [de Beaurepaire, Isaure; Grevent, David; Rio, Marlene; Desguerre, Isabelle; de Lonlay, Pascale; Levy, Raphael; Dangouloff-Ros, Volodia; Bonnefont, Jean-Paul; Barcia, Giulia; Funalot, Benoit; Besmond, Claude; Metodiev, Metodi D.; Ruzzenente, Benedetta; Assouline, Zahra; Munnich, Arnold; Rotig, Agnes; Boddaert, Nathalie] Paris Descartes Univ, Sorbonne Paris Cite, Hop Necker Enfants Malad, INSERM U1000, Paris, France.
   [Grevent, David; Dangouloff-Ros, Volodia; Besmond, Claude; Metodiev, Metodi D.; Ruzzenente, Benedetta; Assouline, Zahra; Munnich, Arnold; Rotig, Agnes; Boddaert, Nathalie] INSERM UMR 1163, IMAGINE Inst, Paris, France.
   [Rio, Marlene; Bonnefont, Jean-Paul; Barcia, Giulia; Funalot, Benoit; Munnich, Arnold] INSERM UMR 1163, Dept Genet, Paris, France.
   [Desguerre, Isabelle; de Lonlay, Pascale] INSERM UMR 1163, Dept Neurol & Metab, Paris, France.
   [Funalot, Benoit] GHU Henri Mondor, Dept Genet, Creteil, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP);
   Universite Paris Cite; Hopital Universitaire Necker-Enfants Malades -
   APHP; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite Paris Cite; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Paris Cite; Institut National de
   la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire
   Henri-Mondor - APHP
RP de Beaurepaire, I (corresponding author), Hop Necker Enfants Malad, Dept Radiopediat, Batiment Laennec, F-75015 Paris, France.
EM isaure.debeaurepaire@orange.fr
RI Barcia, Giulia/H-7907-2017; Ruzzenente, Benedetta/H-4793-2017;
   Dangouloff-Ros, Volodia/AAK-1241-2020; BESMOND, Claude/L-8451-2018;
   boddaert, nathalie/GWV-2865-2022; ROTIG, AGNES/G-9592-2017; Metodiev,
   Metodi D/C-4780-2015
OI Ruzzenente, Benedetta/0000-0001-7366-114X; ROTIG,
   AGNES/0000-0003-0589-0703; BESMOND, Claude/0000-0001-9073-8225; Grevent,
   David/0000-0001-6557-2331; Metodiev, Metodi D/0000-0002-9596-2434;
   Funalot, Benoit/0000-0001-6352-6518
CR Alfadhel M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-83
   Argov Z, 1998, EUR NEUROL, V39, P65, DOI 10.1159/000007912
   Baertling F, 2016, CHILD NERV SYST, V32, P2077, DOI 10.1007/s00381-016-3190-3
   Bianchi MC, 2007, BIOSCIENCE REP, V27, P69, DOI 10.1007/s10540-007-9046-z
   Bricout M, 2014, J MED GENET, V51, P429, DOI 10.1136/jmedgenet-2013-102256
   da Rocha AJ, 2008, J NEUROIMAGING, V18, P1, DOI 10.1111/j.1552-6569.2007.00205.x
   Ortigoza-Escobar JD, 2016, BRAIN, V139, P31, DOI 10.1093/brain/awv342
   Delonlay P, 2013, HAND CLINIC, V113, P1651, DOI 10.1016/B978-0-444-59565-2.00033-2
   Diogo L, 2010, PEDIATR NEUROL, V42, P196, DOI 10.1016/j.pediatrneurol.2009.09.010
   Ferreira CR, 2017, AM J MED GENET A, V173, P1502, DOI 10.1002/ajmg.a.38189
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2005, METAB BRAIN DIS, V20, P219, DOI 10.1007/s11011-005-7209-9
   Friedman SD, 2010, DEV DISABIL RES REV, V16, P129, DOI 10.1002/ddrr.103
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   Kevelam SH, 2013, BRAIN, V136, P1534, DOI 10.1093/brain/awt054
   Kim J, 2008, EUR RADIOL, V18, P1741, DOI 10.1007/s00330-008-0921-1
   Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005
   Lebre AS, 2010, PATHOL BIOL, V58, P353, DOI 10.1016/j.patbio.2009.09.012
   Lee SK, 2010, YONSEI MED J, V51, P672, DOI 10.3349/ymj.2010.51.5.672
   Longo N, 2003, NEUROL CLIN, V21, P817, DOI 10.1016/S0733-8619(03)00015-X
   Parikh S, 2015, GENET MED, V17, P689, DOI 10.1038/gim.2014.177
   Pyle A, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000006
   Rötig A, 2014, REV NEUROL-FRANCE, V170, P309, DOI 10.1016/j.neurol.2013.11.006
   Rötig A, 2011, BBA-BIOENERGETICS, V1807, P1198, DOI 10.1016/j.bbabio.2011.06.010
   Tabarki B, 1993, GENEREVIEWS
   Valanne L, 1998, AM J NEURORADIOL, V19, P369
   Wong SSN, 2017, MITOCHONDRION, V32, P36, DOI 10.1016/j.mito.2016.11.008
NR 27
TC 15
Z9 15
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD JUN
PY 2018
VL 55
IS 6
BP 378
EP 383
DI 10.1136/jmedgenet-2017-105094
PG 6
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GU2OP
UT WOS:000445109900003
PM 29358270
DA 2024-11-01
ER

PT J
AU Antipova, VN
   Lomaeva, MG
   Zyrina, NV
AF Antipova, Valeriya N.
   Lomaeva, Milena G.
   Zyrina, Nadezhda V.
TI Mitochondrial DNA deletions in tissues of mice after ionizing radiation
   exposure
SO INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
LA English
DT Article
DE Large mitochondrial DNA deletions; ionizing radiation; mice
ID SUBSTANTIA-NIGRA NEURONS; MULTIPLE DELETIONS; SKELETAL-MUSCLE; COPY
   NUMBER; BLOOD-CELLS; X-RAYS; GENOME; DISEASE; ACCUMULATION; IRRADIATION
AB Purpose: The objective of the study was to estimate the presence of large mtDNA deletions in brain and spleen tissues of mice four months after exposure to 2 and 5Gy.Materials and methods: The male BALB/c mice underwent X-ray total-body acute radiation. Four months after irradiation, the mice were decapitated, and the samples of spleen and brain tissues were examined. A long-distance PCR was used to detect mtDNA deletions and their levels in samples of brain and spleen tissues.Results: Four months after irradiation the levels of mtDNA deletions in the brain and spleen tissues were higher in animals exposed to 5Gy than in animals at an irradiation dose of 2Gy and in control mice. The levels of deletions in the mice brain tissues were higher 4 months than 1 month after X-ray exposure to both doses (2 and 5Gy). In spleen tissues, a higher level of deletions was observed only at an irradiation dose of 5Gy.Conclusions: Our data have shown that ionizing radiation induces an increase of mtDNA copies with deletions in tissues of mice four months after the post-irradiation period. The level of deletions depends on the animal age, type of tissue, irradiation dose and length of the post-irradiation period.
C1 [Antipova, Valeriya N.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Biophys Act Media, Pushchino 142290, Moscow Region, Russia.
   [Lomaeva, Milena G.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Radiat Mol Biol, Pushchino, Moscow Region, Russia.
   [Zyrina, Nadezhda V.] Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Crystallophys & Xray Res, Pushchino, Moscow Region, Russia.
C3 Russian Academy of Sciences; Pushchino Scientific Center for Biological
   Research (PSCBI) of the Russian Academy of Sciences; Institute of
   Theoretical & Experimental Biophysics; Russian Academy of Sciences;
   Pushchino Scientific Center for Biological Research (PSCBI) of the
   Russian Academy of Sciences; Institute of Theoretical & Experimental
   Biophysics; Russian Academy of Sciences; Pushchino Scientific Center for
   Biological Research (PSCBI) of the Russian Academy of Sciences;
   Institute of Theoretical & Experimental Biophysics
RP Antipova, VN (corresponding author), Russian Acad Sci, Inst Theoret & Expt Biophys, Lab Biophys Act Media, Pushchino 142290, Moscow Region, Russia.
EM valery_a@rambler.ru
RI Antipova, Valeriya/J-3121-2016
CR [Anonymous], 1989, MOL CLONING LAB MANU
   Antipova V N, 2011, Biofizika, V56, P439
   Antipova V N, 2011, Genetika, V47, P425
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Blakely WF, 2001, RADIAT PROT DOSIM, V97, P17, DOI 10.1093/oxfordjournals.rpd.a006633
   BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Copeland WC, 2014, DNA REPAIR, V19, P190, DOI 10.1016/j.dnarep.2014.03.010
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Diaz F, 2002, NUCLEIC ACIDS RES, V30, P4626, DOI 10.1093/nar/gkf602
   Eimon PM, 1996, DEV GENET, V18, P107, DOI 10.1002/(SICI)1520-6408(1996)18:2<107::AID-DVG3>3.0.CO;2-D
   Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499
   Fukui H, 2009, HUM MOL GENET, V18, P1028, DOI 10.1093/hmg/ddn437
   Hamada A, 2003, INT CONGR SER, V1258, P169, DOI 10.1016/S0531-5131(03)01221-4
   Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1
   Ikushima T, 2002, INT CONGR SER, V1236, P331, DOI 10.1016/S0531-5131(01)00852-4
   IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Khrapko K, 2009, TRENDS GENET, V25, P91, DOI 10.1016/j.tig.2008.11.007
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Kubota N, 1997, RADIAT RES, V148, P395, DOI 10.2307/3579525
   Malakhova L. V, 2006, Voprosy Onkologii (St. Petersburg), V52, P398
   Marcelino LA, 1999, MUTAT RES-DNA REPAIR, V434, P177, DOI 10.1016/S0921-8777(99)00028-2
   Nicholas A, 2009, EXP NEUROL, V218, P316, DOI 10.1016/j.expneurol.2009.04.029
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Prasanna Pataje G S, 2002, Mil Med, V167, P10
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018
   Sawyer DE, 1999, MUTAT RES-DNA REPAIR, V434, P161, DOI 10.1016/S0921-8777(99)00027-0
   Schilling-Tóth B, 2011, MUTAT RES-FUND MOL M, V716, P33, DOI 10.1016/j.mrfmmm.2011.07.018
   Seol MA, 2012, J VET SCI, V13, P331, DOI 10.4142/jvs.2012.13.4.331
   Siqueira RG, 2014, AN ACAD BRAS CIENC, V86, P685, DOI 10.1590/0001-37652014110912
   Takeda K, 2000, GENETICS, V155, P777
   TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wardell TM, 2003, MUTAT RES-FUND MOL M, V525, P19, DOI 10.1016/S0027-5107(02)00313-5
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhang SB, 2013, RADIAT RES, V180, P407, DOI 10.1667/RR3373.1
   Zhao XT, 2012, BIOMED ENVIRON SCI, V25, P533, DOI 10.3967/0895-3988.2012.05.006
NR 44
TC 4
Z9 4
U1 0
U2 5
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0955-3002
EI 1362-3095
J9 INT J RADIAT BIOL
JI Int. J. Radiat. Biol.
PY 2018
VL 94
IS 3
BP 282
EP 288
DI 10.1080/09553002.2018.1419299
PG 7
WC Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine &
   Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Nuclear Science &
   Technology; Radiology, Nuclear Medicine & Medical Imaging
GA FY7ZD
UT WOS:000427081300008
PM 29256737
DA 2024-11-01
ER

PT J
AU Majamaa-Voltti, KAM
   Winqvist, S
   Remes, AM
   Tolonen, U
   Pyhtinen, J
   Uimonen, S
   Kärppä, M
   Sorri, M
   Peuhkurinen, K
   Majamaa, K
AF Majamaa-Voltti, K. A. M.
   Winqvist, S.
   Remes, A. M.
   Tolonen, U.
   Pyhtinen, J.
   Uimonen, S.
   Karppa, M.
   Sorri, M.
   Peuhkurinen, K.
   Majamaa, K.
TI A 3-year clinical follow-up of adult patients with 3243A&gt;G in
   mitochondrial DNA
SO NEUROLOGY
LA English
DT Article
ID STROKE-LIKE EPISODES; A3243G MUTATION; LACTIC-ACIDOSIS; MELAS;
   INVOLVEMENT; ENCEPHALOMYOPATHY; IMPAIRMENT; SPECTRUM; CARRIERS; DISEASES
AB Objective: To follow the clinical course of patients with the mitochondrial DNA mutation 3243A > G for 3 years. Methods: Thirty-three adult patients with the 3243A > G mutation entered a 3-year follow-up study. They were clinically evaluated annually, audiometry was performed, and samples were drawn for the analysis of blood chemistry and mutation heteroplasmy in leukocytes. Holter recording was performed three times during the follow-up and echocardiography, neuropsychological assessment, and quantitative EEG and brain imaging conducted at entry and after 3 years. Results: The incidence of new neurologic events was low during the 3-year follow-up. Sensorineural hearing impairment (SNHI) progressed, left ventricular wall thickness increased, mean alpha frequency in the occipital and parietal regions decreased, and the severity of disease index ( modified Rankin score) progressed significantly. The rate of SNHI progression correlated with mutation heteroplasmy in muscle. The increase in left ventricular wall thickness was seen almost exclusively in diabetic patients. Seven patients died during the follow-up, and they were generally more severely affected than those who survived. Conclusions: Significant changes in the severity of disease, sensorineural hearing impairment, left ventricular hypertrophy, and quantitative EEG were seen in adult patients with 3243A > G during the 3-year follow-up.
C1 Univ Oulu, Dept Internal Med, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Neurol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Radiol, FIN-90014 Oulu, Finland.
   Univ Oulu, Dept Otorhinolaryngol, FIN-90014 Oulu, Finland.
   Oulu Univ Hosp, Dept Clin Neurophysiol, Oulu, Finland.
   Univ Kuopio, Dept Internal Med, FIN-70211 Kuopio, Finland.
   Univ Turku, Dept Neurol, FIN-20520 Turku, Finland.
C3 University of Oulu; University of Oulu; University of Oulu; University
   of Oulu; University of Oulu; University of Eastern Finland; University
   of Turku
RP Majamaa-Voltti, KAM (corresponding author), Univ Oulu, Dept Internal Med, POB 5000, FIN-90014 Oulu, Finland.
EM kirsi.majamaa-voltti@oulu.fi
RI Majamaa, Kari/A-1344-2012
OI Majamaa, Kari/0000-0002-9070-3791
CR ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   BENTON AL, 1978, BENTON REVISED VISUA
   Carugo S, 2001, J HYPERTENS, V19, P1675, DOI 10.1097/00004872-200109000-00021
   Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   CHRISTENSEN AL, 1975, LURIAS NEUROPSYCHOLI
   Damian MS, 1998, EUR NEUROL, V39, P9, DOI 10.1159/000007892
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P1388, DOI 10.1016/0002-9149(86)90224-9
   Devereux RB, 2000, CIRCULATION, V101, P2271, DOI 10.1161/01.CIR.101.19.2271
   Diagnosis, 2003, Diabetes Care, V26, ps5, DOI 10.2337/diacare.26.2007.S5
   Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002
   Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z
   Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2
   *EUR WORK GROUP GE, 1996, BIOM HLTH RES PROGR
   FEIGENBAUM H, 1994, MITRAL VALVE FLOW EC, V188
   FEIGENBAUM H, 1994, ECHOCARDIOGRAPHIC ME, V658
   GUY E, 1976, ECDEU ASSESSMENT MAN, P218
   Kärppä M, 2005, BRAIN, V128, P1861, DOI 10.1093/brain/awh515
   Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27
   Kessels RPC, 2000, J NEUROL NEUROSUR PS, V69, P389, DOI 10.1136/jnnp.69.3.389
   Klopstock T, 1999, NEUROLOGY, V53, P855, DOI 10.1212/WNL.53.4.855
   KNOPMAN DS, 1994, NEUROLOGY, V44, P2315, DOI 10.1212/WNL.44.12.2315
   KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5
   LAFFEY PA, 1984, NEURORADIOLOGY, V26, P273
   Lezak M. D., 1995, Neuropsychological assessment, V3rd ed.
   Lien LM, 2001, ACTA NEUROL SCAND, V103, P159, DOI 10.1034/j.1600-0404.2001.103003159.x
   LIU XZ, 1994, ANN OTO RHINOL LARYN, V103, P428, DOI 10.1177/000348949410300602
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Okhuijsen-Kroes EJ, 2001, NEUROPEDIATRICS, V32, P183, DOI 10.1055/s-2001-17372
   PARVING ANV, 1995, GUIDELINES DESCRIPTI, P2
   Phillips RA, 1998, J CLIN ENDOCR METAB, V83, P4284, DOI 10.1210/jc.83.12.4284
   RANKIN J, 1957, Scott Med J, V2, P254
   REISBERG B, 1982, AM J PSYCHIAT, V139, P1136
   Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509
   REZEK DL, 1987, NEUROLOGY, V37, P1365, DOI 10.1212/WNL.37.8.1365
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Uimonen S, 2001, HUM GENET, V108, P284, DOI 10.1007/s004390100475
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wechsler D., 1997, Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV)
   Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223
NR 44
TC 53
Z9 59
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD MAY 23
PY 2006
VL 66
IS 10
BP 1470
EP 1475
DI 10.1212/01.wnl.0000216136.61640.79
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 044XM
UT WOS:000237706900004
PM 16717204
DA 2024-11-01
ER

PT J
AU Kade, G
   Spaleniak, SK
   Brodacki, B
   Pollak, A
   Moczulski, D
   Oldak, M
   Saracyn, M
AF Kade, Grzegorz
   Spaleniak, Sebastian Krzysztof
   Brodacki, Bogdan
   Pollak, Agnieszka
   Moczulski, Dariusz
   Oldak, Monika
   Saracyn, Marek
TI Maternally inherited diabetes and deafness (MIDD) syndrome with
   m.3243A&gt;G mutation associated with renal failure - a case report
SO CLINICAL DIABETOLOGY
LA English
DT Article
DE mitochondrial diabetes; sensorineural deafness; m.3243A > G mutation;
   renal failure; incomplete distal renal tubular acidosis
ID MITOCHONDRIAL; MELAS
AB Maternally-inherited diabetes with deafness (MIDD) is a rare form of monogenic diabetes that results, in most cases, from an A-to-G transition at position 3243 of mitochondrial DNA (m.3243A>G). The clinical presentation of m.3243A>G mutation is variable, ranging from mild to severe phenotypes. Diabetes is often accompanied by sensorineural deafness, cardiomyopathy, neuromuscular, psychiatric disorders, macular dystrophy and renal failure (kidney manifestations in adults presenting with this mutation remain poorly defined).
   The study presents a case of a 40-years-old woman with a history of bilateral sensorineural deafness, renal failure and diabetes that was diagnosed due to increasing muscle weakness during exercise. MIDD was diagnosed based on the clinical picture and the results of laboratory studies including genetic testing. As far as we know, glomerulopathy with incomplete distal renal tubular acidosis has never been described before as a cause of renal failure in MIDD patients.
C1 [Kade, Grzegorz] Mil Inst Med, Dept Internal Med Nephrol & Dialysis, Warsaw, Poland.
   [Spaleniak, Sebastian Krzysztof; Moczulski, Dariusz] Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Zeromskiego 113, PL-90549 Lodz, Poland.
   [Brodacki, Bogdan] Mil Inst Med, Neurol Clin, Warsaw, Poland.
   [Pollak, Agnieszka; Oldak, Monika] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.
   [Saracyn, Marek] Mil Inst Med, Dept Endocrinol & Isotope Therapy, Warsaw, Poland.
C3 Military Institute of Aviation Medicine; Medical University Lodz;
   Military Institute of Aviation Medicine; Institute of Physiology &
   Hearing Pathology; Military Institute of Aviation Medicine
RP Spaleniak, SK (corresponding author), Med Univ Lodz, Dept Internal Med & Nephrodiabetol, Zeromskiego 113, PL-90549 Lodz, Poland.
EM sebastian19860@op.pl
RI Spaleniak, Sebastian/AAG-2729-2020
OI Spaleniak, Sebastian/0000-0001-5631-6467; Oldak,
   Monika/0000-0002-4216-9141; Moczulski, Dariusz/0000-0002-0926-9909
CR BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11
   Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Dinour D, 2004, CLIN NEPHROL, V62, P149
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   Guéry B, 2003, J AM SOC NEPHROL, V14, P2099, DOI 10.1097/01.ASN.0000080180.51098.02
   Hotta O, 2001, KIDNEY INT, V59, P1236, DOI 10.1046/j.1523-1755.2001.0590041236.x
   Iwanicka-Pronicka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044054
   Jansen JJ, 1997, J AM SOC NEPHROL, V8, P1118
   Löwik MM, 2005, NEPHROL DIAL TRANSPL, V20, P336, DOI 10.1093/ndt/gfh546
   Malecki Maciej, 2008, Pol Arch Med Wewn, V118, P435
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Sue CM, 1998, ANN NEUROL, V43, P350, DOI 10.1002/ana.410430313
   SZABOLCS MJ, 1994, KIDNEY INT, V45, P1388, DOI 10.1038/ki.1994.181
   Takeshima T, 2005, INTERNAL MED, V44, P276, DOI 10.2169/internalmedicine.44.276
   YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164
NR 15
TC 0
Z9 0
U1 0
U2 1
PU VIA MEDICA
PI GDANSK
PA UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND
SN 2450-8187
J9 CLIN DIABETOL
JI Clin. Diabetol.
PY 2020
VL 9
IS 6
BP 475
EP 478
DI 10.5603/DK.2020.0058
PG 4
WC Endocrinology & Metabolism
WE Emerging Sources Citation Index (ESCI)
SC Endocrinology & Metabolism
GA PN7ZG
UT WOS:000604692300014
OA gold
DA 2024-11-01
ER

PT J
AU Melchionda, L
   Damseh, NS
   Abu Libdeh, B
   Nasca, A
   Elpeleg, O
   Zanolini, A
   Ghezzi, D
AF Melchionda, Laura
   Damseh, Nadirah S.
   Abu Libdeh, BassamY.
   Nasca, Alessia
   Elpeleg, Orly
   Zanolini, Alice
   Ghezzi, Daniele
TI A novel mutation in <i>TTC19</i> associated with isolated complex III
   deficiency, cerebellar hypoplasia, and bilateral basal ganglia lesions
SO FRONTIERS IN GENETICS
LA English
DT Article
ID ENCEPHALOPATHY; IMPAIRMENT; REVEALS
AB Isolated complex III (cIII) deficiency is a rare biochemical finding in mitochondrial disorders, mainly associated with mutations in mitochondrial DNA MTCYB gene, encoding cytochrome b, or in assembly factor genes (BCS1L, TTC19, UQCC2, and LYRM7), whereas mutations in nuclear genes encoding cIII structural subunits are extremely infrequent. We report here a patient, a 9 year old female born from first cousin related parents, with normal development till 18 months when she showed unsteady gait with frequent falling down, cognitive, and speech worsening. Her course deteriorated progressively. Brain MRI showed cerebellar vermis hypoplasia and bilateral lentiform nucleus high signal lesions. Now she is bed ridden with tetraparesis and severely impaired cognitive and language functions. Biochemical analysis revealed isolated cIII deficiency in muscle, and impaired respiration in fibroblasts. We identified a novel homozygous rearrangement in TTC19 (c.213_229dup), resulting in frameshift with creation of a premature termination codon (p.G1n77Argfs*30). Western blot analysis demonstrated the absence of TTC19 protein in patient's fibroblasts, while Blue-Native Gel Electrophoresis analysis revealed the presence of cIII-specific assembly intermediates. Mutations in TTC19 have been rarely associated with mitochondrial disease to date, being described in about ten patients with heterogeneous clinical presentations, ranging from early onset encephalomyopathy to adult forms with cerebellar ataxia. Contrariwise, the biochemical defect was a common hallmark in TTC19 mutant patients, confirming the importance of TTC19 in cIII assembly/stability. Therefore, we suggest extending the TTC19 mutational screening to all patients with cIII deficiency, independently from their phenotypes.
C1 [Melchionda, Laura; Nasca, Alessia; Zanolini, Alice; Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy.
   [Damseh, Nadirah S.; Abu Libdeh, BassamY.] Al Makassed Islamic Charitable Hosp, Genet Unit, Jerusalem, Israel.
   [Elpeleg, Orly] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.
C3 Fondazione IRCCS Istituto Neurologico Carlo Besta; Hebrew University of
   Jerusalem; Hadassah University Medical Center
RP Ghezzi, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurogenet, Via Temolo 4, I-20126 Milan, Italy.
EM dghezzi@istituto-besta.it
RI ; Nasca, Alessia/K-2227-2016; Ghezzi, Daniele/J-7873-2016
OI Damseh, Nadirah/0000-0002-2673-7612; Nasca, Alessia/0000-0002-0640-9929;
   Ghezzi, Daniele/0000-0002-6564-3766
CR Atwal P. S., 2013, JIMD REP, V14, P43, DOI [10.1007/8904_2013_282, DOI 10.1007/8904_2013_282]
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706
   De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171
   Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753
   Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Gil Borlado M. C., 2010, PLOS ONE, V5, pe125, DOI [10.1371/journal.pone.0012801, DOI 10.1371/JOURNAL.PONE.0012801]
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Invernizzi F, 2013, HUM MUTAT, V34, P1619, DOI 10.1002/humu.22441
   Iwata K, 1998, BIOCHEM BIOPH RES CO, V253, P648, DOI 10.1006/bbrc.1998.9769
   Morino H, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-5
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034
NR 14
TC 15
Z9 15
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD NOV 14
PY 2014
VL 5
AR 397
DI 10.3389/fgene.2014.00397
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA AZ0ND
UT WOS:000347941100001
PM 25452764
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Moore, J
   Ewoldt, J
   Venturini, G
   Pereira, AC
   Padilha, K
   Lawton, M
   Lin, WW
   Goel, R
   Luptak, I
   Perissi, V
   Seidman, CE
   Seidman, J
   Chin, MT
   Chen, C
   Emili, A
AF Moore, Jarrod
   Ewoldt, Jourdan
   Venturini, Gabriela
   Pereira, Alexandre C. C.
   Padilha, Kallyandra
   Lawton, Matthew
   Lin, Weiwei
   Goel, Raghuveera
   Luptak, Ivan
   Perissi, Valentina
   Seidman, Christine E. E.
   Seidman, Jonathan
   Chin, Michael T. T.
   Chen, Christopher
   Emili, Andrew
TI Multi-Omics Profiling of Hypertrophic Cardiomyopathy Reveals Altered
   Mechanisms in Mitochondrial Dynamics and Excitation-Contraction Coupling
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hypertrophic cardiomyopathy; human induced pluripotent stem-cell-derived
   cardiomyocytes; myectomy; liquid chromatography-tandem mass
   spectrometry; phosphoproteomics; metabolomics; network systems biology
ID LIGHT-CHAIN PHOSPHATASE; BASE EXCISION-REPAIR; OXIDATIVE STRESS;
   SARCOMERE FUNCTION; PHOSPHORYLATION; DYSFUNCTION; ENERGETICS; FISSION;
   MUSCLE; DNA
AB Hypertrophic cardiomyopathy is one of the most common inherited cardiomyopathies and a leading cause of sudden cardiac death in young adults. Despite profound insights into the genetics, there is imperfect correlation between mutation and clinical prognosis, suggesting complex molecular cascades driving pathogenesis. To investigate this, we performed an integrated quantitative multi-omics (proteomic, phosphoproteomic, and metabolomic) analysis to illuminate the early and direct consequences of mutations in myosin heavy chain in engineered human induced pluripotent stem-cell-derived cardiomyocytes relative to late-stage disease using patient myectomies. We captured hundreds of differential features, which map to distinct molecular mechanisms modulating mitochondrial homeostasis at the earliest stages of pathobiology, as well as stage-specific metabolic and excitation-coupling maladaptation. Collectively, this study fills in gaps from previous studies by expanding knowledge of the initial responses to mutations that protect cells against the early stress prior to contractile dysfunction and overt disease.
C1 [Moore, Jarrod; Lawton, Matthew; Lin, Weiwei; Goel, Raghuveera; Perissi, Valentina; Emili, Andrew] Boston Univ, Ctr Network Syst Biol, Dept Biochem, Sch Med, Boston, MA 02118 USA.
   [Ewoldt, Jourdan; Chen, Christopher] Boston Univ, Dept Biomed Engn, Boston, MA 02218 USA.
   [Venturini, Gabriela; Pereira, Alexandre C. C.; Seidman, Christine E. E.; Seidman, Jonathan] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.
   [Padilha, Kallyandra] Univ Sao Paulo, Clin Hosp, Fac Med, Lab Genet & Mol Cardiol, BR-05508000 Sao Paulo, Brazil.
   [Luptak, Ivan] Boston Univ, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA.
   [Seidman, Christine E. E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA.
   [Seidman, Christine E. E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
   [Chin, Michael T. T.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02145 USA.
   [Chen, Christopher] Harvard Univ, Wyss Inst Biolog Inspired Engn, Boston, MA 02115 USA.
C3 Boston University; Boston University; Harvard University; Harvard
   Medical School; Universidade de Sao Paulo; Boston University; Harvard
   University; Brigham & Women's Hospital; Howard Hughes Medical Institute;
   Tufts Medical Center; Harvard University
RP Emili, A (corresponding author), Boston Univ, Ctr Network Syst Biol, Dept Biochem, Sch Med, Boston, MA 02118 USA.
EM aemili@bu.edu
RI PADILHA (A), KALLYANDRA/JZT-5702-2024; Perissi, Valentina/HNO-9945-2023;
   Chen, Christopher/ABD-8499-2021; Pereira, Antonio/B-9085-2012; Venturini
   da Silva, Gabriela/D-1630-2012
OI Emili, Andrew/0000-0001-8995-246X; Luptak, Ivan/0000-0001-7498-7694;
   Ewoldt, Jourdan/0000-0001-5466-8557; Venturini da Silva,
   Gabriela/0000-0003-2913-2296; Chin, Michael/0000-0003-3065-8498; Lawton,
   Matthew Luke/0000-0002-7244-1337
FU National Science Foundation Engineering Research Center on Cellular
   Metamaterials grant [HL080494]; National Institution of Health National
   Heart Lung and Blood Institute [DGE-1840990]; Engineering Research
   Centers Program of the National Science Foundation NSF Cooperative
   Agreement; National Science Foundation Graduate Research Fellowship [F31
   HL158195-03]; Boston University; Howard Hughes Medical Institute;
   National Institute of Health National Heart Lung and Blood; BioDesign
   Center
FX This research was funded by the National Science Foundation Engineering
   Research Center on Cellular Metamaterials grant EEC-1647837 (C.E.S.,
   J.S., C.C.), National Institution of Health National Heart Lung and
   Blood Institute HL080494 (C.E.S. and J.S.), the Engineering Research
   Centers Program of the National Science Foundation NSF Cooperative
   Agreement EEC-1647837 (C.E.S. and J.S.), National Science Foundation
   Graduate Research Fellowship DGE-1840990 (J.E.), National Institute of
   Health National Heart Lung and Blood grant F31 HL158195-03 (J.E.),
   Boston University and the BioDesign Center, grant name: Mass
   Spectrometry-Based Identification of Paracrine Signals Driving Fibrosis
   in a New Model of Hypertrophic Cardiomyopathy (J.M.), and the Howard
   Hughes Medical Institute (C.E.S.)
CR Adebayo M, 2021, FASEB J, V35, DOI 10.1096/fj.202100067R
   Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924
   Akhtar Mohammed, 2018, Glob Cardiol Sci Pract, V2018, P36, DOI 10.21542/gcsp.2018.36
   Ambruso DR, 2013, METHOD ENZYMOL, V527, P145, DOI 10.1016/B978-0-12-405882-8.00008-8
   Anderson RL, 2018, P NATL ACAD SCI USA, V115, pEB143, DOI 10.1073/pnas.1809540115
   Arimura T, 2001, J BIOL CHEM, V276, P6073, DOI 10.1074/jbc.M008566200
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Baier MJ, 2021, FEBS OPEN BIO, V11, P2756, DOI 10.1002/2211-5463.13274
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147
   Blighe K., 2023, EnhancedVolcano: Publication-Ready Volcano Plots with Enhanced Colouring and Labeling
   Blum BC, 2021, BIOINFORM ADV, V1, DOI 10.1093/bioadv/vbab024
   Blum BC, 2022, MOL CELL PROTEOMICS, V21, DOI 10.1016/j.mcpro.2021.100189
   Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028
   Campalans A, 2013, NUCLEIC ACIDS RES, V41, P3115, DOI 10.1093/nar/gkt025
   Candasamy AJ, 2014, J BIOL CHEM, V289, P1282, DOI 10.1074/jbc.M113.479030
   Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730
   Chaanine AH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113582
   Chang AN, 2016, J MOL CELL CARDIOL, V101, P35, DOI 10.1016/j.yjmcc.2016.10.004
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen XR, 2015, P NATL ACAD SCI USA, V112, P12687, DOI 10.1073/pnas.1512464112
   Cho E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43410-4
   Codden Christina J, 2022, Cardiol Cardiovasc Med, V6, P398, DOI 10.26502/fccm.92920277
   Codden CJ, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020946
   Cohn R, 2019, STEM CELL REP, V12, P71, DOI 10.1016/j.stemcr.2018.11.015
   Coppini R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01391
   Fan TWM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-79
   Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163
   Frohman MA, 2015, J MOL MED, V93, P263, DOI 10.1007/s00109-014-1237-z
   Gansemer ER, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101116
   Gao J, 2014, J CELL BIOL, V207, P213, DOI 10.1083/jcb.201403129
   Ge TX, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00365
   GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I
   Geske JB, 2018, JACC-HEART FAIL, V6, P364, DOI 10.1016/j.jchf.2018.02.010
   Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7
   Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018
   Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11
   Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009
   Hirota Y, 2015, AUTOPHAGY, V11, P332, DOI 10.1080/15548627.2015.1023047
   Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536
   Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002
   Knöll R, 2011, CIRC RES, V109, P758, DOI 10.1161/CIRCRESAHA.111.245787
   Knollmann BC, 2009, J PHYSIOL-LONDON, V587, P3081, DOI 10.1113/jphysiol.2009.172098
   Korotkevich G, 2019, bioRxiv, DOI [10.1101/060012, 10.1101/060012, DOI 10.1101/060012]
   Kraft LJ, 2016, AUTOPHAGY, V12, P1660, DOI 10.1080/15548627.2016.1199299
   Kraus I, 2015, SCI REP-UK, V5, DOI 10.1038/srep12767
   Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583
   Kudin AP, 2012, BBA-BIOENERGETICS, V1817, P1901, DOI 10.1016/j.bbabio.2012.02.023
   Kuzmanov U, 2020, NAT BIOMED ENG, V4, P889, DOI 10.1038/s41551-020-0585-y
   Kwon SH, 2003, J MOL CELL CARDIOL, V35, P615, DOI 10.1016/S0022-2828(03)00084-1
   Landstrom AP, 2010, CIRCULATION, V122, P2441, DOI 10.1161/CIRCULATIONAHA.110.954446
   Larson A, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-08561-x
   Larson A, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-01011-z
   Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109
   Liu MR, 2022, REDOX BIOL, V53, DOI 10.1016/j.redox.2022.102323
   Lu Fujian, 2020, Biophys Rev, V12, P1007, DOI 10.1007/s12551-020-00729-x
   Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008
   Lynch TL, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/424751
   Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059
   Mattiazzi A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00005
   McDonald TS, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0341-16.2017
   McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116
   McNamara JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180064
   Michas C, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm3791
   Moore J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222413644
   Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005
   Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006
   Ommen SR, 2020, CIRCULATION, V142, pe558, DOI 10.1161/CIR.0000000000000937
   Pangou E, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109129
   Paradies G, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070728
   Perdiz D, 2017, CELL SIGNAL, V39, P32, DOI 10.1016/j.cellsig.2017.07.020
   Pla-Martin D, 2020, EMBO J, V39, DOI 10.15252/embj.2019102731
   Prakash A, 2015, J CELL BIOCHEM, V116, P1490, DOI 10.1002/jcb.25103
   Ranjbarvaziri S, 2021, CIRCULATION, V144, P1714, DOI 10.1161/CIRCULATIONAHA.121.053575
   Ribas V, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00151
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roe AJ, 2018, BIOCHEM BIOPH RES CO, V496, P706, DOI 10.1016/j.bbrc.2018.01.114
   Ronson GE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03159-2
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Ruiz DG, 2022, BIOCHEMISTRY-US, V61, P2165, DOI 10.1021/acs.biochem.2c00349
   Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560
   Sang LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12239
   Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009
   Schmidt TA, 1998, CARDIOVASC RES, V37, P335, DOI 10.1016/S0008-6363(97)00261-7
   Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200
   Seco-Cervera M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121257
   Senthil V, 2005, CIRC RES, V97, P285, DOI 10.1161/01.RES.0000177090.07296.ac
   Sequeira V, 2019, FEBS LETT, V593, P1616, DOI 10.1002/1873-3468.13496
   Sharma Arun, 2018, Curr Protoc Hum Genet, V96, DOI 10.1002/cphg.52
   Sheikh F, 2015, GENE, V569, P14, DOI 10.1016/j.gene.2015.06.027
   Shimada YJ, 2021, CIRC-HEART FAIL, V14, P777, DOI 10.1161/CIRCHEARTFAILURE.120.007849
   Singh Gyanesh, 2015, F1000Res, V4, P176, DOI 10.12688/f1000research.6665.1
   Spindler M, 1998, J CLIN INVEST, V101, P1775, DOI 10.1172/JCI1940
   Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200
   Szygula-Jurkiewicz B, 2022, MEDICINA-LITHUANIA, V58, DOI 10.3390/medicina58010031
   Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Terentyev D, 2003, P NATL ACAD SCI USA, V100, P11759, DOI 10.1073/pnas.1932318100
   Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339
   Toepfer CN, 2019, CIRC RES, V124, P1172, DOI 10.1161/CIRCRESAHA.118.314505
   Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011
   Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009
   van der Velden J, 2018, CARDIOVASC RES, V114, P1273, DOI 10.1093/cvr/cvy147
   Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002
   Viola HM, 2019, ARCH BIOCHEM BIOPHYS, V665, P166, DOI 10.1016/j.abb.2019.03.006
   Wakim J, 2017, J CELL SCI, V130, P1940, DOI 10.1242/jcs.201616
   Wang WM, 2022, NAT CARDIOVASC RES, V1, P445, DOI 10.1038/s44161-022-00057-1
   Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202
   Watanabe K, 2021, BIOCHEM BIOPH RES CO, V534, P687, DOI 10.1016/j.bbrc.2020.11.018
   Wijnker PJM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165774
   Wijnker PJM, 2019, ANTIOXID REDOX SIGN, V31, P318, DOI 10.1089/ars.2017.7236
   Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639
   Witjas-Paalberends ER, 2014, J PHYSIOL-LONDON, V592, P3257, DOI 10.1113/jphysiol.2014.274571
   Yamada T, 2019, AUTOPHAGY, V15, P2012, DOI 10.1080/15548627.2019.1643185
   Yang H, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29071-4
   Yu R, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-01161-7
   Yuan M, 2019, NAT PROTOC, V14, P313, DOI 10.1038/s41596-018-0102-x
   Zhang C, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03484-3
   Zhang KH, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abh3995
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
NR 120
TC 7
Z9 7
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-6596
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2023
VL 24
IS 5
AR 4724
DI 10.3390/ijms24054724
PG 24
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 9U7EF
UT WOS:000947869100001
PM 36902152
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Onesto, E
   Colombrita, C
   Gumina, V
   Borghi, MO
   Dusi, S
   Doretti, A
   Fagiolari, G
   Invernizzi, F
   Moggio, M
   Tiranti, V
   Silani, V
   Ratti, A
AF Onesto, Elisa
   Colombrita, Claudia
   Gumina, Valentina
   Borghi, Maria Orietta
   Dusi, Sabrina
   Doretti, Alberto
   Fagiolari, Gigliola
   Invernizzi, Federica
   Moggio, Maurizio
   Tiranti, Valeria
   Silani, Vincenzo
   Ratti, Antonia
TI Gene-specific mitochondria dysfunctions in human <i>TARDBP</i> and
   <i>C9ORF72</i> fibroblasts
SO ACTA NEUROPATHOLOGICA COMMUNICATIONS
LA English
DT Article
DE ALS; FTD; TDP-43; C9ORF72; Fibroblast; Mitochondria dysfunction
ID AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; SKIN FIBROBLASTS;
   TDP-43; MUTATIONS; MODEL; PHOSPHORYLATION; ULTRASTRUCTURE; EXPANSIONS;
   MUSCLE
AB Dysregulation of RNA metabolism represents an important pathogenetic mechanism in both amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) due to the involvement of the DNA/RNA-binding proteins TDP-43 and FUS and, more recently, of C9ORF72. A potential link between dysregulation of RNA metabolism and mitochondrial dysfunction is recently emerged in TDP-43 disease models. To further investigate the possible relationship between these two pathogenetic mechanisms in ALS/FTD, we studied mitochondria functionality in human mutant TARDBP(p.A382T) and C9ORF72 fibroblasts grown in galactose medium to induce a switch from a glycolytic to an oxidative metabolism. In this condition we observed significant changes in mitochondria morphology and ultrastructure in both mutant cells with a fragmented mitochondria network particularly evident in TARDBP(p.A382T) fibroblasts. From analysis of the mitochondrial functionality, a decrease of mitochondria membrane potential with no alterations in oxygen consumption rate emerged in TARDBP fibroblasts. Conversely, an increased oxygen consumption and mitochondria hyperpolarization were observed in C9ORF72 fibroblasts in association to increased ROS and ATP content. We found evidence of autophagy/mitophagy in dynamic equilibrium with the biogenesis of novel mitochondria, particularly in mutant C9ORF72 fibroblasts where an increase of mitochondrial DNA content and mass, and of PGC1-alpha protein was observed. Our imaging and biochemical data show that wild-type and mutant TDP-43 proteins do not localize at mitochondria so that the molecular mechanisms responsible for such mitochondria impairment remain to be further elucidated. For the first time our findings assess a link between C9ORF72 and mitochondria dysfunction and indicate that mitochondria functionality is affected in TARDBP and C9ORF72 fibroblasts with gene-specific features in oxidative conditions. As in neuronal metabolism mitochondria are actively used for ATP production, we speculate that TARDBP and C9ORF72 mutations might trigger cell death by impairing not only RNA metabolism, but also mitochondria activity in ALS/FTD neurons.
C1 [Onesto, Elisa; Colombrita, Claudia; Gumina, Valentina; Doretti, Alberto; Silani, Vincenzo; Ratti, Antonia] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Via Zucchi 18, I-20095 Milanino, MI, Italy.
   [Colombrita, Claudia; Gumina, Valentina; Doretti, Alberto; Silani, Vincenzo; Ratti, Antonia] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Borghi, Maria Orietta] IRCCS Ist Auxol Italiano, Lab Immunorheumatol, Milan, Italy.
   [Borghi, Maria Orietta] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy.
   [Dusi, Sabrina; Invernizzi, Federica; Tiranti, Valeria] Fdn IRCCS Neurol Inst Carlo Besta, Mol Neurogenet Unit, Milan, Italy.
   [Fagiolari, Gigliola; Moggio, Maurizio] Univ Milan, Dept Neurosci, Neuromuscular & Rare Dis Unit, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy.
C3 IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto
   Auxologico Italiano; University of Milan; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico;
   University of Milan
RP Ratti, A (corresponding author), IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Via Zucchi 18, I-20095 Milanino, MI, Italy.; Ratti, A (corresponding author), Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy.
EM antonia.ratti@unimi.it
RI Silani, Vincenzo/P-4421-2017; colombrita, claudia/A-3295-2009; Dusi,
   Sabrina/H-6561-2016; Gumina, Valentina/K-8848-2016; Borghi,
   Maria/K-8768-2016; Doretti, Alberto/AAF-1857-2019; Invernizzi,
   Federica/J-9849-2016; Ratti, Antonia/K-8243-2016; Tiranti,
   Valeria/J-8233-2016
OI Invernizzi, Federica/0000-0001-8072-0152; Ratti,
   Antonia/0000-0002-4264-6614; Colombrita, Claudia/0000-0001-6567-8910;
   Borghi, Maria Orietta/0000-0001-8967-9678; Gumina,
   Valentina/0000-0003-2307-9391; Dusi, Sabrina/0000-0002-4935-5174;
   Doretti, Alberto/0000-0002-1015-7365; Tiranti,
   Valeria/0000-0002-3584-7338
FU Telethon Network of Genetic Biobanks [GTB07001, GTB12001]
FX A special thanks to the patients because without their generous
   contribution this study would have not been possible. We thank the Cell
   line and DNA bank of pediatric movement disorders and mitochondrial
   diseases of the Telethon Network of Genetic Biobanks (Project GTB07001)
   for donation of two healthy fibroblast cell lines, and the Pierfranco
   and Luisa Mariani Foundation. MM and GF thank the Biobank of skeletal
   muscle, peripheral nerve, DNA and cell cultures, member of the Telethon
   Network of Genetic Biobanks (Project GTB12001), and the Eurobiobank
   Network. We would like also to thank Drs. Francesca and Jenny Sassone,
   and Prof. Poletti's lab for their technical support.
CR AFIFI AK, 1966, NEUROLOGY, V16, P475, DOI 10.1212/WNL.16.5.475
   Aguirre T, 1998, ANN NEUROL, V43, P452, DOI 10.1002/ana.410430407
   Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360
   Allen SP, 2015, NEUROBIOL AGING, V36, P2893, DOI 10.1016/j.neurobiolaging.2015.07.013
   Allen SP, 2014, NEUROBIOL AGING, V35, P1499, DOI 10.1016/j.neurobiolaging.2013.11.025
   ATSUMI T, 1981, ACTA NEUROPATHOL, V55, P193, DOI 10.1007/BF00691318
   Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1
   Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028
   Brömme HJ, 2008, EXP GERONTOL, V43, P638, DOI 10.1016/j.exger.2008.01.010
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Crugnola V, 2010, ARCH NEUROL-CHICAGO, V67, P849, DOI 10.1001/archneurol.2010.128
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z
   Hong K, 2012, NEUROSCI LETT, V530, P144, DOI 10.1016/j.neulet.2012.10.003
   Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001
   Kirk K, 2014, ANN NEUROL, V76, P620, DOI 10.1002/ana.24244
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu JS, 2012, BRAIN RES BULL, V89, P185, DOI 10.1016/j.brainresbull.2012.09.005
   Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2
   Mead RJ, 2013, FREE RADICAL BIO MED, V61, P438, DOI 10.1016/j.freeradbiomed.2013.04.018
   Ramamoorthy M, 2012, FREE RADICAL BIO MED, V53, P1371, DOI 10.1016/j.freeradbiomed.2012.07.018
   Raman R, 2015, NEUROPATH APPL NEURO, V41, P201, DOI 10.1111/nan.12147
   Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625
   Ratti A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.06.008
   Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5
   Rohrer JD, 2015, LANCET NEUROL, V14, P291, DOI 10.1016/S1474-4422(14)70233-9
   Sasaki S, 2007, ACTA NEUROPATHOL, V114, P633, DOI 10.1007/s00401-007-0299-1
   Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b
   Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107
   Stribl C, 2014, J BIOL CHEM, V289, P10769, DOI 10.1074/jbc.M113.515940
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319
   Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73
   Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010
NR 40
TC 133
Z9 147
U1 6
U2 32
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-5960
J9 ACTA NEUROPATHOL COM
JI Acta Neuropathol. Commun.
PD MAY 5
PY 2016
VL 4
AR 47
DI 10.1186/s40478-016-0316-5
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA DL2RN
UT WOS:000375482900001
PM 27151080
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Kumaran, S
   Subathra, M
   Balu, M
   Panneerselvam, C
AF Kumaran, S
   Subathra, M
   Balu, M
   Panneerselvam, C
TI Age-associated decreased activities of mitochondrial electron transport
   chain complexes in heart and skeletal muscle: role of L-carnitine
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE aging; mitochondria; electron transport chain; carnitine
ID DNA DELETIONS; OXIDASE ACTIVITY; RAT-HEART; BRAIN; SUPPLEMENTATION;
   DECLINE; STRESS; DAMAGE
AB The mitochondrial respiratory chain is a powerful source of reactive oxygen species (ROS), considered as the pathogenic agent of many diseases and aging. L-Carnitine (4-N-trimethylammonium-3-hydroxybutric acid) plays an important role in transport of fatty acid from cytoplasm to mitochondria for energy production. Previous studies in our laboratory reported L-carnitine as a free radical scavenger in aged rats. In the present study we focused the effect of L-carnitine on the activities of electron transport chain in young and aged rats. The activities of electron transport chain complexes were found to be significantly decreased in aged rats when compared to young control rats. Supplementation of carnitine to young and aged rats for 14 and 21 days improved the electron transport chain complexes levels in aged rats when compared with young rats in duration dependent manner. No significant changes were observed in young rats. Our result suggested that L-carnitine improved the activities of electron transport chain enzymes there by improving the energy status in aged rats. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Dr AL Mudaliar Post Grad Inst Basic Med Sci, Dept Med Biochem, Madras 600113, Tamil Nadu, India.
RP Dr AL Mudaliar Post Grad Inst Basic Med Sci, Dept Med Biochem, Taramani Campus, Madras 600113, Tamil Nadu, India.
EM panneerselvam@eth.net
CR Barja G, 2000, AGING CLIN EXP RES, V12, P342, DOI 10.1007/BF03339859
   Beal MF, 2000, BRAIN, V123, P1291, DOI 10.1093/brain/123.7.1291
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   BRICHMACHIN M, 1993, MITOCHRONDRIAL DYSFU, P51
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Drouet M, 1999, EXP GERONTOL, V34, P843, DOI 10.1016/S0531-5565(99)00058-3
   Ernster L., 1967, METHODS ENZYMOLOGY, V10, P86
   Filburn CR, 1996, MECH AGEING DEV, V87, P35, DOI 10.1016/0047-6374(96)01696-X
   Hagen TM, 2002, ANN NY ACAD SCI, V959, P491, DOI 10.1111/j.1749-6632.2002.tb02119.x
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Iossa S, 2002, J NUTR, V132, P636, DOI 10.1093/jn/132.4.636
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Melov S, 1999, MUTAT RES-DNA REPAIR, V434, P233, DOI 10.1016/S0921-8777(99)00031-2
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   PAPA S, 2002, FRONTIERS CELLULAR B
   Paradies G, 1997, FEBS LETT, V406, P136, DOI 10.1016/S0014-5793(97)00264-0
   Ragan C.I., 1987, MITOCHONDRIA PRACTIC, P79
   Rani PJA, 2001, EXP GERONTOL, V36, P1713, DOI 10.1016/S0531-5565(01)00116-4
   REBOUCHE CJ, 1992, FASEB J, V6, P3379, DOI 10.1096/fasebj.6.15.1464372
   Sandhu SK, 2003, BIOGERONTOLOGY, V4, P19, DOI 10.1023/A:1022473219044
   SCHWARZE SR, 1995, MECH AGEING DEV, V83, P91, DOI 10.1016/0047-6374(95)01611-3
   Singh RJ, 2002, J LAB CLIN MED, V140, P380, DOI 10.1067/mlc.2002.129505
   SLATER EC, 1952, BIOCHEM J, V52, P185, DOI 10.1042/bj0520185
   SOHAL RS, 1993, FREE RADICAL BIO MED, V14, P583, DOI 10.1016/0891-5849(93)90139-L
   TAGLIALATELA G, 1994, EXP GERONTOL, V29, P55, DOI 10.1016/0531-5565(94)90062-0
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   Vijg Jan, 1999, Biochimica et Biophysica Acta, V1423, pR1, DOI 10.1016/S0304-419X(98)00028-6
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WALLACE DC, 1992, SCIENCE, V61, P1175
   Wharton D.C., 1967, Methods Enzymol, V10, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]
NR 33
TC 51
Z9 61
U1 1
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD JUN 30
PY 2004
VL 148
IS 1-2
BP 11
EP 18
DI 10.1016/j.cbi.2003.10.010
PG 8
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 838WW
UT WOS:000222745100002
PM 15223352
DA 2024-11-01
ER

PT J
AU De Flora, S
   Izzotti, A
AF De Flora, Silvio
   Izzotti, Alberto
TI Mutagenesis and cardiovascular diseases Molecular mechanisms, risk
   factors, and protective factors
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE atherosclerosis; mutation; DNA adducts; oxidative DNA damage; genetic
   polymorphisms; prevention
ID HUMAN ATHEROSCLEROTIC LESIONS; CORONARY-ARTERY-DISEASE;
   SMOOTH-MUSCLE-CELLS; OXIDATIVE DNA-DAMAGE; SMOKE-EXPOSED RATS;
   S-TRANSFERASE M1; CIGARETTE-SMOKE; CHEMOPREVENTIVE AGENTS; GENE
   POLYMORPHISMS; MITOCHONDRIAL-DNA
AB Although no generalization can be made, it is of interest that cancer, cardiovascular diseases, and other chronic conditions often share common risk factors and common protective factors as well as common pathogenetic determinants, such as DNA damage, oxidative stress, and chronic inflammation. Atherosclerosis is the most important cause of vascular forms representing the major cause of death in the population of many geographical areas. A great deal of studies support the "response-to-injury" theory. A variety of experimental and epidemiological findings are also in favor of the somatic mutation theory, which maintains that the earliest event in the atherogenic process is represented by mutations in arterial smooth muscle cells, akin to formation of a benign tumor. These two theories can be harmonized, also taking into account the highly diversified nature of atherosclerotic lesions. Molecular epidemiology studies performed in our laboratory and other laboratories have shown that DNA adducts are systematically present in arterial smooth muscle cells, and their levels are correlated with atherogenic risk factors known from traditional epidemiology. Oxidative DNA damage was also consistently detected in these cells. The role of glutathione S-transferase polymorphisms on the frequency of the above molecular alterations and of arterial diseases is rather controversial. Prevention of both cancer and atherosclerosis is based on avoidance of exposure to risk factors and on fortification of the host defense mechanisms by means of dietary principles and chemopreventive drugs. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Genoa, Dept Hlth Sci, I-16132 Genoa, Italy.
C3 University of Genoa
RP De Flora, S (corresponding author), Univ Genoa, Dept Hlth Sci, Via A Pastore 1, I-16132 Genoa, Italy.
EM sdf@unige.it
OI izzotti, alberto/0000-0002-8588-0347
CR AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258
   Andreassi MG, 2000, ENVIRON MOL MUTAGEN, V35, P265, DOI 10.1002/1098-2280(2000)35:4<265::AID-EM1>3.0.CO;2-M
   Andreassi MG, 1999, J HYPERTENS, V17, P843, DOI 10.1097/00004872-199917060-00017
   Andreassi MG, 2003, MUTAT RES-REV MUTAT, V543, P67, DOI 10.1016/S1383-5742(02)00089-3
   [Anonymous], INT STAT CLASS DIS R
   [Anonymous], 1985, WHO TECH REP SERV, V143, P1
   Balansky R, 1996, CANCER RES, V56, P1642
   BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753
   Binková B, 2002, MUTAT RES-FUND MOL M, V501, P115, DOI 10.1016/S0027-5107(02)00019-2
   Bogliolo M, 1999, MUTAGENESIS, V14, P77, DOI 10.1093/mutage/14.1.77
   Bogliolo M, 1996, CHEM-BIOL INTERACT, V102, P55, DOI 10.1016/0009-2797(96)03731-3
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   BRIDGES B A, 1990, Mutation Research, V239, P143, DOI 10.1016/0165-1110(90)90002-S
   BUSBEE DL, 1982, CARCINOGENESIS, V3, P1107, DOI 10.1093/carcin/3.10.1107
   CASALONE R, 1991, HUM GENET, V87, P139, DOI 10.1007/BF00204169
   Collins AR, 1998, FASEB J, V12, P1397, DOI 10.1096/fasebj.12.13.1397
   CRAWFORD DW, 1991, ATHEROSCLEROSIS, V89, P97, DOI 10.1016/0021-9150(91)90049-9
   DAGOSTINI F, 1995, CANCER EPIDEM BIOMAR, V4, P111
   De Flora S, 2005, FASEB J, V19, P892, DOI 10.1096/fj.04-3541rev
   de Nigris F, 2003, CELL CYCLE, V2, P325, DOI 10.4161/cc.2.4.414
   DeFlora S, 1997, FASEB J, V11, P1021, DOI 10.1096/fasebj.11.12.9337155
   DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7
   DEFLORA S, 1991, MUTAT RES, V258, P285, DOI 10.1016/0165-1110(91)90013-L
   Duthie G G, 1989, Nutr Res Rev, V2, P51, DOI 10.1079/NRR19890007
   GAIROLA CG, 1991, ENVIRON MOL MUTAGEN, V17, P253, DOI 10.1002/em.2850170406
   GAUBATZ JW, 1986, J MOL CELL CARDIOL, V18, P1317, DOI 10.1016/S0022-2828(86)80435-7
   Godschalk R, 2003, FREE RADICAL RES, V37, P1299, DOI 10.1080/10715760310001621333
   GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600
   GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012
   HOGG SI, 1982, COMP BIOCHEM PHYS B, V73, P669, DOI 10.1016/0305-0491(82)90094-3
   Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119
   IMAI H, 1980, SCIENCE, V207, P651, DOI 10.1126/science.7352277
   INDOLFI C, 1995, NAT MED, V1, P541, DOI 10.1038/nm0695-541
   IZZOTTI A, 1991, CARCINOGENESIS, V12, P1281, DOI 10.1093/carcin/12.7.1281
   Izzotti A, 2003, FASEB J, V17, P1127, DOI 10.1096/fj.02-0967fje
   Izzotti A, 1999, CARCINOGENESIS, V20, P1499, DOI 10.1093/carcin/20.8.1499
   Izzotti A, 1998, FASEB J, V12, P753, DOI 10.1096/fasebj.12.9.753
   Izzotti A, 2001, MUTAT RES-GEN TOX EN, V494, P97, DOI 10.1016/S1383-5718(01)00183-8
   Izzotti A, 2001, FASEB J, V15, P752, DOI 10.1096/fj.00-0312com
   Izzotti A, 2001, CANCER RES, V61, P2472
   IZZOTTI A, 1995, CANCER EPIDEM BIOMAR, V4, P105
   Izzotti A, 2007, MUTAT RES-FUND MOL M, V621, P119, DOI 10.1016/j.mrfmmm.2006.12.012
   Johnson CD, 2003, PHYSIOL GENOMICS, V13, P263, DOI 10.1152/physiolgenomics.00006.2003
   KANNEL WB, 1981, AM HEART J, V101, P319, DOI 10.1016/0002-8703(81)90197-6
   KENDALL CW, 1992, CANCER LETT, V66, P241, DOI 10.1016/0304-3835(92)90253-R
   Knaapen AM, 2007, MUTAT RES-FUND MOL M, V621, P31, DOI 10.1016/j.mrfmmm.2006.12.010
   Kris-Etherton PM, 2002, AM J MED, V113, P71, DOI 10.1016/S0002-9343(01)00995-0
   Lapenna D, 1998, CIRCULATION, V97, P1930, DOI 10.1161/01.CIR.97.19.1930
   LEWTAS J, 1993, ENV HLTH PERSPECT, V99, P88
   Li RL, 2001, ATHEROSCLEROSIS, V154, P729, DOI 10.1016/S0021-9150(00)00582-7
   Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102
   Lopez A.D., 2000, Encyclopedia of Epidemiologic Methods, P617
   MAJESKY MW, 1985, P NATL ACAD SCI USA, V82, P3450, DOI 10.1073/pnas.82.10.3450
   Manfredi S, 2002, ENVIRON MOL MUTAGEN, V40, P110, DOI 10.1002/em.10098
   Manfredi S, 2007, MUTAT RES-FUND MOL M, V621, P106, DOI 10.1016/j.mrfmmm.2007.02.014
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Matturri L, 1997, Cardiologia, V42, P833
   MCMANUS BM, 1987, LAB INVEST, V57, P78
   Mercer J, 2007, MUTAT RES-FUND MOL M, V621, P75, DOI 10.1016/j.mrfmmm.2007.02.011
   Naira J, 2007, MUTAT RES-FUND MOL M, V621, P95, DOI 10.1016/j.mrfmmm.2007.02.013
   PAIGEN B, 1986, CANCER RES, V46, P3321
   PENG SK, 1978, ARCH PATHOL LAB MED, V102, P57
   PENN A, 1986, P NATL ACAD SCI USA, V83, P7951, DOI 10.1073/pnas.83.20.7951
   PENN A, 1988, CARCINOGENESIS, V9, P2185, DOI 10.1093/carcin/9.12.2185
   Peto R, 1997, BRIT MED J, V315, P1030, DOI 10.1136/bmj.315.7115.1030
   PUTNAM JB, 1991, ANN THORAC SURG, V51, P906, DOI 10.1016/0003-4975(91)91003-E
   RAMOS KS, 1996, CASARETT DOULLS TOXI, P487
   RANDERATH E, 1989, JNCI-J NATL CANCER I, V81, P341, DOI 10.1093/jnci/81.5.341
   RANDERATH E, 1988, CARCINOGENESIS, V9, P75, DOI 10.1093/carcin/9.1.75
   RANDERATH E, 1986, CANCER RES, V46, P5869
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   ROSS R, 1993, AM J PATHOL, V143, P987
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   SADHU D, 1993, ANTIMUTAGENESIS ANTI, P263
   Salama SA, 2002, ENVIRON MOL MUTAGEN, V40, P153, DOI 10.1002/em.10106
   SEVANIAN A, 1986, FOOD CHEM TOXICOL, V24, P1103, DOI 10.1016/0278-6915(86)90295-4
   Sorensen M, 2003, MUTAT RES-REV MUTAT, V544, P255, DOI 10.1016/j.mrrev.2003.06.010
   SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160
   SUGIMURA T, 1986, SCIENCE, V233, P312, DOI 10.1126/science.3088728
   Thuillez C, 2005, J HUM HYPERTENS, V19, pS21, DOI 10.1038/sj.jhh.1001889
   TROSKO JE, 1980, MED HYPOTHESES, V6, P455, DOI 10.1016/0306-9877(80)90098-5
   VAN SF, 1998, FASEB J, V12, P1409
   VANNI R, 1991, DIS MARKERS, V9, P81
   Wilson MH, 2003, BIOMARKERS, V8, P43, DOI 10.1080/1354750021000042439
   Wilson MH, 2000, FASEB J, V14, P791, DOI 10.1096/fasebj.14.5.791
   YOSHIDA Y, 1990, ANN NY ACAD SCI, V598, P256, DOI 10.1111/j.1749-6632.1990.tb42298.x
   Zhang YJ, 1998, ATHEROSCLEROSIS, V140, P325, DOI 10.1016/S0021-9150(98)00136-1
   ZWIJSEN RML, 1990, ATHEROSCLEROSIS, V85, P71, DOI 10.1016/0021-9150(90)90184-K
   ZWIJSEN RML, 1992, CARCINOGENESIS, V13, P1913, DOI 10.1093/carcin/13.10.1913
NR 89
TC 56
Z9 65
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0027-5107
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD AUG 1
PY 2007
VL 621
IS 1-2
BP 5
EP 17
DI 10.1016/j.mrfmmm.2006.12.008
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 199SA
UT WOS:000248714300002
PM 17383689
DA 2024-11-01
ER

PT J
AU Akunuru, S
   Geiger, H
AF Akunuru, Shailaja
   Geiger, Hartmut
TI Aging, Clonality, and Rejuvenation of Hematopoietic Stem Cells
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID AGE-RELATED-CHANGES; MITOCHONDRIAL-DNA MUTATIONS; IN-VIVO; OXIDATIVE
   STRESS; SENESCENT CELLS; SKELETAL-MUSCLE; SELF-RENEWAL; BONE-MARROW;
   LIFE-SPAN; DAMAGE
AB Aging is associated with reduced organ function and increased disease incidence. Hematopoietic stem cell (HSC) aging driven by both cell intrinsic and extrinsic factors is linked to impaired HSC self-renewal and regeneration, aging associated immune remodeling, and increased leukemia incidence. Compromised DNA damage responses and the increased production of reactive oxygen species (ROS) have been previously causatively attributed to HSC aging. However, recent paradigm-shifting concepts, such as global epigenetic and cytoskeletal polarity shifts, cellular senescence, as well as the clonal selection of HSCs upon aging, provide new insights into HSC aging mechanisms. Rejuvenating agents that can reprogram the epigenetic status of aged HSCs or senolytic drugs that selectively deplete senescent cells provide promising translational avenues for attenuating hematopoietic aging and, potentially, alleviating aging-associated immune remodeling and myeloid malignancies.
C1 [Akunuru, Shailaja; Geiger, Hartmut] Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.
   [Geiger, Hartmut] Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany.
   [Geiger, Hartmut] Univ Ulm, Aging Res Ctr, D-89081 Ulm, Germany.
C3 Cincinnati Children's Hospital Medical Center; Cincinnati Children's
   Hospital Research Foundation; Ulm University; Ulm University
RP Akunuru, S; Geiger, H (corresponding author), Cincinnati Childrens Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Geiger, H (corresponding author), Univ Ulm, Inst Mol Med, D-89081 Ulm, Germany.; Geiger, H (corresponding author), Univ Ulm, Aging Res Ctr, D-89081 Ulm, Germany.
EM Shailaja.Akunuru@cchmc.org; hartmut.geiger@cchmc.org
FU Edward P. Evans foundation [T32CA117846-06A1]; NIH [HL076604, DK077762,
   AG040118]; DFG [SFB 1074, 1149]; BMBF; Excellence program of the
   Baden-Wurttemberg Foundation; European Commission (FP7 Marie Curie
   Initial Training Network MARRIAGE)
FX S.A. is supported by an Edward P. Evans foundation and a
   T32CA117846-06A1 grant. H.G. is supported by the Edward P. Evans
   Foundation, NIH grants HL076604, DK077762, AG040118, and the DFG SFB
   1074 and 1149, the BMBF, the Excellence program of the Baden-Wurttemberg
   Foundation, and the European Commission (FP7 Marie Curie Initial
   Training Network MARRIAGE). We thank Leesa Sampson for comments.
CR Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242
   Busque L, 1996, BLOOD, V88, P59
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chen JC, 1999, EXP HEMATOL, V27, P928, DOI 10.1016/S0301-472X(99)00018-1
   Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014
   Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301
   deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550
   Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471
   Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102
   Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966
   Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010
   Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARRISON DE, 1989, J IMMUNOL, V142, P3833
   Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617
   Kamminga LM, 2005, STEM CELLS, V23, P82, DOI 10.1634/stemcells.2004-0066
   Kang EJ, 2016, CELL STEM CELL, V18, P625, DOI 10.1016/j.stem.2016.02.005
   Kollman C, 2001, BLOOD, V98, P2043, DOI 10.1182/blood.V98.7.2043
   Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liang FQ, 2003, EXP EYE RES, V76, P397, DOI 10.1016/S0014-4835(03)00023-X
   Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Moehrle BM, 2015, CELL REP, V13, P2412, DOI 10.1016/j.celrep.2015.11.030
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011
   Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114
   Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018
   Nibley WE, 1998, BONE MARROW TRANSPL, V21, P345, DOI 10.1038/sj.bmt.1701097
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rozhok AI, 2014, AGING-US, V6, P1033, DOI 10.18632/aging.100707
   Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014
   Scott LJ, 2016, DRUGS, V76, P889, DOI 10.1007/s40265-016-0585-0
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401
   Smith BD, 2009, J CLIN ONCOL, V27, P2758, DOI 10.1200/JCO.2008.20.8983
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824
   Taiwo O, 2013, EPIGENETICS-US, V8, P1114, DOI 10.4161/epi.26017
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042080
   Vas V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031523
   Verovskaya E, 2013, BLOOD, V122, P523, DOI 10.1182/blood-2013-01-481135
   Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080
   Xing ZL, 2006, BLOOD, V108, P2190, DOI 10.1182/blood-2005-12-010272
   Yancik R, 2005, CANCER J, V11, P437, DOI 10.1097/00130404-200511000-00002
   YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0
NR 79
TC 115
Z9 125
U1 2
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD AUG
PY 2016
VL 22
IS 8
BP 701
EP 712
DI 10.1016/j.molmed.2016.06.003
PG 12
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DT5NR
UT WOS:000381530400011
PM 27380967
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Carra, S
   Crippa, V
   Rusmini, P
   Boncoraglio, A
   Minoia, M
   Giorgetti, E
   Kampinga, HH
   Poletti, A
AF Carra, Serena
   Crippa, Valeria
   Rusmini, Paola
   Boncoraglio, Alessandra
   Minoia, Melania
   Giorgetti, Elisa
   Kampinga, Harm H.
   Poletti, Angelo
TI Alteration of protein folding and degradation in motor neuron diseases:
   Implications and protective functions of small heat shock proteins
SO PROGRESS IN NEUROBIOLOGY
LA English
DT Review
DE Neurodegeneration; Motor neuron diseases; Spinal and bulbar muscular
   atrophy; Amyotrophic lateral sclerosis; Small heat shock proteins;
   Autophagy; HSPB8; Protein misfolding; Protein aggregation; SBMA; ALS
ID AMYOTROPHIC-LATERAL-SCLEROSIS; BULBAR MUSCULAR-ATROPHY;
   MARIE-TOOTH-DISEASE; AGGREGATE-PRONE PROTEINS; UBIQUITIN-PROTEASOME
   SYSTEM; ANDROGEN RECEPTOR PROTEIN; TRANSGENIC MOUSE MODEL; RAT
   SPINAL-CORD; EXPANSION NEURODEGENERATIVE DISEASE; ELONGATED
   POLYGLUTAMINE TRACT
AB Motor neuron diseases (MNDs) are neurodegenerative disorders that specifically affect the survival and function of upper and/or lower motor neurons. Since motor neurons are responsible for the control of voluntary muscular movement, MNDs are characterized by muscle spasticity, weakness and atrophy. Different susceptibility genes associated with an increased risk to develop MNDs have been reported and several mutated genes have been linked to hereditary forms of MNDs. However, most cases of MNDs occur in sporadic forms and very little is known on their causes. Interestingly, several molecular mechanisms seem to participate in the progression of both the inherited and sporadic forms of MNDs. These include cytoskeleton organization, mitochondrial functions, DNA repair and RNA synthesis/processing, vesicle trafficking, endolysosomal trafficking and fusion, as well as protein folding and protein degradation. In particular, accumulation of aggregate-prone proteins is a hallmark of MNDs, suggesting that the protein quality control system (molecular chaperones and the degradative systems: ubiquitin-proteasome-system and autophagy) are saturated or not sufficient to allow the clearance of these altered proteins. In this review we mainly focus on the MNDs associated with disturbances in protein folding and protein degradation and on the potential implication of a specific class of molecular chaperones, the small heat shock proteins (sHSPs/HSPBs), in motor neuron function and survival. How boosting of specific HSPBs may be a potential useful therapeutic approach in MNDs and how mutations in specific HSPBs can directly cause motor neuron degeneration is discussed. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Carra, Serena; Boncoraglio, Alessandra; Minoia, Melania; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.
   [Carra, Serena] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed, I-41125 Modena, Italy.
   [Crippa, Valeria; Rusmini, Paola; Boncoraglio, Alessandra; Giorgetti, Elisa; Poletti, Angelo] Univ Milan, Ctr Eccellenza Studio Malattie Neurodegenerat CEN, Dipartimento Endocrinol Fisiopatol & Biol Applica, I-20133 Milan, Italy.
   [Crippa, Valeria; Rusmini, Paola; Giorgetti, Elisa; Poletti, Angelo] Univ Florence, InterUniv Ctr Neurodegenerat Dis, Genoa, Italy.
   [Crippa, Valeria; Rusmini, Paola; Giorgetti, Elisa; Poletti, Angelo] Univ Florence, InterUniv Ctr Neurodegenerat Dis, Milan, Italy.
C3 University of Groningen; Universita di Modena e Reggio Emilia;
   University of Milan; University of Florence; University of Florence
RP Poletti, A (corresponding author), Dipartimento Endocrinol Fisiopatol & Biol Applica, Via Balzaretti 9, I-20133 Milan, Italy.
EM angelo.poletti@unimi.it
RI Rudolf, Rüdiger/A-6476-2009; Carra, Serena/O-2835-2015; Poletti,
   Angelo/A-9016-2011
OI RUSMINI, PAOLA/0000-0001-9989-0733; Carra, Serena/0000-0003-0939-0140;
   Kampinga, Harm/0000-0002-8966-8466; Poletti, Angelo/0000-0002-8883-0468;
   CRIPPA, VALERIA/0000-0002-3058-5711
FU Fondation Thierry Latran, France; Marie Curie International
   Reintegration Grant [PIRG-03-GA-2008-230908]; Association Francaise
   contre les Myopathies; Fondazione Telethon Funding Source: Custom
FX Telethon - Italy (GGP06063 and GGP07063 to A.P.); Italian Ministry of
   University and Research; Italian Ministry of Labour, Health and Social
   Affairs (2007-36 to A.P.; 2008-15 to A.P. and Convenzione Fondazione
   Mondino/UNIMI); Universita' degli Studi di Milano; Fondazione CARIPLO
   (2008-2307 to A.P.); Fondation Thierry Latran, France (to A.P.), awarded
   to Angelo Poletti. Marie Curie International Reintegration Grant
   (PIRG-03-GA-2008-230908). Prinses Beatrix Fonds/Dutch Huntington
   Association (WAR09-23) and Association Francaise contre les Myopathies
   Trampoline Grant awarded to Serena Carra.
CR Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107
   Ackerley S, 2006, HUM MOL GENET, V15, P347, DOI 10.1093/hmg/ddi452
   Adachi H, 2007, NEUROPATH APPL NEURO, V33, P135, DOI 10.1111/j.1365-2990.2007.00830.x
   Adachi H, 2005, BRAIN, V128, P659, DOI 10.1093/brain/awh381
   Adachi H, 2003, J NEUROSCI, V23, P2203
   Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039
   Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050
   Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200
   An JJ, 2009, BMB REP, V42, P136, DOI 10.5483/BMBRep.2009.42.3.136
   Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022
   Arrigo AP, 2001, IUBMB LIFE, V52, P303, DOI 10.1080/152165401317291156
   Arrigo AP, 2005, M S-MED SCI, V21, P619, DOI 10.1051/medsci/2005216-7619
   Arrigo AP, 2005, ANTIOXID REDOX SIGN, V7, P414, DOI 10.1089/ars.2005.7.414
   Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515
   Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158
   Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011
   Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405
   Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   BREEDLOVE SM, 1980, SCIENCE, V210, P564, DOI 10.1126/science.7423210
   Brooks BP, 1998, J NEUROCHEM, V70, P1054
   BROOKS BP, 1995, TRENDS NEUROSCI, V18, P459, DOI 10.1016/0166-2236(95)94497-S
   Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595
   Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727
   Cappelletti G, 2007, J NEUROSCI RES, V85, P2702, DOI 10.1002/jnr.21235
   Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174
   Carra S., 2006, BOOK REV HEAT SHOCK, P331
   Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200
   Carra S, 2010, J BIOL CHEM, V285, P37811, DOI 10.1074/jbc.M110.127498
   Chai YH, 1999, J NEUROSCI, V19, P10338
   Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000
   Chen Q, 2009, MOL VIS, V15, P1359
   Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8
   CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4
   Cogli L, 2009, BIOCHEM SOC T, V37, P1027, DOI 10.1042/BST0371027
   Copped F, 2007, NEUROSCI LETT, V420, P163, DOI 10.1016/j.neulet.2007.04.067
   Cozzolino M, 2008, ANTIOXID REDOX SIGN, V10, P405, DOI 10.1089/ars.2007.1760
   Cozzolino M, 2009, ANTIOXID REDOX SIGN, V11, P1547, DOI 10.1089/ARS.2009.2545
   Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003
   Crippa V, 2010, AUTOPHAGY, V6, P958, DOI 10.4161/auto.6.7.13042
   Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257
   Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511
   De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A
   Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0
   den Engelsman J, 2009, J MOL BIOL, V393, P1022, DOI 10.1016/j.jmb.2009.08.052
   Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353
   Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dondi D, 2010, ENDOCR-RELAT CANCER, V17, P731, DOI 10.1677/ERC-10-0032
   Drengler SM, 1996, MOL BRAIN RES, V41, P8, DOI 10.1016/0169-328X(96)00060-5
   Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320
   Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354
   Fabrizi GM, 2007, BRAIN, V130, P394, DOI 10.1093/brain/awl284
   Fauconneau B, 2002, J NEUROCHEM, V83, P1338, DOI 10.1046/j.1471-4159.2002.01230.x
   Fernández-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5
   Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103
   Ferri A, 2010, HUM MOL GENET, V19, P4529, DOI 10.1093/hmg/ddq383
   Figlewicz DA, 2003, AMYOTROPH LATERAL SC, V4, P225, DOI 10.1080/14660820310011287
   Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9
   Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603
   Fontaine JM, 2006, FASEB J, V20, P2168, DOI 10.1096/fj.06-5911fje
   FREEMAN LM, 1995, J NEUROBIOL, V27, P51, DOI 10.1002/neu.480270106
   Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907
   Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021
   Fukada Y, 2007, BRAIN RES, V1160, P1, DOI 10.1016/j.brainres.2007.05.044
   Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29
   Garrido C, 2002, CELL DEATH DIFFER, V9, P483, DOI 10.1038/sj.cdd.4401005
   Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448
   Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018
   Graw J, 2006, GRAEF ARCH CLIN EXP, V244, P912, DOI 10.1007/s00417-005-0234-x
   Guerini V, 2005, CANCER RES, V65, P5445, DOI 10.1158/0008-5472.CAN-04-1941
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Haapasalo A, 2010, BIOCHEM SOC T, V38, P150, DOI 10.1042/BST0380150
   Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001
   Hamson DK, 2010, NEURON, V66, P167, DOI 10.1016/j.neuron.2010.04.025
   Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67
   Ikeda Y, 2009, J NEUROL SCI, V277, P9, DOI 10.1016/j.jns.2008.09.031
   Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154
   Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328
   Irobi J, 2010, HUM MOL GENET, V19, P3254, DOI 10.1093/hmg/ddq234
   Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102
   Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200
   James PA, 2008, J NEUROL NEUROSUR PS, V79, P461, DOI 10.1136/jnnp.2007.125179
   JENSTER G, 1994, BIOCHEMISTRY-US, V33, P14064, DOI 10.1021/bi00251a015
   Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941
   Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722
   Kappé G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2
   Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102
   Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878
   Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6
   KAZEMIESFARJANI P, 1995, HUM MOL GENET, V4, P523, DOI 10.1093/hmg/4.4.523
   Khan AO, 2007, AM J OPHTHALMOL, V144, P949, DOI 10.1016/j.ajo.2007.08.005
   Khan AO, 2010, OPHTHALMIC GENET, V31, P30, DOI 10.3109/13816810903452047
   Khanova HA, 2007, BIOPHYS CHEM, V125, P521, DOI 10.1016/j.bpc.2006.11.002
   Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7
   Kijima K, 2005, J HUM GENET, V50, P473, DOI 10.1007/s10038-005-0280-6
   Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831
   Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200
   Kirbach BB, 2011, J NEUROSCI RES, V89, P162, DOI 10.1002/jnr.22536
   Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772
   Kobayashi Z, 2010, J NEUROL SCI, V298, P70, DOI 10.1016/j.jns.2010.08.013
   Kolb SJ, 2010, NEUROLOGY, V74, P502, DOI 10.1212/WNL.0b013e3181cef84a
   Kolb SJ, 2010, MUSCLE NERVE, V41, P5, DOI 10.1002/mus.21428
   Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047
   Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840
   Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021
   Koyama S, 2006, BIOCHEM BIOPH RES CO, V343, P719, DOI 10.1016/j.bbrc.2006.02.170
   Krishnan J, 2006, EXP NEUROL, V200, P301, DOI 10.1016/j.expneurol.2006.02.135
   Krishnan J, 2008, J NEUROCHEM, V106, P2170, DOI 10.1111/j.1471-4159.2008.05545.x
   KUJAWA KA, 1993, J NEUROSCI RES, V35, P268, DOI 10.1002/jnr.490350306
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lafevre-Bernt MA, 2003, J BIOL CHEM, V278, P34918, DOI 10.1074/jbc.M302841200
   Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137
   Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006
   Larkowski TD, 2000, J NEUROBIOL, V45, P207, DOI 10.1002/1097-4695(200012)45:4<207::AID-NEU2>3.0.CO;2-V
   LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0
   LAVOIE JN, 1993, J BIOL CHEM, V268, P24210
   LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505
   Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405
   Li I, 1998, AM J PATHOL, V153, P695, DOI 10.1016/S0002-9440(10)65612-X
   Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443
   Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471
   Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004
   Luigetti M, 2010, J NEUROL SCI, V298, P114, DOI 10.1016/j.jns.2010.09.008
   Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046
   Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0
   Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2
   Mandich P, 2010, J CHILD NEUROL, V25, P107, DOI 10.1177/0883073809334387
   Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x
   Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971
   Matkovich SJ, 2010, J CLIN INVEST, V120, P280, DOI 10.1172/JCI39085
   MATSUMOTO A, 1988, J NEUROSCI, V8, P4168
   Matsumoto A, 1997, BRAIN RES BULL, V44, P539, DOI 10.1016/S0361-9230(97)00240-2
   McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197
   MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184
   Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573
   Musaro Antonio, 2010, World J Biol Chem, V1, P62, DOI 10.4331/wjbc.v1.i5.62
   Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002
   NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   O'Reilly AM, 2010, MOL NEUROBIOL, V42, P124, DOI 10.1007/s12035-010-8143-3
   Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399
   Onesto E, 2011, J NEUROCHEM, V118, P266, DOI 10.1111/j.1471-4159.2011.07298.x
   Palazzolo I, 2008, J STEROID BIOCHEM, V108, P245, DOI 10.1016/j.jsbmb.2007.09.016
   Palazzolo I, 2007, HUM MOL GENET, V16, P1593, DOI 10.1093/hmg/ddm109
   Palazzolo I, 2009, NEURON, V63, P316, DOI 10.1016/j.neuron.2009.07.019
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Pareyson D, 2009, CURR OPIN NEUROL, V22, P451, DOI 10.1097/WCO.0b013e3283311dfd
   Pareyson D, 2009, LANCET NEUROL, V8, P654, DOI 10.1016/S1474-4422(09)70110-3
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Patel YJK, 2005, MOL BRAIN RES, V134, P256, DOI 10.1016/j.molbrainres.2004.10.028
   Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002
   Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006
   Pennuto M, 2009, HUM MOL GENET, V18, pR40, DOI 10.1093/hmg/ddn412
   Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006
   PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355
   Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje
   Poletti A, 2005, ENDOCRINE, V28, P243, DOI 10.1385/ENDO:28:3:243
   Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001
   POLETTI A, 1994, ENDOCRINOLOGY, V135, P2623, DOI 10.1210/en.135.6.2623
   Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x
   Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x
   Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511
   Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123
   Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591
   Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036
   Ravikumar B, 2004, NEUROREPORT, V15, P2443, DOI 10.1097/00001756-200411150-00001
   Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362
   Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107
   Ravikumar Brinda, 2006, Molecular Aspects of Medicine, V27, P520, DOI 10.1016/j.mam.2006.08.008
   Reilich P, 2010, NEUROMUSCULAR DISORD, V20, P255, DOI 10.1016/j.nmd.2010.01.012
   Richter L, 2008, AM J MED GENET A, V146A, P833, DOI 10.1002/ajmg.a.32236
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823
   Rusmini P, 2011, NEUROBIOL DIS, V41, P83, DOI 10.1016/j.nbd.2010.08.023
   Rusmini P, 2010, NEUROBIOL DIS, V40, P361, DOI 10.1016/j.nbd.2010.06.016
   Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003
   Salinthone S, 2007, AM J PHYSIOL-LUNG C, V293, pL1194, DOI 10.1152/ajplung.00453.2006
   Santhiya S, 2006, MOL VIS, V12, P768
   Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447
   Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110
   Sau D, 2011, BIOL CELL, V103, P87, DOI 10.1042/BC20100093
   Schmidt BJ, 2002, NEUROLOGY, V59, P770, DOI 10.1212/WNL.59.5.770
   Seidel K, 2012, NEUROPATH APPL NEURO, V38, P39, DOI 10.1111/j.1365-2990.2011.01198.x
   Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767
   Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002
   Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239
   Shemetov AA, 2011, ARCH BIOCHEM BIOPHYS, V513, P1, DOI 10.1016/j.abb.2011.06.014
   Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133
   SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209
   Song TF, 2009, J INT MED RES, V37, P1375, DOI 10.1177/147323000903700512
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731
   Street VA, 2003, NEUROLOGY, V60, P22, DOI 10.1212/WNL.60.1.22
   Sugiyama Y, 2000, J BIOL CHEM, V275, P1095, DOI 10.1074/jbc.275.2.1095
   Sun X, 2010, CELL STRESS CHAPERON, V15, P567, DOI 10.1007/s12192-010-0169-y
   Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637
   Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237
   Tang BS, 2005, HUM GENET, V116, P222, DOI 10.1007/s00439-004-1218-3
   Thomas M, 2006, HUM MOL GENET, V15, P1876, DOI 10.1093/hmg/ddl110
   Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585
   Tokui K, 2009, HUM MOL GENET, V18, P898, DOI 10.1093/hmg/ddn419
   Tradewell ML, 2009, J NEUROPATH EXP NEUR, V68, P642, DOI 10.1097/NEN.0b013e3181a5deeb
   Traub R, 2011, CURR NEUROL NEUROSCI, V11, P67, DOI 10.1007/s11910-010-0160-0
   Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847
   Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   Vismara G, 2009, NEUROBIOL DIS, V33, P395, DOI 10.1016/j.nbd.2008.11.007
   Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968
   Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398
   Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532
   Waza M, 2005, NAT MED, V11, P1088, DOI 10.1038/nm1298
   Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0
   Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200
   WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K
   Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004
   Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3
   Wong M, 2010, HUM MOL GENET, V19, P2284, DOI 10.1093/hmg/ddq106
   Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x
   Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137
   Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Yamashita H, 2007, J NEUROCHEM, V102, P1497, DOI 10.1111/j.1471-4159.2007.04534.x
   YU WHA, 1989, J NEUROSCI, V9, P3908
   Zhai JB, 2007, HUM MOL GENET, V16, P3103, DOI 10.1093/hmg/ddm272
   Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004
NR 239
TC 56
Z9 57
U1 0
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0301-0082
EI 1873-5118
J9 PROG NEUROBIOL
JI Prog. Neurobiol.
PD MAY
PY 2012
VL 97
IS 2
SI SI
BP 83
EP 100
DI 10.1016/j.pneurobio.2011.09.009
PG 18
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 952MH
UT WOS:000304796100004
PM 21971574
DA 2024-11-01
ER

PT B
AU Alway, SE
   Siu, PM
AF Alway, Stephen E.
   Siu, Parco M.
BE Lynch, GS
TI Nuclear Apoptosis and Sarcopenia
SO SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND
   TREATMENTS
LA English
DT Article; Book Chapter
DE Nuclear cell death; Apoptosis; Skeletal myofiber; Satellite cell;
   Mitochondria; Muscle atrophy
ID NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CYTOCHROME-C RELEASE; PERMEABILITY
   TRANSITION PORE; MITOCHONDRIAL-DNA MUTATIONS; SKELETAL-MUSCLE APOPTOSIS;
   PROGRAMMED CELL-DEATH; BCL-2 FAMILY PROTEINS; CHRONIC HEART-FAILURE;
   X-LINKED INHIBITOR
AB Apoptosis is a well-conserve cellular disassembly process, which has been implicated in a variety of diseases. Unlike cells with a single nucleus, apoptotic signaling can target individual nuclei in multi-nucleated skeletal muscle cells without necessarily eliminating the entire cell (muscle fiber). This targeted apoptosis or "nuclear apoptosis" appears to have a role in regulating aging-induced muscle loss (sarcopenia) by reducing the myofiber volume (i.e. cytoplasm) that can be supported in a single muscle fibre. Recent investigations indicate that apoptotic signaling in aged skeletal muscles occurs through three apoptotic pathways. The intrinsic or mitochondria apoptotic pathway has been most widely studied in muscle. Mitochondria dysfunction and increased mitochondria permeability lead to activation of cysteine-aspartic acid proteases (caspases) and eventually DNA fragmentation in sarcopenia. The death receptor (extrinsic) apoptotic pathway has been strongly implicated in sarcopenia and other conditions of muscle loss with aging or disuse. TNF-alpha is thought to initiate apoptotic signaling via the death receptor, and this can proceed to activate the effort proteases (e.g., caspase 3) independent from mitochondria signaling. Nevertheless, there is some cross-talk between the intrinsic and the extrinsic apoptotic pathways. Finally, a few studies have shown data to suggest that the endoplasmic reticulum-stress apoptotic pathway may also have a role in sarcopenia, although the importance of this pathway relative to the other two pathways is less clear. Both myonuclei and satellite cells appear to be susceptible to nuclear apoptosis in sarcopenia.
C1 [Alway, Stephen E.] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Exercise Physiol, Morgantown, WV 26506 USA.
   [Alway, Stephen E.] W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA.
   [Siu, Parco M.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.
C3 West Virginia University; West Virginia University; Hong Kong
   Polytechnic University
RP Alway, SE (corresponding author), W Virginia Univ, Sch Med, Robert C Byrd Hlth Sci Ctr, Dept Exercise Physiol, 1 Med Ctr Dr, Morgantown, WV 26506 USA.
EM salway@hsc.wvu.edu; htpsiu@inet.polyu.edu.hk
RI Alway, Stephen/AAF-8834-2020
OI Siu, Parco/0000-0002-3548-5058; Alway, Stephen/0000-0002-0378-4707
CR Abmayr S, 2004, HUM MOL GENET, V13, P213, DOI 10.1093/hmg/ddh018
   Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2
   Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002
   Adams V, 1999, J AM COLL CARDIOL, V33, P959, DOI 10.1016/S0735-1097(98)00626-3
   Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680
   Adhihetty PJ, 2008, EXERC SPORT SCI REV, V36, P116, DOI 10.1097/JES.0b013e31817be7b7
   Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006
   Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE748, DOI 10.1152/ajpendo.00311.2006
   Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009
   Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505
   Adhihetty PJ., 2003, BAM PADOVA, V13, P171
   Allen DL, 1999, MUSCLE NERVE, V22, P1350, DOI 10.1002/(SICI)1097-4598(199910)22:10<1350::AID-MUS3>3.0.CO;2-8
   Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579, DOI 10.1152/ajpcell.1997.273.2.C579
   ALWAY SE, 1989, J APPL PHYSIOL, V66, P2725, DOI 10.1152/jappl.1989.66.6.2725
   Alway SE, 1996, J GERONTOL A-BIOL, V51, pB195, DOI 10.1093/gerona/51A.3.B195
   Alway SE, 2003, J GERONTOL A-BIOL, V58, P687
   Alway SE, 2003, AM J PHYSIOL-REG I, V284, pR540, DOI 10.1152/ajpregu.00550.2002
   Alway SE, 2002, AM J PHYSIOL-REG I, V282, pR411, DOI 10.1152/ajpregu.00332.2001
   Alway SE, 2002, AM J PHYSIOL-CELL PH, V283, pC66, DOI 10.1152/ajpcell.00598.2001
   ALWAY SE, 1991, J APPL PHYSIOL, V70, P2111, DOI 10.1152/jappl.1991.70.5.2111
   Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc
   [Anonymous], BIOCH BIOPHYS ACTA
   Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271
   Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173
   Basañez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492
   Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com
   Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395
   Bhuiyan MS, 2007, EUR J PHARMACOL, V557, P168, DOI 10.1016/j.ejphar.2006.10.067
   Blink E, 2004, CELL DEATH DIFFER, V11, P937, DOI 10.1038/sj.cdd.4401409
   Bourdel-Marchasson I, 2007, J NUTR HEALTH AGING, V11, P215
   Brack AS, 2007, STEM CELL REV, V3, P226, DOI 10.1007/s12015-007-9000-2
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602
   Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357
   Bruunsgaard H, 2002, EUR CYTOKINE NETW, V13, P389
   Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x
   Bruunsgaard H, 2003, AM J MED, V115, P278, DOI 10.1016/S0002-9343(03)00329-2
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   Bruusgaard JC, 2006, J APPL PHYSIOL, V100, P2024, DOI 10.1152/japplphysiol.00913.2005
   Burstein E, 2003, CURR OPIN CELL BIOL, V15, P732, DOI 10.1016/j.ceb.2003.10.005
   Cacciapaglia F, 2009, EUR REV MED PHARMACO, V13, P23
   Campisi J, 2009, J GERONTOL A-BIOL, V64, P164, DOI 10.1093/gerona/gln073
   Candé C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210
   Candé C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3
   Carbó N, 2002, BRIT J CANCER, V86, P1012, DOI 10.1038/sj.bjc.6600167
   Cartron PF, 2002, FEBS LETT, V512, P95, DOI 10.1016/S0014-5793(02)02227-5
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929
   Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000
   Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395
   CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821
   CHARETTE SL, 1991, J APPL PHYSIOL, V70, P1912, DOI 10.1152/jappl.1991.70.5.1912
   Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412
   Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010
   Combaret L, 2009, CURR OPIN CLIN NUTR, V12, P37, DOI 10.1097/MCO.0b013e32831b9c31
   Conley KE, 2007, EXERC SPORT SCI REV, V35, P43
   Conley KE, 2007, EXP PHYSIOL, V92, P333, DOI 10.1113/expphysiol.2006.034330
   Conraads VM, 2009, EUR J CARDIOV PREV R, V16, P325, DOI 10.1097/HJR.0b013e3283244436
   Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194
   DALLA L, 2009, INT J CARDIOL, V143, P192
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Daussin FN, 2008, J APPL PHYSIOL, V104, P1436, DOI 10.1152/japplphysiol.01135.2007
   Degens H., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P246
   Degens H, 2003, MUSCLE NERVE, V27, P339, DOI 10.1002/mus.10314
   Degens H, 2007, AM J PHYSIOL-REG I, V293, pR135, DOI 10.1152/ajpregu.00046.2007
   Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107
   Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949
   Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002
   Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.e04-12-1111
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Deschenes MR, 2002, AM J PHYS MED REHAB, V81, pS3, DOI 10.1097/01.PHM.0000029722.06777.E9
   Deveraux QL, 1999, J CLIN IMMUNOL, V19, P388, DOI 10.1023/A:1020502800208
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215
   Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001
   Dirks AJ, 2005, SPORTS MED, V35, P473, DOI 10.2165/00007256-200535060-00002
   Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003
   Dirks AJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1208, DOI 10.1152/ajpcell.00226.2006
   Dirks AJ, 2006, J NUTR BIOCHEM, V17, P501, DOI 10.1016/j.jnutbio.2005.11.002
   Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002
   Duke RC, 1996, SCI AM, V275, P80, DOI 10.1038/scientificamerican1296-80
   Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cellbio.7.1.663
   Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200
   Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11
   Ferketich AK, 1998, ACTA PHYSIOL SCAND, V164, P259
   Figueras M, 2005, INT J ONCOL, V27, P855
   Forsey RJ, 2003, MECH AGEING DEV, V124, P487, DOI 10.1016/S0047-6374(03)00025-3
   Forte M, 2006, CELL DEATH DIFFER, V13, P1287, DOI 10.1038/sj.cdd.4401957
   Foulstone EJ, 2001, J CELL PHYSIOL, V189, P207, DOI 10.1002/jcp.10017
   GARCIAMARTINEZ C, 1993, FEBS LETT, V323, P211, DOI 10.1016/0014-5793(93)81341-V
   GARCIAMARTINEZ C, 1993, MOL CELL BIOCHEM, V125, P11, DOI 10.1007/BF00926829
   GarciaMartinez C, 1995, BIOCHEM BIOPH RES CO, V217, P839, DOI 10.1006/bbrc.1995.2848
   Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524
   Gorman AM, 2000, DEV NEUROSCI-BASEL, V22, P348, DOI 10.1159/000017460
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Grinberg M, 2005, MOL CELL BIOL, V25, P4579, DOI 10.1128/MCB.25.11.4579-4590.2005
   Grütter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9
   Gustafsson ÅB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200
   Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, ANN NY ACAD SCI, V673, P126, DOI 10.1111/j.1749-6632.1992.tb27444.x
   Harman D, 2009, BIOGERONTOLOGY, V10, P773, DOI 10.1007/s10522-009-9234-2
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6
   Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668
   Hu AH, 2008, REJUV RES, V11, P215, DOI 10.1089/rej.2007.0609
   Huang ZT, 2008, FREE RADICAL BIO MED, V44, P1935, DOI 10.1016/j.freeradbiomed.2008.02.016
   Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657
   Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027
   Jin HM, 2001, J TRAUMA, V50, P31, DOI 10.1097/00005373-200101000-00005
   Johnson CR, 2004, APOPTOSIS, V9, P423, DOI 10.1023/B:APPT.0000031457.90890.13
   Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005
   Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004
   Jubrias SA, 2001, J APPL PHYSIOL, V90, P1663, DOI 10.1152/jappl.2001.90.5.1663
   Kadenbach B, 2009, TRENDS MOL MED, V15, P139, DOI 10.1016/j.molmed.2009.02.004
   Kearns JD, 2009, J BIOL CHEM, V284, P5439, DOI 10.1074/jbc.R800008200
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Knudson C. Michael, 2008, V414, P95
   Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021
   Korsmeyer SJ, 1999, CANCER RES, V59, p1693S
   KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1
   KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R
   Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156
   Krajnak K, 2006, MUSCLE NERVE, V34, P720, DOI 10.1002/mus.20656
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kujoth GC, 2006, CANCER RES, V66, P7386, DOI 10.1158/0008-5472.CAN-05-4670
   Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje
   Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lee DH, 2009, BRIT J PHARMACOL, V157, P1189, DOI 10.1111/j.1476-5381.2009.00245.x
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Lee SC, 2007, INT J BIOCHEM CELL B, V39, P497, DOI 10.1016/j.biocel.2006.09.007
   Lees SJ, 2009, AGING CELL, V8, P26, DOI 10.1111/j.1474-9726.2008.00445.x
   Leeuwenburgh C, 2005, AM J PHYSIOL-REG I, V288, pR1288, DOI 10.1152/ajpregu.00576.2004
   Leeuwenburgh C, 2003, J GERONTOL A-BIOL, V58, P999
   Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1
   Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620
   Libera LD, 2001, J MOL CELL CARDIOL, V33, P1871, DOI 10.1006/jmcc.2001.1453
   Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5
   Lipton SA, 2002, CELL, V111, P147, DOI 10.1016/S0092-8674(02)01046-2
   Llovera M, 1997, BIOCHEM BIOPH RES CO, V230, P238, DOI 10.1006/bbrc.1996.5827
   LLovera M, 1998, INT J MOL MED, V2, P69
   Ma YS, 2009, BBA-GEN SUBJECTS, V1790, P1021, DOI 10.1016/j.bbagen.2009.04.012
   Malinska D, 2009, METHOD ENZYMOL, V456, P419, DOI 10.1016/S0076-6879(08)04423-6
   Martin C, 2007, AGING CELL, V6, P165, DOI 10.1111/j.1474-9726.2007.00271.x
   Marzetti E, 2008, MECH AGEING DEV, V129, P542, DOI 10.1016/j.mad.2008.05.005
   Marzetti E, 2008, FREE RADICAL BIO MED, V44, P160, DOI 10.1016/j.freeradbiomed.2007.05.028
   Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007
   Marzetti E, 2009, MECH AGEING DEV, V130, P272, DOI 10.1016/j.mad.2008.12.008
   MAYHEW DL, 2009, J APPL PHYS IN PRESS
   McCall GE, 1998, J APPL PHYSIOL, V84, P1407, DOI 10.1152/jappl.1998.84.4.1407
   McMullen CA, 2009, EXP GERONTOL, V44, P420, DOI 10.1016/j.exger.2009.03.006
   Meadows KA, 2000, J CELL PHYSIOL, V183, P330, DOI 10.1002/(SICI)1097-4652(200006)183:3<330::AID-JCP5>3.0.CO;2-N
   Meissner C, 2007, Z GERONTOL GERIATR, V40, P325, DOI 10.1007/s00391-007-0481-z
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465
   Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200
   Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200
   Molina EJ, 2009, J SURG RES, V153, P287, DOI 10.1016/j.jss.2008.03.043
   Murray AJ, 2007, CURR OPIN CLIN NUTR, V10, P704, DOI 10.1097/MCO.0b013e3282f0ecbe
   Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513
   Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887
   Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681
   Naylor AJD, 2008, EXERC SPORT SCI REV, V36, P19, DOI 10.1097/jes.0b013e31815ddd9d
   Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001
   Parise G, 2005, FREE RADICAL BIO MED, V39, P289, DOI 10.1016/j.freeradbiomed.2005.03.024
   Parise G, 2000, Curr Opin Clin Nutr Metab Care, V3, P489, DOI 10.1097/00075197-200011000-00012
   Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7
   Peterson JM, 2008, J APPL PHYSIOL, V105, P1934, DOI 10.1152/japplphysiol.00037.2008
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T
   Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje
   Pistilli EE, 2006, J GERONTOL A-BIOL, V61, P245, DOI 10.1093/gerona/61.3.245
   Pistilli EE, 2008, BIOCHEM BIOPH RES CO, V373, P20, DOI 10.1016/j.bbrc.2008.05.188
   Pistilli EE, 2007, AM J PHYSIOL-CELL PH, V292, pC1298, DOI 10.1152/ajpcell.00496.2006
   Pistilli EE, 2006, APOPTOSIS, V11, P2115, DOI 10.1007/s10495-006-0194-6
   Podhorska-Okolow M, 1998, NEUROPATH APPL NEURO, V24, P518
   Podhorska-Okolow M, 1999, FOLIA HISTOCHEM CYTO, V37, P127
   Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x
   Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552
   Primeau AJ, 2002, CAN J APPL PHYSIOL, V27, P349, DOI 10.1139/h02-020
   Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867
   Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X
   Renault V, 2002, EXP GERONTOL, V37, P1229, DOI 10.1016/S0531-5565(02)00129-8
   Ricci C, 2007, CAN J PHYSIOL PHARM, V85, P455, DOI 10.1139/Y07-029
   ROMAN WJ, 1993, J APPL PHYSIOL, V74, P750, DOI 10.1152/jappl.1993.74.2.750
   ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607
   Ryan MJ, 2008, J GERONTOL A-BIOL, V63, P1015, DOI 10.1093/gerona/63.10.1015
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Sandmand M, 2003, GERONTOLOGY, V49, P155, DOI 10.1159/000069174
   Sandri M, 1997, J NEUROPATH EXP NEUR, V56, P45, DOI 10.1097/00005072-199701000-00005
   Sanna MG, 2002, MOL CELL BIOL, V22, P1754, DOI 10.1128/MCB.22.6.1754-1766.2002
   Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049
   Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097
   SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181
   Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097
   SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904
   Senoo-Matsuda N, 2003, J BIOL CHEM, V278, P22031, DOI 10.1074/jbc.M211377200
   Seo AY, 2008, AGING CELL, V7, P706, DOI 10.1111/j.1474-9726.2008.00418.x
   Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3
   Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804
   Shi YG, 2002, STRUCTURE, V10, P285, DOI 10.1016/S0969-2126(02)00732-3
   Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106
   Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959
   Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003
   Shiozaki EN, 2002, P NATL ACAD SCI USA, V99, P4197, DOI 10.1073/pnas.072544399
   Siu PM, 2006, APOPTOSIS, V11, P967, DOI 10.1007/s10495-006-6315-4
   Siu PM, 2007, J MOL CELL CARDIOL, V42, P678, DOI 10.1016/j.yjmcc.2007.01.001
   Siu PM, 2009, FRONT BIOSCI-LANDMRK, V14, P432, DOI 10.2741/3253
   Siu PM, 2008, J APPL PHYSIOL, V105, P1695, DOI 10.1152/japplphysiol.90800.2008
   Siu PM, 2006, EXP GERONTOL, V41, P175, DOI 10.1016/j.exger.2005.11.004
   Siu PM, 2006, J APPL PHYSIOL, V100, P907, DOI 10.1152/japplphysiol.01012.2005
   Siu PM, 2005, AM J PHYSIOL-REG I, V289, pR1015, DOI 10.1152/ajpregu.00198.2005
   Siu PM, 2005, J GERONTOL A-BIOL, V60, P976, DOI 10.1093/gerona/60.8.976
   Siu PM, 2005, J APPL PHYSIOL, V99, P204, DOI 10.1152/japplphysiol.00084.2005
   Siu PM, 2005, J PHYSIOL-LONDON, V565, P309, DOI 10.1113/jphysiol.2004.081083
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004
   Siu PM, 2004, FASEB J, V18, pA1298
   Smith MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005097
   Song W, 2006, ANTIOXID REDOX SIGN, V8, P517, DOI 10.1089/ars.2006.8.517
   Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105
   Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002
   Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359
   Stennicke HR, 1999, CELL DEATH DIFFER, V6, P1054, DOI 10.1038/sj.cdd.4400599
   Stewart CEH, 2004, J CELL PHYSIOL, V198, P237, DOI 10.1002/jcp.10387
   SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0
   Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053
   Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343
   Tamilselvan J, 2007, FREE RADICAL BIO MED, V43, P1656, DOI 10.1016/j.freeradbiomed.2007.08.028
   Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303
   Tarnopolsky MA, 2009, APPL PHYSIOL NUTR ME, V34, P348, DOI 10.1139/H09-022
   Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780
   Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017
   Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641
   Vescovo G, 2000, HEART, V84, P431, DOI 10.1136/heart.84.4.431
   Vescovo G, 2006, CURR OPIN CLIN NUTR, V9, P416, DOI 10.1097/01.mco.0000232902.97286.35
   Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326
   Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189
   Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26
   Wang P, 2009, CELL DEATH DIFFER, V16, P1192, DOI 10.1038/cdd.2009.51
   Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017
   Wei YH, 2002, EXP BIOL MED, V227, P671, DOI 10.1177/153537020222700901
   WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422
   WILLIAMS GT, 1991, CELL, V65, P1097, DOI 10.1016/0092-8674(91)90002-G
   Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281
   Yang F, 2009, NEUROSCI LETT, V454, P203, DOI 10.1016/j.neulet.2009.03.027
   Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836
   YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0
   Yu J, 2007, ONCOGENE, V26, P4189, DOI 10.1038/sj.onc.1210196
   Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45
   Yu JG, 2009, J ATHEROSCLER THROMB, V16, P21, DOI 10.5551/jat.E551
   Yu JW, 2009, P NATL ACAD SCI USA, V106, P8169, DOI 10.1073/pnas.0812453106
   Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739
   Yuan JY, 1996, J CELL BIOCHEM, V60, P4, DOI 10.1002/(SICI)1097-4644(19960101)60:1<4::AID-JCB2>3.0.CO;2-1
   Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440
   Zheng A, 2005, P NATL ACAD SCI USA, V102, P12083, DOI 10.1073/pnas.0503374102
NR 265
TC 1
Z9 1
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-90-481-9712-5
PY 2011
BP 173
EP 206
DI 10.1007/978-90-481-9713-2_9
D2 10.1007/978-90-481-9713-2
PG 34
WC Geriatrics & Gerontology; Sport Sciences
WE Book Citation Index – Science (BKCI-S)
SC Geriatrics & Gerontology; Sport Sciences
GA BSR26
UT WOS:000285535100009
DA 2024-11-01
ER

PT J
AU Tzoulis, C
   Neckelmann, G
   Mork, SJ
   Engelsen, BE
   Viscomi, C
   Moen, G
   Ersland, L
   Zeviani, M
   Bindoff, LA
AF Tzoulis, Charalampos
   Neckelmann, Gesche
   Mork, Sverre J.
   Engelsen, Bernt E.
   Viscomi, Carlo
   Moen, Gunnar
   Ersland, Lars
   Zeviani, Massimo
   Bindoff, Laurence A.
TI Localized cerebral energy failure in DNA polymerase gamma-associated
   encephalopathy syndromes
SO BRAIN
LA English
DT Article
DE polymerase gamma; magnetic resonance imaging; pathology; diffusion;
   Alpers' syndrome
ID CORTICAL LAMINAR NECROSIS; AUTOSOMAL RECESSIVE ATAXIA; POLG MUTATIONS;
   PURKINJE-CELLS; BRAIN; MRI; LESIONS; NEUROPATHOLOGY; DISORDERS; INJURY
AB Mutations in the catalytic subunit of the mitochondrial DNA-polymerase gamma cause a wide spectrum of clinical disease ranging from infantile hepato-encephalopathy to juvenile/adult-onset spinocerebellar ataxia and late onset progressive external ophthalmoplegia. Several of these syndromes are associated with an encephalopathy that characteristically shows episodes of rapid neurological deterioration and the development of acute cerebral lesions. The purpose of this study was to investigate the nature, distribution and natural evolution of central nervous system lesions in polymerase gamma associated encephalopathy focusing particularly on lesions identified by magnetic resonance imaging. We compared radiological, electrophysiological and pathological findings where available to study potential mechanisms underlying the episodes of exacerbation and acute cerebral lesions. We studied a total of 112 magnetic resonance tomographies and 11 computed tomographies in 32 patients with polymerase gamma-encephalopathy, including multiple serial examinations performed during both the chronic and acute phases of the disease and, in several cases, magnetic resonance spectroscopy and serial diffusion weighted studies. Data from imaging, electroencephalography and post-mortem examination were compared in order to study the underlying disease process. Our findings show that magnetic resonance imaging in polymerase gamma-related encephalopathies has high sensitivity and can identify patterns that are specific for individual syndromes. One form of chronic polymerase gamma-encephalopathy, that is associated with the c.1399G > A and c.2243G > C mutations, is characterized by progressive cerebral and cerebellar atrophy and focal lesions of the thalamus, deep cerebellar structures and medulla oblongata. Acute encephalopathies, both infantile and later onset, show similar pictures with cortical stroke-like lesions occurring during episodes of exacerbation. These lesions can occur both with and without electroencephalographic evidence of concurrent epileptic activity, and have diffusion, spectroscopic and histological profiles strongly suggestive of neuronal energy failure. We suggest therefore that both infantile and later onset polymerase gamma related encephalopathies are part of a continuum.
C1 [Tzoulis, Charalampos; Bindoff, Laurence A.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
   [Tzoulis, Charalampos; Bindoff, Laurence A.] Univ Bergen, Dept Clin Med, N-5021 Bergen, Norway.
   [Neckelmann, Gesche; Moen, Gunnar] Haukeland Hosp, Dept Radiol, N-5021 Bergen, Norway.
   [Mork, Sverre J.] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway.
   [Viscomi, Carlo; Zeviani, Massimo] Natl Neurol Inst C Besta, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, Unit Mol Neurogenet, I-20133 Milan, Italy.
   [Ersland, Lars] Haukeland Hosp, Dept Clin Engn, N-5021 Bergen, Norway.
   [Ersland, Lars] Haukeland Hosp, Dept Surg Sci, N-5021 Bergen, Norway.
C3 University of Bergen; Haukeland University Hospital; University of
   Bergen; University of Bergen; Haukeland University Hospital; University
   of Bergen; Haukeland University Hospital; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; University of Bergen; Haukeland University
   Hospital; University of Bergen; Haukeland University Hospital
RP Bindoff, LA (corresponding author), Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway.
EM laurence.bindoff@nevro.uib.no
RI Zeviani, Massimo/K-2891-2014; Mörk, Sverre/AAW-1330-2020; viscomi,
   Carlo/R-1940-2016; Tzoulis, Charalampos/AGD-5114-2022
OI Bindoff, Laurence/0000-0003-0988-276X; Viscomi,
   Carlo/0000-0001-6050-0566; Zeviani, Massimo/0000-0002-9067-5508;
   Tzoulis, Charalampos/0000-0003-0341-5191
FU Helse Vest; Norwegian Research council; Pierfranco and Luisa Mariani
   Foundation; Telethon-Italy Foundation [GGP07019]; Italian Ministry of
   Health [RF-INN-2007-634163]
FX Helse Vest (CT, LAB); The Norwegian Research council ( LAB): Pierfranco
   and Luisa Mariani Foundation; Telethon-Italy Foundation grant
   n<SUP>o</SUP> GGP07019; the Italian Ministry of Health grant
   RF-INN-2007-634163 (MZ).
CR Betts J, 2006, NEUROPATH APPL NEURO, V32, P359, DOI 10.1111/j.1365-2990.2006.00731.x
   Böttcher J, 2005, STROKE, V36, pE20, DOI 10.1161/01.STR.0000155733.65215.c2
   Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838
   de Vries MC, 2007, EUR J PEDIATR, V166, P229, DOI 10.1007/s00431-006-0234-9
   Del Bo R, 2003, NEUROLOGY, V61, P903, DOI 10.1212/01.WNL.0000092303.13864.BE
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Fujioka M, 1997, STROKE, V28, P584, DOI 10.1161/01.STR.28.3.584
   Hakonen AH, 2005, AM J HUM GENET, V77, P430, DOI 10.1086/444548
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030
   Iizuka T, 2003, NEUROLOGY, V61, P1238, DOI 10.1212/01.WNL.0000091888.26232.FE
   Johansen KK, 2008, MOVEMENT DISORD, V23, P1624, DOI 10.1002/mds.22178
   Kondo A, 2007, BRAIN DEV-JPN, V29, P174, DOI 10.1016/j.braindev.2006.08.002
   Lo CP, 2007, AM J ROENTGENOL, V189, pW205, DOI 10.2214/AJR.07.2425
   Mena H, 2004, ACTA NEUROPATHOL, V108, P524, DOI 10.1007/s00401-004-0918-z
   NAKKI R, 1995, J NEUROSCI, V15, P2097, DOI 10.1523/JNEUROSCI.15-03-02097.1995
   Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70
   OHearn E, 1997, J NEUROSCI, V17, P8828
   Rachinger J, 2002, AM J NEURORADIOL, V23, P1398
   Rantamäki M, 2001, NEUROLOGY, V57, P1043, DOI 10.1212/WNL.57.6.1043
   Riudavets MA, 2005, AM J FOREN MED PATH, V26, P189, DOI 10.1097/01.pag.0000160680.08769.541
   Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044
   Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331
   Siskas N, 2003, NEURORADIOLOGY, V45, P283, DOI 10.1007/s00234-002-0887-7
   Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454
   TAKAHASHI S, 1993, RADIOLOGY, V189, P449, DOI 10.1148/radiology.189.2.8210374
   Tanji K, 1999, J NEUROL SCI, V166, P64, DOI 10.1016/S0022-510X(99)00114-8
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Tzoulis C, 2009, STROKE, V40, pE15, DOI 10.1161/STROKEAHA.108.523118
   Uemura K, 2001, FORENSIC SCI INT, V116, P213, DOI 10.1016/S0379-0738(00)00375-3
   Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83
   Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   YOKOTA T, 1989, J NEUROL, V236, P115, DOI 10.1007/BF00314408
   Yoneda Y, 2005, DIABETIC MED, V22, P1098, DOI 10.1111/j.1464-5491.2005.01568.x
NR 36
TC 54
Z9 54
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD MAY
PY 2010
VL 133
BP 1428
EP 1437
DI 10.1093/brain/awq067
PN 5
PG 10
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 590KV
UT WOS:000277225700021
PM 20400524
OA Bronze
DA 2024-11-01
ER

PT J
AU Chen, XH
   An, XB
   Chen, DR
   Ye, MQ
   Shen, WL
   Han, WQ
   Zhang, YY
   Gao, PJ
AF Chen, Xiaohui
   An, Xiangbo
   Chen, Dongrui
   Ye, Maoqing
   Shen, Weili
   Han, Weiqing
   Zhang, Youyi
   Gao, Pingjin
TI Chronic Exercise Training Improved Aortic Endothelial and Mitochondrial
   Function via an AMPKα2-Dependent Manner
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE AMPK; exercise; vascular; endothelial function; mitochondrial function
ID ACTIVATED PROTEIN-KINASE; CORONARY-ARTERY-DISEASE; REGULAR
   PHYSICAL-ACTIVITY; NITRIC-OXIDE SYNTHASE; SKELETAL-MUSCLE;
   CELL-PROLIFERATION; OXIDATIVE STRESS; NAD(P)H OXIDASE; BLOOD-PRESSURE;
   DYSFUNCTION
AB Chronic exercise training is known to protect the vasculature; however, the underlying mechanisms remain obscure. The present study hypothesized that exercise may improve aortic endothelial and mitochondrial function through an adenosine monophosphate-activated protein kinase alpha 2 (AMPK alpha 2)-dependent manner. Ten-week-old AMPK alpha 2 knockout (AMPK alpha 2(-/-)) mice and age-matched wild-type (WT) mice were subjected to daily treadmill running for 6 weeks, and the thoracic aorta from these mice were used for further examination. Our results showed that exercise significantly promoted vasodilatation and increased expression and phosphorylation of endothelial nitric oxide synthase (eNOS), concomitant with increased AMPK alpha 2 expression in WT mice. These effects were not observed in AMPK alpha 2(-/-) mice. Furthermore, exercise training increased thoracic aortic mitochondria' content as indicated by increased Complex I and mitochondria' DNA (mtDNA) in WT mice but not in AMPK alpha 2(-/-) mice. This may be caused by decreased mitochondria' autophagy since the expression of BH3 domain-containing BCL2 family members BNIP3-like (BNIP3L) and LC3B were decreased in WT mice with exercise. And these changes were absent with AMPK alpha 2 deletion in mice. Importantly, exercise increased the expression of manganous superoxide dismutase (MnSOD) and catalase, suggesting that mitochondria' antioxidative capacity was increased. Notably, the improved antioxidative capacity was lost in AMPK alpha 2(-/-) mice with exercise. In conclusion, this study illustrated that AMPK alpha 2 plays a critical role in exercise-related vascular protection via increasing endothelial and mitochondria' function in the artery.
C1 [Chen, Xiaohui; Gao, Pingjin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol,Inst Hlth Sci, Shanghai, Peoples R China.
   [Chen, Xiaohui; Gao, Pingjin] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China.
   [An, Xiangbo; Zhang, Youyi] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China.
   [Chen, Dongrui; Ye, Maoqing; Shen, Weili; Han, Weiqing; Gao, Pingjin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China.
   [Chen, Dongrui; Ye, Maoqing; Shen, Weili; Han, Weiqing; Gao, Pingjin] Shanghai Res Inst Hypertens, Shanghai, Peoples R China.
C3 Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Chinese Academy of Sciences; University of Chinese Academy of
   Sciences, CAS; Peking University; Shanghai Jiao Tong University
RP Gao, PJ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Vasc Biol,Inst Hlth Sci, Shanghai, Peoples R China.; Gao, PJ (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai, Peoples R China.; Zhang, YY (corresponding author), Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China.; Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China.; Gao, PJ (corresponding author), Shanghai Res Inst Hypertens, Shanghai, Peoples R China.
EM zhangyy@bjmu.edu.cn; gaopingjin@sibs.ac.cn
RI Han, Weiqing/JXN-0886-2024; Ye, Maoqing/AAN-7945-2020; chen,
   xia/GYR-3948-2022; an, xiangbo/IUO-9525-2023
FU National Natural Science Foundation of China [81100184, 81230071,
   81300089, 81200203, 91539202, 81570221]; Scientific Fund of Shanghai
   Jiao Tong University School of Medicine [14XJ10042]; Pujiang Program of
   the Shanghai Science and Technology Committee [14PJ1406400]; Scientific
   Research Foundation for the Returned Overseas Chinese Scholars of the
   State Education Ministry; Shanghai Medical Bureau Fund [201540037]
FX This study was supported by the National Natural Science Foundation of
   China (81100184, 81230071, 81300089, 81200203, 91539202, and 81570221),
   the Scientific Fund of Shanghai Jiao Tong University School of Medicine
   (14XJ10042), the Pujiang Program of the Shanghai Science and Technology
   Committee (14PJ1406400), the Scientific Research Foundation for the
   Returned Overseas Chinese Scholars of the State Education Ministry, and
   the Shanghai Medical Bureau Fund (201540037).
CR Adams V, 2005, CIRCULATION, V111, P555, DOI 10.1161/01.CIR.0000154560.88933.7E
   Cacicedo JM, 2011, AM J PHYSIOL-HEART C, V301, pH1255, DOI 10.1152/ajpheart.01279.2010
   Chen L, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-230
   Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601
   Ding Hu, 2013, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V29, P543
   Dromparis P, 2013, ANNU REV PHYSIOL, V75, P95, DOI 10.1146/annurev-physiol-030212-183804
   FERNANDO P, 1993, CAN J PHYSIOL PHARM, V71, P854, DOI 10.1139/y93-128
   Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589
   Gonçalves IO, 2016, APPL PHYSIOL NUTR ME, V41, P298, DOI 10.1139/apnm-2015-0470
   Gu Q, 2014, EXP GERONTOL, V56, P37, DOI 10.1016/j.exger.2014.02.014
   Hambrecht R, 2003, CIRCULATION, V107, P3152, DOI 10.1161/01.CIR.0000074229.93804.5C
   Hambrecht R, 2000, NEW ENGL J MED, V342, P454, DOI 10.1056/NEJM200002173420702
   Hamidie RDR, 2015, METABOLISM, V64, P1334, DOI 10.1016/j.metabol.2015.07.010
   Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72
   Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131
   Jorgensen SB, 2006, J PHYSIOL-LONDON, V574, P17, DOI 10.1113/jphysiol.2006.109942
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x
   Kojda G, 2001, CIRCULATION, V103, P2839
   Kroeller-Schoen S, 2013, ARTERIOSCL THROM VAS, V33, P1928, DOI 10.1161/ATVBAHA.113.301717
   Kröller-Schön S, 2012, ARTERIOSCL THROM VAS, V32, P1632, DOI 10.1161/ATVBAHA.111.243980
   Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.1.120
   Kumral ZNO, 2016, J PHYSIOL PHARMACOL, V67, P45
   Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512
   Ma XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129971
   Magnoni LJ, 2014, J EXP BIOL, V217, P1649, DOI 10.1242/jeb.099192
   Marcelino TB, 2013, NEUROSCIENCE, V246, P28, DOI 10.1016/j.neuroscience.2013.04.043
   Marosi K, 2012, NEUROSCIENCE, V226, P21, DOI 10.1016/j.neuroscience.2012.09.001
   McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926
   Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200
   Musi N, 2005, FEBS LETT, V579, P2045, DOI 10.1016/j.febslet.2005.02.052
   Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76
   Pangare Meenal, 2012, Journal of Smooth Muscle Research, V48, P1
   Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Russell AP, 2014, BBA-GEN SUBJECTS, V1840, P1276, DOI 10.1016/j.bbagen.2013.11.016
   Salabei JK, 2013, REDOX BIOL, V1, P542, DOI 10.1016/j.redox.2013.10.011
   Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298
   Steinberg GR, 2007, MINI-REV MED CHEM, V7, P519
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI [10.1152/physrev.00011.2008, 10.15252/embj.201488104]
   Stewart KJ, 2002, JAMA-J AM MED ASSOC, V288, P1622, DOI 10.1001/jama.288.13.1622
   Sun GQ, 2015, CLIN EXP HYPERTENS, V37, P616, DOI 10.3109/10641963.2015.1036060
   Szewczyk A, 2015, PHARMACOL REP, V67, P704, DOI 10.1016/j.pharep.2015.04.009
   Tang XQ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00175
   Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530
   Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   Yan Z, 2012, EXERC SPORT SCI REV, V40, P159, DOI 10.1097/JES.0b013e3182575599
   Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028
   Zhou WG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088722
   Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345
NR 52
TC 20
Z9 22
U1 0
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD DEC 21
PY 2016
VL 7
AR 631
DI 10.3389/fphys.2016.00631
PG 10
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA EF2NJ
UT WOS:000390161100001
PM 28066264
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Gellerich, FN
   Trumbeckaite, S
   Müller, T
   Deschauer, M
   Chen, Y
   Gizatullina, Z
   Zierz, S
AF Gellerich, FN
   Trumbeckaite, S
   Müller, T
   Deschauer, M
   Chen, Y
   Gizatullina, Z
   Zierz, S
TI Energetic depression caused by mitochondrial dysfunction
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Review
DE mitochondria; adenine nucleotides; compartmentation; mtDNA; mutations;
   genotype-phenotype relations; respiratory chain complexes
ID SKELETAL-MUSCLE MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RAT-HEART;
   PERMEABILITY TRANSITION; RABBIT RETICULOCYTES; ADENINE-NUCLEOTIDES;
   OUTER-MEMBRANE; DYNAMIC COMPARTMENTATION; EXTERNAL OPHTHALMOPLEGIA;
   INTERMEMBRANE SPACE
AB Mitochondria, providing most of ATP needed for cell work, realizing numerous specific functions as biosyntheses or degradations, contributing to Ca2+ signalling also play a key role in the pathways to cell death. Impairment of mitochondrial functions caused by mutations of mt-genome and by acute processes are responsible for numerous diseases. The relations between changes on the level of molecules and the clinical state are rather complex, and the prediction of thresholds is difficult. Therefore investigations on different levels of an organismus ( genome, metabolites, enzymes, mitochondrial function in vivo and in vitro) are necessary ( multi level approach). Metabolic control theory is a valuable tool for understanding the different effects of mutations on the level of enzyme activities and mitochondrial function. Decreased concentrations of adenine nucleotides, leaky outer and inner mitochondrial membranes, decreased rates of mitochondrial linked pathways and decreased activities of respiratory chain enzymes contribute to depression of cellular energy metabolism characterized by decreased cytosolic phosphorylation potentials as one of the most important consequences of mitochondrial impairments. This review regards classical bioenergetic mechanisms of mitochondrial impairment which contribute to energetic depression.
C1 Univ Halle Wittenberg, Muskellabor Neurol Klin, D-06097 Halle An Der Saale, Germany.
C3 Martin Luther University Halle Wittenberg
RP Univ Halle Wittenberg, Muskellabor Neurol Klin, Julius Kuhn Str 7, D-06097 Halle An Der Saale, Germany.
EM frank.gellerich@medizin.uni-halle.de
OI Trumbeckaite, Sonata/0000-0002-0246-332X
CR Aguilar HI, 1996, GASTROENTEROLOGY, V110, P558, DOI 10.1053/gast.1996.v110.pm8566604
   ANDREWS PA, 1992, CANCER RES, V52, P1895
   AUGUSTIN W, 1981, EBEC SHORT REPORTS, V40, P603
   BANK W, 1994, ANN NEUROL, V36, P830, DOI 10.1002/ana.410360606
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   Bende S Jr, 1992, Acta Chir Hung, V33, P197
   Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2
   Blachly-Dyson E, 2001, IUBMB LIFE, V52, P113
   BOHNENSACK R, 1986, BIOCHIM BIOPHYS ACTA, V850, P72, DOI 10.1016/0005-2728(86)90010-1
   Brand MD, 1998, MOL CELL BIOCHEM, V184, P13, DOI 10.1023/A:1006893619101
   BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R
   Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X
   Brown G.C., 1995, Bioenergetics: A Practical Approach
   CHEN Y, 2002, EBEC SHORT REPORTS, V12, P323
   Chinnery PF, 2001, AM J MED GENET, V106, P94, DOI 10.1002/ajmg.1426
   CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525
   Crouser ED, 1999, AM J RESP CRIT CARE, V160, P1347, DOI 10.1164/ajrccm.160.4.9810116
   Crouser ED, 2000, AM J RESP CRIT CARE, V161, P1705, DOI 10.1164/ajrccm.161.5.9907043
   Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392
   EVTODIENKO YV, 1994, CELL CALCIUM, V15, P439, DOI 10.1016/0143-4160(94)90108-2
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   FISCHER JC, 1985, CLIN CHIM ACTA, V145, P89, DOI 10.1016/0009-8981(85)90022-1
   Gallitelli MF, 1999, J PHYSIOL-LONDON, V518, P433, DOI 10.1111/j.1469-7793.1999.0433p.x
   Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47
   GELLERICH F, 1998, J NEUROL, V245, P425
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GELLERICH FN, 1987, BIOCHIM BIOPHYS ACTA, V890, P117, DOI 10.1016/0005-2728(87)90012-0
   GELLERICH FN, 1977, ACTA BIOL MED GER, V36, P571
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1554, P48, DOI 10.1016/S0005-2728(02)00212-8
   Gellerich FN, 2002, BIOSCIENCE REP, V22, P99, DOI 10.1023/A:1016017224003
   Gellerich FN, 2000, BIOCHEM SOC T, V28, P164, DOI 10.1042/bst0280164
   GELLERICH FN, 1983, BIOCHIM BIOPHYS ACTA, V722, P381, DOI 10.1016/0005-2728(83)90086-5
   GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1140, P327, DOI 10.1016/0005-2728(93)90073-O
   Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006
   GELLERICH FN, 1990, FEBS LETT, V274, P167, DOI 10.1016/0014-5793(90)81355-R
   Gores GJ, 1998, BBA-BIOENERGETICS, V1366, P167, DOI 10.1016/S0005-2728(98)00111-X
   GORI Z, 1988, BRIT J EXP PATHOL, V69, P639
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   HALANGK W, 1986, BIOMED BIOCHIM ACTA, V45, P331
   HALANGK W, 1985, BIOMED BIOCHIM ACTA, V44, P411
   Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5
   HALLER T, 1994, ANAL BIOCHEM, V218, P338, DOI 10.1006/abio.1994.1188
   HEINRICH R, 1974, EUR J BIOCHEM, V42, P97, DOI 10.1111/j.1432-1033.1974.tb03319.x
   HEINRICH R, 1985, BIOMED BIOCHIM ACTA, V44, P913
   Hirano M, 2001, SEMIN CELL DEV BIOL, V12, P417, DOI 10.1006/scdb.2001.0279
   HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0
   HURKO O, 1990, PEDIATR RES, V28, P542, DOI 10.1203/00006450-199011000-00026
   Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3
   Iotti S, 1996, NMR BIOMED, V9, P24, DOI 10.1002/(SICI)1099-1492(199602)9:1<24::AID-NBM392>3.0.CO;2-B
   Iwamoto H, 1999, J CARDIOVASC PHARM, V33, P580, DOI 10.1097/00005344-199904000-00010
   Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001
   JENNINGS RB, 1975, AM J PATHOL, V81, P179
   JENNINGS RB, 1981, AM J PATHOL, V102, P241
   JENNINGS RB, 1969, LAB INVEST, V20, P548
   Joshi MS, 2000, ANAL CELL PATHOL, V21, P41, DOI 10.1155/2000/201406
   JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0
   KACSER H, 1981, GENETICS, V97, P639
   Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149
   KACSER H, 1983, BIOCHEM SOC T, V11, P35, DOI 10.1042/bst0110035
   KAMMERMEIER H, 1987, J MOL CELL CARDIOL, V19, P115, DOI 10.1016/S0022-2828(87)80550-3
   Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782
   Kay L, 1997, MOL CELL BIOCHEM, V174, P79, DOI 10.1023/A:1006884607272
   Kay L, 1997, CARDIOVASC RES, V34, P547, DOI 10.1016/S0008-6363(97)00058-8
   Kemp GJ, 2002, MOL BIOL REP, V29, P187, DOI 10.1023/A:1020325812680
   Knecht W, 2000, ADV EXP MED BIOL, V486, P267
   Kohli V, 1999, GASTROENTEROLOGY, V116, P168, DOI 10.1016/S0016-5085(99)70241-6
   KROEMER G, 1995, FASEB J, V9, P1277, DOI 10.1096/fasebj.9.13.7557017
   Kudoh A, 1998, CRIT CARE MED, V26, P138, DOI 10.1097/00003246-199801000-00029
   KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F
   Kunz WS, 2001, BBA-BIOENERGETICS, V1504, P12, DOI 10.1016/S0005-2728(00)00235-8
   KUSTER U, 1976, BIOCHIM BIOPHYS ACTA, V440, P391, DOI 10.1016/0005-2728(76)90073-6
   Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6
   Laterveer FD, 1997, MOL CELL BIOCHEM, V174, P43, DOI 10.1023/A:1006899621926
   Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544
   LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004
   Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450
   Lombardi A, 2000, FEBS LETT, V475, P84, DOI 10.1016/S0014-5793(00)01633-1
   Lubisch W, 2002, BIOORG MED CHEM LETT, V12, P1335, DOI 10.1016/S0960-894X(02)00176-2
   LUFT R, 1995, BBA-MOL BASIS DIS, V1271, P1, DOI 10.1016/0925-4439(95)00002-L
   LUFT R, 1995, J INTERN MED, V238, P405, DOI 10.1111/j.1365-2796.1995.tb01218.x
   LUFT R, 1992, MT SINAI J MED, V59, P140
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Maragos WF, 1998, EXP NEUROL, V154, P637, DOI 10.1006/exnr.1998.6918
   MARIOTTI C, 1995, J NEUROL, V242, P304, DOI 10.1007/BF00878873
   Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267
   MITHOFER K, 1992, ARCH BIOCHEM BIOPHYS, V295, P132, DOI 10.1016/0003-9861(92)90498-L
   Morgan-Hughes JA, 1999, BBA-BIOENERGETICS, V1410, P125, DOI 10.1016/S0005-2728(98)00162-5
   Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79
   MULLER T, 2001, EUR J MED RES S, V5, P12
   Opalka JR, 2002, BIOCHEM PHARMACOL, V63, P725, DOI 10.1016/S0006-2952(01)00867-X
   Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425
   Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190
   Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7
   POSTON JM, 1992, ARCH BIOCHEM BIOPHYS, V295, P35, DOI 10.1016/0003-9861(92)90484-E
   RAPOPORT SM, 1983, BIOMED BIOCHIM ACTA, V42, P5
   Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996
   Rawls J, 2000, EUR J BIOCHEM, V267, P2079, DOI 10.1046/j.1432-1327.2000.01213.x
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Rustin P, 2002, EUR J HUM GENET, V10, P289, DOI 10.1038/sj.ejhg.5200793
   SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X
   Schild L, 1998, EUR J BIOCHEM, V252, P508, DOI 10.1046/j.1432-1327.1998.2520508.x
   SCHLAME M, 1981, ACTA BIOL MED GER, V40, P617
   Scholte HR, 1997, MOL CELL BIOCHEM, V174, P61, DOI 10.1023/A:1006803807814
   Schröder R, 2000, J NEUROPATH EXP NEUR, V59, P353, DOI 10.1093/jnen/59.5.353
   Schulte-Mattler WJ, 2003, ARCH NEUROL-CHICAGO, V60, P50, DOI 10.1001/archneur.60.1.50
   SCHULTZE M, 1972, EUR J BIOCHEM, V27, P43, DOI 10.1111/j.1432-1033.1972.tb01808.x
   SCHUMER W, 1971, SURG GYNECOL OBSTETR, V133, P433
   Selivanov VA, 1998, BIOPHYS CHEM, V72, P111, DOI 10.1016/S0301-4622(98)00127-6
   SIMONSON SG, 1994, CIRC SHOCK, V43, P34
   SINGH KK, 1998, MITOCHONDRIAL DNA MU, P1
   Skulachev VP, 2000, IUBMB LIFE, V49, P365, DOI 10.1080/152165400410209
   Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743
   SPENGLER V, 1981, ACTA BIOL MED GER, V40, P973
   Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195
   SUZUKI K, 1995, BIOL CHEM H-S, V376, P523
   Trumbeckaite S, 2003, BIOCHEM PHARMACOL, V65, P911, DOI 10.1016/S0006-2952(02)01610-6
   Trumbeckaite S, 2001, EUR J BIOCHEM, V268, P1422, DOI 10.1046/j.1432-1327.2001.02012.x
   TRUMBECKAITE S, 2000, THESIS M LUTHER U HA
   VANDEGAER KM, 1982, BIOCHEM BIOPH RES CO, V109, P442, DOI 10.1016/0006-291X(82)91741-7
   VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5
   VONARDENNE M, 1988, MED HYPOTHESES, V25, P163, DOI 10.1016/0306-9877(88)90054-0
   Wallace D C, 2001, Novartis Found Symp, V235, P247
   WALLACE DC, 1994, EPILEPSIA, V35, pS43, DOI 10.1111/j.1528-1157.1994.tb05928.x
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231
   WALLACE DC, 1993, SCIENCE, V256, P128
   Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748
   WARBURG O, 1970, Z NATURFORSCH PT B, VB 25, P332, DOI 10.1515/znb-1970-0332
   Wasniewska M, 2001, BIOCHEM BIOPH RES CO, V283, P687, DOI 10.1006/bbrc.2001.4834
   WEINHOUSE S, 1972, CANCER RES, V32, P2007
   WISNIEWSKI E, 1993, J BIOL CHEM, V268, P9343
   Wojtczak L, 1996, ACTA BIOCHIM POL, V43, P361
   WU EY, 1990, ARCH BIOCHEM BIOPHYS, V282, P358, DOI 10.1016/0003-9861(90)90129-M
   Wussling MHP, 1999, FEBS LETT, V463, P103, DOI 10.1016/S0014-5793(99)01595-1
   Zhang CF, 1997, BIOCHEM BIOPH RES CO, V230, P630, DOI 10.1006/bbrc.1996.6020
   ZIERZ S, 1989, NERVENARZT, V60, P545
NR 137
TC 32
Z9 39
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD JAN-FEB
PY 2004
VL 256
IS 1-2
BP 391
EP 405
DI 10.1023/B:MCBI.0000009885.34498.e6
PG 15
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 757AA
UT WOS:000187516900034
PM 14977198
DA 2024-11-01
ER

PT J
AU Napoli, E
   McLennan, YA
   Schneider, A
   Tassone, F
   Hagerman, RJ
   Giulivi, C
AF Napoli, Eleonora
   McLennan, Yingratana Amabel
   Schneider, Andrea
   Tassone, Flora
   Hagerman, Randi J.
   Giulivi, Cecilia
TI Characterization of the Metabolic, Clinical and Neuropsychological
   Phenotype of Female Carriers of the Premutation in the X-Linked
   <i>FMR1</i> Gene
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE mitochondrial dysfunction; omics; cellular response to stress; oxidative
   phosphorylation; glycolysis; fragile X-associated primary ovarian
   insufficiency; fragile X-associated tremor and ataxia syndrome
ID PREMATURE OVARIAN FAILURE; UBIQUITIN-PROTEASOME SYSTEM;
   MITOCHONDRIAL-DNA MUTATIONS; RESPIRATORY-CHAIN ACTIVITY; FRAGILE-X;
   TREMOR/ATAXIA SYNDROME; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; EXPANDED
   ALLELES; SKELETAL-MUSCLE
AB The X-linked FMR1 premutation (PM) is characterized by a 55-200 CGG triplet expansion in the 5'-untranslated region (UTR). Carriers of the PM were originally thought to be asymptomatic; however, they may present general neuropsychiatric manifestations including learning disabilities, depression and anxiety, among others. With age, both sexes may also develop the neurodegenerative disease fragile X-associated tremor/ataxia syndrome (FXTAS). Among carriers, females are at higher risk for developing immune disorders, hypertension, seizures, endocrine disorders and chronic pain, among others. Some female carriers younger than 40 years old may develop fragile X-associated primary ovarian insufficiency (FXPOI). To date, no studies have addressed the metabolic footprint - that includes mitochondrial metabolism - of female carriers and its link to clinical/cognitive manifestations. To this end, we performed a comprehensive biochemical assessment of 42 female carriers (24-70 years old) compared to sex-matched non-carriers. By applying a multivariable correlation matrix, a generalized bioenergetics impairment was correlated with diagnoses of the PM, FXTAS and its severity, FXPOI and anxiety. Intellectual deficits were strongly correlated with both mitochondrial dysfunction and with CGG repeat length. A combined multi-omics approach identified a down-regulation of RNA and mRNA metabolism, translation, carbon and protein metabolism, unfolded protein response, and up-regulation of glycolysis and antioxidant response. The suboptimal activation of the unfolded protein response (UPR) and endoplasmic-reticulum-associated protein degradation (ERAD) response challenges and further compromises the PM genetic background to withstand other, more severe forms of stress. Mechanistically, some of the deficits were linked to an altered protein expression due to decreased protein translation, but others seemed secondary to oxidative stress originated from the accumulation of either toxic mRNA or RAN-derived protein products or as a result of a direct toxicity of accumulated metabolites from deficiencies in critical enzymes.
C1 [Napoli, Eleonora; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.
   [McLennan, Yingratana Amabel; Schneider, Andrea; Tassone, Flora; Hagerman, Randi J.; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.
   [Schneider, Andrea; Hagerman, Randi J.] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA.
   [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis;
   University of California System; University of California Davis;
   University of California System; University of California Davis
RP Giulivi, C (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.; Giulivi, C (corresponding author), Univ Calif Davis, Med Ctr, MIND Inst, Sacramento, CA 95817 USA.
EM cgiulivi@ucdavis.edu
RI Giulivi, Cecilia/AAV-6774-2021; Schneider, Andrea/F-5800-2013; Napoli,
   Eleonora/AAQ-6079-2021
OI Napoli, Eleonora/0000-0001-8808-4242
FU National Institutes of Health [HD036071]; MIND Institute Intellectual
   and Developmental Disabilities Research Center [U54 HD079125]; Health
   and Human Administration of Developmental Disabilities [90DD0596, UL1
   TR001860]
FX This study was funded by the National Institutes of Health (HD036071).
   Support was also obtained from the MIND Institute Intellectual and
   Developmental Disabilities Research Center (U54 HD079125) and the Health
   and Human Administration of Developmental Disabilities grants 90DD0596
   and UL1 TR001860.
CR Allen EG, 2007, HUM REPROD, V22, P2142, DOI 10.1093/humrep/dem148
   Allen EG, 2020, GENET MED, V22, P758, DOI 10.1038/s41436-019-0733-5
   Allingham-Hawkins SJ, 1999, AM J MED GENET, V83, P322, DOI 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B
   Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799
   Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141
   Bailey DB, 2008, AM J MED GENET A, V146A, P2060, DOI 10.1002/ajmg.a.32439
   Belanger HG, 2005, ARCH CLIN NEUROPSYCH, V20, P183, DOI 10.1016/j.acn.2004.05.003
   Bennett CE, 2010, HUM REPROD, V25, P1335, DOI 10.1093/humrep/deq058
   Berry-Kravis E, 2005, ANN NEUROL, V57, P144, DOI 10.1002/ana.20360
   Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522
   Berry-Kravis E, 2007, MOVEMENT DISORD, V22, P2018, DOI 10.1002/mds.21493
   Berry-Kravis E, 2007, AM J MED GENET A, V143A, P19, DOI 10.1002/ajmg.a.31559
   Besterman AD, 2014, FUTUR NEUROL, V9, P227, DOI [10.2217/FNL.14.11, 10.2217/fnl.14.11]
   Biase FH, 2017, OMICS, V21, P156, DOI 10.1089/omi.2016.0177
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boffoli D, 1996, BBA-MOL BASIS DIS, V1315, P66, DOI 10.1016/0925-4439(95)00107-7
   Bourgeois JA, 2007, GEN HOSP PSYCHIAT, V29, P349, DOI 10.1016/j.genhosppsych.2007.03.003
   Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791
   BURCH HB, 1963, J BIOL CHEM, V238, P2267
   Burgin HJ, 2020, FEBS LETT, V594, P590, DOI 10.1002/1873-3468.13735
   BYRNE E, 1991, REV NEUROL, V147, P532
   Cagnetta G, 2016, SCI REP-UK, V6, DOI 10.1038/srep22925
   Capková M, 2002, INT J OBESITY, V26, P1110, DOI 10.1038/sj.ijo.0802055
   CARDELLACH F, 1989, LANCET, V2, P44
   Chiaravalloti A, 2015, NUCL MED COMMUN, V36, P461, DOI 10.1097/MNM.0000000000000272
   Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8
   Claeys T, 2020, ACTA NEUROL BELG, V120, P181, DOI 10.1007/s13760-019-01237-w
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   Demain LAM, 2017, CLIN GENET, V91, P199, DOI 10.1111/cge.12896
   Dioguardi CC, 2016, MOL HUM REPROD, V22, P384, DOI 10.1093/molehr/gaw023
   Drozdick LW., 2012, Contemporary Intellectual Assessment: Theories, Tests, and Issues, P197
   Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8
   El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551
   Elizur SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105121
   Elustondo P, 2017, BBA-MOL CELL BIOL L, V1862, P90, DOI 10.1016/j.bbalip.2016.08.012
   Ennis S, 2006, EUR J HUM GENET, V14, P253, DOI 10.1038/sj.ejhg.5201510
   Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101
   Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002
   Fitzsimons PE, 2018, AM J MED GENET A, V176, P1115, DOI 10.1002/ajmg.a.38658
   Freeman FM, 2000, PHARMACOL BIOCHEM BE, V67, P355, DOI 10.1016/S0091-3057(00)00373-7
   FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003
   Giulivi C, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00071
   Giulivi C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/609602
   Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706
   Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296
   Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X
   Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794
   Hagerman RJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00564
   Hagerman RJ, 2016, NAT REV NEUROL, V12, P403, DOI 10.1038/nrneurol.2016.82
   Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700
   Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127
   Höglund E, 2017, BRIT J NUTR, V117, P1351, DOI 10.1017/S0007114517001428
   Hunter JE, 2010, CLIN GENET, V77, P374, DOI 10.1111/j.1399-0004.2009.01317.x
   Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110
   Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321
   Jenkins TA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010056
   JOHNSON BD, 1993, NEURON, V10, P797, DOI 10.1016/0896-6273(93)90196-X
   Karimov CB, 2011, HUM REPROD, V26, P2077, DOI 10.1093/humrep/der168
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299
   Lozano R, 2016, CEREBELLUM, V15, P587, DOI 10.1007/s12311-016-0805-x
   Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230
   Mendelson WB, 2001, NEUROPSYCHOPHARMACOL, V25, pS36, DOI 10.1016/S0893-133X(01)00341-4
   Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114
   Mosconi L, 2006, J NUCL MED, V47, P1778
   Movaghar A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7195
   MULLERHOCKER J, 1992, BRAIN PATHOL, V2, P149, DOI 10.1111/j.1750-3639.1992.tb00683.x
   MUNSCHER C, 1993, BIOL CHEM H-S, V374, P1099, DOI 10.1515/bchm3.1993.374.7-12.1099
   Murray A, 2014, GENET MED, V16, P19, DOI 10.1038/gim.2013.64
   Napoli E, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00338
   Napoli E, 2016, CEREBELLUM, V15, P552, DOI 10.1007/s12311-016-0779-8
   Napoli E, 2016, FASEB J, V30, P3334, DOI 10.1096/fj.201600315R
   Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360
   Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pastore LM, 2012, REPROD SCI, V19, P1226, DOI 10.1177/1933719112446074
   Patsalis PC, 1999, AM J MED GENET, V84, P195, DOI 10.1002/(SICI)1096-8628(19990528)84:3<195::AID-AJMG4>3.0.CO;2-1
   Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236
   Pouresmaeili F, 2014, INT J FERTIL STERIL, V8, P1
   Quiles JL, 2002, J BIOENERG BIOMEMBR, V34, P517, DOI 10.1023/A:1022530512096
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   Reynier P, 2001, MOL HUM REPROD, V7, P425, DOI 10.1093/molehr/7.5.425
   Rice AC, 2014, J ALZHEIMERS DIS, V40, P319, DOI 10.3233/JAD-131715
   Rifé M, 2004, AM J MED GENET A, V124A, P129, DOI 10.1002/ajmg.a.20342
   Sakai C, 2015, HUM MUTAT, V36, P232, DOI 10.1002/humu.22730
   Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017
   Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1
   Schuettler J, 2011, HUM REPROD, V26, P1241, DOI 10.1093/humrep/der018
   SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419
   SKUDER P, 1995, INTELLIGENCE, V21, P1, DOI 10.1016/0160-2896(95)90035-7
   SMALL GW, 1995, JAMA-J AM MED ASSOC, V273, P942, DOI 10.1001/jama.273.12.942
   Song G, 2016, MOL MED, V22, P548, DOI 10.2119/molmed.2016.00122
   Streuli I, 2009, FERTIL STERIL, V92, P464, DOI 10.1016/j.fertnstert.2008.07.007
   Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI [10.1093/nar/gky1131, 10.1093/nar/gkac1000]
   Tassone F, 1999, AM J MED GENET, V84, P250, DOI 10.1002/(SICI)1096-8628(19990528)84:3<250::AID-AJMG17>3.0.CO;2-4
   Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073
   Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122
   Terracciano A, 2004, EUR J HUM GENET, V12, P333, DOI 10.1038/sj.ejhg.5201154
   Tiosano D, 2019, ENDOCRINOLOGY, V160, P2353, DOI 10.1210/en.2019-00441
   TORII K, 1992, AM J RESP CELL MOL, V6, P88, DOI 10.1165/ajrcmb/6.1.88
   Torres S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01168
   Valera AG, 2005, NEUROSCIENTIST, V11, P583, DOI 10.1177/1073858405280639
   VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H
   Voorhuis M, 2014, HUM REPROD, V29, P1585, DOI 10.1093/humrep/deu095
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   Wallace DC, 1995, LIFE SCI R, V56, P199
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wang LY, 2009, J ZHEJIANG UNIV-SC B, V10, P483, DOI 10.1631/jzus.B0820379
   Watts ME, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00216
   Wheeler AC, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00300
   Wheeler AC, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-30
   Winarni TI, 2012, AM J MED GENET A, V158A, P2473, DOI 10.1002/ajmg.a.35569
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5
   Zini R, 2002, LIFE SCI, V71, P3091, DOI 10.1016/S0024-3205(02)02161-6
NR 120
TC 12
Z9 12
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD OCT 22
PY 2020
VL 7
AR 578640
DI 10.3389/fmolb.2020.578640
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA OL2TS
UT WOS:000585195400001
PM 33195422
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Lai, CQ
   Tucker, KL
   Parnell, LD
   Adiconis, M
   García-Bailo, B
   Griffith, J
   Meydani, M
   Ordovás, JM
AF Lai, Chao-Qiang
   Tucker, Katherine L.
   Parnell, Laurence D.
   Adiconis, Man
   Garcia-Bailo, Bibiana
   Griffith, John
   Meydani, Mohsen
   Ordovas, Jose M.
TI <i>PPARGC1A</i> variation associated with DNA damage, diabetes, and
   cardiovascular diseases -: The Boston Puerto Rican Health Study
SO DIABETES
LA English
DT Article
ID GAMMA COACTIVATOR-1 PGC-1; HUMAN SKELETAL-MUSCLE; PGC-1-ALPHA GENE;
   PHYSICAL-ACTIVITY; TYPE-2; MELLITUS; INSULIN; POLYMORPHISMS;
   COMPLICATIONS; MITOCHONDRIA
AB OBJECTIVE - Individuals with type 2 diabetes exhibit higher DNA damage and increased risk of cardiovascular disease (CVD). However, mechanisms underlying the association between DNA damage and development of type 2 diabetes and CVD are not understood. We sought to link peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PPARGC1A), a master transcriptional regulator of mitochondrial oxidative phosphorylation and cellular energy metabolism, with DNA damage, type 2 diabetes, and CVD.
   RESEARCH DESIGN AND METHODS - We measured DNA damage as urinary 8-hydroxydeoxyguanosine (8-OHdG) concentration and examined the relationship between nine PPARGC1A genetic variants, DNA damage, type 2 diabetes, and self-reported CVD in 959 participants of the Boston Puerto Rican Health Study.
   RESULTS - With respect to urinary 8-OHdG, PPARGC1A variants showed significant association, and PPARGC1A haplotypes exhibited significant association after correction for multiple testing. Two independent PPARGC1A variants associated significantly with type 2 diabetes (odds ratios [ORs] 1.35 and 2.46; P = 0.045 and <0.001). Carriers of minor alleles of two other PPARGC1A variants, both in strong linkage disequilibrium and associated with lower DNA damage, showed lower prevalence of CVD (ORs 0.53 and 0.65; P = 0.030 and 0.175). Moreover, we found that physical activity correlated negatively with DNA damage.
   CONCLUSIONS - It is plausible that low physical activity combined with risk haplotyes contribute to the high prevalence of type 2 diabetes in this population. We propose that PPARGC1A influences development of type 2 diabetes and CVD via DNA damage : Increasing physical activity, which induces PPARGC1A expression, is a potential strategy to slow DNA damage, thereby decreasing the risk of CVD for individuals with type 2 diabetes.
C1 [Lai, Chao-Qiang; Parnell, Laurence D.; Adiconis, Man; Garcia-Bailo, Bibiana; Ordovas, Jose M.] Tufts Univ, Human Nutr Res Ctr Aging, JM USDA, Nutr & Gen Lab, Boston, MA 02111 USA.
   [Tucker, Katherine L.] Tufts Univ, Human Nutr Res Ctr Aging, JM USDA, Dietary Assessment & Epidemiol Res Program, Boston, MA 02111 USA.
   [Griffith, John] Tufts Univ New England Med Ctr, Biostat Res Ctr, Boston, MA USA.
   [Meydani, Mohsen] Tufts Univ, Human Nutr Res Ctr Aging, JM USDA, Vasc Biol Lab, Boston, MA 02111 USA.
C3 Tufts University; United States Department of Agriculture (USDA); Tufts
   University; United States Department of Agriculture (USDA); Tufts
   Medical Center; Tufts University; United States Department of
   Agriculture (USDA)
RP Lai, CQ (corresponding author), Tufts Univ, Human Nutr Res Ctr Aging, JM USDA, Nutr & Gen Lab, Boston, MA 02111 USA.
EM chaoqiang.lai@ars.usda.gov
RI Tucker, Katherine/A-4545-2010
OI Lai, Chao-Qiang/0000-0003-1107-8375; Tucker,
   Katherine/0000-0001-7640-662X
FU NHLBI NIH HHS [R01 HL054776, HL54776] Funding Source: Medline; NIA NIH
   HHS [P01 AG023394-05, P01 AG023394, 5P01-AG-023394-02] Funding Source:
   Medline
CR Andreassi MG, 2003, TRENDS CARDIOVAS MED, V13, P270, DOI 10.1016/S1050-1738(03)00109-9
   Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629
   [Anonymous], 2007, DIABETES CARE, V30, P4, DOI DOI 10.2337/DC07-S004
   Barroso I, 2006, DIABETOLOGIA, V49, P501, DOI 10.1007/s00125-005-0130-2
   Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020
   BIENNAN EL, 1992, ARTERIOSCLER THROMB, V12, P647
   BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x
   Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615
   Choi YS, 2006, BIOCHEM BIOPH RES CO, V344, P708, DOI 10.1016/j.bbrc.2006.03.193
   Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6
   de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669
   Devaraj S, 2000, CIRCULATION, V102, P191, DOI 10.1161/01.CIR.102.2.191
   Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032
   EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921
   Falush D, 2003, GENETICS, V164, P1567
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Franks PW, 2006, EXERC SPORT SCI REV, V34, P171, DOI 10.1249/01.jes.0000240021.92254.23
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z
   Ho GYF, 2006, REV PANAM SALUD PUBL, V19, P331, DOI 10.1590/S1020-49892006000500006
   Hoogerbrugge N, 1996, DIABETES CARE, V19, P1122, DOI 10.2337/diacare.19.10.1122
   Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9
   Kunej T, 2004, FOLIA BIOL-PRAGUE, V50, P157
   Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9
   Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Miwa S, 2003, BIOCHEM SOC T, V31, P1300
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Norrbom J, 2004, J APPL PHYSIOL, V96, P189, DOI 10.1152/japplphysiol.00765.2003
   Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385
   Park KS, 2001, DIABETES, V50, P2837, DOI 10.2337/diabetes.50.12.2837
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463
   RIM JA, 1994, DIABETES, V43, P1103
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   Sriwijitkamol A, 2007, DIABETES, V56, P836, DOI 10.2337/db06-1119
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Takatori A, 2004, DIABETES-METAB RES, V20, P211, DOI 10.1002/dmrr.428
   Tucker Katherine L, 2005, J Med Invest, V52 Suppl, P252, DOI 10.2152/jmi.52.252
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yu ZX, 2007, GENET EPIDEMIOL, V31, P553, DOI 10.1002/gepi.20228
   Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x
   2007, HELIXTREE MANUAL VER
NR 50
TC 64
Z9 72
U1 0
U2 2
PU AMER DIABETES ASSOC
PI ALEXANDRIA
PA 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA
SN 0012-1797
EI 1939-327X
J9 DIABETES
JI Diabetes
PD APR
PY 2008
VL 57
IS 4
BP 809
EP 816
DI 10.2337/db07-1238
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 282UC
UT WOS:000254591700004
PM 18162502
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Khailany, RA
   Gilani, N
   Ozaslan, M
   Safdar, M
   Al-Shamari, I
   Kanabe, BO
   Saadat, KASM
   Homayounvash, J
   Monfaredan, A
   Al-Attar, MS
   Arslan, A
AF Khailany, Rozhgar A.
   Gilani, Naser
   Ozaslan, Mehmet
   Safdar, Muhamad
   Al-Shamari, Ihsan
   Kanabe, Belan O.
   Saadat, Khandakar A. S. M.
   Homayounvash, Javad
   Monfaredan, Amir
   Al-Attar, Mustafa S.
   Arslan, Ahmet
TI Association of a point mutation (m.9176T&gt;G) of the MT-ATP6 gene with
   Leigh syndrome: A case report
SO BIOMEDICAL RESEARCH AND THERAPY
LA English
DT Article
DE Mitochondrial Genome; MT-ATP6; Leigh Syndrome; Clinical Feature;
   Mutation
AB Leigh Syndrome (LS) is an uncommon progressive neurodegenerative mitochondrial disorder. The condition is characterized by progressive mental and developmental disabilities (psychomotor regression) and commonly brings about death within a few years of diagnosis, more often due to respiratory failure. In a small number of patients the disorder does not manifest until adulthood. The principal indications of Leigh syndrome found in early stages typically are diarrhea, vomiting, and difficulty swallowing (dysphagia), which disturbs eating. These problems usually result in powerlessness to develop and put on weight under the normal rate (failure to thrive). Serious movement and muscle problems are basic in Leigh syndrome. In this case report, we introduce the molecular and clinical features of a 19-year-old female as proband, and also, we study other members of the family consequently. The m.9176T>G heteroplasmic mutation in the MT-ATP6 gene was detected by high-resolution melt (HRM) and DNA sequencing techniques. Similarly, the m.9176T>G was heteroplasmic in the mother. In conclusion, this report in compliance with previous studies underlines the necessity of further research on prenatal distinguishing proof of the responsible mutations and avoidance of the disease in families with known cases.
C1 [Khailany, Rozhgar A.] Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Iraq.
   [Khailany, Rozhgar A.] Tishk Int Univ, Dept Biol, Fac Educ, Erbil, Iraq.
   [Gilani, Naser; Ozaslan, Mehmet; Kanabe, Belan O.] Gaziantep Univ, Dept Biol, TR-27310 Gaziantep, Turkey.
   [Safdar, Muhamad] Cholistan Univ Vet & Anim Sci, Dept Breeding & Genet, Bahawalpur, Pakistan.
   [Al-Shamari, Ihsan] Hawler Med Univ, Dept Internal Med, Erbil, Iraq.
   [Saadat, Khandakar A. S. M.] Gaziantep Univ, Dept Med Biol, Fac Med, Gaziantep, Turkey.
   [Homayounvash, Javad] Univ Tehran Med Sci, Fac Med, Tehran, Iran.
   [Monfaredan, Amir] Islamic Univ, Tabriz Branch, Dept Hematol, Fac Med, Tabriz, Iran.
   [Al-Attar, Mustafa S.] Salahaddin Univ Erbil, Dept Environm Sci, Coll Sci, Erbil, Iran.
   [Arslan, Ahmet] Namik Kemal Univ, Dept Med Biol, Fac Med, Tekirdag, Turkey.
C3 Salahaddin University; Tishk International University; Gaziantep
   University; Hawler Medical University; Gaziantep University; Tehran
   University of Medical Sciences; Salahaddin University; Namik Kemal
   University
RP Khailany, RA (corresponding author), Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Iraq.; Khailany, RA (corresponding author), Tishk Int Univ, Dept Biol, Fac Educ, Erbil, Iraq.
EM rozhgar.mohammed@su.edu.krd
RI Saadat, Khandakar/AAG-5761-2020; OZASLAN, Mehmet/T-5549-2018; Ozaslan,
   Mehmet/J-5494-2018; Safdar, Muhammad/M-4831-2013
OI Ozaslan, Mehmet/0000-0001-9380-4902; Safdar,
   Muhammad/0000-0002-3720-2090; Saadat, Khandakar/0000-0003-1313-4457;
   AL-ATTAR, MUSTAFA/0000-0002-2106-130X
CR Akagi M, 2002, NEUROMUSCULAR DISORD, V12, P53, DOI 10.1016/S0960-8966(01)00242-5
   Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169
   Dinesh P, 2014, INT J SCI STUDY, V2, P93
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006
   López-Gallardo E, 2014, HUM MOL GENET, V23, P6191, DOI 10.1093/hmg/ddu339
   Ronchi D, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-85
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-62
   TATUCH Y, 1993, BIOCHEM BIOPH RES CO, V192, P124, DOI 10.1006/bbrc.1993.1390
NR 9
TC 0
Z9 0
U1 0
U2 4
PU BIOMEDPRESS
PI HO CHI MINH
PA BIOMEDPRESS, HO CHI MINH, 00000, VIETNAM
SN 2198-4093
J9 BIOMED RES THER
JI Biomed. Res. Ther.
PY 2020
VL 7
IS 5
BP 3739
EP 3743
DI 10.15419/bmrat.v7i5.601
PG 5
WC Medicine, Research & Experimental
WE Emerging Sources Citation Index (ESCI)
SC Research & Experimental Medicine
GA LS7DM
UT WOS:000536540900001
OA gold
DA 2024-11-01
ER

PT J
AU Kumar, M
   Tyagi, N
   Faruq, M
AF Kumar, Manish
   Tyagi, Nishu
   Faruq, Mohammed
TI The molecular mechanisms of spinocerebellar ataxias for DNA repeat
   expansion in disease
SO EMERGING TOPICS IN LIFE SCIENCES
LA English
DT Review
ID TATA-BINDING PROTEIN; NEURONAL INTRANUCLEAR INCLUSIONS; MITOCHONDRIAL
   APOPTOTIC PATHWAY; DOMINANT CEREBELLAR-ATAXIA; CAG TRINUCLEOTIDE REPEAT;
   UP-REGULATING BAX; CLINICAL-FEATURES; MOUSE MODEL; POLYGLUTAMINE
   EXPANSION; NUCLEOLAR STRESS
AB Spinocerebellar ataxias (SCAs) are a heterogenous group of neurodegenerative disorders which commonly inherited in an autosomal dominant manner. They cause muscle incoordination due to degeneration of the cerebellum and other parts of nervous system. Out of all the characterized (>50) SCAs, 14 SCAs are caused due to microsatellite repeat expansion mutations. Repeat expansions can result in toxic protein gain-of-function, protein loss-of-function, and/or RNA gain-of-function effects. The location and the nature of mutation modulate the underlying disease pathophysiology resulting in varying disease manifestations. Potential toxic effects of these mutations likely affect key major cellular processes such as transcriptional regulation, mitochondrial functioning, ion channel dysfunction and synaptic transmission. Involvement of several common pathways suggests interlinked function of genes implicated in the disease pathogenesis. A better understanding of the shared and distinct molecular pathogenic mechanisms in these diseases is required to develop targeted therapeutic tools and interventions for disease management. The prime focus of this review is to elaborate on how expanded 'CAG' repeats contribute to the common modes of neurotoxicity and their possible therapeutic targets in management of such devastating disorders.
C1 [Kumar, Manish; Tyagi, Nishu; Faruq, Mohammed] CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Institute of Genomics & Integrative Biology (IGIB)
RP Faruq, M (corresponding author), CSIR Inst Genom & Integrat Biol, Mall Rd, Delhi 110007, India.
EM faruq.mohd@igib.res.in
OI Faruq, Mohammed/0000-0001-8278-8396
FU CSIR; ICMR [5/4-5/5/Ad-hoc/Neuro/220/NCD-I (GAP240)]
FX Senior Research Fellowship support for Manish Kumar from CSIR is duly
   acknowledged. Funding support for Mohammed Faruq from ICMR project
   5/4-5/5/Ad-hoc/Neuro/220/NCD-I (GAP240) is acknowledged.
CR Abeti R, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.111
   Abramzon Y, 2021, J NEUROL SCI, V430, DOI 10.1016/j.jns.2021.118061
   Adegbuyiro A, 2017, BIOCHEMISTRY-US, V56, P1199, DOI 10.1021/acs.biochem.6b00936
   Ayhan F, 2018, EMBO J, V37, DOI 10.15252/embj.201899023
   Bain PG, 2002, J NEUROL NEUROSUR PS, V72, pI3
   Banez-Coronel M, 2019, LAB INVEST, V99, P929, DOI 10.1038/s41374-019-0241-x
   Bañez-Coronel M, 2015, NEURON, V88, P667, DOI 10.1016/j.neuron.2015.10.038
   Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132
   Beecroft SJ, 2020, BRAIN, V143, P2673, DOI 10.1093/brain/awaa203
   Beijer D, 2022, EUR J NEUROL, V29, P2156, DOI 10.1111/ene.15310
   Belzil VV, 2013, MOL CELL NEUROSCI, V56, P406, DOI 10.1016/j.mcn.2012.12.006
   Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022
   Berntsson SG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180054
   Bhandari J., SPINOCEREBELLAR ATAX
   Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314
   Bürk K, 2007, CEREBELLUM, V6, P280, DOI 10.1080/14734220601115924
   Burley SK, 1996, CURR OPIN STRUC BIOL, V6, P69, DOI 10.1016/S0959-440X(96)80097-2
   Bushart DD, 2019, NEUROSCI LETT, V688, P41, DOI 10.1016/j.neulet.2018.02.005
   Cancel G, 1997, HUM MOL GENET, V6, P709, DOI 10.1093/hmg/6.5.709
   Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110
   CARPENTER NJ, 1994, NEUROL CLIN, V12, P683, DOI 10.1016/S0733-8619(18)30071-9
   Casse F, 2023, MOV DISORD CLIN PRAC, V10, P664, DOI 10.1002/mdc3.13699
   Castelli LM, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00475-y
   Castro AF, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121418
   Chan HYE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00431
   Chen WL, 2008, BRAIN RES, V1233, P176, DOI 10.1016/j.brainres.2008.07.096
   Chou AH, 2006, NEUROBIOL DIS, V21, P333, DOI 10.1016/j.nbd.2005.07.011
   Choudhry S, 2001, HUM MOL GENET, V10, P2437, DOI 10.1093/hmg/10.21.2437
   Choudhury S, 2018, MOV DISORD CLIN PRAC, V5, P39, DOI 10.1002/mdc3.12551
   Chow MKM, 2004, J BIOL CHEM, V279, P47643, DOI 10.1074/jbc.M405799200
   Ciesiolka A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00097
   Coffin SL, 2023, NEURON, V111, P915, DOI 10.1016/j.neuron.2023.02.030
   Conlon EG, 2017, GENE DEV, V31, P1509, DOI 10.1101/gad.304055.117
   Corman A, 2023, TRENDS BIOCHEM SCI, V48, P274, DOI 10.1016/j.tibs.2022.09.006
   Corral-Juan M, 2018, BRAIN, V141, P1981, DOI 10.1093/brain/awy137
   Cortese A., 2020, RFC1 CANVAS/Spectrum Disorder
   Cortese A., 2021, GENEREVIEW SCOPE, P1
   Cortese A, 2019, NAT GENET, V51, P649, DOI 10.1038/s41588-019-0372-4
   Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1
   Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511
   Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502
   Currò R, 2021, BRAIN, V144, P1542, DOI 10.1093/brain/awab072
   Da Silva JD, 2019, NEUROTHERAPEUTICS, V16, P1009, DOI 10.1007/s13311-019-00798-1
   Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200
   Daoud H, 2011, ARCH NEUROL-CHICAGO, V68, P739, DOI 10.1001/archneurol.2011.111
   Das MR, 2023, P NATL ACAD SCI USA, V120, DOI 10.1073/pnas.2215071120
   Daughters RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000600
   David G, 1998, HUM MOL GENET, V7, P165, DOI 10.1093/hmg/7.2.165
   David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65
   Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9
   Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649
   de Mezer M, 2011, NUCLEIC ACIDS RES, V39, P3852, DOI 10.1093/nar/gkq1323
   Doherty KM, 2014, MOVEMENT DISORD, V29, P36, DOI 10.1002/mds.25770
   Dominik N, 2021, J NEUROL, V268, P1119, DOI 10.1007/s00415-020-10183-0
   Du XF, 2018, ADV EXP MED BIOL, V1049, pE1, DOI 10.1007/978-3-319-71779-1_22
   Duan RH, 2014, J GENET GENOMICS, V41, P473, DOI 10.1016/j.jgg.2014.08.003
   Dueñas AM, 2006, BRAIN, V129, P1357, DOI 10.1093/brain/awl081
   Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030
   Egorova PA, 2016, J NEUROPHYSIOL, V115, P2840, DOI 10.1152/jn.00913.2015
   Eichler L, 2011, AM J NEURORADIOL, V32, P890, DOI 10.3174/ajnr.A2387
   Evers MM, 2014, MOL NEUROBIOL, V49, P1513, DOI 10.1007/s12035-013-8596-2
   Fan HC, 2014, CELL TRANSPLANT, V23, P441, DOI 10.3727/096368914X678454
   Figueiredo AS, 2023, CELLS-BASEL, V12, DOI 10.3390/cells12060826
   Fujino Y, 2022, BIOCHEM SOC T, V50, P119, DOI 10.1042/BST20200143
   Furtado S, 2004, MOVEMENT DISORD, V19, P622, DOI 10.1002/mds.20074
   Gan SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134405
   Ganaraja VH, 2022, TREMOR OTHER HYPERK, V12, DOI 10.5334/tohm.686
   Gao R, 2008, EUR J HUM GENET, V16, P215, DOI 10.1038/sj.ejhg.5201954
   García-Planells J, 1999, J MED GENET, V36, P148
   Garden GA, 2008, CEREBELLUM, V7, P138, DOI 10.1007/s12311-008-0027-y
   GENIS D, 1995, NEUROLOGY, V45, P24, DOI 10.1212/WNL.45.1.24
   Geschwind DH, 1997, AM J HUM GENET, V60, P842
   Ghanekar SD, 2022, EXPERT REV NEUROTHER, V22, P101, DOI 10.1080/14737175.2022.2029703
   Groh M, 2014, BIOCHEM SOC T, V42, P1123, DOI 10.1042/BST20140049
   Hansen ST, 2013, HUM MOL GENET, V22, P271, DOI 10.1093/hmg/dds427
   Havel LS, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-21
   Helmlinger D, 2004, HUM MOL GENET, V13, P1257, DOI 10.1093/hmg/ddh139
   Herrema H, 2014, J NEUROL SCI, V345, P269, DOI 10.1016/j.jns.2014.07.041
   Hoffner G, 2015, MOL NEUROBIOL, V52, P1297, DOI 10.1007/s12035-014-8932-1
   Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913
   Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493
   Holmes SE, 2001, BRAIN RES BULL, V56, P397, DOI 10.1016/S0361-9230(01)00596-2
   Hourez R, 2011, J NEUROSCI, V31, P11795, DOI 10.1523/JNEUROSCI.0905-11.2011
   Hsu JY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00196
   Hsu TC, 2014, HUM MOL GENET, V23, P6878, DOI 10.1093/hmg/ddu410
   Huang SS, 2015, CELL REP, V13, P196, DOI 10.1016/j.celrep.2015.08.060
   Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677
   Huin V, 2022, BRAIN, V145, P2121, DOI 10.1093/brain/awab449
   Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162
   Ikeda Y, 2008, CEREBELLUM, V7, P150, DOI 10.1007/s12311-008-0010-7
   Ikeda Y, 2012, NEUROLOGY, V79, P333, DOI 10.1212/WNL.0b013e318260436f
   Ishiguro T, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.648133
   Ishiguro T, 2017, NEURON, V94, P108, DOI 10.1016/j.neuron.2017.02.046
   Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0
   Ishikawa K, 2011, NEUROLOGY, V77, P1853, DOI 10.1212/WNL.0b013e3182377e3a
   Ishikawa K, 2023, J HUM GENET, V68, P153, DOI 10.1038/s10038-022-01091-4
   Ishikawa K, 2019, NEUROTHERAPEUTICS, V16, P1106, DOI 10.1007/s13311-019-00804-6
   Ishikawa Kinya, 2009, Rinsho Shinkeigaku, V49, P907
   Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386
   Jazurek-Ciesiolka M, 2020, J MOL BIOL, V432, DOI 10.1016/j.jmb.2020.10.033
   Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327
   Johansson J, 1998, HUM MOL GENET, V7, P171, DOI 10.1093/hmg/7.2.171
   Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583
   Kasumu A, 2012, CEREBELLUM, V11, P630, DOI 10.1007/s12311-010-0182-9
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Kim JY, 2009, NEUROLOGY, V72, P1385, DOI 10.1212/WNL.0b013e3181a18876
   Kim JM, 2007, ARCH NEUROL-CHICAGO, V64, P1510, DOI 10.1001/archneur.64.10.1510
   Kino Y, 2015, HUM MOL GENET, V24, P740, DOI 10.1093/hmg/ddu492
   Kobayashi H, 2011, AM J HUM GENET, V89, P121, DOI 10.1016/j.ajhg.2011.05.015
   Koeppen Arnulf H, 2018, Handb Clin Neurol, V154, P129, DOI 10.1016/B978-0-444-63956-1.00008-4
   Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047
   Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5
   Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080
   Kraus-Perrotta Cara, 2016, Cerebellum Ataxias, V3, P20
   Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729
   Kumar KR, 2020, BRAIN, V143, pE82, DOI 10.1093/brain/awaa244
   La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6
   Laço MN, 2012, BBA-MOL BASIS DIS, V1822, P139, DOI 10.1016/j.bbadis.2011.10.010
   Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293
   Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038
   Lee J, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1488
   Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101
   Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909
   Li PP, 2021, MOVEMENT DISORD, V36, P2519, DOI 10.1002/mds.28729
   Li PP, 2016, ANN NEUROL, V80, P600, DOI 10.1002/ana.24761
   Li QF, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1314
   Liang XC, 2009, NEUROL INDIA, V57, P578, DOI 10.4103/0028-3886.57803
   Lieberman AP, 2019, ANNU REV PATHOL-MECH, V14, P1, DOI 10.1146/annurev-pathmechdis-012418-012857
   Lilja A, 2005, J NEUROL SCI, V237, P31, DOI 10.1016/j.jns.2005.05.008
   Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101
   Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018
   Lin YF, 2010, P NATL ACAD SCI USA, V107, P692, DOI 10.1073/pnas.0909740107
   Lindblad K, 1996, GENOME RES, V6, P965, DOI 10.1101/gr.6.10.965
   Lipinski MM, 2004, CURR OPIN PHARMACOL, V4, P85, DOI 10.1016/j.coph.2003.09.008
   Liu Q, 2019, NEUROTHERAPEUTICS, V16, P1097, DOI 10.1007/s13311-019-00762-z
   Liu W, 2014, EUR J NEUROL, V21, P1377, DOI 10.1111/ene.12491
   Loomis EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004294
   Loureiro JR, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11020205
   Lynch DR, 2021, ANN NEUROL, V89, P212, DOI 10.1002/ana.25934
   Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366
   Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X
   Malik I, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202114163
   Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0
   Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763
   Martin JJ, 1999, J NEUROL SCI, V168, P37, DOI 10.1016/S0022-510X(99)00176-8
   Martins CR, 2018, J NEUROL, V265, P2949, DOI 10.1007/s00415-018-9087-1
   Martins CR, 2018, ARQ NEURO-PSIQUIAT, V76, P555, DOI [10.1590/0004-282x20180080, 10.1590/0004-282X20180080]
   Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998
   Matilla A, 2001, HUM MOL GENET, V10, P2821, DOI 10.1093/hmg/10.24.2821
   Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238
   Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911
   McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197
   McFarland KN, 2014, NEUROGENETICS, V15, P59, DOI 10.1007/s10048-013-0385-6
   McGurk L, 2021, HUM MOL GENET, V30, P1797, DOI 10.1093/hmg/ddab148
   McLoughlin HS, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104635
   Meijboom KE, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060161
   Michalik A, 2004, EUR J HUM GENET, V12, P2, DOI 10.1038/sj.ejhg.5201108
   Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439
   Milne SC, 2017, NEUROREHAB NEURAL RE, V31, P609, DOI 10.1177/1545968317712469
   Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827
   Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125
   Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829
   NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14
   Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437
   Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215
   Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501
   Nalavade R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.276
   Naruse H, 2019, NEUROGENETICS, V20, P65, DOI 10.1007/s10048-019-00570-9
   Neuenschwander AG, 2014, JAMA NEUROL, V71, P1529, DOI 10.1001/jamaneurol.2014.2082
   Nezhad HG, 2021, AMYOTROPH LAT SCL FR, V22, P579, DOI 10.1080/21678421.2020.1853172
   Niewiadomska-Cimicka A, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00571
   Nobile V, 2020, HUM GENET, V139, P227, DOI 10.1007/s00439-019-02104-7
   O'Hearn EE, 2015, MOVEMENT DISORD, V30, P1813, DOI 10.1002/mds.26348
   Onofre I, 2016, SCI REP-UK, V6, DOI 10.1038/srep28220
   Orr HT, 2012, PROG NEUROBIOL, V99, P179, DOI 10.1016/j.pneurobio.2012.04.003
   ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221
   Orr HT, 2001, HUM MOL GENET, V10, P2307, DOI 10.1093/hmg/10.20.2307
   Ortiz JMP, 2018, NEUROBIOL DIS, V116, P93, DOI 10.1016/j.nbd.2018.05.002
   Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10
   Özütemiz C, 2020, DIAGN INTERV RADIOL, V26, P596, DOI 10.5152/dir.2020.19607
   Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102
   Pang JT, 2002, BRAIN, V125, P656, DOI 10.1093/brain/awf060
   Paulson Henry, 2018, Handb Clin Neurol, V147, P105, DOI 10.1016/B978-0-444-63233-3.00009-9
   Paulson HL, 2017, NAT REV NEUROSCI, V18, P613, DOI 10.1038/nrn.2017.92
   Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5
   Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269
   Pellerin D, 2023, NEW ENGL J MED, V388, P128, DOI 10.1056/NEJMoa2207406
   Perez BA, 2021, EMBO MOL MED, V13, DOI 10.15252/emmm.202114095
   Polymenidou M, 2018, SCIENCE, V360, P859, DOI 10.1126/science.aat8028
   Rafehi H, 2023, AM J HUM GENET, V110, P105, DOI 10.1016/j.ajhg.2022.11.015
   Rafehi H, 2019, AM J HUM GENET, V105, P151, DOI 10.1016/j.ajhg.2019.05.016
   Rajakulendran Sanjeev, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-4
   Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014
   Ranum Laura P W, 2010, Rinsho Shinkeigaku, V50, P982
   RANUM LPW, 1994, AM J HUM GENET, V55, P244
   Raskin S, 2007, ARCH NEUROL-CHICAGO, V64, P591, DOI 10.1001/archneur.64.4.591
   Rasmussen A, 2001, ANN NEUROL, V50, P234, DOI 10.1002/ana.1081
   Rodriguez CM, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104515
   Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676
   Rondón AG, 2019, MOL CELL, V76, P529, DOI 10.1016/j.molcel.2019.11.001
   Rossi M, 2023, MOVEMENT DISORD, V38, P368, DOI 10.1002/mds.29278
   Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801
   Rudich P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227464
   Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747
   Samukawa M, 2019, CEREBELLUM, V18, P76, DOI 10.1007/s12311-018-0955-0
   Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961
   Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019
   Saucier J, 2023, J NEUROL SCI, V444, DOI 10.1016/j.jns.2022.120527
   Schmidt T, 2002, ANN NEUROL, V51, P302, DOI 10.1002/ana.10101
   Scoles DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128769
   Scriba CK, 2020, BRAIN, V143, P2904, DOI 10.1093/brain/awaa263
   Seidel K, 2012, ACTA NEUROPATHOL, V124, P1, DOI 10.1007/s00401-012-1000-x
   Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007
   Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016
   Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004
   Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21
   Sen NE, 2016, NEUROBIOL DIS, V96, P115, DOI 10.1016/j.nbd.2016.09.002
   Sen NE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235854
   SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6
   Shibata T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20487-4
   Siddique U, 2021, CLIN PARKINSON RELAT, V5, DOI 10.1016/j.prdoa.2021.100102
   Sisakova A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0429-8
   Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766
   Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790
   Srivastava AK, 2017, BRAIN, V140, P27, DOI 10.1093/brain/aww269
   St George-Hyslop P, 2018, BRAIN RES, V1693, P11, DOI 10.1016/j.brainres.2018.04.036
   Stevanovski I, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm5386
   Stone J, 2001, J NEUROL, V248, P229, DOI 10.1007/s004150170232
   Stucki DM, 2016, FREE RADICAL BIO MED, V97, P427, DOI 10.1016/j.freeradbiomed.2016.07.005
   Sugihara K, 2012, MOVEMENT DISORD, V27, P1158, DOI 10.1002/mds.25092
   Sullivan R, 2021, J NEUROL NEUROSUR PS, V92, P444, DOI 10.1136/jnnp-2020-325092
   Sullivan R, 2019, J NEUROL, V266, P533, DOI 10.1007/s00415-018-9076-4
   Switonski PM, 2015, NEUROBIOL DIS, V73, P174, DOI 10.1016/j.nbd.2014.09.020
   Takahashi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050121
   Tan DD, 2023, MOVEMENT DISORD, V38, P1282, DOI 10.1002/mds.29412
   TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995
   Tazen S, 2013, JAMA NEUROL, V70, P1302, DOI 10.1001/jamaneurol.2013.443
   Teive HAG, 2004, NEUROLOGY, V63, P1509
   Teive HAG, 2011, PARKINSONISM RELAT D, V17, P655, DOI 10.1016/j.parkreldis.2011.04.001
   Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026
   Todd T., 2018, MOL CELLULAR BASIS N, P441, DOI DOI 10.1016/B978-0-12-811304-2.00015-8
   Todd TW, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107616
   Toyoshima Y, 2018, ADV EXP MED BIOL, V1049, P219, DOI 10.1007/978-3-319-71779-1_10
   Traschütz A, 2021, NEUROLOGY, V96, pE1369, DOI 10.1212/WNL.0000000000011528
   Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6
   Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109
   Tsuchiya M, 2020, J HUM GENET, V65, P1143, DOI 10.1038/s10038-020-0807-x
   Tusi SK, 2021, HUM MOL GENET, V30, P1020, DOI 10.1093/hmg/ddab098
   Tyagi N., 2023, MEDRNV, DOI [10.1101/2023.06.05.23290839, DOI 10.1101/2023.06.05.23290839]
   Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b
   Wang HL, 2006, CELL SIGNAL, V18, P541, DOI 10.1016/j.cellsig.2005.05.024
   Wang YC, 2011, J BIOL CHEM, V286, P21742, DOI 10.1074/jbc.M110.160697
   White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984
   Wu YR, 2009, HUM GENET, V125, P437, DOI 10.1007/s00439-009-0641-x
   Yang S, 2016, RARE DIS, V4, DOI 10.1080/21675511.2016.1223580
   Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X
   Yu ZM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001340
   Yvert G, 2001, HUM MOL GENET, V10, P1679, DOI 10.1093/hmg/10.16.1679
   Zhang N, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11091567
   Zhang Q, 2018, RNA, V24, P486, DOI 10.1261/rna.062703.117
   Zhou Chengqian, 2023, bioRxiv, DOI 10.1101/2023.04.02.535298
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
   Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247
   Zu T, 2020, P NATL ACAD SCI USA, V117, P18591, DOI 10.1073/pnas.2005748117
   Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110
   Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108
   Zühlke C, 2001, EUR J HUM GENET, V9, P160, DOI 10.1038/sj.ejhg.5200617
   Zühlke C, 2002, EUR J HUM GENET, V10, P204, DOI 10.1038/sj.ejhg.5200788
NR 271
TC 2
Z9 3
U1 1
U2 6
PU PORTLAND PRESS LTD
PI LONDON
PA 1ST FLR, 10 QUEEN STREET PLACE, LONDON, ENGLAND
SN 2397-8554
EI 2397-8562
J9 EMERG TOP LIFE SCI
JI Emerg. Top. Life Sci.
PD DEC
PY 2023
VL 7
IS 3
BP 289
EP 312
DI 10.1042/ETLS20230013
EA SEP 2023
PG 24
WC Biochemistry & Molecular Biology; Biology
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA CQ8Q8
UT WOS:001078979800001
PM 37668011
DA 2024-11-01
ER

PT J
AU Sonam, K
   Khan, NA
   Bindu, PS
   Taly, AB
   Gayathri, N
   Srinivas Bharath, MM
   Govindaraju, C
   Arvinda, HR
   Nagappa, M
   Sinha, S
   Thangaraj, K
AF Sonam, Kothari
   Khan, Nahid Akthar
   Bindu, Parayil Sankaran
   Taly, Arun B.
   Gayathri, N.
   Srinivas Bharath, M. M.
   Govindaraju, C.
   Arvinda, H. R.
   Nagappa, Madhu
   Sinha, Sanjib
   Thangaraj, K.
TI Clinical and magnetic resonance imaging findings in patients with Leigh
   syndrome and <i>SURF1</i> mutations
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Leigh syndrome; COX deficiency; SURF1 mutation; Dentate nucleus;
   Inferior olivary nucleus
ID CYTOCHROME-C-OXIDASE; MITOCHONDRIAL DISEASE; GENE-MUTATIONS; COX
   DEFICIENCY; TISSUE; MUSCLE; DNA
AB Background: Mutation in the SURF1 is one of the most common nuclear mutations associated with Leigh syndrome and cytochrome c oxidase deficiency. This study aims to describe the phenotypic and imaging features in four patients with Leigh syndrome and novel SURF1 mutation. Methods: The study included four patients with Leigh syndrome and SURFI mutations identified from a cohort of 25 children with Leigh syndrome seen over a period of six years (2006-2012). All the patients underwent a detailed neurological assessment, muscle biopsy, and sequencing of the complete mitochondrial genome and SURF1. Results: Three patients had classical presentation of Leigh syndrome. The fourth patient had a later age of onset with ataxia as the presenting manifestation and a stable course. Hypertrichosis, facial dysmorphism and hypopigmentation were the additional phenotypic features noted. On magnetic resonance imaging all patients had brainstem and cerebellar involvement and two had basal ganglia involvement in addition. The bilateral symmetrical hypertrophic olivary degeneration in these patients was striking. The SURF1 analysis identified previously unreported mutations in all the patients. On follow-up three patients expired and one had a stable course. Conclusions: Patients with Leigh syndrome and SURF1 mutation often have skin and hair abnormalities. Bilateral symmetrical hypertrophic olivary degeneration was a consistent finding on magnetic resonance imaging in these patients. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Sonam, Kothari; Bindu, Parayil Sankaran; Taly, Arun B.; Govindaraju, C.; Nagappa, Madhu; Sinha, Sanjib] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
   [Gayathri, N.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuropathol, Bangalore, Karnataka, India.
   [Srinivas Bharath, M. M.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurochem, Bangalore, Karnataka, India.
   [Arvinda, H. R.] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neuroimaging & Intervent Radiol, Bangalore, Karnataka, India.
   [Khan, Nahid Akthar; Thangaraj, K.] CCMB, Dept Evolutionary & Med Genet, Hyderabad, Andhra Pradesh, India.
C3 National Institute of Mental Health & Neurosciences - India; National
   Institute of Mental Health & Neurosciences - India; National Institute
   of Mental Health & Neurosciences - India; National Institute of Mental
   Health & Neurosciences - India; Council of Scientific & Industrial
   Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology
   (CCMB)
RP Sonam, K (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurol, Bangalore, Karnataka, India.
EM sonamkothari86@yahoo.com; nahid.ibu@gmail.com; drpsbindu@yahoo.co.in;
   abtaly@yahoo.com; gayathrin12@rediffmail.com; bharath.nimhans@nic.in;
   drgobiraj_76@yahoo.com; aravind.radiology@gmail.com;
   madhu_nagappa@yahoo.co.in; sanjib_sinha2004@yahoo.co.in;
   thangs@cemb.res.in
RI Thangaraj, Kumarasamy/G-5596-2010; Taly, Arun/AAV-3517-2021
OI Thangaraj, Kumarasamy/0000-0002-0075-0106; Khan,
   Nahid/0000-0002-2835-3655; Sinha, Sanjib/0000-0002-9736-2985
FU Dpt. of Biotechnology, Govt of India [BT/PR7470/MED/14/1011/2006]
FX This study was supported by a grant (Grant No.
   BT/PR7470/MED/14/1011/2006) from Dpt. of Biotechnology, Govt of India.
CR Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038
   Bodemer C, 1999, PEDIATRICS, V103, P428, DOI 10.1542/peds.103.2.428
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Coenen MJH, 2006, J INHERIT METAB DIS, V29, P212, DOI 10.1007/s10545-006-0185-3
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Hat-ney JP, 1998, J INHERIT METAB DIS, V21, P748
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   Lee IC, 2012, HUM MUTAT, V33, P1192, DOI 10.1002/humu.22095
   Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.3.CO;2-G
   Ostergaard E, 2005, AM J MED GENET A, V138A, P384, DOI 10.1002/ajmg.a.30972
   Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060
   Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060
   Savoiardo M., 1991, NEURORADIOLOGY S, P507, DOI 10.1007/978-3-642-49329-4_187
   Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755
   Sonam K, J CHILD NEUROL
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Tanigawa J, 2012, BRAIN DEV-JPN, V34, P861, DOI 10.1016/j.braindev.2012.02.007
   Tay SKH, 2005, J CHILD NEUROL, V20, P670, DOI 10.1177/08830738050200080701
   Tenney JR, 2012, J CHILD NEUROL
   Timothy J, 2009, J CHILD NEUROL, V24, P1296, DOI 10.1177/0883073809333543
   Tiranti V, 1999, ANN NEUROL, V46, P161, DOI 10.1002/1531-8249(199908)46:2<161::AID-ANA4>3.0.CO;2-O
   Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150
   van der Knaap MS., 1993, GENEREVIEWS
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   Wedatilake Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-96
   WILLEMS JL, 1977, PEDIATRICS, V60, P850
   Xie S, 2009, CLIN IMAG, V33, P1, DOI 10.1016/j.clinimag.2008.08.001
   Yasaki E, 2001, NEUROPEDIATRICS, V32, P299
   Yüksel A, 2006, PEDIATR NEUROL, V34, P486, DOI 10.1016/j.pediatrneurol.2005.10.020
   Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804
NR 31
TC 21
Z9 23
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD OCT
PY 2014
VL 36
IS 9
BP 807
EP 812
DI 10.1016/j.braindev.2013.10.012
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA CB2AQ
UT WOS:000349429500010
PM 24262866
DA 2024-11-01
ER

PT J
AU Fortini, P
   Ferretti, C
   Dogliotti, E
AF Fortini, Paola
   Ferretti, Chiara
   Dogliotti, Eugenia
TI The response to DNA damage during differentiation: Pathways and
   consequences
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Review
DE DNA repair; DNA damage response; Apoptosis; Autophagy; Cell
   differentiation; Stem cells
ID EMBRYONIC STEM-CELLS; DOUBLE-STRAND BREAKS; NUCLEOTIDE EXCISION-REPAIR;
   SKELETAL-MUSCLE DIFFERENTIATION; HOMOLOGOUS RECOMBINATION; MITOCHONDRIAL
   BIOGENESIS; SOMATIC-CELLS; SELF-RENEWAL; LIFE-SPAN; CYCLE
AB Damage to genomic DNA triggers a prompt set of signaling events known as the DNA damage response (DDR) which coordinates DNA repair, cell cycle arrest and ultimately cell death or senescence. Although activation of adequate DNA damage signaling and repair systems depends on the type of lesion and the cell-cycle phase in which it occurs, emerging evidence indicates that DNA repair and DDR function differently in different cellular contexts. Depending on the time maintenance and function of a specific cell type the risk of accumulating DNA damage may vary. For instance, damage to stem cells if not repaired can lead to mutation amplification or propagation through the processes of self-renewal and differentiation, respectively, whereas damage to post-mitotic cells can affect mostly tissue homeostasis. Stem cells are therefore expected to address DNA damage differently from their somatic counterparts. In this review the information available on the common and distinct mechanisms of control of genome integrity utilized by different cell types along the self-renewal/differentiation program will be reviewed, with special emphasis on their roles in the prevention of aging and disease. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Fortini, Paola; Ferretti, Chiara; Dogliotti, Eugenia] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy.
C3 Istituto Superiore di Sanita (ISS)
RP Dogliotti, E (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.
EM eugenia.dogliotti@iss.it
RI fortini, paola/K-1197-2018
OI fortini, paola/0000-0001-6206-8498
FU Associazione Italiana per la Ricerca sul Cancro; ISS-NIH
FX We are grateful to Dr. Margherita Bignami for critically reading the
   manuscript. We are also grateful to Prof. Ciro Isidoro and Dr. Monica
   Cagnin (University of Piemonte Orientale, Novara) for kindly providing
   IF images of autophagy during cell differentiation. This work was
   partially supported by Associazione Italiana per la Ricerca sul Cancro
   and ISS-NIH grant to E.D.
CR Adams Bret R, 2010, Aging (Albany NY), V2, P582
   Adams BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010001
   Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x
   Baerga R, 2009, AUTOPHAGY, V5, P1118, DOI 10.4161/auto.5.8.9991
   Bai L, 2008, MOL CELL BIOCHEM, V307, P129, DOI 10.1007/s11010-007-9592-5
   Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776
   Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007
   Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276
   Biton S, 2007, DNA REPAIR, V6, P128, DOI 10.1016/j.dnarep.2006.10.019
   Biton S, 2006, J BIOL CHEM, V281, P17482, DOI 10.1074/jbc.M601895200
   Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179
   Bogomazova A. N., 2011, AGING-US, V3, P1
   Botrugno OA, 2012, CLIN CANCER RES, V18, P2436, DOI 10.1158/1078-0432.CCR-11-0767
   Boucas Jorge, 2012, Frontiers in Genetics, V3, P159, DOI 10.3389/fgene.2012.00159
   Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392
   Briegert M, 2007, CANCER RES, V67, P26, DOI 10.1158/0008-5472.CAN-06-3712
   Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199
   Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Cleaver JE, 2012, NAT GENET, V44, P477, DOI 10.1038/ng.2255
   de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009
   Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119
   Fortini P, 2012, CELL DEATH DIFFER, V19, P1741, DOI 10.1038/cdd.2012.53
   Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179
   Frappart PO, 2008, DNA REPAIR, V7, P1051, DOI 10.1016/j.dnarep.2008.03.007
   Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0
   GREEN MHL, 1994, MUTAT RES, V315, P25, DOI 10.1016/0921-8777(94)90024-8
   Groth P, 2012, NUCLEIC ACIDS RES, V40, P6585, DOI 10.1093/nar/gks315
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105
   Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101
   Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424
   Hyka-Nouspikel N, 2011, BLOOD, V117, P6277, DOI 10.1182/blood-2010-12-326637
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907
   Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064
   Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0
   Kulkarni A, 2008, NUCLEIC ACIDS RES, V36, P5111, DOI 10.1093/nar/gkn480
   Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398
   Latella L, 2004, MOL CELL BIOL, V24, P6350, DOI 10.1128/MCB.24.14.6350-6361.2004
   Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375
   Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211
   Mariño G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001
   Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345
   Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016
   Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410
   Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123
   Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Naka K, 2011, INT J HEMATOL, V93, P434, DOI 10.1007/s12185-011-0793-z
   Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Nouspikel T, 2007, NEUROSCIENCE, V145, P1213, DOI 10.1016/j.neuroscience.2006.07.006
   Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P965, DOI 10.1007/s00018-009-8734-1
   Nouspikel T, 2006, P NATL ACAD SCI USA, V103, P16188, DOI 10.1073/pnas.0607769103
   Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103
   Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339
   Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583
   Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542
   Puri PL, 2002, NAT GENET, V32, P585, DOI 10.1038/ng1023
   Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035
   Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803
   Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Scheibye-Knudsen M, 2012, J EXP MED, V209, P855, DOI 10.1084/jem.20111721
   Schmetsdorf S, 2009, EUR J NEUROSCI, V29, P1096, DOI 10.1111/j.1460-9568.2009.06661.x
   Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129
   Sherman MH, 2010, MOL CELL, V39, P873, DOI 10.1016/j.molcel.2010.08.019
   Shubassi G, 2012, CANCER RES, V72, P1332, DOI 10.1158/0008-5472.CAN-11-3172
   Simonatto M, 2011, CELL CYCLE, V10, P2355, DOI 10.4161/cc.10.14.15948
   Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228
   Smith MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005097
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Tanida I, 2006, AUTOPHAGY, V2, P264, DOI 10.4161/auto.2871
   Taylor R, 2011, CURR PHARM DESIGN, V17, P2056, DOI 10.2174/138161211796904768
   Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007
   Tichy ED, 2011, DNA REPAIR, V10, P445, DOI 10.1016/j.dnarep.2011.01.008
   Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058
   Tomashevski A, 2010, CELL DEATH DIFFER, V17, P1189, DOI 10.1038/cdd.2009.221
   Valentin-Vega YA, 2012, BLOOD, V119, P1490, DOI 10.1182/blood-2011-08-373639
   van der Wees C, 2007, MUTAT RES-FUND MOL M, V614, P16, DOI 10.1016/j.mrfmmm.2006.06.005
   Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276
   Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084
   Vázquez P, 2012, AUTOPHAGY, V8, P187, DOI 10.4161/auto.8.2.18535
   Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003
   Zaky A, 2008, NUCLEIC ACIDS RES, V36, P1555, DOI 10.1093/nar/gkm1173
   Zhang J, 2009, BLOOD, V114, P157, DOI 10.1182/blood-2008-04-151639
   Zhang Y, 2006, J NEUROSCI, V26, P8819, DOI 10.1523/JNEUROSCI.2593-06.2006
   Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106
   Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443
   Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005
   Zhou JM, 2001, EMBO J, V20, P914, DOI 10.1093/emboj/20.4.914
NR 106
TC 41
Z9 45
U1 0
U2 26
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD MAR-APR
PY 2013
VL 743
SI SI
BP 160
EP 168
DI 10.1016/j.mrfmmm.2013.03.004
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 165JW
UT WOS:000320481200017
PM 23562804
DA 2024-11-01
ER

PT J
AU Ficociello, G
   Salemme, A
   Uccelletti, D
   Fiorito, S
   Togna, AR
   Vallan, L
   González-Domínguez, JM
   Da Ros, T
   Francisci, S
   Montanari, A
AF Ficociello, Graziella
   Salemme, Adele
   Uccelletti, Daniela
   Fiorito, Silvana
   Togna, Anna Rita
   Vallan, Lorenzo
   Gonzalez-Dominguez, Jose M.
   Da Ros, Tatiana
   Francisci, Silvia
   Montanari, Arianna
TI Evaluation of the efficacy of carbon nanotubes for delivering peptides
   into mitochondria
SO RSC ADVANCES
LA English
DT Article
ID NEMATODE CAENORHABDITIS-ELEGANS; TARGETED ORGANS; CELLULAR UPTAKE;
   MUTATIONS; TOXICITY; DISEASES; GENE; TRANSLOCATION; NANOPARTICLES;
   TRNA(ILE)
AB Mitochondrial (mt) diseases are devastating neurodegenerative pathologies due to mutations in nuclear or mt genes. Among mtDNA pathogenic mutations, more than one half have been identified in transfer RNA (tRNA) genes. These are responsible for a wide range of pathologies including myopathies, encephalopathies, cardiomyopathies and deafness for which no effective treatment is available at present. Therefore, new strategies to suppress their damaging effects are required to envisage therapeutic approaches for these diseases. Here we report data for carbon nanotube (CNT) derivatives showing that the conjugates bearing a specific peptide sequence are able to target the mitochondria in yeast and human monocyte cells while the control derivative without the peptide diffuses into the cytoplasm. Moreover the compounds do not affect cellular viability and cytotoxicity both in vitro and in vivo. Toxicity of the constructs is also assessed on the simple pluricellular model Caenorhabditis elegans.
C1 [Ficociello, Graziella; Uccelletti, Daniela; Francisci, Silvia; Montanari, Arianna] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Salemme, Adele; Togna, Anna Rita] Univ Roma La Sapienza, Dept Physiol & Pharmacol Vittorio Erspamer, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Fiorito, Silvana] CNR, Inst Translat Pharmacol, Via Fosso Cavaliere 100, I-00133 Rome, Italy.
   [Vallan, Lorenzo; Gonzalez-Dominguez, Jose M.; Da Ros, Tatiana] Univ Trieste, INSTM Unit Trieste, Dept Chem & Pharmaceut Sci, Piazzale Europa 1, I-34127 Trieste, Italy.
   [Montanari, Arianna] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Pasteur Inst, Viale Regina Elena 291, I-00161 Rome, Italy.
C3 Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale
   delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR);
   University of Trieste; Sapienza University Rome; Fondazione Cenci
   Bolognetti
RP Montanari, A (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Montanari, A (corresponding author), Univ Roma La Sapienza, Cenci Bolognetti Fdn, Pasteur Inst, Viale Regina Elena 291, I-00161 Rome, Italy.
EM graziella..cociello@uniroma1.it; adele.salemme@uniroma1.it;
   daniela.uccelletti@uniroma1.it; silvana..orito@i..cnr.it;
   annarita.togna@uniroma1.it; lor.lor.lor.zeno@gmail.com;
   jmgd_chemical@yahoo.es; daros@units.it; silvia.francisci@uniroma1.it;
   ari.montanari@uniroma1.it
RI MONTANARI, ARIANNA/HLW-5611-2023; Salemme, Adele/K-3838-2018
OI Gonzalez-Dominguez, Jose Miguel/0000-0002-0701-7695; Montanari,
   Arianna/0000-0001-6832-7569; Salemme, Adele/0000-0003-1489-4589; Da Ros,
   Tatiana/0000-0003-1932-1560; Vallan, Lorenzo/0000-0001-5267-4849
FU Pasteur Institute - Cenci Bolognetti Foundation; Sapienza University of
   Rome [C26A144BN2]; European Union FP7 RADDEL program (ITN Marie Curie
   Actions) [PEOPLE-2011-290023]
FX All the authors gratefully acknowledge Prof. Laura Frontali for helpful
   discussions. This work was supported by Pasteur Institute - Cenci
   Bolognetti Foundation, and by Sapienza University of Rome (C26A144BN2),
   and by the European Union FP7 RADDEL program (ITN Marie Curie Actions
   PEOPLE-2011-290023).
CR Adhya S, 2011, MITOCHONDRION, V11, P839, DOI 10.1016/j.mito.2011.06.003
   Battigelli A, 2013, NANOSCALE, V5, P9110, DOI 10.1039/c3nr02694a
   BRENNER S, 1974, GENETICS, V77, P71
   Choi J, 2014, ENVIRON CHEM, V11, P227, DOI 10.1071/EN13187
   Coutelle O, 2014, EMBO MOL MED, V6, P624, DOI 10.1002/emmm.201303016
   De Luca C, 2006, GENE, V377, P169, DOI 10.1016/j.gene.2006.04.003
   De Luca C, 2009, MITOCHONDRION, V9, P408, DOI 10.1016/j.mito.2009.07.004
   Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011
   Francisci S, 2011, MITOCHONDRION, V11, P919, DOI 10.1016/j.mito.2011.08.006
   Handy RD, 2012, ENVIRON TOXICOL CHEM, V31, P15, DOI 10.1002/etc.706
   Jung SK, 2015, ENVIRON SCI TECHNOL, V49, P2477, DOI 10.1021/es5056462
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Koopmans RJ, 2010, CURR OPIN MICROBIOL, V13, P327, DOI 10.1016/j.mib.2010.01.012
   Kordatos K, 2001, J ORG CHEM, V66, P4915, DOI 10.1021/jo015608k
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09
   Lopez CF, 2004, P NATL ACAD SCI USA, V101, P4431, DOI 10.1073/pnas.0400352101
   Marrache S, 2013, CURR MED CHEM, V20, P3500, DOI 10.2174/0929867311320280007
   Ménard-Moyon C, 2011, CHEM-EUR J, V17, P3222, DOI 10.1002/chem.201003050
   Ménard-Moyon C, 2010, EXPERT OPIN DRUG DIS, V5, P691, DOI 10.1517/17460441.2010.490552
   Montanari A, 2011, RNA, V17, P1983, DOI 10.1261/rna.2878711
   Montanari A, 2010, BBA-MOL CELL RES, V1803, P1050, DOI 10.1016/j.bbamcr.2010.05.003
   Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a
   Park H, 2008, RNA, V14, P2407, DOI 10.1261/rna.1208808
   Pastorin G, 2006, CHEM COMMUN, P1182, DOI 10.1039/b516309a
   Pathak RK, 2015, WIRES NANOMED NANOBI, V7, P315, DOI 10.1002/wnan.1305
   Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619
   Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198
   Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440
   Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P5787, DOI 10.1093/nar/gkn576
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Serpell CJ, 2016, ACS CENTRAL SCI, V2, P190, DOI 10.1021/acscentsci.6b00005
   THOMAS BJ, 1989, GENETICS, V123, P725
   Wen R, 2016, ADV DRUG DELIVER REV, V99, P52, DOI 10.1016/j.addr.2015.12.024
   Wu QL, 2013, NANOSCALE, V5, P11166, DOI 10.1039/c3nr03917j
   Yoong SL, 2015, NANOSCALE, V7, P13907, DOI 10.1039/c5nr00980d
NR 36
TC 7
Z9 7
U1 0
U2 11
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2016
VL 6
IS 71
BP 67232
EP 67241
DI 10.1039/c6ra14254k
PG 10
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA DS1KD
UT WOS:000380353600102
OA Green Submitted
DA 2024-11-01
ER

PT J
AU Babin, PL
   Rao, SNR
   Chacko, A
   Alvina, FB
   Panwala, A
   Panwala, L
   Fumagalli, DC
AF Babin, Patricia L.
   Rao, Sudheendra N. R.
   Chacko, Anita
   Alvina, Fidelia B.
   Panwala, Anil
   Panwala, Leena
   Fumagalli, Danielle C.
TI Infantile Neuroaxonal Dystrophy: Diagnosis and Possible Treatments
SO FRONTIERS IN GENETICS
LA English
DT Article
DE infantile neuroaxonal dystrophy; rare disease; exome sequencing; enzyme
   replacement therapy; vector gene therapy; CRISPR/Cas9
ID INDEPENDENT PHOSPHOLIPASE A(2); GENETIC-VARIATION; BRAIN; MITOCHONDRIAL;
   THERAPY; CELLS; NEURODEGENERATION; INHIBITION; IPLA(2); DISEASE
AB Infantile Neuroaxonal Dystrophy (INAD) is a rare neurodegenerative disease that often cuts short the life span of a child to 10 years. With a typical onset at 6 months of age, INAD is characterized by regression of acquired motor skills, delayed motor coordination and eventual loss of voluntary muscle control. Biallelic mutations in the PLA2G6 gene have been identified as the most frequent cause of INAD. We highlight the salient features of INAD molecular pathology and the progress made in molecular diagnostics. We reiterate that enhanced molecular diagnostic methodologies such as targeted gene panel testing, exome sequencing, and whole genome sequencing can help ascertain a molecular diagnosis. We describe how the defective catalytic activity of the PLA2G6 gene could be potentially overcome by enzyme replacement or gene correction, giving examples and challenges specific to INAD. This is expected to encourage steps toward developing and testing emerging therapies that might alleviate INAD progression and help realize objectives of patient formed organizations such as the INADcure Foundation.
C1 [Babin, Patricia L.; Rao, Sudheendra N. R.; Chacko, Anita; Alvina, Fidelia B.; Fumagalli, Danielle C.] Rare Genom Inst, Downey, CA 90241 USA.
   [Panwala, Anil; Panwala, Leena] INADcure Fdn, Fairfield, NJ USA.
RP Rao, SNR (corresponding author), Rare Genom Inst, Downey, CA 90241 USA.
EM sudhee26@gmail.com
RI Rao, Sudheendra/K-3017-2014; Rao, Sudheendra/O-2476-2016
OI Rao, Sudheendra/0000-0001-7576-1718
CR [Anonymous], J ASS PHYS INDIA
   BALSINDE J, 1995, P NATL ACAD SCI USA, V92, P8527, DOI 10.1073/pnas.92.18.8527
   Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011
   Bey K, 2017, GENE THER, V24, P325, DOI 10.1038/gt.2017.18
   Dai Wei-Jing, 2016, Mol Ther Nucleic Acids, V5, pe349, DOI 10.1038/mtna.2016.58
   Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897
   FDA, 2017, FDA APPR 1 TREATM FO
   Gregory A, 1993, GENEREVIEWS
   Iodice A, 2017, BRAIN DEV-JPN, V39, P93, DOI 10.1016/j.braindev.2016.08.012
   Jardim L, 2004, J INHERIT METAB DIS, V27, P229, DOI 10.1023/B:BOLI.0000028794.04349.91
   Kapoor S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155605
   Kurian M.A., 2017, PLA2G6 ASS NEURODEGE
   LaFountaine JS, 2015, INT J PHARMACEUT, V494, P180, DOI 10.1016/j.ijpharm.2015.08.029
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Lessard S, 2017, P NATL ACAD SCI USA, V114, pE11257, DOI 10.1073/pnas.1714640114
   Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099
   Liou JY, 2005, EXP CELL RES, V306, P75, DOI 10.1016/j.yexcr.2005.01.011
   Macauley SL, 2009, EXP NEUROL, V218, P5, DOI 10.1016/j.expneurol.2009.03.040
   Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nassif Daniel, 2016, Dement. neuropsychol., V10, P160, DOI 10.1590/S1980-5764-2016DN1002014
   Nishiyama J, 2017, NEURON, V96, P755, DOI 10.1016/j.neuron.2017.10.004
   Ong WY, 2005, J NEUROCYTOL, V34, P447, DOI 10.1007/s11068-006-8730-4
   Pardridge William M, 2005, NeuroRx, V2, P3
   Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057
   Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725
   Ramanadham S, 2015, J LIPID RES, V56, P1643, DOI 10.1194/jlr.R058701
   Roca C, 2017, HUM MOL GENET, V26, P1535, DOI 10.1093/hmg/ddx058
   Scott DA, 2017, NAT MED, V23, P1095, DOI 10.1038/nm.4377
   Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200
   Smith AJ, 2012, GENE THER, V19, P154, DOI 10.1038/gt.2011.161
   Sorrentino NC, 2016, PEDIATR ENDOCR REV P, V13, P630
   Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083
   Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567
   Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023
   Yu-Wai-Man P, 2016, BRIT J OPHTHALMOL, V100, P1322, DOI 10.1136/bjophthalmol-2015-308329
   Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016
NR 37
TC 10
Z9 14
U1 0
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD DEC 10
PY 2018
VL 9
AR 597
DI 10.3389/fgene.2018.00597
PG 5
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HD6MU
UT WOS:000452655000001
PM 30619446
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Bindu, S
   Pillai, VB
   Kanwal, A
   Samant, S
   Mutlu, GM
   Verdin, E
   Dulin, N
   Gupta, MP
AF Bindu, Samik
   Pillai, Vinodkumar B.
   Kanwal, Abhinav
   Samant, Sadhana
   Mutlu, Gokhan M.
   Verdin, Eric
   Dulin, Nickolai
   Gupta, Mahesh P.
TI SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by
   preventing mitochondrial DNA damage
SO AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
LA English
DT Article
DE DNA damage; fibroblasts; pulmonary fibrosis; SIRT3
ID GROWTH-FACTOR-BETA; FATTY-ACID OXIDATION; CELL-DEATH; GENE-EXPRESSION;
   ROS PRODUCTION; LUNG FIBROSIS; TGF-BETA; STRESS; MICE; BLEOMYCIN
AB Myofibroblast differentiation is a key process in the pathogenesis of fibrotic diseases. Transforming growth factor-beta(1) (TGF-beta(1)) is a powerful inducer of myofibroblast differentiation and is implicated in pathogenesis of tissue fibrosis. This study was undertaken to determine the role of mitochondrial deacetylase SIRT3 in TGF-beta(1)-induced myofibroblast differentiation in vitro and lung fibrosis in vivo. Treatment of human lung fibroblasts with TGF-beta(1) resulted in increased expression of fibrosis markers, smooth muscle alpha-actin (alpha-SMA), collagen-1, and fibronectin. TGF-beta(1) treatment also caused depletion of endogenous SIRT3, which paralleled with increased production of reactive oxygen species (ROS), DNA damage, and subsequent reduction in levels of 8-oxoguanine DNA glycosylase (OGG1), an enzyme that hydrolyzes oxidized guanine (8-oxo-dG) and thus protects DNA from oxidative damage. Overexpression of SIRT3 by adenovirus-mediated transduction reversed the effects of TGF-beta(1) on ROS production and mitochondrial DNA damage and inhibited TGF-beta(1)-induced myofibroblast differentiation. To determine the antifibrotic role of SIRT3 in vivo, we used the bleomycin-induced mouse model of pulmonary fibrosis. Compared with wild-type controls, Sirt3-knockout mice showed exacerbated fibrosis after intratracheal instillation of bleomycin. Increased lung fibrosis was associated with decreased levels of OGG1 and concomitant accumulation of 8-oxo-dG and increased mitochondrial DNA damage. In contrast, the transgenic mice with whole body Sirt3 overexpression were protected from bleomycin-induced mtDNA damage and development of lung fibrosis. These data demonstrate a critical role of SIRT3 in the control of myofibroblast differentiation and lung fibrosis.
C1 [Bindu, Samik; Pillai, Vinodkumar B.; Kanwal, Abhinav; Samant, Sadhana; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Mutlu, Gokhan M.; Dulin, Nickolai] Univ Chicago, Dept Med, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Verdin, Eric] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA.
C3 University of Chicago; University of Chicago; University of California
   System; University of California San Francisco; The J David Gladstone
   Institutes
RP Gupta, MP (corresponding author), Univ Chicago, Div Biol Sci, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Gupta, MP (corresponding author), Univ Chicago, Pritzker Sch Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.
EM mgupta@surgery.bsd.uchicago.edu
RI Mutlu, Gokhan/HIR-2545-2022; Verdin, Eric/AAB-7999-2019; Kanwal,
   Abhinav/B-5468-2016
OI Kanwal, Abhinav/0000-0002-6814-3011; Bindu, Samik/0000-0003-1416-2003
FU National Heart, Lung, and Blood Institute [HL-117041, HL-111455,
   1R56HL127395]
FX This study was supported by the National Heart, Lung, and Blood
   Institute RO1 grants HL-117041 and HL-111455 to M. P. Gupta and
   1R56HL127395 to N. O. Dulin.
CR Abrigo J, 2015, PHYTOMEDICINE, V22, P885, DOI 10.1016/j.phymed.2015.06.011
   Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105
   Akamata K, ONCOTARGET IN PRESS, DOI 10.18632/oncotarget.12504
   Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007
   Brar SS, 2012, AM J PHYSIOL-LUNG C, V303, pL413, DOI 10.1152/ajplung.00343.2011
   BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Cheng Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.254
   Cheresh P, 2015, AM J RESP CELL MOL, V52, P25, DOI 10.1165/rcmb.2014-0038OC
   Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Desmoulière A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014
   Gazdhar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05336
   Giralt A, 2012, BIOCHEM J, V444, P1, DOI 10.1042/BJ20120030
   GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Griese M, 2013, AM J RESP CRIT CARE, V188, P83, DOI 10.1164/rccm.201303-0427OC
   Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103
   Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002
   Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com
   Hinz B, 2006, EUR J CELL BIOL, V85, P175, DOI 10.1016/j.ejcb.2005.09.004
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Jablonski RP, 2015, AM J RESP CRIT CARE, V191
   Kach J, 2014, J BIOL CHEM, V289, P7505, DOI 10.1074/jbc.M113.546812
   Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778
   Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200
   Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048
   Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946
   PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649
   Pillai VB, 2016, AM J PHYSIOL-HEART C, V310, pH962, DOI 10.1152/ajpheart.00832.2015
   Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656
   Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015
   Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354
   Rahman M, 2014, J CELL BIOL, V206, P289, DOI 10.1083/jcb.201404118
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Rothfuss O, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1082
   Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13
   Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730
   SANTANA A, 1995, AM J RESP CELL MOL, V13, P34, DOI 10.1165/ajrcmb.13.1.7541221
   Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590
   Singh SK, 2011, NUCLEIC ACIDS RES, V39, P6789, DOI 10.1093/nar/gkr275
   Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08
   Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15
   Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013
   Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810
   Thannickal VJ, 2000, FASEB J, V14, P1741, DOI 10.1096/fj.99-0878com
   Tian F, 2009, REJUV RES, V12, P209, DOI 10.1089/rej.2009.0849
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang QJ, 1999, THORAX, V54, P805, DOI 10.1136/thx.54.9.805
   White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446
   Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21
   Wu YT, 2014, FREE RADICAL RES, V48, P1070, DOI 10.3109/10715762.2014.920956
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yeung M, 2015, APOPTOSIS, V20, P811, DOI 10.1007/s10495-015-1119-z
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
NR 62
TC 74
Z9 80
U1 0
U2 28
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1040-0605
EI 1522-1504
J9 AM J PHYSIOL-LUNG C
JI Am. J. Physiol.-Lung Cell. Mol. Physiol.
PD JAN
PY 2017
VL 312
IS 1
BP L68
EP L78
DI 10.1152/ajplung.00188.2016
PG 11
WC Physiology; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Respiratory System
GA EK2XT
UT WOS:000393791100007
PM 27815257
OA Green Published
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Mahjoub, SZ
AF Finsterer, J.
   Mahjoub, S. Zarrouk
TI Mitochondrial epilepsy in pediatric and adult patients
SO ACTA NEUROLOGICA SCANDINAVICA
LA English
DT Review
DE mitochondrial disorder; epilepsy; seizure; electroencephalography;
   central nervous system involvement; antiepileptic drugs
ID COMPLEX-I-DEFICIENCY; C-OXIDASE DEFICIENCY;
   ALPERS-HUTTENLOCHER-SYNDROME; RAGGED-RED FIBERS; PROGRESSIVE EXTERNAL
   OPHTHALMOPLEGIA; ONSET SPINOCEREBELLAR ATAXIA; PARTIAL STATUS
   EPILEPTICUS; RESPIRATORY-CHAIN DEFECTS; KEARNS-SAYRE-SYNDROME;
   STROKE-LIKE EPISODES
AB Few data are available about the difference between epilepsy in pediatric mitochondrial disorders (MIDs) and adult MIDs. This review focuses on the differences between pediatric and adult mitochondrial epilepsy with regard to seizure type, seizure frequency, and underlying MID. A literature search via Pubmed using the keywords 'mitochondrial', 'epilepsy', 'seizures', 'adult', 'pediatric', and all MID acronyms, was carried out. Frequency of mitochondrial epilepsy strongly depends on the type of MID included and is higher in pediatric compared to adult patients. In pediatric patients, mitochondrial epilepsy is more frequent due to mutations in nDNA-located than mtDNA-located genes and vice versa in adults. In pediatric patients, mitochondrial epilepsy is associated with a syndromic phenotype in half of the patients and in adults more frequently with a non-syndromic phenotype. In pediatric patients, focal seizures are more frequent than generalized seizures and vice versa in adults. Electro-clinical syndromes are more frequent in pediatric MIDs compared to adult MIDs. Differences between pediatric and adult mitochondrial epilepsy concern the onset of epilepsy, frequency of epilepsy, seizure type, type of electro-clinical syndrome, frequency of syndromic versus non-syndromic MIDs, and the outcome. To optimize management of mitochondrial epilepsy, it is essential to differentiate between early and late-onset forms.
C1 [Finsterer, J.] Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
   [Mahjoub, S. Zarrouk] Fac Med Monastir, UR Human Nutr & Metab Disorders, Lab Biochem, Monastir, Tunisia.
C3 Rudolfstiftung Hospital; Universite de Monastir
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
OI ZARROUK-MAHJOUB, SINDA/0000-0002-6763-4644
CR Agapitos Emmanuel, 1997, General and Diagnostic Pathology, V142, P335
   Ahadi AM, 2008, NEUROL NEUROCHIR POL, V42, P263
   [Anonymous], 2010, GENEREVIEWS
   Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489
   Arthur TM, 2007, MITOCHONDRION, V7, P279, DOI 10.1016/j.mito.2007.04.003
   Barghuti F, 2008, MOL GENET METAB, V94, P78, DOI 10.1016/j.ymgme.2007.11.013
   Barnerias C, 2010, DEV MED CHILD NEUROL, V52, pe1, DOI 10.1111/j.1469-8749.2009.03541.x
   Blakely EL, 2009, ARCH NEUROL-CHICAGO, V66, P399, DOI 10.1001/archneurol.2008.576
   Bolszak M, 2009, EPILEPSY RES, V85, P300, DOI 10.1016/j.eplepsyres.2009.03.004
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   Brackmann F, 2012, EUR J PEDIATR, V171, P859, DOI 10.1007/s00431-011-1662-8
   Burglen L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-18
   Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659
   Canafoglia L, 2001, NEUROLOGY, V56, P1340, DOI 10.1212/WNL.56.10.1340
   Cardaioli E, 2011, J NEUROL SCI, V303, P142, DOI 10.1016/j.jns.2010.12.020
   Castro-Gago M, 1999, REV NEUROLOGIA, V29, P912, DOI 10.33588/rn.2910.99062
   Chen Yung-Nien, 2004, Chang Gung Med J, V27, P66
   Cheng J, 2011, AM J HUM GENET, V89, P56, DOI 10.1016/j.ajhg.2011.05.027
   Chou HF, 2008, PEDIATR NEUROL, V38, P143, DOI 10.1016/j.pediatrneurol.2007.09.015
   Corda D, 2006, EPILEPSY BEHAV, V8, P655, DOI 10.1016/j.yebeh.2005.12.011
   Craig AK, 2012, SEIZURE-EUR J EPILEP, V21, P17, DOI 10.1016/j.seizure.2011.08.010
   De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Dermaut B, 2010, J NEUROL NEUROSUR PS, V81, P90, DOI 10.1136/jnnp.2008.157354
   Duncan AJ, 2009, AM J HUM GENET, V84, P558, DOI 10.1016/j.ajhg.2009.03.018
   El Sabbagh S, 2010, EPILEPSIA, V51, P1225, DOI 10.1111/j.1528-1167.2009.02504.x
   El-Hattab A.W., 2012, GeneReviews
   Elia M, 1996, BRAIN DEV-JPN, V18, P207, DOI 10.1016/0387-7604(95)00126-3
   Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843
   Emmanuele V, 2011, MUSCLE NERVE, V44, P448, DOI 10.1002/mus.22149
   Engelsen BA, 2008, BRAIN, V131, P818, DOI 10.1093/brain/awn007
   Ezugha H, 2010, J CHILD NEUROL, V25, P1232, DOI 10.1177/0883073809361165
   Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036
   Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072
   Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Finsterer J, 2009, EUR J NEUROL, V16, P1255, DOI 10.1111/j.1468-1331.2009.02811.x
   Finsterer J, 2012, SEIZURE, V22, P119
   Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013
   Finsterer J, 2012, SEIZURE-EUR J EPILEP, V21, P316, DOI 10.1016/j.seizure.2012.03.003
   Finsterer J, 2012, EXPERT OPIN DRUG MET, V8, P71, DOI 10.1517/17425255.2012.644535
   Finsterer J, 2010, EPILEPTIC DISORD, V12, P330, DOI 10.1684/epd.2010.0338
   Frye RE, 2011, J CHILD NEUROL, V26, P782, DOI 10.1177/0883073810391531
   Furuya H, 1997, Rinsho Shinkeigaku, V37, P680
   Gal A, 2010, ACTA NEUROL SCAND, V122, P252, DOI 10.1111/j.1600-0404.2009.01297.x
   Gati Istvan, 2011, Acta Myol, V30, P188
   Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009
   Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002
   Glamuzina E, 2012, J INHERIT METAB DIS, V35, P459, DOI 10.1007/s10545-011-9413-6
   Gordon N, 2006, DEV MED CHILD NEUROL, V48, P1001, DOI 10.1017/S0012162206002209
   Götz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236
   Gramstad A, 2009, EPILEPSY BEHAV, V16, P172, DOI 10.1016/j.yebeh.2009.01.014
   Grazina MM, 2007, EUR J PAEDIATR NEURO, V11, P115, DOI 10.1016/j.ejpn.2006.11.015
   Gribaa M, 2007, BRAIN, V130, P1921, DOI 10.1093/brain/awm078
   Guerriero S, 2011, MIDDLE EAST AFR J OP, V18, P67, DOI 10.4103/0974-9233.75892
   Hahn A, 2011, NEUROPEDIATRICS, V42, P148, DOI 10.1055/s-0031-1283167
   Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280
   Hakonen Anna H, 2010, Duodecim, V126, P1552
   Hansrote S, 2002, J NEUROL SCI, V197, P63, DOI 10.1016/S0022-510X(02)00048-5
   Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693
   Horváth R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041
   Horvath R, 2012, J NEUROL NEUROSUR PS, V83, P174, DOI 10.1136/jnnp-2011-301258
   HOWARD RS, 1995, QJM-INT J MED, V88, P197
   Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Isohanni P, 2010, J MED GENET, V47, P66, DOI 10.1136/jmg.2009.068221
   Jaksch M, 1998, ANN NEUROL, V44, P635, DOI 10.1002/ana.410440409
   Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795
   Joshi CN, 2009, PEDIATR NEUROL, V40, P314, DOI 10.1016/j.pediatrneurol.2008.10.023
   Jung J, 2007, NEUROLOGY, V68, P1429, DOI 10.1212/01.wnl.0000264019.53959.10
   Kang HC, 2007, CHILD NERV SYST, V23, P1301, DOI 10.1007/s00381-007-0369-7
   Kang HC, 2006, PEDIATR NEUROL, V35, P158, DOI 10.1016/j.pediatrneurol.2006.01.012
   Kaufman KR, 2010, EPILEPSY BEHAV, V18, P494, DOI 10.1016/j.yebeh.2010.05.020
   Keränen T, 2006, EPILEPTIC DISORD, V8, P200
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06
   Kirches E, 1999, PATHOBIOLOGY, V67, P214, DOI 10.1159/000028075
   Koga Y, 2012, BRAIN DEV-JPN, V34, P87, DOI 10.1016/j.braindev.2011.03.003
   KOSINSKI C, 1995, STROKE, V26, P1950, DOI 10.1161/01.STR.26.10.1950
   KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2
   Lee HF, 2011, PEDIATR NEUROL, V45, P169, DOI 10.1016/j.pediatrneurol.2011.04.008
   Lee YM, 2008, EPILEPSIA, V49, P685, DOI 10.1111/j.1528-1167.2007.01522.x
   Lindberg C, 2008, ACTA NEUROL SCAND, V117, P128, DOI 10.1111/j.1600-0404.2007.00913.x
   Liu Yu-Peng, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P561
   Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154
   Lönnqvist T, 2009, BRAIN, V132, P1553, DOI 10.1093/brain/awp045
   López LC, 2006, AM J HUM GENET, V79, P1125, DOI 10.1086/510023
   Lorenzoni PJ, 2011, MITOCHONDRION, V11, P528, DOI 10.1016/j.mito.2011.01.003
   Lupashko S, 2011, CHILD NERV SYST, V27, P1321, DOI 10.1007/s00381-011-1495-9
   Malfatti E, 2010, J NEUROL SCI, V297, P105, DOI 10.1016/j.jns.2010.06.009
   Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1
   Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011
   Mccoy B, 2011, EUR J PAEDIATR NEURO, V15, P558, DOI 10.1016/j.ejpn.2011.05.012
   Melberg A, 1996, ACTA NEUROL SCAND, V94, P233, DOI 10.1111/j.1600-0404.1996.tb07058.x
   Molinari F, 2009, CLIN GENET, V76, P188, DOI 10.1111/j.1399-0004.2009.01236.x
   Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022
   Munakata K, 2007, MUTAT RES-FUND MOL M, V617, P119, DOI 10.1016/j.mrfmmm.2007.01.006
   Naini AB, 2005, ARCH NEUROL-CHICAGO, V62, P473, DOI 10.1001/archneur.62.3.473
   Niehusmann P, 2011, EPILEPSY BEHAV, V20, P38, DOI 10.1016/j.yebeh.2010.11.008
   Nikali K, 2009, GENEREVIEWS, P1993
   Nishigaki Y, 2003, NEUROMUSCULAR DISORD, V13, P334, DOI 10.1016/S0960-8966(02)00283-3
   Nolte KW, 2013, NEUROPATHOLOGY, V33, P59, DOI 10.1111/j.1440-1789.2012.01317.x
   Orcesi S, 2006, J CHILD NEUROL, V21, P79, DOI 10.1177/08830738060210010901
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Pagon, 2010, GENEREVIEWS
   Palin EJH, 2012, J NEUROL SCI, V315, P160, DOI 10.1016/j.jns.2011.11.028
   Parikh S, 2008, PEDIATR NEUROL, V38, P191, DOI 10.1016/j.pediatrneurol.2007.10.011
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Pronicka E, 2011, MED SCI MONITOR, V17, pCR203, DOI 10.12659/MSM.881716
   Pronicki M, 2010, EUR J PAEDIATR NEURO, V14, P253, DOI 10.1016/j.ejpn.2009.09.008
   Quinzii C, 2006, AM J HUM GENET, V78, P345, DOI 10.1086/500092
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Ramelli GP, 2006, J CHILD NEUROL, V21, P253, DOI 10.2310/7010.2006.00047
   Reddy GS, 2011, INDIAN J CLIN BIOCHE, V26, P312, DOI 10.1007/s12291-011-0139-x
   Ribacoba R, 2006, NEUROLOGIA, V21, P1
   Rinalduzzi S, 2012, NEUROL SCI, V33, P419, DOI 10.1007/s10072-011-0755-5
   Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003
   Saitsu H, 2012, EPILEPSIA, V53, P1441, DOI 10.1111/j.1528-1167.2012.03548.x
   Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002
   Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207
   Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772
   Schuelke M, 1998, ANN NEUROL, V44, P700, DOI 10.1002/ana.410440420
   Seaver LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027348
   Seo JH, 2010, BRAIN DEV-JPN, V32, P253, DOI 10.1016/j.braindev.2008.12.020
   Shrikhande DY, 2010, ITAL J PEDIATR, V36, DOI 10.1186/1824-7288-36-62
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434
   Spiegel K, 2012, AM J HUM GENET, V90, P518, DOI 10.1016/j.ajhg.2012.01.009
   Spiegel R, 2011, J MED GENET, V48, P177, DOI 10.1136/jmg.2010.084608
   Sudo A, 2011, J LARYNGOL OTOL, V125, P1282, DOI 10.1017/S0022215111002453
   Sue CM, 2000, ANN NEUROL, V47, P589, DOI 10.1002/1531-8249(200005)47:5<589::AID-ANA6>3.3.CO;2-4
   Sunami Y, 2011, NEUROL SCI, V32, P861, DOI 10.1007/s10072-011-0719-9
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Tam EWY, 2008, NEUROPEDIATRICS, V39, P328, DOI 10.1055/s-0029-1202287
   Taylor RW, 2004, NEUROLOGY, V62, P1420, DOI 10.1212/01.WNL.0000120667.77372.46
   Taylor RW, 2001, ANN NEUROL, V50, P104, DOI 10.1002/ana.1084
   Thorns C, 1998, EXP CLIN ENDOCR DIAB, V106, P384, DOI 10.1055/s-0029-1212003
   Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5
   Toribe Yasuhisa, 2007, No To Hattatsu, V39, P38
   Toyono M, 2001, NEUROMUSCULAR DISORD, V11, P300, DOI 10.1016/S0960-8966(00)00176-0
   Tsao CY, 2001, J CHILD NEUROL, V16, P533, DOI 10.1177/088307380101600716
   Tsao CY, 1997, CLIN ELECTROENCEPHAL, V28, P214, DOI 10.1177/155005949702800405
   Tsuji M, 2003, BRAIN DEV-JPN, V25, P245, DOI 10.1016/S0387-7604(02)00220-6
   Tuppen HAL, 2012, EUR J HUM GENET, V20, P897, DOI 10.1038/ejhg.2012.44
   Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245
   van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716
   vanDomburg PHMF, 1996, BRAIN, V119, P997, DOI 10.1093/brain/119.3.997
   Varlamov DA, 2002, HUM MOL GENET, V11, P1797, DOI 10.1093/hmg/11.16.1797
   Virgilio R, 2009, J NEUROL SCI, V281, P85, DOI 10.1016/j.jns.2009.01.025
   Werner KGE, 2009, PEDIATR NEUROL, V41, P27, DOI 10.1016/j.pediatrneurol.2009.02.010
   YOSHINAGA H, 1993, J CHILD NEUROL, V8, P129, DOI 10.1177/088307389300800204
   Zhao Han-Yue, 2008, Yichuan, V30, P1557, DOI 10.3724/SP.J.1005.2008.01557
   Zsurka G, 2010, NEUROLOGY, V74, P507, DOI 10.1212/WNL.0b013e3181cef7ab
NR 153
TC 16
Z9 17
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6314
EI 1600-0404
J9 ACTA NEUROL SCAND
JI Acta Neurol. Scand.
PD SEP
PY 2013
VL 128
IS 3
BP 141
EP 152
DI 10.1111/ane.12122
PG 12
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 201OY
UT WOS:000323152600004
PM 23480231
OA gold
DA 2024-11-01
ER

PT J
AU Robberecht, K
   Decock, C
   Stevens, A
   Seneca, S
   De Bleecker, J
   Leroy, BP
AF Robberecht, Kirsten
   Decock, Christian
   Stevens, Annemie
   Seneca, Sara
   De Bleecker, Jan
   Leroy, Bart P.
TI Ptosis as an associated finding in maternally inherited diabetes and
   deafness
SO OPHTHALMIC GENETICS
LA English
DT Article
DE Maternally inherited diabetes and deafness; MIDD; Ptosis; mtDNA; m.3243A
   > G
AB Purpose: To report ptosis as an associated finding in 2 patients with maternally inherited diabetes and deafness (MIDD).
   Methods: Two unrelated female patients with genetically proven MIDD are described. A complete ophthalmological examination included evaluation of levator muscle function, vertical fissure height and upper lid crease position measurements, the ice pack test and extensive imaging. In addition, pathology of the levator muscle was performed in 1 patient.
   Results: The first patient had an asymmetric ptosis at presentation. Levator muscle function was initially normal and decreased 3 years after, suggestive of a myogenic ptosis. Fundus examination revealed a macular pattern dystrophy. The second MIDD patient was referred for bilateral pigment alterations at the posterior pole. Gradually bilateral ptosis developed over a 3-year period. In both patients, ocular motility testing revealed a reduced upgaze.
   Conclusions: Myogenic ptosis has been described in association with several of the phenotypes caused by the m.3243A > G mutation, but up to now it had not been described as a finding in MIDD. MIDD has pleomorphic manifestations, and myogenic ptosis should be added to the list of associated clinical features. The additional symmetric elevation deficit in both patients may be an early sign of chronic progressive external ophthalmoplegia (CPEO). The results provide further evidence to suggest that MIDD represents only a part of a continuous spectrum of disease related to the m.3243A > G point mutation in the tRNA<SULeu</SU gene.
C1 [Leroy, Bart P.] Ghent Univ Hosp, Unit Ophthalm Genet & Visual Electrophysiol, Dept Ophthalmol, B-9000 Ghent, Belgium.
   [Seneca, Sara] Brussels Univ Hosp, Ctr Med Genet, Brussels, Belgium.
   [De Bleecker, Jan] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium.
   [Leroy, Bart P.] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.
C3 Ghent University; Ghent University Hospital; University Hospital
   Brussels; Ghent University; Ghent University Hospital; Ghent University;
   Ghent University Hospital
RP Leroy, BP (corresponding author), Ghent Univ Hosp, Unit Ophthalm Genet & Visual Electrophysiol, Dept Ophthalmol, De Pintelaan 185, B-9000 Ghent, Belgium.
EM bart.leroy@ugent.be
RI De Bleecker, Jan/B-7785-2013
OI De Bleecker, Jan/0000-0002-1328-1812; Seneca, Sara/0000-0002-0853-9890
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   ENGEL AG, 2004, MYOLOGY, P681
   Finsterer J, 2007, ACTA NEUROL SCAND, V116, P1, DOI 10.1111/j.1600-0404.2007.00836.x
   Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4
   Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x
   Whittaker RG, 2009, NEUROLOGY, V72, P568, DOI 10.1212/01.wnl.0000342121.91336.4d
NR 6
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1381-6810
EI 1744-5094
J9 OPHTHALMIC GENET
JI Ophthalmic Genet.
PD DEC
PY 2010
VL 31
IS 4
BP 240
EP 243
DI 10.3109/13816810.2010.520297
PG 4
WC Genetics & Heredity; Ophthalmology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Ophthalmology
GA 678WZ
UT WOS:000284115400016
PM 21067488
DA 2024-11-01
ER

PT J
AU Vantyghem, MC
   Dobbelaere, D
   Mention, K
   Wemeau, JL
   Saudubray, JM
   Douillard, C
AF Vantyghem, Marie-Christine
   Dobbelaere, Dries
   Mention, Karine
   Wemeau, Jean-Louis
   Saudubray, Jean-Marie
   Douillard, Claire
TI Endocrine manifestations related to inherited metabolic diseases in
   adults
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Review
DE Inborn errors of metabolism; endocrine dysfunction; hypogonadism;
   diabetes mellitus; thyroid dysfunction; hypopituitarism; adrenal
   failure; hypoparathyroidism
ID PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; X-LINKED ADRENOLEUKODYSTROPHY;
   MITOCHONDRIAL-DNA DELETIONS; CAUSE OVARIAN DYSGENESIS; ONSET
   CEREBELLAR-ATAXIA; KEARNS-SAYRE-SYNDROME; DIABETES-MELLITUS; CONGENITAL
   DISORDERS; HEARING-LOSS; CARBOHYDRATE-METABOLISM
AB Most inborn errors of metabolism (IEM) are recessive, genetically transmitted diseases and are classified into 3 main groups according to their mechanisms: cellular intoxication, energy deficiency, and defects of complex molecules. They can be associated with endocrine manifestations, which may be complications from a previously diagnosed IEM of childhood onset. More rarely, endocrinopathies can signal an IEM in adulthood, which should be suspected when an endocrine disorder is associated with multisystemic involvement (neurological, muscular, hepatic features, etc.). IEM can affect all glands, but diabetes mellitus, thyroid dysfunction and hypogonadism are the most frequent disorders. A single IEM can present with multiple endocrine dysfunctions, especially those involving energy deficiency (respiratory chain defects), and metal (hemochromatosis) and storage disorders (cystinosis). Non-autoimmune diabetes mellitus, thyroid dysfunction and/or goiter and sometimes hypoparathyroidism should steer the diagnosis towards a respiratory chain defect. Hypogonadotropic hypogonadism is frequent in haemochromatosis (often associated with diabetes), whereas primary hypogonadism is reported in Alstrom disease and cystinosis (both associated with diabetes, the latter also with thyroid dysfunction) and galactosemia. Hypogonadism is also frequent in X-linked adrenoleukodystrophy (with adrenal failure), congenital disorders of glycosylation, and Fabry and glycogen storage diseases (along with thyroid dysfunction in the first 3 and diabetes in the last). This is a new and growing field and is not yet very well recognized in adulthood despite its consequences on growth, bone metabolism and fertility. For this reason, physicians managing adult patients should be aware of these diagnoses.
C1 [Vantyghem, Marie-Christine; Wemeau, Jean-Louis; Douillard, Claire] Ctr Hosp Reg & Univ Lille, Hop C Huriez, Serv Endocrinol & Malad Metab, F-59037 Lille, France.
   [Dobbelaere, Dries; Mention, Karine; Douillard, Claire] Ctr Hosp Reg & Univ Lille, Hop Jeanne de Flandres, Ctr Reference Erreurs Innees Metab, F-59037 Lille, France.
   [Saudubray, Jean-Marie] Hop La Pitie Salpetriere, AP HP, Dept Malad Metab, Paris, France.
   [Saudubray, Jean-Marie] Univ Paris 06, F-75252 Paris 05, France.
C3 Universite de Lille; CHU Lille; Universite de Lille; CHU Lille; Sorbonne
   Universite; Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Pitie-Salpetriere - APHP; Sorbonne Universite
RP Vantyghem, MC (corresponding author), Ctr Hosp Reg & Univ Lille, Hop C Huriez, Serv Endocrinol & Malad Metab, 1 Rue Polonovski, F-59037 Lille, France.
EM mcvantyghem@gmail.com
RI VANTYGHEM, Marie/T-8613-2019; VANTYGHEM, Marie-Christine/P-2939-2017
OI VANTYGHEM, Marie-Christine/0000-0002-9369-0463
CR Achouitar S, 2011, J INHERIT METAB DIS, V34, P923, DOI 10.1007/s10545-011-9325-5
   ALTER CA, 1993, AM J DIS CHILD, V147, P97, DOI 10.1001/archpedi.1993.02160250099030
   Alzahrani AS, 2006, EUR J ENDOCRINOL, V155, P787, DOI 10.1530/eje.1.02305
   [Anonymous], J INHERIT METAB DIS
   [Anonymous], BIOCH BIOPHYS ACTA
   Assies J, 1997, INT J ANDROL, V20, P315, DOI 10.1046/j.1365-2605.1997.00066.x
   Aversa A, 1998, HUM REPROD, V13, P2474, DOI 10.1093/humrep/13.9.2474
   Bacchetta J, 2010, PEDIATR NEPHROL, V25, P1081, DOI 10.1007/s00467-010-1453-x
   Balestri P, 2000, J CHILD NEUROL, V15, P755, DOI 10.1177/088307380001501108
   Barton JC, 2008, THYROID, V18, P831, DOI 10.1089/thy.2008.0091
   Baruteau J, 2009, J PEDIATR ENDOCR MET, V22, P1175
   Benelli E, 2008, THYROID, V18, P1001, DOI 10.1089/thy.2007.0228
   Besouw M, 2010, MINERVA PEDIATR, V62, P307
   Bettini V, 2012, PEDIATR DIABETES, V13, P59, DOI 10.1111/j.1399-5448.2011.00789.x
   Boles RG, 1998, EUR J PEDIATR, V157, P643, DOI 10.1007/s004310050902
   Borgna-Pignatti C, 2009, J PEDIATR-US, V155, P295, DOI 10.1016/j.jpeds.2009.01.062
   Bouyahia O, 2009, ANN ENDOCRINOL-PARIS, V70, P477, DOI 10.1016/j.ando.2009.09.001
   Brissot P, 2010, EXPERT REV MOL DIAGN, V10, P755, DOI [10.1586/erm.10.55, 10.1586/ERM.10.55]
   Bruno C, 1998, J INHERIT METAB DIS, V21, P155, DOI 10.1023/A:1005347826664
   Buretic-Tomljanovic A, 2009, FERTIL STERIL, V91, P1793, DOI 10.1016/j.fertnstert.2008.02.129
   Carod-Artal FJ, 2007, EUR J NEUROL, V14, P581, DOI 10.1111/j.1468-1331.2007.01720.x
   Coman D, 2007, J CLIN NEUROSCI, V14, P668, DOI 10.1016/j.jocn.2006.04.008
   COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0
   Cryns K, 2003, HUM MUTAT, V22, P275, DOI 10.1002/humu.10258
   Dahl R, 2011, J MED CHEM, V54, P3661, DOI 10.1021/jm101401a
   DEZEGHER F, 1995, PEDIATR RES, V37, P395
   Dumitrescu AM, 2011, ANN ENDOCRINOL-PARIS, V72, P95, DOI 10.1016/j.ando.2011.03.011
   Ebberink MS, 2011, HUM MUTAT, V32, P59, DOI 10.1002/humu.21388
   Erdem E, 2010, J PEDIATR ENDOCR MET, V23, P503, DOI 10.1515/jpem.2010.082
   Faggiano A, 2006, J CLIN ENDOCR METAB, V91, P4319, DOI 10.1210/jc.2006-0858
   Faggiano A, 2011, MINERVA ENDOCRINOL, V36, P1
   Farahani H, 2010, HORM METAB RES, V42, P792, DOI 10.1055/s-0030-1262826
   Fasano A, 2008, MOVEMENT DISORD, V23, P751, DOI 10.1002/mds.21938
   Ferraris S, 2008, ARCH NEUROL-CHICAGO, V65, P125, DOI 10.1001/archneurol.2007.9
   Filler G, 1998, EUR J PEDIATR, V157, P738, DOI 10.1007/s004310050926
   Forges T, 2006, HUM REPROD UPDATE, V12, P573, DOI 10.1093/humupd/dml031
   Frints SGM, 2008, EUR J HUM GENET, V16, P1029, DOI 10.1038/ejhg.2008.66
   Frishberg Y, 2000, J PEDIATR-US, V136, P255, DOI 10.1016/S0022-3476(00)70112-0
   Gahl WA, 2007, ANN INTERN MED, V147, P242, DOI 10.7326/0003-4819-147-4-200708210-00006
   GAMA R, 1995, POSTGRAD MED J, V71, P297, DOI 10.1136/pgmj.71.835.297
   Gamberini Maria Rita, 2008, Pediatr Endocrinol Rev, V6 Suppl 1, P158
   Giannitrapani L, 2006, ANN NY ACAD SCI, V1089, P228, DOI 10.1196/annals.1386.044
   Girard D, 2011, NAT REV ENDOCRINOL, V7, P77, DOI 10.1038/nrendo.2010.210
   Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7
   Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871
   Gubbels CS, 2008, OBSTET GYNECOL SURV, V63, P334, DOI 10.1097/OGX.0b013e31816ff6c5
   Gubbels CS, 2011, J INHERIT METAB DIS, V34, P387, DOI 10.1007/s10545-010-9180-9
   Harambat J, 2010, KIDNEY INT, V77, P443, DOI 10.1038/ki.2009.435
   Hartemann-Heurtier A, 2009, DIABETES METAB, V35, P233, DOI 10.1016/j.diabet.2009.01.003
   HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P97, DOI 10.1111/j.1365-2265.1992.tb02289.x
   Hauser AC, 2005, J INHERIT METAB DIS, V28, P715, DOI 10.1007/s10545-005-0003-3
   Hopkins SE, 2010, J CHILD NEUROL, V25, P752, DOI 10.1177/0883073809343313
   Hsieh RH, 2001, J BIOMED SCI, V8, P328, DOI 10.1159/000054051
   Hudec M, 2008, THYROID, V18, P255, DOI 10.1089/thy.2007.0140
   Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534
   Vega AI, 2011, J INHERIT METAB DIS, V34, P929, DOI 10.1007/s10545-011-9328-2
   Ismail Heba, 2009, Cases J, V2, P6891, DOI 10.4076/1757-1627-2-6891
   Isotani H, 1996, CLIN ENDOCRINOL, V45, P637, DOI 10.1046/j.1365-2265.1996.00856.x
   Jaeken J, 2011, J INHERIT METAB DIS, V34, P853, DOI 10.1007/s10545-011-9299-3
   Kapoor RR, 2011, DIABETOLOGIA, V54, P2575, DOI 10.1007/s00125-011-2207-4
   Karicheva OZ, 2011, NUCLEIC ACIDS RES, V39, P8173, DOI 10.1093/nar/gkr546
   Kleefstra T, 2011, EUR J HUM GENET, V19, P138, DOI 10.1038/ejhg.2010.171
   Klupa T, 2009, CLIN ENDOCRINOL, V71, P358, DOI 10.1111/j.1365-2265.2008.03478.x
   Kobayashi T, 1997, DIABETES, V46, P1567, DOI 10.2337/diabetes.46.10.1567
   Koç E, 2006, NEPHROLOGY, V11, P81, DOI 10.1111/j.1440-1797.2006.00443.x
   Koyama C, 2005, J HEPATOL, V43, P740, DOI 10.1016/j.jhep.2005.06.024
   Krasnewich D, 2007, AM J MED GENET C, V145C, P302, DOI 10.1002/ajmg.c.30143
   Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041
   KRISTIANSSON B, 1995, ACTA PAEDIATR, V84, P655, DOI 10.1111/j.1651-2227.1995.tb13720.x
   Lacombe D, 2010, REV MED INTERNE, V31, pS214, DOI 10.1016/S0248-8663(10)70014-X
   Laloi-Michelin M, 2009, J CLIN ENDOCR METAB, V94, P3025, DOI 10.1210/jc.2008-2680
   Lanes R, 2000, J PEDIATR ENDOCR MET, V13, P325
   Lecca MR, 2011, J CELL MOL MED, V15, P1788, DOI 10.1111/j.1582-4934.2010.01187.x
   LEE PJ, 1995, CLIN ENDOCRINOL, V42, P601, DOI 10.1111/j.1365-2265.1995.tb02686.x
   Liang W C, 2010, Acta Myol, V29, P351
   Lightfoot YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020617
   Lindroos MM, 2009, DIABETES, V58, P543, DOI 10.2337/db08-0981
   Lopez-Erauskin J, 2011, ANN NEUROL, V70, P84, DOI 10.1002/ana.22363
   Maffei P, 2007, CLIN ENDOCRINOL, V66, P269, DOI 10.1111/j.1365-2265.2007.02721.x
   Marquard J, 2011, EUR J PEDIATR, V170, P241, DOI 10.1007/s00431-010-1313-5
   Marshall JD, 2005, ARCH INTERN MED, V165, P675, DOI 10.1001/archinte.165.6.675
   Massin P, 2008, DIABETOLOGIA, V51, P1664, DOI 10.1007/s00125-008-1073-1
   McDermott JH, 2005, J CLIN ENDOCR METAB, V90, P2451, DOI 10.1210/jc.2004-0980
   Melis D, 2007, J PEDIATR-US, V150, P300, DOI 10.1016/j.jpeds.2006.11.056
   Mezghani N, 2011, BIOCHEM BIOPH RES CO, V411, P247, DOI 10.1016/j.bbrc.2011.06.106
   Miller BS, 2011, MOL GENET METAB, V103, P101, DOI 10.1016/j.ymgme.2011.01.016
   Miller BS, 2003, REV ENDOCR METAB DIS, V4, P103, DOI 10.1023/A:1021883605280
   Misery L, 2002, ANN MED INTERNE, V153, P283
   Mokashi A, 2011, PEDIATR DIABETES, V12, P270, DOI 10.1111/j.1399-5448.2010.00698.x
   MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001
   MOSEWICH RK, 1993, ARCH NEUROL-CHICAGO, V50, P275, DOI 10.1001/archneur.1993.00540030041012
   Nicolino M, 1997, J CLIN ENDOCR METAB, V82, P3063, DOI 10.1210/jc.82.9.3063
   Noormets K, 2011, EXP CLIN ENDOCR DIAB, V119, P271, DOI 10.1055/s-0030-1265163
   Ogimoto M, 2011, INTERNAL MED, V50, P1415, DOI 10.2169/internalmedicine.50.5108
   Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612
   Okada M, 1998, Nihon Shokakibyo Gakkai Zasshi, V95, P445
   Oki Y, 2000, DIABETIC MED, V17, P810, DOI 10.1046/j.1464-5491.2000.00378.x
   Panis B, 2007, EUR J PEDIATR, V166, P443, DOI 10.1007/s00431-006-0255-4
   Papadimitriou A, 1996, NEUROMUSCULAR DISORD, V6, P49, DOI 10.1016/0960-8966(95)00020-8
   Pfeffer G, 2011, CAN J NEUROL SCI, V38, P119, DOI 10.1017/S031716710001115X
   Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108
   Pierce SB, 2010, AM J HUM GENET, V87, P282, DOI 10.1016/j.ajhg.2010.07.007
   Polgreen LE, 2011, EUR J PEDIATR, V170, P1049, DOI 10.1007/s00431-011-1401-1
   QUADE A, 1992, CLIN INVESTIGATOR, V70, P396
   Ramos HE, 2011, EUR J ENDOCRINOL, V164, P309, DOI 10.1530/EJE-10-0679
   Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401
   Rubio-Gozalbo ME, 2010, HUM REPROD UPDATE, V16, P177, DOI 10.1093/humupd/dmp038
   Rubio-Gozalbo ME, 2006, MOL GENET METAB, V89, P316, DOI 10.1016/j.ymgme.2006.07.005
   Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687
   Sansanwal P, 2010, J INHERIT METAB DIS, V33, P775, DOI 10.1007/s10545-010-9203-6
   Saudubray JM, 2009, ANN ENDOCRINOL-PARIS, V70, P14, DOI 10.1016/j.ando.2008.12.004
   Schiff M, 2009, J INHERIT METAB DIS, V32, P684, DOI 10.1007/s10545-009-1263-0
   Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653
   Schoffer KL, 2006, MOVEMENT DISORD, V21, P869, DOI 10.1002/mds.20804
   Schomburg L, 2009, THYROID, V19, P277, DOI 10.1089/thy.2008.0397
   Schweitzer-Krantz S, 2003, EUR J PEDIATR, V162, pS50, DOI 10.1007/s00431-003-1352-2
   Sevin C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-8
   Shimizu J, 2008, CLIN NEPHROL, V70, P348
   Spiegel R, 2005, J PEDIATR ENDOCR MET, V18, P617
   STRISCIUGLIO P, 1987, EUR J PEDIATR, V146, P431, DOI 10.1007/BF00444957
   SUZUKI S, 1994, DIABETOLOGIA, V37, P818, DOI 10.1007/s001250050183
   Tengan CH, 1998, J CLIN ENDOCR METAB, V83, P125, DOI 10.1210/jc.83.1.125
   Tintillier M, 2004, CLIN NEPHROL, V62, P155
   Tyni T, 1997, J PEDIATR-US, V131, P766, DOI 10.1016/S0022-3476(97)70111-2
   Valenti L, 2009, OSTEOPOROSIS INT, V20, P549, DOI 10.1007/s00198-008-0701-4
   Vantyghem MC, 2006, EUR J ENDOCRINOL, V154, P835, DOI 10.1530/eje.1.02152
   Wang Y, 2011, MOL GENET METAB, V104, P160, DOI 10.1016/j.ymgme.2011.05.016
   Watanabe M, 2010, INTERNAL MED, V49, P1581, DOI 10.2169/internalmedicine.49.3508
   Wémeau JL, 2008, J CLIN ENDOCR METAB, V93, P2084, DOI 10.1210/jc.2007-2719
   WINKLER L, 1993, EUR J PEDIATR, V152, P244, DOI 10.1007/BF01956154
   Wirth EK, 2011, EUR J ENDOCRINOL, V165, P555, DOI 10.1530/EJE-11-0369
   Yamasaki Ryo, 2004, Rinsho Shinkeigaku, V44, P291
NR 132
TC 29
Z9 31
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD JAN 28
PY 2012
VL 7
AR 11
DI 10.1186/1750-1172-7-11
PG 19
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA 940GF
UT WOS:000303877300001
PM 22284844
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Fitzsimmons, CM
   Mandler, MD
   Lunger, JC
   Chan, DL
   Maligireddy, SS
   Schmiechen, AC
   Gamage, ST
   Link, C
   Jenkins, LM
   Chan, K
   Andresson, T
   Crooks, DR
   Meier, JL
   Linehan, WM
   Batista, PJ
AF Fitzsimmons, Christina M.
   Mandler, Mariana D.
   Lunger, Judith C.
   Chan, Dalen
   Maligireddy, Siddhardha S.
   Schmiechen, Alexandra C.
   Gamage, Supuni Thalalla
   Link, Courtney
   Jenkins, Lisa M.
   Chan, King
   Andresson, Thorkell
   Crooks, Daniel R.
   Meier, Jordan L.
   Linehan, W. Marston
   Batista, Pedro J.
TI Rewiring of RNA methylation by the oncometabolite fumarate in renal cell
   carcinoma
SO NAR CANCER
LA English
DT Article
ID MESSENGER-RNA; HEREDITARY LEIOMYOMATOSIS; SUCCINATE-DEHYDROGENASE;
   MITOCHONDRIAL DYSFUNCTION; SDH MUTATIONS; CANCER HLRCC; TCA CYCLE;
   IN-VIVO; HYDRATASE; M(6)A
AB Metabolic reprogramming is a hallmark of cancer that facilitates changes in many adaptive biological processes. Mutations in the tricarboxylic acid cycle enzyme fumarate hydratase (FH) lead to fumarate accumulation and cause hereditary leiomyomatosis and renal cell cancer (HLRCC). HLRCC is a rare, inherited disease characterized by the development of non-cancerous smooth muscle tumors of the uterus and skin, and an increased risk of an aggressive form of kidney cancer. Fumarate has been shown to inhibit 2-oxoglutarate-dependent dioxygenases (2OGDDs) involved in the hydroxylation of HIF1 alpha, as well as in DNA and histone demethylation. However, the link between fumarate accumulation and changes in RNA post-transcriptional modifications has not been defined. Here, we determine the consequences of fumarate accumulation on the activity of different members of the 2OGDD family targeting RNA modifications. By evaluating multiple RNA modifications in patient-derived HLRCC cell lines, we show that mutation of FH selectively affects the levels of N6-methyladenosine (m6A), while the levels of 5-formylcytosine (f5C) in mitochondrial tRNA are unaffected. This supports the hypothesis of a differential impact of fumarate accumulation on distinct RNA demethylases. The observation that metabolites modulate specific subsets of RNA-modifying enzymes offers new insights into the intersection between metabolism and the epitranscriptome.
   Graphical Abstract
C1 [Fitzsimmons, Christina M.; Mandler, Mariana D.; Lunger, Judith C.; Chan, Dalen; Maligireddy, Siddhardha S.; Schmiechen, Alexandra C.; Jenkins, Lisa M.; Batista, Pedro J.] NCI, NIH, Ctr Canc Res, Lab Cell Biol, Bethesda, MD 20892 USA.
   [Gamage, Supuni Thalalla; Link, Courtney; Meier, Jordan L.] NCI, Ctr Canc Res, Chem Biol Lab, Frederick, MD 21702 USA.
   [Chan, King; Andresson, Thorkell] NCI, NIH, Res Technol Program, Prot Characterizat Lab,Frederick Natl Lab Canc Res, Frederick, MD 21701 USA.
   [Crooks, Daniel R.; Linehan, W. Marston] NCI, NIH, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); National Institutes of Health (NIH) - USA; NIH National
   Cancer Institute (NCI); Frederick National Laboratory for Cancer
   Research; National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI)
RP Batista, PJ (corresponding author), NCI, NIH, Ctr Canc Res, Lab Cell Biol, Bethesda, MD 20892 USA.
EM pedro.batista@nih.gov
OI Mandler, Mariana/0000-0003-1609-6871; Fitzsimmons,
   Christina/0000-0002-6743-2671; Maligireddy,
   Siddhardha/0000-0003-1143-7788; Link, Courtney/0000-0001-7302-4124;
   Lunger, Judith/0000-0002-6241-1070
FU National Cancer Institute; Center for Cancer Research (CCR) Genomics
   Core in Bethesda, Maryland
FX We thank Jaye Gardiner, Susan Gottesman, Sezen Meydan Marks, Khoa Tran,
   Joana Vidigal and members of her lab, and Sandra Wolin for critical
   reading of the manuscript. The authors thank the Center for Cancer
   Research (CCR) Genomics Core in Bethesda, Maryland, as well as the CCR
   Sequencing Facility in Frederick, Maryland, for help with
   high-throughput sequencing. The authors would also like to thank the CCR
   mass spectrometry core for their help with the metabolite MS
   experiments, and the CCR Microscopy core for their help with the IF
   experiments. This work utilized the computational resources of the NIH
   HPC Biowulf cluster (http://hpc.nih.gov). We appreciate the editorial
   assistance of George Leiman. The views expressed in this article are
   those of authors and may not reflect the official policy or position of
   the National Institute of Health, Department of the Army, Department of
   Defense. Mention of trade names, commercial products, or organizations
   does not imply endorsement by the U.S. Government.
CR Adam J, 2013, CELL REP, V3, P1440, DOI 10.1016/j.celrep.2013.04.006
   Aguilo F, 2015, CELL STEM CELL, V17, P689, DOI 10.1016/j.stem.2015.09.005
   Akichika S, 2019, SCIENCE, V363, P141, DOI 10.1126/science.aav0080
   Akram M, 2014, CELL BIOCHEM BIOPHYS, V68, P475, DOI 10.1007/s12013-013-9750-1
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1
   Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030
   Arguello AE, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31876-2
   Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003
   Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019
   Boulias K, 2019, MOL CELL, V75, P631, DOI 10.1016/j.molcel.2019.06.006
   Brunner JS, 2023, NAT REV ENDOCRINOL, V19, P134, DOI 10.1038/s41574-022-00773-5
   Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981
   Covelo-Molares H, 2021, NUCLEIC ACIDS RES, V49, P10895, DOI 10.1093/nar/gkab900
   CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y
   Crooks DR, 2021, SCI SIGNAL, V14, DOI 10.1126/scisignal.abc4436
   De Sousa SMC, 2020, J ENDOCR SOC, V4, DOI 10.1210/jendso/bvaa071
   Delaunay S, 2022, NATURE, V607, P593, DOI 10.1038/s41586-022-04898-5
   Dobin A, 2016, METHODS MOL BIOL, V1415, P245, DOI 10.1007/978-1-4939-3572-7_13
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Fedeles BI, 2015, J BIOL CHEM, V290, P20734, DOI 10.1074/jbc.R115.656462
   Flynn RA, 2016, NAT PROTOC, V11, P273, DOI 10.1038/nprot.2016.011
   Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710
   Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417
   Gokhale NS, 2020, MOL CELL, V77, P542, DOI 10.1016/j.molcel.2019.11.007
   Grozhik AV, 2017, METHODS MOL BIOL, V1562, P55, DOI 10.1007/978-1-4939-6807-7_5
   Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   He PC, 2021, EMBO J, V40, DOI 10.15252/embj.2020105977
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Herzog VA, 2017, NAT METHODS, V14, P1198, DOI [10.1038/NMETH.4435, 10.1038/nmeth.4435]
   Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086
   Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017
   Islam MS, 2018, ANNU REV BIOCHEM, V87, P585, DOI 10.1146/annurev-biochem-061516-044724
   Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772
   Joberty G, 2016, ACS CHEM BIOL, V11, P2002, DOI 10.1021/acschembio.6b00080
   Justus CR, 2014, JOVE-J VIS EXP, DOI 10.3791/51046
   Kamp M., 2023, bioRxiv, DOI [10.1101/2023.07.02.547209, DOI 10.1101/2023.07.02.547209]
   Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354
   Killian JK, 2013, CANCER DISCOV, V3, P648, DOI 10.1158/2159-8290.CD-13-0092
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Kluesner MG, 2018, CRISPR J, V1, P239, DOI 10.1089/crispr.2018.0014
   Kulkarni RA, 2019, CHEMBIOCHEM, V20, P360, DOI 10.1002/cbic.201800651
   Lee H, 2019, NAT CELL BIOL, V21, P700, DOI 10.1038/s41556-019-0318-1
   Letouzé E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017
   Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917
   Link CN, 2022, BIOCHEMISTRY-US, V61, P535, DOI 10.1021/acs.biochem.1c00761
   Liu C, 2023, NAT BIOTECHNOL, V41, P355, DOI 10.1038/s41587-022-01487-9
   Liu L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1808-4
   Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468
   Losman JA, 2020, NAT REV CANCER, V20, P710, DOI 10.1038/s41568-020-00303-3
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840
   Martin M., 2011, EMBnet.Journal, V17, P10, DOI 10.14806/ej.17.1.200
   Martinez-Pastor B, 2013, CANCER DISCOV, V3, P497, DOI 10.1158/2159-8290.CD-13-0059
   Mauer J, 2019, NAT CHEM BIOL, V15, P340, DOI 10.1038/s41589-019-0231-8
   McIntyre ABR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63355-3
   Menko FH, 2014, FAM CANCER, V13, P637, DOI 10.1007/s10689-014-9735-2
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Miettinen M, 2014, INT J BIOCHEM CELL B, V53, P514, DOI 10.1016/j.biocel.2014.05.033
   Miyazawa H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.131110
   Müller TA, 2018, BIOCHEM BIOPH RES CO, V495, P98, DOI 10.1016/j.bbrc.2017.10.158
   Muhar M, 2018, SCIENCE, V360, P800, DOI 10.1126/science.aao2793
   Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]
   Olarerin-George Anthony O, 2017, Bioinformatics, V33, P1563, DOI 10.1093/bioinformatics/btx002
   Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002
   Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038
   Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227
   Qu JW, 2022, J HEMATOL ONCOL, V15, DOI 10.1186/s13045-022-01224-4
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ricketts CJ, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0278108
   Safra M, 2017, NATURE, V551, P251, DOI 10.1038/nature24456
   Sandhu IS, 2015, BIOCHEM SOC T, V43, P650, DOI 10.1042/BST20150041
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]
   Schvartzman JM, 2018, J CELL BIOL, V217, P2247, DOI 10.1083/jcb.201803061
   Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353
   Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022
   Sieber MH, 2017, CURR OPIN GENET DEV, V45, P58, DOI 10.1016/j.gde.2017.03.002
   Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116
   Su R, 2018, CELL, V172, P90, DOI 10.1016/j.cell.2017.11.031
   Sun GX, 2021, CLIN CANCER RES, V27, P1734, DOI 10.1158/1078-0432.CCR-20-3788
   Sun HX, 2019, CELL RES, V29, P80, DOI 10.1038/s41422-018-0117-4
   Sun LD, 2016, CELL CYCLE, V15, P2647, DOI 10.1080/15384101.2016.1211214
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Tandon N, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3073
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   Tong WH, 2011, CANCER CELL, V20, P315, DOI 10.1016/j.ccr.2011.07.018
   Tsujikawa K, 2007, J CELL MOL MED, V11, P1105, DOI 10.1111/j.1582-4934.2007.00094.x
   Van Deuren V, 2020, DNA REPAIR, V96, DOI 10.1016/j.dnarep.2020.102995
   Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039
   Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011
   Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200
   Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112
   Xiao Y, 2018, ANGEW CHEM INT EDIT, V57, P15995, DOI 10.1002/anie.201807942
   Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
   Yang YF, 2012, CANCER GENET-NY, V205, P377, DOI 10.1016/j.cancergen.2012.05.001
   Yang Y, 2010, CANCER GENET CYTOGEN, V196, P45, DOI 10.1016/j.cancergencyto.2009.08.018
   Zhang CJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf6045
   Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116
   Zhang Y, 2021, MOL BIOL REP, V48, P4747, DOI 10.1007/s11033-021-06421-x
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zheng L, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-12
   Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6
   Zuidhof HR, 2022, CANCER RES, V82, P2201, DOI [10.1158/0008-5472.CAN-21-371, 10.1158/0008-5472.CAN-21-3710]
NR 110
TC 4
Z9 4
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2632-8674
J9 NAR CANCER
JI NAR Cancer
PD JAN 9
PY 2024
VL 6
IS 1
AR zcae004
DI 10.1093/narcan/zcae004
PG 20
WC Biochemistry & Molecular Biology; Oncology
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology; Oncology
GA HD9R0
UT WOS:001157678300001
PM 38328795
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Di Nottia, M
   Marchese, M
   Verrigni, D
   Mutti, CD
   Torraco, A
   Oliva, R
   Fernandez-Vizarra, E
   Morani, F
   Trani, G
   Rizza, T
   Ghezzi, D
   Ardissone, A
   Nesti, C
   Vasco, G
   Zeviani, M
   Minczuk, M
   Bertini, E
   Santorelli, FM
   Carrozzo, R
AF Di Nottia, Michela
   Marchese, Maria
   Verrigni, Daniela
   Mutti, Christian Daniel
   Torraco, Alessandra
   Oliva, Romina
   Fernandez-Vizarra, Erika
   Morani, Federica
   Trani, Giulia
   Rizza, Teresa
   Ghezzi, Daniele
   Ardissone, Anna
   Nesti, Claudia
   Vasco, Gessica
   Zeviani, Massimo
   Minczuk, Michal
   Bertini, Enrico
   Santorelli, Filippo Maria
   Carrozzo, Rosalba
TI A homozygous <i>MRPL24</i> mutation causes a complex movement disorder
   and affects the mitoribosome assembly
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE Mitochondrial disorders; Movement disorder; MRPL24; Mitoribosomes;
   Mitochondrial protein synthesis; Zebrafish; Molecular modeling; Protein
   interactions
ID FATTY LIVER-DISEASE; MITOCHONDRIAL RIBOSOMES; SUBUNIT; GENES; REVEALS;
   LEADS
AB Mitochondrial ribosomal protein large 24 (MRPL24) is 1 of the 82 protein components of mitochondrial ribosomes, playing an essential role in the mitochondrial translation process.
   We report here on a baby girl with cerebellar atrophy, choreoathetosis of limbs and face, intellectual disability and a combined defect of complexes I and IV in muscle biopsy, caused by a homozygous missense mutation identified in MRPL24. The variant predicts a Leu91Pro substitution at an evolutionarily conserved site. Using human mutant cells and the zebrafish model, we demonstrated the pathological role of the identified variant. In fact, in fibroblasts we observed a significant reduction of MRPL24 protein and of mitochondrial respiratory chain complex I and IV subunits, as well a markedly reduced synthesis of the mtDNA-encoded peptides. In zebrafish we demonstrated that the orthologue gene is expressed in metabolically active tissues, and that gene knockdown induced locomotion impairment, structural defects and low ATP production. The motor phenotype was complemented by human WT but not mutant cRNA. Moreover, sucrose density gradient fractionation showed perturbed assembly of large subunit mitoribosomal proteins, suggesting that the mutation leads to a conformational change in MRPL24, which is expected to cause an aberrant interaction of the protein with other components of the 39S mitoribosomal subunit.
C1 [Di Nottia, Michela; Verrigni, Daniela; Torraco, Alessandra; Trani, Giulia; Rizza, Teresa; Bertini, Enrico; Carrozzo, Rosalba] Bambino Gesu Pediat Hosp, Unit Muscular & Neurodegenerat Disorders, Lab Mol Med, IRCCS, Viale San Paolo 15, I-00146 Rome, Italy.
   [Marchese, Maria; Morani, Federica; Nesti, Claudia; Santorelli, Filippo Maria] IRCCS Fdn Stella Maris, Mol Med & Neurogenet, Pisa, Italy.
   [Mutti, Christian Daniel; Fernandez-Vizarra, Erika; Zeviani, Massimo; Minczuk, Michal] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England.
   [Oliva, Romina] Univ Parthenope Naples, Dept Sci & Technol, Naples, Italy.
   [Ghezzi, Daniele] Fdn IRCCS Ist Neurol Carlo Besta, Unit Med Genet & Neurogenet, Milan, Italy.
   [Ghezzi, Daniele] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Ardissone, Anna] Fdn IRCCS Ist Neurol Carlo Besta, Child Neurol Unit, Milan, Italy.
   [Ardissone, Anna] Univ Milano Bicocca, Dept Mol & Translat Med DIMET, Milan, Italy.
   [Vasco, Gessica] IRCCS Bambino Gesu Children Hosp, Dept Neurosci, Rome, Italy.
C3 IRCCS Bambino Gesu; IRCCS Fondazione Stella Maris; University of
   Cambridge; Parthenope University Naples; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; University of Milan; Fondazione IRCCS Istituto
   Neurologico Carlo Besta; University of Milano-Bicocca; IRCCS Bambino
   Gesu
RP Carrozzo, R (corresponding author), Bambino Gesu Pediat Hosp, Unit Muscular & Neurodegenerat Disorders, Lab Mol Med, IRCCS, Viale San Paolo 15, I-00146 Rome, Italy.
EM rosalba.carrozzo@opbg.net
RI Torraco, Alessandra/AAA-6212-2020; Oliva, Romina/ABA-6313-2021; Zeviani,
   Massimo/AAU-2632-2021; Rizza, Teresa/AAA-6260-2020; daniela,
   verrigni/K-3645-2014; Bertini, Enrico/ABG-1278-2020; Di Nottia,
   Michela/J-5207-2018; Morani, Federica/ISV-0165-2023; Carrozzo,
   Rosalba/A-2808-2014; Bertini, Enrico/A-2284-2014; Nesti,
   Claudia/K-5866-2016; Minczuk, Michal/G-1638-2014; Morani,
   Federica/D-2365-2018; Ardissone, Anna/K-8495-2016; marchese,
   maria/J-8703-2014; vasco, gessica/K-8144-2016; Santorelli, Filippo
   M/ABE-5124-2020
OI Carrozzo, Rosalba/0000-0002-3327-4054; Oliva,
   Romina/0000-0002-6156-6249; Bertini, Enrico/0000-0001-9276-4590; Nesti,
   Claudia/0000-0001-5769-8655; Minczuk, Michal/0000-0001-8242-1420;
   Morani, Federica/0000-0002-4903-6878; Ardissone,
   Anna/0000-0003-1969-0147; Zeviani, Massimo/0000-0002-9067-5508;
   marchese, maria/0000-0002-0194-0702; Fernandez-Vizarra,
   Erika/0000-0002-2469-142X; vasco, gessica/0000-0001-9807-9578;
   Santorelli, Filippo M/0000-0002-1359-9062
FU Italian Ministry of Health; Italian Ministry of Health
   [RF-2016-02361241]; Regione Toscana (RR/NUTRA-FISH); Telethon Foundation
   [GGP15041]; MIUR-FFABR (Fondo per il Finanziamento Attivita Base di
   Ricerca); Italian Minister of Health Ricerca Finalizzata; MRC
   [MC_UU_00015/4, MC_UU_00015/5]; ERC [FP7-322424]; NRJ-Institut de France
   Grant; MRC [MC_UU_00015/4, MC_UU_00015/8, MC_UU_00015/5] Funding Source:
   UKRI
FX EB and RC are supported by the Italian Ministry of Health Ricerca
   Corrente; EB is supported also by the Italian Ministry of Health Ricerca
   Finalizzata (RF-2016-02361241). FMS was partially supported by a grant
   from Regione Toscana (RR/NUTRA-FISH). DG is supported by the Telethon
   Foundation (GGP15041). RO thanks MIUR-FFABR (Fondo per il Finanziamento
   Attivita Base di Ricerca) for funding. M.M. was partially supported by
   the Starting Grant from Italian Minister of Health Ricerca Finalizzata.
   M.Z. was supported by the Core Grant from the MRC (Grant MC_UU_00015/5);
   ERC Advanced GrantFP7-322424 and NRJ-Institut de France Grant. Mi.M. and
   C.D.M. were supported by the Core Grant from the MRC (Grant
   MC_UU_00015/4). We also thank Dr. Letizia Pitto for technical and
   scientific assistance at the Italian National Research Council
   (NRC)-zebrafish core facility.
CR Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193
   Baertling F, 2015, NEUROGENETICS, V16, P237, DOI 10.1007/s10048-015-0440-6
   Bieri P, 2018, CURR OPIN STRUC BIOL, V49, P44, DOI 10.1016/j.sbi.2017.12.009
   Bogenhagen DF, 2018, CELL REP, V22, P1935, DOI 10.1016/j.celrep.2018.01.066
   Brodersen DE, 2005, FEBS J, V272, P2098, DOI 10.1111/j.1742-4658.2005.04651.x
   Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bugiardini E, 2019, HUM MOL GENET, V28, P2711, DOI 10.1093/hmg/ddz093
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Carroll CJ, 2013, J MED GENET, V50, P151, DOI 10.1136/jmedgenet-2012-101375
   Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8
   De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672
   DeLano WL., 2002, The PyMOL molecular graphics system
   Desmond E, 2011, RES MICROBIOL, V162, P53, DOI 10.1016/j.resmic.2010.10.004
   Distelmaier F, 2015, NEUROGENETICS, V16, P319, DOI 10.1007/s10048-015-0444-2
   Fernández-Silva P, 2007, METHOD CELL BIOL, V80, P571, DOI 10.1016/S0091-679X(06)80028-2
   Fraher D, 2016, CELL REP, V14, P1317, DOI 10.1016/j.celrep.2016.01.016
   Galmiche L, 2011, HUM MUTAT, V32, P1225, DOI 10.1002/humu.21562
   Gardeitchik T, 2018, AM J HUM GENET, V102, P685, DOI 10.1016/j.ajhg.2018.02.012
   Gibert Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4300
   Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008
   Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343
   Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872
   Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895
   Greber BJ, 2014, NATURE, V505, P515, DOI 10.1038/nature12890
   Howarth DL, 2013, ZEBRAFISH, V10, P199, DOI 10.1089/zeb.2012.0821
   Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356
   Kenmochi N, 2001, GENOMICS, V77, P65, DOI 10.1006/geno.2001.6622
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Lake NJ, 2018, AM J HUM GENET, V102, P713, DOI 10.1016/j.ajhg.2018.03.015
   Lee WS, 2007, SEMIN LIVER DIS, V27, P259, DOI 10.1055/s-2007-985071
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Marchese M, 2016, BIOCHEM BIOPH RES CO, V477, P137, DOI 10.1016/j.bbrc.2016.06.033
   Menezes MJ, 2015, HUM MOL GENET, V24, P2297, DOI 10.1093/hmg/ddu747
   Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282
   O'Brien TW, 2005, GENE, V354, P147, DOI 10.1016/j.gene.2005.03.026
   O'Brien TW, 2000, J BIOL CHEM, V275, P18153, DOI 10.1074/jbc.M909762199
   Ott M, 2010, BBA-MOL CELL RES, V1803, P767, DOI 10.1016/j.bbamcr.2009.11.010
   Rizza T, 2009, BIOCHEM BIOPH RES CO, V383, P58, DOI 10.1016/j.bbrc.2009.03.121
   Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113
   Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Serre V, 2013, BBA-MOL BASIS DIS, V1832, P1304, DOI 10.1016/j.bbadis.2013.04.014
   Smith L.S., 2013, JOVE-J VIS EXP, V82
   Smits P, 2007, NUCLEIC ACIDS RES, V35, P4686, DOI 10.1093/nar/gkm441
   Smits P, 2011, EUR J HUM GENET, V19, P394, DOI 10.1038/ejhg.2010.214
   Spirina O, 2000, GENE, V261, P229, DOI 10.1016/S0378-1119(00)00504-7
   Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514
   Tolomeo D, 2019, J NEUROL SCI, V399, P69, DOI 10.1016/j.jns.2019.02.010
   Torraco A, 2018, HUM MOL GENET, V27, P3650, DOI 10.1093/hmg/ddy273
   Vacaru AM, 2014, DIS MODEL MECH, V7, P823, DOI 10.1242/dmm.014472
   Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484
   Westerfield M., 2000, ZEBRAFISH BOOK GUIDE
NR 53
TC 25
Z9 25
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD JUL
PY 2020
VL 141
AR 104880
DI 10.1016/j.nbd.2020.104880
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA MC0EQ
UT WOS:000542971000010
PM 32344152
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Hobson, S
   Arefin, S
   Witasp, A
   Hernandez, L
   Kublickiene, K
   Shiels, PG
   Stenvinkel, P
AF Hobson, S.
   Arefin, S.
   Witasp, A.
   Hernandez, L.
   Kublickiene, K.
   Shiels, P. G.
   Stenvinkel, P.
TI Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for
   Novel Therapies
SO CIRCULATION RESEARCH
LA English
DT Article
DE aging; biology; inflammation; oxidative stress; progeria; renal
   insufficiency; chronic
ID SMOOTH-MUSCLE-CELL; VITAMIN-K SUPPLEMENTATION; MATRIX GLA PROTEIN;
   CLONAL HEMATOPOIESIS; OXIDATIVE STRESS; SENESCENT CELLS; DNA-DAMAGE;
   MITOCHONDRIAL DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; CHRONIC INFLAMMATION
AB The pathophysiology of vascular disease is linked to accelerated biological aging and a combination of genetic, lifestyle, biological, and environmental risk factors. Within the scenario of uncontrolled artery wall aging processes, CKD (chronic kidney disease) stands out as a valid model for detailed structural, functional, and molecular studies of this process. The cardiorenal syndrome relates to the detrimental bidirectional interplay between the kidney and the cardiovascular system. In addition to established risk factors, this group of patients is subjected to a plethora of other emerging vascular risk factors, such as inflammation, oxidative stress, mitochondrial dysfunction, vitamin K deficiency, cellular senescence, somatic mutations, epigenetic modifications, and increased apoptosis. A better understanding of the molecular mechanisms through which the uremic milieu triggers and maintains early vascular aging processes, has provided important new clues on inflammatory pathways and emerging risk factors alike, and to the altered behavior of cells in the arterial wall. Advances in the understanding of the biology of uremic early vascular aging opens avenues to novel pharmacological and nutritional therapeutic interventions. Such strategies hold promise to improve future prevention and treatment of early vascular aging not only in CKD but also in the elderly general population.
C1 [Hobson, S.; Arefin, S.; Witasp, A.; Hernandez, L.; Kublickiene, K.; Stenvinkel, P.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden.
   [Shiels, P. G.] Univ Glasgow, Sch Mol Biosci, MVLS, Glasgow, Lanark, Scotland.
C3 Karolinska Institutet; University of Glasgow
RP Stenvinkel, P (corresponding author), Karolinska Univ Hosp Stockholm, Dept Renal Med M99, Stockholm, Sweden.
EM peter.stenvinkel@ki.se
OI Hernandez, Leah/0000-0002-7443-1626; Stenvinkel,
   Peter/0000-0002-8785-4820; Hobson, Sam/0000-0002-5880-885X; Kublickiene,
   Karolina/0000-0002-4841-6836
FU Hjaert-lungfonden; CIMED; Swedish Research Council [2018-00932,
   2021-01102]; Stiftelsen Stig och Gunborg Westman; Njurfonden; EU
   Innovative Training Network CaReSyAn [764474]; Swedish Research Council
   [2018-00932, 2021-01102] Funding Source: Swedish Research Council;
   Vinnova [2021-01102] Funding Source: Vinnova
FX The work was supported by the Hjaert-lungfonden (P. Stenvinkel), CIMED
   (P. Stenvinkel and A. Witasp), Swedish Research Council (2018-00932 [K.
   Kub-lickiene] and 2021-01102 [P. Stenvinkel]), Stiftelsen Stig och
   Gunborg Westman (A. Witasp and P. Stenvinkel), Njurfonden (P.
   Stenvinkel, K. Kublickiene, S. Arefin) and EU Innovative Training
   Network CaReSyAn (H2020-MSCA-ITN-764474; P. Stenvinkel and S. Hobson).
CR Afanas'ev I, 2010, AGING DIS, V1, P75
   Aghagolzadeh P, 2017, ATHEROSCLEROSIS, V265, P78, DOI 10.1016/j.atherosclerosis.2017.08.012
   Agrawal M, 2022, BLOOD, V140, P1094, DOI 10.1182/blood.2022015384
   Alexander Y, 2021, CARDIOVASC RES, V117, P29, DOI 10.1093/cvr/cvaa085
   Anders HJ, 2011, J AM SOC NEPHROL, V22, P1007, DOI 10.1681/ASN.2010080798
   Arefin S, 2020, CLIN CHIM ACTA, V505, P108, DOI 10.1016/j.cca.2020.02.026
   Arnold R, 2016, JRSM CARDIOVASC DIS, V5, DOI 10.1177/2048004016677687
   Asai K, 2000, ARTERIOSCL THROM VAS, V20, P1493, DOI 10.1161/01.ATV.20.6.1493
   Asenjo-Bueno A, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10081308
   Avesani CM., 2022, J REN NUTR, Vs1051-2276, P00161
   Axelsson AS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4477
   Bailey MJ, 2020, GUT MICROBES, V11, P1188, DOI 10.1080/19490976.2020.1749754
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   Sandoval SB, 2010, MUTAGENESIS, V25, P603, DOI 10.1093/mutage/geq047
   Bhattacharya R, 2022, STROKE, V53, P788, DOI 10.1161/STROKEAHA.121.037388
   Bisbal F, 2020, J AM COLL CARDIOL, V75, P222, DOI 10.1016/j.jacc.2019.11.013
   Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434
   Boraldi F, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010131
   Briet M, 2012, CLIN SCI, V123, P399, DOI 10.1042/CS20120074
   Brunner AM, 2017, BLOOD ADV, V1, P2032, DOI 10.1182/bloodadvances.2017010165
   Bruno RM, 2021, ARTERY RES, V27, P59, DOI 10.2991/artres.k.201124.001
   Byon CH, 2008, J BIOL CHEM, V283, P15319, DOI 10.1074/jbc.M800021200
   Cagan A, 2022, NATURE, V604, P517, DOI 10.1038/s41586-022-04618-z
   Carafa V, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0224-3
   Cardozo LFMF, 2021, NUTR REV, V79, P1204, DOI 10.1093/nutrit/nuaa129
   Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x
   Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181
   Chang J, 2013, AM J PHYSIOL-RENAL, V304, pF348, DOI 10.1152/ajprenal.00568.2012
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen SC, 2018, KIDNEY BLOOD PRESS R, V43, P1388, DOI 10.1159/000492953
   Chirinos JA, 2019, J AM COLL CARDIOL, V74, P1237, DOI 10.1016/j.jacc.2019.07.012
   Chowdhury A, 2022, PHARMACEUTICALS-BASE, V15, DOI 10.3390/ph15050493
   Chung AWY, 2009, CIRCULATION, V120, P792, DOI 10.1161/CIRCULATIONAHA.109.862565
   Clarkson MT, 2019, AM J PHYSIOL-RENAL, V316, pF856, DOI 10.1152/ajprenal.00317.2018
   Cobo G, 2018, NEPHROL DIAL TRANSPL, V33, P35, DOI 10.1093/ndt/gfy175
   Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047
   Corredor Z, 2020, MUTAT RES-GEN TOX EN, V852, DOI 10.1016/j.mrgentox.2020.503167
   Csiszar A, 2004, PHYSIOL GENOMICS, V17, P21, DOI 10.1152/physiolgenomics.00136.2003
   Cunha PG, 2017, CURR HYPERTENS REV, V13, P8, DOI 10.2174/1573402113666170413094319
   Dai L, 2021, CLIN SCI, V135, P1251, DOI 10.1042/CS20201452
   Dai L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247623
   Dai L, 2020, NEPHROL DIAL TRANSPL, V35, P31, DOI 10.1093/ndt/gfaa006
   Dai L, 2019, COMPUT STRUCT BIOTEC, V17, P721, DOI 10.1016/j.csbj.2019.06.015
   Dawoud AAZ, 2022, LEUKEMIA, V36, P507, DOI 10.1038/s41375-021-01382-3
   De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9
   de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dihingia A, 2018, FOOD FUNCT, V9, P450, DOI [10.1039/c7fo01491k, 10.1039/C7FO01491K]
   Disthabanchong Sinee, 2012, World J Nephrol, V1, P43, DOI 10.5527/wjn.v1.i2.43
   Düsing P, 2021, J MOL MED, V99, P335, DOI 10.1007/s00109-021-02037-7
   Ebert T, 2022, MOL ASPECTS MED, V86, DOI 10.1016/j.mam.2022.101099
   Ebert T, 2020, TOXINS, V12, DOI 10.3390/toxins12040227
   Ellaway A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214380
   Erlandsson H, 2022, J INTERN MED, V291, P813, DOI 10.1111/joim.13459
   Esgalhado M, 2020, FOOD FUNCT, V11, P2617, DOI [10.1039/c9fo02939g, 10.1039/C9FO02939G]
   Evenepoel P, 2015, J CLIN ENDOCR METAB, V100, P4669, DOI 10.1210/jc.2015-3056
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2
   Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/s0140-6736(18)31694-5, 10.1016/S0140-6736(18)31694-5]
   Fougère B, 2017, J GERONTOL A-BIOL, V72, P1218, DOI 10.1093/gerona/glw240
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034
   Gamboa JL, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12780
   Gerdes EOW, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111591
   Grabowska W, 2017, BIOGERONTOLOGY, V18, P447, DOI 10.1007/s10522-017-9685-9
   Guedj A, 2020, GUT, V69, P1064, DOI 10.1136/gutjnl-2019-318491
   Ha CM, 2014, VASC PHARMACOL, V63, P29, DOI 10.1016/j.vph.2014.06.007
   Hamczyk MR, 2020, J AM COLL CARDIOL, V75, P919, DOI 10.1016/j.jacc.2019.11.062
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harvey A, 2016, CAN J CARDIOL, V32, P659, DOI 10.1016/j.cjca.2016.02.070
   Heather LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026326
   Herman Allison B, 2021, J Cardiovasc Aging, V1, DOI 10.20517/jca.2021.16
   Hernandez L, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-08387-7
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Heyde A, 2021, CELL, V184, P1348, DOI 10.1016/j.cell.2021.01.049
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Hobson S, 2019, TOXINS, V11, DOI 10.3390/toxins11020082
   Holden RM, 2023, NEPHROL DIAL TRANSPL, V38, P746, DOI 10.1093/ndt/gfac191
   Imai T, 2016, NEUROBIOL DIS, V89, P136, DOI 10.1016/j.nbd.2016.02.001
   Incalza MA, 2018, VASC PHARMACOL, V100, P1, DOI 10.1016/j.vph.2017.05.005
   Jaiswal S, 2019, SCIENCE, V366, P586, DOI 10.1126/science.aan4673
   Jaiswal S, 2020, NAT REV CARDIOL, V17, P137, DOI 10.1038/s41569-019-0247-5
   Jaminon A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225694
   Jaminon AMG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63013-8
   Jankowski J, 2021, CIRCULATION, V143, P1157, DOI 10.1161/CIRCULATIONAHA.120.050686
   Ji HW, 2022, CIRC RES, V130, P566, DOI 10.1161/CIRCRESAHA.121.319902
   Jin DH, 2022, FASEB J, V36, DOI 10.1096/fj.202100625RR
   Jin KL, 2019, AGING DIS, V10, P676, DOI 10.14336/AD.2019.0315
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jung J, 2022, BMC NEPHROL, V23, DOI 10.1186/s12882-022-02918-0
   Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208
   Khashan AS, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002875
   King KY, 2020, EXP HEMATOL, V83, P66, DOI 10.1016/j.exphem.2019.12.005
   Kirkman DL, 2018, AM J PHYSIOL-RENAL, V314, pF423, DOI 10.1152/ajprenal.00321.2017
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Kooman JP, 2017, AM J PHYSIOL-RENAL, V313, pF938, DOI 10.1152/ajprenal.00256.2017
   Kooman JP, 2017, EXP GERONTOL, V87, P156, DOI 10.1016/j.exger.2016.02.003
   Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Kyriakidis NC, 2021, TOXINS, V13, DOI 10.3390/toxins13010026
   Lacolley P, 2018, CARDIOVASC RES, V114, P513, DOI 10.1093/cvr/cvy009
   Lanzer P, 2021, J AM COLL CARDIOL, V78, P1145, DOI 10.1016/j.jacc.2021.06.049
   Laurent S, 2019, HYPERTENSION, V74, P218, DOI 10.1161/HYPERTENSIONAHA.119.12655
   Lederbogen F, 2011, NATURE, V474, P498, DOI 10.1038/nature10190
   Leloup AJA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00375
   Lerner H, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00163
   Levy-Schousboe K, 2021, CLIN KIDNEY J, V14, P2114, DOI 10.1093/ckj/sfab017
   Liabeuf S, 2022, NEPHROL DIAL TRANSPL, V37, P33, DOI 10.1093/ndt/gfab223
   Libby P, 2021, NATURE, V592, P524, DOI 10.1038/s41586-021-03392-8
   Liu YZ, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.648639
   London GM, 2016, J AM SOC NEPHROL, V27, P1837, DOI 10.1681/ASN.2015060617
   Lopez-Otin C., 2022, CELL, VS0092-8674, P01377
   Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760
   Luttropp K, 2016, TRANSPLANT DIRECT, V2, DOI 10.1097/TXD.0000000000000629
   M Nilsson Peter, 2015, Eur Endocrinol, V11, P26, DOI 10.17925/EE.2015.11.01.26
   Ma WQ, 2021, FREE RADICAL BIO MED, V165, P229, DOI 10.1016/j.freeradbiomed.2021.01.033
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Mafra D, 2021, NAT REV NEPHROL, V17, P153, DOI 10.1038/s41581-020-00345-8
   Mafra D, 2019, MITOCHONDRION, V47, P206, DOI 10.1016/j.mito.2018.11.006
   MALACHI T, 1993, KIDNEY INT, V44, P385, DOI 10.1038/ki.1993.256
   Marnell CS, 2021, J MOL CELL CARDIOL, V161, P98, DOI 10.1016/j.yjmcc.2021.07.004
   Marton A, 2021, NAT REV NEPHROL, V17, P65, DOI 10.1038/s41581-020-00350-x
   Matsushita K, 2015, J AM SOC NEPHROL, V26, P439, DOI 10.1681/ASN.2014020173
   Mayer O, 2016, J HUM HYPERTENS, V30, P418, DOI 10.1038/jhh.2015.55
   Mazumder MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37935-3
   McClelland R, 2016, AGING-US, V8, P1135, DOI 10.18632/aging.100948
   McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092
   Melnyk BM, 2020, AM J HEALTH PROMOT, V34, P929, DOI 10.1177/0890117120920451
   Mimura J, 2015, FREE RADICAL BIO MED, V88, P221, DOI 10.1016/j.freeradbiomed.2015.06.019
   Mishima E, 2022, NATURE, V608, P778, DOI 10.1038/s41586-022-05022-3
   Missailidis C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141738
   Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075
   Moore L, 2021, NATURE, V597, P381, DOI 10.1038/s41586-021-03822-7
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Mudrovcic N, 2017, PHARMACOL RES, V119, P48, DOI 10.1016/j.phrs.2017.01.011
   Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98
   Nelson AJ, 2020, JACC-BASIC TRANSL SC, V5, P398, DOI 10.1016/j.jacbts.2020.02.002
   Neradova A, 2022, NEPHROL DIAL TRANSPL, V37, P652, DOI 10.1093/ndt/gfab314
   Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319
   Nilsson PM, 2014, AGING DIS, V5, P109, DOI 10.14336/AD.2014.0500109
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Opdebeeck B, 2019, J AM SOC NEPHROL, V30, P751, DOI 10.1681/ASN.2018060609
   Packer M, 2022, CIRCULATION, V146, P1383, DOI 10.1161/CIRCULATIONAHA.122.061732
   Pecoits-Filho R, 2002, NEPHROL DIAL TRANSPL, V17, P1684, DOI 10.1093/ndt/17.9.1684
   Phadwal K, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.611922
   Pongsuwan K, 2022, J CELL PHYSIOL, V237, P4369, DOI 10.1002/jcp.30891
   Querfeld U, 2020, CLIN SCI, V134, P1333, DOI 10.1042/CS20200279
   Raffaele M, 2022, LANCET HEALTH LONGEV, V3, pE67, DOI 10.1016/S2666-7568(21)00300-7
   Raggi P, 2020, CIRCULATION, V141, P728, DOI 10.1161/CIRCULATIONAHA.119.044195
   Rapp N, 2020, TOXINS, V12, DOI 10.3390/toxins12100624
   Raschenberger J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11887
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Ridker PM, 2021, LANCET, V397, P2060, DOI 10.1016/S0140-6736(21)00520-1
   Ridker PM, 2021, CIRC RES, V128, P1728, DOI 10.1161/CIRCRESAHA.121.319077
   Ridker PM, 2018, J AM COLL CARDIOL, V71, P2405, DOI 10.1016/j.jacc.2018.03.490
   Robertson NA, 2019, CURR BIOL, V29, pR786, DOI 10.1016/j.cub.2019.07.011
   Rodríguez-Ribera L, 2015, INT J RADIAT BIOL, V91, P172, DOI 10.3109/09553002.2015.959670
   Rojas-Rueda D, 2019, LANCET PLANET HEALTH, V3, pE469, DOI 10.1016/S2542-5196(19)30215-3
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Santos L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9831825
   Saritas T, 2022, CLIN KIDNEY J, V15, P2300, DOI 10.1093/ckj/sfac184
   Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342
   Schmidlin CJ, 2019, FREE RADICAL BIO MED, V134, P702, DOI 10.1016/j.freeradbiomed.2019.01.016
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Shah AV, 2017, EUR J PHARMACOL, V816, P116, DOI 10.1016/j.ejphar.2017.03.050
   Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216
   Shiels PG, 2021, BIOCHEM J, V478, P2889, DOI 10.1042/BCJ20200958
   Shiels PG, 2019, BIOCHEM SOC T, V47, P1165, DOI 10.1042/BST20190110
   Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78
   Shiels PG, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1415
   Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794
   Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056
   Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191
   Singh RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26777
   Speer T, 2022, NAT REV NEPHROL, V18, P762, DOI 10.1038/s41581-022-00621-9
   Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747
   Steinbach EJ, 2022, FRONT NEUROL, V13, DOI 10.3389/fneur.2022.797503
   Stenvinkel P, 2005, KIDNEY INT, V67, P1216, DOI 10.1111/j.1523-1755.2005.00200.x
   Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x
   Stenvinkel P, 2021, KIDNEY INT REP, V6, P1775, DOI 10.1016/j.ekir.2021.04.023
   Stenvinkel P, 2019, BIOCHEM SOC T, V47, P1157, DOI 10.1042/BST20190105
   Stenvinkel P, 2020, NEPHROL DIAL TRANSPL, V35, P2036, DOI 10.1093/ndt/gfz120
   Stenvinkel P, 2018, NAT REV NEPHROL, V14, P265, DOI 10.1038/nrneph.2017.169
   Stenvinkel P, 2017, AGING-US, V9, P494, DOI 10.18632/aging.101173
   Stopper H, 2001, AM J KIDNEY DIS, V38, P296, DOI 10.1053/ajkd.2001.26094
   Sturmlechner I, 2017, NAT REV NEPHROL, V13, P77, DOI 10.1038/nrneph.2016.183
   Thijssen DHJ, 2016, J PHYSIOL-LONDON, V594, P2275, DOI 10.1113/JP270597
   Thompson AM, 2014, AM J PHYSIOL-HEART C, V307, pH533, DOI 10.1152/ajpheart.00871.2013
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646
   Versari D, 2009, DIABETES CARE, V32, pS314, DOI 10.2337/dc09-S330
   Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571
   Vlasschaert C, 2022, J AM SOC NEPHROL, V33, P985, DOI 10.1681/ASN.2021060774
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Walaszczyk A, 2019, AGING CELL, V18, DOI 10.1111/acel.12945
   Wang HH, 2022, LIFE SCI, V306, DOI 10.1016/j.lfs.2022.120780
   Wang PW, 2022, ATHEROSCLEROSIS, V346, P36, DOI 10.1016/j.atherosclerosis.2022.02.007
   Wang QW, 2015, CIRC RES, V116, P600, DOI 10.1161/CIRCRESAHA.116.304899
   Wang R, 2017, AGING CELL, V16, P564, DOI 10.1111/acel.12587
   Wang W, 2018, CIRC RES, V123, pE35, DOI 10.1161/CIRCRESAHA.118.313283
   Weber T, 2018, EUR HEART J, V39, P3847, DOI 10.1093/eurheartj/ehy346
   Wu FN, 2020, FREE RADICAL BIO MED, V158, P171, DOI 10.1016/j.freeradbiomed.2020.06.038
   Wu SJ, 2019, CANCER MED-US, V8, P2252, DOI 10.1002/cam4.2101
   Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733
   Xie Y, 2022, NAT MED, V28, P583, DOI 10.1038/s41591-022-01689-3
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2016, PHARMACOL RES, V111, P152, DOI 10.1016/j.phrs.2016.05.015
   Ye YZ, 2022, KIDNEY INT, V102, P1259, DOI 10.1016/j.kint.2022.07.034
   Young GH, 2012, KIDNEY INT, V81, P611, DOI 10.1038/ki.2011.461
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Yu B, 2021, J AM COLL CARDIOL, V78, P42, DOI 10.1016/j.jacc.2021.04.085
   Yuan H, 2021, MOL CELL BIOCHEM, V476, P247, DOI 10.1007/s11010-020-03901-9
   Yuille S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201073
   Zhang Y, 2022, MOLECULES, V27, DOI 10.3390/molecules27175422
   Zhu H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.714943
   Zhu Q, 2015, J VASC RES, V52, P291, DOI 10.1159/000442980
NR 220
TC 11
Z9 12
U1 2
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD APR 14
PY 2023
VL 132
IS 8
BP 950
EP 969
DI 10.1161/CIRCRESAHA.122.321751
PG 20
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Hematology
GA D7EM3
UT WOS:000970321200005
PM 37053277
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Asencio, C
   Rodríguez-Hernandez, MA
   Briones, P
   Montoya, J
   Cortés, A
   Emperador, S
   Gavilán, A
   Ruiz-Pesini, E
   Yubero, D
   Montero, R
   Pineda, M
   O'Callaghan, MM
   Alcázar-Fabra, M
   Salviati, L
   Artuch, R
   Navas, P
AF Asencio, Claudio
   Rodriguez-Hernandez, Maria A.
   Briones, Paz
   Montoya, Julio
   Cortes, Ana
   Emperador, Sonia
   Gavilan, Angela
   Ruiz-Pesini, Eduardo
   Yubero, Delia
   Montero, Raquel
   Pineda, Mercedes
   O'Callaghan, Maria M.
   Alcazar-Fabra, Maria
   Salviati, Leonardo
   Artuch, Rafael
   Navas, Placido
TI Severe encephalopathy associated to pyruvate dehydrogenase mutations and
   unbalanced coenzyme Q<sub>10</sub> content
SO EUROPEAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID DEFICIENCY; BIOSYNTHESIS; FIBROBLASTS; TISSUES; PROTEIN; CHAIN; CELLS
AB Coenzyme Q(10) (CoQ(10)) deficiency is associated to a variety of clinical phenotypes including neuromuscular and nephrotic disorders. We report two unrelated boys presenting encephalopathy, ataxia, and lactic acidosis, who died with necrotic lesions in different areas of brain. Levels of CoQ(10) and complex II+III activity were increased in both skeletal muscle and fibroblasts, but it was a consequence of higher mitochondria mass measured as citrate synthase. In fibroblasts, oxygen consumption was also increased, whereas steady state ATP levels were decreased. Antioxidant enzymes such as NQO1 and MnSOD and mitochondrial marker VDAC were overexpressed. Mitochondria recycling markers Fis1 and mitofusin, and mtDNA regulatory Tfam were reduced. Exome sequencing showed mutations in PDHA1 in the first patient and in PDHB in the second. These genes encode subunits of pyruvate dehydrogenase complex (PDH) that could explain the compensatory increase of CoQ(10) and a defect of mitochondrial homeostasis. These two cases describe, for the first time, a mitochondrial disease caused by PDH defects associated with unbalanced of both CoQ(10) content and mitochondria homeostasis, which severely affects the brain. Both CoQ(10) and mitochondria homeostasis appears as new markers for PDH associated mitochondrial disorders.
C1 [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Cortes, Ana; Gavilan, Angela; Alcazar-Fabra, Maria; Navas, Placido] Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.
   [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Cortes, Ana; Gavilan, Angela; Alcazar-Fabra, Maria; Navas, Placido] Inst Salud Carlos III, CIBERER, Carretera Utrera Km 1, Seville 41013, Spain.
   [Asencio, Claudio; Rodriguez-Hernandez, Maria A.; Briones, Paz; Montoya, Julio; Cortes, Ana; Emperador, Sonia; Gavilan, Angela; Ruiz-Pesini, Eduardo; Yubero, Delia; Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Alcazar-Fabra, Maria; Artuch, Rafael; Navas, Placido] ISCIII, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain.
   [Briones, Paz; Yubero, Delia] Hosp Clin Barcelona, IDIBAPS, Serv Bioquim & Genet Mol, Secc Errores Congenitos Metab IBC U737, Barcelona, Spain.
   [Briones, Paz; Yubero, Delia] CSIC, Barcelona, Spain.
   [Montoya, Julio; Emperador, Sonia; Ruiz-Pesini, Eduardo] Univ Zaragoza, Dept Bioquim Biol Mol & Celular, Zaragoza, Spain.
   [Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Artuch, Rafael] Hosp St Joan de Deu, Dept Pathol, Clin Chem, Barcelona, Spain.
   [Montero, Raquel; Pineda, Mercedes; O'Callaghan, Maria M.; Artuch, Rafael] Hosp St Joan de Deu, Dept Neurol, Clin Chem, Barcelona, Spain.
   [Salviati, Leonardo] Univ Padua, Dept Woman & Child Hlth, Clin Genet Unit, Padua, Italy.
   [Salviati, Leonardo] IRP Citta Speranza, Padua, Italy.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Universidad
   Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology
   (CABD); CIBER - Centro de Investigacion Biomedica en Red; CIBERER;
   Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona;
   Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of Zaragoza; University
   of Barcelona; University of Barcelona; University of Padua; Fondazione
   Citta della Speranza
RP Navas, P (corresponding author), Univ Pablo de Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Carretera Utrera Km 1, Seville 41013, Spain.; Navas, P (corresponding author), Inst Salud Carlos III, CIBERER, Carretera Utrera Km 1, Seville 41013, Spain.
EM pnavas@upo.es
RI Salviati, Leonardo/L-1007-2016; Gavilan Naranjo, Angela/GRJ-5581-2022;
   NAVAS, PLACIDO/R-5943-2019; Rodríguez-Hernández, Ángeles/K-9717-2015;
   Alcazar-Fabra, Maria/H-8983-2017
OI Alcazar-Fabra, Maria/0000-0002-3688-2143; Yubero,
   Delia/0000-0001-7742-0589; Artuch, Rafael/0000-0002-3422-9685
FU Spanish Ministry of Health (Fondo de Investigacion Sanitaria, Instituto
   de Salud Carlos III) [PI14/00028, PI10-00662, PI14/01962]; Telethon
   Italy [GGP13222]; University of Padova [CPDA123573/12]; Fondazione
   CARIPARO; University Pablo de Olavide (Plan Propio de Investigacion)
   [APP2D11086]
FX We thank the Bioinformatics Platform for Rare Diseases (CIBERER BIER),
   Valencia, Spain, for their help in the analysis of the exome sequencing
   data. This research was funded by grants PI14/00028 (RA), PI10-00662
   (JM), and PI14/01962 (PN) from the Spanish Ministry of Health (Fondo de
   Investigacion Sanitaria, Instituto de Salud Carlos III). LS was funded
   by Telethon Italy (GGP13222), the University of Padova (CPDA123573/12),
   and Fondazione CARIPARO (to LS). CA was funded by grant APP2D11086 from
   the University Pablo de Olavide (Plan Propio de Investigacion).
CR Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200
   Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147
   Doimo M, 2014, MOL SYNDROMOL, V5, P156, DOI 10.1159/000362826
   Emmanuele V, 2012, ARCH NEUROL-CHICAGO, V69, P978, DOI 10.1001/archneurol.2012.206
   Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008
   Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381
   Laredj LN, 2014, BIOCHIMIE, V100, P78, DOI 10.1016/j.biochi.2013.12.006
   López-Martín JM, 2007, HUM MOL GENET, V16, P1091, DOI 10.1093/hmg/ddm058
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Montero R, 2008, CLIN BIOCHEM, V41, P697, DOI 10.1016/j.clinbiochem.2008.03.007
   Montero R, 2013, MITOCHONDRION, V13, P337, DOI 10.1016/j.mito.2013.04.001
   Parrado-Fernández C, 2011, FREE RADICAL BIO MED, V50, P1728, DOI 10.1016/j.freeradbiomed.2011.03.024
   Quintana E, 2009, J INHERIT METAB DIS, V32, pS339, DOI 10.1007/s10545-009-1343-1
   Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238
   Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058
   Winski SL, 2002, CANCER RES, V62, P1420
NR 19
TC 15
Z9 15
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1018-4813
EI 1476-5438
J9 EUR J HUM GENET
JI Eur. J. Hum. Genet.
PD MAR
PY 2016
VL 24
IS 3
BP 367
EP 372
DI 10.1038/ejhg.2015.112
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DE2PP
UT WOS:000370469500014
PM 26014431
OA Bronze, Green Published
DA 2024-11-01
ER

PT J
AU Adeva, M
   González-Lucán, M
   Seco, M
   Donapetry, C
AF Adeva, M.
   Gonzalez-Lucan, M.
   Seco, M.
   Donapetry, C.
TI Enzymes involved in L-lactate metabolism in humans
SO MITOCHONDRION
LA English
DT Review
DE Lactate dehydrogenase; Alanine aminotransferase; Pyruvate dehydrogenase;
   Tricarboxylic acid cycle; Mitochondrial respiratory chain;
   Gluconeogenesis
ID PYRUVATE-CARBOXYLASE DEFICIENCY; SERUM ALANINE AMINOTRANSFERASE;
   GLYCOGEN-STORAGE-DISEASE; HUMAN SKELETAL-MUSCLE; HUMAN LIVER
   FRUCTOSE-1,6-BISPHOSPHATASE; TRICARBOXYLIC-ACID CYCLE; M-SUBUNIT
   DEFICIENCY; PHOSPHOENOLPYRUVATE CARBOXYKINASE; LACTIC-ACIDOSIS;
   DEHYDROGENASE COMPLEX
AB L-lactate formation occurs via the reduction of pyruvate catalyzed by lactate dehydrogenase. L-lactate removal takes place via its oxidation into pyruvate, which may be oxidized or converted into glucose. Pyruvate oxidation involves the cooperative effort of pyruvate dehydrogenase, the tricarboxylic acid cycle, and the mitochondrial respiratory chain. Enzymes of the gluconeogenesis pathway sequentially convert pyruvate into glucose. In addition, pyruvate may undergo reversible transamination to alanine by alanine aminotransferase. Enzymes involved in L-lactate metabolism are crucial to diabetes pathophysiology and therapy. Elevated plasma alanine aminotransferase concentration has been associated with insulin resistance. Polymorphisms in the G6PC2 gene have been associated with fasting glucose concentration and insulin secretion. In diabetes patients, pyruvate dehydrogenase is down-regulated and the activity of pyruvate carboxylase is diminished in the pancreatic islets. Inhibitors of fructose 1,6-bisphosphatase are being investigated as potential therapy for type 2 diabetes. In addition, enzymes implicated in L-lactate metabolism have revealed to be important in cancer cell homeostasis. Many human tumors have higher LDH5 levels than normal tissues. The LDHC gene is expressed in a broad range of tumors. The activation of PDH is a potential mediator in the body response that protects against cancer and PDH activation has been observed to reduce glioblastoma growth. The expression of PDK1 may serve as a biomarker of poor prognosis in gastric cancer. Mitochondrial DNA mutations have been detected in a number of human cancers. Genes encoding succinate dehydrogenase have tumor suppressor functions and consequently mutations in these genes may cause a variety of tumors. (C) 2013 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
C1 [Adeva, M.; Gonzalez-Lucan, M.; Seco, M.; Donapetry, C.] Hosp Gen Juan Cardona, Div Nephrol, La Coruna 15406, Spain.
RP Adeva, M (corresponding author), Hosp Gen Juan Cardona, Div Nephrol, Ave Pardo Bazan S-N, La Coruna 15406, Spain.
EM madevaa@yahoo.com
CR Abbot EL, 2005, FEBS J, V272, P3004, DOI 10.1111/j.1742-4658.2005.04713.x
   ADAMS A, 1990, J INHERIT METAB DIS, V13, P829, DOI 10.1007/BF01800207
   Adina-Zada A, 2012, ARCH BIOCHEM BIOPHYS, V519, P118, DOI 10.1016/j.abb.2011.11.015
   Alston CL, 2012, J MED GENET, V49, P569, DOI 10.1136/jmedgenet-2012-101146
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002
   ATKIN BM, 1979, PEDIATR RES, V13, P38, DOI 10.1203/00006450-197901000-00009
   Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3
   Banka S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-84
   Barker A, 2011, DIABETES, V60, P1805, DOI 10.2337/db10-1575
   Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57
   Berthold HK, 2006, DRUG SAFETY, V29, P703, DOI 10.2165/00002018-200629080-00007
   Bigl M, 2008, BIOCHEM BIOPH RES CO, V377, P720, DOI 10.1016/j.bbrc.2008.10.045
   Bittar PG, 1996, J CEREBR BLOOD F MET, V16, P1079, DOI 10.1097/00004647-199611000-00001
   BLASS JP, 1972, J CLIN INVEST, V51, P1845, DOI 10.1172/JCI106986
   BONNEFONT JP, 1992, J PEDIATR-US, V121, P255, DOI 10.1016/S0022-3476(05)81199-0
   Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806
   Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099
   Brière JJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1114, DOI 10.1152/ajpcell.00216.2006
   BROWN GK, 1987, J INHERIT METAB DIS, V10, P359, DOI 10.1007/BF01799978
   Cameron JM, 2009, HUM GENET, V125, P319, DOI 10.1007/s00439-009-0629-6
   Cao HN, 2004, J CLIN ENDOCR METAB, V89, P898, DOI 10.1210/jc.2003-031361
   Chen PH, 2009, WORLD J GASTROENTERO, V15, P5598, DOI 10.3748/wjg.15.5598
   Chen XY, 2009, MOL BIOL REP, V36, P669, DOI 10.1007/s11033-008-9227-2
   CHEN YT, 1990, NEW ENGL J MED, V323, P590, DOI 10.1056/NEJM199008303230907
   Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772
   COOKER LA, 1993, BIOL REPROD, V48, P1309, DOI 10.1095/biolreprod48.6.1309
   Däublin G, 2002, EUR J PEDIATR, V161, pS40, DOI [10.1007/s00431-002-1001-1, 10.1007/BF02679992]
   De Bari L, 2010, INT J ONCOL, V37, P1607, DOI 10.3892/ijo_00000815
   Debray FG, 2006, EUR J PEDIATR, V165, P462, DOI 10.1007/s00431-006-0104-5
   DeBrosse SD, 2012, MOL GENET METAB, V107, P394, DOI 10.1016/j.ymgme.2012.09.001
   Delanghe J, 1997, CLIN CHEM, V43, P1665
   DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567
   DiMauro S, 2012, ADV EXP MED BIOL, V748, P341, DOI 10.1007/978-1-4614-3573-0_14
   Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571
   DZUGAJ A, 1980, BIOCHIM BIOPHYS ACTA, V614, P407, DOI 10.1016/0005-2744(80)90230-2
   EDWARDS Y, 1989, ANN HUM GENET, V53, P215, DOI 10.1111/j.1469-1809.1989.tb01787.x
   ELMAGHRABI MR, 1995, GENOMICS, V27, P520, DOI 10.1006/geno.1995.1085
   ELMAGHRABI MR, 1993, J BIOL CHEM, V268, P9466
   FERNANDES J, 1982, LANCET, V1, P113
   Ferriero R., 2013, ONCOTARGET
   Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008
   Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172
   Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870
   Fujisawa K, 2000, J BIOCHEM-TOKYO, V127, P373, DOI 10.1093/oxfordjournals.jbchem.a022618
   Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202
   GIDHJAIN M, 1994, J BIOL CHEM, V269, P27732
   Gizak A, 2003, HISTOL HISTOPATHOL, V18, P135, DOI 10.14670/HH-18.135
   Gizak A, 2001, HISTOL HISTOPATHOL, V16, P53, DOI 10.14670/HH-16.53
   Glinghammar B, 2009, INT J MOL MED, V23, P621, DOI 10.3892/ijmm_00000173
   Glushakova LG, 2011, MOL GENET METAB, V104, P255, DOI 10.1016/j.ymgme.2011.07.023
   Gouni-Berthold I, 2006, DIABETIC MED, V23, P419, DOI 10.1111/j.1464-5491.2006.01819.x
   Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263
   Greaves LC, 2012, J PATHOL, V226, P274, DOI 10.1002/path.3028
   GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989
   Gunji T, 2010, DIGEST LIVER DIS, V42, P882, DOI 10.1016/j.dld.2010.04.001
   Güven AG, 2006, PEDIATR NEPHROL, V21, P761, DOI 10.1007/s00467-006-0077-7
   Hanley AJG, 2007, DIABETES CARE, V30, P1819, DOI 10.2337/dc07-0086
   HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589
   Heard KJ, 2010, PHARMACOTHERAPY, V30, P818, DOI 10.1592/phco.30.8.818
   Herzog B, 2000, BIOCHEM J, V351, P385, DOI 10.1042/0264-6021:3510385
   Hidaka K, 1999, J HUM GENET, V44, P69, DOI 10.1007/s100380050111
   Hoekstra A.S., 2012, Biochim Biophys Acta
   HOMMES FA, 1976, ACTA PAEDIATR SCAND, V65, P233, DOI 10.1111/j.1651-2227.1976.tb16543.x
   Hur H, 2013, INT J ONCOL, V42, P44, DOI 10.3892/ijo.2012.1687
   Hussien R, 2011, PHYSIOL GENOMICS, V43, P255, DOI 10.1152/physiolgenomics.00177.2010
   Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544
   Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008
   ISHIGURO M, 1991, BIOCHEMISTRY-US, V30, P10451, DOI 10.1021/bi00107a013
   Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, pE686, DOI 10.1152/ajpendo.00476.2012
   Jitrapakdee S, 1996, BIOCHEM BIOPH RES CO, V223, P695, DOI 10.1006/bbrc.1996.0958
   Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001
   Jitrapakdee S, 1999, BIOCHEM BIOPH RES CO, V266, P512, DOI 10.1006/bbrc.1999.1846
   Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709
   JOUKYUU R, 1989, CLIN CHEM, V35, P687
   KANNO T, 1988, CLIN CHIM ACTA, V173, P89, DOI 10.1016/0009-8981(88)90359-2
   KAO FT, 1988, SOMAT CELL MOLEC GEN, V14, P515, DOI 10.1007/BF01534717
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kato J, 2010, ACTA CRYSTALLOGR F, V66, P342, DOI 10.1107/S1744309110003131
   Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22
   Kerr D, 2012, METHODS MOL BIOL, V837, P93, DOI 10.1007/978-1-61779-504-6_7
   Kiilerich K, 2011, J APPL PHYSIOL, V111, P751, DOI 10.1152/japplphysiol.00063.2011
   KIKAWA Y, 1994, BIOCHEM BIOPH RES CO, V199, P687, DOI 10.1006/bbrc.1994.1283
   Kikawa Y, 2002, J INHERIT METAB DIS, V25, P41, DOI 10.1023/A:1015129616599
   KITAMURA M, 1971, CLIN CHIM ACTA, V34, P419
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   KREISBERG RA, 1980, ANN INTERN MED, V92, P227, DOI 10.7326/0003-4819-92-2-227
   Larsson NG, 1999, FEBS LETT, V455, P199, DOI 10.1016/S0014-5793(99)00854-6
   Laughton JD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-35
   Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107
   Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550
   Lindblom P, 2007, ARCH BIOCHEM BIOPHYS, V466, P66, DOI 10.1016/j.abb.2007.07.023
   LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637
   MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6
   MACKAY N, 1994, BIOCHEM BIOPH RES CO, V202, P1009, DOI 10.1006/bbrc.1994.2029
   Mak CM, 2010, PATHOLOGY, V42, P94, DOI 10.3109/00313020903434678
   Mamczur P, 2012, HISTOCHEM CELL BIOL, V137, P121, DOI 10.1007/s00418-011-0884-1
   Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205
   MAYEDA K, 1974, AM J HUM GENET, V26, P59
   MCCORMICK K, 1985, AM J MED GENET, V22, P291, DOI 10.1002/ajmg.1320220211
   Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P196, DOI 10.1016/j.bbrc.2010.08.102
   MIYAJIMA H, 1993, NEUROLOGY, V43, P1414, DOI 10.1212/WNL.43.7.1414
   Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359
   Moon S, 2011, METABOLISM, V60, P107, DOI 10.1016/j.metabol.2009.12.021
   NAITO E, 1994, PEDIATR RES, V36, P340, DOI 10.1203/00006450-199409000-00013
   PAGLIARA AS, 1972, J CLIN INVEST, V51, P2115, DOI 10.1172/JCI107018
   Paksu MS, 2011, PEDIATR EMERG CARE, V27, P1180, DOI 10.1097/PEC.0b013e31823b412d
   Patel DA, 2011, METAB SYNDR RELAT D, V9, P211, DOI 10.1089/met.2010.0086
   Patel KP, 2012, MOL GENET METAB, V106, P384, DOI 10.1016/j.ymgme.2012.03.016
   Patel MS, 2009, J MOL CATAL B-ENZYM, V61, P2, DOI 10.1016/j.molcatb.2009.05.001
   Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3
   PILZ AJ, 1992, ANN HUM GENET, V56, P289, DOI 10.1111/j.1469-1809.1992.tb01155.x
   Pizzuto R, 2012, BBA-BIOENERGETICS, V1817, P1679, DOI 10.1016/j.bbabio.2012.05.010
   POPINIGIS J, 1991, ACTA BIOCHIM POL, V38, P169
   Potgieter M, 2013, NUTR REV, V71, P180, DOI 10.1111/nure.12011
   Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003
   Quinonez SC, 2013, PEDIATR NEUROL, V48, P67, DOI 10.1016/j.pediatrneurol.2012.09.013
   Rafter I, 2012, INT J MOL MED, V30, P1241, DOI 10.3892/ijmm.2012.1106
   Rasmussen HN, 2002, J PHYSIOL-LONDON, V541, P575, DOI 10.1113/jphysiol.2002.019216
   Renault S, 2010, TOXICOL APPL PHARM, V242, P9, DOI 10.1016/j.taap.2009.09.002
   ROBINSON BH, 1987, AM J HUM GENET, V40, P50
   Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015
   Rowles J, 1996, J BIOL CHEM, V271, P22376, DOI 10.1074/jbc.271.37.22376
   Rumack B, 2012, PHARMACOTHERAPY, V32, P784, DOI 10.1002/j.1875-9114.2012.01122.x
   RUTLEDGE SL, 1989, PEDIATR NEUROL, V5, P249
   Sanda S, 2013, ACTA DIABETOL, V50, P459, DOI 10.1007/s00592-012-0389-y
   Sarnat HB, 2012, NEUROPATHOLOGY, V32, P617, DOI 10.1111/j.1440-1789.2012.01308.x
   Sato T, 2002, PANCREAS, V25, P130, DOI 10.1097/00006676-200208000-00003
   SAUDUBRAY JM, 1976, ACTA PAEDIATR SCAND, V65, P717, DOI 10.1111/j.1651-2227.1976.tb18009.x
   Saunders AC, 2005, J INHERIT METAB DIS, V28, P695, DOI 10.1007/s10545-005-0090-1
   Shangraw RE, 1998, AM J PHYSIOL-GASTR L, V274, pG569, DOI 10.1152/ajpgi.1998.274.3.G569
   Shieh JJ, 2002, J BIOL CHEM, V277, P5047, DOI 10.1074/jbc.M110486200
   Shieh JJ, 2003, J BIOL CHEM, V278, P47098, DOI 10.1074/jbc.M309472200
   Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170
   Smith AC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-102
   Sohocki MM, 1997, GENOMICS, V40, P247, DOI 10.1006/geno.1996.4604
   Soini Heidi K, 2012, BMC Res Notes, V5, P350, DOI 10.1186/1756-0500-5-350
   Spriet LL, 2004, J APPL PHYSIOL, V96, P2082, DOI 10.1152/japplphysiol.01318.2003
   Spriet LL, 2002, EXERC SPORT SCI REV, V30, P91, DOI 10.1097/00003677-200204000-00009
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Stallknecht B, 1998, SCAND J MED SCI SPOR, V8, P127
   Steller J., 2013, NEUROPEDIATRICS
   STERN HJ, 1995, CLIN BIOCHEM, V28, P85, DOI 10.1016/0009-9120(94)00059-5
   Sue CM, 2000, BRAIN PATHOL, V10, P442
   Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009
   Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038
   Swiderek K, 2011, ARCH BIOCHEM BIOPHYS, V505, P33, DOI 10.1016/j.abb.2010.10.010
   Sybirna N, 2006, CELL BIOL INT, V30, P624, DOI 10.1016/j.cellbi.2006.03.008
   TAKANO T, 1989, BIOCHEM BIOPH RES CO, V159, P579, DOI 10.1016/0006-291X(89)90033-8
   Takatani T, 2001, MOL GENET METAB, V73, P344, DOI 10.1006/mgme.2001.3203
   TAKAYASU S, 1991, J AM ACAD DERMATOL, V24, P339, DOI 10.1016/0190-9622(91)70047-6
   Tang HH, 2009, J ANDROL, V30, P157, DOI 10.2164/jandrol.108.005785
   Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067
   Tillmann H, 1998, GENE, V212, P295, DOI 10.1016/S0378-1119(98)00181-4
   Tillmann H, 2000, GENE, V247, P241, DOI 10.1016/S0378-1119(00)00079-2
   Van Hove JLK, 2010, PEDIATR RES, V68, P159, DOI 10.1203/00006450-201011001-00310
   van Poelje PD, 2011, HANDB EXP PHARMACOL, V203, P279, DOI 10.1007/978-3-642-17214-4_12
   VANCOSTER RN, 1991, NEUROLOGY, V41, P1815, DOI 10.1212/WNL.41.11.1815
   vandenBerghe G, 1996, J INHERIT METAB DIS, V19, P470, DOI 10.1007/BF01799108
   VESELL ES, 1961, J CLIN INVEST, V40, P586, DOI 10.1172/JCI104287
   VIDNES J, 1976, ACTA PAEDIATR SCAND, V65, P307, DOI 10.1111/j.1651-2227.1976.tb04890.x
   Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889
   WALKER ME, 1995, CYTOGENET CELL GENET, V69, P187, DOI 10.1159/000133958
   Wang D, 2008, MOL GENET METAB, V95, P31, DOI 10.1016/j.ymgme.2008.06.006
   Wang H, 2005, INT J MOL MED, V15, P949
   Watts JA, 2003, ACAD EMERG MED, V10, P985, DOI 10.1197/S1069-6563(03)00319-1
   Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027
   WEXLER ID, 1994, BBA-MOL BASIS DIS, V1227, P46, DOI 10.1016/0925-4439(94)90105-8
   Wolfsdorf JI, 1997, J INHERIT METAB DIS, V20, P559, DOI 10.1023/A:1005346824368
   WROBLEWSKI F, 1960, NEW ENGL J MED, V263, P531, DOI 10.1056/NEJM196009152631102
   Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393
   Yánez AJ, 2003, J CELL PHYSIOL, V197, P189, DOI 10.1002/jcp.10337
   Yang RZ, 2002, GENOMICS, V79, P445, DOI 10.1006/geno.2002.6722
   Yen TY, 2008, EUR J PEDIATR, V167, P941, DOI 10.1007/s00431-007-0592-y
   Zhu DW, 2001, ACTA CRYSTALLOGR D, V57, P847, DOI 10.1107/S0907444901004371
NR 175
TC 62
Z9 71
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1567-7249
EI 1872-8278
J9 MITOCHONDRION
JI Mitochondrion
PD NOV
PY 2013
VL 13
IS 6
BP 615
EP 629
DI 10.1016/j.mito.2013.08.011
PG 15
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA 255ZY
UT WOS:000327280500007
PM 24029012
DA 2024-11-01
ER

PT J
AU Koklesova, L
   Samec, M
   Liskova, A
   Zhai, KV
   Büsselberg, D
   Giordano, FA
   Kubatka, P
   Golunitschaja, O
AF Koklesova, Lenka
   Samec, Marek
   Liskova, Alena
   Zhai, Kevin
   Busselberg, Dietrich
   Giordano, Frank A.
   Kubatka, Peter
   Golunitschaja, Olga
TI Mitochondrial impairments in aetiopathology of multifactorial diseases:
   common origin but individual outcomes in context of 3P medicine
SO EPMA JOURNAL
LA English
DT Review
DE Mitochondrial impairment; Injury; ROS; Energy imbalance; Vicious circle;
   Oxidative stress; Aetiopathology multi-organ dysfunction; Suboptimal
   health; Reversible damage; Vasospasm; Mitigating measures; Repair;
   Mechanisms; Multifactorial disease; Ageing; Neurodegeneration; Glaucoma;
   Alzheimer; Cancer; Cardiovascular disease; Predictive preventive
   personalised medicine (PPPM; 3PM); Multi-modal diagnostics; Liquid
   biopsy; Molecular patterns; Biomarker panel; Patient stratification;
   Individualised patient profiling; Origin; Outcomes; Complementary
   medicine; Health policy; Cost efficacy; COVID-19
ID TUMOR-SUPPRESSOR GENE; CHRONIC HEART-FAILURE; PARKINSONS-DISEASE;
   ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; DYSFUNCTION; MUTATIONS; BIOMARKERS;
   EXERCISE; RISKS
AB Mitochondrial injury plays a key role in the aetiopathology of multifactorial diseases exhibiting a "vicious circle" characteristic for pathomechanisms of the mitochondrial and multi-organ damage frequently developed in a reciprocal manner. Although the origin of the damage is common (uncontrolled ROS release, diminished energy production and extensive oxidative stress to life-important biomolecules such as mtDNA and chrDNA), individual outcomes differ significantly representing a spectrum of associated pathologies including but not restricted to neurodegeneration, cardiovascular diseases and cancers. Contextually, the role of predictive, preventive and personalised (PPPM/3P) medicine is to introduce predictive analytical approaches which allow for distinguishing between individual outcomes under circumstance of mitochondrial impairments followed by cost-effective targeted prevention and personalisation of medical services. Current article considers innovative concepts and analytical instruments to advance management of mitochondriopathies and associated pathologies.
C1 [Koklesova, Lenka; Samec, Marek; Liskova, Alena] Comenius Univ, Jessenius Fac Med, Dept Obstet & Gynaecol, Martin 03601, Slovakia.
   [Zhai, Kevin; Busselberg, Dietrich] Qatar Fdn, Weill Cornell Med Qatar, Dept Physiol & Biophys, Doha 24144, Qatar.
   [Giordano, Frank A.] Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, D-53127 Bonn, Germany.
   [Kubatka, Peter] Comenius Univ, Jessenius Fac Med, Dept Med Biol, Martin 03601, Slovakia.
   [Golunitschaja, Olga] Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, Predict Prevent Personalised 3P Med, D-53127 Bonn, Germany.
C3 Comenius University Bratislava; Qatar Foundation (QF); Weill Cornell
   Medical College Qatar; University of Bonn; Comenius University
   Bratislava; University of Bonn
RP Golunitschaja, O (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Univ Hosp Bonn, Dept Radiat Oncol, Predict Prevent Personalised 3P Med, D-53127 Bonn, Germany.
EM olga.golubnitschaja@ukbonn.de
RI Zhai, Kevin/AAL-5702-2021
OI Kubatka, Peter/0000-0003-4312-5076; Golubnitschaja, Prof. Dr.,
   Olga/0000-0001-5427-2018; Busselberg, Dietrich/0000-0001-5196-3366;
   Zhai, Kevin/0000-0003-2556-5641; Mazurakova, Alena/0000-0002-1111-0120;
   Koklesova, Lenka/0009-0000-2732-066X
FU Projekt DEAL; Scientific Grant Agency, VEGA [1/0136/19]; National
   Priorities Research Programme grant from the Qatar National Research
   Fund (QNRF, a member of Qatar Foundation) [NPRP 11S-1214-170101]
FX Open Access funding enabled and organized by Projekt DEAL. This work was
   supported by Scientific Grant Agency, VEGA project No.1/0136/19 and a
   National Priorities Research Programme grant (NPRP 11S-1214-170101;
   awarded to Professor Dr. Dietrich Busselberg, June 2019-Current) from
   the Qatar National Research Fund (QNRF, a member of Qatar Foundation).
CR Alena, 2021, MEDICINE
   ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742
   Annesley SJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070680
   Antosova M., 2015, Eur Respir J, V46, pPA4267
   Ashrafizadeh Milad, 2020, J Basic Clin Physiol Pharmacol, V31, DOI 10.1515/jbcpp-2019-0191
   Ashrafizadeh M, 2020, PHYTOTHER RES, V34, P1745, DOI 10.1002/ptr.6642
   Ashrafizadeh M, 2020, J CELL PHYSIOL, V235, P4135, DOI 10.1002/jcp.29327
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Balakumar P, 2016, PHARMACOL RES, V113, P600, DOI 10.1016/j.phrs.2016.09.040
   Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003
   Baumgartner HK, 2009, J BIOL CHEM, V284, P20796, DOI 10.1074/jbc.M109.025353
   BELARDINELLI R, 1995, J AM COLL CARDIOL, V26, P975, DOI 10.1016/0735-1097(95)00267-1
   Boakye D, 2020, INT J CANCER, V147, P2373, DOI 10.1002/ijc.33018
   BORSCHE M, 2020, J PARKINSONS DIS
   Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607
   Buja LM, 2013, TEX HEART I J, V40, P221
   Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083
   Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9
   Catalá-López F, 2014, PSYCHOTHER PSYCHOSOM, V83, P89, DOI 10.1159/000356498
   Cesari R, 2003, P NATL ACAD SCI USA, V100, P5956, DOI 10.1073/pnas.0931262100
   Chaari L, 2020, EPMA J, V11, P133, DOI 10.1007/s13167-020-00207-0
   Chen AX, 2021, EYE, V35, P74, DOI 10.1038/s41433-020-1110-y
   Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006
   Chen SW, 2018, GENES-BASEL, V9, DOI 10.3390/genes9070355
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Chou CH, 2019, INT J CARDIOL, V274, P214, DOI 10.1016/j.ijcard.2018.07.104
   Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616
   Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155
   Corsetti V, 2015, HUM MOL GENET, V24, P3058, DOI 10.1093/hmg/ddv059
   Crigna AT, 2020, EPMA J, V11, P603, DOI 10.1007/s13167-020-00226-x
   D'Amelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x
   Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166
   Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575
   DE M, 2010, ENVIRON MOL MUTAGEN
   Dominic EA, 2014, HEART, V100, P611, DOI 10.1136/heartjnl-2013-304657
   Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038
   Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115
   El-Soud MRA., 2019, MED RES J, V4, P1, DOI DOI 10.5603/MRJ.A2018.0039
   Elbaz A, 2002, EPIDEMIOLOGY, V13, P157, DOI 10.1097/00001648-200203000-00010
   Faas MM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165845
   Faustini G, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120377
   Feldman AM, 2013, CIRC-HEART FAIL, V6, P461, DOI 10.1161/CIRCHEARTFAILURE.112.000185
   Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017
   Folsom AR, 2016, STROKE, V47, P18, DOI 10.1161/STROKEAHA.115.011035
   Francula-Zaninovic S, 2018, CURR CARDIOL REV, V14, P153, DOI 10.2174/1573403X14666180222102312
   Fujiwara M, 2008, ONCOGENE, V27, P6002, DOI 10.1038/onc.2008.199
   Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042
   Garcia-Heredia JM, 2015, ONCOTARGET, V6, P41582, DOI 10.18632/oncotarget.6057
   García-Moreno JM, 2013, ANTIOXID REDOX SIGN, V18, P1296, DOI 10.1089/ars.2012.5026
   Gaziano J.M., 2005, BRAUNWALDS HEART DIS
   Gerner C, 2020, MASS SPECTROM REV, V39, P442, DOI 10.1002/mas.21612
   Goldenthal MJ, 2016, HEART FAIL REV, V21, P137, DOI 10.1007/s10741-016-9531-1
   Goldstein E, 2020, EPMA J, V11, P505, DOI 10.1007/s13167-020-00221-2
   Golubnitschaja O, 2019, Advances in Predictive, Preventive and Personalised Medicine
   Golubnitschaja O, 2007, SURV OPHTHALMOL, V52, pS155, DOI 10.1016/j.survophthal.2007.08.011
   Golubnitschaja O, 2018, KLIN MONATSBL AUGENH, V235, P146, DOI 10.1055/s-0044-101164
   Golubnitschaja O, 2016, TUMOR BIOL, V37, P12941, DOI 10.1007/s13277-016-5168-x
   Golubnitschaja O, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0072-4
   Gómez-Benito M, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00356
   Goncharenko V, 2019, EPMA J, V10, DOI 10.1007/s13167-019-00164-3
   Guerra F, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00295
   Hadrava Vanova K, 2020, REDOX REP, V25, P26, DOI 10.1080/13510002.2020.1752002
   Hambrecht R, 1997, J AM COLL CARDIOL, V29, P1067, DOI 10.1016/S0735-1097(97)00015-6
   HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   Hepple RT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00211
   Herbert MK, 2014, PARKINSONISM RELAT D, V20, P112, DOI 10.1016/j.parkreldis.2013.09.003
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Hsu CC, 2016, EXP BIOL MED, V241, P1281, DOI 10.1177/1535370216641787
   Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6
   Israeli E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019622
   Jain A, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26874
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jia JY, 2019, J NEUROL NEUROSUR PS, V90, P1347, DOI 10.1136/jnnp-2018-320199
   Jusic A, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0783-5
   Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753
   Kaski JC, 2018, CIRCULATION, V138, P1463, DOI 10.1161/CIRCULATIONAHA.118.031373
   Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406
   Koene S, 2009, J INTERN MED, V265, P193, DOI 10.1111/j.1365-2796.2008.02058.x
   KOKLESOVA L, 2020, CANCERS, V12
   Koklesova L, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10121653
   Koklesova L, 2020, EPMA J, V11, P261, DOI 10.1007/s13167-020-00210-5
   Kosenko EA, 2016, CNS NEUROL DISORD-DR, V15, P113, DOI 10.2174/1871527314666150821103444
   Kozlov S, 2017, REV NEUROSCIENCE, V28, P825, DOI 10.1515/revneuro-2017-0006
   Kralj V., 2013, Cardiol Croat, V8, P373, DOI [DOI 10.15836/CCAR.2013.373, 10.15836/ccar.2013.373]
   Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994
   Kubatka P, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010183
   Kubatka P, 2020, MOLECULES, V25, DOI 10.3390/molecules25061399
   Kubatka P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071749
   Kucera R, 2020, EPMA J, V11, P399, DOI 10.1007/s13167-020-00214-1
   Kumetsov AV, 2004, FEBS LETT, V577, P1, DOI 10.1016/j.febslet.2004.10.021
   Kunin A, 2020, EPMA J, V11, P517, DOI 10.1007/s13167-020-00229-8
   Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911
   Larsen SB, 2018, CELL TISSUE RES, V373, P21, DOI 10.1007/s00441-017-2768-8
   Liskova A, 2020, CLIN EXP MED, V20, P173, DOI 10.1007/s10238-020-00611-w
   Llano DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182098
   Luan H, 2015, PARKINSONISM RELAT D, V21, P1371, DOI 10.1016/j.parkreldis.2015.09.009
   Ma LL, 2014, J ALZHEIMERS DIS, V42, P565, DOI 10.3233/JAD-140168
   Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020
   Marin-Garcia J, 2001, CARDIOVASC RES, V49, P17, DOI 10.1016/S0008-6363(00)00241-8
   McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054
   Meijers WC, 2019, CARDIOVASC RES, V115, P844, DOI 10.1093/cvr/cvz035
   Munzar Michael, 2002, Neurol Clin Neurophysiol, V2002, P2, DOI 10.1162/15268740252769709
   Naoi M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102451
   Nguyen M, 2019, TRENDS NEUROSCI, V42, P140, DOI 10.1016/j.tins.2018.11.001
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Oboudiyat C, 2013, SEMIN NEUROL, V33, P313, DOI 10.1055/s-0033-1359319
   Ording AG, 2019, J ALZHEIMERS DIS, V72, P1269, DOI 10.3233/JAD-190867
   Papageorgakopoulos Tilemachos Nektarios, 2017, Hell J Nucl Med, V20 Suppl, P45
   Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230
   Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824
   Pellecchia MT, 2016, J NEURAL TRANSM, V123, P1399, DOI 10.1007/s00702-016-1622-6
   Peña-Bautista C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246136
   Pérez MJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00441
   Ploumi C, 2017, FEBS J, V284, P183, DOI 10.1111/febs.13820
   PLUNFAVREAU H, 2010, BBA-BIOENERGETICS, V6
   Podlesniy P, 2013, ANN NEUROL, V74, P655, DOI 10.1002/ana.23955
   Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.13
   Polivka J, 2019, EPMA J, V10, DOI 10.1007/s13167-019-00162-5
   Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108
   Qian SH, 2019, EPMA J, V10, P365, DOI 10.1007/s13167-019-00194-x
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1016/j.atherosclerosis.2011.06.012, 10.1093/eurheartj/ehr158]
   Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4
   Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052
   Saeed Anum, 2017, Methodist Debakey Cardiovasc J, V13, P185, DOI 10.14797/mdcj-13-4-185
   Safarzadeh E, 2014, ADV PHARM BULL, V4, P421, DOI 10.5681/apb.2014.062
   Samec M, 2020, EPMA J, V11, P377, DOI 10.1007/s13167-020-00217-y
   Sarasija S, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7090111
   Sato M, 2011, SCIENCE, V334, P1141, DOI 10.1126/science.1210333
   Schmidt LS, 2014, INT J NEPHROL RENOV, V7, P253, DOI 10.2147/IJNRD.S42097
   Scozz, 2020, CIRCULATING MITOCHON, DOI 10.1101/2020.07.30.227553
   Sekino Y, 2020, UROL ONCOL-SEMIN ORI, V38, DOI 10.1016/j.urolonc.2020.04.032
   Shi HB, 2015, J CANCER RES CLIN, V141, P485, DOI 10.1007/s00432-014-1773-5
   Shukla S, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10030126
   Skoumalová A, 2011, EXP GERONTOL, V46, P38, DOI 10.1016/j.exger.2010.09.015
   Smith AM, 2018, MOVEMENT DISORD, V33, P1580, DOI 10.1002/mds.104
   Spencer NY, 2019, SEMIN NEPHROL, V39, P380, DOI 10.1016/j.semnephrol.2019.04.007
   Stockburger C, 2018, J ALZHEIMERS DIS, V64, pS455, DOI 10.3233/JAD-179915
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Taghizadeh G, 2016, FREE RADICAL BIO MED, V99, P11, DOI 10.1016/j.freeradbiomed.2016.07.018
   Takahashi-Niki K, 2012, YAKUGAKU ZASSHI, V132, P1105, DOI 10.1248/yakushi.12-00220-3
   Toraih EA, 2019, CLIN BIOCHEM, V63, P10, DOI 10.1016/j.clinbiochem.2018.12.001
   van der Zwaard S, 2016, J APPL PHYSIOL, V121, P636, DOI 10.1152/japplphysiol.00355.2016
   Vassar R, 2013, NEURON, V80, P250, DOI 10.1016/j.neuron.2013.09.031
   Vida C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030771
   Vilades D, 2020, FASEB J, V34, P4403, DOI 10.1096/fj.201902507R
   Wang LY, 2019, ATHEROSCLEROSIS, V286, P88, DOI 10.1016/j.atherosclerosis.2019.05.006
   Wang YT, 2019, CLIN CARDIOL, V42, P56, DOI 10.1002/clc.23104
   Webster KA, 2009, AM SCI, V97, P384, DOI 10.1511/2009.80.384
   Williams AD, 2007, J CARD FAIL, V13, P79, DOI 10.1016/j.cardfail.2006.10.017
   Wu NN, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9825061
   Yeghiazaryan K, 2010, EPMA J, V1, P263, DOI 10.1007/s13167-010-0032-3
   Zanetti R, 2007, CANCER EPIDEM BIOMAR, V16, P1081, DOI 10.1158/1055-9965.EPI-07-0377
   Zaorsky NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13120-6
   Zhang PC, 2019, ACS CHEM NEUROSCI, V10, P4430, DOI 10.1021/acschemneuro.9b00498
   Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849
   Zhu JB, 2017, J ALZHEIMERS DIS, V58, P631, DOI 10.3233/JAD-170062
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 159
TC 36
Z9 36
U1 2
U2 8
PU SPRINGER INT PUBL AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1878-5077
EI 1878-5085
J9 EPMA J
JI EPMA J.
PD MAR
PY 2021
VL 12
IS 1
SI SI
BP 27
EP 40
DI 10.1007/s13167-021-00237-2
EA MAR 2021
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA QV8OR
UT WOS:000625768400002
PM 33686350
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Kwak, H
   Lee, E
   Karki, R
AF Kwak, Hyosang
   Lee, Ein
   Karki, Rajendra
TI DNA sensors in metabolic and cardiovascular diseases: Molecular
   mechanisms and therapeutic prospects
SO IMMUNOLOGICAL REVIEWS
LA English
DT Review; Early Access
DE AIM2 and IFI16; cGAS-STING pathway; DNA-PK and DDX41; fatty liver and
   heart diseases; inflammation and cell death; obesity and diabetes
ID STRAND BREAK REPAIR; OBESITY-INDUCED INFLAMMATION; OF-FUNCTION MUTATION;
   SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; AIM2 INFLAMMASOME;
   CPG-OLIGODEOXYNUCLEOTIDES; INSULIN-RESISTANCE; MITOCHONDRIAL-DNA;
   PREVENTS OBESITY
AB DNA sensors generally initiate innate immune responses through the production of type I interferons. While extensively studied for host defense against invading pathogens, emerging evidence highlights the involvement of DNA sensors in metabolic and cardiovascular diseases. Elevated levels of modified, damaged, or ectopically localized self-DNA and non-self-DNA have been observed in patients and animal models with obesity, diabetes, fatty liver disease, and cardiovascular disease. The accumulation of cytosolic DNA aberrantly activates DNA signaling pathways, driving the pathological progression of these disorders. This review highlights the roles of specific DNA sensors, such as cyclic AMP-GMP synthase and stimulator of interferon genes (cGAS-STING), absent in melanoma 2 (AIM2), toll-like receptor 9 (TLR9), interferon gamma-inducible protein 16 (IFI16), DNA-dependent protein kinase (DNA-PK), and DEAD-box helicase 41 (DDX41) in various metabolic disorders. We explore how DNA signaling pathways in both immune and non-immune cells contribute to the development of these diseases. Furthermore, we discuss the intricate interplay between metabolic stress and immune responses, offering insights into potential therapeutic targets for managing metabolic and cardiovascular disorders. Understanding the mechanisms of DNA sensor signaling in these contexts provides a foundation for developing novel interventions aimed at mitigating the impact of these pervasive health issues.
C1 [Kwak, Hyosang; Karki, Rajendra] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul, South Korea.
   [Lee, Ein] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.
   [Karki, Rajendra] Nexus Inst Res & Innovat NIRI, Kathmandu, Nepal.
C3 Seoul National University (SNU); Seoul National University (SNU)
RP Karki, R (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea.
EM rkarki@snu.ac.kr
RI Karki, Rajendra/H-6647-2019
OI Karki, Rajendra/0000-0003-4436-9128
FU Seoul National University, Creative-Pioneering Researchers Program;
   National Research Foundation [RS-2023-00251395]
FX Seoul National University, Creative-Pioneering Researchers Program;
   National Research Foundation, Grant/Award Number: RS-2023-00251395
CR Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640
   Afonso MB, 2015, CLIN SCI, V129, P721, DOI 10.1042/CS20140732
   Akazawa Y, 2019, MODERN PATHOL, V32, P997, DOI 10.1038/s41379-019-0218-8
   Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Al-Kafaji G, 2018, EXP THER MED, V16, P1483, DOI 10.3892/etm.2018.6319
   Alkudmani ZS, 2023, BIOLOGY-BASEL, V12, DOI 10.3390/biology12111439
   Anderson AE, 2007, EUR J IMMUNOL, V37, P1548, DOI 10.1002/eji.200636562
   Andreeva L, 2017, NATURE, V549, P394, DOI 10.1038/nature23890
   Bae JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040328
   Bai JL, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0986-1
   Bai JL, 2017, P NATL ACAD SCI USA, V114, P12196, DOI 10.1073/pnas.1708744114
   Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864
   Bartunek J, 2002, J AM COLL CARDIOL, V40, P1097, DOI 10.1016/S0735-1097(02)02122-8
   Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015
   BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0
   Briggs LJ, 2001, BIOCHEM J, V353, P69, DOI 10.1042/bj3530069
   BRUGUERA M, 1977, GASTROENTEROLOGY, V73, P1383
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   Burleigh K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4219
   Cao DJ, 2018, CIRCULATION, V137, P2613, DOI 10.1161/CIRCULATIONAHA.117.031046
   Cao ZJ, 2013, BBA-MOL BASIS DIS, V1832, P96, DOI 10.1016/j.bbadis.2012.08.008
   Chait A, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00022
   Cho CS, 2018, HEPATOLOGY, V68, P1331, DOI 10.1002/hep.29742
   Chou WC, 2021, NATURE, V591, P300, DOI 10.1038/s41586-021-03231-w
   Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140
   Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845
   Csak T, 2014, LIVER INT, V34, P1402, DOI 10.1111/liv.12537
   Devi TD, 2017, AM J PATHOL, V187, P2659, DOI 10.1016/j.ajpath.2017.08.023
   Dihlmann S, 2014, MOL MED, V20, P230, DOI 10.2119/molmed.2013.00162
   Donne R, 2022, DEV CELL, V57, P1728, DOI 10.1016/j.devcel.2022.06.003
   Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127
   Fidler TP, 2021, NATURE, V592, P296, DOI 10.1038/s41586-021-03341-5
   Freitas DF, 2022, MOL BIOL REP, V49, P3225, DOI 10.1007/s11033-022-07157-y
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477
   Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525
   Gao H, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28239-2
   Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885
   Gautheron J, 2014, EMBO MOL MED, V6, P1062, DOI 10.15252/emmm.201403856
   Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004
   Gong ZW, 2019, DIABETOLOGIA, V62, P2325, DOI 10.1007/s00125-019-04983-x
   Goossens P, 2010, CELL METAB, V12, P142, DOI 10.1016/j.cmet.2010.06.008
   Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013
   Hamann L, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00176-y
   Hao B, 2018, INT J MOL MED, V41, P1365, DOI 10.3892/ijmm.2017.3346
   Hasan M, 2017, P NATL ACAD SCI USA, V114, P746, DOI 10.1073/pnas.1611113114
   Hoang AC, 2022, NAT METAB, V4, P1684, DOI 10.1038/s42255-022-00683-w
   Hong CP, 2015, OBESITY, V23, P2199, DOI 10.1002/oby.21215
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Hu B, 2016, SCIENCE, V354, P765, DOI 10.1126/science.aaf7532
   Hu C, 2024, CELL DEATH DISCOV, V10, DOI 10.1038/s41420-024-01870-2
   Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776
   Jakobsen MR, 2014, CYTOKINE GROWTH F R, V25, P649, DOI 10.1016/j.cytogfr.2014.06.004
   Jette N, 2015, PROG BIOPHYS MOL BIO, V117, P194, DOI 10.1016/j.pbiomolbio.2014.12.003
   Johnstone RW, 1998, BIOCHEMISTRY-US, V37, P11924, DOI 10.1021/bi981069a
   Kalo E, 2021, LIVERS-BASEL, V1, P147, DOI 10.3390/livers1030014
   Karki R, 2021, CELL, V184, P149, DOI 10.1016/j.cell.2020.11.025
   Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y
   Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kayserova J, 2014, CLIN IMMUNOL, V153, P49, DOI 10.1016/j.clim.2014.03.018
   King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428
   Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3
   Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011
   KOIVISTO VA, 1989, DIABETES, V38, P641, DOI 10.2337/diabetes.38.5.641
   Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2
   Kong LZ, 2023, EXP MOL MED, V55, P2320, DOI 10.1038/s12276-023-01118-6
   Konno H, 2018, CELL REP, V23, P1112, DOI 10.1016/j.celrep.2018.03.115
   Kou MY, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1259989
   Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113
   Kranzer K, 2000, IMMUNOLOGY, V99, P170, DOI 10.1046/j.1365-2567.2000.00964.x
   Krohn R, 2007, CIRCULATION, V116, P1812, DOI 10.1161/CIRCULATIONAHA.107.708016
   Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
   Kumari M, 2016, J CLIN INVEST, V126, P2839, DOI 10.1172/JCI86080
   Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702
   Kwan HY, 2013, EUR J NUTR, V52, P1621, DOI 10.1007/s00394-012-0467-5
   Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116
   Lee KG, 2015, CELL REP, V10, P1055, DOI 10.1016/j.celrep.2015.01.039
   Leite JA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040959
   Li WJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87315
   Liu FY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1718-7
   Liu HY, 2018, ONCOTARGET, V9, P2887, DOI [10.18632/oncotarget.20812, 10.18632/oncotarget.23208]
   Liu L, 2022, SCI SIGNAL, V15, DOI 10.1126/scisignal.abh2290
   Liu MJ, 2018, DIABETOLOGIA, V61, P2333, DOI 10.1007/s00125-018-4705-0
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu X, 2015, INT J OBESITY, V39, P1548, DOI 10.1038/ijo.2015.93
   Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625
   Liu YY, 2022, RESP RES, V23, DOI 10.1186/s12931-022-02171-x
   Lozano-Ruiz B, 2015, J HEPATOL, V62, P64, DOI 10.1016/j.jhep.2014.08.027
   Lu JL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01173
   Lu S, 2023, FRONT IMMUNOL, V14, DOI 10.3389/fimmu.2023.1052756
   Luo W, 2020, CIRCULATION, V141, P42, DOI 10.1161/CIRCULATIONAHA.119.041460
   Luther J, 2020, P NATL ACAD SCI USA, V117, P11667, DOI 10.1073/pnas.1911870117
   Ma CM, 2021, J EXP MED, V218, DOI 10.1084/jem.20201796
   Macfarlane DE, 1998, J IMMUNOL, V160, P1122
   Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001
   Man SM, 2015, NAT IMMUNOL, V16, P467, DOI 10.1038/ni.3118
   Mao H, 2023, NAT METAB, V5, P1382, DOI 10.1038/s42255-023-00844-5
   Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/ATVBAHA.117.309017, 10.1161/atvbaha.117.309017]
   Markowski P, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0376-7
   Matyszewski M, 2018, P NATL ACAD SCI USA, V115, pE1963, DOI 10.1073/pnas.1712860115
   Medunjanin S, 2015, CARDIOVASC RES, V106, P488, DOI 10.1093/cvr/cvv126
   Melki I, 2017, J ALLERGY CLIN IMMUN, V140, P543, DOI 10.1016/j.jaci.2016.10.031
   Mercer E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3868
   Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052
   Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111
   Mosler T, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27530-y
   Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024
   Nishimoto S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501332
   Nöthen T, 2023, ARTERIOSCL THROM VAS, V43, P300, DOI 10.1161/ATVBAHA.122.317922
   Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992
   Okude H, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.625833
   Okuya K, 2010, J IMMUNOL, V184, P7092, DOI 10.4049/jimmunol.1000490
   Omura H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34756
   Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006
   Panchanathan R, 2010, J IMMUNOL, V185, P7385, DOI 10.4049/jimmunol.1002468
   Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5834
   Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.07.005, 10.1016/j.cmet.2017.04.008]
   Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460
   Paulin N, 2018, CIRCULATION, V138, P321, DOI 10.1161/CIRCULATIONAHA.117.033098
   Pejnovic N, 2009, MOL IMMUNOL, V47, P37, DOI 10.1016/j.molimm.2008.12.032
   Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110
   Pham PT, 2021, EUR HEART J, V42, P4336, DOI 10.1093/eurheartj/ehab249
   Picard C, 2016, CHEST, V150, pE65, DOI 10.1016/j.chest.2016.02.682
   Pollard AE, 2019, NAT METAB, V1, P340, DOI 10.1038/s42255-019-0036-9
   Qiao JT, 2018, METABOLISM, V81, P13, DOI 10.1016/j.metabol.2017.09.010
   Qiao JT, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2101848119
   Ratsimandresy RA, 2017, CELL MOL IMMUNOL, V14, P127, DOI 10.1038/cmi.2016.35
   Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082
   Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914
   Saito Y, 2019, CELL DEATH DIFFER, V26, P470, DOI 10.1038/s41418-018-0131-6
   Sano S, 2019, JACC-BASIC TRANSL SC, V4, P684, DOI 10.1016/j.jacbts.2019.05.013
   Sestan M, 2018, IMMUNITY, V49, P164, DOI 10.1016/j.immuni.2018.05.005
   Sha S, 2021, DIABETES, V70, P504, DOI 10.2337/db20-0373
   Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5
   Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070
   Shepard CR, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.613639
   Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945
   Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110
   Singh RS, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110856
   Smith JR, 2023, CELL REP, V42, DOI 10.1016/j.celrep.2023.112805
   Alegre NS, 2020, CLIN MOL HEPATOL, V26, P216, DOI 10.3350/cmh.2019.0074
   Stadion M, 2018, DIABETOLOGIA, V61, P1167, DOI 10.1007/s00125-018-4571-9
   Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108
   Tan YS, 2015, BIOCHEM BIOPH RES CO, V466, P592, DOI 10.1016/j.bbrc.2015.09.091
   Tang P, 2021, CELL DEATH DIFFER, V28, P3022, DOI 10.1038/s41418-021-00798-9
   Ueda H, 2019, JACC-BASIC TRANSL SC, V4, P348, DOI 10.1016/j.jacbts.2019.01.002
   Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Varshney D, 2020, NAT REV MOL CELL BIO, V21, P459, DOI 10.1038/s41580-020-0236-x
   Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225
   Venkat V, 2023, GENOMICS, V115, DOI 10.1016/j.ygeno.2023.110584
   Vergis N, 2017, GASTROENTEROLOGY, V152, P1068, DOI 10.1053/j.gastro.2016.12.019
   Vogel H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3552-6
   Vogel H, 2012, HUM MOL GENET, V21, P3845, DOI 10.1093/hmg/dds213
   Vollmer J, 2004, EUR J IMMUNOL, V34, P251, DOI 10.1002/eji.200324032
   Wan DS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00615
   Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420
   Wang LT, 2023, REDOX BIOL, V67, DOI 10.1016/j.redox.2023.102893
   Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477
   Wang P, 2024, NAT COMMUN, V15, DOI 10.1038/s41467-024-48611-8
   Wang XF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2296-4
   Wang XA, 2014, HEPATOLOGY, V59, P870, DOI 10.1002/hep.26751
   Wang XA, 2013, AM J PHYSIOL-ENDOC M, V305, pE485, DOI 10.1152/ajpendo.00505.2012
   Wang XY, 2019, LIFE SCI, V221, P249, DOI 10.1016/j.lfs.2019.02.035
   Wang Y, 2022, REDOX BIOL, V52, DOI 10.1016/j.redox.2022.102322
   Wasko MCM, 2015, DIABETOLOGIA, V58, P2336, DOI 10.1007/s00125-015-3689-2
   Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908
   Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040
   Wortmann M, 2019, INFLAMM RES, V68, P337, DOI 10.1007/s00011-019-01212-4
   Wu C, 2014, J IMMUNOL, V193, P3036, DOI 10.4049/jimmunol.1302379
   Xu L, 2021, AM J PHYSIOL-GASTR L, V320, pG1034, DOI 10.1152/ajpgi.00431.2020
   Xu S, 2024, BBA-MOL BASIS DIS, V1870, DOI 10.1016/j.bbadis.2023.166930
   Xue M, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118752
   Ye Z, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.797880
   Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679
   Yoshida K, 2019, CARDIOVASC RES, V115, P658, DOI 10.1093/cvr/cvy209
   Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024
   Yu WJ, 2023, ACTA PHARM SIN B, V13, P4823, DOI 10.1016/j.apsb.2023.09.008
   Yu YS, 2019, J CLIN INVEST, V129, P546, DOI 10.1172/JCI121842
   Yu Z, 2023, J CLIN INVEST, V133, DOI 10.1172/JCI168597
   Zhang Q, 2022, REDOX BIOL, V54, DOI 10.1016/j.redox.2022.102367
   Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492
   Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091
   Zhao BX, 2011, MOL ENDOCRINOL, V25, P1337, DOI 10.1210/me.2011-0081
   Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007
   Zhong ZY, 2018, NATURE, V560, P198, DOI 10.1038/s41586-018-0372-z
   Zhou H, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-019-0773-7
   Zhou H, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12450
NR 191
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0105-2896
EI 1600-065X
J9 IMMUNOL REV
JI Immunol. Rev.
PD 2024 AUG 19
PY 2024
DI 10.1111/imr.13382
EA AUG 2024
PG 21
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA D0S4O
UT WOS:001293368500001
PM 39158380
OA hybrid
DA 2024-11-01
ER

PT J
AU Qi, M
   Liao, SM
   Wang, J
   Deng, YK
   Zha, AD
   Shao, YR
   Cui, ZJ
   Song, TX
   Tang, YL
   Tan, B
   Yin, YL
AF Qi, Ming
   Liao, Simeng
   Wang, Jing
   Deng, Yuankun
   Zha, Andong
   Shao, Yirui
   Cui, Zhijuan
   Song, Tongxing
   Tang, Yulong
   Tan, Bie
   Yin, Yulong
TI MyD88 deficiency ameliorates weight loss caused by intestinal oxidative
   injury in an autophagy-dependent mechanism
SO JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
LA English
DT Article
DE Intestinal epithelial cells; Cachexia; Weight loss; DNA damage repair;
   Mitochondria) fission; Autophagy
ID DNA-DAMAGE; STRESS; MUSCLE; CANCER; PATHOGENESIS; SARCOPENIA; PROTECTS;
   CACHEXIA; INSIGHTS; SYSTEMS
AB Background Gut health plays a vital role in the overall health and disease control of human and animals. Intestinal oxidative stress is a critical player in the induction and progression of cachexia which is conventionally diagnosed and classified by weight loss. Therefore, reduction of intestinal oxidative injury is a common and highly effective strategy for the maintenance of human and animal health. Here we identify intestinal myeloid differentiation primary response gene 88 (MyD88) as a novel target for intestinal oxidative stress using canonical oxidative stress model induced by paraquat (PQ) in vitro and in vivo.
   Methods Intestinal oxidative stress was induced by administration of PQ in intestinal epithelial cells (IECs) and mouse model. Cell proliferation, apoptosis, DNA damage, mitochondrial function, oxidative status, and autophagy process were measured in wild-type and MyD88-deficient IECs during PQ exposure. Autophagy inhibitor (3-methyladenine) and activator (rapamycin) were employed to assess the role of autophagy in MyD88-deficient IECs during PQ exposure. MyD88 specific inhibitor, ST2825, was used to verify function of MyD88 during PQ exposure in mouse model.
   Results MyD88 protein levels and apoptotic rate of IECs are increased in response to PQ exposure (P < 0.001). Intestinal deletion of MyD88 blocks PQ-induced apoptosis (similar to 42% reduction) and DNA damage (similar to 86% reduction), and improves mitochondrial fission (similar to 37% reduction) and function including mitochondrial membrane potential (similar to 23% increment) and respiratory metabolism capacity (similar to 26% increment) (P < 0.01). Notably, there is a marked decrease in reactive oxygen species in MyD88-deficient IECs during PQ exposure (similar to 70% reduction), which are consistent with high activity of antioxidative enzymes (similar to 83% increment) (P < 0.001). Intestinal ablation of MyD88 inhibits mTOR signalling, and further phosphorylates p53 proteins during PQ exposure, which eventually promotes intestinal autophagy (similar to 74% increment) (P < 0.01). Activation of autophagy (rapamycin) promotes IECs growth as compared with 3-methyladenine-treatment during PQ exposure (similar to 173% increment), while inhibition of autophagy (3-methyladenine) exacerbates oxidative stress in MyD88-deficient IECs (P < 0.001). In mouse model, inhibition of MyD88 using specific inhibitor ST2825 followed by PQ treatment effectively ameliorates weight loss (similar to 4% increment), decreased food intake (similar to 92% increment), gastrocnemius and soleus loss (similar to 24% and similar to 20% increment, respectively), and intestinal oxidative stress in an autophagy dependent manner (P < 0.01).
   Conclusions MyD88 modulates intestinal oxidative stress in an autophagy-dependent mechanism, which suggests that reducing MyD88 level may constitute a putative therapeutic target for intestinal oxidative injury-induced weight loss.
C1 [Qi, Ming; Liao, Simeng; Zha, Andong; Shao, Yirui; Cui, Zhijuan; Tang, Yulong; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Lab Anim Nutr Physiol & Metab Proc,Key Lab Agroec, Changsha 410125, Hunan, Peoples R China.
   [Qi, Ming; Wang, Jing; Deng, Yuankun; Cui, Zhijuan; Tan, Bie; Yin, Yulong] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410000, Hunan, Peoples R China.
   [Qi, Ming; Liao, Simeng; Zha, Andong; Shao, Yirui; Yin, Yulong] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Song, Tongxing] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS;
   Hunan Agricultural University; Chinese Academy of Sciences; University
   of Chinese Academy of Sciences, CAS; Huazhong Agricultural University
RP Tang, YL (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Lab Anim Nutr Physiol & Metab Proc,Key Lab Agroec, Changsha 410125, Hunan, Peoples R China.; Tan, B (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410000, Hunan, Peoples R China.
EM bietan@hunau.edu.cn; tangyulong@isa.ac.cn
RI Tan, Bie/KMX-8635-2024; Song, Tongxing/AAH-3942-2019
OI Song, Tongxing/0000-0002-0969-3689
FU National Natural Science Foundation of China [32072745, 32130099];
   Innovation Province Project [2019RS3021]
FX This work was supported by the National Natural Science Foundation of
   China (32072745 and 32130099) and Innovation Province Project
   (2019RS3021). The authors certify that they comply with the ethical
   guidelines for authorship and publishing of the Journal of Cachexia,
   Sarcopenia and Muscle.<SUP>41</SUP>
CR Abrigo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2063179
   Aoki H, 2002, J NUTR, V132, P2258, DOI 10.1093/jn/132.8.2258
   Argilés JM, 2011, EUR J PHARMACOL, V668, pS81, DOI 10.1016/j.ejphar.2011.07.007
   Baraldo M, 2020, J CACHEXIA SARCOPENI, V11, P208, DOI 10.1002/jcsm.12496
   Barazzoni R, 2017, J CACHEXIA SARCOPENI, V8, P991, DOI 10.1002/jcsm.12254
   Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012
   Brown JL, 2020, J CACHEXIA SARCOPENI, V11, P1688, DOI 10.1002/jcsm.12615
   Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232
   Costa RGF, 2019, J CACHEXIA SARCOPENI, V10, P1116, DOI 10.1002/jcsm.12449
   De Zio D, 2013, ANTIOXID REDOX SIGN, V19, P559, DOI 10.1089/ars.2012.4938
   González-Polo RA, 2004, BRAIN RES, V1011, P170, DOI 10.1016/j.brainres.2004.02.078
   Harberts E, 2015, J IMMUNOL, V194, P3127, DOI 10.4049/jimmunol.1402583
   He J, 2019, MOLECULES, V24, DOI 10.3390/molecules24244502
   Hinch ECA, 2013, J CACHEXIA SARCOPENI, V4, P287, DOI 10.1007/s13539-013-0116-8
   Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615
   Hwang J, 2020, REDOX BIOL, V37, DOI 10.1016/j.redox.2020.101760
   Konstam MA, 2018, CIRCULATION, V137, pE578, DOI 10.1161/CIR.0000000000000560
   Pötgens SA, 2021, J CACHEXIA SARCOPENI, V12, P456, DOI 10.1002/jcsm.12684
   Qaisar R, 2018, J CACHEXIA SARCOPENI, V9, P1003, DOI 10.1002/jcsm.12339
   Qi M, 2019, J ANIM SCI, V97, P3795, DOI 10.1093/jas/skz205
   Reczek CR, 2017, NAT CHEM BIOL, V13, P1274, DOI [10.1038/nchembio.2499, 10.1038/NCHEMBIO.2499]
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Ruud J, 2010, BRAIN BEHAV IMMUN, V24, P554, DOI 10.1016/j.bbi.2010.01.006
   Shibata M, 2010, J BIOL CHEM, V285, P20915, DOI 10.1074/jbc.M110.126482
   Siegel MP, 2012, MECH AGEING DEV, V133, P620, DOI 10.1016/j.mad.2012.08.002
   Song XZ, 2017, REDOX BIOL, V11, P219, DOI 10.1016/j.redox.2016.12.015
   Takenaka A, 2003, BIOSCI BIOTECH BIOCH, V67, P278, DOI 10.1271/bbb.67.278
   Takizawa M, 2007, TOXICOL IN VITRO, V21, P355, DOI 10.1016/j.tiv.2006.09.003
   Tang YL, 2015, FREE RADICAL BIO MED, V89, P944, DOI 10.1016/j.freeradbiomed.2015.09.012
   Tao SY, 2019, CURR PROTEIN PEPT SC, V20, P713, DOI 10.2174/1389203720666190124165243
   Thiesen S, 2014, J LEUKOCYTE BIOL, V95, P531, DOI 10.1189/jlb.0113021
   Ulmer TF, 2014, INT J SURG, V12, P426, DOI 10.1016/j.ijsu.2014.03.014
   Van Krimpen SJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13041115
   von Haehling S, 2019, J CACHEXIA SARCOPENI, V10, P1143, DOI 10.1002/jcsm.12501
   Wen CY, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00463-0
   Wyart E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228592
   Yang JH, 2020, FASEB J, V34, P12324, DOI 10.1096/fj.202001252R
   Yin JY, 2019, THERANOSTICS, V9, P4019, DOI 10.7150/thno.33000
   Zha AD, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5363546
   Zhou MX, 2018, EBIOMEDICINE, V35, P345, DOI 10.1016/j.ebiom.2018.08.035
   Zhu XX, 2019, J CACHEXIA SARCOPENI, V10, P378, DOI 10.1002/jcsm.12377
NR 41
TC 16
Z9 16
U1 0
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2190-5991
EI 2190-6009
J9 J CACHEXIA SARCOPENI
JI J. Cachexia Sarcopenia Muscle
PD FEB
PY 2022
VL 13
IS 1
BP 677
EP 695
DI 10.1002/jcsm.12858
EA NOV 2021
PG 19
WC Geriatrics & Gerontology; Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; General & Internal Medicine
GA 2O3QI
UT WOS:000721429400001
PM 34811946
OA Green Published
DA 2024-11-01
ER

PT J
AU Giulivi, C
   Ross-Inta, C
   Omanska-Klusek, A
   Napoli, E
   Sakaguchi, D
   Barrientos, G
   Allen, PD
   Pessah, IN
AF Giulivi, Cecilia
   Ross-Inta, Catherine
   Omanska-Klusek, Alicja
   Napoli, Eleonora
   Sakaguchi, Danielle
   Barrientos, Genaro
   Allen, Paul D.
   Pessah, Isaac N.
TI Basal Bioenergetic Abnormalities in Skeletal Muscle from Ryanodine
   Receptor Malignant Hyperthermia-susceptible R163C Knock-in Mice
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CENTRAL-CORE DISEASE; ACTIVATED PROTEIN-KINASE; SATURATED FATTY-ACIDS;
   RAT SKELETAL; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; FIBER-TYPE;
   SUBCELLULAR-FRACTIONS; CALCIUM-HOMEOSTASIS; DIABETES-MELLITUS
AB Malignant hyperthermia (MH) and central core disease in humans have been associated with mutations in the skeletal ryanodine receptor (RyR1). Heterozygous mice expressing the human MH/central core disease RyR1 R163C mutation exhibit MH when exposed to halothane or heat stress. Considering that many MH symptoms resemble those that could ensue from a mitochondrial dysfunction (e.g. metabolic acidosis and hyperthermia) and that MH-susceptible mice or humans have a higher than normal cytoplasmic Ca2+ concentration at rest, we evaluated the role of mitochondria in skeletal muscle from R163C compared with wild type mice under basal (untriggered) conditions. R163C skeletal muscle exhibited a significant increase in matrix Ca2+, increased reactive oxygen species production, lower expression of mitochondrial proteins, and higher mtDNA copy number. These changes, in conjunction with lower myoglobin and glycogen contents, Myh4 and GAPDH transcript levels, GAPDH activity, and lower glucose utilization suggested a switch to a compromised bioenergetic state characterized by both low oxidative phosphorylation and glycolysis. The shift in bioenergetic state was accompanied by a dysregulation of Ca2+-esponsive signaling pathways regulated by calcineurin and ERK1/2. Chronically elevated resting Ca2+ in R163C skeletal muscle elicited the maintenance of a fast-twitch fiber program and the development of insulin resistance-like phenotype as part of a metabolic adaptation to the R163C RyR1 mutation.
C1 [Giulivi, Cecilia; Ross-Inta, Catherine; Omanska-Klusek, Alicja; Napoli, Eleonora; Sakaguchi, Danielle; Barrientos, Genaro; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA.
   [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.
C3 University of California System; University of California Davis; Harvard
   University; Brigham & Women's Hospital
RP Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, 1120 Haring Hall,1 Shields Ave, Davis, CA 95616 USA.
EM cgiulivi@ucdavis.edu
RI Pessah, Isaac/K-7985-2017; Barrientos, Genaro/I-2778-2013; Napoli,
   Eleonora/AAQ-6079-2021; allen, p/HHZ-1090-2022; Giulivi,
   Cecilia/AAV-6774-2021; Giulivi, Cecilia/C-4015-2012
OI Giulivi, Cecilia/0000-0003-1033-7435; Napoli,
   Eleonora/0000-0001-8808-4242; Barrientos, Genaro/0000-0003-1295-5181
FU National Institutes of Health [012691, RC1DK087307]; NIEHS;  [2R0
   AR043140];  [1P01 AR052354]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants 012691 (to C. G.) and RC1DK087307 (to C. G.) from NIEHS
   and 2R0 AR043140 and 1P01 AR052354.
CR Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25
   Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084
   ALMARAZ L, 1989, FEBS LETT, V244, P417, DOI 10.1016/0014-5793(89)80575-7
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Andrienko T, 2003, J EXP BIOL, V206, P2059, DOI 10.1242/jeb.00242
   Argaud L, 2008, AM J PHYSIOL-HEART C, V294, pH386, DOI 10.1152/ajpheart.01035.2007
   Ashcroft S. J. H., 2002, Biochemical Society Transactions, V30, pA114
   Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1
   Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200
   Bina S, 2006, ANESTHESIOLOGY, V104, P90, DOI 10.1097/00000542-200601000-00015
   Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279
   BOCEK RM, 1966, AM J PHYSIOL, V210, P1108, DOI 10.1152/ajplegacy.1966.210.5.1108
   BOCEK RM, 1966, AM J PHYSIOL, V210, P1101, DOI 10.1152/ajplegacy.1966.210.5.1101
   BOCEK RM, 1966, J HISTOCHEM CYTOCHEM, V14, P549, DOI 10.1177/14.7.549
   BOLENDER RP, 1978, J CELL BIOL, V77, P565, DOI 10.1083/jcb.77.2.565
   Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496
   BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P404, DOI 10.1016/0006-2944(78)90090-X
   Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3
   Britt B. A., 1973, INT S MALIGNANT HYPE, P387
   BRITT BA, 1973, CAN ANAESTH SOC J, V20, P431, DOI 10.1007/BF03026208
   Bruton JD, 1999, P NATL ACAD SCI USA, V96, P3281, DOI 10.1073/pnas.96.6.3281
   Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360
   BULLOCK GR, 1973, BIOCHIM BIOPHYS ACTA, V292, P350, DOI 10.1016/0005-2728(73)90041-8
   BYRNE E, 1985, J NEUROL SCI, V69, P319, DOI 10.1016/0022-510X(85)90143-1
   Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106
   CAMPBELL IT, 1981, ANESTHESIOLOGY, V55, P46, DOI 10.1097/00000542-198107000-00010
   Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007
   Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104
   CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0
   CHANCE B, 1959, CIBA F S REGULATION, P91
   Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020
   Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200
   Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101
   Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299
   Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499
   Cross HR, 2002, J MOL CELL CARDIOL, V34, P361, DOI 10.1006/jmcc.2001.1518
   Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x
   Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3
   Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261
   DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395
   DENBOROUGH MA, 1970, LANCET, V1, P1137
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   DUBOWITZ V, 1960, LANCET, V2, P23
   Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042
   Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200
   Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003
   ELLIS FR, 1973, P ROY SOC MED, V66, P66, DOI 10.1177/00359157730661P132
   Engstrom I, 1996, SCAND J CLIN LAB INV, V56, P345, DOI 10.3109/00365519609090586
   Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339
   Estabrook R.W., 1974, METHODS ENZYMOLOGY, V10, P41
   EVERTS ME, 1993, ACTA PHYSIOL SCAND, V147, P357, DOI 10.1111/j.1748-1716.1993.tb09512.x
   FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9
   FENOGLIO JJ, 1977, AM J PATHOL, V89, P51
   FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6
   FOSTER PS, 1989, MUSCLE NERVE, V12, P390, DOI 10.1002/mus.880120509
   Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594
   GAZZOTTI P, 1985, BIOCHEM BIOPH RES CO, V127, P358, DOI 10.1016/S0006-291X(85)80167-4
   Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5
   GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R
   GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311, DOI [10.1007/0-306-48412-917, DOI 10.1007/0-306-48412-917]
   Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57
   Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604
   Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004
   Hannken T, 2000, J AM SOC NEPHROL, V11, P1387, DOI 10.1681/ASN.V1181387
   HARIGAYA S, 1968, J BIOCHEM, V63, P324
   Hatefi Y, 1978, Methods Enzymol, V53, P21
   Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009
   HEDMAN R, 1962, BIOCHEM BIOPH RES CO, V8, P314, DOI 10.1016/0006-291X(62)90285-1
   Hollander AS, 2003, PEDIATRICS, V111, P1447, DOI 10.1542/peds.111.6.1447
   Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214
   Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4
   Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056
   Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2
   Jungbluth Heinz, 2004, Neuromuscul Disord, V14, P754, DOI 10.1016/j.nmd.2004.07.007
   Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
   Kilbane BJ, 2006, PEDIATR CRIT CARE ME, V7, P169, DOI 10.1097/01.PCC.0000192340.09136.82
   Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   LEBARON FN, 1959, J NEUROCHEM, V4, P1, DOI 10.1111/j.1471-4159.1959.tb13168.x
   Leblondel G, 2001, BIOL TRACE ELEM RES, V83, P191, DOI 10.1385/BTER:83:3:191
   LEBLONDEL G, 1988, BIOL TRACE ELEM RES, V16, P115, DOI 10.1007/BF02797096
   Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7
   LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234
   Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9
   Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200
   López JR, 2005, AM J PHYSIOL-CELL PH, V288, pC606, DOI 10.1152/ajpcell.00297.2004
   MANNESCHI L, 1995, J NEUROL SCI, V128, P151, DOI 10.1016/0022-510X(94)00227-F
   MARBAN E, 1980, NATURE, V286, P845, DOI 10.1038/286845a0
   MAX SR, 1972, ANAL BIOCHEM, V46, P576, DOI 10.1016/0003-2697(72)90328-4
   McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
   Mezin P, 1997, BRIT J ANAESTH, V79, P327, DOI 10.1093/bja/79.3.327
   MEZON BJ, 1974, CAN J BIOCHEM CELL B, V52, P1024, DOI 10.1139/o74-143
   MICKELSON JR, 1980, ANAL BIOCHEM, V109, P255, DOI 10.1016/0003-2697(80)90645-4
   Missihoun C, 2009, MOL CELL BIOCHEM, V321, P45, DOI 10.1007/s11010-008-9908-0
   Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581
   Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Mu XD, 2007, PHYSIOL GENOMICS, V30, P300, DOI 10.1152/physiolgenomics.00286.2006
   Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545
   NISHIYAMA A, 1966, ACTA MED OKAYAMA, V20, P137
   OBRIEN PJ, 1990, RES VET SCI, V48, P124, DOI 10.1016/S0034-5288(18)31522-4
   OBRIEN PJ, 1990, CAN J VET RES, V54, P83
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011
   PAYEN JF, 1993, ANESTHESIOLOGY, V78, P848, DOI 10.1097/00000542-199305000-00007
   PAYEN JF, 1991, LANCET, V337, P1550, DOI 10.1016/0140-6736(91)93247-7
   PETER JB, 1967, BIOCHEM BIOPH RES CO, V29, P430, DOI 10.1016/0006-291X(67)90475-5
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x
   QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51
   Rasmussen HN, 1997, ANAL BIOCHEM, V252, P153, DOI 10.1006/abio.1997.2304
   Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996
   Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004
   Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763
   RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595
   Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356
   Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098
   Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090
   Rueffert H, 2004, AM J MED GENET A, V124A, P248, DOI 10.1002/ajmg.a.20404
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sahlin K, 2002, J PHYSIOL-LONDON, V541, P569, DOI 10.1113/jphysiol.2002.016683
   Sambuughin N, 2001, AM J HUM GENET, V69, P204, DOI 10.1086/321270
   Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200
   SCHILLER HH, 1974, J NEUROL SCI, V21, P93, DOI 10.1016/0022-510X(74)90109-9
   SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97
   Shi H, 2007, AM J PHYSIOL-CELL PH, V292, pC1681, DOI 10.1152/ajpcell.00466.2006
   Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600
   SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004
   SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610
   SMITH MJH, 1956, BIOCHEM J, V63, P524, DOI 10.1042/bj0630524
   Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305
   TAYLOR WM, 1980, BIOCHEM J, V188, P443, DOI 10.1042/bj1880443
   Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879
   Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008
   Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005
   VALLIERES J, 1975, ARCH BIOCHEM BIOPHYS, V170, P659, DOI 10.1016/0003-9861(75)90162-9
   Venkatraman R., 2006, Indian Journal of Pediatrics, V73, P55, DOI 10.1007/BF02758261
   WANG JK, 1969, ANESTHESIOLOGY, V30, P439, DOI 10.1097/00000542-196904000-00015
   Wappler F, 2001, EUR J ANAESTH, V18, P632, DOI 10.1046/j.1365-2346.2001.00888.x
   WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764
   WILSON RD, 1971, SOUTHERN MED J, V64, P411, DOI 10.1097/00007611-197104000-00006
   Wright DC, 2004, LIFE SCI, V74, P815, DOI 10.1016/j.lfs.2003.06.041
   WROGEMANN K, 1973, ARCH BIOCHEM BIOPHYS, V159, P267, DOI 10.1016/0003-9861(73)90453-0
   Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016
   Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006
   Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200
   Yoshida M, 2006, AM J PHYSIOL-REG I, V290, pR449, DOI 10.1152/ajpregu.00684.2004
   Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200
   ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46
   Zhao P, 2008, EXP BIOL MED, V233, P1289, DOI 10.3181/0803-RM-84
   ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N
   Zimmermann P, 2000, LIFE SCI, V67, P949, DOI 10.1016/S0024-3205(00)00688-3
NR 160
TC 41
Z9 45
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 7
PY 2011
VL 286
IS 1
BP 99
EP 113
DI 10.1074/jbc.M110.153247
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 700YZ
UT WOS:000285782800011
PM 20978128
OA Green Published
DA 2024-11-01
ER

PT J
AU Spinazzi, M
   Cazzola, S
   Bortolozzi, M
   Baracca, A
   Loro, E
   Casarin, A
   Solaini, G
   Sgarbi, G
   Casalena, G
   Cenacchi, G
   Malena, A
   Frezza, C
   Carrara, F
   Angelini, C
   Scorrano, L
   Salviati, L
   Vergani, L
AF Spinazzi, Marco
   Cazzola, Silvia
   Bortolozzi, Mario
   Baracca, Alessandra
   Loro, Emanuele
   Casarin, Alberto
   Solaini, Giancarlo
   Sgarbi, Gianluca
   Casalena, Gabriella
   Cenacchi, Giovanna
   Malena, Adriana
   Frezza, Christian
   Carrara, Franco
   Angelini, Corrado
   Scorrano, Luca
   Salviati, Leonardo
   Vergani, Lodovica
TI A novel deletion in the GTPase domain of <i>OPA1</i> causes defects in
   mitochondrial morphology and distribution, but not in function
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED PROTEIN; COMPLEX-I-DEFICIENCY;
   PROTEOLYTIC CLEAVAGE; MTDNA MAINTENANCE; CULTURED MUSCLE; MUTATIONS;
   FUSION; APOPTOSIS; DYSFUNCTION
AB Autosomal dominant optic atrophy (ADOA), the commonest cause of inherited optic atrophy, is caused by mutations in the ubiquitously expressed gene optic atrophy 1 (OPA1), involved in fusion and biogenesis of the inner membrane of mitochondria. Bioenergetic failure, mitochondrial network abnormalities and increased apoptosis have all been proposed as possible causal factors. However, their relative contribution to pathogenesis as well as the prominent susceptibility of the retinal ganglion cell (RGC) in this disease remains uncertain. Here we identify a novel deletion of OPA1 gene in the GTPase domain in three patients affected by ADOA. Muscle biopsy of the patients showed neurogenic atrophy and abnormal morphology and distribution of mitochondria. Confocal microscopy revealed increased mitochondrial fragmentation in fibroblasts as well as in myotubes, where mitochondria were also unevenly distributed, with clustered organelles alternating with areas where mitochondria were sparse. These abnormalities were not associated with altered bioenergetics or increased susceptibility to pro-apoptotic stimuli. Therefore, changes in mitochondrial shape and distribution can be independent of other reported effects of OPA1 mutations, and therefore may be the primary cause of the disease. The arrangement of mitochondria in RGCs, which degenerate in ADOA, may be exquisitely sensitive to disturbance, and this may lead to bioenergetic crisis and/or induction of apoptosis. Our results highlight the importance of mitochondrial dynamics in the disease per se, and point to the loss of the fine positioning of mitochondria in the axons of RGCs as a possible explanation for their predominant degeneration in ADOA.
C1 [Spinazzi, Marco; Cazzola, Silvia; Loro, Emanuele; Malena, Adriana; Angelini, Corrado; Vergani, Lodovica] Univ Padua, Dept Neurosci, I-35100 Padua, Italy.
   [Bortolozzi, Mario; Frezza, Christian; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.
   [Baracca, Alessandra; Solaini, Giancarlo; Sgarbi, Gianluca; Casalena, Gabriella] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy.
   [Casarin, Alberto; Salviati, Leonardo] Univ Padua, Dept Pediat, Padua, Italy.
   [Cenacchi, Giovanna] Univ Bologna, Dept Radiol & Histocytopathol Sci, Bologna, Italy.
   [Carrara, Franco] Ist Neurol C Besta, Milan, Italy.
C3 University of Padua; Veneto Institute Molecular Medicine; Fondazione
   Telethon; Dulbecco Telethon Institute (DTI); University of Bologna;
   University of Padua; University of Bologna; Fondazione IRCCS Istituto
   Neurologico Carlo Besta
RP Spinazzi, M (corresponding author), Neurol Clin 2, Via Facciolati 71, I-35100 Padua, Italy.
EM marco.spinazzi@unipd.it
RI Spinazzi, Marco/AFO-9978-2022; Angelini, Corrado/J-3655-2019; Sgarbi,
   Gianluca/AAD-8061-2021; Salviati, Leonardo/L-1007-2016; Loro,
   Emanuele/J-5212-2019; Loro, Emanuele/L-4999-2017; Bortolozzi,
   Mario/H-6872-2015; Scorrano, Luca/A-6652-2008; Frezza,
   Christian/G-2174-2010
OI Loro, Emanuele/0000-0002-0822-4514; SPINAZZI, Marco/0000-0003-0048-9558;
   Bortolozzi, Mario/0000-0001-7198-9838; Scorrano,
   Luca/0000-0002-8515-8928; BARACCA, ALESSANDRA/0000-0002-0490-1776;
   CENACCHI, GIOVANNA/0000-0001-5824-3118; SOLAINI,
   GIANCARLO/0000-0001-7825-0446; Frezza, Christian/0000-0002-3293-7397;
   Angelini, Corrado/0000-0002-9554-8794
FU Association Francaise Contre le Myopathies [11032]; Telethon Bank
   [GTB07001]; Eurobiobank [QLRT 2001-027769]; Telethon Italy [TELU02016]
FX This study was supported by Association Francaise Contre le Myopathies
   (11032 to L. V.); Telethon Bank (GTB07001 to A. C.); Eurobiobank (QLRT
   2001-027769 to A. C.); Telethon Italy (TELU02016 to L. S.).
CR Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944
   Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681
   Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200
   Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007
   Baracca A, 2005, ARCH NEUROL-CHICAGO, V62, P730, DOI 10.1001/archneur.62.5.730
   Baracca A, 2007, BBA-BIOENERGETICS, V1767, P913, DOI 10.1016/j.bbabio.2007.05.005
   Barron MJ, 2004, BRIT J OPHTHALMOL, V88, P286, DOI 10.1136/bjo.2003.027664
   Bénit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603
   Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8
   Biousse V, 2003, CURR OPIN NEUROL, V16, P35, DOI 10.1097/00019052-200302000-00005
   Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877
   Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009
   Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2
   Cenacchi G, 2005, J CLIN PATHOL, V58, P190, DOI 10.1136/jcp.2004.018978
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004
   Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101
   Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936
   Ferré M, 2005, HUM MUTAT, V25, P423, DOI 10.1002/humu.20161
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112
   Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002
   Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272
   Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270
   Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184
   Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407
   Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3
   Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793
   Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013
   Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003
   Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021
   Martín MA, 2005, ARCH NEUROL-CHICAGO, V62, P659, DOI 10.1001/archneur.62.4.659
   MARTINUZZI A, 1991, BIOCHIM BIOPHYS ACTA, V1095, P217, DOI 10.1016/0167-4889(91)90102-4
   Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200
   Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048
   Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200
   Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X
   Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950
   Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011
   Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359
   Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018
   Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56
   Russell AP, 2003, J CLIN ENDOCR METAB, V88, P5921, DOI 10.1210/jc.2003-030885
   Sgarbi G, 2006, BIOCHEM J, V395, P493, DOI 10.1042/BJ20051748
   Solaini G, 2007, BIOSCIENCE REP, V27, P11, DOI 10.1007/s10540-007-9033-4
   Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369
   Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0
   Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342
   Vergani L, 2007, BRAIN, V130, P2715, DOI 10.1093/brain/awm151
   Verhoeven K, 2006, BRAIN, V129, P2093, DOI 10.1093/brain/awl126
   Wang AG, 2006, EXP EYE RES, V83, P1171, DOI 10.1016/j.exer.2006.06.004
   Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335
   ZEVIANI M, 1988, NEUROLOGY, V38, P1339
   Züchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797
NR 55
TC 80
Z9 92
U1 0
U2 15
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 1
PY 2008
VL 17
IS 21
BP 3291
EP 3302
DI 10.1093/hmg/ddn225
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 359GI
UT WOS:000259974000004
PM 18678599
OA Green Submitted, Bronze
DA 2024-11-01
ER

PT J
AU Paneni, F
   Costantino, S
   Volpe, M
   Lüscher, TF
   Cosentino, F
AF Paneni, Francesco
   Costantino, Sarah
   Volpe, Massimo
   Luescher, Thomas Felix
   Cosentino, Francesco
TI Epigenetic signatures and vascular risk in type 2 diabetes: A clinical
   perspective
SO ATHEROSCLEROSIS
LA English
DT Review
DE Epigenetic changes; Vascular risk; Oxidative stress; Diabetes
ID PROTEIN-KINASE-C; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B;
   CARDIOVASCULAR-DISEASE; MULTIFACTORIAL INTERVENTION; HIGH GLUCOSE;
   RESVERATROL SUPPLEMENTATION; ENDOTHELIAL FUNCTION; PRIMARY PREVENTION;
   METABOLIC MEMORY
AB Risk of diabetic complications continues to escalate overtime despite a multifactorial intervention with glucose-lowering drugs, anti-hypertensive agents and statins. In this perspective, a mechanisms-based therapeutic approach to vascular disease in diabetes represents a major challenge. Epigenetic signatures are emerging as important determinants of vascular disease in this setting. Methylation and acetylation of DNA and histones is a reversible process leading to dysregulation of oxidant and inflammatory genes such as mitochondrial adaptor p66(Shc) and transcription factor NF-kB p65. Epigenetic modifications associated with diabetes may contribute to the early identification of high risk individuals. Ongoing epigenomic analyses will be instrumental in identifying the epigenetic variations that are specifically associated with cardiovascular disease in patients with diabetes. Here, we describe a complex scenario of epigenetic changes and their putative link with diabetic vascular disease. Pharmacological reprogramming of diabetes-induced epigenetic signatures may be a promising option to dampen oxidative stress and inflammation, and thus prevent cardiovascular complications in this setting. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Paneni, Francesco; Costantino, Sarah; Luescher, Thomas Felix; Cosentino, Francesco] Univ Zurich Irchel, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Paneni, Francesco; Costantino, Sarah; Luescher, Thomas Felix; Cosentino, Francesco] Univ Hosp, Zurich, Switzerland.
   [Paneni, Francesco; Volpe, Massimo] IRCCS Neuromed, Pozzilli, Italy.
   [Volpe, Massimo] Univ Rome Sapienza, Dept Clin & Mol Med, Rome, Italy.
   [Luescher, Thomas Felix] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, CH-8006 Zurich, Switzerland.
C3 University of Zurich; University of Zurich; University Zurich Hospital;
   IRCCS Neuromed; Sapienza University Rome; University of Zurich; Zurich
   Center Integrative Human Physiology (ZIHP)
RP Cosentino, F (corresponding author), Univ Zurich Irchel, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM f_cosentino@hotmail.com
RI Cosentino, Francesco/AAE-2426-2020; Volpe, Massimo/K-5240-2016;
   Costantino, Sarah/ABD-7708-2020
OI Costantino, Sarah/0000-0002-3003-7213; Volpe,
   Massimo/0000-0002-9642-8380; Paneni, Francesco/0000-0001-6483-7844;
   Cosentino, Francesco/0000-0002-6967-5685
CR Abbott A, 2010, NATURE, V463, P596, DOI 10.1038/463596b
   Allan GM, 2013, CIRCULATION, V127, P1948, DOI 10.1161/CIRCULATIONAHA.112.000412
   Arca M, 2012, CURR VASC PHARMACOL, V10, P684, DOI 10.2174/157016112803520864
   Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008
   Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359
   Beckman JA, 2013, EUR HEART J
   Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579
   Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666
   Brown AS, 2008, SCHIZOPHRENIA BULL, V34, P1054, DOI 10.1093/schbul/sbn096
   Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104
   Ceriello A, 2010, EUR J CARDIOV PREV R, V17, pS15, DOI 10.1097/01.hjr.0000368193.24732.66
   Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824
   Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5
   Collins R, 2003, LANCET, V361, P2005
   Cooper ME, 2010, CIRC RES, V107, P1403, DOI 10.1161/CIRCRESAHA.110.223552
   Cosentino F, 2008, ARTERIOSCL THROM VAS, V28, P622, DOI 10.1161/ATVBAHA.107.156059
   El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188
   El-Osta A, 2012, CURR OPIN LIPIDOL, V23, P24, DOI 10.1097/MOL.0b013e32834f319d
   Fioretto P, 2010, NAT REV ENDOCRINOL, V6, P19, DOI 10.1038/nrendo.2009.213
   Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39
   Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778
   Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245
   Gæde P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1
   Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117
   Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011
   Handy DE, 2011, CIRCULATION, V123, P2145, DOI 10.1161/CIRCULATIONAHA.110.956839
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Jung CH, 2013, ARCH PHARM RES, V36, P201, DOI 10.1007/s12272-013-0020-y
   Keating ST, 2012, J CARDIOVASC TRANSL, V5, P399, DOI 10.1007/s12265-012-9380-9
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250
   Kim GH, 2013, ANTIOXID REDOX SIGN, V18, P1920, DOI 10.1089/ars.2012.4926
   Kim JK, 2012, CIRCULATION, V125, P1081, DOI 10.1161/CIRCULATIONAHA.111.090134
   Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233
   Krishna SM, 2013, ATHEROSCLEROSIS, V228, P295, DOI 10.1016/j.atherosclerosis.2013.02.019
   Lehnen H, 2013, MOL HUM REPROD, V19, P415, DOI 10.1093/molehr/gat020
   Lekakis J, 2005, EUR J CARDIOV PREV R, V12, P596, DOI 10.1097/00149831-200512000-00013
   Maradana MR, 2013, MOL NUTR FOOD RES, V57, P1550, DOI 10.1002/mnfr.201200791
   Marco LJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/565160
   Mehta NN, 2009, CARDIOVASC DRUG THER, V23, P17, DOI 10.1007/s10557-008-6144-5
   Miao F, 2004, J BIOL CHEM, V279, P18091, DOI 10.1074/jbc.M311786200
   Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645
   Mima A, 2012, DIABETES, V61, P2967, DOI 10.2337/db11-1824
   Napoli C, 2012, CIRCULATION, V125, P2363, DOI 10.1161/CIRCULATIONAHA.111.085787
   Napoli C, 2011, CARDIOVASC RES, V92, P367, DOI 10.1093/cvr/cvr201
   Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283
   Paneni F., 2013, Eur Heart J
   Paneni F, 2013, DIABETES, V62, P1800, DOI 10.2337/db12-1648
   Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593
   Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8
   Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987
   PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502
   PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622
   Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975
   Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795
   Reddy MA, 2008, CIRC RES, V103, P615, DOI 10.1161/CIRCRESAHA.108.175190
   Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017
   Ruemmele FM, 2012, ANN NUTR METAB, V60, P38, DOI 10.1159/000337363
   Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151
   Srivastava G, 2009, J CARDIOVASC PHARM T, V14, P22, DOI 10.1177/1074248408329608
   Tabit CE, 2013, CIRCULATION, V127, P86, DOI 10.1161/CIRCULATIONAHA.112.127514
   Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002
   Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105
   Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010
   Volpe M, 2011, CURR HYPERTENS REP, V13, P318, DOI 10.1007/s11906-011-0205-z
   Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5
   Wang JJ, 2012, ANTIOXID REDOX SIGN, V17, P282, DOI 10.1089/ars.2011.4381
   Wong RHX, 2011, NUTR METAB CARDIOVAS, V21, P851, DOI 10.1016/j.numecd.2010.03.003
   Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200
   Zheng Z, 2012, DIABETES, V61, P217, DOI 10.2337/db11-0416
   Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592
NR 76
TC 58
Z9 60
U1 0
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0021-9150
EI 1879-1484
J9 ATHEROSCLEROSIS
JI Atherosclerosis
PD OCT
PY 2013
VL 230
IS 2
BP 191
EP 197
DI 10.1016/j.atherosclerosis.2013.07.003
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 222RC
UT WOS:000324747800004
PM 24075743
DA 2024-11-01
ER

PT J
AU Oh, J
   Lee, YD
   Wagers, AJ
AF Oh, Juhyun
   Lee, Yang David
   Wagers, Amy J.
TI Stem cell aging: mechanisms, regulators and therapeutic opportunities
SO NATURE MEDICINE
LA English
DT Review
ID MITOCHONDRIAL-DNA MUTATIONS; MOUSE SKELETAL-MUSCLE; AGE-RELATED-CHANGES;
   LIFE-SPAN; OXIDATIVE STRESS; SELF-RENEWAL; CAENORHABDITIS-ELEGANS;
   DAMAGE-RESPONSE; CALORIC RESTRICTION; TUMOR SUPPRESSION
AB Aging tissues experience a progressive decline in homeostatic and regenerative capacities, which has been attributed to degenerative changes in tissue-specific stem cells, stem cell niches and systemic cues that regulate stem cell activity. Understanding the molecular pathways involved in this age-dependent deterioration of stem cell function will be critical for developing new therapies for diseases of aging that target the specific causes of age-related functional decline. Here we explore key molecular pathways that are commonly perturbed as tissues and stem cells age and degenerate. We further consider experimental evidence both supporting and refuting the notion that modulation of these pathways per se can reverse aging phenotypes. Finally, we ask whether stem cell aging establishes an epigenetic 'memory' that is indelibly written or one that can be reset.
C1 [Oh, Juhyun; Lee, Yang David; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Oh, Juhyun; Lee, Yang David; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Lee, Yang David] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Wagers, Amy J.] Howard Hughes Med Inst, Cambridge, MA USA.
C3 Harvard University; Harvard University; Joslin Diabetes Center, Inc.;
   Harvard University; Massachusetts General Hospital; Howard Hughes
   Medical Institute
RP Wagers, AJ (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
EM amy_wagers@harvard.edu
OI Oh, Juhyun/0000-0002-4492-6978; Lee, Yang/0009-0008-1918-5427
FU US National Cancer Institute from the Massachusetts General Hospital
   Department of Pathology [T32CA-0216]; US National Institutes of Health
   (NIH) [T32DK007260]; NIH [1R01 AG033053, 5U01 HL100402]; Paul F. Glenn
   Laboratories for the Biological Mechanisms of Aging
FX We thank all members of the Wagers laboratory for advice and comments
   during the preparation of this article. This work was funded in part by
   US National Cancer Institute grant T32CA-0216 from the Massachusetts
   General Hospital Department of Pathology (Y.D.L.), by US National
   Institutes of Health (NIH) grant T32DK007260 (J.O.), and by NIH grants
   1R01 AG033053 and 5U01 HL100402 and the Paul F. Glenn Laboratories for
   the Biological Mechanisms of Aging (A.J.W.). A.J.W. is an Early Career
   Scientist of the Howard Hughes Medical Institute. Content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH or other funding agencies.
CR Abe M, 2008, J PHARMACOL SCI, V106, P571, DOI 10.1254/jphs.FP0071664
   Abramovich A, 2008, REJUV RES, V11, P489, DOI 10.1089/rej.2008.0658
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Ahmad KA, 2003, ANN NY ACAD SCI, V1010, P365, DOI 10.1196/annals.1299.067
   Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399
   Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Borchin B, 2013, STEM CELL REP, V1, P620, DOI 10.1016/j.stemcr.2013.10.007
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Campisi J, 2000, IN VIVO, V14, P183
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279
   Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chen HQ, 2014, AGEING RES REV, V13, P55, DOI 10.1016/j.arr.2013.12.002
   Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804
   Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006
   Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591
   Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116
   Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019
   Clement MV, 1996, EMBO J, V15, P216, DOI 10.1002/j.1460-2075.1996.tb00352.x
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Cook C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005888
   Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511
   Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007
   Ding QR, 2013, CELL STEM CELL, V12, P393, DOI 10.1016/j.stem.2013.03.006
   Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011
   Drowley L, 2010, MOL THER, V18, P1865, DOI 10.1038/mt.2010.160
   Dupressoir A, 1995, BBA-GENE STRUCT EXPR, V1264, P397, DOI 10.1016/0167-4781(95)00181-6
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082
   Erol A, 2011, CELL SIGNAL, V23, P1076, DOI 10.1016/j.cellsig.2010.11.023
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Feng YL, 2014, STEM CELLS, V32, P462, DOI 10.1002/stem.1571
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Fortini P, 2013, MUTAT RES-FUND MOL M, V743, P160, DOI 10.1016/j.mrfmmm.2013.03.004
   Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517
   Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   González-Suárez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25
   GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001
   HARMAN D, 1972, AM J CLIN NUTR, V25, P839
   Harris JM, 2013, BLOOD, V121, P2483, DOI 10.1182/blood-2012-12-471201
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106
   Hur JH, 2013, AGING-US, V5, P662, DOI 10.18632/aging.100595
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989
   Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015
   Jones M, 2014, J CLIN INVEST, V124, P353, DOI 10.1172/JCI67871
   Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023
   Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054
   Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787
   Kolosova NG, 2012, AGING-US, V4, P686, DOI 10.18632/aging.100493
   Kondratov RV, 2009, AGING-US, V1, P979, DOI 10.18632/aging.100113
   Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107
   Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x
   Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368
   Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Mandal PK, 2011, NAT REV MOL CELL BIO, V12, P198, DOI 10.1038/nrm3060
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   Maxwell PH, 2011, P NATL ACAD SCI USA, V108, P20376, DOI 10.1073/pnas.1100271108
   McArdle A, 2004, FASEB J, V18, DOI 10.1096/fj.03-0395fje
   Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035
   Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846
   Miller RA, 2004, AGING CELL, V3, P53, DOI 10.1111/j.1474-9728.2004.00084.x
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002
   Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571
   Nakamura M, 2013, CELL RES, V23, P70, DOI 10.1038/cr.2012.171
   Narala SR, 2008, MOL BIOL CELL, V19, P1210, DOI 10.1091/mbc.E07-09-0965
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013
   Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010
   Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088
   Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804
   Peserico A, 2013, CELL MOL LIFE SCI, V70, P2015, DOI 10.1007/s00018-012-1244-6
   Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012
   Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014
   Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013
   Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Rübe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487
   Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580
   Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039
   Sadowska AM, 2007, PULM PHARMACOL THER, V20, P9, DOI 10.1016/j.pupt.2005.12.007
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Salani S, 2012, J CELL MOL MED, V16, P1353, DOI 10.1111/j.1582-4934.2011.01498.x
   Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478
   Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637
   Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707
   Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Tabebordbar M, 2013, ANNU REV PATHOL-MECH, V8, P441, DOI 10.1146/annurev-pathol-011811-132450
   Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440
   Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435
   Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080
   Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385
   Xu Y, 2013, GENOME, V56, P9, DOI 10.1139/gen-2012-0124
   Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200
   Yang SA, 2013, DEV BIOL, V382, P124, DOI 10.1016/j.ydbio.2013.07.018
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yu WM, 2013, CELL STEM CELL, V12, P62, DOI 10.1016/j.stem.2012.11.022
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang JQ, 2011, CELL STEM CELL, V8, P31, DOI 10.1016/j.stem.2010.12.002
   Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 190
TC 512
Z9 588
U1 3
U2 107
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD AUG
PY 2014
VL 20
IS 8
BP 870
EP 880
DI 10.1038/nm.3651
PG 11
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA AM7UQ
UT WOS:000340074600018
PM 25100532
OA Green Accepted
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Mkaouar-Rebai, E
   Tlili, A
   Masmoudi, S
   Belguith, N
   Charfeddine, I
   Mnif, M
   Triki, C
   Fakhfakh, F
AF Mkaouar-Rebai, Emna
   Tlili, Abdelaziz
   Masmoudi, Saber
   Belguith, Neila
   Charfeddine, Ilhem
   Mnif, Mouna
   Triki, Chahnez
   Fakhfakh, Faiza
TI Mutational analysis of the mitochondrial tRNA<SUP>Leu(UUR)</SUP> gene in
   Tunisian patients with mitochondrial diseases
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE A3243G mutation; tRNA(Leu(UUR)) gene; mitochondrial ND1 gene; diabetes;
   hearing loss; MIDD; T3396C
ID DNA A3243G MUTATION; DIABETES-MELLITUS; CLINICAL-FEATURES; MELAS
   MUTATION; INSULIN SENSITIVITY; LACTIC-ACIDOSIS; HEARING-LOSS;
   G-TRANSITION; RNA; PREVALENCE
AB The mitochondrial tRNA(Leu(UUR)) gene (MTTL) is a hot spot for pathogenic mutations that are associated with mitochondrial diseases with various clinical features. Among these mutations, the A3243G mutation was associated with various types of mitochondrial multisystem disorders, such as MIDD, MELAS, MERRF, PEO, hypertrophic cardiomyopathy, and a subtype of Leigh syndrome. We screened 128 Tunisian patients for the A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene. This screening was carried out using PCR-RFLP with the restriction endonuclease ApaI. None of the 128 patients or the 100 controls tested were found to carry the mitochondrial A3243G mutation in the tRNA(Leu(UUR)) gene in homoplasmic or heteroplasmic form. After direct sequencing of the entire mitochondrial tRNA(Leu(UUR)) gene and a part of the mitochondrial NADH dehydrogenase 1, we found neither mutations nor polymorphisms in the MTTL1 gene in the tested patients and controls, and we confirmed the absence of the A3243G mutation in this gene. We also found a T3396C transition in the ND1 gene in one family with NSHL which was absent in the other patients and in 100 controls. Neither polymorphisms nor other mutations were found in the mitochondrial tRNA(Leu(UUR)) gene in the tested patients. (c) 2007 Elsevier Inc. All rights reserved.
C1 Fac Med, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
   CHU Habib Bourguiba, Serv ORL, Sfax 3029, Tunisia.
   CHU Habib Bourguiba, Serv Neurol, Sfax 3029, Tunisia.
   CHU Habib Bourguiba, Serv Endocrinol, Sfax 3029, Tunisia.
C3 Universite de Sfax; Universite de Sfax; Hopital Habib Bourguiba;
   Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Hopital
   Hedi Chaker; Hopital Habib Bourguiba
RP Mkaouar-Rebai, E (corresponding author), Fac Med, Lab Genet Mol Humaine, Sfax 3029, Tunisia.
EM emna_mkaouar@mail2world.com; faiza.fakhfakh@gnet.tn
RI Triki, chahnez/AEZ-5216-2022; Masmoudi, Saber/W-1478-2019; Tlili,
   Abdelaziz/AAE-8699-2020; MKAOUAR-REBAI, Emna/AAE-6650-2019
OI Saber, Masmoudi/0000-0002-1076-5256; Mkaouar-Rebai,
   Emna/0000-0003-3095-510X; Tlili, Abdelaziz/0000-0002-8039-3013;
   Charfeddine, Ilhem/0000-0002-4418-584X
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   De Kremer RD, 2001, AM J MED GENET, V99, P83, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1136>3.0.CO;2-X
   Deschauer M, 2001, ARCH NEUROL-CHICAGO, V58, P1885, DOI 10.1001/archneur.58.11.1885
   Deschauer M, 1999, NEUROMUSCULAR DISORD, V9, P305, DOI 10.1016/S0960-8966(99)00019-X
   DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0
   Fabrizi GM, 1996, J NEUROL NEUROSUR PS, V61, P47, DOI 10.1136/jnnp.61.1.47
   Flierl A, 1997, J BIOL CHEM, V272, P27189, DOI 10.1074/jbc.272.43.27189
   GERBITZ KD, 1995, BBA-MOL BASIS DIS, V1271, P253, DOI 10.1016/0925-4439(95)00036-4
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   Helm M, 1999, NUCLEIC ACIDS RES, V27, P756, DOI 10.1093/nar/27.3.756
   Holmes-Walker DJ, 2001, DIABETIC MED, V18, P381, DOI 10.1046/j.1464-5491.2001.00472.x
   Kanaumi T, 2006, PEDIATR NEUROL, V34, P235, DOI 10.1016/j.pediatrneurol.2005.08.024
   Koga Y, 2000, ACTA NEUROPATHOL, V99, P186, DOI 10.1007/PL00007423
   Lee HC, 1997, J CLIN ENDOCR METAB, V82, P372, DOI 10.1210/jc.82.2.372
   Lehto M, 1999, DIABETOLOGIA, V42, P1131, DOI 10.1007/s001250051281
   LEWIN HA, 1992, BIOTECHNIQUES, V13, P522
   Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959
   Mkaouar-Rebai E, 2006, BIOCHEM BIOPH RES CO, V340, P1251, DOI 10.1016/j.bbrc.2005.12.123
   MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q
   Nagata H, 2001, J HUM GENET, V46, P595, DOI 10.1007/s100380170027
   Newkirk JE, 1997, DIABETIC MED, V14, P457, DOI 10.1002/(SICI)1096-9136(199706)14:6<457::AID-DIA372>3.3.CO;2-N
   Ng MCY, 2000, CLIN ENDOCRINOL, V52, P557, DOI 10.1046/j.1365-2265.2000.00989.x
   ODAWARA M, 1995, J CLIN ENDOCR METAB, V80, P1290, DOI 10.1210/jc.80.4.1290
   OTABE S, 1994, J CLIN ENDOCR METAB, V79, P768, DOI 10.1210/jc.79.3.768
   Pang CY, 1999, J FORMOS MED ASSOC, V98, P326
   Park H, 2003, BIOCHEMISTRY-US, V42, P958, DOI 10.1021/bi026882r
   Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4
   Sue CM, 1997, NEUROLOGY, V49, P1013, DOI 10.1212/WNL.49.4.1013
   Suzuki Y, 2003, DIABETES CARE, V26, P1315, DOI 10.2337/diacare.26.4.1315
   Thomas AW, 1996, J MED GENET, V33, P253, DOI 10.1136/jmg.33.3.253
   Uchigata Y, 1996, DIABETOLOGIA, V39, P245, DOI 10.1007/BF00403970
   Ueki I, 2006, MITOCHONDRION, V6, P29, DOI 10.1016/j.mito.2005.10.003
   VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368
   Velho G, 1996, DIABETES, V45, P478, DOI 10.2337/diabetes.45.4.478
   Vilarinho L, 1997, J MED GENET, V34, P607, DOI 10.1136/jmg.34.7.607
   YANG YL, 2006, CHIN MED J, V5, P373
   Yorifuji T, 1996, J MED GENET, V33, P621, DOI 10.1136/jmg.33.7.621
NR 39
TC 19
Z9 21
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 20
PY 2007
VL 355
IS 4
BP 1031
EP 1037
DI 10.1016/j.bbrc.2007.02.083
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 148ZD
UT WOS:000245115000030
PM 17336924
DA 2024-11-01
ER

PT J
AU Yokoi, F
   Dang, MT
   Mitsui, S
   Li, YQ
AF Yokoi, F
   Dang, MT
   Mitsui, S
   Li, YQ
TI Exclusive paternal expression and novel alternatively spliced variants
   of ε-sarcoglycan mRNA in mouse brain
SO FEBS LETTERS
LA English
DT Article
DE epsilon-sarcoglycan; epsilon-sarcoglycan gene; imprinting; PDZ-binding
   motif; myoclonus-dystonia
ID MYOCLONUS-DYSTONIA-SYNDROME; NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL-DNA;
   ALPHA-SARCOGLYCAN; GENE; MUTATIONS; CRE; IDENTIFICATION; RECOMBINASE;
   MUSCLE
AB Mutations of SGCE encoding epsilon-sarcoglycan cause myoclonus-dystonia. SGCE is paternally expressed; however, 5-10% of patients show maternal inheritance of the disease. We found Sgce was exclusively paternally expressed in mice by using a novel polymorphism marker. The result was confirmed in Sgce heterozygous knockout mice. This finding suggests that maternally inherited myoclonus-dystonia may not result from maternal expression of SGCE. Furthermore, we report a new family of alternatively spliced Sgce mRNA expressed in the brain coding for different C-terminal sequences possessing a PDZ-binding motif. Our results provide a better basis for diagnosis and understanding of the pathogenesis of myoclonus-dystonia. (c) 2005 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.
EM y-li4@uiuc.edu
RI mai, dang/KFS-0232-2024; Li, Yuqing/G-1596-2011
OI Li, Yuqing/0000-0003-1211-5529
CR Asmus F, 2002, ANN NEUROL, V52, P489, DOI 10.1002/ana.10325
   Asmus Friedrich, 2004, Adv Neurol, V94, P113
   Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3
   Burset M, 2000, NUCLEIC ACIDS RES, V28, P4364, DOI 10.1093/nar/28.21.4364
   Ettinger AJ, 1998, J BIOL CHEM, V273, P19922
   Ettinger AJ, 1997, J BIOL CHEM, V272, P32534, DOI 10.1074/jbc.272.51.32534
   Fahn S, 1988, Adv Neurol, V50, P1
   Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T
   Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893
   Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893
   Furukawa Y, 2002, NEUROLOGY, V59, P1130, DOI 10.1212/WNL.59.8.1130
   Grabowski M, 2003, EUR J HUM GENET, V11, P138, DOI 10.1038/sj.ejhg.5200938
   Grundmann K, 2004, MOVEMENT DISORD, V19, P1294, DOI 10.1002/mds.20128
   Guo HL, 2000, BIOCHEM BIOPH RES CO, V269, P149, DOI 10.1006/bbrc.2000.2263
   GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0
   Han F, 2003, NEUROLOGY, V61, P244, DOI 10.1212/01.WNL.0000073142.40185.C1
   Kameya S, 1999, J BIOL CHEM, V274, P2193, DOI 10.1074/jbc.274.4.2193
   KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542
   Klein C, 2002, CURR OPIN NEUROL, V15, P491, DOI 10.1097/00019052-200208000-00014
   Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111
   Matise MP, 2000, PRACT APPROACH SER, V212, P101
   McNally EM, 1998, FEBS LETT, V422, P27, DOI 10.1016/S0014-5793(97)01593-7
   Müller B, 2002, AM J HUM GENET, V71, P1303, DOI 10.1086/344531
   Németh AH, 2002, BRAIN, V125, P695, DOI 10.1093/brain/awf090
   Nishiyama A, 2004, MOL BRAIN RES, V125, P1, DOI 10.1016/j.molbrainres.2004.01.012
   Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803
   Papaioannou V, 2000, PRACT APPROACH SER, V212, P133
   Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000
   SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166
   Schüle B, 2004, J NEUROL NEUROSUR PS, V75, P1181, DOI 10.1136/jnnp.2003.027177
   Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080
   Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1
   Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078
   SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8
   Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989
   Valente EM, 2005, NEUROLOGY, V64, P737, DOI 10.1212/01.WNL.0000151979.68010.9B
   Valente EM, 2003, MOVEMENT DISORD, V18, P1047, DOI 10.1002/mds.10476
   Zimprich A, 2001, NAT GENET, V29, P66, DOI 10.1038/ng709
NR 38
TC 25
Z9 30
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD AUG 29
PY 2005
VL 579
IS 21
BP 4822
EP 4828
DI 10.1016/j.febslet.2005.07.065
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 960XF
UT WOS:000231625800045
PM 16099459
OA Bronze
DA 2024-11-01
ER

PT S
AU Perry, JJP
   Shin, DS
   Tainer, JA
AF Perry, J. Jefferson P.
   Shin, David S.
   Tainer, John A.
BE Ahmad, SI
TI Amyotrophic Lateral Sclerosis
SO DISEASES OF DNA REPAIR
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID MOTOR-NEURON DISEASE; CU,ZN SUPEROXIDE-DISMUTASE; FRONTOTEMPORAL LOBAR
   DEGENERATION; TRANSGENIC MOUSE MODEL; GULF-WAR VETERANS;
   CEREBROSPINAL-FLUID; MITOCHONDRIAL-DNA; FUS/TLS-CHOP; RECOMBINANT HUMAN;
   CYCAD HYPOTHESIS
AB Amyotrophic lateral sclerosis (ALS) is a common neurological disorder that results in loss of motor neurons, leading to a rapidly progressive form of muscle paralysis that is fatal. There is no available cure and current therapies only provide minimal benefit at best. The disease is predominantly sporadic and until very recently only the Cu,Zn superoxide dismutase (Cu,ZnSOD), which is involved in a small number of sporadic cases and a larger component of familial ones, have been analyzed in any detail. Here we describe the clinical aspects of ALS and highlight the genetics and molecular mechanisms behind the disease. We discuss the current understanding and controversies of how mutations in Cu,ZnSOD may cause the disease. We also focus on the recent discovery that mutations in either TDP-43 or FUS/TLS, which are both involved in DNA/RNA synthesis, are likely the cause behind many cases of ALS that are not linked to Cu,ZnSOD.
C1 [Perry, J. Jefferson P.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.
C3 Scripps Research Institute
RP Perry, JJP (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.
EM jjperry@scripps.edu
RI Tainer, John/GWQ-4878-2022
OI Tainer, John/0000-0003-1659-2429
FU NCI NIH HHS [P01 CA092584] Funding Source: Medline; NIGMS NIH HHS [R01
   GM039345] Funding Source: Medline
CR Abhinav K, 2007, NEUROEPIDEMIOLOGY, V29, P44, DOI 10.1159/000108917
   Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200
   [Anonymous], COCHRANE DATABASE SY
   Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093
   Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105
   Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb
   BENHAMIDA M, 1990, BRAIN, V113, P347
   Bongioanni P, 2004, Cochrane Database Syst Rev, pCD004302, DOI 10.1002/14651858.CD004302.pub2
   Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851
   Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727
   Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512
   Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769
   Charcot, 1869, ARCH PHYSL NORM PATH, V2, P354
   Chiò A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373
   Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565
   Corrado L, 2009, HUM MUTAT, V30, P688, DOI 10.1002/humu.20950
   Daoud H, 2009, J MED GENET, V46, P112, DOI 10.1136/jmg.2008.062463
   DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519
   Dhaliwal GK, 2000, NEUROREPORT, V11, P2507, DOI 10.1097/00001756-200008030-00032
   DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1
   Distad BJ, 2008, PHYS MED REH CLIN N, V19, P633, DOI 10.1016/j.pmr.2008.04.005
   DISTAD BJ, 2008, PHYS MED REH CLIN N, V19, pR11
   Dobson CM, 2001, BIOCHEM SOC SYMP, V68, P1
   Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008
   Fang F, 2006, NEUROEPIDEMIOLOGY, V27, P217, DOI 10.1159/000096956
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Ferri KF, 2001, BIOESSAYS, V23, P111, DOI 10.1002/1521-1878(200102)23:2<111::AID-BIES1016>3.0.CO;2-Y
   Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013
   Gaudette M, 2000, AMYOTROPH LATERAL SC, V1, P83, DOI 10.1080/14660820050515377
   GETZOFF ED, 1989, PROTEINS, V5, P322, DOI 10.1002/prot.340050408
   GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0
   GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0
   Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344
   Guégan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610
   HALLEWELL RA, 1991, BIOCHEM BIOPH RES CO, V181, P474, DOI 10.1016/S0006-291X(05)81443-3
   HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707
   HAYASHI H, 1989, J NEUROL SCI, V93, P19, DOI 10.1016/0022-510X(89)90158-5
   HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425
   HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001
   Horner RD, 2008, NEUROEPIDEMIOLOGY, V31, P28, DOI 10.1159/000136648
   IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995
   Ince PG, 2005, NEUROPATH APPL NEURO, V31, P345, DOI 10.1111/j.1365-2990.2005.00686.x
   Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y
   JOHNSTON RB, 1978, J EXP MED, V148, P115
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kong JM, 1998, J NEUROSCI, V18, P3241
   Krasnianski A, 2005, BRAIN, V128, P1870, DOI 10.1093/brain/awh540
   Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185
   Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758
   Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006
   Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015
   LEIGH PN, 1989, BRAIN, V112, P521, DOI 10.1093/brain/112.2.521
   Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335
   LI TM, 1988, J NEUROL NEUROSUR PS, V51, P778, DOI 10.1136/jnnp.51.6.778
   Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828
   Mantovani V, 2007, CLIN CHEM, V53, P531, DOI 10.1373/clinchem.2006.074807
   Meininger V, 2004, AMYOTROPH LATERAL SC, V5, P107, DOI 10.1080/14660820410019602
   Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2
   Mills KI, 2000, BRIT J HAEMATOL, V108, P316
   Miranda ML, 2008, NEUROTOXICOLOGY, V29, P964, DOI 10.1016/j.neuro.2008.05.005
   MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315
   NORRIS F, 1993, J NEUROL SCI, V118, P48, DOI 10.1016/0022-510X(93)90245-T
   Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197
   PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109
   Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897
   Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763
   Pérez-Losada J, 2000, ONCOGENE, V19, P6015, DOI 10.1038/sj.onc.1204018
   Pérez-Losada J, 2000, ONCOGENE, V19, P2413, DOI 10.1038/sj.onc.1203572
   Piao YS, 2003, BRAIN PATHOL, V13, P10
   RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0
   Ro LS, 2003, MUSCLE NERVE, V28, P737, DOI 10.1002/mus.10504
   ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0
   ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106
   Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193
   SASAKI S, 1992, ACTA NEUROPATHOL, V84, P211, DOI 10.1007/BF00311398
   SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026
   Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031
   Smith RG, 1998, ANN NEUROL, V44, P696, DOI 10.1002/ana.410440419
   Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Steele JC, 2008, NEUROLOGY, V70, P1984, DOI 10.1212/01.wnl.0000312571.81091.26
   Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007
   TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7
   Talbot K, 2006, HUM MOL GENET, V15, pR182, DOI 10.1093/hmg/ddl202
   Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311
   Tohgi H, 1999, ANN NEUROL, V46, P129, DOI 10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y
   Tohgi H, 1999, NEUROSCI LETT, V260, P204, DOI 10.1016/S0304-3940(98)00986-0
   Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504
   Turner MR, 2003, J NEUROL NEUROSUR PS, V74, P995, DOI 10.1136/jnnp.74.7.995
   Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   VELTEMA AN, 1990, J NEUROL SCI, V97, P93, DOI 10.1016/0022-510X(90)90101-R
   Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x
   Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x
   Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992
   Wanker EE, 2000, MOL MED TODAY, V6, P387, DOI 10.1016/S1357-4310(00)01761-5
   Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P26, DOI 10.1093/aje/kwh179
   WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515
   Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x
   Wiedemann FR, 1998, J NEUROL SCI, V156, P65, DOI 10.1016/S0022-510X(98)00008-2
   Worms PA, 2001, J NEUROL SCI, V191, P3, DOI 10.1016/S0022-510X(01)00630-X
   Yang XZ, 1995, JPN J CLIN ONCOL, V25, P234
   Zoccolella S, 2008, J NEUROL NEUROSUR PS, V79, P33, DOI 10.1136/jnnp.2007.118018
NR 107
TC 24
Z9 24
U1 0
U2 12
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-1-4419-6447-2
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2010
VL 685
BP 9
EP 20
D2 10.1007/978-1-4419-6448-9
PG 12
WC Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA BOZ50
UT WOS:000278107500002
PM 20687491
DA 2024-11-01
ER

PT J
AU Hofer, T
   Servais, S
   Seo, AY
   Marzetti, E
   Hiona, A
   Upadhyay, SJ
   Wohlgemuth, SE
   Leeuwenburgh, C
AF Hofer, Tim
   Servais, Stephane
   Seo, Arnold Young
   Marzetti, Emanuele
   Hiona, Asimina
   Upadhyay, Shashank Jagdish
   Wohlgemuth, Stephanie Eva
   Leeuwenburgh, Christiaan
TI Bioenergetics and permeability transition pore opening in heart
   subsarcolemmal and interfibrillar mitochondria: Effects of aging and
   lifelong calorie restriction
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE Heart disease; Ischemia-reperfusion; Senescence; Hypertrophy
ID ISCHEMIA-REPERFUSION INJURY; CYTOCHROME-C RELEASE; RAT CARDIAC-MUSCLE;
   OXIDATIVE STRESS; CELL-DEATH; HYDROGEN-PEROXIDE; DIASTOLIC FUNCTION;
   H2O2 PRODUCTION; DNA MUTATIONS; BROWN-NORWAY
AB Loss of cardiac mitochondrial function with age may cause increased cardiomyocyte death through mitochondria-mediated release of apoptogenic factors. We investigated ventricular subsarcolemmal (SSM) and interfibrillar (IFM) mitochondrial bioenergetics and susceptibility towards Ca2+-induced permeability transition pore (mPTP) opening with aging and lifelong calorie restriction (CR). Cardiac mitochondria were isolated from 8-, 18-, 29- and 37-month-old male Fischer 344 x Brown Norway rats fed either ad libitum (AL) or 40% calorie restricted diets. With age, H2O2 generation did not increase and oxygen consumption did not significantly decrease in either SSM or IFM. Strikingly, IFM displayed an increased susceptibility towards mPTP opening during senescence. In contrast, Ca2+ retention capacity of SSM was not affected by age, but SSM tolerated much less Ca2+ than IFM. Only modest age-dependent increases in cytosolic caspase activities and cytochrome c levels were observed and were not affected by CR. Levels of putative mPTP-modulating components: cyclophilin-D, the adenine nucleotide translocase (ANT), and the voltage-dependent ion channel (VDAC) were not affected by aging or CR. In summary, the age-related reduction of Ca2+ retention capacity in IFM may explain the increased susceptibility to stress-induced cell death in the aged myocardium. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Hofer, Tim; Servais, Stephane; Seo, Arnold Young; Marzetti, Emanuele; Hiona, Asimina; Upadhyay, Shashank Jagdish; Wohlgemuth, Stephanie Eva; Leeuwenburgh, Christiaan] Univ Florida, Dept Aging & Geriatr Res, Coll Med, Inst Aging,Div Biol Aging, Gainesville, FL 32610 USA.
   [Marzetti, Emanuele] Univ Cattolica Sacro Cuore, Dept Gerontol Geriatr & Physiatr, I-00168 Rome, Italy.
C3 State University System of Florida; University of Florida; Catholic
   University of the Sacred Heart; IRCCS Policlinico Gemelli
RP Hofer, T (corresponding author), Univ Tromso, MabCent SFI, Sykehusvegen 21, N-9019 Tromso, Norway.
EM tim.hofer@comhem.se; cleeuwen@aging.ufl.edu
RI SERVAIS, Stephane/Q-6057-2017; Marzetti, Emanuele/A-9430-2010
OI SERVAIS, Stephane/0000-0002-3127-9679; Marzetti,
   Emanuele/0000-0001-9567-6983; Leeuwenburgh,
   Christiaan/0000-0003-0826-4257
FU National Institute on Aging [AG17994, AG21042]; American Heart
   Postdoctoral Fellowship [0525346B, 0615256B]; Claude D. Pepper Older
   Americans Independence Center (OAIC) [1 P30 AG028740-01]; American Heart
   Association (AHA) [0525346B, 0615256B] Funding Source: American Heart
   Association (AHA)
FX We thank Karen Kelley at the Electron Microscopy unit at the University
   of Florida for taking supporting TEM pictures. TEM pictures, Hazel A.
   Lees for assistance with assays, our statistician Dr. Michael J. Daniels
   for helpful advices on statistical analysis, and Dr. Alberto Sanz for
   critical evaluation of the manuscript. This research was supported by
   grants from the National Institute on Aging (AG17994 and AG21042) to CL,
   an American Heart Postdoctoral Fellowship to TH (0525346B), and an
   American Heart Fellowship to AYS (0615256B). EM and SEW are supported by
   the Claude D. Pepper Older Americans Independence Center (OAIC) (1 P30
   AG028740-01).
CR Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958
   Bianchi K, 2004, BBA-MOL CELL RES, V1742, P119, DOI 10.1016/j.bbamcr.2004.09.015
   BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v
   CHEMNITIUS JM, 1993, INT J BIOCHEM, V25, P589, DOI 10.1016/0020-711X(93)90668-5
   Cocco T, 2005, FREE RADICAL BIO MED, V38, P796, DOI 10.1016/j.freeradbiomed.2004.11.034
   Colom B, 2007, CARDIOVASC RES, V74, P456, DOI 10.1016/j.cardiores.2007.02.001
   Crompton M, 2004, AGING CELL, V3, P3, DOI 10.1046/j.1474-9728.2003.00073.x
   Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9
   DI LF, 2005, CARDIOVASC RES, V66, P222
   Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Ellison Georgina M, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS52, DOI 10.1038/ncpcardio0773
   Fannin SW, 1999, ARCH BIOCHEM BIOPHYS, V372, P399, DOI 10.1006/abbi.1999.1508
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   Gredilla R, 2001, FASEB J, V15, P1589, DOI 10.1096/fj.00-0764fje
   Grimm S, 2007, APOPTOSIS, V12, P841, DOI 10.1007/s10495-007-0747-3
   Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005
   Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025
   Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3
   Jahangir A, 2001, MECH AGEING DEV, V122, P1073, DOI 10.1016/S0047-6374(01)00242-1
   Jekabsone A, 2003, BIOCHEM PHARMACOL, V66, P1513, DOI 10.1016/S0006-2952(03)00506-9
   Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005
   Judge S, 2005, FASEB J, V19, P419, DOI 10.1096/fj.04-2622fje
   Judge S, 2004, AM J PHYSIOL-REG I, V286, pR254, DOI 10.1152/ajpregu.00502.2003
   Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006
   Kajstura J, 1996, AM J PHYSIOL-HEART C, V271, pH1215, DOI 10.1152/ajpheart.1996.271.3.H1215
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P37, DOI 10.1006/jmcc.2000.1273
   Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378
   Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009
   Lipman RD, 1996, J GERONTOL A-BIOL, V51, pB54, DOI 10.1093/gerona/51A.1.B54
   MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4
   MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405
   MENZIES RA, 1971, J BIOL CHEM, V246, P2425
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Miró O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X
   MISARE BD, 1992, J THORAC CARDIOV SUR, V103, P60
   Moghaddas S, 2002, J GERONTOL A-BIOL, V57, pB22, DOI 10.1093/gerona/57.1.B22
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUSCARI C, 1990, BASIC RES CARDIOL, V85, P172, DOI 10.1007/BF01906970
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Olivetti G, 2000, CARDIOVASC RES, V45, P68, DOI 10.1016/S0008-6363(99)00298-9
   PALMER JW, 1977, J BIOL CHEM, V252, P8731
   PALMER JW, 1986, AM J PHYSIOL, V250, pH741, DOI 10.1152/ajpheart.1986.250.5.H741
   PALMER JW, 1985, ARCH BIOCHEM BIOPHYS, V236, P691, DOI 10.1016/0003-9861(85)90675-7
   Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149
   Pepe S, 2000, CLIN EXP PHARMACOL P, V27, P745, DOI 10.1046/j.1440-1681.2000.03326.x
   Petrosillo G, 2001, FEBS LETT, V509, P435, DOI 10.1016/S0014-5793(01)03206-9
   Phaneuf S, 2002, AM J PHYSIOL-REG I, V282, pR423, DOI 10.1152/ajpregu.00296.2001
   Pugh KG, 2001, DRUG AGING, V18, P263, DOI 10.2165/00002512-200118040-00004
   Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sprott Richard L., 1996, P3
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Taffet GE, 1997, J GERONTOL A-BIOL, V52, pB285, DOI 10.1093/gerona/52A.6.B285
   Tanveer A, 1996, EUR J BIOCHEM, V238, P166, DOI 10.1111/j.1432-1033.1996.0166q.x
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
NR 70
TC 75
Z9 82
U1 0
U2 7
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY
PY 2009
VL 130
IS 5
BP 297
EP 307
DI 10.1016/j.mad.2009.01.004
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 442AO
UT WOS:000265812300003
PM 19428447
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Long, HS
   Wen, C
   Zhao, J
   Wang, JW
   Li, Y
   Fu, XX
   Huang, LH
AF Long, Haishan
   Wen, Cheng
   Zhao, Juan
   Wang, Jiawei
   Li, Yang
   Fu, Xinxing
   Huang, Lihui
TI ENT characteristics and therapeutic results in multisystemic disorders
   of mitochondrial encephalomyopathy
SO EUROPEAN JOURNAL OF MEDICAL RESEARCH
LA English
DT Article
DE Hearing loss; Dysphagia; Facial weakness; Ptosis; Exercise intolerance;
   Mitochondrial
ID HEREDITARY OPTIC NEUROPATHY; MUTATION; MANAGEMENT; DYSPHAGIA
AB Here we report the evaluation of the frequency of subjective and objective otolaryngologic findings and therapeutic results in 32 patients with mitochondrial encephalomyopathy (MEM) from September 2001 to June 2021. Our analysis included studying the patients' family histories, the clinical manifestations of MEM, and the therapeutic effects of treatments. The patients' ages ranged from 2 to 77 years, with a median age of 12.3 years. We found that MEM ENT symptoms were characterized by hearing loss, dysphagia, and facial weakness. Most cases of sensorineural hearing loss were bilateral symmetrical progressive or sudden deafness since adolescence, which were often underestimated. Associated neuromuscular symptoms required mtDNA testing. Dysphagia and facial weakness occurred preferentially in middle-aged patients, and muscle biopsies were advised. Distortion product otoacoustic emissions and auditory brainstem responsetesting were more sensitive and reliable than pure tone averages for objective monitoring of pathogenesis. Administration of the mitochondrial synthase complex benefited patients with acute episodes. If patients did not fully recover and exhibitedresidual language deficits, hearing aids or cochlear implants were recommended. Counsel was given regarding synthetical treatments for facial weakness, endoscopic circopharyngealmyotomy for dysphagia, and surgical correction of ptosis. This study demonstrates that increased awareness of these symptoms is important to address appropriate interventions and avoid complications such as ablepsia, aphasia, social isolation, malnutrition, aspiration pneumonia, and heart failure in the setting of MEM.
C1 [Long, Haishan; Wen, Cheng; Fu, Xinxing; Huang, Lihui] Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp, Key Lab Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100730, Peoples R China.
   [Wen, Cheng; Fu, Xinxing; Huang, Lihui] Beijing Inst Otolaryngol, Beijing 100005, Peoples R China.
   [Zhao, Juan; Wang, Jiawei] Capital Med Univ, Beijing Tongren Hosp, Dept Neurol, Cent Lab, Beijing 100730, Peoples R China.
   [Li, Yang] Capital Med Univ, Dept Ophthalmol, Beijing Inst Ophthalmol,Beijing Tongren Hosp, Key Lab Ophthalmol & Visual Sci,Minist Educ,Beiji, Beijing 100730, Peoples R China.
C3 Capital Medical University; Capital Medical University; Capital Medical
   University
RP Huang, LH (corresponding author), Capital Med Univ, Dept Otolaryngol Head & Neck Surg, Beijing Tongren Hosp, Key Lab Otolaryngol Head & Neck Surg,Minist Educ, Beijing 100730, Peoples R China.; Huang, LH (corresponding author), Beijing Inst Otolaryngol, Beijing 100005, Peoples R China.
EM huanglihui@ccmu.edu.cn
RI Fu, Xinxing/HRD-7478-2023
CR Amore G, 2021, DRUGS, V81, P57, DOI 10.1007/s40265-020-01428-3
   Balali M, 2016, THER CLIN RISK MANAG, V12, P117, DOI 10.2147/TCRM.S90581
   Bindu PS, 2018, CLIN NEUROL NEUROSUR, V164, P182, DOI 10.1016/j.clineuro.2017.12.010
   Bottani E, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12111083
   Burgin HJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062139
   Cai T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183394
   Carlot S, 2021, ACTA OPHTHALMOL, V99, DOI 10.1111/j.1755-3768.2020.0177
   Chakrabarty S, 2021, J NEUROL, V268, P2192, DOI 10.1007/s00415-020-10390-9
   Chandra S, 2019, J NEUROL SCI, V405, DOI 10.1016/j.jns.2019.10.1295
   Custers JAE, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0951-y
   Davison JE, 2017, ARCH DIS CHILD, V102, P1082, DOI 10.1136/archdischild-2016-311370
   Doerfer KW, 2020, LARYNGOSCOPE INVEST, V5, P497, DOI 10.1002/lio2.379
   Fang F, 2018, SCI CHINA LIFE SCI, V61, P1606, DOI 10.1007/s11427-017-9130-4
   Finsterer J, 2016, CLIN OPHTHALMOL, V10, P2187, DOI 10.2147/OPTH.S120197
   Ghaoui R, 2018, J NEUROL, V265, P1230, DOI 10.1007/s00415-017-8722-6
   Habbane M, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091007
   Hedermann G, 2017, MITOCHONDRION, V32, P27, DOI 10.1016/j.mito.2016.11.007
   Heighton JN, 2019, MITOCHONDRION, V44, P15, DOI 10.1016/j.mito.2017.12.006
   Humes LE, 2019, INT J AUDIOL, V58, P12, DOI 10.1080/14992027.2018.1518598
   Ichikawa Hiroo, 2016, Brain Nerve, V68, P151, DOI 10.11477/mf.1416200366
   Jiang ZC, 2016, MITOCHONDRIAL DNA A, V27, P1564, DOI 10.3109/19401736.2014.953137
   Jiang ZX, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5184647
   Kisilevsley E, 2020, SURV OPHTHALMOL, V65, P294, DOI 10.1016/j.survophthal.2019.11.001
   Koenig MK, 2016, JAMA NEUROL, V73, P591, DOI 10.1001/jamaneurol.2015.5072
   Koga Y, 2018, J NEUROL, V265, P2861, DOI 10.1007/s00415-018-9057-7
   Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131
   Kousaki H., 2018, PRACT OTOL KYOTO, V152, P8, DOI [10.5631/jibirinsuppl.152.8, DOI 10.5631/JIBIRINSUPPL.152.8]
   Kozak Igor, 2018, Retin Cases Brief Rep, V12, P349, DOI 10.1097/ICB.0000000000000503
   Kullar P, 2016, HEARING BALANC COMMU, V14, P101, DOI 10.3109/21695717.2016.1151124
   Liu GL, 2020, J NEUROL SCI, V408, DOI 10.1016/j.jns.2019.116562
   Masingue M, 2019, J NEUROL SCI, V396, P112, DOI 10.1016/j.jns.2018.11.014
   Mohannak N, 2019, INT J GEN MED, V12, P465, DOI 10.2147/IJGM.S198031
   Morlet T, 2018, J NEUROL, V265, P1580, DOI 10.1007/s00415-018-8884-x
   Mutsumi O, 2015, J PLAST RECONSTR AES, V68, pE113, DOI 10.1016/j.bjps.2015.02.013
   Niu FN, 2017, CNS NEUROSCI THER, V23, P686, DOI 10.1111/cns.12714
   Orsini M, 2018, NEUROL INT, V10, P3, DOI 10.4081/ni.2018.7473
   Ost M, 2018, CURR OPIN CLIN NUTR, V21, P336, DOI 10.1097/MCO.0000000000000486
   Peedikayil Musthafa Chalikandy, 2015, Hematol Oncol Stem Cell Ther, V8, P85, DOI 10.1016/j.hemonc.2014.12.001
   Poulton J, 2017, MOL DIAGN THER, V21, P419, DOI 10.1007/s40291-017-0279-7
   [北京医学会罕见病分会 Rare Diseases Branch of Beijing Medical Association], 2020, [中华神经科杂志, Chinese Journal of Neurology], V53, P171
   Ricardo CP, 2018, HEART, V104, pA8, DOI 10.1136/heartjnl-2018-BSCR.24
   Rinninella E, 2018, EUR REV MED PHARMACO, V22, P4288, DOI 10.26355/eurrev_201807_15425
   Rodríguez-López C, 2020, J MED GENET, V57, P643, DOI 10.1136/jmedgenet-2019-106649
   Saldaña-Martínez A, 2019, GENE, V688, P171, DOI 10.1016/j.gene.2018.11.085
   Silver G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155519
   Sudakov NP, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-016-0241-x
   The Neuro-Ophthalmology Group of the Ophthalmology Branch of the Chinese Medical Association. The Leber hereditary optic neuropathy Collaboration Group, 2019, OPHTHALMOLOGY, V28, P328, DOI [10.13281/j.cnki.issn.1004-4469.2019.05.003, DOI 10.13281/J.CNKI.ISSN.1004-4469.2019.05.003]
   Tsang SH, 2018, ADV EXP MED BIOL, V1085, P163, DOI 10.1007/978-3-319-95046-4_31
   Wang CA, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00431-4
   Wang R, 2021, J MAGN RESON IMAGING, V53, P427, DOI 10.1002/jmri.27353
   Wong RCB, 2017, AGING-US, V9, P1341, DOI 10.18632/aging.101231
   Xia CY, 2016, CHINESE MED J-PEKING, V129, P1945, DOI 10.4103/0366-6999.187845
   Yamamoto N, 2015, OTOL NEUROTOL, V36, pE129, DOI 10.1097/MAO.0000000000000817
   Young MJ, 2016, CURR OPIN GENET DEV, V38, P52, DOI 10.1016/j.gde.2016.03.005
   [袁云 Yuan Yun], 2019, [中华神经科杂志, Chinese Journal of Neurology], V52, P327
   [张哲 Zhang Zhe], 2016, [中华神经科杂志, Chinese Journal of Neurology], V49, P237
   [张志坚 Zhang Zhijian], 2017, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V25, P571
NR 57
TC 2
Z9 2
U1 1
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0949-2321
EI 2047-783X
J9 EUR J MED RES
JI Eur. J. Med. Res.
PD OCT 29
PY 2022
VL 27
IS 1
AR 221
DI 10.1186/s40001-022-00832-7
PG 12
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 5U1KT
UT WOS:000876312700003
PM 36309717
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Casademont, J
   Rodriguez-Santiago, B
   Miró, O
   Beato, A
   López, S
   Nunes, V
   Cardellach, F
AF Casademont, J
   Rodriguez-Santiago, B
   Miró, O
   Beato, A
   López, S
   Nunes, V
   Cardellach, F
TI Mitochondrial respiratory chain in brain homogenates:: activities in
   different brain areas in patients with Alzheimer's disease
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE Alzheimer's disease; dementia; free radicals; mitochondria;
   neurodegenerative disorders; respiratory chain
ID CYTOCHROME-OXIDASE ACTIVITY; OXIDATIVE-PHOSPHORYLATION; DNA; METABOLISM;
   MUTATIONS; MUSCLE; ASSOCIATION; DEFICIENCY; EXPRESSION; RADICALS
AB Background and aims: The potential influence of impaired oxidative metabolism in the modulation of manifestations in sporadic Alzheimer's disease (AD) has attracted much attention in the last 50 years. Unfortunately, many clinical and experimental results aiming at proving this hypothesis are still controversial. The aim was to study the enzymatic activities of respiratory chain (RC) complexes I through V in three brain areas of a group of patients with definite AD, and to compare the results with a group of normal brains. We simultaneously assessed the lipid peroxidation of the samples as a measure of free radical damage. Methods: The specific activity of the individual complexes of the RC was measured spectrophotometrically, and the loss of cis-parinaric acid fluorescence was used to determine the chemical process of lipid peroxidation. Results: We were not able to detect differences in any of the analyzed RC enzymatic activities, or in the level of lipid peroxidation between patients with AD and controls. Instead, differences were found in the number of mitochondria and in the intrinsic enzymatic activities of complexes III and IV in various brain areas. Conclusions: Spectrophotometric enzymatic analyses of respiratory complexes in brain homogenates do not support the primary contribution of mitochondrial RC dysfunction in the pathogenesis of AD.
C1 Univ Barcelona, Fac Med, IDIBAPS, Hosp Clin,Dept Internal Med,Muscle Res Unit, E-08036 Barcelona, Spain.
   Hosp Duran & Reynals, Inst Recerca Oncol, Med & Mol Genet Ctr, Barcelona, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut
   d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i
   Reynals
RP Univ Barcelona, Fac Med, IDIBAPS, Hosp Clin,Dept Med,Grp Invest Muscular, Villarroel 170, E-08036 Barcelona, Spain.
EM jordi@medicina.ub.es
RI Nunes, Virginia/D-4356-2014; Casademont, Jordi/A-6828-2010; Miro,
   Oscar/K-1798-2019; Lopez, Sonia/AAC-8830-2019
OI Miro Andreu, Oscar/0000-0001-8127-166X; Lopez, Sonia/0000-0002-5023-5153
CR BATTINO M, 1991, J BIOENERG BIOMEMBR, V23, P345, DOI 10.1007/BF00762227
   Blass JP, 2001, J NEUROSCI RES, V66, P851, DOI 10.1002/jnr.10087
   Bonilla E, 1999, BBA-BIOENERGETICS, V1410, P171, DOI 10.1016/S0005-2728(98)00165-0
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   CHANDRASEKARAN K, 1994, MOL BRAIN RES, V24, P336, DOI 10.1016/0169-328X(94)90147-3
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   Curti D, 1997, NEUROSCI LETT, V236, P13, DOI 10.1016/S0304-3940(97)00741-6
   Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526
   DUARA R, 1993, NEUROLOGY, V43, P1377, DOI 10.1212/WNL.43.7.1377
   Edland SD, 1996, NEUROLOGY, V47, P254, DOI 10.1212/WNL.47.1.254
   HEDLEY D, 1992, CYTOMETRY, V13, P686, DOI 10.1002/cyto.990130704
   Hensley K, 1996, ANN NY ACAD SCI, V786, P120, DOI 10.1111/j.1749-6632.1996.tb39057.x
   Hirano M, 1997, P NATL ACAD SCI USA, V94, P14894, DOI 10.1073/pnas.94.26.14894
   Honig LS, 2001, AGING CLIN EXP RES, V13, P171, DOI 10.1007/BF03351476
   Hutchin TP, 1997, BIOCHEM BIOPH RES CO, V241, P221, DOI 10.1006/bbrc.1997.7793
   Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0
   KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506
   KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   Lee HC, 1997, J BIOMED SCI, V4, P319, DOI 10.1007/BF02258357
   LIN FH, 1992, BIOCHEM BIOPH RES CO, V182, P238, DOI 10.1016/S0006-291X(05)80136-6
   Manfredi G, 2000, BRAIN PATHOL, V10, P462
   Mecocci P, 1997, Aging (Milano), V9, P51
   Miró O, 1998, J NEUROSCI METH, V80, P107, DOI 10.1016/S0165-0270(97)00204-5
   MIRRA SS, 1993, ARCH PATHOL LAB MED, V117, P132
   MIZUNO Y, 1990, J NEUROL SCI, V96, P49, DOI 10.1016/0022-510X(90)90056-S
   Molina JA, 1997, NEUROLOGY, V48, P636, DOI 10.1212/WNL.48.3.636
   MUTISYA EM, 1994, J NEUROCHEM, V63, P2179
   Nagy Z, 1999, ACTA NEUROPATHOL, V97, P346, DOI 10.1007/s004010050997
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302
   PETRUZZELLA V, 1992, BIOCHEM BIOPH RES CO, V186, P491, DOI 10.1016/S0006-291X(05)80834-4
   REICHMANN H, 1993, J NEUROL, V240, P377, DOI 10.1007/BF00839971
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   SCHAGGER H, 1995, EUR J BIOCHEM, V227, P916, DOI 10.1111/j.1432-1033.1995.tb20219.x
   SCHEUERLE A, 1993, VIRCHOWS ARCH B, V63, P331, DOI 10.1007/BF02899280
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Swerdlow RH, 1997, NEUROLOGY, V49, P918, DOI 10.1212/WNL.49.4.918
   Te Koppele J. M., 1996, Neurobiology of Aging, V17, P819, DOI 10.1016/S0197-4580(96)00165-0
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   VANZUYLEN AJ, 1992, NEUROLOGY, V42, P1246, DOI 10.1212/WNL.42.6.1246
   Wallace DC, 1998, NAT GENET, V19, P105, DOI 10.1038/448
   Wragg MA, 1995, NEUROSCI LETT, V201, P107, DOI 10.1016/0304-3940(95)12146-3
NR 43
TC 11
Z9 15
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD FEB
PY 2005
VL 17
IS 1
BP 1
EP 7
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 906QA
UT WOS:000227655700001
PM 15847115
DA 2024-11-01
ER

PT J
AU Kim, D
   Kim, S
   Sung, A
   Patel, N
   Wong, N
   Conboy, MJ
   Conboy, IM
AF Kim, Daehwan
   Kim, Subin
   Sung, Ashley
   Patel, Neetika
   Wong, Nathan
   Conboy, Michael J.
   Conboy, Irina M.
TI Autologous treatment for ALS with implication for broad neuroprotection
SO TRANSLATIONAL NEURODEGENERATION
LA English
DT Article
DE Neurodegeneration; Amyotrophic lateral sclerosis; SOD1 mutation;
   Pluripotent stem cells; Secretome
ID MESENCHYMAL STEM-CELLS; AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON
   DEGENERATION; HESC-SECRETED PROTEINS; HEAT-SHOCK-PROTEIN; OXIDATIVE
   STRESS; SUPEROXIDE-DISMUTASE; MOUSE MODEL; PROTEOMIC ANALYSIS; EZH2
AB Background: Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of motor neurons (MNs), leading to paralysis, respiratory failure and death within 2-5 years of diagnosis. The exact mechanisms of sporadic ALS, which comprises 90% of all cases, remain unknown. In familial ALS, mutations in superoxide dismutase (SOD1) cause 10% of cases.
   Methods: ALS patient-derived human-induced pluripotent stem cells (ALS hiPSCs, harboring the SOD1(AV4) mutation), were differentiated to MNs (ALS-MNs). The neuroprotective effects of conditioned medium (CM) of hESCs (H9), wt hiPSCs (WTC-11) and the ALS iPSCs, on MN apoptosis and viability, formation and maintenance of neurites, mitochondrial activity and expression of inflammatory genes, were examined. For in vivo studies, 200 mu l of CM from the ALS iPSCs (CS07 and CS053) was injected subcutaneously into the ALS model mice (transgenic for the human SOD1(G93A) mutation). Animal agility and strength, muscle innervation and mass, neurological score, onset of paralysis and lifespan of the ALS mice were assayed. After observing significant disease-modifying effects, the CM was characterized biochemically by fractionation, comparative proteomics, and epigenetic screens for the dependence on pluripotency. CM of fibroblasts that were differentiated from the wt hiPSCs lacked any neuroprotective activity and was used as a negative control throughout the studies.
   Results: The secretome of PSCs including the ALS patient iPSCs was neuroprotective in the H2O2 model. In the model with pathogenic SOD1 mutation, ALS iPSC-CM attenuated all examined hallmarks of ALS pathology, rescued human ALS-MNs from denervation and death, restored mitochondrial health, and reduced the expression of inflammatory genes. The ALS iPSC-CM also improved neuro-muscular health and function, and delayed paralysis and morbidity in ALS mice. Compared side by side, cyclosporine (CsA), a mitochondrial membrane blocker that prevents the leakage of mitochondrial DNA, failed to avert the death of ALS-MNs, although CsA and ALS iPSC-CM equally stabilized MN mitochondria and attenuated inflammatory genes. Biochemical characterization, comparative proteomics, and epigenetic screen all suggested that it was the interactome of several key proteins from different fractions of PSC-CM that delivered the multifaceted neuroprotection.
   Conclusions: This work introduces and mechanistically characterizes a new biologic for treating ALS and other complex neurodegenerative diseases.
C1 [Conboy, Irina M.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA.
C3 University of California System; University of California Berkeley;
   University of California System; University of California Berkeley
RP Conboy, IM (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM iconboy@berkeley.edu
RI Sung, Allan/JED-8333-2023
OI Kim, Subin/0000-0001-9339-5758
FU NIBIB [R01 EB023776]; NIA [R01AG071787]; NHLBI [R01 HL139605]; Open
   Philanthropy; Silicon Valley Community Foundation; Foster Foundation;
   San Francisco Foundation; Georges' Harik Foundation; Donors'Trust
   grants; National Heart Lung and Blood Institute [R01HL139605] Funding
   Source: NIH RePORTER
FX This work was supported by NIBIB (R01 EB023776), NIA (R01AG071787),
   NHLBI (R01 HL139605), Open Philanthropy, Silicon Valley Community
   Foundation, Foster Foundation, San Francisco Foundation, Georges' Harik
   Foundation, and Donors'Trust grants to IC.
CR Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x
   Akbar MT, 2003, J BIOL CHEM, V278, P19956, DOI 10.1074/jbc.M207073200
   Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060
   Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027
   Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021
   Aparicio-Erriu IM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00167
   Ari C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103526
   Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54
   Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019
   Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008
   Basu J, 2016, EXPERT OPIN BIOL TH, V16, P489, DOI 10.1517/14712598.2016.1131976
   Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086
   Boland MJ, 2014, CIRC RES, V115, P311, DOI 10.1161/CIRCRESAHA.115.301517
   Bruneteau G, 2015, ANN CLIN TRANSL NEUR, V2, P362, DOI 10.1002/acn3.179
   Cai M, 2015, TOXINS, V7, P846, DOI 10.3390/toxins7030846
   Cappello V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102092
   Check W A, 1979, JAMA, V242, P319, DOI 10.1001/jama.242.4.319
   Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004
   Chen YT, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1491-7
   Clark JA, 2016, J CHEM NEUROANAT, V76, P35, DOI 10.1016/j.jchemneu.2016.03.003
   Collinson A, 2016, CELL REP, V17, P2700, DOI 10.1016/j.celrep.2016.11.032
   Comley L, 2015, NEUROSCIENCE, V291, P216, DOI 10.1016/j.neuroscience.2015.02.013
   Dahbour S, 2017, CNS NEUROSCI THER, V23, P866, DOI 10.1111/cns.12759
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012
   Duffy LM, 2011, NEUROPATH APPL NEURO, V37, P336, DOI 10.1111/j.1365-2990.2011.01166.x
   Fletcher L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-158
   Fontanilla CV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16953
   Fujimori K, 2018, NAT MED, V24, P1579, DOI 10.1038/s41591-018-0140-5
   Fukuoka H., 2012, AM J COSMETIC SURG, V29, P273, DOI [10.5992/AJCS-D-12-00015.1, DOI 10.5992/AJCS-D-12-00015.1]
   Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c
   Gorecka J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1185-1
   Guerrero EN, 2019, HUM MOL GENET, V28, P2459, DOI 10.1093/hmg/ddz062
   Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Gutierrez-Aranda I, 2010, STEM CELLS, V28, P1568, DOI 10.1002/stem.471
   Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013
   Hatzipetros T, 2015, JOVE-J VIS EXP, DOI 10.3791/53257
   Herrera-Merchan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1623
   Hilkens P, 2014, STEM CELL RES, V12, P778, DOI 10.1016/j.scr.2014.03.008
   Huang JY, 2009, J NEUROCHEM, V109, P1400, DOI 10.1111/j.1471-4159.2009.06061.x
   Huang QR, 2017, BLOOD, V129, P2737, DOI 10.1182/blood-2016-08-735886
   Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630
   Huynh H, 2011, BLOOD, V118, P3236, DOI 10.1182/blood-2011-01-331876
   Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634
   Jang SE, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.558532
   Jiang H, 2014, EXP NEUROL, V261, P245, DOI 10.1016/j.expneurol.2014.05.013
   Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997
   Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008
   Kay AG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18144-w
   Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008
   Kim HS, 2012, J PROTEOME RES, V11, P839, DOI 10.1021/pr200682z
   Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2
   Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559
   Lee YC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091986
   Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335
   Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048
   Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590
   Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468
   Migita T, 2010, AM J PATHOL, V176, P1756, DOI 10.2353/ajpath.2010.090500
   Moore HM, 2013, BREAST CANCER RES TR, V138, P741, DOI 10.1007/s10549-013-2498-x
   O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001
   Patel P, 2014, MOL THER, V22, P498, DOI 10.1038/mt.2013.239
   Patel YJK, 2005, MOL BRAIN RES, V134, P256, DOI 10.1016/j.molbrainres.2004.10.028
   Pawitan JA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965849
   Pedersen WA, 2000, FASEB J, V14, P913, DOI 10.1096/fasebj.14.7.913
   Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048
   Pizurki L, 2003, BRIT J PHARMACOL, V139, P329, DOI 10.1038/sj.bjp.0705259
   Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653
   Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110
   Qu QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4449
   Rabinovich-Toidman P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143420
   Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200
   Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253
   Sagaradze G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071656
   Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x
   Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3
   Sebastià J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52
   Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121
   Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052
   Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019
   Song CG, 2018, NEURAL REGEN RES, V13, P1294, DOI 10.4103/1673-5374.235085
   Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991
   Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004
   Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290
   Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095
   Sultani Masooma, 2012, Chemother Res Pract, V2012, P490804, DOI 10.1155/2012/490804
   Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006
   Tarng DC, 2016, CELL TRANSPLANT, V25, P517, DOI 10.3727/096368915X688542
   Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959
   Tóth ME, 2013, CELL STRESS CHAPERON, V18, P759, DOI 10.1007/s12192-013-0428-9
   Toth ME, 2010, CELL STRESS CHAPERON, V15, P807, DOI 10.1007/s12192-010-0188-8
   Tucker BA, 2013, ELIFE, V2, DOI 10.7554/eLife.00824
   Venugopal A, 2019, EGYPTIAN J MED HUMAN, V20, DOI 10.1186/s43042-019-0023-4
   Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110
   Wang JM, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9070165
   Wang YJ, 2015, INT J CARDIOL, V192, P61, DOI 10.1016/j.ijcard.2015.05.020
   Weeks SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18874-x
   Xiang J, 2017, NEUROSCI LETT, V644, P62, DOI 10.1016/j.neulet.2017.02.040
   Yamashita T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74216-4
   Yang DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054495
   Yao YZ, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100083
   Yin J, 2019, NEUROSCIENCE, V411, P177, DOI 10.1016/j.neuroscience.2019.05.038
   Yousef H, 2014, AGING-US, V6, P602, DOI 10.18632/aging.100659
   Yousef H, 2013, AGING-US, V5, P357, DOI 10.18632/aging.100559
   Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P5403, DOI 10.1167/iovs.07-1478
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zakrzewski W, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1165-5
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhao QC, 2015, BRAIN RES, V1624, P489, DOI 10.1016/j.brainres.2015.08.003
   Zhou BR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519126
   Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003
   Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71
NR 113
TC 2
Z9 3
U1 1
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2047-9158
J9 TRANSL NEURODEGENER
JI Transl. Neurodegener.
PD MAR 11
PY 2022
VL 11
IS 1
AR 16
DI 10.1186/s40035-022-00290-5
PG 19
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA ZQ6IE
UT WOS:000767205600001
PM 35272709
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Lewis, M
   Voelkel, N
   Kadri, F
AF Lewis, Michael
   Voelkel, Norbert
   Kadri, Ferdous
TI Pathobiology of Pulmonary Arterial Hypertension
SO CURRENT RESPIRATORY MEDICINE REVIEWS
LA English
DT Review
DE Pulmonary artery endothelial cells; pulmonary artery smooth muscle
   cells; intimal hyperplasia; medial hypertrophy; plexiform lesions;
   inflammation; immune dysfunction; TGF beta; BMP; mutations; growth
   factors; channelopathy; Warburg phenomenon; mitochondrial dysfunction;
   hypoxia; estrogen paradox; DNA damage; senescence; drug-induced PAH;
   cancer hypothesis
ID SMOOTH-MUSCLE-CELLS; RIGHT-VENTRICULAR FUNCTION; TO-MESENCHYMAL
   TRANSITION; MICROVASCULAR ENDOTHELIAL-CELLS; SEROTONIN-REUPTAKE
   INHIBITORS; GROWTH-FACTOR; DNA-DAMAGE; ADVENTITIAL FIBROBLASTS; PREVENTS
   PROGRESSION; INSULIN-RESISTANCE
AB Pulmonary Arterial Hypertension (PAH) is a progressive disease associated with occlusive pulmonary arterial remodeling of vessels < 500 mu m for which there is no cure. Even in the era of PAH-specific combination therapies, aberrant lung pathology and progressive right ventricular (RV) dysfunction occur, culminating in a median survival of 6.2 years, according to the latest data in the treatment era. While better than a median survival from symptom onset of 2.8 years prior to PAH-specific therapies, it is still poor. Thus, there is an urgent need to move the opportunities forward for meaningful treatment strategies. Clearly, a better understanding of the highly complex pathobiology of PAH is needed if we are to achieve new and novel treatment strategies. This is especially so if we are to pursue a more personalized treatment approach to PAH in light of the multitude of pathobiological abnormalities described in PAH, which likely culminate in a final common pathway for PAH development. In this State-of-the-Art review, we provide comprehensive insights into the complex pathobiology of PAH to provide understanding and insights for the practicing clinician. We review the pathology of PAH and the cells involved and their impact in driving pathological abnormalities (pulmonary artery endothelial cells, smooth muscle cells, fibroblasts and pericytes) as well as the role of the extracellular matrix. Inflammation and immune dysfunction are considered important drivers of PAH and are comprehensively discussed. Another pathway relates to TGF beta/ bone morphogenic protein (BMP) imbalance, which is highlighted, as well as a new novel agent, sotatercept that impacts this imbalance. Genetic factors underlying heritable PAH (HPAH) are addressed, as well as epigenetic influences. Other important pathways highlighted include growth factor signaling, ion channels/channelopathy, hypoxia signaling pathways, and altered metabolism and mitochondrial dysfunction. We also address the "estrogen paradox", whereby PAH is more common in women but more severe in men. The basis for drug-induced PAH is discussed, including the new methamphetamine epidemic. We briefly provide insights into DNA damage and senescence factors in pathobiology and highlight commonalities between PAH and cancer pathobiology. Furthermore, we provide concluding insights for the treating physician. In conclusion, we need to pose the right questions to motivate novel and effective treatment strategies for the management of PAH based on pathobiological principles and understanding.
C1 [Lewis, Michael; Kadri, Ferdous] Cedars Sinai Med Ctr, Pulm Crit Care Div, Los Angeles, CA USA.
   [Lewis, Michael] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA USA.
   [Voelkel, Norbert] Univ Amsterdam, Pulm Div, Med Ctr, Amsterdam, Netherlands.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of
   Amsterdam
RP Voelkel, N (corresponding author), Univ Amsterdam, Pulm Div, Med Ctr, Amsterdam, Netherlands.
EM nfvoelkel@gmail.com
CR Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901
   Aldabbous L, 2016, ARTERIOSCL THROM VAS, V36, P2078, DOI 10.1161/ATVBAHA.116.307634
   Amsellem V, 2014, CIRCULATION, V130, P880, DOI 10.1161/CIRCULATIONAHA.114.010757
   Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009
   Andruska A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092499
   Angelini DJ, 2009, AM J PHYSIOL-LUNG C, V296, pL582, DOI 10.1152/ajplung.90526.2008
   Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951
   Archer SL, 2004, CIRC RES, V95, P308, DOI 10.1161/01.RES.0000137173.42723.fb
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Arends SJ, 2013, CLIN EXP IMMUNOL, V174, P433, DOI 10.1111/cei.12166
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Balabanian K, 2002, AM J RESP CRIT CARE, V165, P1419, DOI 10.1164/rccm.2106007
   Barnes PJ, 2019, AM J RESP CRIT CARE, V200, P556, DOI 10.1164/rccm.201810-1975TR
   Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387
   Bertero T, 2015, SCI REP-UK, V5, DOI 10.1038/srep18277
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010
   Bohnen MS, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.118.002087
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261
   Boucherat O, 2015, EUR RESPIR J, V46, P1167, DOI 10.1183/13993003.00798-2015
   Brittain EL, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.018349
   Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50
   Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973
   Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377
   Chalmers S.J., 2021, PULM CIRC, V10, p2045894020933081
   Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744
   Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890
   Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911
   Chen PI, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90427
   Cheng XY, 2019, HYPERTENSION, V74, P733, DOI 10.1161/HYPERTENSIONAHA.119.13458
   Cheron C, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0330-2020
   Chettimada S, 2015, AM J PHYSIOL-LUNG C, V308, pL287, DOI 10.1152/ajplung.00229.2014
   Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3
   Claessen G, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001602
   Cober ND, 2022, HYPERTENSION, V79, P1580, DOI 10.1161/HYPERTENSIONAHA.122.18261
   Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1
   Cohen-Kaminsky S, 2014, DRUG DISCOV TODAY, V19, P1251, DOI 10.1016/j.drudis.2014.04.007
   Cool CD, 2020, AM J PHYSIOL-LUNG C, V318, pL1115, DOI 10.1152/ajplung.00476.2019
   Courboulin Audrey, 2011, Respir Res, V12, P128, DOI 10.1186/1465-9921-12-128
   Culley MK, 2022, CIRC RES, V130, P928, DOI 10.1161/CIRCRESAHA.121.319815
   Culley MK, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136459
   Cunningham CM, 2022, AM J RESP CRIT CARE, V206, P186, DOI 10.1164/rccm.202110-2309OC
   Dahal BK, 2010, AM J RESP CRIT CARE, V181, P158, DOI 10.1164/rccm.200811-1682OC
   DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343
   Davies RJ, 2012, AM J PHYSIOL-LUNG C, V302, pL604, DOI 10.1152/ajplung.00309.2011
   de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004
   Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059
   Denver N, 2020, PULM CIRC, V10, DOI 10.1177/2045894020908783
   Dhalla IA, 2012, CHEST, V141, P348, DOI 10.1378/chest.11-0426
   Dib H, 2012, EUR RESPIR J, V39, P1405, DOI 10.1183/09031936.00181410
   Din S, 2009, VASC PHARMACOL, V51, P344, DOI 10.1016/j.vph.2009.09.001
   Dorfmüller P, 2007, HUM PATHOL, V38, P893, DOI 10.1016/j.humpath.2006.11.022
   Dorfmüller P, 2003, SARCOIDOSIS VASC DIF, V20, P9
   Dorfmüller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112
   Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC
   Eddahibi S, 2001, RESP RES, V3, DOI 10.1186/rr181
   Eddahibi S, 2002, J LAB CLIN MED, V139, P194, DOI 10.1067/mlc.2002.122181
   El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Fan Y, 2020, AM J RESP CRIT CARE, V202, P1283, DOI 10.1164/rccm.201909-1884OC
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fessel JP, 2013, PULM CIRC, V3, P564, DOI 10.1086/674312
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Frid MG, 2020, AM J RESP CRIT CARE, V201, P224, DOI 10.1164/rccm.201903-0591OC
   Frump AL, 2023, AM J RESP CELL MOL, V68, P341, DOI 10.1165/rcmb.2022-0224LE
   Frump AL, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI129433
   Goldenberg NM, 2019, AM J RESP CRIT CARE, V199, P1566, DOI 10.1164/rccm.201808-1597LE
   Golembeski SA, 2005, CHEST, V128, p572S, DOI 10.1378/chest.128.6_suppl.572S-a
   Gräf S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03672-4
   Granton J, 2015, CIRC RES, V117, P645, DOI 10.1161/CIRCRESAHA.114.305951
   Guignabert C, 2005, CIRCULATION, V111, P2812, DOI 10.1161/CIRCULATIONAHA.104.524926
   Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231
   Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112
   Hassoun PM, 2021, NEW ENGL J MED, V385, P2361, DOI 10.1056/NEJMra2000348
   Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006
   Hautefort A, 2015, CHEST, V147, P1610, DOI 10.1378/chest.14-1678
   HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533
   Hemnes AR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123611
   Hemnes AR, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0093-2017
   Hendriks PM, 2022, PULM CIRC, V12, DOI 10.1002/pul2.12137
   Hester J, 2020, COMPR PHYSIOL, V10, P125, DOI 10.1002/cphy.c190011
   Hlavaty A, 2022, BRIT J CLIN PHARMACO, V88, P5227, DOI 10.1111/bcp.15436
   Hoeper MM, 2023, NEW ENGL J MED, V388, P1478, DOI 10.1056/NEJMoa2213558
   Hoeper MM, 2013, CIRCULATION, V127, P1128, DOI 10.1161/CIRCULATIONAHA.112.000765
   Hoffmann J, 2011, EUR RESPIR J, V37, P1400, DOI 10.1183/09031936.00043310
   Hoffmann J, 2015, AM J PHYSIOL-LUNG C, V308, pL1002, DOI 10.1152/ajplung.00383.2014
   Hong ZG, 2017, AM J RESP CRIT CARE, V195, P515, DOI 10.1164/rccm.201604-0814OC
   Hopper RK, 2016, CIRCULATION, V133, P1783, DOI 10.1161/CIRCULATIONAHA.115.020617
   Huertas A, 2020, CARDIOVASC RES, V116, P885, DOI 10.1093/cvr/cvz308
   Huertas A, 2012, EUR RESPIR J, V40, P895, DOI 10.1183/09031936.00159911
   Humbert M, 2021, NEW ENGL J MED, V384, P1204, DOI 10.1056/NEJMoa2024277
   Humbert M, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01887-2018
   Hunter KS, 2011, COMPR PHYSIOL, V1, P1413, DOI 10.1002/cphy.c100005
   Iqbal M, 2001, POULTRY SCI, V80, P656, DOI 10.1093/ps/80.5.656
   Itoh A, 2003, RESPIROLOGY, V8, P467, DOI 10.1046/j.1440-1843.2003.00491.x
   Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070
   Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291
   Johnson JA, 2012, AM J PHYSIOL-LUNG C, V302, pL474, DOI 10.1152/ajplung.00202.2011
   Jones PL, 1996, CIRC RES, V79, P1131, DOI 10.1161/01.RES.79.6.1131
   Jones RJ, 2022, AM J RESP CRIT CARE, V206, P81, DOI 10.1164/rccm.202108-1919OC
   Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515
   Kim YM, 2011, AM J PATHOL, V179, P1560, DOI 10.1016/j.ajpath.2011.05.051
   Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751
   Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226
   Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC
   Larsen KO, 2011, AM J PHYSIOL-LUNG C, V301, pL50, DOI 10.1152/ajplung.00048.2010
   Le Hiress M, 2015, AM J RESP CRIT CARE, V192, P983, DOI 10.1164/rccm.201402-0322OC
   Le Payec J, 2010, AM J RESP CRIT CARE, V181, P1285, DOI 10.1164/rccm.200909-1331PP
   Lechartier B, 2022, CHEST, V161, P219, DOI 10.1016/j.chest.2021.08.040
   Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135
   Lewis M.I., 2023, ALPHA STUDY PULMONAR
   Li ML, 2014, AM J RESP CELL MOL, V50, P1118, DOI 10.1165/rcmb.2013-0349OC
   Liang SX, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10020341
   Liu AP, 2014, AM J PHYSIOL-HEART C, V307, pH273, DOI 10.1152/ajpheart.00758.2013
   Liu LM, 2022, CLIN EXP PHARMACOL P, V49, P1042, DOI 10.1111/1440-1681.13696
   Liu XD, 2014, J THORAC DIS, V6, P497, DOI 10.3978/j.issn.2072-1439.2014.03.27
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Low AT, 2015, HAEMATOLOGICA, V100, pE244, DOI 10.3324/haematol.2014.120816
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2015, HUM MUTAT, V36, P1113, DOI 10.1002/humu.22904
   Machado RD, 2000, GENOMICS, V68, P220, DOI 10.1006/geno.2000.6291
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Masri FA, 2008, CTS-CLIN TRANSL SCI, V1, P99, DOI 10.1111/j.1752-8062.2008.00035.x
   Mathai SC, 2012, HEART FAIL CLIN, V8, P413, DOI 10.1016/j.hfc.2012.04.001
   McClenaghan C, 2019, HYPERTENSION, V74, P14, DOI 10.1161/HYPERTENSIONAHA.119.12992
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meloche J, 2015, CIRC RES, V117, P525, DOI 10.1161/CIRCRESAHA.115.307004
   Meloche J, 2014, CIRCULATION, V129, P786, DOI 10.1161/CIRCULATIONAHA.113.006167
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Michelakis ED, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4583
   Middleton R, 2021, AM J RESP CRIT CARE, V203
   Middleton RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183557
   Mirsaeidi Mehdi, 2016, Tanaffos, V15, P44
   Montani D, 2016, EUR RESPIR J, V47, P1518, DOI 10.1183/13993003.00026-2016
   Morrell NW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01899-2018
   Moudgil R, 2006, MICROCIRCULATION, V13, P615, DOI 10.1080/10739680600930222
   Muñoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015
   Nasim MT, 2011, HUM MUTAT, V32, P1385, DOI 10.1002/humu.21605
   Nave AH, 2014, ARTERIOSCL THROM VAS, V34, P1446, DOI 10.1161/ATVBAHA.114.303534
   Noureddine H, 2011, CIRC RES, V109, P543, DOI 10.1161/CIRCRESAHA.111.241299
   Ntokou A, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.139067
   Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716
   Olschewski A, 2006, CIRC RES, V98, P1072, DOI 10.1161/01.RES.0000219677.12988.e9
   Olschewski A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00754-2017
   Owen NE, 2020, EBIOMEDICINE, V56, DOI 10.1016/j.ebiom.2020.102794
   Palasset TL, 2021, ANN AM THORAC SOC, V18, P1306, DOI 10.1513/AnnalsATS.202008-913OC
   Patterson KC, 2006, ANN INTERN MED, V145, P152, DOI 10.7326/0003-4819-145-2-200607180-00020
   Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706
   Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC
   Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC
   Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033
   PIETRA GG, 1989, CIRCULATION, V80, P1198, DOI 10.1161/01.CIR.80.5.1198
   Pogoriler JE, 2012, HISTOPATHOLOGY, V61, P597, DOI 10.1111/j.1365-2559.2012.04246.x
   Price LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075415
   Prins KW, 2018, J HEART LUNG TRANSPL, V37, P376, DOI 10.1016/j.healun.2017.08.011
   Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qian J, 2015, HYPERTENSION, V66, P1227, DOI 10.1161/HYPERTENSIONAHA.115.06370
   RABINOVITCH M, 1980, HUM PATHOL, V11, P499
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP
   Ramirez RL, 2018, CURR OPIN PULM MED, V24, P416, DOI 10.1097/MCP.0000000000000513
   Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750
   Ranchoux B, 2015, AM J PATHOL, V185, P356, DOI 10.1016/j.ajpath.2014.10.021
   Raychaudhuri B, 1999, AM J RESP CELL MOL, V21, P311, DOI 10.1165/ajrcmb.21.3.3611
   Redel-Traub G, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12101341
   Renard S, 2016, CHEST, V149, pE69, DOI 10.1016/j.chest.2015.09.018
   Ricard N, 2014, CIRCULATION, V129, P1586, DOI 10.1161/CIRCULATIONAHA.113.007469
   RITCHIE M, 1993, J AM COLL CARDIOL, V22, P1170, DOI 10.1016/0735-1097(93)90433-2
   Ross DJ, 2012, J HEART LUNG TRANSPL, V31, P865, DOI 10.1016/j.healun.2012.04.008
   Rother N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00610
   Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361
   Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje
   Savale L, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-6
   Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838
   Schulman LL, 1996, TRANSPLANTATION, V62, P622, DOI 10.1097/00007890-199609150-00014
   Schweitzer F, 2019, AIDS RES HUM RETROV, V35, P63, DOI [10.1089/AID.2018.0132, 10.1089/aid.2018.0132]
   Shah NP, 2015, AM J HEMATOL, V90, P1060, DOI 10.1002/ajh.24174
   Sharma S, 2020, GENES-BASEL, V11, DOI 10.3390/genes11101224
   Shimoda LA, 2020, PHYSIOLOGY, V35, P222, DOI 10.1152/physiol.00039.2019
   Shu T, 2021, FRONT CARDIOVASC MED, V8, DOI 10.3389/fcvm.2021.680109
   Southgate L, 2020, NAT REV CARDIOL, V17, P85, DOI 10.1038/s41569-019-0242-x
   Souza R, 2006, THORAX, V61, P736, DOI 10.1136/thx.2006.064097
   Spiekerkoetter E, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02449-2016
   Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC
   Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014
   Stenmark KR, 2016, CIRCULATION, V133, P1734, DOI 10.1161/CIRCULATIONAHA.116.022479
   Stenmark Kurt R, 2012, Pulm Circ, V2, P3, DOI 10.4103/2045-8932.94817
   Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009
   Swietlik EM, 2021, CIRC-GENOM PRECIS ME, V14, DOI 10.1161/CIRCGEN.120.003155
   Tamby MC, 2006, EUR RESPIR J, V28, P799, DOI 10.1183/09031936.06.00152705
   Tamby MC, 2005, THORAX, V60, P765, DOI 10.1136/thx.2004.029082
   Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927
   Tang HY, 2018, JACC-BASIC TRANSL SC, V3, P744, DOI 10.1016/j.jacbts.2018.08.009
   Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6
   Tello K, 2020, AM J RESP CRIT CARE, V202, P1042, DOI 10.1164/rccm.202003-0807LE
   Terrier B, 2008, AM J RESP CRIT CARE, V177, P1128, DOI 10.1164/rccm.200707-1015OC
   Thenappan T, 2018, AM J PHYSIOL-HEART C, V315, pH1322, DOI 10.1152/ajpheart.00136.2018
   Tian W, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006674
   Tielemans B, 2019, DRUG DISCOV TODAY, V24, P703, DOI 10.1016/j.drudis.2018.12.001
   Toby IT, 2010, AM J PHYSIOL-LUNG C, V298, pL600, DOI 10.1152/ajplung.00122.2009
   TODOROVICHHUNTER L, 1992, AM REV RESPIR DIS, V146, P213, DOI 10.1164/ajrccm/146.1.213
   Tofovic SP, 2010, J CARDIOVASC PHARM, V56, P696, DOI 10.1097/FJC.0b013e3181f9ea8d
   Tonelli Adriano R, 2012, Pulm Circ, V2, P214, DOI 10.4103/2045-8932.97607
   Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503
   Trip P, 2013, EUR RESPIR J, V42, P1575, DOI 10.1183/09031936.00184412
   Tuder RM, 1998, J LAB CLIN MED, V132, P16, DOI 10.1016/S0022-2143(98)90020-8
   TUDER RM, 1994, AM J PATHOL, V144, P275
   Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025
   Upton PD, 2013, EXP PHYSIOL, V98, P1262, DOI 10.1113/expphysiol.2012.069104
   van de Veerdonk MC, 2015, CHEST, V147, P1063, DOI 10.1378/chest.14-0701
   van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068
   Van der Feen DE, 2019, AM J RESP CRIT CARE, V200, P910, DOI 10.1164/rccm.201812-2275OC
   van der Feen DE, 2019, AM J RESP CELL MOL, V61, P11, DOI 10.1165/rcmb.2018-0329TR
   Vengethasamy L, 2016, PFLUG ARCH EUR J PHY, V468, P1969, DOI 10.1007/s00424-016-1899-1
   Ventetuolo CE, 2016, AM J RESP CRIT CARE, V193, P1168, DOI 10.1164/rccm.201509-1785OC
   WAGENVOORT CA, 1970, J PATHOL, V101, pP1
   Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633
   Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98
   West J, 2020, PULM CIRC, V10, DOI 10.1177/2045894019856483
   West J, 2013, EUR RESPIR J, V41, P861, DOI 10.1183/09031936.00030312
   Xu WL, 2021, ANNU REV PHYSIOL, V83, P551, DOI 10.1146/annurev-physiol-031620-123956
   Xu WL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55053-6
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang SZ, 2012, AM J PHYSIOL-LUNG C, V302, pL521, DOI 10.1152/ajplung.00316.2011
   Yeager ME, 2001, CIRC RES, V88, pE2
   Yu YRA, 2020, J IMMUNOL, V204, P1474, DOI 10.4049/jimmunol.1900239
   Yuan K, 2015, AM J PATHOL, V185, P69, DOI 10.1016/j.ajpath.2014.09.013
   Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6
   Zamanian RT, 2009, EUR RESPIR J, V33, P318, DOI 10.1183/09031936.00000508
   Zamanian RT, 2021, AM J RESP CRIT CARE, V204, P209, DOI 10.1164/rccm.202009-3481OC
   Zhang H, 2017, CIRCULATION, V136, P2468, DOI 10.1161/CIRCULATIONAHA.117.028069
   Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002
   Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b
   Zhao YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088727
   Zhu N, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.001887
NR 245
TC 0
Z9 0
U1 0
U2 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-398X
EI 1875-6387
J9 CURR RESPIR MED REV
JI Curr. Respir. Med. Rev.
PY 2024
VL 20
IS 2
BP 127
EP 155
DI 10.2174/011573398X266579240226064718
EA MAR 2024
PG 29
WC Respiratory System
WE Emerging Sources Citation Index (ESCI)
SC Respiratory System
GA YW0N0
UT WOS:001189816100001
DA 2024-11-01
ER

PT J
AU Tang, S
   You, JY
   Liu, L
   Ouyang, HJ
   Jiang, N
   Duan, JQ
   Li, CL
   Luo, YH
   Zhang, WT
   Zhan, MZ
   Liu, CX
   Lyu, GZ
   Zhang, VW
   Zhao, HM
AF Tang, Shuo
   You, Jieyu
   Liu, Li
   Ouyang, Hongjuan
   Jiang, Na
   Duan, Jiaqi
   Li, Canlin
   Luo, Yanhong
   Zhang, Wenting
   Zhan, Meizheng
   Liu, Chenxi
   Lyu, Gui-Zhen
   Zhang, Victor Wei
   Zhao, Hongmei
TI Expanding the mutational spectrum of ZTTK syndrome: A de novo variant
   with global developmental delay and malnutrition in a Chinese patient
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE genetics; global developmental delay; multiple phylogenetic disorders;
   muscle weakness; SON; Zhu-Tokita-Takenouchi-Kim syndrome
ID INTELLECTUAL-DISABILITY; SON
AB BackgroundZhu-Tokita-Takenouchi-Kim (ZTTK, OMIM 617140) syndrome is a severe multisystem developmental disorder characterized by intellectual disability, developmental delay, cortical malformations, epilepsy, visual problems, musculoskeletal abnormalities, and congenital malformations. ZTTK syndrome is caused by a heterozygous pathogenic variant of the SON gene (NM_138927) at chromosome 21q22.1. The purpose of this study was to investigate the pathogenesis of a 6-month-old Chinese child who exhibited global developmental delay, muscle weakness, malnutrition, weight loss, and strabismus, brain abnormality, immunological system abnormalities. MethodsThe little girl was tested for medical exome sequencing (MES) and mtDNA sequencing in trio. And, the mutation was validated by Sanger sequencing. ResultsA novel de novo frameshift variant, c.1845_1870del26 (p.G616Sfs*61), in the SON gene was found in the proband. ConclusionWe described a 6-month-old Chinese child with global developmental delay caused by pathogenic de novo mutation c.1845_1870del26 (p.G616Sfs*61) in the SON. Apart from a founder mutation, we reviewed the phenotypic abnormalities and genotypes in 79 individuals. The data showed that global developmental delay is accompanied by other system disorders. Our findings expanded the mutational spectrum of ZTTK syndrome and provide genetic counseling of baby with global developmental delay.
C1 [Tang, Shuo; You, Jieyu; Liu, Li; Ouyang, Hongjuan; Jiang, Na; Duan, Jiaqi; Li, Canlin; Luo, Yanhong; Zhang, Wenting; Zhan, Meizheng; Liu, Chenxi; Zhao, Hongmei] Hunan Childrens Hosp, Dept Digest Syst Dis, Changsha, Peoples R China.
   [Lyu, Gui-Zhen; Zhang, Victor Wei] AmCare Genom Lab, Guangzhou, Guangdong, Peoples R China.
   [Zhao, Hongmei] Hunan Childrens Hosp, Dept Digest Syst Dis, 86 Ziyuan Rd, Changsha 410007, Peoples R China.
RP Zhao, HM (corresponding author), Hunan Childrens Hosp, Dept Digest Syst Dis, 86 Ziyuan Rd, Changsha 410007, Peoples R China.
EM 364875977@foxmail.com
RI Chen, Zhenghu/ABB-9207-2021; Zhang, Wen-Bin/B-4514-2014; liu,
   chenxi/AAQ-8429-2020
OI Lyu, Guizhen/0000-0002-9284-7318
CR Ahn EEY, 2013, J BIOL CHEM, V288, P5381, DOI 10.1074/jbc.M112.447227
   Dingemans AJM, 2022, EUR J HUM GENET, V30, P271, DOI 10.1038/s41431-021-00960-4
   Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]
   Indelicato E, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02218-8
   Kim JH, 2019, KIDNEY INT, V95, P1494, DOI 10.1016/j.kint.2019.01.025
   Kim JH, 2016, AM J HUM GENET, V99, P711, DOI 10.1016/j.ajhg.2016.06.029
   Kushary ST, 2021, AM J MED GENET A, V185, P3740, DOI 10.1002/ajmg.a.62445
   Mahler EA, 2019, DTSCH ARZTEBL INT, V116, P197, DOI 10.3238/arztebl.2019.0197
   Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129
   Mena R, 2020, AM J MED GENET C, V184, P996, DOI 10.1002/ajmg.c.31859
   Meng LY, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.3438
   Mithyantha R, 2017, ARCH DIS CHILD, V102, P1071, DOI 10.1136/archdischild-2016-311271
   Ouyang XJ, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.725259
   Peng F., 2021, IDENTIFICATION FRAME, DOI [10.21203/rs.3.rs-191620/v1, DOI 10.21203/RS.3.RS-191620/V1]
   Qi QW, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121397
   Qiao F., 2020, COMPREHENSIVE EVALUA
   Castanedo LQ, 2020, PEDIATR DERMATOL, V37, P517, DOI 10.1111/pde.14113
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Sharma A, 2011, J CELL SCI, V124, P4286, DOI 10.1242/jcs.092239
   Slezak R, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1432
   Takenouchi T, 2016, AM J MED GENET A, V170, P2587, DOI 10.1002/ajmg.a.37761
   Tan Y, 2020, J CLIN LAB ANAL, V34, DOI 10.1002/jcla.23326
   Tokita MJ, 2016, AM J HUM GENET, V99, P720, DOI 10.1016/j.ajhg.2016.06.035
   Xin H., 2022, J MED GENET, V39, P316
   Yang LL, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1496
   Yang Y, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.953
   Yi Z, 2022, INT J DEV NEUROSCI, V82, P271, DOI 10.1002/jdn.10170
   Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191
NR 28
TC 0
Z9 0
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD AUG
PY 2023
VL 11
IS 8
DI 10.1002/mgg3.2188
EA JUL 2023
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FO9G9
UT WOS:001032165900001
PM 37488749
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Koch, J
   Freisinger, P
   Feichtinger, RG
   Zimmermann, FA
   Rauscher, C
   Wagentristl, HP
   Konstantopoulou, V
   Seidl, R
   Haack, TB
   Prokisch, H
   Ahting, U
   Sperl, W
   Mayr, JA
   Maier, EM
AF Koch, Johannes
   Freisinger, Peter
   Feichtinger, Rene G.
   Zimmermann, Franz A.
   Rauscher, Christian
   Wagentristl, Hans P.
   Konstantopoulou, Vassiliki
   Seidl, Rainer
   Haack, Tobias B.
   Prokisch, Holger
   Ahting, Uwe
   Sperl, Wolfgang
   Mayr, Johannes A.
   Maier, Esther M.
TI Mutations in <i>TTC19</i>: expanding the molecular, clinical and
   biochemical phenotype
SO ORPHANET JOURNAL OF RARE DISEASES
LA English
DT Article
DE TTC19; Mitochondrial respiratory chain complex III deficiency; Neonatal
   lactic acidosis; Regression; Loss of speech; Leigh syndrome;
   Hypertrophic olivary nucleus degeneration; Neurodegenerative disorder
ID HYPERTROPHIC OLIVARY DEGENERATION; COMPLEX III DEFICIENCY;
   LEIGH-SYNDROME; MITOCHONDRIAL-DNA; NECROTIZING ENCEPHALOMYELOPATHY;
   CEREBELLAR-ATAXIA; MR FINDINGS; DISEASE; CHILD
AB Background: TTC19 deficiency is a progressive neurodegenerative disease associated with isolated mitochondrial respiratory chain (MRC) complex III deficiency and loss-of-function mutations in the TT19 gene in the few patients reported so far.
   Methods: We performed exome sequencing and selective mutational analysis of TTC19, respectively, in patients from three unrelated families presenting with initially unspecific clinical signs of muscular hypotonia and global developmental delay followed by regression, ataxia, loss of speech, and rapid neurological deterioration. One patient showed severe lactic acidosis at the neonatal age and during intercurrent illness.
   Results: We identified homozygous mutations in all three index cases, in two families novel missense mutations (c.544 T > C/p.Leu185Pro; c.917 T > C/p.Leu324Pro). The younger sister of the severely affected patient 3 showed only mild delay of motor skills and muscular hypotonia so far but is also homozygous for the same mutation. Notably, one patient revealed normal activities of MRC complex III in two independent muscle biopsies. Neuroimaging of the severely affected patients demonstrated lesions in putamen and caudate nuclei, cerebellar atrophy, and the unusual finding of hypertrophic olivary nuclei degeneration. Reviewing the literature revealed striking similarities regarding neuroimaging and clinical course in pediatric patients with TTC19 deficiency: patterns consistent with Leigh or Leigh-like syndrome were found in almost all, hypertrophic olivary nucleus degeneration in all patients reported so far. The clinical course in pediatric patients is characterized by an initially unspecific developmental delay, followed by regression, progressive signs and symptoms of cerebellar, basal ganglia and brainstem affection, especially loss of speech and ataxia. Subsequently, neurological deterioration leading to a vegetative state occurs.
   Conclusions: Our findings add to the phenotypic, genetic, and biochemical spectrum of TTC19 deficiency. However, TTC19 deficient patients do show characteristic clinical and neuroimaging features, which may facilitate diagnosis of this yet rare disorder. Normal MRC complex III activity does not exclude the diagnosis.
C1 [Koch, Johannes; Feichtinger, Rene G.; Zimmermann, Franz A.; Rauscher, Christian; Sperl, Wolfgang; Mayr, Johannes A.; Maier, Esther M.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria.
   [Freisinger, Peter] Kreisklinken Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany.
   [Wagentristl, Hans P.] Krankenhaus Barmherzigen Brueder, Dept Pediat, A-7000 Eisenstadt, Austria.
   [Konstantopoulou, Vassiliki; Seidl, Rainer] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria.
   [Haack, Tobias B.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.
   [Haack, Tobias B.; Prokisch, Holger; Ahting, Uwe] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany.
C3 Paracelsus Private Medical University; Konventhospital Der Barmherzigen
   Bruder; Medical University of Vienna; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Technical University of Munich
RP Maier, EM (corresponding author), Paracelsus Med Univ Salzburg, Dept Pediat, Muellner Hauptstr 48, A-5020 Salzburg, Austria.
EM esther.maier@med.uni-muenchen.de
RI Seidl, Rainer/KIC-4255-2024; Prokisch, Holger/N-8964-2013; Haack,
   Tobias/JLM-8099-2023
OI Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286
FU Salzburg Center Foundation; Vereinigung zur Forderung der padiatrischen
   Forschung und Fortbildung; German Bundesministerium fur Bildung und
   Forschung (BMBF) through German Network for mitochondrial disorders
   (mitoNET) [01GM1113C]; BMBF through Juniorverbund in der Systemmedizin
   "mitOmics" [FKZ 01ZX1405C]; German Bundesministerium fur Bildung und
   Forschung (BMBF) through E-Rare project GENOMIT [01GM1207]
FX Salzburg Center Foundation, the "Vereinigung zur Forderung der
   padiatrischen Forschung und Fortbildung". This study was supported by
   the German Bundesministerium fur Bildung und Forschung (BMBF) through
   the German Network for mitochondrial disorders (mitoNET; 01GM1113C to
   HP) and through the E-Rare project GENOMIT (01GM1207 for HP). TBH was
   supported by the BMBF through the Juniorverbund in der Systemmedizin
   "mitOmics" (FKZ 01ZX1405C).
CR Atwal PS, 2014, JIMD REP, V14, P43, DOI 10.1007/8904_2013_282
   Aulbert W, 2014, NEUROPEDIATRICS, V45, P346, DOI 10.1055/s-0034-1383823
   Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1
   Bindu PS, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130478
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   DAYAN AD, 1970, ARCH DIS CHILD, V45, P39, DOI 10.1136/adc.45.239.39
   Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5
   Farina L, 2002, AM J NEURORADIOL, V23, P1095
   Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621
   Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761
   Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3
   Kinghorn KJ, 2013, J NEUROL, V260, P3, DOI 10.1007/s00415-012-6564-9
   Kulkarni PK, 1999, MOVEMENT DISORD, V14, P689, DOI 10.1002/1531-8257(199907)14:4<689::AID-MDS1022>3.0.CO;2-8
   Kunii M, 2015, J HUM GENET, V14, P43, DOI [10.1038/jhg.2015.7, DOI 10.1038/JHG.2015.7.[]
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b
   MEDINA L, 1990, AM J ROENTGENOL, V154, P1269, DOI 10.2214/ajr.154.6.2159689
   Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104
   Melchionda L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00397
   Meoded A, 2013, CEREBELLUM, V12, P469, DOI 10.1007/s12311-013-0448-0
   Morino H, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-5
   Nogueira C, 2013, NEUROGENETICS, V14, P153, DOI 10.1007/s10048-013-0361-1
   Nowak J, 2014, CHILD NERV SYST, V30, P959, DOI 10.1007/s00381-013-2296-0
   Patel KP, 2014, MOL GENET METAB, V106, P385
   Phatouros CC, 1998, PEDIATR RADIOL, V28, P830, DOI 10.1007/s002470050475
   Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8
   Sanverdi SE, 2012, BRIT J RADIOL, V85, P511, DOI 10.1259/bjr/60727602
   SAVOIARDO M, 1991, J NEUROL NEUROSUR PS, V54, P888, DOI 10.1136/jnnp.54.10.888
   Sofou K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-52
   Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097
   Vossough A, 2012, PEDIATR RADIOL, V42, P481, DOI 10.1007/s00247-011-2330-x
NR 33
TC 20
Z9 21
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-1172
J9 ORPHANET J RARE DIS
JI Orphanet J. Rare Dis.
PD APR 2
PY 2015
VL 10
AR 40
DI 10.1186/s13023-015-0254-5
PG 12
WC Genetics & Heredity; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Research & Experimental Medicine
GA CH4PN
UT WOS:000354015500001
PM 25887401
OA Green Published, Green Accepted, gold
DA 2024-11-01
ER

PT J
AU Piantino, CB
   Reis, ST
   Viana, NI
   Silva, IA
   Morais, DR
   Antunes, AA
   Dip, N
   Srougi, M
   Leite, KR
AF Piantino, Camila B.
   Reis, Sabrina T.
   Viana, Nayara I.
   Silva, Iran A.
   Morais, Denis R.
   Antunes, Alberto A.
   Dip, Nelson
   Srougi, Miguel
   Leite, Katia R.
TI Prima-1 induces apoptosis in bladder cancer cell lines by activating p53
SO CLINICS
LA English
DT Article
DE Bladder cancer; p53; Apoptosis; Prima-1
ID BH3-ONLY PROTEINS PUMA; MOLECULAR ALTERATIONS; CASPASE FAMILY;
   SPECIFICITIES; PATHWAY
AB OBJECTIVES: Bladder cancer represents 3% of all carcinomas in the Brazilian population and ranks second in incidence among urological tumors, after prostate cancer. The loss of p53 function is the main genetic alteration related to the development of high-grade muscle-invasive disease. Prima-1 is a small molecule that restores tumor suppressor function to mutant p53 and induces cancer cell death in various cancer types. Our aim was to investigate the ability of Prima-1 to induce apoptosis after DNA damage in bladder cancer cell lines.
   METHOD: The therapeutic effect of Prima-1 was studied in two bladder cancer cell lines: T24, which is characterized by a p53 mutation, and RT4, which is the wild-type for the p53 gene. Morphological features of apoptosis induced by p53, including mitochondrial membrane potential changes and the expression of thirteen genes involved in apoptosis, were assessed by microscopic observation and quantitative real-time PCR (qRT-PCR).
   RESULTS: Prima-1 was able to reactivate p53 function in the T24 (p53 mt) bladder cancer cell line and promote apoptosis via the induction of Bax and Puma expression, activation of the caspase cascade and disruption of the mitochondrial membrane in a BAK-independent manner.
   CONCLUSION: Prima-1 is able to restore the transcriptional activity of p53. Experimental studies in vivo may be conducted to test this molecule as a new therapeutic agent for urothelial carcinomas of the bladder, which characteristically harbor p53 mutations.
C1 [Piantino, Camila B.; Reis, Sabrina T.; Viana, Nayara I.; Silva, Iran A.; Morais, Denis R.; Antunes, Alberto A.; Dip, Nelson; Srougi, Miguel; Leite, Katia R.] Univ Sao Paulo, Fac Med, Dept Urol, Lab Med Investigat,LIM55, Sao Paulo, Brazil.
C3 Universidade de Sao Paulo
RP Piantino, CB (corresponding author), Univ Sao Paulo, Fac Med, Dept Urol, Lab Med Investigat,LIM55, Sao Paulo, Brazil.
EM camilapiantino@hotmail.com
RI Viana, Nayara/P-6868-2015; Antunes, Alberto/AAT-2023-2020; Srougi,
   Miguel/AAT-8625-2021; Amorim da Silva, Iran/B-2917-2013; Leite,
   Katia/C-2055-2008
OI Reis, Sabrina Thalita dos/0000-0002-3564-3597; Viana,
   Nayara/0000-0003-4505-8508; Amorim da Silva, Iran/0000-0001-5441-790X;
   Leite, Katia/0000-0002-2615-7730
FU State of Sao Paulo Research Foundation (FAPESP)
FX This work was supported by the State of Sao Paulo Research Foundation
   (FAPESP).
CR Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001
   Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006
   Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269
   Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282
   Clavería C, 2004, J BIOL CHEM, V279, P1368, DOI 10.1074/jbc.M309819200
   Cordon-Cardo C, 1998, CANCER SURV, V32, P115
   Cordon-Cardo C, 2008, SCAND J UROL NEPHROL, V42, P154, DOI 10.1080/03008880802291915
   Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   Cote RJ, 2003, CRIT REV ONCOL HEMAT, V46, pS67, DOI 10.1016/S1040-8428(03)00066-0
   Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595
   Feng ZH, 2002, CARCINOGENESIS, V23, P1721, DOI 10.1093/carcin/23.10.1721
   Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019
   Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200
   Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7
   Konstantakou EG, 2009, INT J ONCOL, V35, P401, DOI 10.3892/ijo_00000353
   Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989
   Lei XB, 2006, FASEB J, V20, P2147, DOI 10.1096/fj.05-5665fje
   Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1
   Lomonosova E, 2009, MOL CANCER RES, V7, P1268, DOI 10.1158/1541-7786.MCR-08-0183
   Lu ML, 2002, CLIN CANCER RES, V8, P171
   Messina RL, 2012, INT J CANCER, V130, P2259, DOI 10.1002/ijc.26228
   Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3
   Shen J, 2008, ONCOGENE, V27, P6571, DOI 10.1038/onc.2008.249
   Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603
   Siegel RL., 2019, ANTI-CANCER DRUG, V69, P7, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
   Silverman DT., 2006, Cancer Epidemiology and Prevention, P1101
   Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930
   Szliszka E, 2010, MOLECULES, V15, P5336, DOI 10.3390/molecules15085336
   Talanian RV, 1997, J BIOL CHEM, V272, P9677
   Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312
   Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907
   Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072
   Vousden KH, 2005, SCIENCE, V309, P1685, DOI 10.1126/science.1118232
   Watanabe FT, 2011, CLINICS, V66, P2121, DOI 10.1590/S1807-59322011001200019
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
NR 36
TC 12
Z9 15
U1 0
U2 2
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PY 2013
VL 68
IS 3
BP 297
EP 303
DI 10.6061/clinics/2013(03)OA03
PG 7
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 158VC
UT WOS:000320000800004
PM 23644847
OA Green Published, gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Li, HZ
   Zeng, FC
   Huang, CC
   Pu, QQ
   Thomas, ER
   Chen, Y
   Li, X
AF Li, Hangzhen
   Zeng, Fancai
   Huang, Cancan
   Pu, Qiqi
   Thomas, Elizabeth Rosalind
   Chen, Yan
   Li, Xiang
TI The potential role of glucose metabolism, lipid metabolism, and amino
   acid metabolism in the treatment of Parkinson's disease
SO CNS NEUROSCIENCE & THERAPEUTICS
LA English
DT Review
DE amino acid metabolism; glucose metabolism; lipid metabolism; Parkinson's
   disease
ID MITOCHONDRIAL-DNA DELETIONS; PENTOSE-PHOSPHATE PATHWAY; ALPHA-SYNUCLEIN;
   OXIDATIVE STRESS; SUBSTANTIA-NIGRA; FATTY-ACIDS; CHOLESTEROL-METABOLISM;
   GLUTAMATE TOXICITY; INSULIN-RESISTANCE; ANTIDIABETIC DRUGS
AB Purpose of ReviewParkinson's disease (PD) is a common neurodegenerative disease, which can cause progressive deterioration of motor function causing muscle stiffness, tremor, and bradykinesia. In this review, we hope to describe approaches that can improve the life of PD patients through modifications of energy metabolism. Recent FindingsThe main pathological features of PD are the progressive loss of nigrostriatal dopaminergic neurons and the production of Lewy bodies. Abnormal aggregation of & alpha;-synuclein (& alpha;-Syn) leading to the formation of Lewy bodies is closely associated with neuronal dysfunction and degeneration. The main causes of PD are said to be mitochondrial damage, oxidative stress, inflammation, and abnormal protein aggregation. Presence of abnormal energy metabolism is another cause of PD. Many studies have found significant differences between neurodegenerative diseases and metabolic decompensation, which has become a biological hallmark of neurodegenerative diseases. In this review, we highlight the relationship between abnormal energy metabolism (Glucose metabolism, lipid metabolism, and amino acid metabolism) and PD. Improvement of key molecules in glucose metabolism, fat metabolism, and amino acid metabolism (e.g., glucose-6-phosphate dehydrogenase, triglycerides, and levodopa) might be potentially beneficial in PD. Some of these metabolic indicators may serve well during the diagnosis of PD. In addition, modulation of these metabolic pathways may be a potential target for the treatment and prevention of PD.
C1 [Li, Hangzhen; Zeng, Fancai; Pu, Qiqi; Li, Xiang] Southwest Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Luzhou, Peoples R China.
   [Huang, Cancan; Chen, Yan] Southwest Med Univ, Dept Dermatol, Affiliated Hosp, Luzhou, Peoples R China.
   [Thomas, Elizabeth Rosalind] NEIGRIHMS, Dept Microbiol, Shillong, India.
   [Chen, Yan; Li, Xiang] Southwest Med Univ, Sch Basic Med Sci, Lab Biochem & Mol Biol, Luzhou 646000, Peoples R China.
C3 Southwest Medical University; Southwest Medical University; North
   Eastern Indira Gandhi Regional Institute of Health & Medical Sciences
   (NEIGRIHMS); Southwest Medical University
RP Chen, Y; Li, X (corresponding author), Southwest Med Univ, Sch Basic Med Sci, Lab Biochem & Mol Biol, Luzhou 646000, Peoples R China.
EM chenyan0216@swmu.edu.cn; lix2009@126.com
RI Huang, Cancan/GWR-3699-2022
FU Science and Technology Strategic Cooperation Project of the Luzhou
   People's Government; Southwest Medical University [2019LZXNYDJ34];
   undergraduate innovation and entrepreneurship training program
   [S202110632241]; Sichuan Science and Technology Program [2022YFS0623,
   2023JDRC0109]
FX This study was financially supported by grants from the Science and
   Technology Strategic Cooperation Project of the Luzhou People's
   Government and Southwest Medical University (No. 2019LZXNYDJ34) and the
   undergraduate innovation and entrepreneurship training program
   (S202110632241). This study was financially supported by Sichuan Science
   and Technology Program (Grant No. 2022YFS0623 and 2023JDRC0109).
CR Abraham S, 2005, INDIAN J MED RES, V121, P111
   Ådén E, 2011, NUTR NEUROSCI, V14, P25, DOI 10.1179/174313211X12966635733312
   Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9
   Alecu I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00328
   Ali Z, 2022, NEUROCHEM INT, V157, DOI 10.1016/j.neuint.2022.105344
   Anandhan A, 2017, BRAIN RES BULL, V133, P12, DOI 10.1016/j.brainresbull.2017.03.009
   Anandhan A, 2017, MOL NEUROBIOL, V54, P3825, DOI 10.1007/s12035-016-9906-2
   Anis E, 2022, TRENDS ENDOCRIN MET, V33, P147, DOI 10.1016/j.tem.2021.11.005
   Ashraghi MR, 2016, RECENT PATENTS ENDOC, V10, P11, DOI 10.2174/1872214810999160628105549
   Athauda D, 2016, PROG NEUROBIOL, V145, P98, DOI 10.1016/j.pneurobio.2016.10.001
   Aubert A, 2005, P NATL ACAD SCI USA, V102, P16448, DOI 10.1073/pnas.0505427102
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135
   Bonvento G, 2021, CELL METAB, V33, P1546, DOI 10.1016/j.cmet.2021.07.006
   Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0
   Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782
   Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001
   Brace LE, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.22
   Burks S, 2019, NEUROSCI LETT, V703, P86, DOI 10.1016/j.neulet.2019.03.015
   Butterfield DA, 2022, MOLECULES, V27, DOI 10.3390/molecules27030951
   Cai R, 2019, J CLIN INVEST, V129, P4539, DOI 10.1172/JCI129987
   Camilleri A, 2014, CNS NEUROSCI THER, V20, P591, DOI 10.1111/cns.12264
   Cardoso S, 2020, INT REV NEUROBIOL, V155, P37, DOI 10.1016/bs.irn.2020.02.010
   Corona JC, 2010, J NEUROSCI RES, V88, P1943, DOI 10.1002/jnr.22357
   Cassani E, 2017, PARKINSONISM RELAT D, V42, P40, DOI 10.1016/j.parkreldis.2017.06.007
   Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342
   Chong MFF, 2007, P NUTR SOC, V66, P52, DOI 10.1017/S0029665107005290
   Rosa SCD, 2021, AUTOPHAGY, V17, P2257, DOI 10.1080/15548627.2020.1821548
   Dai LJ, 2021, MOL NEUROBIOL, V58, P2183, DOI 10.1007/s12035-020-02232-6
   Di Maio A, 2023, NEUROBIOL DIS, V184, DOI 10.1016/j.nbd.2023.106203
   Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   Dong MX, 2021, CHEM PHYS LIPIDS, V239, DOI 10.1016/j.chemphyslip.2021.105112
   Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x
   Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001
   Edison P, 2013, NEUROPSYCHOPHARMACOL, V38, P938, DOI 10.1038/npp.2012.255
   Emamzadeh FN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00612
   Emamzadeh FN, 2017, J MOL NEUROSCI, V63, P165, DOI 10.1007/s12031-017-0967-0
   Eriksson I, 2017, EUR J CELL BIOL, V96, P99, DOI 10.1016/j.ejcb.2017.01.002
   Estes RE, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.788695
   Fais M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147630
   Fanning S, 2021, ACTA NEUROPATHOL, V141, P491, DOI 10.1007/s00401-020-02177-z
   Fanning S, 2019, MOL CELL, V73, P1001, DOI 10.1016/j.molcel.2018.11.028
   Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268
   Flores-Dorantes MT, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00863
   Foltynie T, 2020, PROG BRAIN RES, V252, P493, DOI 10.1016/bs.pbr.2019.10.008
   Galper J, 2022, BRAIN, V145, P3472, DOI 10.1093/brain/awac176
   Gao L, 2008, J NEUROL, V255, P1850, DOI 10.1007/s00415-008-0937-0
   García-Sanz P, 2021, MOVEMENT DISORD, V36, P1070, DOI 10.1002/mds.28396
   García-Sanz P, 2018, AUTOPHAGY, V14, P717, DOI 10.1080/15548627.2018.1427396
   Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004
   Gibson GE, 2003, NEUROCHEM INT, V43, P129, DOI 10.1016/S0197-0186(02)00225-5
   Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200
   Gonzalez-Rodríguez P, 2021, NATURE, V599, P650, DOI 10.1038/s41586-021-04059-0
   Goyal MS, 2014, CELL METAB, V19, P49, DOI 10.1016/j.cmet.2013.11.020
   Graham SH, 2017, AGEING RES REV, V34, P30, DOI 10.1016/j.arr.2016.09.011
   Gregory Allison., 1993, GENEREVIEWS
   Guerreiro PS, 2017, NEUROMOL MED, V19, P113, DOI 10.1007/s12017-016-8435-5
   Guo XY, 2015, INT J NEUROSCI, V125, P838, DOI 10.3109/00207454.2014.979288
   Hantikainen E, 2022, EUR J EPIDEMIOL, V37, P603, DOI 10.1007/s10654-022-00863-8
   Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011
   Havelund JF, 2017, METABOLITES, V7, DOI 10.3390/metabo7030042
   Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000
   He Q, 2013, INT J BIOCHEM CELL B, V45, P2749, DOI 10.1016/j.biocel.2013.09.011
   Heilman PL, 2020, MOVEMENT DISORD, V35, P2028, DOI 10.1002/mds.28202
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6
   Holmay MJ, 2013, CLIN NEUROPHARMACOL, V36, P103, DOI 10.1097/WNF.0b013e31829ae713
   Hong CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep25344
   Hu L, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00080
   Hu YY, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/1458143
   Huot P, 2013, PHARMACOL REV, V65, P171, DOI 10.1124/pr.111.005678
   Innos J, 2021, CHEM RES TOXICOL, V34, P1223, DOI 10.1021/acs.chemrestox.0c00522
   Iovino L, 2020, J PHARMACOL SCI, V144, P151, DOI 10.1016/j.jphs.2020.07.011
   Jana BA, 2019, MOL BIOL REP, V46, P957, DOI 10.1007/s11033-018-4551-7
   Janda E, 2012, MOL NEUROBIOL, V46, P639, DOI 10.1007/s12035-012-8318-1
   Jia LL, 2021, DEV CELL, V56, P2980, DOI 10.1016/j.devcel.2021.09.013
   Jiang T, 2020, TOXICOL IN VITRO, V62, DOI 10.1016/j.tiv.2019.104715
   Jiménez-Jiménez FJ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00369
   Jin U, 2019, EXP NEUROBIOL, V28, P554, DOI 10.5607/en.2019.28.5.554
   Julien C, 2006, NEUROCHEM INT, V48, P404, DOI 10.1016/j.neuint.2005.12.002
   Kalani K, 2018, DRUG DISCOV TODAY, V23, P1983, DOI 10.1016/j.drudis.2018.08.001
   Kim D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164906
   Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1
   Kinghorn KJ, 2015, BRAIN, V138, P1801, DOI 10.1093/brain/awv132
   Ko CW, 2020, NAT REV GASTRO HEPAT, V17, P169, DOI 10.1038/s41575-019-0250-7
   Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kubo S, 2015, FRONT BIOSCI-LANDMRK, V20, P263, DOI 10.2741/4308
   Kuruvilla KP, 2013, J NEUROL SCI, V331, P31, DOI 10.1016/j.jns.2013.04.020
   Lei S, 2014, ACS CHEM BIOL, V9, P2032, DOI 10.1021/cb400894a
   Li X, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.678154
   Limbad C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227887
   Liu MQ, 2021, AGING DIS, V12, P2003, DOI 10.14336/AD.2021.0422
   Lu Y, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13865
   Lücke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200
   Magalhaes J, 2016, HUM MOL GENET, V25, P3432, DOI 10.1093/hmg/ddw185
   Mahoney-Sánchez L, 2021, PROG NEUROBIOL, V196, DOI 10.1016/j.pneurobio.2020.101890
   Manini A, 2022, AGEING RES REV, V76, DOI 10.1016/j.arr.2022.101578
   Marcos AL, 2019, BBA-BIOMEMBRANES, V1861, DOI 10.1016/j.bbamem.2019.05.015
   Marrs TC, 2013, CELL BIOL TOXICOL, V29, P381, DOI 10.1007/s10565-013-9259-9
   Mashima K, 2018, ASN NEURO, V10, DOI 10.1177/1759091418775562
   Mazzio E, 2003, NEUROTOXICOLOGY, V24, P137, DOI 10.1016/S0161-813X(02)00110-9
   McNaught KSP, 2000, BIOCHEM PHARMACOL, V60, P979, DOI 10.1016/S0006-2952(00)00415-9
   Mejías R, 2006, J NEUROSCI, V26, P4500, DOI 10.1523/JNEUROSCI.0122-06.2006
   Meng QJ, 2010, EUR J PHARMACOL, V649, P127, DOI 10.1016/j.ejphar.2010.09.046
   Meng XZ, 2015, J NEUROSCI RES, V93, P350, DOI 10.1002/jnr.23488
   Merlini E, 2022, TRENDS NEUROSCI, V45, P53, DOI 10.1016/j.tins.2021.10.014
   Mookerjee SA, 2018, J BIOL CHEM, V293, P12649, DOI 10.1074/jbc.AAC118.004855
   Morari M, 2018, J PHARMACOL EXP THER, V364, P198, DOI 10.1124/jpet.117.245100
   Mori A, 2019, P NATL ACAD SCI USA, V116, P20689, DOI 10.1073/pnas.1902958116
   Morris JK, 2010, AM J PHYSIOL-REG I, V299, pR1082, DOI 10.1152/ajpregu.00449.2010
   Nam GE, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002640
   Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232
   Nunes VS, 2022, AGING-US, V14, P1549, DOI 10.18632/aging.203880
   Öhman A, 2015, NEUROSCI LETT, V594, P36, DOI 10.1016/j.neulet.2015.03.051
   Orth M, 2012, CHOLESTEROL, DOI 10.1155/2012/292598
   Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439
   Pagano G, 2018, NEUROLOGY, V90, pE1654, DOI 10.1212/WNL.0000000000005475
   Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415
   Palavra NC, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.628845
   Pan PY, 2020, HUM MOL GENET, V29, P2300, DOI 10.1093/hmg/ddaa080
   Pereira CMF, 1997, FREE RADICAL BIO MED, V23, P637, DOI 10.1016/S0891-5849(97)00020-8
   Perl A, 2011, TRENDS MOL MED, V17, P395, DOI 10.1016/j.molmed.2011.01.014
   PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4
   PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1
   Pilchova I, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6797460
   Pingale TD, 2021, J PHARM PHARMACOL, V73, P862, DOI 10.1093/jpp/rgaa063
   Pisanò CA, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.108006
   Powers R, 2017, METABOLITES, V7, DOI 10.3390/metabo7020022
   Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x
   Puchades M, 2013, J PARKINSON DIS, V3, P371, DOI 10.3233/JPD-130190
   Quansah E, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0260-x
   Quintana DD, 2020, J ALZHEIMERS DIS, V75, P119, DOI 10.3233/JAD-190964
   Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043
   Raj PS, 2019, FUND CLIN PHARMACOL, V33, P412, DOI 10.1111/fcp.12452
   Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Reeve A, 2014, AGEING RES REV, V14, P19, DOI 10.1016/j.arr.2014.01.004
   Roh JH, 2021, METAB SYNDR RELAT D, V19, P1, DOI 10.1089/met.2020.0060
   Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448
   Sääksjärvi K, 2015, PARKINSONISM RELAT D, V21, P1148, DOI 10.1016/j.parkreldis.2015.07.017
   Sakaue S, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0014-4
   Campos SS, 2018, ARCH BIOCHEM BIOPHYS, V655, P43, DOI 10.1016/j.abb.2018.08.007
   Campos SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130726
   Sánchez E, 2018, MOL NEUROBIOL, V55, P6734, DOI 10.1007/s12035-017-0846-2
   Sarkar S, 2014, NEUROTOXICOLOGY, V44, P250, DOI 10.1016/j.neuro.2014.07.006
   Saxena U, 2012, EXPERT OPIN THER TAR, V16, P351, DOI 10.1517/14728222.2012.664135
   Schmitz Y, 2013, J NEUROSCI, V33, P16778, DOI 10.1523/JNEUROSCI.3041-12.2013
   Schröter N, 2022, NPJ PARKINSONS DIS, V8, DOI 10.1038/s41531-022-00392-x
   Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001
   Scigliano G, 2006, STROKE, V37, P1184, DOI 10.1161/01.STR.0000217384.03237.9c
   Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629
   Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598
   Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2
   SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305
   Simmering JE, 2022, MOVEMENT DISORD, V37, P2210, DOI 10.1002/mds.29184
   Simmering JE, 2021, JAMA NEUROL, V78, P407, DOI 10.1001/jamaneurol.2020.5157
   Sinclair E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21669-4
   SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B
   Sotiriou E, 2010, MUSCLE NERVE, V41, P707, DOI 10.1002/mus.21612
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Subramaniam SR, 2013, PROG NEUROBIOL, V106, P17, DOI 10.1016/j.pneurobio.2013.04.004
   Sun WY, 2021, NAT CHEM BIOL, V17, P465, DOI 10.1038/s41589-020-00734-x
   Surmeier DJ, 2017, BIOCHEM BIOPH RES CO, V483, P1013, DOI 10.1016/j.bbrc.2016.08.168
   Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178
   Takahashi S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126568
   Takahashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P1151, DOI 10.1016/j.bbrc.2011.12.082
   Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489
   Tu DZ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1659-1
   Turri M, 2022, BBA-MOL CELL BIOL L, V1867, DOI 10.1016/j.bbalip.2022.159123
   Udayar V, 2022, TRENDS NEUROSCI, V45, P184, DOI 10.1016/j.tins.2021.12.004
   Vikdahl M, 2015, EUR J CLIN NUTR, V69, P729, DOI 10.1038/ejcn.2014.259
   Vikdahl M, 2014, CLIN NUTR, V33, P1132, DOI 10.1016/j.clnu.2013.12.012
   Xicoy H, 2021, NPJ PARKINSONS DIS, V7, DOI 10.1038/s41531-021-00168-9
   Xilouri M, 2016, AGEING RES REV, V32, P13, DOI 10.1016/j.arr.2016.07.001
   Yang SQ, 2020, NEUROCHEM INT, V135, DOI 10.1016/j.neuint.2020.104692
   Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010
   Yang WW, 2021, MOL NEUROBIOL, V58, P603, DOI 10.1007/s12035-020-02128-5
   Ye ZC, 1999, CANCER RES, V59, P4383
   Yellen G, 2018, J CELL BIOL, V217, P2235, DOI 10.1083/jcb.201803152
   Yin F, 2023, FEBS J, V290, P1420, DOI 10.1111/febs.16344
   Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533
   Zhang QX, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.563054
NR 184
TC 7
Z9 7
U1 7
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-5930
EI 1755-5949
J9 CNS NEUROSCI THER
JI CNS Neurosci. Ther.
PD FEB
PY 2024
VL 30
IS 2
DI 10.1111/cns.14411
EA AUG 2023
PG 14
WC Neurosciences; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA KB7B7
UT WOS:001047999500001
PM 37577934
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Finsterer, J
   Stöllberger, C
AF Finsterer, Josef
   Stoellberger, Claudia
TI Left Ventricular Noncompaction Syndrome: Genetic Insights and
   Therapeutic Perspectives
SO CURRENT CARDIOLOGY REPORTS
LA English
DT Review
DE Noncompaction; Hypertrabeculation; Genetics; Neuromuscular; Myopathy;
   Chromosomal; Hereditary
ID NON-COMPACTION CARDIOMYOPATHY; WEARABLE CARDIOVERTER-DEFIBRILLATOR;
   DE-NOVO MUTATION; PATIENT; HYPERTRABECULATION/NONCOMPACTION; DEFICIENCY;
   DIAGNOSIS; RISK; VARIANTS; DISEASE
AB Purpose of Review To discuss the association of left ventricular hypertrabeculation/noncompaction (LVHT/LVNC/NCCM) with genetic disease and to outline the therapeutic options for non-symptomatic and symptomatic LVHT. Recent Findings A number of new mutated genes have been recently detected being associated with LVHT. There are indications that microtubules changing cell polarity, the transcription factor Nkx2-5, and NOTCH-1 signaling are involved in the pathogenesis of LVHT. There are also indications that the PKC signaling pathway, which is involved in the regulation of gap junction intercellular communication, is disturbed in LVHT. LVHT is the same as LVNC and is associated with pathogenic variants in > 110 mtDNA or nDNA genes. LVHT has been also reported in > 15 chromosomal defects. However, a causal relation between any of these variants and LVHT has not been proven. There is no general agreement on the treatment of LVHT. According to expert opinions, LVHT patients require anticoagulation if they meet the criteria for anticoagulation or an ICD if they meet the appropriate criteria. Heart failure therapy is equal to patients with other causes of heart failure.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
   [Stoellberger, Claudia] Krankenanstalt Rudolfstiftung Wien, Med Dept Cardiol & Intens Care Med 2, Vienna, Austria.
C3 Rudolfstiftung Hospital; Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Messerli Inst, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de; Claudia.stoellberger@chello.at
OI finsterer, josef/0000-0002-2304-4175
CR Abdullah S, 2017, AM J MED GENET A, V173, P3082, DOI 10.1002/ajmg.a.38394
   Ader F, 2019, CLIN GENET, V96, P317, DOI 10.1111/cge.13594
   Al Senaidi K, 2019, AM J MED GENET A, V179, P1235, DOI 10.1002/ajmg.a.61176
   Al-Kindi SG, 2015, J HEART LUNG TRANSPL, V34, P761, DOI 10.1016/j.healun.2014.11.005
   Altenberger J, 2012, AM J CARDIOL, V110, P314, DOI 10.1016/j.amjcard.2012.02.070
   Amiya E, 2016, INT J CARDIOL, V222, P727, DOI 10.1016/j.ijcard.2016.08.011
   Bai XH, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00247
   Bainbridge MN, 2015, CIRC-CARDIOVASC GENE, V8, P544, DOI 10.1161/CIRCGENETICS.115.001026
   Basu R, 2014, CIRC-HEART FAIL, V7, P1059, DOI 10.1161/CIRCHEARTFAILURE.114.001666
   Bavishi A, 2018, J RADIOL CASE REP, V12, P10, DOI 10.3941/jrcr.v12i7.3351
   Bertini M, 2018, J CARDIOVASC MED, V19, P324, DOI 10.2459/JCM.0000000000000657
   Boban M, 2018, YONSEI MED J, V59, P63, DOI 10.3349/ymj.2018.59.1.63
   Bohrer Thomas, 2006, Heart Lung Circ, V15, P269, DOI 10.1016/j.hlc.2006.02.007
   Brndiarova M, 2020, J NEPHROL, V33, P183, DOI 10.1007/s40620-019-00651-w
   Cerar A, 2018, CELL TRANSPLANT, V27, P1027, DOI 10.1177/0963689718779349
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Choquet C, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007502
   Ciolli A, 2015, J CARDIOVASC ECHOGR, V25, P26, DOI 10.4103/2211-4122.158421
   Codron P, 2019, REV NEUROL-FRANCE, V175, P201, DOI 10.1016/j.neurol.2018.04.012
   Cojan-Minzat BO, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014267
   del Monte-Nieto G, 2018, NATURE, V557, P439, DOI 10.1038/s41586-018-0110-6
   Delplancq G, 2020, AM J MED GENET C, V184, P129, DOI 10.1002/ajmg.c.31766
   Dreisbach JG, 2020, J CARDIOVASC MAGN R, V22, DOI 10.1186/s12968-020-0599-3
   Eldomery MK, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0360-6
   Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086
   Fan P, 2019, CHINESE MED J-PEKING, V132, P127, DOI 10.1097/CM9.0000000000000001
   Finsterer J, 2006, INT J CARDIOL, V106, P420, DOI 10.1016/j.ijcard.2005.01.018
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Finsterer J, 2009, INT J CARDIOL, V137, P310, DOI 10.1016/j.ijcard.2008.05.066
   Finsterer J, 2008, SCAND CARDIOVASC J, V42, P25, DOI 10.1080/14017430701744451
   Finsterer J, 2017, NAT REV CARDIOL, V14, P224, DOI 10.1038/nrcardio.2016.207
   Finsterer J, 2013, CARDIOLOGY, V125, P146, DOI 10.1159/000350411
   Finsterer J, 2010, CURR PHARM DESIGN, V16, P2895, DOI 10.2174/138161210793176437
   Finsterer J, 2009, PEDIATR CARDIOL, V30, P659, DOI 10.1007/s00246-008-9359-0
   Fujino Mitsuhiro, 2018, J Cardiol Cases, V18, P33, DOI 10.1016/j.jccase.2018.04.001
   Gan CP, 2014, J CARDIAC SURG, V29, P827, DOI 10.1111/jocs.12339
   García-García J, 2018, NEUROMUSCULAR DISORD, V28, P952, DOI 10.1016/j.nmd.2018.08.003
   Gati S, 2014, CIRCULATION, V130, P475, DOI 10.1161/CIRCULATIONAHA.114.008554
   Gati S, 2013, HEART, V99, P401, DOI 10.1136/heartjnl-2012-303418
   Gleva MJ, 2017, AM J CARDIOL, V120, P1891, DOI 10.1016/j.amjcard.2017.07.103
   Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011
   Grigoratos C, 2019, JACC-CARDIOVASC IMAG, V12, P2141, DOI 10.1016/j.jcmg.2018.12.029
   Grothoff M, 2012, EUR RADIOL, V22, P2699, DOI 10.1007/s00330-012-2554-7
   Hachiya A, 2016, PEDIATR INT, V58, P797, DOI 10.1111/ped.12983
   Hastings R, 2016, CIRC-CARDIOVASC GENE, V9, P426, DOI 10.1161/CIRCGENETICS.116.001431
   Hirono K, 2019, CIRC J, V83, P1737, DOI 10.1253/circj.CJ-19-0116
   Hirono K, 2019, CLIN CASE REP, V7, P553, DOI 10.1002/ccr3.2050
   Hirono K, 2014, J THORAC CARDIOV SUR, V148, pE223, DOI 10.1016/j.jtcvs.2014.08.049
   Howard TS, 2019, J CARD FAIL, V25, P1004, DOI 10.1016/j.cardfail.2019.09.014
   Jacquier A, 2010, EUR HEART J, V31, P1098, DOI 10.1093/eurheartj/ehp595
   Jahnke C, 2017, EUR HEART J, V38, P2633, DOI 10.1093/eurheartj/ehx360
   Jain-Ghai S, 2013, AM J MED GENET A, V161A, P285, DOI 10.1002/ajmg.a.35714
   Kayvanpour E, 2019, CLIN RES CARDIOL, V108, P1297, DOI 10.1007/s00392-019-01465-3
   Kido K, 2019, J CARDIOVASC PHARM T, V24, P31, DOI 10.1177/1074248418783745
   Kornberger A, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0503-2
   Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693
   Lan NSR, 2018, CARDIOVASC PATHOL, V35, P48, DOI 10.1016/j.carpath.2018.04.006
   Li J, 2015, CLIN RES CARDIOL, V104, P241, DOI 10.1007/s00392-014-0778-z
   Liu Y, 2018, PEDIATR CARDIOL, V39, P1099, DOI 10.1007/s00246-018-1882-z
   Lubrano R, 2009, NEPHROL DIAL TRANSPL, V24, P3884, DOI 10.1093/ndt/gfp499
   Luxán G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046
   McMillan HJ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-36
   Minamisawa M, 2016, J CARDIOL, V68, P431, DOI 10.1016/j.jjcc.2015.11.008
   Miszalski-Jamka K, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001763
   Moller DV, 2009, EUR J HUM GENET, V17, P1241, DOI 10.1038/ejhg.2009.34
   Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003
   Muser D, 2017, HEART RHYTHM, V14, P166, DOI 10.1016/j.hrthm.2016.11.014
   Musmar A, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.5107
   Navarrete G, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003718
   Nozaki Y, 2020, CIRC J, V84, P226, DOI 10.1253/circj.CJ-19-0720
   Oechslin E, 2018, J AM COLL CARDIOL, V71, P723, DOI 10.1016/j.jacc.2017.12.031
   Ojala T, 2015, EUR J PEDIATR, V174, P1689, DOI 10.1007/s00431-015-2574-9
   Olgac A, 2020, J PEDIATR ENDOCR MET, V33, P165, DOI 10.1515/jpem-2019-0245
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   Piccolo P, 2017, HUM MOL GENET, V26, P33, DOI 10.1093/hmg/ddw365
   Ping OY, 2011, CLIN CHIM ACTA, V412, P170, DOI 10.1016/j.cca.2010.09.035
   Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
   Prada CE, 2012, PEDIATRICS, V130, pE456, DOI 10.1542/peds.2011-2927
   Ramond F, 2017, CLIN GENET, V91, P126, DOI 10.1111/cge.12780
   Rea G, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001271
   Reuschel E, 2016, INT J CARDIOL, V223, P154, DOI 10.1016/j.ijcard.2016.08.097
   Robinson AA, 2020, JAMA CARDIOL, V5, P685, DOI 10.1001/jamacardio.2020.0652
   Rowland TJ, 2016, J AM COLL CARDIOL, V68, P2237, DOI 10.1016/j.jacc.2016.08.052
   Sakai Yoshitaka, 2007, Int J Cardiol, V117, pe104, DOI 10.1016/j.ijcard.2006.11.223
   Smith JGW, 2018, STEM CELL REP, V11, P1226, DOI 10.1016/j.stemcr.2018.10.006
   Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018
   Stöllberger C, 2007, J CARD FAIL, V13, P211, DOI 10.1016/j.cardfail.2006.11.007
   Stöllberger C, 2015, HERZ, V40, P906, DOI 10.1007/s00059-015-4310-7
   Stöllberger C, 2015, ANN NONINVAS ELECTRO, V20, P79, DOI 10.1111/anec.12155
   Stöllberger C, 2013, INT J CARDIOL, V168, P2910, DOI 10.1016/j.ijcard.2013.03.111
   Stöllberger C, 2013, J STROKE CEREBROVASC, V22, P709, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.014
   Stöllberger C, 2013, INT J CARDIOL, V165, P463, DOI 10.1016/j.ijcard.2011.08.845
   Takasaki A, 2018, PEDIATR RES, V84, P733, DOI 10.1038/s41390-018-0162-1
   Thakur V, 2016, CARDIOL YOUNG, V26, P368, DOI 10.1017/S1047951115000773
   Tian T, 2015, HEART VESSELS, V30, P258, DOI 10.1007/s00380-014-0503-x
   Uribarri A, 2015, INT J CARDIOL, V197, P128, DOI 10.1016/j.ijcard.2015.04.046
   Van der Starre P, 2013, MUSCLE NERVE, V47, P135, DOI 10.1002/mus.23517
   van Waning JI, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012993
   Villa CR, 2015, NEUROMUSCULAR DISORD, V25, P165, DOI 10.1016/j.nmd.2014.09.011
   Vinardell JM, 2016, REV CARDIOVASC MED, V17, P80, DOI 10.3909/riu0817
   Wenger TL, 2017, AM J MED GENET A, V173, P414, DOI 10.1002/ajmg.a.38030
   Williams T, 2011, CLIN RES CARDIOL, V100, P1087, DOI 10.1007/s00392-011-0345-9
   Xie YY, 2017, CELL PHYSIOL BIOCHEM, V44, P828, DOI 10.1159/000485348
   Yilmaz S, 2016, BRAIN DEV-JPN, V38, P124, DOI 10.1016/j.braindev.2015.06.004
   Yokoyama R, 2018, HEART VESSELS, V33, P802, DOI 10.1007/s00380-018-1116-6
   Zhou HM, 2017, INT J CARDIOVAS IMAG, V33, P2013, DOI 10.1007/s10554-017-1209-9
NR 106
TC 17
Z9 18
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1523-3782
EI 1534-3170
J9 CURR CARDIOL REP
JI Curr. Cardiol. Rep.
PD JUL 9
PY 2020
VL 22
IS 9
AR 84
DI 10.1007/s11886-020-01339-5
PG 11
WC Cardiac & Cardiovascular Systems
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA MP1LG
UT WOS:000551972300015
PM 32648009
DA 2024-11-01
ER

PT J
AU Franzke, B
   Neubauer, O
   Wagner, KH
AF Franzke, Bernhard
   Neubauer, Oliver
   Wagner, Karl-Heinz
TI Super DNAging-New insights into DNA integrity, genome stability and
   telomeres in the oldest old
SO MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
LA English
DT Review
DE Genome stability; Centenarians; Nonagenarians; Longevity; Healthy aging;
   Maximum lifespan
ID PERIPHERAL-BLOOD LYMPHOCYTES; AGE-RELATED DISEASES; MITOCHONDRIAL-DNA;
   OXIDATIVE STRESS; SKELETAL-MUSCLE; POINT MUTATIONS; LIFE-STYLE;
   MICRONUCLEUS FREQUENCY; CHROMOSOMAL DAMAGE; PHYSICAL-EXERCISE
AB Reductions in DNA integrity, genome stability, and telomere length are strongly associated with the aging process, age-related diseases as well as the age-related loss of muscle mass. However, in people reaching an age far beyond their statistical life expectancy the prevalence of diseases, such as cancer, cardiovascular disease, diabetes or dementia, is much lower compared to "averagely" aged humans. These inverse observations in nonagenarians (90-99 years), centenarians (100-109 years) and super-centenarians (110 years and older) require a closer look into dynamics underlying DNA damage within the oldest old of our society. Available data indicate improved DNA repair and antioxidant defense mechanisms in "super old" humans, which are comparable with much younger cohorts. Partly as a result of these enhanced endogenous repair and protective mechanisms, the oldest old humans appear to cope better with risk factors for DNA damage over their lifetime compared to subjects whose lifespan coincides with the statistical life expectancy. This model is supported by study results demonstrating superior chromosomal stability, telomere dynamics and DNA integrity in "successful agers". There is also compelling evidence suggesting that life-style related factors including regular physical activity, a well-balanced diet and minimized psycho-social stress can reduce DNA damage and improve chromosomal stability. The most conclusive picture that emerges from reviewing the literature is that reaching "super old" age appears to be primarily determined by hereditary/genetic factors, while a healthy lifestyle additionally contributes to achieving the individual maximum lifespan in humans. More research is required in this rapidly growing population of super old people. In particular, there is need for more comprehensive investigations including short- and long-term lifestyle interventions as well as investigations focusing on the mechanisms causing DNA damage, mutations, and telomere shortening. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Franzke, Bernhard; Neubauer, Oliver; Wagner, Karl-Heinz] Univ Vienna, Res Platform Act Ageing, A-1090 Vienna, Austria.
   [Neubauer, Oliver] Queensland Univ Technol, Tissue Repair & Regenerat Grp, Fac Hlth, Sch Biomed Sci,IHBI, Brisbane, Qld 4059, Australia.
   [Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Fac Life Sci, A-1090 Vienna, Austria.
C3 University of Vienna; Queensland University of Technology (QUT);
   University of Vienna
RP Wagner, KH (corresponding author), Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria.
EM karl-heinz.wagner@univie.ac.at
RI ; Wagner, Karl-Heinz/B-9098-2013
OI Neubauer, Oliver/0000-0001-6835-8787; Franzke,
   Bernhard/0000-0001-6762-2777; Wagner, Karl-Heinz/0000-0002-1683-7265
FU University of Vienna; Austrian National Bank [14541]
FX The authors would like to thank all members of the Vienna Active Ageing
   Study (VAAS) group for their support. This work was supported by the
   University of Vienna by funding the Research Platform Active Ageing and
   the Anniversary Fund of the Austrian National Bank (No. 14541).
CR Ames Bruce N, 2010, J Nucleic Acids, V2010, DOI 10.4061/2010/725071
   Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223
   ARNETZ BB, 1983, PSYCHOSOM MED, V45, P395, DOI 10.1097/00006842-198310000-00003
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Battershill JM, 2008, MUTAGENESIS, V23, P423, DOI 10.1093/mutage/gen040
   Bendix L, 2011, MECH AGEING DEV, V132, P568, DOI 10.1016/j.mad.2011.10.003
   Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10
   BONASSI S, 1995, CANCER EPIDEM BIOMAR, V4, P671
   Bori Z, 2012, EXP GERONTOL, V47, P417, DOI 10.1016/j.exger.2012.03.004
   Borup MT, 2008, J THEOR BIOL, V250, P66, DOI 10.1016/j.jtbi.2007.09.016
   Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132
   Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153
   Chevanne M, 2003, BIOGERONTOLOGY, V4, P97, DOI 10.1023/A:1023399820770
   Chevanne M, 2007, REJUV RES, V10, P191, DOI 10.1089/rej.2006.0514
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Erceg P, 2007, J GENET, V86, P277, DOI 10.1007/s12041-007-0035-6
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   Fenech M, 1998, MUTAT RES-FUND MOL M, V404, P155, DOI 10.1016/S0027-5107(98)00109-2
   Fenech M, 2002, FOOD CHEM TOXICOL, V40, P1113, DOI 10.1016/S0278-6915(02)00028-5
   Fenech M, 2012, MUTAT RES-FUND MOL M, V733, P21, DOI 10.1016/j.mrfmmm.2011.11.003
   Fenech M, 2011, MUTAGENESIS, V26, P43, DOI 10.1093/mutage/geq050
   Fenech MF, 2010, AM J CLIN NUTR, V91, p1438S, DOI 10.3945/ajcn.2010.28674D
   Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224
   FRANCESCHI C, 1992, ANN NY ACAD SCI, V663, P4, DOI 10.1111/j.1749-6632.1992.tb38643.x
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franzke B., 2014, MUTAGENESIS
   Franzke B, 2015, EXP GERONTOL, V65, P16, DOI 10.1016/j.exger.2015.03.001
   Franzke B, 2015, MUTAGENESIS, V30, P147, DOI 10.1093/mutage/geu074
   Garagnani P, 2013, AGING-US, V5, P373, DOI 10.18632/aging.100562
   Gentilini D, 2013, AGE, V35, P1961, DOI 10.1007/s11357-012-9463-1
   Gianni P, 2004, EXP GERONTOL, V39, P1391, DOI 10.1016/j.exger.2004.06.002
   Gidron Y, 2006, BIOL PSYCHOL, V72, P291, DOI 10.1016/j.biopsycho.2005.11.011
   Halaschek-Wiener J, 2008, MECH AGEING DEV, V129, P638, DOI 10.1016/j.mad.2008.07.004
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Hazane F, 2006, J PHOTOCH PHOTOBIO B, V82, P214, DOI 10.1016/j.jphotobiol.2005.10.004
   He YH, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.015
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Houben JMJ, 2011, J GERONTOL A-BIOL, V66, P38, DOI 10.1093/gerona/glq164
   Humphreys V, 2007, AGE AGEING, V36, P521, DOI 10.1093/ageing/afm107
   Hyland P, 2002, EXP GERONTOL, V37, P465, DOI 10.1016/S0531-5565(01)00216-9
   Ishikawa N, 2012, AGE, V34, P795, DOI 10.1007/s11357-011-9280-y
   Joyner MJ, 2013, J APPL PHYSIOL, V114, P1, DOI 10.1152/japplphysiol.01313.2012
   Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1
   Kimura M, 2007, AM J PHYSIOL-REG I, V293, pR2210, DOI 10.1152/ajpregu.00615.2007
   King CM, 1997, MUTAT RES-FUND MOL M, V377, P137, DOI 10.1016/S0027-5107(97)00072-9
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kirkwood TBL, 1997, EXP GERONTOL, V32, P395, DOI 10.1016/S0531-5565(96)00171-4
   Klement K, 2014, EXP CELL RES, V329, P42, DOI 10.1016/j.yexcr.2014.09.003
   Koltai E, 2012, AM J PHYSIOL-REG I, V303, pR127, DOI 10.1152/ajpregu.00337.2011
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821
   Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869
   Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x
   Maugeri D, 2004, ARCH GERONTOL GERIAT, P271
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Moller P, 1996, CHEM-BIOL INTERACT, V102, P17, DOI 10.1016/0009-2797(96)03729-5
   Müezzinler A, 2013, AGEING RES REV, V12, P509, DOI 10.1016/j.arr.2013.01.003
   Müllner E, 2014, MUTAGENESIS, V29, P1, DOI 10.1093/mutage/get056
   Müllner E, 2013, MUTAGENESIS, V28, P205, DOI 10.1093/mutage/ges073
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Nakamura KI, 2007, EXP GERONTOL, V42, P944, DOI 10.1016/j.exger.2007.05.003
   Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008
   Neubauer O, 2008, EXERC IMMUNOL REV, V14, P51
   Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1
   Parise G, 2005, EXP GERONTOL, V40, P173, DOI 10.1016/j.exger.2004.09.002
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park Dong Choon, 2013, Korean J Audiol, V17, P39, DOI 10.7874/kja.2013.17.2.39
   Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Podlevsky JD, 2012, MUTAT RES-FUND MOL M, V730, P3, DOI 10.1016/j.mrfmmm.2011.11.002
   Ponsot E, 2008, MUSCLE NERVE, V37, P467, DOI 10.1002/mus.20964
   Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526
   Radák Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6
   Radak Z, 2007, J APPL PHYSIOL, V102, P1696, DOI 10.1152/japplphysiol.01051.2006
   Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498
   Radak Z, 2011, FREE RADICAL BIO MED, V51, P417, DOI 10.1016/j.freeradbiomed.2011.04.018
   Reichhold S, 2009, MUTAT RES-REV MUTAT, V682, P28, DOI 10.1016/j.mrrev.2009.02.002
   Reichhold S, 2009, FREE RADICAL RES, V43, P753, DOI 10.1080/10715760903040628
   Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Siu PM, 2011, EXP PHYSIOL, V96, P889, DOI 10.1113/expphysiol.2011.058396
   Slijepcevic P, 2008, MECH AGEING DEV, V129, P11, DOI 10.1016/j.mad.2007.10.012
   Smoliner C, 2009, BRIT J NUTR, V102, P1663, DOI 10.1017/S0007114509990900
   Starr JM, 2007, EXP GERONTOL, V42, P571, DOI 10.1016/j.exger.2006.12.002
   Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011
   Tedone E, 2014, EXP GERONTOL, V58, P90, DOI 10.1016/j.exger.2014.06.018
   Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809
   Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009
   Trappe S, 2013, J APPL PHYSIOL, V114, P3, DOI 10.1152/japplphysiol.01107.2012
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Tyson J, 2007, P NUTR SOC, V66, P42, DOI 10.1017/S0029665107005289
   Volkert D, 2011, Z GERONTOL GERIATR, V44, P91, DOI 10.1007/s00391-011-0174-5
   von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5
   W.H. Organisation N.I.o. Aging N.I.o. Health U.S.D.o.H.a.H. Services, 2011, GLOBAL HLTH AGING
   Wallner M, 2012, MUTAGENESIS, V27, P731, DOI 10.1093/mutage/ges039
   Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   WHO, 2014, WORLD HLTH STAT 2014
   Wojda A, 2007, MUTAGENESIS, V22, P195, DOI 10.1093/mutage/gem002
   Wojda A, 2006, J GERONTOL A-BIOL, V61, P763, DOI 10.1093/gerona/61.8.763
   Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006
   Zheng WM, 2006, MUTAT RES-FUND MOL M, V599, P11, DOI 10.1016/j.mrfmmm.2005.12.012
NR 118
TC 30
Z9 36
U1 0
U2 24
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1383-5742
EI 1388-2139
J9 MUTAT RES-REV MUTAT
JI Mutat. Res.-Rev. Mutat. Res.
PD OCT-DEC
PY 2015
VL 766
BP 48
EP 57
DI 10.1016/j.mrrev.2015.08.001
PG 10
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA CZ9HA
UT WOS:000367407400005
PM 26596548
DA 2024-11-01
ER

PT J
AU Saad, FA
   Saad, JF
   Siciliano, G
   Merlini, L
   Angelini, C
AF Saad, Fawzy A.
   Saad, Jasen F.
   Siciliano, Gabriele
   Merlini, Luciano
   Angelini, Corrado
TI Duchenne Muscular Dystrophy Gene Therapy
SO CURRENT GENE THERAPY
LA English
DT Review
DE Duchene muscular dystrophy; microdystrophin; pharmacophore;
   adeno-associated virus; exon skipping; CRISPR/Cas gene editing; gene
   therapy; gene drugs; genetic drugs; genomic drugs
ID POINT MUTATIONS; FULL-LENGTH; MOUSE MODEL; DMD GENE; MITOCHONDRIAL
   DYSFUNCTION; GLYCOPROTEIN COMPLEX; MISSENSE MUTATION; EXON; MUSCLE;
   EXPRESSION
AB Duchenne and Becker muscular dystrophies are allelic X-linked recessive neuromuscular diseases affecting both skeletal and cardiac muscles. Therefore, owing to their single X chromosome, the affected boys receive pathogenic gene mutations from their unknowing carrier mothers. Current pharmacological drugs are palliative that address the symptoms of the disease rather than the genetic cause imbedded in the Dystrophin gene DNA sequence. Therefore, alternative therapies like gene drugs that could address the genetic cause of the disease at its root are crucial, which include gene transfer/implantation, exon skipping, and gene editing. Presently, it is possible through genetic reprogramming to engineer AAV vectors to deliver certain therapeutic cargos specifically to muscle or other organs regardless of their serotype. Similarly, it is possible to direct the biogenesis of exosomes to carry gene editing constituents or certain therapeutic cargos to specific tissue or cell type like brain and muscle. While autologous exosomes are immunologically inert, it is possible to camouflage AAV capsids, and lipid nanoparticles to evade the immune system recognition. In this review, we highlight current opportunities for Duchenne muscular dystrophy gene therapy, which has been known thus far as an incurable genetic disease. This article is a part of Gene Therapy of Rare Genetic Diseases thematic issue.
C1 [Saad, Fawzy A.] Univ Padua, Sch Med, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.
   [Saad, Fawzy A.; Saad, Jasen F.] Saad Pharmaceut, Dept Gene Therapy, Tornimae 7-26, EE-10145 Tallinn, Estonia.
   [Siciliano, Gabriele] Pisa Univ, Sch Med, Dept Clin & Expt Med, Pisa, Italy.
   [Merlini, Luciano] Bologna Univ, Sch Med, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.
   [Angelini, Corrado] Padova Univ, Sch Med, Dept Neurosci, Padua, Italy.
C3 University of Padua; University of Pisa; University of Bologna;
   University of Padua
RP Saad, FA (corresponding author), Univ Padua, Sch Med, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.; Saad, FA (corresponding author), Saad Pharmaceut, Dept Gene Therapy, Tornimae 7-26, EE-10145 Tallinn, Estonia.
EM fa_saad@yahoo.co.uk
RI Angelini, Corrado/J-3655-2019; Saad, Fawzy A/HHC-9993-2022; Siciliano,
   Gabriele/HTP-1909-2023
OI Angelini, Corrado/0000-0002-9554-8794; Saad, Fawzy
   A./0000-0003-3170-3449
FU Italian Ministry of Foreign Affairs
FX This work is dedicated to the memories of Kamal Elkazzaz, Marina Fanin
   and Susan S. Saad. Early molecular genetics analyses of Dystrophin gene
   were done under the supervision of Gian Antonio Danieli and were
   supported by a PhD Fellowship from the Italian Ministry of Foreign
   Affairs to Fawzy Saad. Fawzy Saad is in debt to Gian Antonio Danieli for
   his mentorship, guidance, and continuous encouraging perusing a career
   in human molecular genetics.
CR Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022
   Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918
   Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549
   Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081
   Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104
   Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812
   Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291
   Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4
   Aoki Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/402369
   Baskin B, 2009, NEUROMUSCULAR DISORD, V19, P189, DOI 10.1016/j.nmd.2008.11.003
   Béroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428
   Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758
   Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182
   Buckon Cathleen, 2016, PLoS Curr, V8, DOI 10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0
   Cau M, 1998, Hum Mutat, V12, P70
   Cencic R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109213
   Chemello F, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg4910
   Chen PJ, 2021, CELL, V184, P5635, DOI 10.1016/j.cell.2021.09.018
   Chicoine LG, 2014, MOL THER, V22, P338, DOI 10.1038/mt.2013.244
   Cirak S, 2012, MOL THER, V20, P462, DOI 10.1038/mt.2011.248
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Cotten Matt, 1993, Current Opinion in Biotechnology, V4, P705, DOI 10.1016/0958-1669(93)90053-Y
   Dallas SL, 2013, ENDOCR REV, V34, P658, DOI 10.1210/er.2012-1026
   Donovan JM, 2017, J CLIN PHARMACOL, V57, P627, DOI 10.1002/jcph.842
   Duchenne, 1867, Br Med J, V2, P541
   Echigoya Y, 2018, J PERS MED, V8, DOI 10.3390/jpm8040041
   Eid A, 2018, BIOCHEM J, V475, P1955, DOI 10.1042/BCJ20170793
   ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0
   Fabb SA, 2002, HUM MOL GENET, V11, P733, DOI 10.1093/hmg/11.7.733
   Ferreiro V, 2009, MUSCLE NERVE, V39, P239, DOI 10.1002/mus.21193
   Finkel RS, 2021, NEUROMUSCULAR DISORD, V31, P385, DOI 10.1016/j.nmd.2021.02.001
   Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114
   GALVAGNI F, 1994, HUM GENET, V94, P83, DOI 10.1007/BF02272848
   Gapinske M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1482-5
   Gherardi S, 2017, BBA-GENE REGUL MECH, V1860, P1138, DOI 10.1016/j.bbagrm.2017.08.010
   Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044
   Ginjaar HB, 2000, J NEUROL, V247, P524, DOI 10.1007/s004150070151
   Guiraud S, 2017, CURR OPIN PHARMACOL, V34, P36, DOI 10.1016/j.coph.2017.04.002
   Hagan M, 2018, MED HYPOTHESES, V110, P97, DOI 10.1016/j.mehy.2017.11.009
   Hampton T, 2020, JAMA-J AM MED ASSOC, V323, P405, DOI 10.1001/jama.2019.21827
   HEALD A, 1994, NEUROLOGY, V44, P2388, DOI 10.1212/WNL.44.12.2388
   Heier Christopher R, 2019, Life Sci Alliance, V2, DOI 10.26508/lsa.201800186
   Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382
   Ikezawa M, 1999, Hum Mutat, V13, P170, DOI 10.1002/(SICI)1098-1004(1999)13:2<170::AID-HUMU12>3.0.CO;2-7
   Ilyinskii PO, 2021, MOL THER-METH CLIN D, V22, P279, DOI 10.1016/j.omtm.2021.06.015
   Incitti T, 2010, MOL THER, V18, P1675, DOI 10.1038/mt.2010.123
   Jiang JJ, 2018, FETAL PEDIATR PATHOL, V37, P1, DOI 10.1080/15513815.2017.1369201
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kemaladewi DU, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-36
   KILIMANN MW, 1992, HUM GENET, V89, P253
   KOENIG M, 1989, AM J HUM GENET, V45, P498
   KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6
   Kourakis S, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01758-9
   Lasa A, 1997, HUM MUTAT, V9, P473
   Lau Cia-Hin, 2017, F1000Res, V6, P2153, DOI 10.12688/f1000research.11243.1
   Lee K, 2017, NAT BIOMED ENG, V1, P889, DOI 10.1038/s41551-017-0137-2
   LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877
   Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013
   Li YC, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02458-0
   Long CZ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9004
   Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725
   Loperfido M, 2016, NUCLEIC ACIDS RES, V44, P744, DOI 10.1093/nar/gkv1464
   LOVE DR, 1991, J MED GENET, V28, P860, DOI 10.1136/jmg.28.12.860
   Malerba A, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.54
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3
   Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4
   Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198
   Mendell JR, 2016, CELL RES, V26, P513, DOI 10.1038/cr.2016.28
   Merlini Luciano, 2020, Acta Myol, V39, P200, DOI 10.36185/2532-1900-023
   Merlini L, 2014, NEUROMUSCULAR DISORD, V24, P546, DOI 10.1016/j.nmd.2014.03.009
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Min YL, 2019, ANNU REV MED, V70, P239, DOI 10.1146/annurev-med-081117-010451
   Mirza F, 2015, EUR J ENDOCRINOL, V173, pR131, DOI 10.1530/EJE-15-0118
   Mizobe Y, 2018, METHODS MOL BIOL, V1828, P275, DOI 10.1007/978-1-4939-8651-4_17
   Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9
   Mori-Yoshimura Madoka, 2018, J Neuromuscul Dis, V5, P193, DOI 10.3233/JND-170225
   MOSTACCIUOLO ML, 1993, NEUROEPIDEMIOLOGY, V12, P326, DOI 10.1159/000110334
   Nakamura A, 2017, J HUM GENET, V62, P459, DOI 10.1038/jhg.2016.152
   Nakamura A, 2016, J HUM GENET, V61, P663, DOI 10.1038/jhg.2016.28
   Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012
   Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143
   Novak JS, 2021, J NEUROMUSCULAR DIS, V8, pS383, DOI 10.3233/JND-210696
   Olson EN, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2004840117
   Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244
   Pellegrini C, 2013, J CELL PHYSIOL, V228, P1323, DOI 10.1002/jcp.24290
   Percesepe A, 2005, PRENATAL DIAG, V25, P1011, DOI 10.1002/pd.1238
   Pereira RC, 2002, BONE, V30, P685, DOI 10.1016/S8756-3282(02)00687-7
   PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311
   Rando TA, 2007, BBA-MOL BASIS DIS, V1772, P263, DOI 10.1016/j.bbadis.2006.07.009
   Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1
   ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331
   Rodino-Klapac LR, 2009, MUSCLE NERVE, V39, P283, DOI 10.1002/mus.21244
   Ryu SM, 2018, NAT BIOTECHNOL, V36, P536, DOI 10.1038/nbt.4148
   SAAD FA, 1993, HUM MUTAT, V2, P314, DOI 10.1002/humu.1380020413
   Saad FA, 1998, AM J MED GENET, V80, P99, DOI 10.1002/(SICI)1096-8628(19981102)80:2<99::AID-AJMG1>3.0.CO;2-L
   Saad FA, 1997, HUM MUTAT, V9, P188, DOI 10.1002/(SICI)1098-1004(1997)9:2<188::AID-HUMU15>3.3.CO;2-J
   SAAD FA, 1994, NEUROMUSCULAR DISORD, V4, P335, DOI 10.1016/0960-8966(94)90069-8
   Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345
   Saad FA, 2020, ANN NY ACAD SCI, V1462, P37, DOI 10.1111/nyas.14231
   Sakata RC, 2020, NAT BIOTECHNOL, V38, P865, DOI 10.1038/s41587-020-0509-0
   Schiavone M, 2017, PHARMACOL RES, V125, P122, DOI 10.1016/j.phrs.2017.09.001
   Schreiber A, 2018, DEV MED CHILD NEUROL, V60, P185, DOI 10.1111/dmcn.13590
   Scott JM, 2002, NEUROMUSCULAR DISORD, V12, pS23, DOI 10.1016/S0960-8966(02)00078-0
   Shah D, 2008, INDIAN PEDIATR, V45, P401
   Sitnik R, 1997, HUM MUTAT, V10, P217
   Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177
   Taglia Antonella, 2015, Acta Myol, V34, P9
   Tanihata J, 2018, BIOCHEM BIOPH RES CO, V505, P51, DOI 10.1016/j.bbrc.2018.09.039
   Tiepolo T, 2009, BRIT J PHARMACOL, V157, P1045, DOI 10.1111/j.1476-5381.2009.00316.x
   Todeschini A, 2016, NEUROMUSCULAR DISORD, V26, P662, DOI 10.1016/j.nmd.2016.08.007
   Tuffery S, 1996, EUR J HUM GENET, V4, P143
   Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976
   van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P92, DOI 10.1136/jnnp-2012-304729
   Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993
   Wang JZ, 2017, BRAIN DEV-JPN, V39, P547, DOI 10.1016/j.braindev.2017.03.024
   Wang Y, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01157-0
   Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799
   WELLS DJ, 1995, HUM MOL GENET, V4, P1245, DOI 10.1093/hmg/4.8.1245
   WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521
   Wilton-Clark H, 2022, GENES-BASEL, V13, DOI 10.3390/genes13020257
   Wissing ER, 2010, NEUROMUSCULAR DISORD, V20, P753, DOI 10.1016/j.nmd.2010.06.016
   Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192
   Yang JL, 2009, ACTA BIOCH BIOPH SIN, V41, P1053, DOI 10.1093/abbs/gmp080
   Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469
   Yazaki M, 1999, EUR NEUROL, V42, P145, DOI 10.1159/000008089
   Young Courtney S, 2017, J Neuromuscul Dis, V4, P139, DOI 10.3233/JND-170218
   Yue YP, 2003, CIRCULATION, V108, P1626, DOI 10.1161/01.CIR.0000089371.11664.27
   Zhang Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay6812
   Zhu JF, 2013, INT J MOL MED, V32, P1166, DOI 10.3892/ijmm.2013.1498
   Zimowski JG, 2021, J APPL GENET, V62, P289, DOI 10.1007/s13353-020-00605-0
   Zulian A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00324
   Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081
NR 133
TC 2
Z9 2
U1 11
U2 18
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1566-5232
EI 1875-5631
J9 CURR GENE THER
JI Curr. Gene Ther.
PY 2024
VL 24
IS 1
DI 10.2174/1566523223666221118160932
PG 9
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA HC6H6
UT WOS:001157326100004
PM 36411557
DA 2024-11-01
ER

PT J
AU Li, BM
   Iglesias-Pedraz, JM
   Chen, LY
   Yin, F
   Cadenas, E
   Reddy, S
   Comai, L
AF Li, Baomin
   Iglesias-Pedraz, Juan Manuel
   Chen, Leng-Ying
   Yin, Fei
   Cadenas, Enrique
   Reddy, Sita
   Comai, Lucio
TI Downregulation of the Werner syndrome protein induces a metabolic shift
   that compromises redox homeostasis and limits proliferation of cancer
   cells
SO AGING CELL
LA English
DT Article
DE aging; DNA methylation; molecular biology of aging; muscle; epigenetic
ID EXTRACHROMOSOMAL TELOMERIC CIRCLES; WRN; GENE; HELICASE; EXONUCLEASE;
   INSULIN; MICE; MITOCHONDRIA; STIMULATION; SENSITIVITY
AB The Werner syndrome protein (WRN) is a nuclear protein required for cell growth and proliferation. Loss-of-function mutations in the Werner syndrome gene are associated with the premature onset of age-related diseases. How loss of WRN limits cell proliferation and induces replicative senescence is poorly understood. Here, we show that WRN depletion leads to a striking metabolic shift that coordinately weakens the pathways that generate reducing equivalents for detoxification of reactive oxygen species and increases mitochondrial respiration. In cancer cells, this metabolic shift counteracts the Warburg effect, a defining characteristic of many malignant cells, resulting in altered redox balance and accumulation of oxidative DNA damage that inhibits cell proliferation and induces a senescence-like phenotype. Consistent with these findings, supplementation with antioxidant rescues at least in part cell proliferation and decreases senescence in WRN-knockdown cancer cells. These results demonstrate that WRN plays a critical role in cancer cell proliferation by contributing to the Warburg effect and preventing metabolic stress.
C1 [Li, Baomin; Iglesias-Pedraz, Juan Manuel; Chen, Leng-Ying; Comai, Lucio] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA.
   [Li, Baomin; Iglesias-Pedraz, Juan Manuel; Chen, Leng-Ying; Reddy, Sita; Comai, Lucio] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA.
   [Yin, Fei; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.
   [Cadenas, Enrique; Reddy, Sita] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.
C3 University of Southern California; University of Southern California;
   University of Southern California; University of Southern California
RP Comai, L (corresponding author), Univ So Calif, Keck Sch Med, 2250 Alcazar St,CSC 264, Los Angeles, CA 90033 USA.
EM comai@med.usc.edu
RI Comai, Lucio/L-5905-2019; Iglesias Pedraz, Juan Manuel/AAH-6075-2019;
   Yin, Fei/JEP-5468-2023; Iglesias Pedraz, Juan Manuel/U-7205-2017
OI Iglesias Pedraz, Juan Manuel/0000-0003-0070-8116; Yin,
   Fei/0000-0002-5996-2410; Comai, Lucio/0000-0003-3109-1841
FU NIH [R01AG034156]; National Center for Research Resources, National
   Institutes of Health [C06 RR014514-01, C06 RR10600-01, C06 CA62528]
FX This work was supported by grants from NIH (R01AG034156) and was
   conducted in a facility constructed with support from Research
   Facilities Improvement Program Grant Numbers C06 RR014514-01, C06
   RR10600-01, and C06 CA62528 from the National Center for Research
   Resources, National Institutes of Health.
CR Arai A, 2011, CANCER RES, V71, P4598, DOI 10.1158/0008-5472.CAN-11-0320
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619
   Dickinson BC, 2008, J AM CHEM SOC, V130, P9638, DOI 10.1021/ja802355u
   Dickinson BC, 2011, NAT CHEM BIOL, V7, P106, DOI 10.1038/NCHEMBIO.497
   Düvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999
   FUKUCHI K, 1989, P NATL ACAD SCI USA, V86, P5893, DOI 10.1073/pnas.86.15.5893
   Futami K, 2008, CANCER SCI, V99, P843, DOI 10.1111/j.1349-7006.2008.00778.x
   Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Kirito K, 2009, CELL CYCLE, V8, P2844, DOI 10.4161/cc.8.17.9544
   Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002
   Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001
   Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07
   Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308
   Li BM, 2009, AGING-US, V1, P289, DOI 10.18632/aging.100032
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Machwe A, 2004, ONCOGENE, V23, P149, DOI 10.1038/sj.onc.1206906
   Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3
   Massip L, 2006, EXP GERONTOL, V41, P157, DOI 10.1016/j.exger.2005.10.011
   Moore G, 2008, MECH AGEING DEV, V129, P201, DOI 10.1016/j.mad.2007.12.009
   Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508
   Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009
   Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023
   Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200
   Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200
   Pagano G, 2005, FREE RADICAL RES, V39, P529, DOI 10.1080/10715760500092683
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0
   Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011
   SALK D, 1985, ADV EXP MED BIOL, V190, P541
   Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490
   Slupianek A, 2011, CANCER RES, V71, P842, DOI 10.1158/0008-5472.CAN-10-1066
   Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337
   Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083
   Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803
   Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774
   Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951
   Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258
NR 45
TC 25
Z9 26
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD APR
PY 2014
VL 13
IS 2
BP 367
EP 378
DI 10.1111/acel.12181
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AC4VG
UT WOS:000332518600019
PM 24757718
OA Green Published, Green Accepted
DA 2024-11-01
ER

PT J
AU Yorns, WR
   Hardison, HH
AF Yorns, William R., Jr.
   Hardison, H. Huntley
TI Mitochondrial Dysfunction in Migraine
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID MAGNETIC-RESONANCE-SPECTROSCOPY; BRAIN ENERGY-METABOLISM; THIOCTIC ACID;
   ASTROCYTES; HEADACHE; COENZYME-Q10; RIBOFLAVIN; TOPIRAMATE; DEFICIENCY;
   MECHANISM
AB Migraine is the most frequent type of headache in children. In the 1980s, scientists first hypothesized a connection between migraine and mitochondrial (mt) disorders. More recent studies have suggested that at least some subtypes of migraine may be related to a mt defect. Different types of evidence support a relationship between mitochondria (mt) and migraine: (1) Biochemical evidence: Abnormal mt function translates into high intracellular penetration of Ca2+, excessive production of free radicals, and deficient oxidative phosphorylation, which ultimately causes energy failure in neurons and astrocytes, thus triggering migraine mechanisms, including spreading depression. The mt markers of these events are low activity of superoxide dismutase, activation of cytochrome-c oxidase and nitric oxide, high levels of lactate and pyruvate, and low ratios of phosphocreatine-inorganic phosphate and N-acetylaspartate-choline. (2) Morphologic evidence: mt abnormalities have been shown in migraine sufferers, the most characteristic ones being direct observation in muscle biopsy of ragged red and cytochrome-c oxidase-negative fibers, accumulation of subsarcolemmal mt, and demonstration of giant mt with paracrystalline inclusions. (3) Genetic evidence: Recent studies have identified specific mutations responsible for migraine susceptibility. However, the investigation of the mtDNA mutations found in classic mt disorders (mt encephalomyopathy with lactic acidosis and stroke-like episodes, myoclonus epilepsy with ragged red fibers, Kearns-Sayre syndrome, and Leber hereditary optic neuropathy) has not demonstrated any association. Recently, 2 common mtDNA polymorphisms (16519C -> T and 3010G -> A) have been associated with pediatric cyclic vomiting syndrome and migraine. Also, POLG mutations (eg, p.T851 A, p.N468D, p.Y831C, p.G517V, and p.P163S) can cause disease through impaired replication of mtDNA, including migraine. Further studies to investigate the relationship between mtDNA and migraine will require very large sample sizes to obtain statistically significant results. (4) Therapeutic evidence: Several agents that have a positive effect on mt metabolism have shown to be effective in the treatment of migraines. The agents include riboflavin (B2), coenzyme 910, magnesium, niacin, carnitine, topiramate, and lipoic acid. Further study is warranted to learn how mt interact with other factors to cause migraines. This will facilitate the development of new and more specific treatments that will reduce the frequency or severity or both of this disease. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Yorns, William R., Jr.; Hardison, H. Huntley] St Christophers Hosp Children, Neurol Sect, Philadelphia, PA 19134 USA.
   [Yorns, William R., Jr.; Hardison, H. Huntley] Drexel Univ, Coll Med, Dept Pediat, Philadelphia, PA 19104 USA.
   [Yorns, William R., Jr.; Hardison, H. Huntley] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.
C3 Drexel University; Drexel University
RP Hardison, HH (corresponding author), St Christophers Hosp Children, Neurol Sect, 3601 A St, Philadelphia, PA 19134 USA.
EM hhardiso@drexelmed.edu
FU St. Christopher's Foundation (St. Christopher's Hospital for Children);
   PHEC (Philadelphia Health Education Corporation; DUCOM (Drexel
   University College of Medicine), Philadelphia, Pennsylvania
FX This work was in part supported by grants from the St. Christopher's
   Foundation (St. Christopher's Hospital for Children), PHEC (Philadelphia
   Health Education Corporation, and DUCOM (Drexel University College of
   Medicine), Philadelphia, Pennsylvania.
CR Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676
   ARTS WFM, 1983, LANCET, V2, P581
   Balbi T, 2005, J FORENSIC SCI, V50, P630
   BARBIROLI B, 1993, J CEREBR BLOOD F MET, V13, P469, DOI 10.1038/jcbfm.1993.61
   BARBIROLI B, 1995, J NEUROL, V242, P472, DOI 10.1007/BF00873552
   Boehnke C, 2004, EUR J NEUROL, V11, P475, DOI 10.1111/j.1468-1331.2004.00813.x
   BRESOLIN N, 1991, J NEUROL SCI, V104, P182, DOI 10.1016/0022-510X(91)90308-T
   Chan A, 1998, J NEUROL, V245, P681, DOI 10.1007/s004150050267
   Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C
   Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321
   CODERRE TJ, 1992, J NEUROSCI, V12, P3671
   Crane FL, 1997, MOL ASPECTS MED, V18, pS1
   Cruz M, 2009, CLIN PEDIAT NEUROSCI, P303
   Cruz MJ, 2009, PEDIATR NEUROL, V41, P167, DOI 10.1016/j.pediatrneurol.2009.04.020
   Cutrer FM, 2013, HEADACHE, V53, P401, DOI 10.1111/head.12024
   D'Andrea G, 2006, CEPHALALGIA, V26, P968, DOI 10.1111/j.1468-2982.2006.01141.x
   de Tommaso M, 2012, J HEADACHE PAIN, V13, P389, DOI 10.1007/s10194-012-0448-3
   DEVOTO M, 1986, CEPHALALGIA, V6, P101, DOI 10.1046/j.1468-2982.1986.0602101.x
   Di Lorenzo C, 2009, NEUROLOGY, V72, P1588, DOI 10.1212/WNL.0b013e3181a41269
   Finsterer J, 2006, ACTA NEUROL SCAND, V114, P217, DOI 10.1111/j.1600-0404.2006.00671.x
   Goadsby P.J., 2008, Wolff's headache and other head pain, V8th, P105
   Gu T, 2008, NEUROL RES, V30, P229, DOI 10.1179/016164107X235473
   HAUGAARD N, 1970, BIOCHIM BIOPHYS ACTA, V222, P583, DOI 10.1016/0304-4165(70)90183-2
   Kabbouche MA, 2003, HEADACHE, V43, P490, DOI 10.1046/j.1526-4610.2003.03095.x
   Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008
   Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x
   LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409
   Lemos C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050626
   Lian XY, 2004, EUR J NEUROSCI, V19, P2446, DOI 10.1111/j.0953-816X.2004.03289.x
   LITTLEWOOD J, 1984, J NEUROL NEUROSUR PS, V47, P338, DOI 10.1136/jnnp.47.4.338
   Lodi R, 2001, BRAIN RES BULL, V54, P437, DOI 10.1016/S0361-9230(01)00440-3
   MAESAKA H, 1976, EUR J PEDIATR, V122, P159, DOI 10.1007/BF00466274
   Magis D, 2007, HEADACHE, V47, P52, DOI 10.1111/j.1526-4610.2006.00626.x
   Majamaa K, 1998, LANCET, V352, P455, DOI 10.1016/S0140-6736(05)79190-X
   Majamaa K, 1996, LIFE SCI, V58, P691, DOI 10.1016/0024-3205(95)02338-0
   Markley HG, 2012, HEADACHE, V52, P81, DOI 10.1111/j.1526-4610.2012.02233.x
   Marriage B, 2003, J AM DIET ASSOC, V103, P1029, DOI 10.1016/S0002-8223(03)00476-0
   Mauskop A, 2012, J NEURAL TRANSM, V119, P575, DOI 10.1007/s00702-012-0790-2
   Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006
   MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x
   MONTAGNA P, 1994, CEPHALALGIA, V14, P184, DOI 10.1046/j.1468-2982.1994.014003184.x
   Montagna P, 1997, NEUROLOGY, V48, P113, DOI 10.1212/WNL.48.1.113
   Okada H, 1998, HEADACHE, V38, P39, DOI 10.1046/j.1526-4610.1998.3801039.x
   Prousky J, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-3
   Rosen N, 2008, HEADACHE, V48, P733, DOI 10.1111/j.1526-4610.2008.01118.x
   Rozen TD, 2002, CEPHALALGIA, V22, P137, DOI 10.1046/j.1468-2982.2002.00335.x
   SANGIORGI S, 1994, CEPHALALGIA, V14, P21, DOI 10.1046/j.1468-2982.1994.1401021.x
   Sarchielli P, 2005, NEUROIMAGE, V24, P1025, DOI 10.1016/j.neuroimage.2004.11.005
   Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217
   Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
   Seibel P, 1996, J NEUROL, V243, P305, DOI 10.1007/BF00868402
   Shanker G, 2001, BRAIN RES, V902, P156, DOI 10.1016/S0006-8993(01)02342-3
   SHIMOMURA T, 1994, CEPHALALGIA, V14, P215, DOI 10.1046/j.1468-2982.1994.014003215.x
   SHIMOMURA T, 1994, LANCET, V344, P625, DOI 10.1016/S0140-6736(94)92015-X
   Silberstein S., 2013, Headache
   Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x
   Stuart S, 2012, MOL GENET GENOMICS, V287, P837, DOI 10.1007/s00438-012-0723-7
   TORRES J, 1995, BIOCHEM J, V312, P169, DOI 10.1042/bj3120169
   UNCINI A, 1995, J NEUROL SCI, V129, P214, DOI 10.1016/0022-510X(94)00283-T
   Wanic-Kossowska M, 1997, Pol Arch Med Wewn, V97, P534
   Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x
   WELCH KMA, 1995, J NEUROL SCI, V134, P9, DOI 10.1016/0022-510X(95)00196-1
   WELCH KMA, 1989, NEUROLOGY, V39, P538, DOI 10.1212/WNL.39.4.538
   Woodbridge P, 2013, INTERN MED J, V43, P150, DOI 10.1111/j.1445-5994.2012.02847.x
   Zaki E A, 2009, Cephalalgia, V29, P719, DOI 10.1111/j.1468-2982.2008.01793.x
NR 65
TC 87
Z9 89
U1 0
U2 29
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD SEP
PY 2013
VL 20
IS 3
BP 188
EP 193
DI 10.1016/j.spen.2013.09.002
PG 6
WC Clinical Neurology; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pediatrics
GA 269SK
UT WOS:000328262000004
PM 24331360
DA 2024-11-01
ER

PT J
AU Chaudhary, KR
   El-Sikhry, H
   Seubert, JM
AF Chaudhary, Ketul R.
   El-Sikhry, Haitham
   Seubert, John M.
TI Mitochondria and the aging heart
SO JOURNAL OF GERIATRIC CARDIOLOGY
LA English
DT Review
DE aging; heart; mitochondria; heart diseases; reactive oxygen species
ID PRESERVED EJECTION FRACTION; DIASTOLIC DYSFUNCTION; RATE-VARIABILITY;
   SKELETAL-MUSCLE; LIFE-SPAN; MYOCARDIAL INJURY; OXIDATIVE DAMAGE; DNA
   MUTATIONS; NUCLEAR-DNA; AGE
AB The average human life span has markedly increased in modern society largely attributed to advances in medical and therapeutic sciences that have successfully reduced important health risks. However, advanced age results in numerous alterations to cellular and subcellular components that can impact the overall health and function of an individual. Not surprisingly, advanced age is a major risk factor for the development of heart disease in which elderly populations observe increased morbidity and mortality. Even healthy individuals that appear to have normal heart function under resting conditions, actually have an increased susceptibility and vulnerability to stress. This is confounded by the impact that stress and disease can have over time to both the heart and vessels. Although, there is a rapidly growing body of literature investigating the effects of aging on the heart and how age-related alterations affect cardiac function, the biology of aging and underlying mechanisms remain unclear. In this review, we summarize effects of aging on the heart and discuss potential theories of cellular aging with special emphasis on mitochondrial dysfunction.
C1 [Chaudhary, Ketul R.; El-Sikhry, Haitham; Seubert, John M.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
C3 University of Alberta
RP Seubert, JM (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.
EM jseubert@pharmacy.ualberta.ca
RI Chaudhary, Ketul/ADN-2401-2022
OI Chaudhary, Ketul R./0000-0003-1725-7438
FU Alberta Innovates Health Solutions; Heart and Stroke Foundation of
   Canada; Alberta Heritage Foundation for Medical Research (AHFMR)
FX Chaudhary KR is recipient of a doctoral research award from the Heart
   and Stroke Foundation of Canada and a Studentship Award from Alberta
   Innovates Health Solutions. El-Sikhry H is the recipient of a
   studentship award from Alberta Innovates Health Solutions. Seubert JM is
   the recipient of a new investigator award from the Heart and Stroke
   Foundation of Canada, a health scholar award from the Alberta Heritage
   Foundation for Medical Research (AHFMR). This work was supported by an
   operating grant from Heart and Stroke Foundation of Canada (JMS).
CR Abete P, 1999, J MOL CELL CARDIOL, V31, P227, DOI 10.1006/jmcc.1998.0862
   Ahmed A, 2011, MED CLIN N AM, V95, P439, DOI 10.1016/j.mcna.2011.02.001
   Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015
   Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010
   Brady NR, 2006, ANTIOXID REDOX SIGN, V8, P1651, DOI 10.1089/ars.2006.8.1651
   Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004
   Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011
   Burlew Brad S., 2000, Cardiology Clinics, V18, P435, DOI 10.1016/S0733-8651(05)70154-5
   Carter JB, 2003, MED SCI SPORT EXER, V35, P1333, DOI 10.1249/01.MSS.0000079046.01763.8F
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181
   Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938
   Cuervo AM, 1998, FRONT BIOSCI, V3, pd25
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   DEMEERSMAN RE, 1993, AM HEART J, V125, P726, DOI 10.1016/0002-8703(93)90164-5
   Desler C, 2011, J AGING RES
   Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002
   Desler C, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701518
   Di Lisa F, 2005, CARDIOVASC RES, V66, P222, DOI 10.1016/j.cardiores.2005.02.009
   Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x
   Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7
   FLEG JL, 1995, J APPL PHYSIOL, V78, P890, DOI 10.1152/jappl.1995.78.3.890
   FRENZEL H, 1984, MECH AGEING DEV, V27, P29, DOI 10.1016/0047-6374(84)90080-0
   Gottlieb RA, 2011, BBA-MOL CELL RES, V1813, P1295, DOI 10.1016/j.bbamcr.2010.11.017
   Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010
   Grivennikova VG, 2010, BBA-BIOENERGETICS, V1797, P939, DOI 10.1016/j.bbabio.2010.02.013
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hees PS, 2002, AM J CARDIOL, V90, P1231, DOI 10.1016/S0002-9149(02)02840-0
   Hom J, 2009, J MOL CELL CARDIOL, V46, P811, DOI 10.1016/j.yjmcc.2009.02.023
   Jansen-Duerr Pidder, 2002, EMBO Reports, V3, P1127, DOI 10.1093/embo-reports/kvf247
   Jovanovic S, 2004, AGEING RES REV, V3, P199, DOI 10.1016/j.arr.2003.10.001
   Jugdutt BI, 2010, HEART FAIL REV, V15, P401, DOI 10.1007/s10741-010-9164-8
   Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024
   Khusnutdinova E, 2008, ANN NY ACAD SCI, V1147, P1, DOI 10.1196/annals.1427.001
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055
   Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LESNEFSKY EJ, 1994, J LAB CLIN MED, V124, P843
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LINZBACH AJ, 1973, KLIN WOCHENSCHR, V51, P156, DOI 10.1007/BF01468338
   LIU M, 2011, AGE DORDR IN PRESS
   MARGULIS I, 1970, J THEOR BIOL, V26, P337, DOI 10.1016/S0022-5193(70)80023-6
   Margulis L, 1975, Symp Soc Exp Biol, P21
   Mariani J, 2000, J THORAC CARDIOV SUR, V120, P660, DOI 10.1067/mtc.2000.106528
   MELISSARI M, 1991, Giornale Italiano di Cardiologia, V21, P119
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   MING Z, 2011, J APPL PHYS IN PRESS
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MISARE BD, 1992, J THORAC CARDIOV SUR, V103, P60
   Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   Onose Y, 1999, J AM SOC ECHOCARDIOG, V12, P921, DOI 10.1016/S0894-7317(99)70144-6
   Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007
   Ranki HJ, 2002, MECH AGEING DEV, V123, P695, DOI 10.1016/S0047-6374(01)00415-8
   Raveaud S, 2009, BIOGERONTOLOGY, V10, P537, DOI 10.1007/s10522-008-9196-9
   Reddy AK, 2007, J GERONTOL A-BIOL, V62, P1319, DOI 10.1093/gerona/62.12.1319
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Romanowicz M, 2011, ALCOHOL CLIN EXP RES, V35, P1092, DOI 10.1111/j.1530-0277.2011.01442.x
   Rosenfeldt FL, 1999, BIOFACTORS, V9, P291, DOI 10.1002/biof.5520090226
   SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3
   Sanders David, 2009, Anesthesiol Clin, V27, P497, DOI 10.1016/j.anclin.2009.07.008
   Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHANNON RP, 1991, AM J CARDIOL, V67, P1110, DOI 10.1016/0002-9149(91)90874-K
   Shibata S, 2011, J APPL PHYSIOL, V110, P964, DOI 10.1152/japplphysiol.00826.2010
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Slotwiner DJ, 1998, AM J CARDIOL, V82, P621, DOI 10.1016/S0002-9149(98)00390-7
   Starnes JW, 1997, AGING-CLIN EXP RES, V9, P268, DOI 10.1007/BF03341829
   Statistics Canada, 2007, MORT SUMM LIST CAUS
   Sun JT, 2002, GENETICS, V161, P661
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Ussher JR, 2008, CARDIOVASC RES, V79, P259, DOI 10.1093/cvr/cvn130
   Vendelbo MH, 2011, BBA-MOL CELL RES, V1813, P634, DOI 10.1016/j.bbamcr.2011.01.029
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Wierzbowska-Drabik K, 2008, ECHOCARDIOGR-J CARD, V25, P149, DOI 10.1111/j.1540-8175.2007.00569.x
   Wood P, 2011, CAN J CARDIOL, V27, P302, DOI 10.1016/j.cjca.2011.02.008
   XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yang XP, 2006, FASEB J, V20, P1024, DOI 10.1096/fj.05-5288fje
   Yang XP, 2005, ENDOCRINE, V26, P127, DOI 10.1385/ENDO:26:2:127
   Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289
NR 105
TC 46
Z9 53
U1 1
U2 25
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1671-5411
J9 J GERIATR CARDIOL
JI J. Geriatr. Cardiol.
PY 2011
VL 8
IS 3
BP 159
EP 167
DI 10.3724/SP.J.1263.2011.00159
PG 9
WC Cardiac & Cardiovascular Systems; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Geriatrics & Gerontology
GA 838WV
UT WOS:000296325400005
PM 22783302
OA Green Published, hybrid, Green Submitted
DA 2024-11-01
ER

PT J
AU Xu, XL
   Wang, B
   Ren, CH
   Hu, JN
   Greenberg, DA
   Chen, TX
   Xie, LP
   Jin, KL
AF Xu, Xianglai
   Wang, Brian
   Ren, Changhong
   Hu, Jiangnan
   Greenberg, David A.
   Chen, Tianxiang
   Xie, Liping
   Jin, Kunlin
TI Recent Progress in Vascular Aging: Mechanisms and Its Role in
   Age-related Diseases
SO AGING AND DISEASE
LA English
DT Review
DE vascular aging; stroke; dementia; arterial stiffness; endothelial
   dysfunction
ID SMALL VESSEL DISEASE; CEREBRAL-BLOOD-FLOW; MONOCYTE CHEMOATTRACTANT
   PROTEIN-1; SMOOTH-MUSCLE-CELLS; PULSE-WAVE VELOCITY; MITOCHONDRIAL-DNA
   DELETIONS; TESTOSTERONE REPLACEMENT THERAPY; MILD COGNITIVE IMPAIRMENT;
   RENIN-ANGIOTENSIN SYSTEM; TRANSGENIC MOUSE MODEL
AB As with many age-related diseases including vascular dysfunction, age is considered an independent and crucial risk factor. Complicated alterations of structure and function in the vasculature are linked with aging hence, understanding the underlying mechanisms of age-induced vascular pathophysiological changes holds possibilities for developing clinical diagnostic methods and new therapeutic strategies. Here, we discuss the underlying molecular mediators that could be involved in vascular aging, e.g., the renin-angiotensin system and pro-inflammatory factors, metalloproteinases, calpain-1, monocyte chemoattractant protein-1 (MCP-1) and TGF beta-1 as well as the potential roles of testosterone and estrogen. We then relate all of these to clinical manifestations such as vascular dementia and stroke in addition to reviewing the existing clinical measurements and potential interventions for age-related vascular dysfunction.
C1 [Xu, Xianglai] Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China.
   [Xu, Xianglai; Wang, Brian; Ren, Changhong; Hu, Jiangnan; Jin, Kunlin] Univ North Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.
   [Xie, Liping] Zhejiang Univ, Affiliated Hosp 1, Dept Urol, Hangzhou, Zhejiang, Peoples R China.
   [Ren, Changhong] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing, Peoples R China.
   [Greenberg, David A.] Buck Inst Res Aging, Novato, CA 94945 USA.
   [Chen, Tianxiang] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China.
C3 Fudan University; University of North Texas System; University of North
   Texas Denton; Zhejiang University; Capital Medical University; Buck
   Institute for Research on Aging; Shanghai Jiao Tong University
RP Xu, XL (corresponding author), Fudan Univ, Zhongshan Hosp, Shanghai 200032, Peoples R China.; Xie, LP (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.; Jin, KL (corresponding author), Univ North Texas, Hlth Sci Ctr, Ft Worth, TX 76107 USA.
EM xuxianglai@163.com; xielp@zjuem.zju.edu.cn; Kunlin.Jin@unthsc.edu
RI Wang, Brian/HGA-9535-2022; Chen, Tianxiang/X-7945-2019; Hu,
   John/AAL-6376-2021
FU China Scholarship Council [201406320118]; American Heart Association
   Predoctoral Fellowship [15PRE25700416]; Sigma Xi [G201503151162287];
   National Natural Science Foundation of China [81301996]; Ph. D. Programs
   Foundation of Ministry of Education of China [20130101120017]; National
   Institutes of Health grant [NS084148-01A1]; National Science Foundation
   of Beijing [7161014]; American Heart Association (AHA) [15PRE25700416]
   Funding Source: American Heart Association (AHA)
FX This work was supported by the China Scholarship Council (No.
   201406320118) (to XX), American Heart Association Predoctoral Fellowship
   (15PRE25700416) (to BW), Sigma Xi Grants-in-Aid of Research
   (G201503151162287) (to BW), National Natural Science Foundation of China
   (81301996) (to TC), Ph. D. Programs Foundation of Ministry of Education
   of China (20130101120017) (to TC). National Institutes of Health grant
   NS084148-01A1 (to KJ), the National Science Foundation of Beijing (No.
   7161014) (to KJ).
CR Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080
   Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642
   Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291/hypres.30.1029
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   [Anonymous], COCHRANE DATABASE SY
   [Anonymous], J CLIN NEUROSCI
   Aziz M, 2015, INT J MOL MED, V36, P18, DOI 10.3892/ijmm.2015.2196
   Banoei MM, 2007, CELL MOL NEUROBIOL, V27, P867, DOI 10.1007/s10571-007-9206-5
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   Basso N, 2007, AM J PHYSIOL-HEART C, V293, pH1351, DOI 10.1152/ajpheart.00393.2007
   Beckman JS, 2001, CIRC RES, V89, P295, DOI 10.1161/res.89.4.295
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Bhasin S, 2001, J ANDROL, V22, P718
   Blum Arnon, 2012, J Vasc Interv Neurol, V5, P33
   Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Brisset M, 2013, NEUROLOGY, V80, P662, DOI 10.1212/WNL.0b013e318281ccc2
   Brissette MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036368
   Bullitt E, 2009, AM J NEURORADIOL, V30, P1857, DOI 10.3174/ajnr.A1695
   Çalik AN, 2014, CLIN INTERV AGING, V9, DOI 10.2147/CIA.S63337
   Calvet D, 2014, INT J STROKE, V9, P291, DOI 10.1111/ijs.12015
   Chang-Quan H, 2011, INT J CLIN PRACT, V65, P1295, DOI 10.1111/j.1742-1241.2011.02810.x
   Chen PL, 2006, NEUROLOGY, V67, P1056, DOI 10.1212/01.wnl.0000237526.32692.67
   Chen XL, 1998, CIRC RES, V83, P952
   Cheyuo C, 2012, NEUROPHARMACOLOGY, V62, P890, DOI 10.1016/j.neuropharm.2011.09.018
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   Deplanque D, 2013, INT J STROKE, V8, P413, DOI 10.1111/j.1747-4949.2011.00755.x
   Ding J, 2015, ARTERIOSCL THROM VAS, V35, P1889, DOI 10.1161/ATVBAHA.115.305451
   Dockery F, 2003, J AM GERIATR SOC, V51, P1627, DOI 10.1046/j.1532-5415.2003.51515.x
   Dupuis F, 2005, BRIT J PHARMACOL, V144, P349, DOI 10.1038/sj.bjp.0706001
   English KM, 2000, CLIN SCI, V99, P77, DOI 10.1042/CS19990345
   Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008
   Estato V, 2013, MICROVASC RES, V87, P41, DOI 10.1016/j.mvr.2013.02.007
   Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Fernando MS, 2006, STROKE, V37, P1391, DOI 10.1161/01.STR.0000221308.94473.14
   Fleegal-DeMotta MA, 2009, J CEREBR BLOOD F MET, V29, P640, DOI 10.1038/jcbfm.2008.158
   Fleenor BS, 2010, J PHYSIOL-LONDON, V588, P3971, DOI 10.1113/jphysiol.2010.194753
   Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005
   Fortuño A, 2005, EXP PHYSIOL, V90, P457, DOI 10.1113/expphysiol.2005.030098
   Fournier A, 2009, EXPERT REV NEUROTHER, V9, P1413, DOI [10.1586/ern.09.89, 10.1586/ERN.09.89]
   Franklin SS, 1997, CIRCULATION, V96, P308
   Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936
   Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088
   Fuh JL, 2006, MATURITAS, V53, P447, DOI 10.1016/j.maturitas.2005.07.009
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251
   Gasecki D, 2012, STROKE, V43, P543, DOI 10.1161/STROKEAHA.111.633487
   Gleason CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001833
   Goglia L, 2010, MOL HUM REPROD, V16, P761, DOI 10.1093/molehr/gaq049
   Greendale GA, 2009, NEUROLOGY, V72, P1850, DOI 10.1212/WNL.0b013e3181a71193
   Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08
   Hajjar I, 2013, CURR OPIN CARDIOL, V28, P417, DOI 10.1097/HCO.0b013e3283620745
   Hanon O, 2005, STROKE, V36, P2193, DOI 10.1161/01.STR.0000181771.82518.1c
   Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342
   Hashimoto J, 2008, AM J HYPERTENS, V21, P1304, DOI 10.1038/ajh.2008.291
   Hassan A, 2004, STROKE, V35, P654, DOI 10.1161/01.STR.0000117238.75736.53
   Hassan A, 2003, BRAIN, V126, P424, DOI 10.1093/brain/awg040
   Hatanaka R, 2011, CEREBROVASC DIS, V31, P329, DOI 10.1159/000322599
   Henderson VW, 2007, MENOPAUSE, V14, P572, DOI 10.1097/gme.0b013e31803df49c
   Henderson VW, 2003, NEUROLOGY, V60, P1369, DOI 10.1212/01.WNL.0000059413.75888.BE
   Hisamoto K, 2001, J BIOL CHEM, V276, P3459, DOI 10.1074/jbc.M005036200
   Hodis HN, 2016, NEW ENGL J MED, V374, P1221, DOI 10.1056/NEJMoa1505241
   Huang G, 2016, LANCET DIABETES ENDO, V4, P657, DOI 10.1016/S2213-8587(16)30102-4
   Hughes TM, 2014, JAMA NEUROL, V71, P562, DOI 10.1001/jamaneurol.2014.186
   Hughes TM, 2013, NEUROLOGY, V81, P1711, DOI 10.1212/01.wnl.0000435301.64776.37
   Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008
   Ito T, 2002, STROKE, V33, P2297, DOI 10.1161/01.STR.0000027274.03779.F3
   Jacob MP, 2003, BIOMED PHARMACOTHER, V57, P195, DOI 10.1016/S0753-3322(03)00065-9
   Jamadar RJ, 2012, ASIAN J ANDROL, V14, P232, DOI 10.1038/aja.2011.107
   JAMES MA, 1995, HYPERTENSION, V26, P301, DOI 10.1161/01.HYP.26.2.301
   Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017
   Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840
   Jochemsen HM, 2015, NEUROLOGY, V84, P448, DOI 10.1212/WNL.0000000000001201
   Jones RD, 2003, BRIT J PHARMACOL, V138, P733, DOI 10.1038/sj.bjp.0705141
   Kalaria RN, 2002, CEREBROVASC DIS, V13, P48, DOI 10.1159/000049150
   Kang SM, 2002, AM J CARDIOL, V89, P862, DOI 10.1016/S0002-9149(02)02202-6
   Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582
   Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549
   Kim AS, 2013, STROKE, V44, pS123, DOI 10.1161/STROKEAHA.111.000067
   Kim Y, 2013, PHYS CHEM CHEM PHYS, V15, P18353, DOI 10.1039/c3cp52614c
   Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672
   Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024
   Kuo HK, 2010, INT J CARDIOL, V143, P184, DOI 10.1016/j.ijcard.2009.02.005
   Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2
   Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381
   Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701
   Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129
   Laurent S, 2003, STROKE, V34, P1203, DOI 10.1161/01.STR.0000065428.03209.64
   Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254
   Lee J, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.42
   Li BY, 2011, APOPTOSIS, V16, P732, DOI 10.1007/s10495-011-0602-4
   Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116
   Liu H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.027
   Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0
   Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053
   Lv WS, 2016, MOL NEUROBIOL, V53, P2679, DOI 10.1007/s12035-015-9315-y
   Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400
   Mahmud A, 2004, J RENIN-ANGIO-ALDO S, V5, P102, DOI 10.3317/jraas.2004.025
   Marchesi VT, 2011, FASEB J, V25, P5, DOI 10.1096/fj.11-0102ufm
   Marijic J, 2001, CIRC RES, V88, P210
   Marrero MB, 1997, J BIOL CHEM, V272, P24684, DOI 10.1074/jbc.272.39.24684
   Marshall RS, 2012, J ALZHEIMERS DIS, V32, P633, DOI 10.3233/JAD-2012-120949
   Mathur A, 2009, EUR J ENDOCRINOL, V161, P443, DOI 10.1530/EJE-09-0092
   Matsumoto M, 2007, HYPERTENS RES, V30, P767, DOI 10.1291/hypres.30.767
   Matsuo T, 2005, HEART VESSELS, V20, P8, DOI 10.1007/s00380-004-0793-5
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   McCarrey AC, 2015, HORM BEHAV, V74, P167, DOI 10.1016/j.yhbeh.2015.04.018
   McNulty M, 2005, AM J HYPERTENS, V18, P504, DOI 10.1016/j.amjhyper.2004.11.011
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   Miller VM, 2007, TRENDS PHARMACOL SCI, V28, P263, DOI 10.1016/j.tips.2007.04.004
   Mitchell ES, 2011, CLIMACTERIC, V14, P252, DOI 10.3109/13697137.2010.516848
   Mitchell GF, 2011, BRAIN, V134, P3398, DOI 10.1093/brain/awr253
   Modrick ML, 2009, AM J PHYSIOL-HEART C, V296, pH1914, DOI 10.1152/ajpheart.00300.2009
   Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1
   Nakajima T, 1995, EUR J PHARMACOL, V294, P625, DOI 10.1016/0014-2999(95)00602-8
   Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369
   Nation DA, 2015, JAMA NEUROL, V72, P546, DOI 10.1001/jamaneurol.2014.4477
   Nation DA, 2013, NEUROLOGY, V81, P2024, DOI 10.1212/01.wnl.0000436935.47657.78
   Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008
   Neutzner M, 2007, CANCER RES, V67, P6777, DOI 10.1158/0008-5472.CAN-07-0165
   Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299
   Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478
   Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417
   Novella S, 2012, FRONT PHYSIOL, V3, DOI [10.3389/fphys.2012.00165, 10.3389/fphys.2012.00325]
   Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60
   Ochi N, 2009, HYPERTENS RES, V32, P255, DOI 10.1038/hr.2009.13
   Okamoto Y, 2012, ACTA NEUROPATHOL, V123, P381, DOI 10.1007/s00401-011-0925-9
   Osawa A, 2004, DISABIL REHABIL, V26, P739, DOI 10.1080/09638280410001704331
   Pak JW, 2005, EXP GERONTOL, V40, P209, DOI 10.1016/j.exger.2004.12.005
   Paris D, 2003, NEUROL RES, V25, P642, DOI 10.1179/016164103101201940
   Pase MP, 2014, PHYSIOL BEHAV, V130, P23, DOI 10.1016/j.physbeh.2014.03.015
   Perret-Guillaume C, 2009, J HYPERTENS, V27, pS3, DOI 10.1097/01.hjh.0000354511.14086.f1
   Poels MMF, 2012, STROKE, V43, P2637, DOI 10.1161/STROKEAHA.111.642264
   Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004
   Popp O, 2003, BIOL CHEM, V384, P951, DOI 10.1515/BC.2003.107
   Price JM, 2001, NEUROL RES, V23, P506, DOI 10.1179/016164101101198758
   Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4
   Rabkin SW, 2011, BLOOD PRESSURE, V20, P274, DOI 10.3109/08037051.2011.566246
   Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623
   Rajagopalan S, 2002, AM J CARDIOL, V89, P562, DOI 10.1016/S0002-9149(01)02297-4
   Rajagopalan S, 1996, J CLIN INVEST, V98, P2572, DOI 10.1172/JCI119076
   Rajagopalan Sanjay, 2006, J Clin Hypertens (Greenwich), V8, P783, DOI 10.1111/j.1524-6175.2006.05797.x
   Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076
   Rippe C, 2010, AGING CELL, V9, P304, DOI 10.1111/j.1474-9726.2010.00557.x
   Robb AO, 2009, HYPERTENSION, V53, P952, DOI 10.1161/HYPERTENSIONAHA.109.130898
   Rollins BJ, 1996, MOL MED TODAY, V2, P198, DOI 10.1016/1357-4310(96)88772-7
   Román GC, 2003, J AM GERIATR SOC, V51, pS296, DOI 10.1046/j.1532-5415.5155.x
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Roy AK, 1999, VITAM HORM, V55, P309
   Ryan J, 2014, BJOG-INT J OBSTET GY, V121, P1729, DOI 10.1111/1471-0528.12828
   Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40
   Sbardella D, 2012, MOL ASPECTS MED, V33, P119, DOI 10.1016/j.mam.2011.10.015
   Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233
   Scragg JL, 2004, BIOCHEM BIOPH RES CO, V318, P503, DOI 10.1016/j.bbrc.2004.04.054
   Scuteri A, 2005, J HYPERTENS, V23, P1211, DOI 10.1097/01.hjh.0000170384.38708.b7
   Scuteri A, 2007, J HYPERTENS, V25, P1035, DOI 10.1097/HJH.0b013e3280895b55
   Seo WK, 2008, CEREBROVASC DIS, V26, P618, DOI 10.1159/000166837
   Shah K, 2009, AM J GERIATR PHARMAC, V7, P250, DOI 10.1016/j.amjopharm.2009.11.001
   Smulyan H, 2001, J AM COLL CARDIOL, V37, P1374, DOI 10.1016/S0735-1097(01)01166-4
   Sohn IS, 2014, CURR HYPERTENS REV, V10, P37, DOI 10.2174/157340211001141111160311
   Soucy KG, 2006, J APPL PHYSIOL, V101, P1751, DOI 10.1152/japplphysiol.00138.2006
   Stegbauer J, 2011, CURR OPIN NEPHROL HY, V20, P84, DOI 10.1097/MNH.0b013e3283414d40
   Takahashi K, 2005, GYNECOL OBSTET INVES, V60, P162, DOI 10.1159/000086570
   Tang YH, 2016, AGING DIS, V7, P326, DOI 10.14336/AD.2015.1125
   Tarumi T, 2014, J CEREBR BLOOD F MET, V34, P971, DOI 10.1038/jcbfm.2014.44
   Topouchian J, 2007, VASC HEALTH RISK MAN, V3, P381
   Tota S, 2013, PSYCHOPHARMACOLOGY, V226, P357, DOI 10.1007/s00213-012-2913-8
   Touyz Rhian M, 2003, Expert Rev Cardiovasc Ther, V1, P91, DOI 10.1586/14779072.1.1.91
   Tsao CW, 2013, NEUROLOGY, V81, P984, DOI 10.1212/WNL.0b013e3182a43e1c
   Tsuchiya K, 2006, AM J PHYSIOL-ENDOC M, V291, pE771, DOI 10.1152/ajpendo.00560.2005
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   van Elderen SGC, 2010, EUR RADIOL, V20, P1132, DOI 10.1007/s00330-009-1655-4
   van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888
   Vendemiale G, 2013, AGING CLIN EXP RES, V25, P247, DOI 10.1007/s40520-013-0043-8
   Véron P, 2005, BLOOD CELL MOL DIS, V35, P81, DOI 10.1016/j.bcmd.2005.05.001
   Viboolvorakul S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/230791
   Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409
   Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2
   Wang MY, 2014, TRENDS ENDOCRIN MET, V25, P72, DOI 10.1016/j.tem.2013.10.002
   Wang MY, 2012, AGING CELL, V11, P500, DOI 10.1111/j.1474-9726.2012.00813.x
   Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1
   Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45
   Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8
   Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837
   Webb CM, 1999, CIRCULATION, V100, P1690, DOI 10.1161/01.CIR.100.16.1690
   Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4
   Wentland AL, 2014, CARDIOVASC DIAGN THE, V4, P193, DOI 10.3978/j.issn.2223-3652.2014.03.04
   Wenzel P, 2008, CARDIOVASC RES, V80, P280, DOI 10.1093/cvr/cvn182
   Werner C, 2008, CLIN RES CARDIOL, V97, P418, DOI 10.1007/s00392-008-0668-3
   Williams MRI, 2001, J CLIN ENDOCR METAB, V86, P5389, DOI 10.1210/jc.86.11.5389
   Wiseman S, 2014, CEREBROVASC DIS, V37, P64, DOI 10.1159/000356789
   Wolf G, 2002, KIDNEY INT, V61, P1986, DOI 10.1046/j.1523-1755.2002.00365.x
   Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025
   Wu Z, 2003, ENDOCRINOLOGY, V144, P3251, DOI 10.1210/en.2003-0015
   Xiao QZ, 2014, ARTERIOSCL THROM VAS, V34, P90, DOI 10.1161/ATVBAHA.113.301418
   Xie XD, 2006, LIFE SCI, V78, P2166, DOI 10.1016/j.lfs.2005.09.038
   Yalcin A, 2016, AGING DIS, V7, DOI 10.14336/AD.2015.0819
   Yaron M, 2009, EUR J ENDOCRINOL, V160, P839, DOI 10.1530/EJE-09-0052
   Yeap BB, 2009, J CLIN ENDOCR METAB, V94, P2353, DOI 10.1210/jc.2008-2416
   Yildiz O, 2005, J CARDIOVASC PHARM, V45, P580, DOI 10.1097/01.fjc.0000161400.06704.1e
   Ying WZ, 2013, HYPERTENSION, V62, P951, DOI 10.1161/HYPERTENSIONAHA.113.01835
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu J, 2010, ENDOCRINOLOGY, V151, P1822, DOI 10.1210/en.2009-1048
   Yu Q, 2000, GENE DEV, V14, P163
   Yu WC, 2008, J HUM HYPERTENS, V22, P24, DOI 10.1038/sj.jhh.1002259
   Zaydun G, 2006, ATHEROSCLEROSIS, V184, P137, DOI 10.1016/j.atherosclerosis.2005.03.043
   Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029
   Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009
   Zhou P, 2008, EUR J PHARMACOL, V593, P87, DOI 10.1016/j.ejphar.2008.07.014
NR 212
TC 48
Z9 58
U1 2
U2 34
PU INT SOC AGING & DISEASE
PI FORT WORTH
PA EDITORIAL OFF, 3400 CAMP BOWIE BLVD, FORT WORTH, TX 76106 USA
SN 2152-5250
J9 AGING DIS
JI Aging Dis.
PD JUL
PY 2017
VL 8
IS 4
BP 486
EP 505
DI 10.14336/AD.2017.0507
PG 20
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA FB6EM
UT WOS:000406234100011
PM 28840062
OA Green Published, Green Submitted, gold
DA 2024-11-01
ER

PT J
AU McCastlain, K
   Howell, CR
   Welsh, CE
   Wang, ZM
   Wilson, CL
   Mulder, HL
   Easton, J
   Mertens, AC
   Zhang, JH
   Yasui, Y
   Hudson, MM
   Robison, LL
   Kundu, M
   Ness, KK
AF McCastlain, Kelly
   Howell, Carrie R.
   Welsh, Catherine E.
   Wang, Zhaoming
   Wilson, Carmen L.
   Mulder, Heather L.
   Easton, John
   Mertens, Ann C.
   Zhang, Jinghui
   Yasui, Yutaka
   Hudson, Melissa M.
   Robison, Leslie L.
   Kundu, Mondira
   Ness, Kirsten K.
TI The Association of Mitochondrial Copy Number With Sarcopenia in Adult
   Survivors of Childhood Cancer
SO JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
LA English
DT Article
ID SKELETAL-MUSCLE; PERIPHERAL-BLOOD; OXIDATIVE STRESS;
   MOLECULAR-MECHANISMS; READ ALIGNMENT; DNA MUTATIONS; STEM-CELLS;
   FRAILTY; DYSFUNCTION; MASS
AB Background: Adult childhood cancer survivors are at risk for frailty, including low muscle mass and weakness (sarcopenia). Using peripheral blood mitochondrial DNA copy number (mtDNAcn) as a proxy for functional mitochondria, this study describes cross-sectional associations between mtDNAcn and sarcopenia among survivors. Methods: Among 1762 adult childhood cancer survivors (51.6% male; median age = 29.4 years, interquartile range [IQR] = 23.3-36.8), with a median of 20.6 years from diagnosis (IQR = 15.2-28.2), mtDNAcn estimates were derived from whole-genome sequencing. A subset was validated by quantitative polymerase chain reaction and evaluated cross-sectionally using multivariable logistic regression for their association with sarcopenia, defined by race-, age-, and sex-specific low lean muscle mass or weak grip strength. All statistical tests were 2-sided. Results: The prevalence of sarcopenia was 27.0%, higher among female than male survivors (31.5% vs 22.9%; P < .001) and associated with age at diagnosis; 51.7% of survivors with sarcopenia were diagnosed ages 4-13 years (P = .01). Sarcopenia was most prevalent (39.0%) among central nervous system tumor survivors. Cranial radiation (odds ratio [OR] = 1.84, 95% confidence interval [CI] = 1.32 to 2.59) and alkylating agents (OR = 1.34, 95% CI = 1.04 to 1.72) increased, whereas glucocorticoids decreased odds (OR = 0.72, 95% CI = 0.56 to 0.93) of sarcopenia. mtDNAcn decreased with age (beta = -0.81, P = .002) and was higher among female survivors (beta = 9.23, P = .01) and among survivors with a C allele at mt.204 (beta = -17.9, P = .02). In adjusted models, every standard deviation decrease in mtDNAcn increased the odds of sarcopenia 20% (OR = 1.20, 95% CI = 1.07 to 1.34). Conclusions: A growing body of evidence supports peripheral blood mtDNAcn as a biomarker for adverse health outcomes; however, this study is the first to report an association between mtDNAcn and sarcopenia among childhood cancer survivors.
C1 [McCastlain, Kelly; Kundu, Mondira] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA.
   [Howell, Carrie R.] Univ Alabama Birmingham, Dept Prevent Med, Birmingham, AL USA.
   [Welsh, Catherine E.] Rhodes Coll, Dept Math & Comp Sci, Memphis, TN 38112 USA.
   [Wang, Zhaoming; Mulder, Heather L.; Easton, John; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA.
   [Wang, Zhaoming; Wilson, Carmen L.; Yasui, Yutaka; Hudson, Melissa M.; Robison, Leslie L.; Ness, Kirsten K.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS 735, Memphis, TN 38105 USA.
   [Mertens, Ann C.] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA.
   [Mertens, Ann C.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA.
C3 St Jude Children's Research Hospital; University of Alabama System;
   University of Alabama Birmingham; St Jude Children's Research Hospital;
   St Jude Children's Research Hospital; Children's Healthcare of Atlanta
   (CHOA); Emory University
RP Ness, KK (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS 735, Memphis, TN 38105 USA.
EM kiri.ness@stjude.org
RI Robison, Leslie/N-8122-2018; Wilson, Carmen/N-8072-2018; Zhang,
   Jing/GWZ-7332-2022; Ness, Kirsten/N-2550-2018; Wang,
   Zhaoming/R-5527-2018; Yasui, Yutaka/E-2564-2015; Howell,
   Carrie/G-8787-2018; McCastlain, Kelly/O-3366-2018
OI Wang, Zhaoming/0000-0001-7556-3869; Mulder, Heather/0000-0003-2024-9498;
   Yasui, Yutaka/0000-0002-7717-8638; Howell, Carrie/0000-0002-6554-6237;
   Easton, John/0000-0003-4503-6608; McCastlain, Kelly/0000-0001-7868-3049
FU National Cancer Institute at the National Institutes of Health
   [CA174851, CA195547, CA21765, GM132231]; American Lebanese Syrian
   Associated Charities; National Cancer Institute [U01CA195547] Funding
   Source: NIH RePORTER
FX This work was supported by the National Cancer Institute at the National
   Institutes of Health (CA174851, Ness; CA195547, Hudson; CA21765,
   Roberts; GM132231, Kundu) and the American Lebanese Syrian Associated
   Charities.
CR Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779
   Antipova VN, 2018, INT J RADIAT BIOL, V94, P282, DOI 10.1080/09553002.2018.1419299
   Ashar FN, 2015, J MOL MED, V93, P177, DOI 10.1007/s00109-014-1233-3
   Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811
   BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173
   Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342
   Boland AM, 2016, PHYS THER, V96, P1029, DOI 10.2522/ptj.20150507
   Braun TP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00012
   Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720
   Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116
   Center for Mitochondrial & Epigenomic Medicine Children's Hospital of Philadelphia, 2018, MITOMAP HUM MIT GEN
   Chen Y, 2007, MOL INTERV, V7, P147, DOI 10.1124/mi.7.3.6
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Crouch ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181086
   D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005
   Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013
   Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007
   Ding J, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1005306, 10.1371/journal.pgen.1005549]
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
   Gawade PL, 2014, CURR PEDIATR REV, V10, P249, DOI 10.2174/1573400510666141114223827
   Gouspillou G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08717
   Greaves LC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004620
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Howlader N, 2017, NATL CANC I SURVEILL
   Hudson MM, 2015, J CLIN ONCOL, V33, P479, DOI 10.1200/JCO.2014.57.4863
   Hudson MM, 2011, PEDIATR BLOOD CANCER, V56, P825, DOI 10.1002/pbc.22875
   Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12
   Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038
   Klein Gordon L, 2015, Osteoporos Sarcopenia, V1, P39, DOI 10.1016/j.afos.2015.07.008
   Knez J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181036
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kuznetsova T, 2017, ADV EXP MED BIOL, V982, P347, DOI 10.1007/978-3-319-55330-6_19
   Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863
   LEXELL J, 1992, MUSCLE NERVE, V15, P404, DOI 10.1002/mus.880150323
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989
   Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121
   Liu X, 2019, MOL PHARMACOL, V96, P408, DOI 10.1124/mol.119.116806
   Longchamps RJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228166
   Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001
   MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69
   MATHIOWETZ V, 1985, J HAND SURG-AM, V10A, P694, DOI 10.1016/S0363-5023(85)80210-0
   Meacham LR, 2005, CANCER-AM CANCER SOC, V103, P1730, DOI 10.1002/cncr.20960
   Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Mitsui T, 2002, J NEUROL, V249, P1004, DOI 10.1007/s00415-002-0774-5
   Mkaouar-Rebai E, 2016, BIOCHEM BIOPH RES CO, V473, P578, DOI 10.1016/j.bbrc.2016.03.126
   Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5
   Moore AZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011069
   National Center for Biotechnology Information US National Library of Medicine. NCBI, 2018, DNA RNA
   Ness KK, 2007, PEDIATR BLOOD CANCER, V49, P975, DOI 10.1002/pbc.21091
   Ness KK, 2015, CANCER-AM CANCER SOC, V121, P1540, DOI 10.1002/cncr.29211
   Ness KK, 2013, J CLIN ONCOL, V31, P4496, DOI 10.1200/JCO.2013.52.2268
   Noda A, 2018, J RADIAT RES, V59, DOI 10.1093/jrr/rrx074
   Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006
   Ojha RP, 2013, PEDIATR BLOOD CANCER, V60, P856, DOI 10.1002/pbc.24348
   Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016
   Porter C, 2012, J PHYSIOL-LONDON, V590, P5935, DOI 10.1113/jphysiol.2012.241083
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Romanello V, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00422
   Rygiel KA, 2016, J PHYSIOL-LONDON, V594, P4499, DOI 10.1113/JP271212
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Scheede-Bergdahl C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00049
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Singh AN, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-0977-6
   Sorensen JC, 2016, CANCER CHEMOTH PHARM, V78, P673, DOI 10.1007/s00280-016-3045-3
   Sousa-Victor P, 2016, MOL ASPECTS MED, V50, P109, DOI 10.1016/j.mam.2016.02.002
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Trajanoska K, 2018, J BONE MINER RES, V33, P1209, DOI 10.1002/jbmr.3416
   Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419
   Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707
   van Brussel Marco, 2006, Pediatr Rehabil, V9, P267, DOI 10.1080/13638490500523150
   Venegas Victor, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1907s68
   Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356
   Wachsmuth M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005939
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang X, 2013, HUM MOL GENET, V22, P3976, DOI 10.1093/hmg/ddt251
   Wright Jacqueline D, 2010, NCHS Data Brief, P1
   Xia CY, 2017, CHINESE MED J-PEKING, V130, P2435, DOI 10.4103/0366-6999.216395
   Zhang L, 2017, INT J BIOL SCI, V13, P1152, DOI 10.7150/ijbs.20132
   Zillikens MC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00031-7
   Zou H, 2005, J R STAT SOC B, V67, P768, DOI 10.1111/j.1467-9868.2005.00527.x
NR 88
TC 9
Z9 9
U1 1
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0027-8874
EI 1460-2105
J9 JNCI-J NATL CANCER I
JI JNCI-J. Natl. Cancer Inst.
PD NOV
PY 2021
VL 113
IS 11
BP 1570
EP 1580
AR djab084
DI 10.1093/jnci/djab084
EA APR 2021
PG 11
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Oncology
GA YJ4PY
UT WOS:000744517000020
PM 33871611
OA Green Published
DA 2024-11-01
ER

PT J
AU Awuah, WA
   Tan, JK
   Shkodina, AD
   Ferreira, T
   Adebusoye, FT
   Mazzoleni, A
   Wellington, J
   David, L
   Chilcott, E
   Huang, HL
   Abdul-Rahman, T
   Shet, V
   Atallah, O
   Kalmanovich, J
   Jiffry, R
   Madhu, DE
   Sikora, K
   Kmyta, O
   Delva, MY
AF Awuah, Wireko Andrew
   Tan, Joecelyn Kirani
   Shkodina, Anastasiia D.
   Ferreira, Tomas
   Adebusoye, Favour Tope
   Mazzoleni, Adele
   Wellington, Jack
   David, Lian
   Chilcott, Ellie
   Huang, Helen
   Abdul-Rahman, Toufik
   Shet, Vallabh
   Atallah, Oday
   Kalmanovich, Jacob
   Jiffry, Riaz
   Madhu, Divine Elizabeth
   Sikora, Kateryna
   Kmyta, Oleksii
   Delva, Mykhailo Yu
TI Hereditary spastic paraplegia: Novel insights into the pathogenesis and
   management
SO SAGE OPEN MEDICINE
LA English
DT Review
DE Hereditary spastic hyperplasia; genetics; neurodegeneration; metabolism
ID M-AAA PROTEASE; AXONAL-TRANSPORT; MUTATIONS; AUTOPHAGY; REVEALS;
   COMPLEX; GENE; ER; SPATACSIN; LYSOSOME
AB Hereditary spastic paraplegia is a genetically heterogeneous neurodegenerative disorder characterised primarily by muscle stiffness in the lower limbs. Neurodegenerative disorders are conditions that result from cellular and metabolic abnormalities, many of which have strong genetic ties. While ageing is a known contributor to these changes, certain neurodegenerative disorders can manifest early in life, progressively affecting a person's quality of life. Hereditary spastic paraplegia is one such condition that can appear in individuals of any age. In hereditary spastic paraplegia, a distinctive feature is the degeneration of long nerve fibres in the corticospinal tract of the lower limbs. This degeneration is linked to various cellular and metabolic processes, including mitochondrial dysfunction, remodelling of the endoplasmic reticulum membrane, autophagy, abnormal myelination processes and alterations in lipid metabolism. Additionally, hereditary spastic paraplegia affects processes like endosome membrane trafficking, oxidative stress and mitochondrial DNA polymorphisms. Disease-causing genetic loci and associated genes influence the progression and severity of hereditary spastic paraplegia, potentially affecting various cellular and metabolic functions. Although hereditary spastic paraplegia does not reduce a person's lifespan, it significantly impairs their quality of life as they age, particularly with more severe symptoms. Regrettably, there are currently no treatments available to halt or reverse the pathological progression of hereditary spastic paraplegia. This review aims to explore the metabolic mechanisms underlying the pathophysiology of hereditary spastic paraplegia, emphasising the interactions of various genes identified in recent network studies. By comprehending these associations, targeted molecular therapies that address these biochemical processes can be developed to enhance treatment strategies for hereditary spastic paraplegia and guide clinical practice effectively.
C1 [Awuah, Wireko Andrew; Adebusoye, Favour Tope; Abdul-Rahman, Toufik; Sikora, Kateryna; Kmyta, Oleksii] Sumy State Univ, Sumy, Ukraine.
   [Tan, Joecelyn Kirani] Univ St Andrews, Fac Med, St Andrews, Scotland.
   [Shkodina, Anastasiia D.; Delva, Mykhailo Yu] Poltava State Med Univ, Dept Neurol Dis, Poltava, Ukraine.
   [Ferreira, Tomas] Univ Cambridge, Sch Clin Med, Dept Clin Neurosci, Cambridge, England.
   [Mazzoleni, Adele] Barts & London Queen Marys Sch Med & Dent, London, England.
   [Wellington, Jack; Chilcott, Ellie; Madhu, Divine Elizabeth] Cardiff Univ, Sch Med, Cardiff, Wales.
   [David, Lian] Univ East Anglia, Norwich Med Sch, Norwich, England.
   [Huang, Helen; Jiffry, Riaz] Univ Med & Hlth Sci, Royal Coll Surg Ireland, Dublin, Ireland.
   [Shet, Vallabh] Bangalore Med Coll & Res Inst, Fac Med, Bengaluru, Karnataka, India.
   [Atallah, Oday] Hannover Med Sch, Dept Neurosurg, Hannover, Germany.
   [Kalmanovich, Jacob] Drexel Univ, Coll Med, Philadelphia, PA USA.
   [Awuah, Wireko Andrew] Sumy State Univ, 2,Rymskogo Korsakova St, UA-40007 Sumy, Ukraine.
C3 Ministry of Education & Science of Ukraine; Sumy State University;
   University of St Andrews; Poltava State Medical University; University
   of Cambridge; University of London; Queen Mary University London;
   Cardiff University; University of East Anglia; Royal College of Surgeons
   - Ireland; Bangalore Medical College & Research Institute (BMCRI);
   Hannover Medical School; Drexel University; Ministry of Education &
   Science of Ukraine; Sumy State University
RP Awuah, WA (corresponding author), Sumy State Univ, 2,Rymskogo Korsakova St, UA-40007 Sumy, Ukraine.
EM andyvans36@yahoo.com
RI Atallah, Oday/IYJ-0782-2023; WIREKO, ANDREW AWUAH/ABD-3005-2021;
   Ferreira, Tomas/JRX-1720-2023; Delva, Mykhaylo/KAM-3436-2024; Shkodina,
   Anastasiia/GXU-0271-2022
OI ADEBUSOYE, FAVOUR TOPE/0000-0001-5362-3920; Mazzoleni,
   Adele/0000-0002-0166-105X; Atallah, Oday/0000-0002-3131-4104; Ferreira,
   Tomas/0000-0003-1465-522X; David, Lian/0000-0002-8532-3647; Delva,
   Mykhaylo/0000-0001-5648-7506; Tan, Joecelyn Kirani/0009-0005-3648-6553;
   WIREKO, ANDREW AWUAH/0000-0003-2380-2949; Shkodina,
   Anastasiia/0000-0002-7198-5498
CR Agarwal AK, 2004, TRENDS MOL MED, V10, P440, DOI 10.1016/j.molmed.2004.07.009
   Aly KA, 2022, CURR OPIN CHEM BIOL, V71, DOI 10.1016/j.cbpa.2022.102211
   [Anonymous], 2023, KIF1A gene-GeneCards | KIF1A Protein | KIF1A Antibody
   [Anonymous], 2023, SACS gene-GeneCards | SACS Protein | SACS Antibody
   Antczak J, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/7638675
   Ardolino G, 2021, J SPINAL CORD MED, V44, P46, DOI 10.1080/10790268.2018.1543926
   Arribat Y, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008665
   Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81
   Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112
   Bagshaw RD, 2005, MOL CELL PROTEOMICS, V4, P133, DOI 10.1074/mcp.M400128-MCP200
   Bastani PB, 2023, J CLIN NEUROPHYSIOL, V40, P173, DOI 10.1097/WNP.0000000000000874
   Bellofatto M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00003
   Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400
   Chang J, 2014, J CLIN INVEST, V124, P5249, DOI 10.1172/JCI77598
   Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980
   Chen DD, 2010, SCIENCE, V327, P1261, DOI 10.1126/science.1184840
   Costamagna D, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11213351
   Coutelier M, 2015, BRAIN, V138, P2191, DOI 10.1093/brain/awv143
   De la Casa-Fages B, 2019, MOVEMENT DISORD, V34, P1547, DOI 10.1002/mds.27812
   de Lima FD, 2021, MOVEMENT DISORD, V36, P1654, DOI 10.1002/mds.28523
   Denton Kyle R, 2016, Front Biol (Beijing), V11, P339
   Dor T, 2014, J MED GENET, V51, P137, DOI 10.1136/jmedgenet-2013-102012
   Durand CM, 2022, BMC NEUROL, V22, DOI 10.1186/s12883-022-02553-0
   Ebrahimi-Fakhari D., 2018, GeneReviews
   Edwards TL, 2009, BIOCHEM J, V423, P31, DOI 10.1042/BJ20082398
   Estrada-Cuzcano A, 2017, BRAIN, V140, P287, DOI 10.1093/brain/aww307
   Faber I, 2018, MOVEMENT DISORD, V33, P1650, DOI 10.1002/mds.27491
   Faber I, 2018, NEUROIMAGE-CLIN, V19, P848, DOI 10.1016/j.nicl.2018.05.031
   Fichman Y, 2015, BIOL REV, V90, P1065, DOI 10.1111/brv.12146
   Fowler Philippa C, 2016, J Rare Dis Res Treat, V1, P17
   Frasquet M, 2021, EUR J NEUROL, V28, P1334, DOI 10.1111/ene.14700
   Freeman C, 2013, BBA-MOL BASIS DIS, V1832, P160, DOI 10.1016/j.bbadis.2012.10.011
   Füger P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003066
   Genecards, 2023, MARS1 gene-GeneCards | SYMC Protein | SYMC Antibody
   Gonzalez M, 2013, J NEUROL NEUROSUR PS, V84, P1247, DOI 10.1136/jnnp-2013-305049
   Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935
   Hashimoto Y, 2014, J BIOL CHEM, V289, P12946, DOI 10.1074/jbc.M113.528687
   Hauser S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.544043
   Hauser S, 2019, MOL THER-METH CLIN D, V15, P359, DOI 10.1016/j.omtm.2019.10.011
   Hedera P., 2021, HEREDITARY SPASTIC P
   Hirst J, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000098
   Hsiao CT., 2016, PLoS One, V11
   Ishihara S, 2020, J PERIPHER NERV SYST, V25, P125, DOI 10.1111/jns.12369
   Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070
   Kara E, 2016, BRAIN, V139, P1904, DOI 10.1093/brain/aww111
   Klebe S, 2012, EUR J HUM GENET, V20, P645, DOI 10.1038/ejhg.2011.261
   Koh K, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1108
   Lai LL, 2020, ANN CLIN TRANSL NEUR, V7, P1862, DOI 10.1002/acn3.51169
   LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008
   Lavie J, 2017, HUM MOL GENET, V26, P674, DOI 10.1093/hmg/ddw425
   Lee YK, 2016, BMB REP, V49, P424, DOI 10.5483/BMBRep.2016.49.8.081
   Leo L, 2017, HUM MOL GENET, V26, P2321, DOI 10.1093/hmg/ddx125
   Lim YS, 2015, ANN NEUROL, V78, P679, DOI 10.1002/ana.24488
   Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011
   Ma XR, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00499
   Mackay-Sim A, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11030403
   Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171
   Manganelli V, 2021, AUTOPHAGY, V17, P2528, DOI 10.1080/15548627.2020.1834207
   Marelli C, 2018, BRAIN, V141, P72, DOI 10.1093/brain/awx297
   Martinelli P, 2009, HUM MOL GENET, V18, P2001, DOI 10.1093/hmg/ddp124
   Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068
   Mattera R., 2017, Proc Nat Acad Sci U S A, V114
   Mehta PR, 2019, J NEUROL NEUROSUR PS, V90, P268, DOI 10.1136/jnnp-2018-319089
   Merkwirth C, 2008, CELL, V135, P1165, DOI 10.1016/j.cell.2008.12.005
   Miyake Y, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-62
   Montecchiani C, 2016, BRAIN, V139, P73, DOI 10.1093/brain/awv320
   Montenegro G, 2012, J CLIN INVEST, V122, P538, DOI 10.1172/JCI60560
   Mou YC, 2019, NEURAL REGEN RES, V14, P574, DOI 10.4103/1673-5374.248108
   Murala S, 2021, NEUROL SCI, V42, P883, DOI 10.1007/s10072-020-04981-7
   Musacchio T, 2017, J NEUROL, V264, P11, DOI 10.1007/s00415-016-8301-2
   Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8
   Nam D, 2022, J PERIPHER NERV SYST, V27, P38, DOI 10.1111/jns.12476
   Nicita F, 2021, J MED GENET, V58, P475, DOI 10.1136/jmedgenet-2020-107007
   Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Noetzli L, 2014, GENE, V533, P447, DOI 10.1016/j.gene.2013.09.076
   Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325
   Oz-Levi D, 2012, AM J HUM GENET, V91, P1065, DOI 10.1016/j.ajhg.2012.09.015
   Öztürk Z, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00048
   Panza E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00131
   Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979
   Park TS., 2021, Cureus, V13
   Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371
   Patel H, 2002, NAT GENET, V31, P347, DOI 10.1038/ng937
   Peotter JL, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2210649119
   Piccinelli SC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00580
   Pucks-Faes E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00901
   Ramani P. K., 2023, StatPearls. (Treasure Isl. (FL))
   Rattay TW, 2019, BRAIN, V142, P1561, DOI 10.1093/brain/awz102
   Rebelo AP, 2023, BRAIN, V146, P4191, DOI 10.1093/brain/awad158
   Reinicke AT, 2019, J IMMUNOL, V203, P1730, DOI 10.4049/jimmunol.1801133
   Reversade B, 2009, NAT GENET, V41, P1016, DOI 10.1038/ng.413
   Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046
   Rivière JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013
   Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667
   Rossi S, 2022, NEUROL-GENET, V8, DOI 10.1212/NXG.0000000000000664
   Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801
   Sadr Z, 2023, NEUROMUSCULAR DISORD, V33, P295, DOI 10.1016/j.nmd.2023.02.001
   Sanderson CM, 2006, HUM MOL GENET, V15, P307, DOI 10.1093/hmg/ddi447
   Sardina F, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000799
   Schlipf NA, 2014, MOL GENET GENOM MED, V2, P379, DOI 10.1002/mgg3.87
   Schöls L, 2017, BRAIN, V140, P3112, DOI 10.1093/brain/awx273
   Schüle R, 2016, ANN NEUROL, V79, P646, DOI 10.1002/ana.24611
   Seong E, 2018, ANN NEUROL, V83, P1075, DOI 10.1002/ana.25220
   Shen JL., 2021, Curr Biol, V31
   Shkodina AD, 2022, AGEING RES REV, V74, DOI 10.1016/j.arr.2021.101554
   Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408
   Slosarek EL, 2018, CELL REP, V24, P2248, DOI 10.1016/j.celrep.2018.07.081
   Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245
   Sperfeld AD, 2005, EUR NEUROL, V54, P181, DOI 10.1159/000090294
   Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980
   Tesson C, 2015, HUM GENET, V134, P511, DOI 10.1007/s00439-015-1536-7
   Marchesi LT, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071678
   Trotta N, 2004, CURR BIOL, V14, P1135, DOI 10.1016/j.cub.2004.06.058
   Trummer B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01017
   van de Venis L, 2023, NEUROREHAB NEURAL RE, V37, P27, DOI 10.1177/15459683221147839
   Vander Stichele G, 2022, BMC NEUROL, V22, DOI 10.1186/s12883-022-02595-4
   Varghaei P, 2022, PARKINSONISM RELAT D, V98, P62, DOI 10.1016/j.parkreldis.2022.03.019
   Vavouraki N, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102484
   Velázquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102
   Wali G, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8080142
   Wang AN, 2023, J HEADACHE PAIN, V24, DOI 10.1186/s10194-022-01537-2
   Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004
   Wartosch L, 2015, TRAFFIC, V16, P727, DOI 10.1111/tra.12283
   Williams ET, 2017, J PARKINSON DIS, V7, P219, DOI 10.3233/JPD-161020
   Xu Y, 2019, CELL, V178, P552, DOI 10.1016/j.cell.2019.06.007
   Yahia A, 2023, EUR J HUM GENET, DOI 10.1038/s41431-023-01344-6
   Yao L, 2023, ANN CLIN TRANSL NEUR, V10, P328, DOI 10.1002/acn3.51722
   Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031
   Zhou X, 2023, ANN CLIN TRANSL NEUR, V10, P1590, DOI 10.1002/acn3.51848
   Zhu PP, 2022, HUM MOL GENET, V31, P2779, DOI 10.1093/hmg/ddac072
   Zhu ZY, 2022, EUR J MED GENET, V65, DOI 10.1016/j.ejmg.2022.104608
   Zhu ZY, 2019, PARKINSONISM RELAT D, V69, P125, DOI 10.1016/j.parkreldis.2019.11.007
   Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361
NR 134
TC 2
Z9 2
U1 1
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2050-3121
J9 SAGE OPEN MED
JI SAGE Open Med.
PY 2024
VL 12
AR 20503121231221941
DI 10.1177/20503121231221941
PG 20
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA DR1U2
UT WOS:001133709600001
PM 38162912
OA Green Published, Green Accepted, gold
DA 2024-11-01
ER

PT J
AU Lombardi, M
   Lazzeroni, D
   Pisano, A
   Girolami, F
   Alfieri, O
   La Canna, G
   d'Amati, G
   Olivotto, I
   Rimoldi, OE
   Foglieni, C
   Camici, PG
AF Lombardi, Maria
   Lazzeroni, Davide
   Pisano, Annalinda
   Girolami, Francesca
   Alfieri, Ottavio
   La Canna, Giovanni
   d'Amati, Giulia
   Olivotto, Iacopo
   Rimoldi, Ornella E.
   Foglieni, Chiara
   Camici, Paolo G.
TI Mitochondrial Energetics and Ca<SUP>2+</SUP>-Activated ATPase in
   Obstructive Hypertrophic Cardiomyopathy
SO JOURNAL OF CLINICAL MEDICINE
LA English
DT Article
DE obstructive hypertrophic cardiomyopathy (HCM); mitochondrial energetics;
   mitochondrial Complex I (NADH dehydrogenase); mitochondrial Complex V
   (ATP synthase); reactive oxygen species (ROS) scavenger enzymes;
   Ca2+-activated ATPase
ID OXIDATIVE STRESS; ANTIOXIDATIVE ENZYMES; PHOSPHATE METABOLITES; SYSTOLIC
   DYSFUNCTION; SKELETAL-MUSCLE; MYOSIN ATPASE; HUMAN HEART; GUIDELINES;
   RETICULUM; ACONITASE
AB Hypertrophic cardiomyopathy (HCM) is the most common genetic disease of the myocardium associated to mutations in sarcomeric genes, but the link between genotype and phenotype remains poorly understood. Magnetic resonance spectroscopy studies have demonstrated impaired cardiac energetics in patients with HCM, and altered mitochondria were described in biopsies, but little is known about possible perturbations of mitochondrial function and adenosine triphosphate (ATP) production/consumption. The aim of this study was to investigate possible abnormalities in mitochondrial enzymes generating/scavenging reactive oxygen species, and changes in the Ca2+-activated ATPases in myocardial tissue from patients with obstructive HCM undergoing surgical myectomy compared to unused donor hearts (CTRL). Methods and Results: Both the amount and activity of mitochondrial Complex I (nicotinamide adenine dinucleotide -reduced form, NADH, dehydrogenase) were upregulated in HCM vs. CTRL, whilst the activity of Complex V (ATP synthase) was not reduced and ATP levels were significantly higher in HCM vs. CTRL. Antioxidant Mn-activated superoxide dismutase (SOD2) and (m)-aconitase activities were increased in HCM vs. CTRL. The Cu/Zn-activated superoxide dismutase (SOD1) amount and mtDNA copy number were unaltered in HCM. Total Ca2+-activated ATPase activity and absolute amount were not different HCM vs. CTRL, but the ratio between ATPase sarcoplasmic/endoplasmic reticulum Ca(2+)transporting type 2 (ATP2A2) and type 1 (ATP2A1), ATP2A2/ATP2A1, was increased in HCM in favor of the slow isoform (ATP2A2). Conclusion: HCM is characterized by mitochondrial Complex I hyperactivity and preserved Ca2+-activated ATPase activity with a partial switch towards slow ATP2A2. This data may give insight into the abnormal cellular energetics observed in HCM cardiomyopathy but other studies would need to be performed to confirm the observations described here.
C1 [Lombardi, Maria; Lazzeroni, Davide; Foglieni, Chiara; Camici, Paolo G.] IRCCS San Raffaele Sci Inst, Cardiovasc Res Ctr, I-20132 Milan, Italy.
   [Pisano, Annalinda; d'Amati, Giulia] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, I-00161 Rome, Italy.
   [Pisano, Annalinda; d'Amati, Giulia] Policlin Umberto 1, I-00161 Rome, Italy.
   [Girolami, Francesca] Meyer Childrens Hosp, Cardiol Unit, I-50139 Florence, Italy.
   [Alfieri, Ottavio] IRCCS San Raffaele Sci Inst, Cardiac Surg Unit, I-20132 Milan, Italy.
   [La Canna, Giovanni] Humanitas Clin & Res Hosp, Cardiovasc Dept, Appl Diagnost Echocardiog Unit, I-20089 Rozzano Milan, Italy.
   [Olivotto, Iacopo] Careggi Univ Hosp, Cardiomyopathy Unit, I-50139 Florence, Italy.
   [Rimoldi, Ornella E.] Natl Res Council IBFM CNR, Inst Mol Bioimaging & Physiol, I-20090 Segrate, Italy.
   [Camici, Paolo G.] Univ Vita Salute San Raffaele, Fac Med & Surg, I-20132 Milan, Italy.
C3 Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele;
   Sapienza University Rome; Sapienza University Rome; University Hospital
   Sapienza Rome; University of Florence; Azienda Ospedaliera Universitaria
   (AOU) MEYER; Vita-Salute San Raffaele University; IRCCS Ospedale San
   Raffaele; University of Florence; Azienda Ospedaliero Universitaria
   Careggi; Consiglio Nazionale delle Ricerche (CNR); Istituto di
   Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele
   University
RP Foglieni, C (corresponding author), IRCCS San Raffaele Sci Inst, Cardiovasc Res Ctr, I-20132 Milan, Italy.
EM lombardi.maria@hsr.it; lazzeroni.davide@hsr.it;
   annalinda.pisano@uniroma1.it; girolami.fra@gmail.com;
   alfieri.ottavio@hsr.it; lacannagiovanni.cardio@gmail.com;
   giulia.damati@uniroma1.it; rimoldi.ornella@hsr.it;
   foglieni.chiara@hsr.it; camici.paolo@hsr.it
RI Lombardi, Maria/AAC-2226-2019; Olivotto, Iacopo/AAC-5950-2022;
   Lazzeroni, Davide/AAC-1611-2019; Rimoldi, Ornella/ABH-5358-2020;
   Girolami, Francesca/AAL-6598-2020; La Canna, Giovanni/HJH-6117-2023;
   Foglieni, Chiara/O-2339-2015; Girolami, Francesca/L-5267-2016
OI Lombardi, Maria/0000-0002-8198-5264; La Canna,
   Giovanni/0000-0003-0758-3248; Foglieni, Chiara/0000-0002-5155-6426;
   Girolami, Francesca/0000-0001-9143-3597; Olivotto,
   Iacopo/0000-0003-1751-9266
FU Italian Ministry of Health [NET-2011-02347173]
FX This work was supported by the Italian Ministry of Health (grant number
   NET-2011-02347173).
CR Abraham MR, 2013, AM J CARDIOL, V112, P861, DOI 10.1016/j.amjcard.2013.05.017
   Agbulut O, 1996, BIOL CELL, V88, P131, DOI 10.1016/S0248-4900(97)83528-9
   Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7
   Bäumer AT, 2000, J MOL CELL CARDIOL, V32, P121, DOI 10.1006/jmcc.1999.1061
   Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5
   Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783
   Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391
   Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559
   Christiansen LB, 2015, AM J PHYSIOL-HEART C, V308, pH1237, DOI 10.1152/ajpheart.00727.2014
   Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932
   Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7
   Dass S, 2015, EUR HEART J, V36, P1547, DOI 10.1093/eurheartj/ehv120
   del Monte F, 2004, P NATL ACAD SCI USA, V101, P5622, DOI 10.1073/pnas.0305778101
   Dieterich S, 2000, CIRCULATION, V101, P33, DOI 10.1161/01.CIR.101.1.33
   Eisner V, 2013, J CELL SCI, V126, P2965, DOI 10.1242/jcs.093609
   Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284
   Foglieni C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-77
   Hayashi T, 2020, KEIJO J MED, V69, P77, DOI 10.2302/kjm.2019-0012-OA
   Ho CY, 2015, CARDIOVASC RES, V105, P397, DOI 10.1093/cvr/cvv025
   Hughes SE, 2004, HISTOPATHOLOGY, V44, P412, DOI 10.1111/j.1365-2559.2004.01835.x
   Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536
   Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440
   KATZ AM, 1966, CIRC RES, V19, P611, DOI 10.1161/01.RES.19.3.611
   KATZ LA, 1989, AM J PHYSIOL, V256, pH265, DOI 10.1152/ajpheart.1989.256.1.H265
   KHAN MA, 1974, HISTOCHEMISTRY, V38, P181, DOI 10.1007/BF00499665
   Caldas FRL, 2015, J CARDIOVASC PHARM, V65, P393, DOI 10.1097/FJC.0000000000000210
   Li Q, 2017, AM J HUM GENET, V100, P267, DOI 10.1016/j.ajhg.2017.01.004
   Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462
   Lombardi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05137-y
   Lu TM, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-57
   Lucas DT, 2003, AM J PHYSIOL-HEART C, V284, pH575, DOI 10.1152/ajpheart.00619.2002
   Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059
   Maron BJ, 2018, JACC-HEART FAIL, V6, P353, DOI 10.1016/j.jchf.2017.09.011
   Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682
   MORKIN E, 1977, FEBS LETT, V79, P357, DOI 10.1016/0014-5793(77)80820-X
   Nakamura K, 2005, J CARD FAIL, V11, P117, DOI 10.1016/j.cardfail.2004.05.005
   Ormerod JOM, 2016, NAT REV CARDIOL, V13, P677, DOI 10.1038/nrcardio.2016.98
   Pisano A, 2016, CARDIOVASC PATHOL, V25, P103, DOI 10.1016/j.carpath.2015.09.009
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saha B., 2017, P 65 CARD SOC AUSTR, pS104
   Sam F, 2005, J CARD FAIL, V11, P473, DOI 10.1016/j.cardfail.2005.01.007
   Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266
   Sheeran FL, 2016, AM J PHYSIOL-ENDOC M, V311, pE449, DOI 10.1152/ajpendo.00127.2016
   Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100
   TAUSSKY HH, 1953, J BIOL CHEM, V202, P675
   Timmer SAJ, 2013, EUR HEART J-CARD IMG, V14, P95, DOI 10.1093/ehjci/jes242
   Unno K, 2009, EUR HEART J, V30, P1853, DOI 10.1093/eurheartj/ehp184
   Vakrou S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94493
   Vakrou S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00309
   van der Velden J, 2018, CARDIOVASC RES, V114, P1273, DOI 10.1093/cvr/cvy147
   Vásquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064
   Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923
   WEISBERG A, 1982, CIRC RES, V51, P802, DOI 10.1161/01.RES.51.6.802
   Whiffin N, 2018, GENET MED, V20, P1246, DOI 10.1038/gim.2017.258
   Wilder T, 2015, AM J PHYSIOL-HEART C, V309, pH1720, DOI 10.1152/ajpheart.00339.2015
   Williams B, 2018, J HYPERTENS, V36, P2284, DOI [10.1097/HJH.0000000000001961, 10.1097/HJH.0000000000002026]
NR 56
TC 6
Z9 6
U1 0
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2077-0383
J9 J CLIN MED
JI J. Clin. Med.
PD JUN
PY 2020
VL 9
IS 6
AR 1799
DI 10.3390/jcm9061799
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA ML2RJ
UT WOS:000549319300001
PM 32527005
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU De Paula, IF
   Santos-Araujo, S
   Majerowicz, D
   Ramos, I
   Gondim, KC
AF De Paula, Iron F.
   Santos-Araujo, Samara
   Majerowicz, David
   Ramos, Isabela
   Gondim, Katia C.
TI Knockdown of carnitine palmitoyltransferase I (CPT1) reduces fat body
   lipid mobilization and resistance to starvation in the insect vector
   <i>Rhodnius prolixus</i>
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE carnitine palmitoyltransferase I (CPT1); beta-oxidation; starvation;
   lipid droplet; Rhodnius prolixus
ID MALONYL-COA SENSITIVITY; TIME QUANTITATIVE PCR; ACID OXIDATION;
   FLIGHT-MUSCLE; COENZYME-A; GENOME; IDENTIFICATION; METABOLISM;
   EXPRESSION; ENZYME
AB The energy stored in fatty acids is essential for several critical activities of insects, such as embryogenesis, oviposition, and flight. Rhodnius prolixus is an obligatory hematophagous hemipteran and vector of Chagas disease, and it feeds infrequently on very large blood meals. As digestion slowly occurs, lipids are synthesized and accumulate in the fat body, mainly as triacylglycerol, in lipid droplets. Between feeding bouts, proper mobilization and oxidation of stored lipids are crucial for survival, and released fatty acids are oxidized by mitochondrial beta-oxidation. Carnitine palmitoyl transferase I (CPT1) is the enzyme that catalyzes the first reaction of the carnitine shuttle, where the activated fatty acid, acyl-CoA, is converted to acyl-carnitine to be transported into the mitochondria. Here, we investigated the role of CPT1 in lipid metabolism and in resistance to starvation in Rhodnius prolixus. The expression of the CPT1 gene (RhoprCpt1) was determined in the organs of adult females on the fourth day after a blood meal, and the flight muscle showed higher expression levels than the ovary, fat body, and anterior and posterior midgut. RhoprCpt1 expression in the fat body dramatically decreased after feeding, and started to increase again 10 days later, but no changes were observed in the flight muscle. beta-oxidation rates were determined in flight muscle and fat body homogenates with the use of H-3-palmitate, and in unfed females, they were higher in the flight muscle. In the fat body, lipid oxidation activity did not show any variation before or at different days after feeding, and was not affected by the presence of etomoxir or malonyl-CoA. We used RNAi and generated RhoprCPT1-deficient insects, which surprisingly did not show a decrease in measured H-3-palmitate oxidation rates. However, the RNAi-knockdown females presented increased amounts of triacylglycerol and larger lipid droplets in the fat body, but not in the flight muscle. When subjected to starvation, these insects had a shorter lifespan. These results indicated that the inhibition of RhoprCpt1 expression compromised lipid mobilization and affected resistance to starvation.
C1 [De Paula, Iron F.; Santos-Araujo, Samara; Ramos, Isabela; Gondim, Katia C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Majerowicz, David] Univ Fed Rio de Janeiro, Fac Farm, Dept Biotecnol Farmaceut, Rio De Janeiro, Brazil.
   [Majerowicz, David] Univ Estado Rio de Janeiro, Programa Posgrad Biociencias, Rio De Janeiro, Brazil.
C3 Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de
   Janeiro; Universidade do Estado do Rio de Janeiro
RP Gondim, KC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM katia@bioqmed.ufrj.br
RI Gondim, Katia/AAN-4059-2020; Majerowicz, David/B-5361-2016
OI Calp Gondim, Katia/0000-0002-5313-6919; Santos de Araujo,
   Samara/0009-0006-5762-5820
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   [001]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)
FX This work was supported by the grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Finance Code 001),
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
   to KG, DM and IR. KG, DM and IR are members of the Instituto Nacional de
   Ciencia e Tecnologia em Entomologia Molecular (INCT-EM).
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Alves-Bezerra M, 2017, BBA-MOL CELL BIOL L, V1862, P324, DOI 10.1016/j.bbalip.2016.12.004
   Alves-Bezerra M, 2016, BBA-MOL CELL BIOL L, V1861, P650, DOI 10.1016/j.bbalip.2016.04.007
   Ameer F, 2014, METABOLISM, V63, P895, DOI 10.1016/j.metabol.2014.04.003
   Antinori S, 2017, EUR J INTERN MED, V43, P6, DOI 10.1016/j.ejim.2017.05.001
   Arêdes DS, 2022, FRONT INSECT SCI, V2, DOI 10.3389/finsc.2022.885172
   Bennick RA, 2019, BIOCHEM BIOPH RES CO, V516, P928, DOI 10.1016/j.bbrc.2019.06.151
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012
   CARTER HE, 1952, ARCH BIOCHEM BIOPHYS, V38, P405, DOI 10.1016/0003-9861(52)90047-7
   Chen WB, 2019, INSECT BIOCHEM MOLEC, V110, P112, DOI 10.1016/j.ibmb.2019.05.003
   CHU RY, 1995, J BIOL CHEM, V270, P4908, DOI 10.1074/jbc.270.9.4908
   Cingolani F, 2016, TRENDS ENDOCRIN MET, V27, P696, DOI 10.1016/j.tem.2016.06.003
   Cohen I, 2001, J BIOL CHEM, V276, P5403, DOI 10.1074/jbc.M009555200
   Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x
   Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041
   Defferrari MS, 2016, INSECT BIOCHEM MOLEC, V70, P148, DOI 10.1016/j.ibmb.2015.12.009
   Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   FRAENKEL G, 1948, NATURE, V161, P981, DOI 10.1038/161981a0
   Fraser F, 1997, BIOCHEM J, V323, P711, DOI 10.1042/bj3230711
   Gingras RM, 2014, BIOCHEM BIOPH RES CO, V443, P672, DOI 10.1016/j.bbrc.2013.12.027
   Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200
   Houten SM, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165720
   Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2
   Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483
   Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030
   KIORPES TC, 1984, J BIOL CHEM, V259, P9750
   Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107
   Kishita Y, 2012, BIOCHEM BIOPH RES CO, V419, P344, DOI 10.1016/j.bbrc.2012.02.026
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lavarías S, 2009, COMP BIOCHEM PHYS B, V152, P364, DOI 10.1016/j.cbpb.2009.01.004
   Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692
   Leyria J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67932-4
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOPASCHUK GD, 1990, CIRC RES, V66, P546, DOI 10.1161/01.RES.66.2.546
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lu K, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01535
   Luiken JJFP, 2009, BIOCHEM J, V419, P447, DOI 10.1042/BJ20082159
   Lynch SA, 2017, COMPR REV FOOD SCI F, V16, P330, DOI 10.1111/1541-4337.12254
   Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x
   Majerowicz D, 2017, GENE, V596, P27, DOI 10.1016/j.gene.2016.09.045
   MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021
   McGarry JD, 2001, BIOCHEM SOC T, V29, P241, DOI 10.1042/0300-5127:0290241
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Mesquita RD, 2015, P NATL ACAD SCI USA, V112, P14936, DOI 10.1073/pnas.1506226112
   Miotto PM, 2017, BIOCHEM J, V474, P557, DOI 10.1042/BCJ20160913
   Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913
   Moraes B, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.934667
   Morkholt AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02343-6
   Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005
   Nurk S, 2022, SCIENCE, V376, P44, DOI 10.1126/science.abj6987
   O'Brien DM, 2001, J EXP ZOOL, V290, P108, DOI 10.1002/jez.1040
   Oliveira GA, 2006, ARCH INSECT BIOCHEM, V62, P164, DOI 10.1002/arch.20132
   OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918
   Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009
   Pontes EG, 2008, J INSECT PHYSIOL, V54, P790, DOI 10.1016/j.jinsphys.2008.02.003
   Price NT, 2010, J BIOL CHEM, V285, P7857, DOI 10.1074/jbc.M109.072892
   Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845
   Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784
   Rosenfeld JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10164
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Rufer AC, 2009, CELL MOL LIFE SCI, V66, P2489, DOI 10.1007/s00018-009-0035-1
   Santos-Araujo S, 2020, INSECT BIOCHEM MOLEC, V127, DOI 10.1016/j.ibmb.2020.103484
   Saraiva FB, 2021, INSECT BIOCHEM MOLEC, V133, DOI 10.1016/j.ibmb.2020.103511
   SELBY PL, 1989, TRENDS PHARMACOL SCI, V10, P495, DOI 10.1016/0165-6147(89)90049-7
   Smith BK, 2012, BIOCHEM J, V448, P13, DOI 10.1042/BJ20121110
   STEVENSON E, 1968, BIOCHEM J, V110, P105, DOI 10.1042/bj1100105
   Strub BR, 2008, GENOME, V51, P409, DOI 10.1139/G08-023
   Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120
   Tawbeh A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116093
   Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636
   The International Aphid Genomics Consortium, 2010, PLoS Biology, V8, P1, DOI 10.1371/journal.pbio.1000313
   Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4
   Toprak U, 2020, ARCH INSECT BIOCHEM, V104, DOI 10.1002/arch.21682
   Velasco G, 1998, J BIOL CHEM, V273, P21497, DOI 10.1074/jbc.273.34.21497
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   WARD JP, 1982, J INSECT PHYSIOL, V28, P527, DOI 10.1016/0022-1910(82)90033-6
   Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260
   Yates AD, 2022, NUCLEIC ACIDS RES, V50, pD996, DOI 10.1093/nar/gkab1007
   Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018
NR 84
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 4
PY 2023
VL 14
AR 1201670
DI 10.3389/fphys.2023.1201670
PG 13
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA M8BI2
UT WOS:001032409500001
PM 37469565
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Thenappan, T
   Ormiston, ML
   Ryan, JJ
   Archer, SL
AF Thenappan, Thenappan
   Ormiston, Mark L.
   Ryan, John J.
   Archer, Stephen L.
TI Pulmonary arterial hypertension: pathogenesis and clinical management
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Review
ID RIGHT-VENTRICULAR FUNCTION; CALCIUM-CHANNEL BLOCKERS; CONTINUOUS
   INTRAVENOUS EPOPROSTENOL; MUSCLE-CELL PROLIFERATION; CAPILLARY WEDGE
   PRESSURE; LONG-TERM RESPONSE; ACTIVATED T-CELLS; GATED K+ CHANNELS;
   HEART-FAILURE; SEX-DIFFERENCES
AB Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of pulmonary hypertension that primarily affects the pulmonary vasculature. In PAH, the pulmonary vasculature is dynamically obstructed by vasoconstriction, structurally obstructed by adverse vascular remodeling, and pathologically non-compliant as a result of vascular fibrosis and stiffening. Many cell types are abnormal in PAH, including vascular cells (endothelial cells, smooth muscle cells, and fibroblasts) and inflammatory cells. Progress has been made in identifying the causes of PAH and approving new drug therapies. A cancerlike increase in cell proliferation and resistance to apoptosis reflects acquired abnormalities of mitochondrial metabolism and dynamics. Mutations in the type II bone morphogenetic protein receptor (BMPR2) gene dramatically increase the risk of developing heritable PAH. Epigenetic dysregulation of DNA methylation, histone acetylation, and microRNAs also contributes to disease pathogenesis. Aberrant bone morphogenetic protein signaling and epigenetic dysregulation in PAH promote cell proliferation in part through induction of a Warburg mitochondrial-metabolic state of uncoupled glycolysis. Complex changes in cytokines (interleukins and tumor necrosis factor), cellular immunity (T lymphocytes, natural killer cells, macrophages), and autoantibodies suggest that PAH is, in part, an autoimmune, inflammatory disease. Obstructive pulmonary vascular remodeling in PAH increases right ventricular afterload causing right ventricular hypertrophy. In some patients, maladaptive changes in the right ventricle, including ischemia and fibrosis, reduce right ventricular function and cause right ventricular failure. Patients with PAH have dyspnea, reduced exercise capacity, exertional syncope, and premature death from right ventricular failure. PAH targeted therapies (prostaglandins, phosphodiesterase-5 inhibitors, endothelin receptor antagonists, and soluble guanylate cyclase stimulators), used alone or in combination, improve functional capacity and hemodynamics and reduce hospital admissions. However, these vasodilators do not target key features of PAH pathogenesis and have not been shown to reduce mortality, which remains about 50% at five years. This review summarizes the epidemiology, pathogenesis, diagnosis, and treatment of PAH.
C1 [Thenappan, Thenappan] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Ormiston, Mark L.; Archer, Stephen L.] Queens Univ, Dept Med, Kingston, ON, Canada.
   [Ryan, John J.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   Queens University - Canada; Utah System of Higher Education; University
   of Utah
RP Archer, SL (corresponding author), Queens Univ, Dept Med, Kingston, ON, Canada.
EM stephen.archer@queensu.ca
OI Ormiston, Mark/0000-0003-0907-1940; Thenappan,
   Thenappan/0000-0002-6210-0467
FU Canada Foundation for Innovation [229252, 33012]; NIH [R01 HL113003, R01
   HL071115]; Tier 1 Canada research chair in mitochondrial dynamics and
   translational medicine [950-229252]; William J Henderson Foundation; AHA
   scientist development grant [15SDG25560048]; CIHR [PJT-152916]; Tier 2
   Canada research chair
FX SLA is supported by Canada Foundation for Innovation (229252 and 33012),
   NIH R01s HL113003 and HL071115, a Tier 1 Canada research chair in
   mitochondrial dynamics and translational medicine (950-229252), and a
   grant from the William J Henderson Foundation. TT is funded by AHA
   scientist development grant 15SDG25560048. MLO is supported by a CIHR
   project grant (PJT-152916) and a Tier 2 Canada research chair.
CR Abdelmalak M, 2013, MOL GENET METAB, V109, P139, DOI 10.1016/j.ymgme.2013.03.019
   Abe K, 2016, CARDIOVASC RES, V111, P16, DOI 10.1093/cvr/cvw070
   Addetia K, 2014, CIRC-CARDIOVASC IMAG, V7, P115, DOI 10.1161/CIRCIMAGING.113.000932
   Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398
   Aldred MA, 2010, AM J RESP CRIT CARE, V182, P1153, DOI 10.1164/rccm.201003-0491OC
   Anand V, 2016, JAMA CARDIOL, V1, P1021, DOI 10.1001/jamacardio.2016.3591
   Anavekar NS, 2007, ECHOCARDIOGR-J CARD, V24, P452, DOI 10.1111/j.1540-8175.2007.00424.x
   Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333
   Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Archer SL, 2009, NEW ENGL J MED, V361, P1864, DOI 10.1056/NEJMct0904473
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Austin ED, 2012, CIRC-CARDIOVASC GENE, V5, P336, DOI 10.1161/CIRCGENETICS.111.961888
   Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674
   Badesch DB, 2010, CHEST, V137, P376, DOI 10.1378/chest.09-1140
   Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002
   Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504
   Benza RL, 2013, J HEART LUNG TRANSPL, V32, P889, DOI 10.1016/j.healun.2013.06.008
   Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122
   Benza RL, 2009, PREDICTING SURVIVAL, DOI [10.1164/ajrccm-conference.2009.179.1_MeetingAbstracts.A2651, DOI 10.1164/AJRCCM-CONFERENCE.2009.179.1_MEETINGABSTRACTS.A2651]
   Best DH, 2014, CHEST, V145, P231, DOI 10.1378/chest.13-2366
   Bhave NM, 2013, J AM SOC ECHOCARDIOG, V26, P860, DOI 10.1016/j.echo.2013.05.007
   Bian XM, 1998, AM J PHYSIOL-HEART C, V275, pH169, DOI 10.1152/ajpheart.1998.275.1.H169
   Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC
   Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701
   BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659
   Brittain EL, 2016, CIRCULATION, V133, P1936, DOI 10.1161/CIRCULATIONAHA.115.019351
   Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491
   Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4
   Caruso P, 2017, CIRCULATION, V136, P2451, DOI 10.1161/CIRCULATIONAHA.117.028034
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Caruso P, 2010, ARTERIOSCL THROM VAS, V30, P716, DOI 10.1161/ATVBAHA.109.202028
   Cavasin MA, 2015, PULM CIRC, V5, P63, DOI 10.1086/679700
   Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426
   Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC
   Chaouat A, 2004, THORAX, V59, P446, DOI 10.1136/thx.2003.11890
   Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420
   Cho YK, 2010, CIRC J, V74, P760, DOI 10.1253/circj.CJ-09-0580
   Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013
   Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4
   Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9
   Cogan JD, 2006, AM J RESP CRIT CARE, V174, P590, DOI 10.1164/rccm.200602-165OC
   Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC
   Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812
   Dasgupta A, 2015, CLIN PHARMACOL THER, V97, P88, DOI 10.1002/cpt.10
   Deano RC, 2013, JAMA INTERN MED, V173, P887, DOI 10.1001/jamainternmed.2013.319
   Decoene C, 2001, CAN J ANAESTH, V48, P584, DOI 10.1007/BF03016836
   Diebold I, 2015, CELL METAB, V21, P596, DOI 10.1016/j.cmet.2015.03.010
   Dorfmüller P, 2002, AM J RESP CRIT CARE, V165, P534, DOI 10.1164/rccm.2012112
   Drake KM, 2013, AM J RESP CELL MOL, V49, P403, DOI 10.1165/rcmb.2013-0100OC
   Drake KM, 2011, AM J RESP CRIT CARE, V184, P1400, DOI 10.1164/rccm.201106-1130OC
   Edwards AL, 2013, RESPIROLOGY, V18, P1271, DOI 10.1111/resp.12152
   El Kasmi KC, 2014, J IMMUNOL, V193, P597, DOI 10.4049/jimmunol.1303048
   Ernande L, 2013, J AM SOC ECHOCARDIOG, V26, P297, DOI 10.1016/j.echo.2012.11.011
   Esfandiari S, 2017, MED SCI SPORT EXER, V49, P1293, DOI 10.1249/MSS.0000000000001227
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844
   Fang YH, 2012, J MOL MED, V90, P31, DOI 10.1007/s00109-011-0804-9
   Farha S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95240
   Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832
   Foderaro A, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0689-7
   Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC
   Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714
   Freed BH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-11
   Frid MG, 2006, AM J PATHOL, V168, P659, DOI 10.2353/ajpath.2006.050599
   FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580
   Galiè N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8
   Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687
   Galiè N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010
   Galiè N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510
   Galiè N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galiè N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274
   Georgianos PI, 2015, AM J HYPERTENS, V28, P958, DOI 10.1093/ajh/hpv004
   Ghio S, 2011, AM J CARDIOL, V107, P628, DOI 10.1016/j.amjcard.2010.10.027
   Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657
   Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732
   Graham BB, 2010, CHEST, V137, p20S, DOI 10.1378/chest.10-0048
   Guignabert C, 2009, FASEB J, V23, P4135, DOI 10.1096/fj.09-131664
   Gupta S, 2008, EUR J ECHOCARDIOGR, V9, P766, DOI 10.1093/ejechocard/jen147
   Gutierrez G, 2007, CRIT CARE, V11, DOI 10.1186/cc5739
   Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036
   Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865
   Hashimoto-Kataoka T, 2015, P NATL ACAD SCI USA, V112, pE2677, DOI 10.1073/pnas.1424774112
   Hatton N, 2014, CHEST, V145, P1184, DOI 10.1378/chest.13-3061
   HEATH D, 1991, J CLIN PATHOL, V44, P1003, DOI 10.1136/jcp.44.12.1003
   Hemnes AR, 2016, AM J RESP CRIT CARE, V194, P464, DOI 10.1164/rccm.201508-1678OC
   Hemnes AR, 2015, PULM CIRC, V5, P435, DOI 10.1086/682230
   Hemnes AR, 2015, CIRCULATION, V131, P401, DOI 10.1161/CIRCULATIONAHA.114.013317
   Hoeper MM, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.OA263
   Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032
   Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026
   Hong ZG, 2017, AM J RESP CRIT CARE, V195, P515, DOI 10.1164/rccm.201604-0814OC
   Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC
   HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624
   Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818
   Hurst LA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14079
   Jacobs W, 2014, CHEST, V145, P1230, DOI 10.1378/chest.13-1291
   Jaïs X, 2012, EUR RESPIR J, V40, P881, DOI 10.1183/09031936.00141211
   Jiang R, 2015, HYPERTENS RES, V38, P539, DOI 10.1038/hr.2015.33
   Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913
   Jing ZC, 2013, CIRCULATION, V127, P624, DOI 10.1161/CIRCULATIONAHA.112.124388
   Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293
   Kang K, 2013, J BIOL CHEM, V288, P25414, DOI 10.1074/jbc.M113.460287
   Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515
   Kim J, 2015, CIRCULATION, V131, P190, DOI 10.1161/CIRCULATIONAHA.114.013339
   Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040
   Koehler R, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023101
   Lahm T, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00983-2017
   Larkin EK, 2012, AM J RESP CRIT CARE, V186, P892, DOI 10.1164/rccm.201205-0886OC
   Lavoie JR, 2014, CIRCULATION, V129, P2125, DOI 10.1161/CIRCULATIONAHA.114.008777
   Leather HA, 2006, AM J PHYSIOL-HEART C, V290, pH2369, DOI 10.1152/ajpheart.01211.2004
   Lee SL, 2014, CIRC J, V78, P962, DOI 10.1253/circj.CJ-13-1234
   Li M, 2016, CIRCULATION, V134, P1105, DOI 10.1161/CIRCULATIONAHA.116.023171
   Li M, 2011, J IMMUNOL, V187, P2711, DOI 10.4049/jimmunol.1100479
   Lindqvist P, 2005, ECHOCARDIOGR-J CARD, V22, P305, DOI 10.1111/j.1540-8175.2005.04023.x
   Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC
   Long L, 2015, NAT MED, V21, P777, DOI 10.1038/nm.3877
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Ma L, 2013, NEW ENGL J MED, V369, P351, DOI 10.1056/NEJMoa1211097
   Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947
   Machuca TN, 2015, CIRCULATION, V132, P526, DOI 10.1161/CIRCULATIONAHA.114.012593
   Mair KM, 2014, BRIT J PHARMACOL, V171, P567, DOI 10.1111/bph.12281
   Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827
   Maresca A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00090
   Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848
   Marsboom G, 2012, AM J RESP CRIT CARE, V185, P670, DOI 10.1164/rccm.201108-1562OC
   Mathai SC, 2015, CHEST, V147, P188, DOI 10.1378/chest.14-0263
   McLaughlin V, 2015, EUR RESPIR J, V46, P405, DOI 10.1183/13993003.02044-2014
   McLaughlin VV, 2015, J AM COLL CARDIOL, V65, pA1538, DOI 10.1016/S0735-1097(15)61538-8
   McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027
   McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004
   McMurtry MS, 2007, AM J PHYSIOL-LUNG C, V292, pL872, DOI 10.1152/ajplung.00309.2006
   McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f
   Meluzín J, 2001, EUR HEART J, V22, P340, DOI 10.1053/euhj.2000.2296
   Michelakis ED, 2003, CIRCULATION, V108, P2066, DOI 10.1161/01.CIR.0000099502.17776.C2
   Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974
   Michelakis ED, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4583
   Miyata M, 2000, INT ARCH ALLERGY IMM, V121, P246, DOI 10.1159/000024324
   Momparler RL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00019
   MONCADA S, 1985, J PHARMACOL-PARIS, V16, P71
   Montani D, 2017, LANCET RESP MED, V5, P125, DOI 10.1016/S2213-2600(16)30438-6
   Montani D, 2010, EUR HEART J, V31, P1898, DOI 10.1093/eurheartj/ehq170
   Morisaki H, 2004, HUM MUTAT, V23, P632, DOI 10.1002/humu.9251
   Mukerji B, 2000, SOUTHERN MED J, V93, P673
   Nagata Y, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005384
   Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266
   Nahar K, 2014, MOL PHARMACEUT, V11, P4374, DOI 10.1021/mp500456k
   NOOTENS M, 1995, J AM COLL CARDIOL, V26, P1581, DOI 10.1016/0735-1097(95)00399-1
   Oikawa M, 2005, J AM COLL CARDIOL, V45, P1849, DOI 10.1016/j.jacc.2005.02.065
   Oka M, 2007, CIRC RES, V100, P923, DOI 10.1161/01.RES.0000261658.12024.18
   Olsson KM, 2014, CIRCULATION, V129, P57, DOI 10.1161/CIRCULATIONAHA.113.004526
   Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654
   Ormiston ML, 2012, CIRCULATION, V126, P1099, DOI 10.1161/CIRCULATIONAHA.112.110619
   Overbeek MJ, 2008, EUR RESPIR J, V31, P1160, DOI 10.1183/09031936.00135407
   Pandey A, 2015, CIRC-HEART FAIL, V8, P1032, DOI 10.1161/CIRCHEARTFAILURE.115.002130
   Parikh VN, 2012, CIRCULATION, V125, P1520, DOI 10.1161/CIRCULATIONAHA.111.060269
   Paul GA, 2005, BRIT J CLIN PHARMACO, V60, P107, DOI 10.1111/j.1365-2125.2005.02383.x
   Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306
   Perros F, 2007, EUR RESPIR J, V29, P937, DOI 10.1183/09031936.00104706
   Perros F, 2007, EUR RESPIR J, V29, P462, DOI 10.1183/09031936.00094706
   Perros F, 2012, AM J RESP CRIT CARE, V185, P311, DOI 10.1164/rccm.201105-0927OC
   Piao L, 2012, CIRCULATION, V126, P2859, DOI 10.1161/CIRCULATIONAHA.112.109868
   Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6
   Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3
   Preston IR, 2015, CIRCULATION, V132, P2403, DOI 10.1161/CIRCULATIONAHA.115.018435
   Prins KW, 2017, PULM CIRC, V7, P145, DOI 10.1086/690017
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Pullamsetti SS, 2012, AM J RESP CRIT CARE, V185, P409, DOI 10.1164/rccm.201106-1093OC
   Qian J, 2015, HYPERTENSION, V66, P1227, DOI 10.1161/HYPERTENSIONAHA.115.06370
   Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141
   Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1
   Raymond RJ, 2002, J AM COLL CARDIOL, V39, P1214, DOI 10.1016/S0735-1097(02)01744-8
   Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024
   Rexhaj E, 2011, AM J PHYSIOL-HEART C, V301, pH247, DOI 10.1152/ajpheart.01309.2010
   Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, pL1182, DOI 10.1152/ajplung.00020.2006
   Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC
   Rich JD, 2011, CHEST, V139, P988, DOI 10.1378/chest.10-1269
   RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216
   Rich S, 1998, CHEST, V114, P787, DOI 10.1378/chest.114.3.787
   RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203
   Rich S, 2010, CHEST, V138, P1234, DOI 10.1378/chest.09-2815
   Robbins IM, 2014, CIRC-HEART FAIL, V7, P116, DOI 10.1161/CIRCHEARTFAILURE.113.000468
   Romberg E., 1891, Deutsches Archiv fur klinische Medizin, V48, P197
   Rothman AMK, 2016, J CLIN INVEST, V126, P2495, DOI 10.1172/JCI83361
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Ryan JJ, 2015, CIRCULATION, V131, P1691, DOI 10.1161/CIRCULATIONAHA.114.006979
   Ryan JJ, 2013, AM J RESP CRIT CARE, V187, P865, DOI 10.1164/rccm.201209-1687OC
   Ryan JJ, 2012, AM HEART J, V163, P589, DOI 10.1016/j.ahj.2012.01.024
   Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015
   Sanchez O, 2007, AM J RESP CRIT CARE, V176, P1041, DOI 10.1164/rccm.200610-1559OC
   Sarkar J, 2010, AM J PHYSIOL-LUNG C, V299, pL861, DOI 10.1152/ajplung.00201.2010
   Schlosser K, 2013, AM J RESP CRIT CARE, V188, P1472, DOI 10.1164/rccm.201308-1403LE
   Scourzic L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0134-6
   Seeger W, 2013, J AM COLL CARDIOL, V62, pD109, DOI 10.1016/j.jacc.2013.10.036
   Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2
   Shapiro S, 2012, CHEST, V141, P363, DOI 10.1378/chest.10-3114
   Sharma S, 2004, AM J PHYSIOL-HEART C, V286, pH1185, DOI 10.1152/ajpheart.00916.2003
   Shehata ML, 2011, AM J ROENTGENOL, V196, P87, DOI 10.2214/AJR.09.4114
   Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079
   Simonneau G, 2013, J AM COLL CARDIOL, V62, pD34, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]
   Sitbon O, 2005, CIRCULATION, V111, P3105, DOI 10.1161/CIRCULATIONAHA.104.488486
   Sitbon O, 2015, NEW ENGL J MED, V373, P2522, DOI 10.1056/NEJMoa1503184
   Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313
   Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214
   Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762
   Spiekerkoetter E, 2013, J CLIN INVEST, V123, P3600, DOI 10.1172/JCI65592
   Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992
   Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046
   Syrris P, 2006, AM J HUM GENET, V79, P978, DOI 10.1086/509122
   Taichman DB, 2014, CHEST, V146, P449, DOI 10.1378/chest.14-0793
   Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927
   Tapson VF, 2013, CHEST, V144, P952, DOI 10.1378/chest.12-2875
   Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9
   Thenappan T, 2007, EUR RESPIR J, V30, P1103, DOI 10.1183/09031936.00042107
   Thenappan T, 2010, EUR RESPIR J, V35, P1079, DOI 10.1183/09031936.00072709
   Thenappan T, 2011, CIRC-HEART FAIL, V4, P257, DOI 10.1161/CIRCHEARTFAILURE.110.958801
   Torbicki A, 2003, CIRCULATION, V108, P844, DOI 10.1161/01.CIR.0000084544.54513.E2
   Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503
   Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010
   Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025
   Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438
   Ulrich S, 2017, EUR HEART J, V38, P1159, DOI 10.1093/eurheartj/ehx099
   van Campen JSJA, 2016, EUR RESPIR J, V48, P787, DOI 10.1183/13993003.00090-2016
   van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068
   van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477
   Wang DR, 2014, CIRC RES, V114, P67, DOI 10.1161/CIRCRESAHA.114.301633
   Wang G, 2013, AM J PHYSIOL-HEART C, V305, pH1451, DOI 10.1152/ajpheart.00238.2013
   Waxman AB, 2017, CHEST
   Wei AH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003896
   White K, 2014, HYPERTENSION, V64, P185, DOI 10.1161/HYPERTENSIONAHA.113.03037
   Xu XF, 2010, J HYPERTENS, V28, P2227, DOI 10.1097/HJH.0b013e32833e08f1
   Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458
   Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400
   Zhang HR, 2017, ARTERIOSCL THROM VAS, V37, P2000, DOI 10.1161/ATVBAHA.117.309195
   Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327
   Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176
NR 242
TC 612
Z9 660
U1 16
U2 261
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0959-535X
EI 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD MAR 14
PY 2018
VL 360
AR j5492
DI 10.1136/bmj.j5492
PG 27
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA FZ9FZ
UT WOS:000427916700001
PM 29540357
OA Green Published
HC Y
HP N
DA 2024-11-01
ER

PT J
AU Passtoors, WM
   Beekman, M
   Gunn, D
   Boer, JM
   Heijmans, BT
   Westendorp, RGJ
   Zwaan, BJ
   Slagboom, PE
AF Passtoors, W. M.
   Beekman, M.
   Gunn, D.
   Boer, J. M.
   Heijmans, B. T.
   Westendorp, R. G. J.
   Zwaan, B. J.
   Slagboom, P. E.
TI Genomic studies in ageing research: the need to integrate genetic and
   gene expression approaches
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article; Proceedings Paper
CT Symposium on the Biology of Aging
CY SEP, 2007
CL Stockholm, SWEDEN
SP Biotechnol Biolog Sci Res Council, Med Res Council, Wellcome Trust, Unilever plc, Ellison Med Fdn, Nat Inst Hlth, Swedish Res Council, Swedish Heart Lunch Fdn
DE ageing; expression; genomics; longevity; transcriptomics
ID SEX-SPECIFIC REGULATION; TRANSCRIPTIONAL PROFILE; CALORIC RESTRICTION;
   SKELETAL-MUSCLE; MICROARRAY DATA; HUMAN LONGEVITY; SAMPLE-SIZE;
   OLDEST-OLD; BLOOD; DISEASE
AB Genome-wide and hypothesis-based approaches to the study of ageing and longevity have been dominated by genetic investigations. To identify essential mechanisms of a complex trait such as ageing in higher species, a holistic understanding of interacting pathways is required. More information on such interactions is expected to be obtained from global gene expression analysis if combined with genetic studies. Genetic sequence variation often provides a functional gene marker for the trait, whereas a gene expression profile may provide a quantitative biomarker representing complex cellular pathway interactions contributing to the trait. Thus far, gene expression studies have associated multiple pathways to ageing including mitochondrial electron transport and the oxidative stress response. However, most of the studies are underpowered to detect small age-changes. A systematic survey of gene expression changes as a function of age in human individuals and animal models is lacking. Well designed gene expression studies, especially at the level of biological processes, will provide hypotheses on gene-environmental interactions determining biological ageing rate. Cross-sectional studies monitoring the profile as a chronological marker of ageing must be integrated with prospective studies indicating which profiles represent biomarkers preceding and predicting physiological decline and mortality. New study designs such as the Leiden Longevity Study, including two generations of subjects from longevity families, aim to achieve these combined approaches.
C1 [Passtoors, W. M.; Beekman, M.; Heijmans, B. T.; Slagboom, P. E.] Leiden Univ, Med Ctr, Sect Mol Epidemiol, NL-2300 RC Leiden, Netherlands.
   [Gunn, D.] Unilever Corp Res Corp Res, Colworth Lab, Bedford, England.
   [Westendorp, R. G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.
   [Zwaan, B. J.] Leiden Univ, Inst Biol, Sect Evolutionary Biol, Leiden, Netherlands.
C3 Leiden University - Excl LUMC; Leiden University; Leiden University
   Medical Center (LUMC); Unilever; Leiden University; Leiden University
   Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University;
   Leiden University - Excl LUMC
RP Passtoors, WM (corresponding author), Leiden Univ, Med Ctr, Sect Mol Epidemiol, POB 9600,Zone S5-P, NL-2300 RC Leiden, Netherlands.
EM w.m.passtoors@lumc.nl
RI Boer, Judith/A-7546-2010; Slagboom, Pieternella/R-4790-2016; Zwaan,
   Bas/D-8721-2015; Beekman, Marian/L-3004-2019
OI Boer, Judith/0000-0003-4848-7789; Slagboom,
   Pieternella/0000-0002-2875-4723; Gunn, David/0000-0001-9866-3221; Zwaan,
   Bas/0000-0002-8221-4998; Beekman, Marian/0000-0003-0585-6206
CR Achiron A, 2006, AUTOIMMUN REV, V5, P517, DOI 10.1016/j.autrev.2006.02.009
   Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501
   Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749
   Ambra R, 2004, EXP GERONTOL, V39, P1475, DOI 10.1016/j.exger.2004.07.009
   Baird AE, 2007, STROKE, V38, P694, DOI 10.1161/01.STR.0000250431.99687.7b
   Barzilai N, 2001, J AM GERIATR SOC, V49, P76, DOI 10.1046/j.1532-5415.2001.49013.x
   Batliwalla FM, 2005, MOL MED, V11, P21, DOI 10.2119/2006-00003.Gulko
   Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102
   CAL SX, 2001, P NATL ACAD SCI USA, V98, P10630
   Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8
   Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P401, DOI 10.1007/s10522-004-3188-1
   Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6
   Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871
   Corder EH, 1996, ARCH NEUROL-CHICAGO, V53, P418, DOI 10.1001/archneur.1996.00550050048022
   Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x
   DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279
   Dobbin K, 2005, BIOSTATISTICS, V6, P27, DOI 10.1093/biostatistics/kxh015
   Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034
   Fjaerli HO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-175
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Garge NR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S10
   Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69
   Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382
   Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Han ES, 2001, MECH AGEING DEV, V122, P999, DOI 10.1016/S0047-6374(01)00215-9
   Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917
   Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857
   Heijmans BT, 2006, PLOS MED, V3, P2317, DOI 10.1371/journal.pmed.0030495
   Heijmans BT, 2000, EXP GERONTOL, V35, P865, DOI 10.1016/S0531-5565(00)00171-6
   Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150
   Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135
   Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042
   HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007
   Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298
   Izuhara Kenji, 2006, Allergol Int, V55, P361, DOI 10.2332/allergolint.55.361
   Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Kyng KJ, 2005, AGEING RES REV, V4, P579, DOI 10.1016/j.arr.2005.06.008
   Kyng KJ, 2003, P NATL ACAD SCI USA, V100, P12259, DOI 10.1073/pnas.2130723100
   Lacelle C, 2002, MECH AGEING DEV, V123, P1133, DOI 10.1016/S0047-6374(02)00005-2
   LAGAAY AM, 1992, ARCH GERONTOL GERIAT, V15, P115, DOI 10.1016/0167-4943(92)90012-S
   Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003
   Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   McElwee JJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r132
   Michiels S, 2007, BRIT J CANCER, V96, P1155, DOI 10.1038/sj.bjc.6603673
   Nagasaka Y, 2005, P NATL ACAD SCI USA, V102, P14854, DOI 10.1073/pnas.0504178102
   Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001
   Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115
   Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448
   Perls TT, 1998, LANCET, V351, P1560, DOI 10.1016/S0140-6736(05)61126-9
   Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Qiu HY, 2007, PHYSIOL GENOMICS, V29, P169, DOI 10.1152/physiolgenomics.00229.2006
   Rao DV, 2003, MECH AGEING DEV, V124, P55, DOI 10.1016/S0047-6374(02)00170-7
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502
   Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508
   Sharma A, 2005, PHYSIOL GENOMICS, V21, P117, DOI 10.1152/physiolgenomics.00228.2003
   Sharp FR, 2007, STROKE, V38, P691, DOI 10.1161/01.STR.0000247940.27518.38
   Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529
   Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/136905203770326457
   Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098
   Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V283, pE38, DOI 10.1152/ajpendo.00387.2001
   Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272
   Tan QH, 2005, HUM GENET, V117, P267, DOI 10.1007/s00439-005-1308-x
   Tang Y, 2005, ARCH NEUROL-CHICAGO, V62, P210, DOI 10.1001/archneur.62.2.210
   Tang Y, 2006, J CEREBR BLOOD F MET, V26, P1089, DOI 10.1038/sj.jcbfm.9600264
   Tatar Marc, 2007, V35, P115
   Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x
   Tower J, 2006, MECH AGEING DEV, V127, P705, DOI 10.1016/j.mad.2006.05.001
   van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324
   van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a
   Vijg J, 2003, MECH AGEING DEV, V124, P3, DOI 10.1016/S0047-6374(02)00163-X
   Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011
   Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003
   Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499
   Yang T, 2004, MOL BRAIN RES, V132, P155, DOI 10.1016/j.molbrainres.2003.10.014
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
NR 86
TC 15
Z9 15
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB
PY 2008
VL 263
IS 2
BP 153
EP 166
DI 10.1111/j.1365-2796.2007.01904.x
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC General & Internal Medicine
GA 254AE
UT WOS:000252557900005
PM 18226093
OA Bronze
DA 2024-11-01
ER

PT J
AU Sandford, E
   Burmeister, M
AF Sandford, Erin
   Burmeister, Margit
TI Genes and Genetic Testing in Hereditary Ataxias
SO GENES
LA English
DT Review
DE ataxia; genetics; pathways; testing
ID MACHADO-JOSEPH-DISEASE; DOMINANT CEREBELLAR-ATAXIA; OCULOMOTOR APRAXIA
   TYPE-2; SPINOCEREBELLAR ATAXIA; EPISODIC ATAXIA; UBIQUITIN LIGASE;
   REPEAT EXPANSION; DIAGNOSTIC-TOOL; STRAND BREAKS; CHANNEL GENE
AB Ataxia is a neurological cerebellar disorder characterized by loss of coordination during muscle movements affecting walking, vision, and speech. Genetic ataxias are very heterogeneous, with causative variants reported in over 50 genes, which can be inherited in classical dominant, recessive, X-linked, or mitochondrial fashion. A common mechanism of dominant ataxias is repeat expansions, where increasing lengths of repeated DNA sequences result in non-functional proteins that accumulate in the body causing disease. Greater understanding of all ataxia genes has helped identify several different pathways, such as DNA repair, ubiquitination, and ion transport, which can be used to help further identify new genes and potential treatments. Testing for the most common mutations in these genes is now clinically routine to help with prognosis and treatment decisions, but next generation sequencing will revolutionize how genetic testing will be done. Despite the large number of known ataxia causing genes, however, many individuals with ataxia are unable to obtain a genetic diagnosis, suggesting that more genes need to be discovered. Utilization of next generation sequencing technologies, expression studies, and increased knowledge of ataxia pathways will aid in the identification of new ataxia genes.
C1 [Sandford, Erin; Burmeister, Margit] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.
   [Burmeister, Margit] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan; University of Michigan System;
   University of Michigan; University of Michigan System; University of
   Michigan
RP Burmeister, M (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.
EM esandfor@umich.edu; margit@umich.edu
RI Burmeister, Margit/A-3157-2013
OI Burmeister, Margit/0000-0002-1914-2434
FU National Institutes of Health (NIH) [R01-NS078560]
FX We would like to acknowledge the National Ataxia Foundation (NAF) for
   their assistance in recruitment and opportunity to meet and discuss with
   those affected by ataxia. We would like to thank our many clinical
   colleagues for recruitment and discussions, and all of the families that
   have taken time to donate samples and personal stories. Our ataxia
   research is funded by the National Institutes of Health (NIH) grant
   R01-NS078560.
CR Andersson PL, 2013, NURS ETHICS, V20, P189, DOI 10.1177/0969733012452686
   [Anonymous], TEST CAT
   Archibald AD, 2013, AM J MED GENET A, V161A, P48, DOI 10.1002/ajmg.a.35674
   Baloh Robert W, 2012, Handb Clin Neurol, V103, P595, DOI 10.1016/B978-0-444-51892-7.00042-5
   Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005
   Bertini E, 2000, AM J MED GENET, V92, P53, DOI 10.1002/(SICI)1096-8628(20000501)92:1<53::AID-AJMG9>3.0.CO;2-F
   Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680
   Bidichandani SI, 1997, AM J HUM GENET, V60, P1251
   Bilguvar K, 2013, P NATL ACAD SCI USA, V110, P3489, DOI 10.1073/pnas.1222732110
   BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136
   Cagnoli C., HUM MUTAT
   Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423
   Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771
   Castelnovo G, 2000, J NEUROL NEUROSUR PS, V69, P693, DOI 10.1136/jnnp.69.5.693
   Chapdelaine P, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.41
   Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371
   Conroy J, 2014, EUR J HUM GENET, V22, P505, DOI 10.1038/ejhg.2013.173
   Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707
   Cruz-Mariño T, 2013, J COMMUN GENET, V4, P451, DOI 10.1007/s12687-013-0147-z
   Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1
   Doi H, 2013, INTERNAL MED, V52, P1629, DOI 10.2169/internalmedicine.52.0252
   Dombrowski C, 2002, HUM MOL GENET, V11, P371, DOI 10.1093/hmg/11.4.371
   Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700
   Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452
   Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6
   Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1
   El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314
   Embiruçu EK, 2009, ARQ NEURO-PSIQUIAT, V67, P1143, DOI 10.1590/S0004-282X2009000600036
   Erez A, 2010, AM J MED GENET A, V152A, P1774, DOI 10.1002/ajmg.a.33432
   Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909
   Faruq M, 2014, CLIN GENET, V86, P335, DOI 10.1111/cge.12279
   Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6
   FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5
   HABERHAUSEN G, 1995, J NEUROL SCI, V132, P71, DOI 10.1016/0022-510X(95)90927-I
   Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127
   Hammer MB, 2013, EUR J NEUROL, V20, P486, DOI 10.1111/j.1468-1331.2012.03883.x
   Hartley JN, 2012, CASE REP PEDIAT, V2012, DOI 10.1155/2012/303096
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67
   Iwaki A, 2008, J MED GENET, V45, P32, DOI 10.1136/jmg.2007.053942
   Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a
   Jia DD, 2012, INT J NEUROSCI, V122, P560, DOI 10.3109/00207454.2012.690796
   Joo BE, 2012, CEREBELLUM, V11, P733, DOI 10.1007/s12311-011-0332-8
   Ju H, 2013, J NEUROSCI, V33, P9328, DOI 10.1523/JNEUROSCI.3465-12.2013
   KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221
   Knight MA, 2003, NEUROBIOL DIS, V13, P147, DOI 10.1016/S0969-9961(03)00029-9
   Koht J, 2007, ACTA NEUROL SCAND, V115, P76, DOI 10.1111/j.1600-0404.2007.00853.x
   Konno A, 2014, CEREBELLUM, V13, P29, DOI 10.1007/s12311-013-0516-5
   Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038
   Le Ber I, 2004, BRAIN, V127, P759, DOI 10.1093/brain/awh080
   Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297
   Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014
   Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701
   Lhatoo SD, 2001, NEUROLOGY, V56, P1776, DOI 10.1212/WNL.56.12.1776
   Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032
   Lu JP, 2011, J BIOL CHEM, V286, P24426, DOI 10.1074/jbc.M111.251983
   Margolin DH, 2013, NEW ENGL J MED, V368, P1992, DOI 10.1056/NEJMoa1215993
   Mitsui J, 2013, NEW ENGL J MED, V369, P233, DOI 10.1056/NEJMoa1212115
   Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189
   Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Nikali K, 2005, HUM MOL GENET, V14, P2981, DOI 10.1093/hmg/ddi328
   Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8
   Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2
   ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221
   Paulson HL, 2009, J NEURO-OPHTHALMOL, V29, P227, DOI 10.1097/WNO0b013e3181b416de
   Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269
   Regal JA, 2013, HUM MOL GENET, V22, P5146, DOI 10.1093/hmg/ddt368
   Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51
   ROUSSEAU F, 1995, AM J HUM GENET, V57, P1006
   Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6
   Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277
   Sawyer SL, 2014, HUM MUTAT, V35, P45, DOI 10.1002/humu.22451
   SCHWARTZ CE, 1994, AM J MED GENET, V51, P400, DOI 10.1002/ajmg.1320510419
   Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036
   Shi CH, 2014, HUM MOL GENET, V23, P1013, DOI 10.1093/hmg/ddt497
   STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0
   Sun Y, 2013, HUM MUTAT, V34, P706, DOI 10.1002/humu.22292
   Suraweera A, 2007, J CELL BIOL, V177, P969, DOI 10.1083/jcb.200701042
   Suraweera A, 2009, HUM MOL GENET, V18, P3384, DOI 10.1093/hmg/ddp278
   Suzuki K, 2012, NEUROBIOL DIS, V46, P336, DOI 10.1016/j.nbd.2012.01.014
   Synofzik M, 2012, CEREBELLUM, V11, P1002, DOI 10.1007/s12311-012-0378-2
   Takahashi T, 2007, NUCLEIC ACIDS RES, V35, P3797, DOI 10.1093/nar/gkm158
   Tanaka K, 2013, J HUM GENET, V58, P560, DOI 10.1038/jhg.2013.34
   Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401
   The University of Chicago, AT EX PAN
   Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026
   Valdmanis PN, 2011, BRAIN, V134, P602, DOI 10.1093/brain/awq329
   van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108
   Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015
   Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758
   Winkelmann J, 2012, HUM MOL GENET, V21, P2205, DOI 10.1093/hmg/dds035
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zamba-Papanicolaou E, 2009, Acta Myol, V28, P24
   Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109
   Zhou T, 2005, NUCLEIC ACIDS RES, V33, P289, DOI 10.1093/nar/gki170
   Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62
   Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108
NR 98
TC 25
Z9 25
U1 0
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4425
J9 GENES-BASEL
JI Genes
PD SEP
PY 2014
VL 5
IS 3
BP 586
EP 603
DI 10.3390/genes5030586
PG 18
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA CA4EU
UT WOS:000348857800007
PM 25055202
OA Green Submitted, Green Published, gold
DA 2024-11-01
ER

PT J
AU Vecoli, C
   Borghini, A
   Pulignani, S
   Mercuri, A
   Turchi, S
   Picano, E
   Andreassi, MG
AF Vecoli, Cecilia
   Borghini, Andrea
   Pulignani, Silvia
   Mercuri, Antonella
   Turchi, Stefano
   Picano, Eugenio
   Andreassi, Maria Grazia
TI Independent and Combined Effects of Telomere Shortening and
   mtDNA<SUP>4977</SUP> Deletion on Long-term Outcomes of Patients with
   Coronary Artery Disease
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE major adverse cardiac events; all-cause mortality; leucocyte telomere
   length; mtDNA(4977) common deletion; coronary artery disease
ID MITOCHONDRIAL-DNA DAMAGE; 4977 BP DELETION; PROGNOSTIC VALUE; LENGTH;
   HEART; ATHEROSCLEROSIS; ASSOCIATION; DYSFUNCTION; CANCER; MUSCLE
AB Aging is one of the main risk factors for cardiovascular disease, resulting in a progressive organ and cell decline. This study evaluated a possible joint impact of two emerging hallmarks of aging, leucocyte telomere length (LTL) and common mitochondrial DNA deletion (mtDNA(4977)), on major adverse cardiovascular events (MACEs) and all-cause mortality in patients with coronary artery disease (CAD). We studied 770 patients (673 males, 64.8 +/- 8.3 years) with known or suspected stable CAD. LTL and mtDNA(4977) deletion were assessed in peripheral blood using qRT-PCR. During a median follow-up of 5.4 +/- 1.2 years, MACEs were 140 while 86 deaths were recorded. After adjustments for confounding risk factors, short LTLs and high mtDNA(4977) deletion levels acted independently as predictors of MACEs (HR: 2.2, 95% CI: 1.2-3.9, p = 0.01 and HR: 1.7, 95% CI: 1.1-2.9, p = 0.04; respectively) and all-cause mortality events (HR: 2.1, 95% CI: 1.1-4.6, p = 0.04 and HR: 2.3, 95% CI: 1.1-4.9, p = 0.02; respectively). Patients with both short LTLs and high mtDNA(4977) deletion levels had an increased risk for MACEs (HR: 4.3; 95% CI: 1.9-9.6; p = 0.0006) and all-cause mortality (HR: 6.0; 95% CI: 2.0-18.4; p = 0.001). The addition of mtDNA(4977) deletion to a clinical reference model was associated with a significant net reclassification improvement (NRI = 0.18, p = 0.01). Short LTL and high mtDNA(4977) deletion showed independent and joint predictive value on adverse cardiovascular outcomes and all-cause mortality in patients with CAD. These findings strongly support the importance of evaluating biomarkers of physiological/biological age, which can predict disease risk and mortality more accurately than chronological age.
C1 [Vecoli, Cecilia; Borghini, Andrea; Pulignani, Silvia; Mercuri, Antonella; Turchi, Stefano; Picano, Eugenio; Andreassi, Maria Grazia] CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
C3 Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica
   (IFC-CNR)
RP Vecoli, C; Andreassi, MG (corresponding author), CNR, Inst Clin Physiol, Via Moruzzi 1, I-56124 Pisa, Italy.
EM vecoli@ifc.cnr.it; aborghini@ifc.cnr.it; pulignani@ifc.cnr.it;
   mercuri@ifc.cnr.it; turchi@ifc.cnr.it; picano@ifc.cnr.it;
   mariagrazia.andreassi@ifc.cnr.it
RI Picano, Eugenio/JCR-0697-2023; Vecoli, Cecilia/K-8613-2016
OI Vecoli, Cecilia/0000-0002-5921-3604
FU National Research Council (CNR) grant Progetto di Interesse
   "Invecchiamento"
FX This research was partially funded by the National Research Council
   (CNR) grant Progetto di Interesse "Invecchiamento". The funders had no
   role in the design of the study; in the collection, analyses, or
   interpretation of data; in the writing of the manuscript, or in the
   decision to publish the results.
CR Ait-Aissa K, 2016, PHARMACOL RES, V111, P422, DOI 10.1016/j.phrs.2016.07.003
   Andreassi MG, 2015, JACC-CARDIOVASC INTE, V8, P616, DOI 10.1016/j.jcin.2014.12.233
   Andreassi MG, 2012, ATHEROSCLEROSIS, V223, P409, DOI 10.1016/j.atherosclerosis.2012.05.029
   [Anonymous], 2017, AM J EPIDEMIOL, DOI DOI 10.1093/aje/kww210
   Botto N, 2005, MUTAT RES-FUND MOL M, V570, P81, DOI 10.1016/j.mrfmmm.2004.10.003
   Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373
   Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485
   Fajemiroye JO, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7156435
   Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14
   Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049
   Fetterman JL, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0372-y
   Fyhrquist F, 2013, NAT REV CARDIOL, V10, P274, DOI 10.1038/nrcardio.2013.30
   Goglin SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160748
   Gonzalez-Ebsen AC, 2017, FRONT BIOSCI-LANDMRK, V22, P117, DOI 10.2741/4475
   Hammadah M, 2017, CIRC RES, V120, P1130, DOI 10.1161/CIRCRESAHA.116.309421
   Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Lowsky DJ, 2014, J GERONTOL A-BIOL, V69, P640, DOI 10.1093/gerona/glt162
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004
   Moslehi J, 2012, CIRC RES, V110, P1226, DOI 10.1161/CIRCRESAHA.111.246868
   Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848
   Pallis AG, 2014, J GERIATR ONCOL, V5, P204, DOI 10.1016/j.jgo.2013.09.001
   Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Perez-Rivera JA, 2014, AM J CARDIOL, V113, P418, DOI 10.1016/j.amjcard.2013.10.009
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Sobenin IA, 2015, GERONTOLOGY, V61, P343, DOI 10.1159/000368923
   Vecoli C, 2018, ATHEROSCLEROSIS, V276, P91, DOI 10.1016/j.atherosclerosis.2018.07.015
   Vecoli C, 2016, INT J CARDIOL, V204, P17, DOI 10.1016/j.ijcard.2015.11.133
   Wang Y, 2017, ARTERIOSCL THROM VAS, V37, pE99, DOI 10.1161/ATVBAHA.117.309580
   Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271
   Yu E, 2012, CARDIOVASC RES, V95, P173, DOI 10.1093/cvr/cvs111
NR 40
TC 15
Z9 16
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2019
VL 20
IS 21
AR 5508
DI 10.3390/ijms20215508
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA JQ4VU
UT WOS:000498946100266
PM 31694204
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Nivison, MP
   Ericson, NG
   Green, VM
   Bielas, JH
   Campbell, JS
   Horner, PJ
AF Nivison, Mary P.
   Ericson, Nolan G.
   Green, Virginia M.
   Bielas, Jason H.
   Campbell, Jean S.
   Horner, Philip J.
TI Age-related accumulation of phosphorylated mitofusin 2 protein in
   retinal ganglion cells correlates with glaucoma progression
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Mitofusin; Mitochondria; Phosphorylation; Axon transport;
   Neurodegeneration; Mutation frequency
ID DBA/2J MOUSE MODEL; MITOCHONDRIAL FUSION; PINK1/PARKIN PATHWAY;
   OXIDATIVE STRESS; SKELETAL-MUSCLE; DYSFUNCTION; MUTATIONS;
   QUANTIFICATION; TRANSPORT; ATROPHY
AB Dysregulation of axonal bioenergetics is likely a key mechanism in the initiation and progression of age-related neurodegenerative diseases. Glaucoma is a quintessential neurodegenerative disorder characterized by progressive deterioration of the optic nerve (ON) and eventual death of retinal ganglion cells (RGCs). Age and elevation of intraocular pressure are key risk factors in glaucoma, but the common early hallmarks of decreased axonal transport and increased bioenergetic vulnerability likely underlie disease initiation. We examined the correlation between bioenergetics and axonal transport with mitochondrial mutation frequency and post-translational modifications of mitofusin 2 (Mfn2) in RGCs during glaucoma progression. No increase in the frequency of mtDNA mutations was detected, but we observed significant shifts in mitochondrial protein species. Mfn2 is a fusion protein that functions in mitochondrial biogenesis, maintenance, and mitochondrial transport. We demonstrate that Mfn2 accumulates selectively in RGCs during glaucomatous degeneration, that two novel states of Mfn2 exist in retina and ON, and identify a phosphorylated form that selectively accumulates in RGCs, but is absent in ON. Phosphorylation of Mfn2 is correlated with higher ubiquitination, and failure of the protein to reach the ON. Together, these data suggest that post-translational modification of Mfn2 is associated with its dysregulation during a window of metabolic vulnerability that precedes glaucomatous degeneration. Future work to either manipulate expression of Mfn2 or to prevent its degradation could have therapeutic value in the treatment of neurodegenerative diseases where long-tract axons are vulnerable. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Nivison, Mary P.; Bielas, Jason H.; Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Ericson, Nolan G.; Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Translat Res Program, 1124 Columbia St, Seattle, WA 98104 USA.
   [Green, Virginia M.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA.
   [Bielas, Jason H.] Fred Hutchinson Canc Res Ctr, Human Biol Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Campbell, Jean S.] Fred Hutchinson Canc Res Ctr, Program Immunol, Div Clin Res, Seattle, WA 98109 USA.
   [Horner, Philip J.] Houston Methodist Res Inst, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.
C3 University of Washington; University of Washington Seattle; Fred
   Hutchinson Cancer Center; Benaroya Research Institute; Fred Hutchinson
   Cancer Center; University of Washington; University of Washington
   Seattle; Fred Hutchinson Cancer Center; Houston Methodist Hospital
RP Horner, PJ (corresponding author), Houston Methodist Res Inst, Dept Neurol Surg, Ctr Regenerat & Restorat Neurosurg, Ctr Neuroregenerat Med, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.; Horner, PJ (corresponding author), Houston Methodist Res Inst, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.
EM pjhorner@houstonmethodist.org
RI Horner, Philip/AAF-7012-2021
OI Campbell, Jean/0000-0002-9187-2204
FU Glaucoma Research Foundation Catalyst for a Cure Initiative; Melza M.
   and Frank Theodore Barr Foundation; Ellison Medical Foundation New
   Scholar award [AG-NS-0577-09]; Outstanding New Environmental Scientist
   Award (ONES) from the National Institute of Environmental Health
   Sciences [ES019319]; Congressionally Directed Medical Research
   Programs/U.S. Department of Defense [W81XWH-10-1-0563]
FX This work was supported by the Glaucoma Research Foundation Catalyst for
   a Cure Initiative, and the Melza M. and Frank Theodore Barr Foundation
   (awarded to PJ.H.). Mutational analysis work was supported by the
   following (awarded to J.H.B.): an Ellison Medical Foundation New Scholar
   award (AG-NS-0577-09), an Outstanding New Environmental Scientist Award
   (ONES) (R01) from the National Institute of Environmental Health
   Sciences (ES019319), and a grant from the Congressionally Directed
   Medical Research Programs/U.S. Department of Defense (W81XWH-10-1-0563).
   We thank Renay Bauer, Kathleen R. Braun, Denise M. Inman, PhD, Melissa
   O. Johnson, and Irina Mineyev, PhD for their assistance and support.
CR Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298
   Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794
   Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010
   Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751
   Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337
   Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008
   Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001
   Calkins DJ, 2012, INVEST OPHTH VIS SCI, V53, P2482, DOI 10.1167/iovs.12-9483i
   Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang B, 1999, NAT GENET, V21, P405, DOI 10.1038/7741
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026
   Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026
   Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031
   Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723
   Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2
   Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008
   Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021
   Cooper ML, 2016, EXP EYE RES, V150, P22, DOI 10.1016/j.exer.2015.11.016
   Corazao-Rozas P, 2016, ONCOTARGET, V7, P39473, DOI 10.18632/oncotarget.7790
   Coughlin L, 2015, INVEST OPHTH VIS SCI, V56, P1437, DOI 10.1167/iovs.14-16126
   Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079
   Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Elgass K, 2013, BBA-MOL CELL RES, V1833, P150, DOI 10.1016/j.bbamcr.2012.05.002
   Eschenbacher WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044296
   Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025
   Frogne T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035233
   Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419
   Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x
   Gong GH, 2015, SCIENCE, V350, DOI 10.1126/science.aad2459
   Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181
   Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002
   Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109
   Inman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065389
   Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925
   Jarrett Stuart G, 2013, Methods Mol Biol, V935, P227, DOI 10.1007/978-1-62703-080-9_16
   Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417
   Lambert W., 2008, INVEST OPHTHALMOL VI, V49, P5498
   Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015
   Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130
   Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380
   Mishra P, 2015, CELL METAB, V22, P1033, DOI 10.1016/j.cmet.2015.09.027
   Misko A, 2010, J NEUROSCI, V30, P4232, DOI 10.1523/JNEUROSCI.6248-09.2010
   Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184
   Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100
   Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117
   O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103
   Park J, 2015, J NEUROCHEM, V132, P687, DOI 10.1111/jnc.12984
   Peng KG, 2017, MOL NEUROBIOL, V54, P3783, DOI 10.1007/s12035-016-9944-9
   Perlson E, 2010, TRENDS NEUROSCI, V33, P335, DOI 10.1016/j.tins.2010.03.006
   Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105
   Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054
   Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042
   Shen HW, 2008, BRAIN STRUCT FUNCT, V213, P149, DOI 10.1007/s00429-008-0184-2
   Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004391
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tanwar M, 2010, MOL VIS, V16, P518
   Uo T, 2009, EXP NEUROL, V218, P274, DOI 10.1016/j.expneurol.2009.05.010
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vermulst M, 2008, METHODS, V46, P263, DOI 10.1016/j.ymeth.2008.10.008
   Whitworth AJ, 2009, J BIOENERG BIOMEMBR, V41, P499, DOI 10.1007/s10863-009-9253-3
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yue W, 2014, CELL RES, V24, P482, DOI 10.1038/cr.2014.20
   Zhou B, 2016, J CELL BIOL, V214, P103, DOI 10.1083/jcb.201605101
NR 68
TC 13
Z9 14
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD OCT
PY 2017
VL 296
BP 49
EP 61
DI 10.1016/j.expneurol.2017.07.001
PG 13
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA FE6CC
UT WOS:000408296600006
PM 28684211
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Roh, J
   Rhee, J
   Chaudhari, V
   Rosenzweig, A
AF Roh, Jason
   Rhee, James
   Chaudhari, Vinita
   Rosenzweig, Anthony
TI The Role of Exercise in Cardiac Aging From Physiology to Molecular
   Mechanisms
SO CIRCULATION RESEARCH
LA English
DT Review
DE aging; cardiovascular diseases; exercise; heart; phenotype
ID MITOCHONDRIAL-DNA MUTATIONS; OXIDATIVE STRESS-RESPONSE; ADENOVIRAL
   GENE-TRANSFER; AGE-ASSOCIATED CHANGES; LEFT-VENTRICULAR MASS; CHRONIC
   HEART-FAILURE; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; ENDURANCE
   EXERCISE; CARDIOVASCULAR-RESPONSES
AB Aging induces structural and functional changes in the heart that are associated with increased risk of cardiovascular disease and impaired functional capacity in the elderly. Exercise is a diagnostic and therapeutic tool, with the potential to provide insights into clinical diagnosis and prognosis, as well as the molecular mechanisms by which aging influences cardiac physiology and function. In this review, we first provide an overview of how aging impacts the cardiac response to exercise, and the implications this has for functional capacity in older adults. We then review the underlying molecular mechanisms by which cardiac aging contributes to exercise intolerance, and conversely how exercise training can potentially modulate aging phenotypes in the heart. Finally, we highlight the potential use of these exercise models to complement models of disease in efforts to uncover new therapeutic targets to prevent or treat heart disease in the aging population.
C1 [Roh, Jason; Rhee, James; Chaudhari, Vinita; Rosenzweig, Anthony] Massachusetts Gen Hosp, Div Cardiovasc, Boston, MA 02114 USA.
   [Roh, Jason] Massachusetts Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02114 USA.
   [Rhee, James] Harvard Univ, Sch Med, Boston, MA USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Massachusetts General Hospital; Harvard University; Harvard Medical
   School
RP Rosenzweig, A (corresponding author), Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St,Bigelow 800,Mailstop 817, Boston, MA 02114 USA.
EM arosenzweig@partners.org
RI Rosenzweig, Anthony/AAD-7893-2019; Rhee, James/V-9973-2019
FU National Institutes of Health [R01HL110733, R01HL122987, T32HL073734,
   T32GM007592]; LaDue Fellowship Award from Harvard Medical School
FX This work was supported by grants from the National Institutes of Health
   (A. Rosenzweig [R01HL110733 and R01HL122987], Dr Roh [T32HL073734], and
   J. Rhee [T32GM007592]). Roh was also supported by a LaDue Fellowship
   Award from Harvard Medical School. A. Rosenzweig is a principal faculty
   member of the Harvard Stem Cell Institute.
CR Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a
   Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005
   ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7
   Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615
   Arbab-Zadeh A, 2004, CIRCULATION, V110, P1799, DOI 10.1161/01.CIR.0000142863.71285.74
   Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063
   Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005
   Bayod S, 2012, EXP GERONTOL, V47, P925, DOI 10.1016/j.exger.2012.08.004
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bhella PS, 2014, J AM COLL CARDIOL, V64, P1257, DOI 10.1016/j.jacc.2014.03.062
   Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842
   Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205
   Bodyak N, 2002, NUCLEIC ACIDS RES, V30, P3788, DOI 10.1093/nar/gkf497
   BOHM M, 1993, AM J PHYSIOL, V264, pH805, DOI 10.1152/ajpheart.1993.264.3.H805
   Borlaug BA, 2010, J AM COLL CARDIOL, V56, P845, DOI 10.1016/j.jacc.2010.03.077
   Boström P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036
   Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010
   Brenner DA, 2001, CIRCULATION, V104, P221, DOI 10.1161/01.CIR.104.2.221
   Brodde OE, 1999, PHARMACOL REV, V51, P651
   Brodde OE, 1998, J CLIN INVEST, V101, P471, DOI 10.1172/JCI1113
   Brubaker PH, 2011, CIRCULATION, V123, P1010, DOI 10.1161/CIRCULATIONAHA.110.940577
   Bye A, 2008, PHYSIOL GENOMICS, V33, P100, DOI 10.1152/physiolgenomics.00269.2007
   Cain BS, 1998, J AM COLL CARDIOL, V32, P458, DOI 10.1016/S0735-1097(98)00233-2
   Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582
   Ceylan-Isik AF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0335-3
   Cherry AD, 2014, J BIOL CHEM, V289, P41, DOI 10.1074/jbc.M113.512483
   Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106
   Choi SY, 2009, J KOREAN MED SCI, V24, P32, DOI 10.3346/jkms.2009.24.1.32
   Chung E, 2013, CARDIOVASC RES, V100, P402, DOI 10.1093/cvr/cvt208
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004
   Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403
   Davies CH, 1996, CARDIOVASC RES, V31, P152, DOI 10.1016/S0008-6363(95)00187-5
   de Simone G, 2008, EUR HEART J, V29, P741, DOI 10.1093/eurheartj/ehm605
   DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231
   DEMARIA AN, 1978, CIRCULATION, V57, P237, DOI 10.1161/01.CIR.57.2.237
   Demirel HA, 1998, MED SCI SPORT EXER, V30, P1211, DOI 10.1097/00005768-199808000-00005
   Derumeaux G, 2008, CIRC-CARDIOVASC IMAG, V1, P227, DOI 10.1161/CIRCIMAGING.107.745919
   Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049
   Dillon LM, 2012, IUBMB LIFE, V64, P231, DOI 10.1002/iub.608
   Domenighetti AA, 2005, HYPERTENSION, V46, P426, DOI 10.1161/01.HYP.0000173069.53699.d9
   Edelmann F, 2011, J AM COLL CARDIOL, V58, P1780, DOI 10.1016/j.jacc.2011.06.054
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Eisele JC, 2008, BASIC RES CARDIOL, V103, P12, DOI 10.1007/s00395-007-0684-x
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059
   ESLER M, 1981, CLIN SCI, V60, P217, DOI 10.1042/cs0600217
   ESLER MD, 1995, AM J PHYSIOL-REG I, V268, pR278, DOI 10.1152/ajpregu.1995.268.1.R278
   Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061
   Fares E, 2010, CLIN EXP PHARMACOL P, V37, P1, DOI 10.1111/j.1440-1681.2009.05276.x
   FERRARA N, 1995, J MOL CELL CARDIOL, V27, P1141, DOI 10.1016/0022-2828(95)90050-0
   Ferrara N, 1997, J MOL CELL CARDIOL, V29, P439, DOI 10.1006/jmcc.1996.0397
   Ferrara N, 2008, REJUV RES, V11, P139, DOI 10.1089/rej.2007.0576
   Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459
   FLEG JL, 1994, CIRCULATION, V90, P2333, DOI 10.1161/01.CIR.90.5.2333
   FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147
   FLEG JL, 1995, J APPL PHYSIOL, V78, P890, DOI 10.1152/jappl.1995.78.3.890
   Flynn JM, 2013, AGING CELL, V12, P851, DOI 10.1111/acel.12109
   FORMAN DE, 1992, J GERONTOL, V47, pM56, DOI 10.1093/geronj/47.2.M56
   FOWLER MB, 1986, CIRCULATION, V74, P1290, DOI 10.1161/01.CIR.74.6.1290
   Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB
   Fujimoto N, 2010, CIRCULATION, V122, P1797, DOI 10.1161/CIRCULATIONAHA.110.973784
   Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012
   GERSTENBLITH G, 1977, CIRCULATION, V56, P273, DOI 10.1161/01.CIR.56.2.273
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142
   Gounder SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045697
   Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200
   Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055
   He XQ, 2012, MOL PHARMACOL, V82, P887, DOI 10.1124/mol.112.081133
   Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983
   Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068
   HIGGINBOTHAM MB, 1986, AM J CARDIOL, V57, P1374, DOI 10.1016/0002-9149(86)90221-3
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   Hsu CP, 2008, BIOL CHEM, V389, P221, DOI 10.1515/BC.2008.032
   Huang CY, 2012, J APPL PHYSIOL, V112, P883, DOI 10.1152/japplphysiol.00605.2011
   Iemitsu M, 2004, AM J PHYSIOL-HEART C, V286, pH1696, DOI 10.1152/ajpheart.00761.2003
   Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005
   Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137
   Isenberg G, 2003, CELL CALCIUM, V34, P271, DOI 10.1016/S0143-4160(03)00121-0
   Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455
   Janczewski AM, 2010, HEART FAIL REV, V15, P431, DOI 10.1007/s10741-010-9167-5
   JIANG MT, 1993, CIRC RES, V72, P102, DOI 10.1161/01.RES.72.1.102
   Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664
   KANTER MM, 1985, J APPL PHYSIOL, V59, P1298, DOI 10.1152/jappl.1985.59.4.1298
   Kappagoda T, 2012, HEART FAIL REV, V17, P635, DOI 10.1007/s10741-011-9297-4
   Kavazis AN, 2014, J APPL PHYSIOL, V117, P223, DOI 10.1152/japplphysiol.00210.2014
   Kaye DM, 2008, NEUROMOL MED, V10, P179, DOI 10.1007/s12017-008-8034-1
   Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010
   Kemi OJ, 2008, FRONT BIOSCI-LANDMRK, V13, P356, DOI 10.2741/2685
   Kemi OJ, 2007, J MOL CELL CARDIOL, V43, P354, DOI 10.1016/j.yjmcc.2007.06.013
   Kemi OJ, 2008, EUR J CARDIOV PREV R, V15, P145, DOI 10.1097/HJR.0b013e3282efd4e0
   Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434
   Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265
   KITZMAN DW, 1991, J AM COLL CARDIOL, V17, P1065, DOI 10.1016/0735-1097(91)90832-T
   Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007
   Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807
   Kong SW, 2005, PHYSIOL GENOMICS, V21, P34, DOI 10.1152/physiolgenomics.00226.2004
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje
   Lai CH, 2014, AGE, V36, DOI 10.1007/s11357-014-9706-4
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524
   Laughlin MH, 1999, ADV PHYSIOL EDUC, V22, pS244, DOI 10.1152/advances.1999.277.6.S244
   Lebrasseur NK, 2003, AM J PHYSIOL-CELL PH, V284, pC1149, DOI 10.1152/ajpcell.00487.2002
   Lee CK, 2002, P NATL ACAD SCI USA, V99, P14988, DOI 10.1073/pnas.232308999
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lenk K, 2012, EUR J PREV CARDIOL, V19, P404, DOI 10.1177/1741826711402735
   Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020
   Leosco D, 2007, AM J PHYSIOL-HEART C, V293, pH1596, DOI 10.1152/ajpheart.00308.2007
   Leosco D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00348
   LEVY D, 1990, NEW ENGL J MED, V0322
   LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7
   Liao PH, 2015, ONCOTARGET, V6, P35383, DOI 10.18632/oncotarget.6168
   Lim CC, 2000, J MOL CELL CARDIOL, V32, P2075, DOI 10.1006/jmcc.2000.1239
   Lim CC, 1999, AM J PHYSIOL-HEART C, V277, pH2083, DOI 10.1152/ajpheart.1999.277.5.H2083
   Lin CH, 2014, AGE, V36, DOI 10.1007/s11357-014-9705-5
   Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889
   Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009
   Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014
   Loffredo FS, 2014, CIRC RES, V115, P97, DOI 10.1161/CIRCRESAHA.115.302929
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   LOMPRE AM, 1991, CIRC RES, V69, P1380, DOI 10.1161/01.RES.69.5.1380
   Lujan HL, 2013, AM J PHYSIOL-REG I, V304, pR286, DOI 10.1152/ajpregu.00517.2012
   MANNE ND, 2014, J CLIN EXP CARDIOLOG, V5, P1
   Matsui T, 2001, CIRCULATION, V104, P330
   Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373
   McGuire DK, 2001, CIRCULATION, V104, P1358, DOI 10.1161/hc3701.096099
   McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200
   McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Molkentin JD, 2013, CIRC RES, V113, P16, DOI 10.1161/CIRCRESAHA.113.301667
   Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4
   Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494
   Olfert IM, 2004, J GERONTOL A-BIOL, V59, P801
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075
   Pillai VB, 2014, CIRC RES, V114, P368, DOI 10.1161/CIRCRESAHA.113.300536
   Pillai VB, 2010, CARDIOVASC RES, V88, P250, DOI 10.1093/cvr/cvq250
   Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376
   Platt C, 2015, CELL METAB, V21, P227, DOI 10.1016/j.cmet.2015.01.014
   Poller U, 1997, J AM COLL CARDIOL, V29, P187, DOI 10.1016/S0735-1097(96)00437-8
   POWERS SK, 1993, AM J PHYSIOL, V265, pH2094, DOI 10.1152/ajpheart.1993.265.6.H2094
   Prasad A, 2007, AM J CARDIOL, V99, P1629, DOI 10.1016/j.amjcard.2007.01.050
   Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411
   Putinski C, 2013, P NATL ACAD SCI USA, V110, pE4079, DOI 10.1073/pnas.1315587110
   Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106
   Ritchie RH, 2013, AM J PHYSIOL-HEART C, V304, pH729, DOI 10.1152/ajpheart.00638.2012
   RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203
   Rodgers BD, 2009, J PHYSIOL-LONDON, V587, P4873, DOI 10.1113/jphysiol.2009.172544
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738
   Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036
   Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594
   Rossoni LV, 2011, J HYPERTENS, V29, P2349, DOI 10.1097/HJH.0b013e32834d2532
   Safdar A, 2011, J BIOL CHEM, V286, P10605, DOI 10.1074/jbc.M110.211466
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   SCARPACE PJ, 1994, J APPL PHYSIOL, V77, P737, DOI 10.1152/jappl.1994.77.2.737
   Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2
   Schmidt U, 2000, CIRCULATION, V101, P790, DOI 10.1161/01.CIR.101.7.790
   Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982
   Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   SOMANI SM, 1995, PHARMACOL BIOCHEM BE, V51, P627, DOI 10.1016/0091-3057(94)00427-K
   Spina RJ, 1998, AM J PHYSIOL-HEART C, V274, pH397, DOI 10.1152/ajpheart.1998.274.2.H397
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stratton JR, 2003, J AM COLL CARDIOL, V41, P2077, DOI 10.1016/S0735-1097(03)00418-2
   STRATTON JR, 1992, CIRCULATION, V86, P504, DOI 10.1161/01.CIR.86.2.504
   STRATTON JR, 1994, CIRCULATION, V89, P1648, DOI 10.1161/01.CIR.89.4.1648
   Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359
   Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162
   TAFFET GE, 1993, AM J PHYSIOL, V264, pH1609, DOI 10.1152/ajpheart.1993.264.5.H1609
   TATE CA, 1990, AM J PHYSIOL, V258, pH431, DOI 10.1152/ajpheart.1990.258.2.H431
   Tate CA, 1996, AM J PHYSIOL-HEART C, V271, pH68, DOI 10.1152/ajpheart.1996.271.1.H68
   Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014
   Thomas MM, 2011, EXP GERONTOL, V46, P803, DOI 10.1016/j.exger.2011.06.005
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turturro A, 1999, J GERONTOL A-BIOL, V54, pB492, DOI 10.1093/gerona/54.11.B492
   Ungvari Z, 2010, J GERONTOL A-BIOL, V65, P1028, DOI 10.1093/gerona/glq113
   van Empel VPM, 2004, CARDIOVASC RES, V63, P487, DOI 10.1016/j.cardiores.2004.02.013
   Vella CA, 2005, BRIT J SPORT MED, V39, P190, DOI 10.1136/bjsm.2004.013037
   Viña J, 2009, ADV DRUG DELIVER REV, V61, P1369, DOI 10.1016/j.addr.2009.06.006
   Walton RD, 2016, J GERONTOL A-BIOL, V71, P1005, DOI 10.1093/gerona/glv093
   Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089
   Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa
   Wang WW, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/457429
   Wang Y, 2010, PHYSIOL RES, V59, P633, DOI 10.33549/physiolres.931928
   Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   WHITE M, 1994, CIRCULATION, V90, P1225, DOI 10.1161/01.CIR.90.3.1225
   Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc
   Wright KJ, 2014, EXP GERONTOL, V50, P9, DOI 10.1016/j.exger.2013.11.006
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559
   Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335
   Xu A, 1998, AM J PHYSIOL-HEART C, V275, pH2087, DOI 10.1152/ajpheart.1998.275.6.H2087
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609
   Yamashita N, 1999, J EXP MED, V189, P1699, DOI 10.1084/jem.189.11.1699
   Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326
   Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741
NR 220
TC 99
Z9 104
U1 2
U2 30
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD JAN 22
PY 2016
VL 118
IS 2
BP 279
EP 295
DI 10.1161/CIRCRESAHA.115.305250
PG 17
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Hematology
GA DB7WZ
UT WOS:000368729100014
PM 26838314
OA Green Accepted, Bronze
DA 2024-11-01
ER

PT J
AU Ermolaeva, M
   Neri, F
   Ori, A
   Rudolph, KL
AF Ermolaeva, Maria
   Neri, Francesco
   Ori, Alessandro
   Rudolph, K. Lenhard
TI Cellular and epigenetic drivers of stem cell ageing
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID MITOCHONDRIAL-DNA MUTATIONS; INTESTINAL-STEM; SKELETAL-MUSCLE;
   LIFE-SPAN; CLONAL HEMATOPOIESIS; PROGENITOR CELLS; SELF-RENEWAL; DIETARY
   RESTRICTION; GENE-EXPRESSION; P38 MAPK
AB Adult tissue stem cells have a pivotal role in tissue maintenance and regeneration throughout the lifespan of multicellular organisms. Loss of tissue homeostasis during post-reproductive reproductive lifespan is caused, at least in part, by a decline in stem cell function and is associated with an increased incidence of diseases. Hallmarks of ageing include the accumulation of molecular damage, failure of quality control systems, metabolic changes and alterations in epigenome stability. In this Review, we discuss recent evidence in support of a novel concept whereby cell-intrinsic damage that accumulates during ageing and cell-extrinsic changes in ageing stem cell niches and the blood result in modifications of the stem cell epigenome. These cumulative epigenetic alterations in stem cells might be the cause of the deregulation of developmental pathways seen during ageing. In turn, they could confer a selective advantage to mutant and epigenetically drifted stem cells with altered self-renewal and functions, which contribute to the development of ageing-associated organ dysfunction and disease.
C1 [Ermolaeva, Maria; Neri, Francesco; Ori, Alessandro; Rudolph, K. Lenhard] FLI, Leibniz Inst Aging, Jena, Germany.
   [Rudolph, K. Lenhard] Univ Hosp Jena UKJ, Med Fac Jena, Jena, Germany.
C3 Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI);
   Friedrich Loeffler Institute
RP Ermolaeva, M; Neri, F; Ori, A; Rudolph, KL (corresponding author), FLI, Leibniz Inst Aging, Jena, Germany.; Rudolph, KL (corresponding author), Univ Hosp Jena UKJ, Med Fac Jena, Jena, Germany.
EM Maria.Ermolaeva@leibniz-fli.de; Francesco.Neri@leibniz-fli.de;
   Alessandro.Ori@leibniz-fli.de; Lenhard.Rudolph@leibniz-fli.de
RI Ori, Alessandro/M-8586-2019; Ori, Alessandro/B-7067-2011; neri,
   francesco/A-3321-2014
OI Ori, Alessandro/0000-0002-3046-0871; neri, francesco/0000-0003-3903-1974
FU Alexander von Humboldt Foundation; German Federal Ministry for Education
   and Research; European Research Council Advanced Grant; federal
   government of Germany; State of Thuringia
FX F.N. is supported by the Alexander von Humboldt Foundation and the
   German Federal Ministry for Education and Research. K.L.R. is supported
   by a European Research Council Advanced Grant (StemCellGerontoGenes).
   The Fritz Lipmann Institute is a member of the Leibniz Association and
   is financially supported by the federal government of Germany and the
   State of Thuringia.
CR Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876
   Al Alam D, 2015, AM J PHYSIOL-GASTR L, V308, pG678, DOI 10.1152/ajpgi.00158.2014
   Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918
   Alcolea MP, 2014, NAT CELL BIOL, V16, P612, DOI 10.1038/ncb2963
   Arai K, 2014, ORG LETT, V16, P5560, DOI 10.1021/ol502556c
   Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76
   Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721
   Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001
   Baylin Stephen B, 2012, Proc Am Thorac Soc, V9, P64, DOI 10.1513/pats.201201-001MS
   Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009
   Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928
   Berent-Maoz B, 2012, BLOOD, V119, P5715, DOI 10.1182/blood-2011-12-400002
   Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465
   Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159
   Blagosklonny MV, 2013, CELL CYCLE, V12, P3736, DOI 10.4161/cc.27188
   Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918
   Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Bradley E, 2012, STEM CELLS, V30, P1624, DOI 10.1002/stem.1143
   Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012
   Buchwalter A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00322-z
   Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965
   Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052
   Burkhalter MD, 2015, AGEING RES REV, V23, P29, DOI 10.1016/j.arr.2015.01.004
   Busque L, 2012, NAT GENET, V44, P1179, DOI 10.1038/ng.2413
   Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018
   Cairney CJ, 2009, BBA-MOL BASIS DIS, V1792, P353, DOI 10.1016/j.bbadis.2009.01.015
   Camp JG, 2014, GENOME RES, V24, P1504, DOI 10.1101/gr.165845.113
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034
   Castellano JM, 2017, NATURE, V544, P488, DOI 10.1038/nature22067
   Cecco M, 2013, AGING CELL, V12, P247, DOI 10.1111/acel.12047
   Cellerino A, 2017, SEMIN CELL DEV BIOL, V70, P177, DOI 10.1016/j.semcdb.2017.06.012
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen KY, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167324
   Cheng CW, 2017, CELL, V168, P775, DOI 10.1016/j.cell.2017.01.040
   Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   Ciccocioppo R, 2002, GERONTOLOGY, V48, P204, DOI 10.1159/000058351
   Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Cole JJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1185-3
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Corazza GR, 1998, MECH AGEING DEV, V104, P1, DOI 10.1016/S0047-6374(98)00044-X
   Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464
   Crowder SW, 2016, CELL STEM CELL, V18, P39, DOI 10.1016/j.stem.2015.12.012
   Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002
   D'Aniello C, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/8936156
   Das C, 2012, BBA-GENE REGUL MECH, V1819, P332, DOI 10.1016/j.bbagrm.2011.08.001
   de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144
   Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Elabd C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5082
   Enge M, 2017, CELL, V171, P321, DOI 10.1016/j.cell.2017.09.004
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307
   Espada J, 2008, J CELL BIOL, V181, P27, DOI 10.1083/jcb.200801096
   Famili F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.326
   Fernández AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015
   Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619
   Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010
   Fusco S, 2016, CELL REP, V14, P1195, DOI 10.1016/j.celrep.2015.12.092
   Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381
   Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020
   Gancz D, 2013, ANNU REV CELL DEV BI, V29, P137, DOI 10.1146/annurev-cellbio-101512-122331
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405
   Glorevski N, 2016, NATURE, V539, P560, DOI 10.1038/nature20168
   Goldberg EL, 2015, AGING CELL, V14, P130, DOI 10.1111/acel.12280
   Goloubinoff P, 2018, NAT CHEM BIOL, V14, P388, DOI 10.1038/s41589-018-0013-8
   Gorbunova V, 2016, MUTAT RES-FUND MOL M, V788, P2, DOI 10.1016/j.mrfmmm.2016.02.004
   Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017
   Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103
   Guidi N, 2017, EMBO J, V36, P840, DOI 10.15252/embj.201694969
   Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018
   Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159
   He J, 2010, J MOL CELL BIOL, V2, P231, DOI 10.1093/jmcb/mjp054
   Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97
   Hsieh JCF, 2013, AGING CELL, V12, P269, DOI 10.1111/acel.12053
   Igarashi M, 2016, CELL, V166, P436, DOI 10.1016/j.cell.2016.05.044
   Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002
   Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jadhav U, 2017, CELL STEM CELL, V21, P65, DOI 10.1016/j.stem.2017.05.001
   Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719
   Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Kaaij LTJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r50
   Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppinen TM, 2013, BBA-MOL CELL RES, V1833, P1985, DOI 10.1016/j.bbamcr.2013.04.005
   Kazakevych J, 2017, NUCLEIC ACIDS RES, V45, P5770, DOI 10.1093/nar/gkx167
   Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017
   Kim JH, 2016, NAT CELL BIOL, V18, P930, DOI 10.1038/ncb3401
   Kim JM, 2017, SCIENCE, V356, P717, DOI 10.1126/science.aal3096
   Kim JY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-10
   Kim KM, 2002, ONCOGENE, V21, P5441, DOI 10.1038/sj.onc.1205604
   KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133
   Kirschner K, 2017, CELL REP, V19, P1503, DOI 10.1016/j.celrep.2017.04.074
   Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108
   Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253
   Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053
   Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410
   Lazare S, 2017, EXP HEMATOL, V53, P26, DOI 10.1016/j.exphem.2017.06.002
   Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460
   Liu DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058310
   Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Lu R, 2016, CANCER CELL, V30, P92, DOI 10.1016/j.ccell.2016.05.008
   Lukjanenko L, 2016, NAT MED, V22, P897, DOI 10.1038/nm.4126
   Maegawa S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00607-3
   Mair W, 2010, AGING CELL, V9, P916, DOI 10.1111/j.1474-9726.2010.00602.x
   Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054
   Martin N, 2014, TRENDS MOL MED, V20, P667, DOI 10.1016/j.molmed.2014.09.008
   Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806
   Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901
   Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110
   McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005
   Meena JK, 2015, EMBO J, V34, P1371, DOI 10.15252/embj.201490070
   Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647
   Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012
   Mian SA, 2013, HAEMATOLOGICA, V98, P1058, DOI 10.3324/haematol.2012.075325
   Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Moore DL, 2015, SCIENCE, V349, P1334, DOI 10.1126/science.aac9868
   Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984
   Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Murgatroyd C, 2010, AGING-US, V2, P107
   Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932
   Nalapareddy K, 2017, CELL REP, V18, P2608, DOI 10.1016/j.celrep.2017.02.056
   Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120
   Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104
   Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649
   Nuschke A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0436-7
   O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933
   Okuchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162300
   Öst A, 2014, CELL, V159, P1352, DOI 10.1016/j.cell.2014.11.005
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013
   Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024
   Park JS, 2009, AGING-US, V1, P637, DOI 10.18632/aging.100054
   Parker SJ, 2015, PHARMACOL THERAPEUT, V152, P54, DOI 10.1016/j.pharmthera.2015.05.003
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513
   Reddington JP, 2013, BIOCHEM J, V451, P13, DOI 10.1042/BJ20121585
   Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956
   Ro S, 2001, P NATL ACAD SCI USA, V98, P10519, DOI 10.1073/pnas.201405498
   Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049
   Rodríguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673
   Rosenberger G, 2017, NAT METHODS, V14, P921, DOI [10.1038/NMETH.4398, 10.1038/nmeth.4398]
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rozo M, 2016, NAT MED, V22, P889, DOI 10.1038/nm.4116
   Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004
   Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708
   Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012
   Schwörer S, 2016, NATURE, V540, P428, DOI 10.1038/nature20603
   Scourzic L, 2016, LEUKEMIA, V30, P1388, DOI 10.1038/leu.2016.29
   Sheaffer KL, 2014, GENE DEV, V28, P652, DOI 10.1101/gad.230318.113
   Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442
   Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035
   Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Siudeja K, 2015, CELL STEM CELL, V17, P663, DOI 10.1016/j.stem.2015.09.016
   Smith P, 2017, ELIFE, V6, DOI 10.7554/eLife.27014
   Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016
   Solanas G, 2017, CELL, V170, P678, DOI 10.1016/j.cell.2017.07.035
   Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x
   Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363
   Stearns-Reider KM, 2017, AGING CELL, V16, P518, DOI 10.1111/acel.12578
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Stubbs TM, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1203-5
   Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   Takahashi K, 2011, J BIOL CHEM, V286, P35755, DOI 10.1074/jbc.M111.271007
   Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011
   Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020
   Tang DZ, 2016, J EXP MED, V213, P535, DOI 10.1084/jem.20151100
   Tao S, 2015, EMBO J, V34, P624, DOI 10.15252/embj.201490700
   Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011
   Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436
   van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659
   van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228
   Van Meter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6011
   van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125
   Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008
   Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131
   Wang LF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005220
   Weidner CI, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r24
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313
   Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104
   Yang LB, 2016, CANCER CELL, V29, P922, DOI 10.1016/j.ccell.2016.05.003
   Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895
   Yearim A, 2015, CELL REP, V10, P1122, DOI 10.1016/j.celrep.2015.01.038
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008
   Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996
   Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
   Zhang XT, 2016, NAT GENET, V48, P1014, DOI 10.1038/ng.3610
   Zou CB, 2014, BBA-MOL CELL RES, V1843, P694, DOI 10.1016/j.bbamcr.2013.12.016
NR 257
TC 166
Z9 188
U1 0
U2 49
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD SEP
PY 2018
VL 19
IS 9
BP 594
EP 610
DI 10.1038/s41580-018-0020-3
PG 17
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GR2CL
UT WOS:000442367400008
PM 29858605
DA 2024-11-01
ER

PT S
AU Jung, Y
   Brack, AS
AF Jung, Yunjoon
   Brack, Andrew S.
BE Rendl, M
TI Cellular Mechanisms of Somatic Stem Cell Aging
SO STEM CELLS IN DEVELOPMENT AND DISEASE
SE Current Topics in Developmental Biology
LA English
DT Review; Book Chapter
ID NF-KAPPA-B; MITOCHONDRIAL-DNA MUTATIONS; HEMATOPOIETIC STEM;
   SELF-RENEWAL; LIFE-SPAN; EPIGENETIC INHERITANCE; TELOMERE DYSFUNCTION;
   MEDIATED AUTOPHAGY; TISSUE HOMEOSTASIS; PROGENITOR CELLS
AB Tissue homeostasis and regenerative capacity rely on rare populations of somatic stem cells endowed with the potential to self-renew and differentiate. During aging, many tissues show a decline in regenerative potential coupled with a loss of stem cell function. Cells including somatic stem cells have evolved a series of checks and balances to sense and repair cellular damage to maximize tissue function. However, during aging the mechanisms that protect normal cell function begin to fail. In this review, we will discuss how common cellular mechanisms that maintain tissue fidelity and organismal lifespan impact somatic stem cell function. We will highlight context-dependent changes and commonalities that define aging, by focusing on three age-sensitive stem cell compartments: blood, neural, and muscle. Understanding the interaction between extrinsic regulators and intrinsic effectors that operate within different stem cell compartments is likely to have important implications for identifying strategies to improve health span and treat age-related degenerative diseases.
C1 [Jung, Yunjoon; Brack, Andrew S.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   [Brack, Andrew S.] Harvard Univ, Sch Med, Boston, MA USA.
   [Brack, Andrew S.] Harvard Stem Cell Inst, Boston, MA USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; Harvard University
RP Brack, AS (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
FU NIAMS NIH HHS [R01 AR060868, R01 AR061002] Funding Source: Medline
CR Adler AS, 2008, CELL CYCLE, V7, P556, DOI 10.4161/cc.7.5.5490
   Ahlqvist KJ, 2012, CELL METAB, V15, P100, DOI 10.1016/j.cmet.2011.11.012
   Alberts AS, 1998, CELL, V92, P475, DOI 10.1016/S0092-8674(00)80941-1
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017
   Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007
   Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107
   Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007
   BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4
   Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159
   Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012
   Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926
   Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002
   Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006
   Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001
   Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Brown K, 2013, CELL REP, V3, P319, DOI 10.1016/j.celrep.2013.01.005
   Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262
   Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034
   Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x
   Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2
   Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002
   Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438
   Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002
   Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201
   Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372
   Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Didier N, 2012, EMBO MOL MED, V4, P910, DOI 10.1002/emmm.201101075
   Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490
   Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010
   Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507
   Ellis RJ, 2002, NATURE, V416, P483, DOI 10.1038/416483a
   Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010
   Ergen AV, 2012, BLOOD, V119, P2500, DOI 10.1182/blood-2011-11-391730
   Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043
   Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517
   Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572
   Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195
   Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X
   Grompe M, 2012, CELL STEM CELL, V10, P685, DOI 10.1016/j.stem.2012.04.006
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001
   Heslop L, 2000, J CELL SCI, V113, P2299
   Hidalgo I, 2012, CELL STEM CELL, V11, P649, DOI 10.1016/j.stem.2012.08.001
   Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570
   Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009
   Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815
   Kapetanaki MG, 2013, J PATHOL, V229, P310, DOI 10.1002/path.4122
   KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X
   Kempermann G, 1998, J NEUROSCI, V18, P3206
   Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013
   KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Lee JY, 2010, CELL STEM CELL, V7, P593, DOI 10.1016/j.stem.2010.09.015
   Lee JS, 2009, NAT CELL BIOL, V11, P1355, DOI 10.1038/ncb1980
   Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228
   Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572
   Li J, 2012, J INVEST DERMATOL, V132, P2681, DOI 10.1038/jid.2012.206
   Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794
   Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016
   Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000
   Lugert Sebastian, 2012, Nat Commun, V3, P670, DOI 10.1038/ncomms1670
   Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017
   Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013
   Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109
   Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784
   Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949
   Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001
   Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047
   Navarro S, 2006, MOL THER, V14, P525, DOI 10.1016/j.ymthe.2006.05.018
   Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004
   Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044
   Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875
   Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593
   Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017
   Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025
   Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013
   Paliouras GN, 2012, J NEUROSCI, V32, P15012, DOI 10.1523/JNEUROSCI.2248-12.2012
   Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197
   Pollina EA, 2011, ONCOGENE, V30, P3105, DOI 10.1038/onc.2011.45
   Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035
   Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Sahin E, 2012, NAT REV MOL CELL BIO, V13, P397, DOI 10.1038/nrm3352
   Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002
   Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010
   Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0
   Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015
   Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103
   Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001
   Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608
   Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354
   Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005
   So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503
   Song ZF, 2012, AGING CELL, V11, P449, DOI 10.1111/j.1474-9726.2012.00802.x
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Tóth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030
   Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385
   Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244
   Yilmaz ÖH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163
   Zacharek SJ, 2011, CELL STEM CELL, V9, P272, DOI 10.1016/j.stem.2011.07.007
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004
   Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003
NR 176
TC 50
Z9 55
U1 0
U2 11
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0070-2153
BN 978-0-12-416022-4
J9 CURR TOP DEV BIOL
JI Curr. Top. Dev. Biol.
PY 2014
VL 107
BP 405
EP 438
DI 10.1016/B978-0-12-416022-4.00014-7
PG 34
WC Developmental Biology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Developmental Biology
GA BA1FN
UT WOS:000332424400014
PM 24439814
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Kocken, JMM
   Martins, PDA
AF Kocken, Jordy M. M.
   da Costa Martins, Paula A.
TI Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced
   Vascular and Right Ventricular Remodeling: New Opportunities?
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE right ventricle remodeling; hypertrophy; pulmonary arterial
   hypertension; non-coding RNAs; epigenetics
ID LONG NONCODING RNA; NITRIC-OXIDE SYNTHASE; HISTONE H3 PHOSPHORYLATION;
   SMOOTH-MUSCLE-CELLS; CIRCULAR RNA; DNA METHYLATION; MESSENGER-RNA;
   MITOCHONDRIAL DYSFUNCTION; CHROMATIN MODIFICATION; MOLECULAR-MECHANISMS
AB Pulmonary artery hypertension (PAH) is a rare chronic disease with high impact on patients' quality of life and currently no available cure. PAH is characterized by constant remodeling of the pulmonary artery by increased proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), fibroblasts (FBs) and endothelial cells (ECs). This remodeling eventually leads to increased pressure in the right ventricle (RV) and subsequent right ventricle hypertrophy (RVH) which, when left untreated, progresses into right ventricle failure (RVF). PAH can not only originate from heritable mutations, but also develop as a consequence of congenital heart disease, exposure to drugs or toxins, HIV, connective tissue disease or be idiopathic. While much attention was drawn into investigating and developing therapies related to the most well understood signaling pathways in PAH, in the last decade, a shift towards understanding the epigenetic mechanisms driving the disease occurred. In this review, we reflect on the different epigenetic regulatory factors that are associated with the pathology of RV remodeling, and on their relevance towards a better understanding of the disease and subsequently, the development of new and more efficient therapeutic strategies.
C1 [Kocken, Jordy M. M.; da Costa Martins, Paula A.] Maastricht Univ, Fac Sci & Engn, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands.
   [Kocken, Jordy M. M.; da Costa Martins, Paula A.] Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands.
   [da Costa Martins, Paula A.] Univ Porto, Fac Med, Dept Cirurgia & Fisiol, Unidade Invest Cardiovasc, P-4200319 Porto, Portugal.
C3 Maastricht University; Maastricht University; Universidade do Porto
RP Martins, PDA (corresponding author), Maastricht Univ, Fac Sci & Engn, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands.; Martins, PDA (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands.; Martins, PDA (corresponding author), Univ Porto, Fac Med, Dept Cirurgia & Fisiol, Unidade Invest Cardiovasc, P-4200319 Porto, Portugal.
EM j.kocken@maastrichtuniversity.nl;
   p.dacostamartins@maastrichtuniversity.nl
RI Kocken, Jordy/LCV-0071-2024
FU Dutch CardioVascular Alliance (DCVA); Impulse Grant 2018 [CVON-2018-29];
   Portuguese Foundation for Science and Technology Grant
   [PTDC/BIM-MEC/4578/2014]; Dutch Heart Foundation [NHS2015T066]; Fundação
   para a Ciência e a Tecnologia [PTDC/BIM-MEC/4578/2014] Funding Source:
   FCT
FX J.M.M.K. and P.A.d.C.M. were supported by the Dutch CardioVascular
   Alliance (DCVA) awarded to the Phaedra consortium as well as the Impulse
   Grant 2018 awarded to the Phaedra IMPACT consortium (CVON-2018-29).
   P.A.d.C.M. is further supported by Portuguese Foundation for Science and
   Technology Grant (PTDC/BIM-MEC/4578/2014) and a Dutch Heart Foundation
   grant (NHS2015T066).
CR ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786
   Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567
   Anastasiadou E, 2018, NAT REV CANCER, V18, P5, DOI 10.1038/nrc.2017.99
   Ando M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09937-w
   Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951
   Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006
   Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098
   Arrigo Mattia, 2019, Card Fail Rev, V5, P140, DOI 10.15420/cfr.2019.15.2
   Ashwal-Fluss R, 2014, MOL CELL, V56, P55, DOI 10.1016/j.molcel.2014.08.019
   Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D
   Avazmohammadi R, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4044174
   Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Barnes H, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012785.pub2
   Batkai S, 2017, CARDIOVASC RES, V113, P1433, DOI 10.1093/cvr/cvx153
   Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x
   Bewick AJ, 2016, P NATL ACAD SCI USA, V113, P9111, DOI 10.1073/pnas.1604666113
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Bogaard HJ, 2011, AM J RESP CRIT CARE, V183, P1402, DOI 10.1164/rccm.201007-1106OC
   Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939
   BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28
   BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I
   BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M
   Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7
   Campian ME, 2010, EUR J HEART FAIL, V12, P653, DOI 10.1093/eurjhf/hfq066
   Cao YA, 2018, BIOMED PHARMACOTHER, V106, P1108, DOI 10.1016/j.biopha.2018.07.057
   Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591
   Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426
   Chang WT, 2018, ACTA CARDIOL SIN, V34, P511, DOI 10.6515/ACS.201811_34(6).20180613A
   Chen CN, 2013, VASC PHARMACOL, V58, P211, DOI 10.1016/j.vph.2012.09.001
   Chen DW, 2015, HYPERTENSION, V65, P821, DOI 10.1161/HYPERTENSIONAHA.114.04585
   Chen F, 2016, FREE RADICAL BIO MED, V99, P167, DOI 10.1016/j.freeradbiomed.2016.08.003
   Cheng GS, 2020, MOL CELL BIOCHEM, V475, P239, DOI 10.1007/s11010-020-03877-6
   Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7
   Choi HS, 2005, CANCER RES, V65, P5818, DOI 10.1158/0008-5472.CAN-05-0197
   Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695
   Condon David F, 2019, F1000Res, V8, DOI 10.12688/f1000research.18811.1
   Connolly M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229409
   Cowley PM, 2019, AM J PHYSIOL-HEART C, V316, pH224, DOI 10.1152/ajpheart.00507.2018
   CRICK F H, 1958, Symp Soc Exp Biol, V12, P138
   Dalvi P, 2013, ARTERIOSCL THROM VAS, V33, P2585, DOI 10.1161/ATVBAHA.113.302054
   Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049
   Dhir A, 2015, NAT STRUCT MOL BIOL, V22, P319, DOI 10.1038/nsmb.2982
   Di Salvo TG, 2015, PULM CIRC, V5, P135, DOI 10.1086/679721
   Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108
   Do E, 1997, J MOL CELL CARDIOL, V29, P1903, DOI 10.1006/jmcc.1997.0429
   Durrington HJ, 2010, J BIOL CHEM, V285, P37641, DOI 10.1074/jbc.M110.132415
   Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930
   Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5
   Fagan KA, 1999, J CLIN INVEST, V103, P291, DOI 10.1172/JCI3862
   Faisal M, 2014, PULM MED, V2014, DOI 10.1155/2014/528783
   Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106
   FLORA LM, 2006, CURR MED CHEM, V13, P1655
   Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401
   Fox B, 2013, CAN J CARDIOL, V29, P672, DOI 10.1016/j.cjca.2012.05.013
   FRELIN C, 1994, CARDIOVASC RES, V28, P1613, DOI 10.1093/cvr/28.11.1613
   Gajecki D, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7265487
   Galiè N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510
   Galiè N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
   Galletti M, 2014, BIOCHEM PHARMACOL, V91, P181, DOI 10.1016/j.bcp.2014.07.011
   GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403
   Gomez-Arroyo J, 2013, CIRC-HEART FAIL, V6, P136, DOI 10.1161/CIRCHEARTFAILURE.111.966127
   Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710
   Gray GA, 1996, PHARMACOL THERAPEUT, V72, P109, DOI 10.1016/S0163-7258(96)00101-5
   Grunig G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00955
   Guo JL, 2020, LIFE SCI, V262, DOI 10.1016/j.lfs.2020.118420
   Han P, 2015, RNA BIOL, V12, P1094, DOI 10.1080/15476286.2015.1063770
   Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993
   Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155
   He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130
   HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x
   Hewer RC, 2011, J MOL CELL CARDIOL, V50, P87, DOI 10.1016/j.yjmcc.2010.10.010
   HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338
   Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619
   Hoeper MM, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01906-2018
   Hoeper MM, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00740-2017
   Hsiao KY, 2017, EXP BIOL MED, V242, P1136, DOI 10.1177/1535370217708978
   Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411
   Huusko J, 2012, MOL THER, V20, P2212, DOI 10.1038/mt.2012.145
   Jambhekar A, 2019, NAT REV MOL CELL BIO, V20, P625, DOI 10.1038/s41580-019-0151-1
   Jeoung NH, 2015, DIABETES METAB J, V39, P188
   Jiang SD, 2017, JOINT BONE SPINE, V84, P553, DOI 10.1016/j.jbspin.2016.09.006
   Johnson EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32154-2
   Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965
   Joshi SR, 2016, AM J PHYSIOL-HEART C, V311, pH689, DOI 10.1152/ajpheart.00264.2016
   Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750
   Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106
   Kim HJ, 2011, AM J TRANSL RES, V3, P166
   Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0
   Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750
   Kolb TM, 2015, MICROCIRCULATION, V22, P724, DOI 10.1111/micc.12247
   Koop AMC, 2018, EUR HEART J, V39, P1035
   Krajewski WA, 1998, P NATL ACAD SCI USA, V95, P1540, DOI 10.1073/pnas.95.4.1540
   Lan Norris S H, 2018, Diseases, V6, DOI 10.3390/diseases6020038
   Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792
   Lang IM, 2015, EUR RESPIR REV, V24, P630, DOI 10.1183/16000617.0067-2015
   Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974
   Lau ATY, 2011, J BIOL CHEM, V286, P26628, DOI 10.1074/jbc.M110.215590
   Lau EMT, 2015, NAT REV CARDIOL, V12, P143, DOI 10.1038/nrcardio.2014.191
   Le Ribeuz H, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01444-7
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee SD, 1998, J CLIN INVEST, V101, P927, DOI 10.1172/JCI1910
   Lee YH, 2013, KOREAN J INTERN MED, V28, P701, DOI 10.3904/kjim.2013.28.6.701
   Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017
   Lehners M, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5020020
   Lei S, 2020, AM J PHYSIOL-HEART C, V319, pH377, DOI 10.1152/ajpheart.00717.2019
   Leuchte HH, 2004, CHEST, V125, P580, DOI 10.1378/chest.125.2.580
   Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959
   Liang WC, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1685-4
   Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078
   Liu Y, 2018, J CELL PHYSIOL, V233, P4801, DOI 10.1002/jcp.26279
   Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9
   Lorell BH, 2000, CIRCULATION, V102, P470
   Luo L, 2020, AGING-US, V12, P9014, DOI 10.18632/aging.103163
   MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895
   Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834
   Maenner S, 2012, BIOCHIMIE, V94, P1490, DOI 10.1016/j.biochi.2011.12.026
   Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126
   Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006
   Mathiyalagan P, 2010, CELL CYCLE, V9, P612, DOI 10.4161/cc.9.3.10612
   Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928
   Miao RY, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.117919
   Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224
   Moe GW, 2004, AM J PHYSIOL-HEART C, V287, pH1813, DOI 10.1152/ajpheart.00036.2004
   Moris D, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.27
   Morrell NW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01899-2018
   Müller C, 2001, CURR OPIN GENET DEV, V11, P167, DOI 10.1016/S0959-437X(00)00175-1
   MURAD F, 1994, RECENT PROG HORM RES, V49, P239
   Murray F.S., 2020, AM J RESP CRIT CARE, V201, pA1804
   Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c
   Negi V, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91327
   Nergui S, 2014, CIRC J, V78, P1465, DOI 10.1253/circj.CJ-13-1586
   NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S
   Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676
   Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705
   Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6
   Omura J., 2019, EUR RESPIR J, V54, pPA5040
   Otani J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082961
   Ou MH, 2020, MOL THER NUCL ACIDS, V21, P542, DOI 10.1016/j.omtn.2020.05.022
   Oudiz RJ, 2013, AM J RESP CRIT CARE, V188, P269, DOI 10.1164/rccm.201305-0898ED
   PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7
   Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021
   Patten M, 2001, PFLUG ARCH EUR J PHY, V442, P920
   Piao L, 2010, J MOL MED, V88, P47, DOI 10.1007/s00109-009-0524-6
   Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605
   Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780
   Poller W, 2018, EUR HEART J, V39, P2704, DOI 10.1093/eurheartj/ehx165
   POLLOCK DM, 1995, FASEB J, V9, P1196, DOI 10.1096/fasebj.9.12.7672512
   Power AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214740
   Prins KW, 2016, CARDIOL CLIN, V34, P363, DOI 10.1016/j.ccl.2016.04.001
   Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917
   Qin YJ, 2012, INT J MED SCI, V9, P413, DOI 10.7150/ijms.4514
   Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506
   Reddy S, 2015, CIRCULATION, V132, P1734, DOI 10.1161/CIRCULATIONAHA.114.012975
   Redout EM, 2007, CARDIOVASC RES, V75, P770, DOI 10.1016/j.cardiores.2007.05.012
   Reis A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3924517
   Rich JD, 2014, CIRCULATION, V130, P1820, DOI 10.1161/CIRCULATIONAHA.114.006971
   Ringvold H C, 2017, Adv Pharmacol, V78, P203, DOI 10.1016/bs.apha.2016.06.002
   Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111
   Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975
   Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Russo VEA, 1996, Epigenetic mechanisms of gene regulation
   Salguero KL, 2002, PULM PHARMACOL THER, V15, P1, DOI 10.1006/pupt.2001.0311
   SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852
   Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018
   Saxena A, 2011, BIOESSAYS, V33, P830, DOI 10.1002/bies.201100084
   Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006
   Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713
   Shimony A, 2011, AM J CARDIOL, V108, P460, DOI 10.1016/j.amjcard.2011.03.066
   Sikirica M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0676-0
   Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018
   Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716
   Su H, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0956-z
   Sun ZX, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108933
   Suzuki S, 2017, TRANSCR-AUSTIN, V8, P26, DOI 10.1080/21541264.2016.1246076
   Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC
   Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5
   Tello K, 2019, HERZ, V44, P509, DOI 10.1007/s00059-019-4815-6
   Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X
   Thum T, 2014, PULM CIRC, V4, P185, DOI 10.1086/675981
   Tielemans B, 2019, DRUG DISCOV TODAY, V24, P703, DOI 10.1016/j.drudis.2018.12.001
   Tsutsui H, 2001, CARDIOVASC RES, V49, P103, DOI 10.1016/S0008-6363(00)00197-8
   Tuder RM, 2001, AM J PATHOL, V159, P382, DOI 10.1016/S0002-9440(10)61705-1
   Tuder RM, 2013, J AM COLL CARDIOL, V62, pD4, DOI 10.1016/j.jacc.2013.10.025
   Tuomainen T, 2017, EXP CELL RES, V360, P12, DOI 10.1016/j.yexcr.2017.03.052
   Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001
   Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028
   Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184
   Wang DP, 2019, INT J MOL MED, V44, P871, DOI 10.3892/ijmm.2019.4256
   Wang F, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190338
   Wang H, 2020, SHOCK, V53, P723, DOI 10.1097/SHK.0000000000001410
   Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Wijeratne DT, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003973
   Xiao MS, 2020, TRENDS CELL BIOL, V30, P226, DOI 10.1016/j.tcb.2019.12.004
   Xu F, 2017, BIOMED PHARMACOTHER, V90, P888, DOI 10.1016/j.biopha.2017.03.103
   Xu SW, 2001, J INVEST DERMATOL, V116, P417, DOI 10.1046/j.1523-1747.2001.01256.x
   XUE C, 1995, NEW ENGL J MED, V333, P1642
   Yang YY, 2014, NUCLEIC ACIDS RES, V42, P10460, DOI 10.1093/nar/gku776
   Zehendner CM, 2020, AM J RESP CRIT CARE, V202, P1445, DOI 10.1164/rccm.201910-2041OC
   Zhang LY, 2014, J HYPERTENS, V32, P2188, DOI 10.1097/HJH.0000000000000309
   Zhang R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32635-4
   Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017
   Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147
   Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176
   Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR
   Zhou SJ, 2019, MOL THER-NUCL ACIDS, V18, P275, DOI 10.1016/j.omtn.2019.08.026
   Zhu TT, 2017, LIFE SCI, V174, P35, DOI 10.1016/j.lfs.2017.02.016
NR 211
TC 18
Z9 19
U1 0
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD DEC
PY 2020
VL 21
IS 23
AR 8901
DI 10.3390/ijms21238901
PG 26
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA PD9QG
UT WOS:000598009600001
PM 33255338
OA Green Submitted, gold, Green Published
DA 2024-11-01
ER

PT J
AU Légaré, VP
   Harji, ZA
   Rampal, CJ
   Antonicka, H
   Gurberg, TJN
   Persia, O
   Rodriguez, EC
   Shoubridge, EA
   Armstrong, GAB
AF Legare, Virginie Petel
   Harji, Ziyaan A.
   Rampal, Christian J.
   Antonicka, Hana
   Gurberg, Tyler J. N.
   Persia, Olivia
   Rodriguez, Esteban C.
   Shoubridge, E. A.
   Armstrong, Gary A. B.
TI CHCHD10<SUP>P80L</SUP> knock-in zebrafish display a mild ALS-like
   phenotype
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article
DE Als; Zebrafish; Motor neuron; CHCHD10; Neurodegeneration; Knock-in
   mutation; Mitochondria
ID AMYOTROPHIC-LATERAL-SCLEROSIS; DIFFERENTIAL EXPRESSION ANALYSIS;
   FRONTOTEMPORAL DEMENTIA; MUTATION; DISEASE; MODEL; FTLD
AB Mutations in the nuclear-encoded mitochondrial gene CHCHD10 have been observed in patients with a spectrum of diseases that include amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). To investigate the pathogenic nature of disease-associated variants of CHCHD10 we generated a zebrafish knock-in (KI) model expressing the orthologous ALS-associated CHCHD10(P80L) variant (zebrafish: Chchd10(P83L)). Larval chchd10(P83L/ P83L) fish displayed reduced Chchd(10) protein expression levels, motor impairment, reduced survival and abnormal neuromuscular junctions (NMJ). These deficits were not accompanied by changes in transcripts involved in the integrated stress response (ISR), phenocopying previous findings in our knockout (chchd10(- /-) ). Adult, 11-month old chchd10(P83L/P83L) zebrafish, displayed smaller slow- and fast-twitch muscle cell crosssectional areas compared to wild type zebrafish muscle cells. Motoneurons in the spinal cord of chchd10(P83L/ P83L) zebrafish displayed similar cross-sectional areas to that of wild type motor neurons and significantly fewer motor neurons were observed when compared to chchd2(- /-) adult spinal cords. Bulk RNA sequencing using whole spinal cords of 7-month old fish revealed transcriptional changes associated with neuroinflammation, apoptosis, amino acid metabolism and mt-DNA inflammatory response in our chchd10(P83L/P83L) model. The findings presented here, suggest that the CHCHD10(P80L )variant confers an ALS-like phenotype when expressed in zebrafish.
C1 [Legare, Virginie Petel; Harji, Ziyaan A.; Rampal, Christian J.; Gurberg, Tyler J. N.; Persia, Olivia; Rodriguez, Esteban C.; Armstrong, Gary A. B.] McGill Univ, Montreal Neurol Inst, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
   [Antonicka, Hana; Shoubridge, E. A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada.
C3 McGill University; McGill University
RP Armstrong, GAB (corresponding author), McGill Univ, Montreal Neurol Inst, Fac Med, Dept Neurol & Neurosurg, Montreal, PQ, Canada.
EM gary.armstrong@mcgill.ca
FU Canadian Institutes of Health Research [420108, 133530]; Natural
   Sciences and Engineering Research Council of Canada [RGPIN-2018-05603];
   Canadian Foundation for Innovation and Rare Diseases: Models &
   Mechanisms Network grant
FX This research was funded by the Canadian Institutes of Health Research,
   Grant Numbers: 420108, 133530; Natural Sciences and Engineering Research
   Council of Canada, Grant Number: RGPIN-2018-05603; ALS Canada-Brain
   Canada Discovery grant; Canadian Foundation for Innovation and Rare
   Diseases: Models & Mechanisms Network grant. The funders had no role in
   the design or collection of the research data contained within this
   manuscript.
CR Ajroud-Driss S, 2015, NEUROGENETICS, V16, P1, DOI 10.1007/s10048-014-0421-1
   Anderson CJ, 2019, ACTA NEUROPATHOL, V138, P103, DOI 10.1007/s00401-019-01989-y
   Armstrong GAB, 2013, HUM MOL GENET, V22, P4282, DOI 10.1093/hmg/ddt278
   Armstrong GAB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150188
   Auranen M, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000003
   Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138
   Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004
   Béland LC, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa124
   Benedetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24515
   Boillée S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103
   Burstein SR, 2018, HUM MOL GENET, V27, P160, DOI 10.1093/hmg/ddx397
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   Cavallaro G, 2010, MOL BIOSYST, V6, P2459, DOI 10.1039/c0mb00058b
   Consortium P. M. A. S, 2018, CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?, V84, P110
   Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248
   Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063
   Fryer AL, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.621501
   Fu JJ, 2022, J NEUROINFLAMM, V19, DOI 10.1186/s12974-022-02446-6
   Funayama M, 2015, LANCET NEUROL, V14, P274, DOI 10.1016/S1474-4422(14)70266-2
   Genin EC, 2019, ACTA NEUROPATHOL, V138, P123, DOI 10.1007/s00401-019-01988-z
   Gilbert MJH, 2014, EXP GERONTOL, V50, P106, DOI 10.1016/j.exger.2013.11.013
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Huang XP, 2018, HUM MOL GENET, V27, P3881, DOI 10.1093/hmg/ddy270
   Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110
   Jin M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62756-8
   Keith JL, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000394
   Kumar S, 2021, CELL RES, V31, P379, DOI 10.1038/s41422-020-00461-x
   Legare VP, 2023, DEV NEUROBIOL, V83, P54, DOI 10.1002/dneu.22909
   Legare VP, 2022, COMP BIOCHEM PHYS B, V261, DOI 10.1016/j.cbpb.2022.110756
   Lehmer C, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708558
   Lin MM, 2022, ACTA PHARMACOL SIN, V43, P2439, DOI 10.1038/s41401-022-00879-6
   Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x
   Liu J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01005
   Liu XD, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01133-6
   Liu YT, 2020, HUM MOL GENET, V29, P1547, DOI 10.1093/hmg/ddaa077
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D
   Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077
   Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a
   Matsui H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23452-x
   McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042
   McCauley ME, 2019, ACTA NEUROPATHOL, V137, P715, DOI 10.1007/s00401-018-1933-9
   Mendelsohn BA, 2008, DEV DYNAM, V237, P1780, DOI 10.1002/dvdy.21581
   Modjtahedi N, 2016, TRENDS BIOCHEM SCI, V41, P245, DOI 10.1016/j.tibs.2015.12.004
   Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]
   Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Penttilä S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319
   Perrone F, 2017, NEUROBIOL AGING, V51, DOI 10.1016/j.neurobiolaging.2016.12.008
   Purandare N, 2018, J BIOL CHEM, V293, P6517, DOI 10.1074/jbc.RA117.001073
   Rentzos M, 2010, ACTA NEUROL SCAND, V122, P425, DOI 10.1111/j.1600-0404.2010.01333.x
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roman W, 2018, SEMIN CELL DEV BIOL, V82, P51, DOI 10.1016/j.semcdb.2017.11.005
   Ronchi D, 2015, BRAIN, V138, pE372, DOI 10.1093/brain/awu384
   Sayles NM, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110475
   Shammas MK, 2023, BIOCHEM SOC T, V51, P797, DOI 10.1042/BST20221365
   Shammas MK, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI157504
   Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110
   Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052
   Straub IR, 2021, HUM MOL GENET, V30, P687, DOI 10.1093/hmg/ddab078
   Straub IR, 2018, HUM MOL GENET, V27, P178, DOI 10.1093/hmg/ddx393
   Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002
   Vejnar Charles E, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot086850
   Westerfield M., 1995, The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio)
   Woulfe J, 2001, ACTA NEUROPATHOL, V102, P94
   Xia W, 2022, CELL REGEN, V11, DOI 10.1186/s13619-022-00111-0
   Xiao TT, 2017, MOL NEUROBIOL, V54, P5243, DOI 10.1007/s12035-016-0056-3
   Xiao YT, 2020, HUM MOL GENET, V29, P1784, DOI 10.1093/hmg/ddz154
   Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020
   Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082
NR 75
TC 0
Z9 0
U1 1
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD DEC
PY 2024
VL 382
AR 114945
DI 10.1016/j.expneurol.2024.114945
EA SEP 2024
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA G7A4P
UT WOS:001318120200001
PM 39260590
OA hybrid
DA 2024-11-01
ER

PT J
AU Jurecka, A
   Tylki-Szymanska, A
AF Jurecka, Agnieszka
   Tylki-Szymanska, Anna
TI Inborn errors of purine and pyrimidine metabolism: A guide to diagnosis
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Review
DE Encephalopathy; Hypotonia; Myopathy; Purines; Pyrimidines; Seizures
ID ADENYLOSUCCINATE LYASE DEFICIENCY; MITOCHONDRIAL-DNA DEPLETION;
   BETA-UREIDOPROPIONASE DEFICIENCY; DOMINANT RETINITIS-PIGMENTOSA;
   DIHYDROPYRIMIDINE DEHYDROGENASE; THYMIDINE KINASE; HPRT DEFICIENCY;
   DISORDERS; DEGRADATION; MUTATIONS
AB Inborn errors of purine and pyrimidine (P/P) metabolism are under-reported and rarely mentioned in the general literature or in clinical practice, as well as in reviews dedicated to other inborn errors of metabolism (IEMs). However, their diagnosis is important because genetic counseling can be provided and, in some cases, specific treatment exists that may slow or even reverse clinical signs. The purpose of this review is to provide a practical guideline on the suspicion and investigation of inborn errors of P/P metabolism. Failure of a physician to recognize the presence of these disorders may be devastating for affected infants and children because of its permanent effects in the patient, and for their parents because of implications for future offspring. Diagnosis is crucial because genetic counseling can be provided and, in some cases, specific treatment can be offered that may slow or even reverse clinical symptoms. This review highlights the risk factors in the history, the important examination findings, and the appropriate biochemical investigation of the child. Herein we describe the approach to the diagnosis of P/P disorders and emphasize clinical situations in which physicians should consider these diseases as diagnostic possibilities.
C1 [Jurecka, Agnieszka] CoA Therapeut, Palo Alto, CA USA.
   [Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Warsaw, Poland.
   [Jurecka, Agnieszka] 1800 Owens St,Suite C-1200, San Francisco, CA 94158 USA.
C3 Children's Memorial Health Institute
RP Jurecka, A (corresponding author), 1800 Owens St,Suite C-1200, San Francisco, CA 94158 USA.
EM ajurecka@gmail.com
CR Almannai M, 2021, FRONT NEUROL, V12, DOI 10.3389/fneur.2021.640371
   [Anonymous], 2005, CLIN GUIDE INHERITED
   Asadov Chingiz, 2017, Cardiovascular & Hematological Agents in Medicinal Chemistry, V15, P23, DOI 10.2174/1871525715666170529091921
   Assmann BE, 2006, EPILEPSIA, V47, P215, DOI 10.1111/j.1528-1167.2006.00391.x
   Balasubramaniam S, 2014, J INHERIT METAB DIS, V37, P687, DOI 10.1007/s10545-014-9742-3
   Bierau J., 2014, PHYS GUIDE DIAGNOSIS
   Blau N., 2003, Physicians Guide to the Laboratory Diagnosis of Metabolic Diseases, DOI 10.1007/978-3-642-55878-8
   Burton BK, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.6.e69
   CAMERON JS, 1993, PEDIATR NEPHROL, V7, P105, DOI 10.1007/BF00861588
   Caudle KE, 2013, CLIN PHARMACOL THER, V94, P640, DOI 10.1038/clpt.2013.172
   Christodoulou John, 2004, Semin Neonatol, V9, P275, DOI 10.1016/j.siny.2003.10.004
   Curto R, 1998, BIOCHEM J, V329, P477, DOI 10.1042/bj3290477
   de Goede C, 2016, EUR J PAEDIATR NEURO, V20, P286, DOI 10.1016/j.ejpn.2015.11.012
   De Vivo DC, 1999, J CHILD NEUROL, V14, pS1, DOI 10.1177/0883073899014001011
   del Caño-Ochoa F, 2020, GENET MED, V22, P1598, DOI 10.1038/s41436-020-0833-2
   Fernandes J., 2006, INBORN METABOLIC DIS, VFourth
   Ghosh A, 2017, ARCH DIS CHILD, V102, P1019, DOI 10.1136/archdischild-2017-312738
   GIBLETT ER, 1972, LANCET, V2, P1067
   Gitiaux C, 2009, EUR J HUM GENET, V17, P133, DOI 10.1038/ejhg.2008.174
   Hartmann S, 2006, CLIN CHEM, V52, P1127, DOI 10.1373/clinchem.2005.058842
   Hershfield MS, 1997, J INHERIT METAB DIS, V20, P179, DOI 10.1023/A:1005300621350
   Hoffmann G.F., 2017, INHERITED METABOLIC, V2th
   Holder-Espinasse M, 2002, J MED GENET, V39, P440, DOI 10.1136/jmg.39.6.440
   Jinnah HA, 2013, HAND CLINIC, V113, P1827, DOI 10.1016/B978-0-444-59565-2.00052-6
   Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056
   Jurecka A, 2009, J INHERIT METAB DIS, V32, P247, DOI 10.1007/s10545-009-1094-z
   Jurecka A, 2008, MOL GENET METAB, V94, P435, DOI 10.1016/j.ymgme.2008.04.013
   Jurecka A, 2015, J INHERIT METAB DIS, V38, P231, DOI 10.1007/s10545-014-9755-y
   Jurecka A, 2014, NEUROPEDIATRICS, V45, P50, DOI 10.1055/s-0033-1337335
   Jurecka A, 2010, J INHERIT METAB DIS, V33, pS21, DOI 10.1007/s10545-009-9011-z
   Jurecka A, 2012, J CHILD NEUROL, V27, P645, DOI 10.1177/0883073811424465
   Jurecka A, 2012, EUR J PEDIATR, V171, P131, DOI 10.1007/s00431-011-1503-9
   Kamatani N, 1998, INTERNAL MED, V37, P905, DOI 10.2169/internalmedicine.37.905
   Kassimatis TI, 2005, J NEPHROL, V18, P447
   Kiss A, 1999, UROL INT, V63, P242, DOI 10.1159/000030458
   Kozma P, 2005, AM J OPHTHALMOL, V140, P858, DOI 10.1016/j.ajo.2005.05.027
   Leonard JV, 2006, ACTA PAEDIATR, V95, P6, DOI 10.1080/08035250500349413
   Löffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003
   Lundy CT, 2010, PEDIATR NEUROL, V43, P351, DOI 10.1016/j.pediatrneurol.2010.06.007
   Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A
   Maring JG, 2002, BRIT J CANCER, V86, P1028, DOI 10.1038/sj/bjc/6600208
   McBride MB, 1998, PEDIATR NEPHROL, V12, P357, DOI 10.1007/s004670050466
   MITCHELL G, 1984, CAN MED ASSOC J, V130, P1323
   Mouchegh K, 2007, J PEDIATR-US, V150, P57, DOI 10.1016/j.jpeds.2006.09.027
   Najarian T, 2000, NEUROREHAB NEURAL RE, V14, P237, DOI 10.1177/154596830001400310
   Ng BG, 2015, HUM MOL GENET, V24, P3050, DOI 10.1093/hmg/ddv057
   Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499
   Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122
   Puig JG, 2001, MEDICINE, V80, P102, DOI 10.1097/00005792-200103000-00003
   Ramond F, 2020, J INHERIT METAB DIS, V43, P1254, DOI 10.1002/jimd.12274
   Rymen D, 2020, GENET MED, V22, P1589, DOI 10.1038/s41436-020-0933-z
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   Schatz Patrik, 2005, Ophthalmic Genet, V26, P119, DOI 10.1080/13816810500229090
   Schretlen DJ, 2005, DEV MED CHILD NEUROL, V47, P673, DOI 10.1017/S0012162205001374
   Scriver C.R., 2001, METABOLIC MOL BASES, P2512
   Simmonds H.A., 1991, TECHNIQUES DIAGNOSTI, P397
   Simmonds H.A., 2000, INHERITED METABOLIC, P215
   SIMMONDS HA, 1994, PHARM WORLD SCI, V16, P139, DOI 10.1007/BF01880664
   Simmonds HA, 1997, J INHERIT METAB DIS, V20, P214, DOI 10.1023/A:1005308923168
   Torres RJ, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-48
   VALENTINE WN, 1980, HEMOGLOBIN, V4, P669, DOI 10.3109/03630268008997736
   Valik D, 1997, MAYO CLIN PROC, V72, P719
   Van Gennip AH, 2000, ADV EXP MED BIOL, V486, P233
   Van Gennip AH., 1999, Ned tijdsh Klin Chem, V24, P171
   van Kuilenburg A.B.P., 2008, LAB GUIDE METHODS BI
   Van Kuilenburg ABP, 2002, INT J CANCER, V101, P253, DOI 10.1002/ijc.10599
   van Kuilenburg ABP, 2004, NUCLEOS NUCLEOT NUCL, V23, P1371, DOI 10.1081/NCN-200027624
   van Kuilenburg ABP, 2004, HUM MOL GENET, V13, P2793, DOI 10.1093/hmg/ddh303
   van Kuilenburg ABP, 2004, EUR J CANCER, V40, P939, DOI 10.1016/j.ejca.2003.12.004
   van Kuilenburg ABP, 2003, CLIN CANCER RES, V9, P4363
   Van Kuilenburg ABP, 1999, HUM GENET, V104, P1, DOI 10.1007/PL00008711
   van Kuilenburg ABP, 2000, CLIN CANCER RES, V6, P4705
   vanGennip AH, 1997, J INHERIT METAB DIS, V20, P203, DOI 10.1023/A:1005356806329
   Wada Y, 2005, INVEST OPHTH VIS SCI, V46, P1735, DOI 10.1167/iovs.04-1197
   Zhou L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00064
NR 75
TC 9
Z9 9
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUL
PY 2022
VL 136
IS 3
BP 164
EP 176
DI 10.1016/j.ymgme.2022.02.007
EA JUN 2022
PG 13
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA 2J9ZF
UT WOS:000816004700002
PM 35216884
DA 2024-11-01
ER

PT J
AU Viljoen, S
   Griep, MA
   Nelson, M
   Viljoen, H
AF Viljoen, S
   Griep, MA
   Nelson, M
   Viljoen, H
TI A macroscopic kinetic model for DNA polymerase elongation and
   high-fidelity nucleotide selection
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE biochemical engineering; molecular biology; polymerase chain reaction;
   mathematical model
ID DEOXYRIBONUCLEOSIDE TRIPHOSPHATE POOL; DOUBLE-STRAND BREAKS;
   MITOCHONDRIAL-DNA; REPLICATION FIDELITY; URACIL RECOGNITION; DEPLETION
   MYOPATHY; IMBALANCE; CELLS; MUTANT; ASYMMETRIES
AB The enzymatically catalyzed template-directed extension of ssDNA/primer complex is an important reaction of extraordinary complexity. The DNA polymerase does not merely facilitate the insertion of dNMP, but it also performs rapid screening of substrates to ensure a high degree of fidelity. Several kinetic studies have determined rate constants and equilibrium constants for the elementary steps that make up the overall pathway. The information is used to develop a macroscopic kinetic model, using an approach described by Ninio [Ninio J., 1987. Alternative to the steady-state method: derivation of reaction rates from first-passage times and pathway probabilities. Proc. Natl. Acad. Sci. U.S.A. 84, 663-667]. The principle idea of the Ninio approach is to track a single template/primer complex over time and to identify the expected behavior. The average time to insert a single nucleotide is a weighted sum of several terms, including the actual time to insert a nucleotide plus delays due to polymerase detachment from either the ternary (template-primer-polymerase) or quaternary (+nucleotide) complexes and time delays associated with the identification and ultimate rejection of an incorrect nucleotide from the binding site. The passage times of all events and their probability of occurrence are expressed in terms of the rate constants of the elementary steps of the reaction pathway. The model accounts for variations in the average insertion time with different nucleotides as well as the influence of G + C content of the sequence in the vicinity of the insertion site. Furthermore the model provides estimates of error frequencies. If nucleotide extension is recognized as a competition between successful insertions and time delaying events, it can be described as a binomial process with a probability distribution. The distribution gives the probability to extend a primer/template complex with a certain number of base pairs and in general it maps annealed complexes into extension products. 2005 Elsevier Ltd. All rights reserved.
C1 Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.
   Nebraska Wesleyan Univ, Dept Biochem, Lincoln, NE 68540 USA.
   Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.
   Megabase Res Prod, Lincoln, NE 68540 USA.
C3 University of Nebraska System; University of Nebraska Lincoln;
   University of Nebraska System; University of Nebraska Lincoln
RP Viljoen, H (corresponding author), Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.
EM hviljoen1@unl.edu
RI Griep, Mark/L-7797-2019
CR Ahmed A, 2003, J ANTI-AGING MED, V6, P315, DOI 10.1089/109454503323028911
   AKERBLOM L, 1982, J BIOL CHEM, V257, P6776
   Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338
   Chimploy K, 2000, J BIOL CHEM, V275, P39267, DOI 10.1074/jbc.M006233200
   Connolly BA, 2003, BIOCHEM SOC T, V31, P699, DOI 10.1042/BST0310699
   DAS SK, 1983, BIOCHEM BIOPH RES CO, V114, P458, DOI 10.1016/0006-291X(83)90802-1
   Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867
   Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045
   GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907
   HEINEMANN V, 1995, SEMIN ONCOL, V22, P11
   Jager Joachim, 1999, Current Opinion in Structural Biology, V9, P21, DOI 10.1016/S0959-440X(99)80004-9
   JAMES SJ, 1992, CARCINOGENESIS, V13, P2471, DOI 10.1093/carcin/13.12.2471
   JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345
   Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z
   Julias JG, 1998, J VIROL, V72, P7941, DOI 10.1128/JVI.72.10.7941-7949.1998
   KASAHARA Y, 1993, MUTAT RES, V319, P143, DOI 10.1016/0165-1218(93)90073-M
   Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693
   Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200
   Lehman IR, 2003, J BIOL CHEM, V278, P34733, DOI 10.1074/jbc.X300002200
   Li Y, 2001, CURR ORG CHEM, V5, P871, DOI 10.2174/1385272013375067
   LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035
   Martomo SA, 2002, MUTAT RES-FUND MOL M, V499, P197, DOI 10.1016/S0027-5107(01)00283-4
   MATHEWS CK, 1992, BIOESSAYS, V14, P295, DOI 10.1002/bies.950140502
   Melnyk S, 1999, CANCER LETT, V146, P35, DOI 10.1016/S0304-3835(99)00213-X
   Michaelis L, 1913, BIOCHEM Z, V49, P333
   Miura S, 2004, CURR DRUG TARGETS, V5, P191, DOI 10.2174/1389450043490578
   NINIO J, 1987, P NATL ACAD SCI USA, V84, P663, DOI 10.1073/pnas.84.3.663
   PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SAIKI RK, 1985, SCIENCE, V230
   Shuttleworth G, 2004, J MOL BIOL, V337, P621, DOI 10.1016/j.jmb.2004.01.021
   Smith A J, 1980, Methods Enzymol, V65, P560
   Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200
   SUZUKI K, 1983, MUTAT RES, V122, P293, DOI 10.1016/0165-7992(83)90009-X
   Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001
   Wang LY, 2003, J BIOL CHEM, V278, P6963, DOI 10.1074/jbc.M206143200
   WATAYA Y, 1988, NUCL ACIDS S SER, V53
   Whitney SE, 2004, COMPUT BIOL CHEM, V28, P195, DOI 10.1016/j.compbiolchem.2004.03.001
   YAMATO M, 1992, JPN J CANCER RES, V83, P661, DOI 10.1111/j.1349-7006.1992.tb00141.x
   YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235
NR 40
TC 8
Z9 9
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD APR
PY 2005
VL 29
IS 2
BP 101
EP 110
DI 10.1016/j.compbiolchem.2005.02.003
PG 10
WC Biology; Computer Science, Interdisciplinary Applications
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA 921KU
UT WOS:000228764000004
PM 15833438
DA 2024-11-01
ER

PT J
AU Formichi, P
   Radi, E
   Battisti, C
   Di Maio, G
   Tarquini, E
   Leonini, A
   Di Stefano, A
   Dotti, MT
   Federico, A
AF Formichi, Patrizia
   Radi, Elena
   Battisti, Carla
   Di Maio, Giuseppe
   Tarquini, Ermelinda
   Leonini, Alessandra
   Di Stefano, Anna
   Dotti, Maria Teresa
   Federico, Antonio
TI Apoptosis in CADASIL: An In Vitro Study of Lymphocytes and Fibroblasts
   From a Cohort of Italian Patients
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
ID AUTOSOMAL-DOMINANT ARTERIOPATHY; SMOOTH-MUSCLE-CELLS; DNA FRAGMENTATION;
   SUBCORTICAL INFARCTS; OXIDATIVE STRESS; ATAXIA-TELANGIECTASIA;
   FLOW-CYTOMETRY; NOTCH3 GENE; LEUKOENCEPHALOPATHY; EXPRESSION
AB Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) is a hereditary disease affecting vascular smooth muscle cells of nearly all tissues. Clinical manifestations mainly concern the central nervous system with repeated TIA/stroke, migraine, psychiatric disturbances, and cognitive decline. Minor findings have been reported in muscle, nerve,and skin. CADASIL is due to NOTCH3 gene mutations. This gene has been identified as an up-regulator of c-FLIP, an inhibitor of Fas-ligand-induced apoptosis. The aim of this study was to assess the involvement of oxidative stress-induced apoptosis in cells from 16 Italian CADASIL patients. Peripheral blood lymphocytes (PBLs) and fibroblasts from CADASIL patients were exposed to 2-deoxy-D-ribose (dRib), which induces apoptosis by oxidative stress. Apoptosis was analyzed by flow cytometry, agarose gel electrophoresis and fluorescence microscopy for caspase-3 activation, phosphatidylserine exposure and mitochondrial membrane depolarization. PBLs and fibroblasts from CADASIL patients showed a significantly higher response to dRib-induced apoptosis than those of controls. PBLs from CADASIL patients also showed a significantly higher percentage of apoptotic cells than PBLs from controls, even when cultured without dRib. The greater susceptibility of PBLs and fibroblasts from CADASIL patients to dRib-induced apoptosis suggests that NOTCH3 mutations are an important apoptotic trigger. Since PBLs from patients showed higher levels of apoptosis even in the absence of an apoptotic stimulus, cells from CADASIL patients appear to be physiologically prone to apoptotic cell death.
C1 [Formichi, Patrizia; Radi, Elena; Battisti, Carla; Di Maio, Giuseppe; Dotti, Maria Teresa; Federico, Antonio] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy.
   [Tarquini, Ermelinda] Azienda Osped, Dept Neurol Neurosurg & Behav Sci, Siena, Italy.
   [Leonini, Alessandra; Di Stefano, Anna] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy.
C3 University of Siena; University of Siena; University Hospital of Siena;
   University of Siena
RP Federico, A (corresponding author), Policlin Le Scotte, Sez Sci Neurol, Dipartimento Sci Neurol Neurochirurg & Comportame, Vle Bracci 2, I-53100 Siena, Italy.
EM federico@unisi.it
RI Federico, Antonio/H-8871-2017; formichi, patrizia/Q-3436-2016
OI federico, antonio/0000-0002-5246-1621
FU Regione Toscana [AOOGRT/2120/125.002.006]; Fondazione Monte dei Paschi
   di Siena [27489]
FX Contract grant sponsor: Regione Toscana;Contract grant number:
   AOOGRT/2120/125.002.006.Contract grant sponsor: Fondazione Monte dei
   Paschi di Siena;Contract grant number: 27489.
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   BARBIERI D, 1992, BIOCHEM BIOPH RES CO, V187, P1256, DOI 10.1016/0006-291X(92)90438-Q
   Battisti C, 1996, J NEUROL SCI, V144, P128, DOI 10.1016/S0022-510X(96)00216-X
   BAUDRIMONT M, 1993, STROKE, V24, P122, DOI 10.1161/01.STR.24.1.122
   BOYUM A, 1984, METHOD ENZYMOL, V108, P88
   Campos AH, 2002, CIRC RES, V91, P999, DOI 10.1161/01.RES.0000044944.99984.25
   CHABRIAT H, 1995, NEUROLOGY, V45, P1086, DOI 10.1212/WNL.45.6.1086
   de la Peña P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235
   Dotti MT, 2004, ARCH NEUROL-CHICAGO, V61, P942, DOI 10.1001/archneur.61.6.942
   Duru NK, 2001, J ANDROL, V22, P646
   EASTMAN A, 1995, METHOD CELL BIOL, V46, P41
   Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594
   Finnilä S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268
   Formichi P, 2006, J CELL PHYSIOL, V208, P289, DOI 10.1002/jcp.20662
   Formichi P, 2000, LIFE SCI, V66, P1893, DOI 10.1016/S0024-3205(00)00515-4
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   Gibbons GH, 2000, CIRC RES, V86, P1009, DOI 10.1161/01.RES.86.10.1009
   Haruki N, 2005, CANCER RES, V65, P3555, DOI 10.1158/0008-5472.CAN-04-3132
   Ihalainen S, 2007, MOL MED, V13, P305, DOI 10.2119/2006-00069.Ihalainen
   Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047
   Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0
   Kalimo H, 2002, BRAIN PATHOL, V12, P371
   Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855
   Kletsas D, 1998, BIOCHEM BIOPH RES CO, V243, P416, DOI 10.1006/bbrc.1997.7975
   Lieven CJ, 2003, ANTIOXID REDOX SIGN, V5, P641, DOI 10.1089/152308603770310310
   NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O
   Peters N, 2006, NEUROLOGY, V66, P1517, DOI 10.1212/01.wnl.0000216271.96364.50
   RUCHOUX MM, 1994, STROKE, V25, P2291, DOI 10.1161/01.STR.25.11.2291
   Ruchoux MM, 1997, J NEUROPATH EXP NEUR, V56, P947, DOI 10.1097/00005072-199709000-00001
   RUCHOUX MM, 1995, ACTA NEUROPATHOL, V89, P500
   Ruchoux MM, 2000, ANN NY ACAD SCI, V903, P285, DOI 10.1111/j.1749-6632.2000.tb06378.x
   Rufa A, 2005, NEUROL SCI, V26, P271, DOI 10.1007/s10072-005-0470-1
   SCHRODER JM, 1995, ACTA NEUROPATHOL, V89, P116, DOI 10.1007/BF00296354
   TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x
   TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Viswanathan A, 2006, STROKE, V37, P2690, DOI 10.1161/01.STR.0000245091.28429.6a
   Wang T, 2008, PROG BIOPHYS MOL BIO, V96, P499, DOI 10.1016/j.pbiomolbio.2007.07.006
   Wang WL, 2003, BIOCHEM BIOPH RES CO, V308, P596, DOI 10.1016/S0006-291X(03)01453-0
   Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200
NR 40
TC 28
Z9 30
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD MAY
PY 2009
VL 219
IS 2
BP 494
EP 502
DI 10.1002/jcp.21695
PG 9
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA 425VO
UT WOS:000264666000030
PM 19180562
DA 2024-11-01
ER

PT J
AU Garone, C
   D'Souza, AR
   Dallabona, C
   Lodi, T
   Rebelo-Guiomar, P
   Rorbach, J
   Donati, MA
   Procopio, E
   Montomoli, M
   Guerrini, R
   Zeviani, M
   Calvo, SE
   Mootha, VK
   DiMauro, S
   Ferrero, I
   Minczuk, M
AF Garone, Caterina
   D'Souza, Aaron R.
   Dallabona, Cristina
   Lodi, Tiziana
   Rebelo-Guiomar, Pedro
   Rorbach, Joanna
   Donati, Maria Alice
   Procopio, Elena
   Montomoli, Martino
   Guerrini, Renzo
   Zeviani, Massimo
   Calvo, Sarah E.
   Mootha, Vamsi K.
   DiMauro, Salvatore
   Ferrero, Ileana
   Minczuk, Michal
TI Defective mitochondrial rRNA methyltransferase MRM2 causes
   <i>MELAS</i>-like clinical syndrome
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID SIDEROBLASTIC ANEMIA; HYPERTROPHIC CARDIOMYOPATHY; PHENOTYPIC SPECTRUM;
   LACTIC-ACIDOSIS; MUTATIONS CAUSE; LARGE SUBUNIT; BRAIN-STEM;
   LEUKOENCEPHALOPATHY; RHABDOMYOLYSIS; TRANSLATION
AB Defects in nuclear-encoded proteins of themitochondrial translation machinery cause early-onset and tissue-specific deficiency of one ormore OXPHOS complexes. Here, we report a 7-year-old Italian boy with childhood-onset rapidly progressive encephalomyopathy and stroke-like episodes. Multiple OXPHOS defects and decreased mtDNA copy number (40%) were detected in muscle homogenate. Clinical features combined with low level of plasma citrulline were highly suggestive of mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome, however, the common m. 3243A>G mutation was excluded. Targeted exome sequencing of genes encoding themitochondrial proteome identified a damaging mutation, c.567G>A, affecting a highly conserved amino acid residue (p.Gly189Arg) of the MRM2 protein. MRM2 has never before been linked to a human disease and encodes an enzyme responsible for 2'-O-methyl modification at position U1369 in the human mitochondrial 16S rRNA. We generated a knockout yeast model for the orthologous gene that showed a defect in respiration and the reduction of the 2'-O-methyl modification at the equivalent position (U2791) in the yeastmitochondrial 21S rRNA. Complementation with the mrm2 allele carrying the equivalent yeast mutation failed to rescue the respiratory phenotype, which was instead completely rescued by expressing the wild-type allele. Our findings establish that defective MRM2 causes a MELAS-like phenotype, and suggests the genetic screening of the MRM2 gene in patients with am. 3243A>G negative MELAS-like presentation.
C1 [Garone, Caterina; D'Souza, Aaron R.; Rebelo-Guiomar, Pedro; Rorbach, Joanna; Zeviani, Massimo; Minczuk, Michal] Univ Cambridge, MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England.
   [Garone, Caterina; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA.
   [Dallabona, Cristina; Lodi, Tiziana; Ferrero, Ileana] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, I-43121 Parma, Italy.
   [Rebelo-Guiomar, Pedro] Univ Porto, Grad Program Areas Basic & Appl Biol GABBA, P-4099002 Oporto, Portugal.
   [Donati, Maria Alice; Procopio, Elena] A Meyer Childrens Hosp, Metabol Unit, I-50139 Florence, Italy.
   [Montomoli, Martino; Guerrini, Renzo] Univ Florence, A Meyer Childrens Hosp, Pediatr Neurol Unit & Labs, I-50139 Florence, Italy.
   [Calvo, Sarah E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02115 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Calvo, Sarah E.; Mootha, Vamsi K.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
C3 University of Cambridge; Columbia University; University of Parma;
   Universidade do Porto; University of Florence; Azienda Ospedaliera
   Universitaria (AOU) MEYER; University of Florence; Azienda Ospedaliera
   Universitaria (AOU) MEYER; Harvard University; Massachusetts Institute
   of Technology (MIT); Broad Institute; Harvard University; Massachusetts
   General Hospital; Howard Hughes Medical Institute; Harvard University;
   Massachusetts General Hospital; Harvard University; Harvard Medical
   School
RP Garone, C; Minczuk, M (corresponding author), Univ Cambridge, MRC, Mitochondrial Biol Unit, Wellcome Trust, MRC Bldg,Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.
EM cg562@mrc-mbu.cam.ac.uk; mam@mrc-mbu.cam.ac.uk
RI Zeviani, Massimo/AAU-2632-2021; rorbach, Joanna/AAM-5683-2021;
   Rebelo-Guiomar, Pedro/AAT-3575-2021; Garone, Caterina/AAB-8659-2019;
   Minczuk, Michal/G-1638-2014
OI MARIA ALICE, DONATI/0000-0003-4769-5025; Minczuk,
   Michal/0000-0001-8242-1420; Montomoli, Martino/0000-0003-4046-3133;
   Guerrini, Renzo/0000-0002-7272-7079; DALLABONA,
   Cristina/0000-0003-4397-9143; Garone, Caterina/0000-0003-4928-1037;
   Rorbach, Joanna/0000-0002-2891-2840; Rebelo-Guiomar,
   Pedro/0000-0002-5060-7519; Zeviani, Massimo/0000-0002-9067-5508
FU European Commission under 'Marie Sklodowska-Curie Actions', Individual
   Fellowship - Reintegration Panel [Mitobiopath-705560]; MRC core funding
   [MC_U105697135]; Fundacao para a Ciencia e a Tecnologia, Portugal
   [PD/BD/105750/2014]; Fondazione Telethon (Italy) [GGP15041]; European
   Union Seventh Framework Programme FP7 under the project 'DESIRE'
   [602531]; NRJ-Institut de France grant; ERC advanced grant [FP7-322424];
   National Institutes of Health [NIH R01 GM0077465, R35GM122455]; Medical
   Research Council, UK; Fundação para a Ciência e a Tecnologia
   [PD/BD/105750/2014] Funding Source: FCT; MRC [MC_U105697135,
   MC_UP_1002/1, MC_UU_00015/4, MC_UU_00015/5] Funding Source: UKRI
FX European Commission under 'Marie Sklodowska-Curie Actions', Individual
   Fellowship - Reintegration Panel (Mitobiopath-705560), MRC core funding
   (MC_U105697135), Fundacao para a Ciencia e a Tecnologia, Portugal
   (PD/BD/105750/2014), Fondazione Telethon (Italy) (grant GGP15041),
   European Union Seventh Framework Programme FP7 (602531) under the
   project 'DESIRE', NRJ-Institut de France grant and ERC advanced grant
   FP7-322424 (MZ) and National Institutes of Health (VKM, NIH R01
   GM0077465 and R35GM122455). Funding to pay the Open Access publication
   charges for this article was provided by the Medical Research Council,
   UK.
CR Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391
   AUSUBEL FM, 1994, CURRENT PROTOCOLS MO, V2
   Bar-Yaacov D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002557
   Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002
   Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099
   Blum S, 2011, INTERN MED J, V41, P200, DOI 10.1111/j.1445-5994.2010.02379.x
   Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310
   Chakraborty PK, 2014, BLOOD, V124, P2867, DOI 10.1182/blood-2014-08-591370
   Connolly BS, 2010, BIOCHEM BIOPH RES CO, V402, P443, DOI 10.1016/j.bbrc.2010.10.060
   Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976
   Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072
   DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89
   Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833
   Dombi E, 2016, NEUROLOGY, V86, P1921, DOI 10.1212/WNL.0000000000002688
   Dvorakova V, 2016, MOL GENET METAB, V118, P288, DOI 10.1016/j.ymgme.2016.06.003
   Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227
   El-Hattab AW, 2015, MOL GENET METAB, V116, P4, DOI 10.1016/j.ymgme.2015.06.004
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   Finsterer J, 2016, EUR J PAEDIATR NEURO, V20, P824, DOI 10.1016/j.ejpn.2016.08.002
   Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011
   Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523
   Götz A, 2011, AM J HUM GENET, V88, P635, DOI 10.1016/j.ajhg.2011.04.006
   Haack TB, 2014, MOL GENET METAB, V111, P342, DOI 10.1016/j.ymgme.2013.12.010
   Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006
   Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017
   Kwon JH, 2003, EUR NEUROL, V50, P123, DOI 10.1159/000072517
   Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868
   Lightowlers RN, 2015, SCIENCE, V349, P1494, DOI 10.1126/science.aac7516
   Mai N, 2017, CELL TISSUE RES, V367, P5, DOI 10.1007/s00441-016-2456-0
   Metodiev MD, 2016, AM J HUM GENET, V98, P993, DOI 10.1016/j.ajhg.2016.03.010
   Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001
   Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110
   Nakagaki Hideaki, 2005, Rinsho Shinkeigaku, V45, P502
   Nicholls TJ, 2013, INT J BIOCHEM CELL B, V45, P845, DOI 10.1016/j.biocel.2013.01.005
   Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003
   Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139
   Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011
   Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079
   Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014
   Scheper GC, 2007, NAT GENET, V39, P534, DOI 10.1038/ng2013
   Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064
   Steen C, 1999, EUR J PEDIATR, V158, P730, DOI 10.1007/s004310051189
   Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
   Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390
   Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531
   Tay SKH, 2008, PEDIATR NEUROL, V39, P426, DOI 10.1016/j.pediatrneurol.2008.09.002
   Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184
   Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010
   Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039
   Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z
   Wedatilake Y, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0477-0
   Wortmann SB, 2009, BRAIN, V132, P136, DOI 10.1093/brain/awn296
   Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424
   Yokoyama Jun, 2016, Rinsho Shinkeigaku, V56, P204, DOI 10.5692/clinicalneurol.cn-000834
   Zaganelli S, 2017, J BIOL CHEM, V292, P4519, DOI 10.1074/jbc.M116.771105
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004
NR 61
TC 50
Z9 58
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD NOV 1
PY 2017
VL 26
IS 21
BP 4257
EP 4266
DI 10.1093/hmg/ddx314
PG 10
WC Biochemistry & Molecular Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA FK4HU
UT WOS:000413453900014
PM 28973171
OA hybrid, Green Published
DA 2024-11-01
ER

PT J
AU Solomon, CU
   McVey, DG
   Andreadi, C
   Gong, P
   Turner, L
   Stanczyk, PJ
   Khemiri, S
   Chamberlain, JC
   Yang, W
   Webb, TR
   Nelson, CP
   Samani, NJ
   Ye, S
AF Solomon, Charles U.
   McVey, David G.
   Andreadi, Catherine
   Gong, Peng
   Turner, Lenka
   Stanczyk, Paulina J.
   Khemiri, Sonja
   Chamberlain, Julie C.
   Yang, Wei
   Webb, Tom R.
   Nelson, Christopher P.
   Samani, Nilesh J.
   Ye, Shu
TI Effects of Coronary Artery Disease-Associated Variants on Vascular
   Smooth Muscle Cells
SO CIRCULATION
LA English
DT Article
DE coronary artery disease; genetics; muscle; smooth; vascular;
   transcriptomes
ID MITOCHONDRIAL-FUNCTION; LOCI; GENERATION; SIGNALS; YIPF6; GOLGI; GWAS;
   EQTL
AB Background: Genome-wide association studies have identified many genetic loci that are robustly associated with coronary artery disease (CAD). However, the underlying biological mechanisms are still unknown for most of these loci, hindering the progress to medical translation. Evidence suggests that the genetic influence on CAD susceptibility may act partly through vascular smooth muscle cells (VSMCs). Methods: We undertook genotyping, RNA sequencing, and cell behavior assays on a large bank of VSMCs (n>1499). Expression quantitative trait locus and splicing quantitative trait locus analyses were performed to identify genes with an expression that was influenced by CAD-associated variants. To identify candidate causal genes for CAD, we ascertained colocalizations of VSMC expression quantitative trait locus signals with CAD association signals by performing causal variants identification in associated regions analysis and the summary data-based mendelian randomization test. Druggability analysis was then performed on the candidate causal genes. CAD risk variants were tested for associations with VSMC proliferation, migration, and apoptosis. Collective effects of multiple CAD-associated variants on VSMC behavior were estimated by polygenic scores. Results: Approximately 60% of the known CAD-associated variants showed statistically significant expression quantitative trait locus or splicing quantitative trait locus effects in VSMCs. Colocalization analyses identified 84 genes with expression quantitative trait locus signals that significantly colocalized with CAD association signals, identifying them as candidate causal genes. Druggability analysis indicated that 38 of the candidate causal genes were druggable, and 13 had evidence of drug-gene interactions. Of the CAD-associated variants tested, 139 showed suggestive associations with VSMC proliferation, migration, or apoptosis. A polygenic score model explained up to 5.94% of variation in several VSMC behavior parameters, consistent with polygenic influences on VSMC behavior. Conclusions: This comprehensive analysis shows that a large percentage of CAD loci can modulate gene expression in VSMCs and influence VSMC behavior. Several candidate causal genes identified are likely to be druggable and thus represent potential therapeutic targets.
C1 [Solomon, Charles U.; McVey, David G.; Andreadi, Catherine; Gong, Peng; Turner, Lenka; Stanczyk, Paulina J.; Khemiri, Sonja; Chamberlain, Julie C.; Webb, Tom R.; Nelson, Christopher P.; Samani, Nilesh J.; Ye, Shu] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.
   [Solomon, Charles U.; McVey, David G.; Andreadi, Catherine; Gong, Peng; Turner, Lenka; Stanczyk, Paulina J.; Khemiri, Sonja; Chamberlain, Julie C.; Webb, Tom R.; Nelson, Christopher P.; Samani, Nilesh J.; Ye, Shu] Natl Inst Hlth Res Leicester Biomed Res Ctr, Leicester, Leics, England.
   [Yang, Wei; Ye, Shu] Shantou Univ, Med Coll, Shantou, Peoples R China.
   [Ye, Shu] Natl Univ Singapore, Dept Med, Cardiovasc Dis Translat Res Programme, Singapore, Singapore.
C3 University of Leicester; Shantou University; National University of
   Singapore
RP Ye, S (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Dis Translat Res Programme, Dept Med,Ctr Translat Med, Block MD 6,14 Med Dr, Singapore 117599, Singapore.
EM sy127@leicester.ac.uk
RI Gong, Peng/ABD-6333-2021; Nelson, Christopher/GMX-2575-2022; Webb,
   Tom/GMW-5311-2022; Ye, Shu/R-6384-2017
OI McVey, David Graham/0000-0002-6402-2546; Ye, Shu/0000-0002-4126-4278;
   Solomon, Charles/0000-0002-6462-3384
FU British Heart Foundation [RG/16/13/32609, RG/19/9/34655, PG/16/9/31995,
   PG/18/73/34059, SP/19/2/344612]; National University of Singapore
   [NUHSRO/2022/004/Startup/01]; National University Health System Internal
   Grant Funding [NUHSRO/2022/004/Startup/01]; National Natural Science
   Foundation of China [81370202, 82070466, 82000341]
FX This work was funded by the British Heart Foundation (RG/16/13/32609,
   RG/19/9/34655, PG/16/9/31995, PG/18/73/34059, and SP/19/2/344612), the
   National University of Singapore and the National University Health
   System Internal Grant Funding (NUHSRO/2022/004/Startup/01), and the
   National Natural Science Foundation of China (81370202, 82070466, and
   82000341). This work falls under the portfolio of research conducted
   within the National Institute for Health Research Leicester Biomedical
   Research Centre.
CR Aherrahrou R, 2020, CIRC RES, V127, P1552, DOI 10.1161/CIRCRESAHA.120.317415
   Almontashiri NAM, 2015, CIRCULATION, V132, P1969, DOI 10.1161/CIRCULATIONAHA.114.015023
   Angelakopoulou A, 2012, EUR HEART J, V33, P393, DOI 10.1093/eurheartj/ehr225
   Aragam K.G., 2021, medRxiv, DOI [10.1101/2021.05.24.21257377, DOI 10.1101/2021.05.24.21257377]
   Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1161/CIRCRESAHA.115.306361, 10.1038/s41569-019-0227-9]
   Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120
   Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8
   Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214
   Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656
   Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480
   Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808
   Dituri F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101130
   Djusberg E, 2017, PROSTATE, V77, P625, DOI 10.1002/pros.23307
   Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51
   Erdmann J, 2018, CARDIOVASC RES, V114, P1241, DOI 10.1093/cvr/cvy084
   Finan C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1166
   Freshour SL, 2021, NUCLEIC ACIDS RES, V49, pD1144, DOI 10.1093/nar/gkaa1084
   Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003
   Howson JMM, 2017, NAT GENET, V49, P1113, DOI 10.1038/ng.3874
   Huang CK, 2020, CIRC RES, V126, P663, DOI 10.1161/CIRCRESAHA.119.315856
   Huang QQ, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky780
   Iyer D, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007681
   Kessler T, 2017, CIRCULATION, V136, P476, DOI 10.1161/CIRCULATIONAHA.116.024152
   Khera AV, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2016.160
   Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Leik CE, 2004, HYPERTENSION, V43, P837, DOI 10.1161/01.HYP.0000119191.33112.9c
   Liu BX, 2018, AM J HUM GENET, V103, P377, DOI 10.1016/j.ajhg.2018.08.001
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Low EL, 2019, CELL SIGNAL, V53, P90, DOI 10.1016/j.cellsig.2018.09.004
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   Morrell NW, 2016, NAT REV CARDIOL, V13, P106, DOI 10.1038/nrcardio.2015.156
   Motterle A, 2012, HUM MOL GENET, V21, P4021, DOI 10.1093/hmg/dds224
   Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266
   Nanda V, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007755
   National Center for Biotechnology Information (NCBI), 2002, GEO
   Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913
   Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314
   Nurnberg ST, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005155
   Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051
   Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012
   Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6
   Ricci JE, 2003, J CELL BIOL, V160, P65, DOI 10.1083/jcb.200208089
   Soonthornsit J, 2017, EXP CELL RES, V353, P100, DOI 10.1016/j.yexcr.2017.03.011
   toppgene, TOPPGENE SUITE
   Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521
   van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]
   Webb TR, 2017, J AM COLL CARDIOL, V69, P823, DOI 10.1016/j.jacc.2016.11.056
   Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5
   Xin YL, 2019, BIOCHEM J, V476, P1585, DOI 10.1042/BCJ20190057
   Yang W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006127
   Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538
NR 52
TC 14
Z9 14
U1 2
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD SEP 20
PY 2022
VL 146
IS 12
BP 917
EP 929
DI 10.1161/CIRCULATIONAHA.121.058389
PG 13
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology
GA 4N6ZD
UT WOS:000854165700008
PM 35735005
OA Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Rosen, ED
AF Rosen, E. D.
TI Epigenomic and transcriptional control of insulin resistance
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE adipocyte; chromatin-modifying enzyme; insulin resistance; transcription
   factor; transcriptional cofactor; type 2 diabetes
ID ACTIVATED-RECEPTOR-GAMMA; HEPATIC GLUCOSE OUTPUT; PPAR-GAMMA;
   GLUCOCORTICOID-RECEPTOR; SKELETAL-MUSCLE; ANTIDIABETIC ACTIONS;
   COACTIVATOR TORC2; PROMOTES OBESITY; GENE-EXPRESSION; BINDING
AB Insulin resistance is one of the defining features of type 2 diabetes and the metabolic syndrome and accompanies many other clinical conditions, ranging from obesity to lipodystrophy to glucocorticoid excess. Extraordinary efforts have gone into defining the mechanisms that underlie insulin resistance, with most attention focused on altered signalling as well as mitochondrial and endoplasmic reticulum stress. Here, nuclear mechanisms of insulin resistance, including transcriptional and epigenomic effects, will be discussed. Three levels of control involving transcription factors, transcriptional cofactors, and chromatin-modifying enzymes will be considered. Well-studied examples of the first include PPAR- in adipose tissue and the glucocorticoid receptor and FoxO1 in a variety of insulin-sensitive tissues. These proteins work in concert with cofactors such as PGC-1 and CRTC2, and chromatin-modifying enzymes including DNA methyltransferases and histone acetyltransferases, to regulate key genes that promote insulin-stimulated glucose uptake, gluconeogenesis or other pathways that affect systemic insulin action. Furthermore, genetic variation associated with increased risk of type 2 diabetes is often related to altered transcription factor binding, either by affecting the transcription factor itself, or more commonly by changing the binding affinity of a noncoding regulatory region. Finally, several avenues for therapeutic exploitation in the battle against metabolic disease will be discussed, including small-molecule inhibitors and activators of these factors and their related pathways.
C1 [Rosen, E. D.] Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.
   [Rosen, E. D.] Harvard Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.
C3 Harvard University; Beth Israel Deaconess Medical Center; Harvard
   University; Harvard Medical School
RP Rosen, ED (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab, 330 Brookline Ave, Boston, MA 02215 USA.; Rosen, ED (corresponding author), Harvard Med Sch, 330 Brookline Ave, Boston, MA 02215 USA.
EM erosen@bidmc.harvard.edu
FU NIH [R01 DK 085171, R01 DK 102173, R01 DK 102170]
FX The author is supported by NIH grants R01 DK 085171, R01 DK 102173 and
   R01 DK 102170.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216
   Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.11.1457 , 10.1517/14728220802384047]
   Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887
   Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31
   Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257
   Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723
   Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191
   Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010
   Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014
   Calabuig-Navarro V, 2015, J BIOL CHEM, V290, P15581, DOI 10.1074/jbc.M115.650994
   Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008
   Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383
   Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291
   Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132
   Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058
   Cleasby ME, 2007, MOL ENDOCRINOL, V21, P215, DOI 10.1210/me.2006-0154
   Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105
   Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062
   Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327
   Farese RV, 2012, CELL METAB, V15, P570, DOI 10.1016/j.cmet.2012.03.004
   Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548
   Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637
   Gaulton KJ, 2008, DIABETES, V57, P3136, DOI 10.2337/db07-1731
   Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200
   Giguère V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017
   Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200
   Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851
   Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361
   Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956
   Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561
   Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005
   Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034
   Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Huang-Doran Isabel, 2011, Pediatr Endocrinol Rev, V8, P190
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x
   Jacobson PB, 2005, J PHARMACOL EXP THER, V314, P191, DOI 10.1124/jpet.104.081257
   James AM, 2012, TRENDS ENDOCRIN MET, V23, P429, DOI 10.1016/j.tem.2012.06.008
   Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842
   Kang S, 2015, NAT CELL BIOL, V17, P44, DOI 10.1038/ncb3080
   Keppler BR, 2008, EXPERT OPIN THER TAR, V12, P1301, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384013]
   Kim AY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8585
   Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305
   Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928
   Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049
   Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967
   Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037
   Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109
   Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42
   Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001
   Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001
   Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050
   Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349
   Löwenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602
   Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332
   Majithia AR, 2014, P NATL ACAD SCI USA, V111, P13127, DOI 10.1073/pnas.1410428111
   Masuccio F, 2010, J CHILD NEUROL, V25, P941, DOI 10.1177/0883073809349461
   Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008
   Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029
   Mezza T, 2012, ANN NUTR METAB, V61, P337, DOI 10.1159/000342771
   Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098
   Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043
   Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010
   Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027
   Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, pE1249, DOI 10.1152/ajpendo.2001.281.6.E1249
   Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011
   Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Oh JS, 2015, CELL REP, V10, P1872, DOI 10.1016/j.celrep.2015.02.043
   Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652
   Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846
   Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283
   Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988
   Peirce V, 2013, LANCET DIABETES ENDO, V1, P353, DOI 10.1016/S2213-8587(13)70055-X
   Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8
   Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905
   Vinolo MAR, 2012, AM J PHYSIOL-ENDOC M, V303, pE272, DOI 10.1152/ajpendo.00053.2012
   Rando OJ, 2015, CELL, V161, P93, DOI 10.1016/j.cell.2015.02.021
   Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0
   Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032
   Roohk DJ, 2013, ENDOCRINOLOGY, V154, P1528, DOI 10.1210/en.2011-1047
   Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003
   Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349
   Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009
   Sacta MA, 2016, ANNU REV PHYSIOL, V78, P155, DOI 10.1146/annurev-physiol-021115-105323
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406
   Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682
   Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001
   Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833
   Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025
   Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005
   Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564
   Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686
   Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207
   Sun C, 2014, CELL REP, V9, P2250, DOI 10.1016/j.celrep.2014.11.029
   Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022
   Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744
   Sung CC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/634195
   Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777
   Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200
   Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107
   Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222
   Whorwood CB, 2002, DIABETES, V51, P1066, DOI 10.2337/diabetes.51.4.1066
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433
   Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1
   Yi CX, 2012, DIABETES, V61, P339, DOI 10.2337/db11-1239
NR 115
TC 22
Z9 24
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD NOV
PY 2016
VL 280
IS 5
BP 443
EP 456
DI 10.1111/joim.12547
PG 14
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EA8VL
UT WOS:000386917400003
PM 27739225
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Góth, L
   Nagy, T
AF Goth, Laszlo
   Nagy, Terez
TI Acatalasemia and diabetes mellitus
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Acatalasemia; Diabetes; Reactive oxygen species; Catalase; Hydrogen
   peroxide
ID PROTEIN-TYROSINE PHOSPHATASES; INHERITED CATALASE DEFICIENCY;
   BETA-THALASSEMIC ERYTHROCYTES; CHRONIC OXIDATIVE STRESS;
   HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; HUNGARIAN ACATALASEMIA;
   MITOCHONDRIAL-FUNCTION; SUPEROXIDE-DISMUTASE; GLUCOSE TOXICITY
AB The enzyme catalase catalyzes the breakdown of hydrogen peroxide into oxygen and water. It is the main regulator of hydrogen peroxide metabolism. Hydrogen peroxide is a highly reactive small molecule formed as a natural byproducts of energy metabolism. Excessive concentrations may cause significant damages to protein, DNA, RNA and lipids. Low levels in muscle cells, facilitate insulin signaling. Acatalasemia is a result of the homozygous mutations in the catalase gene, has a worldwide distribution with 12 known mutations. Increased hydrogen peroxide, due to catalase deficiency, plays a role in the pathogenesis of several diseases such as diabetes mellitus. Diabetes mellitus is a disorder caused by multiple genetic and environmental factors. Examination of Hungarian diabetic and acatalasemic patients showed that an increased frequency of catalase gene mutations exists among diabetes patients. Inherited catalase deficiency may increase the risk of type 2 diabetes mellitus, especially for females. Early onset of type 2 diabetes occurs with inherited catalase deficiency. Low levels of SOD and glutathione peroxidase could contribute to complications caused by increased oxidative stress. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Goth, Laszlo; Nagy, Terez] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Lab Analyt, H-4012 Debrecen, Hungary.
C3 University of Debrecen
RP Góth, L (corresponding author), Univ Debrecen, Med & Hlth Sci Ctr, Fac Med, Dept Biomed Lab & Imaging Sci, POB 55, H-4012 Debrecen, Hungary.
EM goth@dote.hu
FU Hungarian Scientific Research Fund (OTKA) [T 71902]
FX This work was supported by T 71902 grant from Hungarian Scientific
   Research Fund (OTKA).
CR Ahlqvist E, 2011, CLIN CHEM, V57, P241, DOI 10.1373/clinchem.2010.157016
   ARONOFF S, 1965, SCIENCE, V150, P72, DOI 10.1126/science.150.3692.72
   Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v
   Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008
   Baumann K, 2010, NAT REV MOL CELL BIO, V11, DOI 10.1038/nrm2878
   Cappellini MD, 1999, BRIT J HAEMATOL, V104, P504, DOI 10.1046/j.1365-2141.1999.01217.x
   Casci T, 2011, NAT REV GENET, V12, P667, DOI 10.1038/nrg3071
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Cheng ML, 2005, BRIT J HAEMATOL, V128, P119, DOI 10.1111/j.1365-2141.2004.05257.x
   Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284
   CRAWFORD DR, 1988, BIOCHEM BIOPH RES CO, V153, P59, DOI 10.1016/S0006-291X(88)81189-6
   da Silva RL, 2011, INT J CLIN PHARM-NET, V33, P471, DOI 10.1007/s11096-011-9511-4
   Denu JM, 2002, METHOD ENZYMOL, V348, P297, DOI 10.1016/S0076-6879(02)48648-X
   Eaton J.W., METABOLIC MOL BASES, V2, P2731
   Elsner M, 2011, DIABETES, V60, P200, DOI 10.2337/db09-1401
   Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A
   Góth L, 2000, LANCET, V356, P1820, DOI 10.1016/S0140-6736(00)03238-4
   Góth L, 2000, BLOOD CELL MOL DIS, V26, P151, DOI 10.1006/bcmd.2000.0288
   Góth L, 2005, CLIN CHEM, V51, P2401, DOI 10.1373/clinchem.2005.055517
   Góth L, 2005, ELECTROPHORESIS, V26, P1646, DOI 10.1002/elps.200410384
   GOTH L, 1992, CLIN CHIM ACTA, V207, P155, DOI 10.1016/0009-8981(92)90160-R
   Góth L, 2000, CLIN CHEM, V46, P564
   Góth L, 2003, FREE RADICAL BIO MED, V35, P882, DOI 10.1016/S0891-5849(03)00435-0
   GOTH L, 1992, ENZYME, V46, P252, DOI 10.1159/000468797
   Góth L, 2001, CLIN CHIM ACTA, V311, P161, DOI 10.1016/S0009-8981(01)00609-X
   Góth L, 2001, ELECTROPHORESIS, V22, P49, DOI 10.1002/1522-2683(200101)22:1<49::AID-ELPS49>3.0.CO;2-W
   Goth L., 2009, HDB TYPE 2 DIABETES, P511
   Góth L, 2007, FREE RADICAL RES, V41, P953, DOI 10.1080/10715760701482451
   Goth Laszlo, 2004, Mol Diagn, V8, P141
   Goth Laszlo, 2008, Diabetes Care, V31, pe93, DOI 10.2337/dc08-1607
   GUY GR, 1993, J BIOL CHEM, V268, P2141
   Hamada Y, 2004, ANESTHESIOLOGY, V101, P247, DOI 10.1097/00000542-200407000-00038
   Heales SJR, 2001, LANCET, V357, P314, DOI 10.1016/S0140-6736(05)71763-3
   Hirono A, 1995, BLOOD CELL MOL DIS, V21, P232, DOI 10.1006/bcmd.1995.0026
   Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634
   Hu FB, 2011, CLIN CHEM, V57, P1224, DOI 10.1373/clinchem.2011.167056
   Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49
   Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919
   Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003
   KISHIMOTO Y, 1992, HUM GENET, V88, P487, DOI 10.1007/BF00219333
   Kósa Z, 2012, MOL BIOL REP, V39, P4787, DOI 10.1007/s11033-011-1272-6
   Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366
   Lei XG, 2011, ANTIOXID REDOX SIGN, V14, P489, DOI 10.1089/ars.2010.3416
   Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7
   Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200
   Maresca V, 2006, J INVEST DERMATOL, V126, P182, DOI 10.1038/sj.jid.5700021
   Mehmeti I, 2011, BBA-MOL CELL RES, V1813, P1827, DOI 10.1016/j.bbamcr.2011.06.022
   Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8
   Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978
   Ogata M, 2008, ACTA MED OKAYAMA, V62, P345
   PARBOOSINGH JS, 1995, ARCH NEUROL-CHICAGO, V52, P1160, DOI 10.1001/archneur.1995.00540360038013
   Pi J., 2007, DIABETES, V56, P1873
   Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006
   Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3
   Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481
   Robertson RP, 2007, CELL BIOCHEM BIOPHYS, V48, P139, DOI 10.1007/s12013-007-0026-5
   Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200
   Rolo AP, 2006, TOXICOL APPL PHARM, V212, P167, DOI 10.1016/j.taap.2006.01.003
   Roma LP, 2009, FREE RADICAL BIO MED, V47, P1386, DOI 10.1016/j.freeradbiomed.2009.08.010
   Sampson SR, 2010, APOPTOSIS, V15, P1165, DOI 10.1007/s10495-010-0517-5
   Scott MD, 2006, FREE RADICAL BIO MED, V40, P1264, DOI 10.1016/j.freeradbiomed.2005.11.017
   SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380
   Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330
   Steck AK, 2011, CLIN CHEM, V57, P176, DOI 10.1373/clinchem.2010.148221
   TAKAHARA S, 1952, LANCET, V263, P1101
   Takemoto K, 2009, CLIN CHIM ACTA, V407, P43, DOI 10.1016/j.cca.2009.06.028
   Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080
   Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004
   Vally V., 2004, J INVEST DERMATOL, V122, p[A85, 506]
   Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968
   Vitai M, 2005, CLIN CHEM LAB MED, V43, P1346, DOI 10.1515/CCLM.2005.230
   Vitai M, 1997, CLIN CHIM ACTA, V261, P35, DOI 10.1016/S0009-8981(97)06514-5
   WEN JK, 1990, J MOL BIOL, V211, P383, DOI 10.1016/0022-2836(90)90359-T
   West IC, 2000, DIABETIC MED, V17, P171, DOI 10.1046/j.1464-5491.2000.00259.x
   Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009
   Wood JM, 2006, J INVEST DERMATOL, V126, P13, DOI 10.1038/sj.jid.5700051
NR 76
TC 51
Z9 57
U1 1
U2 26
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 15
PY 2012
VL 525
IS 2
SI SI
BP 195
EP 200
DI 10.1016/j.abb.2012.02.005
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 990DY
UT WOS:000307612400011
PM 22365890
DA 2024-11-01
ER

PT J
AU Plotz, G
   Casper, M
   Raedle, J
   Hinrichsen, I
   Heckel, V
   Brieger, A
   Trojan, J
   Zeuzem, S
AF Plotz, Guido
   Casper, Markus
   Raedle, Jochen
   Hinrichsen, Inga
   Heckel, Verena
   Brieger, Angela
   Trojan, Joerg
   Zeuzem, Stefan
TI MUTYH gene expression and alternative splicing in controls and polyposis
   patients
SO HUMAN MUTATION
LA English
DT Article
DE MUTYH; alternative splicing; MUTYH-associated polyposis (MAP)
ID EXCISION-REPAIR GENE; MESSENGER-RNA LEVELS; COLORECTAL-CANCER RISK;
   SUBCELLULAR-LOCALIZATION; OXIDATIVE DAMAGE; HOMOLOG HMYH; MYH; DNA;
   MUTATIONS; IDENTIFICATION
AB Mutational loss of the human DNA repair gene MUTYH in the germline predisposes for colorectal polyposis and cancer, a recessively heritable disease called MUTYH-associated polyposis. The MUTYH gene shows heavy alternative splicing, but the transcripts relevant for biological function and cancer prevention have not been determined. This knowledge is required to assess the consequences that germline variants of unknown functional significance may have. We therefore quantified expression and investigated patterns of alternative splicing in control individuals, tissue samples, and carriers of two frequent germline alterations. MUTYH expression differed organ dependently, correlating with proliferative activity. Alternative first exons were used tissue specifically; transcripts for mitochondrial proteins predominated in muscle tissues, while ascending colon and testes showed the highest fractions of transcripts for nuclear proteins. Colon cancer cell lines produced predominant transcripts for nuclear protein. Exon skipping was frequent and governed by splice-site quality. Five transcripts were found to encode the biologically relevant products of the MUTYH gene. Carriers of the disease-causing mutation c.1187G>A (p.Gly396Asp) showed normal transcript composition, but the frequent single-nucleotide polymorphism rs3219468:G>C largely reduced one transcript species of MUTYH. Since this alteration decreases protein production of the gene, an increased cancer risk for compound heterozygous carriers is possible. Hum Mutat 33:10671074, 2012. (c) 2012 Wiley Periodicals, Inc.
C1 [Plotz, Guido; Hinrichsen, Inga; Heckel, Verena; Brieger, Angela; Trojan, Joerg; Zeuzem, Stefan] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Biomed Forsch Lab, D-60590 Frankfurt, Germany.
   [Casper, Markus] Univ Saarlandes Kliniken, Klin Innere Med 2, D-66421 Homburg, Germany.
   [Raedle, Jochen] Westpfalz Klinikum, Med Klin 3, D-67655 Kaiserslautern, Germany.
C3 Goethe University Frankfurt; Goethe University Frankfurt Hospital;
   Universitatsklinikum des Saarlandes; Westpfalz-Klinikum GmbH
RP Plotz, G (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Biomed Forsch Lab, Haus 11,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM plotz@med.uni-frankfurt.de
RI Trojan, Jörg/C-1616-2009; Plotz, Guido/K-8446-2012; Zeuzem,
   Stefan/AAE-7435-2019
OI Plotz, Guido/0000-0001-5314-9739
CR Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828
   Ali M, 2008, GASTROENTEROLOGY, V135, P499, DOI 10.1053/j.gastro.2008.04.035
   Alvarez JD, 2005, J BIOL RHYTHM, V20, P111, DOI 10.1177/0748730404274078
   Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9
   Barnetson RA, 2007, CLIN GENET, V72, P551, DOI 10.1111/j.1399-0004.2007.00900.x
   Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070
   Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Casper M., 2011, Colorectal Dis
   Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050
   Couch FJ, 2008, HUM MUTAT, V29, P1314, DOI 10.1002/humu.20899
   D'Agostino VG, 2010, DNA REPAIR, V9, P700, DOI 10.1016/j.dnarep.2010.03.008
   Desviat Lourdes R, 2003, Methods Mol Biol, V232, P257
   Dunlop MG, 2009, SURG ONCOL CLIN N AM, V18, P599, DOI 10.1016/j.soc.2009.08.003
   Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106
   Hanaoka T, 2000, CANCER EPIDEM BIOMAR, V9, P1255
   Ichinoe A, 2004, NUCLEIC ACIDS RES, V32, P477, DOI 10.1093/nar/gkh214
   Kambara T, 2004, GENE CHROMOSOME CANC, V40, P1, DOI 10.1002/gcc.20011
   Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036
   Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104
   Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301
   Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014
   Lipton L, 2003, CANCER RES, V63, P7595
   Lynch KW, 2006, NAT STRUCT MOL BIOL, V13, P952, DOI 10.1038/nsmb1106-952
   Martin SA, 2010, CANCER CELL, V17, P235, DOI 10.1016/j.ccr.2009.12.046
   Molatore S, 2010, HUM MUTAT, V31, P159, DOI 10.1002/humu.21158
   Müller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x
   Nakabeppu Y, 2004, ANN NY ACAD SCI, V1011, P101, DOI 10.1196/annals.1293.011
   Nielsen M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-184
   Ohtsubo T, 2000, NUCLEIC ACIDS RES, V28, P1355, DOI 10.1093/nar/28.6.1355
   Oka S, 2008, EMBO J, V27, P421, DOI 10.1038/sj.emboj.7601975
   Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x
   Out AA, 2010, HUM MUTAT, V31, P1205, DOI 10.1002/humu.21343
   Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802
   Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283
   Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638
   Takao M, 1998, NUCLEIC ACIDS RES, V26, P2917, DOI 10.1093/nar/26.12.2917
   Tao H, 2008, CANCER SCI, V99, P355, DOI 10.1111/j.1349-7006.2007.00694.x
   Theodoratou E, 2010, BRIT J CANCER, V103, P1875, DOI 10.1038/sj.bjc.6605966
   Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x
   Vogel U, 2000, MUTAT RES-DNA REPAIR, V461, P197, DOI 10.1016/S0921-8777(00)00051-3
   Vogel U, 2002, CARCINOGENESIS, V23, P1505, DOI 10.1093/carcin/23.9.1505
   Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070
   Win AK, 2011, FAM CANCER, V10, P1, DOI 10.1007/s10689-010-9399-5
   Yamaguchi S, 2002, GENES CELLS, V7, P461, DOI 10.1046/j.1365-2443.2002.00532.x
   Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
NR 46
TC 27
Z9 30
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-7794
EI 1098-1004
J9 HUM MUTAT
JI Hum. Mutat.
PD JUL
PY 2012
VL 33
IS 7
BP 1067
EP 1074
DI 10.1002/humu.22059
PG 8
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA 952TK
UT WOS:000304815100011
PM 22473953
OA gold
DA 2024-11-01
ER

PT J
AU Morciano, G
   Rimessi, A
   Patergnani, S
   Vitto, VAM
   Danese, A
   Kahsay, A
   Palumbo, L
   Bonora, M
   Wieckowski, MR
   Giorgi, C
   Pinton, P
AF Morciano, Giampaolo
   Rimessi, Alessandro
   Patergnani, Simone
   Vitto, Veronica A. M.
   Danese, Alberto
   Kahsay, Asrat
   Palumbo, Laura
   Bonora, Massimo
   Wieckowski, Mariusz R.
   Giorgi, Carlotta
   Pinton, Paolo
TI Calcium dysregulation in heart diseases: Targeting calcium channels to
   achieve a correct calcium homeostasis
SO PHARMACOLOGICAL RESEARCH
LA English
DT Article
DE Calcium channels; Mitochondria; Sarcoplasmic reticulum; Heart disease;
   Therapy
ID MITOCHONDRIAL PERMEABILITY TRANSITION; DEPENDENT PROTEIN-KINASE;
   POLYMORPHIC VENTRICULAR-TACHYCARDIA; SARCOPLASMIC-RETICULUM CA2+-ATPASE;
   ISCHEMIA-REPERFUSION INJURY; SINGLE-NUCLEOTIDE POLYMORPHISMS; NA+/CA2+
   EXCHANGER INHIBITOR; CARDIAC RYANODINE RECEPTOR; GENOME-WIDE
   ASSOCIATION; SERCA2A GENE-TRANSFER
AB Intracellular calcium signaling is a universal language source shared by the most part of biological entities inside cells that, all together, give rise to physiological and functional anatomical units, the organ. Although preferentially recognized as signaling between cell life and death processes, in the heart it assumes additional relevance considered the importance of calcium cycling coupled to ATP consumption in excitation-contraction coupling. The concerted action of a plethora of exchangers, channels and pumps inward and outward calcium fluxes where needed, to convert energy and electric impulses in muscle contraction. All this without realizing it, thousands of times, every day. An improper function of those proteins (i.e., variation in expression, mutations onset, dysregulated channeling, differential protein-protein interactions) being part of this signaling network triggers a short circuit with severe acute and chronic pathological consequences reported as arrhythmias, cardiac remodeling, heart failure, reperfusion injury and cardiomyopathies. By acting with chemical, peptide-based and pharmacological modulators of these players, a correction of calcium homeostasis can be achieved accompanied by an amelioration of clinical symptoms. This review will focus on all those defects in calcium homeostasis which occur in the most common cardiac diseases, including myocardial infarction, arrhythmia, hypertrophy, heart failure and cardiomyopathies. This part will be introduced by the state of the art on the proteins involved in calcium homeostasis in cardiomyocytes and followed by the therapeutic treatments that to date, are able to target them and to revert the pathological phenotype.
C1 [Morciano, Giampaolo; Rimessi, Alessandro; Patergnani, Simone; Vitto, Veronica A. M.; Danese, Alberto; Kahsay, Asrat; Palumbo, Laura; Bonora, Massimo; Giorgi, Carlotta; Pinton, Paolo] Univ Ferrara, Dept Med Sci, Sect Expt Med, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy.
   [Morciano, Giampaolo; Pinton, Paolo] Maria Cecilia Hosp, GVM Care & Res, I-48033 Cotignola, RA, Italy.
   [Wieckowski, Mariusz R.] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mitochondrial Biol & Metab, PL-02093 Warsaw, Poland.
C3 University of Ferrara; Maria Cecilia Hospital; Polish Academy of
   Sciences; Nencki Institute of Experimental Biology of the Polish Academy
   of Sciences
RP Morciano, G; Pinton, P (corresponding author), Univ Ferrara, Dept Med Sci, Sect Expt Med, Lab Technol Adv Therapies LTTA, I-44121 Ferrara, Italy.
EM giampaolo.morciano@unife.it; paolo.pinton@unife.it
RI Palumbo, Laura/AAC-6772-2022; Pinton, Paolo/J-8025-2012; Morciano,
   Giampaolo/AAB-8262-2019; Bonora, Massimo/AAC-3609-2022; Vitto,
   Veronica/AAL-5173-2021; Danese, Alberto/AAC-2666-2019; rimessi,
   alessandro/O-3335-2019; Giorgi, Carlotta/K-4649-2016
OI MORCIANO, Giampaolo/0000-0002-5355-0845; Palumbo,
   Laura/0000-0002-9041-5407; Wieckowski, Mariusz/0000-0003-0789-4521
FU Italian Association for Cancer Research [IG-23670, IG-19803]; A-ROSE,
   Progetti di Rilevante Interesse Nazionale [PRIN2017E5L5P3,
   PRIN20177E9EPY]; Italian Ministry of Health [GR-2013-02356747,
   GR-2019-12369862]; European Research Council [853057-InflaPML];
   University of Ferrara; Polish National Science Centre
   [UMO-2014/15/B/NZ1/00490]
FX The Signal Transduction Laboratory is supported by the Italian
   Association for Cancer Research (IG-23670 to P.P. and IG-19803 to C.G.),
   A-ROSE, Progetti di Rilevante Interesse Nazionale (PRIN2017E5L5P3 to P.P
   and PRIN20177E9EPY to C.G.), the Italian Ministry of Health
   (GR-2013-02356747 to C.G. and GR-2019-12369862 to G.M.), the European
   Research Council (853057-InflaPML to C.G.) and local funds from the
   University of Ferrara to C.G. and P.P. P.P. is grateful to C. degli &
   nbsp;Scrovegni for her continuous support. M.R.W. was supporte0d by the
   Polish National Science Centre (Grant: UMO-2014/15/B/NZ1/00490).
CR Ablorh Naa-Adjeley D, 2015, Biophys Rev, V7, P63, DOI 10.1007/s12551-014-0157-z
   Acsai K, 2011, J PHYSIOL-LONDON, V589, P2569, DOI 10.1113/jphysiol.2010.202663
   Akar FG, 2005, J CLIN INVEST, V115, P3527, DOI 10.1172/JCI25371
   Alexandre J, 2018, PHARMACOL THERAPEUT, V189, P89, DOI 10.1016/j.pharmthera.2018.04.009
   ALTMANN P, 1977, HUM GENET, V38, P357, DOI 10.1007/BF00402165
   An DW, 2019, CLIN EXP HYPERTENS, V41, P323, DOI 10.1080/10641963.2018.1481421
   Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996
   Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014
   Andrikopoulos GK, 2015, WORLD J CARDIOL, V7, P76, DOI 10.4330/wjc.v7.i2.76
   Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5
   Arai M, 1998, J MOL CELL CARDIOL, V30, P243, DOI 10.1006/jmcc.1997.0588
   Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8
   Arai M, 1996, J MOL CELL CARDIOL, V28, P1583, DOI 10.1006/jmcc.1996.0149
   Arunachalam K., 2021, FLECAINIDE
   Asghar MY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051739
   Bai T, 2016, AM J PHYSIOL-HEART C, V311, pH1051, DOI 10.1152/ajpheart.00296.2016
   Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575
   Balam Ortiz Eros Osiris, 1999, Archivos del Instituto de Cardiologia de Mexico, V69, P311
   Bartok A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11646-3
   Bauer TM, 2020, CIRC RES, V126, P280, DOI 10.1161/CIRCRESAHA.119.316306
   Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001
   Beauverger P, 2020, CARDIOVASC RES, V116, P329, DOI 10.1093/cvr/cvz097
   Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455
   BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y
   Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049
   Biscaglia S, 2020, AM HEART J, V229, P100, DOI 10.1016/j.ahj.2020.08.007
   Bish LT, 2011, HUM GENE THER, V22, P969, DOI 10.1089/hum.2011.035
   Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763
   Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06
   Bonora M, 2022, NAT REV MOL CELL BIO, V23, P266, DOI 10.1038/s41580-021-00433-y
   Bonora M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10070998
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bootman MD, 2017, ADV EXP MED BIOL, V993, P363, DOI 10.1007/978-3-319-57732-6_19
   Boys JA, 2010, J INVEST MED, V58, P875, DOI 10.231/JIM.0b013e3181e5d719
   BRAUN AP, 1995, J PHYSIOL-LONDON, V488, P37, DOI 10.1113/jphysiol.1995.sp020944
   Brown DA, 2008, CARDIOVASC RES, V79, P141, DOI 10.1093/cvr/cvn053
   Burashnikov E, 2010, HEART RHYTHM, V7, P1872, DOI 10.1016/j.hrthm.2010.08.026
   Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200
   Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120
   Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177
   CARAFOLI E, 1976, CLIN ENDOCRINOL, V5, pS49, DOI 10.1111/j.1365-2265.1976.tb03815.x
   CARAFOLI E, 1974, J MOL CELL CARDIOL, V6, P361, DOI 10.1016/0022-2828(74)90077-7
   Carvalho BMR, 2006, AM J PHYSIOL-HEART C, V291, pH1803, DOI 10.1152/ajpheart.01345.2005
   Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947
   CHAFFMAN M, 1985, DRUGS, V29, P387, DOI 10.2165/00003495-198529050-00001
   Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890
   Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0
   Chen HY, 2013, J GEN PHYSIOL, V142, P127, DOI 10.1085/jgp.201311022
   Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181
   Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995
   Chiamvimonvat N, 2017, J PHYSIOL-LONDON, V595, P2229, DOI 10.1113/JP272883
   Chopra N, 2009, P NATL ACAD SCI USA, V106, P7636, DOI 10.1073/pnas.0902919106
   Chung E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042297
   Connell P, 2020, EXPERT OPIN THER TAR, V24, P25, DOI 10.1080/14728222.2020.1708326
   Coultrap SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025245
   Csordás G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016
   Dambrova M, 2021, FREE RADICAL BIO MED, V165, P24, DOI 10.1016/j.freeradbiomed.2021.01.036
   Danese A, 2023, REV PHYSIOL BIOCH P, V185, P153, DOI 10.1007/112_2020_43
   Darcy YL, 2016, MOL PHARMACOL, V90, P106, DOI 10.1124/mol.115.102277
   García-Rivas GD, 2006, BRIT J PHARMACOL, V149, P829, DOI 10.1038/sj.bjp.0706932
   De Stefani D, 2012, CELL DEATH DIFFER, V19, P267, DOI 10.1038/cdd.2011.92
   del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308
   Dhingra R, 2020, CARDIOVASC RES, V116, P1161, DOI 10.1093/cvr/cvz240
   Di Marco G, 2020, CELL REP, V30, P2321, DOI 10.1016/j.celrep.2020.01.081
   Di Virgilio F, 2015, CURR MED CHEM, V22, P866
   Dow J, 2009, J CARDIOVASC PHARM T, V14, P99, DOI 10.1177/1074248408329606
   Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342
   Elliott WJ, 2011, J CLIN HYPERTENS, V13, P687, DOI 10.1111/j.1751-7176.2011.00513.x
   Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171
   Fan MR, 2020, NATURE, V582, P129, DOI 10.1038/s41586-020-2309-6
   Fernández-Ruiz I, 2017, NAT REV CARDIOL, V14, P633, DOI 10.1038/nrcardio.2017.158
   Ferrandi M, 2013, BRIT J PHARMACOL, V169, P1849, DOI 10.1111/bph.12278
   Flesch M, 1996, CIRCULATION, V94, P992, DOI 10.1161/01.CIR.94.5.992
   Fleury S, 2003, CIRCULATION, V107, P2375, DOI 10.1161/01.CIR.0000065598.46411.EF
   Fontana V, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001398
   Foskett JK, 2015, J MOL CELL CARDIOL, V78, P3, DOI 10.1016/j.yjmcc.2014.11.015
   Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4
   Gambardella J, 2018, ADV EXP MED BIOL, V1067, P373, DOI 10.1007/5584_2017_106
   García-Rivas GD, 2005, FEBS J, V272, P3477, DOI 10.1111/j.1742-4658.2005.04771.x
   Ghali JK, 2007, AM J CARDIOL, V99, p47A, DOI 10.1016/j.amjcard.2006.09.006
   Gheorghiade M, 2008, J AM COLL CARDIOL, V51, P2276, DOI 10.1016/j.jacc.2008.03.015
   Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983
   Godfraind T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00286
   Goel M, 2007, AM J PHYSIOL-HEART C, V292, pH874, DOI 10.1152/ajpheart.00785.2006
   GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52
   Goonasekera SA, 2012, J CLIN INVEST, V122, P280, DOI 10.1172/JCI58227
   Gordan R, 2016, CELL CALCIUM, V60, P363, DOI 10.1016/j.ceca.2016.09.001
   Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005
   GROVER GJ, 1990, J CARDIOVASC PHARM, V16, P783, DOI 10.1097/00005344-199011000-00014
   Guan LC, 2019, INT J IMPLANT DENT, V5, DOI 10.1111/jcmm.14662
   Guo XB, 2003, MOL CELL BIOCHEM, V254, P163, DOI 10.1023/A:1027321130997
   Guo YH, 2016, CARDIOVASC DRUG THER, V30, P1, DOI 10.1007/s10557-016-6644-7
   Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008
   Gurung IS, 2009, J MOL CELL CARDIOL, V47, P622, DOI 10.1016/j.yjmcc.2009.08.001
   Hadri L, 2010, MOL THER, V18, P1284, DOI 10.1038/mt.2010.77
   Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252
   Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892
   Haghighi K, 2012, J MOL CELL CARDIOL, V52, P773, DOI 10.1016/j.yjmcc.2011.11.012
   Hajjar RJ, 1997, CIRCULATION, V95, P423
   Hall AE, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.91
   Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849
   HANSEN JF, 1990, AM J CARDIOL, V66, P779
   Haq S, 2001, CIRCULATION, V103, P670
   Hay I, 2005, AM J PHYSIOL-HEART C, V288, pH1203, DOI 10.1152/ajpheart.00681.2004
   HAYAT LH, 1987, BIOCHEM J, V244, P533, DOI 10.1042/bj2440533
   Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780
   Hilliard FA, 2010, J MOL CELL CARDIOL, V48, P293, DOI 10.1016/j.yjmcc.2009.10.005
   Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361
   Hof T, 2019, NAT REV CARDIOL, V16, P344, DOI 10.1038/s41569-018-0145-2
   Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013
   HOFMANN SL, 1989, J BIOL CHEM, V264, P8260
   HOFMANN SL, 1989, J BIOL CHEM, V264, P18083
   Holmström KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022
   Hu ST, 2011, J PHYSIOL SCI, V61, P363, DOI 10.1007/s12576-011-0154-y
   Hulot JS, 2017, EUR J HEART FAIL, V19, P1534, DOI 10.1002/ejhf.826
   Hulot JS, 2016, EUR HEART J, V37, P1651, DOI 10.1093/eurheartj/ehw019
   Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007
   ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040
   Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391
   Iwamoto T, 2006, MOL PHARMACOL, V70, P2075, DOI 10.1124/mol.106.028464
   Jadiya P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11813-6
   January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI 10.1016/j.jacc.2014.03.022
   Jaski BE, 2009, J CARD FAIL, V15, P171, DOI 10.1016/j.cardfail.2009.01.013
   Jeffs GJ, 2007, J CLIN NEUROSCI, V14, P507, DOI 10.1016/j.jocn.2006.07.013
   Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009
   Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889
   Johnson CN, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.102063
   Johnson T, 2011, AM J HUM GENET, V89, P688, DOI 10.1016/j.ajhg.2011.10.013
   Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444
   Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807
   Kamer KJ, 2017, EMBO REP, V18, P1397, DOI 10.15252/embr.201643748
   Kao YH, 2011, LAB INVEST, V91, P1291, DOI 10.1038/labinvest.2011.92
   Karagueuzian HS, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00036
   Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014
   Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047
   Kayima J, 2017, CLIN GENET, V92, P487, DOI 10.1111/cge.12974
   Kho C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8229
   Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407
   Kim SY, 2006, EXP MOL MED, V38, P535, DOI 10.1038/emm.2006.63
   Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246
   Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106
   Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200
   Kobayashi S, 2020, J CARDIOL, V75, P454, DOI 10.1016/j.jjcc.2019.08.020
   Kobayashi S, 2010, CIRC J, V74, P2579, DOI 10.1253/circj.CJ-10-0680
   Kobayashi S, 2009, J AM COLL CARDIOL, V53, P1993, DOI 10.1016/j.jacc.2009.01.065
   Kon N, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.45
   Kostic M, 2019, SEMIN CELL DEV BIOL, V94, P59, DOI 10.1016/j.semcdb.2019.01.009
   Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107
   Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754
   Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x
   Krebs J, 2017, ADV EXP MED BIOL, V981, P3, DOI 10.1007/978-3-319-55858-5_1
   Kujala K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044660
   Kulkarni S, 2019, INT J APPL BASIC MED, V9, P221, DOI 10.4103/ijabmr.IJABMR_92_19
   Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001
   Ladilov Y, 1999, AM J PHYSIOL-HEART C, V276, pH1868, DOI 10.1152/ajpheart.1999.276.6.H1868
   Landstrom AP, 2017, CIRC RES, V120, P1969, DOI 10.1161/CIRCRESAHA.117.310083
   Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996
   Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377
   Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066
   Lebek S, 2018, J MOL CELL CARDIOL, V118, P159, DOI 10.1016/j.yjmcc.2018.03.020
   Lee HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146841
   Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346
   Lei M, 2018, CIRCULATION, V138, P1879, DOI 10.1161/CIRCULATIONAHA.118.035455
   Leite-Moreira AF, 2006, HEART, V92, P712, DOI 10.1136/hrt.2005.062950
   Leonardi S, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2020-001415
   Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800
   Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384
   Lewis R, 2020, IJC HEART VASC, V26, DOI 10.1016/j.ijcha.2019.100449
   Leychenko A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029055
   Li J, 2013, BIOMED ENVIRON SCI, V26, P577, DOI 10.3967/0895-3988.2013.07.009
   Li J, 2015, AM J HYPERTENS, V28, P1031, DOI 10.1093/ajh/hpu263
   Li N, 2017, INT J CARDIOL, V227, P668, DOI 10.1016/j.ijcard.2016.10.078
   LI WH, 1992, J BIOL CHEM, V267, P17983
   LIGETI E, 1981, BIOCHIM BIOPHYS ACTA, V656, P177
   Lipskaia L, 2013, CURR VASC PHARMACOL, V11, P465
   Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462
   Little R, 2017, AGING CELL, V16, P1104, DOI 10.1111/acel.12637
   Liu LJ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00382
   LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5
   Liu R, 2020, ALCOHOL CLIN EXP RES, V44, P2187, DOI 10.1111/acer.14471
   Liu XP, 2012, CELL, V150, P1055, DOI 10.1016/j.cell.2012.06.052
   Liu XY, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00205
   Liu X, 2016, J GERIATR CARDIOL, V13, P138, DOI 10.11909/j.issn.1671-5411.2016.02.008
   Lu XY, 2016, CIRC RES, V118, P834, DOI 10.1161/CIRCRESAHA.115.308093
   LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302
   LUKACS GL, 1986, BIOCHIM BIOPHYS ACTA, V858, P125, DOI 10.1016/0005-2736(86)90298-1
   LULE SA, 2019, MOL GENETICS GENOMIC, V0007
   Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082
   Ma WZ, 2020, BASIC CLIN PHARMACOL, V126, P166, DOI 10.1111/bcpt.13318
   MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151
   Magi S, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2020.102162
   Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49
   Marchi S, 2020, MOL CELL, V78, P1055, DOI 10.1016/j.molcel.2020.04.017
   Márta K, 2021, J MOL CELL CARDIOL, V151, P135, DOI 10.1016/j.yjmcc.2020.09.014
   Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223
   Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5
   Mattera GG, 2007, AM J CARDIOL, V99, p33A, DOI 10.1016/j.amjcard.2006.09.004
   McCauley MD, 2011, ACTA PHARMACOL SIN, V32, P749, DOI 10.1038/aps.2011.44
   MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170
   McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x
   Mei QB, 2001, AM J PHYSIOL-HEART C, V281, pH334, DOI 10.1152/ajpheart.2001.281.1.H334
   Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005
   Micheletti R, 2007, AM J CARDIOL, V99, p24A, DOI 10.1016/j.amjcard.2006.09.003
   Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004
   Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319
   Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1
   Morciano G, 2022, CARDIOVASC RES, V118, P2548, DOI 10.1093/cvr/cvab267
   Morciano G, 2021, LIFE-BASEL, V11, DOI 10.3390/life11050436
   Morciano G, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.108983
   Morciano G, 2017, ADV EXP MED BIOL, V982, P169, DOI 10.1007/978-3-319-55330-6_9
   Morciano G, 2015, J MOL CELL CARDIOL, V78, P142, DOI 10.1016/j.yjmcc.2014.08.015
   MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421
   Mori Y, 1996, JPN J PHARMACOL, V72, P83, DOI 10.1254/jjp.72.83
   MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137
   Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454
   Most P, 2007, FUTUR CARDIOL, V3, P5, DOI 10.2217/14796678.3.1.5
   Motloch LJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009598
   Nakamura Aki, 1998, Folia Pharmacologica Japonica, V111, P105, DOI 10.1254/fpj.111.105
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Neef S, 2018, J MOL CELL CARDIOL, V115, P73, DOI 10.1016/j.yjmcc.2017.12.015
   Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250
   Nie JL, 2019, J CELL PHYSIOL, V234, P11587, DOI 10.1002/jcp.27791
   Niwano K, 2008, MOL THER, V16, P1026, DOI 10.1038/mt.2008.61
   Norby FL, 2002, AM J PHYSIOL-ENDOC M, V283, pE658, DOI 10.1152/ajpendo.00003.2002
   Nurnberg ST, 2016, CIRC RES, V118, P586, DOI 10.1161/CIRCRESAHA.115.306464
   Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015
   Oguri G, 2014, AM J PHYSIOL-HEART C, V307, pH1339, DOI 10.1152/ajpheart.01021.2013
   Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020
   Okuyama Y, 2018, HYPERTENS RES, V41, P80, DOI 10.1038/hr.2017.92
   Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107
   Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868
   Park C.S., 2013, BASIC RES CARDIOL, V108, P344, DOI [10.1007/s00395-013-0344-2, DOI 10.1007/S00395-013-0344-2.[]
   Pavasini R, 2020, EUR HEART J, V41, P2225, DOI 10.1093/eurheartj/ehaa351
   Pavlov E, 2005, BBA-BIOENERGETICS, V1710, P96, DOI 10.1016/j.bbabio.2005.09.006
   Pearl JM, 2011, J SURG RES, V167, P279, DOI 10.1016/j.jss.2009.05.001
   Peng W, 2020, P NATL ACAD SCI USA, V117, P19266, DOI 10.1073/pnas.2003236117
   Penttinen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125366
   Piquereau J, 2010, J PHYSIOL-LONDON, V588, P2443, DOI 10.1113/jphysiol.2010.189670
   Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701
   Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014
   Priori SG, 2001, CIRCULATION, V103, P196
   Prunier F, 2008, CIRCULATION, V118, P614, DOI 10.1161/CIRCULATIONAHA.108.770883
   Qi XY, 2014, CIRCULATION, V129, P430, DOI 10.1161/CIRCULATIONAHA.113.003019
   Ramaccini D, 2021, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.624216
   Ramachandra CJA, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102884
   Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112
   Redd MA, 2021, CIRCULATION, V144, P947, DOI 10.1161/CIRCULATIONAHA.121.054360
   Reilly L, 2015, FASEB J, V29, P4532, DOI 10.1096/fj.15-276493
   Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t
   Rimessi A, 2020, SEMIN CELL DEV BIOL, V98, P167, DOI 10.1016/j.semcdb.2019.05.015
   Rincon MY, 2015, CARDIOVASC RES, V108, P4, DOI 10.1093/cvr/cvv205
   RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0
   Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412
   Robert V, 2001, EMBO J, V20, P4998, DOI 10.1093/emboj/20.17.4998
   Rosenberg P, 2021, PFLUG ARCH EUR J PHY, V473, P417, DOI 10.1007/s00424-021-02540-3
   Rosencrans WM, 2021, CELL CALCIUM, V95, DOI 10.1016/j.ceca.2021.102355
   Rossato LG, 2013, CARDIOVASC TOXICOL, V13, P413, DOI 10.1007/s12012-013-9224-0
   ROSSI CS, 1973, BIOCHEM BIOPH RES CO, V50, P846, DOI 10.1016/0006-291X(73)91322-3
   Rosso R, 2007, HEART RHYTHM, V4, P1149, DOI 10.1016/j.hrthm.2007.05.017
   Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006
   Roy S, 2017, BBA-MOL CELL RES, V1864, P997, DOI 10.1016/j.bbamcr.2017.01.011
   Rubaiy HN, 2017, J BIOL CHEM, V292, P8158, DOI 10.1074/jbc.M116.773556
   Sabbah HN, 2007, AM J CARDIOL, V99, p41A, DOI 10.1016/j.amjcard.2006.09.005
   Sacherer M, 2012, BRIT J PHARMACOL, V167, P493, DOI 10.1111/j.1476-5381.2012.01995.x
   Sadi A, 2018, CLIN SCI, V132, P641, DOI 10.1042/CS20171337
   Sakai H, 2014, J MOL CELL CARDIOL, V76, P177, DOI 10.1016/j.yjmcc.2014.09.006
   Sakata S, 2007, J MOL CELL CARDIOL, V42, P852, DOI 10.1016/j.yjmcc.2007.01.003
   Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002
   Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015
   Salido GM, 2011, ADV EXP MED BIOL, V704, P413, DOI 10.1007/978-94-007-0265-3_23
   Salimi A, 2019, DRUG RES, V69, P598, DOI 10.1055/a-0866-9356
   Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200
   Samuel TJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041086
   Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993
   Santo-Domingo J, 2007, BRIT J PHARMACOL, V151, P647, DOI 10.1038/sj.bjp.0707260
   Santulli G, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.679725
   Sasaki K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164795
   Schmidt U, 1999, AM J PHYSIOL-HEART C, V277, pH474, DOI 10.1152/ajpheart.1999.277.2.H474
   Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578
   Schotten U, 2003, CIRCULATION, V107, P1433, DOI 10.1161/01.CIR.0000055314.10801.4F
   Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897
   Schwinger RHG, 1999, CIRCULATION, V99, P2105, DOI 10.1161/01.CIR.99.16.2105
   Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111
   Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581
   Shan J, 2010, J CLIN INVEST, V120, P4375, DOI 10.1172/JCI37649
   Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1
   Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013
   Shenouda SK, 2008, CARDIOVASC RES, V79, P662, DOI 10.1093/cvr/cvn129
   Shi G, 2011, GENET EPIDEMIOL, V35, P111, DOI 10.1002/gepi.20556
   Smyth JT, 2002, J BIOL CHEM, V277, P35061, DOI 10.1074/jbc.M202928200
   Solem LE, 1996, J MOL CELL CARDIOL, V28, P1023, DOI 10.1006/jmcc.1996.0095
   Sombié HK, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1136-x
   Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996
   Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7
   Stüdeli R, 2006, AM J TRANSPLANT, V6, P775, DOI 10.1111/j.1600-6143.2006.01241.x
   Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852
   Sulaiman M, 2010, AM J PHYSIOL-HEART C, V298, pH833, DOI 10.1152/ajpheart.00418.2009
   SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E
   Sun XM, 2019, EUR REV MED PHARMACO, V23, P10609, DOI 10.26355/eurrev_201912_19756
   Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833
   Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073
   Tabara Y, 2010, HYPERTENSION, V56, P973, DOI 10.1161/HYPERTENSIONAHA.110.153429
   Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952
   Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2
   Tang L, 2016, NATURE, V537, P117, DOI 10.1038/nature19102
   Terentyev D, 2014, AM J PHYSIOL-HEART C, V306, pH738, DOI 10.1152/ajpheart.00621.2013
   Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423
   Tester David J, 2014, Methodist Debakey Cardiovasc J, V10, P29
   Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296
   Tonet E, 2018, POSTEP KARDIOL INTER, V14, P5, DOI 10.5114/aic.2018.74349
   Traaseth N, 2004, BBA-BIOENERGETICS, V1658, P64, DOI 10.1016/j.bbabio.2004.04.015
   Tsutsui Hiroyuki, 2008, Circ J, V72 Suppl A, pA31, DOI 10.1253/circj.CJ-08-0014
   Vais H, 2020, P NATL ACAD SCI USA, V117, P21731, DOI 10.1073/pnas.2005976117
   Vargas JD, 2016, DATA BRIEF, V7, P229, DOI 10.1016/j.dib.2016.01.048
   VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2
   Waddell HMM, 2016, BIOPHYS J, V110, P2386, DOI 10.1016/j.bpj.2016.04.036
   Wahlquist C, 2014, NATURE, V508, P531, DOI 10.1038/nature13073
   Wallace KB, 2020, CIRC RES, V126, P926, DOI 10.1161/CIRCRESAHA.119.314681
   Wang Y, 2013, MOL BIOL REP, V40, P1867, DOI 10.1007/s11033-012-2242-3
   Wang YW, 2017, J PHYSIOL-LONDON, V595, P7383, DOI 10.1113/JP274110
   Wang YJ, 2012, J R STAT SOC C-APPL, V61, P1, DOI 10.1111/j.1467-9876.2011.01016.x
   Washburn DG, 2013, BIOORG MED CHEM LETT, V23, P4979, DOI 10.1016/j.bmcl.2013.06.047
   Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942
   Watanabe Y, 2006, J PHARMACOL SCI, V102, P7, DOI 10.1254/jphs.FMJ06002X2
   Watanabe Y, 2019, J PHYSIOL SCI, V69, P837, DOI 10.1007/s12576-019-00721-5
   Weber CR, 2002, CIRC RES, V90, P182, DOI 10.1161/hh0202.103940
   Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119
   Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301
   Weinreuter M, 2014, EMBO MOL MED, V6, P1231, DOI 10.15252/emmm.201403848
   Weiss JN, 2015, J MOL CELL CARDIOL, V82, P136, DOI 10.1016/j.yjmcc.2015.02.017
   Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8
   Wiczer BM, 2014, BIOCHEM BIOPH RES CO, V444, P44, DOI 10.1016/j.bbrc.2014.01.009
   Woods JJ, 2019, ACS CENTRAL SCI, V5, P153, DOI 10.1021/acscentsci.8b00773
   Word TA, 2021, J CELL MOL MED, V25, P6115, DOI 10.1111/jcmm.16521
   Wu X, 2009, J CLIN INVEST, V119, P976, DOI 10.1172/JCI36693
   Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081
   Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014
   Xin W, 2011, MOL MED, V17, P201, DOI 10.2119/molmed.2010.00197
   Xu J, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1910565
   Yamashita K, 2016, N-S ARCH PHARMACOL, V389, P1205, DOI 10.1007/s00210-016-1282-y
   Yan Y, 2008, CARDIOVASC RES, V77, P432, DOI 10.1093/cvr/cvm047
   Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE
   Yaradanakul A, 2007, J PHYSIOL-LONDON, V582, P991, DOI 10.1113/jphysiol.2007.132712
   Yoshiyama M, 2004, J PHARMACOL SCI, V95, P196, DOI 10.1254/jphs.FPJ03101X
   Yu ZQ, 2018, INT J CARDIOL, V271, P161, DOI 10.1016/j.ijcard.2018.05.054
   Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654
   Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215
   Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5
   Zhang XH, 2019, STEM CELLS DEV, V28, P920, DOI 10.1089/scd.2018.0234
   Zhang YH, 2013, PFLUG ARCH EUR J PHY, V465, P1439, DOI 10.1007/s00424-013-1291-3
   Zhang YH, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0282-4
   Zhao XY, 2008, BASIC CLIN PHARMACOL, V102, P419, DOI 10.1111/j.1742-7843.2007.00150.x
   ZIZI M, 1994, J BIOL CHEM, V269, P1614
NR 357
TC 29
Z9 29
U1 3
U2 28
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-6618
EI 1096-1186
J9 PHARMACOL RES
JI Pharmacol. Res.
PD MAR
PY 2022
VL 177
AR 106119
DI 10.1016/j.phrs.2022.106119
EA FEB 2022
PG 23
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 0I8XM
UT WOS:000779696800001
PM 35131483
DA 2024-11-01
ER

PT J
AU Kamal, NZM
   Dangnga, MS
   Irmayani
   Naim, DM
AF Kamal, Nur Zawani Mustafa
   Dangnga, Muhammad Siri
   Irmayani
   Naim, Darlina Md
TI Species identification and genetic diversity of <i>Aedes</i> in Penang
   (Malaysia) based on Cytochrome Oxidase Subunit I
SO NUSANTARA BIOSCIENCE
LA English
DT Article
DE Aedes; COI; dengue; mtDNA; phylogenetics
ID NUCLEOTIDE SUBSTITUTIONS; MITOCHONDRIAL; POPULATIONS; DNA
AB Cases of dengue fever are expanding globally and recently it was identified as being notable in remote/rural regions in South-East Asia in spite of the previous belief that it is outbreak to urban areas, especially in Malaysia. In an effort to constraint, the extent of the virus, the most important thing is to know the distribution of the vector that causes the disease. This research aims to recognize all species of mosquitoes distributed in Penang utilizing DNA barcode method in which the mtDNA cytochrome oxidase subunit 1 (COI) as a gene marker. Approximately 497 larvae of mosquitoes were obtained from four regions in Penang, Malaysia namely Central Seberang Perai, North Seberang Perai, North East, and South West of Penang. All samples were extracted and PCR amplified. Sequences were employed in BLAST of GenBank and aligned with MUSCLE. The ABGD analysis was performed to partition all the samples and substitution saturation analysis was employed in DAMBE. Phylogenetic relationships among nucleotides were reconstructed utilizing Maximum Likelihood (ML) and Neighbor-Joining (NJ) calculated following Kimura 2-parameter. Tatra and interspecific genetic variation among population were also conducted based on Tamura-Nei parameter and all analyses were employed in MEGA version 6.0. As a result, COI gene has successfully recognized all larvae obtained in this study. We found a total of six species (including outgroup sequence) as revealed by BLASTn, ABGD and phylogenetic analysis. Genetic distance test has further supported the results. This study revealed that there is no visible population structure and all species have a uniform distribution throughout all sampling locations in Penang. We also found that Ae. albopictus has occupied most areas in Penang, and this includes urban locations, hence, suggest that Ae. albopictus probably succeed Ae. aegypti as the main vector for dengue virus in Penang.
C1 [Kamal, Nur Zawani Mustafa; Naim, Darlina Md] Univ Sains Malaysia, Sch Biol Sci, P Pinang 11800, Malaysia.
   [Dangnga, Muhammad Siri] Univ Muhammadiyah Parepare, Postgrad Program, Parepare 91112, South Sulawesi, Indonesia.
   [Irmayani] Univ Muhammadiyah Parepare, Fac Agr Anim Husb & Fisheries, Parepare 91112, South Sulawesi, Indonesia.
C3 Universiti Sains Malaysia; Universitas Muhammadiyah Parepare;
   Universitas Muhammadiyah Parepare
RP Naim, DM (corresponding author), Univ Sains Malaysia, Sch Biol Sci, P Pinang 11800, Malaysia.
EM darlinamdn@usm.my
FU Ministry of Education Malaysia [304/PBIO/650576]; Universiti Sains
   Malaysia, Penang, Malaysia [1001/PBIOLOGI/8011068]
FX The authors wish to convey their heartfelt gratitude to all individuals
   involved in sample collections. The research was funded by the Ministry
   of Education Malaysia (304/PBIO/650576) and Research University Grant
   (1001/PBIOLOGI/8011068) through Universiti Sains Malaysia, Penang,
   Malaysia.
CR Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692
   Alshehri M. S. A., 2013, World Applied Sciences Journal, V22, P506
   [Anonymous], INT J SCI RES
   [Anonymous], 1988, The natural history of larval mosquito habitats
   [Anonymous], 1993, Mosquito Ecology - Field Sampling Methods
   Barbosa NCCP, 2014, REV BRAS ENTOMOL, V58, P203, DOI 10.1590/S0085-56262014000200012
   Barry GH, 1942, PHYLOGENETIC TREES M
   Bonacum J., 2001, Drosophila Information Service, V84, P201
   Brelsfoard CL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-80
   Chung Chao-Lin, 1997, Chinese Journal of Entomology, V17, P86
   Gutiérrez MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085496
   Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Engdahl C, 2014, MOL ECOL RESOUR, V14, P478, DOI 10.1111/1755-0998.12202
   Feng XR, 2003, P NATL ACAD SCI USA, V100, P8502, DOI 10.1073/pnas.1232502100
   Goswami RP, 2012, J INFECT DEV COUNTR, V6, P208, DOI 10.3855/jidc.2241
   Graur D, 2000, Fundamentals of Molecular Evolution, V2nd
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Harbach R, 2008, FAMILY CULICIDAE MEI
   Herrera F, 2006, MEM I OSWALDO CRUZ, V101, P625, DOI 10.1590/S0074-02762006000600008
   JUKES T H, 1969, P21
   JUKES TH, 1986, J MOL EVOL, V24, P39, DOI 10.1007/BF02099949
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Minakawa N, 2002, AM J TROP MED HYG, V67, P32, DOI 10.4269/ajtmh.2002.67.32
   Ministry of Health Malaysia, 2014, KEN AKHB SIT SEM DEM
   Novak R, 1992, AEDES ALBOPICTUS WIN, V3, P5
   Provan J, 2005, MOL ECOL, V14, P793, DOI 10.1111/j.1365-294X.2005.02447.x
   Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x
   Talbalaghi A, 2011, EUR J ENTOMOL, V108, P35, DOI 10.14411/eje.2011.004
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4
   World Health Organization, 2005, DENG SEV DENG
   Xia X, 2008, DAMBE DATA ANAL MOLE
   Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064
NR 36
TC 1
Z9 2
U1 0
U2 1
PU UNIV SEBELAS MARET
PI SURAKARTA
PA IR SUTAMI 36 A, SURAKARTA, 57126, INDONESIA
SN 2087-3948
EI 2087-3956
J9 NUSANT BIOSCI
JI Nusant. Biosci.
PD MAY
PY 2020
VL 12
IS 1
BP 6
EP 12
DI 10.13057/nusbiosci/n120102
PG 7
WC Biology
WE Emerging Sources Citation Index (ESCI)
SC Life Sciences & Biomedicine - Other Topics
GA NB6ZI
UT WOS:000560662800002
OA gold
DA 2024-11-01
ER

PT J
AU Malinska, D
   Testoni, G
   Duran, J
   Brudnicka, A
   Guinovart, JJ
   Duszynski, J
AF Malinska, Dominika
   Testoni, Giorgia
   Duran, Jordi
   Brudnicka, Alicja
   Guinovart, Joan J.
   Duszynski, Jerzy
TI Hallmarks of oxidative stress in the livers of aged mice with mild
   glycogen branching enzyme deficiency
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Glycogen; Glycogen branching enzyme; Oxidative stress
ID MITOCHONDRIAL-DNA DAMAGE; SKELETAL-MUSCLE; METABOLISM; GLUTATHIONE;
   DISEASE
AB Glycogen branching enzyme (GBE1) introduces branching points in the glycogen molecule during its synthesis. Pathogenic GBE1 gene mutations lead to glycogen storage disease type IV (GSD IV), which is characterized by excessive intracellular accumulation of abnormal, poorly branched glycogen in affected tissues and organs, mostly in the liver. Using heterozygous Gbe1 knock-out mice (Gbe1(+/)), we analyzed the effects of moderate GBE1 deficiency on oxidative stress in the liver. The livers of aged Gbe1(+/) mice (22 months old) had decreased GBE1 protein levels, which caused a mild decrease in the degree of glycogen branching, but did not affect the tissue glycogen content. GBE1 deficiency was accompanied by increased protein carbonylation and elevated oxidation of the glutathione pool, indicating the existence of oxidative stress. Furthermore, we have observed increased levels of glutathione peroxidase and decreased activity of respiratory complex I in Gbe1(+/) livers. Our data indicate that even mild changes in the degree of glycogen branching, which did not lead to excessive glycogen accumulation, may have broader effects on cellular bioenergetics and redox homeostasis. In young animals cellular homeostatic mechanisms are able to counteract those changes, while in aged tissues the changes may lead to increased oxidative stress.
C1 [Malinska, Dominika; Brudnicka, Alicja; Duszynski, Jerzy] Polish Acad Sci, Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland.
   [Testoni, Giorgia; Duran, Jordi; Guinovart, Joan J.] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Duran, Jordi; Guinovart, Joan J.] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain.
   [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona 08028, Spain.
C3 Polish Academy of Sciences; Nencki Institute of Experimental Biology of
   the Polish Academy of Sciences; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER
   - Centro de Investigacion Biomedica en Red; CIBERDEM; University of
   Barcelona
RP Malinska, D (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Pasteur St 3, PL-02093 Warsaw, Poland.
EM d.malinska@nencki.edu.pl
RI Duran, Jordi/AGP-2068-2022
OI Duszynski, Jerzy/0000-0003-2937-6725; Malinska,
   Dominika/0000-0002-0526-7914; Duran, Jordi/0000-0002-8342-4882
FU Human Frontier Science Program, France [RGP0027/2011]; Polish Ministry
   of Science and Higher Education, Poland [SPUB W100/HFSC/2011]; Polish
   National Science Center, Poland [2011/03/B/NZ3/04433]; "La Caixa" PhD
   Fellowship Program; NIH [U01HG004085, U01HG004080]
FX This work was supported by Human Frontier Science Program, France (grant
   number RGP0027/2011), Polish Ministry of Science and Higher Education,
   Poland (grant number SPUB W100/HFSC/2011) and Polish National Science
   Center, Poland (grant number 2011/03/B/NZ3/04433). G.T. was supported by
   the "La Caixa" PhD Fellowship Program. NIH grants to Velocigene at
   Regeneron Inc (U01HG004085) and the CSD Consortium (U01HG004080) funded
   the generation of gene-targeted ES cells in the KOMP Program.
CR Aguilera G, 2018, ANTIOXID REDOX SIGN, V28, P1626, DOI 10.1089/ars.2017.7099
   Angin Y, 2016, EXPERIENTIA SUPPL, V107, P23, DOI 10.1007/978-3-319-43589-3_2
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Tung BT, 2014, J GERONTOL A-BIOL, V69, P398, DOI 10.1093/gerona/glt102
   Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333
   Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701
   Díaz A, 2011, J BIOL CHEM, V286, P18505, DOI 10.1074/jbc.M111.236109
   Dröse S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6
   Ellingwood SS, 2018, J ENDOCRINOL, V238, pR131, DOI 10.1530/JOE-18-0120
   Feng ZY, 2016, ONCOTARGET, V7, P15410, DOI 10.18632/oncotarget.7645
   Froese DS, 2015, HUM MOL GENET, V24, P5667, DOI 10.1093/hmg/ddv280
   Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214
   Graham TE, 2010, ACTA PHYSIOL, V199, P489, DOI 10.1111/j.1748-1716.2010.02131.x
   Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005
   Gusarov I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15868
   Haran M, 2014, MITOCHONDRION, V19, P3, DOI 10.1016/j.mito.2014.09.007
   Hedberg-Oldfors C, 2015, MOL ASPECTS MED, V46, P85, DOI 10.1016/j.mam.2015.08.006
   Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200
   Janecek S, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.107451
   Janzen NR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113344
   Kaczor JJ, 2017, MOL GENET METAB REP, V12, P69, DOI 10.1016/j.ymgmr.2017.05.009
   Kazachkova N, 2013, AGING DIS, V4, P337, DOI 10.14336/AD.2013.0400337
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kitaoka Y, 2013, MOL GENET METAB, V110, P297, DOI 10.1016/j.ymgme.2013.06.022
   KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3
   Kudryavtseva AV, 2016, ONCOTARGET, V7, P44879, DOI 10.18632/oncotarget.9821
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Lim JA, 2015, AUTOPHAGY, V11, P385, DOI 10.1080/15548627.2015.1009779
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586
   Massarsky A, 2017, CHEMOSPHERE, V168, P707, DOI 10.1016/j.chemosphere.2016.11.004
   Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249
   Moses Shimon W., 2002, Current Molecular Medicine (Hilversum), V2, P177, DOI 10.2174/1566524024605815
   Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006
   Park HJ, 2010, ANAL BIOCHEM, V407, P151, DOI 10.1016/j.ab.2010.08.012
   Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416
   Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33
   Sato Y, 2017, STEM CELL TRANSL MED, V6, P31, DOI 10.5966/sctm.2015-0409
   Stapleton D, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-11
   Stapleton D, 2010, PROTEOMICS, V10, P2320, DOI 10.1002/pmic.200900628
   Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X
   Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854
   Winiarska K, 2008, BIOCHIMIE, V90, P450, DOI 10.1016/j.biochi.2007.11.010
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yiu WH, 2010, LAB INVEST, V90, P620, DOI 10.1038/labinvest.2010.38
NR 46
TC 7
Z9 7
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 30
PY 2020
VL 695
AR 108626
DI 10.1016/j.abb.2020.108626
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA OY3SY
UT WOS:000594170700008
PM 33049291
DA 2024-11-01
ER

PT J
AU Chen, CT
   Hsu, SH
   Wei, YH
AF Chen, Chien-Tsun
   Hsu, Shu-Han
   Wei, Yau-Huei
TI Upregulation of mitochondrial function and antioxidant defense in the
   differentiation of stem cells
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article; Proceedings Paper
CT 5th Meeting of the Asian-Society-for-Mitochondrial-Research-and-Medicine
   (ASMRM)
CY NOV 07-09, 2008
CL Tianjin, PEOPLES R CHINA
SP Asian Soc Mitochondria Res & Med
DE Stem cell differentiation; Mitochondria; Metabolic shift; Reactive
   oxygen species (ROS); Warburg effect
ID OXIDATIVE STRESS; GENE-EXPRESSION; IN-VITRO; EMBRYONIC-DEVELOPMENT;
   TRANSCRIPTION FACTORS; DNA DELETIONS; SELF-RENEWAL; BIOGENESIS; HYPOXIA;
   MUSCLE
AB Stem cell research has received increasing attention due to their invaluable potentials in the clinical applications to cure degenerative diseases, genetic disorders and even cancers. A great number of studies have been conducted with an aim to elucidate the molecular mechanisms involved in the regulation of self-renewal of stem cells and the mysterious circuits guiding them to differentiate into all kinds of progenies that can replenish the cell pools. However, little effort has been made in studying the metabolic aspects of stem cells. Mitochondria play essential roles in mammalian cells in the generation of ATP, Ca2+ homeostasis, compartmentalization of biosynthetic pathways and execution of apoptosis. Considering the metabolic roles of mitochondria, they must be also critical in stem cells. This review is primarily focused on the biogenesis and bioenergetic function of mitochondria in the differentiation process and metabolic features of stem cells. In addition, the involvement of reactive oxygen species and hypoxic signals in the regulation of stem cell pluripotency and differentiation is also discussed. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Chen, Chien-Tsun; Hsu, Shu-Han; Wei, Yau-Huei] Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
   [Wei, Yau-Huei] Mackay Med Coll, Dept Med, Taipei 252, Taiwan.
C3 National Yang Ming Chiao Tung University; Mackay Medical College
RP Wei, YH (corresponding author), Natl Yang Ming Univ, Dept Biochem & Mol Biol, Taipei 112, Taiwan.
EM d49303003@ym.edu.tw; lucihsu@gmail.com; joeman@ym.edu.tw
RI Wei, Yau-Huei/ABA-6841-2021
OI Wei, Yau-Huei/0000-0002-6429-2546
CR Annas GJ, 1999, NAT MED, V5, P1339, DOI 10.1038/70900
   ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cb.04.110188.001445
   Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403
   BAKEEVA LE, 1983, J MOL CELL CARDIOL, V15, P413, DOI 10.1016/0022-2828(83)90261-4
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bavister BD, 2006, REPROD FERT DEVELOP, V18, P829, DOI 10.1071/RD06111
   Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381
   Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041
   BERTONCELLO I, 1985, EXP HEMATOL, V13, P999
   Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc
   Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020
   Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010
   Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509
   Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046
   Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020
   Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766
   Chung S, 2008, ANN NY ACAD SCI, V1147, P254, DOI 10.1196/annals.1427.004
   Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906
   Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275
   Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102
   Facucho-Oliveira JM, 2007, J CELL SCI, V120, P4025, DOI 10.1242/jcs.016972
   Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158
   Gibson TC, 2005, MOL HUM REPROD, V11, P785, DOI 10.1093/molehr/gah227
   Gibson TC, 2006, REPROD BIOMED ONLINE, V12, P101, DOI 10.1016/S1472-6483(10)60987-X
   GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Goffart S, 2003, EXP PHYSIOL, V88, P33, DOI 10.1113/eph8802500
   Guo HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2990752
   Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092
   Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005
   HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E
   Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014
   Houten SM, 2004, CELL, V119, P5, DOI 10.1016/j.cell.2004.09.016
   Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388
   Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823
   Jeong CH, 2007, J BIOL CHEM, V282, P13672, DOI 10.1074/jbc.M700534200
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Joshi CV, 2002, CURR OPIN CELL BIOL, V14, P749, DOI 10.1016/S0955-0674(02)00392-7
   KANAMURA S, 1990, J ELECTRON MICR TECH, V14, P92, DOI 10.1002/jemt.1060140204
   KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311
   Karpowicz P, 2005, J CELL BIOL, V170, P721, DOI 10.1083/jcb.200502073
   Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117
   Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220
   Kondoh H, 2007, HISTOL HISTOPATHOL, V22, P85, DOI 10.14670/HH-22.85
   Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467
   Leary SC, 1998, BBA-BIOENERGETICS, V1365, P522, DOI 10.1016/S0005-2728(98)00105-4
   Lee HC, 2007, EXP BIOL MED, V232, P592
   Leemhuis T, 1996, EXP HEMATOL, V24, P1215
   Lin Q, 2006, J BIOL CHEM, V281, P30678, DOI 10.1074/jbc.C600120200
   Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760
   Lonergan T, 2006, J CELL PHYSIOL, V208, P149, DOI 10.1002/jcp.20641
   Ludwig TE, 2001, BIOL REPROD, V65, P1648, DOI 10.1095/biolreprod65.6.1648
   Mannella CA, 2008, ANN NY ACAD SCI, V1147, P171, DOI 10.1196/annals.1427.020
   Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863
   May-Panloup P, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-65
   Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006
   Moyes CD, 1998, J EXP BIOL, V201, P299
   Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1
   Ohman T, 1999, AM J RESP CELL MOL, V21, P119, DOI 10.1165/ajrcmb.21.1.3521
   Piccoli C, 2005, J BIOL CHEM, V280, P26467, DOI 10.1074/jbc.M500047200
   Piccoli C, 2007, FEBS LETT, V581, P3111, DOI 10.1016/j.febslet.2007.05.077
   POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X
   Radley JM, 1999, EXP HEMATOL, V27, P365, DOI 10.1016/S0301-472X(98)00017-4
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3
   Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   Siggins RW, 2008, INT J CLIN EXP MED, V1, P2
   Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354
   Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje
   Squirrell JM, 2003, MICROSC MICROANAL, V9, P190, DOI 10.1017/S1431927603030174
   St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141
   St John JC, 2006, METH MOL B, V331, P347
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Stewart R, 2006, EUR J CANCER, V42, P1257, DOI 10.1016/j.ejca.2006.01.033
   Stojanovski D, 2006, BBA-MOL CELL RES, V1763, P414, DOI 10.1016/j.bbamcr.2006.02.008
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005
   VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763
   Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004
   WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309
   Wei YH, 1998, P SOC EXP BIOL MED, V217, P53
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WOLF NS, 1993, EXP HEMATOL, V21, P614
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
   Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4
NR 92
TC 52
Z9 65
U1 0
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD MAR
PY 2010
VL 1800
IS 3
BP 257
EP 263
DI 10.1016/j.bbagen.2009.09.001
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Biochemistry & Molecular Biology; Biophysics
GA 574GP
UT WOS:000275977700008
PM 19747960
DA 2024-11-01
ER

PT J
AU Durairaj, A
   Limbach, PA
AF Durairaj, Anita
   Limbach, Patrick A.
TI Mass spectrometry of the fifth nucleoside: A review of the
   identification of pseudouridine in nucleic acids
SO ANALYTICA CHIMICA ACTA
LA English
DT Review
DE N-cyclohexyl-N '-beta-(4-methylmorpholinium)ethylcarbodiimide;
   p-tosylate derivatization; cyanoethylation; pseudouridine-synthase;
   matrix-assisted laser; desorption/ionization-mass spectrometry; liquid
   chromatography-mass spectrometry; modified nucleosides
ID 23S RIBOSOMAL-RNA; SIDEROBLASTIC ANEMIA MLASA; ESCHERICHIA-COLI;
   POSTTRANSCRIPTIONAL MODIFICATIONS; MITOCHONDRIAL MYOPATHY;
   PEPTIDYLTRANSFERASE CENTER; THERMUS-THERMOPHILUS; MODIFIED NUCLEOTIDES;
   RECOGNITION REGION; MISSENSE MUTATION
AB Pseudouridine, the so-called fifth nucleoside due to its ubiquitous presence in ribonucleic acids (RNAs), remains among the most challenging modified nucleosides to characterize. As an isomer of the major nucleoside uridine, pseudouridine cannot be detected by standard reverse-transcriptase-based DNA sequencing or RNase mapping approaches. Thus, over the past 15 years, investigators have focused on the unique structural proper-ties of pseudouridine to develop selective derivatization or fragmentation strategies for its determination. While the N-cyclohexyl-N'-beta-(4-methylmorpholinium)ethylcarbodiimide p-tosylate (CMCT)-reverse transcriptase assay remains both a popular and powerful approach to screen for pseudouridine in larger RNAs, mass-spectrometry-based approaches are poised to play an increasingly important role in either confirming the findings of the CMCT-reverse transcriptase assay or in characterizing pseudouridine sequence placement and abundance in smaller RNAs. This review includes a brief discussion of pseudouridine including a summary of its biosynthesis and known importance within various RNAs. The review then focuses on chemical derivatization approaches that can be used to selectively modify pseudouridine to improve its detection, and the development of mass-spectrometry-based assays for the identification and sequencing of pseudouridine in various RNAs. (C) 2008 Published by Elsevier B.V.
C1 [Durairaj, Anita; Limbach, Patrick A.] Univ Cincinnati, Rieueschl Labs Mass Spectrometry, Dept Chem, Cincinnati, OH 45221 USA.
C3 University System of Ohio; University of Cincinnati
RP Limbach, PA (corresponding author), Univ Cincinnati, Rieueschl Labs Mass Spectrometry, Dept Chem, POB 210172, Cincinnati, OH 45221 USA.
EM Pat.Limbach@uc.edu
RI Limbach, Patrick/A-9188-2009
FU NIGMS NIH HHS [R01 GM058843-07, R01 GM058843-08, R01 GM058843, GM58843,
   R56 GM058843] Funding Source: Medline
CR Ansmant I, 2000, NUCLEIC ACIDS RES, V28, P1941, DOI 10.1093/nar/28.9.1941
   BAKIN A, 1994, BIOCHEMISTRY-US, V33, P13475, DOI 10.1021/bi00249a036
   BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030
   Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530
   Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095
   COHN WE, 1960, J BIOL CHEM, V235, P1488
   Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045
   Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020
   Del Lampo M, 2005, RNA, V11, P210, DOI 10.1261/rna.7209905
   Durairaj A, 2008, ANAL CHIM ACTA, V612, P173, DOI 10.1016/j.aca.2008.02.026
   Emmerechts G, 2005, J CHROMATOGR B, V825, P233, DOI 10.1016/j.jchromb.2005.06.041
   Emmerechts G, 2007, NUCLEIC ACIDS RES, V35, P3494, DOI 10.1093/nar/gkm248
   Felden B, 1998, EMBO J, V17, P3188, DOI 10.1093/emboj/17.11.3188
   Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252
   GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X
   Gu XR, 1999, P NATL ACAD SCI USA, V96, P14270, DOI 10.1073/pnas.96.25.14270
   GUPTA RC, 1979, NUCLEIC ACIDS RES, V6, P3443, DOI 10.1093/nar/6.11.3443
   Gutgsell N, 2000, RNA, V6, P1870, DOI 10.1017/S1355838200001588
   Guymon R, 2006, BIOCHEMISTRY-US, V45, P4888, DOI 10.1021/bi052579p
   Hammal T, 2006, CHEM BIOL, V13, P1125, DOI 10.1016/j.chembiol.2006.09.009
   Hansen MA, 2002, RNA, V8, P202, DOI 10.1017/S1355838202013365
   Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471
   HO NWY, 1971, BIOCHEMISTRY-US, V10, P3651
   Hossain M, 2007, RNA, V13, P295, DOI 10.1261/rna.272507
   Kinghorn SM, 2002, MICROBIOL-SGM, V148, P3511, DOI 10.1099/00221287-148-11-3511
   Kirpekar F, 2005, J MOL BIOL, V348, P563, DOI 10.1016/j.jmb.2005.03.009
   Kirpekar F, 2000, RNA, V6, P296, DOI 10.1017/S1355838200992148
   Kowalak JA, 2000, J BIOL CHEM, V275, P24484, DOI 10.1074/jbc.M002153200
   Kowalak JA, 1996, NUCLEIC ACIDS RES, V24, P688, DOI 10.1093/nar/24.4.688
   KOWALAK JA, 1993, NUCLEIC ACIDS RES, V21, P4577, DOI 10.1093/nar/21.19.4577
   LANE BG, 1992, FEBS LETT, V302, P1, DOI 10.1016/0014-5793(92)80269-M
   LANE BG, 1995, BIOCHIMIE, V77, P7, DOI 10.1016/0300-9084(96)88098-9
   LEBOWITZ J, 1977, NUCLEIC ACIDS RES, V4, P1695, DOI 10.1093/nar/4.6.1695
   Limbach PA, 1996, MASS SPECTROM REV, V15, P297, DOI 10.1002/(SICI)1098-2787(1996)15:5<297::AID-MAS2>3.0.CO;2-D
   LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183
   Massenet S, 1999, MOL CELL BIOL, V19, P2142
   Mengel-Jorgensen J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf135
   Mengel-Jorgensen J, 2006, J BIOL CHEM, V281, P22108, DOI 10.1074/jbc.M600377200
   Meroueh M, 2000, NUCLEIC ACIDS RES, V28, P2075, DOI 10.1093/nar/28.10.2075
   Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249
   Ofengand J, 2002, FEBS LETT, V514, P17, DOI 10.1016/S0014-5793(02)02305-0
   Patteson KG, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.10.e49
   PATTON JR, 1991, MOL CELL BIOL, V11, P5998, DOI 10.1128/MCB.11.12.5998
   Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200
   PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760
   POMERANTZ S, 1993, METHOD ENZYMOL, V193, P796
   Pomerantz SC, 2005, ANAL CHEM, V77, P4687, DOI 10.1021/ac058023p
   POWERS T, 1991, EMBO J, V10, P2203, DOI 10.1002/j.1460-2075.1991.tb07756.x
   Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196
   Schroeder KT, 2005, RNA, V11, P1012, DOI 10.1261/rna.2270205
   Spedaliere CJ, 2004, J AM CHEM SOC, V126, P12758, DOI 10.1021/ja046375s
   TANAKA Y, 1980, NUCLEIC ACIDS RES, V8, P1259, DOI 10.1093/nar/8.6.1259
   Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002
   YOSHIDA M, 1968, BIOCHIM BIOPHYS ACTA, V157, P455, DOI 10.1016/0005-2787(68)90145-7
   Zeharia A, 2005, J CHILD NEUROL, V20, P449, DOI 10.1177/08830738050200051301
   Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504
   Zhao XL, 2002, RNA, V8, P1515, DOI 10.1017/S1355838202022537
NR 57
TC 28
Z9 36
U1 2
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD AUG 15
PY 2008
VL 623
IS 2
BP 117
EP 125
DI 10.1016/j.aca.2008.06.027
PG 9
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA 334ED
UT WOS:000258204200001
PM 18620915
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Hsu, BY
   Cossin-Sevrin, N
   Stier, A
   Ruuskanen, S
AF Hsu, Bin-Yan
   Cossin-Sevrin, Nina
   Stier, Antoine
   Ruuskanen, Suvi
TI Prenatal thyroid hormones accelerate postnatal growth and telomere
   shortening in wild great tits
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Developmental programming; Thyroxine; Triiodothyronine; Ageing;
   Mitochondria; Metabolism; Oxidative stress; Maternal effects
ID OXIDATIVE STRESS; IMMUNE FUNCTION; SUCCESS; CONTEXT; MUSCLE; LENGTH;
   TESTS; BIRDS; DNA
AB The early-life environment is known to affect later-life health and disease, which could be mediated by the early-life programming of telomere length, a key hallmark of ageing. According to the fetal programming of telomere biology hypothesis, variation in prenatal exposure to hormones is likely to influence telomere length. Yet, the contribution of key metabolic hormones, i.e. thyroid hormones (THs), has been largely ignored. We recently showed that in contrast to predictions, exposure to elevated prenatal THs increased postnatal telomere length in wild collared flycatchers, but the generality of such effect, the underlying proximate mechanisms and consequences for survival have not been investigated. We therefore conducted a comprehensive study evaluating the impact of THs on potential drivers of telomere dynamics (growth, post-natal THs, mitochondria and oxidative stress), telomere length and medium-term survival using wild great tits as a model system. While prenatal THs did not significantly affect telomere length a week after hatching (i.e. day 7), they influenced postnatal telomere shortening (i.e. shorter telomeres at day 14 and the following winter) but not apparent survival. Circulating THs, mitochondrial density or oxidative stress biomarkers were not significantly influenced, whereas the TH-supplemented group showed accelerated growth, which may explain the observed delayed effect on telomeres. We discuss several alternative hypotheses that may explain the contrast with our previous findings in flycatchers. Given that shorter telomeres in early life tend to be carried until adulthood and are often associated with decreased survival prospects, the effects of prenatal THs on telomeres may have long-lasting effects on senescence.
C1 [Hsu, Bin-Yan; Cossin-Sevrin, Nina; Stier, Antoine; Ruuskanen, Suvi] Univ Turku, Dept Biol, FI-20014 Turku, Finland.
   [Cossin-Sevrin, Nina] Univ Strasbourg, Ctr Natl Rech Sci, UMR 7178, Inst Pluridisciplinaire Hubert Curien, F-67087 Strasbourg, France.
   [Stier, Antoine] Univ Lyon, Univ Claude Bernard Lyon 1, CNRS, UMR 5023,ENTPE,LEHNA, F-69622 Villeurbanne, France.
   [Ruuskanen, Suvi] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland.
C3 University of Turku; Centre National de la Recherche Scientifique
   (CNRS); CNRS - National Institute of Nuclear and Particle Physics
   (IN2P3); Universites de Strasbourg Etablissements Associes; Universite
   de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS
   - Institute of Ecology & Environment (INEE); Universite Claude Bernard
   Lyon 1; University of Jyvaskyla
RP Ruuskanen, S (corresponding author), Univ Turku, Dept Biol, FI-20014 Turku, Finland.; Ruuskanen, S (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland.
EM suvi.k.ruuskanen@gmail.com
RI Cossin-Sevrin, Nina/IYS-5385-2023; Hsu, Bin-Yan/AAF-6513-2019; Stier,
   Antoine/H-8886-2019; Ruuskanen, Suvi/A-1790-2013
OI Hsu, Bin-Yan/0000-0002-3799-0509; Stier, Antoine/0000-0002-5445-5524;
   Cossin-Sevrin, Nina/0000-0002-8174-8357; Ruuskanen,
   Suvi/0000-0001-5582-9455
FU Academy of Finland [332716, 286278]; Opetushallitus; Ella and Georg
   Ehrnrooth Foundation; Turku Collegium for Science and Medicine
   Fellowship; Marie Sklodowska- Curie Postdoctoral Fellowship [894963];
   University of Turku; Academy of Finland (AKA) [332716, 286278] Funding
   Source: Academy of Finland (AKA); Marie Curie Actions (MSCA) [894963]
   Funding Source: Marie Curie Actions (MSCA)
FX This study was financially supported by the Academy of Finland (286278
   to S.R.) . N.C.-S. acknowledges support from Opetushallitus (EDUFI
   Fellowship) and Maupertuis grant. B.-Y.H. was supported by grants from
   the Ella and Georg Ehrnrooth Foundation and Academy of Finland (332716)
   . A.S. was supported by a Turku Collegium for Science and Medicine
   Fellowship and a Marie Sklodowska- Curie Postdoctoral Fellowship
   (894963) at the time of writing. Open Access funding provided by
   University of Turku. Deposited in PMC for immediate release.
CR Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692
   [Anonymous], 2017, REV TOXICOL
   Arbeev KG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0023
   Atema E, 2019, MOL ECOL RESOUR, V19, P648, DOI 10.1111/1755-0998.12996
   Bano A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002957
   Bano A, 2017, JAMA INTERN MED, V177, P1650, DOI 10.1001/jamainternmed.2017.4836
   Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005
   Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Bauer CM, 2016, AUK, V133, P649, DOI 10.1642/AUK-16-56.1
   Noguera JC, 2022, MOL ECOL, V31, P6252, DOI 10.1111/mec.15694
   Casagrande S, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0885
   Chang HW, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-12
   Cioffi F, 2013, MOL CELL ENDOCRINOL, V379, P51, DOI 10.1016/j.mce.2013.06.006
   Cossin-Sevrin N, 2022, J EXP BIOL, V225, DOI 10.1242/jeb.243414
   Criscuolo F, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.232496
   Eastwood JR, 2019, MOL ECOL, V28, P1127, DOI 10.1111/mec.15002
   Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182
   Entringer S, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0151
   Godfrey K M, 2001, Public Health Nutr, V4, P611
   Groothuis TGG, 2020, CURR OPIN BEHAV SCI, V36, P185, DOI 10.1016/j.cobeha.2020.10.006
   Halekoh U, 2014, J STAT SOFTW, V59, P1
   Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913
   Haussmann MF, 2004, ANN NY ACAD SCI, V1019, P186, DOI 10.1196/annals.1297.029
   Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109
   Hsu BY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71511-y
   Hsu BY, 2019, AM NAT, V194, pE96, DOI 10.1086/704738
   Hsu BY, 2019, J AVIAN BIOL, V50, DOI 10.1111/jav.01919
   Hsu BY, 2017, GEN COMP ENDOCR, V240, P174, DOI 10.1016/j.ygcen.2016.10.011
   Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261
   Kärkkäinen T, 2022, MOL ECOL, V31, P6339, DOI 10.1111/mec.16155
   Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   Liu JS, 2006, J THERM BIOL, V31, P386, DOI 10.1016/j.jtherbio.2006.01.002
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marchetto NM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.177
   McNabb FMA, 2007, CRIT REV TOXICOL, V37, P163, DOI 10.1080/10408440601123552
   Medici M., 2013, J CLIN ENDOCR METAB
   Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3
   Mollehave LT, 2020, ENDOCRINE, V68, P358, DOI 10.1007/s12020-020-02216-5
   Monaghan P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0446
   Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12664-x
   Muriel J, 2015, J EVOLUTION BIOL, V28, P1476, DOI 10.1111/jeb.12668
   Parolini M, 2019, PHYSIOL BIOCHEM ZOOL, V92, P459, DOI 10.1086/705037
   Podmokla E, 2018, BIOL REV, V93, P1499, DOI 10.1111/brv.12406
   Radersma R, 2015, IBIS, V157, P351, DOI 10.1111/ibi.12230
   Reichert S, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0463
   Ruuskanen S, 2022, PHYSIOL BIOCHEM ZOOL, V95, P544, DOI 10.1086/721556
   Ruuskanen S, 2019, ENVIRON POLLUT, V247, P725, DOI 10.1016/j.envpol.2019.01.088
   Ruuskanen S, 2018, J CHROMATOGR B, V1093, P24, DOI 10.1016/j.jchromb.2018.06.052
   Ruuskanen S, 2018, PHYSIOL BIOCHEM ZOOL, V91, P904, DOI 10.1086/697380
   Ruuskanen S, 2016, GEN COMP ENDOCR, V235, P29, DOI 10.1016/j.ygcen.2016.05.026
   Ruuskanen S, 2016, HORM BEHAV, V81, P38, DOI 10.1016/j.yhbeh.2016.03.006
   Salmón P, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0155
   Salmón P, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1349
   Sarraude T, 2020, PEERJ, V8, DOI 10.7717/peerj.10175
   Sarraude T, 2020, PHYSIOL BIOCHEM ZOOL, V93, P255, DOI 10.1086/709030
   Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434
   Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x
   Smith SM, 2016, ECOL EVOL, V6, P2833, DOI 10.1002/ece3.2080
   Soriano-Redondo A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19256-0
   Stier A, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0364
   Stier A, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1378
   Stier A, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0536
   Stier A, 2016, J AVIAN BIOL, V47, P134, DOI 10.1111/jav.00714
   Stier A, 2015, OECOLOGIA, V179, P999, DOI 10.1007/s00442-015-3429-9
   Stier A, 2014, J COMP PHYSIOL B, V184, P1021, DOI 10.1007/s00360-014-0856-6
   Tissier ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097705
   Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x
   Verhulst S, 2020, MOL ECOL RESOUR, V20, P11, DOI 10.1111/1755-0998.13114
   Vrijkotte TGM, 2017, J CLIN ENDOCR METAB, V102, P1059, DOI 10.1210/jc.2016-3452
   Weber K, 2002, ENDOCRINOLOGY, V143, P177, DOI 10.1210/en.143.1.177
   Welcker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056229
   Wilbourn RV, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0447
   Zhang C, 2019, J CLIN ENDOCR METAB, V104, P5853, DOI 10.1210/jc.2019-00390
NR 75
TC 3
Z9 3
U1 1
U2 10
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD MAR
PY 2023
VL 226
IS 6
AR jeb243875
DI 10.1242/jeb.243875
PG 10
WC Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Zoology
GA E4AE1
UT WOS:000974978300018
PM 36714994
OA Green Submitted, Green Published, hybrid
DA 2024-11-01
ER

PT J
AU Tajane, TD
   Waghmare, PJ
   Taksande, BA
   Ambulkar, PS
   Waghmare, JE
AF Tajane, Tejas Dilip
   Waghmare, Pranita Jwalant
   Taksande, Bharati Amar
   Ambulkar, Prafulla Shriram
   Waghmare, Jwalant Eknath
TI Role of Mitochondrial Dynamics in Type 2 Diabetes Mellitus Dysfunction
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Review
DE Insulin sensitivity; Oxidative markers; Oxidative stress
ID OXIDATIVE STRESS; INSULIN-RESISTANCE; DNA DELETIONS; MECHANISMS; MUSCLE;
   REPAIR; CELLS; COMPLICATIONS; ISOPROSTANES; ANTIOXIDANTS
AB Type 2 Diabetes Mellitus (T2DM) is influenced by the action of both hereditary and environmental factors. These factors are comprehended in the disease interaction with beta cells and insulin sensitivity to the receptors.The main cause of T2DM development is ageing, obesity, and oxidative stress. The dysfunction of the beta cells of the pancreas leads to insulin insensitivity in the liver, muscle and fat metabolism. These occur due to the result of oxidative stress. Lipid peroxidation is a key initiating factor in the development of oxidative stress, which results in T2DM and its related micro-and macro-vascular problems. These are initially compensated for the generation of excess insulin synthesis, thus ensuring normal glucose tolerance. When these compensatory processes are disrupted, the majority of persons develop T2DM. Although the gene is the primary cause of T2DM, the environment also plays an important role in the disease's progression. Particularly, a sedentary lifestyle characterised by excessive food consumption and physical inactivity is a known risk factor for obesity and type 2 diabetes. This review has briefly discussed the significance of numerous causal factors, and genomic and biochemical pathways which are responsible for increasing the production of oxidative stress, a crucial component for the etiology and development of T2DM. The conclusion drawn was that the analysis of oxidative stress markers may be one of the potential methods for the diagnosis and prognosis of T2DM. Furthermore, this review will be helpful to establish the broaden conceptual framework for future studies on oxidative stress with relation to etiology of type 2 diabetes and therapeutic development.
C1 [Tajane, Tejas Dilip; Waghmare, Jwalant Eknath] Mahatma Gandhi Inst Med Sci, Dept Anat, Wardha, Maharashtra, India.
   [Waghmare, Pranita Jwalant] Mahatma Gandhi Inst Med Sci, Dept Biochem, Wardha, Maharashtra, India.
   [Taksande, Bharati Amar] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.
   [Ambulkar, Prafulla Shriram] Mahatma Gandhi Inst Med Sci, Ctr Genet & Genom, Dept Anat, Wardha, Maharashtra, India.
C3 Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi
   Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of
   Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical
   Sciences, Sevagram
RP Waghmare, JE (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Anat, Wardha, Maharashtra, India.
EM jewaghmare@mgims.ac.in
RI Ambulkar, Prafulla/AAA-4078-2022; Tajane, Tejas/KHZ-0196-2024
FU Indian Council of Medical Research (ICMR), New Delhi, India
   [5/4/5-10/Diab./20-NCD-III]
FX JW is gratified to the funding agency viz Indian Council of Medical
   Research (ICMR), New Delhi, India (5/4/5-10/Diab./20-NCD-III) for this
   financial grant.
CR Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37
   [Anonymous], 2022, Diabetes
   Banerjee M, 2014, REDOX BIOL, V2, P170, DOI [10.4103/0971-6866.132747, 10.1016/j.redox.2013.12.001]
   Baysal BE, 2001, J MOL MED, V79, P495, DOI 10.1007/s001090100267
   Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006
   Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010
   Bigagli E, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5953685
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Boguszewska K, 2020, MOLECULES, V25, DOI 10.3390/molecules25122857
   Boldinova EO, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133279
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Burgstaller JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04797-2
   Chen T, 2011, J HUM GENET, V56, P689, DOI 10.1038/jhg.2011.97
   Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559
   CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Czerska M, 2016, INT J OCCUP MED ENV, V29, P179, DOI 10.13075/ijomeh.1896.00596
   Daryabor G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01582
   Diabetes A., 2022, FACTAND FIG
   Ding Y, 2022, DIABET METAB SYND OB, V15, P1687, DOI 10.2147/DMSO.S363978
   dos Santos KG, 2006, DIS MARKERS, V22, P355, DOI 10.1155/2006/983408
   Fontana GA, 2020, NUCLEIC ACIDS RES, V48, P11244, DOI 10.1093/nar/gkaa804
   Formosa LE, 2018, NAT CELL BIOL, V20, P511, DOI 10.1038/s41556-018-0098-z
   Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665
   Garcia I, 2017, FRONT BIOSCI-LANDMRK, V22, P710, DOI 10.2741/4511
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Goth Laszlo, 2004, Mol Diagn, V8, P141
   Gryszczynska B, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4975264
   Hahn A, 2019, TRENDS CELL BIOL, V29, P227, DOI 10.1016/j.tcb.2018.11.004
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614
   Hotta N, 2010, J DIABETES INVEST, V1, P134, DOI 10.1111/j.2040-1124.2010.00037.x
   Kaneto H, 2012, INT J MOL SCI, V13, P13680, DOI 10.3390/ijms131013680
   Kato Y, 2009, J CLIN BIOCHEM NUTR, V44, P67, DOI 10.3164/jcbn.08-185
   Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x
   Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94
   Lacolley P, 2017, PHYSIOL REV, V97, P1555, DOI 10.1152/physrev.00003.2017
   Lee JH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194924
   Lephart E.D., 2018, COSMETICS-BASEL, V5, DOI [DOI 10.3390/cosmetics5010016, 10.3390/COSMETICS5010016, DOI 10.3390/COSMETICS5010016]
   Leyane TS, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23137273
   Lönn ME, 2012, FREE RADICAL BIO MED, V53, P863, DOI 10.1016/j.freeradbiomed.2012.05.027
   Ma Z.A., 2012, EXP DIABETES RES, V2012, P1
   Maassen JA, 2005, ANN MED, V37, P213, DOI 10.1080/07853890510007188
   Mandal M, 2019, CLIN DIABETOL, V8, P215, DOI 10.5603/DK.2019.0015
   Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001
   Martinez-Moral MP, 2022, ANAL BIOANAL CHEM, V414, P2103, DOI 10.1007/s00216-021-03844-0
   Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   Nandi A, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9613090
   NICHOLLS DG, 1977, BIOCHEM SOC T, V5, P200, DOI 10.1042/bst0050200
   Nissanka N, 2020, EMBO REP, V21, DOI 10.15252/embr.201949612
   Nissanka N, 2019, TRENDS GENET, V35, P235, DOI 10.1016/j.tig.2019.01.001
   Volpe CMO, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0135-z
   Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012
   Patel D. K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P316, DOI 10.1016/S2221-1691(11)60051-8
   Poetsch AR, 2020, COMPUT STRUCT BIOTEC, V18, P207, DOI 10.1016/j.csbj.2019.12.013
   Prasun P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165838
   Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012
   Ritter O, 2015, J MOL MED, V93, P831, DOI 10.1007/s00109-015-1310-2
   Robinson KN, 2020, ENDOCR PRACT, V26, P241, DOI 10.4158/EP-2019-0270
   Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015
   Rong ZY, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.669379
   Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483
   Rovira-Llopis S, 2017, REDOX BIOL, V11, P637, DOI 10.1016/j.redox.2017.01.013
   Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006
   Sharifi-Rad M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00694
   Singh A, 2022, MOLECULES, V27, DOI 10.3390/molecules27030950
   Singh S, 2019, ASIAN J PHARMA CLIN, P204
   St John JC, 2010, HUM REPROD UPDATE, V16, P488, DOI 10.1093/humupd/dmq002
   Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015
   Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754
   Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456
   Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013
   Tiwari Brahm Kumar, 2013, J Biomark, V2013, P378790, DOI 10.1155/2013/378790
   Urbaniak SK, 2020, MOLECULES, V25, DOI 10.3390/molecules25010202
   Vartanian V, 2006, P NATL ACAD SCI USA, V103, P1864, DOI 10.1073/pnas.0507444103
   Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029
   Vona R, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8267234
   Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030
   Westermann B, 2008, J BIOL CHEM, V283, P13501, DOI 10.1074/jbc.R800011200
   Westermann B, 2014, BBA-BIOENERGETICS, V1837, P1039, DOI 10.1016/j.bbabio.2013.10.005
   Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033
   Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8
   Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336
NR 84
TC 0
Z9 0
U1 1
U2 1
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD NOV
PY 2022
VL 16
IS 11
BP GE1
EP GE7
DI 10.7860/JCDR/2022/59325.17165
PG 7
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA 6P4BI
UT WOS:000890875200002
OA gold
DA 2024-11-01
ER

PT J
AU Yao, YF
   Li, H
   Da, XW
   He, ZH
   Tang, B
   Li, Y
   Hu, CQ
   Xu, CQ
   Chen, QY
   Wang, QK
AF Yao, Yufeng
   Li, Hui
   Da, Xinwen
   He, Zuhan
   Tang, Bo
   Li, Yong
   Hu, Changqing
   Xu, Chengqi
   Chen, Qiuyun
   Wang, Qing K.
TI SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular
   smooth muscle cells by activating autophagy in pulmonary arterial
   hypertension
SO PULMONARY PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
DE Vps34; Berlin-1; Atg14
ID DNA-DAMAGE; MITOCHONDRIAL MORPHOLOGY; INDUCED PROLIFERATION; CELLULAR
   SENESCENCE; HYPOXIA; UBIQUITIN; EXPRESSION; INHIBITION; FISSION;
   PATHOGENESIS
AB Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease without effective therapies. PAH is associated with a progressive increase in pulmonary vascular resistance and irreversible pulmonary vascular remodeling. SUMO1 (small ubiquitin-related modifier 1) can bind to target proteins and lead to protein SUMOylation, an important post-translational modification with a key role in many diseases. However, the contribution of SUMO1 to PAH remains to be fully characterized.
   Methods: In this study, we explored the role of SUMO1 in the dedifferentiation of vascular smooth muscle cells (VSMCs) involved in hypoxia-induced pulmonary vascular remodeling and PAH in vivo and in vitro.
   Results: In a mouse model of hypoxic PAH, SUMO1 expression was significantly increased, which was associated with activation of autophagy (increased LC3b and decreased p62), dedifferentiation of pulmonary arterial VSMCs (reduced alpha-SMA, SM22 and SM-MHC), and pulmonary vascular remodeling. Similar results were obtained in a MCT-induced PAH model. Overexpression of SUMO1 significantly increased VSMCs proliferation, migration, hypoxia-induced VSMCs dedifferentiation, and autophagy, but these effects were abolished by inhibition of autophagy by 3-MA in aortic VSMCs. Furthermore, SUMO1 knockdown reversed hypoxia-induced proliferation and migration of PASMCs. Mechanistically, SUMO1 promotes Vps34 SUMOylation and the assembly of the Beclin-l-Vps34-Atg14 complex, thereby inducing autophagy, whereas Vps34 mutation K840R reduces Vps34 SUMOylation and inhibits VSMCs dedifferentiation.
   Discussion: Our data uncovers an important role of SUMO1 in VSMCs proliferation, migration, autophagy, and phenotypic switching (dedifferentiation) involved in pulmonary vascular remodeling and PAH. Targeting of the SUMO1-Vps34-autophagy signaling axis may be exploited to develop therapeutic strategies to treat PAH.
C1 [Yao, Yufeng; Li, Hui; Da, Xinwen; He, Zuhan; Tang, Bo; Li, Yong; Hu, Changqing; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan, Hubei, Peoples R China.
   [Yao, Yufeng; Li, Hui; Da, Xinwen; He, Zuhan; Tang, Bo; Li, Yong; Hu, Changqing; Xu, Chengqi; Wang, Qing K.] Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Hubei, Peoples R China.
   [Chen, Qiuyun; Wang, Qing K.] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.
   [Chen, Qiuyun; Wang, Qing K.] Case Western Reserve Univ, Dept Mol Med, CCLCM, Cleveland, OH 44195 USA.
   [Wang, Qing K.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Cleveland Clinic Foundation; University System of
   Ohio; Case Western Reserve University; University System of Ohio; Case
   Western Reserve University
RP Wang, QK (corresponding author), Huazhong Univ Sci & Technol, Ctr Human Genome Res, Wuhan, Hubei, Peoples R China.; Chen, QY (corresponding author), Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH 44195 USA.
EM cheng3@ccf.org; qkwang@hust.edu.cn
RI Wang, Qing K/JPK-1687-2023
OI Wang, Qing/0000-0002-5639-8519; Xu, Chengqi/0000-0002-4269-6830; Yao,
   Yufeng/0000-0003-0395-3993
FU National Natural Science Foundation of China [81630002, 31430047,
   91439129]; Hubei Province Natural Science Program Innovative Team grant
   [2017CFA014]; China Postdoctoral Science Foundation [2017M622409];
   Certificate of China Postdoctoral Science Foundation fund [2018T110754]
FX This study was supported by the National Natural Science Foundation of
   China grants (81630002, 31430047 and 91439129), the Hubei Province
   Natural Science Program Innovative Team grant (2017CFA014), China
   Postdoctoral Science Foundation funded project (2017M622409) and
   Certificate of China Postdoctoral Science Foundation fund (2018T110754).
CR Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012
   Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233
   Atkins K, 2016, CLIN SCI, V130, P1861, DOI 10.1042/CS20160030
   Boucherat O, 2018, AM J RESP CRIT CARE, V198, P90, DOI 10.1164/rccm.201708-1751OC
   Brun S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178925
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Chang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22147
   Chen KH, 2018, CIRCULATION, V138, P287, DOI 10.1161/CIRCULATIONAHA.117.031258
   Da Silva-Ferrada E, 2016, INT J BIOCHEM CELL B, V79, P443, DOI 10.1016/j.biocel.2016.09.015
   Erzurum S, 2010, AM J RESP CRIT CARE, V182, P1554, DOI 10.1164/rccm.201006-0869WS
   Federici C, 2015, AM J RESP CRIT CARE, V192, P219, DOI 10.1164/rccm.201411-2128OC
   Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200
   Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604
   Grillari J, 2010, ADV EXP MED BIOL, V694, P172
   Guignabert C, 2017, SEMIN RESP CRIT CARE, V38, P571, DOI 10.1055/s-0037-1606214
   Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004
   Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478
   Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200
   HISLOP A, 1976, BRIT J EXP PATHOL, V57, P542
   Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0
   Hou X, 2017, BIOCHEM BIOPH RES CO, V494, P446, DOI 10.1016/j.bbrc.2017.10.103
   Hu JL, 2018, MOL MED REP, V17, P1690, DOI 10.3892/mmr.2017.8037
   Huang YF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005393
   Ivanschitz L, 2015, P NATL ACAD SCI USA, V112, P14278, DOI 10.1073/pnas.1507540112
   Iwata K, 2014, ARTERIOSCL THROM VAS, V34, P110, DOI 10.1161/ATVBAHA.113.302107
   Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017
   Jiang YL, 2015, INT J MOL MED, V36, P271, DOI 10.3892/ijmm.2015.2209
   Jones SA, 2013, IMMUNOL CELL BIOL, V91, P250, DOI 10.1038/icb.2012.82
   KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kuwano K, 2016, RESPIR INVESTIG, V54, P397, DOI 10.1016/j.resinv.2016.03.010
   Lee SJ, 2011, AM J RESP CRIT CARE, V183, P649, DOI 10.1164/rccm.201005-0746OC
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li LZ, 2017, EUR J PHARMACOL, V813, P84, DOI 10.1016/j.ejphar.2017.07.038
   Li XW, 2012, EUR J PHARMACOL, V679, P117, DOI 10.1016/j.ejphar.2012.01.015
   Liu XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063680
   Long L, 2013, CIRC RES, V112, P1159, DOI 10.1161/CIRCRESAHA.111.300483
   Lu QL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002529
   Lu QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046998
   Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207
   MORRELL NW, 1995, AM J PHYSIOL-HEART C, V269, pH1186, DOI 10.1152/ajpheart.1995.269.4.H1186
   OWENS GK, 1995, PHYSIOL REV, V75, P487
   Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394
   Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011
   Provencher S, 2018, CIRC RES, V122, P1021, DOI 10.1161/CIRCRESAHA.117.312579
   Ranchoux B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060990
   Ryter SW, 2013, MOL CELLS, V36, P7, DOI 10.1007/s10059-013-0140-8
   Ryter Stefan W, 2010, Expert Rev Respir Med, V4, P573, DOI 10.1586/ers.10.61
   Ryter SW, 2009, AUTOPHAGY, V5, P235, DOI 10.4161/auto.5.2.7495
   Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X
   Santel A, 2001, J CELL SCI, V114, P867
   Sarangi P, 2014, NUCLEIC ACIDS RES, V42, P6393, DOI 10.1093/nar/gku300
   Schultz K, 2006, AM J PHYSIOL-HEART C, V290, pH2528, DOI 10.1152/ajpheart.01077.2005
   Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143
   Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079
   Shao RJ, 2004, ENDOCRINOLOGY, V145, P384, DOI 10.1210/en.2003-0527
   Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f
   Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0
   Tang Jin-long, 2012, Chinese Journal of Pathology, V41, P573, DOI 10.3760/cma.j.issn.0529-5807.2012.08.018
   Teng BY, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12818
   Wang ZF, 2017, MUTAT RES-FUND MOL M, V803, P56, DOI 10.1016/j.mrfmmm.2017.07.001
   Wauchope OR, 2018, NUCLEIC ACIDS RES, V46, P3458, DOI 10.1093/nar/gky089
   Yang YF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170167
   Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110
   Yao YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00171-w
   Yao YF, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005889
   Ye J, 2016, SCI REP-UK, V6, DOI 10.1038/srep34034
   Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010
   Zhu B., 2017, BIOPHYS RES COMMUN, P2125
   Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418
NR 70
TC 28
Z9 30
U1 1
U2 22
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1094-5539
J9 PULM PHARMACOL THER
JI Pulm. Pharmacol. Ther.
PD APR
PY 2019
VL 55
BP 38
EP 49
DI 10.1016/j.pupt.2019.01.007
PG 12
WC Pharmacology & Pharmacy; Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Respiratory System
GA HQ4ZE
UT WOS:000462419000006
PM 30703554
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Kudin, AP
   Baron, G
   Zsurka, G
   Hampel, KG
   Elger, CE
   Grote, A
   Weber, Y
   Lerche, H
   Thiele, H
   Nürnberg, P
   Schulz, H
   Ruppert, AK
   Sander, T
   Cheng, Q
   Arnér, ESJ
   Schomburg, L
   Seeher, S
   Fradejas-Villar, N
   Schweizer, U
   Kunz, WS
AF Kudin, Alexei P.
   Baron, Gregor
   Zsurka, Gabor
   Hampel, Kevin G.
   Elger, Christian E.
   Grote, Alexander
   Weber, Yvonne
   Lerche, Holger
   Thiele, Holger
   Nuernberg, Peter
   Schulz, Herbert
   Ruppert, Ann-Kathrin
   Sander, Thomas
   Cheng, Qing
   Arner, Elias S. J.
   Schomburg, Lutz
   Seeher, Sandra
   Fradejas-Villar, Noelia
   Schweizer, Ulrich
   Kunz, Wolfram S.
TI Homozygous mutation in TXNRD1 is associated with genetic generalized
   epilepsy
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Generalized seizures; Epilepsy; Oxidative stress; TXNRD1
ID EARLY EMBRYONIC LETHALITY; THIOREDOXIN REDUCTASE; SELENOPROTEIN
   BIOSYNTHESIS; MITOCHONDRIAL DYSFUNCTION; DEFICIENCY; PENETRANCE;
   DISRUPTION; EXPRESSION; SURVIVAL; SEIZURES
AB Increased oxidative stress has been widely implicated in the pathogenesis in various forms of human epilepsy. Here, we report a homozygous mutation in TXNRD1 (thioredoxin reductase 1) in a family with genetic generalized epilepsy. TXNRD1 is an essential selenium-containing enzyme involved in detoxification of reactive oxygen species (ROS) and redox signaling. The TXNRD1 mutation p.Pro190Leu affecting a highly conserved amino acid residue was identified by whole-exome sequencing of blood DNA from the index patient. The detected mutation and its segregation within the family- all siblings of the index patient were homozygous and the parents heterozygous-were confirmed by Sanger sequencing. TXNRD1 activity was determined in subcellular fractions from a skeletal muscle biopsy and skin fibroblasts of the index patient and the expression levels of the mutated protein were assessed by Se-75 labeling and Western blot analysis. As result of the mutation, the activity of TXNRD1 was reduced in the patient's fibroblasts and skeletal muscle (to 34 +/- 3% and 16 +/- 8% of controls, respectively). In fibroblasts, we detected reduced Se-75-labeling of the enzyme (41 +/- 3% of controls). An in-depth in vitro kinetic analysis of the recombinant mutated TXNRD1 indicated 30-40% lowered k(cat)/Se values. Therefore, a reduced activity of the enzyme in the patient's tissue samples is explained by (i) lower enzyme turnover and (ii) reduced abundance of the mutated enzyme as confirmed by Western blotting and Se-75 labeling. The mutant fibroblasts were also found to be less resistant to a hydrogen peroxide challenge. Our data agree with a potential role of insufficient ROS detoxification for disease manifestation in genetic generalized epilepsy.
C1 [Kudin, Alexei P.; Baron, Gregor; Zsurka, Gabor; Hampel, Kevin G.; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Dept Epileptol, Bonn, Germany.
   [Kudin, Alexei P.; Baron, Gregor; Zsurka, Gabor; Hampel, Kevin G.; Elger, Christian E.; Kunz, Wolfram S.] Univ Bonn, Life & Brain Ctr, Bonn, Germany.
   [Grote, Alexander] Univ Bonn, Dept Neurosurg, Bonn, Germany.
   [Weber, Yvonne; Lerche, Holger] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Tubingen, Germany.
   [Thiele, Holger; Nuernberg, Peter; Schulz, Herbert; Ruppert, Ann-Kathrin; Sander, Thomas] Univ Cologne, Cologne Ctr Genom, Cologne, Germany.
   [Cheng, Qing; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys MBB, Div Biochem, Stockholm, Sweden.
   [Schomburg, Lutz] Charite, Inst Biochem & Mol Biol, Berlin, Germany.
   [Seeher, Sandra; Fradejas-Villar, Noelia; Schweizer, Ulrich] Rheinische Friedrich Wilhelms Univ, Inst Biochem & Mol Biol, Bonn, Germany.
   [Hampel, Kevin G.] Hosp Univ & Politecn La Fe, Neurol Serv, Multidisciplinary Epilepsy Unit, Valencia, Spain.
C3 University of Bonn; University of Bonn; University of Bonn; Eberhard
   Karls University of Tubingen; Eberhard Karls University Hospital;
   University of Cologne; Karolinska Institutet; Berlin Institute of
   Health; Free University of Berlin; Humboldt University of Berlin;
   Charite Universitatsmedizin Berlin; University of Bonn; Hospital
   Universitari i Politecnic La Fe
RP Kunz, WS (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Life & Brain Ctr, Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Div Neurochem, Dept Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.; Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Life & Brain Ctr, Sigmund Freud Str 25, D-53105 Bonn, Germany.
EM alexei_kudin@yahoo.com; brain21@gmx.net; gabor.zsurka@ukb.uni-bonn.de;
   kevin.hampel@gmx.de; christian.elger@ukb.uni-bonn.de;
   alexander.grote@ukb.uni-bonn.de; yvonne.weber@uni-tuebingen.de;
   holger.lerche@uni-tuebingen.de; holger.thiele@uni-koeln.de;
   nuemberg@uni-koeln.de; herbert.schulz@uni-koeln.de;
   sandert@uni-koeln.de; Qing.Cheng@ki.se; elias.arner@ki.se;
   lutz.schomburg@charite.de; seeher@gmx.de; nfradejas@uni-bonn.de;
   uschweiz@uni-bonn.de; wolfram.kunz@ukb.uni-bonn.de
RI Schweizer, Ulrich/E-8105-2013; Grote, Alexander/HLP-5518-2023;
   Schomburg, Lutz/D-8096-2013; Nagy, peter/KMY-7425-2024; Arner,
   Elias/J-5832-2012; Kunz, Wolfram/K-1232-2019
OI Schomburg, Lutz/0000-0001-9445-1555; Arner, Elias/0000-0002-4807-6114;
   Schweizer, Ulrich/0000-0003-1380-4780; Cheng, Qing/0000-0002-3170-9333;
   Hampel, Kevin/0000-0003-3582-060X; Zsurka, Gabor/0000-0002-6379-849X;
   Grote, Alexander/0000-0002-6545-0622; Kunz, Wolfram/0000-0003-1113-3493;
   Fradejas-Villar, Noelia/0000-0003-3418-0743
CR Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007
   Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787
   Arner E.S., 2001, CURR PROTOC TOXICOL
   Arnér ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014
   Basmanav FB, 2014, AM J HUM GENET, V94, P135, DOI 10.1016/j.ajhg.2013.12.003
   Bragin DE, 2010, J CEREBR BLOOD F MET, V30, P734, DOI 10.1038/jcbfm.2010.9
   Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304
   Cheng Q, 2010, J BIOL CHEM, V285, P21708, DOI 10.1074/jbc.M110.117259
   Chiueh CC, 2005, ANN NY ACAD SCI, V1042, P403, DOI 10.1196/annals.1338.034
   Claude J, 2013, J NEUROSCI, V33, P18270, DOI 10.1523/JNEUROSCI.2211-13.2013
   Cologne Center for Genomics, 2016, VARBANK DAT AN TOOL
   Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196
   Dubowitz V., 2007, Muscle Biopsy: A Practical Approach
   Exome Aggregation Consortium, 2016, EXAC BROWS
   Folbergrová J, 2012, MITOCHONDRION, V12, P35, DOI 10.1016/j.mito.2011.04.004
   Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155
   Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350
   Hybsier S, 2017, REDOX BIOL, V11, P403, DOI 10.1016/j.redox.2016.12.025
   Iverson SV, 2013, FREE RADICAL BIO MED, V63, P369, DOI 10.1016/j.freeradbiomed.2013.05.028
   Kean W. F., 2008, Inflammopharmacology, V16, P112, DOI 10.1007/s10787-007-0021-x
   Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516
   Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208
   MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
   Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003
   Peng X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.209
   Prasad R, 2014, J CLIN ENDOCR METAB, V99, pE1556, DOI 10.1210/jc.2013-3844
   RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025
   Riveiro-Alvarez R, 2009, BRIT J OPHTHALMOL, V93, P1359, DOI 10.1136/bjo.2008.148155
   Romá-Mateo C, 2015, FREE RADICAL BIO MED, V88, P30, DOI 10.1016/j.freeradbiomed.2015.01.034
   Rossi E, 2008, EXPERT REV HEMATOL, V1, P205, DOI 10.1586/17474086.1.2.205
   Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853
   Schweizer U, 2016, FASEB J, V30, P3669, DOI 10.1096/fj.201600424
   Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369
   Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507
   Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813
   Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612
   Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004
   Valentine WM, 2005, TOXICOL PATHOL, V33, P570, DOI 10.1080/01926230500243045
   Volmering E, 2016, ACTA NEUROPATHOL, V132, P277, DOI 10.1007/s00401-016-1561-1
   WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2
   Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z
   Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974
   WISNIEWSKI E, 1993, J BIOL CHEM, V268, P9343
   Zsurka G, 2015, LANCET NEUROL, V14, P956, DOI 10.1016/S1474-4422(15)00148-9
   Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281
NR 45
TC 32
Z9 33
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY
PY 2017
VL 106
BP 270
EP 277
DI 10.1016/j.freeradbiomed.2017.02.040
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EU0TN
UT WOS:000400724500025
PM 28232204
DA 2024-11-01
ER

PT J
AU Marek-Iannucci, S
   Ozdemir, AB
   Moreira, D
   Gomez, AC
   Lane, M
   Porritt, RA
   Lee, Y
   Shimada, K
   Abe, M
   Stotland, A
   Zemmour, D
   Parker, S
   Sanchez-Lopez, E
   Van Eyk, J
   Gottlieb, RA
   Fishbein, MC
   Karin, M
   Crother, TR
   Noval Rivas, M
   Arditi, M
AF Marek-Iannucci, Stefanie
   Ozdemir, Asli B.
   Moreira, Debbie
   Gomez, Angela C.
   Lane, Malcolm
   Porritt, Rebecca A.
   Lee, Youngho
   Shimada, Kenichi
   Abe, Masanori
   Stotland, Aleksandr
   Zemmour, David
   Parker, Sarah
   Sanchez-Lopez, Elsa
   Van Eyk, Jennifer
   Gottlieb, Roberta A.
   Fishbein, Michael C.
   Karin, Michael
   Crother, Timothy R.
   Noval Rivas, Magali
   Arditi, Moshe
TI Autophagy-mitophagy induction attenuates cardiovascular inflammation in
   a murine model of Kawasaki disease vasculitis
SO JCI INSIGHT
LA English
DT Article
ID NLRP3 INFLAMMASOME; MOUSE MODEL; MITOCHONDRIAL-DNA; METFORMIN; CHILDREN;
   INTERLEUKIN-1-BETA; DYSFUNCTION; ACTIVATION; MANAGEMENT; ANEURYSMS
AB Kawasaki disease (KD) is the leading cause of acquired heart disease among children. Murine and human data suggest that the NLRP3-IL-1 beta pathway is the main driver of KD pathophysiology. NLRP3 can be activated during defective autophagy/mitophagy. We used the Lactobacillus casei cell wall extract (LCWE) murine model of KD vasculitis to examine the role of autophagy/mitophagy on cardiovascular lesion development. LCWE-injected mice had impaired autophagy/mitophagy and increased levels of ROS in cardiovascular lesions, together with increased systemic 8-OHdG release. Enhanced autophagic flux significantly reduced cardiovascular lesions in LCWE-injected mice, whereas autophagy blockade increased inflammation. Vascular smooth muscle cell-specific deletion of Atg16l1 and global Parkin(-/-) significantly increased disease formation, supporting the importance of autophagy/mitophagy in this model. Ogg1(-/-) mice had significantly increased lesions with increased NLRP3 activity, whereas treatment with MitoQ reduced vascular tissue inflammation, ROS production, and systemic 8-OHdG release. Treatment with MN58b or Metformin (increasing AMPK and reducing ROS) resulted in decreased cardiovascular lesions. Our results demonstrate that impaired autophagy/mitophagy and ROS-dependent damage exacerbate the development of murine KD vasculitis. This pathway can be efficiently targeted to reduce disease severity. These findings enhance our understanding of KD pathogenesis and identify potentially novel therapeutic avenues for KD treatment.
C1 [Marek-Iannucci, Stefanie] Cedars Sinai Med Ctr, Grad Sch Biomed Sci, Los Angeles, CA 90048 USA.
   [Marek-Iannucci, Stefanie; Ozdemir, Asli B.; Moreira, Debbie; Gomez, Angela C.; Lane, Malcolm; Porritt, Rebecca A.; Lee, Youngho; Shimada, Kenichi; Abe, Masanori; Crother, Timothy R.; Noval Rivas, Magali; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis & Immunol, Los Angeles, CA 90048 USA.
   [Marek-Iannucci, Stefanie; Ozdemir, Asli B.; Moreira, Debbie; Gomez, Angela C.; Lane, Malcolm; Porritt, Rebecca A.; Lee, Youngho; Shimada, Kenichi; Abe, Masanori; Crother, Timothy R.; Noval Rivas, Magali; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Biomed Sci, Infect & Immunol Dis Res Ctr IIDRC, Los Angeles, CA 90048 USA.
   [Stotland, Aleksandr; Parker, Sarah; Van Eyk, Jennifer] Cedars Sinai Med Ctr, Adv Clin Biosyst Res Inst, Los Angeles, CA 90048 USA.
   [Zemmour, David] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.
   [Zemmour, David] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.
   [Sanchez-Lopez, Elsa; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, San Diego, CA USA.
   [Gottlieb, Roberta A.; Arditi, Moshe] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.
   [Fishbein, Michael C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA.
C3 Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai
   Medical Center; Cedars Sinai Medical Center; Harvard University; Harvard
   Medical School; Harvard University; Brigham & Women's Hospital;
   University of California System; University of California San Diego;
   Cedars Sinai Medical Center; University of California System; University
   of California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Arditi, M (corresponding author), 8700 Beverly Blvd, Los Angeles, CA 90048 USA.
EM moshe.arditi@cshs.org
RI Noval Rivas, Magali/IUO-2002-2023; Lee, Youngho/D-1836-2011; Crother,
   Timothy/E-2879-2010; Sanchez-Lopez, Elsa/K-3987-2015
OI Crother, Timothy/0000-0001-8465-6127; Ozdemir, Asli
   Beyza/0000-0003-3274-0401; Marek-Iannucci, Stefanie/0000-0001-9621-3198;
   Sanchez-Lopez, Elsa/0000-0002-4236-1985; Abe,
   Masanori/0000-0002-5641-4996; Porritt, Rebecca/0000-0002-0973-5092; Van
   Eyk, Jennifer/0000-0001-9050-148X; Lee, Youngho/0000-0002-5227-683X;
   Zemmour, David/0000-0002-0990-217X
FU NIH [R01 HL139766, R01 AI072726]
FX We would like to thank the members of the Arditi laboratory for their
   technical support. We gratefully acknowledge support from the NIH awards
   R01 HL139766 (to MNR) and R01 AI072726 (to MA) .
CR Alphonse MP, 2016, J IMMUNOL, V197, P3481, DOI 10.4049/jimmunol.1600388
   Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416
   Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004
   Barazzuol L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051772
   Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314
   Biasizzo M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.591803
   Bonora M, 2019, NAT REV CARDIOL, V16, P33, DOI 10.1038/s41569-018-0074-0
   Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082
   Brogan P, 2020, HEART, V106, P411, DOI 10.1136/heartjnl-2019-315925
   Burns JC, 2009, INDIAN J PEDIATR, V76, P71, DOI 10.1007/s12098-009-0031-3
   Chistiakov DA, 2018, ANN MED, V50, P121, DOI 10.1080/07853890.2017.1417631
   Clément M, 2019, ARTERIOSCL THROM VAS, V39, P1149, DOI 10.1161/ATVBAHA.118.311727
   Crother TR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00754
   de Souza-Pinto NC, 2001, CANCER RES, V61, P5378
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018
   Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697
   Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768
   Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102
   Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787
   Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757
   Huang FC, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7100166
   Huang SM, 2008, CIRC J, V72, P1583, DOI 10.1253/circj.CJ-08-0121
   KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kinaan M, 2015, MED PRIN PRACT, V24, P401, DOI 10.1159/000381643
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392
   Lee Y, 2015, ARTERIOSCL THROM VAS, V35, P2605, DOI 10.1161/ATVBAHA.115.306475
   Lee Y, 2012, CIRCULATION, V125, P1542, DOI 10.1161/CIRCULATIONAHA.111.072769
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li YB, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0790-6
   Lu M, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw047
   Marek-Iannucci S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46452-w
   MAURY CPJ, 1988, NEW ENGL J MED, V319, P1670
   McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484
   Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704
   Mohsin AA, 2019, J PHARMACOL EXP THER, V369, P282, DOI 10.1124/jpet.118.254300
   Morciano G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030892
   Newburger JW, 2016, J AM COLL CARDIOL, V67, P1738, DOI 10.1016/j.jacc.2015.12.073
   Niedra E, 2014, PEDIATR CARDIOL, V35, P89, DOI 10.1007/s00246-013-0746-9
   Noval Rivas M, 2020, NAT REV RHEUMATOL, V16, P391, DOI 10.1038/s41584-020-0426-0
   Noval Rivas M, 2017, ARTHRITIS RHEUMATOL, V69, P410, DOI 10.1002/art.39939
   Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040
   Peng S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00438
   Porritt RA, CIRC RES, V2021
   Porritt RA, 2020, ARTERIOSCL THROM VAS, V40, P802, DOI 10.1161/ATVBAHA.119.313863
   Ramadan A, 2017, ATHEROSCLEROSIS, V257, P288, DOI 10.1016/j.atherosclerosis.2017.01.017
   Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746
   Salmon M, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14058
   Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011
   Santini E, 2015, J NEUROSCI, V35, P16213, DOI 10.1523/JNEUROSCI.2246-15.2015
   Sasaki Y, 2017, INT HEART J, V58, P666, DOI 10.1536/ihj.17-246
   Sciarretta S, 2018, ANNU REV PHYSIOL, V80, P1, DOI 10.1146/annurev-physiol-021317-121427
   Senzaki H, 2006, ARCH DIS CHILD, V91, P847, DOI 10.1136/adc.2005.087437
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Shires SE, 2015, J MOL MED, V93, P253, DOI 10.1007/s00109-015-1254-6
   Soni PR, 2020, CURR RHEUMATOL REP, V22, DOI 10.1007/s11926-020-0882-1
   Stotland AB, 2020, J MOL CELL CARDIOL, V142, P1, DOI 10.1016/j.yjmcc.2020.03.011
   Sun Q, 2017, MOL MED, V23, P188, DOI 10.2119/molmed.2017.00077
   Tremoulet AH, 2019, J PEDIATR-US, V215, P107, DOI 10.1016/j.jpeds.2019.07.064
   Tsuji G, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0245-8
   Tumurkhuu G, 2016, CIRC RES, V119, pE76, DOI 10.1161/CIRCRESAHA.116.308362
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Vásquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301
   Wakita D, 2016, ARTERIOSCL THROM VAS, V36, P886, DOI 10.1161/ATVBAHA.115.307072
   Wang QL, 2018, METHODS MOL BIOL, V1732, P507, DOI 10.1007/978-1-4939-7598-3_32
   Wang XF, 2018, CANCER RES, V78, P4586, DOI 10.1158/0008-5472.CAN-17-3841
   Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070
   Wei YM, 2013, CELL PHYSIOL BIOCHEM, V31, P925, DOI 10.1159/000350111
   Weng KP, 2010, CIRC J, V74, P544, DOI 10.1253/circj.CJ-09-0664
   Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013
   Xiao L, 2017, REDOX BIOL, V11, P297, DOI 10.1016/j.redox.2016.12.022
   Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680
   Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014
   Zhang H, 2017, J IMMUNOL, V198, P2133, DOI 10.4049/jimmunol.1601293
   Zhang Y, 2020, CIRC RES, V127, P855, DOI 10.1161/CIRCRESAHA.120.316951
   Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709
NR 78
TC 32
Z9 35
U1 0
U2 25
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD SEP 22
PY 2021
VL 6
IS 18
AR e151981
DI 10.1172/jci.insight.151981
PG 20
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA UY7RX
UT WOS:000701717500002
PM 34403365
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Surmeier, DJ
AF Surmeier, D. James
TI Calcium, ageing, and neuronal vulnerability in Parkinson's disease
SO LANCET NEUROLOGY
LA English
DT Article
ID NIGRAL DOPAMINE NEURONS; MITOCHONDRIAL-DNA DELETIONS; SUBSTANTIA-NIGRA;
   FIRING PATTERN; HUMAN-BRAIN; FUNCTIONAL CONSEQUENCES; CHANNEL BLOCKERS;
   CA2+ CHANNELS; RISK; MECHANISMS
AB Parkinson's disease is a common neurodegenerative disorder of unknown cause. There is no cure or proven strategy for slowing the progression of the disease. Although there are signs of pathology in many brain regions, the core symptoms of Parkinson's disease are attributable to the selective degeneration of dopaminergic neurons in the substantia nigra pars compacta. A potential clue to the vulnerability of these neurons is their increasing reliance on Ca2+ channels to maintain autonomous activity with age. This reliance could pose a sustained metabolic stress on mitochondria, accelerating cellular ageing and death. The Ca2+ channels underlying autonomous activity in dopaminergic neurons are closely related to the L-type channels found in the heart and smooth muscle. Systemic administration of isradipine, a dihydropyridine blocker of L-type channels, forces dopaminergic neurons in rodents to revert to a juvenile, Ca2+-independent mechanism to generate autonomous activity. More importantly, reversion confers protection against toxins that produce experimental parkinsonism, pointing to a potential neuroprotective strategy for Parkinson's disease with a drug class that has been used safely in human beings for decades. These studies also suggest that, although genetic and environmental factors can hasten its onset, Parkinson's disease stems from a distinctive neuronal design common to all human beings, making its appearance simply a matter of time.
C1 Northwestern Univ, Feinburg Sch Med, Dept Physiol, Chicago, IL 60611 USA.
C3 Northwestern University; Feinberg School of Medicine
RP Surmeier, DJ (corresponding author), Northwestern Univ, Feinburg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.
EM j-surmeier@northwestern.edu
CR Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868
   Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003
   Bäckman L, 2000, AM J PSYCHIAT, V157, P635
   BEAN BP, 1991, AM J HYPERTENS, V4, pS406, DOI 10.1093/ajh/4.7.406S
   Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769
   Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3
   Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003
   Bonci A, 1998, J NEUROSCI, V18, P6693
   Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9
   BRUCKE T, 1995, J CEREBR BLOOD F MET, V15, P513
   CALABRESI P, 1994, J NEUROSCI, V14, P4871
   Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865
   Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437
   Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3
   Duke DC, 2006, NEUROGENETICS, V7, P139, DOI 10.1007/s10048-006-0033-5
   Eisenberg MJ, 2004, AM J MED, V116, P35, DOI 10.1016/j.amjmed.2003.08.027
   Fahn S, 2005, J NEUROL, V252, P37, DOI 10.1007/s00415-005-4008-5
   Fahn Stanley, 2004, NeuroRx, V1, P139, DOI 10.1602/neurorx.1.1.139
   FITTON A, 1990, DRUGS, V40, P31, DOI 10.2165/00003495-199040010-00004
   GERMAN DC, 1992, ANN NEUROL, V32, P667, DOI 10.1002/ana.410320510
   GERMAN DC, 1992, ANN NY ACAD SCI, V648, P42, DOI 10.1111/j.1749-6632.1992.tb24523.x
   Ghezzi D, 2005, EUR J HUM GENET, V13, P748, DOI 10.1038/sj.ejhg.5201425
   GRACE AA, 1984, J NEUROSCI, V4, P2866
   Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966
   Grobaski KC, 1997, BRIT J PHARMACOL, V120, P575, DOI 10.1038/sj.bjp.0700938
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Helton TD, 2005, J NEUROSCI, V25, P10247, DOI 10.1523/JNEUROSCI.1089-05.2005
   HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427
   HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925
   Huerta C, 2005, J NEUROL SCI, V236, P49, DOI 10.1016/j.jns.2005.04.016
   Hung AY, 2007, CURR OPIN NEUROL, V20, P477, DOI 10.1097/WCO.0b013e32826388d6
   Ishikawa T, 1996, J NUCL MED, V37, P1760
   ITO H, 1992, ANN NEUROL, V32, P543, DOI 10.1002/ana.410320410
   KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402
   Koschak A, 2001, J BIOL CHEM, V276, P22100, DOI 10.1074/jbc.M101469200
   Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778
   Kupsch A, 1996, BRAIN RES, V741, P185, DOI 10.1016/S0006-8993(96)00917-1
   Liang CL, 2007, EXP NEUROL, V203, P370, DOI 10.1016/j.expneurol.2006.08.015
   MATZUK MM, 1985, ANN NEUROL, V18, P552, DOI 10.1002/ana.410180507
   McMahon A, 1998, MOL BRAIN RES, V54, P56, DOI 10.1016/S0169-328X(97)00305-7
   Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718
   MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553
   Oka H, 2007, BRAIN, V130, P2425, DOI 10.1093/brain/awm174
   Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005
   Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100
   Ping HX, 1999, J NEUROPHYSIOL, V81, P977, DOI 10.1152/jn.1999.81.3.977
   Ping HX, 1996, NEUROREPORT, V7, P809, DOI 10.1097/00001756-199602290-00031
   Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007
   Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417
   RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445
   Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005
   Rodnitzky RL, 1999, DRUGS, V57, P845, DOI 10.2165/00003495-199957060-00001
   SAPER CB, 1991, ANN NEUROL, V29, P577, DOI 10.1002/ana.410290602
   Scholze A, 2001, MOL ENDOCRINOL, V15, P1211, DOI 10.1210/me.15.7.1211
   SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299
   Stark AK, 2004, CELL TISSUE RES, V318, P81, DOI 10.1007/s00441-004-0972-9
   Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903
   Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009
   Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417
   Tepper J M, 1998, Adv Pharmacol, V42, P694
   Ton TGN, 2007, PARKINSONISM RELAT D, V13, P165, DOI 10.1016/j.parkreldis.2006.08.011
   van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167
   WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3
   Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084
   Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001
   Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211
   ZIGMOND MJ, 1990, TRENDS NEUROSCI, V13, P290, DOI 10.1016/0166-2236(90)90112-N
NR 69
TC 225
Z9 260
U1 1
U2 23
PU LANCET LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1474-4422
J9 LANCET NEUROL
JI Lancet Neurol.
PD OCT
PY 2007
VL 6
IS 10
BP 933
EP 938
DI 10.1016/S1474-4422(07)70246-6
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 218SQ
UT WOS:000250035600023
PM 17884683
DA 2024-11-01
ER

PT J
AU Kärkkäinen, S
   Peuhkurinen, K
AF Karkkainen, Satu
   Peuhkurinen, Keijo
TI Genetics of dilated cardiomyopathy
SO ANNALS OF MEDICINE
LA English
DT Review
DE cardiomyopathy; dilated; gene
ID LAMIN A/C GENE; GIRDLE MUSCULAR-DYSTROPHY; DELTA-SARCOGLYCAN GENE;
   CONVERTING ENZYME GENE; TROPONIN-T MUTATION; MUSCLE LIM PROTEIN; CARDIAC
   ACTIN GENE; X-LINKED GENE; MITOCHONDRIAL-DNA; HEART-FAILURE
AB Dilated cardiomyopathy (DCM) is a myocardial disease characterized by dilatation and impaired systolic function of the left or both ventricles. The etiology of DCM is multifactorial, and many different clinical conditions can lead to the phenotype of DCM. During recent years it has become evident that genetic factors play an important role in the etiology and pathogenesis of idiopathic DCM. The genetics of DCM have been under intensive investigation lately, and thereby the knowledge on the genetic basis of DCM has increased rapidly. The genetic background of the disease seems to be relatively heterogeneous, and the disease-associated mutations concern mostly single families and only few affected patients. Disease-associated mutations have been detected e.g. in genes encoding sarcomere, cytoskeletal, and nuclear proteins, as well as proteins involved with regulation of Ca2+ metabolism. The mechanisms, by which mutations eventually result in clinical heart failure, are complex and not yet totally resolved. DCM causes considerable morbidity and mortality. Better knowledge of the genetic background and disease-causing mechanisms would probably help us in focusing early treatment on right subjects and potentially also developing new treatment modalities and improving cardiac outcome in the affected patients. This review deals with DCM of genetic origin.
C1 Kuopio Univ Hosp, Dept Internal Med, Kuopio 70211, Finland.
   Univ Kuopio, FIN-70211 Kuopio, Finland.
C3 Kuopio University Hospital; University of Eastern Finland; University of
   Eastern Finland
RP Kärkkäinen, S (corresponding author), Kuopio Univ Hosp, Dept Internal Med, POB 1777, Kuopio 70211, Finland.
EM satu.karkkainen@kuh.fi
CR ABELMANN WH, 1982, HOSP PRACT, V17, P17
   ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955
   Andersson B, 1996, J AM COLL CARDIOL, V28, P162, DOI 10.1016/0735-1097(96)00098-8
   Arbustini E, 2000, J AM COLL CARDIOL, V35, P1760, DOI 10.1016/S0735-1097(00)00650-1
   Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2
   Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200
   Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291
   Badorff C, 2000, J BIOL CHEM, V275, P11191, DOI 10.1074/jbc.275.15.11191
   BAGGER JP, 1984, BRIT HEART J, V52, P327
   Baidasseroni S, 2002, EUR HEART J, V23, P1692, DOI 10.1053/euhj.2001.3157
   Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6
   BELKIN AM, 1988, J CELL BIOL, V107, P545, DOI 10.1083/jcb.107.2.545
   BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904
   Bezzina C, 1999, CIRC RES, V85, P1206
   Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329
   Bies RD, 1997, J MOL CELL CARDIOL, V29, P3175, DOI 10.1006/jmcc.1997.0568
   Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385
   Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532
   BLONDHEIM DS, 1991, AM HEART J, V122, P763, DOI 10.1016/0002-8703(91)90523-K
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922
   Brodsky GL, 2000, CIRCULATION, V101, P473, DOI 10.1161/01.CIR.101.5.473
   Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3
   Chaouch M, 2003, NEUROMUSCULAR DISORD, V13, P60, DOI 10.1016/S0960-8966(02)00196-7
   CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564
   Cox GF, 1997, CURR OPIN CARDIOL, V12, P329
   DAdamo P, 1997, AM J HUM GENET, V61, P862, DOI 10.1086/514886
   Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4
   Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104
   DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307
   Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887
   Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368
   DURAND JB, 1995, CIRCULATION, V92, P3387, DOI 10.1161/01.CIR.92.12.3387
   EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637
   EVANS W, 1949, BRIT HEART J, V11, P68
   Fatkin D, 2002, PHYSIOL REV, V82, P945, DOI 10.1152/physrev.00012.2002
   Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302
   Fauchier L, 2000, EUR HEART J, V21, P306, DOI 10.1053/euhj.1999.1761
   Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1
   Feng JO, 2002, J AM COLL CARDIOL, V40, P1120, DOI 10.1016/S0735-1097(02)02126-5
   FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T
   Franz WM, 2000, LANCET, V355, P1781, DOI 10.1016/S0140-6736(00)02266-2
   Franz WM, 2001, LANCET, V358, P1627, DOI 10.1016/S0140-6736(01)06657-0
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Gavazzi A, 2000, AM J CARDIOL, V85, P1114, DOI 10.1016/S0002-9149(00)00706-2
   Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9
   Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6
   GERULL B, 2002, NAT GENET, V14, P14
   GILLUM RF, 1994, EPIDEMIOLOGY, V5, P383, DOI 10.1097/00001648-199405000-00026
   Goedel-Meinen L, 2001, AM J CARDIOL, V87, P809, DOI 10.1016/S0002-9149(00)01514-9
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   Gregori D, 2001, J APPL STAT, V28, P53, DOI 10.1080/02664760120011590
   Grünig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8
   Hanson EL, 2002, J CARD FAIL, V8, P28, DOI 10.1054/jcaf.2002.31157
   HART KA, 1987, HUM GENET, V75, P281, DOI 10.1007/BF00281075
   Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058
   Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0
   Hershberger RE, 2002, AM HEART J, V144, P1081, DOI 10.1067/mhj.2002.126737
   HOFMANN T, 1988, AM HEART J, V116, P1455, DOI 10.1016/0002-8703(88)90728-4
   Hung J, 1998, AM J CARDIOL, V82, P1301, DOI 10.1016/S0002-9149(98)00624-9
   Hutchison CJ, 2001, J CELL SCI, V114, P9
   Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448
   Jakobs PM, 2001, J CARD FAIL, V7, P249, DOI 10.1054/jcaf.2001.26339
   Johns DR, 1996, NAT MED, V2, P1065, DOI 10.1038/nm1096-1065
   Jung M, 1999, AM J HUM GENET, V65, P1068, DOI 10.1086/302580
   JUNKER A, 1993, CARDIOLOGY, V83, P14, DOI 10.1159/000175942
   Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304
   Kärkkäinen S, 2006, HEART, V92, P524, DOI 10.1136/hrt.2004.056721
   Kärkkäinen S, 2004, EUR J HEART FAIL, V6, P861, DOI 10.1016/j.ejheart.2004.04.017
   Kärkkäinen S, 2004, EUR HEART J, V25, P885, DOI 10.1016/j.ehj.2004.01.020
   Kärkkäinen S, 2003, J MOL MED-JMM, V81, P795, DOI 10.1007/s00109-003-0480-5
   KEELING PJ, 1995, BRIT HEART J, V73, P417
   KEOGH AM, 1990, AM J CARDIOL, V65, P903, DOI 10.1016/0002-9149(90)91434-8
   KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9
   Knöll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6
   Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575
   KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6
   Komajda M, 1999, EUR J HEART FAIL, V1, P121, DOI 10.1016/S1388-9842(99)00026-4
   Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750
   Kostin S, 1998, CELL TISSUE RES, V294, P449, DOI 10.1007/s004410051196
   KRAJINOVIC M, 1995, AM J HUM GENET, V57, P846
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461
   Li DX, 2001, CIRCULATION, V104, P2188, DOI 10.1161/hc4301.098285
   Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059
   MacLeod Heather M, 2003, BMC Med Genet, V4, P4, DOI 10.1186/1471-2350-4-4
   Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17
   Majamaa-Voltti Kirsi, 2002, BMC Cardiovasc Disord, V2, P12
   MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778
   MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A
   MarinGarcia J, 1996, CARDIOVASC RES, V31, P306
   Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500
   Mayosi BM, 1999, J MED GENET, V36, P796, DOI 10.1136/jmg.36.10.796
   McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB
   McNamara DM, 2004, J AM COLL CARDIOL, V44, P2019, DOI 10.1016/j.jacc.2004.08.048
   Messina DN, 1997, AM J HUM GENET, V61, P909, DOI 10.1086/514896
   Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145
   Mestroni L, 1999, J AM COLL CARDIOL, V34, P181, DOI 10.1016/S0735-1097(99)00172-2
   Mestroni L, 1997, CURR OPIN CARDIOL, V12, P303, DOI 10.1097/00001573-199705000-00012
   Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632
   MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201
   Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73
   Miyamoto Y, 2001, EUR HEART J, V22, P2284, DOI 10.1053/euhj.2001.2836
   Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027
   Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460
   Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2
   Mounkes LC, 2001, TRENDS CARDIOVAS MED, V11, P280, DOI 10.1016/S1050-1738(01)00126-8
   MUNTONI F, 1995, J CLIN INVEST, V96, P693, DOI 10.1172/JCI118112
   Muntoni F, 1997, HEART, V78, P608, DOI 10.1136/hrt.78.6.608
   MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304
   Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8
   Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1
   Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601
   Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195
   Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448
   Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908
   O'Toole L, 1998, J CARDIOVASC PHARM, V32, P988, DOI 10.1097/00005344-199812000-00017
   Olson TM, 1996, J CLIN INVEST, V97, P528, DOI 10.1172/JCI118445
   Olson TM, 2001, J MOL CELL CARDIOL, V33, P723, DOI 10.1006/jmcc.2000.1339
   Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750
   Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930
   OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434
   Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841
   Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200
   Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578
   SCHOELLER R, 1993, AM J CARDIOL, V71, P720, DOI 10.1016/0002-9149(93)91017-C
   Schönberger J, 2001, AM J HUM GENET, V69, P249, DOI 10.1086/321978
   SCHOWENGERDT KO, 1995, CURR OPIN CARDIOL, V10, P312, DOI 10.1097/00001573-199505000-00013
   Sébillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560
   *SGCD, LEID MUSC DYSTR PAG
   SIMPSON DG, 1994, J CELL PHYSIOL, V161, P89, DOI 10.1002/jcp.1041610112
   Sinagra G, 2001, Ital Heart J, V2, P280
   Siu BL, 1999, CIRCULATION, V99, P1022, DOI 10.1161/01.CIR.99.8.1022
   Sjöberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191
   Stefanelli CB, 2004, MOL GENET METAB, V83, P188, DOI 10.1016/j.ymgme.2004.04.013
   Stelken AM, 1996, J AM COLL CARDIOL, V27, P345, DOI 10.1016/0735-1097(95)00464-5
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   SUGRUE DD, 1992, ANN INTERN MED, V117, P117, DOI 10.7326/0003-4819-117-2-117
   SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3
   Sylvius N, 2001, AM J HUM GENET, V68, P241, DOI 10.1086/316929
   Takai E, 1999, AM J MED GENET, V86, P325, DOI 10.1002/(SICI)1096-8628(19991008)86:4<325::AID-AJMG5>3.0.CO;2-U
   Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250
   Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6
   Tesson F, 2000, EUR HEART J, V21, P1872, DOI 10.1053/euhj.2000.2245
   TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854
   Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867
   Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224
   VALANTINE HA, 1989, AM J CARDIOL, V63, P959, DOI 10.1016/0002-9149(89)90148-3
   Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3
   van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1
   vanderKooi AJ, 1997, AM J HUM GENET, V60, P891
   Vasile VC, 2006, MOL GENET METAB, V87, P169, DOI 10.1016/j.ymgme.2005.08.006
   Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021
   Vatta M, 2004, J AM COLL CARDIOL, V43, P811, DOI 10.1016/j.jacc.2003.09.052
   Verga L, 2003, VIRCHOWS ARCH, V443, P664, DOI 10.1007/s00428-003-0865-4
   Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193
   Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200
   WILLIAMS DG, 1985, BRIT HEART J, V54, P153
   Yoshida K, 1998, HUM MOL GENET, V7, P1129, DOI 10.1093/hmg/7.7.1129
   Zannad F, 2001, HYPERTENSION, V38, P1227, DOI 10.1161/hy1101.099484
   Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092
NR 162
TC 94
Z9 113
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0785-3890
EI 1365-2060
J9 ANN MED
JI Ann. Med.
PY 2007
VL 39
IS 2
BP 91
EP 107
DI 10.1080/07853890601145821
PG 17
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 159UH
UT WOS:000245892500002
PM 17453673
OA Bronze
DA 2024-11-01
ER

PT J
AU Maselli, RA
   Vázquez, J
   Schrumpf, L
   Arredondo, J
   Lara, M
   Strober, JB
   Pytel, P
   Wollmann, RL
   Ferns, M
AF Maselli, Ricardo A.
   Vazquez, Jessica
   Schrumpf, Leah
   Arredondo, Juan
   Lara, Marian
   Strober, Jonathan B.
   Pytel, Peter
   Wollmann, Robert L.
   Ferns, Michael
TI Presynaptic congenital myasthenic syndrome with altered synaptic vesicle
   homeostasis linked to compound heterozygous sequence variants in
   <i>RPH3A</i>
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE congenital myasthenic syndrome (CMS); presynaptic; rabphilin 3a; RPH3A
ID CORTICAL HYPEREXCITABILITY; RABPHILIN; SYNAPTOTAGMIN; PROTEIN; CA2+;
   EXOCYTOSIS; MUTATIONS; BINDING; DOMAIN
AB BackgroundMonogenic defects of synaptic vesicle (SV) homeostasis have been implicated in many neurologic diseases, including autism, epilepsy, and movement disorders. In addition, abnormal vesicle exocytosis has been associated with several endocrine dysfunctions.
   MethodsWe report an 11year old girl with learning disabilities, tremors, ataxia, transient hyperglycemia, and muscle fatigability responsive to albuterol sulfate. Failure of neuromuscular transmission was confirmed by single fiber electromyography. Electron microscopy of motor nerve terminals revealed marked reduction in SV density, double-membrane-bound sacs containing SVs, abundant endosomes, and degenerative lamellar bodies. The patient underwent whole exome sequencing (WES) and relevant sequence variants were expressed and studied in a mammalian cell line.
   ResultsChromosomal microarray studies and next generation sequencing (NGS) of mitochondrial DNA were unrevealing; however, NGS of genomic DNA showed two rare sequence variants in the gene encoding rabphilin 3a (RPH3A). The paternally inherited variant c.806G>A (p.Arg269Gln) involves a substitution of a conserved residue in the linker region, while the maternally inherited variant c.1390G>T (p.Val464Leu) involves a conserved amino acid substitution in the highly conserved C2A region. Expression studies revealed that p.Arg269Gln strongly impairs the binding of rabphilin 3a to 14-3-3, which is a proposed regulator of synaptic transmission and plasticity. In contrast, the binding of rabphilin 3a to 14-3-3 is only marginally impaired by p.Val464Leu; thus, the pathogenic role of p.Val464Leu remains unclear.
   ConclusionIn summary, we report a patient with a multisystem neurologic disorder and altered SV regulation attributed to defects in RPH3A, which grants further studies of this gene in human disorders of synaptic transmission.
C1 [Maselli, Ricardo A.; Vazquez, Jessica; Schrumpf, Leah; Arredondo, Juan; Lara, Marian] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA.
   [Strober, Jonathan B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Pytel, Peter; Wollmann, Robert L.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Ferns, Michael] Univ Calif Davis, Dept Anesthesiol & Pain Med, Sacramento, CA 95817 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California San Francisco;
   University of Chicago; University of California System; University of
   California Davis
RP Maselli, RA (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.
EM ramaselli@ucdavis.edu
OI Schrumpf, Leah/0000-0002-9797-4682; Ferns, Michael/0000-0002-1545-3024
FU National Institute of Neurological Disorders and Stroke [R01NS049117-01]
FX National Institute of Neurological Disorders and Stroke, Grant/Award
   Number: Grant R01NS049117-01
CR Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243
   CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667
   CHUNG SH, 1995, J BIOL CHEM, V270, P16714, DOI 10.1074/jbc.270.28.16714
   Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008
   Cossins J, 2013, BRAIN, V136, P944, DOI 10.1093/brain/awt010
   Coudevylle N, 2008, J BIOL CHEM, V283, P35918, DOI 10.1074/jbc.M804094200
   Deák F, 2006, EMBO J, V25, P2856, DOI 10.1038/sj.emboj.7601165
   Engel AG, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000105
   Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7
   Foletti DL, 2001, J NEUROSCI, V21, P5461, DOI 10.1523/JNEUROSCI.21-15-05461.2001
   Herrmann DN, 2014, AM J HUM GENET, V95, P332, DOI 10.1016/j.ajhg.2014.08.007
   Kato M, 1996, J BIOL CHEM, V271, P31775, DOI 10.1074/jbc.271.50.31775
   Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006
   Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072
   Schlüter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999
   Shen XM, 2017, ANN CLIN TRANSL NEUR, V4, P130, DOI 10.1002/acn3.387
   Shen XM, 2014, NEUROLOGY, V83, P2247, DOI 10.1212/WNL.0000000000001079
   SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061
   Staunton J, 2001, J NEUROSCI, V21, P9255, DOI 10.1523/JNEUROSCI.21-23-09255.2001
   Sun L, 2003, J BIOL CHEM, V278, P38301, DOI 10.1074/jbc.M212801200
   Tsuboi T, 2005, J BIOL CHEM, V280, P39253, DOI 10.1074/jbc.M507173200
NR 21
TC 8
Z9 8
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD MAY
PY 2018
VL 6
IS 3
BP 434
EP 440
DI 10.1002/mgg3.370
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA GK2HD
UT WOS:000435947300015
PM 29441694
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Hervé, D
   Touraine, P
   Verloes, A
   Miskinyte, S
   Krivosic, V
   Logeart, D
   Alili, N
   Laredo, JD
   Gaudric, A
   Houdart, E
   Metzger, JP
   Tournier-Lasserve, E
   Woimant, F
AF Herve, D.
   Touraine, P.
   Verloes, A.
   Miskinyte, S.
   Krivosic, V.
   Logeart, D.
   Alili, N.
   Laredo, J. D.
   Gaudric, A.
   Houdart, E.
   Metzger, J. P.
   Tournier-Lasserve, E.
   Woimant, F.
TI A hereditary moyamoya syndrome with multisystemic manifestations
SO NEUROLOGY
LA English
DT Article
ID FAMILIAL DILATED CARDIOMYOPATHY; DISEASE; HYPOGONADISM; SECONDARY;
   RELATIVES; CATARACT; LINKAGE; LOCUS
AB Objective: We report a detailed description of a family affected by a hereditary multisystem disorder associated with moyamoya syndrome.
   Methods: In this family case report, we evaluated 9 members of the same family originating from Algeria. Investigations included neuroimaging, cardiologic and ophthalmologic evaluation, hormonal testing, hemoglobin electrophoresis, chromosomal karyotyping, muscle biopsy for morphology, immunohistochemistry and enzyme assays, mtDNA mutation screening, and haplotype analysis of 2 loci previously linked to moyamoya, on chromosomes 10 (ACTA2) and 17.
   Results: Five males related through a maternal lineage were affected, suggesting an X-linked inheritance. Four of them had symptomatic moyamoya syndrome with an onset of acute neurologic manifestations between 4 and 32 years. Hypergonadotropic hypogonadism, azoospermia, short stature of postnatal onset (-2 to -4 SD in adulthood), premature graying of hair, and dysmorphism were present in all patients. The other features of the disease included early cataract in 4, dilated cardiomyopathy in 3, and partial growth hormone deficiency in 2 members. Muscle biopsy data did not reveal signs of a mitochondrial disorder. All conditions known to be associated with moyamoya syndrome such as Down syndrome, neurofibromatosis, and sickle cell disease were excluded. We also excluded linkage to the 2 loci previously reported to be involved in autosomal dominant syndromic and nonsyndromic moyamoya. Carrier females had normal phenotype and clinical history.
   Conclusions: These data strongly suggest that this family is affected by a hereditary moyamoya multisystem disorder with X-linked recessive pattern of inheritance. Neurology (R) 2010;75:259-264
C1 [Herve, D.; Alili, N.; Woimant, F.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neurol, Paris, France.
   [Krivosic, V.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Ophtalmol, Paris, France.
   [Logeart, D.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Cardiol, Paris, France.
   [Houdart, E.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Serv Neuroradiol, Paris, France.
   [Tournier-Lasserve, E.] Grp Hosp Lariboisiere Fernand Widal, AP HP, Genet Lab, Paris, France.
   [Touraine, P.] Grp Hosp Pitie Salpetriere, Dept Endocrinol & Med Reprod, AP HP, F-75634 Paris, France.
   [Metzger, J. P.] Grp Hosp Pitie Salpetriere, Serv Cardiol, AP HP, F-75634 Paris, France.
   [Verloes, A.] Hop Robert Debre, AP HP, UF Genet Clin, F-75019 Paris, France.
   [Miskinyte, S.; Tournier-Lasserve, E.] Univ Paris 07, INSERM, UMR S 740, F-75221 Paris 05, France.
   [Laredo, J. D.] Univ Paris Diderot, Serv Radiol Osteoarticulaire, Grp Hosp Lariboisiere Fernand Widal, AP HP, Paris, France.
   [Gaudric, A.] Univ Paris Diderot, Serv Ophtalmol, Grp Hosp Lariboisiere Fernand Widal, AP HP, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Lariboisiere-Fernand-Widal - APHP; Assistance Publique
   Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Sorbonne
   Universite; Sorbonne Universite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Robert-Debre - APHP; Universite Paris Cite; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Assistance
   Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital
   Universitaire Lariboisiere-Fernand-Widal - APHP; Universite Paris Cite;
   Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire
   Lariboisiere-Fernand-Widal - APHP
RP Hervé, D (corresponding author), Hop Lariboisiere, Serv Neurol, Ctr Reference Malad Vasc Rares Cerveau & Oeil CER, 2 Rue Ambroise Pare, F-75010 Paris, France.
EM dominique.herve@lrb.ap-hop-paris.fr
RI ; VERLOES, Alain/E-7287-2014; Tournier-Lasserve, Elisabeth/N-7134-2017
OI Herve, Dominique/0000-0001-6197-6275; VERLOES,
   Alain/0000-0003-4819-0264; Tournier-Lasserve,
   Elisabeth/0000-0002-3039-1677; Gaudric, Alain/0000-0002-2486-4722
FU Novartis; Alcon; Boston Scientific; MicroVention Inc.; Servier; Leducq
   [ANR-07-MRAR-002]; Programme Hospitalier de Recherche Clinique [AOM 06
   037]; INSERM
FX Dr. Herve and Dr. Touraine report no disclosures. Dr. Verloes has
   served/serves as an Associate Editor of the American Journal of Medical
   Genetics and on the editorial boards of the European Journal of Medical
   Genetics and Clinical Dysmorphology. Dr. Krivosic, Dr. Logeart, Dr.
   Alili, Dr. Laredo, and S. Miskinyte report no disclosures. Dr. Gaudric
   serves on the editorial board of the American Journal of Ophthalmology;
   has served on scientific advisory boards for Allergan, Inc., Novartis,
   and Thrombo Genics; receives royalties from the publication of OCT de la
   Macula (Elsevier, 2007); and has received research support (to his
   department) from Novartis and Alcon. Dr. Houdart has received funding
   for travel from Boston Scientific and MicroVention Inc. and serves as a
   consultant for Boston Scientific. Dr. Metzger has received funding for
   travel and speaker honoraria from Servier and has received gifts from
   Cordis Corporation, Abbott, and BIOTRONIK. Dr. Tournier-Lasserve
   receives research support from Leducq 07 CVD 02 (ANR-07-MRAR-002) and
   Programme Hospitalier de Recherche Clinique (AOM 06 037) and receives
   license fee and royalty payments from INSERM for patents related to
   Notch3 gene identification. Dr. Woimant reports no disclosures.
CR *CCNE, 1998, 58 CCNE NAT ETH ADV
   Coccia M, 2009, HUM MOL GENET, V18, P2643, DOI 10.1093/hmg/ddp206
   Francis PJ, 2002, J MED GENET, V39, P105, DOI 10.1136/jmg.39.2.105
   Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007
   Gursoy A, 2006, AM J MED GENET A, V140A, P895, DOI 10.1002/ajmg.a.31161
   Hankinson TC, 2008, J NEUROSURG-PEDIATR, V1, P211, DOI 10.3171/PED/2008/1/3/211
   HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054
   Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243
   Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307
   Jea A, 2005, PEDIATRICS, V116, pE694, DOI 10.1542/peds.2005-0568
   Kalina Maria, 2004, Hormones (Athens), V3, P204
   Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714
   Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0
   Lin TJ, 2005, J CLIN NEUROSCI, V12, P472, DOI 10.1016/j.jocn.2004.05.022
   Longo N, 2008, AM J MED GENET A, V146A, P361, DOI 10.1002/ajmg.a.31841
   MACKENZIE CA, 1990, ARCH DIS CHILD, V65, P232, DOI 10.1136/adc.65.2.232
   Mahon NG, 2005, ANN INTERN MED, V143, P108, DOI 10.7326/0003-4819-143-2-200507190-00009
   Matsumura Y, 2006, HEART, V92, P405, DOI 10.1136/hrt.2005.065474
   Mineharu Y, 2008, NEUROLOGY, V70, P2357, DOI 10.1212/01.wnl.0000291012.49986.f9
   Rosser TL, 2005, NEUROLOGY, V64, P553, DOI 10.1212/01.WNL.0000150544.00016.69
   Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6
   Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622
   STEWART PM, 1988, LANCET, V1, P1208
   Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930
NR 24
TC 36
Z9 36
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD JUL 20
PY 2010
VL 75
IS 3
BP 259
EP 264
DI 10.1212/WNL.0b013e3181e8ee3f
PG 6
WC Clinical Neurology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 628ES
UT WOS:000280097900013
PM 20644152
DA 2024-11-01
ER

PT J
AU Espinoza-Derout, J
   Hasan, KM
   Shao, XSM
   Jordan, MC
   Sims, C
   Lee, DL
   Sinha, S
   Simmons, Z
   Mtume, N
   Liu, YJ
   Roos, KP
   Sinha-Hikim, AP
   Friedman, TC
AF Espinoza-Derout, Jorge
   Hasan, Kamrul M.
   Shao, Xuesi M.
   Jordan, Maria C.
   Sims, Carl
   Lee, Desean L.
   Sinha, Satyesh
   Simmons, Zena
   Mtume, Norma
   Liu, Yanjun
   Roos, Kenneth P.
   Sinha-Hikim, Amiya P.
   Friedman, Theodore C.
TI Chronic intermittent electronic cigarette exposure induces cardiac
   dysfunction and atherosclerosis in apolipoprotein-E knockout mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
LA English
DT Article
DE atherosclerosis; cardiomyopathy; cardiovascular disease; inflammation;
   myocardial biology
ID HIGH-FAT DIET; OXIDATIVE STRESS; HEART-FAILURE; MITOCHONDRIAL
   DYSFUNCTION; CARDIOVASCULAR TOXICITY; MYOCARDIAL-INFARCTION; NICOTINE
   IMPLICATIONS; CIRCADIAN CLOCK; SKELETAL-MUSCLE; EXPRESSION
AB Electronic cigarettes (e-cigarettes), also known as electronic nicotine delivery systems, are a popular alternative to conventional nicotine cigarettes, both among smokers and those who have never smoked. In spite of the widespread use of e-cigarettes and the proposed detrimental cardiac and atherosclerotic effects of nicotine, the effects of e-cigarettes on these systems are not known. In this study, we investigated the cardiovascular and cardiac effects of e-cigarettes with and without nicotine in apolipoprotein-E knockout (ApoE(-/-)) mice. We developed an e-cigarette exposure model that delivers nicotine in a manner similar to that of human e-cigarettes users. Using commercially available e-cigarettes, bluCig PLUS, ApoE(-/-) mice were exposed to saline, e-cigarette without nicotine [e-cigarette (0%)], and e-cigarette with 2.4% nicotine [e-cigarette (2.4%)] aerosol for 12 wk. Echocardiographic data show that mice treated with e-cigarette (2.4%) had decreased left ventricular fractional shortening and ejection fraction compared with e-cigarette (0%) and saline. Ventricular transcriptomic analysis revealed changes in genes associated with metabolism, circadian rhythm, and inflammation in e-cigarette (2.4%)-treated ApoE(-/-) mice. Transmission electron microscopy revealed that cardiomyocytes of mice treated with e-cigarette (2.4%) exhibited ultrastructural abnormalities indicative of cardiomyopathy. Additionally, we observed increased oxidative stress and mitochondrial DNA mutations in mice treated with e-cigarette (2.4%). ApoE(-/-) mice on e-cigarette (2.4%) had also increased atherosclerotic lesions compared with saline aerosol-treated mice. These results demonstrate adverse effects of e-cigarettes on cardiac function in mice.
   NEW & NOTEWORTHY The present study is the first to show that mice exposed to nicotine electronic cigarettes (e-cigarettes) have decreased cardiac fractional shortening and ejection fraction in comparison with controls. RNA-seq analysis reveals a proinflammatory phenotype induced by e-cigarettes with nicotine. We also found increased atherosclerosis in the aortic root of mice treated with e-cigarettes with nicotine. Our results show that e-cigarettes with nicotine lead to detrimental effects on the heart that should serve as a warning to e-cigarette users and agencies that regulate them.
C1 [Espinoza-Derout, Jorge; Hasan, Kamrul M.; Shao, Xuesi M.; Sims, Carl; Lee, Desean L.; Sinha, Satyesh; Simmons, Zena; Mtume, Norma; Liu, Yanjun; Sinha-Hikim, Amiya P.; Friedman, Theodore C.] Charles R Drew Univ Med & Sci, Dept Internal Med, Div Endocrinol Metab & Mol Med, Los Angeles, CA 90059 USA.
   [Shao, Xuesi M.; Jordan, Maria C.; Sinha, Satyesh; Liu, Yanjun; Roos, Kenneth P.; Sinha-Hikim, Amiya P.; Friedman, Theodore C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 Charles R. Drew University of Medicine & Science; University of
   California System; University of California Los Angeles; University of
   California Los Angeles Medical Center; David Geffen School of Medicine
   at UCLA
RP Espinoza-Derout, J (corresponding author), Charles R Drew Univ Med & Sci, 1731 E 120th St LSRNE Bldg,Rm N220, Los Angeles, CA 90059 USA.
EM jorgeespinozaderout@cdrewu.edu
RI 刘, 严君/GZL-5764-2022; hasan, kamrul/HGV-0910-2022; Shao,
   Max/HKW-4718-2023; Jordan, Maria/HHN-5358-2022
FU Diversity-Promoting Institution Drug Abuse Research Program
   [R24DA017298]; National Institutes of Health (NIH) [5U54MD007598];
   California Tobacco-Related Disease Research Program Grant [251P003]; NIH
   [SC1-DK-104821]; National Institute on Minority Health and Health
   Disparities Grant [S21-MD000103]
FX This work was supported by Diversity-Promoting Institution Drug Abuse
   Research Program Grant R24DA017298; a pilot project grant and vouchers
   from Accelerating Excellence in Translational Science Grant 5U54MD007598
   from the National Institutes of Health (NIH); and a California
   Tobacco-Related Disease Research Program Grant 251P003. Y. Liu is
   supported by NIH Grant SC1-DK-104821. J. Espinoza-Derout has been
   supported in part by National Institute on Minority Health and Health
   Disparities Grant S21-MD000103.
CR Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726
   Akoumianakis I, 2017, CARDIOVASC RES, V113, P999, DOI 10.1093/cvr/cvx111
   Alzahrani T, 2018, AM J PREV MED, V55, P455, DOI 10.1016/j.amepre.2018.05.004
   Antoniewicz L, 2016, ATHEROSCLEROSIS, V255, P179, DOI 10.1016/j.atherosclerosis.2016.09.064
   Baglione Julie, 2006, V129, P83
   Ballinger SW, 1996, CANCER RES, V56, P5692
   Barrera-Vilarmau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021413
   Benowitz NL, 2017, NAT REV CARDIOL, V14, P447, DOI 10.1038/nrcardio.2017.36
   Benowitz NL, 2016, TRENDS CARDIOVAS MED, V26, P515, DOI 10.1016/j.tcm.2016.03.001
   Benowitz NL, 1997, J AM COLL CARDIOL, V29, P1422, DOI 10.1016/S0735-1097(97)00079-X
   Benowitz NL, 1997, BRIT J CLIN PHARMACO, V43, P259, DOI 10.1111/j.1365-2125.1997.00566.x
   Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107
   Bitzer ZT, 2018, CHEM RES TOXICOL, V31, P4, DOI 10.1021/acs.chemrestox.7b00116
   Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09
   Bonney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071493
   Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011
   Chong CR, 2017, CARDIOVASC RES, V113, P422, DOI 10.1093/cvr/cvx018
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   Colombo ES, 2013, CARDIOVASC TOXICOL, V13, P364, DOI 10.1007/s12012-013-9217-z
   Daniele G, 2014, DIABETES, V63, P2812, DOI 10.2337/db13-1130
   Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957
   Fowler PA, 2014, HUM REPROD, V29, P1471, DOI 10.1093/humrep/deu117
   Friedman TC, 2012, ENDOCRINOLOGY, V153, P5809, DOI 10.1210/en.2012-1750
   Ge F, 2012, J OBES, V2012, DOI 10.1155/2012/205648
   Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693
   Ghosh A, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0357-5
   Glantz SA, 2018, ANNU REV PUBL HEALTH, V39, P215, DOI 10.1146/annurev-publhealth-040617-013757
   Gonçalves N, 2016, AM J PHYSIOL-HEART C, V310, pH655, DOI 10.1152/ajpheart.00684.2015
   Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001
   Hajek P, 2019, NEW ENGL J MED, V380, P629, DOI 10.1056/NEJMoa1808779
   Herder C, 2017, HEART, V103, P63, DOI 10.1136/heartjnl-2015-309181
   Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296
   Hirabara SM, 2010, J CELL PHYSIOL, V222, P187, DOI 10.1002/jcp.21936
   Ho E, 2013, REDOX BIOL, V1, P483, DOI 10.1016/j.redox.2013.07.006
   Hoeks J, 2010, DIABETES, V59, P2117, DOI 10.2337/db10-0519
   Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3
   Husari A, 2016, NICOTINE TOB RES, V18, P613, DOI 10.1093/ntr/ntv169
   Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686
   Jacob P, 2011, J CHROMATOGR B, V879, P267, DOI 10.1016/j.jchromb.2010.12.012
   Koskivirta I, 2010, J BIOL CHEM, V285, P24487, DOI 10.1074/jbc.M110.136820
   Kristjansson AL, 2017, SUBST ABUS, V38, P473, DOI 10.1080/08897077.2017.1343218
   La Carrubba S, 2013, J CARDIOVASC ECHOGR, V23, P96, DOI 10.4103/2211-4122.127410
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee J, 2011, ATHEROSCLEROSIS, V215, P281, DOI 10.1016/j.atherosclerosis.2011.01.003
   Lee SR, 2017, FRONT BIOSCI-LANDMRK, V22, P1177, DOI 10.2741/4541
   Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x
   Lerner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116732
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067
   Lo Sasso G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0901-1
   Lukyanenko V, 2009, INT J BIOCHEM CELL B, V41, P1957, DOI 10.1016/j.biocel.2009.03.011
   Madrigal-Matute J, 2015, CARDIOVASC RES, V108, P139, DOI 10.1093/cvr/cvv204
   Mak KM, 2016, ANAT REC, V299, P613, DOI 10.1002/ar.23330
   Mandl A, 2011, CIRCULATION, V124, P31, DOI 10.1161/CIRCULATIONAHA.110.988303
   Mangubat M, 2012, J ENDOCRINOL, V212, P317, DOI 10.1530/JOE-11-0350
   Miedema MD, 2014, AM J CARDIOL, V114, P843, DOI 10.1016/j.amjcard.2014.06.012
   Mitchell T, 2013, AM J PHYSIOL-ENDOC M, V305, pE585, DOI 10.1152/ajpendo.00093.2013
   Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008
   MORTON LF, 1982, ATHEROSCLEROSIS, V42, P41, DOI 10.1016/0021-9150(82)90124-1
   Nelluri B, 2016, FUTUR CARDIOL, V12, P167, DOI 10.2217/fca.15.83
   Nojiri H, 2006, J BIOL CHEM, V281, P33789, DOI 10.1074/jbc.M602118200
   OECD, 2009, SER PEST, V39, P1
   Olfert IM, 2018, J APPL PHYSIOL, V124, P573, DOI 10.1152/japplphysiol.00713.2017
   Patenge N, 2017, METHODS MOL BIOL, V1644, P159, DOI 10.1007/978-1-4939-7187-9_14
   Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200
   Rapti K, 2017, FREE RADICAL BIO MED, V110, P206, DOI 10.1016/j.freeradbiomed.2017.06.010
   Redmann M, 2018, REDOX BIOL, V17, P59, DOI 10.1016/j.redox.2018.04.005
   Ren MY, 2012, MOL BIOL REP, V39, P9971, DOI 10.1007/s11033-012-1867-6
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004
   Schönfeld P, 2008, FREE RADICAL BIO MED, V45, P231, DOI 10.1016/j.freeradbiomed.2008.04.029
   Schroeder J, 2016, IMPLEMENT SCI, V11
   Shao XSM, 2018, J APPL PHYSIOL, V125, P1555, DOI 10.1152/japplphysiol.00357.2018
   Shao XSM, 2013, NICOTINE TOB RES, V15, P1248, DOI 10.1093/ntr/nts261
   Sinha-Hikim I, 2017, CELL TISSUE RES, V368, P159, DOI 10.1007/s00441-016-2536-1
   Sinha-Hikim I, 2014, ENDOCRINOLOGY, V155, P865, DOI 10.1210/en.2013-1795
   Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719
   Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114
   United States Environmental Protection Agency (USEPA), 1998, HLTH EFF TEST GUID O
   Wang C, 2017, ARTERIOSCL THROM VAS, V37, P53, DOI 10.1161/ATVBAHA.116.307264
   Wang ZY, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3102737
   Wu Y, 2015, NAT MED, V21, P373, DOI 10.1038/nm.3826
   Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504
   Zaragoza C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/497841
NR 84
TC 68
Z9 76
U1 0
U2 23
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6135
EI 1522-1539
J9 AM J PHYSIOL-HEART C
JI Am. J. Physiol.-Heart Circul. Physiol.
PD AUG
PY 2019
VL 317
IS 2
BP H445
EP H459
DI 10.1152/ajpheart.00738.2018
PG 15
WC Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular
   Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Physiology
GA IX4PV
UT WOS:000485669000020
PM 31172811
OA Green Published, Bronze
DA 2024-11-01
ER

PT J
AU Sengupta, D
   Sengupta, K
AF Sengupta, Duhita
   Sengupta, Kaushik
TI Lamin A and telomere maintenance in aging: Two to Tango
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE Lamin A; Telomere; HGPS; Aging
ID NUCLEAR-ENVELOPE; FIBROBLASTS; EXPRESSION; CHROMATIN; PROGERIN; CELLS;
   PROGRESSION; SENESCENCE; PERIPHERY; MUTANT
AB Lamin proteins which constitute the nuclear lamina in almost all higher eukaryotes, are mainly of two types A & B encoded by LMNA and LMNB1/B2 genes respectively. While lamin A remains the principal product of LMNA gene, variants like lamin C, C2 and A Delta 10 are also formed as alternate splice products. Role of lamin A in aging has been highlighted in recent times due to its association with progeroid or premature aging syndromes which is classified as a type of laminopathy. Progeria caused by accelerated accumulation of lamin A Delta 50 or progerin occurs due to a mutation in this LMNA gene leading to defects in post translational modification of lamin A. One of the most common and severe symptoms of progeroid laminopathy is accelerated cellular senescence or aging along with bone resorption, muscle weakness, lipodystrophy and cardiovascular disorders. On the other hand, progerin accumulation and telomere dysfunction merge as common traits in the process of chronological aging. Two major hallmarks of physiological aging in humans include loss of genomic integrity and telomere attrition which can result from defective laminar organization leading to deformed nuclear architecture and culminates into replicative senescence. This also adversely affects epigenetic landscape, mitochondrial dysfunction and several signalling pathways like DNA repair, mTOR, MAPK, TGF beta. In this review, we discuss the telomere-lamina interplay in the context of physiological aging and progeria.
C1 [Sengupta, Duhita; Sengupta, Kaushik] Saha Inst Nucl Phys, 1-AF Bidhannagar, Kolkata 700064, West Bengal, India.
   [Sengupta, Duhita; Sengupta, Kaushik] Homi Bhabha Natl Inst, Training Sch Complex, Mumbai 400094, India.
C3 Saha Institute of Nuclear Physics; Homi Bhabha National Institute
RP Sengupta, K (corresponding author), Saha Inst Nucl Phys, 1-AF Bidhannagar, Kolkata 700064, West Bengal, India.
EM kaushik.sengupta@saha.ac.in
CR Afilalo J, 2007, AM J PHYSIOL-HEART C, V293, pH1451, DOI 10.1152/ajpheart.01194.2006
   Ahn J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11684-x
   Arai Y, 2015, EBIOMEDICINE, V2, P1549, DOI 10.1016/j.ebiom.2015.07.029
   Arii J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75852-6
   Ashapkin VV, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00455
   Baek JH, 2015, HUM MOL GENET, V24, P1305, DOI 10.1093/hmg/ddu541
   Bajpai G, 2021, ELIFE, V10, DOI 10.7554/eLife.63976
   Bedrosian TA, 2021, EMBO J, V40, DOI 10.15252/embj.2020105819
   Benson EK, 2010, J CELL SCI, V123, P2605, DOI 10.1242/jcs.067306
   Bhattacharjee P, 2017, BBA-GEN SUBJECTS, V1861, P2598, DOI 10.1016/j.bbagen.2017.08.016
   Brunet A, 2021, NUCLEUS-PHILA, V12, P6, DOI 10.1080/19491034.2020.1868105
   Burla R, 2020, NUCLEUS-PHILA, V11, P205, DOI 10.1080/19491034.2020.1806661
   Casciaro F, 2018, AGING-US, V10, P2911, DOI 10.18632/aging.101599
   Cenni V, 2020, AGEING RES REV, V62, DOI 10.1016/j.arr.2020.101073
   Chen L, 2019, J GERONTOL A-BIOL, V74, P91, DOI 10.1093/gerona/gly223
   Chen RJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.333
   Cho S, 2019, DEV CELL, V49, P920, DOI 10.1016/j.devcel.2019.04.020
   Chojnowski A, 2015, ELIFE, V4, DOI 10.7554/eLife.07759
   Cohen-Carmon D, 2020, MOL NEUROBIOL, V57, P1768, DOI 10.1007/s12035-019-01839-8
   Das A, 2013, NUCLEUS-AUSTIN, V4, P410, DOI 10.4161/nucl.26873
   De Majo F, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022974118
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297
   Erdos MR, 2021, NAT MED, V27, P536, DOI 10.1038/s41591-021-01274-0
   Gonzalez-Suarez I, 2009, EMBO J, V28, P2414, DOI 10.1038/emboj.2009.196
   Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357
   Hartmann A, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.686320
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hilton BA, 2017, FASEB J, V31, P3882, DOI 10.1096/fj.201700014R
   Huang S, 2008, EXP CELL RES, V314, P82, DOI 10.1016/j.yexcr.2007.08.004
   Katsumata K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006304
   Kawamura T, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5566880
   Koblan LW, 2021, NATURE, V589, P608, DOI 10.1038/s41586-020-03086-7
   Komari CJ, 2020, DNA REPAIR, V96, DOI 10.1016/j.dnarep.2020.102975
   Kronenberg-Tenga R, 2021, J CELL SCI, V134, DOI 10.1242/jcs.256156
   Kychygina A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92631-z
   Lacavalla MA, 2021, EUR J HISTOCHEM, V65, DOI 10.4081/ejh.2021.3229
   Li W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010062
   Li YH, 2019, AGING CELL, V18, DOI 10.1111/acel.12979
   Margalef P, 2018, CELL, V172, P439, DOI 10.1016/j.cell.2017.11.047
   Martins F, 2020, AGING CELL, V19, DOI 10.1111/acel.13143
   Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205
   McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269
   Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898
   Misteli T, 2021, CELL, V184, P293, DOI 10.1016/j.cell.2020.12.029
   Morgan RG, 2019, J MOL CELL CARDIOL, V127, P74, DOI 10.1016/j.yjmcc.2018.11.014
   Mukherjee C, 2021, SOFT MATTER, V17, P6787, DOI 10.1039/d1sm00293g
   Naetar N, 2021, ELIFE, V10, DOI 10.7554/eLife.63476
   Ottaviani A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000394
   Pan XM, 2020, FASEB J, V34, P7905, DOI 10.1096/fj.201903048RR
   Ranade D, 2019, BMC MOL CELL BIOL, V20, DOI 10.1186/s12860-019-0192-5
   Rauschert I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175953
   Röhrl JM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010153
   Rogerson C, 2021, CELL DEATH DIFFER, V28, P1849, DOI 10.1038/s41418-020-00712-9
   Romero-Bueno R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070664
   Sapra KT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20049-8
   Skoczynska A, 2015, MENOPAUSE REV, V14, P53, DOI 10.5114/pm.2015.49532
   Srivastava LK, 2021, J CELL SCI, V134, DOI 10.1242/jcs.248559
   Stroik S, 2020, NUCLEIC ACIDS RES, V48, P4960, DOI 10.1093/nar/gkaa199
   Tedone E, 2019, AGING CELL, V18, DOI 10.1111/acel.12859
   Travina AO, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073293
   Tsoukalas D, 2021, INT J MOL MED, V48, DOI 10.3892/ijmm.2021.5032
   Vautrot V, 2016, HUM MUTAT, V37, P280, DOI 10.1002/humu.22945
   Wheaton K, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00659-16
   Willaume S, 2021, GENES-BASEL, V12, DOI 10.3390/genes12040552
   Wood AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6467
   Yu KR, 2013, J CELL SCI, V126, P5422, DOI 10.1242/jcs.133314
   Zhang J, 2020, AGING CELL, V19, DOI 10.1111/acel.13215
   Zorin V, 2019, AGING-US, V11, P4536, DOI 10.18632/aging.102067
   Zwerger M, 2015, J CELL SCI, V128, P3607, DOI 10.1242/jcs.171843
NR 70
TC 6
Z9 6
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0027-5107
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL-DEC
PY 2022
VL 825
AR 111788
DI 10.1016/j.mrfmmm.2022.111788
EA JUN 2022
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA 2C4RX
UT WOS:000810858700001
OA Bronze
DA 2024-11-01
ER

PT J
AU Sonkodi, B
AF Sonkodi, Balazs
TI Miswired Proprioception in Amyotrophic Lateral Sclerosis in Relation to
   Pain Sensation (and in Delayed Onset Muscle Soreness)-Is Piezo2
   Channelopathy a Principal Transcription Activator in Proprioceptive
   Terminals Besides Being the Potential Primary Damage?
SO LIFE-BASEL
LA English
DT Article
DE amyotrophic lateral sclerosis; Piezo2 channelopathy; transcription;
   pain; WDR neuron; aging
ID OXIDATIVE STRESS; MECHANICAL HYPERALGESIA; ANALYSES IDENTIFY;
   NEURAL-CONTROL; MITOCHONDRIAL; EXERCISE; GRANULES; MECHANOTRANSDUCTION;
   PHOSPHORYLATION; CLASSIFICATION
AB Amyotrophic lateral sclerosis (ALS) is a lethal neurodegenerative multisystem disease, with an unknown pathomechanism, resulting in progressive motoneuron loss. In 90-95% of cases, ALS is sporadic, but close to 10% of ALS is familial with inherited gene mutations from family members. Recently, a non-contact dying-back injury mechanism theory of ALS postulated that irreversible intrafusal proprioceptive terminal degeneration induces the non-resolving progressive impairment of the proprioceptive circuitry, leading to motoneuron loss, progressive overloading and depletion of the central nervous system, and eventually to death. The current manuscript proposes that irreversible Piezo2 channelopathy of this proprioceptive terminal degeneration induces constantly activated and dysregulated transcription process in ALS, providing access to underlying pathogenic gene variants and letting the cell-type-specific noncoding DNA mutations become more apparent. This opinion piece proposes that ALS genes are associated with the Piezo2 channelopathy mechanism both downstream and upstream, and their mutations, along with the aging process, could explain the non-contact dying-back injury mechanism theory of ALS. Moreover, irreversible microinjury of the Piezo2 ion channel could be the primary damage or the root cause of death in ALS. Finally, the current manuscript also depicts the pathomechanism as to why ALS is considered a painless disease.
C1 [Sonkodi, Balazs] Hungarian Univ Sports Sci, Dept Hlth Sci & Sport Med, H-1123 Budapest, Hungary.
RP Sonkodi, B (corresponding author), Hungarian Univ Sports Sci, Dept Hlth Sci & Sport Med, H-1123 Budapest, Hungary.
EM bsonkodi@gmail.com
RI Sonkodi, Balazs/ABG-7605-2021
OI Sonkodi, Balazs/0000-0003-1267-1306
CR ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P380, DOI 10.1113/jphysiol.1952.sp004755
   Aguiar P, 2010, J NEUROPHYSIOL, V104, P1155, DOI 10.1152/jn.00834.2009
   Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x
   BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219
   Bewick GS, 2021, J PHYSIOL-LONDON, V599, P2781, DOI 10.1113/JP281624
   Borghi SM, 2022, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.734091
   Borghi SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162267
   Brownstone RM, 2018, J NEUROPHYSIOL, V119, P1782, DOI 10.1152/jn.00331.2017
   Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003
   CAMUS G, 1994, INTENS CARE MED, V20, P602, DOI 10.1007/BF01705731
   Cartoni R, 2009, EXP NEUROL, V218, P268, DOI 10.1016/j.expneurol.2009.05.003
   Case LK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20939-5
   Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048
   Chang WP, 2020, J NEUROPHYSIOL, V124, P1824, DOI 10.1152/jn.00502.2020
   Chen YX, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12781
   Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y
   CHUNG JM, 1986, J NEUROPHYSIOL, V56, P308, DOI 10.1152/jn.1986.56.2.308
   Close GL, 2004, EUR J APPL PHYSIOL, V91, P615, DOI 10.1007/s00421-003-1012-2
   Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x
   Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812
   Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Del Rosario J.S., 2021, BIORXIV, DOI [10.1085/jgp.202213164, DOI 10.1085/JGP.202213164]
   Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999
   dos Santos RS, 2020, J NEUROCHEM, V155, P29, DOI 10.1111/jnc.15006
   Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014
   Duchateau J, 2016, J EXP BIOL, V219, P197, DOI 10.1242/jeb.123158
   Duchateau J, 2014, J APPL PHYSIOL, V116, P1418, DOI 10.1152/japplphysiol.00002.2013
   Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673
   Ellefsen KL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0514-3
   Espino CM, 2022, ELIFE, V11, DOI 10.7554/eLife.79917
   Fang Y, 2022, FRONT CARDIOVASC MED, V9, DOI 10.3389/fcvm.2022.842885
   Fernández-Trillo J, 2020, J NEUROSCI, V40, P8976, DOI 10.1523/JNEUROSCI.0247-20.2020
   GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E
   Greco M, 2003, FASEB J, V17, P1706, DOI 10.1096/fj.02-1009fje
   Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660
   Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949
   Held A, 2019, J NEUROSCI, V39, P2347, DOI 10.1523/JNEUROSCI.1771-18.2019
   Hentilä J, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13069
   Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194
   Hody S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00536
   Holt JR, 2021, ELIFE, V10, DOI [10.7554/eLife.65415, 10.7554/eLife.65415.sa1, 10.7554/eLife.65415.sa2]
   HORTOBAGYI T, 1990, EUR J APPL PHYSIOL, V60, P395, DOI 10.1007/BF00713506
   Hu X, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.770808
   Huang JQ, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02954-8
   Izumikawa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06953-y
   Jagaraj CJ, 2021, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.581950
   Janes K, 2013, PAIN, V154, P2432, DOI 10.1016/j.pain.2013.07.032
   Jia ZF, 2016, J BIOL CHEM, V291, P9087, DOI 10.1074/jbc.M115.692384
   Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173
   Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003
   Komka Z, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0277978
   Kubo A, 2012, NEUROSCI RES, V73, P56, DOI 10.1016/j.neures.2012.02.005
   Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896
   Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5
   Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111
   Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701
   Martins JR, 2016, PFLUG ARCH EUR J PHY, V468, P1197, DOI 10.1007/s00424-016-1811-z
   Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00043
   Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007
   McGaraughty S, 2008, J NEUROPHYSIOL, V100, P3158, DOI 10.1152/jn.90768.2008
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971
   Mendelsohn AI, 2015, NEURON, V87, P111, DOI 10.1016/j.neuron.2015.05.045
   Metodiewa D, 1999, NEUROTOX RES, V1, P197, DOI 10.1007/BF03033290
   Milone M, 2012, NEUROLOGY, V78, P1612, DOI 10.1212/WNL.0b013e3182563c46
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Misko AL, 2012, J NEUROSCI, V32, P4145, DOI 10.1523/JNEUROSCI.6338-11.2012
   Mukhtar E, 2014, MOL CANCER THER, V13, P275, DOI 10.1158/1535-7163.MCT-13-0791
   Murase S, 2010, J NEUROSCI, V30, P3752, DOI 10.1523/JNEUROSCI.3803-09.2010
   Narayanan P, 2018, ELIFE, V7, DOI [10.7554/elife.32346, 10.7554/eLife.32346]
   Nicolas A, 2018, NEURON, V97, P1268, DOI 10.1016/j.neuron.2018.02.027
   Nilsson MI, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020040
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   Onate J., 2019, RETURN SPORT ACL REC
   Oswald DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044574
   Ota H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065751
   Papa S, 1996, BBA-BIOENERGETICS, V1276, P87, DOI 10.1016/0005-2728(96)00077-1
   Pareyson D, 2013, LANCET NEUROL, V12, P1011, DOI 10.1016/S1474-4422(13)70158-3
   Pidoux L, 2022, FRONT MOL NEUROSCI, V15, DOI 10.3389/fnmol.2022.880651
   Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007
   PRICE DD, 1977, J INVEST DERMATOL, V69, P167, DOI 10.1111/1523-1747.ep12497942
   Puja G, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.764396
   Radwani H, 2016, J PHYSIOL-LONDON, V594, P6607, DOI 10.1113/JP272725
   Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038
   Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980
   Ridone P, 2020, J GEN PHYSIOL, V152, DOI 10.1085/jgp.201912515
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   Rode B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00429-3
   Roh J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113834
   Romero LO, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16816-2
   Ryan M, 2019, JAMA NEUROL, V76, P1367, DOI 10.1001/jamaneurol.2019.2044
   Sabado J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/852163
   Scuteri A, 2009, NEUROTOXICOLOGY, V30, P312, DOI 10.1016/j.neuro.2009.01.003
   Seki S, 2019, J NEUROSCI, V39, P8798, DOI 10.1523/JNEUROSCI.1214-19.2019
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sonkodi B, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231911940
   Sonkodi B, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms231911117
   Sonkodi B, 2022, METABOLITES, V12, DOI 10.3390/metabo12090857
   Sonkodi B, 2022, BIOMOLECULES, V12, DOI 10.3390/biom12091207
   Sonkodi B, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23169046
   Sonkodi B, 2022, J FUNCT MORPHOL KIN, V7, DOI 10.3390/jfmk7020043
   Sonkodi B, 2022, J MOL NEUROSCI, V72, P1598, DOI 10.1007/s12031-022-02015-9
   Sonkodi B, 2022, OPEN MED-WARSAW, V17, P397, DOI 10.1515/med-2022-0444
   Sonkodi B, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10081867
   Sonkodi B, 2021, LIFE-BASEL, V11, DOI 10.3390/life11050443
   Sonkodi B, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11010108
   Sonkodi B, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9030212
   Suchyna TM, 2017, PROG BIOPHYS MOL BIO, V130, P244, DOI 10.1016/j.pbiomolbio.2017.07.011
   Szczot M, 2021, ANNU REV BIOCHEM, V90, P507, DOI 10.1146/annurev-biochem-081720-023244
   Szczot M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat9892
   Thorburn D.R., 1993, GeneReviews
   Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778
   van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622
   Vaughan SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34510-8
   Vaughan SK, 2015, J COMP NEUROL, V523, P2477, DOI 10.1002/cne.23848
   Vina J, 2006, FREE RADICAL RES, V40, P111, DOI 10.1080/10715760500405778
   Vincent AM, 2004, ENDOCR REV, V25, P612, DOI 10.1210/er.2003-0019
   Vincent JA, 2016, NEUROBIOL DIS, V95, P54, DOI 10.1016/j.nbd.2016.07.004
   Vincent JA, 2015, J ANAT, V227, P221, DOI 10.1111/joa.12312
   Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2
   Volkers L, 2015, PFLUG ARCH EUR J PHY, V467, P95, DOI 10.1007/s00424-014-1578-z
   Walczak J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14964-y
   Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452
   Wilkinson KA, 2022, CURR OPIN NEUROBIOL, V74, DOI 10.1016/j.conb.2022.102542
   Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406
   Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162
   Woo SH, 2014, NATURE, V509, P622, DOI 10.1038/nature13251
   Xu X, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126429
   Ye YY, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31103-y
   Zechini L, 2022, CURR BIOL, V32, P3584, DOI 10.1016/j.cub.2022.06.041
   Zeng WZ, 2018, SCIENCE, V362, P464, DOI 10.1126/science.aau6324
   Zhang S, 2022, NEURON, V110, P992, DOI 10.1016/j.neuron.2021.12.019
NR 133
TC 12
Z9 12
U1 0
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-1729
J9 LIFE-BASEL
JI Life-Basel
PD MAR
PY 2023
VL 13
IS 3
AR 657
DI 10.3390/life13030657
PG 18
WC Biology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Microbiology
GA C0AQ1
UT WOS:000958655100001
PM 36983813
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Terawaki, Y
   Nomiyama, T
   Kawanami, T
   Hamaguchi, Y
   Takahashi, H
   Tanaka, T
   Murase, K
   Nagaishi, R
   Tanabe, M
   Yanase, T
AF Terawaki, Yuichi
   Nomiyama, Takashi
   Kawanami, Takako
   Hamaguchi, Yuriko
   Takahashi, Hiroyuki
   Tanaka, Tomoko
   Murase, Kunitaka
   Nagaishi, Ryoko
   Tanabe, Makito
   Yanase, Toshihiko
TI Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima
   formation after vascular injury
SO CARDIOVASCULAR DIABETOLOGY
LA English
DT Article
DE DPP-4 inhibitor; Linagliptin; Neointima formation; VSMC proliferation
ID TYPE-2 DIABETES-MELLITUS; GLP-1 RECEPTOR AGONIST; CARDIOVASCULAR SAFETY;
   MITOCHONDRIAL-DNA; SOMATIC MUTATION; POOLED ANALYSIS; SITAGLIPTIN;
   EFFICACY; DISEASE; CELLS
AB Background: Recently, glucagon-like peptide-1 (GLP-1)-based therapy, including dipeptidyl peptidase-4 (DPP-4) inhibitors and GLP-1 receptor agonists, has emerged as one of the most popular anti-diabetic therapies. Furthermore, GLP-1-based therapy has attracted increased attention not only for its glucose-lowering ability, but also for its potential as a tissue-protective therapy. In this study, we investigated the vascular-protective effect of the DPP-4 inhibitor, linagliptin, using vascular smooth muscle cells (VSMCs).
   Methods: Six-week-old male C57BL/6 mice were divided into control (n = 19) and linagliptin (3 mg/kg/day, n = 20) treated groups. Endothelial denudation injuries were induced in the femoral artery at 8 weeks of age, followed by evaluation of neointima formation at 12 weeks. To evaluate cell proliferation of rat aortic smooth muscle cells, a bromodeoxyuridine (BrdU) incorporation assay was performed.
   Results: Linagliptin treatment reduced vascular injury-induced neointima formation, compared with controls (p < 0.05). In these non-diabetic mice, the body weight and blood glucose levels did not change after treatment with linagliptin. Linagliptin caused an approximately 1.5-fold increase in serum active GLP-1 concentration, compared with controls. In addition, the vascular injury-induced increase in the oxidative stress marker, urinary 8-OHdG, was attenuated by linagliptin treatment, though this attenuation was not statistically significant (p = 0.064). Moreover, linagliptin did not change the serum stromal cell-derived factor-1 alpha (SDF-1 alpha) or the serum platelet-derived growth factor (PDGF) concentration. However, linagliptin significantly reduced in vitro VSMC proliferation.
   Conclusion: Linagliptin attenuates neointima formation after vascular injury and VSMC proliferation beyond the glucose-lowering effect.
C1 [Terawaki, Yuichi; Nomiyama, Takashi; Kawanami, Takako; Hamaguchi, Yuriko; Takahashi, Hiroyuki; Tanaka, Tomoko; Murase, Kunitaka; Nagaishi, Ryoko; Tanabe, Makito; Yanase, Toshihiko] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, Fukuoka 8140180, Japan.
C3 Fukuoka University
RP Nomiyama, T (corresponding author), Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.
EM tnomiyama@fukuoka-u.ac.jp
OI Tanaka, Tomoko/0000-0002-3826-3653
FU Boehringer Ingelheim; Eli Lilly
FX YT received a travel grant from Boehringer Ingelheim. TN received a
   lecture fee from Boehringer Ingelheim and Eli Lilly. TY received a
   lecture fee from Eli Lilly. The other authors have no competing
   interests.
CR Albiero M, 2013, VASC PHARMACOL, V58, P253, DOI 10.1016/j.vph.2013.01.003
   Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694
   Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256
   Ceriello A, 2008, DIABETES VASC DIS RE, V5, P260, DOI 10.3132/dvdr.2008.038
   Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006
   Doupis J, 2014, DRUG DES DEV THER, V8, P431, DOI 10.2147/DDDT.S59523
   Engel SS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-3
   Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855
   Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187
   Golightly LK, 2012, CLIN PHARMACOKINET, V51, P501, DOI 10.2165/11632930-000000000-00000
   Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Ishibashi Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-125
   Johansen OE, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-3
   Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029
   Kröller-Schön S, 2012, CARDIOVASC RES, V96, P140, DOI 10.1093/cvr/cvs246
   Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707
   Lim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035007
   Murohara T, 2012, J AM COLL CARDIOL, V59, P277, DOI 10.1016/j.jacc.2011.09.050
   Nomiyama T, 2004, ANN NY ACAD SCI, V1011, P193, DOI 10.1196/annals.1293.020
   Nomiyama T, 2004, BIOCHEM BIOPH RES CO, V320, P639, DOI 10.1016/j.bbrc.2004.06.019
   Nomiyama T, 2002, DIABETOLOGIA, V45, P1577, DOI 10.1007/s00125-002-0893-7
   Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169
   Nomiyama T, 2012, DIABETES RES CLIN PR, V95, pE27, DOI 10.1016/j.diabres.2011.08.016
   Nomiyama T, 2009, CIRCULATION, V119, P577, DOI 10.1161/CIRCULATIONAHA.108.822056
   Ogawa M, 2006, IND HEALTH, V44, P179, DOI 10.2486/indhealth.44.179
   Pratley Richard E, 2008, Rev Diabet Stud, V5, P73, DOI 10.1900/RDS.2008.5.73
   Round EM, 2014, DRUG AGING, V31, P203, DOI 10.1007/s40266-014-0155-7
   Scheen AJ, 2004, DIABETES CARE, V27, P1840, DOI 10.2337/diacare.27.7.1840
   Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684
   Takai S, 2014, J PHARMACOL SCI, V125, P386, DOI 10.1254/jphs.14052FP
   Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F
   Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958
   Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052
   von Eynatten M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-60
   White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889
   Zeng ZP, 2013, CURR MED RES OPIN, V29, P921, DOI 10.1185/03007995.2013.805123
NR 37
TC 40
Z9 43
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1475-2840
J9 CARDIOVASC DIABETOL
JI Cardiovasc. Diabetol.
PD NOV 19
PY 2014
VL 13
AR 154
DI 10.1186/s12933-014-0154-3
PG 8
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism
GA AW1QP
UT WOS:000346064700002
PM 25407968
OA Green Published, gold
DA 2024-11-01
ER

PT J
AU Ponsonnard, S
AF Ponsonnard, Sebastien
TI Hereditary spastic paraplegia
SO ANASTHESIOLOGIE & INTENSIVMEDIZIN
LA English
DT Article
DE Strumpell-Lorrain disease (designating one type of HSP called SPG4);
   familial spastic paraplegia
AB Disease summary: Strumpell-Lorrain disease or hereditary spastic paraplegia describes a group of rare and heterogeneous genetic neurological disorders [1]. In Europe, HSP is estimated to affect 1 to 9 per 100,000 individuals [2-6].
   HSP is an inherited neurodegenerative group of disorders which affects primarily the corticospinal tract with a distal to proximal retrograde axonal degeneration. For this reason, in the so-called pure HSP cases, the clinical picture is characterised mainly by a progressive spasticity of the lower limbs leading to paraparesis or paraplegia affecting several members of the same family. Many patients experience only stiffness and weakening of the leg muscles; a few require the use of a wheelchair. The progression of the disease to the rest of the corticospinal tracts, to peripheral nerves, the cerebellum or the brain explains the other additional symptoms commonly found in complicated or complex HSP cases: cerebellar ataxia, dysarthria, extrapyramidal disorder, mental retardation, dementia, epilepsy, retinopathy, deafness, axonal or demyelinating neuropathy and eventually systemic signs. The clinical diagnosis is based on four criteria [7]: exclusion of differential diagnoses, compatible family history (although not obligatory), progressive disturbance of gait and corticospinal tract deficits in the lower limbs with hyperreflexia.
   Spinal cord atrophy is a common finding in HSP [8]. Conventional brain magnetic resonance imaging findings are usually normal in patients with HSP, but multiple diffusion tensor indices can be disrupted [9]. It can disclose different findings in complicated or complex HSP, such as thin corpus callosum, leukoencephalopathy and hyperintensity sign in the corticospinal tract.
   Diagnosis must be confirmed by DNA analysis. The most commonly involved genes are the SPG4 and SPG3A which encode for the proteins spastin and atlastin, respectively. Transmission of HSP can be autosomal dominant, autosomal recessive, X-linked or maternally inherited (mitochondrial inheritance) [10]. Mutations in more than 80 distinct loci and more than 50 mutated gene products have been identified in patients with HSP [11,12]. The main pathogenic mechanisms underlying the clinical phenotype include membrane trafficking disturbance, impairment of organelle transport, morphogenesis and distribution in neuronal cells, and mitochondrial dysfunction. Membrane trafficking and organelle morphogenesis and distribution are important for axonal development, maintenance and degeneration [1,13].
   There is no specific pharmacological treatment. Treatment is symptomatic and includes physical therapy, benzodiazepines, oral or intrathecal baclofen [14] and injections of botulinum toxin [15] to reduce spasticity. By blocking potassium channels, prolonging action potentials and thereby increasing neurotransmitter release at the neuromuscular junction, dalfampridine may be useful in the treatment of HSP [16,17].
C1 [Ponsonnard, Sebastien] Polyclin Limoges, Limoges, France.
RP Ponsonnard, S (corresponding author), Polyclin Limoges, Limoges, France.
EM sponsonnard@gmail.com
RI Ponsonnard, Sebastien/AAP-9995-2021
OI Ponsonnard, Sebastien/0000-0002-7972-935X
CR Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897
   Franco-Hernández JA, 2013, REV BRAS ANESTESIOL, V63, P113, DOI [10.1016/j.bjane.2012.05.002, 10.1016/S0034-7094(13)70203-4]
   Béreau M, 2015, J NEUROL, V262, P1285, DOI 10.1007/s00415-015-7707-6
   Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946
   Braschinsky M, 2009, NEUROEPIDEMIOLOGY, V32, P89, DOI 10.1159/000177033
   CAPRINI JA, 1991, SEMIN THROMB HEMOST, V17, P304
   Dallman M., 2010, INT STUD J NURSE ANE, V9, P28
   Deruddre S, 2006, ANESTH ANALG, V102, P1910, DOI 10.1213/01.ANE.0000215148.29795.70
   Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056
   Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507
   Hedera P, 2005, NEURORADIOLOGY, V47, P730, DOI 10.1007/s00234-005-1415-3
   HOUSTON T, 1984, BRIT J ANAESTH, V56, P1139, DOI 10.1093/bja/56.10.1139
   Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006
   King AM, 2012, J MED TOXICOL, V8, P314, DOI 10.1007/s13181-012-0248-9
   KOMULAINEN A, 1991, AM J VET RES, V52, P585
   Kunisawa Takayuki, 2002, Masui, V51, P64
   Lamore R., 2010, P & T, V35, P665
   Ma HC, 2005, ACTA PHARMACOL SIN, V26, P181, DOI 10.1111/j.1745-7254.2005.00521.x
   Margetis K, 2014, CLIN NEUROL NEUROSUR, V123, P142, DOI 10.1016/j.clineuro.2014.05.024
   MARTINEZ-AGUIRRE E, 1980, Acta Anaesthesiologica Belgica, V31, P289
   Marvulli R, 2016, CURR PHARM DESIGN, V22, P758, DOI 10.2174/1381612822666151204001830
   Mc Monagle P, 2002, J NEUROL NEUROSUR PS, V72, P43, DOI 10.1136/jnnp.72.1.43
   McIver T, 2007, INT J OBSTET ANESTH, V16, P190, DOI 10.1016/j.ijoa.2006.11.002
   McTiernan C, 1999, CAN J ANAESTH, V46, P679, DOI 10.1007/BF03013958
   MIMURA M, 1992, ACTA ANAESTH SCAND, V36, P460, DOI 10.1111/j.1399-6576.1992.tb03497.x
   Mohammed Imran, 2004, BMC Clin Pharmacol, V4, P6, DOI 10.1186/1472-6904-4-6
   Naguib M, 1998, DRUG SAFETY, V18, P99, DOI 10.2165/00002018-199818020-00002
   Orsucci D, 2014, CLIN NEUROL NEUROSUR, V120, P14, DOI 10.1016/j.clineuro.2014.02.002
   Ponsonnard S, 2017, EUR J ANAESTH, V34, P562, DOI 10.1097/EJA.0000000000000615
   Richard S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005911
   Ross JC, 2011, NEUROCRIT CARE, V14, P103, DOI 10.1007/s12028-010-9422-6
   Salazar ML, 2008, PEDIATR EMERG CARE, V24, P691, DOI 10.1097/PEC.0b013e318188a952
   Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8
   Santiago-Palma J, 2004, ANESTH ANALG, V99, P227, DOI 10.1213/01.ANE.0000121347.11127.99
   SCHMUTZLER S, 1984, ANAESTHESIST, V33, P294
   de Souza PVS, 2017, CEREBELLUM, V16, P525, DOI 10.1007/s12311-016-0803-z
   SIA RL, 1981, BRIT J ANAESTH, V53, P865, DOI 10.1093/bja/53.8.865
   Silva MC, 1997, J CLIN EPIDEMIOL, V50, P1377, DOI 10.1016/S0895-4356(97)00202-3
   Solowska JM, 2015, BRAIN, V138, P2471, DOI 10.1093/brain/awv178
   Thomas I, 2006, INT J OBSTET ANESTH, V15, P254, DOI 10.1016/j.ijoa.2006.01.002
NR 40
TC 0
Z9 0
U1 1
U2 2
PU AKTIV DRUCK & VERLAG GMBH
PI EBELSBACH
PA AN DER LOHWIESE 36, EBELSBACH, 97500, GERMANY
SN 0170-5334
EI 1439-0256
J9 ANASTH INTENSIVMED
JI Anasthesiol. Intensivmed.
PD JUL-AUG
PY 2020
VL 61
SU 17
AR S290
DI 10.19224/ai2020.S290
PG 8
WC Anesthesiology; Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anesthesiology; General & Internal Medicine
GA VK9FJ
UT WOS:000766083200002
DA 2024-11-01
ER

PT J
AU Hofman, P
   Nelson, AM
AF Hofman, Paul
   Nelson, Ann Marie
TI The pathology induced by highly active antiretroviral therapy against
   human immunodeficiency virus: an update
SO CURRENT MEDICINAL CHEMISTRY
LA English
DT Review
DE AIDS; HIV; antiretroviral therapy; pathology; toxicity; lipodystrophy;
   immune restoration syndrome
ID HIV-INFECTED PATIENTS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
   IMMUNE RESTORATION DISEASE; RECONSTITUTION INFLAMMATORY SYNDROME;
   PNEUMOCYSTIS-CARINII PNEUMONIA; AVASCULAR NECROSIS; CYTOMEGALOVIRUS
   RETINITIS; MITOCHONDRIAL-DNA; LACTIC-ACIDOSIS; NUCLEOSIDE ANALOG
AB The use of highly active antiretroviral therapy (HAART) has considerably improved the quality of life and has increased the survival of HIV-infected individuals. Although HAART can successfully suppress viral replication in the long term, it is not without significant toxicity, which can seriously compromise treatment effectiveness. Moreover, the rapid rate of virus mutation and subsequent emergence of drug-resistant HIV variants threaten the longer-term efficacy of HIV treatment. The most common adverse effects caused by HAART include a metabolic syndrome with lipodystrophy, hyperlipidemia and insulin resistance, deterioration in the clinical status due to various exaggerated local and systemic inflammatory reactions during the immunerestoration disease, and various hepatic, peripheral and cardiac muscle, kidney, bone, bone marrow, retinal, ear, and skin toxicities. The heterogeneity in the organs affected by the different drugs and the morphological features observed in tissues in HAART-treated patients raise possible explanations including differential distribution or activation of these agents. Antiretroviral drugs from new classes, as well as new drugs from existing classes with favorable resistance and side effect profiles are in various stages of development. However, new tissue disorders will be certainly described in the future in patients treated with these drugs. The different pathophysiology of the main adverse effects and the less common known side effects of antiretroviral therapy against HIV are described here, with special emphasis on the histological features induced by HAART.
C1 Hop Louis Pasteur, Lab Clin & Expt Pathol, F-06002 Nice 01, France.
   Univ Nice Sophia Antipolis, INSERM, ESPRI 2006, F-06108 Nice 2, France.
   Armed Forces Inst Pathol, Div AIDS Pathol, Washington, DC 20306 USA.
C3 CHU Nice; Universite Cote d'Azur; Institut National de la Sante et de la
   Recherche Medicale (Inserm); United States Department of Defense
RP Hofman, P (corresponding author), Hop Louis Pasteur, Lab Clin & Expt Pathol, BP69, F-06002 Nice 01, France.
EM hofman@unice.fr
RI Hofman, Paul/P-7654-2018
OI Hofman, Paul/0000-0003-0431-9353
CR Abino JF, 2002, AIDS, V16, P1429, DOI 10.1097/00002030-200207050-00018
   Aboulafia DM, 2000, AIDS PATIENT CARE ST, V14, P13, DOI 10.1089/108729100318091
   Aldeen T, 2000, HIV Med, V1, P252, DOI 10.1046/j.1468-1293.2000.00037.x
   ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5
   Babl FE, 1999, LANCET, V353, P1243, DOI 10.1016/S0140-6736(98)05754-7
   Bachmeyer C, 2000, BRIT J DERMATOL, V143, P1336, DOI 10.1046/j.1365-2133.2000.03924.x
   Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6
   BELMONTE MA, 1993, J RHEUMATOL, V20, P1425
   Bersoff-Matcha SJ, 2001, CLIN INFECT DIS, V32, P124, DOI 10.1086/317536
   BISSUEL F, 1994, J INTERN MED, V235, P367, DOI 10.1111/j.1365-2796.1994.tb01088.x
   Blanche P, 1998, SCAND J INFECT DIS, V30, P615, DOI 10.1080/00365549850161223
   Blanche P, 2002, CLIN INFECT DIS, V34, P1279, DOI 10.1086/338720
   Breton G, 2006, AIDS, V20, P119, DOI 10.1097/01.aids.0000199014.66139.39
   Breton G, 2002, AM J MED, V113, P155, DOI 10.1016/S0002-9343(02)01130-0
   Brown P, 2001, CLIN INFECT DIS, V32, P1221, DOI 10.1086/319745
   CANOSO RT, 1987, BRIT J HAEMATOL, V65, P495, DOI 10.1111/j.1365-2141.1987.tb04157.x
   Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6
   Carr A, 2000, CLIN INFECT DIS, V30, pS135, DOI 10.1086/313854
   Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9
   Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003
   Carr A, 1996, AIDS, V10, P635, DOI 10.1097/00002030-199606000-00009
   Carr A, 2002, LANCET, V360, P81, DOI 10.1016/S0140-6736(02)09341-8
   Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3
   Carr A, 1998, LANCET, V351, P1736, DOI 10.1016/S0140-6736(05)77775-8
   Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1
   Casariego Z, 2001, Med Oral, V6, P19
   Chariot P, 1991, Neuromuscul Disord, V1, P357, DOI 10.1016/0960-8966(91)90122-9
   CHARIOT P, 1993, ANN NEUROL, V34, P561, DOI 10.1002/ana.410340409
   Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8
   CHATTHA G, 1993, ANN INTERN MED, V118, P37, DOI 10.7326/0003-4819-118-1-199301010-00007
   Cheng VCC, 2000, CLIN INFECT DIS, V30, P882, DOI 10.1086/313809
   Cherry CL, 2003, J CLIN VIROL, V26, P195, DOI 10.1016/S1386-6532(02)00118-X
   CHEUNG NT, 1995, BRIT J RHEUMATOL, V34, P387
   CHEVALIER X, 1993, J BONE JOINT SURG BR, V75, P160, DOI 10.1302/0301-620X.75B1.8421018
   Chien JW, 1998, CHEST, V114, P933, DOI 10.1378/chest.114.3.933
   CHIMELLI L, 1992, NEUROPATH APPL NEURO, V18, P478, DOI 10.1111/j.1365-2990.1992.tb00815.x
   Cinque P, 2001, J NEUROVIROL, V7, P358
   Cossarizza A, 2002, J BIOL REG HOMEOS AG, V16, P18
   Cossarizza A, 2001, BIOESSAYS, V23, P1070, DOI 10.1002/bies.1152
   Crump JA, 1998, CLIN INFECT DIS, V26, P1008, DOI 10.1086/517636
   DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602
   Dean GL, 2002, AM J RESP CRIT CARE, V165, P1670, DOI 10.1164/ajrccm.165.12.165121
   Deayton J, 1999, AIDS, V13, P1203, DOI 10.1097/00002030-199907090-00008
   Deayton JR, 2000, AIDS, V14, P1163, DOI 10.1097/00002030-200006160-00013
   Diri E, 2000, J RHEUMATOL, V27, P2711
   Domingo P, 1999, AIDS, V13, P2261, DOI 10.1097/00002030-199911120-00008
   Dworkin MS, 1998, ARCH INTERN MED, V158, P1828, DOI 10.1001/archinte.158.16.1828
   Emery S, 1997, CURR OPIN IMMUNOL, V9, P568, DOI 10.1016/S0952-7915(97)80112-4
   FESSEL WJ, 2000, ANTIVIR THER S, V5, P25
   FORTGANG IS, 1995, AM J GASTROENTEROL, V90, P1433
   Foudraine NA, 1999, AIDS, V13, P177, DOI 10.1097/00002030-199902040-00005
   Foulon G, 2004, CLIN INFECT DIS, V38, P418, DOI 10.1086/381094
   Fox P A, 1999, HIV Med, V1, P10, DOI 10.1046/j.1468-1293.1999.00003.x
   French MA, 2004, AIDS RES HUM RETROV, V20, P157, DOI 10.1089/088922204773004879
   Furrer H, 1999, AM J MED, V106, P371, DOI 10.1016/S0002-9343(99)00015-7
   Gea-Banacloche JC, 1999, AIDS, V13, pS25
   Gerster JC, 1998, J RHEUMATOL, V25, P604
   GERSTER JC, 1991, J RHEUMATOL, V18, P300
   GOORNEY BP, 1990, GENITOURIN MED, V66, P451
   HAVLIR D, 1995, J INFECT DIS, V171, P537, DOI 10.1093/infdis/171.3.537
   Heath KV, 2002, J ACQ IMMUN DEF SYND, V30, P440, DOI [10.1097/01.QAI.0000021701.48448.20, 10.1097/00042560-200208010-00010]
   Hofman P, 1999, PATHOL RES PRACT, V195, P209, DOI 10.1016/S0344-0338(99)80037-5
   HOFMAN P, 1993, BRIT HEART J, V70, P376, DOI 10.1136/hrt.70.4.376
   HOFMAN P, 1993, PATHOL RES PRACT, V189, P894
   Hofman V, 2000, HUM PATHOL, V31, P75, DOI 10.1016/S0046-8177(00)80202-6
   Jacobson Jeffrey M, 2005, Curr HIV/AIDS Rep, V2, P90, DOI 10.1007/s11904-005-0024-4
   Jacobson MA, 1997, LANCET, V349, P1443, DOI 10.1016/S0140-6736(96)11431-8
   Jaquet D, 2000, AIDS, V14, P2123, DOI 10.1097/00002030-200009290-00008
   Jenny-Avital ER, 2002, CLIN INFECT DIS, V35, pE128, DOI 10.1086/344467
   John M, 1998, AIDS, V12, P2289, DOI 10.1097/00002030-199817000-00010
   Jubault V, 2000, J CLIN ENDOCR METAB, V85, P4254, DOI 10.1210/jc.85.11.4254
   Kalkut G, 2005, CURR OPIN ONCOL, V17, P479, DOI 10.1097/01.cco.0000174035.39161.d8
   Karavellas MP, 1998, ARCH OPHTHALMOL-CHIC, V116, P169
   KLATT EC, 1994, ARCH PATHOL LAB MED, V118, P884
   Koeger AC, 1999, J RHEUMATOL, V26, P752
   KOHLBRENNER V, 1996, INT C AIDS, V11, P89
   KOTECHA N, 1999, CLIN INFECT DIS, V28, P1152
   Koval CE, 2002, CLIN INFECT DIS, V35, P491, DOI 10.1086/341974
   Krambovitis E, 2005, ACTA PHARMACOL SIN, V26, P1165, DOI 10.1111/j.1745-7254.2005.00193.x
   LAI KK, 1991, ANN INTERN MED, V115, P283, DOI 10.7326/0003-4819-115-4-283
   Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008
   Lanzafame M, 1999, CHEST, V116, P848, DOI 10.1378/chest.116.3.848-a
   Lascaux AS, 2001, AIDS, V15, P819, DOI 10.1097/00002030-200104130-00028
   Lawn SD, 2003, CLIN INFECT DIS, V36, pE5, DOI 10.1086/344446
   Lefkowitch JH, 1997, SEMIN LIVER DIS, V17, P335, DOI 10.1055/s-2007-1007210
   Lenzo NP, 1997, AIDS, V11, P1294, DOI 10.1097/00002030-199710001-00003
   LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417
   Lewis W, 2001, LAB INVEST, V81, P1527, DOI 10.1038/labinvest.3780366
   Lewis W, 2000, PROG CARDIOVASC DIS, V43, P151, DOI 10.1053/pcad.2000.9031
   Li QS, 2004, J INFECT DIS, V189, P572, DOI 10.1086/381396
   Llauger J, 1998, AM J ROENTGENOL, V171, P987, DOI 10.2214/ajr.171.4.9762981
   Lloreta J, 2002, VIRCHOWS ARCH, V441, P599, DOI 10.1007/s00428-002-0667-0
   Lo JC, 1998, LANCET, V351, P867, DOI 10.1016/S0140-6736(97)11443-X
   MANJI H, 1993, J NEUROL, V240, P479, DOI 10.1007/BF00874117
   Martín-Carbonero L, 2002, AIDS, V16, P1423, DOI 10.1097/00002030-200207050-00016
   Martínez E, 1998, CLIN INFECT DIS, V27, P1510, DOI 10.1086/515019
   Mayo J, 1998, AIDS, V12, P1720
   MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702
   Meyer D, 1999, AIDS, V13, P1147, DOI 10.1097/00002030-199906180-00025
   MHIRI C, 1991, ANN NEUROL, V29, P606, DOI 10.1002/ana.410290607
   Miller J, 2000, AIDS, V14, P2406, DOI 10.1097/00002030-200010200-00025
   Miralles P, 2001, AIDS, V15, P1900, DOI 10.1097/00002030-200109280-00028
   Mirmirani P, 1999, J AM ACAD DERMATOL, V41, P285, DOI 10.1016/S0190-9622(99)70364-6
   Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0
   Mokrzycki MH, 2000, CLIN INFECT DIS, V30, P198, DOI 10.1086/313594
   Monier P, 2000, CLIN INFECT DIS, V31, P1488, DOI 10.1086/317503
   Morris AAM, 1999, LANCET, V354, P1046, DOI 10.1016/S0140-6736(99)00301-3
   Mur A, 2005, PEDIATR INFECT DIS J, V24, P742, DOI 10.1097/01.inf.0000172936.20623.fd
   Naccache JM, 1999, AM J RESP CRIT CARE, V159, P2009, DOI 10.1164/ajrccm.159.6.9807152
   Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001
   Naseri A, 2001, BRIT J OPHTHALMOL, V85, P1390
   Navas E, 2002, ARCH INTERN MED, V162, P97, DOI 10.1001/archinte.162.1.97
   Nguyen QD, 2000, AM J OPHTHALMOL, V129, P634, DOI 10.1016/S0002-9394(00)00356-1
   Nolan RC, 2003, CLIN INFECT DIS, V36, P1191, DOI 10.1086/374603
   Núñez M, 2005, DRUG SAFETY, V28, P53
   Núñez M, 2001, J ACQ IMMUN DEF SYND, V27, P426, DOI 10.1097/00126334-200108150-00002
   Nussenblatt RB, 1998, AM J OPHTHALMOL, V125, P374, DOI 10.1016/S0002-9394(99)80149-4
   OLANO JP, 1995, CLIN INFECT DIS, V21, P973, DOI 10.1093/clinids/21.4.973
   Orenstein JM, 1999, AIDS, V13, P2219, DOI 10.1097/00002030-199911120-00004
   PANEGYRES PK, 1990, J NEUROL NEUROSUR PS, V53, P649, DOI 10.1136/jnnp.53.8.649
   Panse I, 2000, BRIT J DERMATOL, V142, P496, DOI 10.1046/j.1365-2133.2000.03363.x
   PEZESHKPOUR G, 1991, HUM PATHOL, V22, P1281, DOI 10.1016/0046-8177(91)90112-3
   Phillips P, 1999, J ACQ IMMUN DEF SYND, V20, P122, DOI 10.1097/00042560-199902010-00003
   Piliero PJ, 2003, CLIN INFECT DIS, V36, pE111, DOI 10.1086/368311
   Proia LA, 2000, AM J MED, V108, P249, DOI 10.1016/S0002-9343(99)00437-4
   Pujol RM, 2000, J AM ACAD DERMATOL, V42, P193, DOI 10.1016/S0190-9622(00)90125-7
   Puoti M, 2003, JAIDS-J ACQ IMM DEF, V32, P259, DOI 10.1097/00126334-200303010-00004
   Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3
   Rademaker J, 1997, J RHEUMATOL, V24, P601
   Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002
   REICHERT CM, 1983, AM J PATHOL, V112, P357
   Ridolfo AL, 2000, J INFECTION, V40, P199, DOI 10.1053/jinf.1999.0630
   Roge BT, 2002, AIDS, V16, P973, DOI 10.1097/00002030-200205030-00003
   Rubio A, 2002, CLIN EXP IMMUNOL, V130, P121, DOI 10.1046/j.1365-2249.2002.01950.x
   Ruiz L, 1999, AIDS, V13, pF1, DOI 10.1097/00002030-199901140-00001
   Safdar A, 2002, CLIN INFECT DIS, V35, P1250, DOI 10.1086/344056
   Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002
   Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009
   Salama C, 2003, CLIN INFECT DIS, V37, pE35, DOI 10.1086/375895
   Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]
   Sellier P, 2000, AM J MED, V109, P510, DOI 10.1016/S0002-9343(00)00562-3
   SeminoMora C, 1997, LAB INVEST, V76, P487
   Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005
   Shikuma CM, 2001, AIDS, V15, P1801, DOI 10.1097/00002030-200109280-00009
   SHOUBRIDGE EA, 1994, J BIOENERG BIOMEMBR, V26, P301, DOI 10.1007/BF00763101
   SORICE M, 1994, THROMB RES, V73, P165, DOI 10.1016/0049-3848(94)90095-7
   Spring M, 2001, VIROLOGY, V279, P221, DOI 10.1006/viro.2000.0720
   STAHL CP, 1993, BLOOD, V81, P1801
   Stone SF, 2001, J INFECT DIS, V184, P1073, DOI 10.1086/323599
   Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005
   Sutinen J, 2005, CURR OPIN INFECT DIS, V18, P25, DOI 10.1097/00001432-200502000-00005
   Tanji N, 2001, HUM PATHOL, V32, P734, DOI 10.1053/hupa.2001.25586
   Tantisiriwat W, 1999, CLIN INFECT DIS, V28, P1152, DOI 10.1086/514762
   Trevenzoli M, 2002, J INFECTION, V45, P173, DOI 10.1053/jinf.2002.1052
   Viraben R, 1998, AIDS, V12, pF37, DOI 10.1097/00002030-199806000-00001
   Vittecoq D, 2002, JAIDS, V31, P299, DOI 10.1097/00126334-200211010-00005
   Woods ML, 1998, AIDS, V12, P1491, DOI 10.1097/00002030-199812000-00011
   YARCHOAN R, 1989, NEW ENGL J MED, V321, P726, DOI 10.1056/NEJM198909143211106
   Zaera MG, 2001, AIDS, V15, P1643, DOI 10.1097/00002030-200109070-00006
   Zietz C, 1999, NEW ENGL J MED, V340, P1923, DOI 10.1056/NEJM199906173402415
NR 160
TC 31
Z9 34
U1 1
U2 6
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8673
EI 1875-533X
J9 CURR MED CHEM
JI Curr. Med. Chem.
PY 2006
VL 13
IS 26
BP 3121
EP 3132
DI 10.2174/092986706778742891
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology &
   Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 090DR
UT WOS:000240931300002
PM 17168701
DA 2024-11-01
ER

PT J
AU Dewulf, JP
   Barrea, C
   Vincent, MF
   De Laet, C
   Van Coster, R
   Seneca, S
   Marie, S
   Nassogne, MC
AF Dewulf, Joseph P.
   Barrea, Catherine
   Vincent, Marie-Francoise
   De Laet, Corinne
   Van Coster, Rudy
   Seneca, Sara
   Marie, Sandrine
   Nassogne, Marie-Cecile
TI Evidence of a wide spectrum of cardiac involvement due to <i>ACAD9</i>
   mutations: Report on nine patients
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE ACAD9; Acyl-COA dehydrogenase 9; Cardiomyopathy; Complex I deficiency
ID COMPLEX-I DEFICIENCY; ACYL-COA DEHYDROGENASE; OXIDATION; DISEASE; GENE
AB Acyl-CoA dehydrogenase 9 (ACAD9) is a mitochondrial protein involved in oxidative phosphorylation complex I biogenesis. This protein also exhibits acyl-CoA dehydrogenase (ACAD) activity. ACAD9-mutated patients have been reported to suffer from primarily heart, muscle, liver, and nervous system disorders. ACAD9 mutation is suspected in cases of elevated lactic acid levels combined with complex I deficiency, and confirmed by ACAD9 gene analysis. At least 18 ACAD9-mutated patients have previously been reported, usually displaying severe cardiac involvement. We retrospectively studied nine additional patients from three unrelated families with a wide spectrum of cardiac involvement between the families as well as the patients from the same families. All patients exhibited elevated lactate levels. Deleterious ACAD9 mutations were identified in all patients except one for whom it was not possible to recover DNA. To our knowledge, this is one of the first reports on isolated mild ventricular hypertrophy due to ACAD9 mutation in a family with moderate symptoms during adolescence. This report also confirms that dilated cardiomyopathy may occur in conjunction with ACAD9 mutation and that some patients may respond clinically to riboflavin treatment. Of note, several patients suffered from patent ductus arteriosus (PDA), with one exhibiting a complex congenital heart defect. It is yet unknown whether these cardiac manifestations were related to ACAD9 mutation. In conclusion, this disorder should be suspected in the presence of lactic acidosis, complex I deficiency, and any cardiac involvement, even mild. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Dewulf, Joseph P.; Vincent, Marie-Francoise; Marie, Sandrine] Catholic Univ Louvain, Clin Univ St Luc, Serv Biochim Genet, B-1200 Brussels, Belgium.
   [Barrea, Catherine] Catholic Univ Louvain, Clin Univ St Luc, Serv Cardiol Pediat, B-1200 Brussels, Belgium.
   [De Laet, Corinne] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Nutr & Metab Unit, Brussels, Belgium.
   [Van Coster, Rudy] Univ Hosp, Pediat Neurol, De Pintelaan 185, B-9000 Ghent, Belgium.
   [Seneca, Sara] Res Grp Reprod & Genet VUB, UZ Brussel, Ctr Med Genet, Laarbeeklaan 101, B-1090 Brussels, Belgium.
   [Nassogne, Marie-Cecile] Catholic Univ Louvain, Clin Univ St Luc, Serv Neurol Pediat, Ave Hippocrate 10-1062, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain; Cliniques Universitaires Saint-Luc;
   Universite Catholique Louvain; Cliniques Universitaires Saint-Luc;
   Universite Libre de Bruxelles; Ghent University; Ghent University
   Hospital; University Hospital Brussels; Universite Catholique Louvain;
   Cliniques Universitaires Saint-Luc
RP Nassogne, MC (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Serv Neurol Pediat, Ave Hippocrate 10-1062, B-1200 Brussels, Belgium.
EM Marie-cecile.nassogne@uclouvain.be
RI Dewulf, Joseph/AAW-1996-2021
OI Nassogne, Marie-Cecile/0000-0001-6936-1611; Dewulf,
   Joseph/0000-0001-7223-2706; Seneca, Sara/0000-0002-0853-9890
CR Collet M., 2015, EUR J HUM GENET
   Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058
   Garone C, 2013, JAMA NEUROL, V70, P1177, DOI 10.1001/jamaneurol.2013.3197
   Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273
   Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846
   Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577
   Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706
   He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219
   Koene S, 2012, J INHERIT METAB DIS, V35, P737, DOI 10.1007/s10545-012-9492-z
   Lagoutte-Renosi J., 2015, JIMD REP
   Leslie N, 2016, HUM PATHOL, V49, P27, DOI 10.1016/j.humpath.2015.09.039
   Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242
   Nouws J, 2014, HUM MOL GENET, V23, P1311, DOI 10.1093/hmg/ddt521
   Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002
   Oey NA, 2006, BIOCHEM BIOPH RES CO, V346, P33, DOI 10.1016/j.bbrc.2006.05.088
   Schiff M, 2015, HUM MOL GENET, V24, P3238, DOI 10.1093/hmg/ddv074
   SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T
   Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7
NR 18
TC 18
Z9 21
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD JUL
PY 2016
VL 118
IS 3
BP 185
EP 189
DI 10.1016/j.ymgme.2016.05.005
PG 5
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA DQ1SX
UT WOS:000378981800009
PM 27233227
DA 2024-11-01
ER

PT J
AU Denham, J
AF Denham, Joshua
TI Canonical and extra-telomeric functions of telomerase: Implications for
   healthy ageing conferred by endurance training
SO AGING CELL
LA English
DT Review
DE epigenetics; exercise; metabolism; oxidative stress; telomeres; TERT
ID TERT PROMOTER MUTATIONS; DNA-DAMAGE RESPONSE; MESSENGER-RNA EXPRESSION;
   HUMAN SKELETAL-MUSCLE; MOUSE CELLS LACKING; REVERSE-TRANSCRIPTASE;
   TERMINAL TRANSFERASE; LENGTH MAINTENANCE; ALZHEIMERS-DISEASE; METABOLIC
   DISEASE
AB Telomerase preserves genomic integrity by maintaining and protecting the telomeres. Seminal findings from 1985 revealed the canonical role of telomerase and motivated investigations into potential therapeutic strategies to combat one of the hallmarks of ageing-telomere attrition. Since then, the field of telomere biology has rapidly expanded, with telomerase serving essential roles in cancer and cell development through its canonical function. However, telomerase also exerts critical extra-telomeric functions through its protein (telomerase reverse transcriptase, TERT) and RNA components (telomerase RNA component, TERC). Telomerase re-activation or ectopic expression promotes survival and permits unlimited proliferation in tumours and healthy non-malignant cells. TERT gene therapies improve health and lifespan in ageing mice and mouse models of age-related diseases. The extra-telomeric functions of telomerase are critical to ageing. These include protection against oxidative stress, orchestration of chromatin modifications and transcription, and regulation of angiogenesis and metabolism (e.g. mitochondrial function and glucose control). Given these biological functions are key adaptations to endurance training and the recent meta-analytical findings that indicate exercise up-regulates TERT and telomerase, a comprehensive discussion on the implications of the canonical and extra-telomeric roles of telomerase is warranted. This review highlights the therapeutic benefits of telomerase-based treatments for idiopathic and chronic diseases that are linked to ageing. Discussion on the canonical and extra-telomeric roles of telomerase are presented, followed by a detailed summary of the evidence on how exercise influences telomerase. Finally, the potential cell signalling underpinning the exercise-induced modulation of telomerase are discussed with directions for future research.
C1 [Denham, Joshua] Univ Southern Queensland, Sch Hlth & Med Sci, Toowoomba, Qld, Australia.
   [Denham, Joshua] Inst Resilient Reg, Ctr Hlth Res, Toowoomba, Qld, Australia.
   [Denham, Joshua] Univ Southern Queensland, Sch Hlth & Med Sci, Room 111,Bldg P Ipswich Campus, Ipswich, Qld 4305, Australia.
C3 University of Southern Queensland; University of Southern Queensland;
   University of Southern Queensland
RP Denham, J (corresponding author), Univ Southern Queensland, Sch Hlth & Med Sci, Room 111,Bldg P Ipswich Campus, Ipswich, Qld 4305, Australia.
EM josh.denham@usq.edu.au
OI Denham, Joshua/0000-0001-5804-4960
CR Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372
   Akiyama M, 2004, BIOCHEM BIOPH RES CO, V316, P528, DOI 10.1016/j.bbrc.2004.02.080
   Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092
   Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399
   Bär C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6863
   Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036
   Bär C, 2016, BLOOD, V127, P1770, DOI 10.1182/blood-2015-08-667485
   Bell RJA, 2016, MOL CANCER RES, V14, P315, DOI 10.1158/1541-7786.MCR-16-0003
   Bennudez Y, 2007, GYNECOL ONCOL, V106, P526, DOI 10.1016/j.ygyno.2007.05.005
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019
   Beyer AM, 2016, CIRC RES, V118, P856, DOI 10.1161/CIRCRESAHA.115.307918
   BLACKBURN EH, 1989, GENOME, V31, P553, DOI 10.1139/g89-104
   Blasco MA, 2002, SPRINGER SEMIN IMMUN, V24, P75, DOI 10.1007/s00281-001-0096-1
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Chen SF, 2014, AGING-US, V6, P414, DOI 10.18632/aging.100671
   Cheng FF, 2021, LANCET DIABETES ENDO, V9, P117, DOI 10.1016/S2213-8587(20)30365-X
   Chilton WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092088
   Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010
   Cluckey TG, 2017, EXP GERONTOL, V96, P7, DOI 10.1016/j.exger.2017.06.003
   Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566
   Coffey VG, 2017, J PHYSIOL-LONDON, V595, P2883, DOI 10.1113/JP272270
   Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602
   De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]
   de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882
   de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921
   Denham J, 2021, AGEING RES REV, V70, DOI 10.1016/j.arr.2021.101411
   Denham J, 2020, AM J PHYSIOL-ENDOC M, V319, pE320, DOI 10.1152/ajpendo.00215.2020
   Denham J, 2016, SPORTS MED, V46, P1213, DOI 10.1007/s40279-016-0482-4
   Denham J, 2016, J APPL PHYSIOL, V120, P148, DOI 10.1152/japplphysiol.00587.2015
   Denham J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069377
   Derevyanko A, 2017, AGING CELL, V16, P1353, DOI 10.1111/acel.12677
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Diman A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600031
   Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433
   Drevytska TI, 2014, CELL BIOCHEM FUNCT, V32, P565, DOI 10.1002/cbf.3051
   Eitan E, 2016, CEREBELLUM, V15, P509, DOI 10.1007/s12311-015-0720-6
   Eitan E, 2012, EMBO MOL MED, V4, P313, DOI 10.1002/emmm.201200212
   Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639
   Forero DA, 2016, J GERONTOL A-BIOL, V71, P1069, DOI 10.1093/gerona/glw053
   Gala K, 2021, CANCER LETT, V502, P120, DOI 10.1016/j.canlet.2020.12.036
   Gao JX, 2022, NAT REV CANCER, V22, P515, DOI 10.1038/s41568-022-00490-1
   García-Castillo J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015528118
   Gielen S, 2010, CIRCULATION, V122, P1221, DOI 10.1161/CIRCULATIONAHA.110.939959
   Gioscia-Ryan RA, 2016, AGING-US, V8, P2897, DOI 10.18632/aging.101099
   Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x
   González-Suárez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002
   Gorbunova V, 2009, MECH AGEING DEV, V130, P3, DOI 10.1016/j.mad.2008.02.008
   Granata C, 2018, SPORTS MED, V48, P1809, DOI 10.1007/s40279-018-0936-y
   GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0
   GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Guo N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017858
   Guterres AN, 2020, ONCOGENE, V39, P5811, DOI 10.1038/s41388-020-01405-w
   Haendeler J, 2004, CIRC RES, V94, P768, DOI 10.1161/01.RES.0000121104.05977.F3
   Haendeler J, 2003, MOL CELL BIOL, V23, P4598, DOI 10.1128/MCB.23.13.4598-4610.2003
   Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hagman M, 2020, PROG CARDIOVASC DIS, V63, P738, DOI 10.1016/j.pcad.2020.05.009
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014
   Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029
   Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Heaphy CM, 2011, AM J PATHOL, V179, P1608, DOI 10.1016/j.ajpath.2011.06.018
   Heidenreich B, 2017, MUTAT RES-REV MUTAT, V771, P15, DOI 10.1016/j.mrrev.2016.11.002
   Hendrickse PW, 2021, EUR J APPL PHYSIOL, V121, P3161, DOI 10.1007/s00421-021-04768-4
   Henstridge DC, 2016, J APPL PHYSIOL, V120, P683, DOI 10.1152/japplphysiol.00811.2015
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370
   Hoier B, 2014, MICROCIRCULATION, V21, P301, DOI 10.1111/micc.12117
   Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062
   Hu B, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0207-x
   Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259
   Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010
   Jaijyan DK, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2121499119
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   Kim W, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000016
   Kimura M, 2010, EXP HEMATOL, V38, P854, DOI 10.1016/j.exphem.2010.06.010
   Kramer HF, 2007, J APPL PHYSIOL, V103, P388, DOI 10.1152/japplphysiol.00085.2007
   Lansdorp PM, 2022, BLOOD, V139, P813, DOI 10.1182/blood.2021014299
   LaRocca TJ, 2010, MECH AGEING DEV, V131, P165, DOI 10.1016/j.mad.2009.12.009
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Lassmann T, 2015, INT J MOL SCI, V16, P1192, DOI 10.3390/ijms16011192
   Laudadio I, 2019, EMBO REP, V20, DOI 10.15252/embr.201845969
   Laye MJ, 2012, J APPL PHYSIOL, V112, P773, DOI 10.1152/japplphysiol.00997.2011
   Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013
   Leung FP, 2008, SPORTS MED, V38, P1009, DOI 10.2165/00007256-200838120-00005
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   Li J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080656
   Li XJ, 2020, NAT CELL BIOL, V22, P282, DOI 10.1038/s41556-020-0471-6
   Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Liu BC, 2022, NATURE, V604, P578, DOI 10.1038/s41586-022-04582-8
   Liu N, 2016, NUCLEIC ACIDS RES, V44, P8693, DOI 10.1093/nar/gkw549
   Liu TJ, 2019, J BIOL CHEM, V294, P8861, DOI 10.1074/jbc.RA118.006615
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludlow AT, 2017, EXP PHYSIOL, V102, P397, DOI 10.1113/EP086189
   Ludlow AT, 2012, J APPL PHYSIOL, V113, P1737, DOI 10.1152/japplphysiol.00200.2012
   Ludlow AT, 2008, MED SCI SPORT EXER, V40, P1764, DOI 10.1249/MSS.0b013e31817c92aa
   Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283
   Mandal S, 2022, PFLUG ARCH EUR J PHY, V474, P1159, DOI 10.1007/s00424-022-02745-0
   Mangaonkar AA, 2018, MAYO CLIN PROC, V93, P904, DOI 10.1016/j.mayocp.2018.03.020
   Povedano JM, 2018, ELIFE, V7, DOI 10.7554/eLife.31299
   Martínez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111
   Martínez P, 2010, AGING CELL, V9, P653, DOI 10.1111/j.1474-9726.2010.00596.x
   Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102
   McAllister RM, 2008, APPL PHYSIOL NUTR ME, V33, P173, DOI 10.1139/H07-146
   McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908
   Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719
   Memme JM, 2021, J PHYSIOL-LONDON, V599, P803, DOI 10.1113/JP278853
   Miao Guo-Ying, 2016, Asian Pac J Cancer Prev, V17, P1993
   Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Miwa S, 2016, AGING-US, V8, P2551, DOI 10.18632/aging.101089
   Morland C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15557
   Mundstock E, 2015, OBESITY, V23, P2165, DOI 10.1002/oby.21183
   Mundstock E, 2015, AGEING RES REV, V22, P72, DOI 10.1016/j.arr.2015.02.004
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12664-x
   Murphy RM, 2020, NAT METAB, V2, P805, DOI 10.1038/s42255-020-0258-x
   Nickels M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04151
   Niida H, 1998, NAT GENET, V19, P203, DOI 10.1038/580
   Ogasawara R, 2019, EXERC SPORT SCI REV, V47, P188, DOI 10.1249/JES.0000000000000189
   Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072
   Pallini R, 2001, J NEUROSURG, V94, P961, DOI 10.3171/jns.2001.94.6.0961
   Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137
   Perera ON, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4409
   Pérez-Rivero G, 2006, CIRCULATION, V114, P309, DOI 10.1161/CIRCULATIONAHA.105.611111
   Perry CGR, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029686
   Pestana A, 2017, J MOL ENDOCRINOL, V58, pR129, DOI 10.1530/JME-16-0195
   Pickett HA, 2015, NAT STRUCT MOL BIOL, V22, P875, DOI 10.1038/nsmb.3106
   Ponsot E, 2012, EXP PHYSIOL, V97, P774, DOI 10.1113/expphysiol.2011.063818
   Roake CM, 2020, NAT REV MOL CELL BIO, V21, P384, DOI 10.1038/s41580-020-0234-z
   Rossiello F, 2022, NAT CELL BIOL, V24, P135, DOI 10.1038/s41556-022-00842-x
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1
   Sampson MJ, 2006, DIABETES CARE, V29, P283, DOI 10.2337/diacare.29.02.06.dc05-1715
   Santos JH, 2004, AGING CELL, V3, P399, DOI 10.1111/j.1474-9728.2004.00124.x
   Saraswati S, 2021, NATURE AGING, V1, P269, DOI 10.1038/s43587-021-00040-8
   Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498
   Shaheen F, 2014, BBA-MOL BASIS DIS, V1842, P1762, DOI 10.1016/j.bbadis.2014.06.018
   Sharma NK, 2012, NUCLEIC ACIDS RES, V40, P712, DOI 10.1093/nar/gkr758
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Shim HS, 2021, NATURE AGING, V1, P1162, DOI 10.1038/s43587-021-00146-z
   Singhapol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052989
   Slusher AL, 2022, MED SCI SPORT EXER, V54, P931, DOI 10.1249/MSS.0000000000002868
   Smith EM, 2020, CELL MOL LIFE SCI, V77, P61, DOI 10.1007/s00018-019-03369-x
   Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985
   Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015
   Strong MA, 2011, MOL CELL BIOL, V31, P2369, DOI 10.1128/MCB.05312-11
   Sun LL, 2019, P NATL ACAD SCI USA, V116, P18983, DOI 10.1073/pnas.1907199116
   Sundin T, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.1
   Suvorava T, 2018, CURR MED CHEM, V25, P4457, DOI 10.2174/0929867325666180307112557
   Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Toupance S, 2017, HYPERTENSION, V70, P420, DOI 10.1161/HYPERTENSIONAHA.117.09354
   Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004
   Valente C, 2021, J AM GERIATR SOC, V69, P3285, DOI 10.1111/jgs.17334
   Vidal-Cardenas SL, 2010, NUCLEIC ACIDS RES, V38, P60, DOI 10.1093/nar/gkp855
   Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454
   Wang JF, 2016, J INT MED RES, V44, P1156, DOI 10.1177/0300060516667132
   Wariyar SS, 2022, EXP NEUROL, V353, DOI 10.1016/j.expneurol.2022.114029
   Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034
   Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005
   Werner CM, 2019, EUR HEART J, V40, P34, DOI 10.1093/eurheartj/ehy585
   Whittemore K, 2019, AGING-US, V11, P2916, DOI 10.18632/aging.101982
   Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379
   Widegren U, 2000, PFLUG ARCH EUR J PHY, V441, P317, DOI 10.1007/s004240000417
   Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019
   WYNFORDTHOMAS D, 1997, NATURE, V389, P551, DOI DOI 10.1038/39207
   Xiong SQ, 2015, CELL REP, V12, P1391, DOI 10.1016/j.celrep.2015.07.047
   Yeh JK, 2019, JACC-BASIC TRANSL SC, V4, P855, DOI 10.1016/j.jacbts.2019.05.009
   Yu JY, 2018, CANCER LETT, V434, P33, DOI 10.1016/j.canlet.2018.07.013
   Yuan XM, 1999, GENES CELLS, V4, P563, DOI 10.1046/j.1365-2443.1999.00284.x
   Zaccagnini G, 2005, J BIOL CHEM, V280, P14790, DOI 10.1074/jbc.M414644200
   Zhao L, 2019, LAB INVEST, V99, P1661, DOI 10.1038/s41374-019-0290-1
   Zheng Q, 2019, PROTEIN CELL, V10, P631, DOI 10.1007/s13238-019-0612-5
   Zietzer A, 2017, ACTA PHYSIOL, V220, P251, DOI 10.1111/apha.12820
   Zinder JC, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2201662119
NR 194
TC 7
Z9 7
U1 1
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD JUN
PY 2023
VL 22
IS 6
AR e13836
DI 10.1111/acel.13836
EA APR 2023
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA I9NV0
UT WOS:000969086100001
PM 37041671
OA gold
DA 2024-11-01
ER

PT J
AU Han, SJ
   Noh, MR
   Jung, JM
   Ishii, I
   Yoo, J
   Kim, JI
   Park, KM
AF Han, Sang Jun
   Noh, Mi Ra
   Jung, Jung-Min
   Ishii, Isao
   Yoo, Jeongsoo
   Kim, Jee In
   Park, Kwon Moo
TI Hydrogen sulfide-producing cystathionine γ-lyase is critical in the
   progression of kidney fibrosis
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Chronic kidney disease; Cystathionine gamma-lyase; Reactive oxygen
   species; Kidney fibrosis; Hydrogen sulfide
ID METHIONINE SULFOXIDE REDUCTASE; OXIDATIVE STRESS; RENAL
   ISCHEMIA/REPERFUSION; TRANSSULFURATION PATHWAY; DIABETIC-NEPHROPATHY;
   N-ACETYLCYSTEINE; ISCHEMIC-INJURY; DEFICIENT MICE; GLUTATHIONE; CYSTEINE
AB Cystathionine gamma-lyase (CSE), the last key enzyme of the transsulfuration pathway, is involved in the production of hydrogen sulfide (H2S) and glutathione (GSH), which regulate redox balance and act as important antioxidant molecules. Impairment of the H2S- and GSH-mediated antioxidant system is associated with the progression of chronic kidney disease (CKD), characterized by kidney fibrosis and dysfunction. Here, we evaluated the role of CSE in the progression of kidney fibrosis after unilateral ureteral obstruction (UUO) using mice deficient in the Cse gene. UUO of wild-type mice reduced the expression of H2S-producing enzymes, CSE, cystathionine beta-synthase, and 3-mercaptopyruvate sulfurtransferase in the obstructed kidneys, resulting in decreased H2S and GSH levels. Cse gene deletion lowered H2S and GSH levels in the kidneys. Deleting the Cse gene exacerbated the decrease in H2S and GSH levels and increase in superoxide formation and oxidative damage to proteins, lipids, and DNA in the kidneys after UUO, which were accompanied by greater kidney fibrosis, deposition of extracellular matrixes, expression of a-smooth muscle actin, tubular damage, and infiltration of inflammatory cells. Furthermore, Cse gene deletion exacerbated mitochondrial fragmentation and apoptosis of renal tubule cells after UUO. The data provided herein constitute in vivo evidence that Cse deficiency impairs renal the H2S- and GSH-producing activity and exacerbates UUO-induced kidney fibrosis. These data propose a novel therapeutic approach against CKD by regulating CSE and the transsulfuration pathway.
C1 [Han, Sang Jun; Noh, Mi Ra; Park, Kwon Moo] Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Dept Anat, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Han, Sang Jun; Noh, Mi Ra; Park, Kwon Moo] Kyungpook Natl Univ, Sch Med, Plus BK21, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Jung, Jung-Min; Yoo, Jeongsoo] Kyungpook Natl Univ, Plus BK21, Dept Mol Med, Sch Med, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
   [Ishii, Isao] Showa Pharmaceut Univ, Lab Hlth Chem, Machida, Tokyo 1948543, Japan.
   [Kim, Jee In] Keimyung Univ, Coll Med, Dept Mol Med, 1095 Dalgubeol Daero 250 Gil, Daegu 42601, South Korea.
   [Kim, Jee In] Keimyung Univ, Coll Med, MRC, 1095 Dalgubeol Daero 250 Gil, Daegu 42601, South Korea.
C3 Kyungpook National University (KNU); Kyungpook National University
   (KNU); Kyungpook National University (KNU); Showa Pharmaceutical
   University; Keimyung University; Keimyung University
RP Park, KM (corresponding author), Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Dept Anat, 680 Gukchaebosang Ro, Daegu 41944, South Korea.; Park, KM (corresponding author), Kyungpook Natl Univ, Sch Med, Plus BK21, 680 Gukchaebosang Ro, Daegu 41944, South Korea.
EM kmpark@knu.ac.kr
OI Noh, Mira/0000-0001-5402-5260; Ishii, Isao/0000-0002-5367-205X
FU National Research Foundation of Korea (NRF) [2015R1A2A1A15052400];
   Minister of Health & Welfare by the Korean government [HI14C2011];
   Grants-in-Aid for Scientific Research [16K15194] Funding Source: KAKEN
FX This study was supported by grants from the National Research Foundation
   of Korea (NRF) (Grant number: 2015R1A2A1A15052400) funded and Minister
   of Health & Welfare (Grant number: HI14C2011) by the Korean government.
CR Akerboom T P, 1981, Methods Enzymol, V77, P373
   Aminzadeh MA, 2012, NEPHROL DIAL TRANSPL, V27, P498, DOI 10.1093/ndt/gfr560
   ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548
   Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268
   Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829
   CeballosPicot I, 1996, FREE RADICAL BIO MED, V21, P845, DOI 10.1016/0891-5849(96)00233-X
   Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86
   Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005
   El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7
   Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109
   Han S. J., 2016, J AM SOC NEPHROL
   Han SJ, 2015, NEPHROL DIAL TRANSPL, V30, P1497, DOI 10.1093/ndt/gfv226
   Ida T, 2014, P NATL ACAD SCI USA, V111, P7606, DOI 10.1073/pnas.1321232111
   Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439
   Jang HS, 2008, TRANSPLANTATION, V85, P447, DOI 10.1097/TP.0b013e318160f0d1
   Jang HS, 2012, NEPHROL DIAL TRANSPL, V27, P3762, DOI 10.1093/ndt/gfs097
   Jiang DP, 2014, NEUROUROL URODYNAM, V33, P538, DOI 10.1002/nau.22450
   Jung KJ, 2013, BBA-MOL BASIS DIS, V1832, P1989, DOI 10.1016/j.bbadis.2013.06.015
   Kim JI, 2015, FREE RADICAL BIO MED, V89, P201, DOI 10.1016/j.freeradbiomed.2015.07.018
   Kim JI, 2013, ANTIOXID REDOX SIGN, V18, P2241, DOI 10.1089/ars.2012.4598
   Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008
   Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x
   Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282
   LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218
   Lee ES, 2016, NEPHROL DIAL TRANSPL, V31, P391, DOI 10.1093/ndt/gfv377
   Lee ZW, 2014, BIOCHEM J, V460, P425, DOI 10.1042/BJ20131434
   Li Y, 2017, RENAL FAILURE, V39, P265, DOI 10.1080/0886022X.2016.1257433
   Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038
   Marí M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]
   McBean GJ, 2012, AMINO ACIDS, V42, P199, DOI 10.1007/s00726-011-0864-8
   Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200
   Otunctemur A, 2014, RENAL FAILURE, V36, P925, DOI 10.3109/0886022X.2014.900599
   Perna AF, 2012, NEPHROL DIAL TRANSPL, V27, P486, DOI 10.1093/ndt/gfr737
   Perna AF, 2009, NEPHROL DIAL TRANSPL, V24, P3756, DOI 10.1093/ndt/gfp378
   Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200
   Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85
   Rushworth GF, 2014, PHARMACOL THERAPEUT, V141, P150, DOI 10.1016/j.pharmthera.2013.09.006
   Shen Y, 2016, ACTA PHARMACOL SIN, V37, P637, DOI 10.1038/aps.2016.12
   Song K, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/458720
   Song K, 2014, KIDNEY INT, V85, P1318, DOI 10.1038/ki.2013.449
   Stallons LJ, 2013, CURR PATHOBIOL REP, V1
   Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684
   Wang P, 2014, PHYSL REP, V2, P12
   Wu DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2715718
   Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142
   Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667
   Yuan P, 2011, NEPHROL DIAL TRANSPL, V26, P2119, DOI 10.1093/ndt/gfq749
   Zhang S., 2015, OXID MED CELL LONGEV, V2015, P12
   Zhou X, 2014, J BIOL CHEM, V289, P28827, DOI 10.1074/jbc.M114.596593
NR 49
TC 42
Z9 45
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD NOV
PY 2017
VL 112
BP 423
EP 432
DI 10.1016/j.freeradbiomed.2017.08.017
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA FI3BD
UT WOS:000411829300037
PM 28842346
DA 2024-11-01
ER

PT J
AU Shafique, A
   Arif, B
   Chu, ML
   Moran, E
   Hussain, T
   Zamora, FM
   Wohler, E
   Sobreira, N
   Klein, C
   Lohmann, K
   Naz, S
AF Shafique, Anum
   Arif, Beenish
   Chu, Mary Lynn
   Moran, Ellen
   Hussain, Tooba
   Zamora, Francisca Millan
   Wohler, Elizabeth
   Sobreira, Nara
   Klein, Christine
   Lohmann, Katja
   Naz, Sadaf
TI <i>MRM2</i> variants in families with complex dystonic syndromes:
   evidence for phenotypic heterogeneity
SO JOURNAL OF MEDICAL GENETICS
LA English
DT Article
DE movement disorders; human genetics; gene expression profiling; germ-line
   mutation; high-throughput nucleotide sequencing
ID RIBOSOMAL-RNA; LARGE SUBUNIT; MUTATION; DONOR; SITE
AB Background Dystonia involves repetitive movements and muscle contractions leading to abnormal postures. We investigated patients in two families, DYAF11 and M, exhibiting dystonic or involuntary movement disorders. Methods Clinical investigations were performed for all patients. Genetic analyses included genome-wide linkage analysis and exome sequencing followed by Sanger sequencing validation. MRM2-specific transcripts were analysed from participants' blood samples in Family DYAF11 after cloning of gene-specific cDNA. Results Four affected siblings in Family DYAF11 had progressive dystonic features. Two patients in Family M exhibited a neurodevelopmental disorder accompanied by involuntary movements. In Family DYAF11, linkage was detected to the telomere at chromosome 7p22.3, spanning <2 Mb. Exome sequencing identified a donor splice-site variant, c.8+1G>T in MRM2, which segregated with the phenotype, corresponding to the linkage data since all affected individuals were homozygous while the obligate unaffected carriers were heterozygous for the variant. In the MRM2 c.8+1G>T allele, an aberrant alternative acceptor splice-site located within exon 2 was used in a subset of the transcripts, creating a frameshift in the open reading frame. Exome sequencing in Family M revealed a rare missense variant c.242C>T, p.(Ala81Val), which affected a conserved amino acid. Conclusions Our results expand the clinical and allelic spectrum of MRM2 variants. Previously, these descriptions were based on observations in a single patient, diagnosed with mitochondrial DNA depletion syndrome 17, in whom movement disorder was accompanied by recurrent strokes and epilepsy. We also demonstrate a subset of correctly spliced tt-ag MRM2 transcripts, raising the possibility to develop treatment by understanding the disease mechanism.
C1 [Shafique, Anum; Arif, Beenish; Hussain, Tooba; Naz, Sadaf] Univ Punjab, Sch Biol Sci, Quaid i Azam Campus, Lahore, Pakistan.
   [Chu, Mary Lynn] NYU, Grossman Sch Med, Dept Neurol, New York, NY 10016 USA.
   [Chu, Mary Lynn] NYU, Langone Orthoped Hosp, New York, NY USA.
   [Moran, Ellen] NYU, Hassenfeld Childrens Hosp, Ctr Children, Clin Genet, New York, NY USA.
   [Zamora, Francisca Millan] GeneDx, Gaithersburg, MD USA.
   [Wohler, Elizabeth; Sobreira, Nara] Johns Hopkins Univ, McKusick Nathans Dept Genet Med, Baltimore, MD USA.
   [Klein, Christine; Lohmann, Katja] Univ Lubeck, Inst Neurogenet, Lubeck, Germany.
C3 University of Punjab; New York University; New York University; New York
   University; Johns Hopkins University; University of Lubeck
RP Naz, S (corresponding author), Univ Punjab, Sch Biol Sci, Quaid i Azam Campus, Lahore, Pakistan.
EM naz.sbs@pu.edu.pk
RI Chu, Ming-chung/M-2655-2018; Naz, Sadaf/C-3911-2019; Klein,
   Christine/AGK-8003-2022
OI Naz, Sadaf/0000-0002-1912-0235; Klein, Christine/0000-0003-2102-3431
FU Baylor-Hopkins Center for Mendelian Genomics, USA; DFG, Germany [LO
   1555/8-1, FOR 2488]; Damp Foundation, Germany and Higher Education
   Commission, Pakistan [2877]
FX This research was funded by the Baylor-Hopkins Center for Mendelian
   Genomics, USA, the DFG, Germany (LO 1555/8-1, FOR 2488), the Damp
   Foundation, Germany and Higher Education Commission, Pakistan 2877.
CR Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475
   Amir El-Ad David, 2010, Hum Genomics, V4, P394
   Capuano A, 2020, APPL CLIN GENET, V13, P71, DOI 10.2147/TACG.S210325
   Charlesworth G, 2013, CURR OPIN NEUROL, V26, P406, DOI 10.1097/WCO.0b013e3283633696
   Ching YP, 2002, GENOMICS, V79, P2, DOI 10.1006/geno.2001.6670
   Erro R, 2019, J NEUROL NEUROSUR PS, V90, P227, DOI 10.1136/jnnp-2018-318932
   Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314
   Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016
   Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006
   Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137
   Lange LM, 2022, MOVEMENT DISORD, V37, P905, DOI 10.1002/mds.28982
   Lee HH, 2001, J ENDOCRINOL, V171, P397, DOI 10.1677/joe.0.1710397
   Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868
   Lee KW, 2013, J BIOL CHEM, V288, P31386, DOI 10.1074/jbc.M113.515692
   Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009
   Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139
   Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148
   Rorbach J, 2014, MOL BIOL CELL, V25, P2542, DOI 10.1091/mbc.E14-01-0014
   Rowlands CF, 2022, AM J HUM GENET, V109, P210, DOI 10.1016/j.ajhg.2021.12.014
   Sacoto MJG, 2020, AM J HUM GENET, V107, P352, DOI 10.1016/j.ajhg.2020.06.013
   Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369
   Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844
   Zech M, 2020, LANCET NEUROL, V19, P908, DOI 10.1016/S1474-4422(20)30312-4
NR 23
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-2593
EI 1468-6244
J9 J MED GENET
JI J. Med. Genet.
PD APR
PY 2023
VL 60
IS 4
BP 352
EP 358
DI 10.1136/jmg-2022-108521
EA AUG 2022
PG 7
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA L4ZI5
UT WOS:000844724100001
PM 36002240
DA 2024-11-01
ER

PT J
AU Kaur, SJ
   McKeown, SR
   Rashid, S
AF Kaur, Simran J.
   McKeown, Stephanie R.
   Rashid, Shazia
TI Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis
SO GENE
LA English
DT Review
DE Amyotrophic lateral sclerosis; SOD1; Neurodegeneration; Familial ALS;
   Mutations
ID SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; AXONAL-TRANSPORT; MOTOR-NEURONS;
   FAMILIAL ALS; MUTATIONS; EPIDEMIOLOGY; AGGREGATION; DIAGNOSIS; TOXICITY
AB Amyotrophic lateral sclerosis (ALS) is a neural disorder that causes death of the motor neurons in the brain and spinal cord; this affects the voluntary muscles and gradually leads to paralysis of the whole body. Most ALS cases are sporadic, though about 5-10% are familial. ALS is caused by multiple factors including mutation in any one of a number of specific genes, one of the most frequently affected is superoxide dismutase (SOD) 1. Alterations in SOD 1 have been linked with several variants of familial ALS. SOD 1 is a powerful antioxidant enzyme that protects cells from the damaging effects of superoxide radicals. The enzyme binds both copper and zinc ions that are directly involved in the deactivation of toxic superoxide radicals. Mutated SOD1 gene can acquire both gain and loss of function mutations. The most commonly identified mutations in SOD1 that affect protein activity are D90A, A4V and G93A. Deleterious mutations have been shown to modify SOD1 activity, which leads to the accumulation of highly toxic hydroxyl radicals. Accumulation of these free radicals causes degradation of both nuclear and mitochondrial DNA and protein misfolding, features which can be used as pathological indicators associated with ALS. Numerous clinical trials have been carried out over last few years with limited success. In some patients advanced techniques like gene and stem cell therapy have been trialed. However no definitive treatment option can provide a cure and currently ALS is managed by drugs and other supportive therapies. Consequently there is a need to identify new approaches for treatment of this ultimately fatal disease. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kaur, Simran J.; Rashid, Shazia] Amity Univ, Noida 201303, India.
   [McKeown, Stephanie R.] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland.
C3 Amity University Noida; Ulster University
RP Rashid, S (corresponding author), Amity Univ, Noida 201303, India.
EM simran.arora0905@gmail.com; sr.mckeown@ulster.ac.uk; srashid@amity.edu
RI Rashid, Shazia/ABI-2978-2020
OI Rashid, Shazia/0000-0002-8125-6790
CR Allen S, 2003, J BIOL CHEM, V278, P6371, DOI 10.1074/jbc.M209915200
   Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9
   Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200
   Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018
   Battistini S, 2010, AMYOTROPH LATERAL SC, V11, P210, DOI 10.3109/17482960902995592
   Boillée S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018
   Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28
   Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212
   De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226
   DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011
   Dugdale D. C., 2010, AMYOTROPHIC LATERAL
   Eisen A, 2001, CLIN NEUROPHYSIOL, V112, P2190, DOI 10.1016/S1388-2457(01)00692-7
   Eisen A, 1999, DRUG AGING, V14, P173, DOI 10.2165/00002512-199914030-00003
   Emery A E, 1982, Adv Neurol, V36, P139
   Ferrera L, 2003, AMYOTROPH LATERAL SC, V4, P167, DOI 10.1080/aml.4.3.167.170
   García-Escudero V, 2015, J CELL MOL MED, V19, P1284, DOI 10.1111/jcmm.12488
   Ge WW, 2006, NEUROBIOL DIS, V23, P342, DOI 10.1016/j.nbd.2006.03.007
   Gibson S. B., 2015, AMYOTROPH LATERAL SC, P1
   Gordon PH, 2011, CNS DRUGS, V25, P1, DOI 10.2165/11586000-000000000-00000
   Graffmo K.S., 2012, Human Molecular genetics
   Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742
   Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004
   Hand CK, 2001, ANN NEUROL, V49, P267, DOI 10.1002/1531-8249(20010201)49:2<267::AID-ANA51>3.0.CO;2-D
   Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153
   Ikenaka K, 2012, INT J MOL SCI, V13, P1225, DOI 10.3390/ijms13011225
   Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164
   Irvin CW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00248
   Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137
   Kelly Evelyn B., 2013, ENCY HUMAN GENETICS, P79
   Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016
   Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828
   Marc G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/845345
   Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474
   Mazzini L, 2008, J NEUROL SCI, V265, P78, DOI 10.1016/j.jns.2007.05.016
   McAllum EJ, 2015, NEUROBIOL DIS, V81, P20, DOI 10.1016/j.nbd.2015.02.023
   MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848
   Miller R. G., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001447
   Münch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108
   Niemann S, 2004, J NEUROL NEUROSUR PS, V75, P1186, DOI 10.1136/jnnp.2003.028324
   PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954
   Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971
   Pouget J, 2000, AMYOTROPH LATERAL SC, V1, pS45
   Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260
   Riancho J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00250
   Robberecht W, 2000, J NEUROL, V247, P1
   Robelin L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/525097
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543
   Rowland LP, 2001, ARCH NEUROL-CHICAGO, V58, P512, DOI 10.1001/archneur.58.3.512
   Rutkove SB, 2007, CLIN NEUROPHYSIOL, V118, P2413, DOI 10.1016/j.clinph.2007.08.004
   Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104
   Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005
   Siddique T., 1994, AM J HUMAN GENETICS, V55
   SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x
   Soo K. Y., 2015, ACTA NEUROPATHOL, P1
   Swash M, 2001, AMYOTROPH LATERAL SC, V2, pS3, DOI 10.1080/231-146608201300079355
   Therrien M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00085
   Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X
   Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P109, DOI 10.1001/archneur.57.1.109
   Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603
   Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100
   Yoon EJ, 2009, EXP MOL MED, V41, P611, DOI 10.3858/emm.2009.41.9.067
NR 62
TC 217
Z9 245
U1 1
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD FEB 15
PY 2016
VL 577
IS 2
BP 109
EP 118
DI 10.1016/j.gene.2015.11.049
PG 10
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA DC4LD
UT WOS:000369191500002
PM 26657039
DA 2024-11-01
ER

PT J
AU Keller, SH
   Johnson, GS
   Bullock, G
   Mhlanga-Mutangadura, T
   Schwartz, M
   Pattridge, SG
   Guo, JY
   Kortz, GD
   Katz, ML
AF Keller, Stefan H.
   Johnson, Gary S.
   Bullock, Garrett
   Mhlanga-Mutangadura, Tendai
   Schwartz, Malte
   Pattridge, Savannah G.
   Guo, Juyuan
   Kortz, Gregg D.
   Katz, Martin L.
TI Homozygous <i>CNP</i> Mutation and Neurodegeneration in Weimaraners:
   Myelin Abnormalities and Accumulation of Lipofuscin-like Inclusions
SO GENES
LA English
DT Article
DE neuronal ceroid lipofuscinosis; neurodegeneration; brain; optic nerve;
   cardiac muscle; mitochondria; lipofuscin
ID CANINE DEGENERATIVE MYELOPATHY; TRANSITION PORE; GENE; LOCALIZATION;
   DISRUPTION
AB A progressive neurological disorder was observed in a male neutered Weimaraner. Clinical signs included fecal incontinence, lethargy, moderate paraparesis, proprioceptive pelvic limb ataxia, falling, cognitive decline, incoordination, decreased interest in food, changes in posture, and episodes of trance-like behavior. Neurologic signs were first observed at approximately 4 years, 10 months of age and progressed slowly. Magnetic resonance imaging showed generalized brain atrophy with areas of white matter pathology. Humane euthanasia was elected at 6 years, 7 months of age due to increasing severity of the neurological signs. Autofluorescent intracellular granules were observed in the cerebral and cerebellar cortexes, optic nerve, and cardiac muscle of the affected dog. These abnormal inclusions in the cerebral cortex and cardiac muscle immunolabeled with antibodies to mitochondrial ATP synthase subunit c protein, like that observed in the neuronal ceroid lipofuscinosis group of lysosomal storage diseases. Immunolabeling also demonstrated pronounced neuroinflammation in brain tissues. The ultrastructural appearances of the disease-related inclusion bodies in the brain and optic nerve were quite variable. The ultrastructure and locations of many of the inclusions in the nervous tissues suggested that they were derived, at least in part, from the myelin surrounding axons. The storage bodies in the cardiac muscle were located in mitochondria-rich regions and consisted of parallel arrays of membrane-like components interspersed with electron-dense flocculent material. The disease was characterized by pronounced abnormalities in the myelin of the brain and optic nerve consisting of distinctive areas of ballooning between the layers of myelin. The whole genome sequence generated from the affected dog contained a homozygous G-to-A missense mutation in CNP, which encodes proteins with CNPase enzyme activity and a structural role in myelin. The mutation predicts a Thr42Met amino acid sequence substitution. Genotyping of archived Weimaraner DNA samples identified an additional G > A variant homozygote with a clinical history and brain lesions similar to those of the proband. Of 304 Weimaraners and over 4000 other dogs of various breeds, the proband and the other Weimaraner that exhibited similar signs were the only two that were homozygous for the CNP missense variant. CNPase immunolabeling was widespread in brain tissues from normal dogs but was undetectable in the same tissues from the proband. Based on the clinical history, fluorescence and electron-microscopy, immunohistochemistry, and molecular genetic findings, the late-onset Weimaraner disorder likely results from the missense mutation that results in CNPase deficiency, leading to myelin abnormalities, accumulation of lysosomal storage bodies, and brain atrophy. Similar disorders have been associated with different CNP variants in Dalmatians and in human subjects.
C1 [Keller, Stefan H.; Johnson, Gary S.; Bullock, Garrett; Mhlanga-Mutangadura, Tendai; Pattridge, Savannah G.; Guo, Juyuan] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.
   [Schwartz, Malte] Summit Vet Referral Ctr, Tacoma, WA 98409 USA.
   [Kortz, Gregg D.] VCA Sacramento Vet Referral Ctr, Sacramento, CA 95827 USA.
   [Katz, Martin L.] Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
C3 University of Missouri System; University of Missouri Columbia;
   University of Missouri System; University of Missouri Columbia
RP Katz, ML (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Neurodegenerat Dis Res Lab, Columbia, MO 65212 USA.
EM shkgb6@missouri.edu; gebkd2@mail.missouri.edu; tendai@missouri.edu;
   sgpgqq@missouri.edu; guoj@missouri.edu; gregg.kortz@vca.com;
   katzm@health.missouri.edu
OI Bullock, Garrett/0000-0002-9231-8758
FU American Kennel Club Canine Health Foundation
FX Our thanks to Cheryl Jensen and the staff members of the University of
   Missouri Electron Microscopy Core Facility and the Veterinary Medicine
   Diagnostic Laboratory for their assistance in tissue sample preparation.
CR Al-Abdi L, 2020, HUM GENET, V139, P615, DOI 10.1007/s00439-020-02144-4
   Anderson GW, 2013, BBA-MOL BASIS DIS, V1832, P1807, DOI 10.1016/j.bbadis.2012.11.014
   Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]
   Baburina Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113499
   Bernardi P, 2023, CELL DEATH DIFFER, V30, P1869, DOI 10.1038/s41418-023-01187-0
   Bouché TV, 2023, J VET INTERN MED, V37, P1815, DOI 10.1111/jvim.16829
   Bullock G, 2023, GENES-BASEL, V14, DOI 10.3390/genes14091746
   Bullock G, 2022, GENE, V830, DOI 10.1016/j.gene.2022.146513
   Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001
   Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893
   Elleder M, 2008, ACTA NEUROPATHOL, V116, P119, DOI 10.1007/s00401-008-0349-3
   Goebel H H, 2001, Eur J Paediatr Neurol, V5 Suppl A, P203, DOI 10.1053/ejpn.2000.0463
   Goebel HH, 2000, NEUROL SCI, V21, pS27, DOI 10.1007/s100720070037
   Götzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6
   Hagemeyer N, 2012, EMBO MOL MED, V4, P528, DOI 10.1002/emmm.201200230
   Hu Gang, 2019, Curr Protoc Protein Sci, V95, pe71, DOI 10.1002/cpps.71
   Jackson EK, 2017, HANDB EXP PHARMACOL, V238, P229, DOI 10.1007/164_2015_40
   Jagannathan V, 2021, GENES-BASEL, V12, DOI 10.3390/genes12060847
   Katz ML, 2017, NEUROBIOL DIS, V108, P277, DOI 10.1016/j.nbd.2017.08.017
   Katz ML, 2005, BIOCHEM BIOPH RES CO, V327, P541, DOI 10.1016/j.bbrc.2004.12.038
   Kountourantzis A, 2023, RES VET SCI, V162, DOI 10.1016/j.rvsc.2023.104959
   Kurata K, 1999, BRAIN DEV-JPN, V21, P63, DOI 10.1016/S0387-7604(98)00062-X
   KURIHARA T, 1990, BIOCHEM BIOPH RES CO, V170, P1074, DOI 10.1016/0006-291X(90)90502-E
   Kursula P, 2001, INT J MOL MED, V8, P475
   Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095
   Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017
   Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026
   Mole S.E., 2011, The Neuronal Ceroid Lipofuscinoses (Batten Disease), V2nd
   Morgan BR, 2014, J NEUROSCI RES, V92, P531, DOI 10.1002/jnr.23332
   Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004
   Olga K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093217
   ONeill RC, 1997, J NEUROSCI RES, V50, P248
   Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014
   Pemberton TJ, 2014, GLIA, V62, P39, DOI 10.1002/glia.22582
   Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5
   Rasband MN, 2005, GLIA, V50, P86, DOI 10.1002/glia.20165
   Robichaux DJ, 2023, J MOL CELL CARDIOL, V174, P47, DOI 10.1016/j.yjmcc.2022.11.003
   Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337
   Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646
   Siems SB, 2020, ELIFE, V9, DOI 10.7554/eLife.51406
   Umehara F, 1997, ACTA NEUROPATHOL, V93, P628, DOI 10.1007/s004010050661
   VOGEL US, 1988, J NEUROCHEM, V50, P1667, DOI 10.1111/j.1471-4159.1988.tb02461.x
   Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317
   Zhou SY, 2023, CURR PHARM DESIGN, V29, P620, DOI 10.2174/1381612829666230313111314
NR 44
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4425
J9 GENES-BASEL
JI Genes
PD FEB
PY 2024
VL 15
IS 2
AR 246
DI 10.3390/genes15020246
PG 27
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA JS0Y2
UT WOS:001175047900001
PM 38397235
OA gold, Green Published, Green Submitted
DA 2024-11-01
ER

PT J
AU Buda, P
   Piekutowska-Abramczuk, D
   Karkucinska-Wieckowska, A
   Jurkiewicz, E
   Chelstowska, S
   Pajdowska, M
   Migdal, M
   Ksiazyk, J
   Kotulska, K
   Pronicka, E
AF Buda, Piotr
   Piekutowska-Abramczuk, Dorota
   Karkucinska-Wieckowska, Agnieszka
   Jurkiewicz, Elzbieta
   Chelstowska, Sylwia
   Pajdowska, Magdalena
   Migdal, Marek
   Ksiazyk, Janusz
   Kotulska, Katarzyna
   Pronicka, Ewa
TI "Drop attacks" as first clinical symptoms in a child carrying MTTK
   m.8344A&gt;G mutation
SO FOLIA NEUROPATHOLOGICA
LA English
DT Article
DE Leigh syndrome; MERRF mutation; pyruvate dehydrogenase dysfunction;
   ketogenic diet
ID LEIGH-SYNDROME; A8344G MUTATION; MERRF; DEFICIENCY; FEATURES
AB We describe a child with dyslexia and difficulty in school who, at the age of 13 years, began to suffer from several head injuries resulting from falls of uncertain cause. Two years later, the patient developed symptoms of a severe mitochondria, disorder (involving bulbar-pyramidal paralysis, ophthalmoplegia, and hyperlactatemia) that coincided with VPA administration. Brain MR imaging revealed rapidly developing Leigh syndrome (LS), and muscle biopsy showed ragged blue fibres (RBF). A diminished expression of the E1 alpha subunit of pyruvate dehydrogenase was found in muscle homogenate (signal 28.7% of normal).
   The accurate diagnosis of mitochondrially inherited LS (MILS) and the identification of an almost homoplasmic m.8344G>A mutation in the MTTK gene was delayed due to an initial incorrect diagnosis of epilepsy, misdiagnosis of neuroinfection, and failure to note LS on the first brain MRI.
   Periods of exacerbation or improvement were observed in association with the administration of certain drugs or procedures (VPA administration or intensive rehabilitation associated with worsening; ketogenic diet associated with remission). However, the random association of these factors with natural disease fluctuations cannot be excluded. Conclusions: 1) To improve the early detection of mitochondrial disorder, we recommend screening for mtDNA (and nDNA) mutations in all patients with LS present on brain MRI. 2) Brain MRI protocols should include diffusion-weighted and T2-weighted imaging, and LS-like changes should be analysed by a neuro radiologist experienced in the field. 3) Additional controlled studies are urgently needed to assess the causal relationship between management strategies and the natural history of the disease. Until the association between VPA and disease exacerbation can be ruled out, VPA should be avoided in patients with these symptoms unless the mitochondria( disorder has been excluded.
C1 [Buda, Piotr; Ksiazyk, Janusz] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, PL-04730 Warsaw, Poland.
   [Piekutowska-Abramczuk, Dorota; Pronicka, Ewa] Childrens Mem Hlth Inst, Dept Med Genet, PL-04730 Warsaw, Poland.
   [Karkucinska-Wieckowska, Agnieszka] Childrens Mem Hlth Inst, Dept Pathol, PL-04730 Warsaw, Poland.
   [Jurkiewicz, Elzbieta; Chelstowska, Sylwia] Childrens Mem Hlth Inst, Dept Radiol, MR Unit, PL-04730 Warsaw, Poland.
   [Pajdowska, Magdalena] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland.
   [Migdal, Marek] Childrens Mem Hlth Inst, Dept Anaesthesia & Intens Care, PL-04730 Warsaw, Poland.
   [Kotulska, Katarzyna] Childrens Mem Hlth Inst, Dept Child Neurol & Epileptol, PL-04730 Warsaw, Poland.
C3 Children's Memorial Health Institute; Children's Memorial Health
   Institute; Children's Memorial Health Institute; Children's Memorial
   Health Institute; Children's Memorial Health Institute; Children's
   Memorial Health Institute; Children's Memorial Health Institute
RP Kotulska, K (corresponding author), Childrens Mem Hlth Inst, Dept Child Neurol & Epileptol, Al Dzieci Polskich, PL-04730 Warsaw, Poland.
EM k.kotulska@czd.pl
RI ; Ksiazyk, Janusz/L-8752-2017; Pajdowska, Magdalena/V-9639-2018
OI Karkucinska-Wieckowska, Agnieszka/0000-0003-4936-1571; Ksiazyk,
   Janusz/0000-0002-9136-2722; Buda, Piotr/0000-0002-3891-4989; Pronicka,
   Ewa/0000-0002-5705-4814; Jurkiewicz, Elzbieta/0000-0003-4505-8815;
   Piekutowska-Abramczuk, Dorota/0000-0002-9786-3704; Pajdowska,
   Magdalena/0000-0002-1334-3534; Kotulska-Jozwiak,
   Katarzyna/0000-0002-5015-250X; Migdal, Marek/0000-0001-6686-5988
FU Children's Memorial Health Institute for young researchers [M2/2012]
FX The work was supported by the grant of the Children's Memorial Health
   Institute for young researchers no. M2/2012.
CR Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713
   Erol I, 2009, NEUROMUSCULAR DISORD, V19, P275, DOI 10.1016/j.nmd.2009.01.012
   Horvath R, 2007, NEUROLOGY, V68, P56, DOI 10.1212/01.wnl.0000250334.48038.7a
   Koene S, 2011, J INHERIT METAB DIS, V34, P315, DOI 10.1007/s10545-010-9162-y
   Molnar MJ, 2009, J NEUROL, V256, P264, DOI 10.1007/s00415-009-0841-2
   Piekutowska-Abramczuk D, 2008, NEUROL NEUROCHIR POL, V42, P238
   Piekutowska-Abramczuk D, 2009, EUR J PAEDIATR NEURO, V13, P146, DOI 10.1016/j.ejpn.2008.03.009
   Pronicka E, 2001, J INHERIT METAB DIS, V24, P707, DOI 10.1023/A:1012937204315
   Pronicka E, 2011, MED SCI MONITOR, V17, pCR203, DOI 10.12659/MSM.881716
   Pronicki M, 2007, FOLIA NEUROPATHOL, V45, P187
   Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311
   Remes AM, 2003, J NEUROL NEUROSUR PS, V74, P1158, DOI 10.1136/jnnp.74.8.1158
   Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8
   SILVESTRI G, 1993, NEUROLOGY, V43, P1200, DOI 10.1212/WNL.43.6.1200
   Swiderska N, 2010, J CHILD NEUROL, V25, P782, DOI 10.1177/0883073809347594
   Tsao CY, 2003, J CHILD NEUROL, V18, P62, DOI 10.1177/08830738030180011401
   Wexler ID, 1997, NEUROLOGY, V49, P1655, DOI 10.1212/WNL.49.6.1655
   Wilichowski E, 1998, J NEUROL SCI, V157, P206, DOI 10.1016/S0022-510X(98)00068-9
   Wu SB, 2010, MOL NEUROBIOL, V41, P256, DOI 10.1007/s12035-010-8123-7
NR 19
TC 8
Z9 8
U1 0
U2 6
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA ST 2, POZNAN, 61-615, POLAND
SN 1641-4640
EI 1509-572X
J9 FOLIA NEUROPATHOL
JI Folia Neuropathol.
PY 2013
VL 51
IS 4
BP 347
EP 354
DI 10.5114/fn.2013.39726
PG 8
WC Neurosciences; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Pathology
GA 288FW
UT WOS:000329598400010
PM 24374964
OA gold, Green Submitted
DA 2024-11-01
ER

PT J
AU Yalcouyé, A
   Diallo, SH
   Cissé, L
   Karembé, M
   Diallo, S
   Coulibaly, T
   Diarra, S
   Coulibaly, D
   Keita, M
   Guinto, CO
   Fischbeck, KH
   Wonkam, A
   Landouré, G
AF Yalcouye, Abdoulaye
   Diallo, Seybou H.
   Cisse, Lassana
   Karembe, Mamadou
   Diallo, Salimata
   Coulibaly, Thomas
   Diarra, Salimata
   Coulibaly, Dramane
   Keita, Mohamed
   Guinto, Cheick O.
   Fischbeck, Kenneth H.
   Wonkam, Ambroise
   Landoure, Guida
CA H3Africa Consortium
TI <i>GJB1</i> variants in Charcot-Marie-Tooth disease X-linked type 1 in
   Mali
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Article
DE Africa; CMTX1; GJB1; inherited neuropathies; Mali
ID CONNEXIN32; MUTATIONS; GENE; NEUROPATHIES; PATHOGENESIS; SUBTYPES;
   FAMILY; COHORT; MOTOR; CELL
AB X-linked Charcot-Marie-Tooth type 1 (CMTX1) disease is one of the most common subtypes of inherited neuropathies and is caused by mutations in the GJB1 gene. To date, more than 400 mutations have been reported in GJB1 worldwide but none in sub-Saharan Africa (SSA). We aimed to clinically characterize patients with CMTX1 and identify the genetic defects. All patients were examined thoroughly, and Nerve Conduction Studies (NCS) were done. EEG and pure tone audiometry (PTA) were also done in select individuals having additional symptoms. DNA was extracted for CMT gene panel testing (50 genes + mtDNA and PMP22 duplication), and putative variants were screened in available relatives. The predominant starting symptom was tingling, and the chief complaint was gait difficulty. Neurological examination found a distal muscle weakness and atrophy, and sensory loss, skeletal deformities, decreased or absent reflexes and steppage gait. The inheritance pattern was consistent with dominant X-linked. NCS showed no response in most of the tested nerves in lower limbs, and normal or reduced amplitudes in upper limbs. A severe sensorineural hearing impairment and a focal epileptic seizure were observed in one patient each. A high intra and inter-familial clinical variability was observed. Genetic testing found three pathogenic missense variants in GJB1, one in each of the families (Val91Met, Arg15Trp, and Phe235Cys). This is the first report of genetically confirmed cases of CMTX1 in SSA, and confirms its clinical and genetic heterogeneity.
C1 [Yalcouye, Abdoulaye; Wonkam, Ambroise] Univ Cape Town, Dept Pathol, Div Human Genet, Cape Town, South Africa.
   [Yalcouye, Abdoulaye; Diallo, Seybou H.; Coulibaly, Thomas; Diarra, Salimata; Keita, Mohamed; Guinto, Cheick O.; Landoure, Guida] USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
   [Diallo, Seybou H.; Diallo, Salimata] Ctr Hosp Univ Gabriel Toure, Serv Neurol, Bamako, Mali.
   [Cisse, Lassana; Karembe, Mamadou; Coulibaly, Thomas; Guinto, Cheick O.; Landoure, Guida] Ctr Hosp Univ Point G, Serv Neurol, Bamako, Mali.
   [Diarra, Salimata; Fischbeck, Kenneth H.; Landoure, Guida] NINDS, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Coulibaly, Dramane] Ctr Hosp Univ Mere Enfant Luxembourg, Serv Med, Bamako, Mali.
   [Keita, Mohamed] Ctr Hosp Univ Gabriel Toure, Serv ORL, Bamako, Mali.
C3 University of Cape Town; University of Science & Technology of Bamako;
   National Institutes of Health (NIH) - USA; NIH National Institute of
   Neurological Disorders & Stroke (NINDS)
RP Landouré, G (corresponding author), USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
EM guida@icermali.org
RI Wonkam, Ambroise/AFU-6901-2022
OI Yalcouye, Abdoulaye/0000-0003-4279-7380
FU National Institute of Neurological Disorders and Stroke [U01HG007044];
   NINDS [NS002974]; Wellcome Trust [107755Z/15/Z]; NIH, USA
   [U01-HG-009716]; African Academy of Science/Wellcome Trust [H3A/18/001];
   National Institute on Deafness and Other Communication Disorders; NIH
   Office of the Director [U01HG009716] Funding Source: NIH RePORTER
FX This study is supported by grant number U01HG007044 funded by the
   National Institute of Neurological Disorders and Stroke and administered
   by the National Human Genome Research Institute under the H3Afria
   initiative, NINDS intramural funds NS002974, to Guida Landoure; Wellcome
   Trust, grant number 107755Z/15/Z to Ambroise Wonkam (co-applicants);
   NIH, USA, grant number U01-HG-009716 to Ambroise Wonkam; and the African
   Academy of Science/Wellcome Trust, grant number H3A/18/001 to Ambroise
   Wonkam.
CR Abrams CK, 2019, NEUROSCI LETT, V695, P91, DOI 10.1016/j.neulet.2017.05.037
   Abrams CK, 2003, J NEUROSCI, V23, P10548
   Arthur-Farraj PJ, 2012, NEUROMUSCULAR DISORD, V22, P622, DOI 10.1016/j.nmd.2012.02.008
   Bähr M, 1999, J NEUROL NEUROSUR PS, V66, P202, DOI 10.1136/jnnp.66.2.202
   BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101
   Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94
   Bissar-Tadmouri N, 2000, CLIN GENET, V58, P396, DOI 10.1034/j.1399-0004.2000.580511.x
   Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152
   DiVincenzo C, 2014, MOL GENET GENOM MED, V2, P522, DOI 10.1002/mgg3.106
   Dubourg O, 2001, BRAIN, V124, P1958, DOI 10.1093/brain/124.10.1958
   Fridman V, 2015, J NEUROL NEUROSUR PS, V86, P873, DOI 10.1136/jnnp-2014-308826
   Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068
   Lee MJ, 2002, J NEUROL NEUROSUR PS, V73, P304, DOI 10.1136/jnnp.73.3.304
   Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459
   Lu YY, 2017, CHINESE MED J-PEKING, V130, P1049, DOI 10.4103/0366-6999.204925
   Meggouh F, 1998, J MED GENET, V35, P251, DOI 10.1136/jmg.35.3.251
   Murakami T, 2019, ADV EXP MED BIOL, V1190, P301, DOI 10.1007/978-981-32-9636-7_19
   Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A
   Panosyan FB, 2017, NEUROLOGY, V89, P927, DOI 10.1212/WNL.0000000000004296
   Pareyson D, 1999, MUSCLE NERVE, V22, P1498, DOI 10.1002/(SICI)1097-4598(199911)22:11<1498::AID-MUS4>3.0.CO;2-9
   Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001
   Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30
   Saporta ASD, 2011, ANN NEUROL, V69, P22, DOI 10.1002/ana.22166
   Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3
   Senderek J, 1998, ACTA NEUROPATHOL, V95, P443, DOI 10.1007/s004010050823
   Shahrizaila N, 2014, MUSCLE NERVE, V49, P198, DOI 10.1002/mus.23892
   Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d
   Totland MZ, 2020, CELL MOL LIFE SCI, V77, P573, DOI 10.1007/s00018-019-03285-0
   Tsai PC, 2016, ANN CLIN TRANSL NEUR, V3, P854, DOI 10.1002/acn3.347
   VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1
   Wicklein EM, 1997, J NEUROL NEUROSUR PS, V63, P379, DOI 10.1136/jnnp.63.3.379
   Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076
   Yiu EM, 2011, NEUROLOGY, V76, P461, DOI 10.1212/WNL.0b013e31820a0ceb
NR 33
TC 1
Z9 2
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD JUN
PY 2022
VL 27
IS 2
BP 113
EP 119
DI 10.1111/jns.12486
EA APR 2022
PG 7
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 1W1IS
UT WOS:000778176800001
PM 35383424
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Finsterer, J
AF Finsterer, Josef
TI Cardiogenetics, Neurogenetics, and Pathogenetics of Left Ventricular
   Hypertrabeculation/Noncompaction
SO PEDIATRIC CARDIOLOGY
LA English
DT Article; Proceedings Paper
CT Riley-Heart-Center Symposium on Cardiac Development - Growth and
   Morphogenesis of the Ventricular Wall
CY SEP 07-09, 2008
CL Indiana Univ Sch Med, Bloomington, IN
SP Riley Hosp Children, Riley Heart Ctr
HO Indiana Univ Sch Med
DE Cardiac disease; Genetics; Hypertrophic cardiomyopathy; Mutation;
   Myocardium; Neuromuscular disorder
ID APICAL HYPERTROPHIC CARDIOMYOPATHY; MYOADENYLATE DEAMINASE DEFICIENCY;
   NON-COMPACTION CARDIOMYOPATHY; NAIL-PATELLA SYNDROME; ACUTE METABOLIC
   DECOMPENSATION; CONGENITAL HEART-DEFECTS; PARKINSON-WHITE-SYNDROME;
   SARCOMERE PROTEIN GENES; DISTAL 1Q MONOSOMY; BARTH-SYNDROME
AB Left ventricular hypertrabeculation (LVHT), also known as noncompaction or spongy myocardium, is a cardiac abnormality of unknown etiology and pathogenesis frequently associated with genetic cardiac and noncardiac disorders, particularly genetic neuromuscular disease. This study aimed to review the current knowledge about the genetic or pathogenetic background of LVHT.
   A literature review of all human studies dealing with the association of LVHT with genetic cardiac and noncardiac disorders, particularly neuromuscular disorders, was conducted.
   Most frequently, LVHT is associated with mitochondrial disorders (mtDNA, nDNA mutations), Barth syndrome (G4.5, TAZ mutations), hypertrophic cardiomyopathy (MYH7, ACTC mutations), zaspopathy (ZASP/LDB3 mutations), myotonic dystrophy 1 (DMPK mutations), and dystrobrevinopathy (DTNA mutations). More rarely, LVHT is associated with mutations in the DMD, SCNA5, MYBPC3, FNLA1, PTPN11, LMNA, ZNF9, AMPD1, PMP22, TNNT2, fibrillin2, SHP2, MMACHC, LMX1B, HCCS, or NR0B1 genes. Additionally, LVHT occurs with a number of chromosomal disorders, polymorphisms, and not yet identified genes, as well in a familial context. The broad heterogeneity of LVHT's genetic background suggests that the uniform morphology of LVHT not only is attributable to embryonic noncompaction but also may result from induction of hypertrabeculation as a compensatory reaction of an impaired myocardium.
   Most frequently, LVHT is associated with mutations in genes causing muscle or cardiac disease, or with chromosomal disorders. These associations require comprehensive cardiac, neurologic, and cytogenetic investigations.
C1 Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
C3 Rudolfstiftung Hospital
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, Postfach 20, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Abe M, 2000, NEUROMUSCULAR DISORD, V10, P472, DOI 10.1016/S0960-8966(00)00127-9
   Adwani SS, 1997, PEDIATR CARDIOL, V18, P143, DOI 10.1007/s002469900135
   ALTENBERGER H, 2008, ACTA CARDIO IN PRESS
   AMANN G, 1992, PEDIATR PATHOL, V12, P83, DOI 10.3109/15513819209023283
   Anderson RH, 2008, EUR HEART J, V29, P10, DOI 10.1093/eurheartj/ehm536
   Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200
   Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660
   Battaglia A, 2008, PEDIATRICS, V121, P404, DOI 10.1542/peds.2007-0929
   Belanger AR, 2008, AM J CARDIOL, V102, P92, DOI 10.1016/j.amjcard.2008.02.107
   Benedetti S, 2005, J NEUROL NEUROSUR PS, V76, P1019, DOI 10.1136/jnnp.2004.046110
   Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154
   Bleyl SB, 1997, AM J MED GENET, V72, P257, DOI 10.1002/(SICI)1096-8628(19971031)72:3<257::AID-AJMG2>3.0.CO;2-O
   Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879
   Bohrer Thomas, 2006, Heart Lung Circ, V15, P269, DOI 10.1016/j.hlc.2006.02.007
   Bongers EMHF, 2008, EUR J HUM GENET, V16, P1240, DOI 10.1038/ejhg.2008.83
   BRAILEY LL, 2006, AM COLL MED GENET
   Breckenridge RA, 2007, CARDIOL YOUNG, V17, P124, DOI 10.1017/S1047951107000273
   Budde BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001362
   Burke A, 2005, HUM PATHOL, V36, P403, DOI 10.1016/j.humpath.2005.02.004
   Chen R, 2002, MOL GENET METAB, V77, P319, DOI 10.1016/S1096-7192(02)00195-6
   CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507
   Corrado G, 2006, CARDIOLOGY, V105, P142, DOI 10.1159/000091152
   Davili Z, 2007, EUR J PEDIATR, V166, P867, DOI 10.1007/s00431-006-0310-1
   De Rosa G, 2005, EUR J PEDIATR, V164, P255, DOI 10.1007/s00431-005-1620-4
   de Vries PJ, 2006, J INTELL DISABIL RES, V50, P690, DOI 10.1111/j.1365-2788.2006.00817.x
   Donati MA, 2006, J INHERIT METAB DIS, V29, P684, DOI 10.1007/s10545-006-0388-7
   DUSEK J, 1975, ARCH PATHOL, V99, P312
   EDSTON E, 2008, INT J LEGAL IN PRESS
   ENGBERDING R, 1984, AM J CARDIOL, V53, P1733, DOI 10.1016/0002-9149(84)90618-0
   EURLINGS LW, 2008, INT J CARDI IN PRESS
   Fazio G, 2007, J CARDIOVASC MED, V8, P904, DOI 10.2459/JCM.0b013e32801462b0
   Fichet J, 2007, PACE, V30, P444, DOI 10.1111/j.1540-8159.2007.00690.x
   Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005
   Finsterer J, 1998, HEART, V80, P632, DOI 10.1136/hrt.80.6.632
   Finsterer J, 2000, EUR NEUROL, V44, P37, DOI 10.1159/000008190
   Finsterer J, 2006, INT J CARDIOL, V106, P420, DOI 10.1016/j.ijcard.2005.01.018
   Finsterer J, 2005, CARDIOLOGY, V103, P167, DOI 10.1159/000084588
   Finsterer J, 2004, CARDIOLOGY, V102, P228, DOI 10.1159/000081015
   Finsterer J, 2004, ACTA CARDIOL, V59, P453, DOI 10.2143/AC.59.4.2005215
   Finsterer J, 2001, EUR NEUROL, V46, P92, DOI 10.1159/000050770
   Finsterer J, 2001, CAN J CARDIOL, V17, P464
   Finsterer J, 2001, HERZ, V26, P477, DOI 10.1007/PL00002051
   FINSTERER J, 2008, INT J CARDI IN PRESS
   FINSTERER J, 2008, HEART VESSE IN PRESS
   Finsterer J, 2008, CLIN CARDIOL, V31, P225, DOI 10.1002/clc.20224
   Finsterer J, 2008, SCAND CARDIOVASC J, V42, P25, DOI 10.1080/14017430701744451
   Finsterer J, 2008, INT J CARDIOL, V123, pE45, DOI 10.1016/j.ijcard.2006.11.120
   Finsterer J, 2007, J CARDIOVASC MED, V8, P1069, DOI 10.2459/JCM.0b013e3280bad892
   Finsterer J, 2007, CARDIOVASC PATHOL, V16, P310, DOI 10.1016/j.carpath.2006.12.005
   Finsterer J, 2007, J ELECTROCARDIOL, V40, P352, DOI 10.1016/j.jelectrocard.2006.11.008
   Finsterer J, 2006, SOUTH MED J, V99, P1304, DOI 10.1097/01.smj.0000247264.90880.d1
   Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO;2-L
   Gasser T, 2001, EUR J NEUROL, V8, P407
   Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034
   HAPPLE R, 1993, AM J MED GENET, V47, P710, DOI 10.1002/ajmg.1320470525
   Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029
   Hoedemaekers YM, 2007, EUR HEART J, V28, P2732, DOI 10.1093/eurheartj/ehm429
   Hofer M, 2007, INT J CARDIOL, V121, P296, DOI 10.1016/j.ijcard.2006.08.065
   Hook S, 1996, PEDIATR CARDIOL, V17, P43, DOI 10.1007/s002469900008
   Hussein A, 1999, KLIN PADIATR, V211, P175, DOI 10.1055/s-2008-1043782
   Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9
   Ichida F, 2001, CIRCULATION, V103, P1256
   Iglesias LM, 2008, REV ESP CARDIOL, V61, P112, DOI 10.1016/S1885-5857(08)60085-7
   Ilercil A, 2006, ECHOCARDIOGR-J CARD, V23, P432, DOI 10.1111/j.1540-8175.2006.00232.x
   Jenni R, 2007, HEART, V93, P11, DOI 10.1136/hrt.2005.082271
   Jenni R, 2002, J AM COLL CARDIOL, V39, P450, DOI 10.1016/S0735-1097(01)01765-X
   Johnson MT, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2006.01.021
   Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X
   Junga G, 1999, EUR HEART J, V20, P910, DOI 10.1053/euhj.1998.1398
   Kaneda T, 2005, CIRCULATION, V112, pE96, DOI 10.1161/CIRCULATIONAHA.104.500256
   Kanemoto N, 2006, EUR J MED GENET, V49, P247, DOI 10.1016/j.ejmg.2005.06.004
   Kaski JP, 2008, HEART, V94, P1478, DOI 10.1136/hrt.2007.134684
   Kawasaki T, 2005, INT J CARDIOL, V99, P147, DOI 10.1016/j.ijcard.2003.11.029
   Kenton AB, 2004, MOL GENET METAB, V82, P162, DOI 10.1016/j.ymgme.2004.02.009
   KHALID SK, 2004, J AM SOC ECHOCARDIOG, V17, P87
   Kherbaoui-Redouani L, 2003, ARCH PEDIATRIE, V10, P224, DOI 10.1016/S0929-693X(03)00014-9
   Kirsch Jacobo, 2007, Int J Cardiol, V118, pe46, DOI 10.1016/j.ijcard.2006.12.056
   Klaassen S, 2008, CIRCULATION, V117, P2893, DOI 10.1161/CIRCULATIONAHA.107.746164
   Kline AD, 2007, AM J MED GENET A, V143A, P1287, DOI 10.1002/ajmg.a.31757
   Kobza R, 2008, PACE, V31, P461, DOI 10.1111/j.1540-8159.2008.01015.x
   Korcyk D, 2004, J CARDIOVASC MAGN R, V6, P569, DOI 10.1081/JCMR-120030586
   Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940
   Limongelli G, 2007, AM J CARDIOL, V100, P736, DOI 10.1016/j.amjcard.2007.03.093
   Lofiego C, 2006, AM J CARDIOL, V97, P738, DOI 10.1016/j.amjcard.2005.09.109
   MAKITA N, 2006, AM HEART ASS SCI SES
   Mandel K, 2001, CARDIOL YOUNG, V11, P240, DOI 10.1017/S1047951101000208
   Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0
   Marziliano N, 2007, AM J MED GENET A, V143A, P907, DOI 10.1002/ajmg.a.31653
   Matsumoto Tae, 2006, Journal of Nippon Medical School, V73, P285, DOI 10.1272/jnms.73.285
   Mazzocco MMM, 2001, AM J MED GENET, V102, P372, DOI 10.1002/ajmg.1487
   McMahon CJ, 2007, HEART, V93, P676, DOI 10.1136/hrt.2006.093880
   Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563
   Monserrat L, 2007, EUR HEART J, V28, P1953, DOI 10.1093/eurheartj/ehm239
   Moorman A.F.M., 1999, HEART DEV, P195
   Murphy RT, 2005, EUR HEART J, V26, P187, DOI 10.1093/eurheartj/ehi025
   Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756
   Nemes A, 2008, INT J CARDIOVAS IMAG, V24, P237, DOI 10.1007/s10554-007-9261-5
   Neudorf UE, 2001, CARDIOL YOUNG, V11, P439, DOI 10.1017/S1047951101000567
   Norman B, 1998, J APPL PHYSIOL, V85, P1273, DOI 10.1152/jappl.1998.85.4.1273
   Oechslin EN, 2000, J AM COLL CARDIOL, V36, P493, DOI 10.1016/S0735-1097(00)00755-5
   Olasoji H O, 2007, Niger Postgrad Med J, V14, P140
   Pascal C, 2005, ARCH MAL COEUR VAISS, V98, P443
   Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S
   Petersen SE, 2005, J AM COLL CARDIOL, V46, P101, DOI 10.1016/j.jacc.2005.03.045
   PFAMMATTER JP, 1995, Z KARDIOL, V84, P947
   Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406
   Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8
   Porciello R, 2008, Dermatol Online J, V14, P7
   Rankin J, 2008, AM J MED GENET A, V146A, P1530, DOI 10.1002/ajmg.a.32331
   RIBEIRO MCM, 1987, ANN GENET-PARIS, V30, P126
   Rico-Sanz J, 2003, PHYSIOL GENOMICS, V14, P161, DOI 10.1152/physiolgenomics.00165.2002
   Ronghe MD, 2001, ACTA PAEDIATR, V90, P584, DOI 10.1080/080352501750197773
   SA MI, 2007, REV PORT CARDIOL, V27, P829
   Sabina RL, 2000, NEUROL CLIN, V18, P185, DOI 10.1016/S0733-8619(05)70184-5
   Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13
   Sasse-Klaassen S, 2004, CIRCULATION, V109, P2720, DOI 10.1161/01.CIR.0000131865.21260.56
   Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718
   Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108
   Sedmera David, 2008, Heart Fail Clin, V4, P235, DOI 10.1016/j.hfc.2008.02.007
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376
   Sen-Chowdhry S, 2008, CURR OPIN CARDIOL, V23, P171, DOI 10.1097/HCO.0b013e3282fdc939
   Serés L, 2003, CLIN CARDIOL, V26, P46, DOI 10.1002/clc.4960260111
   Shan L, 2008, MOL GENET METAB, V93, P468, DOI 10.1016/j.ymgme.2007.10.009
   SIBERG K, 2008, EUR J MED G IN PRESS
   Soler R, 2002, J COMPUT ASSIST TOMO, V26, P373, DOI 10.1097/00004728-200205000-00011
   Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667
   Spirito P, 2007, EUR HEART J, V28, P1923, DOI 10.1093/eurheartj/ehm266
   Steiner I, 1996, CARDIOVASC PATHOL, V5, P47, DOI 10.1016/1054-8807(95)00058-5
   Stöllberger C, 2007, J CARD FAIL, V13, P211, DOI 10.1016/j.cardfail.2006.11.007
   Stollberger C, 1996, HEART, V76, P380, DOI 10.1136/hrt.76.4.380
   Stöllberger C, 2002, AM J CARDIOL, V90, P899, DOI 10.1016/S0002-9149(02)02723-6
   Stöllberger C, 2004, J AM SOC ECHOCARDIOG, V17, P91, DOI 10.1016/S0894-7317(03)00514-5
   STOLLBERGER C, 2008, ACTA CARDIO IN PRESS
   Stöllberger C, 2007, INT J CARDIOL, V121, P189, DOI 10.1016/j.ijcard.2006.11.007
   TANPAIBOON P, 2006, AM SOC HUM GEN ANN M
   Thienpont B, 2007, EUR J MED GENET, V50, P233, DOI 10.1016/j.ejmg.2007.01.002
   Toyono M, 2001, Heart, V86, pE4
   TURLEAU C, 1983, ANN GENET-PARIS, V26, P161
   van Heerde M, 2003, CARDIOL YOUNG, V13, P364, DOI 10.1017/S1047951103000738
   Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021
   Vijayvergiya R, 2008, INT J CARDIOL, V123, pE54, DOI 10.1016/j.ijcard.2006.11.147
   Wahbi K, 2008, NEUROMUSCULAR DISORD, V18, P331, DOI 10.1016/j.nmd.2007.11.012
   Wang JC, 2007, AM J MED GENET A, V143A, P2744, DOI 10.1002/ajmg.a.32004
   Watson WJ, 2007, J ULTRAS MED, V26, P1209, DOI 10.7863/jum.2007.26.9.1209
   Wessels MW, 2008, HUM GENET, V122, P595, DOI 10.1007/s00439-007-0436-x
   Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064
   Wong JA, 1997, AM J MED GENET, V71, P72, DOI 10.1002/(SICI)1096-8628(19970711)71:1<72::AID-AJMG13>3.0.CO;2-S
   Xing YL, 2006, MOL GENET METAB, V88, P71, DOI 10.1016/j.ymgme.2005.11.009
   Yaplito-Lee J, 2007, J PEDIATR-US, V150, P407, DOI 10.1016/j.jpeds.2006.12.047
   Yen TY, 2008, EUR J PEDIATR, V167, P941, DOI 10.1007/s00431-007-0592-y
   Zaragoza MV, 2007, CURR OPIN PEDIATR, V19, P619, DOI 10.1097/MOP.0b013e3282f1ecbc
   Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092
   Zimpfer A, 2007, FETAL PEDIATR PATHOL, V26, P169, DOI 10.1080/15513810701696874
NR 153
TC 166
Z9 192
U1 2
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JUL
PY 2009
VL 30
IS 5
BP 659
EP 681
DI 10.1007/s00246-008-9359-0
PG 23
WC Cardiac & Cardiovascular Systems; Pediatrics
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cardiovascular System & Cardiology; Pediatrics
GA 458ON
UT WOS:000267033500012
PM 19184181
DA 2024-11-01
ER

PT J
AU Rustamov, J
   Rustamov, Z
   Mohamad, MS
   Zaki, N
   Al Tenaiji, A
   Al Harbi, M
   Al Jasmi, F
AF Rustamov, Jaloliddin
   Rustamov, Zahiriddin
   Mohamad, Mohd Saberi
   Zaki, Nazar
   Al Tenaiji, Amal
   Al Harbi, Mariam
   Al Jasmi, Fatma
TI An expert rule-based approach for identifying infantile-onset Pompe
   disease patients using retrospective electronic health records
SO SCIENTIFIC REPORTS
LA English
DT Article
DE Pompe disease; Infantile onset Pompe disease; Electronic health records;
   Expert rule-based screening; PowerBI; Dashboard analytics
ID RESPIRATORY-FAILURE; DIAGNOSIS
AB Pompe disease (OMIM #232300), a rare genetic disorder, leads to glycogen buildup in the body due to an enzyme deficiency, particularly harming the heart and muscles. Infantile-onset Pompe disease (IOPD) requires urgent treatment to prevent mortality, but the unavailability of these methods often delays diagnosis. Our study aims to streamline IOPD diagnosis in the UAE using electronic health records (EHRs) for faster, more accurate detection and timely treatment initiation. This study utilized electronic health records from the Abu Dhabi Healthcare Company (SEHA) healthcare network in the UAE to develop an expert rule-based screening approach operationalized through a dashboard. The study encompassed six diagnosed IOPD patients and screened 93,365 subjects. Expert rules were formulated to identify potential high-risk IOPD patients based on their age, particular symptoms, and creatine kinase levels. The proposed approach was evaluated using accuracy, sensitivity, and specificity. The proposed approach accurately identified five true positives, one false negative, and four false positive IOPD cases. The false negative case involved a patient with both Pompe disease and congenital heart disease. The focus on CHD led to the overlooking of Pompe disease, exacerbated by no measurement of creatine kinase. The false positive cases were diagnosed with Mitochondrial DNA depletion syndrome 12-A (SLC25A4 gene), Immunodeficiency-71 (ARPC1B mutation), Niemann-Pick disease type C (NPC1 gene mutation leading to frameshift), and Group B Streptococcus meningitis. The proposed approach of integrating expert rules with a dashboard facilitated efficient data visualization and automated patient screening, which aids in the early detection of Pompe disease. Future studies are encouraged to investigate the application of machine learning methodologies to enhance further the precision and efficiency of identifying patients with IOPD.
C1 [Rustamov, Jaloliddin; Al Jasmi, Fatma] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Genet & Genom, Al Ain, U Arab Emirates.
   [Rustamov, Zahiriddin; Zaki, Nazar] United Arab Emirates Univ, Coll Informat Technol, Dept Comp Sci & Software Engn, Al Ain, U Arab Emirates.
   [Rustamov, Zahiriddin; Zaki, Nazar; Al Jasmi, Fatma] United Arab Emirates Univ, ASPIRE Precis Med Res Inst Abu Dhabi, Al Ain, U Arab Emirates.
   [Al Tenaiji, Amal] Sheikh Khalifa Med City, Dept Pediat, Abu Dhabi, U Arab Emirates.
   [Al Harbi, Mariam] SEHA Corp Med & Clin Affairs, Res Dept, Abu Dhabi, U Arab Emirates.
   [Al Jasmi, Fatma] Tawam Hosp, Dept Pediat, Al Ain, U Arab Emirates.
   [Mohamad, Mohd Saberi] United Arab Emirates Univ, Coll Med & Hlth Sci, Hlth Data Sci Lab, Al Ain, U Arab Emirates.
   [Mohamad, Mohd Saberi] Multimedia Univ, Fac Engn & Technol, Ctr Engn Computat Intelligence, Melaka, Malaysia.
C3 United Arab Emirates University; United Arab Emirates University; United
   Arab Emirates University; United Arab Emirates University; Multimedia
   University
RP Rustamov, J; Al Jasmi, F (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Genet & Genom, Al Ain, U Arab Emirates.; Al Jasmi, F (corresponding author), United Arab Emirates Univ, ASPIRE Precis Med Res Inst Abu Dhabi, Al Ain, U Arab Emirates.; Al Jasmi, F (corresponding author), Tawam Hosp, Dept Pediat, Al Ain, U Arab Emirates.
EM 700043175@uaeu.ac.ae; aljasmif@uaeu.ac.ae
RI Rustamov, Zahiriddin/HKN-2400-2023
OI Rustamov, Zahiriddin/0000-0003-4977-1781
FU Sanofi; ASPIRE, the technology program management pillar of Abu Dhabi's
   Advanced Technology Research Council (ATRC); ASPIRE Precision Medicine
   Research Institute Abu Dhabi (ASPIREPMRIAD) [VRI-20-10];  [21M142]
FX This research is supported by ASPIRE, the technology program management
   pillar of Abu Dhabi's Advanced Technology Research Council (ATRC), via
   the ASPIRE Precision Medicine Research Institute Abu Dhabi
   (ASPIREPMRIAD) award grant number VRI-20-10. We also express our
   profound gratitude to Sanofi for their financial support of our research
   (grant fund code 21M142).
CR Al Hassnan Z, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02545-w
   Al Jasmi F, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0412-3
   Al-Hassnan Z, 2023, ORPHANET J RARE DIS, V18, DOI 10.1186/s13023-023-02967-0
   Al-Jasmi FA, 2016, JIMD REP, V28, P127, DOI 10.1007/8904_2015_512
   Alonso-Pérez J, 2020, MED CLIN-BARCELONA, V154, P80, DOI 10.1016/j.medcli.2019.03.036
   Ansong AK, 2006, GENET MED, V8, P297, DOI 10.1097/01.gim.0000195896.04069.5f
   Bay LB, 2019, ARCH ARGENT PEDIATR, V117, P271, DOI 10.5546/aap.2019.eng.271
   Bembi B, 2003, J INHERIT METAB DIS, V26, P675, DOI 10.1023/B:BOLI.0000005618.76542.ed
   Case LE, 2007, PEDIATR RADIOL, V37, P437, DOI 10.1007/s00247-007-0428-y
   Chien YH, 2013, PEDIATR NEONATOL, V54, P219, DOI 10.1016/j.pedneo.2013.03.009
   Crossen K, 2022, INT J NEONAT SCREEN, V8, DOI 10.3390/ijns8030043
   Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807
   Howell RR, 2006, GENET MED, V8, P289, DOI 10.1097/01.gim.0000204462.42910.b8
   Kishnani PS, 2023, GENET MED, V25, DOI 10.1016/j.gim.2022.10.010
   Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033
   Kishnani PS, 2006, GENET MED, V8, P267, DOI 10.1097/01.gim.0000218152.87434.f3
   Kishnani PS, 2006, J PEDIATR-US, V149, P89, DOI 10.1016/j.jpeds.2006.02.035
   Lin SM, 2023, FRONT NEUROL, V14, DOI 10.3389/fneur.2023.1108222
   Mellies U, 2005, NEUROLOGY, V64, P1465, DOI 10.1212/01.WNL.0000158682.85052.C0
   Mellies U, 2001, NEUROLOGY, V57, P1290, DOI 10.1212/WNL.57.7.1290
   Richardson JS, 2021, GENET MED, V23, P758, DOI 10.1038/s41436-020-01038-0
   Rustamov J, 2023, SUSTAINABILITY-BASEL, V15, DOI 10.3390/su15107782
   Sawada T, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-02146-z
   Stevens D, 2022, CURR TREAT OPTION NE, V24, P573, DOI 10.1007/s11940-022-00736-1
   Talukdar J., 2023, Artificial Intelligence in Healthcare Industry, P145, DOI [10.1007/978-981-99-3157-68, DOI 10.1007/978-981-99-3157-68]
   van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332
   van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X
   Zaki N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-150
   Zhao YY, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1054-0
NR 29
TC 0
Z9 0
U1 0
U2 0
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 14
PY 2024
VL 14
IS 1
AR 21523
DI 10.1038/s41598-024-72259-5
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA H3M6P
UT WOS:001322516400034
PM 39277702
OA gold
DA 2024-11-01
ER

PT J
AU Di Marco, LY
   Venneri, A
   Farkas, E
   Evans, PC
   Marzo, A
   Frangi, AF
AF Di Marco, Luigi Yuri
   Venneri, Annalena
   Farkas, Eszter
   Evans, Paul C.
   Marzo, Alberto
   Frangi, Alejandro F.
TI Vascular dysfunction in the pathogenesis of Alzheimer's disease - A
   review of endothelium-mediated mechanisms and ensuing vicious circles
SO NEUROBIOLOGY OF DISEASE
LA English
DT Review
DE Alzheimer's disease; Blood-brain barrier permeability; Cerebral
   hypoperfusion; Endothelial dysfunction; Mitochondrial dysfunction;
   Ultrastructural damage
ID BLOOD-BRAIN-BARRIER; PROTEIN-KINASE-C; AMYLOID-BETA PROTEIN;
   NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; CHRONIC CEREBRAL
   HYPOPERFUSION; POSITRON EMISSION TOMOGRAPHY; MITOCHONDRIA DNA DELETIONS;
   RECEPTOR-RELATED PROTEIN-1; CENTRAL-NERVOUS-SYSTEM
AB Late-onset dementia is a major health concern in the ageing population. Alzheimer's disease (AD) accounts for the largest proportion (65-70%) of dementia cases in the older population.
   Despite considerable research effort, the pathogenesis of late-onset AD remains unclear. Substantial evidence suggests that the neurodegenerative process is initiated by chronic cerebral hypoperfusion (CCH) caused by ageing and cardiovascular conditions. CCH causes reduced oxygen, glucose and other nutrient supply to the brain, with direct damage not only to the parenchymal cells, but also to the blood-brain barrier (BBB), a key mediator of cerebral homeostasis. BBB dysfunction mediates the indirect neurotoxic effects of CCH by promoting oxidative stress, inflammation, paracellular permeability, and dysregulation of nitric oxide, a key regulator of regional blood flow. As such, BBB dysfunction mediates a vicious circle in which cerebral perfusion is reduced further and the neurodegenerative process is accelerated. Endothelial interaction with pericytes and astrocytes could also play a role in the process. Reciprocal interactions between vascular dysfunction and neurodegeneration could further contribute to the development of the disease.
   A comprehensive overview of the complex scenario of interacting endothelium-mediated processes is currently lacking, and could prospectively contribute to the identification of adequate therapeutic interventions.
   This study reviews the current literature of in vitro and ex vivo studies on endothelium-mediated mechanisms underlying vascular dysfunction in AD pathogenesis, with the aim of presenting a comprehensive overview of the complex network of causative relationships. Particular emphasis is given to vicious circles which can accelerate the process of neurovascular degeneration. (C) 2015 Published by Elsevier Inc.
C1 [Di Marco, Luigi Yuri; Frangi, Alejandro F.] Univ Sheffield, Dept Elect & Elect Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
   [Venneri, Annalena] Univ Sheffield, Sch Med, Dept Neurosci, Sheffield S1 3JD, S Yorkshire, England.
   [Venneri, Annalena] IRCCS San Camillo Fdn Hosp, Venice, Italy.
   [Farkas, Eszter] Univ Szeged, Fac Med, Dept Med Phys & Informat, Szeged, Hungary.
   [Farkas, Eszter] Univ Szeged, Fac Sci & Informat, Szeged, Hungary.
   [Evans, Paul C.] Univ Sheffield, Sch Med, Dept Cardiovasc Sci, Sheffield S1 3JD, S Yorkshire, England.
   [Marzo, Alberto] Univ Sheffield, Dept Mech Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
C3 University of Sheffield; University of Sheffield; IRCCS Ospedale San
   Camillo; Szeged University; Szeged University; University of Sheffield;
   University of Sheffield
RP Di Marco, LY (corresponding author), Univ Sheffield, Dept Elect & Elect Engn, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield S1 3JD, S Yorkshire, England.
EM luigiyuri.dimarco@gmail.com
RI ; Frangi, Alejandro/C-6500-2008
OI Farkas, Eszter/0000-0002-8478-9664; Evans, Paul/0000-0001-7975-681X;
   Frangi, Alejandro/0000-0002-2675-528X
FU European Union's Seventh Framework Programme (FP7) as part of the
   project VPH-DARE@IT [601055]; Engineering and Physical Sciences Research
   Council (EPSRC) (OCEAN Project) [EP/M006328/1]; Bolyai Janos Research
   Scholarship of the Hungarian Academy of Sciences [BO/00327/14/5]; EPSRC
   [EP/M006328/1] Funding Source: UKRI
FX This study was partially funded by the European Union's Seventh
   Framework Programme (FP7/2007-2013) as part of the project VPH-DARE@IT
   (grant agreement no. 601055); and by the Engineering and Physical
   Sciences Research Council (EPSRC) (OCEAN Project, grant no.
   EP/M006328/1). Dr Farkas is supported by the Bolyai Janos Research
   Scholarship of the Hungarian Academy of Sciences (BO/00327/14/5). There
   are no conflicts of interest associated with this work.
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
   Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668
   Abete P, 2014, AGEING RES REV, V18, P41, DOI 10.1016/j.arr.2014.07.003
   AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F
   Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303
   Aliev G, 2003, NEUROTOX RES, V5, P491, DOI 10.1007/BF03033159
   Aliev G, 2002, ANN NY ACAD SCI, V977, P45, DOI 10.1111/j.1749-6632.2002.tb04798.x
   Aliev G, 2002, BRAIN PATHOL, V12, P21
   Aliev Gjumrakch, 2011, Recent Pat Cardiovasc Drug Discov, V6, P222
   Aliev G, 2008, VASC HEALTH RISK MAN, V4, P721, DOI 10.2147/VHRM.S2608
   Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5
   Aliyev A, 2005, J NEUROL SCI, V229, P285, DOI 10.1016/j.jns.2004.11.040
   Alonso A, 2009, J NEUROL SCI, V280, P79, DOI 10.1016/j.jns.2009.02.004
   Andjelkovic AV, 1998, J NEUROSCI RES, V51, P423, DOI 10.1002/(SICI)1097-4547(19980215)51:4<423::AID-JNR2>3.0.CO;2-E
   Atamna H, 2007, MITOCHONDRION, V7, P297, DOI 10.1016/j.mito.2007.06.001
   Austin SA, 2013, J NEUROCHEM, V127, P691, DOI 10.1111/jnc.12334
   Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080
   Bamji-Mirza M, 2014, J ALZHEIMERS DIS, V40, P105, DOI 10.3233/JAD-131949
   Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612
   Bauer HC, 2000, CELL MOL NEUROBIOL, V20, P13, DOI 10.1023/A:1006939825857
   Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043
   Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3
   Bennett SAL, 2000, NEUROBIOL AGING, V21, P207, DOI 10.1016/S0197-4580(00)00131-7
   Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041
   BENSON DF, 1983, ARCH NEUROL-CHICAGO, V40, P711, DOI 10.1001/archneur.1983.04050110029003
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   Blanc EM, 1997, J NEUROCHEM, V68, P1870
   Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14
   BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698
   BROADWELL RD, 1981, P NATL ACAD SCI-BIOL, V78, P7820, DOI 10.1073/pnas.78.12.7820
   Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001
   Brown RC, 2005, BIOCHEM BIOPH RES CO, V327, P1114, DOI 10.1016/j.bbrc.2004.12.123
   Bürger S, 2009, INT J DEV NEUROSCI, V27, P517, DOI 10.1016/j.ijdevneu.2009.06.011
   Bulbarelli A, 2012, MOL CELL NEUROSCI, V49, P415, DOI 10.1016/j.mcn.2012.01.007
   Burgmans S, 2013, J ALZHEIMERS DIS, V35, P859, DOI 10.3233/JAD-122155
   BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U
   Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9
   Calderone V, 2010, BIOCHEM PHARMACOL, V79, P39, DOI 10.1016/j.bcp.2009.07.017
   Cardoso SM, 2004, NEUROBIOL AGING, V25, P105, DOI 10.1016/S0197-4580(03)00033-2
   Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje
   Chaitanya GV, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-7
   Ciallella JR, 1999, THROMB HAEMOSTASIS, V81, P630
   Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247
   Claudio L, 1996, ACTA NEUROPATHOL, V91, P6
   COLE G, 1988, BRAIN RES, V452, P165, DOI 10.1016/0006-8993(88)90021-2
   Coma M, 2008, NEUROBIOL AGING, V29, P969, DOI 10.1016/j.neurobiolaging.2007.01.009
   Cordonnier C, 2011, BRAIN, V134, P335, DOI 10.1093/brain/awq321
   Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005
   Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021
   De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001
   de la Torre JC, 2002, J ALZHEIMERS DIS, V4, P497, DOI 10.3233/jad-2002-4606
   de la Torre JC, 2012, J ALZHEIMERS DIS, V32, P553, DOI 10.3233/JAD-2012-120793
   de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002
   de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057
   de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0
   de la Torre JC, 2000, BRAIN RES REV, V34, P119, DOI 10.1016/S0165-0173(00)00043-6
   Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890
   Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663
   DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465
   DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x
   Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8
   Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759
   Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3
   Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469
   DORHEIM MA, 1994, BIOCHEM BIOPH RES CO, V205, P659, DOI 10.1006/bbrc.1994.2716
   DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879
   Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080
   Engelhardt S, 2014, J CELL PHYSIOL, V229, P1096, DOI 10.1002/jcp.24544
   Farkas E, 2000, ACTA NEUROPATHOL, V100, P395, DOI 10.1007/s004010000195
   Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X
   Farkas E., 2006, VASC DIS PREV, V3, P253, DOI [10.2174/156727006778019167, DOI 10.2174/156727006778019167]
   Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003
   Farkas IG, 2003, ACTA HISTOCHEM, V105, P115, DOI 10.1078/0065-1281-00696
   FAULSTICH ME, 1991, INT J NEUROSCI, V57, P39, DOI 10.3109/00207459109150345
   FERRARIDILEO G, 1985, J CEREBR BLOOD F MET, V5, P458, DOI 10.1038/jcbfm.1985.62
   Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367
   Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812
   Folin M, 2005, INT J MOL MED, V15, P929
   Fonseca A.C., 2014, Mol Neurobiol
   Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007
   Fossati S, 2012, NEURODEGENER DIS, V10, P324, DOI 10.1159/000332821
   FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605
   FRIEDLAND RP, 1989, NEUROLOGY, V39, P1427, DOI 10.1212/WNL.39.11.1427
   FROHMAN EM, 1991, J NEUROL SCI, V106, P105, DOI 10.1016/0022-510X(91)90202-I
   Garcia-Escudero V., 2013, OXID MED CELL LONGEV, V2013, DOI DOI 10.1155/2013/162152
   Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9
   Gentile MT, 2004, J BIOL CHEM, V279, P48135, DOI 10.1074/jbc.M407358200
   Giri R, 2002, AM J PHYSIOL-CELL PH, V283, pC895, DOI 10.1152/ajpcell.00293.2001
   Giri R, 2000, AM J PHYSIOL-CELL PH, V279, pC1772, DOI 10.1152/ajpcell.2000.279.6.C1772
   Gonzalez-Velasquez FJ, 2008, J NEUROCHEM, V104, P500, DOI 10.1111/j.1471-4159.2007.04988.x
   Gonzalez-Velasquez FJ, 2011, CURR ALZHEIMER RES, V8, P81
   GRAMMAS P, 1995, DEMENTIA, V6, P126, DOI 10.1159/000106934
   Grammas P, 2004, J ALZHEIMERS DIS, V6, P275
   GRAMMAS P, 1995, NEUROBIOL AGING, V16, P563, DOI 10.1016/0197-4580(95)00048-J
   Grammas P, 2002, J ALZHEIMERS DIS, V4, P217, DOI 10.3233/JAD-2002-4311
   Grammas P, 2001, NEUROBIOL AGING, V22, P837, DOI 10.1016/S0197-4580(01)00276-7
   Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4
   Grammas P, 2006, J ALZHEIMERS DIS, V9, P51
   Grammas Paula, 2011, Cleve Clin J Med, V78 Suppl 1, pS50, DOI 10.3949/ccjm.78.s1.09
   Grammas P, 2011, INT J CLIN EXP PATHO, V4, P616
   Grammas P, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001918
   Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26
   Guglielmotto M, 2009, J NEUROCHEM, V108, P1045, DOI 10.1111/j.1471-4159.2008.05858.x
   Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165
   Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7
   Harb R, 2013, J CEREBR BLOOD F MET, V33, P146, DOI 10.1038/jcbfm.2012.152
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067
   HARIK SI, 1981, J CEREBR BLOOD F MET, V1, P329, DOI 10.1038/jcbfm.1981.36
   HARIK SI, 1986, P NATL ACAD SCI USA, V83, P4067, DOI 10.1073/pnas.83.11.4067
   HARIK SI, 1992, CAN J PHYSIOL PHARM, V70, pS113, DOI 10.1139/y92-252
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516
   HEISS WD, 1991, J NEURAL TRANSM-GEN, P13
   Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008
   Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295
   Hughes TF, 2010, AM J ALZHEIMERS DIS, V25, P432, DOI 10.1177/1533317510368399
   Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6
   Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163
   JAGUST WJ, 1991, J CEREBR BLOOD F MET, V11, P323, DOI 10.1038/jcbfm.1991.65
   Jellinger KA, 2005, J NEUROL SCI, V229, P37, DOI 10.1016/j.jns.2004.11.018
   Jeynes B, 2008, CURR ALZHEIMER RES, V5, P432, DOI 10.2174/156720508785908937
   Jeynes B, 2009, NEUROSCI LETT, V463, P244, DOI 10.1016/j.neulet.2009.07.091
   JOHSHITA H, 1993, ADV EXP MED BIOL, V331, P61
   Kalaria RN, 2012, J NEUROL SCI, V322, P141, DOI 10.1016/j.jns.2012.07.032
   Kalaria RN, 1995, BRAIN RES, V705, P349, DOI 10.1016/0006-8993(95)01250-8
   KALARIA RN, 1995, NEUROREPORT, V6, P477, DOI 10.1097/00001756-199502000-00018
   KALARIA RN, 1989, NEUROSCI LETT, V106, P233, DOI 10.1016/0304-3940(89)90231-0
   KALARIA RN, 1989, NEUROSCI LETT, V97, P203, DOI 10.1016/0304-3940(89)90164-X
   KALARIA RN, 1989, J NEUROCHEM, V53, P1083, DOI 10.1111/j.1471-4159.1989.tb07399.x
   Kalaria RN, 2003, INT PSYCHOGERIATR, V15, P47, DOI 10.1017/S1041610203008950
   Kalaria RN, 1996, MOL BRAIN RES, V35, P58, DOI 10.1016/0169-328X(95)00180-Z
   Kalaria RN, 1997, ANN NY ACAD SCI, V826, P263, DOI 10.1111/j.1749-6632.1997.tb48478.x
   Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1
   Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008
   Katusic ZS, 2014, EUR HEART J, V35, P888, DOI 10.1093/eurheartj/eht544
   Kelleher RJ, 2013, AM J CARDIOVASC DIS, V3, P197
   KOBAYASHI H, 1982, NEUROLOGY, V32, P1384, DOI 10.1212/WNL.32.12.1384
   Kook SY, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23993
   Kook SY, 2012, J NEUROSCI, V32, P8845, DOI 10.1523/JNEUROSCI.6102-11.2012
   Krizbai IA, 2005, CELL MOL NEUROBIOL, V25, P129, DOI 10.1007/s10571-004-1378-7
   Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x
   Latta C.H., 2014, NEUROSCIENCE
   Lenzsér G, 2005, BRAIN RES, V1051, P72, DOI 10.1016/j.brainres.2005.05.064
   Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007
   Lucke-Wold BP, 2015, J ALZHEIMERS DIS, V43, P711, DOI 10.3233/JAD-141422
   Lue LF, 2001, GLIA, V35, P72, DOI 10.1002/glia.1072
   Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23
   Lyros E, 2014, CURR ALZHEIMER RES, V11, P18, DOI 10.2174/1567205010666131119235254
   Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029
   Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066
   Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001
   MARTINEZ M, 1994, NEUROSCI LETT, V170, P121, DOI 10.1016/0304-3940(94)90254-2
   MASLIAH E, 1991, J NEUROSCI, V11, P2759
   Matsushima H, 1996, J NEUROCHEM, V67, P317
   Maxwell AJ, 2002, NITRIC OXIDE-BIOL CH, V6, P101, DOI 10.1006/niox.2001.0394
   McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8
   Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001
   Miller MC, 2008, BRAIN RES, V1230, P273, DOI 10.1016/j.brainres.2008.06.124
   Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Moore P, 1998, NEUROSCI LETT, V254, P29, DOI 10.1016/S0304-3940(98)00653-3
   MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829
   Müller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5
   MUTISYA EM, 1994, J NEUROCHEM, V63, P2179
   Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024
   Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532
   Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759
   Nunomura A, 2006, J NEUROPATH EXP NEUR, V65, P631, DOI 10.1097/01.jnen.0000228136.58062.bf
   Oishi K, 2007, MICROVASC RES, V73, P20, DOI 10.1016/j.mvr.2006.08.004
   Owen JB, 2010, FREE RADICAL BIO MED, V49, P1798, DOI 10.1016/j.freeradbiomed.2010.09.013
   Pakaski M, 2002, NEUROCHEM INT, V41, P409, DOI 10.1016/S0197-0186(02)00026-8
   Palmer JC, 2013, J ALZHEIMERS DIS, V36, P577, DOI 10.3233/JAD-130383
   Paris Daniel, 2004, Angiogenesis, V7, P75, DOI 10.1023/B:AGEN.0000037335.17717.bf
   Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005
   Park R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.258
   PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090
   Peers C, 2009, ANN NY ACAD SCI, V1177, P169, DOI 10.1111/j.1749-6632.2009.05026.x
   Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193
   Perluigi M, 2014, AGEING RES REV, V13, P75, DOI 10.1016/j.arr.2013.12.005
   PEROUTKA SJ, 1980, SCIENCE, V208, P610, DOI 10.1126/science.6102801
   Perry G, 2000, INT J DEV NEUROSCI, V18, P417, DOI 10.1016/S0736-5748(00)00006-X
   Placido AI., 2014, Molecular neurobiology
   Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998
   Provias J, 2014, Int J Alzheimers Dis, V2014, P191863, DOI 10.1155/2014/191863
   Provias J, 2008, CURR NEUROVASC RES, V5, P199, DOI 10.2174/156720208785425729
   Reinhardt CA, 1997, TOXICOL IN VITRO, V11, P513, DOI 10.1016/S0887-2333(97)00039-8
   Roberts KF, 2014, ANN NEUROL, V76, P837, DOI 10.1002/ana.24270
   Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44
   Roher AE, 2011, ALZHEIMERS DEMENT, V7, P436, DOI 10.1016/j.jalz.2010.08.228
   Rosengarten B, 2006, J NEUROL, V253, P58, DOI 10.1007/s00415-005-0926-5
   RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725
   Ruzali WAW, 2013, J ALZHEIMERS DIS, V33, P95, DOI 10.3233/JAD-2012-121336
   Sagare A.P., 2012, COLD SPRING HARB PER
   Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932
   Sanchez A, 2013, J ALZHEIMERS DIS, V34, P281, DOI 10.3233/JAD-121636
   Sanchez A, 2012, J ALZHEIMERS DIS, V32, P587, DOI 10.3233/JAD-2012-120829
   SATO A, 1995, ALZ DIS ASSOC DIS, V9, P28, DOI 10.1097/00002093-199505000-00007
   Schini-Kerth VB, 1999, TRANSFUS CLIN BIOL, V6, P355, DOI 10.1016/S1246-7820(00)88980-6
   Shah K, 2012, INT J MOL SCI, V13, P12629, DOI 10.3390/ijms131012629
   Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P1034, DOI 10.1097/NEN.0b013e3181f46e25
   Silverberg GD, 2010, J NEUROPATH EXP NEUR, V69, P98, DOI 10.1097/NEN.0b013e3181c8ad2f
   SIMPSON IA, 1994, ANN NEUROL, V35, P546, DOI 10.1002/ana.410350507
   Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5
   Smith MA, 1997, J NEUROSCI, V17, P2653
   Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0
   STEWART PA, 1992, LAB INVEST, V67, P734
   Strasser A, 1997, ACT NEUR S, V70, P8
   Suhara T, 2003, NEUROBIOL AGING, V24, P437, DOI 10.1016/S0197-4580(02)00135-5
   Sun MK, 2004, J ALZHEIMERS DIS, V6, P355
   Suo ZM, 1998, BRAIN RES, V807, P110, DOI 10.1016/S0006-8993(98)00780-X
   Toda N, 2012, J ALZHEIMERS DIS, V32, P569, DOI 10.3233/JAD-2012-120670
   Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547
   Tong XK, 1999, NEUROSCIENCE, V92, P163, DOI 10.1016/S0306-4522(98)00750-7
   Tripathy D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00019
   Uchihara T, 1997, STROKE, V28, P1948, DOI 10.1161/01.STR.28.10.1948
   Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   van Assema DME, 2012, BRAIN, V135, P181, DOI 10.1093/brain/awr298
   Van Beek AHEA, 2011, BEHAV BRAIN RES, V221, P537, DOI 10.1016/j.bbr.2009.12.047
   van Norden AGW, 2012, BBA-MOL BASIS DIS, V1822, P340, DOI 10.1016/j.bbadis.2011.07.003
   Vogelgesang S, 2002, PHARMACOGENETICS, V12, P535, DOI 10.1097/00008571-200210000-00005
   Vromman A, 2013, AGING CELL, V12, P358, DOI 10.1111/acel.12056
   Vukic V, 2009, NEUROBIOL DIS, V34, P95, DOI 10.1016/j.nbd.2008.12.007
   Walsh T, 2009, J AM GERIATR SOC, V57, P140, DOI 10.1111/j.1532-5415.2008.02051.x
   WANG HY, 1994, NEUROBIOL AGING, V15, P293, DOI 10.1016/0197-4580(94)90023-X
   Wang JY, 2006, CURR PHARM DESIGN, V12, P3521, DOI 10.2174/138161206778343109
   Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004
   Whitehouse PJ, 1997, PSYCHOPHARMACOL BULL, V33, P129
   Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050
   Wilson RS, 2011, ALZHEIMERS DEMENT, V7, P74, DOI 10.1016/j.jalz.2010.11.006
   Winkler EA, 2014, BRAIN PATHOL, V24, P371, DOI 10.1111/bpa.12152
   Wong D, 2004, EXP NEUROL, V190, P446, DOI 10.1016/j.expneurol.2004.08.008
   Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287
   Xu J, 2001, J CEREBR BLOOD F MET, V21, P702, DOI 10.1097/00004647-200106000-00008
   Yamagata K, 2004, NEUROBIOL DIS, V17, P491, DOI 10.1016/j.nbd.2004.08.001
   Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106
   Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200
   Zhu XW, 2007, J NEUROL SCI, V257, P240, DOI 10.1016/j.jns.2007.01.039
   Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003
   Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114
   Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x
NR 245
TC 194
Z9 215
U1 0
U2 44
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD OCT
PY 2015
VL 82
BP 593
EP 606
DI 10.1016/j.nbd.2015.08.014
PG 14
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA CW4RO
UT WOS:000364980000056
PM 26311408
OA Green Accepted
DA 2024-11-01
ER

PT J
AU Machiela, E
   Dues, DJ
   Senchuk, MM
   Van Raamsdonk, JM
AF Machiela, Emily
   Dues, Dylan J.
   Senchuk, Megan M.
   Van Raamsdonk, Jeremy M.
TI Oxidative stress is increased in <i>C</i>. <i>elegans</i> models of
   Huntington's disease but does not contribute to polyglutamine toxicity
   phenotypes
SO NEUROBIOLOGY OF DISEASE
LA English
DT Article
DE Huntington's disease; polyglutamine toxicity disorder; aggregation;
   oxidative stress; superoxide dismutase; reactive oxygen species (ROS);
   C. elegans; animal model; genetics
ID YAC128 MOUSE MODEL; UNFOLDED PROTEIN RESPONSE; SUPEROXIDE-DISMUTASE
   GENE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; MUTANT HUNTINGTIN; NEUROLOGICAL
   PHENOTYPE; MITOCHONDRIAL-DNA; CELLULAR TOXICITY; MOTOR DYSFUNCTION
AB Huntington's disease (HD) is an adult onset neurodegenerative disorder for which there is currently no cure. While HD patients and animal models of the disease exhibit increased oxidative damage, it is currently uncertain to what extent oxidative stress contributes to disease pathogenesis. In this work, we use a genetic approach to define the role of oxidative stress in HD. We find that a C. elegans model of HD expressing a disease-length polyglutamine tract in the body wall muscle is hypersensitive to oxidative stress and shows an upregulation of antioxidant defense genes, indicating that the HD worm model has increased levels of oxidative stress. To determine whether this increase in oxidative stress contributes to the development of polyglutamine-toxicity phenotypes in this HD model, we examined the effect of deleting individual superoxide dismutase (sod) genes in the HD worm model. As predicted, we found that deletion of sod genes in the HD worm model resulted in a clear increase in sensitivity to oxidative stress. However, we found that increasing oxidative stress in the HD worm model did not exacerbate deficits caused by polyglutamine toxicity. We confirmed these observations in two worm models expressing disease-length polyglutamine tracts in neurons. Furthermore, we found that treatment with antioxidants failed to rescue movement deficits or decrease aggregation in HD worm models. Combined, this suggests that the increase in oxidative stress in worm models of HD does not contribute to the phenotypic deficits observed in these worms, and provides a possible explanation for the failure of antioxidants in HD clinical trials. (C) 2016 Elsevier Inc All rights reserved.
C1 [Machiela, Emily; Dues, Dylan J.; Senchuk, Megan M.; Van Raamsdonk, Jeremy M.] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Aging & Neurodegenerat Dis, Grand Rapids, MI USA.
   [Van Raamsdonk, Jeremy M.] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA.
   [Van Raamsdonk, Jeremy M.] Michigan State Univ, Dept Genet, E Lansing, MI 48824 USA.
C3 Van Andel Institute; Michigan State University; Michigan State
   University
RP Van Raamsdonk, JM (corresponding author), Van Andel Res Inst, 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.
EM jeremy.vanraamsdonk@vai.org
RI Machiela, Emily/AAB-2426-2021; Van Raamsdonk, Jeremy/AAK-8930-2020
FU Hereditary Disease Foundation; Canadian Institutes of Health Research;
   Van Andel Research Institute; Van Andel Institute Graduate School
FX This work was supported by the Hereditary Disease Foundation; the
   Canadian Institutes of Health Research; the Van Andel Research
   Institute; and the Van Andel Institute Graduate School. We would like to
   thank Richard Morimoto for sharing worm models of Huntington's disease
   with the C. elegans research community. We would also like to
   acknowledge the C elegans knockout consortium, the Caenorhabditis
   Genetics Center and the National Bioresource Project of Japan for
   providing strains used in this research.
CR Ajayi A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-86
   Alam ZI, 2000, J NEUROCHEM, V75, P840, DOI 10.1046/j.1471-4159.2000.0750840.x
   Andre R, 2016, CURR OPIN PHARMACOL, V26, P33, DOI 10.1016/j.coph.2015.09.008
   Andreassen OA, 2001, NEUROREPORT, V12, P3371, DOI 10.1097/00001756-200110290-00044
   Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998
   Blackwell TK, 2015, FREE RADIC BIOL MED
   Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x
   Bonanomi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129727
   Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006
   Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514
   Browne SE, 1999, BRAIN PATHOL, V9, P147
   Browne SE, 2006, ANTIOXID REDOX SIGN, V8, P2061, DOI 10.1089/ars.2006.8.2061
   Cooper JF, 2015, NPJ PARKINSONS DIS, V1, DOI 10.1038/npjparkd.2015.22
   Cotto JJ, 1999, BIOCHEM SOC SYMP, P105
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Dues DJ, 2016, AGING-US, V8, P777, DOI 10.18632/aging.100939
   Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179
   Ferrante RJ, 2000, J NEUROSCI, V20, P4389, DOI 10.1523/JNEUROSCI.20-12-04389.2000
   Ferrante RJ, 1997, J NEUROCHEM, V69, P2064
   Ferrante RJ, 2002, J NEUROSCI, V22, P1592, DOI 10.1523/JNEUROSCI.22-05-01592.2002
   Fujii M, 1998, DNA Res, V5, P25, DOI 10.1093/dnares/5.1.25
   GIGLIO AM, 1994, BIOCHEM MOL BIOL INT, V33, P41
   GIGLIO MP, 1994, BIOCHEM MOL BIOL INT, V33, P37
   Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x
   Gil-Mohapel J, 2014, CURR DRUG TARGETS, V15, P454, DOI 10.2174/1389450115666140115113734
   Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2
   Hersch SM, 2006, NEUROLOGY, V66, P250, DOI 10.1212/01.wnl.0000194318.74946.b6
   Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652
   Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200
   Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738
   Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5
   Klepac N, 2007, J NEUROL, V254, P1676, DOI 10.1007/s00415-007-0611-y
   Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207
   Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057
   MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E
   Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0
   Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717
   Miyata R, 2008, J NEUROL SCI, V264, P133, DOI 10.1016/j.jns.2007.08.025
   Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x
   Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166
   Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099
   Parker JA, 2001, P NATL ACAD SCI USA, V98, P13318, DOI 10.1073/pnas.231476398
   Pérez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003
   Pérez-Severiano F, 2000, BRAIN RES, V862, P234, DOI 10.1016/S0006-8993(00)02082-5
   Polidori MC, 1999, NEUROSCI LETT, V272, P53, DOI 10.1016/S0304-3940(99)00578-9
   Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006
   Praticò D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010
   Ramzan F, 2015, J NEUROSCI, V35, P6444, DOI 10.1523/JNEUROSCI.3599-14.2015
   Rebec GV, 2003, NEUROREPORT, V14, P1263, DOI 10.1097/00001756-200307010-00015
   Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297
   Schäkel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499
   Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169
   Snijder P. M., 2015, MOL MED
   Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014
   Sorolla MA, 2012, BIOFACTORS, V38, P173, DOI 10.1002/biof.1013
   Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008
   Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x
   Suzuki N, 1996, DNA Res, V3, P171, DOI 10.1093/dnares/3.3.171
   Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390
   Van Raamsdonk JM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-80
   Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006
   Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361
   Van Raamsdonk Jeremy Michael, 2015, Worm, V4, pe1094607, DOI 10.1080/21624054.2015.1094607
   Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109
   Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215
   Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378
   Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147
   Van Raamsdonk JM, 2005, EXP NEUROL, V196, P266, DOI 10.1016/j.expneurol.2005.07.021
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wei YH, 2016, P NATL ACAD SCI USA, V113, pE2832, DOI 10.1073/pnas.1524727113
   Yanase S, 2009, J GERONTOL A-BIOL, V64, P530, DOI 10.1093/gerona/glp020
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556
   Yu YC, 2009, J NEUROSCI RES, V87, P1884, DOI 10.1002/jnr.22011
   Zhang Y, 2006, EMBO J, V25, P5896, DOI 10.1038/sj.emboj.7601445
   Zhou C, 2008, ANN NY ACAD SCI, V1147, P93, DOI 10.1196/annals.1427.023
   Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217
   Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009
NR 80
TC 33
Z9 39
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0969-9961
EI 1095-953X
J9 NEUROBIOL DIS
JI Neurobiol. Dis.
PD DEC
PY 2016
VL 96
BP 1
EP 11
DI 10.1016/j.nbd.2016.08.008
PG 11
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA EC3WX
UT WOS:000388058900001
PM 27544481
DA 2024-11-01
ER

PT J
AU Yalcouyé, A
   Diallo, SH
   Coulibaly, T
   Cissé, L
   Diallo, S
   Samassékou, O
   Diarra, S
   Coulibaly, D
   Keita, M
   Guinto, CO
   Fischbeck, K
   Landouré, G
AF Yalcouye, Abdoulaye
   Diallo, Seybou H.
   Coulibaly, Thomas
   Cisse, Lassana
   Diallo, Salimata
   Samassekou, Oumar
   Diarra, Salimata
   Coulibaly, Dramane
   Keita, Mohamed
   Guinto, Cheick O.
   Fischbeck, Kenneth
   Landoure, Guida
CA H3Africa Consortium
TI A novel mutation in the <i>GARS</i> gene in a Malian family with
   Charcot-Marie-Tooth disease
SO MOLECULAR GENETICS & GENOMIC MEDICINE
LA English
DT Article
DE CMT; CMT2D; GARS; Mali; novel mutation
AB Background Charcot-Marie-Tooth (CMT) disease is a very heterogeneous neurological condition with more than 90 reported genetic entities. It is the most common inherited peripheral neuropathy; however, cases are rarely reported in sub-Saharan Africa. In addition, only few families, mostly of Caucasian ancestry, have been reported to have Charcot-Marie-Tooth disease type 2D (CMT2D) mutations. To date no case of CMT2D was reported in Africa. We present here a consanguineous family with CMT phenotype in which a novel mutation in the GARS (glycyl-tRNA synthetase) gene was identified. Methods Patients were examined thoroughly and nerve conduction studies (NCS) were performed. DNA from the proband was used for CMT gene panel testing (including 50 genes, PMP22 duplication and mtDNA). Putative mutations were verified in all available family members to check for segregation. Results Two individuals, a male and a female, were found to be affected. Symptoms started in their teenage years with muscle weakness and atrophy in hands. Later, distal involvement of the lower limbs was noticed. Patients complained of minor sensory impairment. NCS showed no response in the upper as well as the lower limbs. Genetic testing surprisingly identified a novel heterozygous missense mutation c.794C>A (p.Ser265Tyr) in the GARS gene associated with CMT2D. This variant segregated with the disease in the family and was also seen in the mother who presented no symptoms. Conclusion This is the first report of a genetically confirmed CMT2D case in Africa, expanding its genetic epidemiology. Increasing access to genetic testing may reveal more novel CMT variants or genes in the African population that could be relevant to other populations and further our understanding of their mechanism.
C1 [Yalcouye, Abdoulaye; Diallo, Seybou H.; Coulibaly, Thomas; Samassekou, Oumar; Diarra, Salimata; Keita, Mohamed; Guinto, Cheick O.; Landoure, Guida] USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
   [Diallo, Seybou H.; Diallo, Salimata] Ctr Hosp Univ Gabriel Toure, Serv Neurol, Bamako, Mali.
   [Coulibaly, Thomas; Cisse, Lassana; Guinto, Cheick O.; Landoure, Guida] Ctr Hosp Univ Point G, Serv Neurol, Bamako, Mali.
   [Diarra, Salimata; Fischbeck, Kenneth; Landoure, Guida] NINDS, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
   [Coulibaly, Dramane] Ctr Hosp Univ Mere Enfant Luxembourg, Serv Med, Bamako, Mali.
   [Keita, Mohamed] Ctr Hosp Univ Gabriel Toure, Serv ORL, Bamako, Mali.
C3 University of Science & Technology of Bamako; National Institutes of
   Health (NIH) - USA; NIH National Institute of Neurological Disorders &
   Stroke (NINDS)
RP Landouré, G (corresponding author), USTTB, Fac Med & Odontostomatol, BP 1805, Bamako, Mali.
EM guida@icermali.org
OI Yalcouye, Abdoulaye/0000-0003-4279-7380
FU National Institutes of Neurological Disorders and Stroke, H3 Africa
   Initiative [U01HG007044]; National Institutes of Neurological Disorders
   and Stroke [NS00297]
FX This work was supported by National Institutes of Neurological Disorders
   and Stroke, H3 Africa Initiative U01HG007044; National Institutes of
   Neurological Disorders and Stroke, Intramural funds NS00297.
CR Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039
   Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04
   Griffin LB, 2014, HUM MUTAT, V35, P1363, DOI 10.1002/humu.22681
   Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617
   Lee HJ, 2012, J PERIPHER NERV SYST, V17, P418, DOI 10.1111/j.1529-8027.2012.00442.x
   Liao YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133423
   Motley WW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002399
   Rohkamm B, 2007, J NEUROL SCI, V263, P100, DOI 10.1016/j.jns.2007.06.047
   Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590
   Sleigh JN, 2017, P NATL ACAD SCI USA, V114, pE3324, DOI 10.1073/pnas.1614557114
NR 10
TC 10
Z9 12
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2324-9269
J9 MOL GENET GENOM MED
JI Mol. Genet. Genom. Med.
PD JUL
PY 2019
VL 7
IS 7
AR e782
DI 10.1002/mgg3.782
PG 4
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA IJ1RC
UT WOS:000475675000021
PM 31173493
OA gold, Green Published
DA 2024-11-01
ER

PT J
AU Vantyghem, MC
   Balavoine, AS
   Douillard, C
   Defrance, F
   Dieudonne, L
   Mouton, F
   Lemaire, C
   Bertrand-Escouflaire, N
   Bourdelle-Hego, MF
   Devemy, F
   Evrard, A
   Gheerbrand, D
   Girardoth, C
   Gumuche, S
   Hober, C
   Topolinski, H
   Lamblin, B
   Mycinski, B
   Ryndak, A
   Karrouz, W
   Duvivier, E
   Merlen, E
   Cortet, C
   Weill, J
   Lacroix, D
   Wémeau, JL
AF Vantyghem, Marie-Christine
   Balavoine, Anne-Sophie
   Douillard, Claire
   Defrance, Frederique
   Dieudonne, Lucile
   Mouton, Fanny
   Lemaire, Christine
   Bertrand-Escouflaire, Nicole
   Bourdelle-Hego, Marie-Francoise
   Devemy, Fabrice
   Evrard, Anne
   Gheerbrand, Dominique
   Girardoth, Caroline
   Gumuche, Sophie
   Hober, Christine
   Topolinski, Helene
   Lamblin, Blandine
   Mycinski, Benedicte
   Ryndak, Amelie
   Karrouz, Wassila
   Duvivier, Etienne
   Merlen, Emilie
   Cortet, Christine
   Weill, Jacques
   Lacroix, Dominique
   Wemeau, Jean-Louis
TI How to diagnose a lipodystrophy syndrome
SO ANNALES D ENDOCRINOLOGIE
LA English
DT Review
ID FAMILIAL PARTIAL LIPODYSTROPHY; ACQUIRED GENERALIZED LIPODYSTROPHY; LMNA
   R482W MUTATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SKELETAL-MUSCLE;
   DUNNIGAN-TYPE; HIV-1-INFECTED PATIENTS; METABOLIC PHENOTYPES; MADELUNGS
   DISEASE
AB The spectrum of adipose tissue diseases ranges from obesity to lipodystrophy, and is accompanied by insulin resistance syndrome, which promotes the occurrence of type 2 diabetes, dyslipidemia and cardiovascular complications. Lipodystrophy refers to a group of rare diseases characterized by the generalized or partial absence of adipose tissue, and occurs with or without hypertrophy of adipose tissue in other sites. They are classified as being familial or acquired, and generalized or partial. The genetically determined partial forms usually occur as Dunnigan syndrome, which is a type of laminopathy that can also manifest as muscle, cardiac, neuropathic or progeroid involvement. Gene mutations encoding for PPAR-gamma, Akt2, CIDEC, perilipin and the ZMPSTE 24 enzyme are much more rare. The genetically determined generalized forms are also very rare and are linked to mutations of seipin AGPAT2, FBN1, which is accompanied by Marfan syndrome, or of BANF1, which is characterized by a progeroid syndrome without insulin resistance and with early bone complications. Glycosylation disorders are sometimes involved. Some genetically determined forms have recently been found to be due to autoinflammatory syndromes linked to a proteasome anomaly (PSMB8). They result in a lipodystrophy syndrome that occurs secondarily with fever, dermatosis and panniculitis. Then there are forms that are considered to be acquired. They may be iatrogenic (protease inhibitors in HIV patients, glucocorticosteroids, insulin, graft-versus-host disease, etc.), related to an immune system disease (sequelae of dermatopolymyositis, autoimmune polyendocrine syndromes, particularly associated with type I diabetes, Barraquer-Simons and Lawrence syndromes), which are promoted by anomalies of the complement system. Finally, lipomatosis is currently classified as a painful form (adiposis dolorosa or Dercum's disease) or benign symmetric multiple form, also known as Launois-Bensaude syndrome or Madelung's disease, which are sometimes related to mitochondrial DNA mutations, but are usually promoted by alcohol. In addition to the medical management of metabolic syndrome and the sometimes surgical treatment of lipodystrophy, recombinant leptin provides hope for genetically determined lipodystrophy syndromes, whereas modifications in antiretroviral treatment and tesamorelin, a GHRH analog, is effective in the metabolic syndrome of HIV patients. Other therapeutic options will undoubtedly be developed, dependent on pathophysiological advances, which today tend to classify genetically determined lipodystrophy as being related to laminopathy or to lipid droplet disorders. (C) 2012 Published by Elsevier Masson SAS.
C1 [Vantyghem, Marie-Christine; Balavoine, Anne-Sophie; Douillard, Claire; Defrance, Frederique; Mouton, Fanny; Bertrand-Escouflaire, Nicole; Bourdelle-Hego, Marie-Francoise; Gumuche, Sophie; Ryndak, Amelie; Karrouz, Wassila; Merlen, Emilie; Cortet, Christine; Wemeau, Jean-Louis] CHRU Lille, Hop Huriez, Serv Endocrinol & Malad Metab, Inserm U859, F-59000 Lille, France.
   [Defrance, Frederique; Lemaire, Christine] Ctr Hosp Bethune, F-62660 Beuvry, France.
   [Dieudonne, Lucile; Hober, Christine; Topolinski, Helene] Ctr Hosp Henin Beaumont, F-62251 Henin Beaumont, France.
   [Mouton, Fanny] Ctr Hosp Douai, F-59507 Douai, France.
   [Devemy, Fabrice] Ctr Hosp Lens, F-62307 Lens, France.
   [Evrard, Anne] Polyclin Riaumont, F-62806 Lievin, France.
   [Gheerbrand, Dominique] Polyclin Bois Bernard, F-62320 Bois Bernard, France.
   [Girardoth, Caroline] Clin Louviere, F-59800 Lille, France.
   [Lamblin, Blandine] Clin Parc, F-59170 Croix, France.
   [Mycinski, Benedicte] Ctr Hosp Calais, F-62107 Calais, France.
   [Duvivier, Etienne] Grand Hop Charleroi, Serv Med Interne, B-6061 Montignies Sur Sambre, Belgium.
   [Weill, Jacques] CHRU, Hop Jeanne de Flandre, F-59037 Lille, France.
   [Lacroix, Dominique] Univ Lille 2, CHRU Lille, Clin Cardiol, F-59000 Lille, France.
   [Lacroix, Dominique] Univ Lille 2, Fac Med, F-59000 Lille, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Lille; CHU Lille; Grand Hopital De Charleroi; Universite
   de Lille; CHU Lille; Universite de Lille; CHU Lille; Universite de Lille
RP Vantyghem, MC (corresponding author), CHRU Lille, Hop Huriez, Serv Endocrinol & Malad Metab, Inserm U859, 1 Rue Polonovski, F-59000 Lille, France.
EM mc-vantyghem@chru-lille.fr
RI Evrard, Anne-Sophie/GYV-3391-2022; VANTYGHEM, Marie/T-8613-2019;
   VANTYGHEM, Marie-Christine/P-2939-2017
OI VANTYGHEM, Marie-Christine/0000-0002-9369-0463
CR Al-Attar Salam A, 2006, BMC Med Imaging, V6, P11, DOI 10.1186/1471-2342-6-11
   Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221
   Ampollini L, 2011, NEW ENGL J MED, V364, P465, DOI 10.1056/NEJMicm1003531
   Barroso E, 2011, ENDOCRINOLOGY, V152, P1848, DOI 10.1210/en.2010-1468
   Barrowman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032120
   Ben Yaou R, 2011, EUR J HUM GENET, V19, P647, DOI 10.1038/ejhg.2010.256
   Béréziat V, 2011, AM J PATHOL, V179, P2443, DOI 10.1016/j.ajpath.2011.07.049
   Bingham A, 2008, MEDICINE, V87, P70, DOI 10.1097/MD.0b013e31816bc604
   Boufassa F, 2012, ANTIVIR THER, V17, P91, DOI 10.3851/IMP1916
   Bouloumié A, 2008, ARTERIOSCL THROM VAS, V28, P1211, DOI 10.1161/ATVBAHA.108.168229
   Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856
   Cabanillas R, 2011, AM J MED GENET A, V155A, P2617, DOI 10.1002/ajmg.a.34249
   Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776
   Casado M, 2012, CEREBELLUM, V11, P557, DOI 10.1007/s12311-011-0313-y
   Caux F, 2003, J CLIN ENDOCR METAB, V88, P1006, DOI 10.1210/jc.2002-021506
   Cenni V, 2011, EUR J HISTOCHEM, V55, P200, DOI 10.4081/ejh.2011.e36
   Chan JL, 2011, ENDOCR PRACT, V17, P922, DOI 10.4158/EP11229.OR
   Chen WQ, 2012, MOL CELL BIOL, V32, P1099, DOI 10.1128/MCB.06465-11
   Couturier J, 2012, OBESITY, V20, P253, DOI 10.1038/oby.2011.275
   Decaudain A, 2007, J CLIN ENDOCR METAB, V92, P4835, DOI 10.1210/jc.2007-0654
   Duband-Goulet I, 2011, EXP CELL RES, V317, P2800, DOI 10.1016/j.yexcr.2011.09.012
   Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016
   Fardet L, 2012, CLIN ENDOCRINOL OXF
   Fiorenza CG, 2011, NAT REV ENDOCRINOL, V7, P137, DOI 10.1038/nrendo.2010.199
   Gandotra S, 2011, NEW ENGL J MED, V364, P740, DOI 10.1056/NEJMoa1007487
   Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159
   Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x
   Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623
   Hegele RA, 2006, AM J HUM GENET, V79, P383, DOI 10.1086/505885
   Herbst KL, 2009, INT J OBESITY, V33, P1031, DOI 10.1038/ijo.2009.119
   Herbst KL, 2003, DIABETES CARE, V26, P1819, DOI 10.2337/diacare.26.6.1819
   Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107
   Horn D, 2011, AM J MED GENET A, V155A, P721, DOI 10.1002/ajmg.a.33905
   Hu M, 2012, HEPATOLOGY, V55, P437, DOI 10.1002/hep.24708
   Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216
   Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108
   Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414
   Kobayashi J, 2010, INTERNAL MED, V49, P479, DOI 10.2169/internalmedicine.49.2996
   Kulkarni SS, 2011, J BIOL CHEM, V286, P34567, DOI 10.1074/jbc.M111.268292
   Le Dour C, 2011, J CLIN ENDOCR METAB, V96, pE856, DOI 10.1210/jc.2010-2234
   Lee P, 2011, ENDOCRINOLOGY, V152, P3597, DOI 10.1210/en.2011-1349
   Livadas S, 2011, PEDIAT TRANSPLANT
   Llamas-Velasco M, 2011, ACTAS DERMOSIFILIOGR
   Luedtke A, 2012, HORM METAB RES, V44, P306, DOI 10.1055/s-0031-1301284
   Lungu AO, 2012, J CLIN ENDOCR METAB, V97, P563, DOI 10.1210/jc.2011-1896
   Lupsa BC, 2010, MEDICINE, V89, P245, DOI 10.1097/MD.0b013e3181e9442f
   Madej-Pilarczyk A, 2009, AM J MED GENET A, V149A, P2387, DOI 10.1002/ajmg.a.33018
   Mathiesen P, 2012, SCAND J RHEUMATOL, V41, P50, DOI 10.3109/03009742.2011.608376
   MCKEON FD, 1983, P NATL ACAD SCI-BIOL, V80, P4374, DOI 10.1073/pnas.80.14.4374
   Milan G, 2010, J CLIN ENDOCR METAB, V95, P3126, DOI 10.1210/jc.2009-2773
   Misra A, 2003, MEDICINE, V82, P129, DOI 10.1097/00005792-200303000-00007
   Moreau F, 2007, DIABETES METAB, V33, P385, DOI 10.1016/j.diabet.2007.04.005
   Oriot P, 2011, ANN ENDOCRINOL-PARIS, V72, P244, DOI 10.1016/j.ando.2011.04.003
   Park JY, 2008, J CLIN ENDOCR METAB, V93, P26, DOI 10.1210/jc.2007-1856
   Pelosini C, 2011, ACTA DIABETOL, V48, P243, DOI 10.1007/s00592-011-0308-7
   Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034
   Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037
   Rzymski P, 2011, ARCH MED SCI, V7, P1017, DOI [10.5114/aoms.2011.26614, 10.5114/AOMS.2011.26614]
   Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913
   Saini-Chohan HK, 2012, J LIPID RES, V53, P4, DOI 10.1194/jlr.R012120
   Sankar J, 2012, INDIAN J PEDIAT
   Savage DB, 2009, J CLIN ENDOCR METAB, V94, P10, DOI 10.1210/jc.2008-1703
   Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271
   Simha V, 2012, J CLIN ENDOCR METAB, V97, P785, DOI 10.1210/jc.2011-2229
   Sokolov M, 2010, ISR MED ASSOC J, V12, P253
   Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196
   Spooner LM, 2012, ANN PHARMACOTHER, V46, P240, DOI 10.1345/aph.1Q629
   Spuler S, 2007, NEUROLOGY, V68, P677, DOI 10.1212/01.wnl.0000255939.73424.f8
   Sysi-Aho M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015744
   Tan K, 2007, DIABETES, V56, P714, DOI 10.2337/db06-0921
   Vantyghem MC, 2008, J CLIN ENDOCR METAB, V93, P2223, DOI 10.1210/jc.2007-2521
   Vantyghem MC, 2007, CLIN ENDOCRINOL, V67, P247, DOI 10.1111/j.1365-2265.2007.02870.x
   Vantyghem MC, 1999, DIABETES CARE, V22, P1374, DOI 10.2337/diacare.22.8.1374
   Vantyghem MC, 2004, J CLIN ENDOCR METAB, V89, P5337, DOI 10.1210/jc.2003-031658
   Vantyghem MC, 2011, ANN ENDOCRINOL, V5, P347
   Veloso S, 2012, CYTOKINE, V58, P253, DOI 10.1016/j.cyto.2012.01.013
   Vigouroux C, 2000, DIABETES, V49, P1958, DOI 10.2337/diabetes.49.11.1958
   Visser ME, 2011, DIABETOLOGIA, V54, P1639, DOI 10.1007/s00125-011-2142-4
   Wong SPY, 2005, DIABETOLOGIA, V48, P2641, DOI 10.1007/s00125-005-0038-x
   Xia GX, 2012, MOL CELL ENDOCRINOL, V358, P46, DOI 10.1016/j.mce.2012.02.017
   Yee JK, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-19
   Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534
NR 82
TC 51
Z9 59
U1 4
U2 33
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0003-4266
EI 2213-3941
J9 ANN ENDOCRINOL-PARIS
JI Ann Endocrinol.
PD JUN
PY 2012
VL 73
IS 3
BP 170
EP 189
DI 10.1016/j.ando.2012.04.010
PG 20
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 992AM
UT WOS:000307747100003
PM 22748602
DA 2024-11-01
ER

PT S
AU Liu, S
   Xie, SZ
   Lee, YF
   Chang, CS
AF Liu, Su
   Xie, Shaozhen
   Lee, Yi-Fen
   Chang, Chawnshang
BE Bunce, CM
   Campbell, MJ
TI PHYSIOLOGICAL FUNCTIONS OF TR2 AND TR4 ORPHAN NUCLEAR RECEPTOR
SO NUCLEAR RECEPTORS: CURRENT CONCEPTS AND FUTURE CHALLENGES
SE Proteins and Cell Regulation
LA English
DT Article; Book Chapter
ID DIRECT REPEAT 4; MITOCHONDRIAL DISEASES; GENE; EXPRESSION; MICE;
   EXERCISE; MUSCLE; DIAGNOSIS; MEMBER; TRANSACTIVATION
AB The human testicular receptor 2 and 4 (TR2 and TR4) are two evolutionarily related orphan nuclear receptors belonging to the same nuclear receptor subfamily (Lee et al. 2002, J Steroid Biochem Mol Biol 81(4-5), 291-308). They regulate gene expression by binding to DNA as homodimers or a heterodimer with each other. TR4 may also cross-talk with other nuclear receptors, to control its target genes. In vitro and in vivo studies have identified several TR4 target genes, including ciliary neurotrophic factor alpha (CNTFR alpha) (Young et al. 1997, J Biol Chem 272(5), 3109-3116), apolipoprotein E (ApoE) (Kim et al. 2003, J Biol Chem 278(47), 46919-46926) and phosphenolpyruvate carboxykinase (PEPCK) (Liu et al. 2007, Diabetes 56(12), 2901-2909). Recent studies using TR4 knockout (TR4(-/-)) mice suggested that TR4 may play essential roles in growth, development, and metabolism (Zhang et al. 2007, Mol Endocrinol 21(4), 908-920; Kim et al. 2005, Biochem Biophys Res Commun 328(1), 85-90; Chen et al. 2005, Mol Cell Biol 25(7), 2722-2732; Mu et al. 2004, Mol Cell Biol 24(13), 58875899; Collins et al. 2004, Proc Natl Acad Sci USA 101(42), 15058-15063). Mice with a germline deletion of TR4 are viable but have high early postnatal mortality, growth retardation, and profound reduction in body weight. Further studies showed that TR4 plays essential roles in the development and functioning in the central nervous system (Chen et al. 2005, Mol Cell Biol 25(7), 2722-2732), such as proper myelination and oligodendrocyte differentiation (Zhang et al. 2007, Mol Endocrinol 21(4), 908-920). Studies also showed that TR4 is important for spermatogenesis in male mice (Mu et al. 2004, Mol Cell Biol 24(13), 5887-5899) and folliculogenesis in female mice (Chen et al. 2008, Mol Endocrinol 22,858-867). In addition, TR4 might be involved in skeletal muscle function and bone remodeling. TR4 and TR2 also regulate embryonic and fetal globin gene transcription (Tanabe et al. 2002, EMBO J 21(13), 3434-3442; Tanabe et al. 2007, EMBO J 26(9). 2295-2306). Surprisingly, mice lacking TR2 are viable and have no serious developmental defects. Thus, TR2 may either not be important in spermatogenesis and testis development, or its roles may be compensated by other closely related proteins such as TR4. Therefore, this chapter will focus on the in vivo roles of TR4.
C1 [Liu, Su; Xie, Shaozhen; Lee, Yi-Fen; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
   [Liu, Su; Xie, Shaozhen; Lee, Yi-Fen; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
C3 University of Rochester; University of Rochester
RP Liu, S (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George H Whipple Lab Canc Res, Rochester, NY 14642 USA.
EM chang@urmc.rochester.edu
CR Arpa J, 2003, MUSCLE NERVE, V28, P690, DOI 10.1002/mus.10507
   Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049
   Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326
   CHANG CS, 1994, P NATL ACAD SCI USA, V91, P6040, DOI 10.1073/pnas.91.13.6040
   Chen LM, 2008, MOL ENDOCRINOL, V22, P858, DOI 10.1210/me.2007-0181
   Chen YT, 2008, CEREBELLUM, V7, P9, DOI 10.1007/s12311-008-0006-3
   Chen YT, 2007, BRAIN RES, V1168, P72, DOI 10.1016/j.brainres.2007.06.069
   Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005
   Chevessier F, 2005, J PATHOL, V207, P313, DOI 10.1002/path.1832
   Cohen P, 2004, J NUTR, V134, p2455S, DOI 10.1093/jn/134.9.2455S
   Cohen Paul, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P271, DOI 10.2174/1568008033340117
   Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101
   Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9
   DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003
   DiMauro S, 2005, NEUROMUSCULAR DISORD, V15, P276, DOI 10.1016/j.nmd.2004.12.008
   Downey PA, 2006, PHYS THER, V86, P77, DOI 10.1093/ptj/86.1.77
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Gartland A, 2005, BONE, V37, P530, DOI 10.1016/j.bone.2005.04.034
   Gellerich FN, 2004, MOL CELL BIOCHEM, V256, P391, DOI 10.1023/B:MCBI.0000009885.34498.e6
   Giguère V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689
   Giguère Y, 2000, CLIN GENET, V57, P161, DOI 10.1034/j.1399-0004.2000.570301.x
   Grosveld F, 1999, CURR OPIN GENET DEV, V9, P152, DOI 10.1016/S0959-437X(99)80023-9
   Harada H, 1998, ENDOCRINOLOGY, V139, P204, DOI 10.1210/en.139.1.204
   HIROSE T, 1995, BIOCHEM BIOPH RES CO, V211, P83, DOI 10.1006/bbrc.1995.1781
   Houstek J, 2004, BBA-BIOENERGETICS, V1658, P115, DOI 10.1016/j.bbabio.2004.04.012
   Hwang SB, 1998, ENDOCRINE, V8, P169, DOI 10.1385/ENDO:8:2:169
   Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285
   Kiefer CM, 2008, MUTAT RES-FUND MOL M, V647, P68, DOI 10.1016/j.mrfmmm.2008.07.014
   Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803
   Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146
   Kim E, 2003, J BIOL CHEM, V278, P46919, DOI 10.1074/jbc.M304088200
   KIM EL, METFORMIN INHI UNPUB
   Kinugawa S, 2005, CIRCULATION, V111, P1480, DOI 10.1161/01.CIR.0000159261.11520.63
   Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757
   Koritschoner NP, 2001, CELL GROWTH DIFFER, V12, P563
   Langman CB, 2005, PEDIATR NEPHROL, V20, P352, DOI 10.1007/s00467-004-1687-6
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lee CH, 1998, J BIOL CHEM, V273, P25209, DOI 10.1074/jbc.273.39.25209
   LEE HJ, 1995, J BIOL CHEM, V270, P30129
   Lee YF, 2002, J STEROID BIOCHEM, V81, P291, DOI 10.1016/S0960-0760(02)00118-8
   Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437
   Lee YF, 1999, J BIOL CHEM, V274, P16198, DOI 10.1074/jbc.274.23.16198
   Lee YF, 1997, J BIOL CHEM, V272, P12215, DOI 10.1074/jbc.272.18.12215
   Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359
   Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004
   McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321
   McKenzie M, 2004, NEUROCHEM RES, V29, P589, DOI 10.1023/B:NERE.0000014829.42364.dd
   Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004
   Mulder JE, 2006, NAT CLIN PRACT ENDOC, V2, P670, DOI 10.1038/ncpendmet0325
   MULLERHOCKER J, 1983, VIRCHOWS ARCH A, V402, P61, DOI 10.1007/BF00695049
   Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303
   Popov VM, 2007, STEROIDS, V72, P221, DOI 10.1016/j.steroids.2006.12.001
   Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7
   Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758
   Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247
   Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0
   Shepherd RK, 2006, J INHERIT METAB DIS, V29, P86, DOI 10.1007/s10545-006-0148-8
   Shyr CR, 2002, J BIOL CHEM, V277, P14622, DOI 10.1074/jbc.M110051200
   Shyr CR, 2002, MOL CELL BIOL, V22, P4661, DOI 10.1128/MCB.22.13.4661-4666.2002
   Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340
   Tanabe O, 2007, GENE DEV, V21, P2832, DOI 10.1101/gad.1593307
   Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676
   Tarnopolsky MA, 2005, MED SCI SPORT EXER, V37, P2086, DOI 10.1249/01.mss.0000177341.89478.06
   Taylor RW, 2004, NEUROMUSCULAR DISORD, V14, P237, DOI 10.1016/j.nmd.2003.12.004
   Thorburn DR, 2004, BBA-BIOENERGETICS, V1659, P121, DOI 10.1016/j.bbabio.2004.08.006
   Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Willson TM, 2002, MOL ENDOCRINOL, V16, P1135, DOI 10.1210/me.16.6.1135
   Yan ZH, 1998, J BIOL CHEM, V273, P10948, DOI 10.1074/jbc.273.18.10948
   Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050
   Yoshikawa T, 1996, ENDOCRINOLOGY, V137, P1562, DOI 10.1210/en.137.5.1562
   Young WJ, 1998, J BIOL CHEM, V273, P20877, DOI 10.1074/jbc.273.33.20877
   Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109
   Zebaze RMD, 2003, OSTEOPOROSIS INT, V14, P301, DOI 10.1007/s00198-002-1356-1
   Zhang G, 2007, RAPID COMMUN MASS SP, V21, P920, DOI 10.1002/rcm.2914
NR 76
TC 1
Z9 2
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1567-2530
BN 978-90-481-3302-4
J9 PROTEINS CELL REGUL
JI Proteins Cell Regul.
PY 2010
VL 8
BP 327
EP 343
DI 10.1007/978-90-481-3303-1_13
D2 10.1007/978-90-481-3303-1
PG 17
WC Biochemistry & Molecular Biology; Cell Biology
WE Book Citation Index – Science (BKCI-S)
SC Biochemistry & Molecular Biology; Cell Biology
GA BOH92
UT WOS:000276683200013
DA 2024-11-01
ER

PT J
AU Edgar, JA
   Molyneux, RJ
   Colegate, SM
AF Edgar, John A.
   Molyneux, Russell J.
   Colegate, Steven M.
TI 1,2-Dehydropyrrolizidine Alkaloids: Their Potential as a Dietary Cause
   of Sporadic Motor Neuron Diseases
SO CHEMICAL RESEARCH IN TOXICOLOGY
LA English
DT Article
ID AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; DECREASED
   GLUTATHIONE LEVELS; EXOGENOUS RISK-FACTOR; PYRROLIZIDINE ALKALOIDS;
   PULMONARY-HYPERTENSION; VENOOCCLUSIVE DISEASE; SUPEROXIDE-DISMUTASE;
   CROTALARIA-RETUSA; CYTOCHROME-P450 ENZYMES
AB Sporadic motor neuron diseases (MNDs), such as amyotrophic lateral sclerosis (ALS), can be caused by spontaneous genetic mutations. However, many sporadic cases of ALS and other debilitating neurodegenerative diseases (NDDs) are believed to be caused by environmental factors, subject to considerable debate and requiring intensive research. A common pathology associated with MND development involves progressive mitochondrial dysfunction and oxidative stress in motor neurons and glial cells of the central nervous system (CNS), leading to apoptosis. Consequent degeneration of skeletal and respiratory muscle cells can lead to death from respiratory failure. A significant number of MND cases present with cancers and liver and lung pathology. This Perspective explores the possibility that MNDs could be caused by intermittent, low-level dietary exposure to 1,2-dehydropyrrolizidine alkaloids (1,2-dehydroPAs) that are increasingly recognized as contaminants of many foods consumed throughout the world. Nontoxic, per se, 1,2-dehydroPAs are metabolized, by particular cytochrome P450 (CYP450) isoforms, to 6,7-dihydropyrrolizines that react with nucleophilic groups (-NH, -SH, -OH) on DNA, proteins, and other vital biochemicals, such as glutathione. Many factors, including aging, gender, smoking, and alcohol consumption, influence CYP450 isoform activity in a range of tissues, including glial cells and neurons of the CNS. Activation of 1,2-dehydroPAs in CNS cells can be expected to cause gene mutations and oxidative stress, potentially leading to the development of MNDs and other NDDs. While relatively high dietary exposure to 1,2-dehydroPAs causes hepatic sinusoidal obstruction syndrome, pulmonary venoocclusive disease, neurotoxicity, and diverse cancers, this Perspective suggests that, at current intermittent, low levels of dietary exposure, neurotoxicity could become the primary pathology that develops over time in susceptible individuals, along with a tendency for some of them to also display liver and lung pathology and diverse cancers co-occurring with some MND/NDD cases. Targeted research is recommended to investigate this proposal.
C1 [Molyneux, Russell J.] Univ Hawaii Hilo, Daniel K Inouye Coll Pharm, Hilo, HI 96720 USA.
   [Colegate, Steven M.] ARS USDA, Poisonous Plant Res Lab, Logan, UT 84341 USA.
   [Edgar, John A.] CSIRO Agr & Food, N Ryde, NSW 2113, Australia.
C3 University of Hawaii System; University Hawaii Hilo; United States
   Department of Agriculture (USDA); Commonwealth Scientific & Industrial
   Research Organisation (CSIRO)
RP Edgar, JA (corresponding author), CSIRO Agr & Food, N Ryde, NSW 2113, Australia.
EM john.a.edgar@hotmail.com
CR Abass K, 2012, TOXICOLOGY, V294, P17, DOI 10.1016/j.tox.2012.01.010
   Acevedo K, 2019, J BIOL INORG CHEM, V24, P1141, DOI 10.1007/s00775-019-01731-9
   Agarwal AN, 2019, ARCH PATHOL LAB MED, V143, P1256, DOI 10.5858/arpa.2018-0455-OA
   Ahuja A, 2015, J TRACE ELEM MED BIO, V29, P11, DOI 10.1016/j.jtemb.2014.05.003
   AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4
   Akan O, 2021, ACTA NEUROL BELG, V121, P1123, DOI 10.1007/s13760-020-01337-y
   ALLEN JR, 1972, EXP MOL PATHOL, V17, P220, DOI 10.1016/0014-4800(72)90071-8
   ALLEN JR, 1975, CANCER RES, V35, P997
   Allgaier C, 2015, REGUL TOXICOL PHARM, V73, P494, DOI 10.1016/j.yrtph.2015.09.024
   Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150
   [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2406
   [Anonymous], 1957, AUST VET J
   [Anonymous], 1988, Pyrrolizidine alkaloids. Environmental Health Criteria 80
   Armon C, 2018, J NEUROL SCI, V391, P134, DOI 10.1016/j.jns.2018.05.016
   Babu GN, 2008, NEUROCHEM INT, V52, P1284, DOI 10.1016/j.neuint.2008.01.009
   Bjorklund G, 2021, NEUROSCI BIOBEHAV R, V120, P470, DOI 10.1016/j.neubiorev.2020.10.004
   Boppré M, 2005, J AGR FOOD CHEM, V53, P594, DOI 10.1021/jf0484531
   Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660
   BRAIN, 1965, BRAIN, V88, P479, DOI 10.1093/brain/88.3.479
   Brasil AA, 2013, FEMS YEAST RES, V13, P433, DOI 10.1111/1567-1364.12045
   Braun AT, 2018, CLIN CHEST MED, V39, P391, DOI 10.1016/j.ccm.2018.01.003
   Bull L.B., 1968, The Pyrrolizidine Alkaloids
   BURNS J, 1972, J PATHOL, V106, P187, DOI 10.1002/path.1711060306
   BUTLER WH, 1970, J PATHOL, V100, P169, DOI 10.1002/path.1711000305
   Cantó-Santos J, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100964
   Carrì MT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00041
   Caudle WM, 2012, NEUROTOXICOLOGY, V33, P178, DOI 10.1016/j.neuro.2012.01.010
   Chen T, 2010, J APPL TOXICOL, V30, P183, DOI 10.1002/jat.1504
   Chen Y, 2020, TOXICOL LETT, V323, P41, DOI 10.1016/j.toxlet.2020.01.021
   CHESNEY CF, 1973, CARDIOVASC RES, V7, P508, DOI 10.1093/cvr/7.4.508
   CHESNEY CF, 1973, AM J PATHOL, V70, P489
   Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064
   Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005
   Ciecko-Michalska I, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/642108
   CIRIOLO MR, 1990, J BIOL CHEM, V265, P11030
   Cooper RA, 1996, TOXICON, V34, P604, DOI 10.1016/0041-0101(95)00169-7
   Corcia P, 2015, AMYOTROPH LAT SCL FR, V16, P252, DOI 10.3109/21678421.2014.965178
   Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469
   Dau SL, 2019, ACTA SCI VET, V47, DOI 10.22456/1679-9216.91989
   DeLeve LD, 2003, GASTROENTEROLOGY, V125, P882, DOI 10.1016/S0016-5085(03)01056-4
   DeLeve LD, 2003, AM J PHYSIOL-GASTR L, V284, pG1045, DOI 10.1152/ajpgi.00526.2002
   DeLeve LD, 2002, SEMIN LIVER DIS, V22, P27, DOI 10.1055/s-2002-23204
   Santa-Cruz LD, 2016, ACS CHEM NEUROSCI, V7, P886, DOI 10.1021/acschemneuro.6b00032
   dos Santos AB, 2009, TOXICON, V54, P16, DOI 10.1016/j.toxicon.2009.03.004
   Dumitrascu R, 2011, EUR RESPIR J, V37, P1104, DOI 10.1183/09031936.00126010
   Dunlop RA, 2019, NEUROTOX RES, V36, P602, DOI 10.1007/s12640-019-00089-9
   Dunlop RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075376
   Dutheil F, 2008, BIOCHIMIE, V90, P426, DOI 10.1016/j.biochi.2007.10.007
   Dutheil F, 2010, EXPERT OPIN DRUG MET, V6, P1161, DOI 10.1517/17425255.2010.510832
   Edgar JA, 2011, FOOD ADDIT CONTAM A, V28, P308, DOI 10.1080/19440049.2010.547520
   Edgar JA, 2015, CHEM RES TOXICOL, V28, P4, DOI 10.1021/tx500403t
   EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4572
   Ferguson CS, 2011, TRENDS PHARMACOL SCI, V32, P708, DOI 10.1016/j.tips.2011.08.005
   Filipi T, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010261
   FISHMAN AP, 1974, CIRC RES, V35, P657, DOI 10.1161/01.RES.35.5.657
   FISMAN M, 1987, ARCH NEUROL-CHICAGO, V44, P997, DOI 10.1001/archneur.1987.00520220007005
   Forsyth PA, 1997, ANN NEUROL, V41, P722, DOI 10.1002/ana.410410608
   Freedman DM, 2013, CANCER CAUSE CONTROL, V24, P55, DOI 10.1007/s10552-012-0089-5
   Fu PP, 2004, DRUG METAB REV, V36, P1, DOI 10.1081/DMR-120028426
   Furukawa Y, 2020, TRANSL NEURODEGENER, V9, DOI 10.1186/s40035-020-00209-y
   Gao A. F., 2017, INT J PATHOL CLIN RE, V3
   Gao H, 2012, J DIGEST DIS, V13, P33, DOI 10.1111/j.1751-2980.2011.00552.x
   Garbuzova-Davis S, 2020, CELL TRANSPLANT, V29, DOI 10.1177/0963689720913494
   García ML, 2013, J NEUROL SCI, V330, P18, DOI 10.1016/j.jns.2013.03.019
   Ghasemi M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024125
   Ghosh C, 2016, DRUG DISCOV TODAY, V21, P1609, DOI 10.1016/j.drudis.2016.06.004
   Giampietro R, 2018, MOL PHARMACEUT, V15, P808, DOI 10.1021/acs.molpharmaceut.7b00841
   Gil-Bea FJ, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.9
   Golden TR, 2009, ANTIOXID REDOX SIGN, V11, P555, DOI [10.1089/ars.2008.2256, 10.1089/ARS.2008.2256]
   Goodfellow J, 2019, NEUROL SCI, V40, P1461, DOI 10.1007/s10072-019-03784-9
   Gromadzka G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239259
   GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868
   Günthardt BF, 2021, ENVIRON SCI TECHNOL, V55, P1036, DOI 10.1021/acs.est.0c06411
   Guo LY, 2019, DRUG DES DEV THER, V13, P2799, DOI 10.2147/DDDT.S213817
   Hadjihambi A, 2018, HEPATOL INT, V12, pS135, DOI 10.1007/s12072-017-9812-3
   Hama JR, 2021, SCI TOTAL ENVIRON, V755, DOI 10.1016/j.scitotenv.2020.142822
   Hanumegowda UM, 2003, TOXICOL SCI, V76, P237, DOI 10.1093/toxsci/kfg222
   Hartmann T., 1995, Alkaloids: Chemical and biological perspectives, P155
   Harwood CA, 2016, AMYOTROPH LAT SCL FR, V17, P377, DOI 10.3109/21678421.2016.1154575
   Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739
   He YS, 2021, ARCH TOXICOL, V95, P103, DOI 10.1007/s00204-020-02921-0
   HEATH D, 1975, THORAX, V30, P399, DOI 10.1136/thx.30.4.399
   Henden L, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-00139-8
   Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC
   HSU IC, 1975, RES COMMUN CHEM PATH, V11, P99
   HSU IC, 1976, CHEM-BIOL INTERACT, V12, P19, DOI 10.1016/0009-2797(76)90063-6
   Huxtable R. J., 1999, NATURAL SELECTED SYN, P100
   Huxtable RJ, 1996, NEUROCHEM RES, V21, P141, DOI 10.1007/BF02529131
   Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505
   Ismailov N. I., 1970, KLIN DIAGNOSTIKA LEC, P85
   Jayakumar AR, 2018, J CLIN EXP HEPATOL, V8, P272, DOI 10.1016/j.jceh.2018.06.007
   Ji LL, 2010, HUM EXP TOXICOL, V29, P303, DOI 10.1177/0960327110361757
   Jiang Z, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0037-x
   Kakar F, 2010, J TOXICOL-US, V2010, DOI 10.1155/2010/313280
   KAY JM, 1966, J PATHOL BACTERIOL, V92, P385, DOI 10.1002/path.1700920216
   KAY JM, 1967, THORAX, V22, P176, DOI 10.1136/thx.22.2.176
   Killoy KM, 2018, EXP NEUROL, V302, P129, DOI 10.1016/j.expneurol.2018.01.004
   Kisielius V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76586-1
   Knottenbelt D. C., 1996, Equine Veterinary Education, V8, P196, DOI [10.1111/j.2042-3292.1996.tb01701.x, 10.1111/j.2042-3292.1996.tb01687.x]
   Kok JR, 2021, CELL MOL LIFE SCI, V78, P5707, DOI 10.1007/s00018-021-03872-0
   Kreuzer M, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000069
   Lagrange E, 2021, J NEUROL SCI, V427, DOI 10.1016/j.jns.2021.117558
   Le Gall L, 2020, J PERS MED, V10, DOI 10.3390/jpm10030101
   Leal PV, 2019, ACTA SCI VET, V47, DOI 10.22456/1679-9216.89439
   Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997
   Lee SH, 2018, NEURODEGENER DIS, V18, P200, DOI 10.1159/000491392
   Leong ZP, 2019, VASC PHARMACOL, V122, DOI 10.1016/j.vph.2019.106599
   Liu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080779
   Logroscino G, 2018, LANCET NEUROL, V17, P1083, DOI 10.1016/S1474-4422(18)30404-6
   Lohse JC, 2018, AUSTRAL J VET SCI, V50, P107, DOI 10.4067/S0719-81322018000200107
   Longinetti E, 2019, CURR OPIN NEUROL, V32, P771, DOI 10.1097/WCO.0000000000000730
   Lu Y, 2018, ARCH TOXICOL, V92, P3403, DOI 10.1007/s00204-018-2309-6
   Lu Y, 2014, J NEUROL SCI, V343, P15, DOI 10.1016/j.jns.2014.05.033
   Ma J, 2021, ARCH TOXICOL, V95, P759, DOI 10.1007/s00204-020-02947-4
   Manjaly ZR, 2010, AMYOTROPH LATERAL SC, V11, P439, DOI 10.3109/17482961003610853
   Mann A, 2008, NEUROPHARMACOLOGY, V55, P1147, DOI 10.1016/j.neuropharm.2008.07.017
   Marangi G, 2015, BRAIN RES, V1607, P75, DOI 10.1016/j.brainres.2014.10.009
   Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012
   MASUI Y, 1985, J NEUROL, V232, P15, DOI 10.1007/BF00314034
   MATTOCKS AR, 1973, CHEM-BIOL INTERACT, V6, P297, DOI 10.1016/0009-2797(73)90044-6
   Mattocks AR., 1986, CHEM TOXICOLOGY PYRR
   McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010
   Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01310
   Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159
   Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9
   Miksys S, 2002, J NEUROCHEM, V82, P1376, DOI 10.1046/j.1471-4159.2002.01069.x
   Mitchell JD, 1998, J NEUROL NEUROSUR PS, V65, P842, DOI 10.1136/jnnp.65.6.842
   Mohajer A., 2019, Comparative Clinical Pathology, V28, P397, DOI 10.1007/s00580-019-02913-2
   Mora JS, 2020, AMYOTROPH LAT SCL FR, V21, P5, DOI 10.1080/21678421.2019.1632346
   Moreira R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061668
   Nakamura K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235885
   NAKANO Y, 1987, ARCH NEUROL-CHICAGO, V44, P103, DOI 10.1001/archneur.1987.00520130079022
   Nascimento RP, 2017, TOXICON, V134, P41, DOI 10.1016/j.toxicon.2017.04.005
   Navarro-Mabarak C, 2018, DRUG METAB REV, V50, P95, DOI 10.1080/03602532.2018.1439502
   Ninan J, 2017, J HOSP MED, V12, P659, DOI 10.12788/jhm.2794
   Nobre VMD, 2004, PESQUI VET BRASIL, V24, P132, DOI 10.1590/S0100-736X2004000300004
   Nowicka N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112616
   O'Callaghan A, 2018, J PARKINSONISM RESTL, V8, P13, DOI 10.2147/JPRLS.S114309
   OBENOUR WH, 1972, AM REV RESPIR DIS, V105, P382
   Obrador E, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090901
   PAN LC, 1993, TOXICOL APPL PHARM, V118, P87, DOI 10.1006/taap.1993.1013
   Pan-Montojo F, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-10
   Pansarasa O, 2014, MOL NEUROBIOL, V49, P984, DOI 10.1007/s12035-013-8578-4
   Panziera W, 2017, PESQUI VET BRASIL, V37, P313, DOI [10.1590/S0100-736X2017000400003, 10.1590/s0100-736x2017000400003]
   Paré B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31773-z
   Patten SA, 2014, DIS MODEL MECH, V7, P799, DOI 10.1242/dmm.015719
   PEARSON EG, 1991, J AM VET MED ASSOC, V198, P1651
   Pehar M, 2016, MOL CELL PROTEOMICS, V15, P493, DOI 10.1074/mcp.M115.049288
   Peng B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072316
   Peters S, 2020, J NEUROL NEUROSUR PS, V91, P33, DOI 10.1136/jnnp-2019-320986
   Peters TL, 2017, OCCUP ENVIRON MED, V74, P87, DOI 10.1136/oemed-2016-103700
   Picron JF, 2021, FOOD ADDIT CONTAM A, V38, P962, DOI 10.1080/19440049.2021.1889043
   Pitanga BPS, 2011, NEUROTOXICOLOGY, V32, P776, DOI 10.1016/j.neuro.2011.07.002
   Pokusa M, 2020, PHYSIOL RES, V69, pS69, DOI 10.33549/physiolres.934405
   Polkey MI, 2017, AM J RESP CRIT CARE, V195, P86, DOI 10.1164/rccm.201604-0848OC
   Prakash AS, 1999, MUTAT RES-GEN TOX EN, V443, P53, DOI 10.1016/S1383-5742(99)00010-1
   Rakhit R, 2006, BBA-MOL BASIS DIS, V1762, P1025, DOI 10.1016/j.bbadis.2006.05.004
   Ramachandran Anup, 2018, J Clin Transl Res, V4, P75
   Rasenack R, 2003, FETAL DIAGN THER, V18, P223, DOI 10.1159/000070799
   Ravindranath V, 2013, EXPERT OPIN DRUG MET, V9, P551, DOI 10.1517/17425255.2013.759208
   Honorio JER, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/697541
   Rickman OJ, 2020, BRAIN, V143, P1073, DOI 10.1093/brain/awz382
   RIDKER PM, 1985, GASTROENTEROLOGY, V88, P1050, DOI 10.1016/S0016-5085(85)80027-5
   Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430
   Rollason V, 2016, EUR J CLIN PHARMACOL, V72, P507, DOI 10.1007/s00228-015-1986-9
   ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0
   Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253
   Sabate M, 1996, J NEUROL SCI, V138, P114, DOI 10.1016/0022-510X(96)00003-2
   Salehi B, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01300
   Sauzéat L, 2018, ISCIENCE, V6, P264, DOI 10.1016/j.isci.2018.07.023
   SCHOENTAL R, 1975, CANCER RES, V35, P2020
   Pitanga BPS, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00144
   Segura-Ibarra V, 2017, INT J PHARMACEUT, V524, P257, DOI 10.1016/j.ijpharm.2017.03.069
   Selmar D, 2019, ENVIRON POLLUT, V248, P456, DOI 10.1016/j.envpol.2019.02.026
   Shao O, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.11977
   SHUMAKER RC, 1976, JNCI-J NATL CANCER I, V56, P787, DOI 10.1093/jnci/56.4.787
   Silva-Neto JP, 2010, TOXICON, V55, P105, DOI 10.1016/j.toxicon.2009.07.007
   Siracusa R, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01114
   Skopp A, 2019, BIOMETALS, V32, P695, DOI 10.1007/s10534-019-00206-3
   Smith EF, 2019, NEUROSCI LETT, V710, DOI 10.1016/j.neulet.2017.06.052
   SMITH LW, 1981, J NAT PROD, V44, P129, DOI 10.1021/np50014a001
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Song ZH, 2018, J CHIN MED ASSOC, V81, P1077, DOI 10.1016/j.jcma.2018.03.013
   Song ZJ, 2020, J ENV SCI HEAL C-TOX, V38, P124, DOI 10.1080/26896583.2020.1743608
   Soo SK, 2020, MECH AGEING DEV, V190, DOI 10.1016/j.mad.2020.111297
   Spencer PS, 2021, CHEM RES TOXICOL, V34, P1953, DOI 10.1021/acs.chemrestox.1c00150
   Spencer PS, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00754
   Spencer PS, 2018, TOXICON, V155, P49, DOI 10.1016/j.toxicon.2018.10.005
   Spencer PS, 2018, J NEUROL SCI, V391, P141, DOI 10.1016/j.jns.2018.05.017
   STILLMAN AE, 1977, GASTROENTEROLOGY, V73, P349
   SVOBODA DJ, 1972, CANCER RES, V32, P908
   SWICK RA, 1982, J TOXICOL ENV HEALTH, V10, P757, DOI 10.1080/15287398209530293
   Swinnen B, 2014, NAT REV NEUROL, V10, P661, DOI 10.1038/nrneurol.2014.184
   Taguchi YH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100243
   Tang BL, 2020, TOXICS, V8, DOI 10.3390/toxics8020021
   Tokuda E, 2013, NEUROBIOL DIS, V54, P308, DOI 10.1016/j.nbd.2013.01.001
   Tokuda E, 2009, J NEUROCHEM, V111, P181, DOI 10.1111/j.1471-4159.2009.06310.x
   Trias Emiliano, 2018, Clin Exp Neuroimmunol, V9, P225, DOI 10.1111/cen3.12476
   Trinh D, 2021, J NEUROCHEM, V156, P715, DOI 10.1111/jnc.15154
   Trist BG, 2021, ANGEW CHEM INT EDIT, V60, P9215, DOI 10.1002/anie.202000451
   Trist BG, 2018, CELL CHEM BIOL, V25, P807, DOI 10.1016/j.chembiol.2018.05.004
   VALK J, 1992, AM J NEURORADIOL, V13, P747
   Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025
   Vigliani MC, 2000, J NEUROL, V247, P778, DOI 10.1007/s004150070092
   VINCKEN WG, 1984, NEW ENGL J MED, V311, P438, DOI 10.1056/NEJM198408163110704
   Violi F, 2020, METALLOMICS, V12, P668, DOI 10.1039/d0mt00051e
   Visser AE, 2018, J NEUROL NEUROSUR PS, V89, P797, DOI 10.1136/jnnp-2017-317724
   Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367
   Wang WQ, 2020, J APPL TOXICOL, V40, P1534, DOI 10.1002/jat.4004
   Wang XD, 2000, HEPATOLOGY, V31, P428, DOI 10.1002/hep.510310224
   Watkins J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76070-w
   Wiedenfeld H, 2011, FOOD ADDIT CONTAM A, V28, P282, DOI 10.1080/19440049.2010.541288
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3
   Wolf D. C., HEPATIC ENCEPHALOPAT
   Xia QS, 2020, J FOOD DRUG ANAL, V28, P167, DOI 10.1016/j.jfda.2019.12.001
   Xia QS, 2015, CHEM RES TOXICOL, V28, P615, DOI 10.1021/tx500417q
   Xia QS, 2013, CHEM RES TOXICOL, V26, P1384, DOI 10.1021/tx400241c
   Xiong AZ, 2016, PHYTOMEDICINE, V23, P931, DOI 10.1016/j.phymed.2016.06.006
   Xue YC, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00063
   Yang XQ, 2019, WORLD J GASTROENTERO, V25, P3753, DOI 10.3748/wjg.v25.i28.3753
   Yoshida T, 2020, EXP THER MED, V20, DOI 10.3892/etm.2020.9278
   Yu XH, 2020, ANN NEUROL, V88, P195, DOI 10.1002/ana.25721
   Zhan YQ, 2019, ANN NEUROL, V85, P482, DOI 10.1002/ana.25443
   Zhang CF, 2019, J CELL PHYSIOL, V234, P16755, DOI 10.1002/jcp.28531
   Zhang JL, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172500
NR 225
TC 0
Z9 0
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0893-228X
EI 1520-5010
J9 CHEM RES TOXICOL
JI Chem. Res. Toxicol.
PD MAR 21
PY 2022
VL 35
IS 3
BP 340
EP 354
DI 10.1021/acs.chemrestox.1c00384
PG 15
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Chemistry; Toxicology
GA 0O9IM
UT WOS:000783836900001
PM 35238548
DA 2024-11-01
ER

PT J
AU Mittur, A
   VanMeter, SA
   Orujov, E
   Glidden, P
AF Mittur, Aravind
   VanMeter, Susan A.
   Orujov, Elmar
   Glidden, Paul
TI Pharmacokinetics and Safety of a 1:1 Mixture of Doxecitine and
   Doxribtimine: Open-label Phase 1 Single Ascending Dose and Food Effect
   Studies in Healthy Adults
SO CLINICAL THERAPEUTICS
LA English
DT Article
DE Doxecitine (deoxycytidine); Doxribtimine (deoxythymidine);
   Pharmacokinetics; Food effect; Thymidine kinase 2 deficiency;
   Mitochondrial DNA depletion
ID KINASE 2 DEFICIENCY; THYMIDINE KINASE; INFUSIONS
AB Purpose: Doxecitine (deoxycytidine [dC]) and doxribtimine (deoxythymidine [dT]) powder for oral solution is a 1:1 mixture consisting of equal weights 2'-deoxycytidine (dC) and 2'-deoxythymidine (dT). Doxecitine and doxribtimine (referred to as study drug) is being developed as treatment for people with thymidine kinase 2 deficiency (TK2d). TK2d is an ultra-rare mitochondrial DNA depletion and multiple deletion syndrome characterized by progressive muscle weakness and premature death. Here, we report the pharmacokinetics (PK), the effect of food, and the tolerability of 2 study drug formulations, evaluated in 2 studies (Study MT-1621-103 and Study MT-1621-105). Methods: A sequential, ascending 1:1 dose ratio was used for both studies (n = 14 healthy volunteer adult participants/study). After a 28-day (Study MT-1621-103) or 35-day (Study MT-1621-105) screening period, participants fasted overnight and sequentially received 86.6, 173.4, and 266.6 mg/kg study drug with a 48-hour PK assessment period and 48-hour washout period between doses. After 48 additional hours, participants were fed a high-fat meal and received 266.6 mg/kg study drug. Plasma and urine were collected before dosing and throughout the 48-hour PK period. dC and dT concentrations were analyzed by validated liquid chromatography mass spectrometry methods. Safety was evaluated throughout the study and at 2-week follow-up. Findings: Plasma levels of dC and dT increased rapidly and dose-dependently above endogenous levels for both formulations, with a median T-max of 1 to 2 hours under fasting conditions. Post-dose plasma dC and dT concentrations declined to nearly pre-dose (baseline) concentrations after 8 to 12 hours, suggesting rapid elimination. Peak and extent of plasma exposure (baseline-corrected C(max )and AUC0-t) tended to increase less than dose- proportionally for plasma dC and greater than dose-proportionally for plasma dT. PK variability of dC and dT was moderate-to-high ( > 30%). Administration with food delayed T-max to a median of 2 to 4 hours and increased plasma exposure: baseline-corrected plasma dC C-max and AUC0-t increased by similar to 79% to 96% and 137% to 250%, respectively, and dT C-max and AUC0-t increased by 27% to 29% and 74% to 89%, respectively, indicating a significant food effect. Renal clearance played a minor role in the elimination of systemically available intact dC and dT (Fe < 0.3%). The study drug was generally well tolerated; most frequent study-drug-related adverse events (AEs) were diarrhea (n = 4/29, 14%) and dizziness (n = 3/29, 10%). Most AEs were mild-to-moderate in severity. Implications: Doxecitine and doxribtimine are orally bioavailable in the intended clinical dose range. The PK profile supports a formulation consisting of equal doses of doxecitine and doxribtimine, a 3-times-daily dosing regimen, and administration with food.
C1 [Mittur, Aravind; VanMeter, Susan A.] UCB Biosci Inc, 4000 Paramount Pkwy,Suite 200, Morrisville, NC 27560 USA.
   [Orujov, Elmar] Aurinia Pharmaceut Inc, Rockville, MD USA.
   [Glidden, Paul] Corino Therapeut Inc, New York, NY USA.
   [Glidden, Paul] Pierrepont Therapeut Inc, New York, NY USA.
RP Mittur, A (corresponding author), UCB Biosci Inc, 4000 Paramount Pkwy,Suite 200, Morrisville, NC 27560 USA.
EM Aravind.Mittur@ucb.com
FU UCB
FX This study was sponsored by UCB. The sponsor reviewed the drafts and
   provided medical writing support for draft preparation.
CR Berardo A, 2022, J NEUROMUSCULAR DIS, V9, P225, DOI 10.3233/JND-210786
   Blázquez-Bermejo C, 2019, EBIOMEDICINE, V46, P342, DOI 10.1016/j.ebiom.2019.07.042
   Camilleri M, 2006, GASTROENTEROLOGY, V131, P640, DOI 10.1053/j.gastro.2006.03.023
   Domínguez-González C, 2022, J NEUROL, V269, P3550, DOI 10.1007/s00415-021-10957-0
   Domínguez-González C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506
   Domínguez-González C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z
   ENSMINGER WD, 1977, CANCER RES, V37, P1857
   FDA, 2022, Assessing the Effects of Food on Drugs in INDs and NDAs - Clinical Pharmacology Considerations Guidance For Industry
   Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012
   Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114
   HOWELL SB, 1981, CANCER RES, V41, P945
   Koziolek M, 2019, EUR J PHARM SCI, V134, P31, DOI 10.1016/j.ejps.2019.04.003
   Lopez-Gomez C, 2019, EBIOMEDICINE, V46, P356, DOI 10.1016/j.ebiom.2019.07.037
   Lopez-Gomez C, 2017, ANN NEUROL, V81, P641, DOI 10.1002/ana.24922
   Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev
   Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018
   Mistry P, 2017, PEDIATR DRUGS, V19, P223, DOI 10.1007/s40272-017-0223-7
   PHEAR G, 1987, P NATL ACAD SCI USA, V84, P4450, DOI 10.1073/pnas.84.13.4450
   Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751
   SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419
   Toren D, 2016, NUCLEIC ACIDS RES, V44, pD1262, DOI 10.1093/nar/gkv1187
   Tsuruda L, 2020, NEUROMUSCULAR DISORD, V30, pS139, DOI 10.1016/j.nmd.2020.08.313
   VANGROENINGEN CJ, 1991, J NATL CANCER I, V83, P437
   Wang J, 2019, Gene Reviews. TK2-related mitochondrial DNA maintenance defect, myopathic form
   Wang JL, 2018, MOL GENET METAB, V124, P124, DOI 10.1016/j.ymgme.2018.04.012
   ZAHARKO DS, 1979, CANCER TREAT REP, V63, P945
   ZAHARKO DS, 1979, CANCER RES, V39, P4777
   Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4
NR 28
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI BRIDGEWATER
PA 685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA
SN 0149-2918
EI 1879-114X
J9 CLIN THER
JI Clin. Ther.
PD JUL
PY 2024
VL 46
IS 7
BP 576
EP 587
DI 10.1016/j.clinthera.2024.06.006
EA AUG 2024
PG 12
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA E4M0G
UT WOS:001302749200001
PM 39025716
DA 2024-11-01
ER

PT J
AU Rovelli, V
   Manzoni, F
   Viau, K
   Pasquali, M
   Longo, N
AF Rovelli, Valentina
   Manzoni, Francesca
   Viau, Krista
   Pasquali, Marzia
   Longo, Nicola
TI Clinical and biochemical outcome of patients with very long-chain
   acyl-CoA dehydrogenase deficiency
SO MOLECULAR GENETICS AND METABOLISM
LA English
DT Article
DE Very long chain AcylCoA dehydrogenase (VLCAD) deficiency; Fatty acid
   oxidation; Newborn screening; Outcome; Carnitine; CK
ID FATTY-ACID OXIDATION; VENTRICULAR SEPTAL-DEFECT; VLCAD-DEFICIENCY;
   MUTATION ANALYSIS; INBORN-ERRORS; NEWBORN; MITOCHONDRIAL; DISORDERS;
   CARNITINE; COENZYME
AB Background: Very-Long-Chain Acyl-CoA Dehydrogenase (VLCAD) deficiency is a disorder of fatty acid oxidation included in the recommended uniform newborn screening (NBS) panel in the USA. It can have variable clinical severity and there is limited information on the natural history of this condition, clinical presentation according to genotype and effectiveness of newborn screening.
   Methods: Retrospective data (growth parameters, morbidity, biochemical and genetic testing results) were collected from patients with VLCAD deficiency, to evaluate biochemical and clinical outcomes. Descriptive statistics was used for qualitative variables, while linear regression analysis was used to correlate continuous variables.
   Results: VLCAD deficiency (screened by measuring elevated levels of C14:1-carnitine in blood spots) was more frequent in Utah than the national average (1:27,617 versus 1:63,481) in the first ten years of screening. Twenty-six patients had a confirmed diagnosis of VLCAD deficiency using DNA testing or functional studies. The c.848T > C (p.V283A) variant in the ACADVL gene was the most frequent in our population. Novel variants (c.623-21A > G (IVS7-21A > G); c.1052C > T (p.T351I); c.1183-7A > G (IVS11-7A > G); c.1281G > C (p.W427C); c.1923G > C (p.L641F); c.1924G > A (p.V642M)) were identified in this study, with their pathogenicity remaining unclear in most cases. C14:1-carnitine levels decreased with age and significantly correlated with CK levels as index of muscle involvement. There were no cases of HELLP syndrome nor liver disease during pregnancies in the mothers of VLCAD patients. None of our patients developed cardiac involvement after birth and all patients had normal growth parameters while on treatment. Clinical manifestations were related to concomitant infections and altered biochemical parameters.
   Discussion: VLCAD deficiency can be identified by neonatal screening. Most patients compliant with therapy normalized biochemical parameters and had no major clinical manifestations. Complications were completely prevented with a relatively low number of pre-emptive ER visits or hospital admissions. It remains unclear whether neonatal screening is now identifying less severely affected patient or if complications will arise as subjects become older. Observation beyond puberty is necessary to fully understand the impact of VLCAD deficiency on morbidity in patients with VLCAD deficiency.
C1 [Rovelli, Valentina; Manzoni, Francesca; Viau, Krista; Pasquali, Marzia; Longo, Nicola] Univ Utah, Div Med Genet Pediat, Salt Lake City, UT 84108 USA.
   [Rovelli, Valentina] Univ Milan, San Paolo Hosp, Clin Dept Pediat, Milan, Italy.
   [Manzoni, Francesca] Univ Milan, San Paolo Hosp, Clin Dept Neuropsychiat, Milan, Italy.
   [Viau, Krista] Boston Childrens Hosp, Boston, MA USA.
   [Pasquali, Marzia; Longo, Nicola] ARUP Labs, Salt Lake City, UT USA.
   [Pasquali, Marzia; Longo, Nicola] Univ Utah, Dept Pathol, Salt Lake City, UT USA.
C3 Utah System of Higher Education; University of Utah; San Paolo-Polo
   Universitaria Hospital; University of Milan; San Paolo-Polo
   Universitaria Hospital; University of Milan; Harvard University; Boston
   Children's Hospital; Utah System of Higher Education; University of
   Utah; ARUP Laboratories; Utah System of Higher Education; University of
   Utah
RP Longo, N (corresponding author), Univ Utah, Div Med Genet, Dept Pediat, 295 Chipeta Way, Salt Lake City, UT 84108 USA.
EM Nicola.Longo@hsc.utah.edu
RI Rovelli, Valentina/AAW-4849-2021
OI , Valentina/0000-0002-7703-8635
CR Andresen BS, 1996, HUM MOL GENET, V5, P461, DOI 10.1093/hmg/5.4.461
   Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261
   AOYAMA T, 1995, AM J HUM GENET, V57, P273
   AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368
   Arnold GL, 2009, MOL GENET METAB, V96, P85, DOI 10.1016/j.ymgme.2008.09.008
   Bastin J, 2008, J CLIN ENDOCR METAB, V93, P1433, DOI 10.1210/jc.2007-1701
   BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9
   Boneh A, 2006, MOL GENET METAB, V88, P166, DOI 10.1016/j.ymgme.2005.12.012
   Bonnet D, 1999, CIRCULATION, V100, P2248, DOI 10.1161/01.CIR.100.22.2248
   BrownHarrison MC, 1996, BIOCHEM MOL MED, V58, P59, DOI 10.1006/bmme.1996.0033
   Costa CG, 1998, J INHERIT METAB DIS, V21, P391, DOI 10.1023/A:1005354624735
   Costa CG, 1997, J LIPID RES, V38, P173
   Coughlin CR, 2010, J INHERIT METAB DIS, V33, pS129, DOI 10.1007/s10545-009-9041-6
   Cox GF, 1998, J PEDIATR-US, V133, P247, DOI 10.1016/S0022-3476(98)70228-8
   Cox KB, 2009, LAB INVEST, V89, P1348, DOI 10.1038/labinvest.2009.86
   Diekman EF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147818
   Diekman EF, 2015, GENET MED, V17, P989, DOI 10.1038/gim.2015.22
   Diekman EF, 2014, J INHERIT METAB DIS, V37, P405, DOI 10.1007/s10545-013-9666-3
   Gillingham MB, 2006, MOL GENET METAB, V89, P58, DOI 10.1016/j.ymgme.2006.06.004
   Gillingham MB, 2017, J INHERIT METAB DIS, V40, P831, DOI 10.1007/s10545-017-0085-8
   Goetzman ES, 2007, MOL GENET METAB, V91, P138, DOI 10.1016/j.ymgme.2007.01.013
   Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x
   Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174
   HALE DE, 1990, PROG CLIN BIOL RES, V321, P303
   Hall PL, 2014, MOL GENET METAB, V113, P274, DOI 10.1016/j.ymgme.2014.10.007
   Hoffmann L, 2012, J INHERIT METAB DIS, V35, P269, DOI 10.1007/s10545-011-9391-8
   Liebig M, 2006, PEDIATRICS, V118, P1065, DOI 10.1542/peds.2006-0666
   Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8
   Longo N, 2006, AM J MED GENET C, V142C, P77, DOI 10.1002/ajmg.c.30087
   Lund AM, 2010, J INHERIT METAB DIS, V33, P495, DOI 10.1007/s10545-009-9000-2
   Marsden D, 2001, EUR J PEDIATR, V160, P599, DOI 10.1007/s004310100808
   Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337
   McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67
   Merinero B, 1999, J INHERIT METAB DIS, V22, P802, DOI 10.1023/A:1005553907216
   Merritt JL, 2014, MOL GENET METAB, V111, P484, DOI 10.1016/j.ymgme.2014.01.009
   Miller MJ, 2015, MOL GENET METAB, V116, P139, DOI 10.1016/j.ymgme.2015.08.011
   MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385
   Oey NA, 2006, J INHERIT METAB DIS, V29, P71, DOI 10.1007/s10545-006-0199-x
   Orii KO, 1995, BIOCHEM BIOPH RES CO, V217, P987, DOI 10.1006/bbrc.1995.2867
   Parini R, 1998, EUR J PEDIATR, V157, P992, DOI 10.1007/s004310050984
   Pena LDM, 2016, MOL GENET METAB, V118, P272, DOI 10.1016/j.ymgme.2016.05.007
   Rakheja D, 2002, PLACENTA, V23, P447, DOI 10.1053/plac.2002.0808
   ROGUIN N, 1995, J AM COLL CARDIOL, V26, P1545, DOI 10.1016/0735-1097(95)00358-4
   Ryder B, 2016, J INHERIT METAB DIS, V39, P409, DOI 10.1007/s10545-015-9911-z
   Sahai I, 2011, J PEDIATR-US, V158, P172, DOI 10.1016/j.jpeds.2010.09.026
   Sands AJ, 1999, ARCH DIS CHILD-FETAL, V81, pF61, DOI 10.1136/fn.81.1.F61
   Schymik I, 2006, J PEDIATR-US, V149, P128, DOI 10.1016/j.jpeds.2006.02.037
   Solis JO, 2002, J AM DIET ASSOC, V102, P1800, DOI 10.1016/S0002-8223(02)90386-X
   Souri M, 1996, AM J HUM GENET, V58, P97
   Spiekerkoetter U, 2005, PEDIATR RES, V57, P760, DOI 10.1203/01.PDR.0000157915.26049.47
   Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x
   Spiekerkoetter U, 2012, JIMD REP, V6, P113, DOI 10.1007/8904_2012_129
   Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0
   Spiekerkoetter U, 2007, J Inherit Metab Dis, V30, P405, DOI 10.1007/s10545-007-0548-4
   Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P498, DOI 10.1007/s10545-009-1126-8
   Spiekerkoetter U, 2008, MOL GENET METAB, V94, P428, DOI 10.1016/j.ymgme.2008.04.002
   Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7
   Spiekerkötter U, 2000, ACTA PAEDIATR, V89, P492, DOI 10.1080/080352500750028267
   Therrell BL, 2014, MOL GENET METAB, V113, P14, DOI 10.1016/j.ymgme.2014.07.009
   Tucci S, 2017, J INHERIT METAB DIS, V40, P317, DOI 10.1007/s10545-017-0016-8
   Vockley J, 2015, MOL GENET METAB, V116, P53, DOI 10.1016/j.ymgme.2015.06.006
   Wanders RJA, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00083
   Winter SC, 2003, J INHERIT METAB DIS, V26, P171, DOI 10.1023/A:1024433100257
   Wood JC, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e19
   YAMAGUCHI S, 1993, PEDIATR RES, V34, P111, DOI 10.1203/00006450-199307000-00025
NR 65
TC 21
Z9 27
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1096-7192
EI 1096-7206
J9 MOL GENET METAB
JI Mol. Genet. Metab.
PD MAY
PY 2019
VL 127
IS 1
BP 64
EP 73
DI 10.1016/j.ymgme.2019.04.001
PG 10
WC Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental
   Medicine
GA ID5SD
UT WOS:000471735400009
PM 31031081
DA 2024-11-01
ER

EF